PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Arai, K; Moriai, K; Ogawa, A; Iwaoka, M				Arai, Kenta; Moriai, Kenji; Ogawa, Akinobu; Iwaoka, Michio			An Amphiphilic Selenide Catalyst Behaves Like a Hybrid Mimic of Protein Disulfide Isomerase and Glutathione Peroxidase 7	CHEMISTRY-AN ASIAN JOURNAL			English	Article						amphiphiles; antioxidants; enzyme models; protein folding; selenides	SELENOXIDE REAGENT; BOND FORMATION; LYSOZYME	Protein disulfide isomerase (PDI) and glutathione peroxidase 7 (GPx7) cooperatively promote the oxidative folding of disulfide (SS)-containing proteins in endoplasmic reticulum by recognizing the nascent proteins to convert them into the native folds by means of SS formation and SS isomerization and by catalyzing reoxidation of reduced PDI with H2O2, respectively. In this study, new amphiphilic selenides with a long-chain alkyl group were designed as hybrid mimics of PDI and GPx7 and were applied to the refolding of reduced hen egg-white lysozyme (HEL-R). Competitive SS formation at pH4 using HEL-R and glutathione (GSH) in the presence of the selenide catalyst and H2O2 showed that the amphiphilic selenides can preferentially catalyze SS formation of HEL-R, probably on account of hydrophobic interactions between the protein and the catalyst. In contrast, simple water-soluble selenides did not exhibit such behavior. In addition, when the pH of the solution was adjusted to 8.5 after the SS formation, surviving GSH promoted the SS isomerization of misfolded HEL to recover the native SS linkages. Thus, the amphiphilic selenides designed here could mimic the function of the PDI-GPx7 system. The combination of a water-soluble selenide and a long-chain alkyl group would be a useful motif in designing medicines for both protein misfolding diseases and antioxidant therapy.	[Arai, Kenta; Moriai, Kenji; Ogawa, Akinobu; Iwaoka, Michio] Tokai Univ, Sch Sci, Dept Chem, Hiratsuka, Kanagawa 2591292, Japan	Iwaoka, M (reprint author), Tokai Univ, Sch Sci, Dept Chem, Hiratsuka, Kanagawa 2591292, Japan.	miwaoka@tokai.ac.jp			Japanese Society for the Promotion Science; Ministry of Education, Culture, Sports, Science and Technology of Japan [23550198]	K.A. thanks Japanese Society for the Promotion Science for the Research Fellowship for Young Scientists. We gratefully acknowledge Mr. M. Noguchi (Tokai University) for HRMS measurements and technical support. This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid for Scientific Research (C) no. 23550198).	ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Arai K, 2013, FEBS OPEN BIO, V3, P55, DOI [10.1016/j.fob.2012.12.004, 10.1016/j.fob.2014.12.004]; Kumakura F, 2010, EUR J ORG CHEM, P440, DOI 10.1002/ejoc.200901114; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Arai K, 2013, INT J MOL SCI, V14, P13194, DOI 10.3390/ijms140713194; Ashton TD, 2007, BIOORG MED CHEM LETT, V17, P6779, DOI 10.1016/j.bmcl.2007.10.028; THANNHAUSER TW, 1984, ANAL BIOCHEM, V138, P181, DOI 10.1016/0003-2697(84)90786-3; Iwaoka M, 2001, HETEROATOM CHEM, V12, P293, DOI 10.1002/hc.1047; KLAYMAN DL, 1973, J AM CHEM SOC, V95, P197, DOI 10.1021/ja00782a034; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Lukesh JC, 2012, J AM CHEM SOC, V134, P4057, DOI 10.1021/ja211931f; SAXENA VP, 1970, BIOCHEMISTRY-US, V9, P5015; Huang X, 2011, CHEM SOC REV, V40, P1171, DOI 10.1039/c0cs00046a; Yamaguchi S, 2013, BIOTECHNOL J, V8, P17, DOI 10.1002/biot.201200025; Hevehan DL, 1997, BIOTECHNOL BIOENG, V54, P221, DOI 10.1002/(SICI)1097-0290(19970505)54:3<221::AID-BIT3>3.0.CO;2-H; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Arai K, 2012, FEBS OPEN BIO, V2, P60, DOI 10.1016/j.fob.2012.04.001; Arai K, 2011, CHEM-EUR J, V17, P481, DOI 10.1002/chem.201002742; Arai K, 2010, BIOCHEMISTRY-US, V49, P10535, DOI 10.1021/bi101392w; Wang L, 2014, ANTIOXID REDOX SIGN, V20, P545, DOI 10.1089/ars.2013.5236; Sato Y, 2012, FEBS J, V279, P2262, DOI 10.1111/j.1742-4658.2012.08593.x; Alberto EE, 2010, J BRAZIL CHEM SOC, V21, P2032, DOI 10.1590/S0103-50532010001100004; Bhabak KP, 2010, ACCOUNTS CHEM RES, V43, P1408, DOI 10.1021/ar100059g; Bruice T.W., 1982, J PROTEIN CHEM, V1, P47, DOI 10.1007/BF01025550; Chang RJY, 2011, PROTEIN REV, V14, P1, DOI 10.1007/978-1-4419-7273-6; DOBSON CM, 1994, TRENDS BIOCHEM SCI, V19, P31, DOI 10.1016/0968-0004(94)90171-6; Flohe R. B., 2013, BIOCHIM BIOPHYS ACTA, V1830, P3289; Gurbhele-Tupkar MC, 2008, BIOORGAN MED CHEM, V16, P2579, DOI 10.1016/j.bmc.2007.11.047; Irvine AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082511; Iwaoka M, 2008, PHOSPHORUS SULFUR, V183, P1009, DOI 10.1080/10426500801901038; Iwaoka M., 2014, ORGANOSELENIUM CHEM, P361; JOLLES P, 1962, METHOD ENZYMOL, V5, P137, DOI 10.1016/S0076-6879(62)05194-0; Lees WJ, 2011, PROTEIN REV, V14, P109, DOI 10.1007/978-1-4419-7273-6_6; Lees WJ, 2008, CURR OPIN CHEM BIOL, V12, P740, DOI 10.1016/j.cbpa.2008.08.032; Madar DJ, 2009, J BIOTECHNOL, V142, P214, DOI 10.1016/j.jbiotec.2009.05.003; Mugesh G., 2013, CURR CHEM BIOL, V7, P47; Ramming T., 2013, INT J CELL BIOL, V2013; Santi C., 2013, CURR CHEM BIOL, V7, P25	38	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	DEC	2014	9	12					3464	3471		10.1002/asia.201402726		8	Chemistry, Multidisciplinary	Chemistry	AU3LE	WOS:000345513900014		
J	Murai, K; Nakajima, J; Nakamura, A; Hyogo, N; Fujioka, H				Murai, Kenichi; Nakajima, Junki; Nakamura, Akira; Hyogo, Norimichi; Fujioka, Hiromichi			Enantioselective, Desymmetrizing, Bromolactonization Reactions of Symmetric Olefinic Dicarboxylic Acids	CHEMISTRY-AN ASIAN JOURNAL			English	Article						asymmetric synthesis; bromolactonization; carboxylic acids; desymmetrization; organocatalysis	C-3-SYMMETRIC CHIRAL TRISIMIDAZOLINE; BRANCHED NONCOVALENT COMPLEXES; PHASE-TRANSFER CATALYSIS; ASYMMETRIC BROMOLACTONIZATION; KINETIC RESOLUTION; CARBOXYLIC-ACIDS; ALKENOIC ACIDS; CHLOROCYCLIZATION; HALOCYCLIZATION; IODOLACTONIZATION	The results of studies leading to the development of enantioselective desymmetrizing, bromolactonization reactions of symmetric olefinic dicarboxylic acids, which are promoted by a C-3-symmetric trisimidazoline catalyst, are described. These processes generated carboxylic-acid-containing bromolactones in moderately high enantiomeric excesses. The results of optimization studies showed that reactions in a mixed solvent system of toluene and acetone proceeded with the highest levels of enantioselectivity. NMR studies probing the interactions between the catalyst and dicarboxylic acid substrates, as well as the effect of acetone on the stereochemistry of the process, are also described.	[Murai, Kenichi; Nakajima, Junki; Nakamura, Akira; Hyogo, Norimichi; Fujioka, Hiromichi] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan	Murai, K (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, 1-6 Yamada Oka, Suita, Osaka 5650871, Japan.	murai@phs.osaka-u.ac.jp; fujioka@phs.osaka-u.ac.jp			MEXT	This work was financially supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Advanced Molecular Transformations by Organocatalysts" and by a Platform for Drug Discovery, Informatics, and Structural Life Science grant from MEXT.	Nakatsuji H, 2014, ANGEW CHEM INT EDIT, V53, P6974, DOI 10.1002/anie.201400946; Huang DS, 2013, J AM CHEM SOC, V135, P8101, DOI 10.1021/ja4010877; Wilking M, 2013, J AM CHEM SOC, V135, P8133, DOI 10.1021/ja402910d; Murai K, 2011, TETRAHEDRON, V67, P4862, DOI 10.1016/j.tet.2011.05.005; Denmark SE, 2012, ANGEW CHEM INT EDIT, V51, P10938, DOI 10.1002/anie.201204347; Whitehead DC, 2010, J AM CHEM SOC, V132, P3298, DOI 10.1021/ja100502f; Hennecke U, 2011, ORG LETT, V13, P860, DOI 10.1021/ol1028805; Yousefi R, 2013, J AM CHEM SOC, V135, P14524, DOI 10.1021/ja4072145; Kwon HY, 2008, CHEM-EUR J, V14, P1023, DOI 10.1002/chem.200701199; Shunatona HP, 2013, ANGEW CHEM INT EDIT, V52, P7724, DOI 10.1002/anie.201302002; Chen F, 2013, J AM CHEM SOC, V135, P1232, DOI 10.1021/ja311202e; Yin Q, 2014, ORG LETT, V16, P2426, DOI 10.1021/ol5007532; Arai T, 2014, CHEM COMMUN, V50, P8287, DOI 10.1039/c4cc02415j; Murai K, 2013, ORG LETT, V15, P2526, DOI 10.1021/ol401007u; Ke ZH, 2014, J AM CHEM SOC, V136, P5627, DOI 10.1021/ja5029155; Zheng SQ, 2014, ASIAN J ORG CHEM, V3, P366, DOI 10.1002/ajoc.201400030; Tan CK, 2013, CHEM COMMUN, V49, P7985, DOI 10.1039/c3cc43950j; Zhang W, 2010, J AM CHEM SOC, V132, P3664, DOI 10.1021/ja100173w; Kang SH, 2003, J AM CHEM SOC, V125, P15748, DOI 10.1021/ja0369921; Murai K, 2013, HETEROCYCLES, V87, P763, DOI 10.3987/REV-12-762; Zhao Y, 2013, ANGEW CHEM INT EDIT, V52, P8597, DOI 10.1002/anie.201304107; Cheng YA, 2014, ORG BIOMOL CHEM, V12, P2333, DOI 10.1039/c3ob42335b; Sakakura A, 2007, NATURE, V445, P900, DOI 10.1038/nature05553; Castellanos A, 2011, CHEM-EUR J, V17, P5766, DOI 10.1002/chem.201100105; Murai K, 2010, ANGEW CHEM INT EDIT, V49, P9174, DOI 10.1002/anie.201005409; Zhou L, 2010, J AM CHEM SOC, V132, P15474, DOI 10.1021/ja1048972; Miles DH, 2013, CHEM SCI, V4, P3427, DOI 10.1039/c3sc50811k; Hennecke U, 2012, CHEM-ASIAN J, V7, P456, DOI 10.1002/asia.201100856; Lee HJ, 2012, TETRAHEDRON LETT, V53, P6984, DOI 10.1016/j.tetlet.2012.10.051; Zeng XH, 2013, CHEM COMMUN, V49, P2418, DOI 10.1039/c2cc38436a; Brindle CS, 2013, CHEM SCI, V4, P2100, DOI 10.1039/c3sc50410g; Jaganathan A, 2013, J AM CHEM SOC, V135, P14806, DOI 10.1021/ja407241d; Tungen JE, 2012, ORG LETT, V14, P5884, DOI 10.1021/ol302798g; Chen GF, 2010, ANGEW CHEM INT EDIT, V49, P8306, DOI 10.1002/anie.201003114; Tay DW, 2014, ANGEW CHEM INT EDIT, V53, P5161, DOI 10.1002/anie.201310136; Ikeuchi K, 2012, ORG LETT, V14, P6016, DOI [10.1021/ol302908a, 10.1021/o1302908a]; Takizawa S, 2014, ORG BIOMOL CHEM, V12, P5827, DOI 10.1039/c4ob00925h; Yin Q, 2013, ORG LETT, V15, P4266, DOI 10.1021/ol4020943; Garzan A, 2013, CHEM-EUR J, V19, P9015, DOI 10.1002/chem.201300189; Muller CH, 2014, CHEM-ASIAN J, V9, P2162, DOI 10.1002/asia.201402229; Paull DH, 2012, J AM CHEM SOC, V134, P11128, DOI 10.1021/ja305117m; Murai K, 2012, CHEM-EUR J, V18, P8448, DOI 10.1002/chem.201200647; Denmark SE, 2012, ORG LETT, V14, P256, DOI 10.1021/ol203033k; Murai K, 2010, ORG LETT, V12, P964, DOI 10.1021/ol902958m; Veitch GE, 2010, ANGEW CHEM INT EDIT, V49, P7332, DOI 10.1002/anie.201003681; Wang YM, 2012, J AM CHEM SOC, V134, P12928, DOI 10.1021/ja305795x; Huang DS, 2011, ORG LETT, V13, P6350, DOI 10.1021/ol202527g; Arai T., 2013, SYNLETT, P2045; Chen G. F., 2010, ANGEW CHEM, V122, P8484; Denmark S. E., 2012, ANGEW CHEM, V124, P11098; Fujioka H, 2012, SYNLETT, P825, DOI 10.1055/s-0031-1290620; Haas J, 2002, ORG LETT, V4, P297, DOI 10.1021/ol0171113; Hennecke U., 2014, SYNLETT, P1633; Kim SM, 2011, EUR J ORG CHEM, P4747, DOI 10.1002/ejoc.201100692; Kitagawa O, 1999, SYNLETT, P1191; Kraft A, 1999, J ORG CHEM, V64, P6425, DOI 10.1021/jo990830z; Kraft A, 1998, CHEM COMMUN, P1085, DOI 10.1039/a802111b; KRAPCHO AP, 1982, SYNTHESIS-STUTTGART, P805; Murai K., 2010, ANGEW CHEM, V122, P9360, DOI 10.1002/ange.201005409; Nakatsuji H., 2014, ANGEW CHEM, V126, P7094; Poldy J, 2012, EUR J ORG CHEM, P5818, DOI 10.1002/ejoc.201200795; Shunatona H. P., 2013, ANGEW CHEM, V125, P7878; Snyde SA, 2011, ALDRICHIM ACTA, V44, P27; Tan CK, 2011, SYNLETT, P1335, DOI 10.1055/s-0030-1260578; Tay D. W., 2014, ANGEW CHEM, V126, P5261; Veitch G. E., 2010, ANGEW CHEM, V122, P7490; Zhao Y., 2013, ANGEW CHEM, V125, P8759	67	4	4	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	DEC	2014	9	12					3511	3517		10.1002/asia.201402865		7	Chemistry, Multidisciplinary	Chemistry	AU3LE	WOS:000345513900019		
J	Biela-Banas, A; Oulaidi, F; Front, S; Gallienne, E; Ikeda-Obatake, K; Asano, N; Wenger, DA; Martin, OR				Biela-Banas, Anna; Oulaidi, Farah; Front, Sophie; Gallienne, Estelle; Ikeda-Obatake, Kyoko; Asano, Naoki; Wenger, David A.; Martin, Olivier R.			Iminosugar-Based Galactoside Mimics as Inhibitors of Galactocerebrosidase: SAR Studies and Comparison with Other Lysosomal Galactosidases	CHEMMEDCHEM			English	Article						galactocerebrosidase; iminosugars; inhibitors; Krabbe disease; pharmacological chaperones	GLOBOID-CELL LEUKODYSTROPHY; KRABBE-DISEASE; PHARMACOLOGICAL CHAPERONES; FABRY DISEASE; STEREOSELECTIVE-SYNTHESIS; BETA-GALACTOSIDASE; L-ARABINITOL; MOUSE MODEL; D-XYLITOL; ISOFAGOMINE	Several families of iminosugar-based galactoside mimics were designed, synthesized, and evaluated as galactocerebrosidase (GALC) inhibitors. They were also tested as inhibitors of lysosomal - and -galactosidases in order to find new potent and selective pharmacological chaperones for treatment of the lysosomal storage disorder, Krabbe disease. Whereas 1-C-alkyl imino-L-arabinitols are totally inactive toward the three enzymes, 1-C-alkyl imino-D-galactitols were found to be active only toward -galactosidaseA. Finally, 1-N-iminosugars provided the best results, as 4-epi-isofagomine was found to be a good inhibitor of both lysosomal -galactosidase and GALC. Further elaboration of this structure is required to achieve selectivity between these two galactosidases.	[Biela-Banas, Anna; Oulaidi, Farah; Front, Sophie; Gallienne, Estelle; Martin, Olivier R.] Univ Orleans, UMR 7311, ICOA, F-45067 Orleans 2, France; [Biela-Banas, Anna; Oulaidi, Farah; Front, Sophie; Gallienne, Estelle; Martin, Olivier R.] Univ Orleans, CNRS, F-45067 Orleans 2, France; [Ikeda-Obatake, Kyoko; Asano, Naoki] Hokuriku Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 9201181, Japan; [Wenger, David A.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Neurol, Philadelphia, PA 19107 USA	Biela-Banas, A (reprint author), Univ Orleans, UMR 7311, ICOA, Rue Chartres,BP 6759, F-45067 Orleans 2, France.	olivier.martin@univ-orleans.fr			European Leukodystrophy Association (ELA) [2011-028I1]; LABEX SynOrg [ANR-11-LABX-0029]	Financial support by a grant from the European Leukodystrophy Association (ELA; grant number 2011-028I1) is gratefully acknowledged. We also thank LABEX SynOrg (ANR-11-LABX-0029) for financial support.	Heightman TD, 1999, ANGEW CHEM INT EDIT, V38, P750, DOI 10.1002/(SICI)1521-3773(19990315)38:6<750::AID-ANIE750>3.0.CO;2-6; Berardi AS, 2014, MOL GENET METAB, V112, P294, DOI 10.1016/j.ymgme.2014.05.009; Simone MI, 2012, TETRAHEDRON-ASYMMETR, V23, P401, DOI 10.1016/j.tetasy.2012.03.007; Wenger DA, 2000, MOL GENET METAB, V70, P1, DOI 10.1006/mgme.2000.2990; Spanu P, 2010, TETRAHEDRON LETT, V51, P2400, DOI 10.1016/j.tetlet.2010.02.093; Fan JQ, 2003, TRENDS PHARMACOL SCI, V24, P355, DOI 10.1016/S0165-6147(03)00158-5; Biela A, 2013, TETRAHEDRON, V69, P3348, DOI 10.1016/j.tet.2012.12.082; Ribbens J, 2013, ANAL BIOCHEM, V434, P15, DOI 10.1016/j.ab.2012.10.034; Reddy YS, 2012, ORG BIOMOL CHEM, V10, P2760, DOI 10.1039/c2ob06851f; Lee WC, 2007, FASEB J, V21, P2520, DOI 10.1096/fj.06-6169com; Boyd RE, 2013, J MED CHEM, V56, P2705, DOI 10.1021/jm301557k; Ichikawa Y, 1998, J AM CHEM SOC, V120, P3007, DOI 10.1021/ja973443k; Lee WC, 2010, J NEUROSCI, V30, P5489, DOI 10.1523/JNEUROSCI.6383-09.2010; Rigat BA, 2012, MOL GENET METAB, V107, P203, DOI 10.1016/j.ymgme.2012.06.007; SUZUKI K, 1970, P NATL ACAD SCI USA, V66, P302, DOI 10.1073/pnas.66.2.302; Duffner PK, 2009, GENET MED, V11, P450, DOI 10.1097/GIM.0b013e3181a16e04; Deane JE, 2011, P NATL ACAD SCI USA, V108, P15169, DOI 10.1073/pnas.1105639108; Matsuda J, 2003, P NATL ACAD SCI USA, V100, P15912, DOI 10.1073/pnas.2536657100; Rafi MA, 2012, MOL THER, V20, P2031, DOI 10.1038/mt.2012.153; Suzuki K, 1998, NEUROCHEM RES, V23, P251, DOI 10.1023/A:1022436928925; IGISU H, 1984, SCIENCE, V224, P753, DOI 10.1126/science.6719111; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Aguilar-Moncayo M, 2012, CHEM COMMUN, V48, P6514, DOI 10.1039/c2cc32065g; Ishii S, 2012, P JPN ACAD B-PHYS, V88, P18, DOI 10.2183/pjab.88.18; Schonemann W, 2013, CHEMMEDCHEM, V8, P1805, DOI 10.1002/cmdc.201300327; BERNOTAS RC, 1990, TETRAHEDRON LETT, V31, P3393, DOI 10.1016/S0040-4039(00)97405-7; Biela-Banas A, 2014, TETRAHEDRON LETT, V55, P838, DOI 10.1016/j.tetlet.2013.12.024; Bulow A, 2000, J AM CHEM SOC, V122, P8567, DOI 10.1021/ja001762x; Compain P., 2007, IMINOSUGARS SYNTHESI; Compain P, 2006, CHEMBIOCHEM, V7, P1356, DOI 10.1002/cbic.200600217; Fan J.-Q., 2007, IMINOSUGARS SYNTHESI, P225, DOI 10.1002/9780470517437.ch10; Fantur K, 2010, MOL GENET METAB, V100, P262, DOI 10.1016/j.ymgme.2010.03.019; Front S., UNPUB; Giugliani R, 2013, MOL GENET METAB, V109, P86, DOI 10.1016/j.ymgme.2013.01.009; Heightman T.D., 1999, ANGEW CHEM, V111, P794, DOI 10.1002/(SICI)1521-3757(19990315)111:6<794::AID-ANGE794>3.0.CO;2-K; ICHIKAWA M, 1995, BIOORGAN MED CHEM, V3, P161, DOI 10.1016/0968-0896(95)00010-E; Kato A, 2011, BIOORGAN MED CHEM, V19, P3558, DOI 10.1016/j.bmc.2011.04.011; KECK GE, 1985, J ORG CHEM, V50, P4317, DOI 10.1021/jo00222a023; Liang XF, 2000, J ORG CHEM, V65, P7432, DOI 10.1021/jo000699r; Mihara Y, 2007, HETEROCYCLES, V72, P633; Mohal N, 2005, HELV CHIM ACTA, V88, P3232, DOI 10.1002/hlca.200590260; Ohto U, 2012, J BIOL CHEM, V287, P1801, DOI 10.1074/jbc.M111.293795; Oulaidi F, 2011, TETRAHEDRON-ASYMMETR, V22, P609, DOI 10.1016/j.tetasy.2011.02.024; Wenger DA, 1991, TECHNIQUES DIAGNOSTI, P587; Wenger D.A., 1997, MOL GENETIC BASIS NE, P421; WENGER DA, 1974, CLIN CHIM ACTA, V56, P199, DOI 10.1016/0009-8981(74)90228-9	46	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1860-7179	1860-7187		CHEMMEDCHEM	ChemMedChem	DEC	2014	9	12					2647	2652		10.1002/cmdc.201402411		6	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3MC	WOS:000345516300005		
J	Ichihara, O; Shimada, Y; Yoshidome, D				Ichihara, Osamu; Shimada, Yuzo; Yoshidome, Daisuke			The Importance of Hydration Thermodynamics in Fragment-to-Lead Optimization	CHEMMEDCHEM			English	Article						druggability; fragment-based drug design; hot spot; hydrophobic effect; protein hydration thermodynamics	PROTEIN-LIGAND BINDING; CARBONIC-ANHYDRASE; HOT-SPOTS; ENTHALPY/ENTROPY COMPENSATION; SITE THERMODYNAMICS; WATER-MOLECULES; DRUG DISCOVERY; SOLVENT; DRUGGABILITY; RECOGNITION	Using a computational approach to assess changes in solvation thermodynamics upon ligand binding, we investigated the effects of water molecules on the binding energetics of over 20 fragment hits and their corresponding optimized lead compounds. Binding activity and X-ray crystallographic data of published fragment-to-lead optimization studies from various therapeutically relevant targets were studied. The analysis reveals a distinct difference between the thermodynamic profile of water molecules displaced by fragment hits and those displaced by the corresponding optimized lead compounds. Specifically, fragment hits tend to displace water molecules with notably unfavorable excess entropiesconfigurationally constrained water moleculesrelative to those displaced by the newly added moieties of the lead compound during the course of fragment-to-lead optimization. Herein we describe the details of this analysis with the goal of providing practical guidelines for exploiting thermodynamic signatures of binding site water molecules in the context of fragment-to-lead optimization.	[Ichihara, Osamu; Shimada, Yuzo; Yoshidome, Daisuke] Schrodinger KK, Chiyoda Ku, Tokyo 1000005, Japan	Ichihara, O (reprint author), Schrodinger KK, Chiyoda Ku, 17F Marunouchi Trust Tower North,1-8-1 Marunouchi, Tokyo 1000005, Japan.	osamu.ichihara@schrodinger.com					Amin N., 2011, FRAGMENTS 3 3 RSC BM; Congreve M, 2008, J MED CHEM, V51, P3661, DOI 10.1021/jm8000373; Sgobba M, 2012, EUR J MED CHEM, V58, P431, DOI 10.1016/j.ejmech.2012.10.024; Murray CW, 2012, TRENDS PHARMACOL SCI, V33, P224, DOI 10.1016/j.tips.2012.02.006; Baron R, 2010, J AM CHEM SOC, V132, P12091, DOI 10.1021/ja1050082; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; JORGENSEN WL, 1985, MOL PHYS, V56, P1381, DOI 10.1080/00268978500103111; Bakan A, 2012, J CHEM THEORY COMPUT, V8, P2435, DOI 10.1021/ct300117j; Kuhn B, 2000, J MED CHEM, V43, P3786, DOI 10.1021/jm000241h; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Talhout R, 2003, J AM CHEM SOC, V125, P10570, DOI 10.1021/ja034676g; Snyder PW, 2011, P NATL ACAD SCI USA, V108, P17889, DOI 10.1073/pnas.1114107108; Lockett MR, 2013, ANGEW CHEM INT EDIT, V52, P7714, DOI 10.1002/anie.201301813; OOI T, 1987, P NATL ACAD SCI USA, V84, P3086, DOI 10.1073/pnas.84.10.3086; Ferenczy GG, 2012, J CHEM INF MODEL, V52, P1039, DOI 10.1021/ci200608b; Hajduk PJ, 2005, J MED CHEM, V48, P2518, DOI 10.1021/jm049131r; Ferenczy GG, 2013, J MED CHEM, V56, P2478, DOI 10.1021/jm301851v; Mattos C, 2006, J MOL BIOL, V357, P1471, DOI 10.1016/j.jmb.2006.01.039; Brenke R, 2009, BIOINFORMATICS, V25, P621, DOI 10.1093/bioinformatics/btp036; Lazaridis T, 1998, J PHYS CHEM B, V102, P3531, DOI 10.1021/jp9723574; Guimaraes CRW, 2010, J CHEM INF MODEL, V50, P547, DOI 10.1021/ci900497d; Setny P, 2010, J CHEM THEORY COMPUT, V6, P2866, DOI 10.1021/ct1003077; Olsson TSG, 2008, J MOL BIOL, V384, P1002, DOI 10.1016/j.jmb.2008.09.073; Reynolds CH, 2011, ACS MED CHEM LETT, V2, P433, DOI 10.1021/ml200010k; SHARP KA, 1991, SCIENCE, V252, P106, DOI 10.1126/science.2011744; Hou TJ, 2011, J COMPUT CHEM, V32, P866, DOI 10.1002/jcc.21666; Young T, 2007, P NATL ACAD SCI USA, V104, P808, DOI 10.1073/pnas.0610202104; Wojciechowski M, 2004, J PHYS CHEM B, V108, P18368, DOI 10.1021/jp046748b; Krishnamurthy VM, 2006, J AM CHEM SOC, V128, P5802, DOI 10.1021/ja060070r; Beuming T, 2012, PROTEINS, V80, P871, DOI 10.1002/prot.23244; Breiten B, 2013, J AM CHEM SOC, V135, P15579, DOI 10.1021/ja4075776; Edfeldt FNB, 2011, DRUG DISCOV TODAY, V16, P284, DOI 10.1016/j.drudis.2011.02.002; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Haider MK, 2011, J CHEM INF MODEL, V51, P1092, DOI 10.1021/ci100469n; GILSON MK, 1988, J COMPUT CHEM, V9, P327, DOI 10.1002/jcc.540090407; Kulp JL, 2011, J AM CHEM SOC, V133, P10740, DOI 10.1021/ja203929x; Fenley AT, 2012, P NATL ACAD SCI USA, V109, P20006, DOI 10.1073/pnas.1213180109; Murray CW, 2010, CURR OPIN STRUC BIOL, V20, P497, DOI 10.1016/j.sbi.2010.04.003; Wang LL, 2013, J CHEM THEORY COMPUT, V9, P1282, DOI 10.1021/ct300911a; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Chaplin M, 2006, NAT REV MOL CELL BIO, V7, P861, DOI 10.1038/nrm2021; Michel J, 2009, J AM CHEM SOC, V131, P15403, DOI 10.1021/ja906058w; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Wang L, 2011, P NATL ACAD SCI USA, V108, P1326, DOI 10.1073/pnas.1016793108; Lexa KW, 2011, J AM CHEM SOC, V133, P200, DOI 10.1021/ja1079332; Southall NT, 2002, J PHYS CHEM B, V106, P521, DOI 10.1021/jp015514e; Abel R, 2008, J AM CHEM SOC, V130, P2817, DOI 10.1021/ja0771033; Coyne AG, 2010, CURR OPIN CHEM BIOL, V14, P299, DOI 10.1016/j.cbpa.2010.02.010; Alexeev Y, 2012, CURR TOP MED CHEM, V12, P2013; Landon MR, 2007, J MED CHEM, V50, P1231, DOI 10.1021/jm061134b; Guvench O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000435; Higgs C, 2010, ACS MED CHEM LETT, V1, P160, DOI 10.1021/ml100008s; Knegtel RMA, 2011, MOL INFORM, V30, P950, DOI 10.1002/minf.201100086; Leipinsh E., 1997, NAT BIOTECHNOL, V15, P264; Lockett M. R., 2013, ANGEW CHEM, V125, P7868; Orita M, 2011, METHOD ENZYMOL, V493, P383, DOI 10.1016/B978-0-12-381274-2.00015-7; Privalov L., 1988, ADV PROTEIN CHEM, V39, P191; Robinson DD, 2010, CHEMMEDCHEM, V5, P618, DOI 10.1002/cmdc.200900501; Shah F, 2012, J CHEM INF MODEL, V52, P696, DOI 10.1021/ci2005516; Whitaker Gina M., 2008, V491, P189, DOI 10.1007/978-1-59745-526-8_15; Whitesides G. M., 2005, REV BIOPHYS, V38, P385; Yang Y., 2013, EXPERT OPIN DRUG DIS, P1; Yu HT, 2009, J AM CHEM SOC, V131, P6608, DOI 10.1021/ja809696s	63	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1860-7179	1860-7187		CHEMMEDCHEM	ChemMedChem	DEC	2014	9	12					2708	2717		10.1002/cmdc.201402207		10	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3MC	WOS:000345516300011		
J	Kawashima, Y; Ohkubo, K; Okada, H; Matsuo, Y; Fukuzumi, S				Kawashima, Yuki; Ohkubo, Kei; Okada, Hiroshi; Matsuo, Yutaka; Fukuzumi, Shunichi			Supramolecular Formation of Li+@PCBM Fullerene with Sulfonated Porphyrins and Long-Lived Charge Separation	CHEMPHYSCHEM			English	Article						charge separation; endohedral fullerenes; electron transfer; porphyrinoids; supramolecular chemistry	PHOTOINDUCED ELECTRON-TRANSFER; PHOTOSYNTHETIC REACTION-CENTER; SMALL REORGANIZATION ENERGIES; SENSITIZED SOLAR-CELLS; ZINC CHLORIN-C-60 DYAD; ARTIFICIAL PHOTOSYNTHESIS; 9-MESITYL-10-METHYLACRIDINIUM ION; PHOTOPHYSICAL PROPERTIES; TRANSIENT ABSORPTION; PHOTOVOLTAIC CELLS	Lithium-ion-encapsulated [6,6]-phenyl-C-61-butyric acid methyl ester fullerene (Li+@PCBM) was utilized to construct supramolecules with sulfonated meso-tetraphenylporphyrins (MTPPS4-; M=Zn, H-2) in polar benzonitrile. The association constants were determined to be 1.8x10(5)M(-1) for ZnTPPS4-/Li+@PCBM and 6.2x10(4)M(-1) for H2TPPS4-/Li+@PCBM. From the electrochemical analyses, the energies of the charge-separated (CS) states were estimated to be 0.69 eV for ZnTPPS4-/Li+@PCBM and 1.00 eV for H2TPPS4-/Li+@PCBM. Upon photoexcitation of the porphyrin moieties of MTPPS4-/Li+@PCBM, photoinduced electron transfer occurred to produce the CS states. The lifetimes of the CS states were 560 s for ZnTPPS4-/Li+@PCBM and 450 s for H2TPPS4-/Li+@PCBM. The spin states of the CS states were determined to be triplet by electron paramagnetic resonance spectroscopy measurements at 4 K. The reorganization energies () and electronic coupling term (V) for back electron transfer (BET) were determined from the temperature dependence of k(BET) to be =0.36 eV and V=8.5x10(-3) cm(-1) for ZnTPPS4-/Li+@PCBM and =0.62 eV and V=7.9x10(-3) cm(-1) for H2TPPS4-/Li+@PCBM based on the Marcus theory of nonadiabatic electron transfer. Such small V values are the result of a small orbital interaction between the MTPPS4- and Li+@PCBM moieties. These small V values and spin-forbidden charge recombination afford a long-lived CS state.	[Kawashima, Yuki; Ohkubo, Kei; Fukuzumi, Shunichi] Osaka Univ, Grad Sch Engn, Dept Mat & Life Sci, Suita, Osaka 5650871, Japan; [Okada, Hiroshi; Matsuo, Yutaka] Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Matsuo, Y (reprint author), Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan.	matsuo@chem.s.u-tokyo.ac.jp; fukuzumi@chem.eng.osaka-u.ac.jp	Matsuo, Yutaka/C-9897-2011; Fukuzumi, Shunichi /E-4728-2010; Ohkubo, Kei/E-5127-2012	Matsuo, Yutaka/0000-0001-9084-9670; Ohkubo, Kei/0000-0001-8328-9249	Funding Program for Next-Generation World-Leading Researchers [GR030]; Japan Society for the Promotion of Science (JSPS) from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [25.627];  [26620154];  [26288037]	This work was financially supported by a Grant-in-Aid (Nos. 26620154 and 26288037 to K.O.), Funding Program for Next-Generation World-Leading Researchers (no. GR030 to Y.M.) and Japan Society for the Promotion of Science (JSPS) Fellows 25.627 to Y.K. (DC1) from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Guldi DM, 2004, J PHYS CHEM A, V108, P541, DOI 10.1021/jp036382n; Odobel F, 2009, CHEM-EUR J, V15, P3130, DOI 10.1002/chem.200801880; Benniston AC, 2008, MATER TODAY, V11, P26, DOI 10.1016/S1369-7021(08)70250-5; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; D'Souza F, 2005, COORDIN CHEM REV, V249, P1410, DOI 10.1016/j.ccr.2005.01.002; Elliott KJ, 2009, PHYS CHEM CHEM PHYS, V11, P8767, DOI 10.1039/b905548g; Guldi DM, 2011, CHEM COMMUN, V47, P606, DOI 10.1039/c0cc02411b; Kamat PV, 2007, J PHYS CHEM C, V111, P2834, DOI 10.1021/jp066952u; TANG CW, 1986, APPL PHYS LETT, V48, P183, DOI 10.1063/1.96937; MARCUS RA, 1964, ANNU REV PHYS CHEM, V15, P155, DOI 10.1146/annurev.pc.15.100164.001103; Wijesinghe CA, 2011, CHEM-EUR J, V17, P3147, DOI 10.1002/chem.201002446; Fukuzumi S, 2001, J AM CHEM SOC, V123, P10676, DOI 10.1021/ja015738a; Ohkubo K, 2002, J PHYS CHEM A, V106, P10991, DOI 10.1021/jp026603+; D'Souza F, 2002, J PHYS CHEM A, V106, P3243, DOI 10.1021/jp013165i; Matsuo Y, 2009, J AM CHEM SOC, V131, P16048, DOI 10.1021/ja9048702; Ohkubo K, 2004, ANGEW CHEM INT EDIT, V43, P853, DOI 10.1002/anie.200352870; Kawashima Y, 2013, J PHYS CHEM A, V117, P6737, DOI 10.1021/jp4047165; Ohkubo K, 2006, CHEM PHYS, V326, P3, DOI 10.1016/j.chemphys.2006.01.034; EBBESEN TW, 1991, CHEM PHYS LETT, V181, P501, DOI 10.1016/0009-2614(91)80302-E; Imahori H, 2001, J AM CHEM SOC, V123, P2607, DOI 10.1021/ja003346i; Kashiwagi Y, 2003, ORG LETT, V5, P2719, DOI 10.1021/ol0349256; Matsuo Y, 2012, ORG LETT, V14, P3784, DOI 10.1021/ol301671n; Grimm B, 2011, CHEM SCI, V2, P1530, DOI 10.1039/c0sc00569j; Fukuzumi S, 2011, PHYS CHEM CHEM PHYS, V13, P17019, DOI 10.1039/c1cp22364j; Kawashima Y, 2012, J PHYS CHEM A, V116, P8942, DOI 10.1021/jp3059036; Yamamoto S, 2008, ADV FUNCT MATER, V18, P2555, DOI 10.1002/adfm.200800411; Fukuzumi S, 2003, J AM CHEM SOC, V125, P14984, DOI 10.1021/ja037214b; Murakami M, 2010, J MATER CHEM, V20, P1457, DOI 10.1039/b918462g; D'Souza F, 2009, J AM CHEM SOC, V131, P8787, DOI 10.1021/ja903467w; Subbaiyan NK, 2009, J AM CHEM SOC, V131, P14646, DOI 10.1021/ja9067113; El-Khouly ME, 2003, CHEMPHYSCHEM, V4, P474, DOI 10.1002/cphc.200200540; ARBOGAST JW, 1991, J AM CHEM SOC, V113, P8886, DOI 10.1021/ja00023a041; D'Souza F, 2010, J PHYS CHEM LETT, V1, P2586, DOI 10.1021/jz1009407; Kamimura T, 2013, CHEM SCI, V4, P1451, DOI 10.1039/c3sc22065f; Bottari G, 2010, CHEM REV, V110, P6768, DOI 10.1021/cr900254z; Sun LC, 2001, CHEM SOC REV, V30, P36, DOI 10.1039/a801490f; Imahori H, 2001, ADV MATER, V13, P1197, DOI 10.1002/1521-4095(200108)13:15<1197::AID-ADMA1197>3.0.CO;2-4; Hagfeldt A, 2000, ACCOUNTS CHEM RES, V33, P269, DOI 10.1021/ar980112j; Blas-Ferrando VM, 2012, CHEM COMMUN, V48, P6241, DOI 10.1039/c2cc31087b; SARICIFTCI NS, 1992, SCIENCE, V258, P1474, DOI 10.1126/science.258.5087.1474; LORIUS C, 1990, NATURE, V347, P139, DOI 10.1038/347139a0; Yoon MC, 2013, CHEM SCI, V4, P1756, DOI 10.1039/c3sc22151b; ARBOGAST JW, 1991, J PHYS CHEM-US, V95, P11, DOI 10.1021/j100154a006; Fukuzumi S, 2012, CHEM COMMUN, V48, P9801, DOI 10.1039/c2cc32848h; Fukuzumi S, 2013, DALTON T, V42, P15846, DOI 10.1039/c3dt51883c; Ohkubo K, 2013, CHEM COMMUN, V49, P4474, DOI 10.1039/c3cc41187g; Kim KS, 2008, J PHOTOCH PHOTOBIO C, V9, P13, DOI 10.1016/j.jphotochemrev.2008.01.001; Fukuzumi S, 2004, J AM CHEM SOC, V126, P1600, DOI 10.1021/ja038656q; Choi JH, 2010, J MATER CHEM, V20, P475, DOI 10.1039/b916597e; Imahori H, 2004, CHEM-EUR J, V10, P3184, DOI 10.1002/chem.200305308; Imahori H, 2009, ACCOUNTS CHEM RES, V42, P1809, DOI 10.1021/ar900034t; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Fukuzumi S, 1998, J AM CHEM SOC, V120, P8060, DOI 10.1021/ja9813459; Martin N, 2007, ACCOUNTS CHEM RES, V40, P1015; Murakami M, 2010, CHEM-EUR J, V16, P7820, DOI 10.1002/chem.200903236; Ueno H, 2012, NANO RES, V5, P558, DOI 10.1007/s12274-012-0241-2; Fukuzumi S, 2014, ACCOUNTS CHEM RES, V47, P1455, DOI 10.1021/ar400200u; Aoyagi S, 2012, ANGEW CHEM INT EDIT, V51, P3377, DOI 10.1002/anie.201108551; Shaheen SE, 2001, APPL PHYS LETT, V78, P841, DOI 10.1063/1.1345834; Martin-Gomis L, 2008, J PHYS CHEM C, V112, P17694, DOI 10.1021/jp804983k; Xiao SQ, 2005, J PHYS CHEM B, V109, P3658, DOI 10.1021/jp045163e; Ross RB, 2009, NAT MATER, V8, P208, DOI [10.1038/nmat2379, 10.1038/NMAT2379]; Imahori H, 2001, J AM CHEM SOC, V123, P6617, DOI 10.1021/ja004123v; KURRECK H, 1995, ANGEW CHEM INT EDIT, V34, P849, DOI 10.1002/anie.199508491; Griffith MJ, 2012, CHEM COMMUN, V48, P4145, DOI 10.1039/c2cc30677h; Aoyagi S, 2010, NAT CHEM, V2, P678, DOI [10.1038/nchem.698, 10.1038/NCHEM.698]; HAGFELDT A, 1995, CHEM REV, V95, P49, DOI 10.1021/cr00033a003; Fukuzumi S, 2011, J AM CHEM SOC, V133, P15938, DOI 10.1021/ja207588c; Kawashima Y, 2013, J PHYS CHEM C, V117, P21166, DOI 10.1021/jp407976b; Guldi DM, 2006, CHEM SOC REV, V35, P471, DOI 10.1039/b511541h; Ohkubo K, 2009, B CHEM SOC JPN, V82, P303, DOI 10.1246/bcsj.82.303; Ohkubo K, 2012, CHEM COMMUN, V48, P4314, DOI 10.1039/c2cc31186k; Lee SH, 2012, CHEM SCI, V3, P257, DOI 10.1039/c1sc00614b; RAVAL A, 1989, NATURE, V342, P758, DOI 10.1038/342758a0; Guldi DM, 2000, J PHYS CHEM A, V104, P8601, DOI 10.1021/jp0016838; SLOVIC P, 1991, SCIENCE, V254, P1603, DOI 10.1126/science.254.5038.1603; Wang ZS, 2004, COORDIN CHEM REV, V248, P1381, DOI 10.1016/j.ccr.2004.03.006; Armaroli N, 2007, ANGEW CHEM INT EDIT, V46, P52, DOI 10.1002/anie.200602373; Jimenez AJ, 2007, ORG LETT, V9, P2481, DOI 10.1021/ol0707968; HIRAMOTO M, 1991, APPL PHYS LETT, V58, P1062, DOI 10.1063/1.104423; Armarego WLF, 2009, PURIFICATION OF LABORATORY CHEMICALS, 6TH EDITION, P1; Bixon M., 1992, Israel Journal of Chemistry, V32, P369; Cespedes-Guirao F. J., 2009, J ORG CHEM, V74, P5871; Connolly J. S., 1988, PHOTOINDUCED ELECT D, P303; D'Souza F, 2009, CHEM COMMUN, P4913, DOI 10.1039/b905753f; Echegoyen L., 2000, FULLERENES CHEM PHYS, P1; Flamigni L, 2002, CHEM-EUR J, V8, P3938, DOI 10.1002/1521-3765(20020902)8:17<3938::AID-CHEM3938>3.0.CO;2-3; Fukuzumi S, 1998, J AM CHEM SOC, V120, P9220, DOI 10.1021/ja9815430; Fukuzumi S, 2010, CHEM-EUR J, V16, P354, DOI 10.1002/chem.200901163; Fukuzumi S., 2001, ELECT TRANSFER CHEM, V2, P270; Fukuzumi S, 2002, J PHYS CHEM A, V106, P1903, DOI 10.1021/jp011613g; Fukuzumi S, 2008, PHYS CHEM CHEM PHYS, V10, P5159, DOI 10.1039/b809264h; Gratzel M., 2003, NATURE, V421, P586; Green A., 2014, PROG PHOTOVOLTAICS, V22, P1; Grtzel M., 2001, NATURE, V414, P338; Guldi D. M., 2003, FULLERENES SYNTHESIS, P237; Gust D., 2000, PORPHYRIN HDB, V8, P153; Gust D., 2001, ELECT TRANSFER CHEM, V3, P272; HANSEN JE, 1990, NATURE, V346, P713, DOI 10.1038/346713a0; Hatano J, 2012, J MATER CHEM, V22, P19258, DOI 10.1039/c2jm33956k; Imahori H, 2002, J AM CHEM SOC, V124, P5165, DOI 10.1021/ja016655x; KAJII Y, 1991, CHEM PHYS LETT, V181, P100, DOI 10.1016/0009-2614(91)90339-B; Hara K, 2003, NEW J CHEM, V27, P783, DOI 10.1039/b300694h; Kurreck H., 1995, ANGEW CHEM, V107, P929, DOI 10.1002/ange.19951070804; Mann C. K., 1970, ELECT REACTIONS NONA; Marcus R. A., 1993, ANGEW CHEM, V105, DOI DOI 10.1002/ANGE.19931050804; MARCUS RA, 1993, ANGEW CHEM INT EDIT, V32, P1111, DOI 10.1002/anie.199311113; Martin-Gomis L, 2010, CHEM COMMUN, V46, P3944, DOI 10.1039/c002077j; MIKAMI K, 1995, J AM CHEM SOC, V117, P11134, DOI 10.1021/ja00150a013; Murakami M, 2010, CHEMPHYSCHEM, V11, P2594, DOI 10.1002/cphc.201000096; Nyambuu U, 2014, ECON MODEL, V37, P271, DOI 10.1016/j.econmod.2013.11.020; Ohkubo K, 2005, CHEM COMMUN, P4520, DOI 10.1039/b506479a; Sgobba V, 2006, CARBON NANOTUBES ELE; Tokuji S., 2012, ANGEW CHEM, V124, P12523; Tokuji S, 2012, ANGEW CHEM INT EDIT, V51, P12357, DOI 10.1002/anie.201207763; Verhoeven J. W., 1999, ELECT TRANSFER ISO 1, P603; Wasielewski M. R., 1988, PHOTOINDUCED ELECT A, P161	117	4	4	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1439-4235	1439-7641		CHEMPHYSCHEM	ChemPhysChem	DEC 1	2014	15	17					3782	3790		10.1002/cphc.201402512		9	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	AU3KY	WOS:000345513200013		
J	Toyouchi, S; Kajimoto, S; Barzan, D; Kiel, A; Enderlein, J; Fukumura, H; Herten, DP				Toyouchi, Shuichi; Kajimoto, Shinji; Barzan, Daniel; Kiel, Alexander; Enderlein, Joerg; Fukumura, Hiroshi; Herten, Dirk-Peter			Observation of Unusual Molecular Diffusion Behaviour below the Lower Critical Solution Temperature of Water/2-Butoxyethanol Mixtures by using Fluorescence Correlation Spectroscopy	CHEMPHYSCHEM			English	Article						binary liquids; fluorescence spectroscopy; lower critical solution temperature; molecular diffusion; solvent effects	X-RAY-SCATTERING; 2-BUTOXYETHANOL PLUS WATER; ANGLE NEUTRON-SCATTERING; ELASTIC LIGHT-SCATTERING; TERT-BUTYL ALCOHOL; AQUEOUS-SOLUTIONS; CONCENTRATION FLUCTUATIONS; ANOMALOUS DIFFUSION; BINARY-SOLUTIONS; SHEAR VISCOSITY	The effect of solute affinity on solute diffusion in binary liquids well below the lower critical solution temperature (LCST) was studied by using fluorescence correlation spectroscopy. We measured the hydrodynamic radii of a hydrophobic and an amphiphilic fluorescent dye under systematic variation of the relative molar fractions of water/2-butoxyethanol and, for comparison, of water/methanol mixtures, which do not show phase separation. We found that the apparent hydrodynamic radius of the hydrophobic dye almost doubled in water/2-butoxyethanol, whereas it remained largely unchanged for the amphiphilic dye and in water/methanol mixtures. Our results indicate that the translational diffusion of solutes is influenced by transient local solution structures, even at temperatures well below the LCST. We conclude that, even far below LCST, different solutes can experience different environments in binary liquid mixtures depending on both the solute and solvent properties, all of which impact their reactivity.	[Toyouchi, Shuichi; Kajimoto, Shinji; Fukumura, Hiroshi] Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan; [Toyouchi, Shuichi; Barzan, Daniel; Herten, Dirk-Peter] Heidelberg Univ, Cellnetworks Cluster, D-69120 Heidelberg, Germany; [Toyouchi, Shuichi; Barzan, Daniel; Herten, Dirk-Peter] Heidelberg Univ, Inst Phys Chem, D-69120 Heidelberg, Germany; [Kiel, Alexander] Hamamatsu Germany, D-82211 Herrsching Am Ammersee, Germany; [Enderlein, Joerg] Univ Gottingen, Inst Phys Biophys 3, D-37077 Gottingen, Germany	Fukumura, H (reprint author), Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan.	fukumura@m.tohoku.ac.jp; dirk.herten@bioquant.uni-heidelberg.de	Kajimoto, Shinji/N-4229-2014; Fukumura, Hiroshi/G-4535-2011	Kajimoto, Shinji/0000-0001-7432-8090; 	JST Mathematics Program (CREST, A Mathematical Challenge to a New Phase of Material Science); JSPS KAKENHI [21750003, 23710117]; Deutsche Forschungsgemeinschaft (DFG) [EXC81, SFB623]; JASSO (ICI ECP: Industrialised Countries Instrument Education Co-operation Program); Heidelberg University from within the German-Japanese University consortium HeKK-SaGOn	The authors express their sincere thanks to Professor K. Kurihara and Dr. M. Kasuya for the use of a viscometer as well as A. Haderspeck for his fast emergency measurements. The authors also acknowledge partial support from the JST Mathematics Program (CREST, A Mathematical Challenge to a New Phase of Material Science), and JSPS KAKENHI grants 21750003 and 23710117, as well as from the Deutsche Forschungsgemeinschaft (DFG: EXC81 and SFB623). Thanks are also due to Dr. M. Lear for his valuable comments on the manuscript. S.T. is grateful to a student exchange program supported by JASSO (ICI ECP: Industrialised Countries Instrument Education Co-operation Program) and D.P.H. acknowledges financial support by Heidelberg University from within the German-Japanese University consortium HeKK-SaGOn.	KIRKWOOD JG, 1951, J CHEM PHYS, V19, P774, DOI 10.1063/1.1748352; Takamuku T, 2000, Z NATURFORSCH A, V55, P513; NISHIKAWA K, 1993, J PHYS CHEM-US, V97, P10824, DOI 10.1021/j100143a049; Krichevsky O, 2002, REP PROG PHYS, V65, P251, DOI 10.1088/0034-4885/65/2/203; Mele S, 2004, J PHYS CHEM B, V108, P17751, DOI 10.1021/jp049696z; Mirzaev SZ, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2188396; Chattoraj S, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4808217; Yoshida K, 2005, J MOL LIQ, V119, P125, DOI 10.1016/j.molliq.2004.10.019; Enderlein J, 2004, CURR PHARM BIOTECHNO, V5, P155, DOI 10.2174/1389201043377020; NISHI N, 1995, J PHYS CHEM-US, V99, P462, DOI 10.1021/j100001a068; Takamuku T, 2002, Z NATURFORSCH A, V57, P982; NILSSON PG, 1983, J PHYS CHEM-US, V87, P1377, DOI 10.1021/j100231a021; HAYASHI H, 1990, J PHYS CHEM-US, V94, P8334, DOI 10.1021/j100384a062; IWASAKI K, 1977, J PHYS CHEM-US, V81, P1908, DOI 10.1021/j100535a005; Perera A, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2178787; Banks DS, 2005, BIOPHYS J, V89, P2960, DOI 10.1529/biophysj.104.051078; Behrends R, 2002, J CHEM PHYS, V117, P9828, DOI 10.1063/1.1517609; DANGELO M, 1994, CHEM PHYS LETT, V220, P59, DOI 10.1016/0009-2614(94)00128-6; DArrigo G, 1997, J MOL STRUCT, V404, P319, DOI 10.1016/S0022-2860(96)09411-2; Du ZY, 2013, J PHYS CHEM A, V117, P283, DOI 10.1021/jp3111502; Du ZY, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4829901; Enderlein J, 2005, CHEMPHYSCHEM, V6, P2324, DOI 10.1002/cphc.200500414; Grabowski CA, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.207801; HAYASHI H, 1992, B CHEM SOC JPN, V65, P600, DOI 10.1246/bcsj.65.600; ITO N, 1983, B CHEM SOC JPN, V56, P379, DOI 10.1246/bcsj.56.379; Kajimoto S, 2013, LANGMUIR, V29, P5889, DOI 10.1021/la400377k; Kasuya M, 2006, JPN J APPL PHYS 2, V45, pL1016, DOI 10.1143/JJAP.45.L1016; KATO T, 1985, J PHYS CHEM-US, V89, P5750, DOI 10.1021/j100272a035; Kim YW, 2004, INT J THERMOPHYS, V25, P1025, DOI 10.1023/B:IJOT.0000038497.48181.11; Koga Y, 1996, J PHYS CHEM-US, V100, P5172, DOI 10.1021/jp952372d; MALLAMACE F, 1992, NUOVO CIMENTO D, V14, P333, DOI 10.1007/BF02457392; Mallamace F., 1995, PHYS REV E, V51, P2349; Masuda A, 2001, J AM CHEM SOC, V123, P11468, DOI 10.1021/ja016401b; Masuda A, 2006, J PHOTOCH PHOTOBIO A, V183, P304, DOI 10.1016/j.jphotochem.2006.06.040; Masuda A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.060101; Menzel K, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011501; NISHIKAWA K, 1987, J PHYS CHEM-US, V91, P3694, DOI 10.1021/j100297a047; Stepanek M, 2005, LANGMUIR, V21, P10783, DOI 10.1021/la0516680; Sturlaugson AL, 2010, J PHYS CHEM B, V114, P5350, DOI 10.1021/jp101369e; Tada T, 2013, J PHYS CHEM C, V117, P10818, DOI 10.1021/jp4027173; Telgmann T, 2002, LANGMUIR, V18, P3068, DOI 10.1021/la011687j	41	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1439-4235	1439-7641		CHEMPHYSCHEM	ChemPhysChem	DEC 1	2014	15	17					3832	3838		10.1002/cphc.201402308		7	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	AU3KY	WOS:000345513200020		
J	Saitoh, H; Machida, A; Aoki, K				Saitoh, Hiroyuki; Machida, Akihiko; Aoki, Katsutoshi			Synchrotron X-ray diffraction techniques for in situ measurement of hydride formation under several gigapascals of hydrogen pressure	CHINESE SCIENCE BULLETIN			English	Article						Aluminum; Hydride; High pressure and high temperature; In situ measurement; Synchrotron radiation X-ray diffraction measurement	ALUMINUM-HYDRIDE; CRYSTAL-STRUCTURE; PHASE; APPARATUS; METALS; SYSTEM; ALH3; IRON; NI	The high-pressure technique is a fundamental tool for realizing novel phase transitions, chemical reactions, and other exotic phenomena. Hydrogenation is one example of a high-pressure reaction; at high pressures of several gigapascals, hydrogen becomes chemically active and reacts with metals and alloys to form hydrides. This paper covers a high-pressure study of the hydrogenation process and the synthesis of hydrides using a cubic-type multi-anvil apparatus. The experimental details of a hydrogenation cell assembly, high-temperature and high-pressure generation, and an in situ observation technique are presented. These experiments are conducted with the aid of in situ synchrotron radiation X-ray diffraction measurements operated in an energy-dispersive mode in the conventional manner for time-resolved measurements and a newly developed angle-dispersive mode for observation of the crystal growth process during formation of metal hydrides. Two successful cases of high-pressure hydrogenation are presented: aluminum hydride, AlH3, and an aluminum-based alloy hydride, Al2CuH (x) , which are potential candidates for hydrogen storage materials.	[Saitoh, Hiroyuki; Machida, Akihiko] Japan Atom Energy Agcy, Quantum Beam Sci Directorate, Sayo, Hyogo 6795148, Japan; [Aoki, Katsutoshi] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan	Saitoh, H (reprint author), Japan Atom Energy Agcy, Quantum Beam Sci Directorate, Sayo, Hyogo 6795148, Japan.	cyto@spring8.or.jp			New Energy and Industrial Technology Development Organization (NEDO) under "Advanced Fundamental Research Project on Hydrogen Storage Materials"; New Energy and Industrial Technology Development Organization (NEDO) under "Feasibility Study on Advanced Hydrogen Storage Materials for Automotive Applications"; Ministry of Education, Culture, Sports, Science and Technology (MEXT) under the "Photon and Quantum Basic Research Coordinated Development Program"; Japan Society for the Promotion of Science (JSPS) KAKENHI [25220911, 24241032, 25420725]	This work was partially supported by New Energy and Industrial Technology Development Organization (NEDO) under "Advanced Fundamental Research Project on Hydrogen Storage Materials" and "Feasibility Study on Advanced Hydrogen Storage Materials for Automotive Applications (2012)", by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) under the "Photon and Quantum Basic Research Coordinated Development Program", and by Japan Society for the Promotion of Science (JSPS) KAKENHI (25220911, 24241032, and 25420725). The synchrotron radiation experiments were performed at BL14B1 of SPring-8 with the approval of Japan Atomic Energy Agency (JAEA) (2011B3602 and 2012B3602).	Zhao YS, 2008, J APPL CRYSTALLOGR, V41, P1095, DOI 10.1107/S0021889808031762; Antonov VE, 1998, J ALLOY COMPD, V264, P214, DOI 10.1016/S0925-8388(97)00298-3; Moser D, 2009, J MATER CHEM, V19, P8150, DOI 10.1039/b911263d; Zidan R, 2009, CHEM COMMUN, P3717, DOI 10.1039/b901878f; Errandonea D, 2010, J APPL PHYS, V108, DOI 10.1063/1.3468149; TURLEY JW, 1969, INORG CHEM, V8, P18, DOI 10.1021/ic50071a005; UCHIDA H, 1984, J LESS-COMMON MET, V101, P459, DOI 10.1016/0022-5088(84)90122-X; Kamegawa A, 2008, RENEW ENERG, V33, P221, DOI 10.1016/j.renene.2007.05.008; Goncharenko I, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.045504; MEETSMA A, 1989, J SOLID STATE CHEM, V83, P370, DOI 10.1016/0022-4596(89)90188-6; DECKER DL, 1971, J APPL PHYS, V42, P3239, DOI 10.1063/1.1660714; Graetz J, 2013, MRS BULL, V38, P473, DOI 10.1557/mrs.2013.107; SUGIMOTO H, 1992, ACTA METALL MATER, V40, P2327, DOI 10.1016/0956-7151(92)90151-4; Antonov VE, 2002, J ALLOY COMPD, V330, P110, DOI 10.1016/S0925-8388(01)01532-8; Filipek SM, 2010, SOLID STATE IONICS, V181, P306, DOI 10.1016/j.ssi.2010.01.009; Filipek SM, 2007, J ADV SCI, V19, P1; Fukai Y, 2005, J ALLOY COMPD, V404- 406, P2; FUKAI Y, 1982, JPN J APPL PHYS 2, V21, pL318, DOI 10.1143/JJAP.21.L318; FUKAI Y, 1993, JPN J APPL PHYS 2, V32, pL1256; Graetz J, 2011, J ALLOY COMPD, V509, pS517, DOI 10.1016/j.jallcom.2010.11.115; Hattori T, 2012, MLF ANN REPORT 2011, P88; Hattori T, 2012, MLF ANNUAL REPORT; Hattori T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.255504; Kato S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3269598; KONOVALOV SK, 1995, INORG CHEM, V34, P172, DOI 10.1021/ic00105a029; Kyoi D, 2003, J ALLOY COMPD, V361, P252, DOI 10.1016/S0925-8388(03)00431-6; Machida A, 2006, SOLID STATE COMMUN, V138, P436, DOI 10.1016/j.ssc.2006.04.011; Nishihara Y, 2009, J SYNCHROTRON RADIAT, V16, P757, DOI 10.1107/S0909049509034955; Ohmura A, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.104105; Orimo S, 2006, APPL PHYS A-MATER, V83, P5, DOI 10.1007/s00339-005-3468-x; OSUGI J, 1964, REV PHYS CHEM JPN, V34, P1; Saitoh H, 2013, APL MATER, V1, DOI 10.1063/1.4821632; Saitoh H, 2010, J APPL PHYS, V108, DOI 10.1063/1.3486215; Saitoh H, 2009, APPL PHYS LETT, V94; Saitoh H, 2010, J ALLOY COMPD, V496, pL25, DOI 10.1016/j.jallcom.2010.02.112; Saitoh H, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3002374; Sakharov MK, 2007, THE DIAGRAM OF PHASE, P202; Takemura K., 2001, REV SCI INSTRUM, V72, P3873; TKACZ M, 1983, POL J CHEM, V57, P651; Utsumi W, 2002, J PHYS-CONDENS MAT, V14, P10497, DOI 10.1088/0953-8984/14/44/322; WAKAMORI K, 1983, REV SCI INSTRUM, V54, P1410, DOI 10.1063/1.1137257	41	2	2	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1001-6538	1861-9541		CHINESE SCI BULL	Chin. Sci. Bull.	DEC	2014	59	36					5290	5301		10.1007/s11434-014-0543-8		12	Multidisciplinary Sciences	Science & Technology - Other Topics	AU1LF	WOS:000345381500020		
J	Higashimoto, K; Jozaki, K; Kosho, T; Matsubara, K; Fuke, T; Yamada, D; Yatsuki, H; Maeda, T; Ohtsuka, Y; Nishioka, K; Joh, K; Koseki, H; Ogata, T; Soejima, H				Higashimoto, K.; Jozaki, K.; Kosho, T.; Matsubara, K.; Fuke, T.; Yamada, D.; Yatsuki, H.; Maeda, T.; Ohtsuka, Y.; Nishioka, K.; Joh, K.; Koseki, H.; Ogata, T.; Soejima, H.			A novel de novo point mutation of the OCT-binding site in the IGF2/H19-imprinting control region in a Beckwith-Wiedemann syndrome patient	CLINICAL GENETICS			English	Article						Beckwith-Wiedemann syndrome; ICR1 methylation defect; IGF2; H19; OCT-binding site; Silver-Russell syndrome	INSULATOR PROTEIN CTCF; IMPRINTING CENTER; CHROMOSOME 11P15; WILMS-TUMOR; METHYLATION; MAINTENANCE; EXPRESSION; DISORDERS; CHROMATIN; DEFECTS	The IGF2/H19-imprinting control region (ICR1) functions as an insulator to methylation-sensitive binding of CTCF protein, and regulates imprinted expression of IGF2 and H19 in a parental origin-specific manner. ICR1 methylation defects cause abnormal expression of imprinted genes, leading to Beckwith-Wiedemann syndrome (BWS) or Silver-Russell syndrome (SRS). Not only ICR1 microdeletions involving the CTCF-binding site, but also point mutations and a small deletion of the OCT-binding site have been shown to trigger methylation defects in BWS. Here, mutational analysis of ICR1 in 11 BWS and 12 SRS patients with ICR1 methylation defects revealed a novel de novo point mutation of the OCT-binding site on the maternal allele in one BWS patient. In BWS, all reported mutations and the small deletion of the OCT-binding site, including our case, have occurred within repeat A2. These findings indicate that the OCT-binding site is important for maintaining an unmethylated status of maternal ICR1 in early embryogenesis.	[Higashimoto, K.; Jozaki, K.; Yatsuki, H.; Maeda, T.; Ohtsuka, Y.; Nishioka, K.; Joh, K.; Soejima, H.] Saga Univ, Div Mol Genet & Epigenet, Dept Biomol Sci, Fac Med, Saga 8498501, Japan; [Kosho, T.] Shinshu Univ, Sch Med, Dept Med Genet, Matsumoto, Nagano 390, Japan; [Matsubara, K.; Fuke, T.] Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Tokyo, Japan; [Yamada, D.; Koseki, H.] RIKEN Ctr Integrat Med Sci IMS, Lab Dev Genet, Yokohama, Kanagawa, Japan; [Ogata, T.] Hamamatsu Univ Sch Med, Dept Pediat, Hamamatsu, Shizuoka 4313192, Japan	Soejima, H (reprint author), Saga Univ, Div Mol Genet & Epigenet, Dept Biomol Sci, Fac Med, 5-1-1 Nabeshima, Saga 8498501, Japan.	soejimah@cc.saga-u.ac.jp			Ministry of Health, Labor, and Welfare; National Center for Child Health and Development; Japan Society for the Promotion of Science	This study was supported, in part, by a Grant for Research on Intractable Diseases from the Ministry of Health, Labor, and Welfare; a Grant for Child Health and Development from the National Center for Child Health and Development; a Grant-in-Aid for Challenging Exploratory Research; and, a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science.	Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187; Sparago A, 2004, NAT GENET, V36, P958, DOI 10.1038/ng1410; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Bell AC, 2000, NATURE, V405, P482; Beygo J, 2013, HUM MOL GENET, V22, P544, DOI 10.1093/hmg/dds465; Hark AT, 2000, NATURE, V405, P486; Hori N, 2002, J BIOL CHEM, V277, P27960, DOI 10.1074/jbc.M202280200; Weksberg R, 2010, EUR J HUM GENET, V18, P8, DOI 10.1038/ejhg.2009.106; Hori N, 2012, J BIOL CHEM, V287, P44006, DOI 10.1074/jbc.M112.424580; Poole RL, 2013, AM J MED GENET A, V161, P2174, DOI 10.1002/ajmg.a.36049; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; Demars J, 2010, HUM MOL GENET, V19, P803, DOI 10.1093/hmg/ddp549; Sakaguchi R, 2013, HUM MOL GENET, V22, P4627, DOI 10.1093/hmg/ddt311; Gicquel C, 2005, NAT GENET, V37, P1003, DOI 10.1038/ng1629; Berland S, 2013, EUR J HUM GENET, V21, P1344, DOI 10.1038/ejhg.2013.71; Higashimoto K, 2012, AM J MED GENET A, V158A, P1670, DOI 10.1002/ajmg.a.35335; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Prawitt D, 2005, P NATL ACAD SCI USA, V102, P4085, DOI 10.1073/pnas.0500037102; Soejima H, 2004, ONCOGENE, V23, P4380, DOI 10.1038/sj.onc.1207576; Sparago A, 2007, HUM MOL GENET, V16, P254, DOI 10.1093/hmg/ddl448	20	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9163	1399-0004		CLIN GENET	Clin. Genet.	DEC	2014	86	6					539	544		10.1111/cge.12318		6	Genetics & Heredity	Genetics & Heredity	AU1EN	WOS:000345363900006		
J	Kawasaki, Y				Kawasaki, Yuko			Consultation Techniques Using Shared Decision Making for Patients With Cancer and Their Families	CLINICAL JOURNAL OF ONCOLOGY NURSING			English	Article						decision making; shared decision-support techniques; oncology nursing consultation	MODEL; CARE	This article elucidates the nursing consultation techniques in shared decision making (SDM) for patients with cancer and their family members. Descriptive data (207 records) from the nurse-led SDM consultation facility and content analysis were used to extract the nursing consultation techniques. In addition, the order in which these techniques were used to structure the SDM process for patients with cancer was identified. The author extracted eight categories pertaining to nurse consultation techniques for the SDM process: sharing feelings, helping to identify the focus of the consultations, helping to devise a personalized recovery plan, providing information in accordance with the patient's responses, supporting the patient to understand the information provided, ensuring continued treatment and care, strengthening the patient support system, and exploring possibilities on the basis of patient needs. The identified logical order in which these techniques were applied may be useful as a guide to systematic decision-making support.	Univ Hyogo, Coll Nursing, Kobe, Hyogo 6500044, Japan	Kawasaki, Y (reprint author), Univ Hyogo, Coll Nursing, Kobe, Hyogo 6500044, Japan.	yuko_kawasaki@cnas.u-hyogo.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology	This study was supported, in part, by a grant from Grants-in-Aid for Scientific Research by the Japanese Ministry of Education, Culture, Sports, Science, and Technology. The content of this article has been reviewed by independent peer reviewers to ensure that it is balanced, objective, and free from commercial bias. No financial relationships relevant to the content of this article have been disclosed by the independent peer reviewers or editorial staff. Kawasaki can be reached at yuko_kawasaki@cnas.u-hyogo.ac.jp, with copy to editor at CJONEditor@ons.org. (Submitted July 2013. Revision submitted March 2014. Accepted for publication March 15, 2014.)	Elwyn G, 2010, MED DECIS MAKING, V30, P701, DOI 10.1177/0272989X10386231; Obeidat RF, 2013, ONCOL NURS FORUM, V40, P454, DOI 10.1188/13.ONF.454-463; Legare F, 2013, J INTERPROF CARE, V27, P214, DOI 10.3109/13561820.2013.763777; Legare F, 2011, J INTERPROF CARE, V25, P18, DOI 10.3109/13561820.2010.490502; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; Moumjid N, 2007, MED DECIS MAKING, V27, P539, DOI 10.1177/0272989x07306779; Brand PLP, 2013, PAEDIATR RESPIR REV, V14, P224, DOI 10.1016/j.prrv.2013.01.002; Charles C., 2009, SHARED DECISION MAKI; Duncan E, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007297.pub2; Gillies K., 2012, COCHRANE DATABASE SY; Glaser B., 1967, DISCOVERY GROUNDED T; Grunfeld EA, 2006, J CLIN ONCOL, V24, P1090, DOI 10.1200/JCO.2005.01.9208; Joseph-Williams N, 2014, PATIENT EDUC COUNS, V94, P291, DOI 10.1016/j.pec.2013.10.031; Lincoln Y. S., 1985, NATURALISTIC INQUIRY; Martin-Fernandez R, 2013, REV ESP SALUD PUBLIC, V87, P59, DOI 10.4321/S1135-57272013000100007; Radina ME, 2011, CANCER NURS, V34, pE1, DOI 10.1097/NCC.0b013e3181faab7c; Stacey D, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001431.pub3	17	0	0	ONCOLOGY NURSING SOC	PITTSBURGH	125 ENTERPRISE DR, PITTSBURGH, PA 15275 USA	1092-1095	1538-067X		CLIN J ONCOL NURS	Clin. J. Oncol. Nurs.	DEC	2014	18	6					701	706		10.1188/14.CJON.701-706		6	Oncology; Nursing	Oncology; Nursing	AU5AF	WOS:000345618700018		
J	Itabashi, H; Jin, K; Iwasaki, M; Okumura, E; Kanno, A; Kato, K; Tominaga, T; Kawashima, R; Nakasato, N				Itabashi, Hisashi; Jin, Kazutaka; Iwasaki, Masaki; Okumura, Eiichi; Kanno, Akitake; Kato, Kazuhiro; Tominaga, Teiji; Kawashima, Ryuta; Nakasato, Nobukazu			Electro-and magneto-encephalographic spike source localization of small focal cortical dysplasia in the dorsal peri-rolandic region	CLINICAL NEUROPHYSIOLOGY			English	Article						Focal cortical dysplasia; EEG; Magnetoencephalography; Source localization; Magnetic resonance imaging; Sensori-motor seizure	EPILEPSY PATIENTS; FDG-PET; MRI; MEG; EEG; PREDICTORS; LESIONS; BOTTOM; SULCUS; FOCUS	Objective: Small focal cortical dysplasia (FCD) may be ambiguous or overlooked on magnetic resonance (MR) imaging. Source localization of EEG and magnetoencephalography (MEG) spikes was evaluated to confirm the diagnosis of small FCD. Methods: This study included 6 epilepsy patients with a single small lesion on MR imaging suggesting FCD within a single gyrus among 181 consecutive epilepsy patients admitted to our epilepsy monitoring unit over 27 months. Stereotypical interictal spikes were detected on simultaneous EEG and MEG recordings and the onset-related source of averaged spikes was estimated. Results: All 6 patients had unique clinical characteristics as follows: leg sensori-motor seizures in 5 patients and eye version in 1 patient; a small MR imaging lesion suggesting FCD in the dorsal perirolandic region, which had been overlooked until our evaluation; and both EEG and MEG dipoles were estimated adjacent to the MR imaging lesion. Conclusions: Source localization of EEG and MEG spikes can confirm the diagnosis of FCD based on a single small MR imaging lesion, which was overlooked by previous examination of MR images. Significance: Examination of MR images should be based on spike source localization as well as seizure semiology to identify subtle MR imaging abnormalities. (C) 2014 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Itabashi, Hisashi; Jin, Kazutaka; Okumura, Eiichi; Kato, Kazuhiro; Nakasato, Nobukazu] Tohoku Univ, Grad Sch Med, Dept Epileptol, Sendai, Miyagi 9808575, Japan; [Itabashi, Hisashi] Dokkyo Med Univ, Koshigaya Hosp, Dept Pediat, Koshigaya, Saitama, Japan; [Iwasaki, Masaki; Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi 9808575, Japan; [Kanno, Akitake; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Dept Funct Brain Imaging, Sendai, Miyagi 9808575, Japan	Jin, K (reprint author), Tohoku Univ, Grad Sch Med, Dept Epileptol, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	jink@med.tohoku.ac.jp		Iwasaki, Masaki/0000-0002-4204-7144			Blenkmann A, 2012, EPILEPSY RES, V98, P223, DOI 10.1016/j.eplepsyres.2011.09.018; Chassoux F, 2010, NEUROLOGY, V75, P2168, DOI 10.1212/WNL.0b013e31820203a9; Besson P, 2008, BRAIN, V131, P3246, DOI 10.1093/brain/awn224; Schneider F, 2013, EPILEPSIA, V54, P359, DOI 10.1111/epi.12004; Tassi L, 2002, BRAIN, V125, P1719, DOI 10.1093/brain/awf175; Brodbeck V, 2010, EPILEPSIA, V51, P583, DOI 10.1111/j.1528-1167.2010.02521.x; Widdess-Walsh P, 2007, NEUROLOGY, V69, P660, DOI 10.1212/01.wnl.0000267427.91987.21; Lerner JT, 2009, EPILEPSIA, V50, P1310, DOI 10.1111/j.1528-1167.2008.01998.x; Bast T, 2004, EPILEPSIA, V45, P621, DOI 10.1111/j.0013-9580.2004.56503.x; Hofman PAM, 2011, AM J ROENTGENOL, V196, P881, DOI 10.2214/AJR.10.4423; Heers M, 2012, SEIZURE-EUR J EPILEP, V21, P128, DOI 10.1016/j.seizure.2011.10.005; Kim SK, 2000, J COMPUT ASSIST TOMO, V24, P296, DOI 10.1097/00004728-200003000-00022; Cohen-Gadol AA, 2004, J NEUROSURG, V101, P55, DOI 10.3171/jns.2004.101.1.0055; COHEN D, 1983, ELECTROEN CLIN NEURO, V56, P38, DOI 10.1016/0013-4694(83)90005-6; Ebersole JS, 2000, EPILEPSIA, V41, pS24, DOI 10.1111/j.1528-1157.2000.tb01531.x; Kim DW, 2009, NEUROLOGY, V72, P211, DOI 10.1212/01.wnl.0000327825.48731.c3; Lee SK, 2001, EPILEPSIA, V42, P850, DOI 10.1046/j.1528-1157.2001.042007850.x; Widdess-Walsh P, 2006, J NEUROIMAGING, V16, P185, DOI 10.1111/j.1552-6569.2006.00025.x; Palmini A, 2010, EPILEPSIA, V51, P23, DOI 10.1111/j.1528-1167.2009.02437.x; Widjajaa E, 2008, EPILEPSY RES, V82, P147, DOI 10.1016/j.eplepsyres.2008.07.013; Wilenius J, 2013, EPILEPSY RES, V105, P337, DOI 10.1016/j.eplepsyres.2013.02.023; Yoshinaga H, 2002, EPILEPSIA, V43, P924, DOI 10.1046/j.1528-1157.2002.42901.x	22	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	DEC	2014	125	12					2358	2363		10.1016/j.clinph.2014.02.028		6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AU3NK	WOS:000345520200008		
J	Hironaga, N; Hagiwara, K; Ogata, K; Hayamizu, M; Urakawa, T; Tobimatsu, S				Hironaga, Naruhito; Hagiwara, Koichi; Ogata, Katsuya; Hayamizu, Mariko; Urakawa, Tomokazu; Tobimatsu, Shozo			Proposal for a new MEG-MRI co-registration: A 3D laser scanner system	CLINICAL NEUROPHYSIOLOGY			English	Article						Magnetoencephalography; Co-registration; Source localization; 3D laser scanner; Tactile finger representations; Minimum norm estimate	PRIMARY SOMATOSENSORY CORTEX; CAMERA PHOTOGRAMMETRY SYSTEM; CORTICAL ACTIVITY; FUNCTIONAL MRI; EEG; SURFACE; LOCALIZATION; FINGER; BRAIN; SPACE	Objective: Co-registration between the head shape extracted from anatomical images that are obtained using a 3D digitizer is a non-negligible factor for magnetoencephalographic (MEG) utilization. The study aimed to propose a novel quick system based on a laser scanning technique involving a 3D laser scanner system that allows instant measurement while maintaining high accuracy and reproducibility. Methods: The measurement duration, accuracy, and reproducibility of the finger representations in response to tactile stimulation between the 3D laser scanner-based method and the conventional magnetic field digitizer-based method were compared in 11 healthy subjects. Day-to-day variance in target registration error (TRE), day-to-day and session-to-session variability in head position indicator error (HRE) and source localization accuracy were evaluated with visualization of the source estimation and analysis of variance (ANOVA). Results: Our proposed one-snapshot approach enabled 3D digitization measurements in < 5 s, and significantly reduced TRE, while mean HREs were a comparable level. Although there was less dramatic improvement of source localization, we found a significant reduction in session-to-session variability and day-to-day variance using our proposed method. Conclusions: Our results clearly demonstrated improvements in speed, comfort, accuracy, and reproducibility when using our new MEG co-registration method. Significance: A systematic improvement in MEG measurement will be beneficial for routine clinical use. (C) 2014 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Hironaga, Naruhito; Hagiwara, Koichi; Ogata, Katsuya; Hayamizu, Mariko; Urakawa, Tomokazu; Tobimatsu, Shozo] Kyushu Univ, Fac Med, Grad Sch Med Sci, Neurol Inst,Dept Clin Neurophysiol, Fukuoka 8128582, Japan	Hironaga, N (reprint author), Kyushu Univ, Fac Med, Grad Sch Med Sci, Neurol Inst,Dept Clin Neurophysiol,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hironaga@med.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [22390177, 23135525]	We thank the participants who took part in our study and agreed to have their facial images used. We also thank Ms. Tachibana from UC Davis for applying native English redaction. This work was supported in part by a Grant-in-Aid for Scientists, No. 22390177 and No. 23135525, from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Audette MA, 2000, MED IMAGE ANAL, V4, P201, DOI 10.1016/S1361-8415(00)00014-1; Taulu S, 2004, BRAIN TOPOGR, V16, P269; Schweizer R, 2008, NEUROIMAGE, V42, P28, DOI 10.1016/j.neuroimage.2008.04.184; Maurer CR, 1998, IEEE T MED IMAGING, V17, P753, DOI 10.1109/42.736031; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Hlustik P, 2001, CEREB CORTEX, V11, P312, DOI 10.1093/cercor/11.4.312; Schwartz D, 1996, BRAIN TOPOGR, V9, P101, DOI 10.1007/BF01200710; Bardouille T, 2012, IEEE T BIO-MED ENG, V59, P3491, DOI 10.1109/TBME.2012.2220356; Molins A, 2008, NEUROIMAGE, V42, P1069, DOI 10.1016/j.neuroimage.2008.05.064; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Whalen C, 2008, HUM BRAIN MAPP, V29, P1288, DOI 10.1002/hbm.20465; Kozinska D, 2001, CLIN NEUROPHYSIOL, V112, P1553, DOI 10.1016/S1388-2457(01)00556-9; Singh KD, 1997, ELECTROEN CLIN NEURO, V102, P81, DOI 10.1016/S0921-884X(96)96570-4; Russell GS, 2005, CLIN NEUROPHYSIOL, V116, P1130, DOI 10.1016/j.clinph.2004.12.022; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Adjamian P, 2004, CLIN NEUROPHYSIOL, V115, P691, DOI 10.1016/j.clinph.2003.10.023; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bauer H, 2000, NEUROIMAGE, V11, pS461, DOI 10.1016/S1053-8119(00)91392-2; Baysal U, 2010, ANN BIOMED ENG, V38, P1539, DOI 10.1007/s10439-010-9950-4; de Munck JC, 2001, PHYS MED BIOL, V46, P2041, DOI 10.1088/0031-9155/46/8/301; Gondo K, 2001, NEUROREPORT, V12, P3227, DOI 10.1097/00001756-200110290-00017; Gouws AD, 2009, NEUROIMAGE, V47, pS100; Hironaga N, 2002, P 13 INT C BIOM, P931; Huppertz HJ, 1998, ELECTROEN CLIN NEURO, V106, P409, DOI 10.1016/S0013-4694(98)00021-2; Kober H, 2002, STEREOT FUNCT NEUROS, V79, P272, DOI 10.1159/000072396; Koessler L, 2010, ANN BIOMED ENG, V39, P983; Koessler L, 2008, NEUROIMAGE, V41, P914, DOI 10.1016/j.neuroimage.2008.02.039; Koikkalainen J, 2004, IEEE T INF TECHNOL B, V8, P377, DOI 10.1109/TITB.2004.834401; Lamm C, 2001, BRAIN TOPOGR, V14, P93, DOI 10.1023/A:1012988728672; Maintz J B, 1998, Med Image Anal, V2, P1, DOI 10.1016/S1361-8415(01)80026-8; Martuzzi R, 2012, HUM BRAIN MAPP, V35, P213; Onishi H, 2010, CLIN NEUROPHYSIOL, V121, P588, DOI 10.1016/j.clinph.2009.12.022; Qian S, 2011, ANN BIOMED ENG, V39, P2844, DOI 10.1007/s10439-011-0374-6; ROSSINI PM, 1994, BRAIN RES, V642, P169, DOI 10.1016/0006-8993(94)90919-9; Schaefer M, 2004, BRAIN TOPOGR, V17, P47, DOI 10.1023/B:BRAT.0000047336.15770.86; Schweisfurth MA, 2011, NEUROIMAGE, V56, P2138, DOI 10.1016/j.neuroimage.2011.03.038; Wang Binseng, 1994, Brain Topography, V6, P185, DOI 10.1007/BF01187708; WILLIAMSON S J, 1989, Brain Topography, V2, P129, DOI 10.1007/BF01128850; WILLIAMSON S J, 1991, Brain Topography, V4, P169, DOI 10.1007/BF01132773; Wilson H, 2007, INT C SER, V1300, P623, DOI 10.1016/j.ics.2007.02.051; YAMAMOTO T, 1988, P NATL ACAD SCI USA, V85, P8732, DOI 10.1073/pnas.85.22.8732	43	2	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	DEC	2014	125	12					2404	2412		10.1016/j.clinph.2014.03.029		9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AU3NK	WOS:000345520200014		
J	Tsutsumi, S; Akiba, C; Suzuki, T; Nakanishi, H; Izumi, H; Yasumoto, Y; Ito, M				Tsutsumi, Satoshi; Akiba, Chihiro; Suzuki, Takamoto; Nakanishi, Hajime; Izumi, Hiroshi; Yasumoto, Yukimasa; Ito, Masanori			Skull Base Chondroid Chordoma: Atypical Case Manifesting as Intratumoral Hemorrhage and Literature Review	CLINICAL NEURORADIOLOGY			English	Review						Chondroid chordoma; Skull base; Intratumoral hemorrhage; Neuroimaging findings	PETROUS TEMPORAL BONE; CLIVAL CHORDOMA; TRIGEMINAL NEURINOMA; IMMUNOHISTOCHEMICAL ANALYSIS; SUBARACHNOID HEMORRHAGE; CHONDROSARCOMA; TUMORS; INVOLVEMENT; RECURRENCE; METASTASES	Chondroid chordoma (CC) is a rare but commonest subtype of chordoma with little reported clinical information. The present study summarizes and updates present knowledge of CC. Literature search for demographic data and clinical appearance of cranial CCs except for those entirely confined to the sinonasal region. A total of 48 English language papers published from 1968-2013 were retrieved describing 132 CCs as skull base tumors. The male-to-female ratio was 1:1. The mean age at diagnosis was 43 years, predisposing to the third to fifth decades of life. The clival (34 %) and spheno-occipital (29 %) regions were the most frequent sites of origin followed by the sellar (12 %) and sphenoid (5 %) regions. Intratumoral calcification and bony erosion were identified as the characteristic neuroimaging findings. Surgical resection by the transcranial, transsphenoidal, transnasal, transpharyngeal, or transpalatal route with or without adjuvant radiotherapy was the main treatment option. The initial treatment outcome was satisfactory in 82 % of cases with considerably better prognosis compared with typical chordomas. CC is a distinct entity to be discriminated from the typical type of chordoma. There are no distinguishing features on magnetic resonance imaging between CC and typical chordoma. Intratumoral calcification and concurrent bony erosion on neuroimaging should suggest the possibility of CC. Extensive surgical resection and adjuvant radiotherapy can achieve satisfactory outcome.	[Tsutsumi, Satoshi; Akiba, Chihiro; Suzuki, Takamoto; Nakanishi, Hajime; Yasumoto, Yukimasa; Ito, Masanori] Juntendo Univ, Urayasu Hosp, Dept Neurol Surg, Chiba 2790021, Japan; [Izumi, Hiroshi] Juntendo Univ, Urayasu Hosp, Dept Pathol, Chiba, Japan	Tsutsumi, S (reprint author), Juntendo Univ, Urayasu Hosp, Dept Neurol Surg, 2-1-1 Tomioka, Chiba 2790021, Japan.	shotaro@juntendo-urayasu.jp					Agrawal A, 2008, J CANC RES THER, V4, P91; Akai T, 1997, J CLIN NEUROSCI, V4, P244, DOI 10.1016/S0967-5868(97)90081-3; Stark AM, 2003, NEW ENGL J MED, V349, pE10, DOI 10.1056/ENEJMicm010745; Jian BJ, 2010, J NEURO-ONCOL, V98, P101, DOI 10.1007/s11060-009-0068-1; Mangubat EZ, 2010, SKULL BASE-INTERD AP, V20, P469, DOI 10.1055/s-0030-1261266; Krisht KM, 2012, J NEUROSURG, V116, P861, DOI 10.3171/2011.12.JNS111020; Majoie CBLM, 1999, NEURORADIOLOGY, V41, P100; ASARI S, 1992, CLIN NEUROL NEUROSUR, V94, P219, DOI 10.1016/0303-8467(92)90092-H; BASTIAENSEN LAK, 1983, DOC OPHTHALMOL, V55, P5, DOI 10.1007/BF00140455; BROOKS JJ, 1987, ACTA NEUROPATHOL, V72, P229; Brooks J J, 1989, Curr Top Pathol, V80, P165; CLARK WC, 1982, J NEUROSURG, V57, P842, DOI 10.3171/jns.1982.57.6.0842; Drummond DS, 1997, J OTOLARYNGOL, V26, P197; FALCONER MA, 1968, J NEUROSURG, V29, P261, DOI 10.3171/jns.1968.29.3.0261; Harada K, 2006, J NEURO-ONCOL, V77, P221, DOI 10.1007/s11060-005-9023-y; HARBOUR JW, 1991, SKULL BASE SURG, V1, P200, DOI 10.1055/s-2008-1057099; HASEGAWA M, 1985, J LARYNGOL OTOL, V99, P485, DOI 10.1017/S0022215100097097; HEFFELFI.MJ, 1973, CANCER, V32, P410, DOI 10.1002/1097-0142(197308)32:2<410::AID-CNCR2820320219>3.0.CO;2-S; Hirosawa RM, 2011, ISRN ENDOCRINOL, V2011; ISHIDA T, 1994, J NEURO-ONCOL, V18, P199, DOI 10.1007/BF01328954; Iwasaki S, 2004, ANN OTO RHINOL LARYN, V113, P82; JEFFREY PB, 1995, AM J CLIN PATHOL, V103, P271; Jiagang Liu, 2010, J Clin Neurosci, V17, P402, DOI 10.1016/j.jocn.2009.05.017; KAUFMAN BA, 1995, PEDIATR NEUROSURG, V23, P159, DOI 10.1159/000120953; Kitai R, 2005, NEURORADIOLOGY, V47, P368, DOI 10.1007/s00234-005-1367-7; Komatsu M, 2012, TURK NEUROSURG, V22, P123; KOSHIYAMA H, 1992, INTERNAL MED, V31, P1366, DOI 10.2169/internalmedicine.31.1366; KUBOTA T, 1981, SURG NEUROL, V16, P157, DOI 10.1016/0090-3019(81)90123-3; Lee HJ, 1998, NEURORADIOLOGY, V40, P720; Lieu A S, 1998, Kaohsiung J Med Sci, V14, P181; MIERAU GW, 1987, ULTRASTRUCT PATHOL, V11, P731; MITCHELL A, 1993, CANCER, V72, P2943, DOI 10.1002/1097-0142(19931115)72:10<2943::AID-CNCR2820721014>3.0.CO;2-6; Mohanty PP, 2003, CLIN ONCOL-UK, V15, P365, DOI 10.1016/S0936-6555(03)00151-1; Moriki T, 1999, DIAGN CYTOPATHOL, V21, P335, DOI 10.1002/(SICI)1097-0339(199911)21:5<335::AID-DC8>3.0.CO;2-D; Nabeshima K, 1997, ACTA CYTOL, V41, P913; Nakau R, 2003, NEUROL MED-CHIR, V43, P605, DOI 10.2176/nmc.43.605; Nguyen G K, 1985, Diagn Cytopathol, V1, P161, DOI 10.1002/dc.2840010213; Nishigaya K, 1998, J NEUROSURG, V88, P764, DOI 10.3171/jns.1998.88.4.0764; Okamoto K, 1996, AM J NEURORADIOL, V17, P117; Ooi GC, 1996, BRIT J RADIOL, V69, P363; PERSSON S, 1991, PATHOL RES PRACT, V187, P828; RICHTER HJ, 1975, ANN OTO RHINOL LARYN, V84, P327; ROSENBERG AE, 1994, AM J CLIN PATHOL, V101, P36; Rossiello R, 2001, ORL J OTO-RHINO-LARY, V63, P114, DOI 10.1159/000055722; RUPA V, 1989, J LARYNGOL OTOL, V103, P771, DOI 10.1017/S0022215100110035; Sagit M, 2011, J CRANIOFAC SURG, V22, P1720, DOI 10.1097/SCS.0b013e31822e6434; SALISBURY JR, 1987, J PATHOL, V153, P37, DOI 10.1002/path.1711530106; Sastri Savitr B, 2011, Neurol India, V59, P773, DOI 10.4103/0028-3886.86567; SHIMABUKURO H, 1983, SURG NEUROL, V19, P346, DOI 10.1016/0090-3019(83)90241-0; Shinde S V, 2005, J Postgrad Med, V51, P220; Shintaku M, 2010, MED MOL MORPHOL, V43, P241, DOI 10.1007/s00795-010-0509-0; SHOTTON JC, 1992, SKULL BASE SURG, V2, P112, DOI 10.1055/s-2008-1057120; Sorimachi T, 2008, J NEUROSURG, V109, P904, DOI 10.3171/JNS/2008/109/11/0904; SPODEN JE, 1980, ANN OTO RHINOL LARYN, V89, P279; TAKENAKA K, 1992, Neurologia Medico-Chirurgica, V32, P28, DOI 10.2176/nmc.32.28; Uda T, 2006, NEUROL INDIA, V54, P306; Uggowitzer MM, 1999, NEURORADIOLOGY, V41, P504; VALDERRAMA E, 1983, AM J SURG PATHOL, V7, P625, DOI 10.1097/00000478-198310000-00003; WALKER WP, 1991, MODERN PATHOL, V4, P661; Watson D, 1991, Indiana Med, V84, P18; WENIG BL, 1985, OTOLARYNG HEAD NECK, V93, P559; WOJNO KJ, 1992, AM J SURG PATHOL, V16, P1144, DOI 10.1097/00000478-199212000-00002; Zemmoura I, 2012, BRIT J NEUROSURG, V26, P102, DOI 10.3109/02688697.2011.595844	63	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1869-1439	1869-1447		CLIN NEURORADIOL	Clin. Neuroradiol.	DEC	2014	24	4					313	320		10.1007/s00062-014-0321-7		8	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AU1SJ	WOS:000345400200002		
J	Kanzaki, F; Hiwatashi, A; Yoshiura, T; Togao, O; Yamashita, K; Kamano, H; Kikuchi, K; Honda, H				Kanzaki, F.; Hiwatashi, A.; Yoshiura, T.; Togao, O.; Yamashita, K.; Kamano, H.; Kikuchi, K.; Honda, H.			Minute Subsequent Fracture at Prophylactically Treated Adjacent Vertebra After Percutaneous Vertebroplasty	CLINICAL NEURORADIOLOGY			English	Editorial Material							COMPRESSION FRACTURES; CEMENT LEAKAGE; RISK-FACTORS; OSTEOPOROSIS; BODIES; BODY; DISC		[Kanzaki, F.; Hiwatashi, A.; Yoshiura, T.; Togao, O.; Yamashita, K.; Kamano, H.; Kikuchi, K.; Honda, H.] Kyushu Univ, Dept Clin Radiol, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan	Kanzaki, F (reprint author), Kyushu Univ, Dept Clin Radiol, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hiwatasi@radiol.med.kyushu-u.ac.jp					Voormolen MHJ, 2006, J VASC INTERV RADIOL, V17, P71, DOI 10.1097/01.RVI.0000190910.43602.3C; Uppin AA, 2003, RADIOLOGY, V226, P119, DOI 10.1148/radiol.2261011911; Grados F, 2000, RHEUMATOLOGY, V39, P1410, DOI 10.1093/rheumatology/39.12.1410; Kobayashi N, 2009, ACAD RADIOL, V16, P136, DOI 10.1016/j.acra.2008.05.005; ROSS PD, 1991, ANN INTERN MED, V114, P919; Tanigawa N, 2007, AM J ROENTGENOL, V189, pW348, DOI 10.2214/AJR.07.2186; Trout AT, 2006, AM J NEURORADIOL, V27, P217; Baroud G, 2003, EUR SPINE J, V12, P421, DOI 10.1007/s00586-002-0512-9; Lin WC, 2008, J VASC INTERV RADIOL, V19, P225, DOI 10.1016/j.jvir.2007.09.008; Trout AT, 2006, J BONE MINER RES, V21, P1797, DOI 10.1359/JBMR.060723; Kim SH, 2004, ACTA RADIOL, V45, P440, DOI 10.1080/02841850410005615; Lin EP, 2004, AM J NEURORADIOL, V25, P175; Hiwatashi A, 2009, AM J NEURORADIOL, V30, P1830, DOI 10.3174/ajnr.A1722; Hiwatashi A, 2007, AM J NEURORADIOL, V28, P1055, DOI 10.3174/ajnr.A0519; Hiwatashi A, 2007, AM J ROENTGENOL, V188, P1089, DOI 10.2214/AJR.06.0903; Kamano H, 2011, AM J ROENTGENOL, V197, P451, DOI 10.2214/AJR.10.5937; Lin CC, 2007, AM J NEURORADIOL, V28, P1042, DOI 10.3174/ajnr.A0520; Lin CC, 2009, RADIOLOGY, V251, P866, DOI 10.1148/radiol.2513080914; Syed MI, 2006, AM J NEURORADIOL, V27, P1938; Trout AT, 2006, AM J NEURORADIOL, V27, P1586	20	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1869-1439	1869-1447		CLIN NEURORADIOL	Clin. Neuroradiol.	DEC	2014	24	4					381	383		10.1007/s00062-013-0254-6		3	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AU1SJ	WOS:000345400200011		
J	Matsumoto, K; Hayakawa, N; Nakamura, S				Matsumoto, K.; Hayakawa, N.; Nakamura, S.			Granulocyte Colony-stimulating Factor-producing Upper Urinary Tract Carcinoma: Systematic Review of 46 Cases Reported in Japan	CLINICAL ONCOLOGY			English	Article						Granulocyte colony-stimulating factor; G-CSF; renal pelvis; upper urinary tract carcinoma; ureter	TRANSITIONAL-CELL CARCINOMA; UROTHELIAL CARCINOMA; RENAL PELVIS; CANCER; URETER; GROWTH	Aims: Granulocyte colony-stimulating factor (G-CSF)-producing upper urinary tract carcinoma is extremely rare, and we do not yet have a comprehensive understanding of the disease. This study was carried out to determine the characteristics of G-CSF-producing upper urinary tract carcinoma. Materials and methods: A systematic MEDLINE and ICHUSHI WEB (Japan Medical Abstract Society) search was carried out to identify articles and conference proceedings describing patients with G-CSF-producing upper urinary tract carcinoma. The final cohort included 46 patients: eight studies were published in English, 16 in Japanese and there were 18 Japanese conference proceedings. Results: The average age of patients was 67 years and the male to female ratio was 2.5 to 1. The mean white blood cell count was as high as 33 900/ml (range 10 000-121 000) in these patients. Pretreatment serum G-CSF levels were measured in 23 patients, all of which were higher (range 55-1220 pg/ml) than normal levels. Metastasis was detected in 29 patients (63%) and lymph node and lung metastases were well observed. The most commonly reported primary treatment was surgery (33 patients), but the median survival period for these patients was short (4.5 months). Multivariate analysis showed that lymph node and/or distant metastasis (hazard ratio 2.92, P = 0.020) and the absence of adjuvant therapy (hazard ratio 3.20, P = 0.014) were independent risk factors for mortality. A total of only seven patients survived more than 1 year and most had a history of neoadjuvant/adjuvant chemotherapy and/or radiation therapy. Conclusion: We believe that the presence of G-CSF-induced leukocytosis represents a distinct and highly aggressive form of upper urinary tract carcinoma. However, the results of our systematic review indicate that a multidisciplinary approach including surgery, neoadjuvant or adjuvant chemotherapy and radiotherapy may have the potential to control the disease, although we cannot provide definitive recommendations from this retrospective study. (C) 2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.	[Matsumoto, K.; Hayakawa, N.; Nakamura, S.] Tokyo Saiseikai Cent Hosp, Dept Urol, Tokyo 1080073, Japan	Matsumoto, K (reprint author), Tokyo Saiseikai Cent Hosp, Dept Urol, Minato Ku, Mita 1-4-17, Tokyo 1080073, Japan.	kazz_matsumoto@yahoo.co.jp					Akatsuka J, 2014, INT CANC C J, V3, P19; METCALF D, 1985, SCIENCE, V229, P16, DOI 10.1126/science.2990035; Yamamoto S, 1999, J GASTROENTEROL, V34, P640, DOI 10.1007/s005350050387; Raman JD, 2011, UROL ONCOL-SEMIN ORI, V29, P716, DOI 10.1016/j.urolonc.2009.11.007; ASANO S, 1977, BLOOD, V49, P845; Margulis V, 2009, CANCER, V115, P1224, DOI 10.1002/cncr.24135; Chakraborty A, 2006, UROLOGY, V68, P208, DOI 10.1016/j.urology.2006.01.046; Czito B, 2004, J UROLOGY, V172, P1271, DOI 10.1097/01.ju.0000137910.38441.8a; Fujii Hidetaka, 2008, Hinyokika Kiyo, V54, P733; Fujikawa N, 2012, RINSYO HINYOKIKA, V66, P429; Fujita T, 2006, SURG TODAY, V36, P63, DOI 10.1007/s00595-005-3100-x; Fukuhara Hideo, 2010, Hinyokika Kiyo, V56, P505; Hakariya T, 2008, SASEBO KIYO, V34, P33; Higaki I, 2001, SURG TODAY, V31, P266; Hirasawa Kiyoshi, 2002, Journal of Urology, V167, P2130, DOI 10.1016/S0022-5347(05)65104-X; Ishigami T, 2001, J ORAL MAXIL SURG, V59, P804, DOI 10.1053/joms.2001.24299; Kajiwara Mitsuru, 2005, Hinyokika Kiyo, V51, P627; Kamai T, 1998, J NATL CANCER I, V90, P249, DOI 10.1093/jnci/90.3.249; Kitayama S, 2004, UROLOGY, V63, P377, DOI 10.1016/j.urology.2003.09.071; MORITA T, 1995, UROL INT, V55, P32; Nemoto Kaoru, 2006, Nihon Hinyokika Gakkai Zasshi, V97, P852; Nezasa S, 1997, JPN J UROL SURG, V10, P681; Nomata K., 2009, BOUKOUGAN FRONTIER, V1, P27; Nomura Yoshihiro, 2013, Hinyokika Kiyo, V59, P737; Okada Takuya, 2002, Hinyokika Kiyo, V48, P155; Oki Takashi, 2013, Hinyokika Kiyo, V59, P353; Omura N, 1999, AM J GASTROENTEROL, V94, P273; Osaka Kimito, 2009, Hinyokika Kiyo, V55, P223; ROBINSON WA, 1974, ANN NY ACAD SCI, V230, P212, DOI 10.1111/j.1749-6632.1974.tb14451.x; Saitoh H, 2000, JPN J UROL SURG, V13, P1395; Shirakawa H, 2012, SCAND J UROL NEPHROL, V46, P136, DOI 10.3109/00365599.2011.644863; Suzuki K, 2009, J MED SOC TOHO, V56, P33; TACHIBANA M, 1995, CANCER RES, V55, P3438; TAHARA E, 1990, J CANCER RES CLIN, V116, P121, DOI 10.1007/BF01612665; Takahashi H, 2008, WORLD J SURG ONCOL, V6, DOI 10.1186/1477-7819-6-70; Tanaka Hiromasa, 2013, Nihon Naika Gakkai Zasshi, V102, P710; Terao S, 2005, INT J UROL, V12, P500, DOI 10.1111/j.1442-2042.2005.01084.x; Washino Satoshi, 2008, Nihon Hinyokika Gakkai Zasshi, V99, P703; Yamamoto Takumi, 1997, Rinsho Hinyokika, V51, P239; Zigeuner R, 2011, EUR UROL, V59, P584	40	0	0	ELSEVIER SCIENCE LONDON	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0936-6555	1433-2981		CLIN ONCOL-UK	Clin. Oncol.	DEC	2014	26	12					781	788		10.1016/j.clon.2014.08.006		8	Oncology	Oncology	AU2JM	WOS:000345444500010		
J	Ogawa, R; Stachnik, JM; Echizen, H				Ogawa, Ryuichi; Stachnik, Joan M.; Echizen, Hirotoshi			Clinical Pharmacokinetics of Drugs in Patients with Heart Failure: An Update (Part 2, Drugs Administered Orally)	CLINICAL PHARMACOKINETICS			English	Review							IMPAIRED RENAL-FUNCTION; STEADY-STATE PHARMACOKINETICS; ELDERLY HYPERTENSIVE PATIENTS; CONVERTING ENZYME-INHIBITION; CONGESTIVE CARDIAC-FAILURE; TREATED JAPANESE PATIENTS; II RECEPTOR ANTAGONIST; TROUGH SCREEN ANALYSIS; FACTOR XA INHIBITOR; POPULATION PHARMACOKINETICS	The purpose of the present review article is to update the information regarding pharmacokinetics of drugs in patients with heart failure that has accumulated since the last review article published in 1988 in Clinical Pharmacokinetics. Since this last review, our understanding of the pathophysiology of heart failure has changed from the cardio-renal model to the neuro-humoral model, and the pharmacologic approach to treatment of heart failure has been shifted from inotropic agents to those acting on the renin-angiotensin-aldosterone system. The pharmacologic agents now used for heart failure include many important classes of drugs, such as ACE inhibitors, angiotensin receptor blockers (antagonists) (ARBs), and mineralocorticoid receptor antagonists. In Part 1 of this review, we summarized the pharmacokinetic properties of relevant drugs administered intravenously. In Part 2, the present article, we describe pharmacokinetics of drugs following oral administration. For this purpose we conducted a systematic search of literature using MEDLINE, EMBASE, and Japan Centra Revuo Medicina (in Japanese). We retrieved a total of 110 relevant publications for 49 drugs and updated the information for ten drugs and provided new information for 31 drugs. We recognized that the pharmacokinetic data were obtained primarily from stable heart failure patients with moderate severity [New York Heart Association (NYHA) class II or III]. In addition, most patients were classified as heart failure with reduced ejection fraction. Furthermore, because most of the studies retrieved had no comparative groups of healthy subjects or patients without heart failure, historical controls from previous studies were used for comparisons. In Part 2, we also discuss the pharmacokinetics of active metabolites as well as parent drugs, because many drugs given by oral administration for the treatment of heart failure are prodrugs (e.g., ACE inhibitors and ARBs). The pharmacokinetic changes of drugs in patients with heart failure are discussed in the light of a physiologically based pharmacokinetic model. In addition, we discuss the effects of intestinal tissue heart failure-associated edema on drug absorption as it relates to the biopharmaceutical classification system, particularly for drugs demonstrating reduced systemic exposure as measured by the area under the plasma concentration-time curve after oral administration (AUC(po)) in patients with heart failure as compared with healthy subjects. After review of the available data, it was seen that among patients with asymptomatic or compensated chronic heart failure there seemed to be no or minimal alterations in the maximum concentration (C (max)) and AUC(po) of the included drugs, unless there was concurrent liver and/or renal dysfunction. In contrast, the AUC(po) of at least 14 drugs (captopril, cilazaprilat, enalapril/enalaprilat, perindopril, carvedilol, candesartan, pilsicainide, felodipine, furosemide, enoximone, milrinone, flosequinan, molsidomine, and ibopamine) were suspected or documented to increase after oral administration by 50 % or more in patients with symptomatic or decompensated heart failure.	[Ogawa, Ryuichi; Echizen, Hirotoshi] Meiji Pharmaceut Univ, Dept Pharmacotherapy, Tokyo 2048588, Japan; [Stachnik, Joan M.] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL USA	Ogawa, R (reprint author), Meiji Pharmaceut Univ, Dept Pharmacotherapy, 2-522-1 Noshio, Tokyo 2048588, Japan.	smridron@my-pharm.ac.jp; echizen@my-pharm.ac.jp					Abo Y, 1996, J N REMEDIES CLIN, V45, P1662; Albers S, 2008, BRIT J CLIN PHARMACO, V65, P511, DOI 10.1111/j.1365-2125.2007.03046.x; Andros E, 1996, EUR J CLIN PHARMACOL, V50, P41, DOI 10.1007/s002280050067; VERPOOTEN GA, 1991, BRIT J CLIN PHARMACO, V32, P187; Ravis WR, 2005, J CLIN PHARMACOL, V45, P810, DOI 10.1177/0091270005275894; Bjorkman S, 2005, BRIT J CLIN PHARMACO, V59, P691, DOI 10.1111/j.1365-2125.2004.02225.x; Wargo KA, 2009, ANN PHARMACOTHER, V43, P1836, DOI 10.1345/aph.1M177; [Anonymous], 2013, ALTACE RAM CUPS; [Anonymous], 2012, LUVOX CR FLUV MAL EX; [Anonymous], 2013, COREG CARV TABL; [Anonymous], 2012, DIOVAN VALS TABL; [Anonymous], 2013, XARELTO RIV TABL; Fradette C, 2004, CURR DRUG METAB, V5, P257, DOI 10.2174/1389200043335577; VERHO M, 1995, CURR MED RES OPIN, V13, P264, DOI 10.1185/03007999509111551; Graham GG, 2011, CLIN PHARMACOKINET, V50, P81, DOI 10.2165/11534750-000000000-00000; Borlaug BA, 2011, EUR HEART J, V32, P670, DOI 10.1093/eurheartj/ehq426; Sandek A, 2007, J AM COLL CARDIOL, V50, P1561, DOI 10.1016/j.jacc.2007.07.016; Arutyunov GP, 2008, INT J CARDIOL, V125, P240, DOI 10.1016/j.ijcard.2007.11.103; HEEL RC, 1980, DRUGS, V20, P409, DOI 10.2165/00003495-198020060-00001; Taylor AA, 2011, J CLIN HYPERTENS, V13, P677, DOI 10.1111/j.1751-7176.2011.00518.x; Morgan ET, 2009, CLIN PHARMACOL THER, V85, P434, DOI 10.1038/clpt.2008.302; [Anonymous], 2011, ACEON PER ERB TABL; Labbe L, 1999, CLIN PHARMACOKINET, V37, P361, DOI 10.2165/00003088-199937050-00002; [Anonymous], 2013, INSPRA EPL TABL; Brookman LJ, 1997, CLIN PHARMACOL THER, V62, P272, DOI 10.1016/S0009-9236(97)90029-1; [Anonymous], 2003, MEXITIL MEX HYDR CAP; Saito M, 2010, BIOL PHARM BULL, V33, P1378; [Anonymous], 2012, MIDAZOLAM MID HYDR I, DOI Schaumburg; White CM, 1998, PHARMACOTHERAPY, V18, P588; Gleiter CH, 2002, CLIN PHARMACOKINET, V41, P7, DOI 10.2165/00003088-200241010-00002; Prasad PP, 2002, J CARDIOVASC PHARM, V40, P801, DOI 10.1097/00005344-200211000-00018; [Anonymous], 2013, PROCARDIA NIF CAPS; Rouleau JL, 2000, LANCET, V356, P615, DOI 10.1016/S0140-6736(00)02602-7; Gehr TWB, 1999, EUR J CLIN PHARMACOL, V55, P269, DOI 10.1007/s002280050628; LEOPOLD G, 1986, J CLIN PHARMACOL, V26, P616; [Anonymous], 2013, MERK IND; Kubitza D, 2013, BRIT J CLIN PHARMACO, V76, P89, DOI 10.1111/bcp.12054; Murray MD, 1997, PHARMACOTHERAPY, V17, P98; [Anonymous], 2013, SAMSCA TOLV TABL; Zordoky BNM, 2008, CURR DRUG METAB, V9, P122; Fuhr U, 2007, CLIN PHARMACOL THER, V81, P270, DOI 10.1038/sj.clpt.6100050; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492; Laer S, 2002, AM HEART J, V143, P916, DOI 10.1067/mhj.2002.121265; Honda M, 2005, BIOL PHARM BULL, V28, P1476, DOI 10.1248/bpb.28.1476; [Anonymous], 1999, LANCET, V353, p[9, 3]; Gheorghiade M, 2011, J HEART LUNG TRANSPL, V30, P218, DOI 10.1016/j.healun.2010.08.027; [Anonymous], 2013, TOPROL XL MET SUCC E; [Anonymous], 2013, ZESTRIL LIS TABL; AMIDON GL, 1995, PHARMACEUT RES, V12, P413, DOI 10.1023/A:1016212804288; Lo MW, 1995, CLIN PHARMACOL THER, V58, P641, DOI 10.1016/0009-9236(95)90020-9; NIEMEYER C, 1983, EUR J CLIN PHARMACOL, V24, P661, DOI 10.1007/BF00542218; Tenero D, 2000, J CLIN PHARMACOL, V40, P844, DOI 10.1177/00912700022009576; Campbell TJ, 1998, BRIT J CLIN PHARMACO, V46, P307, DOI 10.1046/j.1365-2125.1998.t01-1-00768.x; Sica DA, 2005, CLIN PHARMACOKINET, V44, P797, DOI 10.2165/00003088-200544080-00003; [Anonymous], 2012, DRUG FACTS COMP; Anpo Y, 1996, J N REMEDIES CLIN, V45, P1662; Aoi W., 1996, RINSHO IYAKU, V12, P2429; APPLEFELD MM, 1981, J CLIN PHARMACOL, V21, P114; AZZOLLINI F, 1988, INT J CLIN PHARM TH, V26, P105; AZZOLLINI F, 1988, INT J CLIN PHARM TH, V26, P544; BARR WH, 1990, PR PHARM CL, V8, P29; BEERMANN B, 1979, BRIT J CLIN PHARMACO, V7, P579; BEERMANN B, 1988, AM J MED, V85, P25, DOI 10.1016/0002-9343(88)90346-4; BEGG EJ, 1994, BRIT J CLIN PHARMACO, V37, P302; BEGG EJ, 1990, BRIT J CLIN PHARMACO, V30, P213; Bellissant E, 2001, BRIT J CLIN PHARMACO, V52, P25, DOI 10.1046/j.0306-5251.2001.01410.x; Bleske BE, 1998, J CLIN PHARMACOL, V38, P708; BRATER DC, 1984, KIDNEY INT, V26, P183, DOI 10.1038/ki.1984.153; BRATER DC, 1992, EUR HEART J, V13, P10; BRAUN J, 1987, EUR J CLIN PHARMACOL, V31, P711, DOI 10.1007/BF00541300; BRAZZELL RK, 1984, CLIN PHARMACOL THER, V36, P613; Breslin E, 1996, J CLIN PHARMACOL, V36, P414; BUHRING KU, 1986, J CARDIOVASC PHARM, V8, pS21; Buter H, 1999, EUR J CLIN PHARMACOL, V54, P953, DOI 10.1007/s002280050581; CANAL M, 1983, EUR J CLIN PHARMACOL, V24, P509, DOI 10.1007/BF00609894; Carlton LD, 1996, J CLIN PHARMACOL, V36, P247; Carlton LD, 1996, J CLIN PHARMACOL, V36, P257; Carter NJ, 2013, DRUGS, V73, P715, DOI 10.1007/s40265-013-0056-9; CAVALLI A, 1988, CLIN PHARMACOKINET, V14, P187; CHATURVEDI PR, 1987, INT J CLIN PHARM TH, V25, P123; CHEN DG, 1990, CHINESE MED J-PEKING, V103, P1008; CHU KM, 1995, CLIN PHARMACOL THER, V57, P610, DOI 10.1016/0009-9236(95)90223-6; CHU KM, 1995, EUR J CLIN PHARMACOL, V47, P537; CLARKE AF, 1986, BIOPHARM DRUG DISPOS, V7, P47, DOI 10.1002/bdd.2510070107; COHEN AF, 1993, BRIT J CLIN PHARMACO, V35, P136; Cook CS, 2003, DRUG METAB DISPOS, V31, P1448, DOI 10.1124/dmd.31.11.1448; COOK JA, 1988, CLIN PHARMACOL THER, V44, P487; CRAWFORD MH, 1985, CLIN PHARMACOL THER, V38, P538; CUZZOLIN L, 1990, Pharmacological Research, V22, P137; Cyong J-C, 1998, RINSHO IYAKU, V14, P1727; DAHLSTROM U, 1983, EUR J CLIN PHARMACOL, V24, P495, DOI 10.1007/BF00609892; EL Desoky Ehab S, 2002, Am J Ther, V9, P492, DOI 10.1097/00045391-200211000-00006; DEVISSAGUET JP, 1990, FUNDAM CLIN PHARM, V4, P175; DOHERTY JE, 1961, ARCH INTERN MED, V108, P531; DUNSELMAN PHJM, 1989, BRIT J CLIN PHARMACO, V28, P45; Easthope SE, 2002, DRUGS, V62, P1253, DOI 10.2165/00003495-200262080-00016; ECKERT HG, 1984, ARZNEIMITTEL-FORSCH, V34-2, P1435; EDELSON J, 1986, CIRCULATION, V73, P145; EDGAR B, 1985, CLIN PHARMACOL THER, V38, P205; EDGAR B, 1987, BIOPHARM DRUG DISPOS, V8, P235, DOI 10.1002/bdd.2510080305; FINCH MB, 1984, BRIT J CLIN PHARMACO, V17, P353; Franciosa JA, 1983, J AM COLL CARDIOL, V1, P669; GAUTAM PC, 1987, J PHARM PHARMACOL, V39, P929; Giallourakis Cosmas C, 2002, Clin Liver Dis, V6, P947, DOI 10.1016/S1089-3261(02)00056-9; Gill KS, 1996, CLIN PHARMACOKINET, V31, P1; GIUDICELLI JF, 1987, BRIT J CLIN PHARMACO, V23, pS51; Goodman L. S., 1996, GOODMAN GILMANS PHAR; Gottlieb SS, 1998, AM J MED, V104, P533, DOI 10.1016/S0002-9343(98)00111-9; GREITHER A, 1979, PHARMACOLOGY, V19, P121, DOI 10.1159/000137299; GRETZER I, 1986, EUR J CLIN PHARMACOL, V31, P415, DOI 10.1007/BF00613516; GRYGIEL JJ, 1979, CLIN PHARMACOL THER, V26, P660; HANSON A, 1983, EUR J CLIN PHARMACOL, V25, P467, DOI 10.1007/BF00542113; HARRON DWG, 1992, DRUGS, V43, P734, DOI 10.2165/00003495-199243050-00008; HEINTZ B, 1993, J CARDIOVASC PHARM, V22, pS36; HEIZMANN P, 1981, ARZNEIMITTEL-FORSCH, V31-2, P2220; HEIZMANN P, 1983, BRIT J CLIN PHARMACO, V16, pS43; HINSON JL, 1994, J PHARM SCI, V83, P382, DOI 10.1002/jps.2600830323; Horiuchi I, 2008, BIOL PHARM BULL, V31, P976, DOI 10.1248/bpb.31.976; HUBER T, 1992, INT J CLIN PHARM TH, V30, P491; ITOH H, 1992, CARDIOLOGY, V80, P356, DOI 10.1159/000175026; JOHNSTON D, 1992, AM J CARDIOL, V70, pC151; Keating GM, 2003, DRUGS, V63, P1697, DOI 10.2165/00003495-200363160-00006; KESSLER KM, 1974, NEW ENGL J MED, V290, P706, DOI 10.1056/NEJM197403282901303; KIM JS, 2006, MOL PHARMACEUT, V3, P686; Kimata S, 1995, RINSHO IYAKU, V11, P299; KIRCH W, 1987, CLIN PHARMACOKINET, V13, P110, DOI 10.2165/00003088-198713020-00003; Knauf H, 1998, CLIN PHARMACOKINET, V34, P1, DOI 10.2165/00003088-199834010-00001; Kobayashi M, 2006, BIOL PHARM BULL, V29, P2267, DOI 10.1248/bpb.29.2267; Kondo K, 1986, JPN PHARMACOL THER, V14, P803; Kostis JB, 2001, J CLIN PHARMACOL, V41, P935, DOI 10.1177/00912700122010906; Kostis JB, 1995, CLIN PHARMACOL THER, V58, P660, DOI 10.1016/0009-9236(95)90022-5; Kostis JB, 2001, J CLIN PHARMACOL, V41, P1280, DOI 10.1177/00912700122012869; Kubitza D, 2010, BRIT J CLIN PHARMACO, V70, P703, DOI 10.1111/j.1365-2125.2010.03753.x; LANDAHL S, 1988, CLIN PHARMACOKINET, V14, P374; LECOCQ B, 1990, CLIN PHARMACOL THER, V47, P397; LESNE M, 1988, ARZNEIMITTEL-FORSCH, V38-1, P160; Li P, 2012, PHARM RES-DORDR, V29, P1658, DOI 10.1007/s11095-012-0690-z; LIMA JJ, 1984, J PHARMACOKINET BIOP, V12, P289, DOI 10.1007/BF01061722; LIMA JJ, 1986, J CLIN PHARMACOL, V26, P253; LIMA JJ, 1987, J CLIN PHARMACOL, V27, P654; Lo MW, 1998, J CLIN PHARMACOL, V38, P525; Machida M, 2007, JPN J THER DRUG MONI, V24, P155; Malhotra BK, 2001, J CLIN PHARMACOL, V41, P833, DOI 10.1177/00912700122010726; Mann DL., 2011, BRAUNWALDS HEART DIS, P487; Marino MR, 2002, J CARDIOVASC PHARM, V40, P112, DOI 10.1097/01.FJC.0000016134.88772.9B; MASSARELLA J, 1989, BRIT J CLIN PHARMACO, V27, pS199; MASSARELLA JW, 1987, J CLIN PHARMACOL, V27, P187; MCTAVISH D, 1993, DRUGS, V45, P232, DOI 10.2165/00003495-199345020-00006; MEREDITH PA, 1989, BRIT J CLIN PHARMACO, V27, pS263; Miyagawa T, 1990, RINSHO IYAKU, V6, P2001; MOHIUDDIN SM, 1983, CLIN PHARMACOL THER, V34, P596; MOLINARO M, 1992, EUR J CLIN PHARMACOL, V42, P203, DOI 10.1007/BF00278485; MUJAIS SK, 1992, AM J KIDNEY DIS, V19, P121; Muller FO, 1997, BRIT J CLIN PHARMACO, V44, P393, DOI 10.1046/j.1365-2125.1997.t01-1-00586.x; NAAFS MAB, 1985, EUR J CLIN PHARMACOL, V28, P249, DOI 10.1007/BF00543318; Nakajima M, 1998, RINSHO IYAKU, V14, P47; NEUGEBAUER G, 1990, EUR J CLIN PHARMACOL, V38, pS108, DOI 10.1007/BF01409476; Nicholls DP, 1996, EUR J CLIN PHARMACOL, V50, P289, DOI 10.1007/s002280050110; Nikolic VN, 2013, J PHARM SCI-US, V102, P2851, DOI 10.1002/jps.23626; Nikolic VN, 2013, EUR J CLIN PHARMACOL, V69, P859, DOI 10.1007/s00228-012-1427-y; NISHIDA M, 1990, JPN CIRC J, V54, P1497; NITSCH J, 1987, DEUT MED WOCHENSCHR, V112, P1698, DOI 10.1055/s-2008-1068315; Oda Y, 1999, BRIT J ANAESTH, V82, P900; OHNHAUS EE, 1979, EUR J CLIN PHARMACOL, V15, P115, DOI 10.1007/BF00609874; OHTAWA M, 1993, BRIT J CLIN PHARMACO, V35, P290; Orlando R, 2010, BRIT J CLIN PHARMACO, V69, P279, DOI 10.1111/j.1365-2125.2009.03587.x; Othman AA, 2007, AAPS J, V9, pE208, DOI 10.1208/aapsj0902023; Packer M, 2006, AM J CARDIOL, V98, p39L, DOI 10.1016/j.amjcard.2006.07.018; PARK GB, 1983, J PHARM SCI, V72, P817, DOI 10.1002/jps.2600720726; PATEL IH, 1990, BRIT J CLIN PHARMACO, V29, P565; PERUCCA E, 1994, CLIN PHARMACOKINET, V27, P175; Plosker GL, 2010, DRUGS, V70, P455, DOI 10.2165/11204960-000000000-00000; POULSEN HE, 1988, J HEPATOL, V6, P374, DOI 10.1016/S0168-8278(88)80057-6; Preechagoon Yupaporn, 2009, Journal of the Medical Association of Thailand, V92, P1324; REHNQVIST N, 1987, DRUGS, V34, P33; RIETBROCK N, 1976, EUR J CLIN PHARMACOL, V9, P373, DOI 10.1007/BF00606551; RISSAM HS, 1983, INT J CLIN PHARM TH, V21, P602; ROSENTHAL E, 1989, BRIT J CLIN PHARMACO, V27, pS267; Rowland M, 2011, CLIN PHARMACOKINETIC; RUDER MA, 1991, J CLIN PHARMACOL, V31, P702; SAKAI M, 1993, EUR J CLIN PHARMACOL, V44, P387, DOI 10.1007/BF00316479; SCHUNKERT H, 1989, EUR J CLIN PHARMACOL, V37, P249, DOI 10.1007/BF00679779; SCHWARTZ JB, 1985, J CARDIOVASC PHARM, V7, P767, DOI 10.1097/00005344-198507000-00023; SCOTT AK, 1988, BRIT J CLIN PHARMACO, V25, P165; SEINO Y, 1995, CARDIOLOGY, V86, P34, DOI 10.1159/000176828; SHAMMAS FV, 1988, CLIN PHARMACOKINET, V15, P94, DOI 10.2165/00003088-198815020-00002; SHEN DD, 1980, J PHARMACOKINET BIOP, V8, P53, DOI 10.1007/BF01059448; SHEPHERD AMM, 1980, CLIN PHARMACOL THER, V28, P804; SHIONOIRI H, 1990, J CARDIOVASC PHARM, V16, P594, DOI 10.1097/00005344-199010000-00010; Sica Domenic A, 2003, Congest Heart Fail, V9, P287, DOI 10.1111/j.1527-5299.2003.02399.x; SILKE B, 1981, J CARDIOVASC PHARM, V3, P329, DOI 10.1097/00005344-198103000-00011; SINGHVI SM, 1988, BRIT J CLIN PHARMACO, V25, P9; SPREUXVAROQUAUX O, 1991, BRIT J CLIN PHARMACO, V32, P399; SQUIRE IB, 1994, BRIT J CLIN PHARMACO, V38, P117; Suematsu F, 2001, JPN J PHARM HLTH CAR, V27, P426; Suematsu F, 2002, BIOPHARM DRUG DISPOS, V23, P173, DOI 10.1002/bdd.306; vanLier JJ, 1997, J HUM HYPERTENS, V11, pS27; Taguchi M, 2004, BIOL PHARM BULL, V27, P1642, DOI 10.1248/bpb.27.1642; TAKABATAKE T, 1991, EUR J CLIN PHARMACOL, V40, P411, DOI 10.1007/BF00265853; TAKAGI T, 2006, MOL PHARMACEUT, V3, P631; Thireau J, 2011, PHARMACOL THERAPEUT, V132, P125, DOI 10.1016/j.pharmthera.2011.03.003; THUILLEZ C, 1990, J CARDIOVASC PHARM, V15, P527, DOI 10.1097/00005344-199004000-00002; TICE FD, 1992, CLIN PHARMACOL THER, V52, P496; TILL AE, 1989, BRIT J CLIN PHARMACO, V27, P199; TILSTONE WJ, 1974, CLIN PHARMACOL THER, V16, P322; TROVATO GM, 1983, CURR THER RES CLIN E, V33, P158; U. S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), 2000, GUID IND WAIV IN VIV; Uchida S, 2003, CLIN PHARMACOL THER, V74, P505, DOI 10.1016/j.clpt.2003.08.001; UENO K, 1990, CLIN PHARMACY, V9, P936; ULM EH, 1982, BRIT J CLIN PHARMACO, V14, P357; Vachharajani NN, 1998, J CLIN PHARMACOL, V38, P702; Van Wart SA, 2013, BIOPHARM DRUG DISPOS, V34, P336, DOI 10.1002/bdd.1849; VARGO DL, 1995, CLIN PHARMACOL THER, V57, P601, DOI 10.1016/0009-9236(95)90222-8; VASKO MR, 1985, ANN INTERN MED, V102, P314; VOZEH S, 1982, EUR J CLIN PHARMACOL, V23, P445, DOI 10.1007/BF00605996; Warren JV, 1944, SCIENCE, V100, P108, DOI 10.1126/science.100.2588.108; WEINBERGER M, 1978, NEW ENGL J MED, V299, P852, DOI 10.1056/NEJM197810192991603; WILLIAMS PEO, 1989, BRIT J CLIN PHARMACO, V27, pS181; WILSON H, 1987, RES COMMUN CHEM PATH, V56, P3; WISEMAN MN, 1991, J PHARM PHARMACOL, V43, P406; Yi S, 2012, J CARDIOVASC PHARM, V59, P315, DOI 10.1097/FJC.0b013e318241e89c; Yokota M., 1989, THER RES, V10, P2135; Yukawa E, 2001, CLIN PHARMACOKINET, V40, P773, DOI 10.2165/00003088-200140100-00005; Yukawa E, 1997, J CLIN PHARMACOL, V37, P92; Yukawa M, 2011, DRUG AGING, V28, P831, DOI 10.2165/11594230-000000000-00000; Yukawa M, 2010, JPN J THER DRUG MONI, V27, P78; Yukawa M, 2011, J CLIN PHARMACOL, V51, P857, DOI 10.1177/0091270010374475; Zhou XD, 2010, ACTA PHARMACOL SIN, V31, P753, DOI 10.1038/aps.2010.51	228	0	0	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0312-5963	1179-1926		CLIN PHARMACOKINET	Clin. Pharmacokinet.	DEC	2014	53	12					1083	1114		10.1007/s40262-014-0189-3		32	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU1OF	WOS:000345389300002		
J	Hirashima, H; Yamaguchi, S; Katsushima, T				Hirashima, Hiroyuki; Yamaguchi, Satoru; Katsushima, Takafumi			A multi-dimensional water transport model to reproduce preferential flow in the snowpack	COLD REGIONS SCIENCE AND TECHNOLOGY			English	Article						Water transport in the snowpack; Numerical model; Preferential flow; Water entry suction	HYDRAULIC CONDUCTIVITY; LAYERED SOILS; SURFACE-AREA; PERMEABILITY; INFILTRATION; MICROSTRUCTURE; RETENTION; EQUATION	A multi-dimensional water transport model for a snowpack was developed to reproduce preferential flow. Darcy-Buckingham's law and the van Genuchten model were used to simulate water movement. Parameters for the van Genuchten model were determined as functions of snow density and grain size, based on a previous gravity drainage column experiment. Water entry suction was newly incorporated to simulate liquid water infiltrating dry snow, based on the results of a previous capillary pressure experiment. Heterogeneity of grain size and snow density were also implemented. Heterogeneity alone was not sufficient for the development of preferential flow paths. When both water entry suction and heterogeneity were implemented, the model could simulate the formation of a preferential flow path. Validation of the simulation results by comparison with the results of a previous laboratory experiment showed that the simulated preferential flow path reproduced the experimental result fairly well. The size of the preferential flow path was negatively correlated with grain size and positively correlated with the water supply rate in both the simulation and the experiment. Comparison of the time series of suction between the simulation and the experimental result suggested that some additional measurements need to be obtained experimentally to improve the accuracy of the model. Sensitivity experiments showed that grain size and snow density heterogeneity affected both the size of the preferential flow path and the arrival time of liquid water at the snow base. These results suggest that more measurements of small-scale spatial variability in natural snow are needed to improve the model. (C) 2014 Elsevier B.V. All rights reserved.	[Hirashima, Hiroyuki; Yamaguchi, Satoru] NIED, Snow & Ice Res Ctr, Nagaoka, Niigata, Japan; [Katsushima, Takafumi] Toyama Natl Coll Technol, Toyama, Japan	Hirashima, H (reprint author), Natl Res Inst Earth Sci & Disaster Prevent, Snow & Ice Res Ctr, 187-16 Maeyama,Suyoshi Machi, Nagaoka, Niigata 9400821, Japan.	hirasima@bosai.go.jp					Adachi S., 2012, ISSW P 2012 ANCH AL, P918; HILLEL D, 1988, SOIL SCI, V146, P51, DOI 10.1097/00010694-198807000-00008; Calonne N, 2012, CRYOSPHERE, V6, P939, DOI 10.5194/tc-6-939-2012; MCCLUNG DM, 1987, J GEOPHYS RES-SOLID, V92, P6301, DOI 10.1029/JB092iB07p06301; Mitterer C, 2011, ANN GLACIOL, V52, P201, DOI 10.3189/172756411797252077; Courville Z, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001549; Matzl M, 2006, J GLACIOL, V52, P558, DOI 10.3189/172756506781828412; Wever N, 2014, CRYOSPHERE, V8, P257, DOI 10.5194/tc-8-257-2014; Hirashima H, 2010, COLD REG SCI TECHNOL, V64, P94, DOI 10.1016/j.coldregions.2010.09.003; Yamaguchi S, 2010, COLD REG SCI TECHNOL, V64, P87, DOI 10.1016/j.coldregions.2010.05.008; ILLANGASEKARE TH, 1990, WATER RESOUR RES, V26, P1001, DOI 10.1029/WR026i005p01001; Yamaguchi S, 2012, ANN GLACIOL, V53, P6, DOI 10.3189/2012AoG61A001; Waldner PA, 2004, HYDROL PROCESS, V18, P1271, DOI 10.1002/hyp.1401; Zermatten E, 2011, J GLACIOL, V57, P811; MUALEM Y, 1976, WATER RESOUR RES, V12, P513, DOI 10.1029/WR012i003p00513; Katsushima T, 2013, COLD REG SCI TECHNOL, V85, P206, DOI 10.1016/j.coldregions.2012.09.012; BAKER RS, 1990, SOIL SCI SOC AM J, V54, P20; BOX GEP, 1958, ANN MATH STAT, V29, P610, DOI 10.1214/aoms/1177706645; DiCarlo DA, 2013, WATER RESOUR RES, V49, P4531, DOI 10.1002/wrcr.20359; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892; Lehning M, 2002, COLD REG SCI TECHNOL, V35, P147, DOI 10.1016/S0165-232X(02)00073-3; Arakawa H., 2010, SEPPYO, V72, P311; Colbeck S. C., 1974, J GLACIOL, V13, P85; Colbeck S.C., 1973, INT ASS HYDROLOGICAL, V107, P242; COLBECK SC, 1975, WATER RESOUR RES, V11, P261, DOI 10.1029/WR011i002p00261; Daanen RP, 2009, J COLD REG ENG, V23, P43, DOI 10.1061/(ASCE)0887-381X(2009)23:2(43); Daanen R.P., 2004, THESIS U MINNESOTA; Fierz C., 2009, INT CLASSIFICATION S, V1; Gustafsson D, 2004, HYDROL PROCESS, V18, P1165, DOI 10.1002/hyp.1398; Hirashima H, 2009, ISSW 09 EUROPE: INTERNATIONAL SNOW SCIENCE WORKSHOP, PROCEEDINGS, P252; JORDAN R, 1995, DEFENCE SCI J, V45, P79; KATTELMANN R, 1985, ANN GLACIOL, V6, P272; Kattelmann R, 1984, ISSW P 1984, P102; Schneebeli M, 1999, COLD REG SCI TECHNOL, V30, P101, DOI 10.1016/S0165-232X(99)00030-0; Shimizu H, 1970, CONTRIB I LOW TEMP A, VA22, P1; SOMMERFELD RA, 1993, WATER RESOUR RES, V29, P2485, DOI 10.1029/93WR01071; Sugie S., 2000, SEPPYO, V62, P117; Wankiewicz A., 1979, P M MOD SNOW COV RUN, P222	38	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-232X	1872-7441		COLD REG SCI TECHNOL	Cold Reg. Sci. Tech.	DEC	2014	108						80	90		10.1016/j.coldregions.2014.09.004		11	Engineering, Environmental; Engineering, Civil; Geosciences, Multidisciplinary	Engineering; Geology	AU2WM	WOS:000345475400010		
J	Ikeda, S; Katsushima, T; Matsushita, H; Ito, Y; Takeuchi, Y; Akiyama, K				Ikeda, Shinji; Katsushima, Takafumi; Matsushita, Hiroki; Ito, Yasuhiko; Takeuchi, Yukari; Akiyama, Kazuya			Comparison of snowpack on a slope and on flat land focusing on the effects of water infiltration	COLD REGIONS SCIENCE AND TECHNOLOGY			English	Article						Water infiltration of snowpack; Wet snow; Snowpack stratigraphy; Snowpack model; Wet avalanche	FLOW; ALBEDO	Water infiltration of snowpack plays an important role in the formation of wet avalanches. Several studies have examined water infiltration of snowpack on flat land. However, because water flow has a directional component parallel to the slope in snowpack on a slope, the effects of water infiltration into snowpack may differ between flat land and slopes, where avalanches are more likely to occur. From January 2012 to April 2012, we simultaneously observed snow pits on flat land and on a slope (40 degrees incline; NE aspect). The observations showed that MFr (the ratio of the total thickness of the layers composed of melt forms to the thickness of all layers of the snowpack) was, on average, 23% higher for the snowpack on the slope than for the snowpack on flat land, despite the slope's being a shaded side slope. The largest difference between the MFr of the slope and that of the flat land was observed in early March, when MFr was 99% at the slope and 46% at the flat-land site. We analyzed these observations using a one-dimensional multi-layer snowpack model proposed by Katsushima et al. (2009). The model included parameterization of the vertical water-channel process in snowpack. Based on the results, to represent the MFr at each site, the amount of water infiltrating through vertical water channels was estimated at 27.4 mm (2% of the total amount of water provided from the snow surface) for the slope and 797.2 mm (54%) for the flat land. Our results indicate that in wet-snow regions, differences in the water infiltration process can generate notable differences between snowpack on a slope and that on flat land. (C) 2014 Elsevier B.V. All rights reserved.	[Ikeda, Shinji; Matsushita, Hiroki; Akiyama, Kazuya] Publ Works Res Inst, Snow Avalanche & Landslide Res Ctr, Myoko, Niigata 9440051, Japan; [Katsushima, Takafumi] Toyama Natl Coll Technol, Imizu, Toyama, Japan; [Ito, Yasuhiko] Publ Works Res Inst, Civil Engn Res Inst Cold Reg, Sapporo, Hokkaido, Japan; [Takeuchi, Yukari] Forestry & Forest Prod Res Inst, Tohkamachi Expt Stn, Tohkamachi, Niigata, Japan	Ikeda, S (reprint author), Publ Works Res Inst, Snow Avalanche & Landslide Res Ctr, 2-6-8 Nishiki Cho, Myoko, Niigata 9440051, Japan.	s-ikeda55@pwri.go.jp					PEREZ R, 1990, SOL ENERGY, V44, P271, DOI 10.1016/0038-092X(90)90055-H; Calonne N, 2012, CRYOSPHERE, V6, P939, DOI 10.5194/tc-6-939-2012; REINDL DT, 1990, SOL ENERGY, V45, P1, DOI 10.1016/0038-092X(90)90060-P; Katsushima T, 2009, COLD REG SCI TECHNOL, V59, P143, DOI 10.1016/j.coldregions.2009.09.002; Baggi S, 2009, NAT HAZARDS, V50, P97, DOI 10.1007/s11069-008-9322-7; Hirashima H, 2010, COLD REG SCI TECHNOL, V64, P94, DOI 10.1016/j.coldregions.2010.09.003; Yamaguchi S, 2010, COLD REG SCI TECHNOL, V64, P87, DOI 10.1016/j.coldregions.2010.05.008; Yamaguchi S, 2012, ANN GLACIOL, V53, P6, DOI 10.3189/2012AoG61A001; Waldner PA, 2004, HYDROL PROCESS, V18, P1271, DOI 10.1002/hyp.1401; WISCOMBE WJ, 1980, J ATMOS SCI, V37, P2712, DOI 10.1175/1520-0469(1980)037<2712:AMFTSA>2.0.CO;2; Katsushima T, 2013, COLD REG SCI TECHNOL, V85, P206, DOI 10.1016/j.coldregions.2012.09.012; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892; Aoki T, 2007, ANN GLACIOL-SER, V46, P375, DOI 10.3189/172756407782871747; COLBECK SC, 1979, COLD REG SCI TECHNOL, V1, P37, DOI 10.1016/0165-232X(79)90017-X; COLBECK SC, 1978, ADV HYDROSCI, V11, P165; Conway H., 1988, P INT SNOW SCI WORKS, P211; Fierz C., 2009, TECHNICAL DOCUMENTS, P80; JORDAN P, 1983, WATER RESOUR RES, V19, P971, DOI 10.1029/WR019i004p00971; Kattelmann R., 1985, P INT SNOW SCI WORKS, P102; KONDO J, 1986, BOUND-LAY METEOROL, V34, P415, DOI 10.1007/BF00120992; McClung D., 2006, AVALANCHE HDB, P271; Rango A., 2008, PRINCIPLES SNOW HYDR; Takeuchi Y, 1998, ANN GLACIOL, V26, P27; Techel F., 2010, P ISSW 2010 INT SNOW, P187; Wakahama G., 1963, LOW TEMPERATURE SC A, V21, P45; Wankiewicz A., 1979, P M MOD SNOW COV RUN, P222; Yamanoi K., 2002, J JPN SOC SNOW ICE, V64, P443, DOI 10.5331/seppyo.64.443; Yamanoi K., 2000, B FORESTRY FOREST PR, V377, P61; Yamazaki T., 1998, J JAPANESE SOC SNOW, V60, P131, DOI 10.5331/seppyo.60.131	29	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-232X	1872-7441		COLD REG SCI TECHNOL	Cold Reg. Sci. Tech.	DEC	2014	108						91	97		10.1016/j.coldregions.2014.08.010		7	Engineering, Environmental; Engineering, Civil; Geosciences, Multidisciplinary	Engineering; Geology	AU2WM	WOS:000345475400011		
J	Iizuka, S; Endo, Y; Hirose, M; Kanamori, Y; Mitani, J; Fukui, Y				Iizuka, S.; Endo, Y.; Hirose, M.; Kanamori, Y.; Mitani, J.; Fukui, Y.			Object Repositioning Based on the Perspective in a Single Image	COMPUTER GRAPHICS FORUM			English	Article						image; video editing; image and video processing	SALIENT REGION DETECTION	We propose an image editing system for repositioning objects in a single image based on the perspective of the scene. In our system, an input image is transformed into a layer structure that is composed of object layers and a background layer, and then the scene depth is computed from the ground region that is specified by the user using a simple boundary line. The object size and order of overlapping are automatically determined during the reposition based on the scene depth. In addition, our system enables the user to move shadows along with objects naturally by extracting the shadow mattes using only a few user-specified scribbles. Finally, we demonstrate the versatility of our system through applications to depth-of-field effects, fog synthesis and 3D walkthrough in an image.	[Iizuka, S.; Endo, Y.; Hirose, M.; Kanamori, Y.; Mitani, J.; Fukui, Y.] Univ Tsukuba, Tsukuba, Ibaraki, Japan	Iizuka, S (reprint author), Univ Tsukuba, Tsukuba, Ibaraki, Japan.	iizuka@npal.cs.tsukuba.ac.jp; endo@npal.cs.tsukuba.ac.jp; hirose@npal.cs.tsukuba.ac.jp; kanamori@cs.tsukuba.ac.jp; mitani@cs.tsukuba.ac.jp; fukui@cs.tsukuba.ac.jp					Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Sun J, 2004, ACM T GRAPHIC, V23, P315, DOI 10.1145/1015706.1015721; Lempitsky V, 2009, IEEE I CONF COMP VIS, P277, DOI 10.1109/ICCV.2009.5459262; Achanta R, 2009, PROC CVPR IEEE, P1597; Saxena A, 2008, INT J COMPUT VISION, V76, P53, DOI 10.1007/s11263-007-0071-y; Hoiem D, 2005, ACM T GRAPHIC, V24, P577, DOI 10.1145/1073204.1073232; Goldberg C, 2012, COMPUT GRAPH FORUM, V31, P265, DOI 10.1111/j.1467-8659.2012.03005.x; Perazzi F, 2012, PROC CVPR IEEE, P733, DOI 10.1109/CVPR.2012.6247743; Li Y, 2004, ACM T GRAPHIC, V23, P303, DOI 10.1145/1015706.1015719; Perez P, 2003, ACM T GRAPHIC, V22, P313, DOI 10.1145/882262.882269; Wexler Y, 2007, IEEE T PATTERN ANAL, V29, P463, DOI 10.1109/TPAMI.2007.60; Cheng MM, 2011, PROC CVPR IEEE, P409, DOI 10.1109/CVPR.2011.5995344; [Anonymous], 2001, 8 IEEE INT C COMP VI; Yang Y, 2012, IEEE T PATTERN ANAL, V34, P1731, DOI 10.1109/TPAMI.2011.208; Rother C, 2004, ACM T GRAPHIC, V23, P309, DOI 10.1145/1015706.1015720; WANG JYA, 1994, IEEE T IMAGE PROCESS, V3, P625, DOI 10.1109/83.334981; Barnes C., 2009, ACM T GRAPHIC, V28, P3; Cheng M.-M., 2010, ACM T GRAPHIC, V29, P83; Cho TS, 2010, IEEE T PATTERN ANAL, V32, P1489, DOI 10.1109/TPAMI.2009.133; Everingham M., PASCAL VISUAL OBJECT; Fattal R, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1360612.1360671; Hoiem D., 2006, CVPR, V2, P2137; Hou X., 2007, IEEE C COMP VIS PATT, V1, P1, DOI DOI 10.1109/CVPR.2007.383267; Iizuka S., 2011, IEEE COMPUT GRAPH, V32, P18; Jia JY, 2006, ACM T GRAPHIC, V25, P631, DOI 10.1145/1141911.1141934; Kang H., 2001, COMPUT GRAPH FORUM, V20, P132, DOI 10.1111/1467-8659.00506; Kass M., 1988, INT J COMPUT VISION, V1, P321, DOI DOI 10.1007/BF00133570; Lalonde JF, 2007, ACM T GRAPHIC, V26, DOI [10.1145/1276377.1276381, 10.1145/1239451.1239454]; Liu J., 2009, TOG, V28, P69; LO WY, 2010, ACM T GRAPHIC, V29; MANSFIELD A, 2010, ECCV 10, V6311, P143; Mortensen E. N., 1995, SIGGRAPH 95, P191, DOI DOI 10.1145/218380.218442; SHESH A, 2009, GI 09, P47; Simakov D., 2008, P IEEE C COMP VIS PA, P1; Wei Y., 2012, EUR C COMP VIS, P29; WU TP, 2007, ACM T GRAPHICS, V26; ZHAI Y, 2006, MULTIMEDIA 06, P815, DOI DOI 10.1145/1180639.1180824	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0167-7055	1467-8659		COMPUT GRAPH FORUM	Comput. Graph. Forum	DEC	2014	33	8					157	166		10.1111/cgf.12423		10	Computer Science, Software Engineering	Computer Science	AU4HY	WOS:000345572500013		
J	Mokodongan, DF; Tanaka, R; Yamahira, K				Mokodongan, Daniel F.; Tanaka, Rieko; Yamahira, Kazunori			A New Ricefish of the Genus Oryzias (Beloniformes, Adrianichthyidae) from Lake Tiu, Central Sulawesi, Indonesia	COPEIA			English	Article							BAROMBI-MBO; WEST-CAMEROON; CRATER LAKES; CICHLIDS; FISHES; STRATIFICATION; AFRICA	We describe Oryzias soerotoi, a new species of ricefish, from Lake Tiu, Central Sulawesi, Indonesia. The new species is distinguished from all other species in the genus Oryzias in Sulawesi by combination of brilliant orange coloration in the dorsal and ventral margins of the caudal fins of adult males, 30-32 scales along the lateral midline, 9-10 pectoral-fin rays, head lengths of 21.9-24.9% SL, anal-fin base lengths of 23.7-29.7% SL, and maximum SL up to 32.1 mm. The orange margins of the caudal fins of males become more brilliant during courtship. Kami mendiskripsi Oryzias soerotoi, satu jenis baru ikan padi dari Danau Tiu, Sulawesi Tengah, Indonesia. Jenis baru ini dengan mudah dapat dibedakan dari semua jenis anggota genus Oryzias di Sulawesi dengan adanya kombinasi warna jingga yang sangat mencolok di bagian atas dan bawah sirip ekor pada jantan dewasa, 30-32 jumlah sisik sepanjang garis sisi, 9-10 jumlah jari-jari sirip dada, ukuran kepala pendek 21.9-24.9% SL, panjang pada pangkal sirip anal 23.7-29.7% SL, dan maksimal SL mencapai 32.1 mm. Warna jingga di sirip ekor pada jantan menjadi lebih mencolok selama proses percumbuan.	[Mokodongan, Daniel F.; Yamahira, Kazunori] Univ Ryukyus, Trop Biosphere Res Ctr, Okinawa 9030213, Japan; [Tanaka, Rieko] Nagoya Higashiyama Zool Pk, Worlds Medaka Aquarium, Nagoya, Aichi 4640804, Japan	Mokodongan, DF (reprint author), Univ Ryukyus, Trop Biosphere Res Ctr, Okinawa 9030213, Japan.	dh4ni31.ichi.san@gmail.com; rieko-f@mbr.nifty.com; yamahira@lab.u-ryukyu.ac.jp			Basler Stiftung fur Experimentelle Zoologie; Czech Science Foundation [14-36098G]; Germany Research Foundation [DFG SCHL567/1]; Basler Stiftung fur Biologische Forschung	We would like to thank the Ministry of Scientific Research and Innovation (MINRESI) for issuing of research permits, the Barombi villagers and fishermen for their good reception as well as for their invaluable help with fishing. We thank C. Dening and N. Ephesians Jiku for their willingness to share their experience. We thank M. Smith for providing the species picture. The project was funded by the Basler Stiftung fur Experimentelle Zoologie and Basler Stiftung fur Biologische Forschung (ZM and AI); R.T. was financed by the Czech Science Foundation (14-36098G), and U.K.S was supported by the Germany Research Foundation grant DFG SCHL567/1	SCHLIEWEN UK, 1994, NATURE, V368, P629, DOI 10.1038/368629a0; BILONG CFB, 1991, ANN PARASIT HUM COMP, V66, P105; Bitja Nyom A. R., 2012, THESIS U YAOUNDE YAO; CORNEN G, 1992, J VOLCANOL GEOTH RES, V51, P357, DOI 10.1016/0377-0273(92)90108-P; DOMINEY WJ, 1988, ENVIRON BIOL FISH, V22, P155, DOI 10.1007/BF00001545; Dunz AR, 2013, MOL PHYLOGENET EVOL, V68, P64, DOI 10.1016/j.ympev.2013.03.015; Friedman M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1733; GREEN J, 1973, J ZOOL, V170, P299; Harrison Ian J., 1999, P271; IUCN, 2012, IUCN RED LIST CAT CR; KLING GW, 1988, LIMNOL OCEANOGR, V33, P27; KUSAKABE M, 1989, J VOLCANOL GEOTH RES, V39, P167, DOI 10.1016/0377-0273(89)90056-5; Lamboj A., 2004, CICHLID FISHES W AFR; Martin CH, 2012, AM NAT, V180, pE90, DOI 10.1086/667586; Moelants T, 2010, IUCN 2013 IUCN RED L; Reid M. G., 1991, ANN MUSEE ROYAL AFRI, V263, P109; Reid M. G., 1990, J FISH BIOL        S, V37; Schliewen Ulrich K., 2004, Frontiers in Zoology, V1, P1; TREWAVAS E, 1972, J ZOOL, V167, P41; Trewavas E., 1962, Bonner Zoologische Beitraege, V13, P146	20	1	1	AMER SOC ICHTHYOLOGISTS & HERPETOLOGISTS	MIAMI	MAUREEN DONNELLY, SECRETARY FLORIDA INT UNIV BIOLOGICAL SCIENCES, 11200 SW 8TH STREET, MIAMI, FL 33199 USA	0045-8511	1938-5110		COPEIA	Copeia	DEC	2014		3					561	567		10.1643/CI-13-081		7	Zoology	Zoology	AU3OR	WOS:000345523700006		
J	Watanabe, S; Aoyama, J; Tsukamoto, K				Watanabe, Shun; Aoyama, Jun; Tsukamoto, Katsumi			On the Identities of Anguilla borneensis, A. malgumora, and Muraena malgumora	COPEIA			English	Article							FRESH-WATER EELS; GENUS ANGUILLA; MOLECULAR PHYLOGENY; ICELANDIC EELS; ATLANTIC; VARIABILITY; EVOLUTION	To determine the valid name of the Borneo eel that has a plain body coloration and is endemic to Borneo Island, three type specimens of Anguilla borneensis Popta, 1924, Anguilla malgumora Kaup, 1856, and Muraena malgumora Bleeker, 1864 were examined and compared to the morphological characters of the 42 longfin eels from Borneo, A. anguilla (44), A. japonica (37), and A. dleffenbachii (14), all of which have the same external appearance of a long dorsal fin and plain body color, except for M. malgumora Bleeker, 1864, which has a short dorsal fin. Discriminant analysis using 13 proportional characters and the relationship among three vertebral characters clearly showed that the type specimen of Anguilla malgumora Kaup, 1856 upon which Bauchot et al. (1993) proposed the revival of that name to replace A. borneensis Popta, 1924, based on priority without examining the specimen, was in fact clearly not a specimen of the Borneo eel as was concluded by Ege (1939). Therefore A. borneensis Popta, 1924 is the valid name for the Borneo eel, and A. malgumora Kaup, 1856 appears to be a junior synonym of A. anguilla (Linnaeus, 1758), and M. malgumora Bleeker is a junior synonym of A. bicolor McClelland, 1844.	[Watanabe, Shun; Tsukamoto, Katsumi] Nihon Univ, Coll Bioresource Sci, Fujisawa, Kanagawa 2520880, Japan; [Aoyama, Jun] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan	Watanabe, S (reprint author), Nihon Univ, Coll Bioresource Sci, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	watanabe.shun@nihon-u.ac.jp			Ito Foundation for Promotion of Ichthyology; Japan Science Society; Japan Society for the Promotion of Science [18780143, JSPS-RFTF 97L00901]; Ministry of Education, Culture, Sports, Science and Technology of Japan [07306022, 08041139, 11691177, 12NP0201, 18208018, 21228005, 23580246]; Touwa Shokuhin Shinkoukai; Eel Research Foundation of Nobori-kai	This study could not have been possible without generous assistance by the following colleagues during sampling expeditions, for which we sincerely thank them: D. Limbong, T. Yoshinaga, K. Watanabe, T. Arai, T. Otake, D. Jellyman, and H. Sugeha. The paper benefited from critical comments and suggestions by K. Matsuura, M. Miller, G. Shinohara, K. Shibukawa, R. Arai, and C. Lord. We thank M. Oya for her assistance in many aspects of the project and thank the scientists, fish curators, and collection managers of many distinguished institutions for making specimens under their care available: P. Keith, T. Robinet, E. Feunteun, P. Pruvost, and C. Gregorio (MNHN), P. Campbell and O. Crimmen (BMNH), and M. van Oijen (RMNH). SW was partly supported by the Ito Foundation for Promotion of Ichthyology, a Sasakawa Scientific Research Grant from the Japan Science Society, and Research Fellowships for Young Scientists (No. 18780143) from the Japan Society for the Promotion of Science. This study was supported partly by Grants-in-aid (No. 07306022, 08041139, 11691177, 12NP0201, 18208018, 21228005, and 23580246) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; "Research for the Future'' Program No. JSPS-RFTF 97L00901 from the Japan Society for the Promotion of Science; Touwa Shokuhin Shinkoukai; and the Eel Research Foundation of Nobori-kai.	Aoyama J, 2001, MOL PHYLOGENET EVOL, V20, P450, DOI 10.1006/mpev.2001.0959; Miller MJ, 2009, AM FISH S S, V69, P231; Watanabe S, 2013, FISHERIES SCI, V79, P375, DOI 10.1007/s12562-013-0620-y; Albert V, 2006, MOL ECOL, V15, P1903, DOI 10.1111/j.1365-294X.2006.02917.x; AVISE JC, 1990, EVOLUTION, V44, P1254, DOI 10.2307/2409286; Inoue JG, 2010, BIOL LETTERS, V6, P363, DOI 10.1098/rsbl.2009.0989; Minegishi Y, 2005, MOL PHYLOGENET EVOL, V34, P134, DOI 10.1016/j.ympev.2004.09.003; Lin YS, 2001, MOL PHYLOGENET EVOL, V20, P252, DOI 10.1006/mpev.2001.0969; Tsukamoto K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1174; Watanabe S, 2004, B MAR SCI, V74, P337; Zenimoto K, 2009, J FISH BIOL, V74, P1878, DOI 10.1111/j.1095-8649.2009.02295.x; Aoyama J, 2003, BIOL BULL-US, V204, P104, DOI 10.2307/1543500; Watanabe S, 2009, FISHERIES SCI, V75, P387, DOI 10.1007/s12562-009-0087-z; Teng HY, 2009, ZOOL STUD, V48, P808; Aoyama Jun, 2009, Aqua-Bioscience Monographs, V2, P1; Avise J. C., 2003, CATADROMOUS EELS N A, P31; Bauchot M. L., 1993, Cybium, V17, P91; Bleeker P., 1864, ATLAS ICHTHYOLOGIQUE, VIV; BOETIUS J, 1980, Dana, V1, P93; Ege V, 1939, DANA REP, V16, P1; Eschmeyer WN, 2014, CATALOG FISHES GENER; Gunther A, 1870, CATALOGUE FISHES BRI, V8; Kaup J.J., 1856, CATALOGUE APODAL FIS; Lin YS, 2002, ZOOL STUD, V41, P421; Lin YS, 2005, ZOOL SCR, V34, P225, DOI 10.1111/j.1463-6409.2005.00192.x; Martin-Smith KM, 1998, RAFFLES B ZOOL, V46, P573; Menon A.G.K., 1999, RECORDS ZOOLOGICAL S, V175, P1; Miller Michael J., 2009, Aqua-Bioscience Monographs, V2, P1; Silfvergrip A. M. C., 2009, CITES IDENTIFICATION; Smith D. G., 1999, FAO SPECIES IDENTIFI, V3, P1630; Watanabe S, 2003, EEL BIOLOGY, P3; Watanabe S, 2006, NEW ZEAL J MAR FRESH, V40, P325; Watanabe S., 2012, EELS PHYSL HABITAT C, P1; Weber M, 1912, ZOOL HB S15, V1; WILLIAMS GC, 1984, COPEIA, P221	35	0	0	AMER SOC ICHTHYOLOGISTS & HERPETOLOGISTS	MIAMI	MAUREEN DONNELLY, SECRETARY FLORIDA INT UNIV BIOLOGICAL SCIENCES, 11200 SW 8TH STREET, MIAMI, FL 33199 USA	0045-8511	1938-5110		COPEIA	Copeia	DEC	2014		3					568	576		10.1643/CI-14-059		9	Zoology	Zoology	AU3OR	WOS:000345523700007		
J	Kim, TH; Kojima, S; Ko, JH				Kim, Tae Hyun; Kojima, Seiji; Ko, Jae-Hyeon			Electric field effects on the dielectric and acoustic anomalies of Pb [(Mg1/3Nb2/3)(0.83)Ti-0.17]O-3 single crystals studied by dielectric and Brillouin spectroscopies	CURRENT APPLIED PHYSICS			English	Article						Relaxor; PMN-PT; Field effect; Brillouin scattering; Acoustic anomaly	ELECTROMECHANICAL RESPONSE; PHASE-TRANSITIONS; FERROELECTRICS	The effect of the electric field on the dielectric and acoustic properties of Pb[(Mg1/3Nb2/3)(0.83)Ti-0.17]O-3 single crystals was investigated as functions of temperature and the electric field strength. The dielectric constant and the acoustic mode behaviors exhibited typical relaxor behaviors when there was no bias field. The longitudinal acoustic mode showed splitting under a moderate electric field of 1 kV/cm applied along the [001] direction, indicating coexistence of macroscopic/mesoscopic ferroelectric states and relaxor states. Further increase in the electric field up to 2 kV/cm induced a clear ferroelectric phase transition, which became smeared out due to the proximity of the electric field to the critical point. The electric field-temperature phase diagram of Pb[( Mg1/3Nb2/3)(0.83)Ti-0.17]O-3 was suggested based on the observed field-induced changes in the dielectric and the acoustic properties. (C) 2014 Elsevier B.V. All rights reserved.	[Kim, Tae Hyun; Kojima, Seiji] Univ Tsukuba, Grad Sch Pure & Appl Phys, Tsukuba, Ibaraki 3058573, Japan; [Ko, Jae-Hyeon] Hallym Univ, Dept Phys, Chunchon 200702, Gangwondo, South Korea	Ko, JH (reprint author), Hallym Univ, Dept Phys, 39 Hallymdaehakgil 39, Chunchon 200702, Gangwondo, South Korea.	hwangko1@gmail.com			Marubun Research Promotion Foundation; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2013R1A1A2006582]	One of the authors (SK) is thankful to SICCAS for providing the single crystals. This research was supported in part by the Marubun Research Promotion Foundation and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2013R1A1A2006582).	REHWALD W, 1973, ADV PHYS, V22, P721, DOI 10.1080/00018737300101379; Park SE, 1997, J APPL PHYS, V82, P1804, DOI 10.1063/1.365983; Ko JH, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.104110; Kutnjak Z, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.054102; Fu HX, 2000, NATURE, V403, P281; Kojima S, 2011, CURR APPL PHYS, V11, pS22, DOI 10.1016/j.cap.2011.04.038; Fu DS, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.207601; Novak N, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.037601; Ye ZG, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.104104; Zhao X, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.104106; Jin YM, 2003, J APPL PHYS, V94, P3629, DOI 10.1063/1.1599632; Alguero M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2010608; Kutnjak Z, 2006, NATURE, V441, P956, DOI 10.1038/nature04854; Ko JH, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3663622; DEMATHAN N, 1991, J PHYS-CONDENS MAT, V3, P8159, DOI 10.1088/0953-8984/3/42/011; Ye ZG, 1998, KEY ENG MATER, V155-1, P81; Bidault O, 1996, J PHYS-CONDENS MAT, V8, P8017, DOI 10.1088/0953-8984/8/42/020; Bokov A.A., 2006, J MATER SCI, V41, P313; BURNS G, 1990, FERROELECTRICS, V104, P25, DOI 10.1080/00150199008223809; Cao H, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.184110; Iwata M, 2011, J KOREAN PHYS SOC, V59, P2449, DOI 10.3938/jkps.59.2449; Ko JH, 2006, J APPL PHYS, V100, DOI 10.1063/1.2338829; Lushnikov SG, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.104122; Perantie J, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2993345; Rozic B, 2011, J APPL PHYS, V110, DOI 10.1063/1.3641975; Tsukada S, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.033707	26	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-1739	1878-1675		CURR APPL PHYS	Curr. Appl. Phys.	DEC	2014	14	12					1643	1648		10.1016/j.cap.2014.09.014		6	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AU1RM	WOS:000345397900008		
J	Isshiki, M; Sichanugrist, P; Abe, Y; Oyama, T; Odaka, H; Konagai, M				Isshiki, Masanobu; Sichanugrist, Porponth; Abe, Yusuke; Oyama, Takuji; Odaka, Hidefumi; Konagai, Makoto			New method to measure whole-wavelength transmittance of TCO substrates for thin-film silicon solar cells	CURRENT APPLIED PHYSICS			English	Article						TCO; Transmittance; Texture; Thin-film silicon solar cell	SIC-H; A-SI; EFFICIENCY	High transmittance of transparent conductive oxide (TCO) substrates is one of the most important factors for achieving high efficiency in thin-film silicon solar cells. Immersion (IM) method with CH2I2 liquid is widely used for the evaluation of optical properties (transmittance, reflectance and absorption) for TCO substrates with textured surface in order to reduce the scattering at the TCO surface. However, in order to measure transmittance accurately, three problems have been found. (1) CH2I2 liquid itself absorbs the light in short wavelength region. (2) The transmittance around the absorption edge of CH2I2 liquids is very sensitive to its amount. (3) Scattering cannot be suppressed when the scattering surfaces are more than 2 surfaces (for example, TCO on reactive ion etching (RIE) processed glass). To overcome these problems, we proposed a new setup to measure optical properties of TCO substrates by holding the samples inside the integral sphere. As the results, we have confirmed that their absorption in all wavelength could be measured accurately and the transmittance measured by the new method was well consistent with the external quantum efficiency (EQE) of the fabricated cell while the transmittance measured with conventional IM method showed differently. Therefore, this new method could be a useful tool to evaluate TCO substrates for thin-film silicon solar cells. (C) 2014 Elsevier B.V. All rights reserved.	[Isshiki, Masanobu; Sichanugrist, Porponth; Abe, Yusuke; Konagai, Makoto] Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528552, Japan; [Konagai, Makoto] Tokyo Inst Technol, Photovolta Res Ctr PVREC, Meguro Ku, Tokyo 1528552, Japan; [Isshiki, Masanobu; Oyama, Takuji; Odaka, Hidefumi] Asahi Glass Co Ltd, Res Ctr, Yokohama, Kanagawa 2218755, Japan	Isshiki, M (reprint author), Asahi Glass Co Ltd, Res Ctr, Yokohama, Kanagawa 2218755, Japan.	masanobu-isshiki@agc.com	Sichanugrist, Porponth/D-6102-2015		New Energy and Industrial Technology Development Organization under METI, Japan	This study was supported by the New Energy and Industrial Technology Development Organization under METI, Japan.	TAWADA Y, 1981, APPL PHYS LETT, V39, P237, DOI 10.1063/1.92692; Hongsingthong A, 2013, THIN SOLID FILMS, V537, P291, DOI 10.1016/j.tsf.2013.04.138; Das D, 1997, J NON-CRYST SOLIDS, V210, P148, DOI 10.1016/S0022-3093(96)00597-2; Lazo MAG, 2012, SOL ENERG MAT SOL C, V103, P147, DOI 10.1016/j.solmat.2012.04.034; Konagai M, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.030001; Kim S, 2013, SOL ENERG MAT SOL C, V119, P26, DOI 10.1016/j.solmat.2013.04.016; Battaglia C, 2011, NANO LETT, V11, P661, DOI 10.1021/nl1037787; KITAGAWA M, 1983, J APPL PHYS, V54, P3269, DOI 10.1063/1.332436; Iftiquar SM, 1998, J PHYS D APPL PHYS, V31, P1630, DOI 10.1088/0022-3727/31/14/004; TAWADA Y, 1982, J APPL PHYS, V53, P5273, DOI 10.1063/1.331363; SOLOMON I, 1988, PHYS REV B, V38, P13263, DOI 10.1103/PhysRevB.38.13263; Hongsingthong A, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.051102; Feltrin A, 2013, SOL ENERG MAT SOL C, V119, P219, DOI 10.1016/j.solmat.2013.07.012; Bessonov A, 2011, SOL ENERG MAT SOL C, V95, P2886, DOI 10.1016/j.solmat.2011.06.007; Despeisse M., 2011, 21 INT PHOT SCI ENG; Escarre J, 2011, SOL ENERG MAT SOL C, V95, P881, DOI 10.1016/j.solmat.2010.11.010; Fujikake S., 2011, MRS P, V258, P875; HAMAKAWA Y, 1983, APPL PHYS LETT, V43, P644, DOI 10.1063/1.94462; Isshiki M., 2013, 23 INT PHOT SCI ENG, P2; Isshiki M., 2014, MRS P, V1536; Kambe M., 2010, RES REPORTS ASAHI GL, V60; Kambe M., 2009, 2009 34 IEEE PHOT SP; MIZUHASHI M, 1988, JPN J APPL PHYS 1, V27, P2053, DOI 10.1143/JJAP.27.2053; Oyama T., 2008, MRS P, V1101; Steinhauser J., 2008, LOW PRESSURE CHEM VA; Stiebig H, 2006, PROG PHOTOVOLTAICS, V14, P13, DOI 10.1002/pip.638; Yunaz IA, 2007, JPN J APPL PHYS 2, V46, pL1152, DOI 10.1143/JJAP.46.L1152	27	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-1739	1878-1675		CURR APPL PHYS	Curr. Appl. Phys.	DEC	2014	14	12					1813	1818		10.1016/j.cap.2014.10.021		6	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AU1RM	WOS:000345397900037		
J	Shiozawa, M; Takahashi, H; Iwasaki, N; Wada, T; Uo, M				Shiozawa, Maho; Takahashi, Hidekazu; Iwasaki, Naohiko; Wada, Takahiro; Uo, Motohiro			Effect of immersion time of restorative glass ionomer cements and immersion duration in calcium chloride solution on surface hardness	DENTAL MATERIALS			English	Article						Glass ionomer cement; Calcium chloride; Surface hardness; Elemental analysis	MECHANICAL-PROPERTIES; MICROHARDNESS; CHEMISTRY; STORAGE; WATER; ACID	Objectives. The objective of this study was to evaluate the effect of immersion time of restorative glass ionomer cements (GICs) and immersion duration in calcium chloride (CaCl2) solution on the surface hardness. Methods. Two high-viscosity GICs, Fuji IX GP and GlasIonomer FX-II, were selected. Forty-eight specimens were randomly divided into two groups. Sixty minutes after being mixed, half of them were immersed in a 42.7 wt% CaCl2 solution for 10, 30, or 60 min (Group 1); the remaining specimens were immersed after an additional 1-week of storage (Group 2). The surface hardness of the specimens was measured and analyzed with two-way ANOVA and the Tukey HSD test (alpha = 0.05). The surface compositions were examined using energy dispersive X-ray spectroscopy and X-ray photoelectron spectroscopy. Results. The surface hardness of Group 1 significantly increased as the immersion duration in CaCl2 increased; that of Group 2 significantly increased only after 60-minute CaCl2 immersion. After CaCl2 immersion, the amounts of Ca increased as the immersion duration increased. The surface hardness after CaCl2 immersion significantly correlated with the amount of Ca in Group 1, but not in Group 2. The binding energy of the Ca2p peak was similar to that of calcium polyalkenoate. These findings indicated that the Ca ions from the CaCl2 solution created chemical bonds with the carboxylic acid groups in the cement matrix. Significance. Immersion of GICs in CaCl2 solution at the early stage of setting was considered to enhance the formation of the polyacid salt matrix; as a result, the surface hardness increased. (C) 2014 Published by Elsevier Ltd on behalf of Academy of Dental Materials. All rights reserved.	[Shiozawa, Maho] Tokyo Med & Dent Univ, Grad Sch, Dept Masticatory Funct Rehabil, Div Oral Hlth Sci, Tokyo 1138549, Japan; [Takahashi, Hidekazu; Iwasaki, Naohiko] Tokyo Med & Dent Univ, Fac Dent, Sch Oral Hlth Care Sci, Course Oral Hlth Engn, Tokyo 1138549, Japan; [Wada, Takahiro; Uo, Motohiro] Tokyo Med & Dent Univ, Grad Sch, Dept Restorat Sci, Div Oral Hlth Sci, Tokyo 1138549, Japan	Takahashi, H (reprint author), Tokyo Med & Dent Univ, Fac Dent, Sch Oral Hlth Care Sci, Course Oral Hlth Engn,Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	takahashi.bmoe@tmd.ac.jp		WADA, Takahiro/0000-0001-8456-8282			Sidhu SK, 2011, AUST DENT J, V56, P23, DOI 10.1111/j.1834-7819.2010.01293.x; SEYAMA H, 1984, J CHEM SOC FARAD T 1, V80, P237, DOI 10.1039/f19848000237; Zoergiebel J, 2013, CLIN ORAL INVEST, V17, P619, DOI 10.1007/s00784-012-0733-1; WREN AG, 1979, J COLLOID INTERF SCI, V70, P544, DOI 10.1016/0021-9797(79)90062-6; CRISP S, 1974, J DENT RES, V53, P1414, DOI 10.1177/00220345740530062001; Kleverlaan CJ, 2004, DENT MATER, V20, P45, DOI 10.1016/S0109-5641(03)00067-8; Demri B, 1995, J MATER PROCESS TECH, V55, P311, DOI 10.1016/0924-0136(95)02023-3; Nicholson JW, 1998, BIOMATERIALS, V19, P485, DOI 10.1016/S0142-9612(97)00128-2; Ellakuria J, 2003, DENT MATER, V19, P286, DOI 10.1016/S0109-5641(02)00042-8; Guggenberger R, 1998, BIOMATERIALS, V19, P479, DOI 10.1016/S0142-9612(97)00127-0; Yoshida Y, 2000, J DENT RES, V79, P709; Matsuya S, 1996, J DENT RES, V75, P1920; Frencken JE, 2010, DENT MATER, V26, P1, DOI 10.1016/j.dental.2009.08.013; Zanata RL, 2011, J DENT, V39, P834, DOI 10.1016/j.jdent.2011.09.003; BARRY TI, 1979, J DENT RES, V58, P1072, DOI 10.1177/00220345790580030801; Bonifacio CC, 2009, AUST DENT J, V54, P233, DOI 10.1111/j.1834-7819.2009.01125.x; Bowen R L, 1992, Adv Dent Res, V6, P44; CRISP S, 1976, J DENT RES, V55, P1023, DOI 10.1177/00220345760550060401; deGee AJ, 1996, J DENT RES, V75, P1613; Okada K, 2001, DENT MATER, V17, P34, DOI 10.1016/S0109-5641(00)00053-1; Saito S, 1999, ADV GLASS IONOMER CE, P22; Shintome Luciana Keiko, 2009, Braz Oral Res, V23, P439, DOI 10.1590/S1806-83242009000400014; Shiozawa M, 2013, CLIN ORAL INVEST; Shiozawa M, 2013, DENT MATER J, V32, P828, DOI 10.4012/dmj.2013-143; Wagner CD, 1977, HDB XRAY ULTRAVIOLET; Yap AU, 2002, J ORAL REHABIL	26	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0109-5641	1879-0097		DENT MATER	Dent. Mater.	DEC	2014	30	12					E377	E383		10.1016/j.dental.2014.08.366		7	Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials	Dentistry, Oral Surgery & Medicine; Materials Science	AU3PI	WOS:000345525500010		
J	Hayashi, S; Ochi, H; Ogino, H; Kawasumi, A; Kamei, Y; Tamura, K; Yokoyama, H				Hayashi, Shinichi; Ochi, Haruki; Ogino, Hajime; Kawasumi, Aiko; Kamei, Yasuhiro; Tamura, Koji; Yokoyama, Hitoshi			Transcriptional regulators in the Hippo signaling pathway control organ growth in Xenopus tadpole tail regeneration	DEVELOPMENTAL BIOLOGY			English	Article						Tail regeneration; Yap1; Tead4; Hippo pathway; Size control; Xenopus	SPINAL-CORD REGENERATION; LIMB REGENERATION; GENE INDUCTION; SIZE-CONTROL; STEM-CELL; INFRARED-LASER; IN-VIVO; CARDIOMYOCYTE PROLIFERATION; MATRIX-METALLOPROTEINASE; APPENDAGE REGENERATION	The size and shape of tissues are tightly controlled by synchronized processes among cells and tissues to produce an integrated organ. The Hippo signaling pathway controls both cell proliferation and apoptosis by dual signal-transduction states regulated through a repressive kinase cascade. Yap1 and Tead, transcriptional regulators that act downstream of the Hippo signaling kinase cascade, have essential roles in regulating cell proliferation. In amphibian limb or tail regeneration, the local tissue outgrowth terminates when the correct size is reached, suggesting that organ size is strictly controlled during epimorphic organ-level regeneration. We recently demonstrated that Yap1 is required for the regeneration of Xenopus tadpole limb buds (Hayashi et al., 2014, Dev. Biol. 388, 57-67), but the molecular link between the Hippo pathway and organ size control in vertebrate epimorphic regeneration is not fully understood. To examine the requirement of Hippo pathway transcriptional regulators in epimorphic regeneration, including organ size control, we inhibited these regulators during Xenopus tadpole tail regeneration by overexpressing a dominant-negative form of Yap (dnYap) or Tead4 (dnTead4) under a heat-shock promoter in transgenic animal lines. Each inhibition resulted in regeneration defects accompanied by reduced cell mitosis and increased apoptosis. Single-cell gene manipulation experiments indicated that Tead4 cell-autonomously regulates the survival of neural progenitor cells in the regenerating tail. In amphibians, amputation at the proximal level of the tail (deep amputation) results in faster regeneration than that at the distal level (shallow amputation), to restore the original-sized tail with similar timing. However, dnTead4 overexpression abolished the position-dependent differential growth rate of tail regeneration. These results suggest that the transcriptional regulators in the Hippo pathway, Tead4 and Yap1, are required for general vertebrate epimorphic regeneration as well as for organ size control in appendage regeneration. In regenerative medicine, these findings should contribute to the development of three-dimensional organs with the correct size for a patient's body. (C) 2014 Elsevier Inc. All rights reserved.	[Hayashi, Shinichi; Kawasumi, Aiko; Tamura, Koji; Yokoyama, Hitoshi] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Ochi, Haruki] Yamagata Univ, Fac Med, Yamagata 9909585, Japan; [Ogino, Hajime] Nagahama Inst Biosci & Technol, Dept Anim Biosci, Nagahama, Shiga 5260829, Japan; [Ogino, Hajime] JST, CREST, Chiyoda Ku, Tokyo, Japan; [Kamei, Yasuhiro] Natl Inst Basic Biol, Spectrog & Bioimaging Facil, Okazaki, Aichi 4448585, Japan; [Kamei, Yasuhiro] Grad Univ Adv Studies SOKENDAI, Dept Basic Biol, Sch Life Sci, Okazaki, Aichi 4448585, Japan	Yokoyama, H (reprint author), Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Aoba Ku, Aramaki Aza Aoba 6-3, Sendai, Miyagi 9808578, Japan.	yokoyoko@m.tohoku.ac.jp			JSPS KAKENHI [25870058, 22124005, 25124704, 25124705, 22124001]; MEXT; Cabinet Office, Government of Japan [LS007]; CREST (JST); Kurata Memorial Hitachi Science and Technology Foundation; Asahi Glass Foundation; NIBB Collaborative Research Program [12-367, 13-347, 14-330]	We thank Drs. Hiroshi Sasaki and Yoshikazu Hirate for providing the cDNA encoding the dominant-negative form of Tead4 (dnTead4). We thank Drs. Stefan Hoppler, Tim Mohun, Masahiko Hibi, and Roger Tsien for the Xenopus hsp70 promoter, Xenopus gamma-crystallin promoter, 2A peptide, and tdTomato, respectively. We thank Dr. Yumi Izutsu for providing the hsp70-GFP Tg Xenopus frogs. We thank Yoshiko Yoshizawa-Ohuchi and Natsume Sagawa for excellent animal care. We thank all the staff members of the Spectrography and Bioimaging Facility and the NIBB Core Research Facilities for kind support in setting up the IR-LEGO experiments in Xenopus. This work was supported by MEXT and JSPS KAKENHI Grant number 22124005 to HY, 25124704 to H. Ochi, 25124705 to H. Ogino, JSPS KAKENHI Grant number 25870058 to HY, "Funding Program for Next Generation World-Leading Researchers" (Grant no. LS007) from the Cabinet Office, Government of Japan to KT, CREST (JST) to H. Ogino, the Kurata Memorial Hitachi Science and Technology Foundation to HY, and the Asahi Glass Foundation to HY. This work was also supported by the NIBB Collaborative Research Program (Grant no. 12-367, 13-347, 14-330) to HY. This work was also supported by MEXT and JSPS KAKENHI Grant number 22124001.	Pobbati AV, 2013, CANCER BIOL THER, V14, P390, DOI 10.4161/cbt.23788; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Judson RN, 2012, J CELL SCI, V125, P6009, DOI 10.1242/jcs.109546; Sawada A, 2008, MOL CELL BIOL, V28, P3177, DOI 10.1128/MCB.01759-07; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; Yokoyama H, 2007, DEV BIOL, V306, P170, DOI 10.1016/j.ydbio.2007.03.014; MUNEOKA K, 1986, J EXP ZOOL, V240, P47, DOI 10.1002/jez.1402400107; Schreiber AM, 2001, P NATL ACAD SCI USA, V98, P10739, DOI 10.1073/pnas.191361698; Nejigane S, 2011, INT J DEV BIOL, V55, P121, DOI 10.1387/ijdb.103130sn; Beck CW, 2009, DEV DYNAM, V238, P1226, DOI 10.1002/dvdy.21890; Vinarsky V, 2005, DEV BIOL, V279, P86, DOI 10.1016/j.ydbio.2004.12.003; Lin G, 2008, DEV BIOL, V316, P323, DOI 10.1016/j.ydbio.2008.01.032; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; Jiang Q, 2009, BIOCHEM BIOPH RES CO, V384, P114, DOI 10.1016/j.bbrc.2009.04.070; Kamei Y, 2009, NAT METHODS, V6, P79, DOI [10.1038/nmeth.1278, 10.1038/NMETH.1278]; Halloran MC, 2000, DEVELOPMENT, V127, P1953; FRENCH V, 1976, SCIENCE, V193, P969, DOI 10.1126/science.948762; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; Ogino H, 2008, DEVELOPMENT, V135, P249, DOI 10.1242/dev.009548; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Tamura K, 2010, DEV GROWTH DIFFER, V52, P89, DOI 10.1111/j.1440-169X.2009.01144.x; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sato-Maeda M, 2006, DEVELOPMENT, V133, P937, DOI 10.1242/dev.02268; DENT JN, 1962, J MORPHOL, V110, P61, DOI 10.1002/jmor.1051100105; Beck CW, 2003, DEV CELL, V5, P429, DOI 10.1016/S1534-5807(03)00233-8; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; Gargioli C, 2004, DEVELOPMENT, V131, P2669, DOI 10.1242/dev.01155; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Deguchi T, 2009, DEV GROWTH DIFFER, V51, P769, DOI 10.1111/j.1440-169X.2009.01135.x; Echeverri K, 2001, DEV BIOL, V236, P151, DOI 10.1006/dbio.2001.0312; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Tseng AS, 2008, J DENT RES, V87, P806; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Satoh A, 2011, DEV BIOL, V355, P263, DOI 10.1016/j.ydbio.2011.04.017; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Mchedlishvili L, 2007, DEVELOPMENT, V134, P2083, DOI 10.1242/dev.02852; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Hao YW, 2008, J BIOL CHEM, V283, P5496; Kimura E, 2013, ARTERIOSCL THROM VAS, V33, P1264, DOI 10.1161/ATVBAHA.112.300602; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; ITEN LE, 1976, J EXP ZOOL, V196, P293, DOI 10.1002/jez.1401960304; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Straube WL, 2006, ARTIF ORGANS, V30, P743, DOI 10.1111/j.1525-1594.2006.00296.x; Slack JMW, 2008, CELL MOL LIFE SCI, V65, P54, DOI 10.1007/s00018-007-7431-1; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; von Gise A, 2012, P NATL ACAD SCI USA, V109, P2394, DOI 10.1073/pnas.1116136109; Mammoto A, 2012, J CELL SCI, V125, P3061, DOI 10.1242/jcs.093005; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Grusche FA, 2011, DEV BIOL, V350, P255, DOI 10.1016/j.ydbio.2010.11.020; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; CHEN Z, 1994, GENE DEV, V8, P2293, DOI 10.1101/gad.8.19.2293; Brockes JP, 1997, SCIENCE, V276, P81, DOI 10.1126/science.276.5309.81; Bando T, 2009, DEVELOPMENT, V136, P2235, DOI 10.1242/dev.035204; Van Hateren NJ, 2011, DEVELOPMENT, V138, P1893, DOI 10.1242/dev.064204; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Dong AW, 2011, J BIOL CHEM, V286, P18301, DOI 10.1074/jbc.M110.215707; Gaete M, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-13; Gee ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020309; Hayashi S, 2014, DEV BIOL, V388, P57, DOI 10.1016/j.ydbio.2014.01.018; Love NR, 2014, BIOESSAYS, V36, P27, DOI 10.1002/bies.201300110; Malt AL, 2013, FEBS LETT, V587, P3216, DOI 10.1016/j.febslet.2013.08.013; Mauviel A, 2012, ONCOGENE, V31, P1743, DOI 10.1038/onc.2011.363; Michiue T, 2005, DEV DYNAM, V232, P369, DOI 10.1002/dvdy.20233; Miyazaki K, 1996, P NATL ACAD SCI USA, V93, P6819, DOI 10.1073/pnas.93.13.6819; Mochii M, 2007, DEV GROWTH DIFFER, V49, P155, DOI 10.1111/j.1440-169X.2007.00912.x; Mondia JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024953; Mukaigasa K, 2009, P NATL ACAD SCI USA, V106, P18309, DOI 10.1073/pnas.0708837106; Nieuwkoop P., 1994, NORMAL TABLE XENOPUS; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; Nojima H, 2010, DEVELOPMENT, V137, P923, DOI 10.1242/dev.046425; Offield MF, 2000, DEVELOPMENT, V127, P1789; Shimada A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2643; Taniguchi Y, 2008, DEV GROWTH DIFFER, V50, P109, DOI [10.1111/j.1440-169X.2007.00981.x, 10.1111/j.1440-169x.2007.00981.x]; Watt KI, 2010, BIOCHEM BIOPH RES CO, V393, P619, DOI 10.1016/j.bbrc.2010.02.034; Wheeler GN, 2000, CURR BIOL, V10, P849, DOI 10.1016/S0960-9822(00)00596-0; YANG EV, 1994, DEV BIOL, V166, P696, DOI 10.1006/dbio.1994.1348; Yokoyama H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021721; Zhao P, 2006, J BIOL CHEM, V281, P429, DOI 10.1074/jbc.M507440200	92	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	DEC 1	2014	396	1					31	41		10.1016/j.ydbio.2014.09.018		11	Developmental Biology	Developmental Biology	AU3YY	WOS:000345547600004		
J	Makanae, A; Mitogawa, K; Satoh, A				Makanae, Aki; Mitogawa, Kazumasa; Satoh, Akira			Co-operative Bmp- and Fgf-signaling inputs convert skin wound healing to limb formation in urodele amphibians	DEVELOPMENTAL BIOLOGY			English	Article						Limb regeneration; Accessory limb model; Bmp; Fgf	AXOLOTL AMBYSTOMA-MEXICANUM; NEUROTROPHIC REGULATION; REGENERATION; EXPRESSION; INDUCTION; PROTEIN; GROWTH; DEDIFFERENTIATION; DEPENDENCE; BLASTEMAS	Urodele amphibians have remarkable organ regeneration capability, and their limb regeneration capability has been investigated as a representative phenomenon. In the early 19th century, nerves were reported to be an essential tissue for the successful induction of limb regeneration. Nerve substances that function in the induction of limb regeneration responses have long been sought. A new experimental system called the accessory limb model CALM) has been established to identify the nerve factors. Skin wounding in urodele amphibians results in skin wound healing but never in limb induction. However, nerve deviation to the wounded skin induces limb formation in ALM. Thus, nerves can be considered to have the ability to transform skin wound healing to limb formation. In the present study, co-operative Bmp and Fgf application, instead of nerve deviation, to wounded skin transformed skin wound healing to limb formation in two urodele amphibians, axolotl (Ambystoma mexicanum) and newt (Pleurodeles waltl): Our findings demonstrate that defined factors can induce homeotic transformation in postembryonic bodies of urodele amphibians. The combination of Bmp and Fgf(s) may contribute to the development of novel treatments for organ regeneration. (C) 2014 The Authors. Published by Elsevier Inc.	[Makanae, Aki; Mitogawa, Kazumasa; Satoh, Akira] Okayama Univ, RCIS, Kita Ku, Okayama 7008530, Japan	Satoh, A (reprint author), Okayama Univ, RCIS, Kita Ku, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	satoha@cc.okayama-u.ac.jp	SATOH, Akira/B-2420-2011		KAKENHI [23124508]; Senri life science foundation	We thank Drs. E. Tanaka, Y. Umesono, D.M. Gardiner, and JST PRESTO advisors for their constructive comments and discussions; Dr. T. Hayashi for providing newts and for constructive discussions; and Ms. T. Satoh for her enormous support. This work was supported by KAKENHI (#23124508) and Senri life science foundation.	Acosta CG, 2001, J NEUROSCI, V21, P8873; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; Robert B, 2007, DEV GROWTH DIFFER, V49, P455, DOI 10.1111/j.1440-169x.2007.00946.x; Han MJ, 2001, DEV DYNAM, V220, P40, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1085>3.0.CO;2-8; Aoki H, 2001, J CELL SCI, V114, P1483; Satoh A, 2011, DEV BIOL, V355, P263, DOI 10.1016/j.ydbio.2011.04.017; Nye HLD, 2003, DEV DYNAM, V226, P280, DOI 10.1002/dvdy.10236; Suzuki M, 2005, DEV BIOL, V286, P361, DOI 10.1016/j.ybio.2005.08.021; Levesque M, 2010, J EXP ZOOL PART B, V314B, P684, DOI 10.1002/jez.b.21371; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Li GD, 2002, NEUROREPORT, V13, P1903, DOI 10.1097/00001756-200210280-00014; ATHIPPOZHY A, 2014, REGENERATION, V1, P1, DOI DOI 10.1002/REG2.14; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Carlson MRJ, 1998, J EXP ZOOL, V282, P715, DOI 10.1002/(SICI)1097-010X(19981215)282:6<715::AID-JEZ7>3.0.CO;2-F; Chen X, 2006, J MOL CELL CARDIOL, V41, P26, DOI 10.1016/j.yjmcc.2006.03.421; Dungan KM, 2002, J EXP ZOOL, V292, P540, DOI 10.1002/jez.10104; Makanae A, 2012, ANAT REC, V295, P1566, DOI 10.1002/ar.22529; Makanae A, 2013, DEV BIOL, V381, P213, DOI 10.1016/j.ydbio.2013.05.010; Mullen LM, 1996, DEVELOPMENT, V122, P3487; Satoh A, 2012, ZOOL SCI, V29, P191, DOI 10.2108/zsj.29.191; Satoh A, 2010, DEV BIOL, V337, P444, DOI 10.1016/j.ydbio.2009.11.023; Satoh A, 2008, DEV BIOL, V319, P321, DOI 10.1016/j.ydbio.2008.04.030; Satoh A, 2007, DEV BIOL, V312, P231, DOI 10.1016/j.ydbio.2007.09.021; Satoh A, 2012, DEV BIOL, V366, P374, DOI 10.1016/j.ydbio.2012.03.022; Seifert AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032875; SINGER MARCUS, 1952, QUART REV BIOL, V27, P169, DOI 10.1086/398873; Stocum DL, 2011, EUR J NEUROSCI, V34, P908, DOI 10.1111/j.1460-9568.2011.07827.x; Todd TJ, 1823, Q J SCI LIT ARTS, V16, P84; Tonge DA, 2000, NEUROSCIENCE, V100, P201, DOI 10.1016/S0306-4522(00)00255-4; Tsonis P.A., 1996, LIMB REGENERATION; Wan Mei, 2005, Biochemical and Biophysical Research Communications, V328, P651, DOI 10.1016/j.bbrc.2004.11.067	31	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	DEC 1	2014	396	1					57	66		10.1016/j.ydbio.2014.09.021		10	Developmental Biology	Developmental Biology	AU3YY	WOS:000345547600006		
J	Thompson, SA; Suzuki, R				Thompson, Sandra A.; Suzuki, Ryoko			Reenactments in conversation: Gaze and recipiency	DISCOURSE STUDIES			English	Article						Conversation; English; gaze; gesture; Japanese; recipiency; reenactments	RESOURCES; GESTURE; TALK; ORGANIZATION; SPEECH; STANCE; FORMS	In a reenactment, a speaker re-presents or depicts a previously occurring event, often dramatically. In this article we examine the role of gaze in reenactments in conversations from Japanese and American English. Following Goodwin in viewing a reenacted story as a multi-modal, multi-party field of activity', we show how tellers' and recipients' gaze during reenactments is deployed to achieve specific interactional ends. We argue that there are two layers of activities involved in doing reenacting - a) the habitat of the original event; b) the habitat of the reenacting event, including the dynamics of gaining appreciative recipiency - and show how they are interwoven in the joint production of a reenactment.	[Thompson, Sandra A.] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA; [Suzuki, Ryoko] Keio Univ, Tokyo 108, Japan	Thompson, SA (reprint author), Univ Calif Santa Barbara, Dept Linguist, Santa Barbara, CA 93106 USA.	sathomps@linguistics.ucsb.edu					Holt E, 2010, J PRAGMATICS, V42, P1513, DOI 10.1016/j.pragma.2010.01.011; Heritage J, 2005, SOC PSYCHOL QUART, V68, P15; Clift R, 2006, J SOCIOLING, V10, P569, DOI 10.1111/j.1467-9841.2006.00296.x; Raymond G, 2006, LANG SOC, V35, P677, DOI 10.1017/S0047404506060325; Park Y, 2009, DISCOURSE STUD, V11, P79, DOI 10.1177/1461445608098499; GOODWIN MH, 1980, SOCIOL INQ, V50, P303, DOI 10.1111/j.1475-682X.1980.tb00024.x; KENDON A, 1967, ACTA PSYCHOL, V26, P22, DOI 10.1016/0001-6918(67)90005-4; Tutt D, 2011, RES LANG SOC INTERAC, V44, P211, DOI 10.1080/08351813.2011.591765; Janzen T, 2012, VIEWPOINT IN LANGUAGE: A MULTIMODAL PERSPECTIVE, P156; Kent A, 2012, DISCOURSE STUD, V14, P711, DOI 10.1177/1461445612457485; Curl TS, 2008, RES LANG SOC INTERAC, V41, P129, DOI 10.1080/08351810802028613; Stivers T, 2010, RES LANG SOC INTERAC, V43, P3, DOI 10.1080/08351810903471258; Sidnell J, 2006, RES LANG SOC INTERAC, V39, P377, DOI 10.1207/s15327973rlsi3904_2; Goodwin C, 2000, J PRAGMATICS, V32, P1489, DOI 10.1016/S0378-2166(99)00096-X; Liddell SK, 1998, J PRAGMATICS, V30, P657, DOI 10.1016/S0378-2166(98)00061-7; Goodwin C, 2013, J PRAGMATICS, V46, P8, DOI 10.1016/j.pragma.2012.09.003; GOODWIN C, 1980, SOCIOL INQ, V50, P272, DOI 10.1111/j.1475-682X.1980.tb00023.x; Wilkinson R, 2010, RES LANG SOC INTERAC, V43, P57, DOI 10.1080/08351810903471506; Goodwin C, 2006, TEXT TALK, V26, P443, DOI 10.1515/TEXT.2006.018; Bakhtin M., 1984, PROBLEMS DOSTOEVSKYS; Du Bois J., 1993, TALKING DATA TRANSCR, P45; Glenn Phillip, 2003, LAUGHTER INTERACTION; Goffman E., 1981, FORMS TALK; Golato A, 2000, J PRAGMATICS, V32, P29, DOI 10.1016/S0378-2166(99)00030-2; Goodwin C., 1992, RETHINKING CONTEXT L, P147; Goodwin C., 2004, COMPANION LINGUISTIC, P222; Goodwin C, 2007, STUD INTERACT SOCIO, P16; Goodwin C, 2007, GESTURE STUD, V1, P195; Goodwin Charles, 1981, CONVERSATIONAL ORG I; Goodwin Charles, 1979, EVERYDAY LANGUAGE ST, P97; Goodwin Charles, 1987, IPRA PAPERS PRAGMATI, V1, P1; Goodwin Charles, 1984, STRUCTURES SOCIAL AC, P225; Goodwin Charles, 1992, CONTEXTUALIZATION LA, P77; Haddington P, 2006, TEXT TALK, V26, P281, DOI 10.1515/TEXT.2006.011; Heritage J., 2012, QUESTIONS FORMAL FUN, P179; Koike C, 2005, P ANN M BERK LING SO, V27, P381; Labov William, 1967, ESSAYS VERBAL VISUAL, P12; Lee RG, 1997, SYNTACTIC STRUCTURE, P24; Makino S., 1986, DICT BASIC JAPANESE; Metzger Melanie, 1995, SOCIOLINGUISTICS DEA, P255; Ono T, 2006, EMOTIVE COMMUNICATIO, P139; Ono Tsuyoshi, 1992, TEXT, V12, P429, DOI 10.1515/text.1.1992.12.3.429; Rayman Jennifer, 1999, STORYTELLING CONVERS, P59; Rossano F, 2009, CONVERSATION ANAL CO, P187, DOI DOI 10.1017/CBO9780511635670.008; Rossano F., 2012, HDB CONVERSATION ANA, P308; Schegloff EA, 2007, SEQUENCE ORGANIZATION IN INTERACTION: A PRIMER IN CONVERSATION ANALYSIS I, P1, DOI 10.2277/ 0521532795; Streeck J, 1992, NONVERBAL COMMUNICAT, P3; STREECK J, 1993, COMMUN MONOGR, V60, P275; Tannen D, 2007, TALKING VOICES REPET; Thompson SA, GRAMMAR EVE IN PRESS; WOOTTON AJ, 1981, J PRAGMATICS, V5, P511, DOI 10.1016/0378-2166(81)90016-3; Wootton Anthony, 2005, SYNTAX LEXIS CONVERS, P185	52	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1461-4456	1461-7080		DISCOURSE STUD	Discourse Stud.	DEC	2014	16	6					816	846		10.1177/1461445614546259		31	Communication	Communication	AU2PO	WOS:000345460600006		
J	Tanaka, Y; Hirata, S				Tanaka, Yoshiya; Hirata, Shintaro			Intensive Intervention Can Lead to a Treatment Holiday from Biological DMARDs in Patients with Rheumatoid Arthritis	DRUGS			English	Article							LOW DISEASE-ACTIVITY; ADALIMUMAB PLUS METHOTREXATE; DRUG-FREE REMISSION; CLINICAL REMISSION; CONTROLLED-TRIAL; DOUBLE-BLIND; INDUCTION THERAPY; DISCONTINUATION; INFLIXIMAB; WITHDRAWAL	Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by inflammation and joint destruction that causes significant morbidity and mortality. However, the combined use of methotrexate (MTX), a synthetic disease-modifying anti-rheumatic drug (sDMARD) and biological DMARDs (bDMARDs) has revolutionized treatment of RA and clinical remission or low disease activity (LDA) are now realistic targets, achieved by a large proportion of RA patients. We are now in a position to evaluate if it is possible to maintain remission or LDA while at the same time reducing the burden of treatment on the patient and healthcare system. Data are emerging from large, well-conducted studies designed to answer this question, shedding light on which patient populations and treatment algorithms can survive treatment discontinuation or tapering with low risk of disease flare. For early RA, approximately half of early RA patients could discontinue TNF-targeted bDMARDs without clinical flare and functional impairment after obtaining clinical remission by bDMARDs with MTX. In contrast, for established RA, fewer patients sustained remission or LDA after the discontinuation of bDMARDs and "deep remission" at the discontinuation was a key factor to maintain the treatment holiday of bDMARDs. Thus, this article provides a brief outline on withdrawing or tapering bDMARDs once patients have achieved remission or LDA in RA.	[Tanaka, Yoshiya; Hirata, Shintaro] Univ Occupat & Environm Hlth Japan, Sch Med, Dept Internal Med 1, Kitakyushu, Fukuoka 8078555, Japan	Tanaka, Y (reprint author), Univ Occupat & Environm Hlth Japan, Sch Med, Dept Internal Med 1, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	tanaka@med.uoeh-u.ac.jp			Abbvie; Chugai; Astellas; Takeda; Santen; Mitsubishi-Tanabe; Pfizer; Janssen; Eisai; Daiichi-Sankyo; UCB; GlaxoSmithKline; Bristol-Myers; MSD; Novartis	Y. Tanaka, has received consulting fees, speaking fees, and/or honoraria from Abbvie, Chugai, Astellas, Takeda, Santen, Mitsubishi-Tanabe, Pfizer, Janssen, Eisai, Daiichi-Sankyo, UCB, GlaxoSmithKline, Bristol-Myers and has received research grants from Mitsubishi-Tanabe, Chugai, MSD, Astellas, Novartis. S. Hirata declares no conflicts of interest. No funding was used to support the writing of the manuscript.	Nishimoto N, 2014, MOD RHEUMATOL, V24, P17, DOI 10.3109/14397595.2013.854079; Tanaka Y, 2013, CLIN EXP RHEUMATOL, V31, pS22; Brocq O, 2009, JOINT BONE SPINE, V76, P350, DOI 10.1016/j.jbspin.2008.11.009; van der Kooij SM, 2009, ANN RHEUM DIS, V68, P914, DOI 10.1136/ard.2008.092254; Nawata M, 2008, MOD RHEUMATOL, V18, P460, DOI 10.1007/s10165-008-0089-1; Tanaka Y, 2010, ANN RHEUM DIS, V69, P1286, DOI 10.1136/ard.2009.121491; [Anonymous], 2013, ANN RHEUM DIS S3; Nam JL, 2014, ANN RHEUM DIS, V73, P1027, DOI 10.1136/annrheumdis-2013-204882; Tanaka Y, 2015, ANN RHEUM DIS, V74, P389, DOI 10.1136/annrheumdis-2013-204016; van der Maas A, 2012, ANN RHEUM DIS, V71, P1849, DOI 10.1136/annrheumdis-2011-200945; Nam JL, 2014, ANN RHEUM DIS, V73, P75, DOI 10.1136/annrheumdis-2013-203440; Bejarano V, 2010, RHEUMATOLOGY, V49, P1971, DOI 10.1093/rheumatology/keq194; Aguilar-Lozano L, 2013, J RHEUMATOL, V40, P1069, DOI 10.3899/jrheum.121427; van den Broek M, 2011, ANN RHEUM DIS, V70, P1389, DOI 10.1136/ard.2010.147751; Kaine J, 2012, ANN RHEUM DIS, V71, P38, DOI 10.1136/annrheumdis-2011-200344; Harigai M, 2012, MOD RHEUMATOL, V22, P814, DOI 10.1007/s10165-011-0586-5; Allaart CF, 2013, CLIN EXP RHEUMATOL, V31, pS14; van der Bijl AE, 2007, ARTHRITIS RHEUM, V56, P2129, DOI 10.1002/art.22718; Klarenbeek NB, 2011, ANN RHEUM DIS, V70, P315, DOI 10.1136/ard.2010.136556; Quinn MA, 2005, ARTHRITIS RHEUM, V52, P27, DOI 10.1002/art.20712; Detert J, 2013, ANN RHEUM DIS, V72, P844, DOI 10.1136/annrheumdis-2012-201612; Saleem B, 2010, ANN RHEUM DIS, V69, P1636, DOI 10.1136/ard.2009.117341; Chatzidionysiou K, 2012, ARTHRITIS RHEUM-US, V64, pS336; Emery P, 2014, ANN RHEUM DIS S2, V73; Hirata S, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4315; Huizinga TWJ, 2015, ANN RHEUM DIS, V74, P35, DOI 10.1136/annrheumdis-2014-205752; Kavanaugh A, 2013, CLIN EXP RHEUMATOL, V31, pS19; Oster-Gaard M, 2013, ARTHRITIS RHEUM-US, V65, pS1017; Pham T, 2013, ARTHRITIS RHEUM-US, V65, pS1021; Pincus T, 2013, CLIN EXP RHEUMATOL, V31, pS1; Smolen JS, 2014, LANCET, V383, P321, DOI 10.1016/S0140-6736(13)61751-1; Smolen JS, 2014, ANN RHEUM DIS, DOI [10.1136/annrheumdis-2013-204632, DOI 10.1136/ANNRHEUMDIS-2013-204632]; Takeuchi T, 2014, RHEUMATOLOGY OXFORD; Tanaka Y, 2013, ANN RHEUM DIS, V72, P124, DOI 10.1136/annrheumdis-2012-202350; Tanaka Y, 2013, CLIN THER, V35, P2028, DOI 10.1016/j.clinthera.2013.10.008; Wevers-De Boer KVC, 2013, ANN RHEUM DIS, V72, P114	36	2	3	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0012-6667	1179-1950		DRUGS	Drugs	DEC	2014	74	18					2129	2139		10.1007/s40265-014-0323-4		11	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	AU4MU	WOS:000345586200002		
J	Ishizuka, O; Umino, S; Taylor, RN; Kanayama, K				Ishizuka, Osamu; Umino, Susumu; Taylor, Rex N.; Kanayama, Kyoko			Evidence for Hydrothermal Activity in the Earliest Stages of Intraoceanic Arc Formation: Implications for Ophiolite-Hosted Hydrothermal Activity	ECONOMIC GEOLOGY			English	Article							IZU-BONIN ARC; TRACE-ELEMENT COMPOSITIONS; MASSIVE SULFIDE DEPOSITS; BETTS COVE OPHIOLITE; TROODOS OPHIOLITE; OMAN OPHIOLITE; SUBDUCTION INITIATION; MARIANA ARC; SUMISU RIFT; ISLAND-ARC	Forearcs within intraoceanic arcs preserve a record of earliest arc volcanism that took place at the initiation of subduction. In this study we have investigated the submarine section of the Bonin Ridge, which forms part of the Izu-Bonin intraoceanic arc and/or forearc system. The crustal stratigraphy of this forearc is found to have many similarities with suprasubduction zone ophiolite sequences, including the occurrence of sheeted dikes overlain by depleted tholeiites and/or boninitic magmatism. We propose that the Izu-Bonin forearc is potentially analogous to suprasubduction ophiolites. Hydrothermal alteration, together with sulfide disseminations, is exposed on some of the subaerial Bonin Islands. Based on geologic observations, the hydrothermal activity appears, in general, to have been contemporaneous with the boninite and boninitic andesite host volcanics. The sulfide mineral assemblage associated with the hydrothermal alteration is dominated by pyrite accompanied by minor chalcopyrite, sphalerite, and pyrrhotite. These sulfides are mainly found as disseminations in pillow breccias and hyaloclastite, or along the margins of dikes, but are also found as sulfide nodules in hydrothermal clay-rich zones. This forearc mineral assemblage contrasts with the Pb-rich mineralization associated with the Quaternary submarine hydrothermal deposits found along the main Izu-Bonin arc. Hydrothermal alteration in the Eocene Izu-Bonin forearc represents the style of hydrothermal activity generated by magmatism immediately after the initiation of intraoceanic subduction. Similarities in the style of hydrothermal activity and in the stratigraphy of the hosting volcanic sequence imply that the Bonin Ridge can be regarded as an in situ (i.e., not obducted or dismembered) analogue for a suprasubduction ophiolite including Cyprus-type massive sulfide deposits.	[Ishizuka, Osamu] Geol Survey Japan, AIST, Inst Earthquake & Volcano Geol, Tsukuba, Ibaraki 3058567, Japan; [Ishizuka, Osamu] JAMSTEC, Res & Dev Ctr Ocean Drilling Sci, Yokosuka, Kanagawa 2370061, Japan; [Umino, Susumu; Kanayama, Kyoko] Kanazawa Univ, Dept Earth Sci, Kanazawa, Ishikawa 9201192, Japan; [Taylor, Rex N.] Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England	Ishizuka, O (reprint author), Geol Survey Japan, AIST, Inst Earthquake & Volcano Geol, Cent 7,1-1-1 Higashi, Tsukuba, Ibaraki 3058567, Japan.	o-ishizuka@aist.go.jp			Japan Society for the Promotion of Science [22540473]; project "Basic Researches on Exploration Technologies for Deep-Sea Natural Resources" by Japan Oil, Gas and Metals National Corporation	We would like to thank K. Yamanobe for assistance with the ICP-MS measurements. We are grateful to N. Geshi and I. Ogitsu for their help in SEM-EDS and electron microprobe analyses. OI acknowledges the Japan Society for the Promotion of Science for their support of a Japan-UK joint research program, and for providing Grant-in-Aid for Scientific Research (C) 22540473. Part of this study was supported by the project "Basic Researches on Exploration Technologies for Deep-Sea Natural Resources" by Japan Oil, Gas and Metals National Corporation. The authors acknowledge the constructive reviews by A.G. Galley, an anonymous reviewer, and C.E.J. de Ronde.	Adamides N., 1987, GEOLOGICAL SURVEY CA, P153; HOCHSTAEDTER AG, 1990, EARTH PLANET SC LETT, V100, P195, DOI 10.1016/0012-821X(90)90185-Z; Tamura Y, 2002, J PETROL, V43, P1029, DOI 10.1093/petrology/43.6.1029; Godard M, 2006, CHEM GEOL, V234, P58, DOI 10.1016/j.chemgeo.2006.04.005; STERN RJ, 1992, GEOL SOC AM BULL, V104, P1621, DOI 10.1130/0016-7606(1992)104<1621:SZIEFT>2.3.CO;2; KARPOFF AM, 1988, TECTONOPHYSICS, V151, P223, DOI 10.1016/0040-1951(88)90247-8; ALABASTER T, 1985, ECON GEOL, V80, P1; [Anonymous], 1986, J VOLCANOLOGY GEOTHE, V29, P125; Dilek Y, 2009, LITHOS, V113, P1, DOI 10.1016/j.lithos.2009.04.022; VONDAMM KL, 1985, GEOCHIM COSMOCHIM AC, V49, P2221, DOI 10.1016/0016-7037(85)90223-6; Ishizuka O, 2011, EARTH PLANET SC LETT, V306, P229, DOI 10.1016/j.epsl.2011.04.006; Ishizuka O, 2009, CHEM GEOL, V266, P274, DOI 10.1016/j.chemgeo.2009.06.014; ALABASTER T, 1982, CONTRIB MINERAL PETR, V81, P168, DOI 10.1007/BF00371294; Reagan MK, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002871; Ishizuka O, 2003, EARTH PLANET SC LETT, V211, P221, DOI 10.1016/S0012-821X(03)00201-2; PETER JM, 1988, CAN MINERAL, V26, P567; ZIERENBERG RA, 1993, ECON GEOL BULL SOC, V88, P2069; Moore G, 1998, AM MINERAL, V83, P36; Marumo K, 2008, RESOUR GEOL, V58, P220, DOI 10.1111/j.1751-3928.2008.00059.x; HALBACH P, 1993, ECON GEOL BULL SOC, V88, P2210; URABE T, 1990, EARTH PLANET SC LETT, V100, P283, DOI 10.1016/0012-821X(90)90191-Y; Baker ET, 2004, GEOPH MONOG SERIES, V148, P245, DOI 10.1029/148GM10; Plank T, 1998, CHEM GEOL, V145, P325, DOI 10.1016/S0009-2541(97)00150-2; Savov IP, 2006, J PETROL, V47, P277, DOI 10.1093/petrology/egi075; HOCHSTAEDTER AG, 1990, EARTH PLANET SC LETT, V100, P179, DOI 10.1016/0012-821X(90)90184-Y; Dilek Y, 2009, LITHOS, V113, P68, DOI 10.1016/j.lithos.2009.05.044; Bedard JH, 1999, J PETROL, V40, P1853, DOI 10.1093/petrology/40.12.1853; Stern RJ, 2004, EARTH PLANET SC LETT, V226, P275, DOI 10.1016/j.epsl.2004.08.007; Ishizuka O, 2010, EARTH PLANET SC LETT, V294, P111, DOI 10.1016/j.epsl.2010.03.016; Ishizuka O, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003440; de Ronde CEJ, 2011, MINER DEPOSITA, V46, P541, DOI 10.1007/s00126-011-0345-8; Cosca MA, 1998, ISL ARC, V7, P579, DOI 10.1111/j.1440-1738.1998.00211.x; Pearce JA, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000895; RAUTENSCHLEIN M, 1985, EARTH PLANET SC LETT, V75, P369, DOI 10.1016/0012-821X(85)90180-3; Pearce JA, 2010, GONDWANA RES, V18, P60, DOI 10.1016/j.gr.2009.12.003; Baker ET, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005423; TAYLOR RN, 1994, J PETROL, V35, P577; Hall CE, 2003, EARTH PLANET SC LETT, V212, P15, DOI 10.1016/S0012-821X(03)00242-5; Ishikawa T, 2002, GEOLOGY, V30, P899, DOI 10.1130/0091-7613(2002)030<0899:BVITOO>2.0.CO;2; Konig S, 2008, EARTH PLANET SC LETT, V274, P82, DOI 10.1016/j.epsl.2008.07.002; BIRD DK, 1984, ECON GEOL, V79, P671; Ishizuka O, 2006, EARTH PLANET SC LETT, V250, P385, DOI 10.1016/j.epsl.2006.08.007; [Anonymous], 1998, J GEOPHYS RES, V103, P20963; REYES AG, 1990, J VOLCANOL GEOTH RES, V43, P279, DOI 10.1016/0377-0273(90)90057-M; Banerjee NB., 2001, J GEOPHYS RES, V106, P21; Banerjee NB., 2001, J GEOPHYS RES, V106, P750; Banerjee NR, 2000, GEOLOGY, V28, P151; Banerjee N.R., 2001, J GEOPHYS RES, V106, P737; Barnes H.L., 1997, GEOCHEMISTRY HYDROTH, P303; Bedard JH, 1998, TECTONOPHYSICS, V284, P233, DOI 10.1016/S0040-1951(97)00182-0; BETTISORVARGA L, 1992, GEOLOGY, V20, P987; Bloomer S.H., 1998, EOS T AM GEOPHYS UN, V79, pF420; BLOOMER S.H., 1995, GEOPHYS MONOGR SER, V88, P1; CONSTANT.G, 1973, ECON GEOL, V68, P843; Crawford A.J., 1989, BONINITES RELATED RO, P1; de Ronde CEJ, 2003, SOC EC GEOLOGISTS SP, V10, P91; de Ronde CEJ, 2001, EARTH PLANET SC LETT, V193, P359, DOI 10.1016/S0012-821X(01)00534-9; Dobson P.F., 1986, THESIS STANFORD U ST; DOBSON PF, 1995, CONTRIB MINERAL PETR, V118, P414, DOI 10.1007/s004100050023; DOBSON PF, 1987, EARTH PLANET SC LETT, V82, P75, DOI 10.1016/0012-821X(87)90108-7; Franklin J.M., 2005, EC GEOLOGY 100 ANNIV, P523; Fujita K., 1995, OGASAWARA RES REP, V19, P53; Galley A.G., 1999, REV EC GEOL, V8, P221; Geshi N, 2001, J VOLCANOL GEOTH RES, V106, P285, DOI 10.1016/S0377-0273(00)00271-7; Godard M., 2003, GEOCHEM GEOPHY GEOSY, V4; GOODFELLOW WD, 1993, ECON GEOL BULL SOC, V88, P2037; HAYMON RM, 1989, GEOLOGY, V17, P531, DOI 10.1130/0091-7613(1989)017<0531:HDZBMS>2.3.CO;2; HICKEYVARGAS R, 1991, EARTH PLANET SC LETT, V107, P290, DOI 10.1016/0012-821X(91)90077-U; Hochstaedter A, 2001, GEOCHEM GEOPHY GEOSY, V2, DOI 10.1029/2000GC000105; Iizasa K, 1999, SCIENCE, V283, P975, DOI 10.1126/science.283.5404.975; Iizasa K., 1994, RESOUR GEOL, V44, P275; Ishibashi J. -I., 1995, BACKARC BASINS TECTO, P451; Ishida Y, 2004, SCI REPORTS KANAZAWA, V48, P31; Ishikawa Y., 1988, AKITA PREFECTURE MIN, V12, P57; Ishizuka O, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001475; Ishizuka O, 2002, EARTH PLANET SC LETT, V198, P381, DOI 10.1016/S0012-821X(02)00515-0; Ixer R.A., 1986, METALLOGENY BASIC UL, P33; Kodaira S, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006968; Lydon J.W, 1986, METALLOGENY BASIC UL, P49; McLennan SM, 2001, GEOCHEM GEOPHY GEOSY, V2; Miyashiro A., 1974, AM J SCI, V257, P609; Morishita T, 2005, GEOCHEM J, V39, P327, DOI 10.2343/geochemj.39.327; Morishita T, 2005, GEOSTAND GEOANAL RES, V29, P107, DOI 10.1111/j.1751-908X.2005.tb00659.x; Nagaoka N., 1992, JAMSTEC S DEEP SEA R, V8, P237; Nakajima K., 1991, THESIS SHIZUOKA U SH; Noguchi T, 2007, GEOCHEM J, V41, P141; RICHARDS HG, 1989, ECON GEOL, V84, P91; ROBINSON PT, 1983, GEOLOGY, V11, P400, DOI 10.1130/0091-7613(1983)11<400:VGCOTT>2.0.CO;2; Seyfried Jr W.E., 1995, GEOPHYS MONOGR SER, V91, P248; SHERVAIS JW, 1982, EARTH PLANET SC LETT, V59, P101, DOI 10.1016/0012-821X(82)90120-0; Shervais J. W., 2001, GEOCHEM GEOPHY GEOSY, V2, DOI DOI 10.1029/2000GC000080; STRONG DF, 1988, ECON GEOL, V83, P239; Sun S. S., 1989, GEOL SOC SPEC PUBL, V42, P313, DOI DOI 10.1144/GSL.SP.1989.042.01.19; Suyehiro K, 1996, SCIENCE, V272, P390, DOI 10.1126/science.272.5260.390; Tanahashi M, 2006, SHIGEN CHISHITSU, V56, P185; Tatsumi Y, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005121; Taylor B., 1992, P OCEAN DRILLING PRO, V126, P627; TAYLOR RN, 1988, GEOLOGY, V16, P448, DOI 10.1130/0091-7613(1988)016<0448:LREEOS>2.3.CO;2; Taylor RN, 1998, EARTH PLANET SC LETT, V164, P79, DOI 10.1016/S0012-821X(98)00182-4; Taylor R.N., 1995, GEOLOGICAL SOC LONDO, V81, P-134; Togashi S, 1997, GEOCHIM COSMOCHIM AC, V61, P543, DOI 10.1016/S0016-7037(96)00369-9; Togashi S., 2000, GEOCHEM GEOPHY GEOSY, V1, P1, DOI DOI 10.1029/2000GC000083; Umino S., 1985, J GEOL SOC JPN, V91, P505; Umino S., 1989, BONINITES RELATED RO, P89; Umino S., 1990, OPHIOLITES OCEANIC C, P375; UPADHYAY HD, 1973, ECON GEOL, V68, P161; URABE T, 1987, MAR GEOL, V74, P295, DOI 10.1016/0025-3227(87)90056-9; Varga RJ, 1999, EARTH PLANET SC LETT, V171, P221, DOI 10.1016/S0012-821X(99)00147-8; Watanabe K, 1994, RESOUR GEOL, V44, P133; Whattam SA, 2011, CONTRIB MINERAL PETR, V162, P1031, DOI 10.1007/s00410-011-0638-z	110	2	2	SOC ECONOMIC GEOLOGISTS, INC	LITTLETON	7811 SCHAFFER PARKWAY, LITTLETON, CO 80127 USA	0361-0128	1554-0774		ECON GEOL	Econ. Geol.	DEC	2014	109	8					2159	2177				19	Geochemistry & Geophysics	Geochemistry & Geophysics	AU3XY	WOS:000345545100006		
J	Hein, JR; de Ronde, CEJ; Koski, RA; Ditchburn, RG; Mizell, K; Tamura, Y; Stern, RJ; Conrad, TA; Ishizuka, O; Leybourne, MI				Hein, James R.; de Ronde, Cornel E. J.; Koski, Randolph A.; Ditchburn, Robert G.; Mizell, Kira; Tamura, Yoshihiko; Stern, Robert J.; Conrad, Tracey A.; Ishizuka, Osamu; Leybourne, Matthew I.			Layered Hydrothermal Barite-Sulfide Mound Field, East Diamante Caldera, Mariana Volcanic Arc	ECONOMIC GEOLOGY			English	Article							BLACK SMOKER CHIMNEYS; DE-FUCA RIDGE; SUBMARINE VOLCANO; BACK-ARC; KERMADEC ARC; DEPOSITS; SULFATE; FLUIDS; GEOCHEMISTRY; MINERALOGY	East Diamante is a submarine volcano in the southern Mariana arc that is host to a complex caldera similar to 5 X 10 km (elongated ENE-WSW) that is breached along its northern and southwestern sectors. A large field of barite-sulfide mounds was discovered in June 2009 and revisited in July 2010 with the R/V Natsushima, using the ROV Hyper-Dolphin. The mound field occurs on the northeast flank of a cluster of resurgent dacite domes in the central caldera, near an active black smoker vent field. A Ar-40/Ar-39 age of 20,000 +/- 4000 years was obtained from a dacite sample. The mound field is aligned along a series of fractures and extends for more than 180 m east-west and >120 m north-south. Individual mounds are typically 1 to 3 m tall and 0.5 to 2 m wide, with lengths from about 3 to 8 m. The mounds are dominated by barite + sphalerite layers with the margins of each layer composed of barite with disseminated sulfides. Rare, inactive spires and chimneys sit atop some mounds and also occur as clusters away from the mounds. Iron and Mn oxides are currently forming small (<1-m diam, similar to 0.5-m tall) knolls on the top surface of some of the barite-sulfide mounds and may also drape their flanks. Both diffusely and focused fluids emanate from the small oxide knolls. Radiometric ages of the layered barite-sulfide mounds and chimneys vary from similar to 3,920 to 3,350 years. One layer, from an outcrop of 10- to 100-cm-thick Cu-rich layers, is notably younger with an age of 2,180 years. The Fe-Mn oxides were <5 years old at the time of collection in 2009. Most mound, chimney, and layered outcrop samples are dominated by barite, silica, and sphalerite; other sulfides, in decreasing order of abundance, are galena, chalcopyrite, and rare pyrite. Anglesite, cerussite, and unidentified Pb oxychloride and Pb phosphate minerals occur as late-stage interstitial phases. The samples contain high Zn (up to 23 wt %), Pb (to 16 wt %), Ag (to 487 ppm), and Au (to 19 ppm) contents. Some layered outcrop samples are dominated by chalcopyrite resulting in <= 4.78 wt % Cu in a bulk sample (28 wt % for a single lens), with a mean of 0.28 wt % for other samples. Other significant metal enrichments are Sb (to 1,320 ppm), Cd (to 1,150 ppm), and Hg (to 55 ppm). The East Diamante mound field has a unique set of characteristics compared to other hydrothermal sites in the Mariana arc and elsewhere. The geochemical differences may predominantly reflect the distribution of fractures and faults and consequently the rock/water ratio, temperature of the fluid in the upper parts of the circulation system, and extensive and prolonged mixing with seawater. The location of mineralization is controlled by fractures. Following resurgent doming within the caldera, mineralization resulted from focused flow along small segments of linear fractures rather than from a point source, typical of hydrothermal chimney fields. Based on the mineral assemblage, the maximum fluid temperatures were similar to 260 degrees C, near the boiling point for the water depths of the mound field (367-406 m). Lateral fluid flow within the mounds precipitated interstitial sphalerite, silica, and Pb minerals within a network of barite with disseminated sulfides; silica was the final phase to precipitate. The current low-temperature precipitation of Fe and Mn oxides and silica may represent rejuvenation of the system.	[Hein, James R.; Mizell, Kira; Conrad, Tracey A.] US Geol Survey, Santa Cruz, CA 95060 USA; [de Ronde, Cornel E. J.; Ditchburn, Robert G.] GNS Sci, Lower Hutt 5010, New Zealand; [Koski, Randolph A.] US Geol Survey, Menlo Pk, CA 94025 USA; [Tamura, Yoshihiko] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Inst Res Earth Evolut IFREE, Yokosuka, Kanagawa 2370061, Japan; [Stern, Robert J.] Univ Texas Dallas, Geosci Dept, Richardson, TX 75080 USA; [Ishizuka, Osamu] Geol Survey Japan, AIST, Inst Geosci, Tsukuba 3058567, Japan; [Leybourne, Matthew I.] ALS Minerals, N Vancouver, BC V7H 0A7, Canada	Hein, JR (reprint author), US Geol Survey, 400 Nat Bridges Dr, Santa Cruz, CA 95060 USA.	jhein@usgs.gov					Paytan A, 1998, SCIENCE, V282, P1459, DOI 10.1126/science.282.5393.1459; Berkenbosch HA, 2012, ECON GEOL, V107, P1613; [Anonymous], 2000, MAR SCI SER; HANNINGTON MD, 1988, CAN MINERAL, V26, P603; FOUQUET Y, 1993, ECON GEOL BULL SOC, V88, P2154; [Anonymous], 1997, MANGANESE MINERALIZA; BLOUNT CW, 1969, GEOCHIM COSMOCHIM AC, V33, P227, DOI 10.1016/0016-7037(69)90140-9; Gamo T, 1997, GEOLOGY, V25, P139, DOI 10.1130/0091-7613(1997)025<0139:AASRHF>2.3.CO;2; Hein JR, 2013, ORE GEOL REV, V51, P1, DOI 10.1016/j.oregeorev.2012.12.001; de Ronde CEJ, 2011, MINER DEPOSITA, V46, P541, DOI 10.1007/s00126-011-0345-8; Tivey MK, 2007, OCEANOGRAPHY, V20, P50; HANNINGTON M, 1991, MAR GEOL, V101, P217, DOI 10.1016/0025-3227(91)90073-D; Embley RW, 2007, OCEANOGRAPHY, V20, P68, DOI 10.5670/oceanog.2007.07; TREFRY JH, 1994, J GEOPHYS RES-SOL EA, V99, P4925, DOI 10.1029/93JB02108; Butterfield DA, 2011, GEOLOGY, V39, P803, DOI 10.1130/G31901.1; Staudigel H, 2008, EARTH-SCI REV, V89, P156, DOI 10.1016/j.earscirev.2008.04.005; BISCHOFF JL, 1984, EARTH PLANET SC LETT, V68, P172, DOI 10.1016/0012-821X(84)90149-3; Qin LP, 2008, GEOCHIM COSMOCHIM AC, V72, P1660, DOI 10.1016/j.gca.2008.01.012; HEDENQUIST JW, 1994, NATURE, V370, P519, DOI 10.1038/370519a0; Baker E.T., 2008, J GEOPHYS RES, V113, P1; BISCHOFF JL, 1987, AM J SCI, V287, P953; de Ronde CEJ, 1995, MINERALOGICAL ASS CA, V23, P479; de Ronde CEJ, 2014, ECON GEOL, V109, P2261; de Ronde CEJ, 2003, SOC EC GEOLOGISTS SP, V10, P91; de Ronde C.E.J., 2004, EOS T AM GEOPHYS UNI, V85; de Ronde CEJ, 2003, MINER DEPOSITA, V38, P217, DOI 10.1007/s00126-002-0305-4; Ditchburn R.G., 2008, HIGH SULFIDATION SUB, P1; Ditchburn RG, 2012, ECON GEOL, V107, P1635; Furnes H., 2001, GEOCHEMISTRY GEOPHYS, V2, DOI 10.1029/2000GC000150; Halbach P.E., 2003, ENERGY MASS TRANSFER, P85; Hanningtion M., 2005, EC GEOLOGY 100 ANNIV, P111; Hannington M.D., 1995, GEOPHYS MONOGR SER, V91, P178; HAYMON RM, 1983, NATURE, V301, P695, DOI 10.1038/301695a0; Hein J., 1999, EXPLOR MIN GEOL, V8, P299; Hein J.R., 2009, SCI POL WORKSH 1 2 A, P32; Hein J.R., 2008, J GEOPHYS RES, V113, P1; Herzig P. M., 2000, MARINE GEOCHEMISTRY, P397; HERZIG PM, 1993, ECON GEOL BULL SOC, V88, P2182; Jones B, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005482; Juniper S.K., 1995, GEOPHYS MONOGR SER, V91, P178; Klovan J. E., 1971, MATH GEOL, V3, P61, DOI DOI 10.1007/BF02047433; Koski R.A., 2003, ENERGY MASS TRANSFER, P85; Resing JA, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002141; Resing JA, 2007, ECON GEOL, V102, P1047, DOI 10.2113/gsecongeo.102.6.1047; Stern R.J., 2013, GEOLOGICAL SOC LONDO, V385; Tivey M.H., 1995, J GEOPHYS RES, V100, P12; USUI A, 1992, MAR GEOL, V106, P203, DOI 10.1016/0025-3227(92)90130-A; Yang KH, 1996, NATURE, V383, P420, DOI 10.1038/383420a0	48	3	3	SOC ECONOMIC GEOLOGISTS, INC	LITTLETON	7811 SCHAFFER PARKWAY, LITTLETON, CO 80127 USA	0361-0128	1554-0774		ECON GEOL	Econ. Geol.	DEC	2014	109	8					2179	2206				28	Geochemistry & Geophysics	Geochemistry & Geophysics	AU3XY	WOS:000345545100007		
J	Lazaros, L; Pamporaki, C; Vlahos, N; Takenaka, A; Kitsou, C; Kosmas, I; Sofikitis, N; Stefos, T; Zikopoulos, K; Hatzi, E; Georgiou, I				Lazaros, Leandros; Pamporaki, Christina; Vlahos, Nikolaos; Takenaka, Atsushi; Kitsou, Chrysoula; Kosmas, Ioannis; Sofikitis, Nikolaos; Stefos, Theodoros; Zikopoulos, Konstantinos; Hatzi, Elissavet; Georgiou, Ioannis			The follicular outcome after standard gonadotropin stimulation is associated with ER alpha and ER beta genotypes	ENDOCRINE			English	Article						Assisted reproduction; Estrogen receptor gene polymorphism; Follicles; IVF; Oocytes; Ovarian stimulation; RFLP	ESTROGEN-RECEPTOR-ALPHA; IN-VITRO FERTILIZATION; OVARIAN STIMULATION; GENE POLYMORPHISMS; MICE; DISRUPTION; MATURATION; RESPONSES; PITUITARY; MOUSE	The aim is to study the association of estrogen receptor alpha (ER alpha) and estrogen receptor beta (ER beta) gene polymorphisms and diplotypes with ovarian response to follicle-stimulating hormone (FSH) stimulation and the hormone levels [FSH, luteinizing hormone (LH), E-2] at the third day of the menstrual cycle. Three hundred women undergoing medically assisted reproduction and 300 women with at least one spontaneous pregnancy participated in the study. ER alpha PvuII and XbaI polymorphisms as well as ER beta AluI polymorphism were genotyped. The FSH, LH, and E-2 levels were determined at the third day of the menstrual cycle, while the follicular size, the follicle, and oocyte numbers were recorded during oocyte retrieval. PvuII CC, XbaI GG, and AluI GG women were characterized by increased amounts of large follicles compared to PvuII TT, XbaI AA, and AluI AA women (p = 0.045, 0.01, and 0.033, respectively). The PvuII CC/XbaI GG diplotype was also significantly associated with higher large follicle numbers compared to the PvuII TT/XbaI AA diplotype (p = 0.024). However, no associations were observed between ER gene polymorphisms and the hormonal profile, the follicle/oocyte numbers, and the pregnancy rates. ER alpha and ER beta genetic variants were associated with ovarian response to standard gonadotropin stimulation of women undergoing in-vitro fertilization affecting mainly the follicular growth.	[Lazaros, Leandros; Pamporaki, Christina; Kitsou, Chrysoula; Stefos, Theodoros; Zikopoulos, Konstantinos; Hatzi, Elissavet; Georgiou, Ioannis] Univ Ioannina, Sch Med, Dept Obstet & Gynecol, Genet & IVF Unit, GR-45110 Ioannina, Greece; [Vlahos, Nikolaos] Univ Athens, Aretaie Hosp, Dept Obstet & Gynecol 2, Athens, Greece; [Takenaka, Atsushi] Tottori Univ, Fac Med, Dept Urol, Tottori 680, Japan; [Kosmas, Ioannis] Ioannina State Gen Hosp G Chatzikosta, Dept Obstet & Gynecol, Ioannina, Greece; [Sofikitis, Nikolaos] Univ Ioannina, Sch Med, Dept Urol, GR-45110 Ioannina, Greece	Georgiou, I (reprint author), Univ Ioannina, Sch Med, Dept Obstet & Gynecol, Genet & IVF Unit, GR-45110 Ioannina, Greece.	igeorgio@uoi.gr					Altmae S, 2007, MOL HUM REPROD, V13, P521, DOI 10.1093/molehr/gam035; TONETTA SA, 1989, ENDOCR REV, V10, P205; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Hegele-Hartung C, 2004, P NATL ACAD SCI USA, V101, P5129, DOI 10.1073/pnas.0306720101; van Heusden AM, 2002, CLIN ENDOCRINOL, V56, P509, DOI 10.1046/j.1365-2265.2002.01518.x; Ayvaz OU, 2009, J ASSIST REPROD GEN, V26, P503, DOI 10.1007/s10815-009-9354-2; KORACH KS, 1994, SCIENCE, V266, P1524, DOI 10.1126/science.7985022; WANG XN, 1993, J REPROD FERTIL, V99, P403; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; RICHARDS JS, 1980, PHYSIOL REV, V60, P51; Georgiou I, 1997, HUM REPROD, V12, P1430, DOI 10.1093/humrep/12.7.1430; Boudjenah R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038700; Chen Y., 2010, BMC BIOINFORMATICS S, V18, pS45; Choi YS, 2009, GYNECOL OBSTET INVES, V67, P73, DOI 10.1159/000162104; de Castro F, 2004, PHARMACOGENETICS, V14, P285, DOI 10.1097/01.fpc.0000114727.08559.a4; Fritz MA, 2005, CLIN GYNECOLOGIC END; Hatzi E, 2011, GYNECOL ENDOCRINOL, V27, P27, DOI 10.3109/09513590.2010.493961; Hewitt SC, 2000, STEROIDS, V65, P551, DOI 10.1016/S0039-128X(00)00113-6; Hurst BS, 1997, MOL HUM REPROD, V3, P643, DOI 10.1093/molehr/3.8.643; IRELAND JJ, 1978, ENDOCRINOLOGY, V102, P876; Lazaros L, 2008, ACTA NEUROL SCAND, V117, P186, DOI 10.1111/j.1600-0404.2007.00926.x; Lazaros LA, 2010, J ANDROL, V31, P291, DOI 10.2164/jandrol.109.007542; Putnik M, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-55; Schomberg DW, 1999, ENDOCRINOLOGY, V140, P2733, DOI 10.1210/en.140.6.2733; Sundarrajan C, 1999, MOL HUM REPROD, V5, P797, DOI 10.1093/molehr/5.9.797	25	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1355-008X	1559-0100		ENDOCRINE	Endocrine	DEC	2014	47	3					930	935		10.1007/s12020-014-0249-3		6	Endocrinology & Metabolism	Endocrinology & Metabolism	AU1UG	WOS:000345404900035		
J	Okada, K; Kotani, K; Yagyu, H; Ando, A; Osuga, J; Ishibashi, S				Okada, Kenta; Kotani, Kazuhiko; Yagyu, Hiroaki; Ando, Akihiko; Osuga, Jun-ichi; Ishibashi, Shun			Effects of treatment with liraglutide on oxidative stress and cardiac natriuretic peptide levels in patients with type 2 diabetes mellitus	ENDOCRINE			English	Article							CARDIOVASCULAR RISK BIOMARKERS; OUTCOMES; GLUCOSE; DISEASE		[Okada, Kenta; Ando, Akihiko; Osuga, Jun-ichi; Ishibashi, Shun] Jichi Med Univ, Div Endocrinol & Metab, Dept Internal Med, Shimotsuke, Tochigi 3290498, Japan; [Kotani, Kazuhiko] Jichi Med Univ, Dept Publ Hlth, Shimotsuke, Tochigi 3290498, Japan; [Yagyu, Hiroaki] Univ Tsukuba, Dept Internal Med, Inst Clin Med, Mito, Ibaraki 3100015, Japan	Okada, K (reprint author), Jichi Med Univ, Div Endocrinol & Metab, Dept Internal Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	kokada@jichi.ac.jp					Noyan-Ashraf MH, 2009, DIABETES, V58, P975, DOI 10.2337/db08-1193; Degn KB, 2004, DIABETES, V53, P1187, DOI 10.2337/diabetes.53.5.1187; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Vassalle Cristina, 2008, V477, P31, DOI 10.1007/978-1-60327-517-0_3; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Diaz-Soto G, 2014, DIABETES RES CLIN PR, V104, P92, DOI 10.1016/j.diabres.2014.01.019; Courreges JP, 2008, DIABETIC MED, V25, P1129, DOI 10.1111/j.1464-5491.2008.02484.x; Davidson MH, 2012, AM J CARDIOL, V110, p43B, DOI 10.1016/j.amjcard.2012.08.033; Giorda CB, 2014, ENDOCRINE, V46, P406, DOI 10.1007/s12020-014-0179-0; Levin ER, 1998, NEW ENGL J MED, V339, P321; Li CJ, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-36; Migdalis IN, 2005, RES COMMUN MOL PATH, V117, P5; Mikhail N, 2014, ENDOCRINE, V47, P21, DOI 10.1007/s12020-014-0175-4; NOBERASCO G, 1991, BIOMED PHARMACOTHER, V45, P193, DOI 10.1016/0753-3322(91)90107-5; Notsu Y., 2004, JPN J MED PHARM SCI, V52, P397; Sayin R, 2014, ENDOCRINE, V47, P146, DOI 10.1007/s12020-013-0136-3	16	4	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1355-008X	1559-0100		ENDOCRINE	Endocrine	DEC	2014	47	3					962	964		10.1007/s12020-014-0246-6		3	Endocrinology & Metabolism	Endocrinology & Metabolism	AU1UG	WOS:000345404900040		
J	Taguchi, T; Inoue, K; Terada, Y				Taguchi, Takafumi; Inoue, Keiji; Terada, Yoshio			Concentric-ring sign in adrenal hemorrhage	ENDOCRINE			English	Editorial Material						Adrenal hematoma; Idiopathic adrenal hemorrhage			[Taguchi, Takafumi; Terada, Yoshio] Kochi Univ, Kochi Med Sch, Dept Endocrinol Metab & Nephrol, Nankoku, Kochi 7838505, Japan; [Inoue, Keiji] Kochi Univ, Kochi Med Sch, Dept Urol, Nankoku, Kochi 7838505, Japan	Taguchi, T (reprint author), Kochi Univ, Kochi Med Sch, Dept Endocrinol Metab & Nephrol, Oko Cho, Nankoku, Kochi 7838505, Japan.	ttagu27k@axel.ocn.ne.jp					HAHN PF, 1987, AM J ROENTGENOL, V148, P115; Siegelman ES, 1996, AM J ROENTGENOL, V166, P1493	2	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1355-008X	1559-0100		ENDOCRINE	Endocrine	DEC	2014	47	3					965	966		10.1007/s12020-014-0224-z		2	Endocrinology & Metabolism	Endocrinology & Metabolism	AU1UG	WOS:000345404900041		
J	Sasano, H; Satoh, F; Nakamura, Y				Sasano, Hironobu; Satoh, Fumitoshi; Nakamura, Yasuhiro			Roles of the Pathologist in Evaluating Surrogate Markers for Medical Therapy in Adrenocortical Carcinoma	ENDOCRINE PATHOLOGY			English	Article						Adrenal; Pathology; Carcinoma; Immunohistochemistry; Mitotane; Chemotherapy; EGFR; Surrogate marker	EPIDERMAL-GROWTH-FACTOR; PLATINUM-BASED CHEMOTHERAPY; RENAL-CELL CARCINOMA; FACTOR RECEPTOR; WEISS SYSTEM; EXPRESSION; TUMORS; UPDATE; CANCER; IMMUNOHISTOCHEMISTRY	Adrenocortical carcinoma is a rare malignancy. Medical treatment including op'DDD or mitotane with or without platinum-based cytotoxic chemotherapy is frequently administered to the patients in an adjuvant setting following surgery or in advanced disease, because of aggressive clinical behavior in some cases. Potential roles of pathologists in determining the clinical algorithm of medical therapy are histopathological confirmation of adrenocortical carcinoma, both malignant features using the criteria of Weiss and adrenocortical origin applying immunohistochemistry of steroid factor-1 (SF-1); providing the relevant pathological information to determine the precise pathological stage in individual patients; and providing the accurate Ki67 labeling index of the patients. There are no established pathological surrogate markers for response to mitotane or op' DDD therapy available at this juncture but as in other malignancies, Ki67 LI could provide information as to the potential clinical response to platinum-based cytotoxic chemotherapy. Epidermal growth factor receptor (EGFR) is significantly overexpressed in adrenocortical carcinoma but the absence of gene mutations could limit the therapeutic application of anti-EGFR antibody and/or EGFR tyrosine kinase inhibitor in the patients.	[Sasano, Hironobu; Nakamura, Yasuhiro] Tohoku Univ, Dept Pathol, Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Satoh, Fumitoshi] Tohoku Univ, Dept Med, Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan	Sasano, H (reprint author), Tohoku Univ, Dept Pathol, Sch Med, Aoba Ku, 2-1 Seiryou Machi, Sendai, Miyagi 9808575, Japan.	hsasano@patholo2.med.tohoku.ac.jp					Ronchi CL, 2009, ENDOCR-RELAT CANCER, V16, P907, DOI 10.1677/ERC-08-0224; Lughezzani G, 2010, EUR J CANCER, V46, P713, DOI 10.1016/j.ejca.2009.12.007; WEISS LM, 1989, AM J SURG PATHOL, V13, P202, DOI 10.1097/00000478-198903000-00004; Adam P, 2010, MODERN PATHOL, V23, P1596, DOI 10.1038/modpathol.2010.153; Almeida MQ, 2008, J CLIN ENDOCR METAB, V93, P3524, DOI 10.1210/jc.2008-0065; Aubert S, 2002, AM J SURG PATHOL, V26, P1612, DOI 10.1097/00000478-200212000-00009; Sorbye H, 2013, ANN ONCOL, V24, P152, DOI 10.1093/annonc/mds276; Nakamura M, 2009, ENDOCR PATHOL, V20, P17, DOI 10.1007/s12022-009-9058-2; Fassnacht M, 2013, J CLIN ENDOCR METAB, V98, P4551, DOI 10.1210/jc.2013-3020; Fassnacht M, 2011, NAT REV ENDOCRINOL, V7, P323, DOI 10.1038/nrendo.2010.235; Sangoi AR, 2011, AM J SURG PATHOL, V35, P678, DOI 10.1097/PAS.0b013e3182152629; Allolio B, 2006, J CLIN ENDOCR METAB, V91, P2027, DOI 10.1210/jc.2005-2639; Papotti Mauro, 2011, Hormones & Cancer, V2, P333, DOI 10.1007/s12672-011-0088-0; Malandrino P, 2010, ENDOCR-RELAT CANCER, V17, P797, DOI 10.1677/ERC-09-0341; Fassnacht M, 2009, CANCER, V115, P243, DOI 10.1002/cncr.24030; Beuschlein F, 2013, ENDOCR REV, V34, P29; De Martino MC, 2014, ENDOCR-RELAT CANCER, V21, P601, DOI 10.1530/ERC-13-0112; Duregon E, 2013, AM J SURG PATHOL, V37, P1433, DOI 10.1097/PAS.0b013e31828d387b; Fassnacht M, 2011, CLIN ENDOCRINOL, V73, P561; Fraenkel M, 2013, ENDOCRINE, V44, P187, DOI 10.1007/s12020-013-9878-1; Iino K, 2000, CLIN ENDOCRINOL, V53, P243, DOI 10.1046/j.1365-2265.2000.01036.x; Mondal SK, 2013, J CANCER RES THER, V9, P436, DOI 10.4103/0973-1482.119329; SASANO H, 1992, ENDOCR PATHOL, V3, P4, DOI 10.1007/BF02921338; SASANO H, 1994, MODERN PATHOL, V7, P741; SASANO H, 1995, HUM PATHOL, V26, P1154, DOI 10.1016/0046-8177(95)90280-5; Sbiera S, 2009, J CLIN ENDOCR METAB, V95, P161; Terzolo M, 2007, NEW ENGL J MED, V356, P372; Volante M, 2012, CLIN CANCER RES, V18, P3452, DOI 10.1158/1078-0432.CCR-11-2692; WEISS LM, 1984, AM J SURG PATHOL, V8, P163, DOI 10.1097/00000478-198403000-00001; Zhang J, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-19	30	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1046-3976	1559-0097		ENDOCR PATHOL	Endocr. Pathol.	DEC	2014	25	4					366	370		10.1007/s12022-014-9334-7		5	Endocrinology & Metabolism; Pathology	Endocrinology & Metabolism; Pathology	AU1UM	WOS:000345405500002		
J	Wada, R; Yagihashi, S				Wada, Ryuichi; Yagihashi, Soroku			The Expression of Glucagon-Like Peptide-1 Receptor and Dipeptidyl Peptidase-IV in Neuroendocrine Neoplasms of the Pancreas and Gastrointestinal Tract	ENDOCRINE PATHOLOGY			English	Article						Neuroendocrine neoplasm; GLP1R; DPP-IV; Ki-67	GLP-1 RECEPTOR; TUMORS; CELLS; LOCALIZATION; GRANULES; TISSUES; SYSTEM; MOUSE; GUT	Neuroendocrine neoplasm (NEN) of the pancreas and gastrointestinal tract is infrequent but often produces hormones to cause distinct clinical features. Glucagon-like peptide-1 receptor (GLP1R) is a G-protein coupled receptor for GLP1, which is cleaved by dipeptidyl peptidase (DPP)-IV, a peptidase that regulates the activity of peptide hormones. Since these molecules are involved in the neuroendocrine function of NEN, they could serve molecular targets for diagnosis and therapy of NEN. However, the expressions of these molecules in NEN are not well studied. We therefore examined the expression of GLP1R and DPP-IV in 22 cases of pancreatic NEN (P-NEN) and 20 cases of gastrointestinal NEN (GI-NEN) by immunostaining. GLP1R was expressed in all eight insulinomas (100 %) but so in only four out of 14 cases (29 %) of non-insulinomas. In contrast to GLP1R, DPP-IV was detected in one out of eight insulinomas (13 %) and in 12 out of 14 cases (86 %) of non-insulinomas. In GI-NEN, GLP1R was negative in all 10 cases of the foregut NEN, whereas it was expressed in all three cases (100 %) of midgut NEN and four out of seven cases (57 %) of hindgut NEN. DPP-IV was expressed in five out of 10 cases (50 %) of the foregut NEN. The expression was detected in two out of three cases (67 %) of midgut NEN and in all seven cases (100 %) of hindgut NEN. In conclusion, we found distinct expression patterns of GLP1R and DPP-IV depending on the neuroendocrine cell types in P-NEN and the anatomical sites in GI-NEN.	[Wada, Ryuichi; Yagihashi, Soroku] Hirosaki Univ, Grad Sch Med, Dept Pathol & Mol Med, Hirosaki, Aomori 0368562, Japan	Wada, R (reprint author), Nippon Med Sch, Dept Integrated Diagnost Pathol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	w-ryuichi@nms.ac.jp					Brubaker PL, 2004, ENDOCRINOLOGY, V145, P2653, DOI 10.1210/en.2004-0015; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Butler AE, 2013, DIABETES, V62, P2595, DOI 10.2337/db12-1686; Korner M, 2007, J NUCL MED, V48, P736, DOI 10.2967/jnumed.106.038679; Ito T, 2010, J GASTROENTEROL, V45, P234, DOI 10.1007/s00535-009-0194-8; Lambeir AM, 2003, CRIT REV CL LAB SCI, V40, P209, DOI 10.1080/713609354; Reubi JC, 2003, EUR J NUCL MED MOL I, V30, P781, DOI 10.1007/s00259-003-1184-3; Rindi G, 2004, ANN NY ACAD SCI, V1014, P1, DOI 10.1196/annals.1294.001; Elashoff M, 2011, GASTROENTEROLOGY, V141, P150, DOI 10.1053/j.gastro.2011.02.018; POULSEN MD, 1993, J HISTOCHEM CYTOCHEM, V41, P81; Hansen L, 1999, ENDOCRINOLOGY, V140, P5356, DOI 10.1210/en.140.11.5356; Rinke A, 2009, J CLIN ONCOL, V27, P4656, DOI 10.1200/JCO.2009.22.8510; Richards P, 2014, DIABETES, V63, P1224, DOI 10.2337/db13-1440; Frerker N, 2007, PEPTIDES, V28, P257, DOI 10.1016/j.peptides.2006.09.027; Kunz PL, 2013, PANCREAS, V42, P557, DOI 10.1097/MPA.0b013e31828e34a4; Tornehave D, 2008, J HISTOCHEM CYTOCHEM, V56, P841, DOI 10.1369/jhc.2008.951319; Zhang JL, 2013, JNCI-J NATL CANCER I, V105, P1005, DOI 10.1093/jnci/djt135; Rindi G, 2006, VIRCHOWS ARCH, V449, P395, DOI 10.1007/s00428-006-0250-1; Grondin G, 1999, J HISTOCHEM CYTOCHEM, V47, P489; Pyke C, 2014, ENDOCRINOLOGY, V155, P1280, DOI 10.1210/en.2013-1934; Rindi G, 2010, WHO CLASSIFICATION T, V3, P13; Umeki K, 1996, ENDOCR J, V43, P53, DOI 10.1507/endocrj.43.53	22	1	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1046-3976	1559-0097		ENDOCR PATHOL	Endocr. Pathol.	DEC	2014	25	4					390	396		10.1007/s12022-014-9326-7		7	Endocrinology & Metabolism; Pathology	Endocrinology & Metabolism; Pathology	AU1UM	WOS:000345405500006		
J	Sato, N; Nakamura, Y; Takanami, K; Ono, Y; Omata, K; Morimoto, R; Satoh, F; Ise, K; Yamada, S; Kasajima, A; Fujishima, F; Watanabe, M; Arai, Y; Sasano, H				Sato, Naomi; Nakamura, Yasuhiro; Takanami, Kentaro; Ono, Yoshikiyo; Omata, Kei; Morimoto, Ryo; Satoh, Fumitoshi; Ise, Kazue; Yamada, Shigeyuki; Kasajima, Atsuko; Fujishima, Fumiyoshi; Watanabe, Mika; Arai, Yoichi; Sasano, Hironobu			Case Report: Adrenal Oncocytoma Associated with Markedly Increased FDG Uptake and Immunohistochemically Positive for GLUT1	ENDOCRINE PATHOLOGY			English	Article						Adrenal gland; Oncocytoma; FDG-PET; GLUT1	SYSTEMIC-LUPUS-ERYTHEMATOSUS; ADRENOCORTICAL ONCOCYTOMA; HEXOKINASE II; F-18-FDG PET; TUMORS; CANCER; LESIONS; MALIGNANCIES; EXPRESSION; CARCINOMA	Usually, benign tumors are not associated with an increased F-18 fluorodeoxyglucose (F-18 FDG) uptake on positron emission tomography (PET), although some exceptions have been reported in adrenal neoplasms. We present a rare case of adrenocortical oncocytoma associated with markedly increased FDG uptake, demonstrating a maximum standardized uptake value of 46.8. Histological examination demonstrated diffuse proliferation of tumor cells with eosinophilic and granular cytoplasm that were diffusely immunopositive for mitochondria and glucose transport protein 1, with focal and weak immunopositivity for 3 beta-hydroxysteroid dehydrogenase. Ultrastructural examination also revealed abundant mitochondria in the tumor cells. The tumor was diagnosed as adrenocortical oncocytoma and was considered benign according to Lin-Weiss-Bisceglia criteria. Diagnosis of adrenocortical oncocytoma can pose difficulties during both preoperative radiological and postoperative histopathological investigations.	[Sato, Naomi; Nakamura, Yasuhiro; Ise, Kazue; Kasajima, Atsuko; Fujishima, Fumiyoshi; Watanabe, Mika; Sasano, Hironobu] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 980, Japan; [Takanami, Kentaro] Tohoku Univ, Grad Sch Med, Dept Radiol, Sendai, Miyagi 980, Japan; [Ono, Yoshikiyo; Omata, Kei; Morimoto, Ryo; Satoh, Fumitoshi] Tohoku Univ Hosp, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi 980, Japan; [Yamada, Shigeyuki; Arai, Yoichi] Tohoku Univ, Grad Sch Med, Dept Urol, Sendai, Miyagi 980, Japan	Nakamura, Y (reprint author), Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 980, Japan.	yasu-naka@patholo2.med.tohoku.ac.jp					Abdulla S, 2014, EUR J NUCL MED MOL I, V41, P350, DOI 10.1007/s00259-013-2579-4; Acar C, 2008, UROL INT, V80, P444, DOI 10.1159/000132706; Yun MJ, 2001, J NUCL MED, V42, P1795; Wong DD, 2011, HUM PATHOL, V42, P489, DOI 10.1016/j.humpath.2010.08.010; Mearini L, 2013, UROL INT, V91, P125, DOI 10.1159/000345141; Deron P, 2011, NUKLEARMED-NUCL MED, V50, P15, DOI 10.3413/nukmed-0324-10-06; Aide N, 2003, EUR J NUCL MED MOL I, V30, P1236, DOI 10.1007/s00259-003-1211-4; Bisceglia M, 2004, INT J SURG PATHOL, V12, P231, DOI 10.1177/106689690401200304; Duregon E, 2011, AM J SURG PATHOL, V35, P1882, DOI 10.1097/PAS.0b013e31822da401; Barnes Leon, 2005, PATHOLOGY GENETICS H, P266; Bisceglia M, 2005, PATHOL CASE REV, V10, P228, DOI 10.1097/01.pcr.0000175102.22075.54; BOLAND GW, 1995, RADIOLOGY, V194, P131; Eble John N., 2004, PATHOLOGY GENETICS T, P42; Hoang MP, 2002, MODERN PATHOL, V15, P973, DOI 10.1038/modpathol.3880638; Kim DJ, 2008, ANN NUCL MED, V22, P821, DOI 10.1007/s12149-008-0199-z; Kobayashi M, 2012, CLIN NUCL MED, V37, P447, DOI 10.1097/RLU.0b013e31823924bb; Kochhar R, 2010, J MED IMAG RADIAT ON, V54, P347, DOI 10.1111/j.1754-9485.2010.02181.x; Lee R, 2006, NAT CLIN PRACT UROL, V3, P618, DOI 10.1038/ncpuro0631; Lin ATH, 2002, J RHEUMATOL, V29, P1334; Minamimoto R, 2007, CLIN NUCL MED, V32, P582, DOI 10.1097/RLU.0b013e31806541a4; Nakajo M, 2012, EUR J RADIOL, V81, P146, DOI 10.1016/j.ejrad.2010.08.010; Nakamura Y, 2009, J CLIN ENDOCR METAB, V94, P2192, DOI 10.1210/jc.2008-2374; Ni J, 2014, LUPUS, V23, P284, DOI 10.1177/0961203313520060; Sasano Hironobu, 2006, Endocr Pathol, V17, P345, DOI 10.1007/s12022-006-0006-0; SASANO H, 1990, INT J GYNECOL PATHOL, V9, P352, DOI 10.1097/00004347-199010000-00007; SASANO H, 1991, AM J SURG PATHOL, V15, P949, DOI 10.1097/00000478-199110000-00005; Schittenhelm J, 2009, ENDOCR PATHOL, V20, P73, DOI 10.1007/s12022-008-9051-1; Shimizu M, 2002, INTERNAL MED, V41, P1044, DOI 10.2169/internalmedicine.41.1044; Son SH, 2014, ANN NUCL MED, V28, P69, DOI 10.1007/s12149-013-0764-y; Tan GJS, 2014, ABDOM IMAGING, V39, P187, DOI 10.1007/s00261-013-0043-3; Terui K, 2010, J CLIN ENDOCR METAB, V95, P3597, DOI 10.1210/jc.2009-2787; Tong SY, 2012, INT J GYNECOL CANCER, V22, P654, DOI 10.1097/IGC.0b013e31824864e6; WEISS LM, 1984, AM J SURG PATHOL, V8, P163, DOI 10.1097/00000478-198403000-00001; Wu Tao, 2008, Zhongguo Fei Ai Za Zhi, V11, P555, DOI 10.3779/j.issn.1009-3419.2008.04.009	34	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1046-3976	1559-0097		ENDOCR PATHOL	Endocr. Pathol.	DEC	2014	25	4					410	415		10.1007/s12022-014-9337-4		6	Endocrinology & Metabolism; Pathology	Endocrinology & Metabolism; Pathology	AU1UM	WOS:000345405500009		
J	Ogawa, Y; Watanabe, M; Tominaga, T				Ogawa, Yoshikazu; Watanabe, Mika; Tominaga, Teiji			Spontaneous Alteration from Rathke's Cleft Cyst to Craniopharyngioma-Possible Involvement of Transformation Between These Pathologies	ENDOCRINE PATHOLOGY			English	Article						Craniopharyngioma; Pathogenesis; Rathke's cleft cyst; Transformation	OUTCOMES; SURGERY; LESIONS	Both Rathke's cleft cyst and craniopharyngioma are considered to arise from the remnants of Rathke's diverticulum despite the quite different histological characteristics. These two lesions may consist of a disease spectrum extending from Rathke's cleft cyst to craniopharyngioma. However, in spite of increasing evidence of these intermediate histologies, very few cases of the actual transformation from Rathke's cleft cyst to craniopharyngioma have been reported in the same patient. A 47-year-old man suffered from recurrent visual dysfunction. Aspiration and partial cystectomy was performed to a suprasellar massive cystic lesion. The histological diagnosis was Rathke's cleft cyst with a small component of squamous metaplasia. Seven months later, the cyst was re-expanded. The cyst wall was irregularly thickened. Re-operation was performed, and the thickened anterior wall was widely removed. Postoperative histological examination showed multiplication of stratified squamous epithelia forming a papillary arrangement. Ki-67 staining showed positive cells randomly distributed not only in the basal layer but also in various epithelial layers, with a labeling index of more than 20 %. The histological diagnosis was squamous papillary type of craniopharyngioma with high potential of proliferation. Subsequent immunohistochemical examinations showed positive reaction to cytokeratin 8 only in the initial epithelium and negative in the latter epithelium. The present case was thought as an actual evidence of the proposed link between Rathke's cleft cyst and craniopharyngioma. Cytokeratin 8 could be the important examination to differentiate Rathke's cleft cyst from craniopharyngioma.	[Ogawa, Yoshikazu] Kohnan Hosp, Dept Neurosurg, Taihaku Ku, Sendai, Miyagi 9828523, Japan; [Watanabe, Mika] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 980, Japan; [Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi 980, Japan	Ogawa, Y (reprint author), Kohnan Hosp, Dept Neurosurg, Taihaku Ku, Sendai, Miyagi 9828523, Japan.	yogawa@kohnan-sendai.or.jp					Benveniste RJ, 2004, J NEUROSURG, V101, P577, DOI 10.3171/jns.2004.101.4.0577; Aho CJ, 2005, J NEUROSURG, V102, P189, DOI 10.3171/jns.2005.102.2.0189; Wolfe SQ, 2010, J NEUROSURG, V112, P1322, DOI 10.3171/2009.10.JNS091265; Ogawa Y, 2013, ACTA NEUROCHIR, V155, P1069, DOI 10.1007/s00701-012-1593-9; Xin W, 2002, ARCH PATHOL LAB MED, V126, P1174; Ogawa Y, 2010, J NEUROSURG, V112, P1324, DOI 10.3171/2009.10.JNS09826; Pekmezci M, 2010, NEUROSURGERY, V67, P1341, DOI 10.1227/NEU.0b013e3181f2b583; Kim JE, 2004, J NEUROSURG, V100, P33, DOI 10.3171/jns.2004.100.1.0033; Ogawa Y, 2011, ACTA NEUROCHIR, V153, P2427, DOI 10.1007/s00701-011-1072-8; Burger PC, 1994, TUMORS CENTRAL NERVO, P357; Le BH, 2007, ENDOCR PATHOL, V18, P23, DOI 10.1007/s12022-007-0011-y; MATSUSHIMA T, 1988, SURG NEUROL, V30, P197, DOI 10.1016/0090-3019(88)90272-8; Oka H, 1995, Noshuyo Byori, V12, P97; Park YS, 2009, CLIN NEUROPATHOL, V28, P177; Thaper K, 1998, RUSSELL RUBINSTEINS, P648; Zada G, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS09318	16	2	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1046-3976	1559-0097		ENDOCR PATHOL	Endocr. Pathol.	DEC	2014	25	4					422	426		10.1007/s12022-014-9328-5		5	Endocrinology & Metabolism; Pathology	Endocrinology & Metabolism; Pathology	AU1UM	WOS:000345405500011		
J	Ogawa, Y; Watanabe, M; Tominaga, T				Ogawa, Yoshikazu; Watanabe, Mika; Tominaga, Teiji			Spontaneous Alteration from Rathke's Cleft Cyst to Craniopharyngioma-Possible Involvement of Transformation Between These Pathologies (vol 25, pg 422, 2014)	ENDOCRINE PATHOLOGY			English	Correction									[Ogawa, Yoshikazu] Kohnan Hosp, Dept Neurosurg, Taihaku Ku, Sendai, Miyagi 9828523, Japan; [Watanabe, Mika] Tohoku Univ, Dept Pathol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Tominaga, Teiji] Tohoku Univ, Dept Neurosurg, Grad Sch Med, Sendai, Miyagi 980, Japan	Ogawa, Y (reprint author), Kohnan Hosp, Dept Neurosurg, Taihaku Ku, Sendai, Miyagi 9828523, Japan.	yogawa@kohnan-sendai.or.jp					Ogawa Y, 2014, ENDOCR PATHOL, V25, P422, DOI 10.1007/s12022-014-9328-5	1	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1046-3976	1559-0097		ENDOCR PATHOL	Endocr. Pathol.	DEC	2014	25	4					446	446		10.1007/s12022-014-9336-5		1	Endocrinology & Metabolism; Pathology	Endocrinology & Metabolism; Pathology	AU1UM	WOS:000345405500018		
J	Onozuka, D; Hirata, T; Furue, M				Onozuka, Daisuke; Hirata, Teruaki; Furue, Masutaka			Net survival after exposure to polychlorinated biphenyls and dioxins: The Yusho study	ENVIRONMENT INTERNATIONAL			English	Article						Cohort study; Dioxins; Food contamination; Net survival; Polychlorinated biphenyls; Yusho	RELATIVE SURVIVAL; CANCER-MORTALITY; FOLLOW-UP; FRANCE; DIBENZOFURANS; MODELS	Background: Net survival is an important measure of the overall outcome of disease management. This net survival is the most appropriate for international comparisons of disease impact between countries or time periods with different patterns of all-cause mortality because it is not influenced by other causes of death. However, little information is available on net survival among Yusho patients, who were accidentally exposed to PCBs and other dioxin-related compounds. Methods: We estimated the net survival of 1664 Yusho patients (860 males, 804 females) as Yusho cohort subjects using the unbiased Pohar-Perme method. Results: Among males, 1-, 5-, 10-, and 15-year net survival were 99.5% (95% confidence interval (CI): 97.9, 99.9), 99.1% (CI: 95.0, 99.9), 97.4% (CI: 86.5, 99.5), and 97.4% (CI: 84.2, 99.6), respectively. Among females, net survival remained almost constant. 1-, 5-, 10-, and 15-year net survival were generally higher in females than in males. Conclusions: This study provides the first unbiased estimations of net survival among Yusho patients. We confirmed that older male Yusho patients have experienced a significant decrease in net survival. Our results suggest that the excess hazard of PCBs and dioxins must be taken into account when evaluating unbiased estimates of net survival. (C) 2014 Elsevier Ltd. All rights reserved.	[Onozuka, Daisuke] Kyushu Univ, Dept Hlth Care Adm & Management, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan; [Onozuka, Daisuke; Hirata, Teruaki] Fukuoka Inst Hlth & Environm Sci, Dazaifu, Fukuoka 8180135, Japan; [Furue, Masutaka] Kyushu Univ, Dept Dermatol, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan	Onozuka, D (reprint author), Kyushu Univ, Dept Hlth Care Adm & Management, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	onozukad@hcam.med.kyushu-u.ac.jp	Onozuka, Daisuke/F-5067-2014	Onozuka, Daisuke/0000-0001-9596-9188	Ministry of Health, Labour and Welfare, Japan; budgets for research of the Department of Public Health and Medical Affairs, Fukuoka Prefectural Government	The study was supported by grants from the Ministry of Health, Labour and Welfare, Japan and budgets for research of the Department of Public Health and Medical Affairs, Fukuoka Prefectural Government. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript	Jooste V, 2013, INT J CANCER, V132, P2370, DOI 10.1002/ijc.27857; Nelson CP, 2007, STAT MED, V26, P5486, DOI 10.1002/sim.3064; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI [10.1016/S1470-2045(08)70179-7, 10.1016/S470-2045(08)70179-7]; Danieli C, 2012, STAT MED, V31, P775, DOI 10.1002/sim.4464; Spillman BC, 2000, NEW ENGL J MED, V342, P1409, DOI 10.1056/NEJM200005113421906; Onozuka D, 2009, AM J EPIDEMIOL, V169, P86, DOI 10.1093/aje/kwn295; Steenland K, 2001, AM J EPIDEMIOL, V154, P451, DOI 10.1093/aje/154.5.451; Perme MP, 2012, BIOMETRICS, V68, P113, DOI 10.1111/j.1541-0420.2011.01640.x; Monnereau A, 2013, INT J CANCER, V132, P2378, DOI 10.1002/ijc.27889; Roche L, 2013, INT J CANCER, V132, P2359, DOI 10.1002/ijc.27830; Begg CB, 2002, J NATL CANCER I, V94, P1044; Ruder AM, 2014, INT J HYG ENVIR HEAL, V217, P176, DOI 10.1016/j.ijheh.2013.04.006; Lambert PC, 2010, STAT MED, V29, P885, DOI 10.1002/sim.3762; MANZ A, 1991, LANCET, V338, P959, DOI 10.1016/0140-6736(91)91835-I; Dickman PW, 2013, STATA J, P1; Flesch-Janys D, 1998, ENVIRON HEALTH PERSP, V106, P655, DOI 10.2307/3433816; FURUE M, 2005, J DERMATOL SCI S, V1, pS3, DOI DOI 10.1016/J.DESCS.2005.03.002; Ikeda M, 1996, CHEMOSPHERE, V32, P559, DOI 10.1016/0045-6535(95)00315-0; Kuratsune M, 1972, Environ Health Perspect, V1, P119, DOI 10.2307/3428163; Li MC, 2013, ENVIRON RES, V120, P71, DOI 10.1016/j.envres.2012.09.003; Onozuka D, 2011, SCI TOTAL ENVIRON, V409, P2361, DOI 10.1016/j.scitotenv.2011.03.007; Rollot F, 2013, DIS COLON RECTUM, V56, P1118, DOI 10.1097/DCR.0b013e31829f3436; Seppa K, 2013, EUR J CANC; URABE H, 1985, ENVIRON HEALTH PERSP, V59, P11, DOI 10.2307/3429868	24	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0160-4120	1873-6750		ENVIRON INT	Environ. Int.	DEC	2014	73						28	32		10.1016/j.envint.2014.07.008		5	Environmental Sciences	Environmental Sciences & Ecology	AU3WE	WOS:000345540700004		
J	Nishiyama, H; Watanabe, T; Inoue, Y				Nishiyama, Hiroshi; Watanabe, Tomoya; Inoue, Yasunobu			Activation of immobilized enzymes by acoustic wave resonance oscillation	ENZYME AND MICROBIAL TECHNOLOGY			English	Article						Immobilized enzymes; Resonance oscillation; Acoustic waves; Galactose oxidase; Amino acid oxidases; Enzyme activation	CO OXIDATION; ETHANOL DECOMPOSITION; SURFACE-PROPERTIES; GLUCOSE-OXIDASE; PT(110); THICKNESS; CATALYSIS; CRYSTAL; AG	Acoustic wave resonance oscillation has been used successfully in the development of methods to activate immobilized enzyme catalysts. In this study, resonance oscillation effects were demonstrated for enzyme reactions on galactose oxidase (GAD), D-amino acid oxidase (DAAO), and L-amino acid oxidase (LAAO), all of which were immobilized covalently on a ferroelectric lead zirconate titanate (PZT) device that could generate thickness-extensional resonance oscillations (TERO) of acoustic waves. For galactose oxidation on immobilized GAD in a microreactor, TERO generation immediately increased enzyme activity 2- to 3-fold. Eliminating TERO caused a slight decrease in the activity, with similar to 90% of the enhanced activity retained while the reaction proceeded. Contact of the enhanced enzyme with a galactose-free solution caused almost complete reversion of the activity to the original low level before TERO generation, indicating that, not only TERO-induced GAD activation, but also preservation of the increased activity, required a galactose substrate. Similar activity changes with TERO were observed for enzyme reactions on DAAO and LAAO. Kinetic analysis demonstrated that TERO helped strengthen the interactions of the immobilized enzyme with the reactant substrate and promoted formation of an activation complex. (C) 2014 Elsevier Inc. All rights reserved.	[Nishiyama, Hiroshi; Watanabe, Tomoya; Inoue, Yasunobu] Nagaoka Univ Technol, Dept Mat Sci & Technol, Nagaoka, Niigata 9402188, Japan	Inoue, Y (reprint author), Nagaoka Univ Technol, Dept Mat Sci & Technol, 1603-1 Kamitomioka, Nagaoka, Niigata 9402188, Japan.	inoue@analysis.nagaokaut.ac.jp			KAKENHI from Japan Society for the Promotion of Science [23246137]	This work was supported by KAKENHI Grant number 23246137 from Japan Society for the Promotion of Science.	Kelling S, 1997, J CHEM PHYS, V107, P5609, DOI 10.1063/1.474236; Inoue Y, 2007, SURF SCI REP, V62, P305, DOI 10.1016/j.surfrep.2007.01.001; Auld BA, 1973, ACOUSTIC FIELDS WAVE, V2, P163; Ikeda T, 1990, FUNDAMENTALS PIEZOEL, V117, P83; INOUE Y, 1989, J AM CHEM SOC, V111, P8965, DOI 10.1021/ja00206a055; INOUE Y, 1992, J MOL CATAL, V74, P459, DOI 10.1016/0304-5102(92)80263-G; INOUE Y, 1992, J CHEM SOC FARADAY T, V88, P449, DOI 10.1039/ft9928800449; Kelling S, 1998, CHEM PHYS LETT, V293, P325, DOI 10.1016/S0009-2614(98)00811-2; Kelling S, 1997, FARADAY DISCUSS, V107, P435, DOI 10.1039/a703246c; Nishiyama H, 1997, FARADAY DISCUSS, V107, P425, DOI 10.1039/a703302h; Nishiyama H, 2010, PHYS CHEM CHEM PHYS, V12, P5970, DOI 10.1039/b923715a; Nishiyama H, 2014, APPL SURF SCI, V294, P66, DOI 10.1016/j.apsusc.2013.12.016; Nishiyama H, 2005, SURF SCI, V594, P156, DOI 10.1016/j.susc.2005.07.021; Nishiyama H, 2014, CHEM LETT, V43, P618, DOI 10.1246/cl.131218; Saito N, 2003, J PHYS CHEM B, V107, P2040, DOI 10.1021/jp022136k; Yukawa Y, 2004, J PHYS CHEM B, V108, P20199, DOI 10.1021/jp049891d	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0141-0229	1879-0909		ENZYME MICROB TECH	Enzyme Microb. Technol.	DEC	2014	67						27	31		10.1016/j.enzmictec.2014.08.005		5	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	AU2WQ	WOS:000345475800004		
J	Matsuyama, J; Ikeda, H; Sato, S; Yamamoto, K; Ohashi, G; Watanabe, K				Matsuyama, Junko; Ikeda, Hidetoshi; Sato, Shunsuke; Yamamoto, Koh; Ohashi, Genichiro; Watanabe, Kazuo			Early water intake restriction to prevent inappropriate antidiuretic hormone secretion following transsphenoidal surgery: low BMI predicts postoperative SIADH	EUROPEAN JOURNAL OF ENDOCRINOLOGY			English	Article							DELAYED HYPONATREMIA; PITUITARY-ADENOMA; MANAGEMENT	Objective: The goals of this study were to assess the incidence of and risk factors for the syndrome of inappropriate antidiuretic hormone secretion (SIADH) in patients following transsphenoidal surgery (TSS), and to validate the effectiveness of early prophylactic restriction of water intake. Design: Retrospective analysis was performed for 207 patients who had undergone TSS, including 156 patients not placed on early prophylactic water restriction. Sixty-four patients received treatment for SIADH. Methods: We compared the incidence of SIADH between patients with and without early water intake restriction, and analyzed various risk factors for SIADH using statistical analyses. Results: BMI was significantly lower for patients with SIADH than for those patients without SIADH. Statistical analysis revealed that the threshold BMI predicting SIADH was 26. Serum sodium levels on postoperative days 5-10 and daily urine volumes on postoperative days 5-10 were significantly lower in patients with SIADH than in those without SIADH. Postoperative body weight loss on days 6, 8, 10, and 11 was significantly higher in patients with SIADH. The incidence of SIADH after starting prophylactic water intake restriction (14%) was significantly lower than the rate before early water restriction (38%; P < 0.05). Conclusions: SIADH is relatively common after TSS, and serum sodium concentrations and daily urine volumes should be carefully monitored. Patients with low preoperative BMI should be closely observed, as this represented a significant preoperative risk factor for SIADH. Early prophylactic water intake restriction appears effective at preventing postoperative SIADH.	[Matsuyama, Junko; Ikeda, Hidetoshi; Sato, Shunsuke; Yamamoto, Koh; Ohashi, Genichiro; Watanabe, Kazuo] Southern Tohoku Gen Hosp, Res Inst Pituitary Dis, Koriyama, Fukushima, Japan; [Matsuyama, Junko] Southern Tohoku Gen Hosp, Dept Neurosurg, Iwanuma, Miyagi 9892483, Japan	Matsuyama, J (reprint author), Southern Tohoku Gen Hosp, Res Inst Pituitary Dis, Koriyama, Fukushima, Japan.	junko9106@hotmail.com					Kristof RA, 2009, J NEUROSURG, V111, P555, DOI 10.3171/2008.9.JNS08191; Zada G, 2007, J NEUROSURG, V106, P66, DOI 10.3171/jns.2007.106.1.66; Hussain NS, 2013, J NEUROSURG, V119, P1453, DOI 10.3171/2013.8.JNS13411; Olson BR, 1997, J NEUROSURG, V87, P499, DOI 10.3171/jns.1997.87.4.0499; KELLY DF, 1995, J NEUROSURG, V83, P363, DOI 10.3171/jns.1995.83.2.0363; Kinoshita Y, 2011, ENDOCR J, V58, P373; Lee Jae Il, 2008, Neurol Med Chir (Tokyo), V48, P489, DOI 10.2176/nmc.48.489; SANE T, 1994, J CLIN ENDOCR METAB, V79, P1395, DOI 10.1210/jc.79.5.1395	8	0	0	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	0804-4643	1479-683X		EUR J ENDOCRINOL	Eur. J. Endocrinol.	DEC	2014	171	6					711	716		10.1530/EJE-14-0530		6	Endocrinology & Metabolism	Endocrinology & Metabolism	AU4GH	WOS:000345567700011		
J	Yaguchi, Y; Komura, T; Kashima, N; Tamura, M; Kage-Nakadai, E; Saeki, S; Terao, K; Nishikawa, Y				Yaguchi, Yukie; Komura, Tomomi; Kashima, Noriko; Tamura, Miho; Kage-Nakadai, Eriko; Saeki, Shigeru; Terao, Keiji; Nishikawa, Yoshikazu			Influence of oral supplementation with sesamin on longevity of Caenorhabditis elegans and the host defense	EUROPEAN JOURNAL OF NUTRITION			English	Article						Longevity; Nematodes; Sesamin; Aging; Host defense	C-ELEGANS; OXIDATIVE STRESS; LIFE-SPAN; RESTRICTION; IMMUNE; ACID; MAINTENANCE; METABOLISM; SKN-1/NRF; DAF-16	Nutritional control has been proposed as a potential therapy for slowing the senescence of immune function and decreasing mortality. This study investigated whether sesamin could modify host defense systems and extend the lifespan of the nematode Caenorhabditis elegans. Nematodes were fed standard food (the bacterium Escherichia coli strain OP50) supplemented with various doses of sesamin/gamma-cyclodextrin inclusion compounds starting from young adulthood. The mean lifespan, muscle function, lipofuscin accumulation, protein carbonyl content, and stress resistance of the worms were examined. Then, C. elegans mutants harboring loss-of-function lesions in longevity- and host defense-related signaling pathways were supplemented with sesamin to identify the genes involved in the longevity effects. Worms supplemented with sesamin displayed higher locomotion and prolongevity and produced offspring at levels similar to unsupplemented control animals. The growth curves of nematodes were similar to those of controls, suggesting that sesamin did not induce prolongevity effects through dietary restriction. Notably, sesamin made the worms more resistant to infection by Legionella pneumophila and more resistant to oxidative stressors such as paraquat and hydrogen peroxide and prolonged the lifespan of a mev-1 mutant that produces abundant superoxide anions. However, the accumulation of protein carbonyls and lipofuscin was similar in sesamin-exposed and control worms, suggesting that sesamin is unlikely to work simply as an antioxidant. Sesamin supplementation failed to extend the lifespan of loss-of-function mutants of daf-2, daf-16, pmk-1, and skn-1. Sesamin enhances the host defense of C. elegans and increases the average lifespan via activation of both skn-1 (encoding a component of the p38 MAPK pathway) and daf-16 (encoding a component of the IGF-1 pathway).	[Yaguchi, Yukie; Komura, Tomomi; Kashima, Noriko; Tamura, Miho; Saeki, Shigeru; Nishikawa, Yoshikazu] Osaka City Univ, Grad Sch Human Life Sci, Dept Food & Human Hlth Sci, Sumiyoshi Ku, Osaka 5588585, Japan; [Kage-Nakadai, Eriko] Osaka City Univ, OCU Adv Res Inst Nat Sci & Technol, Sumiyoshi Ku, Osaka 5588585, Japan; [Terao, Keiji] CycloChem Co Ltd, Chuo Ku, Kobe, Hyogo 6500047, Japan	Nishikawa, Y (reprint author), Osaka City Univ, Grad Sch Human Life Sci, Dept Food & Human Hlth Sci, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.	nisikawa@life.osaka-cu.ac.jp	Nishikawa, Yoshikazu/K-6873-2015		Japan Society for the Promotion of Science [23617017, 23247045]; NIH National Center for Research Resources (NCRR)	This study was supported in part by a Grant-in-aid for Scientific Research C (No. 23617017) and a Grant-in-aid for Scientific Research A (No. 23247045) from the Japan Society for the Promotion of Science. The nematodes used in this study were kindly provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	Kashima N, 2012, BIOGERONTOLOGY, V13, P337, DOI 10.1007/s10522-012-9378-3; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Barsyte D, 2001, FASEB J, V15, P627, DOI 10.1096/fj.99-0966com; HOSONO R, 1980, EXP GERONTOL, V15, P285, DOI 10.1016/0531-5565(80)90032-7; Wu DQ, 2006, EXP GERONTOL, V41, P261, DOI 10.1016/j.exger.2006.01.003; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Yasuda K, 2012, EXPERT OPIN DRUG MET, V8, P93, DOI 10.1517/17425255.2012.637917; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Villanueva A, 2001, EMBO J, V20, P5114, DOI 10.1093/emboj/20.18.5114; Ide T, 2001, BBA-MOL CELL BIOL L, V1534, P1, DOI 10.1016/S1388-1981(01)00167-6; Anyanful A, 2005, MOL MICROBIOL, V57, P988, DOI 10.1111/j.1365-2958.2005.04739.x; Hirata F, 1996, ATHEROSCLEROSIS, V122, P135, DOI 10.1016/0021-9150(95)05769-2; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Zuo YY, 2013, BIOGERONTOLOGY, V14, P107, DOI 10.1007/s10522-012-9413-4; Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x; Cannizzo ES, 2011, J PROTEOMICS, V74, P2313, DOI 10.1016/j.jprot.2011.06.005; Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x; Pincus Z, 2010, DEV DYNAM, V239, P1306, DOI 10.1002/dvdy.22224; Fulop T, 2007, CLIN INTERV AGING, V2, P33, DOI 10.2147/ciia.2007.2.1.33; Pawelec G, 2008, EXP GERONTOL, V43, P34, DOI 10.1016/j.exger.2007.09.609; HIROSE N, 1992, ANTICANCER RES, V12, P1259; Komura T, 2013, BIOGERONTOLOGY, V14, P73, DOI 10.1007/s10522-012-9411-6; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/nchembio.607, 10.1038/NCHEMBIO.607]; Shibamura A, 2009, MECH AGEING DEV, V130, P652, DOI 10.1016/j.mad.2009.06.008; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Austad SN, 2012, NATURE, V489, P210, DOI 10.1038/nature11484; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Ikeda T, 2007, APPL ENVIRON MICROB, V73, P6404, DOI 10.1128/AEM.00704-07; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Bagnati M, 1999, BIOCHEM J, V340, P143, DOI 10.1042/0264-6021:3400143; Bogden J. D., 2004, Diet and human immune function, P79; BRADLEY SF, 1990, EXP GERONTOL, V25, P75, DOI 10.1016/0531-5565(90)90012-Q; EFFROS RB, 1991, J GERONTOL, V46, pB142; GrubeckLoebenstein B, 1997, BIOLOGICALS, V25, P205, DOI 10.1006/biol.1997.0085; Gruber J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019444; Gu JY, 1998, BIOSCI BIOTECH BIOCH, V62, P1917, DOI 10.1271/bbb.62.1917; Hayek MG, 1997, J INFECT DIS, V176, P273, DOI 10.1086/517265; Kashima N, 2012, TOCOTRIENOLS VITAMIN, P279; Komura T, 2010, APPL ENVIRON MICROB, V76, P4105, DOI 10.1128/AEM.03021-09; Matsumura Y, 1998, BIOL PHARM BULL, V21, P469; MOULIAS R, 1985, MECH AGEING DEV, V31, P123, DOI 10.1016/S0047-6374(85)80023-3; Putker M, 2013, MOL CELL, V49, P730, DOI 10.1016/j.molcel.2012.12.014; Stiernagle T, 1999, PRACT APPROACH SER, V213, P51; Sulston JE, 1988, NEMATODE CAENORHABDI, P587	46	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1436-6207	1436-6215		EUR J NUTR	Eur. J. Nutr.	DEC	2014	53	8					1659	1668		10.1007/s00394-014-0671-6		10	Nutrition & Dietetics	Nutrition & Dietetics	AU1IE	WOS:000345373500007		
J	Citron, CA; Rabe, P; Barra, L; Nakano, C; Hoshino, T; Dickschat, JS				Citron, Christian A.; Rabe, Patrick; Barra, Lena; Nakano, Chiaki; Hoshino, Tsutomu; Dickschat, Jeroen S.			Synthesis of Isotopically Labelled Oligoprenyl Diphosphates and Their Application in Mechanistic Investigations of Terpene Cyclases	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Synthetic methods; Biosynthesis; Terpenoids; Isotopic labelling; Phosphorylation	ENZYMATIC CYCLIZATION; STEREOCHEMICAL COURSE; GERANYL DIPHOSPHATE; DITERPENE CYCLASE; BIOSYNTHESIS; SYNTHASE; GENOME; SESQUITERPENE; DISPOSITION	A flexible, efficient and robust method for the synthesis of isotopically labelled oligoprenyl diphosphates was developed. The method makes use of just a few building blocks (acetone, triethyl phosphonoacetate, and ethyl acetoacetate) from which several isotopomers with deuterium or C-13-labelling are commercially available or can be easily obtained by synthesis. Besides these building blocks, a few deuterated reagents were used for the introduction of deuterium labelling. Furthermore, the synthesis of [14-H-2]geranylgeranyl diphosphate is reported. The material was used for a stereochemical analysis of the cyclisation reaction catalysed by tuberculosinyl diphosphate synthase from Mycobacterium tuberculosis.	[Citron, Christian A.; Rabe, Patrick; Barra, Lena; Dickschat, Jeroen S.] Univ Bonn, Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany; [Nakano, Chiaki; Hoshino, Tsutomu] Niigata Univ, Fac Agr, Dept Appl Biol Chem, Nishi Ku, Niigata 9502181, Japan; [Nakano, Chiaki; Hoshino, Tsutomu] Niigata Univ, Grad Sch Sci & Technol, Nishi Ku, Niigata 9502181, Japan	Dickschat, JS (reprint author), Univ Bonn, Kekule Inst Organ Chem & Biochem, Gerhard Domagk Str 1, D-53121 Bonn, Germany.	dickschat@uni-bonn.de			Deutsche Forschungsgemeinschaft (DFG) [DI1536/4-1, DI1536/2-1]; Beilstein Institut zur Forderung der Chemischen Wissenschaften	This work was funded by the Deutsche Forschungsgemeinschaft (DFG) with a Heisenberg fellowship (grant DI1536/4-1, to J. S. D. and project "Fragrants from Actinomycetes", grant DI1536/2-1) and by the Beilstein Institut zur Forderung der Chemischen Wissenschaften with a Scholarship (to P. R.).	Citron CA, 2014, CHEM COMMUN, V50, P5224, DOI 10.1039/c3cc45982a; Dickschat JS, 2011, NAT PROD REP, V28, P1917, DOI 10.1039/c1np00063b; Chou WKW, 2010, J AM CHEM SOC, V132, P8850, DOI 10.1021/ja103087w; Thulasiram HV, 2006, J ORG CHEM, V71, P1739, DOI 10.1021/jo052384n; Brock NL, 2011, CHEMBIOCHEM, V12, P2667, DOI 10.1002/cbic.201100516; Hu YF, 2011, CHEM BIOL, V18, P32, DOI 10.1016/j.chembiol.2010.11.008; Citron CA, 2012, ANGEW CHEM INT EDIT, V51, P4053, DOI 10.1002/anie.201201110; Jiang JY, 2006, J AM CHEM SOC, V128, P8128, DOI 10.1021/ja062669x; ARIGONI D, 1993, PHYTOCHEMISTRY, V32, P623, DOI 10.1016/S0031-9422(00)95146-X; Baer P, 2014, CHEMBIOCHEM, V15, P213, DOI 10.1002/cbic.201300708; Brock NL, 2013, ANGEW CHEM INT EDIT, V52, P2100, DOI 10.1002/anie.201209173; CANE DE, 1990, J AM CHEM SOC, V112, P3209, DOI 10.1021/ja00164a051; CANE DE, 1990, J AM CHEM SOC, V112, P4513, DOI 10.1021/ja00167a059; Citron CA, 2013, ORG BIOMOL CHEM, V11, P7447, DOI 10.1039/c3ob41755g; Comeskey DJ, 2006, J LABELLED COMPD RAD, V49, P47, DOI 10.1002/jlcr.1027; Dickschat JS, 2011, EUR J ORG CHEM, P3339, DOI 10.1002/ejoc.201100188; IZUMI S, 1991, J LABELLED COMPD RAD, V29, P591, DOI 10.1002/jlcr.2580290511; Miller DJ, 2008, ORG BIOMOL CHEM, V6, P2346, DOI 10.1039/b804198a; Nakano C, 2005, CHEM COMMUN, P1016, DOI 10.1039/b415346d; Nakano C, 2009, CHEMBIOCHEM, V10, P2060, DOI 10.1002/cbic.200900248; Raptis C, 2009, CHEM-EUR J, V15, P11918, DOI 10.1002/chem.200901563; Subramanian T, 2013, J LABELLED COMPD RAD, V56, P370, DOI 10.1002/jlcr.3049; SUGA T, 1992, J CHEM SOC CHEM COMM, P1556, DOI 10.1039/c39920001556; Tsangarakis C, 2006, EUR J ORG CHEM, P4435, DOI 10.1002/ejoc.200600367; Wise ML, 2001, TETRAHEDRON, V57, P5327, DOI 10.1016/S0040-4020(01)00451-3	25	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	DEC	2014		34					7684	7691		10.1002/ejoc.201403002		8	Chemistry, Organic	Chemistry	AU3IT	WOS:000345506700022		
J	Miyazono, A; Abe, J; Ogura, M; Sato, M; Fujimaru, T; Kamei, K; Ito, S				Miyazono, Akinori; Abe, Jun; Ogura, Masao; Sato, Mai; Fujimaru, Takuya; Kamei, Koichi; Ito, Shuichi			Successful remission induced by plasma exchange combined with leukocytapheresis against refractory systemic juvenile idiopathic arthritis	EUROPEAN JOURNAL OF PEDIATRICS			English	Article						Systemic juvenile idiopathic arthritis; Plasma exchange; Leukocytapheresis; Cytokine; Macrophage activation syndrome	MACROPHAGE ACTIVATION SYNDROME; RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; THERAPY; TRIAL	Systemic juvenile idiopathic arthritis (sJIA) is an inflammatory cytokine-related disorder associated with overproduction of interleukin (IL)-6, IL-1 beta, and IL-18. Macrophage activation syndrome (MAS) is a critical and lethal complication of sJIA. Therefore, prompt induction of remission in the active phase of sJIA is important for prevention of MAS. However, treatment of corticosteroid-resistant sJIA is still challenging. We propose a new strategy to induce remission in the active phase of sJIA. A 7-year-old boy with new-onset sJIA was treated with oral prednisolone, methylprednisolone pulse therapy, and parenteral cyclosporine, but he continuously showed remittent high fever, arthralgia, skin rash, and elevation of inflammatory markers, including hyperferritinemia. Because of impending MAS, plasma exchange was started, but he was resistant to plasma exchange. Therefore, we combined leukocytapheresis with PE. After five PE and two leukocytapheresis sessions, he finally achieved remission in accordance with a reduction in inflammatory cytokines. Elevated serum tumor necrosis factor-alpha, interferon-gamma, and IL-12 levels returned to normal 10 days after initiating plasma exchange combined with leukocytapheresis, with a reduction in white blood cell count. In conclusion, plasma exchange combined with leukocytapheresis is a new alternative option to induce remission for patients with methylprednisolone pulse therapy- or cyclosporine-refractory sJIA.	[Miyazono, Akinori; Ogura, Masao; Sato, Mai; Fujimaru, Takuya; Kamei, Koichi; Ito, Shuichi] Natl Ctr Child Hlth & Dev, Div Nephrol & Rheumatol, Setagaya Ku, Tokyo 1578535, Japan; [Abe, Jun] Natl Ctr Child Hlth & Dev, Dept Allergy & Immunol, Setagaya Ku, Tokyo 1578535, Japan	Ito, S (reprint author), Natl Ctr Child Hlth & Dev, Div Nephrol & Rheumatol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	ito-shu@ncchd.go.jp					Ruperto N, 2012, NEW ENGL J MED, V367, P2396, DOI 10.1056/NEJMoa1205099; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Billiau AD, 2005, BLOOD, V105, P1648, DOI 10.1082/blood-2004-08-2997; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Yokota S, 2008, LANCET, V371, P998, DOI 10.1016/S0140-6736(08)60454-7; Ravelli A, 1996, J PEDIATR-US, V128, P275, DOI 10.1016/S0022-3476(96)70408-0; Demirkol D, 2012, CRIT CARE, V16, DOI 10.1186/cc11256; Hidaka T, 2001, J CLIN APHERESIS, V16, P74, DOI 10.1002/jca.1016; Hidaka T, 1999, ARTHRITIS RHEUM, V42, P431, DOI 10.1002/1529-0131(199904)42:3<431::AID-ANR6>3.0.CO;2-2; SAWADA K, 1995, J GASTROENTEROL, V30, P322, DOI 10.1007/BF02347507; Tanaka H, 2007, CLIN RHEUMATOL, V26, P1014, DOI 10.1007/s10067-006-0256-8; Umekita K, 2009, MOD RHEUMATOL, V19, P265, DOI 10.1007/s10165-009-0164-2	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6199	1432-1076		EUR J PEDIATR	Eur. J. Pediatr.	DEC	2014	173	12					1557	1560		10.1007/s00431-013-2093-5		4	Pediatrics	Pediatrics	AU4ND	WOS:000345587200004		
J	Yamamoto, N; Nishimura, N; Takeuchi, M; Ito, T; Yokozaki, H; Hirase, S; Kubokawa, I; Mori, T; Yanai, T; Hayakawa, A; Takeshima, Y; Nishio, H; Matsuo, M; Imadome, KI; Iijima, K				Yamamoto, Nobuyuki; Nishimura, Noriyuki; Takeuchi, Mai; Ito, Tomoo; Yokozaki, Hiroshi; Hirase, Satoshi; Kubokawa, Ikuko; Mori, Takeshi; Yanai, Tomoko; Hayakawa, Akira; Takeshima, Yasuhiro; Nishio, Hisahide; Matsuo, Masafumi; Imadome, Ken-Ichi; Iijima, Kazumoto			The emergence of CD20-/CD19-tumor cells after rituximab therapy for Epstein-Barr virus-associated post-transplant lymphoproliferative disorder complicated with hemophagocytic lymphohistiocytosis	EUROPEAN JOURNAL OF PEDIATRICS			English	Article						Epstein-Barr virus; Post-transplant lymphoproliferative disorder; Hemophagocytic lymphohistiocytosis; Rituximab; Shaving/trogocytosis	CHRONIC LYMPHOCYTIC-LEUKEMIA; TRANSPLANTATION	Post-transplant lymphoproliferative disorder (PTLD) is a well-recognized aggressive disease commonly associated with Epstein-Barr virus (EBV) infection after hematopoietic stem cell transplantation (HSCT). Although rituximab (RTX) is incorporated into the first-line therapy for EBV-PTLD patients, the outcome of the clinically overt disease is still not optimal mainly due to the regrowth of tumor cells. The proliferation of CD20-/CD19+ tumor cells is increasingly reported in RTX-treated EBV-PTLD patients, whereas the emergence of CD20-/CD19- tumor cells is barely recognized. Here, we report a fatal case of an 18-year-old patient who developed EBV-PTLD after allogeneic HSCT for anaplastic large-cell lymphoma. On day 60 after HSCT, the patient developed abdominal pain, watery diarrhea, and low-grade fever. Colon biopsy revealed the proliferation of CD20+/CD19+/EBV-encoded RNA (EBER)+ tumor cells, and an increase of EBV DNA was detected in peripheral blood (PB). He was treated with RTX for EBV-PTLD and was cleared of EBV DNA in PB. However, he manifested high-grade fever, pancytopenia, and elevated soluble interleukin-2 receptor with a prominent hemophagocytosis in bone marrow aspirates and was treated with etoposide for hemophagocytic lymphohistiocytosis (HLH) complication. He then developed EBV DNA positivity in PB and finally died of Bacteroides fragilis sepsis subsequent to bloody stool and ileus on day 163. Autopsy revealed erosion and bleeding in the whole colon with the proliferation of CD20-/CD19-/EBER+ tumor cells. Immunohistochemical analysis uncovered the CD3-/CD56-/CD79a+/CD79b+ B-cell origin of tumor cells. This case clinically demonstrates the removal of both CD20 and CD19 antigens from EBER+ B cells in an RTX-treated EBV-PTLD patient with HLH complication.	[Yamamoto, Nobuyuki; Nishimura, Noriyuki; Hirase, Satoshi; Kubokawa, Ikuko; Mori, Takeshi; Yanai, Tomoko; Hayakawa, Akira; Takeshima, Yasuhiro; Nishio, Hisahide; Iijima, Kazumoto] Kobe Univ, Grad Sch Med, Dept Pediat, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Nishimura, Noriyuki; Nishio, Hisahide] Kobe Univ, Grad Sch Med, Dept Epidemiol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Takeuchi, Mai; Ito, Tomoo] Kobe Univ Hosp, Dept Diagnost Pathol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Takeuchi, Mai; Ito, Tomoo] Kobe Univ Hosp, Kobe Adv Tissue Staining Ctr, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Yokozaki, Hiroshi] Kobe Univ, Grad Sch Med, Dept Pathol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Matsuo, Masafumi] Kobe Gakuin Univ, Dept Rehabil Med, Nishi Ku, Kobe, Hyogo 6512180, Japan; [Imadome, Ken-Ichi] Natl Res Inst Child Hlth & Dev, Dept Infect Dis, Setagaya Ku, Tokyo 1578535, Japan	Nishimura, N (reprint author), Kobe Univ, Grad Sch Med, Dept Pediat, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	nnishi@med.kobe-u.ac.jp					Jordan MB, 2011, BLOOD, V118, P4041, DOI 10.1182/blood-2011-03-278127; Taylor RP, 2010, SEMIN HEMATOL, V47, P124, DOI 10.1053/j.seminhematol.2010.01.006; Heslop HE, 2009, BLOOD, V114, P4002, DOI 10.1182/blood-2009-07-143545; Janka GE, 2007, EUR J PEDIATR, V166, P95, DOI 10.1007/s00431-006-0258-1; Comoli P, 2007, AM J TRANSPLANT, V7, P1648, DOI 10.1111/j.1600-6143.2007.01823.x; Beum PV, 2006, J IMMUNOL, V176, P2600; Rossi EA, 2013, BLOOD, V122, P3020, DOI 10.1182/blood-2012-12-473744; Williams ME, 2006, J IMMUNOL, V177, P7435; Evens AM, 2010, CURR ONCOL REP, V12, P383, DOI 10.1007/s11912-010-0132-1; Jones JD, 2012, ARTHRITIS RHEUM-US, V64, P3111, DOI 10.1002/art.34560; Takahashi S, 2007, EUR J DERMATOL, V17, P242; Wang IJ, 2005, PEDIATR BLOOD CANCER, V45, P340, DOI 10.1002/pbc.20191	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6199	1432-1076		EUR J PEDIATR	Eur. J. Pediatr.	DEC	2014	173	12					1615	1618		10.1007/s00431-013-2181-6		4	Pediatrics	Pediatrics	AU4ND	WOS:000345587200019		
J	Yamaguchi, H; Nagumo, K; Nakashima, T; Kinugawa, Y; Kumaki, S				Yamaguchi, Hiroshi; Nagumo, Kiyoshi; Nakashima, Taiji; Kinugawa, Yoshikazu; Kumaki, Satoru			Life-threatening QT prolongation in a boy with attention-deficit/hyperactivity disorder on atomoxetine	EUROPEAN JOURNAL OF PEDIATRICS			English	Article						Atomoxetine; Attention-deficit/hyperactivity disorder; Loss of consciousness; Prolongation; QT; Takotsubo cardiomyopathy	DEFICIT HYPERACTIVITY DISORDER; CARDIOVASCULAR EVENTS; CHILDREN; ADHD; ADOLESCENTS	As a noncentral nerve-stimulating agent blocking reuptake of noradrenalin, atomoxetine is used for treatment of attention-deficit/hyperactivity disorder (ADHD). Because it has less potential for addiction and abuse and improves core symptoms of ADHD, it is commonly prescribed in many children and adolescents internationally. Its common side effects include headache, abdominal pain, decreased appetite, and weight loss. In addition, cardiac effects such as tachycardia and hypertension have also been reported. In this case report, an 11-year-old Japanese boy with a past medical history of ADHD on atomoxetine for more than 2 years presented with a loss of consciousness. Initial electrocardiogram (ECG) showed significant QT prolongation, and 9 h later, it worsened, along with bradycardia, inversed T waves, and multiple premature ventricle contractions (PVCs). Transthoracic echocardiography showed akinesis with dilation and systolic ballooning of the left ventricle's (LV) apical segment (Takotsubo cardiomyopathy). At that point, bisoprolol and transcutaneous pacing were started. After 5 days, transcutaneous pacing was discontinued due to improvement in his cardiac rhythm. He continued to remain asymptomatic for the next year, while his QT interval returned to normal. Conclusion: This case report suggests a serious side effect of atomoxetine, and to avoid life-threatening cardiovascular events for children and adolescents with ADHD on atomoxetine, prior screening for cardiovascular conditions by ECG with close monitoring is necessary.	[Yamaguchi, Hiroshi; Nagumo, Kiyoshi; Nakashima, Taiji; Kinugawa, Yoshikazu; Kumaki, Satoru] Teine Keijinkai Hosp, Dept Pediat, Sapporo, Hokkaido, Japan	Nagumo, K (reprint author), 1 Jo 12-1-40 Maeda,Teine Ku, Sapporo, Hokkaido 0068555, Japan.	knag.tdr@keijinkai.or.jp					Geller D, 2007, J AM ACAD CHILD PSY, V46, P1119, DOI 10.1097/chi.0b013e3180ca8385; Donnelly C, 2009, J AM ACAD CHILD PSY, V48, P176, DOI 10.1097/CHI.0b013e318193060e; Schelleman H, 2011, PEDIATRICS, V127, P1102, DOI 10.1542/peds.2010-3371; Martinez-Raga J, 2013, CNS DRUGS, V27, P15, DOI 10.1007/s40263-012-0019-9; Ring BJ, 2002, DRUG METAB DISPOS, V30, P319, DOI 10.1124/dmd.30.3.319; Cooper WO, 2011, NEW ENGL J MED, V365, P1896, DOI 10.1056/NEJMoa1110212; Michelson D, 2002, AM J PSYCHIAT, V159, P1896, DOI 10.1176/appi.ajp.159.11.1896; Scherer D, 2009, BRIT J PHARMACOL, V156, P226, DOI 10.1111/j.1476-5381.2008.00018.x; Sawant S, 2004, AM J PSYCHIAT, V161, P757, DOI 10.1176/appi.ajp.161.4.757; Bangs ME, 2008, PEDIATRICS, V121, P314; Eli Lilly and Company, 2013, PRESCR INF STRATT, P1; Kelsey DK, 2004, PEDIATRICS, V114, P1	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6199	1432-1076		EUR J PEDIATR	Eur. J. Pediatr.	DEC	2014	173	12					1631	1634		10.1007/s00431-013-2206-1		4	Pediatrics	Pediatrics	AU4ND	WOS:000345587200023		
J	Yamamoto, K; Kawabata, H				Yamamoto, Kosuke; Kawabata, Hideaki			Adaptation to delayed auditory feedback induces the temporal recalibration effect in both speech perception and production	EXPERIMENTAL BRAIN RESEARCH			English	Article						Temporal recalibration; Simultaneity judgment; Delayed auditory feedback; Speech; Multimodal integration	SENSORIMOTOR ADAPTATION; SIMULTANEITY; TIME; PERTURBATIONS; CALIBRATION; SYNCHRONY	We ordinarily speak fluently, even though our perceptions of our own voices are disrupted by various environmental acoustic properties. The underlying mechanism of speech is supposed to monitor the temporal relationship between speech production and the perception of auditory feedback, as suggested by a reduction in speech fluency when the speaker is exposed to delayed auditory feedback (DAF). While many studies have reported that DAF influences speech motor processing, its relationship to the temporal tuning effect on multimodal integration, or temporal recalibration, remains unclear. We investigated whether the temporal aspects of both speech perception and production change due to adaptation to the delay between the motor sensation and the auditory feedback. This is a well-used method of inducing temporal recalibration. Participants continually read texts with specific DAF times in order to adapt to the delay. Then, they judged the simultaneity between the motor sensation and the vocal feedback. We measured the rates of speech with which participants read the texts in both the exposure and re-exposure phases. We found that exposure to DAF changed both the rate of speech and the simultaneity judgment, that is, participants' speech gained fluency. Although we also found that a delay of 200 ms appeared to be most effective in decreasing the rates of speech and shifting the distribution on the simultaneity judgment, there was no correlation between these measurements. These findings suggest that both speech motor production and multimodal perception are adaptive to temporal lag but are processed in distinct ways.	[Yamamoto, Kosuke; Kawabata, Hideaki] Keio Univ, Dept Psychol, Minato Ku, Tokyo 1088345, Japan	Kawabata, H (reprint author), Keio Univ, Dept Psychol, Minato Ku, 2-15-45 Mita, Tokyo 1088345, Japan.	kawabata@flet.keio.ac.jp			 [256554]	This research was carried out under the JSPS KAKENHI (24680029) to H. K., and K. Y. was supported by a Grant-in-Aid for JSPS Fellows (256554).	ABBS JH, 1984, J NEUROPHYSIOL, V51, P705; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; PORT RF, 1987, J ACOUST SOC AM, V81, P1574, DOI 10.1121/1.394510; Tremblay S, 2003, NATURE, V423, P866, DOI 10.1038/nature01710; Nasir SM, 2009, P NATL ACAD SCI USA, V106, P20470, DOI 10.1073/pnas.0907032106; Sugano Y, 2010, EXP BRAIN RES, V201, P393, DOI 10.1007/s00221-009-2047-3; Miyazaki M, 2006, NAT NEUROSCI, V9, P875, DOI 10.1038/nn1712; Spence C, 2003, CURR BIOL, V13, pR519, DOI 10.1016/S0960-9822(03)00445-7; Stetson C, 2006, NEURON, V51, P651, DOI 10.1016/j.neuron.2006.08.006; Jones JA, 2000, J ACOUST SOC AM, V108, P1246, DOI 10.1121/1.1288414; Cunningham DW, 2001, PSYCHOL SCI, V12, P532, DOI 10.1111/1467-9280.00398; Keetels M, 2012, EXP BRAIN RES, V219, P431, DOI 10.1007/s00221-012-3081-0; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Keetels M, 2008, NEUROSCI LETT, V430, P130, DOI 10.1016/j.neulet.2007.10.044; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; BORDEN GJ, 1979, BRAIN LANG, V7, P307, DOI 10.1016/0093-934X(79)90025-7; Galantucci B, 2006, PSYCHON B REV, V13, P361, DOI 10.3758/BF03193857; Houde JF, 1998, SCIENCE, V279, P1213, DOI 10.1126/science.279.5354.1213; Sugita Y, 2003, NATURE, V421, P911, DOI 10.1038/421911a; Harrar V, 2005, EXP BRAIN RES, V166, P465, DOI 10.1007/s00221-005-2386-7; Yarrow K, 2013, J EXP PSYCHOL HUMAN, V39, P1678, DOI 10.1037/a0032534; Villacorta VM, 2007, J ACOUST SOC AM, V122, P2306, DOI 10.1121/1.2773966; Hanson JVM, 2008, EXP BRAIN RES, V185, P347, DOI 10.1007/s00221-008-1282-3; Howell P, 2002, J ACOUST SOC AM, V111, P2842, DOI 10.1121/1.1474444; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Arnold DH, 2012, FRONT HUM NEUROSCI, V6, P1; Black JW, 1951, J SPEECH HEAR DISORD, V16, P56; Di Luca M, 2009, J VISION, V9, DOI 10.1167/9.12.7; GRACCO VL, 1985, J NEUROPHYSIOL, V54, P418; Heron J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007681; Houde JF, 2002, J SPEECH LANG HEAR R, V45, P295, DOI 10.1044/1092-4388(2002/023); Howell P, 2004, STAMMERING RES, V1, P31; KATZ DI, 1977, PERCEPT PSYCHOPHYS, V22, P476, DOI 10.3758/BF03199514; LEE BS, 1950, J ACOUST SOC AM, V22, P824, DOI 10.1121/1.1906696; Max L., 2004, CONT ISSUES COMMUNIC, V31, P105; Nasir SM, 2006, CURR BIOL, V16, P1918, DOI 10.1016/j.cub.2006.07.069; Navarra J, 2012, FRONTIERS PSYCHOL, V3, P1; NOVAK A, 1978, FOLIA PHONIATR, V30, P278; Parsons BD, 2013, FRONT PSYCHOL, V4, P1; Scharnowski F, 2013, TRENDS COGN SCI, V17, P51, DOI 10.1016/j.tics.2012.12.005; Shiller DM, 2009, J ACOUST SOC AM, V125, P1103, DOI 10.1121/1.3058638; Stekelenburg JJ, 2012, FRONT INTEGR NEUROSC, V6, P1; Sugano Y, 2012, FRONT PSYCHOL, V3, P1; Tsujita M, 2012, FRONT PSYCHOL, V3, P1; Yamamoto K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029414	47	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	DEC	2014	232	12					3707	3718		10.1007/s00221-014-4055-1		12	Neurosciences	Neurosciences & Neurology	AU1UZ	WOS:000345406800002		
J	Rosli, NB; Amagai, K				Rosli, Nurrina Binti; Amagai, Kenji			Measurement of liquid sheet using laser tagging method by photochromic dye	EXPERIMENTS IN FLUIDS			English	Article							ACTIVATION TECHNIQUE; FLOW MEASUREMENTS	Liquid atomization system has been extensively applied as the most significant process in many industrial fields. In the internal combustion engine, the combustion phenomenon is strongly influenced by the spray characteristics of the fuel given by the atomization process. In order to completely understand the whole atomization process, a detail investigation of relations between the liquid jet characteristics and the breakup phenomenon is required. In this study, a non-intrusive method called as laser tagging method by photochromic dye has been developed with aim to study the breakup process of liquid sheet in detail, covering from the behavior in film until disintegrated into ligament and droplets. The laser tagging method by photochromic dye is based on a shift in the absorption spectrum of photochromic dye molecules tagged by ultraviolet laser. The shift results a color change at the tagged region of liquid containing the dye. In this study, the motions of the dye traces were analyzed as the liquid surface velocity. As a result, liquid sheet was found to keep its velocity constantly in film before suddenly increase around broken point. However, it then decreased after broken into droplets. By forming a set of four points of dye traces on the liquid sheet, the change of relative position of the set enabled the measurement of deformation and rotational motion of the liquid sheet. As a result, the normal strain of the liquid sheet parallel to the flow direction depended on the flow behavior of ligament formation.	[Rosli, Nurrina Binti; Amagai, Kenji] Gunma Univ, Dept Mech Sci & Technol, Kiryu, Gumma 3768515, Japan	Amagai, K (reprint author), Gunma Univ, Dept Mech Sci & Technol, Kiryu, Gumma 3768515, Japan.	amagai@gunma-u.ac.jp			Japan Society for the Promotion of Science, JSPS KAKENHI [24560183]; Universiti Malaysia Pahang; Ministry of Higher Education of Malaysia	This research was funded by Japan Society for the Promotion of Science, JSPS KAKENHI (Grant No. 24560183). The author would also like to acknowledge Universiti Malaysia Pahang and Ministry of Higher Education of Malaysia for supporting and motivations. Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.	Agui Garcia JC, 1989, PHYS FLUIDS A-FLUID, V2, P688; POPOVICH AT, 1967, CHEM ENG SCI, V22, P21, DOI 10.1016/0009-2509(67)80100-3; Kai T, 2003, POWDER TECHNOL, V129, P22, DOI 10.1016/S0032-5910(02)00155-9; Fogwell TW, 1987, EXP HEAT TRANSFER, V1, P141; Homescu D, 2004, OPT LASER ENG, V41, P879, DOI 10.1016/S0143-8166(03)00064-2; Hosokawa S, 2009, EXP FLUIDS, V47, P745, DOI 10.1007/s00348-009-0690-x; JOHNSON G, 1986, INT J MULTIPHAS FLOW, V12, P127, DOI 10.1016/0301-9322(86)90008-X; Kawaji M, 1998, NUCL ENG DES, V184, P379, DOI 10.1016/S0029-5493(98)00210-6; Koso T, 2000, P ANN C JSME JAP, V4, P223; Park H, 1999, EXP FLUIDS, V26, P55, DOI 10.1007/s003480050264; Rosli N, 2011, J JSME, V11, P147; Sanada T, 2007, CHEM ENG SCI, V62, P7264, DOI 10.1016/j.ces.2007.08.037	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0723-4864	1432-1114		EXP FLUIDS	Exp. Fluids	DEC	2014	55	12							1843	10.1007/s00348-014-1843-0		15	Engineering, Mechanical; Mechanics	Engineering; Mechanics	AU0RI	WOS:000345331300003		
J	Aino, M; Nishida, E; Fujieda, Y; Orimoto, A; Mitani, A; Noguchi, T; Makino, H; Murakami, S; Umezawa, A; Yoneda, T; Saito, M				Aino, Makoto; Nishida, Eisaku; Fujieda, Yoshiyasu; Orimoto, Ai; Mitani, Akio; Noguchi, Toshihide; Makino, Hatsune; Murakami, Shinya; Umezawa, Akihiro; Yoneda, Toshiyuki; Saito, Masahiro			Isolation and characterization of the human immature osteoblast culture system from the alveolar bones of aged donors for bone regeneration therapy	EXPERT OPINION ON BIOLOGICAL THERAPY			English	Article						aging; bone morphogenic protein; bone regeneration; human immature osteoblast; NEBULETTE	MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; IN-VITRO; GENE-THERAPY; DIFFERENTIATION; PROLIFERATION; STRATEGIES; MEDICINE; MOUSE; VIVO	Background: Establishment of human osteoblast cultures that retain bone-forming capacity is one of the prerequisites for successful bone regeneration therapy. Because osteoblasts harvested from adults exhibit limited growth, the use of immature osteoblasts that can expand ex vivo should greatly facilitate bone regeneration therapy. In this study, we developed immature human osteoblasts isolated from aged alveolar bone (HAOBs). Methods: HAOBs obtained after the collagenase digestion of alveolar bones from elderly donors. Then, we assessed osteogenic ability of HAOB after treatment with recombinant human bone morphogenic protein-2 or transplantation into immunodeficient mice. In addition, we performed global gene expression analysis to identify functional marker for HAOB. Results: HAOBs, which can differentiate into osteoblasts and have a robust bone-forming ability, were successfully extracted from donors who were > 60 years of age. We found that the HAOBs exhibited a higher osteogenic ability compared with those of human mesenchymal stem cells and highly expressed NEBULETTE (NEBL) with osteogenic abilities. Conclusions: HAOBs have properties similar to those of human immature osteoblasts and appear to be a novel material for cell-based bone regeneration therapy. Additionally, the expression level of NEBL may serve as a marker for the osteogenic ability of these cells.	[Aino, Makoto; Nishida, Eisaku; Mitani, Akio; Noguchi, Toshihide] Aichi Gakuin Univ, Sch Dent, Dept Periodontol, Nagoya, Aichi 464, Japan; [Orimoto, Ai] Univ Grad Sch Dent, Dept Restorat Dent, Sendai, Miyagi, Japan; [Murakami, Shinya] Osaka Univ, Grad Sch Dent, Dept Periodontol & Oral Pathol, Suita, Osaka, Japan; [Makino, Hatsune] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan; [Umezawa, Akihiro] Natl Res Inst Child & Hlth Dev, Dept Reprod Biol & Pathol, Tokyo, Japan; [Yoneda, Toshiyuki] Indiana Univ Sch Med, Div Hematol Oncol, Indianapolis, IN 46202 USA; [Fujieda, Yoshiyasu] Tokyo Univ Sci, Grad Sch Ind Sci & Technol, Dept Biol Sci & Technol, Noda, Chiba 2788510, Japan; [Saito, Masahiro] Tohoku Univ, Grad Sch Dent, Div Operat Dent, Dept Restorat Dent,Aoba Ku, Sendai, Miyagi 9808575, Japan	Saito, M (reprint author), Tohoku Univ, Grad Sch Dent, Div Operat Dent, Dept Restorat Dent, Sendai, Miyagi 9808575, Japan.	mssaito@dent.tohoku.ac.jp			Ministry of Health Labour and Welfare through a Health Labour Sciences Research Grant for Comprehensive Research on Aging and Health	This work was supported by the Ministry of Health Labour and Welfare through a Health Labour Sciences Research Grant for Comprehensive Research on Aging and Health to M Saito. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Purevjav E, 2010, J AM COLL CARDIOL, V56, P1493, DOI 10.1016/j.jacc.2010.05.045; Handa K, 2002, BONE, V31, P606, DOI 10.1016/S8756-3282(02)00868-2; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Matsubara T, 2005, J BONE MINER RES, V20, P399, DOI 10.1359/JBMR.041117; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Solchaga LA, 2010, TISSUE ENG PT A, V16, P1009, DOI 10.1089/ten.TEA.2009.0100; Pappas CT, 2011, TRENDS CELL BIOL, V21, P29, DOI 10.1016/j.tcb.2010.09.005; Bang ML, 2001, J CELL BIOL, V153, P413, DOI 10.1083/jcb.153.2.413; Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2; Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153; Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x; Phillips JE, 2007, BIOMATERIALS, V28, P211, DOI 10.1016/j.biomaterials.2006.07.032; MONCMAN CL, 1995, CELL MOTIL CYTOSKEL, V32, P205, DOI 10.1002/cm.970320305; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Stenderup K, 2001, J BONE MINER RES, V16, P1120, DOI 10.1359/jbmr.2001.16.6.1120; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chang J, 2007, J BIOL CHEM, V282, P30938, DOI 10.1074/jbc.M702391200; Caverzasio J, 2013, J BONE MINER RES, V28, P260, DOI 10.1002/jbmr.1748; Zhang ZY, 2010, BIOMATERIALS, V31, P608, DOI 10.1016/j.biomaterials.2009.09.078; Mistry AS, 2005, ADV BIOCHEM ENG BIOT, V94, P1, DOI 10.1007/b99997; Melsen B, 1999, ANGLE ORTHOD, V69, P151; Cohen MM, 2006, AM J MED GENET A, V140A, P2646, DOI 10.1002/ajmg.a.31368; Perinpanayagam H, 2006, ARCH ORAL BIOL, V51, P406, DOI 10.1016/j.archoralbio.2005.09.004; Tsuchiya K, 2004, CELL TISSUE RES, V316, P141, DOI 10.1007/s00441-004-0862-1; Oreffo ROC, 1998, CLIN SCI, V94, P549; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; Sen B, 2014, J BONE MINER RES, V29, P78, DOI 10.1002/jbmr.2031; Yamada Y, 2003, J CRANIO MAXILL SURG, V31, P27, DOI 10.1016/S1010-5182; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Gruber R, 2006, EXP GERONTOL, V41, P1080, DOI 10.1016/j.exger.2006.09.008; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; Greenwood SK, 2004, ENVIRON MOL MUTAGEN, V43, P36, DOI 10.1002/em.10207; Lin CY, 2005, TISSUE ENG, V11, P1589, DOI 10.1089/ten.2005.11.1589; Maegawa N, 2007, J TISSUE ENG REGEN M, V1, P306, DOI 10.1002/term.41; Baron Roland, 2007, Curr Osteoporos Rep, V5, P73; Bauer TW, 2000, CLIN ORTHOP RELAT R, P10; Candeliere GA, 2001, BONE, V28, P351, DOI 10.1016/S8756-3282(01)00410-0; Choi BH, 2005, INT J ORAL MAX SURG, V34, P420, DOI 10.1016/j.ijom.2004.10.018; Cowan CM, 2003, J BIOL CHEM, V278, P32005, DOI 10.1074/jbc.M304698200; Eslaminejad MB, 2007, YAKHTEH, V9, P158; Guang LG, 2013, INT J BIOCHEM CELL B, V45, P1813, DOI 10.1016/j.biocel.2013.05.034; Kami D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002407; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055861; Li P, 2013, J BONE MINER METAB; Liu JZ, 2014, CELL BIOCHEM BIOPHYS, V68, P479, DOI 10.1007/s12013-013-9726-1; Mravic M., 2014, BIOMED RES INT, V2014; Oryan A, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-18; PALMER RM, 1987, ARCH ORAL BIOL, V32, P281, DOI 10.1016/0003-9969(87)90022-7; Xiao Y, 2003, TISSUE ENG, V9, P1167, DOI 10.1089/10763270360728071; Zhu Shi-Jiang, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, P164, DOI 10.1016/j.tripleo.2005.04.006; zur Nieden NI, 2003, DIFFERENTIATION, V71, P18, DOI 10.1046/j.1432-0436.2003.700602.x	56	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1471-2598	1744-7682		EXPERT OPIN BIOL TH	Expert Opin. Biol. Ther.	DEC	2014	14	12					1731	1744		10.1517/14712598.2014.960387		14	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	AU4TT	WOS:000345605000003		
J	Seino, Y				Seino, Yutaka			Luseogliflozin for the treatment of type 2 diabetes	EXPERT OPINION ON PHARMACOTHERAPY			English	Editorial Material						luseogliflozin; sodium glucose cotransporter 2 inhibitor; sodium glucose cotransport; type 2 diabetes mellitus	2 SGLT2 INHIBITOR; JAPANESE PATIENTS; DOUBLE-BLIND; MELLITUS; DAPAGLIFLOZIN; ASSOCIATION; MANAGEMENT; SAFETY; POTENT; TS-071	Introduction: Sodium glucose cotransporter 2 (SGLT2) inhibitors are expected to provide adequate glycemic control, and be safe and well tolerated, for treating type 2 diabetes mellitus (T2DM). Luseogliflozin is a highly selective SGLT2 inhibitor that was recently approved for marketing and launched in Japan to treat T2DM. Areas covered: This review summarizes the published data regarding the mechanism of action, clinical efficacy, and safety of luseogliflozin for treating T2DM. Other potential benefits of luseogliflozin, including lowering body weight and blood pressure, beyond its glucose-lowering effects are also discussed. Expert opinion: Luseogliflozin lowers plasma glucose concentration and body weight, and has beneficial effects on other clinically relevant parameters, including blood pressure and uric acid, in patients with T2DM. Although it had a good safety profile in clinical trials, there may be some safety concerns, including a possible decrease in muscle mass and an increase in ketone bodies. Therefore, careful administration and consideration of its benefit-risk balance are necessary. When using luseogliflozin, it is important to select appropriate patients and to adhere to its guidelines for use. If used correctly, luseogliflozin is expected to be positioned as a new type of oral hypoglycemic drug for treating T2DM.	Kansai Elect Power Hosp, Fukushima Ku, Osaka, JP 5530003, Japan	Seino, Y (reprint author), Kansai Elect Power Hosp, Fukushima Ku, 2-1-7 Fukushima, Osaka, JP 5530003, Japan.	seino.yutaka@e2.kepco.co.jp					Ahren B, 2012, J DIABETES INVEST, V3, P3, DOI 10.1111/j.2040-1124.2011.00184.x; Qaseem A, 2012, ANN INTERN MED, V156, P218, DOI 10.7326/0003-4819-156-3-201202070-00011; Sasaki T, 2014, ADV THER, V31, P345, DOI 10.1007/s12325-014-0102-3; Seino Y, 2014, CURR MED RES OPIN, V30, P1245, DOI 10.1185/03007995.2014.912983; Seino Y, 2013, J DIABETES INVEST, V4, P108, DOI 10.1111/jdi.12065; [Anonymous], 2014, LUS TABL 2 5 5 MG PA; Johnsson KM, 2013, J DIABETES COMPLICAT, V27, P473, DOI 10.1016/j.jdiacomp.2013.05.004; Musso G, 2012, ANN MED, V44, P375, DOI 10.3109/07853890.2011.560181; Kurosaki E, 2013, PHARMACOL THERAPEUT, V139, P51, DOI 10.1016/j.pharmthera.2013.04.003; Zoungas S, 2012, DIABETOLOGIA, V55, P636, DOI 10.1007/s00125-011-2404-1; Johnsson KM, 2013, J DIABETES COMPLICAT, V27, P479, DOI 10.1016/j.jdiacomp.2013.04.012; Garber AJ, 2013, ENDOCR PRACT, V19, P536, DOI 10.4158/EP13176.CS; Kakinuma H, 2010, J MED CHEM, V53, P3247, DOI 10.1021/jm901893x; Yamamoto K, 2011, BRIT J PHARMACOL, V164, P181, DOI 10.1111/j.1476-5381.2011.01340.x; [Anonymous], 2014, PHARM INT SUPPL PACK; Chino Y, 2011, 26 JSSX ANN M 16 18; Clar C, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001007; Haneda M, 2012, 48 EUR ASS STUD DIAB; International Diabetes Federation, IDF DIABETES ATLAS; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI [10.2337/dc12-0413, 10.2337/dc12-041.3]; Miyata A, 2013, 28 JSSX ANN M 9 11 O; Poole RM, 2014, DRUGS, V74, P939, DOI 10.1007/s40265-014-0229-1; Sasaki M, 2012, 72 SCI SESS AM DIAB; Sasaki T, 2013, INT DIAB FED 2013 WO; Sasaki T, 2011, 47 EUR ASS STUD DIAB; Seino Y, 2014, CURR MED RES OPIN, V30, P1231, DOI 10.1185/03007995.2014.909390; Seino Y, 2013, INT DIAB FED 2013 WO	27	3	3	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1465-6566	1744-7666		EXPERT OPIN PHARMACO	Expert Opin. Pharmacother.	DEC	2014	15	18					2741	2749		10.1517/14656566.2014.978290		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AT8XY	WOS:000345213500011		
J	Seino, S; Tsuchiya, A; Watanabe, M				Seino, Satoshi; Tsuchiya, Atsunori; Watanabe, Masashi			A Rare Primary Liver Tumor That Responded to Sorafenib - c-kit-Positive Liver Cancer (Hepatic Progenitor Cell Marker-Positive Tumor)	GASTROENTEROLOGY			English	Editorial Material							CARCINOMA		[Seino, Satoshi; Watanabe, Masashi] Niigata Prefectural Shibata Hosp, Dept Gastroenterol & Hepatol, Shibata, Japan; [Seino, Satoshi; Tsuchiya, Atsunori] Niigata Univ, Grad Sch Med & Dent Sci, Dept Gastroenterol & Hepatol, Niigata, Japan	Seino, S (reprint author), Niigata Prefectural Shibata Hosp, Dept Gastroenterol & Hepatol, Shibata, Japan.						Llovet JM, 2012, CLIN CANCER RES, V18, P2290, DOI 10.1158/1078-0432.CCR-11-2175; Zhang HL, 2013, CLIN GENITOURIN CANC, V11, P134, DOI 10.1016/j.clgc.2012.08.007; Becker G, 2007, CLIN ONCOL-UK, V19, P204, DOI 10.1016/j.clon.2006.12.009	3	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	DEC	2014	147	6					1226	1227		10.1053/j.gastro.2014.07.035		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AU3PC	WOS:000345524800019		
J	Lammers, WJ; van Buuren, HR; Hirschfield, GM; Janssen, HLA; Invernizzi, P; Mason, AL; Ponsioen, CY; Floreani, A; Corpechot, C; Mayo, MJ; Battezzati, PM; Pares, A; Nevens, F; Burroughs, AK; Kowdley, KV; Trivedi, PJ; Kumagi, T; Cheung, A; Lleo, A; Imam, MH; Boonstra, K; Cazzagon, N; Franceschet, I; Poupon, R; Caballeria, L; Pieri, G; Kanwar, PS; Lindor, KD; Hansen, BE				Lammers, Willem J.; van Buuren, Henk R.; Hirschfield, Gideon M.; Janssen, Harry L. A.; Invernizzi, Pietro; Mason, Andrew L.; Ponsioen, Cyriel Y.; Floreani, Annarosa; Corpechot, Christophe; Mayo, Marlyn J.; Battezzati, Pier M.; Pares, Albert; Nevens, Frederik; Burroughs, Andrew K.; Kowdley, Kris V.; Trivedi, Palak J.; Kumagi, Teru; Cheung, Angela; Lleo, Ana; Imam, Mohamad H.; Boonstra, Kirsten; Cazzagon, Nora; Franceschet, Irene; Poupon, Raoul; Caballeria, Llorenc; Pieri, Giulia; Kanwar, Pushpjeet S.; Lindor, Keith D.; Hansen, Bettina E.		Global PBC Study Grp	Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study	GASTROENTEROLOGY			English	Article						Autoimmune Liver Disease; Response To Treatment; Biomarker; New Therapies	URSODEOXYCHOLIC-ACID THERAPY; RANDOMIZED CONTROLLED-TRIALS; BIOCHEMICAL RESPONSE; SERUM BILIRUBIN; CLINICAL-TRIALS; PROGNOSIS; METAANALYSIS; PROGRESSION; SURVIVAL; MODEL	BACKGROUND & AIMS: Noninvasive surrogate end points of long-term outcomes of patients with primary biliary cirrhosis (PBC) are needed to monitor disease progression and evaluate potential treatments. We performed a meta-analysis of individual patient data from cohort studies to evaluate whether patients' levels of alkaline phosphatase and bilirubin correlate with their outcomes and can be used as surrogate end points. METHODS: We performed a meta-analysis of data from 4845 patients included in 15 North American and European long-term follow-up cohort studies. Levels of alkaline phosphatase and bilirubin were analyzed in different settings and sub-populations at different time points relative to the clinical end point (liver transplantation or death). RESULTS: Of the 4845 patients, 1118 reached a clinical end point. The median follow-up period was 7.3 years; 77% survived for 10 years after study enrollment. Levels of alkaline phosphatase and bilirubin measured at study enrollment (baseline) and each year for 5 years were strongly associated with clinical outcomes (lower levels were associated with longer transplant-free survival). At 1 year after study enrollment, levels of alkaline phosphatase that were 2.0 times the upper limit of normal (ULN) best predicted patient outcome (C statistic, 0.71) but not significantly better than other thresholds. Of patients with alkaline phosphatase levels <= 2.0 times the ULN, 84% survived for 10 years compared with 62% of those with levels >2.0 times the ULN (P < .0001). Absolute levels of alkaline phosphatase 1 year after study enrollment predicted patient outcomes better than percentage change in level. One year after study enrollment, a bilirubin level 1.0 times the ULN best predicted patient transplant-free survival (C statistic, 0.79). Of patients with bilirubin levels <= 1.0 times the ULN, 86% survived for 10 years after study enrollment compared with 41% of those with levels >1.0 times the ULN (P < .0001). Combining levels of alkaline phosphatase and bilirubin increased the ability to predict patient survival times. We confirmed the predictive value of alkaline phosphatase and bilirubin levels in multiple subgroups, such as patients who had not received treatment with ursodeoxycholic acid, and at different time points after study enrollment. CONCLUSIONS: Levels of alkaline phosphatase and bilirubin can predict outcomes (liver transplantation or death) of patients with PBC and might be used as surrogate end points in therapy trials.	[Lammers, Willem J.; van Buuren, Henk R.; Hansen, Bettina E.] Erasmus Univ, Med Ctr, Dept Gastroenterol & Hepatol, NL-3015 CE Rotterdam, Netherlands; [Hirschfield, Gideon M.; Trivedi, Palak J.] Univ Birmingham, NIHR Biomed Res Unit, Birmingham, W Midlands, England; [Hirschfield, Gideon M.; Trivedi, Palak J.] Univ Birmingham, Liver Res Ctr, Birmingham, W Midlands, England; [Janssen, Harry L. A.; Kumagi, Teru; Cheung, Angela] Univ Hlth Network, Toronto Western & Gen Hosp, Liver Clin, Toronto, ON, Canada; [Invernizzi, Pietro; Lleo, Ana] Humanitas Clin & Res Ctr, Liver Unit, Rozzano, Italy; [Invernizzi, Pietro; Lleo, Ana] Humanitas Clin & Res Ctr, Ctr Autoimmune Liver Dis, Rozzano, Italy; [Mason, Andrew L.] Univ Alberta, Div Gastroenterol & Hepatol, Edmonton, AB, Canada; [Ponsioen, Cyriel Y.; Boonstra, Kirsten] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands; [Floreani, Annarosa; Cazzagon, Nora; Franceschet, Irene] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy; [Corpechot, Christophe; Poupon, Raoul] Hop St Antoine, APHP, Ctr Reference Malad Inflammatoires VoiesBiliaires, F-75571 Paris, France; [Mayo, Marlyn J.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Battezzati, Pier M.] Univ Milan, Dept Hlth Sci, Milan, Italy; [Pares, Albert; Caballeria, Llorenc] Univ Barcelona, IDIBAPS, CIBERehd, Liver Unit,Hosp Clin, Barcelona, Spain; [Nevens, Frederik] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Hepatol, Leuven, Belgium; [Burroughs, Andrew K.; Pieri, Giulia] Royal Free Hosp, Sheila Sherlock Liver Ctr, London NW3 2QG, England; [Kowdley, Kris V.; Kanwar, Pushpjeet S.] Virginia Mason Med Ctr, Liver Ctr Excellence, Inst Digest Dis, Seattle, WA 98101 USA; [Kumagi, Teru] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Matsuyama, Ehime 790, Japan; [Imam, Mohamad H.; Lindor, Keith D.] Mayo Clin, Dept Gastroenterol & Hepatol, Rochester, MN USA; [Lindor, Keith D.] Arizona State Univ, Coll Hlth Solut, Phoenix, AZ USA	Hansen, BE (reprint author), Erasmus Univ, Med Ctr, Dept Gastroenterol & Hepatol, S Gravendijkwal 230,Room Ha 203, NL-3015 CE Rotterdam, Netherlands.	b.hansen@erasmusmc.nl	Lammers, Willem/P-5456-2014; Burroughs, Andrew/C-5645-2009; Pares, Albert/G-1328-2011; Hirschfield, Gideon/M-2143-2015; Hansen, Bettina/P-5468-2014	Lammers, Willem/0000-0002-5455-5242; Burroughs, Andrew/0000-0001-6527-457X; Pares, Albert/0000-0002-5413-9687; Hirschfield, Gideon/0000-0002-6736-2255; Hansen, Bettina/0000-0001-8307-3341	Intercept Pharmaceuticals; Zambon Nederland BV; Foundation for Liver and Gastrointestinal Research (a not-for-profit foundation) in Rotterdam, The Netherlands	This investigator-initiated study was supported by unrestricted grants from Intercept Pharmaceuticals and Zambon Nederland BV and was funded by the Foundation for Liver and Gastrointestinal Research (a not-for-profit foundation) in Rotterdam, The Netherlands. The supporting parties had no influence on the study design, data collection and analyses, writing of the manuscript, or the decision to submit the manuscript for publication.	Kumagi T, 2010, AM J GASTROENTEROL, V105, P2186, DOI 10.1038/ajg.2010.216; Fleming TR, 2005, HEALTH AFFAIR, V24, P67, DOI 10.1377/hlthaff.24.1.67; Fleming TR, 2012, STAT MED, V31, P2973, DOI 10.1002/sim.5403; LUDWIG J, 1978, VIRCHOWS ARCH A, V379, P103, DOI 10.1007/BF00432479; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Angulo P, 1999, LIVER, V19, P115, DOI 10.1111/j.1478-3231.1999.tb00020.x; Pares A, 2006, GASTROENTEROLOGY, V130, P715, DOI 10.1053/j.gastro.2005.12.029; Bonnand AM, 1999, HEPATOLOGY, V29, P39, DOI 10.1002/hep.510290140; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Momah N, 2012, LIVER INT, V32, P790, DOI 10.1111/j.1478-3231.2011.02678.x; Corpechot C, 2011, J HEPATOL, V55, P1361, DOI 10.1016/j.jhep.2011.02.031; Goulis J, 1999, LANCET, V354, P1053, DOI 10.1016/S0140-6736(98)11293-X; Krzeski P, 1999, HEPATOLOGY, V30, P865, DOI 10.1002/hep.510300415; DICKSON ER, 1989, HEPATOLOGY, V10, P1, DOI 10.1002/hep.1840100102; POUPON RE, 1994, NEW ENGL J MED, V330, P1342, DOI 10.1056/NEJM199405123301903; Azemoto N, 2011, HEPATOL RES, V41, P310, DOI 10.1111/j.1872-034X.2011.00782.x; ter Borg PCJ, 2006, AM J GASTROENTEROL, V101, P2044, DOI 10.1111/j.1572-0241.2006.00699.x; Poupon RE, 1997, GASTROENTEROLOGY, V113, P884, DOI 10.1016/S0016-5085(97)70183-5; Corpechot C, 2012, HEPATOLOGY, V56, P198, DOI 10.1002/hep.25599; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; SHAPIRO JM, 1979, GUT, V20, P137, DOI 10.1136/gut.20.2.137; Carbone M, 2013, GASTROENTEROLOGY, V144, P560, DOI 10.1053/j.gastro.2012.12.005; Shi J, 2006, AM J GASTROENTEROL, V101, P1529, DOI 10.1111/j.1572-0241.2006.00634.x; Kuiper EMM, 2009, GASTROENTEROLOGY, V136, P1281, DOI 10.1053/j.gastro.2009.01.003; Corpechot C, 2005, GASTROENTEROLOGY, V128, P297, DOI 10.1016/j.gastro.2004.11.009; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Corpechot C, 2008, HEPATOLOGY, V48, P871, DOI 10.1002/hep.22428; Carbone M, 2013, GASTROENTEROLOGY, V144, pe13; Child C G, 1964, Major Probl Clin Surg, V1, P1; European Association for the Study of the Liver, 2009, J HEPATOL, V51, P237, DOI DOI 10.1016/J.JHEP.2009.04.009; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Rudic JS, 2012, COCHRANE DB SYST REV, V12; SCHEUER PJ, 1967, P ROY SOC MED, V60, P1257; WARNES TW, 1972, GUT, V13, P926, DOI 10.1136/gut.13.11.926	34	16	18	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	DEC	2014	147	6					1338	+		10.1053/j.gastro.2014.08.029		17	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AU3PC	WOS:000345524800031		
J	Nikaido, M; Miyamoto, S; Iinuma, S				Nikaido, Mitsuhiro; Miyamoto, Shin'ichi; Iinuma, Shoji			Systemic Ulcerative Lesions in a Patient With Ischemic Heart Disease - Nicorandil-Induced Ulceration	GASTROENTEROLOGY			English	Editorial Material									[Nikaido, Mitsuhiro; Iinuma, Shoji] Kyoto Univ, Grad Sch Med, Rakuwakai Otowa Hosp, Dept Gastroenterol, Kyoto, Japan; [Nikaido, Mitsuhiro; Miyamoto, Shin'ichi] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan	Nikaido, M (reprint author), Kyoto Univ, Grad Sch Med, Rakuwakai Otowa Hosp, Dept Gastroenterol, Kyoto, Japan.						Reichert S, 1997, EUR J DERMATOL, V7, P132; Lee BC, 2011, DIGEST DIS SCI, V56, P2404, DOI 10.1007/s10620-011-1634-x; Cooke NS, 2006, BRIT J DERMATOL, V154, P199, DOI 10.1111/j.1365-2133.2005.07025.x	3	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	DEC	2014	147	6					E7	E8		10.1053/j.gastro.2014.06.040		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AU3PC	WOS:000345524800004		
J	Kobayashi, R; Kurita, S; Miyata, M; Maruo, T; Mandai, K; Rikitake, Y; Takai, Y				Kobayashi, Reiko; Kurita, Souichi; Miyata, Muneaki; Maruo, Tomohiko; Mandai, Kenji; Rikitake, Yoshiyuki; Takai, Yoshimi			s-Afadin binds more preferentially to the cell adhesion molecules nectins than l-afadin	GENES TO CELLS			English	Article							SMALL G-PROTEINS; GROWTH-FACTOR; ADHERENS JUNCTIONS; PROMOTES SPINE; BREAST-CANCER; DOMAIN; AF-6; MOUSE; MIGRATION; POLARITY	l-Afadin was originally purified from rat brain as an actin filament (F-actin)-binding protein that was homologous to the AF-6 gene product. Concomitantly, s-afadin that did not show an F-actin-binding capability was copurified with l-afadin. Structurally, s-afadin lacks the C-terminal F-actin-binding domain but has two short sequences that were not present in l-afadin. The properties and roles of l-afadin have intensively been investigated, but those of s-afadin have poorly been understood. We show here an additional difference in their biochemical properties other than binding to F-actin between l-afadin and s-afadin. Both l-afadin and s-afadin bound to nectins, immunoglobulin-like cell adhesion molecules, whereas s-afadin more preferentially bound to nectins than l-afadin. The PDZ domain of l-afadin and s-afadin was essential for their binding to nectin-3. The dilute domain of l-afadin negatively regulated its binding to nectin-3, but the deletion of the C-terminal F-actin-binding domain of l-afadin did not increase the binding of l-afadin to nectin-3. These results indicate that the s-afadin-specific C-terminal inserts may be involved in its preference of binding to nectin-3 and raise the possibility that there are proteins other than nectins that more preferentially bind s-afadin than l-afadin.	[Kobayashi, Reiko; Kurita, Souichi; Maruo, Tomohiko; Mandai, Kenji; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Div Pathogenet Signaling, Dept Biochem & Mol Biol, Kobe, Hyogo 6500047, Japan; [Kobayashi, Reiko; Kurita, Souichi; Maruo, Tomohiko; Mandai, Kenji; Rikitake, Yoshiyuki; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Div Mol & Cellular Biol, Dept Biochem & Mol Biol, Kobe, Hyogo 6500017, Japan; [Miyata, Muneaki; Rikitake, Yoshiyuki] Kobe Univ, Grad Sch Med, Div Signal Transduct, Dept Biochem & Mol Biol, Kobe, Hyogo 6500017, Japan	Takai, Y (reprint author), Kobe Univ, Grad Sch Med, Div Pathogenet Signaling, Dept Biochem & Mol Biol, Kobe, Hyogo 6500047, Japan.	rikitake@med.kobe-u.ac.jp; ytakai@med.kobe-u.ac.jp			Global COE Program 'Global Center for Education and Research in Integrative Membrane Biology'; Targeted Proteins Research Program from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Society for the Promotion of Science [21227005]; Naito Foundation; Sagawa Foundation for Promotion of Cancer Research; Yasuda Medical Foundation	We thank Satomi Minami for excellent technical assistance. This work was supported by the Global COE Program 'Global Center for Education and Research in Integrative Membrane Biology' and the Targeted Proteins Research Program (http://www.tanpaku.org/e_index.php) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, Grants-in-Aid for Scientific Research (S) (21227005 to Y.T.) from the Japan Society for the Promotion of Science, and the grants (to Y.T.) from the Naito Foundation, the Sagawa Foundation for Promotion of Cancer Research, and the Yasuda Medical Foundation.	Boettner B, 2000, P NATL ACAD SCI USA, V97, P9064, DOI 10.1073/pnas.97.16.9064; Letessier A, 2007, ONCOGENE, V26, P298, DOI 10.1038/sj.onc.1209772; Miyata M, 2009, J BIOL CHEM, V284, P24595, DOI 10.1074/jbc.M109.016436; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Nakata S, 2007, J BIOL CHEM, V282, P37815, DOI 10.1074/jbc.M707461200; Xie Z, 2008, J NEUROSCI, V28, P6079, DOI 10.1523/JNEUROSCI.1170-08.2008; Satoh-Horikawa K, 2000, J BIOL CHEM, V275, P10291, DOI 10.1074/jbc.275.14.10291; Asada M, 2003, J BIOL CHEM, V278, P4103, DOI 10.1074/jbc.M209832200; Sun TT, 2014, BBA-MOL CELL RES, V1843, P618, DOI 10.1016/j.bbamcr.2013.12.013; Miyata M, 2009, J CELL SCI, V122, P4319, DOI 10.1242/jcs.048439; Mandai K, 2013, PROG MOL BIOL TRANSL, V116, P433, DOI 10.1016/B978-0-12-394311-8.00019-4; Fournier G, 2011, ONCOGENE, V30, P3862, DOI 10.1038/onc.2011.106; Yang ZF, 2013, DEVELOPMENT, V140, P1774, DOI 10.1242/dev.087957; Gil-Sanz C, 2013, NEURON, V79, P461, DOI 10.1016/j.neuron.2013.06.040; VanLeeuwen JE, 2014, J BIOL CHEM, V289, P10831, DOI 10.1074/jbc.M113.536391; Reymond N, 2001, J BIOL CHEM, V276, P43205, DOI 10.1074/jbc.M103810200; Chojnacki A, 2008, NAT PROTOC, V3, P935, DOI 10.1038/nprot.2008.55; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Srivastava DP, 2012, J BIOL CHEM, V287, P35964, DOI 10.1074/jbc.M112.363358; Ikeda W, 1999, J CELL BIOL, V146, P1117, DOI 10.1083/jcb.146.5.1117; Beaudoin GMJ, 2012, J NEUROSCI, V32, P99, DOI 10.1523/JNEUROSCI.4565-11.2012; Buchert M, 2007, J CELL PHYSIOL, V210, P212, DOI 10.1002/jcp.20853; Fukumoto Y, 2011, J BIOL CHEM, V286, P43537, DOI 10.1074/jbc.M111.308858; Gil-Sanz C, 2014, J NEUROSCI, V34, P10475, DOI 10.1523/JNEUROSCI.1793-14.2014; Haskin J, 2013, HUM MOL GENET, V22, P2083, DOI 10.1093/hmg/ddt058; Hock B, 1998, P NATL ACAD SCI USA, V95, P9779, DOI 10.1073/pnas.95.17.9779; Iwasawa N, 2012, MOL BIOL CELL, V23, P2793, DOI 10.1091/mbc.E12-02-0103; Kanzaki N, 2008, J CELL SCI, V121, P2008, DOI 10.1242/jcs.024620; Liedtke M, 2010, BLOOD, V116, P63, DOI 10.1182/blood-2009-09-243386; Lorger M, 2006, J CELL SCI, V119, P3385, DOI 10.1242/jcs.03027; Majima T, 2009, BIOCHEM BIOPH RES CO, V385, P539, DOI 10.1016/j.bbrc.2009.05.097; Majima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068134; Nishioka H, 2000, J COMP NEUROL, V424, P297, DOI 10.1002/1096-9861(20000821)424:2<297::AID-CNE8>3.0.CO;2-J; PRASAD R, 1993, CANCER RES, V53, P5624; Rikitake Y, 2011, INT REV CEL MOL BIO, V287, P97, DOI 10.1016/B978-0-12-386043-9.00003-7; Saito S, 1998, DNA Res, V5, P115, DOI 10.1093/dnares/5.2.115; Sakamoto Y, 2006, J BIOL CHEM, V281, P19631, DOI 10.1074/jbc.M600301200; Takekuni K, 2003, J BIOL CHEM, V278, P5497, DOI 10.1074/jbc.C200707200; Tanaka-Okamoto M, 2011, J CELL SCI, V124, P2231, DOI 10.1242/jcs.081000; Tawa H, 2010, CIRC RES, V106, P1731, DOI 10.1161/CIRCRESAHA.110.216747; Toyoshima D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089763; Xie Z, 2005, NEURON, V48, P605, DOI 10.1016/j.neuron.2005.09.027; Yamamoto H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080356; Zhadanov AB, 1999, CURR BIOL, V9, P880, DOI 10.1016/S0960-9822(99)80392-3	44	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	DEC	2014	19	12					853	863		10.1111/gtc.12185		11	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	AU2JD	WOS:000345443100001		
J	Furusawa, Y; Uruno, A; Yagishita, Y; Higashi, C; Yamamoto, M				Furusawa, Yuki; Uruno, Akira; Yagishita, Yoko; Higashi, Chika; Yamamoto, Masayuki			Nrf2 induces fibroblast growth factor 21 in diabetic mice	GENES TO CELLS			English	Article							DIET-INDUCED OBESITY; ACTIVATED-RECEPTOR-GAMMA; PPAR-ALPHA; METABOLIC SYNDROME; KEAP1-NRF2 SYSTEM; STRESS-RESPONSE; BETA-KLOTHO; FGF21; EXPRESSION; ANTIOXIDANT	Transcription factor Nrf2 (nuclear factor E2-related factor 2) is a master regulator of cellular defense system against oxidative and electrophilic stresses and is negatively regulated by an adaptor protein Keap1 (Kelch-like ECH-associated protein 1). Nrf2 also plays a pivotal role in metabolic homeostasis, such as lipid metabolism and energy expenditure as well as redox homeostasis. FGF21 (fibroblast growth factor 21) is known as a key mediator of glucose and lipid metabolism. Here, we found that Nrf2 is involved in FGF21 regulation in diabetic model mice. Nrf2 induction by genetic knockdown of Keap1 increased plasma FGF21 level and hepatic Fgf21 expression in diabetic db/db mice and high-calorie-diet-induced obesity model mice. Administration of CDDO-Im (oleanolic triterpenoid 1-[2-cyano-3,12-dioxooleane-1, 9(11)-dien-28-oyl] imidazole), a potent Nrf2 inducer, up-regulated plasma FGF21 level and hepatic Fgf21 expression in db/db mice, whereas CDDO-Im did not induce FGF21 in db/db mice with Nrf2 knockout background. Furthermore, in Keap1-knockdown db/db mice, Nrf2 enhanced expression of glucose-and lipid-metabolism-related genes in adipose tissues, which improved plasma lipid profiles. These results show that Nrf2 positively regulates FGF21 expression in diabetic mice. We propose that FGF21 is a potential efficacy biomarker that mediates metabolic regulation by the Keap1-Nrf2 system.	[Furusawa, Yuki; Uruno, Akira; Yagishita, Yoko; Higashi, Chika; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Furusawa, Yuki; Higashi, Chika] Mochida Pharmaceut Co Ltd, Pharmaceut Res Ctr, Gotemba, Shizuoka 4128524, Japan	Yamamoto, M (reprint author), Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	uruno@med.tohoku.ac.jp; masiyamamoto@med.tohoku.ac.jp	Yamamoto, Masayuki/A-4873-2010		Ministry of Education, Science, Sports and Culture (MEXT); create revolutionary technological seeds for science and technology innovation (CREST) from JST; Japan Society for the Promotion of Science (JSPS) [24249015, 90396474]; Takeda Foundation; Naito Foundation; Japanese Foundation for Applied Enzymology; Mochida Pharmaceutical Co., Ltd.	We thank Ms Sayoi Inomata (Tohoku University) for technical assistance and Biomedical Research Core of Tohoku University Graduate School of Medicine for technical support. This work was supported by the Grants-in-Aids for Scientific Research on Innovative Areas and Scientific Research from the Ministry of Education, Science, Sports and Culture (MEXT) (M.Y.), create revolutionary technological seeds for science and technology innovation (CREST) from JST (M.Y.), Grants-in-Aids for Scientific Research from the Japan Society for the Promotion of Science (JSPS) (Number 24249015 (M.Y.) and 90396474 (A. U.)), the Takeda Foundation (M.Y.), the Naito Foundation (M.Y.) and the Japanese Foundation for Applied Enzymology (A. U.). Y.F. and C. H. are employees of Mochida Pharmaceutical Co. Ltd. M.Y. has received grant support from Mochida Pharmaceutical Co., Ltd. No other potential conflicts of interest relevant to this article were reported.	Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Hiramoto K, 2014, CANCER PREV RES, V7, P835, DOI 10.1158/1940-6207.CAPR-14-0094; Muise ES, 2008, MOL PHARMACOL, V74, P403, DOI 10.1124/mol.108.044826; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Yates MS, 2007, MOL CANCER THER, V6, P154, DOI 10.1158/1535-7163.MCT-06-0516; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Uruno A, 2011, NITRIC OXIDE-BIOL CH, V25, P153, DOI 10.1016/j.niox.2011.02.007; Ye DW, 2014, HEPATOLOGY, V60, P977, DOI 10.1002/hep.27060; Xue P, 2013, DIABETES, V62, P845, DOI 10.2337/db12-0584; Hirotsu Y, 2014, GENES CELLS, V19, P650, DOI 10.1111/gtc.12165; Saha PK, 2010, J BIOL CHEM, V285, P40581, DOI 10.1074/jbc.M110.176545; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Meher AK, 2012, FREE RADICAL BIO MED, V52, P1708, DOI 10.1016/j.freeradbiomed.2012.02.022; Wente W, 2006, DIABETES, V55, P2470, DOI 10.2337/db05-1435; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Pi JB, 2010, J BIOL CHEM, V285, P9292, DOI 10.1074/jbc.M109.093955; ITOH K, 1995, MOL CELL BIOL, V15, P4184; Ito S, 2000, MECH DEVELOP, V98, P115, DOI 10.1016/S0925-4773(00)00439-1; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Shin S, 2009, EUR J PHARMACOL, V620, P138, DOI 10.1016/j.ejphar.2009.08.022; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Mashili FL, 2011, DIABETES-METAB RES, V27, P286, DOI 10.1002/dmrr.1177; Uruno A, 2013, MOL CELL BIOL, V33, P2996, DOI 10.1128/MCB.00225-13; Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005; Chartoumpekis DV, 2011, DIABETES, V60, P2465, DOI 10.2337/db11-0112; Hirotsu Y, 2012, NUCLEIC ACIDS RES, V40, P10228, DOI 10.1093/nar/gks827; Yagishita Y, 2014, DIABETES, V63, P605, DOI 10.2337/db13-0909; Uruno A, 2011, J LEUKOCYTE BIOL, V90, P235, DOI 10.1189/jlb.0109025; Takaya K, 2012, FREE RADICAL BIO MED, V53, P817, DOI 10.1016/j.freeradbiomed.2012.06.023; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Ge X, 2011, J BIOL CHEM, V286, P34533, DOI 10.1074/jbc.M111.248591; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Uruno A, 2011, J MOL ENDOCRINOL, V46, P37, DOI 10.1677/JME-10-0088; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Aleksunes LM, 2010, J PHARMACOL EXP THER, V333, P140, DOI 10.1124/jpet.109.162271; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Yamazaki H, 2012, MOL CELL BIOL, V32, P808, DOI 10.1128/MCB.06543-11; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Frank R, 2003, NAT REV DRUG DISCOV, V2, P566, DOI 10.1038/nrd1130; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476; Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054; Taguchi K, 2010, MOL CELL BIOL, V30, P3016, DOI 10.1128/MCB.01591-09; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; Lewin DA, 2004, DRUG DISCOV TODAY, V9, P976, DOI 10.1016/S1359-6446(04)03272-6; Iizuka K, 2009, FEBS LETT, V583, P2882, DOI 10.1016/j.febslet.2009.07.053; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Zhang Jian, 2008, Nutr Res Pract, V2, P200, DOI 10.4162/nrp.2008.2.4.200	56	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	DEC	2014	19	12					864	878		10.1111/gtc.12186		15	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	AU2JD	WOS:000345443100002		
J	Akimoto, Y; Yamamoto, S; Iida, S; Hirose, Y; Tanaka, A; Hanaoka, F; Ohkuma, Y				Akimoto, Yusuke; Yamamoto, Seiji; Iida, Satoshi; Hirose, Yutaka; Tanaka, Aki; Hanaoka, Fumio; Ohkuma, Yoshiaki			Transcription cofactor PC4 plays essential roles in collaboration with the small subunit of general transcription factor TFIIE	GENES TO CELLS			English	Article							RNA-POLYMERASE-II; C-TERMINAL DOMAIN; COACTIVATOR PC4; BASAL TRANSCRIPTION; MULTIPLE FUNCTIONS; COMPLEX-FORMATION; DNA-BINDING; PHOSPHORYLATION; INITIATION; SUB1	In eukaryotes, positive cofactor 4 (PC4) stimulates activator-dependent transcription by facilitating transcription initiation and the transition from initiation to elongation. It also forms homodimers and binds to single-stranded DNA and various transcriptional activators, including the general transcription factor TFIIH. In this study, we further investigated PC4 from Homo sapiens and the nematode Caenorhabditis elegans (hPC4 and cePC4, respectively). hPC4 strongly stimulated transcription on a linearized template, whereas it alleviated transcription on a supercoiled template. Transcriptional stimulation by PC4 was also alleviated by increasing the amount of TFIID. GST pull-down studies with general transcription factors indicated that both hPC4 and cePC4 bind strongly to TFIIB, TFIIE beta, TFIIF alpha, TFIIF beta and TFIIH XPB subunits and weakly to TBP and TFIIH p62. However, only hPC4 bound to CDK7. The effect of each PC4 on transcription was studied in combination with TFIIE beta. hPC4 stimulated both basal and activated transcription, whereas cePC4 primarily stimulated activated transcription, especially in the presence of TFIIE beta from C. elegans. Finally, hPC4 bound to the C-terminal region of hTFIIE beta adjacent to the basic region. These results indicate that PC4 plays essential roles in the transition step from transcription initiation to elongation by binding to melted DNA in collaboration with TFIIE beta.	[Akimoto, Yusuke; Yamamoto, Seiji; Iida, Satoshi; Hirose, Yutaka; Tanaka, Aki; Ohkuma, Yoshiaki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Lab Gene Regulat, Toyama 9300194, Japan; [Yamamoto, Seiji; Tanaka, Aki; Hanaoka, Fumio; Ohkuma, Yoshiaki] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Hanaoka, Fumio] Gakushuin Univ, Dept Life Sci, Fac Sci, Toshima Ku, Tokyo 1718588, Japan	Ohkuma, Y (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Lab Gene Regulat, 2630 Sugitani, Toyama 9300194, Japan.	ohkumay@pha.u-toyama.ac.jp			MEXT KAKENHI from Ministry of Education, Science and Culture of Japan [17054022]; Natural Sciences Division of the Mitsubishi Foundation	We thank Tomomichi Watanabe (Osaka University) for hTFIIE beta mutants, Mineyuki Mizuguchi (University of Toyama) and Masahiko Okuda (Yokohama City University) for performing hPC4 and hTFIIE beta amino acid sequence comparisons and useful discussions on structural considerations, and our colleagues at the University of Toyama for helpful advice and discussions. This work was supported in part by Grant-in-Aid for Scientific Research on Priority Areas (Y.O., MEXT KAKENHI Grant Number: 17054022) and Grant-in-Aid for Scientific Research on Innovative Areas (Y.O., MEXT KAKENHI Grant Number: 24118003) from the Ministry of Education, Science and Culture of Japan, and in part by research grants from the Natural Sciences Division of the Mitsubishi Foundation (Y.O.).	Knaus R, 1996, EMBO J, V15, P1933; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/S0968-0004(96)10050-5; Werten S, 2006, NAT STRUCT MOL BIOL, V13, P181, DOI 10.1038/nsmb1044; Werten S, 1998, EMBO J, V17, P5103, DOI 10.1093/emboj/17.17.5103; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Brandsen J, 1997, NAT STRUCT BIOL, V4, P900, DOI 10.1038/nsb1197-900; Fukuda A, 2004, MOL CELL BIOL, V24, P6525, DOI 10.1128/MCB.24.14.6525.6535.2004; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; OHKUMA Y, 1995, MOL CELL BIOL, V15, P4856; Reboul J, 2001, NAT GENET, V27, P332, DOI 10.1038/85913; Calvo O, 2005, EMBO J, V24, P1009, DOI 10.1038/sj.emboj.7600575; Garcia A, 2012, MOL BIOL CELL, V23, P4297, DOI 10.1091/mbc.E12-04-0331; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; CHIANG CM, 1993, EMBO J, V12, P2749; Fukuda A, 2003, J BIOL CHEM, V278, P14827, DOI 10.1074/jbc.M213172200; Garcia A, 2010, MOL CELL BIOL, V30, P5180, DOI 10.1128/MCB.00819-10; GE H, 1994, P NATL ACAD SCI USA, V91, P12691, DOI 10.1073/pnas.91.26.12691; Hayashi K, 2005, GENES CELLS, V10, P207, DOI 10.1111/j.1365-2443.2005.00833.x; Jonker HRA, 2006, FEBS J, V273, P1430, DOI 10.1111/j.1742-4658.2006.05165.x; KAISER K, 1995, EMBO J, V14, P3520; Malik S, 2005, MOL CELL BIOL, V25, P2117, DOI 10.1128/MCB.25.6.2117-2129.2005; OHKUMA Y, 1994, NATURE, V368, P160, DOI 10.1038/368160a0; Ohkuma Y, 1997, J BIOCHEM-TOKYO, V122, P481; Okamoto T, 1998, J BIOL CHEM, V273, P19866, DOI 10.1074/jbc.273.31.19866; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SUMIMOTO H, 1991, NATURE, V354, P401, DOI 10.1038/354401a0; SUMIMOTO H, 1990, P NATL ACAD SCI USA, V87, P9158, DOI 10.1073/pnas.87.23.9158; Watanabe T, 2003, MOL CELL BIOL, V23, P2914, DOI 10.1128/MCB.23.8.2914-2926.2003; Werten S, 1999, J BIOL CHEM, V274, P3693, DOI 10.1074/jbc.274.6.3693; Werten S, 1998, J MOL BIOL, V276, P367, DOI 10.1006/jmbi.1997.1534; Wu SY, 1998, J BIOL CHEM, V273, P12492, DOI 10.1074/jbc.273.20.12492; Yamamoto S, 2001, MOL CELL BIOL, V21, P1, DOI 10.1128/MCB.21.1.1-15.2001	35	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	DEC	2014	19	12					879	890		10.1111/gtc.12187		12	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	AU2JD	WOS:000345443100003		
J	Nakazaki, Y; Watanabe, YH				Nakazaki, Yosuke; Watanabe, Yo-Hei			ClpB chaperone passively threads soluble denatured proteins through its central pore	GENES TO CELLS			English	Article							ATP-BINDING-SITES; CASEINOLYTIC PEPTIDASE B; THERMUS-THERMOPHILUS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; DISAGGREGATING MACHINE; AGGREGATED PROTEINS; MITOCHONDRIAL HSP78; STRUCTURAL BASIS; TERMINAL DOMAIN	ClpB disaggregase forms a ring-shaped hexamer that threads substrate proteins through the central pore using energy from ATP. The ClpB protomer consists of an N-terminal domain, a middle domain, and two AAA+ modules. These two AAA+ modules bind and hydrolyze ATP and construct the core of the hexameric ring. Here, we investigated the roles of the two AAA+ modules in substrate threading. BAP is an engineered ClpB that can bind ClpP proteolytic chamber; substrates threaded by BAP are degraded by ClpP. We combined BAP with conserved motif mutations in two AAA+ modules and measured the steady-state rates of threading of soluble denatured proteins by these mutants over a range of substrate concentrations. By fitting the data to the Michaelis-Menten equation, k(cat) and K-m values were determined. We found that the kinetic parameters of the substrate threading correlate with the type of mutation introduced rather than the ATPase activity of the mutant. Moreover, some mutants having no or marginal ATPase activity could thread denatured proteins significantly. These results indicate that ClpB can passively thread soluble denatured proteins.	[Nakazaki, Yosuke; Watanabe, Yo-Hei] Konan Univ, Dept Biol, Fac Sci & Engn, Kobe, Hyogo 6588501, Japan; [Nakazaki, Yosuke; Watanabe, Yo-Hei] Konan Univ, Inst Integrat Neurobiol, Kobe, Hyogo 6588501, Japan	Watanabe, YH (reprint author), Konan Univ, Dept Biol, Fac Sci & Engn, Okamoto 8-9-1, Kobe, Hyogo 6588501, Japan.	ywatanab@center.konan-u.ac.jp			JSPS KAKENHI [21770151, 24241048, 26440085]	This work was supported by JSPS KAKENHI Grant Number 21770151, 24241048, and 26440085.	Rosenzweig R, 2013, SCIENCE, V339, P1080, DOI 10.1126/science.1233066; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Watanabe Y, 2004, J BIOL CHEM, V279, P15723, DOI 10.1074/jbc.M308782200; Schlee S, 2001, J MOL BIOL, V306, P889, DOI 10.1006/jmbi.2001.4455; Biter AB, 2012, P NATL ACAD SCI USA, V109, P12515, DOI 10.1073/pnas.1207040109; Oguchi Y, 2012, NAT STRUCT MOL BIOL, V19, P1338, DOI 10.1038/nsmb.2441; Weibezahn J, 2003, J BIOL CHEM, V278, P32608, DOI 10.1074/jbc.M303653200; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Zolkiewski M, 1999, PROTEIN SCI, V8, P1899; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Haslberger T, 2008, NAT STRUCT MOL BIOL, V15, P641, DOI 10.1038/nsmb.1425; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Zolkiewski M, 1999, J BIOL CHEM, V274, P28083, DOI 10.1074/jbc.274.40.28083; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Lee J, 2013, P NATL ACAD SCI USA, V110, P8513, DOI 10.1073/pnas.1217988110; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Lipinska N, 2013, J BIOL CHEM, V288, P2857, DOI 10.1074/jbc.M112.387589; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Doyle SM, 2012, J BIOL CHEM, V287, P28470, DOI 10.1074/jbc.M112.383091; Motohashi K, 1999, P NATL ACAD SCI USA, V96, P7184, DOI 10.1073/pnas.96.13.7184; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; SINGH SK, 1994, J BIOL CHEM, V269, P29537; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Thomas JG, 1998, J BACTERIOL, V180, P5165; Krzewska J, 2001, FEBS LETT, V489, P92, DOI 10.1016/S0014-5793(00)02423-6; Akoev V, 2004, PROTEIN SCI, V13, P567, DOI 10.1110/ps.03422604; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; Fernandez-Higuero JA, 2011, J BIOL CHEM, V286, P25547, DOI 10.1074/jbc.M111.231365; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Krzewska J, 2001, J MOL BIOL, V314, P901, DOI 10.1006/jmbi.2001.5190; Mizuno S, 2012, FEBS J, V279, P1474, DOI 10.1111/j.1742-4658.2012.08540.x; Mizutani T, 2009, GENES CELLS, V14, P1405, DOI 10.1111/j.1365-2443.2009.01357.x; Motohashi K, 1997, FEBS LETT, V412, P633, DOI 10.1016/S0014-5793(97)00847-8; Motohashi K, 1996, J BIOL CHEM, V271, P17343; PARSELL DA, 1994, J BIOL CHEM, V269, P4480; Stiggall D L, 1979, Methods Enzymol, V55, P308; Watanabe Y, 2005, J BIOL CHEM, V280, P24562, DOI 10.1074/jbc.M414623200; Watanabe YH, 2002, J BIOL CHEM, V277, P5804, DOI 10.1074/jbc.M109349200; Watanabe YH, 2009, BIOCHEM J, V421, P71, DOI 10.1042/BJ20082238; Yamasaki T, 2011, FEBS J, V278, P2395, DOI 10.1111/j.1742-4658.2011.08167.x	43	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	DEC	2014	19	12					891	900		10.1111/gtc.12188		10	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	AU2JD	WOS:000345443100004		
J	Moriuchi, T; Muraoka, T; Mio, K; Osumi, T; Hirose, F				Moriuchi, Takanobu; Muraoka, Takuya; Mio, Kazuhiro; Osumi, Takashi; Hirose, Fumiko			Long-term expression of the lamin A mutant associated with dilated cardiomyopathy induces senescence	GENES TO CELLS			English	Article							GILFORD-PROGERIA-SYNDROME; NUCLEAR LAMINS; A-TYPE; SUMO MODIFICATION; PRELAMIN-A; CELLS; DISEASE; DOMAIN; DIFFERENTIATION; LAMINOPATHIES	Mutation of the lamin A gene (LMNA) causes a diverse range of diseases referred to as laminopathies. Because most laminopathies have a dominant inheritance pattern and progress gradually, cultured cells stably expressing mutant lamin A at the same level as endogenous wild-type cells are required for chronological analysis. In this study, we showed that an expression system involving a lentiviral vector that carries the human metallothionein gene basal promoter ensures stable and basal-level expression of proteins and is thus suitable for investigating the properties of lamin A mutants. The small ubiquitin-related modifier (SUMO) modification (SUMOylation)-defective E203G mutant that is associated with familial dilated cardiomyopathy exhibited abnormal subnuclear distribution and inhibited normal localization of WT lamin A in a dominant-negative manner. Low-level and long-term expression of the E203G mutant resulted in multinucleated giant cells, aberrant lipid droplet accumulation in the cytoplasm and premature senescence. Expression of another SUMOylation-defective mutant (K201R) did not induce any phenotypes observed in cells expressing E203G. These results indicate that the E203G mutant may inhibit the normal functions of wild-type lamin A in a dominant-negative manner, but a defect in SUMOylation itself may not be involved in disease pathogenesis.	[Moriuchi, Takanobu; Muraoka, Takuya; Osumi, Takashi; Hirose, Fumiko] Univ Hyogo, Grad Sch Life Sci, Koto Ku, Kamigori, Hyogo 6781297, Japan; [Mio, Kazuhiro] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Koto Ku, Tokyo 1350064, Japan	Hirose, F (reprint author), Univ Hyogo, Grad Sch Life Sci, Koto Ku, Kamigori, Hyogo 6781297, Japan.	fhirose@sci.u-hyogo.ac.jp					Davidson MM, 2005, J MOL CELL CARDIOL, V39, P133, DOI 10.1016/j.yjmcc.2005.03.003; YE QA, 1995, EXP CELL RES, V219, P292, DOI 10.1006/excr.1995.1230; Solovei I, 2013, CELL, V152, P584, DOI 10.1016/j.cell.2013.01.009; Lloyd DJ, 2002, HUM MOL GENET, V11, P769, DOI 10.1093/hmg/11.7.769; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Delbarre E, 2006, HUM MOL GENET, V15, P1113, DOI 10.1093/hmg/ddl026; PARRY DAD, 1986, BIOCHEM J, V238, P305; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Kiyono T, 1998, NATURE, V396, P84; Subramanian L, 2003, J BIOL CHEM, V278, P9134, DOI 10.1074/jbc.M210440200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Yamashita D, 2004, GENES CELLS, V9, P1017, DOI 10.1111/j.1365-2443.2004.00786.x; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Zhang YQ, 2008, J CELL BIOL, V182, P35, DOI 10.1083/jcb.200712124; Hall AHS, 2003, J VIROL, V77, P6066, DOI 10.1128/JVI.77.10.6066-6069.2003; Schreiber KH, 2013, CELL, V152, P1365, DOI 10.1016/j.cell.2013.02.015; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Sapetschnig A, 2002, EMBO J, V21, P5206, DOI 10.1093/emboj/cdf510; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; BHARATI S, 1992, PACE, V15, P1720, DOI 10.1111/j.1540-8159.1992.tb02960.x; Caron M, 2007, CELL DEATH DIFFER, V14, P1759, DOI 10.1038/sj.cdd.4402197;; Dechat T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000547; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Fumoto T, 2007, J BIOCHEM, V141, P181, DOI 10.1093/jb/mvm018; Kudlow BA, 2008, MOL BIOL CELL, V19, P5238, DOI 10.1091/mbc.E08-05-0492; Maraldi NM, 2010, ADV ENZYME REGUL, V50, P248, DOI 10.1016/j.advenzreg.2009.10.019; Nelson EJR, 2010, GENE THER, V17, P672, DOI 10.1038/gt.2010.7; Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987; WEBER K, 1989, FEBS LETT, V257, P411, DOI 10.1016/0014-5793(89)81584-4; Yamashita D, 2007, J BIOL CHEM, V282, P7563, DOI 10.1074/jbc.M607180200; Ye ZQ, 1998, HUM GENE THER, V9, P2197, DOI 10.1089/hum.1998.9.15-2197	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	DEC	2014	19	12					901	918		10.1111/gtc.12189		18	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	AU2JD	WOS:000345443100005		
J	Oki, S; Maehara, K; Ohkawa, Y; Meno, C				Oki, Shinya; Maehara, Kazumitsu; Ohkawa, Yasuyuki; Meno, Chikara			SraTailor: Graphical user interface software for processing and visualizing ChIP-seq data	GENES TO CELLS			English	Article							BURROWS-WHEELER TRANSFORM; READ ALIGNMENT; GALAXY; GENOME	Raw data from ChIP-seq (chromatin immunoprecipitation combined with massively parallel DNA sequencing) experiments are deposited in public databases as SRAs (Sequence Read Archives) that are publically available to all researchers. However, to graphically visualize ChIP-seq data of interest, the corresponding SRAs must be downloaded and converted into BigWig format, a process that involves complicated command-line processing. This task requires users to possess skill with script languages and sequence data processing, a requirement that prevents a wide range of biologists from exploiting SRAs. To address these challenges, we developed SraTailor, a GUI (Graphical User Interface) software package that automatically converts an SRA into a BigWig-formatted file. Simplicity of use is one of the most notable features of SraTailor: entering an accession number of an SRA and clicking the mouse are the only steps required to obtain BigWig-formatted files and to graphically visualize the extents of reads at given loci. SraTailor is also able to make peak calls, generate files of other formats, process users' own data, and accept various command-line-like options. Therefore, this software makes ChIP-seq data fully exploitable by a wide range of biologists. SraTailor is freely available at http://www.devbio.med.kyushu-u.ac.jp/sra_tailor/, and runs on both Mac and Windows machines.	[Oki, Shinya; Meno, Chikara] Kyushu Univ, Grad Sch Med Sci, Dept Dev Biol, Higashi Ku, Fukuoka 8128582, Japan; [Maehara, Kazumitsu; Ohkawa, Yasuyuki] Kyushu Univ, Grad Sch Med Sci, Dept Epigenet, Higashi Ku, Fukuoka 8128582, Japan	Oki, S (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Dev Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	soki@dev.med.kyushu-u.ac.jp; meno@dev.med.kyushu-u.ac.jp			JSPS KAKENHI [23770254, 25840087, 21116002, 25670491]; Kyushu University Interdisciplinary Programs in Education and Projects in Research Development (PP)	We thank K. Takaoka for testing the software. This work was supported by JSPS KAKENHI Grants 23770254, 25840087, 21116002, and 25670491, and by Kyushu University Interdisciplinary Programs in Education and Projects in Research Development (P&P).	Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Furey TS, 2012, NAT REV GENET, V13, P840, DOI 10.1038/nrg3306; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	12	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	DEC	2014	19	12					919	926		10.1111/gtc.12190		8	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	AU2JD	WOS:000345443100006		
J	Oda, T; Chiba, S; Nagai, T; Mizuno, K				Oda, Toshiaki; Chiba, Shuhei; Nagai, Tomoaki; Mizuno, Kensaku			Binding to Cep164, but not EB1, is essential for centriolar localization of TTBK2 and its function in ciliogenesis	GENES TO CELLS			English	Article							CILIARY VESICLE DOCKING; TAU-TUBULIN KINASE; MOTHER CENTRIOLE; PRIMARY CILIUM; MUTATIONS; DISEASE; PHOSPHORYLATION; CILIOPATHIES; SPECIFICITY; MECHANISMS	Primary cilia are formed by extending the microtubule-based axoneme from the mother centriole-derived basal body. Recruitment of Tau tubulin kinase-2 (TTBK2) to the mother centriole and subsequent removal of CP110 and its interactor Cep97 are crucial for the initiation of ciliogenesis. We analyzed the roles of two TTBK2-binding proteins, EB1 and Cep164, in centriolar localization of TTBK2. TTBK2 bound EB1 and Cep164 through its SxIP motifs and a proline-rich motif, respectively. Using TTBK2 variants that contained mutations in the SxIP or proline-rich motifs, we obtained evidence that Cep164, but not EB1, is essential for centriolar localization of TTBK2. Depletion of TTBK2 inhibited CP110 removal and ciliogenesis, whereas expression of wild-type TTBK2, but not non-Cep164-binding mutants, rescued CP110 removal and ciliogenesis in TTBK2-depleted cells. Therefore, Cep164 binding is essential for the function of TTBK2 in promoting CP110 removal and ciliogenesis. We also provide evidence that TTBK2 has the potential to effectively phosphorylate Cep164 and Cep97 and inhibits the interaction between Cep164 and its binding partner Dishevelled-3 (an important regulator of ciliogenesis) in a kinase activity-dependent manner.	[Oda, Toshiaki; Chiba, Shuhei; Nagai, Tomoaki; Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan	Mizuno, K (reprint author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan.	kmizuno@biology.tohoku.ac.jp			Ministry of Education, Culture, Science, Sports and Technology of Japan; Uehara Memorial Foundation	We thank Y. Kudo, S. Umeda and T. Funaya for technical assistance. We also thank T. Tsuji, A. Kikuchi and B. D. Dynlacht for providing plasmids, H. Nakanishi and M. Matsuyama for providing hTERT-RPE1 cells and I. Manabe, K. Fujiu, S. Ishikawa and T. Ohtani for providing IMCD-3 cells. This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Science, Sports and Technology of Japan and the Uehara Memorial Foundation.	Chaki M, 2012, CELL, V150, P533, DOI 10.1016/j.cell.2012.06.028; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Lee KH, 2012, EMBO J, V31, P3104, DOI 10.1038/emboj.2012.144; Slep KC, 2010, CURR OPIN CELL BIOL, V22, P88, DOI 10.1016/j.ceb.2009.10.009; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Jiang K, 2012, CURR BIOL, V22, P1800, DOI 10.1016/j.cub.2012.07.047; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Goetz SC, 2012, CELL, V151, P847, DOI 10.1016/j.cell.2012.10.010; Kobayashi T, 2011, J CELL BIOL, V193, P435, DOI 10.1083/jcb.201101005; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Schmidt KN, 2012, J CELL BIOL, V199, P1083, DOI 10.1083/jcb.201202126; Joo K, 2013, P NATL ACAD SCI USA, V110, P5987, DOI 10.1073/pnas.1220927110; Tanos BE, 2013, GENE DEV, V27, P163, DOI 10.1101/gad.207043.112; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Marshall WF, 2008, J CELL BIOL, V180, P17, DOI 10.1083/jcb.200710085; Nagai T, 2013, J CELL SCI, V126, P4369, DOI 10.1242/jcs.127209; Ye X, 2014, P NATL ACAD SCI USA, V111, P2164, DOI 10.1073/pnas.1318737111; Bouskila M, 2011, BIOCHEM J, V437, P157, DOI 10.1042/BJ20110276; Schroder JM, 2007, CURR BIOL, V17, P1134, DOI 10.1016/j.cub.2007.05.055; Schroder JM, 2011, J CELL SCI, V124, P2539, DOI 10.1242/jcs.085852; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Bettencourt-Dias M, 2008, TRENDS CELL BIOL, V18, P8, DOI 10.1016/j.tcb.2007.11.002; Cajanek L, 2014, P NATL ACAD SCI USA, V111, pE2841, DOI 10.1073/pnas.1401777111; Chiba S, 2013, EMBO J, V32, P874, DOI 10.1038/emboj.2013.32; Houlden H, 2007, NAT GENET, V39, P1434, DOI 10.1038/ng.2007.43; Ilsley JL, 2002, CELL SIGNAL, V14, P183, DOI 10.1016/S0898-6568(01)00236-4; Sivasubramaniam S, 2008, GENE DEV, V22, P587, DOI 10.1101/gad.1627708; TAKAHASHI M, 1995, FEBS LETT, V372, P59, DOI 10.1016/0014-5793(95)00955-9; Tsang William Y, 2013, Cilia, V2, P9, DOI 10.1186/2046-2530-2-9	31	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1356-9597	1365-2443		GENES CELLS	Genes Cells	DEC	2014	19	12					927	940		10.1111/gtc.12191		14	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	AU2JD	WOS:000345443100007		
J	Hmon, KPW; Shehzad, T; Okuno, K				Hmon, Khaing Pann Witt; Shehzad, Tariq; Okuno, Kazutoshi			QTLs underlying inflorescence architecture in sorghum (Sorghum bicolor (L.) Moench) as detected by association analysis	GENETIC RESOURCES AND CROP EVOLUTION			English	Article						Genome-wide association mapping; Inflorescence architecture; Panicle traits; Sorghum bicolor; SSRs; Yield-related traits	SIMPLE-SEQUENCE REPEATS; GRAIN-SORGHUM; GENETIC-VARIABILITY; PEARL-MILLET; LINKAGE-MAP; TRAITS; IDENTIFICATION; POPULATION; RICE; CLASSIFICATION	The pattern of the panicle is an important characteristic of sorghum that is used to identify race divisions and species values. The knowledge of the genetic basis of sorghum inflorescence architecture and its component traits can enhance the process of improvement in sorghum breeding. This study was undertaken to better understand the genetic basis of sorghum inflorescence architecture and its association with yield-related traits. We investigated 98 simple sequence repeat maps in the sorghum diversity research set (SDRS) of 107 landraces from the worldwide sorghum germplasm. A significant difference between accessions was observed for 14 measured traits. In several components of sorghum inflorescence architecture, we found that the significance and high correlations between pairs of traits revealed that these variations are dependent not only on the panicle length (PanL) but also on the total branch number, maximum length of the primary branch (MaxLBZ/MxLBZ) , rachis length (Rac), and panicle diameter (PanD) and width (Panw). Significant mean squares were obtained for almost all characters in the individual analysis and combined analysis of variance for each season and across two seasons, suggesting that, the components of inflorescence architecture and yield related traits were highly variable in SDRS population, therefore, would respond to selection for yield improvement. Molecular markers divided the germplasm into three sub-populations with different groups of inflorescence/panicle types (PanT) (broom, open and compact). The SDRS was composed of six different PanT that were associated with 14 inflorescence traits. Using different models of association analysis, 16 loci on 8 chromosomes were found to be significantly related to the patterns of observed panicle traits. Among these loci, four QTLs were responsible for length-based traits, and three QTLs were responsible for dimentional traits. Four QTLs were responsible for panicle feature such as PanT and shape, one QTL responsible for yield related trait such as grain weight. Two QTLs were responsible for branch-based traits, such as the total node number and branch number with -Log(10) (P) values ranging from 1.5 to 7.6 as the threshold value. Several genomic regions affected multiple traits, including one region that affected PanL and MxLBZ/MaxLBZ. QTLs for different traits tended to be found in the same region on chromosome 4 and on chromosome 9. Additionally, QTL was involved on Chr-2, Chr-5, Chr-6 and Chr-10 as a novel QTL that controlled Rac, total node number, PanD and PanT. These results will serve as preliminary findings of QTLs for sorghum inflorescence architecture, and a further evaluation of the germplasm for these traits is in progress. Moreover, these findings can lead to the emergence of a new era of sorghum genomics, which are aimed at bridging the knowledge gap between genotype and phenotype in sorghum inflorescence architecture.	[Hmon, Khaing Pann Witt; Shehzad, Tariq; Okuno, Kazutoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Shehzad, Tariq; Okuno, Kazutoshi] Univ Tsukuba, Alliance Res North Africa ARENA, Tsukuba, Ibaraki 3058572, Japan	Okuno, K (reprint author), Univ Tsukuba, Alliance Res North Africa ARENA, Tennodai 1-1-1, Tsukuba, Ibaraki 3058572, Japan.	okuno.kazutoshi.fu@u.tsukuba.ac.jp					Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Klein RR, 2001, THEOR APPL GENET, V102, P307, DOI 10.1007/s001220051647; Casa AM, 2008, CROP SCI, V48, P30, DOI 10.2135/cropsci2007.02.0080; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Colasanti J, 1998, CELL, V93, P593, DOI 10.1016/S0092-8674(00)81188-5; Pritchard JK, 2000, GENETICS, V155, P945; Zou GH, 2011, AUST J CROP SCI, V5, P1232; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Taramino G, 1997, THEOR APPL GENET, V95, P66, DOI 10.1007/s001220050533; Casa AM, 2005, THEOR APPL GENET, V111, P23, DOI 10.1007/s00122-005-1952-5; Singh V, 2011, CROP SCI, V51, P2011, DOI 10.2135/cropsci2011.01.0038; Srinivas G, 2009, THEOR APPL GENET, V118, P1439, DOI 10.1007/s00122-009-0993-6; Zhu KM, 2010, GENETICS, V184, P343, DOI 10.1534/genetics.109.112045; Murray SC, 2009, PLANT GENOME-US, V2, P48, DOI 10.3835/plantgenome2008.10.0011; Abdi A, 2002, HEREDITAS, V137, P161, DOI 10.1034/j.1601-5223.2002.01604.x; Ikeda M, 2010, BREEDING SCI, V60, P55; Doust AN, 2005, GENETICS, V169, P1659, DOI 10.1534/genetics.104.035543; Yan CJ, 2007, THEOR APPL GENET, V115, P1093, DOI 10.1007/s00122-007-0635-9; Stich B, 2008, GENETICS, V178, P1745, DOI 10.1534/genetics.107.079707; Doust AN, 2002, AM J BOT, V89, P1203, DOI 10.3732/ajb.89.8.1203; Bhattramakki D, 2000, GENOME, V43, P988, DOI 10.1139/gen-43-6-988; Arunkumar B., 2004, Karnataka Journal of Agricultural Sciences, V17, P471; Bala RS, 1996, J CROP IMPROV, V23, P169; Barkworth M, 2003, FLORA N AM N MEXICO, V25, P626; Barnaud A, 2008, AM J BOT, V96, P1869; Bello D, 2007, AM EURASIAN J AGR EN, V3, P297; Bello D, 2001, NIGERIAN J TROPICAL, V3, P4; Bommert P, 2005, PLANT CELL PHYSIOL, V46, P69, DOI 10.1093/pcp/pci504; Brown PJ, 2006, THEOR APPL GENET, V113, P931, DOI 10.1007/s00122-006-0352-9; Brown PJ, 2011, CROP SCI, V51, P224, DOI 10.2135/cropsci2010.03.0179; Dahlberg J. A., 2000, SORGHUM ORIGIN HIST, P99; Delserone L. M., 2007, Journal of Agricultural & Food Information, V8, P9, DOI 10.1300/J108v08n01_03; Doggett H, 1988, SORGHUM, P75; Emma SM, 2013, NAT COMMUN, V4, P20; Futsuhara Y., 1979, Japanese Journal of Breeding (Ikushugaku Zasshi), V29, P239; Futsuhara Y., 1979, Japanese Journal of Breeding (Ikushugaku Zasshi), V29, P151; HANSON C. H., 1956, AGRON JOUR, V48, P268; HARLAN JR, 1972, CROP SCI, V12, P172; House LR, 1985, GUIDE SORGHUM BREEDI, P11; IBPGR and ICRISAT, 1993, DESCR SORGH; Kaitaniemi P, 1999, FIELD CROP RES, V61, P51, DOI 10.1016/S0378-4290(98)00148-8; Kellogg EA, 2000, GRASS SYSTEMATICS EV, V2, P148; Kim JS, 2005, GENETICS, V169, P1169, DOI 10.1534/genetics.104.035980; KOCK N, 2012, WARPPLS 3 0 USER MAN; Kong L, 2000, THEOR APPL GENET, V101, P438, DOI 10.1007/s001220051501; LIANG GHL, 1968, CROP SCI, V8, P77; LIANG GHL, 1966, CROP SCI, V6, P76; Maman N, 2004, CROP SCI, V44, P2138; Negash Geleta, 2005, Crop Research (Hisar), V30, P439; Patel R. H., 1980, Sorghum Newsletter, V23, P22; Bouchet S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033470; Rai KN, 1999, GENOME, V42, P617, DOI 10.1139/gen-42-4-617; ROBINSON HF, 1951, AGRON J, V43, P282; SAEED M, 1983, CROP SCI, V23, P683; SAS Institute Inc, 2010, JMP STAT GRAPH GUID; Shehzad T, 2009, BREEDING SCI, V59, P217, DOI 10.1270/jsbbs.59.217; Shehzad T, 2009, GENET RESOUR CROP EV, V56, P809, DOI 10.1007/s10722-008-9403-1; Singh D, 1973, SCI CULT, V39, P455; Snowden JD, 1936, CULTIVATED RACES SOR; Vanderlip RL, 1972, CROP SCI, V64, P13; Wannows AK, 2010, AGR BIOL J N AM, V4, P630; Witt Hmon KP, 2013, PLANT GENET RES, V11, P1; Zhao K, 2007, PLOS GENET, V3, pe1	64	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-9864	1573-5109		GENET RESOUR CROP EV	Genet. Resour. Crop Evol.	DEC	2014	61	8					1545	1564		10.1007/s10722-014-0129-y		20	Agronomy; Plant Sciences	Agriculture; Plant Sciences	AU1JU	WOS:000345377800009		
J	Chizzola, R; Saeidnejad, AH; Azizi, M; Oroojalian, F; Mardani, H				Chizzola, Remigius; Saeidnejad, Amir Hossein; Azizi, Majid; Oroojalian, Fatemeh; Mardani, Hossein			Bunium persicum: variability in essential oil and antioxidants activity of fruits from different Iranian wild populations	GENETIC RESOURCES AND CROP EVOLUTION			English	Article						Apiaceae; Bunium persicum; Cuminaldehyde; Essential oil; alpha-Terpinen-7-al; gamma-Terpinen-7-al	SOLID-PHASE MICROEXTRACTION; APIACEAE; SPICES; SEEDS; MICRODISTILLATION; HYDRODISTILLATION; CONSTITUENTS; COMPONENTS; VOLATILES; L.	The fruits of Bunium persicum (Boiss.) B. Fedtsch were collected throughout Iran from ten populations and assessed for their essential oil composition and antioxidant activity. The volatiles were analyzed by GC/MS/FID after microdistillation and SPME. All 10 accessions had the same major volatiles roughly in the order gamma-terpinene = cuminal > gamma-terpinen-7-al > p-cymene > limonene > alpha-terpinen-7-al although they origin from quite different sites. Nevertheless these plants that are able to grow in a wide range of environments may present the base for domestication with the aim to optimize essential oil yield with a high proportion of aldehydes. The methanolic extracts of the fruits showed a moderate antioxidant potential.	[Chizzola, Remigius] Univ Vet Med Vienna, Inst Anim Nutr & Funct Plant Cpds, A-1210 Vienna, Austria; [Saeidnejad, Amir Hossein] Ferdowsi Univ Mashhad, Dept Agron, Fac Agr, Mashhad, Iran; [Azizi, Majid] Ferdowsi Univ Mashhad, Dept Hort, Fac Agr, Mashhad, Iran; [Oroojalian, Fatemeh] Univ Tehran, Fac New Sci & Technol, Dept Life Sci Engn, Tehran, Iran; [Mardani, Hossein] Tokyo Univ Agr & Technol, Dept Int Environm & Agr Sci, Tokyo, Japan	Chizzola, R (reprint author), Univ Vet Med Vienna, Inst Anim Nutr & Funct Plant Cpds, Vet Pl 1, A-1210 Vienna, Austria.	Remigius.Chizzola@vetmeduni.ac.at					Adams R.P., 2007, IDENTIFICATION ESSEN; Oroojalian F, 2010, FOOD CHEM, V120, P765, DOI 10.1016/j.foodchem.2009.11.008; Shahsavari N, 2008, PLANT FOOD HUM NUTR, V63, P183, DOI 10.1007/s11130-008-0091-y; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Mazidi S, 2012, J AGR SCI TECH-IRAN, V14, P1013; Talei GR, 2009, ASIAN J CHEM, V21, P4749; Drew DP, 2012, PHYTOCHEM ANALYSIS, V23, P44, DOI 10.1002/pca.1323; Bozin B, 2006, J AGR FOOD CHEM, V54, P1822, DOI 10.1021/jf051922u; Leontowicz M, 2003, J AGR FOOD CHEM, V51, P5780, DOI 10.1021/jf030137j; Sekine T, 2007, J CHEM ECOL, V33, P2123, DOI 10.1007/s10886-007-9374-2; Mortazavi SV, 2010, FOOD BIOPROD PROCESS, V88, P222, DOI 10.1016/j.fbp.2009.11.005; Azimzadeh M., 2012, Journal of Medicinal Plants Research, V6, P1119; Azizi M, 2009, J ESSENT OIL RES, V21, P78; Baser K. H. C., 1997, Journal of Essential Oil Research, V9, P597; Baser KHC, 2006, J ESSENT OIL RES, V18, P515; Chizzola R, 2009, NAT PROD COMMUN, V4, P1235; Foroumadi A, 2002, J ESSENT OIL RES, V14, P161; Hanelt P., 2001, MANSFELDS ENCY AGR H; Jahansooz F, 2012, J ESSENT OIL BEAR PL, V15, P761, DOI 10.1080/0972060X.2012.10644117; Kruger H, 2007, STEWARTPOSTHARV REV, V4, P1; Kurkcuoglu M, 2003, CHEM NAT COMPD+, V39, P355, DOI 10.1023/B:CONC.0000003415.49701.8b; MCLAFFERTY F. W., 1989, REGISTRY MASS SPECTR; Nickavar B, 2009, PAK J PHARM SCI, V22, P30; Omidbaigi R, 2009, J ESSENT OIL BEAR PL, V12, P34; Panwar K, 2000, SPICE CROPS INDIA, P172; Panwar K. S., 1993, Agricultural Situation in India, V48, P151; Pourmortazavi SM, 2005, J FOOD COMPOS ANAL, V18, P439, DOI 10.1016/j.jfca.2004.01.003; Rafieiolhossaini M, 2012, NAT PROD COMMUN, V7, P97; Saeidnejad AH, 2013, SEED SCI TECHNOL, V41, P452; Saeidnejad H, 2013, TURK J BOT, V37, P930; Sharififar F, 2010, PAK J PHARM SCI, V23, P300; Sofi PA, 2009, TURK J BIOL, V33, P249, DOI 10.3906/biy-0803-18; Souri E, 2008, DARU, V16, P83; THAPPA RK, 1991, FOOD CHEM, V41, P129, DOI 10.1016/0308-8146(91)90040-U; Zangiabadi M., 2012, Journal of Medicinal Plants, V11, P8	35	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-9864	1573-5109		GENET RESOUR CROP EV	Genet. Resour. Crop Evol.	DEC	2014	61	8					1621	1631		10.1007/s10722-014-0158-6		11	Agronomy; Plant Sciences	Agriculture; Plant Sciences	AU1JU	WOS:000345377800014		
J	Majka, J; Rosen, A; Janak, M; Froitzheim, N; Klonowska, I; Manecki, M; Sasinkova, V; Yoshida, K				Majka, Jaroslaw; Rosen, Ake; Janak, Marian; Froitzheim, Nikolaus; Klonowska, Iwona; Manecki, Maciej; Sasinkova, Vlasta; Yoshida, Kenta			Microdiamond discovered in the Seve Nappe (Scandinavian Caledonides) and its exhumation by the "vacuum-cleaner" mechanism	GEOLOGY			English	Article							WESTERN GNEISS REGION; PRESSURE METAMORPHIC ROCKS; BALTOSCANDIAN MARGIN; SWEDISH CALEDONIDES; GARNET PERIDOTITES; CENTRAL JAMTLAND; RAMAN SPECTRUM; NORWAY; EVOLUTION; COMPLEX	When a continent collides with an island arc or other continent, continental crust of the subducted continent may be buried to depths exceeding 100 km, and exposed to pressures that can cause formation of coesite and diamond. This process leads to substantial density increase in SiO2-rich rocks and, in turn, to a reduction of the buoyancy of the subducted material, which should inhibit exhumation. Nevertheless, coesite- and diamond-bearing continental crustal rocks are known from several occurrences worldwide. We report on the discovery of microdiamond in kyanite-garnet gneiss from allochthonous metasediments of the Seve Nappe Complex in the Scandinavian Caledonides. Our discovery calls for general reconsideration of existing exhumation models of deeply subducted continental crust. We propose that the diamond-bearing rocks were subducted in an arc-continent collision setting, and their exhumation was facilitated by local pressure reduction resulting from extraction of the forearc lithospheric block.	[Majka, Jaroslaw; Rosen, Ake; Klonowska, Iwona] Uppsala Univ, Dept Earth Sci, CEMPEG, S-75236 Uppsala, Sweden; [Janak, Marian] Slovak Acad Sci, Inst Geol, Bratislava 84005, Slovakia; [Froitzheim, Nikolaus] Univ Bonn, Steinmann Inst, D-53115 Bonn, Germany; [Manecki, Maciej] AGH Univ Sci & Technol, Fac Geol Geophys & Environm Protect, PL-30059 Krakow, Poland; [Sasinkova, Vlasta] Slovak Acad Sci, Inst Chem, Bratislava 84005, Slovakia; [Yoshida, Kenta] Kyoto Univ, Grad Sch Sci, Dept Geol & Mineral, Kyoto 6068502, Japan	Majka, J (reprint author), Uppsala Univ, Dept Earth Sci, CEMPEG, Villavagen 16, S-75236 Uppsala, Sweden.			Majka, Jaroslaw/0000-0002-6792-6866; Klonowska, Iwona/0000-0001-7346-1770	Metamorphic Map of Sweden project - Geological Survey of Sweden, Swedish Research Council (VR) project [2012-4441]; Slovak Scientific Grant Agency VEGA project [2/0013/12]; Slovak Research and Development Agency project [APVV-0080-11]; Polish AGH-UST statutory funds [11.11.140.319]	We thank H. Brueckner, H. Fossen, an anonymous reviewer, and the editor J. Spotila for their helpful comments. D. G. Gee is acknowledged for encouraging us to climb Tvaraklumparna and sample gneisses there. M. Nosko is thanked for the SEM imaging, and T. Hirajima for a non-cost Raman analysis in Kyoto. This work was supported by the Metamorphic Map of Sweden project (funded by the Geological Survey of Sweden), Swedish Research Council (VR) project no. 2012-4441 to Majka, Slovak Scientific Grant Agency VEGA project no. 2/0013/12 and Slovak Research and Development Agency project no. APVV-0080-11 to Janak, and Polish AGH-UST statutory funds 11.11.140.319 to Manecki.	Perraki M, 2009, AM MINERAL, V94, P546, DOI 10.2138/am.2009.2973; Kylander-Clark ARC, 2007, CHEM GEOL, V242, P137, DOI 10.1016/j.chemgeo.2007.03.006; Brueckner HK, 2000, J METAMORPH GEOL, V18, P123; Brun JP, 2008, EARTH PLANET SC LETT, V272, P1, DOI 10.1016/j.epsl.2008.02.038; Perrillat JP, 2003, J PETROL, V44, P773, DOI 10.1093/petrology/44.4.773; DOBRZHINETSKAYA LF, 1995, GEOLOGY, V23, P597, DOI 10.1130/0091-7613(1995)023<0597:MIHGMR>2.3.CO;2; TUINSTRA F, 1970, J CHEM PHYS, V53, P1126, DOI 10.1063/1.1674108; Shyu JBH, 2011, J ASIAN EARTH SCI, V42, P415, DOI 10.1016/j.jseaes.2011.05.015; Fossen H, 2010, GEOL SOC SPEC PUBL, V335, P767, DOI 10.1144/SP335.31; Wojdyr M, 2010, J APPL CRYSTALLOGR, V43, P1126, DOI 10.1107/S0021889810030499; Smith DC, 2013, J METAMORPH GEOL, V31, P19, DOI 10.1111/jmg.12007; SMITH DC, 1984, NATURE, V310, P641, DOI 10.1038/310641a0; Terry MP, 2000, AM MINERAL, V85, P1651; LESPADE P, 1982, CARBON, V20, P427, DOI 10.1016/0008-6223(82)90043-4; Brueckner HK, 2004, TECTONICS, V23, DOI 10.1029/2003TC001502; GRIFFIN WL, 1980, NATURE, V285, P319, DOI 10.1038/285319a0; Andersen TB, 2012, J GEOL SOC LONDON, V169, P601, DOI 10.1144/0016-76492012-011; Gee DG, 2010, GFF, V132, P29, DOI 10.1080/11035891003759188; Brueckner HK, 2004, J PETROL, V45, P415, DOI 10.1093/petrology/egg088; SOLIN SA, 1970, PHYS REV B, V1, P1687, DOI 10.1103/PhysRevB.1.1687; Janak M, 2013, J METAMORPH GEOL, V31, P691, DOI 10.1111/jmg.12040; Janak M, 2013, GONDWANA RES, V23, P865, DOI 10.1016/j.gr.2012.06.012; CHOPIN C, 1984, CONTRIB MINERAL PETR, V86, P107, DOI 10.1007/BF00381838; Froitzheim N, 2006, J STRUCT GEOL, V28, P1388, DOI 10.1016/j.jsg.2006.05.002; Froitzheim N, 2003, GEOLOGY, V31, P925, DOI 10.1130/G19748.1; Gee DG, 2014, GEOL SOC SPEC PUBL, V390, P131, DOI 10.1144/SP390.20; Gee DG, 2013, LITHOSPHERE-US, V5, P169, DOI 10.1130/L220.1; Gilotti JA, 2013, ELEMENTS, V9, P255, DOI 10.2113/gselements.9.4.255; Hacker BR, 2013, ELEMENTS, V9, P289, DOI 10.2113/gselements.9.4.289; Klonowska I, 2014, GEOL SOC SPEC PUBL, V390, P321, DOI 10.1144/SP390.7; Koyi H, 2013, J STRUCT GEOL, V50, P82, DOI 10.1016/j.jsg.2012.08.008; Majka J, 2014, GEOL SOC SPEC PUBL, V390, P369, DOI 10.1144/SP390.14; Majka J, 2012, J GEOSCI-CZECH, V57, P3, DOI 10.3190/jgeosci.112; Malavieille J, 2009, TECTONOPHYSICS, V466, P377, DOI 10.1016/j.tecto.2007.11.016; Robinson P, 2014, GEOL SOC SPEC PUBL, V390, P241, DOI 10.1144/SP390.24; SOBOLEV NV, 1990, NATURE, V343, P742, DOI 10.1038/343742a0; STEPHENS M. B., 1989, GEOLOGICAL SOC AM SP, V230, P17; van Roermund H, 2009, EUR J MINERAL, V21, P1085, DOI 10.1127/0935-1221/2009/0021-1976	38	4	4	GEOLOGICAL SOC AMER, INC	BOULDER	PO BOX 9140, BOULDER, CO 80301-9140 USA	0091-7613	1943-2682		GEOLOGY	Geology	DEC	2014	42	12					1107	1110		10.1130/G36108.1		4	Geology	Geology	AU2IE	WOS:000345440600021		
J	Viens, L; Laurendeau, A; Bonilla, LF; Shapiro, NM				Viens, L.; Laurendeau, A.; Bonilla, L. F.; Shapiro, N. M.			Broad-band acceleration time histories synthesis by coupling low-frequency ambient seismic field and high-frequency stochastic modelling	GEOPHYSICAL JOURNAL INTERNATIONAL			English	Article						Interferometry; Earthquake ground motions; Asia	GROUND-MOTION PREDICTION; CROSS-CORRELATION; GREENS-FUNCTIONS; KIK-NET; K-NET; SIMULATION; SPECTRUM; NOISE; JAPAN; EQUATIONS	In this study, information carried by the ambient seismic field is exploited to extract impulse response functions between two seismic stations using one as a 'virtual' source. Interferometry by deconvolution method is used and validated by comparing the extracted ambient noise impulse response waveforms with records of moderate magnitude earthquakes (from M-w 4 to 5.8) that occurred close to the virtual source station in Japan. As the information is only available at low frequencies (less than 0.25 Hz), the ambient seismic field approach is coupled to a non-stationary stochastic model to simulate time domain accelerograms up to 50 Hz. This coupling allows the predicted ground motion to have both the deterministic part at low frequencies coming from the source and the crust structure and the high-frequency random contribution from the seismic waves scattering. The resulting combined accelerograms for an M-w 5.8 event show a good agreement with observed ground motions from a real earthquake.	[Viens, L.] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan; [Viens, L.; Shapiro, N. M.] Inst Phys Globe Paris, Equipe Sismol, Paris, France; [Laurendeau, A.] Univ Grenoble Alpes, ISTerre, F-38041 Grenoble, France; [Bonilla, L. F.] Univ Paris Est, IFSTTAR, Paris, France	Viens, L (reprint author), Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	viens@eri.u-tokyo.ac.jp			ERC [227507]	The authors thank the two anonymous reviewers who gave useful comments for improving the paper. We acknowledge the NIED of Japan for providing the K-NET, KiK-net and Hi-net continuous data. We also thank the Japan Meteorological Agency (JMA) for the information about the earthquakes. We also thank Hiroe Miyake for valuable discussions on the ambient seismic field analysis. The work of NS was supported by an FP7 ERC Advanced grant 227507 (WHISPER).	AKI K, 1967, J GEOPHYS RES, V72, P1217, DOI 10.1029/JZ072i004p01217; Aki K., 2002, QUANTITATIVE SEISMOL; Denolle MA, 2014, SCIENCE, V343, P399, DOI 10.1126/science.1245678; HARTZELL SH, 1978, GEOPHYS RES LETT, V5, P1, DOI 10.1029/GL005i001p00001; ABRAHAMSON NA, 1992, B SEISMOL SOC AM, V82, P505; Bommer JJ, 2009, B SEISMOL SOC AM, V99, P3217, DOI 10.1785/0120080298; Stockwell RG, 1996, IEEE T SIGNAL PROCES, V44, P998, DOI 10.1109/78.492555; Cotton F, 2008, B SEISMOL SOC AM, V98, P2244, DOI 10.1785/0120060084; Boore DM, 2003, PURE APPL GEOPHYS, V160, P635, DOI 10.1007/PL00012553; Weaver RL, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.134301; Wapenaar K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.254301; Roux P, 2005, J ACOUST SOC AM, V117, P79, DOI 10.1121/1.1830673; Gouedard P, 2008, GEOPHYS PROSPECT, V56, P375, DOI 10.1111/j.1365-2478.2007.00684.x; Shapiro NM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019491; Foulser-Piggott R, 2012, EARTHQ ENG STRUCT D, V41, P431, DOI 10.1002/eqe.1137; Olsen KB, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025472; Lobkis OI, 2001, J ACOUST SOC AM, V110, P3011, DOI 10.1121/1.1417528; Boore DM, 2008, EARTHQ SPECTRA, V24, P99, DOI 10.1193/1.2830434; Kamae K, 1998, B SEISMOL SOC AM, V88, P357; Obara K, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1854197; Komatitsch D, 2004, B SEISMOL SOC AM, V94, P187, DOI 10.1785/0120030077; Sabetta F, 1996, B SEISMOL SOC AM, V86, P337; Bensen GD, 2007, GEOPHYS J INT, V169, P1239, DOI 10.1111/j.1365-246X.2007.03374.x; Roux P, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023803; Campillo M, 2003, SCIENCE, V299, P547, DOI 10.1126/science.1078551; Shapiro NM, 2005, SCIENCE, V307, P1615, DOI 10.1126/science.1108339; Causse M, 2009, GEOPHYS J INT, V179, P1627, DOI 10.1111/j.1365-246X.2009.04354.x; Snieder R, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.046610; HANKS TC, 1982, B SEISMOL SOC AM, V72, P1867; Douglas J, 2008, SURV GEOPHYS, V29, P187, DOI 10.1007/s10712-008-9046-y; Bommer JJ, 2004, J EARTHQ ENG, V8, P43; Prieto GA, 2009, COMPUT GEOSCI-UK, V35, P1701, DOI 10.1016/j.cageo.2008.06.007; Aoi S., 2004, J JPN ASS EARTHQUAKE, V4, P65; Arias A., 1970, SEISMIC DESIGN NUCL, P438; BOORE DM, 1983, B SEISMOL SOC AM, V73, P1865; Campillo M., 2011, ENCY SOLID EARTH GEO, P1230; Denolle MA, 2013, J GEOPHYS RES-SOL EA, V118, P2102, DOI 10.1029/2012JB009603; Frankel A., 1996, NATL SEISMIC HAZARD; Gasparini D., 1976, SIMULATED EARTHQUAKE; Husid R.L., 1969, REV IDIEM, V8, P21; Irikura K., 1983, B DISASTER PREV RES, V33, P63; LAI SSP, 1982, B SEISMOL SOC AM, V72, P259; Laurendeau A., 2013, THESIS U J FOURIER G; Okada Y, 2004, EARTH PLANETS SPACE, V56, pXV; Peterson J, 1993, 93322 US GEOL SURV, P93; Pousse G, 2006, B SEISMOL SOC AM, V96, P2103, DOI 10.1785/0120050134; Prieto GA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034428; Pulido N, 2004, TECTONOPHYSICS, V390, P177, DOI 10.1016/j.tecto.2004.03.032; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Vasconcelos I, 2008, GEOPHYSICS, V73, pS115, DOI 10.1190/1.2904554	50	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0956-540X	1365-246X		GEOPHYS J INT	Geophys. J. Int.	DEC	2014	199	3					1784	1797		10.1093/gji/ggu362		14	Geochemistry & Geophysics	Geochemistry & Geophysics	AU3JT	WOS:000345509800035		
J	Moriya, S; Notani, K; Miura, H; Inoue, N				Moriya, Shingo; Notani, Kenji; Miura, Hiroko; Inoue, Nobuo			Relationship between masticatory ability and physical performance in community-dwelling edentulous older adults wearing complete dentures	GERODONTOLOGY			English	Article						elderly; masticatory ability; physical performance; edentulous; complete dentures	CHANGEABLE CHEWING GUM; GENDER-DIFFERENCES; DENTAL OCCLUSION; ELDERLY POPULATION; MUSCLE-ACTIVITY; MIXING ABILITY; H REFLEX; BALANCE; FALLS; JAW	ObjectiveThis study aimed to elucidate the association between masticatory ability and physical performance in community-dwelling edentulous older adults wearing complete dentures. BackgroundPhysical performance parameters are significant predictors of decreased activities of daily living. Previous studies have shown the relationships between oral conditions and these parameters. Here, we focused on complete denture wearers. MethodsTwo hundred and ten edentulous adults aged 65years and wearing complete dentures were enrolled. The following oral conditions were examined: masticatory ability measured by colour-changing chewing gum, number of foods considered chewable, pain when using dentures and denture base fit. Handgrip strength (HG) and one-leg standing time with eyes open (OLST) were used to evaluate muscle strength and static balance. Spearman's rank correlation coefficients were calculated to examine the correlations between oral conditions and physical performance. Forward stepwise linear regression models were applied with each physical performance parameters as the dependent variable and oral conditions as the independent variable. ResultsThe women did not show significant correlations between oral conditions and the physical performance. In men, significant and positive correlations were found between the number of chewable foods and HG, and between the colour scores and OLST. The significant correlation between the colour scores and OLST was still noted in the stepwise liner regression analysis after adjusting for demographic, social and medical conditions, and other oral conditions. ConclusionIn Japanese elderly edentulous men wearing complete dentures, masticatory ability evaluated as the mixing ability may be associated with static balance.	[Moriya, Shingo; Miura, Hiroko] Natl Inst Publ Hlth, Dept Hlth Promot, Wako, Saitama 3510197, Japan; [Notani, Kenji; Inoue, Nobuo] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Hlth Sci, Div Geriatr Dent, Sapporo, Hokkaido, Japan	Moriya, S (reprint author), Natl Inst Publ Hlth, Dept Hlth Promot, 2-3-6 Minami, Wako, Saitama 3510197, Japan.	shyomi@niph.go.jp			Hokkaido University	This study was funded by Hokkaido University. We thank the public authorities of Kucchan, Iwanai and Tomamae, Hokkaido, Japan, for their cooperation.	Al Snih Soham, 2004, Aging Clin Exp Res, V16, P481; Demers M, 1996, J PROSTHET DENT, V75, P188, DOI 10.1016/S0022-3913(96)90098-0; Miyahara T, 1996, J NEUROPHYSIOL, V76, P2033; Ferrario VF, 2006, J ORAL REHABIL, V33, P341, DOI 10.1111/j.1365-2842.2005.01558.x; Schimmel M, 2011, J DENT RES, V90, P230, DOI 10.1177/0022034510383860; Gill TM, 2009, J AM GERIATR SOC, V57, P1850, DOI 10.1111/j.1532-5415.2009.02443.x; Era P, 2006, GERONTOLOGY, V52, P204, DOI 10.1159/000093652; Moriya S, 2009, INT DENT J, V59, P369, DOI 10.1922/IDJ_2323Moriya07; Devoize L, 2010, BRAIN RES, V1343, P75, DOI 10.1016/j.brainres.2010.04.076; Ehrlich R, 1999, J OROFAC PAIN, V13, P115; Wojcik LA, 1999, J GERONTOL A-BIOL, V54, pM44, DOI 10.1093/gerona/54.1.M44; Yamaga T, 2002, J GERONTOL A-BIOL, V57, pM616; Lund JP, 2006, DYSPHAGIA, V21, P167, DOI 10.1007/s00455-006-9027-6; van der Bilt A, 2010, J ORAL REHABIL, V37, P79, DOI 10.1111/j.1365-2842.2009.02040.x; Onder G, 2005, J GERONTOL A-BIOL, V60, P74; Takada Y, 2000, J NEUROPHYSIOL, V83, P2063; Bryant EC, 2005, CLIN BIOMECH, V20, P330, DOI 10.1016/j.clinbiomech.2004.11.006; Takata Y, 2004, ORAL DIS, V10, P44, DOI 10.1046/j.1354-523X.2003.00972.x; ALEXANDER NB, 1994, J AM GERIATR SOC, V42, P93; Komagamine Y, 2011, J ORAL REHABIL, V38, P555, DOI 10.1111/j.1365-2842.2011.02204.x; Gangloff P, 2000, NEUROSCI LETT, V293, P203, DOI 10.1016/S0304-3940(00)01528-7; WOLFSON L, 1994, J GERONTOL, V49, pM160; Speksnijder CM, 2009, EUR J ORAL SCI, V117, P580, DOI 10.1111/j.1600-0722.2009.00675.x; Hellmann D, 2011, J ORAL REHABIL, V38, P729, DOI 10.1111/j.1365-2842.2011.02211.x; Takata Y, 2010, ARCH GERONTOL GERIAT, V50, P272, DOI 10.1016/j.archger.2009.04.005; Morris M, 2004, AUST J PHYSIOTHER, V50, P153; Aoyagi K, 1998, J BONE MINER RES, V13, P1468, DOI 10.1359/jbmr.1998.13.9.1468; Shinkai S, 2000, AGE AGEING, V29, P441, DOI 10.1093/ageing/29.5.441; BROWNE PA, 1993, J DENT RES, V72, P1503, DOI 10.1177/00220345930720110801; Hayakawa I, 1998, INT J PROSTHODONT, V11, P173; Ishikawa Yasutaka, 2007, Journal of Medical and Dental Sciences, V54, P65; KAPUR KK, 1967, J PROSTHET DENT, V18, P550, DOI 10.1016/0022-3913(67)90221-1; Kibana Y, 2002, J ORAL REHABIL, V29, P58, DOI 10.1046/j.1365-2842.2002.00794.x; Kim JW, 2010, GERIATR GERONTOL INT, V10, P191, DOI 10.1111/j.1447-0594.2009.00582.x; Masui T, 2005, ARCH GERONTOL GERIAT, V41, P201, DOI 10.1016/j.archger.2005.02.003; Ministry of Health Labor and Welfare of Japan, REP SURV DENT DIS JA; Osterberg T, 1996, Gerodontology, V13, P110, DOI 10.1111/j.1741-2358.1996.tb00162.x; PANZER VP, 1995, ARCH PHYS MED REHAB, V76, P151, DOI 10.1016/S0003-9993(95)80024-7; Peyron MA, 2004, J NEUROPHYSIOL, V92, P773, DOI 10.1152/jn.01122.2003; So K, 2004, J ORAL REHABIL, V31, P417, DOI 10.1111/j.1365-2842.2004.01265.x; Statistical Bureau of the Ministry of Internal Affairs and Communications, POP EST AG 5 YEAR AG; Woda A, 2011, J ORAL REHABIL, V38, P781, DOI 10.1111/j.1365-2842.2011.02235.x; Yoshida M, 2005, J AM GERIATR SOC, V53, P1631, DOI 10.1111/j.1532-5415.2005.53487_1.x	43	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0734-0664	1741-2358		GERODONTOLOGY	Gerodontology	DEC	2014	31	4					251	259		10.1111/ger.12029		9	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	AU5FS	WOS:000345633200004		
J	Moriya, S; Notani, K; Murata, A; Inoue, N; Miura, H				Moriya, Shingo; Notani, Kenji; Murata, Ayumi; Inoue, Nobuo; Miura, Hiroko			Analysis of moment structures for assessing relationships among perceived chewing ability, dentition status, muscle strength, and balance in community-dwelling older adults	GERODONTOLOGY			English	Article						chewing; dental status; balance; Amos; Muscle strength; BMI	DENTAL OCCLUSION; ELDERLY POPULATION; PHYSICAL-FITNESS; BODY-COMPOSITION; RABBIT; MASTICATION; DISABILITY; AFFERENTS; DISCHARGE; POSTURE	ObjectiveThe aim of this study was to assess relationships among perceived chewing ability, dentition status, muscle strength and balance in community-dwelling older adults using analysis of moment structures (Amos). BackgroundPhysical performance parameters such as muscle strength and balance can predict the future onset of disabilities in activities of daily living among older adults. In this context, elucidation of the relationships among oral conditions and physical performance parameters is necessary. Materials and methodsData on occlusal contact patterns of natural teeth (OPNT), self-assessed masticatory ability (mastication), body mass index (BMI), handgrip strength (HG) and one-leg standing time with eyes open (OLST) were collected from 501 independently living adults aged 65-74years. The relationships among these parameters were analysed using Spearman's rank correlation coefficients and Amos. ResultsSubjects of both genders showed significant correlations among OPNT, mastication, HG and OLST, evaluated using Spearman's rank correlation coefficients. For each Amos model, the goodness-of-fit statistic indicated a good level of fit. In both men and women, OPNT was significantly related to mastication, and mastication was related to HG but not to OLST. OPNT was related to neither HG nor OLST in women and was related to OLST but not HG in men. ConclusionThe findings observed in this study present a possible importance of dental status and perceived chewing ability for the onset of disability by influencing physical performance in community-dwelling older adults.	[Moriya, Shingo] Natl Inst Publ Hlth, Wako, Saitama 3510197, Japan; [Notani, Kenji; Murata, Ayumi; Inoue, Nobuo] Hokkaido Univ, Grad Sch Dent Med, Sappro, Japan; [Miura, Hiroko] Natl Inst Publ Hlth, Area Community Healthcare, Wako, Saitama 3510197, Japan	Moriya, S (reprint author), Natl Inst Publ Hlth, 2-3-6 Minami, Wako, Saitama 3510197, Japan.	shyomi@niph.go.jp			Hokkaido University	This study was funded by Hokkaido University. We thank the public authorities of Iwanai and Tomamae, Hokkaido, Japan, for their cooperation.	Al Snih Soham, 2004, Aging Clin Exp Res, V16, P481; Gill TM, 2009, J AM GERIATR SOC, V57, P1850, DOI 10.1111/j.1532-5415.2009.02443.x; Moriya S, 2009, INT DENT J, V59, P369, DOI 10.1922/IDJ_2323Moriya07; Krall E, 1998, J AM DENT ASSOC, V129, P1261; Bracco P, 2004, NEUROSCI LETT, V356, P228, DOI 10.1016/j.neulet.2003.11.055; Yamaga T, 2002, J GERONTOL A-BIOL, V57, pM616; Moriya S, 2011, J ORAL REHABIL, V38, P674, DOI 10.1111/j.1365-2842.2011.02207.x; Lund JP, 2006, DYSPHAGIA, V21, P167, DOI 10.1007/s00455-006-9027-6; Visser M, 2005, AM J CLIN NUTR, V82, P531; Takata Y, 2004, ORAL DIS, V10, P44, DOI 10.1046/j.1354-523X.2003.00972.x; Gangloff P, 2000, NEUROSCI LETT, V293, P203, DOI 10.1016/S0304-3940(00)01528-7; WOLFSON L, 1994, J GERONTOL, V49, pM160; Holm-Pedersen P, 2008, J AM GERIATR SOC, V56, P429, DOI 10.1111/j.1532-5415.2007.01602.x; Campbell WW, 2001, J GERONTOL A-BIOL, V56, pM373; Morris M, 2004, AUST J PHYSIOTHER, V50, P153; Shinkai S, 2000, AGE AGEING, V29, P441, DOI 10.1093/ageing/29.5.441; APPENTENG K, 1982, J NEUROPHYSIOL, V48, P27; Arbuckle JL, 1995, GETTING STARTED AM 1, P1; GOODWIN GM, 1975, J NEUROPHYSIOL, V38, P560; LUND JP, 1979, J PHYSIOL-LONDON, V293, pP38; Masuda Y, 1997, J NEUROPHYSIOL, V77, P2227; Moriya S, 2010, INT J GERONTOL, V4, P89; N'gom Papa Ibrahima, 2002, J Prosthet Dent, V87, P667, DOI 10.1067/mpr.2002.123229; Newman AB, 2005, AM J CLIN NUTR, V82, P872; OLSSON KA, 1988, J NEUROPHYSIOL, V59, P341; Sasaki K, 2002, J JPN PROSTHODONT SO, V46, P463; Schermelleh-Engel K., 2003, METHODS PSYCHOL RES, V8, P23; TAYLOR A, 1981, CAN J PHYSIOL PHARM, V59, P636; Yoshida M, 2005, J AM GERIATR SOC, V53, P1631, DOI 10.1111/j.1532-5415.2005.53487_1.x	29	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0734-0664	1741-2358		GERODONTOLOGY	Gerodontology	DEC	2014	31	4					281	287		10.1111/ger.12036		7	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	Dentistry, Oral Surgery & Medicine; Geriatrics & Gerontology	AU5FS	WOS:000345633200008		
J	Torii, T; Yoshimura, T; Narumi, M; Hitoshi, S; Takaki, Y; Tsuji, S; Ikenaka, K				Torii, Tomohiro; Yoshimura, Takeshi; Narumi, Mai; Hitoshi, Seiji; Takaki, Yoshie; Tsuji, Shuichi; Ikenaka, Kazuhiro			Determination of major sialylated N-glycans and identification of branched sialylated N-glycans that dynamically change their content during development in the mouse cerebral cortex	GLYCOCONJUGATE JOURNAL			English	Article						Sialylated N-glycan; Mouse brain development; Pyridylamination; Siglec	LINKED SUGAR CHAINS; CARBOHYDRATE MOIETIES; CELL-INTERACTIONS; HUMAN-MILK; RAT-BRAIN; TISSUE; DIFFERENTIATION; COMPLEX; BINDING; MYELIN	Oligosaccharides of glycoproteins expressed on the cell surface play important roles in cell-cell interactions, particularly sialylated N-glycans having a negative charge, which interact with sialic acid-binding immunoglobulin-like lectins (siglecs). The entire structure of sialylated N-glycans expressed in the mouse brain, particularly the linkage type of sialic acid residues attached to the backbone N-glycans, has not yet been elucidated. An improved method to analyze pyridylaminated sugar chains using high performance liquid chromatography (HPLC) was developed to determine the entire structure of sialylated N-linked sugar chains expressed in the adult and developing mouse cerebral cortices. Three classes of sialylated sugar chains were prevalent: 1) N-glycans containing alpha(2-3)-sialyl linkages on a type 2 antennary (Gal beta(1-4)GlcNAc), 2) sialylated N-glycans with alpha(2-6)-sialyl linkages on a type 2 antennary, and 3) a branched sialylated N-glycan with a [Gal beta(1-3){NeuAc alpha(2-6)}GlcNAc-] structure, which was absent at embryonic day 12 but then increased during development. This branched type sialylated N-glycan structure comprised approximately 2 % of the total N-glycans in the adult brain. Some N-glycans (containing type 2 antennary) were found to change their type of sialic acid linkage from alpha(2-6)-Gal to alpha(2-3)-Gal. Thus, the linkages and expression levels of sialylated N-glycans change dramatically during brain development.	[Torii, Tomohiro; Yoshimura, Takeshi; Narumi, Mai; Hitoshi, Seiji; Ikenaka, Kazuhiro] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Physiol Sci, Hayama, Kanagawa 2400193, Japan; [Torii, Tomohiro; Yoshimura, Takeshi; Narumi, Mai; Hitoshi, Seiji; Ikenaka, Kazuhiro] Natl Inst Nat Sci, Natl Inst Physiol Sci, Div Neurobiol & Bioinformat, Okazaki, Aichi 4448787, Japan; [Takaki, Yoshie; Tsuji, Shuichi] Tokai Univ, Inst Glycosci, Hiratsuka, Kanagawa 2591292, Japan	Ikenaka, K (reprint author), Natl Inst Nat Sci, Natl Inst Physiol Sci, Div Neurobiol & Bioinformat, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi 4448787, Japan.	ikenaka@nips.ac.jp			Japan Society for the Promotion of Science (JSPS), KAKENHI [21700420]	We thank: Dr. T. Toda (Research Team for Molecular Biomarkers, Tokyo Metropolitan Institute of Gerontology) and Dr. H. Yagi (Graduate School of Pharmaceutical Sciences, Nagoya City University) for helpful advice on MALDI/TOF-MS analysis; Mr. Y. Kano, Ms. T. Koike and Ms. I. Itoh for their technical assistance; the Functional Genomics Facility in the National Institute for Basic Biology for use of equipment. This work was supported in part by Grants-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (JSPS), KAKENHI Grant Number 21700420.	Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Yoshimura T, 2012, ANAL BIOCHEM, V423, P253, DOI 10.1016/j.ab.2012.01.023; HASE S, 1994, METHOD ENZYMOL, V230, P225; Crocker PR, 2002, CURR OPIN STRUC BIOL, V12, P609, DOI 10.1016/S0959-440X(02)00375-5; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; Attrill H, 2006, BIOCHEM J, V397, P271, DOI 10.1042/BJ20060103; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; Dallerac G, 2013, NEUROCHEM RES, V38, P1163, DOI 10.1007/s11064-013-1007-2; Yu RK, 2009, J LIPID RES, V50, pS440, DOI 10.1194/jlr.R800028-JLR200; Audry M, 2011, GLYCOBIOLOGY, V21, P716, DOI 10.1093/glycob/cwq189; Bao GM, 2010, BIOORGAN MED CHEM, V18, P3760, DOI 10.1016/j.bmc.2010.04.067; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Ishii A, 2007, GLYCOBIOLOGY, V17, P261, DOI 10.1093/glycob/cwl076; Muhlenhoff M, 2013, NEUROCHEM RES, V38, P1134, DOI 10.1007/s11064-013-0979-2; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; MIZUOCHI T, 1983, J BIOL CHEM, V258, P6020; Ngamukote S, 2007, J NEUROCHEM, V103, P2327, DOI 10.1111/j.1471-4159.2007.04910.x; Bakhti M, 2013, P NATL ACAD SCI USA, V110, P3143, DOI 10.1073/pnas.1220104110; Eggers K, 2011, J CELL SCI, V124, P3279, DOI 10.1242/jcs.084863; FISCHER E, 1995, GLYCOCONJUGATE J, V12, P707, DOI 10.1007/BF00731268; Fujimoto I, 1999, ANAL BIOCHEM, V267, P336, DOI 10.1006/abio.1998.2968; HASE S, 1988, J CHROMATOGR-BIOMED, V434, P51, DOI 10.1016/0378-4347(88)80061-6; KRUSIUS T, 1977, EUR J BIOCHEM, V78, P369, DOI 10.1111/j.1432-1033.1977.tb11749.x; MIYOSHI E, 1993, CANCER RES, V53, P3899; MIZUOCHI T, 1980, J BIOL CHEM, V255, P3526; MIZUOCHI T, 1979, J BIOL CHEM, V254, P6419; Otake Y, 2001, J BIOCHEM-TOKYO, V129, P537; PRIETO PA, 1985, ARCH BIOCHEM BIOPHYS, V241, P281, DOI 10.1016/0003-9861(85)90384-4; Schachner M, 2000, GLIA, V29, P154, DOI 10.1002/(SICI)1098-1136(20000115)29:2<154::AID-GLIA9>3.0.CO;2-3; SCHENGRUND CL, 1990, BRAIN RES BULL, V24, P131, DOI 10.1016/0361-9230(90)90297-D; SMITH DF, 1978, ANAL BIOCHEM, V85, P602, DOI 10.1016/0003-2697(78)90261-0; Tanabe K, 2006, ANAL BIOCHEM, V348, P324, DOI 10.1016/j.ab.2005.10.035; Vyas AA, 2005, J BIOL CHEM, V280, P16305, DOI 10.1074/jbc.M500250200; Yamaji T, 2002, J BIOL CHEM, V277, P6324, DOI 10.1074/jbc.M110146200; Zamze S, 1998, EUR J BIOCHEM, V258, P243, DOI 10.1046/j.1432-1327.1998.2580243.x	36	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0282-0080	1573-4986		GLYCOCONJUGATE J	Glycoconjugate J.	DEC	2014	31	9					671	683		10.1007/s10719-014-9566-2		13	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AU4NQ	WOS:000345588700007		
J	Katagiri, J; Matsushima, T; Yamada, Y				Katagiri, Jun; Matsushima, Takashi; Yamada, Yasuo			Variations in shear behavior among specimens with different packing patterns	GRANULAR MATTER			English	Article						DEM; Multi-sphere model; Specimen preparation method; Simple shear; Coordination number	DISCRETE ELEMENT SIMULATIONS; GRANULAR-MATERIALS; STRESS TRANSMISSION; PARTICLE-SHAPE; MODEL; DEM; ASSEMBLIES; GENERATION; ARRAYS; MICROSTRUCTURE	This paper describes variations in shear behavior among specimens with the same packing fraction but different coordination number (different packing patterns). The multi-sphere models to express grain shapes of Toyoura sand were employed in discrete-element method (DEM) simulation. Specimens with different packing patterns were produced by two methods: changing interparticle friction angle (FC method) and applying cyclic simple shear (CC method). A series of simple shear DEM simulation was carried out using the FC and CC specimens. The shear response in small strain range (secant shear modulus) of FC was larger than CC specimens, while difference in peak shear stress (bulk shear friction) between FC and CC specimens were insignificant. Strong correlation was found in the relation between secant shear modulus and coordination number of the system, as well as between the bulk shear friction and packing fraction. The initial coordination number rapidly decreases with increasing shear strain, and thereafter it reaches an isostatic value. On the other hand, the packing density required large shear strain for reaching the critical state. It was found that the initial difference in coordination number between FC and CC specimens disappeared before reaching their bulk shear frictions. Therefore, the bulk shear friction strongly correlates with the packing density.	[Katagiri, Jun] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Matsushima, Takashi; Yamada, Yasuo] Univ Tsukuba, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki, Japan	Katagiri, J (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan.	j-katagiri@aist.go.jp					Stahl M, 2011, GRANUL MATTER, V13, P417, DOI 10.1007/s10035-010-0239-y; ROTHENBURG L, 1992, GEOTECHNIQUE, V42, P79; Al-Raoush R, 2007, PHYSICA A, V377, P545, DOI 10.1016/j.physa.2006.11.090; Duttine A, 2008, SOILS FOUND, V48, P297, DOI 10.3208/sandf.48.297; Latham JP, 2008, MINER ENG, V21, P797, DOI 10.1016/j.mineng.2008.05.015; Matsushima T, 2011, GRANUL MATTER, V13, P269, DOI 10.1007/s10035-011-0263-6; Bagi K, 2005, GRANUL MATTER, V7, P31, DOI 10.1007/s10035-004-0187-5; CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47; Ball RC, 2001, PHYSICA A, V292, P167, DOI 10.1016/S0378-4371(00)00580-X; Jiang MJ, 2003, COMPUT GEOTECH, V30, P579, DOI [10.1016/S0266-352X(03)00064-8, 10.1016/S0266-325X(03)00064-8]; Garcia X, 2009, GEOTECHNIQUE, V59, P779, DOI 10.1680/geot.8.T.037; Song C, 2008, NATURE, V453, P629, DOI 10.1038/nature06981; Lu M, 2007, GRANUL MATTER, V9, P69, DOI 10.1007/s10035-006-0021-3; Al-Raoush R, 2006, PHYSICA A, V361, P441, DOI 10.1016/j.physa.2005.05.043; Wood DM, 2008, ACTA GEOTECH, V3, P3, DOI 10.1007/s11440-007-0041-0; Mollon G, 2012, GRANUL MATTER, V14, P621, DOI 10.1007/s10035-012-0356-x; Smith WO, 1929, PHYS REV, V34, P1271, DOI 10.1103/PhysRev.34.1271; Lin X, 1997, GEOTECHNIQUE, V47, P319; Feng YT, 2003, INT J NUMER METH ENG, V56, P699, DOI 10.1002/nme.583; Nezami EG, 2006, INT J NUMER ANAL MET, V30, P783, DOI 10.1002/nag.500; Oda M, 1998, GEOTECHNIQUE, V48, P465; Katagiri J, 2010, GRANUL MATTER, V12, P491, DOI 10.1007/s10035-010-0207-6; Favier JF, 1999, ENG COMPUTATION, V16, P467, DOI 10.1108/02644409910271894; EDWARDS SF, 1989, PHYSICA D, V38, P88, DOI 10.1016/0167-2789(89)90176-0; Edwards SF, 1999, PHYS REV LETT, V82, P5397, DOI 10.1103/PhysRevLett.82.5397; Matsushima T, 2009, J AEROSPACE ENG, V22, P15, DOI 10.1061/(ASCE)0893-1321(2009)22:1(15); Benabbou A, 2009, INT J NUMER METH ENG, V80, P425, DOI 10.1002/nme.2644; CHANG CS, 1995, INT J SOLIDS STRUCT, V32, P1989, DOI 10.1016/0020-7683(94)00225-L; CHANG CS, 1990, J ENG MECH-ASCE, V116, P2310, DOI 10.1061/(ASCE)0733-9399(1990)116:10(2310); Cui L, 2003, GRANUL MATTER, V5, P135, DOI 10.1007/s10035-003-0145-7; CUNDALL PA, 1988, INT J ROCK MECH MIN, V25, P107, DOI 10.1016/0148-9062(88)92293-0; Fukushima S., 1984, SOILS FOUND, V24, P30, DOI DOI 10.3208/SANDF1972.24.4_; MiDi GDR, 2004, EUR PHYS J E, V14, P341, DOI 10.1140/epje/i2003-10153-0; Goncu F, 2013, ACTA GEOTECH, V8, P629, DOI 10.1007/s11440-013-0258-z; Imam S.M.R., 2001, SOILS FOUND, V51, P619; Iwasaki T., 1977, SOILS FOUND, V17, P19, DOI DOI 10.3208/SANDF1972. 17. 3_19; Iwasaki T., 1978, SOILS FOUND, V18, P39, DOI DOI 10.3208/SANDF1972.18.39; Katagiri J., 2012, THESIS U TSKUBA; Katagiri J., 2012, J JSCE, V68, P67; Katagiri J, 2015, J AEROSPACE ENG, V28, DOI 10.1061/(ASCE)AS.1943-5525.0000421; Kokusho T., 1980, SOILS FOUND, V20, P45; Liu J, 2012, INT J NUMER ANAL MET, V36, P653, DOI 10.1002/nag.1088; Ludewig F, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.051307; Maeda K, 2010, GRANUL MATTER, V12, P499, DOI 10.1007/s10035-010-0208-5; Matsushima T., 2008, J APPL MECH JSCE, V11, P507; Mogami T, 1969, SOIL MECH; Oda M, 1977, SOILS FOUND, V17, P163; OSullivan C, 2011, APPL GEOTECH, V4, P1; Pradhan T. B. S., 1988, SOILS FOUND, V28, P131; Saint-Cyr E., 2011, P PART BAS METH 2 FU, P427; Saomoto H., 2002, P NUMGE2002 NUM METH, P239; Schofield A. N., 1968, CRITICAL STATE SOIL; Shahnazari H, 2002, SOILS FOUND, V42, P105; Tatsuoka F., 1998, SOILS FOUND, V38, P163; Tatsuoka F., 1986, SOILS FOUND, V26, P30; Vincens E, 2015, ACTA GEOTECH, V10, P291, DOI 10.1007/s11440-014-0308-1	56	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1434-5021	1434-7636		GRANUL MATTER	Granul. Matter	DEC	2014	16	6					891	901		10.1007/s10035-014-0530-4		11	Materials Science, Multidisciplinary; Mechanics; Physics, Applied	Materials Science; Mechanics; Physics	AU1KD	WOS:000345378600006		
J	Inoue, K; Murakawa, Y; Nogami, A; Shoda, M; Naito, S; Kumagai, K; Miyauchi, Y; Yamane, T; Morita, N; Okumura, K				Inoue, Koichi; Murakawa, Yuji; Nogami, Akihiko; Shoda, Morio; Naito, Shigeto; Kumagai, Koichiro; Miyauchi, Yasushi; Yamane, Teiichi; Morita, Norishige; Okumura, Ken		Japanese Heart Rhythm Soc Members	Clinical and procedural predictors of early complications of ablation for atrial fibrillation: Analysis of the national registry data	HEART RHYTHM			English	Article						Atrial fibrillation; Catheter ablation; Complication; Deep sedation; Novel oral anticoagulant	MULTICENTER PROSPECTIVE REGISTRY; HIGH-VOLUME CENTER; CATHETER ABLATION; SAFETY	BACKGROUND The risk assessment of the complication from atrial fibrillation (AF) ablation is important and needs to be updated. OBJECTIVE The purpose of this study was to investigate the clinical and procedural factors associated with AF ablation-related early complications. METHODS The Japanese Heart Rhythm Society invited electrophysiology centers in Japan to register data regarding all AF ablation procedures performed in September 2011, March 2012, and September 2012. Of the 46 putative predictors assessed in the univariate analysis, significant variables (P < .1) were entered into a stepwise logistic regression model for multivariate analysis. RESULTS Data for 3373 cases were submitted by 165 centers, with 158 early complications reported in 151 patients (4.5%). We identified 13 significant variables in the univariate analysis. Multivariate analysis revealed that 8 (62%) of them were independent predictors of early complications. Female sex (odds ratio and 95% confidence interval 1.6; 1.13-2.27), hypertrophic cardiomyopathy (2.2; 1.08-4.5), valvular heart disease (2.53; 1.28-5.05), deep sedation during the procedure (1.53; 1.09-2.12), and complex fractionated atrial electrocardiogram ablation (1.88; 1.23-2.87) increased early complications. Preprocedural transesophageal echocardiography (0.63; 0.43-0.92), irrigated-tip catheter use (0.46; 0.3-0.69), and periprocedural novel oral anticoagulant use (0.55; 0.32-0.97) decreased them. CONCLUSION The risk of early complications is increased by female sex, hypertrophic cardiomyopathy, valvular heart disease, deep sedation, and complex fractionated atrial electrocardiogram ablation. It is decreased by preprocedural transesophageal echocardiography, periprocedural novel oral anticoagulant, and irrigated-tip catheter use.	[Inoue, Koichi] Sakurabashi Watanabe Hosp, Ctr Cardiovasc, Osaka 5300001, Japan; [Murakawa, Yuji] Teikyo Univ, Mizonokuchi Hosp, Dept Internal Med, Kawasaki, Kanagawa, Japan; [Nogami, Akihiko] Univ Tsukuba, Fac Med, Div Cardiovasc, Tsukuba, Ibaraki, Japan; [Shoda, Morio] Tokyo Womens Med Univ, Dept Cardiol, Tokyo, Japan; [Naito, Shigeto] Gunma Prefectural Cardiovasc Ctr, Div Cardiol, Maebashi, Gumma, Japan; [Kumagai, Koichiro] Fukuoka Sanno Hosp, Heart Rhythm Ctr, Fukuoka, Japan; [Miyauchi, Yasushi] Nippon Med Sch, Dept Cardiovasc Med, Tokyo 113, Japan; [Yamane, Teiichi] Jikei Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Morita, Norishige] Tokai Univ, Hachioji Hosp, Dept Med, Div Cardiol, Hachioji, Tokyo, Japan; [Okumura, Ken] Hirosaki Univ, Grad Sch Med, Div Cardiol, Hirosaki, Aomori, Japan	Inoue, K (reprint author), Sakurabashi Watanabe Hosp, Ctr Cardiovasc, Kita Ku, 2-4-32 Umeda, Osaka 5300001, Japan.	koichi@inoue.name					Aldhoon B, 2013, EUROPACE, V15, P24, DOI 10.1093/europace/eus304; Bertaglia E, 2007, HEART RHYTHM, V4, P1265, DOI 10.1016/j.hrthm.2007.06.016; Spragg DD, 2008, J CARDIOVASC ELECTR, V19, P627, DOI 10.1111/j.1540-8167.2008.01181.x; Dagres N, 2009, J CARDIOVASC ELECTR, V20, P1014, DOI 10.1111/j.1540-8167.2009.01493.x; Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098; Cappato R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P32, DOI 10.1161/CIRCEP.109.859116; Inoue K, 2014, CIRC J, V78, P1112, DOI 10.1253/circj.CJ-13-1179; Hoyt H, 2011, HEART RHYTHM, V8, P1869, DOI 10.1016/j.hrthm.2011.07.025; Thomas SP, 2004, EUROPACE, V6, P330, DOI 10.1016/j.eupc.2004.03.001; Shah RU, 2012, J AM COLL CARDIOL, V59, P143, DOI 10.1016/j.jacc.2011.08.068; Lakkireddy D, 2012, J AM COLL CARDIOL, V59, P1168, DOI 10.1016/j.jacc.2011.12.014; Masuda M, 2012, PACE, V35, P327, DOI 10.1111/j.1540-8159.2011.03284.x; Bohnen M, 2011, HEART RHYTHM, V8, P1661, DOI 10.1016/j.hrthm.2011.05.017; Li WJ, 2011, CIRC-ARRHYTHMIA ELEC, V4, P143, DOI 10.1161/CIRCEP.110.958405; Baman TS, 2011, J CARDIOVASC ELECTR, V22, P626, DOI 10.1111/j.1540-8167.2010.01995.x; Bertaglia E, 2013, J CARDIOVASC ELECTR, V24, P1069, DOI 10.1111/jce.12194; Inoue K., 2013, J ARRHYTHMIA, V29, P221; Murakawa Y, 2012, J ARRHYTHMIA, V28, P122; Murakawa Y, J ARRHYTHM IN PRESS; Murakawa Y, 2012, J ARRHYTHMIA, V28, P202	20	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1547-5271	1556-3871		HEART RHYTHM	Heart Rhythm	DEC	2014	11	12					2247	2253		10.1016/j.hrthm.2014.08.021		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AU1SM	WOS:000345400500019		
J	Aizawa, Y; Sato, M; Ohno, S; Hone, M; Takatsuki, S; Fukuda, K; Chinushi, M; Usui, T; Aonuma, K; Hosaka, Y; Haissaguerre, M; Aizawa, Y				Aizawa, Yoshiyasu; Sato, Masahito; Ohno, Seiko; Hone, Minoru; Takatsuki, Seiji; Fukuda, Keiichi; Chinushi, Masaomi; Usui, Tatsuya; Aonuma, Kazutaka; Hosaka, Yukio; Haissaguerre, Michel; Aizawa, Yoshifusa			Circadian pattern of fibrillatory events in non-Brugada-type idiopathic ventricular fibrillation with a focus on J waves	HEART RHYTHM			English	Article						Idiopathic ventricular fibrillation; Circadian rhythm; J waves; Ventricular fibrillation; Sudden cardiac death	SUDDEN CARDIAC DEATH; EARLY REPOLARIZATION PATTERN; ST SEGMENT ELEVATION; BUNDLE-BRANCH BLOCK; QT SYNDROME; AUGMENTATION; CHANNEL; METAANALYSIS; MUTATIONS; SURVIVORS	BACKGROUND The circadian pattern of ventricular fibrillation (VF) episodes in patients with idiopathic ventricular fibrillation (IVF) is poorly understood. OBJECTIVE The purpose of this study was to assess the circadian pattern of VF occurrence in patients with IVF. METHODS Excluding Brugada syndrome and other primary electrical diseases, the circadian pattern of VF occurrence was determined in 64 patients with IVF. The clinical and electrocardiographic characteristics were compared among patients with nocturnal (midnight to 6:00 AM) VF and nonnocturnal VF in relation to 3 waves. A 3 wave was defined as either notching or a slur at the QRS terminal >0.1 mV above the isoelectric line in contiguous leads. RESULTS The overall distribution pattern of VF occurrence showed 2 peaks at approximately 6:00 AM and around 8:00 PM, Nocturnal VF was observed in 20 patients (31.3%), and J waves were present in 14 of these 20 individuals (70.0%), whereas 3 waves were less frequent in the 44 nonnocturnal patients with VF: 16 (36.4%) (P = .0117). Among patients with J waves, nocturnal VF was observed in 46.7% with a peak at approximately 4:00 AM. Nocturnal VF was Less common in patients without 3 waves, occurring in only 17.6% (P = .0124). Both the type and Location of J waves and the pattern of the ST segment were similar between the nocturnal and nonnocturnal VF groups. 3 waves were associated with a VF storm and Long-term arrhythmia recurrence. CONCLUSION In IVF, the presence of J waves may characterize a higher nocturnal incidence of VF and a higher acute and chronic risk of recurrence.	[Aizawa, Yoshiyasu; Takatsuki, Seiji; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo 1608582, Japan; [Sato, Masahito; Aizawa, Yoshifusa] Tachikawa Gen Hosp, Dept Cardiol, Niigata, Japan; [Ohno, Seiko; Hone, Minoru] Shiga Univ Med Sci Shiga, Dept Cardiovasc & Resp Med, Shiga, Japan; [Chinushi, Masaomi] Niigata Univ, Sch Med, Grad Sch Hlth Sci, Niigata, Japan; [Usui, Tatsuya] Nagano Red Cross Hosp, Dept Cardiol, Nagano, Japan; [Aonuma, Kazutaka] Univ Tsukuba, Fac Med, Div Cardiovasc, Ibaraki, Japan; [Hosaka, Yukio] Niigata City Hosp, Dept Cardiol, Niigata, Japan; [Haissaguerre, Michel] Hop Cardiol Haut Leveque, Bordeaux, France	Aizawa, Y (reprint author), Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	yoshiyaaizawa-circ@umin.ac.jp	Fukuda, Keiichi/L-3777-2013		Research Fund of Tachikawa Medical Center; MEXT KAKENHI [26461087]; Ministry of Health, Labor and Welfare of Japan for Clinical Research on Intractable Diseases [H26-040]	This work was supported by the Research Fund of Tachikawa Medical Center (to Dr Aizawa), by MEXT KAKENHI (grant no. 26461087, to Dr Aizawa), and by grants from the Ministry of Health, Labor and Welfare of Japan for Clinical Research on Intractable Diseases (grant no. H26-040, to Dr Fukuda).	Wilde AAM, 2010, J MOL CELL CARDIOL, V49, P543, DOI 10.1016/j.yjmcc.2010.07.012; Mizumaki K, 2012, HEART RHYTHM, V9, P249, DOI 10.1016/j.hrthm.2011.09.055; Schwartz PJ, 2013, EUR HEART J, V34, P3109, DOI 10.1093/eurheartj/eht089; Rosso R, 2012, HEART RHYTHM, V9, P225, DOI 10.1016/j.hrthm.2011.09.012; Haissaguerre M, 2009, J AM COLL CARDIOL, V53, P612, DOI 10.1016/j.jacc.2008.10.044; Yan GX, 1996, CIRCULATION, V93, P372; Noseworthy PA, 2011, J AM COLL CARDIOL, V57, P2284, DOI 10.1016/j.jacc.2011.04.003; Burashnikov E, 2010, HEART RHYTHM, V7, P1872, DOI 10.1016/j.hrthm.2010.08.026; MULLER JE, 1987, CIRCULATION, V75, P131; Surawicz B, 2011, J AM COLL CARDIOL, V57, P1584, DOI 10.1016/j.jacc.2010.11.040; Abe A, 2010, HEART RHYTHM, V7, P675, DOI 10.1016/j.hrthm.2010.01.023; Cohen MC, 1997, AM J CARDIOL, V79, P1512; Aizawa Y, 2013, HEART RHYTHM, V10, P1028, DOI 10.1016/j.hrthm.2013.03.013; Aizawa Y, 2012, J AM COLL CARDIOL, V59, P1948, DOI 10.1016/j.jacc.2012.02.028; Miyazaki H, 2013, CIRC J, V77, P330, DOI 10.1253/circj.CJ-12-0749; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391; Tikkanen JT, 2011, CIRCULATION, V123, P2666, DOI 10.1161/CIRCULATIONAHA.110.014068; Fujiki A, 1999, J CARDIOVASC ELECTR, V10, P214, DOI 10.1111/j.1540-8167.1999.tb00662.x; Haissaguerre M, 2009, J CARDIOVASC ELECTR, V20, P93, DOI 10.1111/j.1540-8167.2008.01326.x; Aizawa Y, 2013, J AM COLL CARDIOL, V62, P1015, DOI 10.1016/j.jacc.2013.05.030; Rosso R, 2008, J AM COLL CARDIOL, V52, P1231, DOI 10.1016/j.jacc.2008.07.010; Kim SH, 2012, J CARDIOVASC ELECTR, V23, P757, DOI 10.1111/j.1540-8167.2011.02287.x; AIZAWA Y, 1993, AM HEART J, V126, P1473, DOI 10.1016/0002-8703(93)90550-S; Matsuo K, 1999, EUR HEART J, V20, P465, DOI 10.1053/euhj.1998.1332; Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968; Nam GB, 2010, EUR HEART J, V31, P330, DOI 10.1093/eurheartj/ehp423; Antzelevitch C, 2007, AM J PHYSIOL-HEART C, V293, pH2024, DOI 10.1152/ajpheart.00355.2007; BELHASSEN B, 1993, J CARDIOVASC ELECTR, V4, P356, DOI 10.1111/j.1540-8167.1993.tb01236.x; Fukuyama M, 2013, CIRC J, V77, P1799, DOI 10.1253/circj.CJ-12-1457; IGARASHI Y, 1993, CORONARY ARTERY DIS, V4, P177, DOI 10.1097/00019501-199302000-00008; Lavery CE, 1997, CIRCULATION, V96, P3321; Myerburg RJ, 1992, HEART DIS TXB CARDIO, P756; Nam GB, 2008, NEW ENGL J MED, V358, P2078, DOI 10.1056/NEJMc0708182; Patel C, 2010, CIRC-ARRHYTHMIA ELEC, V3, P401, DOI 10.1161/CIRCEP.109.921056; Sinner MF, 2012, HEART RHYTHM, V9, P1627, DOI 10.1016/j.hrthm.2012.06.008; Viskin S, 2000, HEART, V84, P31, DOI 10.1136/heart.84.1.31	36	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1547-5271	1556-3871		HEART RHYTHM	Heart Rhythm	DEC	2014	11	12					2261	2266		10.1016/j.hrthm.2014.08.022		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AU1SM	WOS:000345400500021		
J	Balwani, M; Burton, B; Baric, I; Bialer, M; Burrow, TA; Grande, CC; Coker, M; Sanchez, AC; Deegan, P; Di Rocco, M; Enns, GM; Erbe, RW; Ezgu, FS; Feillet, F; Ficicioglu, C; Furuya, KN; Guelbert, NB; Kane, J; Kostyleva, M; Laukaitis, CM; Malinova, V; Mengel, E; Murphy, E; Neilan, EG; Nightingale, S; Rosado, JP; Peters, H; Rahman, Y; Scarpa, M; Schwab, KO; Smolka, V; Taybert, J; Valayannopoulos, V; Wood, M; Zeniya, M; Yang, YJ; Eckert, S; Rojas-Caro, S; Quinn, AG				Balwani, Manisha; Burton, Barbara; Baric, Ivo; Bialer, Martin; Burrow, Thomas A.; Camarena Grande, Carmen; Coker, Mahmut; Consuelo Sanchez, Alejandra; Deegan, Patrick; Di Rocco, Maja; Enns, Gregory M.; Erbe, Richard W.; Ezgu, Fatih Suheyl; Feillet, Francois; Ficicioglu, Can; Furuya, Katryn N.; Bernardo Guelbert, Norberto; Kane, John; Kostyleva, Maria; Laukaitis, Christina M.; Malinova, Vera; Mengel, Eugen; Murphy, Elaine; Neilan, Edward G.; Nightingale, Scott; Pastor Rosado, Jose; Peters, Heidi; Rahman, Yusof; Scarpa, Maurizio; Schwab, Karl Otfried; Smolka, Vratislav; Taybert, Joanna; Valayannopoulos, Vassili; Wood, Marnie; Zeniya, Mikio; Yang, Yijun; Eckert, Stephen; Rojas-Caro, Sandra; Quinn, Anthony G.			Results of a Global Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Sebelipase Alfa as an Enzyme Replacement Therapy in Children and Adults with Lysosomal Acid Lipase Deficiency	HEPATOLOGY			English	Meeting Abstract									[Yang, Yijun; Eckert, Stephen; Rojas-Caro, Sandra; Quinn, Anthony G.] Synageva BioPharma Corp, R&D, Lexington, MA USA; [Balwani, Manisha] Mt Sinai Sch Med, New York, NY USA; [Burton, Barbara] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Burton, Barbara] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp, Chicago, IL 60611 USA; [Baric, Ivo] Univ Hosp Ctr, Zagreb, Croatia; [Bialer, Martin] North Shore Long Isl Jewish, Manhasset, NY USA; [Burrow, Thomas A.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Camarena Grande, Carmen] Hosp Univ La Paz, La Paz, Bolivia; [Coker, Mahmut] Ege Univ, Fac Med, Izmir, Turkey; [Consuelo Sanchez, Alejandra] Hosp Infantil Mexico Dr Federico Gomez, Mexico City, DF, Mexico; [Deegan, Patrick] Cambridge Univ Hosp, Cambridge, England; [Di Rocco, Maja] Inst G Gaslini, Genoa, Italy; [Enns, Gregory M.] Stanford Univ, Palo Alto, CA 94304 USA; [Erbe, Richard W.] Womens & Childrens Hosp Buffalo, Buffalo, NY USA; [Ezgu, Fatih Suheyl] Gazi Univ, Fac Med, Ankara, Turkey; [Feillet, Francois] Hop Enfants, CHU Brabois, Vandoeuvre Les Nancy, France; [Ficicioglu, Can] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Furuya, Katryn N.] Nemours Fdn, Alfred I DuPont Hosp Children, Wilmington, DE USA; [Bernardo Guelbert, Norberto] Hosp Ninos Cordoba Santisima Trinidad, Cordoba, Argentina; [Kane, John] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Kostyleva, Maria] Russian Childrens Clin Hosp, Fed State Inst, Moscow, Russia; [Laukaitis, Christina M.] Univ Arizona, Ctr Canc, Tucson, AZ USA; [Malinova, Vera] Charles Univ Prague, Fac Med 1, Prague 2, Czech Republic; [Mengel, Eugen] Johannes Gutenberg Univ Mainz, D-55122 Mainz, Germany; [Murphy, Elaine] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; [Neilan, Edward G.] Boston Childrens Hosp, Boston, MA USA; [Nightingale, Scott] Hunter Childrens Hosp, New Lambton, NSW, Australia; [Pastor Rosado, Jose] Hosp Gen Univ Elche, Elche, Spain; [Peters, Heidi] Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Rahman, Yusof] Guys & St Thomas Hosp NHS Fdn Trust, London, England; [Scarpa, Maurizio] Univ Padua, Padua, Italy; [Schwab, Karl Otfried] Univ Hosp Freiburg, Freiburg, Germany; [Smolka, Vratislav] Palacky Univ, Fac Hosp, CR-77147 Olomouc, Czech Republic; [Taybert, Joanna] Inst Pomnik Ctr Zdrowia Dziecka, Warsaw, Poland; [Valayannopoulos, Vassili] Univ Hop Necker Enfants Malad, Paris, France; [Valayannopoulos, Vassili] IMAGINE Inst, Paris, France; [Wood, Marnie] Royal Brisbane Hosp, Brisbane, Qld 4029, Australia; [Zeniya, Mikio] Jikei Univ Hosp, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-9139	1527-3350		HEPATOLOGY	Hepatology	DEC	2014	60	6				LB-5	1270A	1270A				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AU3MI	WOS:000345517000006		
J	Hayashi, H; Naoi, S; Hirose, Y; Inoue, T; Hasegawa, Y; Kondou, H; Bessho, K; Tanikawa, K; Kage, M; Nagasaka, H; Inui, A; Kusuhara, H				Hayashi, Hisamitsu; Naoi, Sotaro; Hirose, Yu; Inoue, Takeshi; Hasegawa, Yasuhiro; Kondou, Hiroki; Bessho, Kazuhiko; Tanikawa, Ken; Kage, Masayoshi; Nagasaka, Hironori; Inui, Ayano; Kusuhara, Hiroyuki			Beneficial effects of 4-phenylbutylate therapy in patients with familial intrahepatic cholestasis	HEPATOLOGY			English	Meeting Abstract									[Hayashi, Hisamitsu; Naoi, Sotaro; Hirose, Yu; Kusuhara, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Inoue, Takeshi] Dokkyo Med Univ, Koshigaya Hosp, Dept Pediat, Saitama, Japan; [Hasegawa, Yasuhiro; Kondou, Hiroki; Bessho, Kazuhiko] Osaka Univ, Grad Sch Med, Dept Pediat, Osaka, Japan; [Tanikawa, Ken; Kage, Masayoshi] Kurume Univ Hosp, Dept Diagnost Pathol, Fukuoka, Japan; [Inui, Ayano] Saiseikai Yokohamashi Tobu Hosp, Dept Pediat Hepatol & Gastroenterol, Yokohama, Kanagawa, Japan; [Nagasaka, Hironori] Takarazuka City Hosp, Dept Pediat, Takarazuka, Hyogo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-9139	1527-3350		HEPATOLOGY	Hepatology	DEC	2014	60	6				LB-27	1283A	1283A				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AU3MI	WOS:000345517000028		
J	Kim, S; Date, T; Yokokawa, H; Kono, T; Aizaki, H; Maurel, P; Gondeau, C; Wakita, T				Kim, Sulyi; Date, Tomoko; Yokokawa, Hiroshi; Kono, Tamaki; Aizaki, Hideki; Maurel, Patrick; Gondeau, Claire; Wakita, Takaji			Development of Hepatitis C Virus Genotype 3a Cell Culture System	HEPATOLOGY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; INFECTION IN-VITRO; EFFICIENT REPLICATION; JFH-1 STRAIN; STEATOSIS; LIVER; CORE; 2A; MECHANISMS; REPLICON	Hepatitis C virus (HCV) genotype 3a infection poses a serious health problem worldwide. A significant association has been reported between HCV genotype 3a infections and hepatic steatosis. Nevertheless, virological characterization of genotype 3a HCV is delayed due to the lack of appropriate virus cell culture systems. In the present study, we established the first infectious genotype 3a HCV system by introducing adaptive mutations into the S310 strain. HCV core proteins had different locations in JFH-1 and S310 virus-infected cells. Furthermore, the lipid content in S310 virus-infected cells was higher than Huh7.5.1 cells and JFH-1 virus-infected cells as determined by the lipid droplet staining area. Conclusion: This genotype 3a infectious cell culture system may be a useful experimental model for studying genotype 3a viral life cycles, molecular mechanisms of pathogenesis, and genotype 3a-specific antiviral drug development.	[Kim, Sulyi; Date, Tomoko; Yokokawa, Hiroshi; Kono, Tamaki; Aizaki, Hideki; Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo 1628640, Japan; [Yokokawa, Hiroshi] Toray Industries Ltd, Pharmaceut Res Labs, Kamakura, Kanagawa, Japan; [Maurel, Patrick; Gondeau, Claire] Biotherapy Res Inst, Inserm U1040, Montpellier, France; [Gondeau, Claire] CHU Montpellier, Dept Hepatogastroenterol A, Hosp St Eloi, Montpellier, France	Wakita, T (reprint author), Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	wakita@nih.go.jp					Hui JM, 2002, J GASTROEN HEPATOL, V17, P873, DOI 10.1046/j.1440-1746.2002.02813.x; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kato T, 2007, J VIROL, V81, P4405, DOI 10.1128/JVI.02334-06; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Kumar D, 2002, HEPATOLOGY, V36, P1266, DOI 10.1053/jhep.2002.36370; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Videla LA, 2004, CLIN SCI, V106, P261, DOI 10.1042/CS20030285; Gastaminza P, 2010, J VIROL, V84, P10999, DOI 10.1128/JVI.00526-10; Saeed M, 2013, GASTROENTEROLOGY, V144, P56, DOI 10.1053/j.gastro.2012.09.017; Jackel-Cram C, 2007, J HEPATOL, V46, P999, DOI 10.1016/j.jhep.2006.10.019; Takeuchi T, 1999, GASTROENTEROLOGY, V116, P636, DOI 10.1016/S0016-5085(99)70185-X; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Rubbia-Brandt L, 2000, J HEPATOL, V33, P106, DOI 10.1016/S0168-8278(00)80166-X; Feld JJ, 2006, HEPATOLOGY, V43, pS194, DOI 10.1002/hep.21065; Gottwein JM, 2011, GASTROENTEROLOGY, V141, P1067, DOI 10.1053/j.gastro.2011.06.004; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Date T, 2007, HEPATOL RES, V37, P433, DOI 10.1111/j.1872-034X.2007.00056.x; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Mirandola S, 2006, GASTROENTEROLOGY, V130, P1661, DOI 10.1053/j.gastro.2006.02.035; Butt S, 2010, INFECT GENET EVOL, V10, P595, DOI 10.1016/j.meegid.2010.04.012; Date T, 2012, J VIROL, V86, P10805, DOI 10.1128/JVI.07235-11; Jhaveri R, 2008, J INFECT DIS, V197, P283, DOI 10.1086/524846; Jhaveri R, 2009, J INFECT DIS, V200, P1781, DOI 10.1086/648094; Ma ST, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-154; OLMSTEAD AD, 2012, PLOS PATHOG, V8; QIANG G, 2012, ISRN GASTROENTEROL, V2012; Rehman Irshad-Ur, 2011, Genet Vaccines Ther, V9, P2, DOI 10.1186/1479-0556-9-2; Saeed M, 2009, J CLIN MICROBIOL, V47, P4141, DOI 10.1128/JCM.01437-09; Saeed M, 2012, ANTIMICROB AGENTS CH, V56, P5365, DOI 10.1128/AAC.01256-12; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Wakita Takaji, 2009, V510, P305, DOI 10.1007/978-1-59745-394-3_23	36	7	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-9139	1527-3350		HEPATOLOGY	Hepatology	DEC	2014	60	6					1838	1850		10.1002/hep.27197		13	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AU3MI	WOS:000345517000049		
J	Dubois-Pot-Schneider, H; Fekir, K; Coulouarn, C; Glaise, D; Aninat, C; Jarnouen, K; Le Guevel, R; Kubo, T; Ishida, S; Morel, F; Corlu, A				Dubois-Pot-Schneider, Helene; Fekir, Karim; Coulouarn, Cedric; Glaise, Denise; Aninat, Caroline; Jarnouen, Kathleen; Le Guevel, Remy; Kubo, Takashi; Ishida, Seiichi; Morel, Fabrice; Corlu, Anne			Inflammatory Cytokines Promote the Retrodifferentiation of Tumor-Derived Hepatocyte-Like Cells to Progenitor Cells	HEPATOLOGY			English	Article							NF-KAPPA-B; ACETAMINOPHEN-INDUCED HEPATOTOXICITY; ALPHA-DEPENDENT APOPTOSIS; KINASE NIK; IKK-ALPHA; SIGNALING PATHWAY; LIVER; ACTIVATION; PHOSPHORYLATION; INJURY	Human hepatocellular carcinoma (HCC) heterogeneity promotes recurrence and resistance to therapies. Recent studies have reported that HCC may be derived not only from adult hepatocytes and hepatoblasts but also hepatic stem/progenitors. In this context, HepaRG cells may represent a suitable cellular model to study stem/progenitor cancer cells and the retrodifferentiation of tumor-derived hepatocyte-like cells. Indeed, they differentiate into hepatocyte-and biliary-like cells. Moreover, tumor-derived HepaRG hepatocyte-like cells (HepaRG-tdHep) differentiate into both hepatocyte-and biliary-like cells through a hepatic progenitor. In this study we report the mechanisms and molecular effectors involved in the retrodifferentiation of HepaRG-tdHep into bipotent progenitors. Gene expression profiling was used to identify genomic changes during the retrodifferentiation of HepaRG-tdHep into progenitors. We demonstrated that gene expression signatures related to a poor-prognosis HCC subclass, proliferative progenitors, or embryonic stem cells were significantly enriched in HepaRG progenitors derived from HepaRGtdHep. HepaRG-tdHep retrodifferentiation is mediated by crosstalk between transforming growth factor beta 1 (TGFb1) and inflammatory cytokine pathways (e. g., tumor necrosis factor alpha [TNFa] and interleukin 6 [IL6]). Signatures related to TNFa, IL6, and TGFb activation pathways are induced within the first hour of retrodifferentiation. Moreover, specific activation or inhibition of these signaling pathways allowed us to determine that TNFa and IL6 contribute to the loss of hepatic-specific marker expression and that TGFb1 induces an epithelial-to-mesenchymal transition of HepaRG-tdHep. Interestingly, the retrodifferentiation process is blocked by the histone deacetylase inhibitor trichostatin A, opening new therapeutic opportunities. Conclusion: Cancer progenitor cells (or metastasis progenitors) may derive from tumor-derived hepatocyte-like cells in an inflammatory environment that is frequently associated with HCC.	[Dubois-Pot-Schneider, Helene; Fekir, Karim; Coulouarn, Cedric; Glaise, Denise; Aninat, Caroline; Jarnouen, Kathleen; Morel, Fabrice; Corlu, Anne] INSERM, UMR991, F-35033 Rennes, France; [Dubois-Pot-Schneider, Helene; Fekir, Karim; Coulouarn, Cedric; Glaise, Denise; Aninat, Caroline; Morel, Fabrice; Corlu, Anne] Univ Rennes 1, F-35043 Rennes, France; [Le Guevel, Remy; Corlu, Anne] Univ Rennes 1, SFR Biosit, ImPACcell, F-35043 Rennes, France; [Kubo, Takashi; Ishida, Seiichi] Natl Inst Hlth Sci, Div Pharmacol, Biol Safety Res Ctr, Setagaya Ku, Tokyo, Japan	Corlu, A (reprint author), INSERM, UMR991, F-35033 Rennes, France.	anne.corlu@inserm.fr					Ku NO, 2010, NAT CELL BIOL, V12, P876, DOI 10.1038/ncb2091; Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477; Habib AA, 2001, J BIOL CHEM, V276, P8865, DOI 10.1074/jbc.M008458200; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; McGill MR, 2012, J CLIN INVEST, V122, P1574, DOI 10.1172/JCI59755; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Sheng L, 2013, AM J PHYSIOL-ENDOC M, V305, pE1115, DOI 10.1152/ajpendo.00401.2013; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Saitoh Y, 2008, BLOOD, V111, P5118, DOI 10.1182/blood-2007-09-110635; Xiao GT, 2004, J BIOL CHEM, V279, P30099, DOI 10.1074/jbc.M401428200; Sheng L, 2012, NAT MED, V18, P943, DOI 10.1038/nm.2756; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Thu YM, 2010, CYTOKINE GROWTH F R, V21, P213, DOI 10.1016/j.cytogfr.2010.06.002; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Dibra D, 2012, HEPATOLOGY, V55, P1204, DOI 10.1002/hep.24814; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Fan SJ, 2009, J BIOL CHEM, V284, P7561, DOI 10.1074/jbc.M807497200; Jijon H, 2004, CELL SIGNAL, V16, P1023, DOI 10.1016/j.cellsig.2004.02.005; Nishina T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002056; Park GY, 2006, J BIOL CHEM, V281, P18684, DOI 10.1074/jbc.M600733200; Sasaki Y, 2008, P NATL ACAD SCI USA, V105, P10883, DOI 10.1073/pnas.0805186105; Sunami Y, 2012, HEPATOLOGY, V56, P1117, DOI 10.1002/hep.25711; Usynin IF, 1999, BIOCHEMISTRY-MOSCOW+, V64, P620	30	5	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-9139	1527-3350		HEPATOLOGY	Hepatology	DEC	2014	60	6					2077	2090		10.1002/hep.27353		14	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AU3MI	WOS:000345517000071		
J	Imawari, M				Imawari, Michio			Does vitamin D supplementation improve sustained virological response in cirrhotic patients with hepatitis C virus genotype 1b and high viral load?	HEPATOLOGY RESEARCH			English	Editorial Material							FIBROSIS		Shin Yurigaoka Gen Hosp, Inst Gastrointestinal & Liver Dis, Kawasaki, Kanagawa, Japan	Imawari, M (reprint author), Shin Yurigaoka Gen Hosp, Inst Gastrointestinal & Liver Dis, Kawasaki, Kanagawa, Japan.						Gal-Tanamy M, 2011, HEPATOLOGY, V54, P1570, DOI 10.1002/hep.24575; Abu-Mouch S, 2011, WORLD J GASTROENTERO, V17, P5184, DOI 10.3748/wjg.v17.i47.5184; Kitson MT, 2013, J HEPATOL, V58, P467, DOI 10.1016/j.jhep.2012.11.017; Petta S, 2010, HEPATOLOGY, V51, P1158, DOI 10.1002/hep.23489; Nanri A, 2011, J EPIDEMIOL, V21, P346, DOI 10.2188/jea.JE20100161; Yokoyama S, 2014, J VIRAL HEPATITIS, V21, P348, DOI 10.1111/jvh.12146; Matsumura T, 2012, HEPATOLOGY, V56, P1231, DOI 10.1002/hep.25763; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Atsukawa M, 2014, HEPATOL RES, V44, P1277, DOI 10.1111/hepr.12298; Bietto D, 2011, HEPATOLOGY, V53, P1118; Hayashi N, 2014, J GASTROENTEROL, V49, P138, DOI 10.1007/s00535-013-0875-1; IMAWARI M, 1979, J LAB CLIN MED, V93, P171	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	DEC	2014	44	13					1265	1267		10.1111/hepr.12328		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AU1DX	WOS:000345362300001		
J	Shiba, S; Okusaka, T; Ikeda, M; Saito, H; Ichida, T				Shiba, Satoshi; Okusaka, Takuji; Ikeda, Masafumi; Saito, Hidetsugu; Ichida, Takafumi			Characteristics of 18 patients with hepatocellular carcinoma who obtained a complete response after treatment with sorafenib	HEPATOLOGY RESEARCH			English	Article						adverse drug event; complete response; data collection; hepatocellular carcinoma; population characteristics; sorafenib	COMPLETE REMISSION; EFFICACY; CANCER; THERAPY; MANAGEMENT; SAFETY; ANGIOGENESIS; TOXICITY; EXPOSURE; TIME	AimSorafenib, a multi-targeted tyrosine kinase inhibitor, is a first-line systemic treatment for advanced hepatocellular carcinoma (HCC). However, possible predictors of the efficacy of sorafenib treatment in HCC patients remain unclear. MethodsWe conducted a nationwide survey to examine the situation of patients with HCC treated with sorafenib who obtained a complete response (CR) according to the modified response evaluation criteria in solid tumors (mRECIST). The investigation was intended to collect clinical information regarding CR patients and to compare this data with an interim report examining all-patient surveillance for sorafenib use in Japan, which was released in May 2012. ResultsAmong the 3047 patients who were treated at institutions belonging to the Liver Cancer Study Group of Japan, 18 patients (0.6%) obtained a CR. Significant factors in the CR group were a female sex, a low bodyweight (<59kg), an early clinical stage and a small initial dose of sorafenib (P<0.05). Furthermore, specific adverse events (palmar-plantar erythrodysesthesia syndrome, hypertension, diarrhea, alopecia, fatigue, nausea and anorexia) were frequently observed in the CR group (P<0.05). ConclusionThis study identified the characteristics of CR patients during sorafenib treatment. The evaluation of patients receiving sorafenib, including the investigation of biomarkers, warrants further exploration in future clinical studies to identify a population in which sorafenib treatment is remarkably effective.	[Shiba, Satoshi; Okusaka, Takuji] Natl Canc Ctr, Hepatobiliary & Pancreat Oncol Div, Tokyo 1040045, Japan; [Ikeda, Masafumi] Natl Canc Ctr Hosp East, Hepatobiliary & Pancreat Oncol Div, Chiba, Japan; [Saito, Hidetsugu] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol, Tokyo, Japan; [Ichida, Takafumi] Juntendo Univ, Shizuoka Hosp, Dept Internal Med, Div Gastroenterol, Shizuoka, Japan	Okusaka, T (reprint author), Natl Canc Ctr, Hepatobiliary & Pancreat Oncol Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	tokusaka@ncc.go.jp			National Cancer Center Research and Development Fund [23-A-22]	This work was supported by the National Cancer Center Research and Development Fund (23-A-22).	Strumberg D, 2006, EUR J CANCER, V42, P548, DOI 10.1016/j.ejca.2005.11.014; Abbadessa G, 2011, WORLD J GASTROENTERO, V17, P2450, DOI 10.3748/wjg.v17.i19.2450; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74; Cheng AL, 2012, EUR J CANCER, V48, P1452, DOI 10.1016/j.ejca.2011.12.006; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Ueshima K, 2011, DIGEST DIS, V29, P321, DOI 10.1159/000327570; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Miyahara K, 2011, J GASTROEN HEPATOL, V26, P1604, DOI 10.1111/j.1440-1746.2011.06887.x; Irtan S, 2011, LIVER INT, V31, P740, DOI 10.1111/j.1478-3231.2010.02441.x; Vincenzi B, 2010, ONCOLOGIST, V15, P85, DOI 10.1634/theoncologist.2009-0143; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Wang SX, 2010, TARGET ONCOL, V5, P59, DOI 10.1007/s11523-010-0133-x; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Norton L, 2005, ONCOLOGIST, V10, P370, DOI 10.1634/theoncologist.10-6-370; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Boudou-Rouquette P, 2012, ONCOLOGIST, V17, P1204, DOI 10.1634/theoncologist.2011-0439; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Yeganeh M, 2009, AM J TRANSPLANT, V9, P2851, DOI 10.1111/j.1600-6143.2009.02860.x; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639; Kudo M, 2010, ONCOLOGY-BASEL, V78, P154, DOI 10.1159/000315245; Allgayer H, 2000, J CLIN ONCOL, V18, P2201; Arrondeau J, 2012, INVEST NEW DRUG, V30, P2046, DOI 10.1007/s10637-011-9764-8; Iavarone M, 2011, HEPATOLOGY, V54, P2055, DOI 10.1002/hep.24644; Estfan B, 2013, AM J CLIN ONCOL-CANC, V36, P319, DOI 10.1097/COC.0b013e3182468039; Llovet JM, 2008, J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Shao YY, 2010, CANCER-AM CANCER SOC, V116, P4590, DOI 10.1002/cncr.25257; Bettinger D, 2012, HEPATOLOGY, V56, DOI 10.1002/hep.25637; Chelis L, 2011, MED ONCOL, V28, pS165, DOI 10.1007/s12032-010-9669-y; Curtit E, 2011, J CLIN ONCOL, V29, pE330, DOI 10.1200/JCO.2010.32.6785; Inuzuka T, 2011, ONCOLOGY-BASEL, V81, P152, DOI 10.1159/000333279; Post-Marketing Surveillance Manager, 2012, POSTM SURV MAN NEX T; Poullenot F, 2013, ACTA ONCOL; Sacco R, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-4; So BJ, 2008, J HEMATOL ONCOL, V1, DOI 10.1186/1756-8722-1-18; Takeda H, 2013, 7 INT LIV CANC ASS A	37	3	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	DEC	2014	44	13					1268	1276		10.1111/hepr.12297		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AU1DX	WOS:000345362300002		
J	Atsukawa, M; Tsubota, A; Shimada, N; Kondo, C; Itokawa, N; Nakagawa, A; Hashimoto, S; Fukuda, T; Matsushita, Y; Narahara, Y; Iwakiri, K; Nakatsuka, K; Kawamoto, C; Sakamoto, C				Atsukawa, Masanori; Tsubota, Akihito; Shimada, Noritomo; Kondo, Chisa; Itokawa, Norio; Nakagawa, Ai; Hashimoto, Satomi; Fukuda, Takeshi; Matsushita, Yoko; Narahara, Yoshiyuki; Iwakiri, Katsuhiko; Nakatsuka, Katsuhisa; Kawamoto, Chiaki; Sakamoto, Choitsu			Serum 25-hydroxyvitamin D-3 levels affect treatment outcome in pegylated interferon/ribavirin combination therapy for compensated cirrhotic patients with hepatitis C virus genotype 1b and high viral load	HEPATOLOGY RESEARCH			English	Article						cirrhosis; hepatitis C virus; 25-hydroxyvitamin D-3; pegylated interferon; ribavirin; sustained virological response	SUSTAINED VIROLOGICAL RESPONSE; GENOME-WIDE ASSOCIATION; COMMON GENETIC-DETERMINANTS; RANDOMIZED CONTROLLED-TRIAL; VITAMIN-D LEVELS; HEPATOCELLULAR-CARCINOMA; PLUS RIBAVIRIN; PEGINTERFERON ALPHA-2B; ADVANCED FIBROSIS; NATURAL-HISTORY	AimMuch is unknown about the effect of 25-hydroxyvitamin D-3 levels on the outcome of pegylated interferon/ribavirin (PEG IFN/RBV) therapy for hepatitis C virus-related cirrhosis. The purpose of the present study was to analyze and elucidate factors, including 25-hydroxyvitamin D-3, that contribute to a sustained virological response (SVR) in patients with cirrhosis. MethodsWe analyzed whether 25-hydroxyvitamin D-3 contributes to the response to PEG IFN/RBV therapy among 134 cirrhotic patients. ResultsSVR was achieved in 43 patients. The median 25-hydroxyvitamin D-3 level was 20ng/mL. Univariate analysis showed that the following factors contributed to SVR: low-density lipoprotein cholesterol, albumin, 25-hydroxyvitamin D-3, core a.a.70 (a.a.70) substitutions, the number of mutations at the interferon sensitivity-determining region and IL28B genotype. Multivariate analysis identified IL28B genotype and 25-hydroxyvitamin D-3 as independent factors contributing to SVR. Subsequently, SVR rate was examined by using 25-hydroxyvitamin D-3 and other important factors. The SVR rate was 51.8% in patients with core a.a.70 wild and 15ng/mL of 25-hydroxyvitamin D-3, whereas the SVR rate was 7.1% in patients with core a.a.70 wild and <15ng/mL of 25-hydroxyvitamin D-3. The SVR rate was 56.9% in patients with IL28B major genotype and 15ng/mL of 25-hydroxyvitamin D-3. Surprisingly, the SVR rate was 0% in patients with IL28B minor genotype and <15ng/mL of 25-hydroxyvitamin D-3. ConclusionIL28B genotype and 25-hydroxyvitamin D-3 were identified as independent factors contributing to SVR. Stratified analyses according to core a.a.70 substitution and IL28B genotype suggested that 25-hydroxyvitamin D-3 influences the outcome of PEG IFN/RBV therapy for cirrhosis.	[Atsukawa, Masanori; Kondo, Chisa; Itokawa, Norio; Nakagawa, Ai; Iwakiri, Katsuhiko] Chiba Hokusoh Hosp, Nippon Med Sch, Dept Internal Med, Div Gastroenterol, Inzai, Japan; [Tsubota, Akihito] Jikei Univ, Sch Med, ICMR, Kashiwa, Chiba, Japan; [Shimada, Noritomo] Shinmatsudo Cent Gen Hosp, Div Gastroenterol & Hepatol, Matsudo, Chiba, Japan; [Hashimoto, Satomi; Fukuda, Takeshi; Matsushita, Yoko; Narahara, Yoshiyuki; Nakatsuka, Katsuhisa; Kawamoto, Chiaki; Sakamoto, Choitsu] Nippon Med Sch, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo 113, Japan	Atsukawa, M (reprint author), Chiba Hokusoh Hosp, Nippon Med Sch, Dept Internal Med, Div Gastroenterol, 1715 Kamakari, Chiba 2701694, Japan.	momogachi@yahoo.co.jp					Shiratori Y, 2005, ANN INTERN MED, V142, P105; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Di Bisceglie AM, 2000, HEPATOLOGY, V31, P1014, DOI 10.1053/he.2000.5762; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Gal-Tanamy M, 2011, HEPATOLOGY, V54, P1570, DOI 10.1002/hep.24575; Vezali E, 2010, CLIN THER, V32, P2117, DOI [10.1016/S0149-2918(11)00022-1, 10.1016/j.clinthera.2010.12.013]; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Abu-Mouch S, 2011, WORLD J GASTROENTERO, V17, P5184, DOI 10.3748/wjg.v17.i47.5184; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Kitson MT, 2013, J HEPATOL, V58, P467, DOI 10.1016/j.jhep.2012.11.017; Falleti E, 2012, HEPATOLOGY, V56, P1641, DOI 10.1002/hep.25848; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Petta S, 2010, HEPATOLOGY, V51, P1158, DOI 10.1002/hep.23489; Kasahara A, 1998, HEPATOLOGY, V27, P1394, DOI 10.1002/hep.510270529; Di Marco V, 2013, J VIRAL HEPATITIS, V20, P113, DOI 10.1111/j.1365-2893.2012.01637.x; Bitetto D, 2011, HEPATOLOGY, V53, P1118, DOI 10.1002/hep.24201; Di Marco V, 2007, J HEPATOL, V47, P484, DOI 10.1016/j.jhep.2007.04.020; Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; SIMONETTI RG, 1992, ANN INTERN MED, V116, P97; Cardoso AC, 2010, J HEPATOL, V52, P652, DOI 10.1016/j.jhep.2009.12.028; Asahina Y, 2010, HEPATOLOGY, V52, P518, DOI 10.1002/hep.23691; Bruno S, 2010, HEPATOLOGY, V51, P388, DOI 10.1002/hep.23340; Ikeda K, 1999, HEPATOLOGY, V29, P1124, DOI 10.1002/hep.510290439; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Matsumura T, 2012, HEPATOLOGY, V56, P1231, DOI 10.1002/hep.25763; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346; Yoshida H, 1999, ANN INTERN MED, V131, P174; Abergel A, 2006, J VIRAL HEPATITIS, V13, P811, DOI 10.1111/j.1365-2893.2006.00768.x; Petta S, 2013, J VIRAL HEPATITIS, V20, P486, DOI 10.1111/jvh.12072; Bruno S, 2013, J HEPATOL, V58, P479, DOI 10.1016/j.jhep.2012.11.020; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Bietto D, 2011, TRANSPL INT, V24, P43; Giannini EG, 2009, J INTERN MED, V266, P537, DOI 10.1111/j.1365-2796.2009.02130.x; Gramenzi A, 2001, GUT, V48, P843, DOI 10.1136/gut.48.6.843; MOREL PA, 1986, J IMMUNOL, V136, P2181; Manuel Quesada J, 1989, NEW ENGL J MED, V21, P833; Nishiguchi S, 2001, LANCET, V357, P196, DOI 10.1016/S0140-6736(00)03595-9; Thomas David L, 2005, Clin Liver Dis, V9, P383, DOI 10.1016/j.cld.2005.05.003	47	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	DEC	2014	44	13					1277	1285		10.1111/hepr.12298		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AU1DX	WOS:000345362300003		
J	Miyake, Y; Yamamoto, K; Matsushita, H; Abe, M; Takahashi, A; Umemura, T; Tanaka, A; Nakamuta, M; Nakamoto, Y; Ueno, Y; Saibara, T; Takikawa, H; Yoshizawa, K; Ohira, H; Zeniya, M; Onji, M; Tsubouchi, H				Miyake, Yasuhiro; Yamamoto, Kazuhide; Matsushita, Hiroshi; Abe, Masanori; Takahashi, Atsushi; Umemura, Takeji; Tanaka, Atsushi; Nakamuta, Makoto; Nakamoto, Yasunari; Ueno, Yoshiyuki; Saibara, Toshiji; Takikawa, Hajime; Yoshizawa, Kaname; Ohira, Hiromasa; Zeniya, Mikio; Onji, Morikazu; Tsubouchi, Hirohito		Intractable Hepato-Biliary Dis	Multicenter validation study of anti-programmed cell death-1 antibody as a serological marker for type 1 autoimmune hepatitis	HEPATOLOGY RESEARCH			English	Article						autoantibody; autoimmune hepatitis; drug-induced liver injury; programmed cell death-1; validation	INDUCED LIVER-INJURY; ANTI-PD-1 ANTIBODY; PD-1 BLOCKADE; T-CELLS; JAPAN; CRITERIA; VIVO	AimRecently, serum levels of anti-programmed cell death-1 (anti-PD-1) antibodies have been reported to be useful for the discrimination of type 1 autoimmune hepatitis (AIH) from drug-induced liver injury (DILI) and to be associated with clinical features of type 1 AIH. This multicenter study aimed to validate the usefulness of serum anti-PD-1 antibody as a serological marker for type 1 AIH. MethodsSerum samples before the initiation of corticosteroid treatment were obtained from 71 type 1 AIH patients and 37 DILI patients. Serum levels of anti-PD-1 antibodies were measured by indirect enzyme-linked immunosorbent assay. ResultsSerum levels of anti-PD-1 antibodies were higher in type 1 AIH patients than in DILI patients (P<0.001). The receiver-operator curve analysis showed that serum levels of anti-PD-1 antibodies were useful for the discrimination of type 1 AIH from DILI (area under the curve, 0.80). On the other hand, the multivariate Cox proportional hazard model showed that positivity for serum anti-PD-1 antibody, probable diagnosis based on the revised scoring system proposed by the International Autoimmune Hepatitis Group, and prothrombin activity of less than 60% were associated with the later normalization of serum transaminase levels. During the clinical course, the disease relapsed more frequently in patients positive for serum anti-PD-1 antibody (36% vs 11%). ConclusionThis study suggests that serum anti-PD-1 antibody is useful for the diagnosis of type 1 AIH as an auxiliary diagnostic marker, and that serum levels of anti-PD-1 antibodies reflect clinical features of type 1 AIH.	[Miyake, Yasuhiro; Yamamoto, Kazuhide; Matsushita, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama 7008558, Japan; [Abe, Masanori; Onji, Morikazu] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan; [Takahashi, Atsushi; Ohira, Hiromasa] Fukushima Med Univ, Dept Gastroenterol & Rheumatol, Fukushima, Japan; [Umemura, Takeji; Yoshizawa, Kaname] Shinshu Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Matsumoto, Nagano 390, Japan; [Tanaka, Atsushi; Takikawa, Hajime] Teikyo Univ, Sch Med, Dept Med, Itabashi Ku, Tokyo 173, Japan; [Nakamuta, Makoto] Natl Hosp Org, Dept Gastroenterol, Kyushu Med Ctr, Fukuoka, Japan; [Nakamoto, Yasunari] Univ Fukui, Grad Sch Med, Dept Gastroenterol, Fukui 910, Japan; [Ueno, Yoshiyuki] Yamagata Univ, Fac Med, Dept Gastroenterol, Yamagata 990, Japan; [Saibara, Toshiji] Kochi Med Sch, Dept Gastroenterol & Hepatol, Nankoku, Kochi, Japan; [Zeniya, Mikio] Jikei Univ, Grad Sch Med, Dept Gastroenterol, Minato Ku, Tokyo, Japan; [Tsubouchi, Hirohito] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Digest Dis & Lifestyle Related Dis, Kagoshima 890, Japan	Miyake, Y (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	miyake43@md.okayama-u.ac.jp			MINISTRY OF Health, Welfare and Labor of Japan	THE MINISTRY OF Health, Welfare and Labor of Japan has supported this study as a project of the Intractable Hepato-Biliary Disease Study Group of Japan from April 2011 to March 2014.	Abe M, 2007, CLIN GASTROENTEROL H, V5, P255, DOI 10.1016/j.cgh.2006.10.011; Alvarez F., 1999, Journal of Hepatology, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Hennes EM, 2008, HEPATOLOGY, V48, P169, DOI 10.1002/hep.22322; Kido M, 2008, GASTROENTEROLOGY, V135, P1333, DOI 10.1053/j.gastro.2008.06.042; Bjornsson E, 2011, CLIN GASTROENTEROL H, V9, P57, DOI 10.1016/j.cgh.2010.07.016; Mochida S, 2011, HEPATOL RES, V41, P805, DOI 10.1111/j.1872-034X.2011.00860.x; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Tan P, 2005, LIVER INT, V25, P728, DOI 10.1111/j.1478-3231.2005.01121.x; Abe M, 2011, J GASTROENTEROL, V46, P1136, DOI 10.1007/s00535-011-0421-y; Miyake Y, 2005, J HEPATOL, V43, P951, DOI 10.1016/j.jhep.2005.06.006; Rosenblatt J, 2011, J IMMUNOTHER, V34, P409, DOI 10.1097/CJI.0b013e31821ca6ce; Miyake Y, 2006, ALIMENT PHARM THERAP, V24, P1197, DOI 10.1111/j.1365-2036.2006.03113.x; Serriari NE, 2010, J IMMUNOL, V185, P3140, DOI 10.4049/jimmunol.0902487; Czaja AJ, 2009, J HEPATOL, V51, P161, DOI 10.1016/j.jhep.2009.02.026; Matsumoto K, 2014, J GASTROEN HEPATOL, V29, P110, DOI 10.1111/jgh.12340; Zachou K, 2013, ALIMENT PHARM THER, V38, P887, DOI 10.1111/apt.12470; Yoshizawa K, 2012, HEPATOLOGY, V56, P668, DOI 10.1002/hep.25658; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Hoeroldt B, 2011, GASTROENTEROLOGY, V140, P1980, DOI 10.1053/j.gastro.2011.02.065; Maruoka R, 2013, GASTROENTEROLOGY, V145, P209, DOI 10.1053/j.gastro.2013.03.011; McGee HS, 2010, AM J RESP CELL MOL, V43, P432, DOI 10.1165/rcmb.2009-0258OC; Onji M, 2011, HEPATOL RES, V41, P497, DOI 10.1111/j.1872-034X.2011.00810.x; Takikawa H, 2005, HEPATOL RES, V32, P250, DOI 10.1016/j.hepres.2005.05.007; Takikawa H, 2009, HEPATOL RES, V39, P427, DOI 10.1111/j.1872-034X.2008.00486.x	24	3	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	DEC	2014	44	13					1299	1307		10.1111/hepr.12305		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AU1DX	WOS:000345362300005		
J	Nanashima, A; Sakamoto, A; Sakamoto, I; Hayashi, H; Abo, T; Wakata, K; Murakami, G; Arai, J; Wada, H; Takagi, K; Takeshita, H; Hidaka, S; To, K; Nagayasu, T				Nanashima, Atsushi; Sakamoto, Ayami; Sakamoto, Ichiro; Hayashi, Hideyuki; Abo, Takafumi; Wakata, Kouki; Murakami, Goushi; Arai, Junichi; Wada, Hideo; Takagi, Katsunori; Takeshita, Hiroaki; Hidaka, Shigekazu; To, Kazuo; Nagayasu, Takeshi			Usefulness of evaluating hepatic elasticity using artificial acoustic radiation force ultrasonography before hepatectomy	HEPATOLOGY RESEARCH			English	Article						acoustic radiation force impulse; hepatectomy; hepatic fibrosis; liver tumor; morbidity; ultrasonography	TIME TISSUE ELASTOGRAPHY; SERUM HYALURONIC-ACID; TRANSIENT ELASTOGRAPHY; LIVER FIBROSIS; HEPATOCELLULAR-CARCINOMA; NONINVASIVE ASSESSMENT; IMPULSE ELASTOGRAPHY; DECISION-MAKING; RESECTION; ARFI	AimTo evaluate hepatic fibrosis and tumor diagnosis preoperatively, we investigated the elasticity calculated by the new parameter of ultrasonography, acoustic radiation force impulse (ARFI). MethodsWe examined ARFI of the non-tumorous right and left lateral liver and in the tumor by push pulse of probe in 95 patients with hepatic malignancies undergoing hepatectomy. Measurement of ARFI as hepatic stiffness was indicated as the Vs (m/s). ResultsMeasuring the Vs in the non-tumor region was achieved in the right liver in 99% and at the left lateral liver in 94%. The Vs in the right liver was significantly lower than in the left lateral liver, and the Vs of the liver tumor was significantly higher than in the non-tumorous liver. The Vs in the right and left lateral liver was correlated with the platelet count, aspartate aminotransferase, fibrotic indices and indocyanine green test. The Vs in the right liver was significantly correlated with the fibrotic marker or index. The Vs of liver cirrhosis and histological stage 4 in the right and left liver was significantly the highest compared to the others. The Vs in the right liver showed a high area under the receiver-operator curve value predicting histological fibrosis. The Vs in the right was significantly correlated with blood loss and postoperative complications, particularly uncontrolled ascites. ConclusionNon-invasive ARFI imaging elastography is useful in evaluating impaired liver function or in the differential diagnosis of liver malignancies, highly hepatic fibrosis and in predicting posthepatectomy morbidity.	[Nanashima, Atsushi; Abo, Takafumi; Wakata, Kouki; Murakami, Goushi; Arai, Junichi; Wada, Hideo; Takagi, Katsunori; Takeshita, Hiroaki; Hidaka, Shigekazu; To, Kazuo; Nagayasu, Takeshi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg Oncol, Nagasaki 8528501, Japan; [Sakamoto, Ayami; Sakamoto, Ichiro; Hayashi, Hideyuki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiol, Nagasaki 8528501, Japan	Nanashima, A (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Div Surg Oncol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	a-nanasm@nagasaki-u.ac.jp					Altendorf-Hofmann Annelore, 2003, Surg Oncol Clin N Am, V12, P165, DOI 10.1016/S1055-3207(02)00091-1; Anaparthy R, 2011, ALIMENT PHARM THER, V34, P83, DOI 10.1111/j.1365-2036.2011.04673.x; Yashima Y, 2012, J GASTROENTEROL, V47, P427, DOI 10.1007/s00535-011-0491-x; Davies G, 2011, BRIT J RADIOL, V84, P939, DOI 10.1259/bjr/97637841; Colombo S, 2012, J GASTROENTEROL, V47, P461, DOI 10.1007/s00535-011-0509-4; Lupsor M, 2009, J GASTROINTEST LIVER, V18, P303; Cescon M, 2009, ANN SURG, V249, P995, DOI 10.1097/SLA.0b013e3181a63c74; van Vledder MG, 2010, HPB, V12, P717, DOI 10.1111/j.1477-2574.2010.00247.x; Kubota K, 1997, HEPATOLOGY, V26, P1176; Vermehren J, 2012, LIVER INT, V32, P852, DOI 10.1111/j.1478-3231.2011.02736.x; Strasberg SM, 2011, J AM COLL SURGEONS, V213, P616, DOI 10.1016/j.jamcollsurg.2011.07.019; Clevert DA, 2009, CLIN HEMORHEOL MICRO, V43, P95, DOI 10.3233/CH-2009-1224; Cho SH, 2010, ULTRASOUND MED BIOL, V36, P202, DOI 10.1016/j.ultrasmedbio.2009.10.009; Roulot D, 2008, J HEPATOL, V48, P606, DOI 10.1016/j.jhep.2007.11.020; Yu HJ, 2011, ULTRASOUND Q, V27, P217, DOI 10.1097/RUQ.0b013e318239422e; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Kwon AH, 2006, SURGERY, V140, P379, DOI 10.1016/j.surg.2006.02.011; Laurent TC, 1996, ANN MED, V28, P241, DOI 10.3109/07853899609033126; Vauthey JN, 2002, LIVER TRANSPLANT, V8, P233, DOI 10.1053/jlts.2002.31654; Kwon HJ, 2011, WORLD J GASTROENTERO, V17, P1874, DOI 10.3748/wjg.v17.i14.1874; Heide R, 2010, ULTRASCHALL MED, V31, P405, DOI 10.1055/s-0029-1245565; Grgurevic I, 2011, ULTRASCHALL MED, V32, P160, DOI 10.1055/s-0029-1245807; Alric L, 2009, TRANSPL INT, V22, P568, DOI 10.1111/j.1432-2277.2009.00834.x; Guglielmi A, 2009, WORLD J SURG, V33, P1247, DOI 10.1007/s00268-009-9970-0; Song TJ, 2004, GASTROENTEROLOGY, V127, pS248, DOI 10.1053/j.gastro.2004.09.039; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Han KH, 2008, INTERVIROLOGY, V51, P11, DOI 10.1159/000122594; Nanashima A, 2010, J HEPATO-BIL-PAN SCI, V17, P871, DOI 10.1007/s00534-010-0281-5; Baranova A, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-91; Ding HF, 2012, J HUAZHONG U SCI-MED, V32, P69, DOI 10.1007/s11596-012-0012-z; Eiler J, 2012, ULTRASCHALL MED, V33, P474, DOI 10.1055/s-0032-1313145; Friedrich-Rust M, 2009, ULTRASCHALL MED, V30, P478, DOI 10.1055/s-0028-1109488; Hodge A, 2011, J GASTROEN HEPATOL, V26, P217, DOI 10.1111/j.1440-1746.2010.06589.x; Khan JA, 2007, JCPSP-J COLL PHYSICI, V17, P323; Makuuchi M, 2009, GEN RULES CLIN PATHO, P24; Mayo Skye C, 2009, Expert Rev Gastroenterol Hepatol, V3, P131, DOI 10.1586/egh.09.8; MURAWAKI Y, 1994, HEPATOLOGY, V20, P780, DOI 10.1002/hep.1840200403; Nanashima A, 2003, DIGEST DIS SCI, V48, P1517, DOI 10.1023/A:1024759606402; Nanashima A, 2013, SURG TODAY, V43, P485, DOI 10.1007/s00595-012-0374-7; Nanashima A, 2009, ANN SURG ONCOL, V16, P2123, DOI 10.1245/s10434-009-0494-5; Nanashima A, 2011, ANTICANCER RES, V31, P4545; Nanashima A, 2001, J GASTROEN HEPATOL, V16, P1158, DOI 10.1046/j.1440-1746.2001.02599.x; Nguyen-Khac E, 2006, EUR J GASTROEN HEPAT, V18, P1321, DOI 10.1097/01.meg.0000243884.55562.37; Oh S, 2001, Curr Gastroenterol Rep, V3, P12, DOI 10.1007/s11894-001-0035-2; Osaki A, 2010, WORLD J GASTROENTERO, V16, P2918, DOI 10.3748/wjg.v16.i23.2918; Pesce A, 2012, HPB, V14, P403, DOI 10.1111/j.1477-2574.2012.00465.x; Poon RT, 2005, J HEPATO-BILIARY-PAN, V12, P31, DOI 10.1007/s00534-004-0945-0; Son CY, 2012, J GASTROEN HEPATOL, V27, P130, DOI 10.1111/j.1440-1746.2011.06814.x; Sporea Ioan, 2011, World J Radiol, V3, P188, DOI 10.4329/wjr.v3.i7.188; Sumida Y, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-2; Taniguchi H, 2006, J GASTROEN HEPATOL, V21, P281, DOI 10.1111/j.1440-1746.2006.04201.x	51	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	DEC	2014	44	13					1308	1319		10.1111/hepr.12306		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AU1DX	WOS:000345362300006		
J	Kawaoka, T; Aikata, H; Kan, H; Fujino, H; Fukuhara, T; Kobayashi, T; Naeshiro, N; Miyaki, D; Hiramatsu, A; Imamura, M; Kawakami, Y; Hyogo, H; Chayama, K				Kawaoka, Tomokazu; Aikata, Hiroshi; Kan, Hiromi; Fujino, Hatsue; Fukuhara, Takayuki; Kobayashi, Tomoki; Naeshiro, Noriaki; Miyaki, Daisuke; Hiramatsu, Akira; Imamura, Michio; Kawakami, Yoshiiku; Hyogo, Hideyuki; Chayama, Kazuaki			Clinical outcome and prognostic factors of patients with hepatocellular carcinoma and extrahepatic metastasis treated with sorafenib	HEPATOLOGY RESEARCH			English	Article						extrahepatic metastasis; hepatocellular carcinoma; intrahepatic tumor stage; sorafenib	5-FLUOROURACIL/INTERFERON COMBINATION THERAPY; SUBCUTANEOUS INTERFERON-ALPHA; INTRAARTERIAL 5-FLUOROURACIL; POOR-PROGNOSIS; FEATURES; CLASSIFICATION; FETOPROTEIN; PROGRESSION; THROMBOSIS	AimThe purpose of this study was to assess the clinical outcome and identify prognostic factors following treatment of patients with advanced hepatocellular carcinoma (HCC) and extrahepatic metastasis with sorafenib. MethodsSixty-one HCC patients with extrahepatic metastasis who were treated with sorafenib were enrolled in this retrospective cohort study. ResultsThe median survival time (MST) of all patients was 11months. The median time to radiological progression was 4.2months. The response rates (complete response [CR]+partial response [PR]) by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST were 3.0% and 8.0%, respectively, while the disease control rates (CR+PR+stable disease) were 49% and 49%, respectively. Multivariate analysis identified T factor (intrahepatic tumor stage, T 0-2), response to disease control and des--carboxy prothrombin (<2600mAU/mL) as significant and independent determinants of survival. Intrahepatic tumor stage before treatment allows stratification of prognosis of patients treated with sorafenib. Four T0 patients remained alive. The MST of patients with T1 (n=6), T2 (n=10), T3 (n=23) and T4 (n=18) of intrahepatic tumor stage was 20, 23, 7 and 5months, respectively. Among the progressive disease group, patients with T0-2 intrahepatic tumor stage had better prognosis than patients with T3-4. ConclusionIn HCC patients with extrahepatic metastasis who are treated with sorafenib, intrahepatic tumor stage was a significant and independent prognostic factor.	[Kawaoka, Tomokazu; Aikata, Hiroshi; Kan, Hiromi; Fujino, Hatsue; Fukuhara, Takayuki; Kobayashi, Tomoki; Naeshiro, Noriaki; Miyaki, Daisuke; Hiramatsu, Akira; Imamura, Michio; Kawakami, Yoshiiku; Hyogo, Hideyuki; Chayama, Kazuaki] Hiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci, Hiroshima 7348551, Japan	Aikata, H (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Med & Mol Sci,Programs Biomed Res, Div Frontier Med Sci,Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	aikata@hiroshima-u.ac.jp					Cheng AL, 2012, EUR J CANCER, V48, P1452, DOI 10.1016/j.ejca.2011.12.006; Uka K, 2007, WORLD J GASTROENTERO, V13, P414; TaylorRobinson SD, 1997, LANCET, V350, P1142, DOI 10.1016/S0140-6736(05)63789-0; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Miyaaki H, 2007, J GASTROENTEROL, V42, P962, DOI 10.1007/s00535-007-2117-x; [Anonymous], 1989, JPN J SURG, V19, P98; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Natsuizaka M, 2005, J GASTROEN HEPATOL, V20, P1781, DOI 10.1111/j.1440-1746.2005.03919.x; Kobayashi M, 2009, CANCER, V115, P571, DOI 10.1002/cncr.24031; Sakon M, 2002, CANCER, V94, P435, DOI 10.1002/cncr.10246; Uchino K, 2011, CANCER-AM CANCER SOC, V117, P4475, DOI 10.1002/cncr.25960; Uka K, 2007, LIVER INT, V27, P1209, DOI 10.1111/j.1478-3231.2007.01554.x; Gomaa AI, 2009, WORLD J GASTROENTERO, V15, P1301, DOI 10.3748/wjg.15.1301; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Miyaki D, 2012, J GASTROEN HEPATOL, V27, P1850, DOI 10.1111/j.1440-1746.2012.07276.x; Kawaoka T, 2012, ONCOLOGY-BASEL, V83, P192, DOI 10.1159/000341347; Ota H, 2005, BRIT J CANCER, V93, P557, DOI 10.1038/sj.bjc.6602742; Uka K, 2007, J GASTROENTEROL, V42, P845, DOI 10.1007/s00535-007-2099-8; Obi S, 2006, CANCER, V106, P1990, DOI 10.1002/cncr.21832; Katamura Y, 2010, J GASTROEN HEPATOL, V25, P1117, DOI 10.1111/j.1440-1746.2009.06110.x; Ishii H, 2004, JPN J CLIN ONCOL, V34, P733, DOI 10.1093/jjco/hyh135; Nagaoka S, 2003, CANCER, V98, P2671, DOI 10.1002/cncr.11839; Okita K, 2006, J GASTROENTEROL, V41, P100, DOI 10.1007/s00535-005-1763-0	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	DEC	2014	44	13					1320	1328		10.1111/hepr.12307		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AU1DX	WOS:000345362300007		
J	Jo, M; Yasui, K; Kirishima, T; Shima, T; Niimi, T; Katayama, T; Mori, T; Funaki, J; Sumida, Y; Fujii, H; Takami, S; Kimura, H; Mitsumoto, Y; Minami, M; Yamaguchi, K; Yoshinami, N; Mizuno, M; Sendo, R; Tanaka, S; Shintani, H; Kagawa, K; Okanoue, T; Itoh, Y				Jo, Masayasu; Yasui, Kohichiroh; Kirishima, Toshihiko; Shima, Toshihide; Niimi, Toshihisa; Katayama, Takayuki; Mori, Takahiro; Funaki, Jun; Sumida, Yoshio; Fujii, Hideki; Takami, Shiro; Kimura, Hiroyuki; Mitsumoto, Yasuhide; Minami, Masahito; Yamaguchi, Kanji; Yoshinami, Naomi; Mizuno, Masayuki; Sendo, Rei; Tanaka, Saiyu; Shintani, Hiroyuki; Kagawa, Keizo; Okanoue, Takeshi; Itoh, Yoshito			Efficacy and safety of sorafenib in very elderly patients aged 80 years and older with advanced hepatocellular carcinoma	HEPATOLOGY RESEARCH			English	Article						elderly patient; hepatocellular carcinoma; sorafenib	TOXICITY	AimSorafenib is the standard systemic therapy for patients with advanced hepatocellular carcinoma (HCC). We aimed to assess the efficacy and safety of sorafenib therapy in very elderly patients aged 80 years and older with advanced HCC. MethodsIn a retrospective multicenter study in Japan, we reviewed 185 patients (median age, 71 years; 82% male; 95% Child-Pugh class A) with advanced HCC who received sorafenib therapy. Data were compared between 24 (13%) patients aged 80 years and older and 161 (87%) patients aged less than 80 years. We used propensity score matching to adjust for differences between the two groups. ResultsMedian overall survival was 10.6 months in all patients: 11.7 months in patients aged 80 years and older and 10.5 months in those aged less than 80 years. There were no significant differences in overall survival, tumor response, and frequency and severity of drug-related adverse events between patients aged 80 years and older and those aged less than 80 years in both the entire study cohort and the propensity-matched cohort. ConclusionSorafenib may be effective and well tolerated, even in patients with advanced HCC who are aged 80 years and older, as well as those aged less than 80 years.	[Jo, Masayasu; Yasui, Kohichiroh; Katayama, Takayuki; Sumida, Yoshio; Minami, Masahito; Yamaguchi, Kanji; Itoh, Yoshito] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Gastroenterol & Hepatol, Kyoto 6028566, Japan; [Kirishima, Toshihiko; Yoshinami, Naomi; Shintani, Hiroyuki] Kyoto City Hosp, Dept Gastroenterol, Kyoto, Japan; [Funaki, Jun] Koseikai Takeda Hosp, Dept Gastroenterol, Kyoto, Japan; [Fujii, Hideki] Aiseikai Yamashina Hosp, Dept Internal Med, Kyoto, Japan; [Kimura, Hiroyuki] Japanese Red Cross Kyoto Daiichi Hosp, Dept Gastroenterol, Kyoto, Japan; [Mitsumoto, Yasuhide] Social Insurance Kyoto Hosp, Dept Gastroenterol, Kyoto, Japan; [Jo, Masayasu] Kyoto Prefectural Univ Med, North Med Ctr, Dept Mol Gastroenterol & Hepatol, Yosano, Japan; [Shima, Toshihide; Mizuno, Masayuki; Sendo, Rei; Okanoue, Takeshi] Saiseikai Suita Hosp, Dept Gastroenterol & Hepatol, Suita, Osaka, Japan; [Niimi, Toshihisa; Katayama, Takayuki; Sendo, Rei; Kagawa, Keizo] Fukuchiyama City Hosp, Dept Gastroenterol, Fukuchiyama, Japan; [Mori, Takahiro; Mitsumoto, Yasuhide] West Japan Railway Co, Osaka Gen Hosp, Dept Gastroenterol, Osaka, Japan; [Sumida, Yoshio; Tanaka, Saiyu] Nara City Hosp, Ctr Digest & Liver Dis, Nara, Japan; [Takami, Shiro] Otsu Municipal Hosp, Dept Gastroenterol, Otsu, Shiga, Japan	Yasui, K (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Gastroenterol & Hepatol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	yasuik@koto.kpu-m.ac.jp					Wong H, 2011, ONCOLOGIST, V16, P1721, DOI 10.1634/theoncologist.2011-0192; Morimoto M, 2011, HEPATOL RES, V41, P296, DOI 10.1111/j.1872-034X.2011.00778.x; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Ikai I, 2007, HEPATOL RES, V37, P676, DOI 10.1111/j.1872-034X.2007.00119.x; Gauthier A, 2013, HEPATOL RES, V43, P147, DOI 10.1111/j.1872-034X.2012.01113.x; Connors AF, 1996, JAMA-J AM MED ASSOC, V276, P889, DOI 10.1001/jama.276.11.889; Liver Cancer Study Group of Japan, 2010, GEN RUL CLIN PATH ST; Montella L, 2013, ONCOLOGY-BASEL, V84, P265, DOI 10.1159/000345558; Di Costanzo GG, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0446-y	15	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	DEC	2014	44	13					1329	1338		10.1111/hepr.12308		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AU1DX	WOS:000345362300008		
J	Komatsu, N; Motosugi, U; Maekawa, S; Shindo, K; Sakamoto, M; Sato, M; Tatsumi, A; Miura, M; Amemiya, F; Nakayama, Y; Inoue, T; Fukasawa, M; Uetake, T; Ohtaka, M; Sato, T; Asahina, Y; Kurosaki, M; Izumi, N; Ichikawa, T; Araki, T; Enomoto, N				Komatsu, Nobutoshi; Motosugi, Utaroh; Maekawa, Shinya; Shindo, Kuniaki; Sakamoto, Minoru; Sato, Mitsuaki; Tatsumi, Akihisa; Miura, Mika; Amemiya, Fumitake; Nakayama, Yasuhiro; Inoue, Taisuke; Fukasawa, Mitsuharu; Uetake, Tomoyoshi; Ohtaka, Masahiko; Sato, Tadashi; Asahina, Yasuhiro; Kurosaki, Masayuki; Izumi, Namiki; Ichikawa, Tomoaki; Araki, Tsutomu; Enomoto, Nobuyuki			Hepatocellular carcinoma risk assessment using gadoxetic acid-enhanced hepatocyte phase magnetic resonance imaging	HEPATOLOGY RESEARCH			English	Article						gadoxetic acid; hepatocellular carcinoma; hepatocyte phase; magnetic resonance imaging; risk assessment	GD-EOB-DTPA; FOCAL LIVER-LESIONS; HYPOVASCULAR HYPOINTENSE NODULES; HEPATOBILIARY PHASE; MR-IMAGES; SIGNAL INTENSITY; CIRRHOSIS; HEPATITIS; DISEASE; CT	AimTo investigate whether the patients with hypovascular liver nodules determined on the arterial phase and hypointensity on the hepatocyte phase gadoxetic acid-enhanced magnetic resonance imaging (hypovascular hypointense nodules) are at increased risk of hepatocarcinogenesis, we assessed subsequent typical hepatocellular carcinoma (HCC) development at any sites of the liver with and without such nodules. MethodsOne hundred and twenty-seven patients with chronic hepatitis B or C and without a history of HCC, including 68 with liver cirrhosis, were divided into those with (non-clean liver group, n=18) and without (clean liver group, n=109) hypovascular hypointense nodules. All the patients were followed up for 3years, and HCC development rates and risk factors were analyzed with the Kaplan-Meier method and the Cox proportional hazard model, respectively. ResultsA total of 17 patients (10 in the non-clean liver group and seven in the clean liver group) developed typical HCC. Cumulative 3-year rates of HCC development were 55.5% in the non-clean liver group and 6.4% in the clean liver group (P<0.001), and those at the different sites from the initial nodules was also higher in the non-clean liver group (22.2%) than the clean liver group (6.4%) (P=0.003). Multivariate analysis identified older age (P=0.024), low platelet counts (P=0.017) and a non-clean liver (P<0.001) as independent risk factors for subsequent HCC development. ConclusionPatients with hypovascular hypointense liver nodules are at a higher risk for HCC development at any sites of the liver than those without such nodules.	[Komatsu, Nobutoshi; Maekawa, Shinya; Shindo, Kuniaki; Sakamoto, Minoru; Sato, Mitsuaki; Tatsumi, Akihisa; Miura, Mika; Amemiya, Fumitake; Nakayama, Yasuhiro; Inoue, Taisuke; Fukasawa, Mitsuharu; Uetake, Tomoyoshi; Ohtaka, Masahiko; Sato, Tadashi; Enomoto, Nobuyuki] Univ Yamanashi, Dept Internal Med 1, Chuo, Yamanashi 4093898, Japan; [Motosugi, Utaroh; Ichikawa, Tomoaki; Araki, Tsutomu] Univ Yamanashi, Dept Radiol, Chuo, Yamanashi 4093898, Japan; [Asahina, Yasuhiro] Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Kurosaki, Masayuki; Izumi, Namiki] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan	Enomoto, N (reprint author), Univ Yamanashi, Dept Internal Med 1, Chuo Ku, 1110 Shimokato, Kofu, Yamanashi 4093898, Japan.	enomoto@yamanashi.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [23390195, 23791404, 24590964, 24590965]; Ministry of Health, Labor and Welfare of Japan [H23-kanen-001, H23-kanen-004, H23-kanen-006, H24-kanen-002, H24-kanen-004, H25-kanen-006]	This study was supported in part by a Grant-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan (23390195, 23791404, 24590964 and 24590965), and in part by a Grant-in-Aid from the Ministry of Health, Labor and Welfare of Japan (H23-kanen-001, H23-kanen-004, H23-kanen-006, H24-kanen-002, H24-kanen-004 and H25-kanen-006).	Hyodo T, 2013, RADIOLOGY, V266, P480, DOI 10.1148/radiol.12112677; Degos F, 2000, GUT, V47, P131, DOI 10.1136/gut.47.1.131; Kumada T, 2011, AM J ROENTGENOL, V197, P58, DOI 10.2214/AJR.10.5390; Sano K, 2011, RADIOLOGY, V261, P834, DOI 10.1148/radiol.11101840; Huppertz A, 2004, RADIOLOGY, V230, P266, DOI 10.1148/radiol.2301020269; HAMM B, 1995, RADIOLOGY, V195, P785; Hammerstingl R, 2008, EUR RADIOL, V18, P457, DOI 10.1007/s00330-007-0716-9; Golfieri R, 2011, EUR RADIOL, V21, P1233, DOI 10.1007/s00330-010-2030-1; Motosugi U, 2013, RADIOLOGY, V267, P317, DOI 10.1148/radiol.13122186; Ichikawa T, 2010, INVEST RADIOL, V45, P133, DOI 10.1097/RLI.0b013e3181caea5b; Motosugi U, 2009, J MAGN RESON IMAGING, V30, P1042, DOI 10.1002/jmri.21956; Di Martino M, 2010, RADIOLOGY, V256, P806, DOI 10.1148/radiol.10091334; Motosugi U, 2011, J MAGN RESON IMAGING, V34, P88, DOI 10.1002/jmri.22630; Tarao K, 1999, CANCER, V86, P589, DOI 10.1002/(SICI)1097-0142(19990815)86:4<589::AID-CNCR7>3.0.CO;2-K; Halavaara J, 2006, J COMPUT ASSIST TOMO, V30, P345, DOI 10.1097/00004728-200605000-00001; Nasu K, 2009, AM J ROENTGENOL, V193, P438, DOI 10.2214/AJR.08.1424; Narita M, 2009, J GASTROENTEROL, V44, P793, DOI 10.1007/s00535-009-0056-4; Kim YK, 2012, RADIOLOGY, V265, P104, DOI 10.1148/radiol.12112649; Inoue T, 2012, J GASTROENTEROL, V47, P1036, DOI 10.1007/s00535-012-0571-6; IKEDA K, 1993, HEPATOLOGY, V18, P47, DOI 10.1016/0270-9139(93)90505-H; Motosugi U, 2013, MAGN RESON MED SCI, V12, P161, DOI 10.2463/mrms.2012-0085; Bartolozzi C, 2013, ABDOM IMAGING, V38, P290, DOI 10.1007/s00261-012-9952-9; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Ikeda K, 1998, J HEPATOL, V28, P930, DOI 10.1016/S0168-8278(98)80339-5; Kitao A, 2010, RADIOLOGY, V256, P817, DOI 10.1148/radiol.10092214; Golfieri R, 2012, J MAGN RESON IMAGING, V36, P648, DOI 10.1002/jmri.23685; Asayama Y, 2008, AM J ROENTGENOL, V190, pW28, DOI 10.2214/AJR.07.2117	27	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	DEC	2014	44	13					1339	1346		10.1111/hepr.12309		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AU1DX	WOS:000345362300009		
J	Nakamura, S; Nouso, K; Onishi, H; Kuwaki, K; Hagihara, H; Takeuchi, Y; Wada, N; Morimoto, Y; Miyahara, K; Yasunaka, T; Ikeda, F; Miyake, Y; Kobayashi, Y; Shiraha, H; Ishikawa, S; Takaki, A; Yamamoto, K				Nakamura, Shinichiro; Nouso, Kazuhiro; Onishi, Hideki; Kuwaki, Kenji; Hagihara, Hiroaki; Takeuchi, Yasuto; Wada, Nozomu; Morimoto, Yuki; Miyahara, Koji; Yasunaka, Tetsuya; Ikeda, Fusao; Miyake, Yasuhiro; Kobayashi, Yoshiyuki; Shiraha, Hidenori; Ishikawa, Shinichi; Takaki, Akinobu; Yamamoto, Kazuhide			Prevention of vagotonia and pain during radiofrequency ablation of liver tumors	HEPATOLOGY RESEARCH			English	Article						complications; hepatocellular carcinoma; pain; radiofrequency ablation	POSTPROCEDURAL PAIN	Radiofrequency ablation (RFA) is frequently used to treat early stage hepatocellular carcinoma. Two of the most cumbersome side-effects of the ablation procedure are intractable pain and vagotonia when deep sedation is not used. We describe local injection of anesthetic into Glisson's sheath as a new technique for overcoming these problems. Lidocaine was injected into Glisson's sheath when radiofrequency ablation of hepatocellular carcinomas, which were located adjacent to Glisson's sheath, could not be continued due to severe pain (n=8) or bradycardia (n=3). In all three patients who showed vagotonia with bradycardia during the ablations, injection of lidocaine prevented bradycardia, allowing completion of the radiofrequency ablation. Pain was reduced in all eight patients who experienced pain during ablation. No side-effects were observed during the procedures. Injection of anesthetic into Glisson's sheath is simple and effective for reducing intractable pain and vagotonia associated with RFA.	[Nakamura, Shinichiro; Kuwaki, Kenji; Hagihara, Hiroaki; Takeuchi, Yasuto; Wada, Nozomu; Morimoto, Yuki; Miyahara, Koji; Yasunaka, Tetsuya; Miyake, Yasuhiro; Shiraha, Hidenori; Takaki, Akinobu; Yamamoto, Kazuhide] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama 7008558, Japan; [Nouso, Kazuhiro; Onishi, Hideki; Ikeda, Fusao] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Hepatol, Okayama 7008558, Japan; [Ishikawa, Shinichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Anesthesiol & Resuscitol, Okayama 7008558, Japan; [Kobayashi, Yoshiyuki] Hiroshima City Hosp, Dept Internal Med, Hiroshima, Japan	Nouso, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Hepatol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	nouso@cc.okayama-u.ac.jp					Lee S, 2009, AM J ROENTGENOL, V192, P1064, DOI 10.2214/AJR.08.1350; Berthoud HR, 2004, ANAT REC PART A, V280A, P827, DOI 10.1002/ar.a.20088; Hinshaw JL, 2006, AM J ROENTGENOL, V186, pS306, DOI 10.2214/AJR.05.0140	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	DEC	2014	44	13					1367	1370		10.1111/hepr.12321		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AU1DX	WOS:000345362300012		
J	Farley, A; Pahom, O; Ramonda, K				Farley, Andrew; Pahom, Olga; Ramonda, Kris			Is a Picture Worth a Thousand Words? Using Images to Create a Concreteness Effect for Abstract Words: Evidence from Beginning L2 Learners of Spanish	HISPANIA-A JOURNAL DEVOTED TO THE TEACHING OF SPANISH AND PORTUGUESE			English	Article						abstract words/palabras abstractas; bilingualism/bilinguismo; concrete words/palabras concretas; concreteness effect/efecto de la concrecion; dual coding theory/teoria de la codificacion dual; lexical representation/representacion lexica	DUAL CODING THEORY; SHORT-TERM-MEMORY; BILINGUAL MEMORY; VOCABULARY; RECALL; TRANSLATION; LEXICON	This study examines the lexical representation and recall of abstract words by beginning L2 learners of Spanish in the light of the predictions of the dual coding theory (Paivio 1971; Paivio and Desrochers 1980). Ninety-seven learners (forty-four males and fifty-three females) were randomly placed in the picture or non-picture group and taught twelve concrete and twelve abstract words they did not previously know. Subjects performed a recall task on an immediate and a delayed posttest. The results showed that associating abstract words with pictures had a significant effect on their recall on the immediate posttest, but no such effect was found on the delayed posttest. The results suggest that associating abstract lexical items with pictures has a significant effect on memory representation and recall in the short term. The findings also support the predictions of the dual coding theory and show that a concreteness effect can be created for abstract words by associating them with visual images.	[Farley, Andrew; Pahom, Olga] Texas Tech Univ, Lubbock, TX 79409 USA; [Ramonda, Kris] Ritsumeikan Asia Pacific Univ, Beppu, Oita, Japan	Farley, A (reprint author), Texas Tech Univ, Lubbock, TX 79409 USA.						DEGROOT AMB, 1994, J MEM LANG, V33, P600, DOI 10.1006/jmla.1994.1029; ELLIS N, 1993, Q J EXP PSYCHOL-A, V46, P533; Chun DM, 1996, MOD LANG J, V80, P183, DOI 10.2307/328635; Altarriba J, 2004, AM J PSYCHOL, V117, P389, DOI 10.2307/4149007; Boers F, 2007, LANG TEACH RES, V11, P43, DOI 10.1177/1362168806072460; Shen HH, 2010, LANG TEACH RES, V14, P485, DOI 10.1177/1362168810375370; Barcroft J, 2009, LANG AWARE, V18, P74, DOI 10.1080/09658410802557535; Barcroft Joe, 2008, MENTAL LEXICON, V3, P325; CARAMAZZA A, 1980, CAN J PSYCHOL, V34, P77, DOI 10.1037/h0081016; DEGROOT AMB, 1992, J EXP PSYCHOL LEARN, V18, P1001, DOI 10.1037/0278-7393.18.5.1001; Duthie JK, 2008, APPL PSYCHOLINGUIST, V29, P151, DOI 10.1017/S0142716408080077; Farley AP, 2012, LANG TEACH RES, V16, P449, DOI 10.1177/1362168812436910; GOGGIN J, 1971, J VERB LEARN VERB BE, V10, P453, DOI 10.1016/S0022-5371(71)80046-4; HEREDIA R. R., 2008, INTRO BILINGUALISM P, P39; Jones L, 2004, LANG LEARN TECHNOL, V8, P122; Liu J, 2004, TESOL QUART, V38, P225; PAIVIO A, 1991, CAN J PSYCHOL, V45, P255, DOI 10.1037/h0084295; Paivio A, 2000, CAN J EXP PSYCHOL, V54, P149, DOI 10.1037/h0087337; PAIVIO A, 1981, J VERB LEARN VERB BE, V20, P532, DOI 10.1016/S0022-5371(81)90156-0; Paivio A., 1971, IMAGERY VERBAL PROCE; PAIVIO A, 1980, CAN J PSYCHOL, V34, P388, DOI 10.1037/h0081101; Sadoski M., 2005, READ WRIT Q, V21, P221, DOI [10.1080/10573560590949359, DOI 10.1080/10573560590949359]; SCHWANENFLUGEL PJ, 1986, J MEM LANG, V25, P605, DOI 10.1016/0749-596X(86)90014-8; SCHWANENFLUGEL PJ, 1992, MEM COGNITION, V20, P96, DOI 10.3758/BF03208259; VAID J, 1988, CAN J PSYCHOL, V42, P84, DOI 10.1037/h0084176	25	0	0	AMER  ASSOC TEACHERS SPANISH PORTUGUESE, INC	WALLED LAKE	900 LADD RD, WALLED LAKE, MI 48390 USA	0018-2133	2153-6414		HISPANIA-J DEV INTER	Hispania-J. Devoted Teach. Span. Port.	DEC	2014	97	4					634	650				17	Linguistics; Language & Linguistics; Literature, Romance	Linguistics; Literature	AU3DZ	WOS:000345494100010		
J	Uozaki, H; Morita, S; Kumagai, A; Aso, T; Soejima, Y; Takahashi, Y; Fukusato, T				Uozaki, Hiroshi; Morita, Shigeki; Kumagai, Arisa; Aso, Tatsuya; Soejima, Yurie; Takahashi, Yoshihisa; Fukusato, Toshio			Stromal miR-21 is more important than miR-21 of tumour cells for the progression of gastric cancer	HISTOPATHOLOGY			English	Article						cancer stroma; cancer-associated fibroblast; gastric cancer; in-situ hybridization; miR-21	MICRORNA-21; PROLIFERATION; EXPRESSION; BIOMARKERS; CARCINOMA; SURVIVAL; INVASION; PDCD4	BackgroundGastric cancer (GC) is a common cancer globally. miRNA-21 (miR-21) appears to be important in the tumourigenesis of almost all types of human cancer. However its precise localization in GC has yet to be clarified. We thus examined miR-21 localization in GC and revealed its clinicopathological importance. MethodsTissue arrays of 469 GCs from 454 patients were examined for miR-21 using in situ hybridization (ISH). The positivity was evaluated separately in tumour cells and stromal cells. Conventional sections of 10 GCs were also stained. Eight cases were examined by quantitative RT-PCR (qRT-PCR). ResultsmiR-21 was highly expressed in tumour cells of 44% of cases and in cancer stroma of 51% of cases. miR-21 of tumour cells was not related to clinicopathological factors, whereas stromal miR-21 was related to many factors including tumour stage, size, and nodal metastasis. Stromal miR-21 gradually increased during tumour progression. ISH of whole sections showed stronger stromal positivity in invasive areas with desmoplastic reaction. Cancer stroma also showed higher miR-21 expression than tumour and non-tumourous tissue in the qRT-PCR study. ConclusionStromal miR-21 is closely related to tumour progression in GC. Stromal miR-21 of tumours might be a target of treatment.	[Uozaki, Hiroshi; Morita, Shigeki; Kumagai, Arisa; Aso, Tatsuya; Soejima, Yurie; Takahashi, Yoshihisa; Fukusato, Toshio] Teikyo Univ, Dept Pathol, Sch Med, Tokyo 1738605, Japan	Uozaki, H (reprint author), Teikyo Univ, Dept Pathol, Sch Med, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	uozaki@med.teikyo-u.ac.jp					Pan XA, 2010, CANCER BIOL THER, V10, P1224, DOI 10.4161/cbt.10.12.14252; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Li L, 2014, J BUON, V19, P228; Zhang BG, 2012, ONCOL REP, V27, P1019, DOI 10.3892/or.2012.1645; Song SM, 2013, NAT REV GASTRO HEPAT, V10, P109, DOI 10.1038/nrgastro.2012.210; Cui L, 2013, CANCER-AM CANCER SOC, V119, P1618, DOI 10.1002/cncr.27903; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Nielsen BS, 2011, CLIN EXP METASTAS, V28, P27, DOI 10.1007/s10585-010-9355-7; Wu WKK, 2010, ONCOGENE, V29, P5761, DOI 10.1038/onc.2010.352; Li XH, 2010, GUT, V59, P579, DOI 10.1136/gut.2008.175497; Barua RR, 2006, J GASTROENTEROL, V41, P733, DOI 10.1007/s00535-006-1841-y; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94; Tili E, 2013, IMMUNOL REV, V253, P167, DOI 10.1111/imr.12050; Yao Q, 2011, INT J CANCER, V128, P1783, DOI 10.1002/ijc.25506; Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Rask L, 2011, APMIS, V119, P663, DOI 10.1111/j.1600-0463.2011.02782.x; Price TJ, 2012, EXPERT REV GASTROENT, V6, P199, DOI [10.1586/egh.11.103, 10.1586/EGH.11.103]; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Song JN, 2013, ONCOL LETT, V6, P1733, DOI 10.3892/ol.2013.1626; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31; Horimoto Y, 2012, CELL ADHES MIGR, V6, P193, DOI 10.4161/cam.20631; Motoyama K, 2010, INT J ONCOL, V36, P1089, DOI 10.3892/ijo_00000590; Wang F, 2012, CANCER BIOMARK, V11, P259, DOI 10.3233/CBM-2012-00284; Belair C, 2009, CLIN MICROBIOL INFEC, V15, P806, DOI 10.1111/j.1469-0691.2009.02960.x; Bullock MD, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.213; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/PL00011681]; Kadera BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071978; Li Q, 2013, SCI REP-UK, V3, DOI 10.1038/srep02038; Nouraee N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073009; Wang JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073683; Zhu X, 2013, DIGEST DIS SCI, V59, P911	31	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	DEC	2014	65	6					775	783		10.1111/his.12491		9	Cell Biology; Pathology	Cell Biology; Pathology	AU4IO	WOS:000345574400006		
J	Zen, Y; Britton, D; Mitra, V; Pike, I; Sarker, D; Itoh, T; Heaton, N; Quaglia, A				Zen, Yoh; Britton, David; Mitra, Vikram; Pike, Ian; Sarker, Debashis; Itoh, Tomoo; Heaton, Nigel; Quaglia, Alberto			Tubulin beta-III: a novel immunohistochemical marker for intrahepatic peripheral cholangiocarcinoma	HISTOPATHOLOGY			English	Article						bile duct; biomarker; cancer; cholangiocarcinoma; liver; proteomics	CELL LUNG-CANCER; BILIARY INTRAEPITHELIAL NEOPLASIA; INTRADUCTAL PAPILLARY NEOPLASM; HEPATOCELLULAR-CARCINOMA; METASTATIC ADENOCARCINOMA; BINDING AGENTS; BILE-DUCT; EXPRESSION; LIVER; PACLITAXEL	AimsOur recent proteomic study identified tubulin -III (TUBB3) as a potential tissue marker for intrahepatic cholangiocarcinomas (CCs). This validation study was conducted to see whether or not TUBB3 can serve as a novel immunohistochemical marker for peripheral CCs, using a large cohort (n=197) covering various liver tumours and premalignant conditions. Methods and resultsImmunostaining using a monoclonal antibody demonstrated TUBB3 expression in 14/28 cases of peripheral CCs (50%), while its expression was significantly less common in perihilar CCs (6/40, 15%) (P=0.002). No significant difference was identified in clinicopathological features between TUBB3-positive and -negative cases. TUBB3 expression was entirely negative in hepatocellular carcinomas, biliary premalignant lesions (i.e., biliary intraepithelial neoplasias, intraductal papillary neoplasms), peribiliary gland hamartomas (bile duct adenomas), and non-neoplastic biliary epithelium. TUBB3 expression was only focally noted in 2/12 cases of mixed hepatocellular and cholangiocarcinomas (<10% of cancer cells). Compared with other biliary (CK7 and CK19) and malignant markers (p53 and MUC1), TUBB3 was less sensitive but more specific for peripheral CCs. TUBB3 was also expressed in 40% of metastatic colorectal or breast cancers. ConclusionsThis study revealed that TUBB3 is a moderately sensitive and highly specific tissue marker for discriminating peripheral CCs from other primary liver tumours.	[Zen, Yoh; Sarker, Debashis; Heaton, Nigel; Quaglia, Alberto] Kings Coll Hosp London, Inst Liver Studies, London SE5 8RX, England; [Zen, Yoh; Itoh, Tomoo] Kobe Univ, Grad Sch Med, Dept Diagnost Pathol, Kobe, Hyogo 6500017, Japan; [Britton, David; Mitra, Vikram; Pike, Ian] Proteome Sci Plc, Cobham, Surrey, England	Zen, Y (reprint author), Kobe Univ, Grad Sch Med, Dept Diagnost Pathol, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	yohzen@med.kobe-u.ac.jp					Aishima S, 2007, AM J SURG PATHOL, V31, P1059, DOI 10.1097/PAS.0b013e31802b34b6; Aishima S, 2003, MODERN PATHOL, V16, P1019, DOI 10.1097/01.MP.0000086860.65672.73; Fujimoto K, 2011, ONCOL REP, V25, P1211, DOI 10.3892/or.2011.1194; Aishima S, 2011, AM J SURG PATHOL, V35, P590, DOI 10.1097/PAS.0b013e31820ffdf1; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Zhang HL, 2012, LUNG CANCER, V77, P9, DOI 10.1016/j.lungcan.2012.01.005; Mozzetti S, 2005, CLIN CANCER RES, V11, P298; Seve P, 2005, MOL CANCER THER, V4, P2001, DOI 10.1158/1535-7163.MCT-05-0244; Rizvi S, 2013, GASTROENTEROLOGY, V145, P1215, DOI 10.1053/j.gastro.2013.10.013; Verhey KJ, 2007, CELL CYCLE, V6, P2152; Yan BC, 2010, AM J SURG PATHOL, V34, P1147, DOI 10.1097/PAS.0b013e3181e5dffa; Seve P, 2008, LANCET ONCOL, V9, P168, DOI 10.1016/S1470-2045(08)70029-9; Liau JY, 2014, MODERN PATHOL, V27, P1163, DOI 10.1038/modpathol.2013.241; Zen C, 2011, LIVER TRANSPLANT, V17, P943, DOI 10.1002/lt.22314; Zen Y, 2006, J HEPATOL, V44, P350, DOI 10.1016/j.jhep.2005.09.025; Edelman MJ, 2013, J CLIN ONCOL, V31, P1990, DOI 10.1200/JCO.2012.45.3282; Shimonishi T, 2000, HISTOPATHOLOGY, V37, P55, DOI 10.1046/j.1365-2559.2000.00932.x; Ward SC, 2010, MODERN PATHOL, V23, P1180, DOI 10.1038/modpathol.2010.105; Toffart AC, 2014, LUNG CANCER, V83, P182, DOI 10.1016/j.lungcan.2013.12.003; Zhu ZW, 2001, GUT, V48, P558, DOI 10.1136/gut.48.4.558; Sempoux C, 2011, SEMIN LIVER DIS, V31, P49, DOI 10.1055/s-0031-1272839; Lau SK, 2002, HUM PATHOL, V33, P1175, DOI 10.1053/hupa.2002.130104; Bosman FT, 2010, PATHOLOGY GENETICS T; Edge SB, 2010, AJCC CANC STAGING MA; Guedj N, 2009, J HEPATOL, V51, P93, DOI 10.1016/j.jhep.2009.03.017; Hwang JE, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-431; Komuta M, 2012, HEPATOLOGY, V55, P1876, DOI 10.1002/hep.25595; Kuhn R, 2002, INVEST NEW DRUG, V20, P351, DOI 10.1023/A:1016209901417; Nakanishi Y, 2008, HUM PATHOL, V39, P1153, DOI 10.1016/j.humpath.2007.11.018; OJANGUREN I, 1995, HISTOPATHOLOGY, V26, P63, DOI 10.1111/j.1365-2559.1995.tb00622.x; Porcell AI, 2000, MODERN PATHOL, V13, P773, DOI 10.1038/modpathol.3880134; SAXTON WM, 1984, J CELL BIOL, V99, P2175, DOI 10.1083/jcb.99.6.2175; Zen Y, 2011, HISTOPATHOLOGY, V59, P1100, DOI 10.1111/j.1365-2559.2011.04048.x; Zen Y., 2013, EUPA OPEN PROTEOMICS, V1, P38	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	DEC	2014	65	6					784	792		10.1111/his.12497		9	Cell Biology; Pathology	Cell Biology; Pathology	AU4IO	WOS:000345574400007		
J	Takahashi, H; Ohkuma, T; Tsuruta, T; Saegusa, M				Takahashi, Hiroyuki; Ohkuma, Takuya; Tsuruta, Tomoko; Saegusa, Makoto			combination of nuclear beta-catenin and atypical scores as useful diagnostic markers for borderline malignancy of gastric tumours	HISTOPATHOLOGY			English	Article						atypical score; ESD; gastric carcinoma; -catenin	CANCER STEM-CELLS; EPITHELIAL-DYSPLASIA; CARCINOMA; EXPRESSION; DIFFERENTIATION; RESECTION; ADHESION; BIOPSY; WNT	AimsAlthough recent advances in endoscopic technology, including submucosal dissection (ESD), contribute to significant improvement in detection and treatment for early gastric carcinomas (GCas), discrepant diagnosis between forceps biopsied and ESD sections sometimes occurs. Here, we focused on histological markers for accurate diagnosis of gastric tumours in forceps biopsied samples before ESD treatment. Methods and resultsA total of 136 cases of gastric tumours, including 25 adenomas and 111 GCas, were investigated using a combination of forceps biopsied and ESD samples. Atypical scores based on both nuclear and branching parameters could distinguish between adenomas and GCas in both samples. The labelling indices (LIs) of nuclear -catenin were significantly higher in GCas than adenomas, and positively correlated with atypical scores, as well as branching parameters. In addition, nuclear -catenin immunoreactivity showing small cluster pattern was colocalized with immunoreactivity for aldehyde dehydrogenase 1 (ALDH1), known as a cancer stem cell (CSC) marker, which suggests the presence of some CSC population, and may be due to formation of dynamic tubular branching in GCas. ConclusionsA combination of nuclear -catenin and atypical scores may be useful for differential diagnosis of borderline malignancy of gastric tumours.	[Takahashi, Hiroyuki; Ohkuma, Takuya; Tsuruta, Tomoko; Saegusa, Makoto] Kitasato Univ, Dept Pathol, Sch Med, Sagamihara, Kanagawa 2520374, Japan	Saegusa, M (reprint author), Kitasato Univ, Dept Pathol, Sch Med, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	msaegusa@med.kitasato-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24790361]; 'Parents' Association Grant of Kitasato University	This study was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#24790361) and 'Parents' Association Grant of Kitasato University.	Saegusa M, 2009, AM J PATHOL, V174, P2107, DOI 10.2353/ajpath.2009.081018; Saegusa M, 2001, J PATHOL, V194, P59, DOI 10.1002/path.856; Park JS, 2013, DIGEST LIVER DIS, V45, P170, DOI 10.1016/j.dld.2012.09.008; Pollack AL, 1997, J CELL BIOL, V137, P1651, DOI 10.1083/jcb.137.7.1651; HOWSON CP, 1986, EPIDEMIOL REV, V8, P1; Katoh M, 2011, CURR PHARM BIOTECHNO, V12, P160, DOI 10.2174/138920111794295710; Kokkola A, 1996, J CLIN PATHOL, V49, P979, DOI 10.1136/jcp.49.12.979; FERTITTA AM, 1993, ENDOSCOPY, V25, P265, DOI 10.1055/s-2007-1010311; Wong MH, 1998, J CELL BIOL, V141, P765, DOI 10.1083/jcb.141.3.765; Schlemper RJ, 1997, LANCET, V349, P1725, DOI 10.1016/S0140-6736(96)12249-2; RUGGE M, 1994, GASTROENTEROLOGY, V107, P1288; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; SARAGA EP, 1987, AM J SURG PATHOL, V11, P788, DOI 10.1097/00000478-198710000-00006; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; Zhi QM, 2011, BIOMED PHARMACOTHER, V65, P509, DOI 10.1016/j.biopha.2011.06.006; Hull MJ, 2006, AM J SURG PATHOL, V30, P114, DOI 10.1097/01.pas.0000180438.56528.a0; OZAWA M, 1989, EMBO J, V8, P1711; DIGREGORIO C, 1993, AM J GASTROENTEROL, V88, P1714; FORMAN D, 1993, LANCET, V341, P1359; LANSDOWN M, 1990, GUT, V31, P977, DOI 10.1136/gut.31.9.977; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; Brabletz T, 1998, PATHOL RES PRACT, V194, P701; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Gotoda T, 2000, GASTRIC CANCER, V3, P219, DOI 10.1007/PL00011720; Gumbiner B, 1997, CURR OPIN CELL BIOL, V7, P634; Hirota T, 1992, PATHOLOGY GASTROINTE, P570; Japanese Gastric Cancer Association, 2001, GASTRIC CANCER, V14, P101; KANEKO E, 1977, Gut, V18, P626, DOI 10.1136/gut.18.8.626; Kirchner T, 2000, AM J PATHOL, V157, P1113, DOI 10.1016/S0002-9440(10)64626-3; Lauwers GY, 2010, WHO CLASSIFICATION T, P48; Lee IS, 2013, ANN SURG ONCOL, V20, P4231, DOI 10.1245/s10434-013-3196-y; Lewin KJ, 1992, GASTROINTESTINAL PAT; Okamoto K, 2012, SURG ENDOSC, V26, P3676, DOI 10.1007/s00464-012-2364-7; RUGGE M, 1991, HUM PATHOL, V22, P1002, DOI 10.1016/0046-8177(91)90008-D; SANO T, 1992, BRIT J SURG, V79, P241, DOI 10.1002/bjs.1800790319; Seagusa M, 2004, AM J PATHOL, V164, P1739; Shimada Y, 2004, Jpn J Clin Oncol, V34, P58; Weston CR, 2001, SCIENCE, V292, P2439, DOI 10.1126/science.1063279	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	DEC	2014	65	6					828	838		10.1111/his.12513		11	Cell Biology; Pathology	Cell Biology; Pathology	AU4IO	WOS:000345574400011		
J	Tse, GM; Ni, YB; Tsang, JYS; Shao, MM; Huang, YH; Luo, MH; Lacambra, MD; Yamaguchi, R; Tan, PH				Tse, Gary M.; Ni, Yun-Bi; Tsang, Julia Y. S.; Shao, Mu-Min; Huang, Yu-Hua; Luo, Ming-Hua; Lacambra, Maribel D.; Yamaguchi, Rin; Tan, Puay-Hoon			Immunohistochemistry in the diagnosis of papillary lesions of the breast	HISTOPATHOLOGY			English	Article						breast cancer; diagnosis; immunohistochemistry; papillary lesions	CARCINOMA IN-SITU; INTRADUCTAL PAPILLOMA; DIFFERENTIAL-DIAGNOSIS; CYTOKERATINS; P63	AimsMany immunohistochemical markers have been studied for differentiating papillary lesions. However, their differentiating power has not been evaluated comprehensively. Additionally, assessment of some markers will require the difficult task of identifying different cell types. In the current study, we aimed to devise a simple papillary panel which can aid in diagnosis irrespective of architectural pattern and cell type differentiation. Methods and resultsImmunohistochemical analysis of papillary lesions using myoepithelial markers [p63 and smooth muscle actin (SMA)], high molecular weight cytokeratins (HMWCKs: CK5, CK5/6, CK14 and 34E12), hormone receptors (ER and PR) and neuroendocrine markers (chromogranin and synaptophysin) was performed. Among them, neuroendocrine markers showed high specificity but low sensitivity. HMWCK specificity was better than that for myoepithelial markers. Homogeneous staining pattern for hormonal receptors rather than their percentage positivity was more effective in identifying malignant lesions. Negative staining for two or more of HMWCKs, namely CK5/6, CK14 and 34E12, achieved the best overall specificity and sensitivity of 87.8% and 94.1%, respectively, irrespective of the architecture. Their discriminatory power was validated with an independent cohort of core needle biopsies. ConclusionsA marker panel with HMWCKs could be used in differentiating papillary lesions irrespective of architectural pattern or cell type differentiation.	[Tse, Gary M.; Ni, Yun-Bi; Tsang, Julia Y. S.; Lacambra, Maribel D.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Shao, Mu-Min] Guangzhou Univ Tradit Chinese Med, Shenzhen Affiliated Hosp, Dept Pathol, Shenzhen, Peoples R China; [Huang, Yu-Hua] Shenzhen Second People Hosp, Dept Pathol, Shenzhen, Peoples R China; [Luo, Ming-Hua] Peking Univ, Shenzhen Hosp, Dept Pathol, Shenzhen, Peoples R China; [Yamaguchi, Rin] Kurume Univ, Dept Pathol, Kurume, Fukuoka 830, Japan; [Tan, Puay-Hoon] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore	Tse, GM (reprint author), Prince Wales Hosp, Dept Anat & Cellular Pathol, Ngan Shing St, Shatin, Hong Kong, Peoples R China.	garytse@cuhk.edu.hk					Collins LC, 2008, HISTOPATHOLOGY, V52, P20, DOI 10.1111/j.1365-2559.2007.02898.x; Reisenbichler ES, 2011, MODERN PATHOL, V24, P185, DOI 10.1038/modpathol.2010.197; Hill CB, 2005, AM J CLIN PATHOL, V123, P36, DOI 10.1309/XG7TPQ16DMJAV8P1; Ichihara S, 2007, PATHOL INT, V57, P126, DOI 10.1111/j.1440-1827.2006.02069.x; Furuya C, 2012, PATHOL INT, V62, P381, DOI 10.1111/j.1440-1827.2012.02811.x; Grin A, 2009, AM J SURG PATHOL, V33, P1615, DOI 10.1097/PAS.0b013e3181aec446; KRAUS FT, 1962, CANCER, V15, P444, DOI 10.1002/1097-0142(196205/06)15:3<444::AID-CNCR2820150303>3.0.CO;2-0; MacGrogen G, 2012, INTRADUCTAL PAPILLAR; Moritani S, 2007, VIRCHOWS ARCH, V450, P539, DOI 10.1007/s00428-007-0402-y; Nicolas MM, 2007, HISTOPATHOLOGY, V51, P657, DOI 10.1111/j.1365-2559.2007.02849.x; Tan PH, 2005, AM J SURG PATHOL, V29, P625, DOI 10.1097/01.pas.0000157941.88161.39; Tse GMK, 2007, J CLIN PATHOL, V60, P315, DOI 10.1136/jcp.2006.036830; Yamaguchi R, 2014, J CLIN PATHOL, V67, DOI 10.1136/jclinpath-2013-201749	13	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-0167	1365-2559		HISTOPATHOLOGY	Histopathology	DEC	2014	65	6					839	853		10.1111/his.12453		15	Cell Biology; Pathology	Cell Biology; Pathology	AU4IO	WOS:000345574400012		
J	Zheng, PM; Aoki, D; Yoshida, M; Matsushita, Y; Imai, T; Fukushima, K				Zheng, Peiming; Aoki, Dan; Yoshida, Masato; Matsushita, Yasuyuki; Imai, Takanori; Fukushima, Kazuhiko			Lignification of ray parenchyma cells in the xylem of Pinus densiflora. Part I: Microscopic investigation by POM, UV microscopy, and TOF-SIMS	HOLZFORSCHUNG			English	Article						heartwood; lignification; Pinus densiflora; polarized optical microscopy (POM); ray parenchyma cells; sapwood; time-of-flight secondary ion mass spectrometry (TOF-SIMS); ultraviolet (UV) microscopy	WOOD; LIGNIN; TRACHEIDS; HEARTWOOD; CAMBIUM; TREES; DEATH	The lignification process from sapwood (sW) to heartwood (hW) in ray parenchyma cells (P-ray) of Pinus densiflora has been analyzed by means of ultraviolet (UV) microscopy, acetyl bromide (CH3COBr) lignin determination, and time-of-flight secondary ion mass spectrometry (TOF-SIMS). The cell wall layers were localized by polarized optical microscopy (POM). POM revealed that P-ray have almost no secondary wall in sW and have only the outer layer of secondary wall (S-1) in the transition zone (TZ) and hW. UV microscopic observations indicated that the secondary wall of P-ray, which is in contact with ray tracheids (Tr-ray), begins to lignify in sW, while the secondary wall of P-ray, which is not in contact with Tr-ray, is partially lignified in the TZ. The secondary wall of both types of P-ray is completely lignified in hW. The CH3COBr lignin content in sW is slightly lower than that in hW. In the TOF-SIMS measurements, the relative intensities of the secondary ions of guaiacyl-lignin (G-lignin) in the rays in sW are significantly lower than those in hW.	[Fukushima, Kazuhiko] Nagoya Univ, Grad Sch Bioagr Sci, Wood Chem Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Zheng, Peiming; Aoki, Dan; Yoshida, Masato; Matsushita, Yasuyuki; Imai, Takanori] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	Fukushima, K (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Wood Chem Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	kazu@agr.nagoya-u.ac.jp	Aoki, Dan/I-6926-2014		Japan Society for the Promotion of Science [21228004, 25252032, 25114508]	This work was supported by the Japan Society for the Promotion of Science (Nos. 21228004, 25252032, and 25114508). We thank Hiroyuki Yamamoto (Graduate School of Bioagricultural Science, Nagoya University, Nagoya, Japan) for support with sample preparation and Ruka Takama (Technical Center, Nagoya University, Nagoya, Japan) for technical support with the TOF-SIMS measurements.	Yoshinaga A, 2012, TREE PHYSIOL, V32, P1129, DOI 10.1093/treephys/tps075; Goacher RE, 2011, ANAL CHEM, V83, P804, DOI 10.1021/ac1023028; Fukushima RS, 2001, J AGR FOOD CHEM, V49, P3133, DOI 10.1021/jf010449r; Hatfield R, 2005, CROP SCI, V45, P832, DOI 10.2135/cropsci2004.0238; Plomion C, 2001, PLANT PHYSIOL, V127, P1513, DOI 10.1104/pp.127.4.1513; Song K, 2011, J TROP FOR SCI, V23, P478; Rabbani S, 2011, ANAL CHEM, V83, P3793, DOI 10.1021/ac200288v; Burtin P, 1998, TREES-STRUCT FUNCT, V12, P258; Catesson A.M., 1990, VASCULAR CAMBIUM, P63; Chaffey N, 2001, PLANTA, V213, P811, DOI 10.1007/s004250100560; Filippis L.D., 2012, HOLZFORSCHUNG, V66, P543; Fujikawa S., 1975, Mokuzai Gakkaishi (Journal of the Japan Wood Research Society), V21, P445; Funada R, 2000, PLANT MICROTUBULES, P51; Harada H., 1965, CELLULAR ULTRASTRUCT, P215; Johnson D. B., 1961, TAPPI, V44, P793; Magel E., 2000, MOL CELL BIOL WOOD F, P363; Morais C.M., 2012, WOOD SCI TECHNOL, V46, P709; Nakaba S, 2006, PLANT CELL REP, V25, P1143, DOI 10.1007/s00299-006-0194-6; Nakaba S, 2008, TREES-STRUCT FUNCT, V22, P623, DOI 10.1007/s00468-008-0220-0; PANDALAI RC, 1985, WOOD SCI TECHNOL, V19, P201; Saito K, 2005, BIOMACROMOLECULES, V6, P678, DOI 10.1021/bm049521v; Sauter JJ, 2000, EXPTL BIOL REV, P71; Spicer R, 2007, PLANT CELL ENVIRON, V30, P934, DOI 10.1111/j.1365-3040.2007.01677.x; Wardrop A.B., 1964, FORMATION WOOD FORES, P87; YAMAMOTO K, 1977, Research Bulletin of the Hokkaido University Forests, V34, P79; Yamamoto K., 1982, Research Bulletins, College Experiment Forests, Hokkaido University, V39, P245	26	2	2	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0018-3830	1437-434X		HOLZFORSCHUNG	Holzforschung	DEC	2014	68	8					897	905		10.1515/hf-2013-0231		9	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	AU4GY	WOS:000345569600006		
J	Zheng, PM; Aoki, D; Matsushita, Y; Yagami, S; Fukushima, K				Zheng, Peiming; Aoki, Dan; Matsushita, Yasuyuki; Yagami, Sachie; Fukushima, Kazuhiko			Lignification of ray parenchyma cells in the xylem of Pinus densiflora. Part II: Microchemical analysis by laser microdissection and thioacidolysis	HOLZFORSCHUNG			English	Article						dimeric thioacidolysis product; heartwood; laser microdissection; lignification; ray parenchyma cells; sapwood; thioacidolysis; thioacidolysis followed by Raney nickel desulfuration; thioacidolysis monomer	LIGNIN; DEATH	The lignification of ray parenchyma cells in the sapwood (sW) and heartwood (hW) of Pinus densiflora was investigated by thioacidolysis and the subsequent Raney nickel desulfuration. The samples rich and less rich in ray parenchyma cells were prepared by laser microdissection (LMD). The whole sections burned randomly by the laser served as the controls. Guaiacyl (G) monomers were detected in all the samples, and p-hydroxyphenyl (H) monomers were detectable only in trace amounts, while syringyl (S) units were absent, as expected in softwood. In sW samples rich in ray parenchyma cells, the yields of G monomers are significantly lower than in the other samples. The various types of G-G and one G-H dimers were detected, and the beta-1', beta-5', and 5-5' dimers were dominant. The relative distributions of lignin interunit linkages were very similar in all the samples regardless of the abundance of the ray parenchyma cells in the sW or hW tissues.	[Fukushima, Kazuhiko] Nagoya Univ, Grad Sch Bioagr Sci, Wood Chem Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Zheng, Peiming; Aoki, Dan; Matsushita, Yasuyuki; Yagami, Sachie] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	Fukushima, K (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Wood Chem Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	kazu@agr.nagoya-u.ac.jp	Aoki, Dan/I-6926-2014		Japan Society for the Promotion of Science [21228004, 25252032, 25114508]	This work was supported by the Japan Society for the Promotion of Science (Nos. 21228004, 25252032, and 25114508). We thank Hiroyuki Yamamoto (Graduate School of Bioagricultural Science, Nagoya University) for the support with sample preparation and Ikuyo Mizuguchi (Graduate School of Medicine, Nagoya University) for the technical support with the LMD.	Rencoret J, 2011, PLANT PHYSIOL, V155, P667, DOI 10.1104/pp.110.167254; LAPIERRE C, 1991, HOLZFORSCHUNG, V45, P61, DOI 10.1515/hfsg.1991.45.1.61; ADLER E, 1977, WOOD SCI TECHNOL, V11, P169; Rencoret J, 2008, HOLZFORSCHUNG, V62, P514, DOI 10.1515/HF.2008.096; Zheng PM, 2014, HOLZFORSCHUNG, V68, P897, DOI 10.1515/hf-2013-0231; Saito K, 2005, J WOOD SCI, V51, P246, DOI 10.1007/s10086-004-0644-0; SAKAKIBARA A, 1980, WOOD SCI TECHNOL, V14, P89; Bamber R. K., 1985, Forestry Abstracts, V46, P567; Burtin P, 1998, TREES-STRUCT FUNCT, V12, P258; Catesson A.M., 1990, VASCULAR CAMBIUM, P63; Chaffey N, 2001, PLANTA, V213, P811, DOI 10.1007/s004250100560; Filippis L.D., 2012, HOLZFORSCHUNG, V66, P543; Fujikawa S., 1975, Mokuzai Gakkaishi (Journal of the Japan Wood Research Society), V21, P445; Funada R, 2000, PLANT MICROTUBULES, P51; Jacquet G, 1997, HOLZFORSCHUNG, V51, P349, DOI 10.1515/hfsg.1997.51.4.349; Lapierre C., 1987, INT S WOOD PULPING C, V2, P431; Lin SY, 1992, METHODS LIGNIN CHEM, P334; Magel E., 2000, MOL CELL BIOL WOOD F, P363; Nakaba S, 2006, PLANT CELL REP, V25, P1143, DOI 10.1007/s00299-006-0194-6; Nakaba S, 2008, TREES-STRUCT FUNCT, V22, P623, DOI 10.1007/s00468-008-0220-0; Sauter JJ, 2000, EXPTL BIOL REV, P71; YAMAMOTO K, 1977, Research Bulletin of the Hokkaido University Forests, V34, P79; Yamamoto K., 1982, Research Bulletins, College Experiment Forests, Hokkaido University, V39, P245	23	1	1	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0018-3830	1437-434X		HOLZFORSCHUNG	Holzforschung	DEC	2014	68	8					907	913		10.1515/hf-2013-0232		7	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	AU4GY	WOS:000345569600007		
J	Okamoto, D; Sometani, M; Harada, S; Kosugi, R; Yonezawa, Y; Yano, H				Okamoto, Dai; Sometani, Mitsuru; Harada, Shinsuke; Kosugi, Ryoji; Yonezawa, Yoshiyuki; Yano, Hiroshi			Improved Channel Mobility in 4H-SiC MOSFETs by Boron Passivation	IEEE ELECTRON DEVICE LETTERS			English	Article						Boron passivation; channel mobility; interface state density; SiC MOSFETs	INTERFACE PROPERTIES; OXIDE; SIO2; DENSITY; N2O	We propose another process for fabricating 4H-SiC metal-oxide-semiconductor field-effect transistors (MOSFETs) with high channel mobility. The B atoms were introduced into a SiO2/4H-SiC interface by thermal annealing with a BN planar diffusion source. The interface state density near the conduction band edge of 4H-SiC was effectively reduced by the B diffusion and the fabricated 4H-SiC MOSFETs showed a peak field-effect mobility of 102 cm(2)/Vs. The obtained high channel mobility cannot be explained by counter doping because B atoms act as acceptors in 4H-SiC. We suggest that the interfacial structural change of SiO2 may be responsible for the reduced trap density and enhanced channel mobility.	[Okamoto, Dai; Sometani, Mitsuru; Harada, Shinsuke; Kosugi, Ryoji; Yonezawa, Yoshiyuki] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Yano, Hiroshi] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3050006, Japan	Okamoto, D (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan.	dai.okamoto@ieee.org			JSPS KAKENHI [26820136]	This work was supported by JSPS KAKENHI under Grant 26820136 [Grant-in-Aid for Young Scientists (B)]. The review of this letter was arranged by Editor M. Tabib-Azar.	Allerstam F., 2007, J APPL PHYS, V101; Sharma YK, 2013, IEEE ELECTR DEVICE L, V34, P175, DOI 10.1109/LED.2012.2232900; Penumatcha AV, 2013, IEEE T ELECTRON DEV, V60, P923, DOI 10.1109/TED.2013.2237777; Liu G, 2013, IEEE ELECTR DEVICE L, V34, P181, DOI 10.1109/LED.2012.2233458; Rozen J, 2011, IEEE T ELECTRON DEV, V58, P3808, DOI 10.1109/TED.2011.2164800; Yang XY, 2014, MATER SCI FORUM, V778-780, P557, DOI 10.4028/www.scientific.net/MSF.778-780.557; Afanas'ev VV, 2003, APPL PHYS LETT, V82, P568, DOI 10.1063/1.1532103; Gudjonsson G, 2005, IEEE ELECTR DEVICE L, V26, P96, DOI 10.1109/LED.2004.841191; Chung GY, 2001, IEEE ELECTR DEVICE L, V22, P176, DOI 10.1109/55.915604; Modic A, 2014, IEEE ELECTR DEVICE L, V35, P894, DOI 10.1109/LED.2014.2336592; Kimoto T, 2005, JPN J APPL PHYS 1, V44, P1213, DOI 10.1143/JJAP.44.1213; Harada S, 2002, J APPL PHYS, V91, P1568, DOI 10.1063/1.1428085; Okamoto D, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3432404; Saks NS, 2000, APPL PHYS LETT, V77, P3281, DOI 10.1063/1.1326046; Li HF, 1997, APPL PHYS LETT, V70, P2028, DOI 10.1063/1.118773; Okamoto D, 2010, IEEE ELECTR DEVICE L, V31, P710, DOI 10.1109/LED.2010.2047239; Fiorenza P, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824980; Miyazaki S, 2001, SOL ST PHEN, V76-77, P149; Morino K., 1997, P INT C SOL STAT DEV, P18; Yoshioka H, 2012, J APPL PHYS, V111, DOI 10.1063/1.3673572	20	3	3	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0741-3106	1558-0563		IEEE ELECTR DEVICE L	IEEE Electron Device Lett.	DEC	2014	35	12					1176	1178		10.1109/LED.2014.2362768		3	Engineering, Electrical & Electronic	Engineering	AU4IY	WOS:000345575400005		
J	Kashio, N; Hoshi, T; Kurishima, K; Ida, M; Matsuzaki, H				Kashio, Norihide; Hoshi, Takuya; Kurishima, Kenji; Ida, Minoru; Matsuzaki, Hideaki			Composition- and Doping-Graded-Base InP/InGaAsSb Double Heterojunction Bipolar Transistors Exhibiting Simultaneous f(t) and f(max) of Over 500 GHz	IEEE ELECTRON DEVICE LETTERS			English	Article						InGaAsSb; double heterojunction bipolar transistors (DHBTs); InP/GaAsSb; composition-graded base	DHBTS	We demonstrate composition- and doping-graded-base InP/InGaAsSb double heterojunction bipolar transistors (DHBTs) with a passivation ledge fabricated in a self-aligned process with i-line lithography. We obtained a high current gain of 52 and high breakdown voltage of 5 V for 0.2-mu m-emitter DHBTs featuring 30-nm-thick composition- and doping-graded InGaAsSb base and 100-nm-thick InP collector. The HBTs exhibit an f(t) of 501 GHz and an f(max) of 503 GHz at a collector current density of 10.6 mA/mu m(2).	[Kashio, Norihide] NTT Corp, NTT Device Innovat Ctr, Atsugi, Kanagawa 2430198, Japan; [Hoshi, Takuya; Kurishima, Kenji; Ida, Minoru; Matsuzaki, Hideaki] NTT Corp, NTT Device Technol Labs, Atsugi, Kanagawa 2430198, Japan	Kashio, N (reprint author), NTT Corp, NTT Device Innovat Ctr, Atsugi, Kanagawa 2430198, Japan.	kashio.norihide@lab.ntt.co.jp					SPIEGEL SJ, 1995, IEEE T ELECTRON DEV, V42, P1059, DOI 10.1109/16.387237; Xu HM, 2014, IEEE ELECTR DEVICE L, V35, P24, DOI 10.1109/LED.2013.2290299; Lovblom R, 2013, IEEE ELECTR DEVICE L, V34, P984, DOI 10.1109/LED.2013.2269711; Dvorak MW, 2001, IEEE ELECTR DEVICE L, V22, P361, DOI 10.1109/55.936343; Fluckiger R, 2014, IEEE ELECTR DEVICE L, V35, P166, DOI 10.1109/LED.2013.2295424; Fluckiger R, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.034105; Hoshi T., 2013, J CRYST GROWTH, V395, P31; Ida M, 2002, IEEE ELECTR DEVICE L, V23, P694, DOI 10.1109/LED.2002.806300; Kashio N, 2014, IEEE T ELECTRON DEV, V61, P3423, DOI 10.1109/TED.2014.2349872; Snodgrass W, 2007, INT EL DEVICES MEET, P663, DOI 10.1109/IEDM.2007.4419031; Snodgrass W, 2006, IEEE ELECTR DEVICE L, V27, P84, DOI 10.1109/LED.2005.862673; Urteaga M., 2011, P 69 ANN DEV RES C J, P281; Xu HuanWen, 2013, Journal of Southwest Forestry University, V33, P34	13	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0741-3106	1558-0563		IEEE ELECTR DEVICE L	IEEE Electron Device Lett.	DEC	2014	35	12					1209	1211		10.1109/LED.2014.2365216		3	Engineering, Electrical & Electronic	Engineering	AU4IY	WOS:000345575400016		
J	Kitagawa, S; Suzuki, S; Asada, M				Kitagawa, Seiichirou; Suzuki, Safumi; Asada, Masahiro			650-GHz Resonant-Tunneling-Diode VCO With Wide Tuning Range Using Varactor Diode	IEEE ELECTRON DEVICE LETTERS			English	Article						Resonant tunneling devices; submillimeter wave integrated circuits; varactors; voltage-controlled oscillators	TERAHERTZ; OSCILLATORS; TECHNOLOGY	We fabricated a wide-range varactor-tuned terahertz oscillator using a resonant tunneling diode (RTD). An AlAs/InGaAs double-barrier RTD and a varactor-diode mesa were integrated into a 20-mu m-long slot antenna. A wide tuning range of similar to 11% (70 GHz) of the center frequency of 655 GHz was achieved by changing the depletion-layer capacitance of the varactor diode with a dc sweep from -4 to 0.5 V. The dependence of the output power on the varactor-diode bias was also measured. These experimental results agreed well with theory.	[Kitagawa, Seiichirou; Asada, Masahiro] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Meguro Ku, Tokyo 1528550, Japan; [Suzuki, Safumi] Tokyo Inst Technol, Grad Sch Sci & Engn, Meguro Ku, Tokyo 1528552, Japan	Kitagawa, S (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Meguro Ku, Tokyo 1528550, Japan.	suzuki.s.av@m.titech.ac.jp			Industry-Academia Collaborative Research and Development Program through the Japan Science and Technology Agency, Japan; Strategic Information and Communications Research and Development Promotion Programme through the Ministry of Internal Affairs and Communications; Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported in part by the Industry-Academia Collaborative Research and Development Program through the Japan Science and Technology Agency, Japan, in part by the Strategic Information and Communications Research and Development Promotion Programme through the Ministry of Internal Affairs and Communications, and in part by the Scientific Grants-in-Aid through the Ministry of Education, Culture, Sports, Science and Technology, Japan. The review of this letter was arranged by Editor R. Quay.	Seo M, 2011, IEEE J SOLID-ST CIRC, V46, P2203, DOI 10.1109/JSSC.2011.2163213; Suzuki S, 2013, IEEE J SEL TOP QUANT, V19, DOI 10.1109/JSTQE.2012.2215017; Maekawa T, 2014, ELECTRON LETT, V50, P1214, DOI 10.1049/el.2014.2362; Qin Q, 2011, OPT LETT, V36, P692, DOI 10.1364/OL.36.000692; Tonouchi M, 2007, NAT PHOTONICS, V1, P97, DOI 10.1038/nphoton.2007.3; Kitagawa S, 2014, J INFRARED MILLIM TE, V35, P445, DOI 10.1007/s10762-014-0061-4; Orihashi N, 2005, ELECTRON LETT, V41, P872, DOI 10.1049/el:20051828; Tousi YM, 2012, IEEE J SOLID-ST CIRC, V47, P3032, DOI 10.1109/JSSC.2012.2217853	8	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0741-3106	1558-0563		IEEE ELECTR DEVICE L	IEEE Electron Device Lett.	DEC	2014	35	12					1215	1217		10.1109/LED.2014.2364826		3	Engineering, Electrical & Electronic	Engineering	AU4IY	WOS:000345575400018		
J	Abderrahmane, A; Ko, PJ; Okada, H; Sato, SI; Ohshima, T; Shibasaki, I; Sandhu, A				Abderrahmane, Abdelkader; Ko, Pil Ju; Okada, Hiroshi; Sato, Shin-Ichiro; Ohshima, Takeshi; Shibasaki, Ichiro; Sandhu, Adarsh			High Proton Radiation Tolerance of InAsSb Quantum-Well-Based micro-Hall Sensors	IEEE ELECTRON DEVICE LETTERS			English	Article						InAsSb quantum well; two-dimensional electron gas; micro-Hall sensors; proton irradiation		Tolerance of AlInSb/InAsSb/AlInSb heterostructures quantum-well-based micro-Hall sensors against proton irradiation of 380 keV and proton fluence in the range 10(11) and 10(16) (proton/cm(2)) is reported. Defects and deep levels induced by proton irradiation into the heterostructures caused decreases in the mobility of the micro-Hall sensors. Degradation of the magnetic sensitivity started at a proton fluence of 10(13) (proton/cm(2)) and continued with increasing proton fluence. The variation of the micro-Hall sensors sensitivity was minimal in low-doped AlInSb/InAsSb/AlInSb heterostructure quantum wells. These micro-Hall sensors were operable even at proton fluence of 10(16) (proton/cm(2)), which makes these devices suitable for space applications with lifetime of thousands of years in the outer space.	[Abderrahmane, Abdelkader; Shibasaki, Ichiro] Toyohashi Univ Technol, Dept Elect & Elect Informat Engn, Toyohashi, Aichi 4418580, Japan; [Ko, Pil Ju; Okada, Hiroshi; Sandhu, Adarsh] Toyohashi Univ Technol, Elect Inspired Interdisciplinary Res Inst, Toyohashi, Aichi 4418580, Japan; [Sato, Shin-Ichiro; Ohshima, Takeshi] Japan Atom Energy Agcy, Quantum Beam Sci Directorate, Takasaki, Gumma 3701292, Japan	Abderrahmane, A (reprint author), Toyohashi Univ Technol, Dept Elect & Elect Informat Engn, Toyohashi, Aichi 4418580, Japan.	sandhu@eiiris.tut.ac.jp	Okada, Hiroshi/G-9612-2011; Sandhu, Adarsh/A-1818-2011	Okada, Hiroshi/0000-0003-0921-880X; 			Abderrahmane A, 2012, IEEE T MAGN, V48, P4421, DOI 10.1109/TMAG.2012.2196986; Persson A, 2013, SENSOR ACTUAT A-PHYS, V189, P459, DOI 10.1016/j.sna.2012.10.037; Brudnyi VN, 2007, SEMICONDUCTORS+, V41, P1011, DOI 10.1134/S1063782607090023; Bando M., 2009, J APPL PHYS, V105; Elliot T. B., 2005, FOCUS SEMICONDUCTOR, P136; Goetz P. G., 2001, P IEEE AER C MAR, V3, P31523; Henriksen A. D., 2010, APPL PHYS LETT, V97; Kunets VP, 2009, IEEE T ELECTRON DEV, V56, P683, DOI 10.1109/TED.2009.2014187; Mango T., 2009, J CRYST GROWTH, V311, P1711; Steenbergen E. H., 2013, P SOC PHOTO-OPT INS, V8876; Sun X, 2013, MICROELECTRON ENG, V111, P77, DOI 10.1016/j.mee.2013.01.063; Weaver B. D., 2005, APPL PHYS LETT, V87	12	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0741-3106	1558-0563		IEEE ELECTR DEVICE L	IEEE Electron Device Lett.	DEC	2014	35	12					1305	1307		10.1109/LED.2014.2359879		3	Engineering, Electrical & Electronic	Engineering	AU4IY	WOS:000345575400048		
J	Nagata, M; Breems, LJ; Samori, C; Mattisson, S; Hanumolu, PK				Nagata, Makoto; Breems, Lucien J.; Samori, Carlo; Mattisson, Sven; Hanumolu, Pavan Kumar			Introduction to the Special Issue on the 2014 IEEE International Solid-State Circuits Conference (ISSCC)	IEEE JOURNAL OF SOLID-STATE CIRCUITS			English	Editorial Material									[Nagata, Makoto] Kobe Univ, Kobe, Hyogo 657, Japan; [Breems, Lucien J.] NXP Semicond, Eindhoven, Netherlands; [Samori, Carlo] Samori Politecn Milano, Milan, Italy; [Mattisson, Sven] Ericsson AB, Lund, Sweden; [Hanumolu, Pavan Kumar] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA	Nagata, M (reprint author), Kobe Univ, Kobe, Hyogo 657, Japan.							0	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9200	1558-173X		IEEE J SOLID-ST CIRC	IEEE J. Solid-State Circuit	DEC	2014	49	12			SI		2743	2747		10.1109/JSSC.2014.2366411		5	Engineering, Electrical & Electronic	Engineering	AU5AS	WOS:000345620100001		
J	Kousai, S; Onizuka, K; Wadatsumi, J; Yamaguchi, T; Kuriyama, Y; Nagaoka, M				Kousai, Shouhei; Onizuka, Kohei; Wadatsumi, Junji; Yamaguchi, Takashi; Kuriyama, Yasuhiko; Nagaoka, Masami			Polar Antenna Impedance Detection and Tuning for Efficiency Improvement in a 3G/4G CMOS Power Amplifier	IEEE JOURNAL OF SOLID-STATE CIRCUITS			English	Article						Antenna impedance detection; automatic antenna impedance tuning; back-off power efficiency improvement; CMOS power amplifier; SOI tuner		An antenna load impedance detection and automatic tuning technique is presented. An antenna load impedance detection circuit as well as burst detector enabling autonomous tuning is integrated on a CMOS-PA chip. A low-loss impedance tuner with an SOI switch is also demonstrated. The proposed impedance detection circuit employs polar detection technique, so that the antenna impedance is tuned in a vector fashion to track the time-varying antenna impedance promptly. Also, it can operate with nonconstant envelope signal thanks to an introduced relative detection technique. At the back-off operation, the impedance can be automatically tuned to optimum value. The circuit is time shared with PA linearization loop, minimizing the overhead of the circuit. When the VSWR is approximately 2.5, the peak PAE is kept more than 40% with tuning, whereas it varies from 28% to 45% without tuning. The linear efficiency without the tuning is 15% as the worst case, while more than 30% of PAE is maintained when the tuning and PA-closed loop are enabled. The drain efficiency at 6 dB back-off is improved from 30% to 40%. The tuner can cover a VSWR of around 6, while achieving a loss ranging from 0.3 to 4.6 dB.	[Kousai, Shouhei; Wadatsumi, Junji] Toshiba Co Ltd, Ctr Semicond R&D, Kawasaki, Kanagawa 2128520, Japan; [Onizuka, Kohei] Toshiba Co Ltd, Corp R&D Ctr, Kawasaki, Kanagawa 2128582, Japan; [Yamaguchi, Takashi; Kuriyama, Yasuhiko; Nagaoka, Masami] Toshiba Co Ltd, Discrete Semicond Div, Kawasaki, Kanagawa 2128582, Japan	Kousai, S (reprint author), Toshiba Co Ltd, Ctr Semicond R&D, Kawasaki, Kanagawa 2128520, Japan.						Neo WCE, 2006, IEEE J SOLID-ST CIRC, V41, P2166, DOI 10.1109/JSSC.2006.880586; Jager H, 2002, IEEE MTT-S, P1035, DOI 10.1109/MWSYM.2002.1011812; [Anonymous], 2008, IEEE J SOLID-ST CIRC; Okazaki H, 2013, URSI INT SYM ELECT, P432; Berretta G, 2006, IEEE RADIO WIRELESS, P523, DOI 10.1109/RWS.2006.1615209; Boyle KR, 2007, IEEE T ANTENN PROPAG, V55, P364, DOI 10.1109/TAP.2006.889834; Aoki I, 2002, IEEE T MICROW THEORY, V50, P316, DOI 10.1109/22.981284; Kousai S, 2012, IEEE J SOLID-ST CIRC, V47, P2964, DOI 10.1109/JSSC.2012.2217833; Asbeck P., 2012, P IEEE CICC, P1; Boyle K., 2010, P IEEE INT WORKSH AN, P1; Cheng N., 2011, P IEEE CSICS, P1; Cripps S. C., RF POWER AMPLIFIERS; Hau G., 2008, P IEEE RAD FREQ INT, P409; Ji D., 2013, P IEEE RFIC S, P341; Kousai S., 2012, IEEE INT SOL STAT CI, P84; Kousai S., 2014, IEEE INT SOL STAT CI, P58; Song H., 2009, IEEE ISSCC, P384; Yoon Y, 2014, IEEE J SOLID-ST CIRC, V49, P608, DOI 10.1109/JSSC.2013.2297414	18	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9200	1558-173X		IEEE J SOLID-ST CIRC	IEEE J. Solid-State Circuit	DEC	2014	49	12			SI		2902	2914		10.1109/JSSC.2014.2361322		13	Engineering, Electrical & Electronic	Engineering	AU5AS	WOS:000345620100015		
J	Oishi, K; Yoshida, E; Sakai, Y; Takauchi, H; Kawano, Y; Shirai, N; Kano, H; Kudo, M; Murakami, T; Tamura, T; Kawai, S; Suto, K; Yamazaki, H; Mori, T				Oishi, Kazuaki; Yoshida, Eiji; Sakai, Yasufumi; Takauchi, Hideki; Kawano, Yoichi; Shirai, Noriaki; Kano, Hideki; Kudo, Masahiro; Murakami, Tomotoshi; Tamura, Tetsuro; Kawai, Shigeaki; Suto, Kazuo; Yamazaki, Hiroshi; Mori, Toshihiko			A 1.95 GHz Fully Integrated Envelope Elimination and Restoration CMOS Power Amplifier Using Timing Alignment Technique for WCDMA and LTE	IEEE JOURNAL OF SOLID-STATE CIRCUITS			English	Article						CMOS; envelope elimination and restoration; efficiency; LTE; power amplifier	KAHN EER TECHNIQUE; DESIGN	A fully integrated envelope elimination and restoration (EER) CMOS power amplifier (PA) has been developed for WCDMA and LTE handsets. EER is a supply modulation technique that first divides modulated RF signal into envelope and phase signals and then restores it at a switching PA output. Supply voltage of the switching PA is modulated by the envelope signal through a high-speed supply modulator. EER PA is highly efficient due to the switching PA and the supply modulation. However, it generally has difficulty, especially for a wide bandwidth baseband application like LTE, achieving a wide bandwidth for phase signal path and highly accurate timing between envelope and phase signals. To overcome these challenges, an envelope/phase generator based on a mixer and a limiter was proposed to generate the wide bandwidth phase signal, and a timing aligner based on a delay locked loop with a variable high-pass filter (HPF) was proposed to compensate for the timing mismatch. The chip was implemented in 90 nm CMOS technology. Measured power-added efficiency (PAE) and adjacent channel leakage ratio (ACLR) were 39% and -41 dBc for WCDMA, and measured PAE and ACLR E-UTRA1 were 32% and -33 dBc for 20 MHz-BW LTE.	[Oishi, Kazuaki; Yoshida, Eiji; Sakai, Yasufumi; Takauchi, Hideki; Kawano, Yoichi; Yamazaki, Hiroshi; Mori, Toshihiko] Fujitsu Labs Ltd, Kawasaki, Kanagawa 211, Japan; [Shirai, Noriaki; Kano, Hideki; Kudo, Masahiro; Murakami, Tomotoshi; Tamura, Tetsuro; Kawai, Shigeaki; Suto, Kazuo] Fujitsu Semicond Ltd, Yokohama, Kanagawa, Japan	Oishi, K (reprint author), Fujitsu Labs Ltd, Kawasaki, Kanagawa 211, Japan.	k.oishi@jp.fujitsu.com					Rudolph D, 2002, IEEE T MICROW THEORY, V50, P1979, DOI 10.1109/TMTT.2002.801349; Hassan M, 2012, IEEE T MICROW THEORY, V60, P1321, DOI 10.1109/TMTT.2012.2187537; Ye L, 2013, IEEE J SOLID-ST CIRC, V48, P3160, DOI 10.1109/JSSC.2013.2281142; Yoo SM, 2013, IEEE J SOLID-ST CIRC, V48, P1212, DOI 10.1109/JSSC.2013.2252754; Wang FP, 2006, IEEE T MICROW THEORY, V54, P4086, DOI 10.1109/TMTT.2006.885575; Hanington G, 1999, IEEE T MICROW THEORY, V47, P1471, DOI 10.1109/22.780397; Wang FP, 2005, IEEE T MICROW THEORY, V53, P1244, DOI 10.1109/TMTT.2005.845716; Jeong J, 2009, IEEE J SOLID-ST CIRC, V44, P2629, DOI 10.1109/JSSC.2009.2026845; KAHN LR, 1952, P IRE, V40, P803, DOI 10.1109/JRPROC.1952.273844; Woo YY, 2006, IEEE T MICROW THEORY, V54, P1969, DOI 10.1109/TMTT.2006.872805; Buoli C., 1995, P 25 EUR MICR C SEPT, P31; Chowdhury D., 2009, IEEE INT SOL STAT CI, P378; Tsai KC, 1999, IEEE J SOLID-ST CIRC, V34, P962; Kanda K., 2012, ISSCC, P86; Kang Daehyun, 2012, IEEE INT MICR S; Kaymaksut E., 2014, IEEE INT SOL STAT CI, P64; Koo B., 2012, IEEE ISSCC, P82; Kousai S., 2012, IEEE INT SOL STAT CI, P84; Kousai S., 2014, IEEE INT SOL STAT CI, P58; Onizuka K., 2013, IEEE ISSCC, P90; Park B, 2012, EUR MICROW INTEGRAT, P341; Pinon V, 2008, IEEE INT SOL STAT CI, P564; Rudolph D, 2003, IEEE T MICROW THEORY, V51, P548, DOI 10.1109/TMTT.2002.807810; Wang CZ, 2001, IEEE RAD FREQ INTEGR, P39	24	1	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9200	1558-173X		IEEE J SOLID-ST CIRC	IEEE J. Solid-State Circuit	DEC	2014	49	12			SI		2915	2924		10.1109/JSSC.2014.2358554		10	Engineering, Electrical & Electronic	Engineering	AU5AS	WOS:000345620100016		
J	Hayashi, N; Mizuno, Y; Nakamura, K				Hayashi, Neisei; Mizuno, Yosuke; Nakamura, Kentaro			Alternative Implementation of Simplified Brillouin Optical Correlation-Domain Reflectometry	IEEE PHOTONICS JOURNAL			English	Article						Brillouin scattering; distributed measurement; optical fiber sensors; strain sensing; temperature sensing	DISTRIBUTED STRAIN-MEASUREMENT; MEASUREMENT RANGE ENLARGEMENT; SPATIAL-RESOLUTION; FREQUENCY-SHIFT; FIBER; SENSOR; MODULATION; SPECTRUM; PROPOSAL; SCHEME	We developed an alternative configuration of simplified Brillouin optical correlation-domain reflectometry, which can overcome the drawbacks of the original configuration. This system uses, as reference light, the light that is Fresnel reflected at a partial reflection point artificially produced near an optical circulator. We show that the influence of the zeroth correlation peak fixed at the partial reflection point can be suppressed by replacing the nearby fibers with other fibers having different Brillouin frequency shift values (here, multimode fibers are used). Finally, we demonstrate a distributed measurement for detecting a 1.46-m-long strained section with a high signal-to-noise (SN) ratio.	[Hayashi, Neisei; Mizuno, Yosuke; Nakamura, Kentaro] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan	Hayashi, N (reprint author), Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan.	hayashi@sonic.pi.titech.ac.jp			Japan Society for the Promotion of Science (JSPS) [26630180]; General Sekiyu Foundation; Iwatani Naoji Foundation; SCAT Foundation;  [25709032];  [25007652]	This work was supported in part by Grants-in-Aid for Young Scientists (A) under Grant 25709032 and for Challenging Exploratory Research under Grant 26630180 from the Japan Society for the Promotion of Science (JSPS) and in part by research grants from the General Sekiyu Foundation, the Iwatani Naoji Foundation, and the SCAT Foundation. The work of N. Hayashi was supported by Grants-in-Aid for JSPS Fellows under Grant 25007652.	Agrawal G. P., 1995, NONLINEAR FIBER OPTI; KURASHIMA T, 1990, APPL OPTICS, V29, P2219, DOI 10.1364/AO.29.002219; Bernini R, 2012, IEEE PHOTONICS J, V4, P48, DOI 10.1109/JPHOT.2011.2179024; HORIGUCHI T, 1989, J LIGHTWAVE TECHNOL, V7, P1170, DOI 10.1109/50.32378; Garus D, 1996, OPT LETT, V21, P1402, DOI 10.1364/OL.21.001402; Song KY, 2006, OPT LETT, V31, P2526, DOI 10.1364/OL.31.002526; Hotate K, 2000, IEICE T ELECTRON, VE83C, P405; Hotate K, 2002, IEEE PHOTONIC TECH L, V14, P179, DOI 10.1109/68.980502; Mizuno Y, 2011, J LIGHTWAVE TECHNOL, V29, P2616, DOI 10.1109/JLT.2011.2161754; SHIMIZU K, 1994, J LIGHTWAVE TECHNOL, V12, P730, DOI 10.1109/50.293961; Mizuno Y, 2010, OPT COMMUN, V283, P2438, DOI 10.1016/j.optcom.2010.02.002; Song KY, 2008, IEEE PHOTONIC TECH L, V20, P2150, DOI 10.1109/LPT.2008.2007744; Sperber T, 2010, OPT EXPRESS, V18, P8671, DOI 10.1364/OE.18.008671; HORIGUCHI T, 1995, J LIGHTWAVE TECHNOL, V13, P1296, DOI 10.1109/50.400684; Mizuno Y, 2010, J LIGHTWAVE TECHNOL, V28, P3300, DOI 10.1109/JLT.2010.2081348; KURASHIMA T, 1993, IEICE T COMMUN, VE76B, P382; Mizuno Y, 2009, OPT EXPRESS, V17, P9040, DOI 10.1364/OE.17.009040; Alahbabi MN, 2005, J OPT SOC AM B, V22, P1321, DOI 10.1364/JOSAB.22.001321; Li WH, 2008, OPT EXPRESS, V16, P21616, DOI 10.1364/OE.16.021616; Mizuno Y, 2009, IEEE PHOTONIC TECH L, V21, P474, DOI 10.1109/LPT.2009.2013643; Mizuno Y, 2008, OPT EXPRESS, V16, P12148, DOI 10.1364/OE.16.012148; Brown AW, 2007, J LIGHTWAVE TECHNOL, V25, P381, DOI 10.1109/JLT.2006.886672; Fellay A., 1997, OSA TECHNICAL DIGEST, V16, P324; Hayashi N, 2014, IEEE PHOTONICS J, V6, DOI 10.1109/JPHOT.2014.2361638; Hayashi N, 2014, J LIGHTWAVE TECHNOL, V32, P3999, DOI 10.1109/JLT.2014.2339361; Horiguchi T., 1989, IEEE Photonics Technology Letters, V1, DOI 10.1109/68.34756; Hotate K, 2002, MEAS SCI TECHNOL, V13, P1746, DOI 10.1088/0957-0233/13/11/311; Minardo A, 2014, IEEE PHOTONIC TECH L, V26, P387, DOI 10.1109/LPT.2013.2294878; Mizuno Y, 2010, OPT EXPRESS, V18, P5926, DOI 10.1364/OE.18.005926; Naruse H, 1999, APPL OPTICS, V38, P6516, DOI 10.1364/AO.38.006516; Song KY, 2007, J LIGHTWAVE TECHNOL, V25, P1238, DOI 10.1109/JLT.2007.893904; Song KY, 2010, OPT LETT, V35, P52, DOI 10.1364/OL.35.000052; Soto MA, 2008, OPT EXPRESS, V16, P19097, DOI 10.1364/OE.16.019097; Vedadi A, 2007, IEEE PHOTONIC TECH L, V19, P179, DOI 10.1109/LPT.2006.890039; Wosniok A, 2013, PROC SPIE, V8794, DOI 10.1117/12.2025378	35	3	3	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1943-0655	1943-0647		IEEE PHOTONICS J	IEEE Photonics J.	DEC	2014	6	6							6803108	10.1109/JPHOT.2014.2366107		8	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	AU4JJ	WOS:000345576700026		
J	Liu, Z; Kleiner, Y				Liu, Zheng; Kleiner, Yehuda			Computational Intelligence for Urban Infrastructure Condition Assessment: Water Transmission and Distribution Systems	IEEE SENSORS JOURNAL			English	Article						Computational intelligence; water pipe; information fusion	PIPELINE LEAK DETECTION; NEURAL-NETWORKS; GENETIC ALGORITHMS; PIPES; PREDICTION; TRANSIENTS; CORROSION; LOCATION; MODEL	Water transmission and distribution systems are critical urban infrastructure. The aging of water mains can lead to increased breakage rate, decreased hydraulic capacity, and deterioration of water quality. Condition assessment of water mains encompasses building computational model of failures, discerning distress indicators from inspection, rating health condition, and forecasting future failures. In this process, computational intelligence helps to achieve high-level awareness of system condition and facilitates the decision making in water main renewal and rehabilitation using the combined information from field knowledge, historical records, inspection results, and sensory data. This paper reviews computational approaches to achieve condition assessment of water mains. Inspection and sensor technologies involved in the assessment process are also briefly discussed.	[Liu, Zheng] Toyota Technol Inst, Nagoya, Aichi 4688511, Japan; [Kleiner, Yehuda] Natl Res Council Canada, Ottawa, ON K1A 0R6, Canada	Liu, Z (reprint author), Toyota Technol Inst, Nagoya, Aichi 4688511, Japan.	zheng.liu@ieee.org; yehuda.kleiner@nrc-cnrc.gc.ca					Achim D, 2007, J INFRASTRUCT SYST, V13, P26, DOI 10.1061/(ASCE)1076-0342(2007)13:1(26); BENKHEROUF A, 1988, IEE PROC-D, V135, P142; Allouche E. N., 2007, P 7 ANN TUL U ENG FO; American National Standard for Polyethylene Encasement for Ductile-Iron Pipe Systems, 1999, C105A21599 ANSIAWWA; [Anonymous], PHAS ARR TECHN GUID; LIGGETT JA, 1994, J HYDRAUL ENG-ASCE, V120, P934, DOI 10.1061/(ASCE)0733-9429(1994)120:8(934); [Anonymous], 2007, THAM WAT AIMS RED LE; Kwun H, 2003, MATER EVAL, V61, P80; Brunone B, 1999, J WATER RES PL-ASCE, V125, P302, DOI 10.1061/(ASCE)0733-9496(1999)125:5(302); Al-Barqawi H, 2006, J PERFORM CONSTR FAC, V20, P126, DOI 10.1061/(ASCE)0887-3828(2006)20:2(126); Dandy GC, 2001, J WATER RES PL-ASCE, V127, P214, DOI 10.1061/(ASCE)0733-9496(2001)127:4(214); Costello SB, 2007, TUNN UNDERGR SP TECH, V22, P524, DOI 10.1016/j.tust.2007.06.001; [Anonymous], 2009, SMARTB WAT LEAK DET; Kobayashi M, 2006, IEEE T ULTRASON FERR, V53, P1478, DOI 10.1109/TUFFC.2006.1665105; WANG GZ, 1993, IEEE T INSTRUM MEAS, V42, P68, DOI 10.1109/19.206686; Polikar R, 2001, IEEE T SYST MAN CY C, V31, P497, DOI 10.1109/5326.983933; Wang XJ, 2002, J HYDRAUL ENG-ASCE, V128, P697, DOI 10.1061/(ASCE)0733-9429(2002)128:7(697); Kobayashi M, 2009, NDT&E INT, V42, P157, DOI 10.1016/j.ndteint.2008.11.003; Rajani B, 2006, J WATER SUPPLY RES T, V55, P11, DOI 10.2166/aqua.2005.069; [Anonymous], 2007, PAN 3D OPT SCANN; [Anonymous], 2011, BACKSC COMP TOM; Liu Z, 2013, MEASUREMENT, V46, P1, DOI 10.1016/j.measurement.2012.05.032; Liu Z, 2010, J COMPUT CIVIL ENG, V24, P289, DOI 10.1061/(ASCE)CP.1943-5487.0000032; Ariaratnam S. T., 2010, DTPH5607BAA000002 AR; Arun D. K., 2002, 90892 AWWA RES FDN A; Babovic V., 2002, URBAN WATER, V4, P401, DOI 10.1016/S1462-0758(02)00034-1; Bai H, 2008, J COMPUT CIVIL ENG, V22, P114, DOI 10.1061/(ASCE)0887-3801(2008)22:2(114); Bell G. E. C., 2007, P NACE INT REC DEV F; Beller M., 2006, P EUR C NOND TEST BE; Bosch J., 2004, P 2 GRON WORKSH SOFT, P1; Cauchi S., 2007, PIPELINE GAS J, V2, P36; Chen XL, 2007, SENSOR ACTUAT A-PHYS, V135, P126, DOI 10.1016/j.sna.2006.06.056; Crouch A. E., 2003, DEFC2602NT41644 SW R; Crouse B., 2009, NDT RESOURCE CTR; CUES, 2008, SON PROF SYST SUBM S; Davis D., 1999, New Review of Applied Expert Systems, V5; Farrar C.R., 2013, STRUCTURAL HLTH MONI; Feeney C. S., 2009, EPA600R10101; Galvagni A., 2011, REV PROGR QUANTITATI, V31; Higgins M. S., 2006, P C PIP SERV OWN CHI; Hunaidi O., 2004, P INT C WAT DEM MAN; Hunaidi O., 1998, P 7 INT C GROUND PEN, P783; Hunaidi O., 2006, P C NOND TEST; Hydraomax, 2006, SSET INSP SID SCANN; Iyer S., 2005, Journal of the Indian Institute of Science, V85; Jaganathan A., 2006, P NO DIG BRISB AUSTR, P25; Jiao Y., 2007, P IEEE INT C CONTR A, P774; Juliano T., 2005, CONCEPTUAL FRAMEWORK; Kim S, 2013, SMART STRUCT SYST, V11, P511, DOI 10.12989/sss.2013.11.5.511; Klein L.A., 1999, SENSOR DATA FUSION C; Kleiner Y, 2006, J WATER SUPPLY RES T, V55, P67; Kleiner Y., 2001, URBAN WATER, V3, P131, DOI DOI 10.1016/S1462-0758(01)00033-4; Kleiner Y., 2005, RISK MANAGEMENT LARG; Kleiner Y., 2006, P NATO ADV RES WORKS, P294; Kwun H., 1991, BACK STYLE MAGNETOST; Kwun H., TECHNICAL BACKGROUND; Lambert A., 2003, WATER, V21, P50; Liou CP, 1998, J FLUID ENG-T ASME, V120, P833, DOI 10.1115/1.2820746; Liou C. P., 1994, ASCE J FLUIDS ENG, V116, P103; Liu Z, 2012, IEEE SENS J, V12, DOI 10.1109/JSEN.2011.2181161; Liu Z., 2012, P 1 INT C COGN SYST; Liu Z., 2012, EPC05057; Lowe M., 2006, LONG RANGE GUIDED WA; Luo W., 2003, INSIGHT, V45, P1; Maldague X., 2001, THEORY PRACTICE INFR; Mandayam S., 2006, DEFC2602NT41648 ROW; Marlow D., 2007, 03CTS20CO AWW RES FD; MB, 2008, PULS EDD CURR SYST I; Mergelas B., 2005, P CONF LEAK HAL NS C, P1; Mergelas B., 2001, ELECTROMAGNETIC INSP; Misiunas D, 2005, THESIS LUND U LUND; Moglia M., 2006, ELECT J INFORM TECH, V11, P237; Moselhi O, 2008, J INFRASTRUCT SYST, V14, P272, DOI 10.1061/(ASCE)1076-0342(2007)13:1(26); Mounce S. R., 2003, Information Fusion, V4, DOI 10.1016/S1566-2535(03)00034-4; Munser R., 1999, P 9 INT TRAD FAIR C; Najjaran H, 2006, COMPUT-AIDED CIV INF, V21, P67, DOI 10.1111/j.1467-8667.2005.00417.x; Nestleroth B., 2012, EPC05057; PPIC, 2006, TRANSM MAIN LEAK LOC; PUDAR RS, 1992, J HYDRAUL ENG-ASCE, V118, P1031, DOI 10.1061/(ASCE)0733-9429(1992)118:7(1031); RedZone, 2008, MULT SON FIN TUN YOU; RedZone, 2011, 2D VS 3D LAS LARG PI; Rose J. L., 2008, P 17 WORLD C NOND TE; Russell B., 2009, SEE SNAKE BROCHURE; Sack D. A., 1998, IMPACT ECHO TESTING; Sadiq R., 2004, J INFRASTRUCT SYST, V10, P149, DOI DOI 10.1061/(ASCE)1076-0342(2004)10:4(149); Sansalone M. J., 1998, IMPACT ECHO METHOD; Savic DA, 1999, ANTI-CORROS METHOD M, V46, P415, DOI 10.1108/00035599910299379; Shaw D., 2004, P AD COMP DES MAN; Silva RA, 1996, COMPUT CHEM ENG, V20, pS491, DOI 10.1016/0098-1354(96)00091-9; Sinske SA, 2004, WATER SA, V30, P71; Spickelmire B, 2002, MATER PERFORMANCE, V41, P16; Thomson J., 2009, EPC05057; U.S. EPA, 2007, EPA600X09003; Vairavamoorthy K., 2006, RISK ASSESSMENT CONT; Vitkovsky JP, 2000, J WATER RES PL-ASCE, V126, P262; WATERPIPE, 2009, 3 WAT NEWSL; WATERPIPE, 2009, INT HIGH RES IM GROU; Waters C., 2005, RTD INCOTEST DETECTI; Whaley R. S., 1992, TUTORIAL SOFTWARE BA; Wilson J, 2008, NY TIMES BK REV, P17; Wu W, 2015, PATTERN ANAL APPL, V18, P263, DOI 10.1007/s10044-013-0355-5; Wylie E., 1983, ASCE J HYDRAUL ENG, V109, P1723; Zhang J, 2001, PIPELINE GAS J, V228, P42; Liu Z, 2007, IEEE T INSTRUM MEAS, V56, P2435, DOI 10.1109/TIM.2007.908139; Zhou Y., 2009, P IEEE ANT PROP SOC, P1	105	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1530-437X	1558-1748		IEEE SENS J	IEEE Sens. J.	DEC	2014	14	12					4122	4133		10.1109/JSEN.2014.2336240		12	Engineering, Electrical & Electronic; Instruments & Instrumentation; Physics, Applied	Engineering; Instruments & Instrumentation; Physics	AU4ZP	WOS:000345617100002		
J	Liu, JQ; Davis, P				Liu, Jian-Qin; Davis, Peter			Synchronization-Dependence of Path Switching in an Autonomous Flow Network	IEEE SYSTEMS JOURNAL			English	Article						Adaptation; congestion; networks; path switching; synchronization	SELECTION	We present a fundamental model that treats the problem of synchronicity of path switches in a packet flow network. The model assumes a network with multiple concurrent multihop flows. Each flow source monitors its flow path for a certain period of time, and then randomly selects a new flow path if the current path is congested. We examine the effect of having synchronized switch cycles in a basic two-hop network topology. It is shown that there can be a large difference in flow characteristics for flows with synchronized in-phase and antiphase switching cycles. The effect is shown as a large difference in the packet delay time distributions around a critical value of load parameter.	[Liu, Jian-Qin] Natl Inst Informat & Commun Technol, ICT Res Inst, Nishi Ku, Kobe, Hyogo 6512492, Japan; [Davis, Peter] Telecognix Corp, Kyoto 6068314, Japan	Liu, JQ (reprint author), Natl Inst Informat & Commun Technol, ICT Res Inst, Nishi Ku, 588-2 Iwaoka, Kobe, Hyogo 6512492, Japan.	liu@nict.go.jp; davis@telecognix.com					Andersen D. G., 2001, ACM SIGOPS OPERATING, V35, P131, DOI DOI 10.1145/502034.502048; Chatterjee D, 2007, IEEE T AUTOMAT CONTR, V52, P2390, DOI 10.1109/TAC.2007.904253; Savage S, 1999, COMP COMM R, V29, P289; BERTSEKAS DP, 1982, IEEE T AUTOMAT CONTR, V27, P60, DOI 10.1109/TAC.1982.1102884; HUBERMAN BA, 1993, P NATL ACAD SCI USA, V90, P7716, DOI 10.1073/pnas.90.16.7716; Schonfisch B, 1999, BIOSYSTEMS, V51, P123, DOI 10.1016/S0303-2647(99)00025-8; FLOYD S, 1994, IEEE ACM T NETWORK, V2, P122, DOI 10.1109/90.298431; Saadatpour A, 2010, J THEOR BIOL, V266, P641, DOI 10.1016/j.jtbi.2010.07.022; Bhanu B., 2011, DISTRIBUTED VIDEO SE; ELSAYED HM, 1988, INFORM DECIS TECHNOL, V14, P65; Fei T., 2006, P IEEE INFOCOM, P1; Gao R., 2006, P IEEE INFOCOM, P1, DOI DOI 10.1109/INF0C0M.2006.124; Haider A, 2008, ATNAC: 2008 AUSTRALASIAN TELECOMMUNICATION NETWOKS AND APPLICATIONS CONFERENCE, P355; Huang DW, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.056124; Jain M, 2007, LECT NOTES COMPUT SC, V4479, P628; Khanna A., 1989, P ACM SIGCOMM, P45; Lewis T. G., 2009, NETWORK SCI THEORY A; Liljenstrom H, 2008, ADVANCES IN COGNITIVE NEURODYNAMICS, PROCEEDINGS, P661, DOI 10.1007/978-1-4020-8387-7_114; Liu J.-Q., 2011, P INT S NONL THEOR A, P132; MITRA D, 1991, IEEE T COMMUN, V39, P102, DOI 10.1109/26.68281; Mitzenmacher M., 1997, Proceedings of the Sixteenth Annual ACM Symposium on Principles of Distributed Computing, DOI 10.1145/259380.259426; Naulin R., 1998, ELECT J DIFFERENTIAL, V33, P1; Ohira T, 1998, PHYS REV E, V58, P193, DOI 10.1103/PhysRevE.58.193; Qiu LL, 2003, ACM SIGCOMM COMP COM, V33, P151; Seshadri M., 2003, UCBCSD031291 EECS DE; Tao S., 2004, P ACM SIGMETRICS 200, P418, DOI 10.1145/1005686.1005746; Wang Z., 1992, COMPUT COMMUN REV, V22, P63; Weyns D., 2003, P 2 INT JOINT C AUT, P1156; Wilensky V., 1999, NETLOGO	29	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1932-8184	1937-9234		IEEE SYST J	IEEE Syst. J.	DEC	2014	8	4					1040	1048		10.1109/JSYST.2013.2247175		9	Computer Science, Information Systems; Engineering, Electrical & Electronic; Operations Research & Management Science; Telecommunications	Computer Science; Engineering; Operations Research & Management Science; Telecommunications	AU5AZ	WOS:000345620800004		
J	Kim, I; Watada, J				Kim, Ikno; Watada, Junzo			Consumer and Service Characteristic Segmentations in Services Marketing Using a Biologically Systematic Computational Method	IEEE SYSTEMS JOURNAL			English	Article						Applied fuzzy method; biologically systematic computational method; consumer market segmentation; services marketing; similarity subset		In the field of services marketing, consumers can be segmented into separate subgroups with homogeneous service requirements in the process of consumer market segmentation. In this process, a computable number of consumers and the services that they can select are not difficult to handle. However, when there is a large consumer base and the services that the consumers can select have multiple shared and distinct characteristics, measurement and segmentation in polynomial time are extremely difficult. Therefore, in this paper, we propose a biologically systematic computational method that would be appropriate for the segmentation of consumer and service characteristics. We also demonstrate the application of this biologically systematic computational method to a services marketing problem model.	[Kim, Ikno; Watada, Junzo] Waseda Univ, Grad Sch Informat Prod & Syst, Kitakyushu, Fukuoka 8080135, Japan	Kim, I (reprint author), Waseda Univ, Grad Sch Informat Prod & Syst, Kitakyushu, Fukuoka 8080135, Japan.	octoberkim@akane.waseda.jp; watada@waseda.jp					ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Xu E, 2011, ENTERP INF SYST-UK, V5, P385, DOI 10.1080/17517575.2011.566630; Sakamoto K, 1999, BIOSYSTEMS, V52, P81, DOI 10.1016/S0303-2647(99)00035-0; Shen CW, 2010, ENTERP INFORM SYST, V4, P61, DOI 10.1080/17517570903154567; Kim I, 2009, IEEE T NANOBIOSCI, V8, P181, DOI 10.1109/TNB.2009.2023788; Ouyang Q, 1997, SCIENCE, V278, P446, DOI 10.1126/science.278.5337.446; Kari L, 1998, ACTA INFORM, V35, P401, DOI 10.1007/s002360050125; Duan L, 2011, ENTERP INF SYST-UK, V5, P169, DOI 10.1080/17517575.2010.541287; Zdravkovic M, 2011, ENTERP INF SYST-UK, V5, P401, DOI 10.1080/17517575.2011.593104; Chiang DMH, 2011, ENTERP INF SYST-UK, V5, P219, DOI 10.1080/17517575.2010.537784; Bomze I. M, 1999, HDB COMBINATORIAL OP, V4, P1; CHAUDHRY SS, 1986, OMEGA-INT J MANAGE S, V14, P383, DOI 10.1016/0305-0483(86)90079-4; Dubois D., 1980, FUZZY SETS SYSTEMS T, P19; Gabbott M., 1998, CONSUMERS SERVICES, P97; Greenman J, 2008, INT J UNCONV COMPUT, V4, P23; Hartl D. L., 2004, GENETICS ANAL GENES, P222; Johnston M. W., 2002, CHURCHILL FORD WALKE, P95; Kim Ikno, 2008, Simulation Modelling Practice and Theory, V16, DOI 10.1016/j.simpat.2007.11.003; LIN WL, 2009, P 3 INT C COMPL INT, P904; Ma JP, 2011, ENTERP INF SYST-UK, V5, P423, DOI 10.1080/17517575.2011.580007; Mordeson J. N., 2000, FUZZY GRAPHS FUZZY H, P1; Pedrycz A, 2006, SOFT COMPUT, V10, P244, DOI 10.1007/s00500-005-0478-8; Rosenfeld A., 1975, FUZZY SETS THEIR APP, P77; Skiena S. S., 2008, ALGORITHM DESIGN MAN, P3; Stix V, 2004, COMPUT OPTIM APPL, V27, P173, DOI 10.1023/B:COAP.0000008651.28952.b6; van Noort D, 2004, LECT NOTES COMPUT SC, V2943, P190; Wang H., 2002, P 2002 ACM SIGMOD IN, P394; Wang K, 2010, ENTERP INF SYST-UK, V4, P225, DOI 10.1080/17517575.2010.498525; Watada J., 2006, P 1 INT C INN COMP I, V2, P652; Watada J, 2008, STUD COMPUT INTELL, V115, P1065	30	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1932-8184	1937-9234		IEEE SYST J	IEEE Syst. J.	DEC	2014	8	4					1227	1235		10.1109/JSYST.2013.2280850		9	Computer Science, Information Systems; Engineering, Electrical & Electronic; Operations Research & Management Science; Telecommunications	Computer Science; Engineering; Operations Research & Management Science; Telecommunications	AU5AZ	WOS:000345620800021		
J	Hinamoto, T; Doi, A; Lu, WS				Hinamoto, Takao; Doi, Akimitsu; Lu, Wu-Sheng			Roundoff Noise Minimization in State-Space Discrete-Time Systems Using Joint Optimization of High-Order Error Feedback and Realization	IEEE TRANSACTIONS ON CIRCUITS AND SYSTEMS I-REGULAR PAPERS			English	Article						High-order error-feedback; joint optimization; l(2)-scaling; roundoff noise minimization	POINT DIGITAL-FILTERS; IMPLEMENTATION; REDUCTION	This paper deals with the joint optimization problem of high-order error-feedback and realization for minimizing roundoff noise at the output of a closed-loop system with a full-order observer feedback system subject to l(2)-scaling constraints. It is shown that the problem can be converted into an unconstrained optimization problem by using linear-algebraic techniques. The unconstrained optimization problem at hand is then solved iteratively by employing an efficient quasi-Newton algorithm with closed-form formulas for key gradient evaluation. A case study is presented to demonstrate the validity and effectiveness of the proposed technique.	[Hinamoto, Takao] Hiroshima Univ, Higashihiroshima 7398527, Japan; [Doi, Akimitsu] Hiroshima Inst Technol, Fac Appl Informat Sci, Hiroshima 7315193, Japan; [Lu, Wu-Sheng] Univ Victoria, Dept Elect & Comp Engn, Victoria, BC V8W 3P6, Canada	Hinamoto, T (reprint author), Hiroshima Univ, Higashihiroshima 7398527, Japan.	hinamoto@ieee.org; doi@cc.it-hiroshima.ac.jp; wslu@ece.uvic.ca					MULLIS CT, 1976, IEEE T CIRCUITS SYST, V23, P551, DOI 10.1109/TCS.1976.1084254; DENNIS JE, 1977, SIAM REV, V19, P46; CHANG TL, 1981, IEEE T CIRCUITS SYST, V28, P339; Fletcher R, 1987, PRACTICAL METHODS OP; HIGGINS WE, 1984, IEEE T CIRCUITS SYST, V31, P429, DOI 10.1109/TCS.1984.1085528; HIGGINS WE, 1982, IEEE T ACOUST SPEECH, V30, P963, DOI 10.1109/TASSP.1982.1163989; Hinamoto T, 2008, IEEE T CIRCUITS-I, V55, P2402, DOI 10.1109/TCSI.2008.920126; Hinamoto T, 2013, IEEE T SIGNAL PROCES, V61, P5893, DOI 10.1109/TSP.2013.2281300; Hinamoto T., 2008, P 16 EUR SIGN PROC C; Hinamoto T, 2003, IEEE T CIRCUITS-I, V50, P23, DOI 10.1109/TCSI.2002.807512; HWANG SY, 1976, IEEE T ACOUST SPEECH, V24, P256; HWANG SY, 1977, IEEE T ACOUST SPEECH, V25, P273; JACKSON LB, 1979, IEEE T CIRCUITS SYST, V26, P149, DOI 10.1109/TCS.1979.1084623; LAAKSO TI, 1992, IEEE T SIGNAL PROCES, V40, P1096, DOI 10.1109/78.134473; LI G, 1990, IEEE T CIRCUITS SYST, V37, P1487; Lu WS, 2005, IEEE T SIGNAL PROCES, V53, P2135, DOI 10.1109/TSP.2005.847847; MUNSON DC, 1981, IEEE T CIRCUITS SYST, V28, P160, DOI 10.1109/TCS.1981.1084950; Renfors M., 1983, Proceedings of ICASSP 83. IEEE International Conference on Acoustics, Speech and Signal Processing; Spang H.A.  III, 1962, Institute of Radio Engineers Transactions on Communication Systems, VCS-10, DOI 10.1109/TCOM.1962.1088681; Thong T., 1977, IEEE T ACOUST SPEECH, V25, P200; VAIDYANATHAN PP, 1985, IEEE T CIRCUITS SYST, V32, P88, DOI 10.1109/TCS.1985.1085587; WILLIAMSON D, 1986, IEEE T ACOUST SPEECH, V34, P1210, DOI 10.1109/TASSP.1986.1164958	22	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1549-8328	1558-0806		IEEE T CIRCUITS-I	IEEE Trans. Circuits Syst. I-Regul. Pap.	DEC	2014	61	12					3460	3468		10.1109/TCSI.2014.2337233		9	Engineering, Electrical & Electronic	Engineering	AU4KZ	WOS:000345581200015		
J	Oohama, Y				Oohama, Yasutada			Indirect and Direct Gaussian Distributed Source Coding Problems	IEEE TRANSACTIONS ON INFORMATION THEORY			English	Article						Distributed source coding; remote sources; Gaussian CEO problem; multiterminal source coding; rate distortion region	RATE-DISTORTION FUNCTION; SIDE INFORMATION; CEO PROBLEM; DECODER	We consider the distributed source coding system of L correlated Gaussian sources Y-l, l = 1, 2, . . . , L, which are noisy observations of correlated Gaussian remote sources X-k, k = 1, 2, . . . , K. We assume that Y-L = (t)(Y-1, Y-2 , . . . , Y-L) is an observation of the source vector X-K = (t)(X-1, X-2 , . . . , X-K), having the form Y-L = AX(K) + N-L, where A is a LxK matrix and N-L = (t)(N-1, N-2, . . . , N-L) is a vector of L-independent Gaussian random variables also independent of X-K. In this system, L correlated Gaussian observations are separately compressed by L encoders and sent to the information processing center. We study the remote source coding problem, where the decoder at the center attempts to reconstruct the remote source X-K. We consider three distortion criteria based on the covariance matrix of the estimation error on X-K. For each of those three criteria, we derive explicit inner and outer bounds of the rate distortion region. Next, in the case of K = L and A = I-L, we study the multiterminal source coding problem, where the decoder wishes to reconstruct the observation Y-L = X-L + N-L. To investigate this problem, we shall establish a result that provides a strong connection between the remote source coding problem and multiterminal source coding problem. Using this result, we derive several new partial solutions to the multiterminal source coding problem.	Univ Electrocommun, Dept Commun Engn & Informat, Tokyo 1828585, Japan	Oohama, Y (reprint author), Univ Electrocommun, Dept Commun Engn & Informat, Tokyo 1828585, Japan.	oohama@uec.ac.jp					Oohama Y, 2012, IEEE T INFORM THEORY, V58, P5059, DOI 10.1109/TIT.2012.2201347; Oohama Y, 2005, IEEE T INFORM THEORY, V51, P2577, DOI 10.1109/TIT.2005.850110; Yang Y, 2012, IEEE T INFORM THEORY, V58, P3350, DOI 10.1109/TIT.2012.2184667; SLEPIAN D, 1973, IEEE T INFORM THEORY, V19, P471, DOI 10.1109/TIT.1973.1055037; FLYNN TJ, 1987, IEEE T INFORM THEORY, V33, P773, DOI 10.1109/TIT.1987.1057384; Viswanathan H, 1997, IEEE T INFORM THEORY, V43, P1549, DOI 10.1109/18.623151; COVER TM, 1975, IEEE T INFORM THEORY, V21, P226, DOI 10.1109/TIT.1975.1055356; Wang J, 2013, IEEE T INFORM THEORY, V59, P3693, DOI 10.1109/TIT.2013.2245397; WYNER AD, 1976, IEEE T INFORM THEORY, V22, P1, DOI 10.1109/TIT.1976.1055508; BERGER T, 1989, IEEE T INFORM THEORY, V35, P228, DOI 10.1109/18.32119; Oohama Y, 1998, IEEE T INFORM THEORY, V44, P1057, DOI 10.1109/18.669162; BERGER T, 1979, IEEE T INFORM THEORY, V25, P664, DOI 10.1109/TIT.1979.1056105; Itoh K., 1980, IECE T, VE63, P700; KASPI AH, 1982, IEEE T INFORM THEORY, V28, P828, DOI 10.1109/TIT.1982.1056586; Longo G., 1978, CISM COURSES LECT, V229, P171; Oohama Y., 2008, P IEEE INT S INF THE, P41; Oohama Y, 1997, IEEE T INFORM THEORY, V43, P1912, DOI 10.1109/18.641555; Oohama Y., 2005, P 43 ALL C ALL IL SE, P2237; Oohama Y., 2008, P 2008 INT S INF THE, P1441; Oohama Y., 2011, DISTRIBUTED SOURCE C; Pandya A., 2004, P 42 ALL C ALL IL OC, P1841; Prabhakaran V., 2004, P IEEE INT S INF THE, P117; Tung S., 1978, THESIS CORNELL U ITH; Wagner AB, 2008, IEEE T INFORM THEORY, V54, P1938, DOI 10.1109/TIT.2008.920343; Wagner AB, 2008, IEEE T INFORM THEORY, V54, P1919, DOI 10.1109/TIT.2008.920249; Wang J, 2010, IEEE T INFORM THEORY, V57, P3946, DOI 10.1109/TIT.2010.2050960; Wang J., 2012, P IEEE INT S INF THE, P576; Wang J, 2012, 2012 IEEE INFORMATION THEORY WORKSHOP (ITW), P182; WYNER AD, 1978, INFORM CONTROL, V38, P60, DOI 10.1016/S0019-9958(78)90034-7; Yang Y, 2012, IEEE T INFORM THEORY, V58, P693, DOI 10.1109/TIT.2011.2173706	30	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9448	1557-9654		IEEE T INFORM THEORY	IEEE Trans. Inf. Theory	DEC	2014	60	12					7506	7539		10.1109/TIT.2014.2361332		34	Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	AU3KH	WOS:000345511400008		
J	Watanabe, S; Kuzuoka, S				Watanabe, Shun; Kuzuoka, Shigeaki			Universal Wyner-Ziv Coding for Distortion Constrained General Side Information	IEEE TRANSACTIONS ON INFORMATION THEORY			English	Article						Average distortion; Heegard-Berger problem; maximum distortion; universal coding; Wyner-Ziv problem	SUCCESSIVE REFINEMENT; INDIVIDUAL SEQUENCES; NETWORKS; THEOREMS; DECODER	We investigate the Wyner-Ziv coding in which the statistics of the principal source is known but the statistics of the channel generating the side information is unknown except that it is in a certain class. The class consists of channels such that the distortion between the principal source and side information is smaller than a threshold, but channels may be neither stationary nor ergodic. In this situation, we define a new rate-distortion function as the minimum rate such that there exists a Wyner-Ziv code that is universal for every channel in the class. Then, we show an upper bound and a lower bound on the rate-distortion function, and derive a matching condition such that the upper and lower bounds coincide. The relation between the new rate-distortion function and rate-distortion function of the Heegard-Berger problem is also discussed.	[Watanabe, Shun] Univ Tokushima, Dept Informat Sci & Intelligent Syst, Tokushima 7708506, Japan; [Watanabe, Shun] Univ Maryland, Syst Res Inst, College Pk, MD 20742 USA; [Kuzuoka, Shigeaki] Wakayama Univ, Dept Comp & Commun Sci, Wakayama 6408510, Japan	Watanabe, S (reprint author), Univ Tokushima, Dept Informat Sci & Intelligent Syst, Tokushima 7708506, Japan.	shun-wata@is.tokushima-u.ac.jp; kuzuoka@ieee.org	Watanabe, Shun/G-3384-2015				Ahlswede R., 1980, J COMBIN INFORM SYST, V5, P10; Hayashi M, 2013, IEEE T INFORM THEORY, V59, P7728, DOI 10.1109/TIT.2013.2278971; Tian C, 2007, IEEE T INFORM THEORY, V53, P2946, DOI 10.1109/TIT.2007.901190; Steinberg Y, 2009, IEEE T INFORM THEORY, V55, P4995, DOI 10.1109/TIT.2009.2030487; Kuzuoka S, 2010, IEEE INT SYMP INFO, P1, DOI 10.1109/ISIT.2010.5513306; Timo R, 2011, IEEE T INFORM THEORY, V57, P5240, DOI 10.1109/TIT.2011.2158472; Muramatsu J, 2014, IEEE T INFORM THEORY, V60, P2667, DOI 10.1109/TIT.2014.2309140; SLEPIAN D, 1973, IEEE T INFORM THEORY, V19, P471, DOI 10.1109/TIT.1973.1055037; Cohen AS, 2002, IEEE T INFORM THEORY, V48, P1639, DOI 10.1109/TIT.2002.1003844; Somekh-Baruch A, 2003, IEEE T INFORM THEORY, V49, P537, DOI 10.1109/TIT.2002.808132; Kimura A, 2009, IEEE T INFORM THEORY, V55, P1360, DOI 10.1109/TIT.2008.2011438; WYNER AD, 1976, IEEE T INFORM THEORY, V22, P1, DOI 10.1109/TIT.1976.1055508; Kelly BG, 2012, IEEE T INFORM THEORY, V58, P5086, DOI 10.1109/TIT.2012.2201346; Moulin P, 2003, IEEE T INFORM THEORY, V49, P563, DOI 10.1109/TIT.2002.808134; Reani A, 2011, IEEE T INFORM THEORY, V57, P6860, DOI 10.1109/TIT.2011.2165815; HEEGARD C, 1985, IEEE T INFORM THEORY, V31, P727, DOI 10.1109/TIT.1985.1057103; Merhav N, 2006, IEEE T INFORM THEORY, V52, P867, DOI 10.1109/TIT.2005.864434; Bertsekas D. P., 2003, CONVEX ANAL OPTIMIZA; CSISZAR I, 1982, IEEE T INFORM THEORY, V28, P585, DOI 10.1109/TIT.1982.1056524; CSISZAR I, 1981, IEEE T INFORM THEORY, V27, P5, DOI 10.1109/TIT.1981.1056281; ElGamal A, 2011, NETWORK INFORMATION THEORY, P1, DOI 10.1017/CBO9781139030687; EQUITZ WHR, 1991, IEEE T INFORM THEORY, V37, P269, DOI 10.1109/18.75242; Jalali S, 2010, IEEE T INFORM THEORY, V56, P1737, DOI 10.1109/TIT.2010.2040889; Korner J., 2011, INFORM THEORY CODING; Muramatsu J, 2010, IEEE T INFORM THEORY, V56, P2143, DOI 10.1109/TIT.2010.2043781; OOHAMA Y, 1994, IEEE T INFORM THEORY, V40, P1908, DOI 10.1109/18.340465; Oohama Y, 1996, IEEE T INFORM THEORY, V42, P837, DOI 10.1109/18.490548; RIMOLDI B, 1994, IEEE T INFORM THEORY, V40, P253, DOI 10.1109/18.272493; Steinberg Y, 2004, IEEE T INFORM THEORY, V50, P1636, DOI 10.1109/TIT.2004.831781; Tian C, 2008, IEEE T INFORM THEORY, V54, P5591, DOI 10.1109/TIT.2008.2006399; Watanabe S, 2013, IEEE T INFORM THEORY, V59, P5678, DOI 10.1109/TIT.2013.2266654; Willems F. M. J., 1983, 83E140 EINDH U; Yassaee M. H., 2012, ACHIEVABILITY PROOF; Ziv J., 1984, IEEE Transactions on Information Theory, VIT-30, DOI 10.1109/TIT.1984.1056878	34	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9448	1557-9654		IEEE T INFORM THEORY	IEEE Trans. Inf. Theory	DEC	2014	60	12					7568	7583		10.1109/TIT.2014.2358682		16	Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	AU3KH	WOS:000345511400011		
J	Watanabe, S; Oohama, Y				Watanabe, Shun; Oohama, Yasutada			Cognitive Interference Channels With Confidential Messages Under Randomness Constraint	IEEE TRANSACTIONS ON INFORMATION THEORY			English	Article						Cognitive interference channel; confidential messages; randomness constraint; stochastic encoder; superposition coding	3-RECEIVER BROADCAST CHANNELS; RADIO CHANNELS; CAPACITY; INFORMATION; RESOLVABILITY; SECRECY; COMMON; SETS	The cognitive interference channel with confidential messages (CICC) proposed by Liang et al. is investigated. When the security is considered in coding systems, it is well-known that the sender needs to use a stochastic encoding to avoid the information about the transmitted confidential message to be leaked to an eavesdropper. For the CICC, the tradeoff between the rate of the random number to realize the stochastic encoding and the communication rates is investigated, and the optimal tradeoff is completely characterized.	[Watanabe, Shun] Univ Tokushima, Dept Informat Sci & Intelligent Syst, Tokushima 7708506, Japan; [Oohama, Yasutada] Univ Electrocommun, Dept Commun Engn & Informat, Tokyo 1820021, Japan	Watanabe, S (reprint author), Univ Maryland, Syst Res Inst, College Pk, MD 20742 USA.	shun-wata@is.tokushima-u.ac.jp; oohama@uec.ac.jp	Watanabe, Shun/G-3384-2015		 [2376033700];  [2336017202];  [2324607101]	Manuscript received June 10, 2013; revised July 31, 2014; accepted September 7, 2014. Date of publication October 17, 2014; date of current version November 18, 2014. This work was supported in part by a Grant-in-Aid for Young Scientist (B) under Grant 2376033700, in part by a Grant-in-Aid for Scientific Research (B) under Grant 2336017202, and in part by a Grant-in-Aid for Scientific Research (A) under Grant 2324607101.	Jovicic A, 2009, IEEE T INFORM THEORY, V55, P3945, DOI 10.1109/TIT.2009.2025539; Hayashi M, 2006, IEEE T INFORM THEORY, V52, P1562, DOI 10.1109/TIT.2006.871040; CSISZAR I, 1978, IEEE T INFORM THEORY, V24, P339, DOI 10.1109/TIT.1978.1055892; Chia YK, 2012, IEEE T INFORM THEORY, V58, P2748, DOI 10.1109/TIT.2012.2184668; Wu W, 2007, IEEE T INFORM THEORY, V53, P4391, DOI [10.1109/TIT.2007.907436, 10.1109/.TIT.2007.907436]; HAN TS, 1993, IEEE T INFORM THEORY, V39, P752, DOI 10.1109/18.256486; Devroye N, 2006, IEEE COMMUN MAG, V44, P44, DOI 10.1109/MCOM.2006.1668418; Bloch MR, 2013, IEEE T INFORM THEORY, V59, P8077, DOI 10.1109/TIT.2013.2283722; Liang YB, 2009, IEEE T INFORM THEORY, V55, P604, DOI 10.1109/TIT.2008.2009584; Zhong YF, 2007, 2007 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY PROCEEDINGS, VOLS 1-7, P1736, DOI 10.1109/ISIT.2007.4557472; Hayashi M, 2011, IEEE T INFORM THEORY, V57, P3989, DOI 10.1109/TIT.2011.2110950; Devroye N, 2006, IEEE T INFORM THEORY, V52, P1813, DOI 10.1109/TIT.2006.872971; WYNER AD, 1975, AT&T TECH J, V54, P1355; Cover T. M., 2006, ELEMENTS INFORM THEO; Csiszar I., 1996, PROBLEMS INFORMATION, V32, P48; ElGamal A, 2011, NETWORK INFORMATION THEORY, P1, DOI 10.1017/CBO9781139030687; Jiang JH, 2008, IEEE T INFORM THEORY, V54, P171, DOI 10.1109/TIT.2007.911257; Liang Y., 2009, INFORM THEORETIC SEC; MAURER UM, 1994, KLUW COMMUN, V276, P271; Mitola III J., 2000, THESIS KTH ROY I TEC; Nair C, 2009, IEEE T INFORM THEORY, V55, P4479, DOI 10.1109/TIT.2009.2027512; Oohama Y., 2009, CAPACITY RESULTS REL; Watanabe S., 2012, BROADCAST CHANNELS C	23	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9448	1557-9654		IEEE T INFORM THEORY	IEEE Trans. Inf. Theory	DEC	2014	60	12					7698	7707		10.1109/TIT.2014.2360683		10	Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	AU3KH	WOS:000345511400019		
J	Shao, XW; Shi, Y; Zhao, HJ; Li, XL; Shibasaki, R				Shao, Xiaowei; Shi, Yun; Zhao, Huijing; Li, Xuelong; Shibasaki, Ryosuke			Efficient Closed-Loop Multiple-View Registration	IEEE TRANSACTIONS ON INTELLIGENT TRANSPORTATION SYSTEMS			English	Article						Loop closure; matrix exponentiated gradient (MEG); multiple-view registration	OUTDOOR ENVIRONMENTS; DATA SETS; SLAM; GEOMETRY	Registering multiple views is an essential and challenging problem for many intelligent transportation applications that employ a mobile sensing platform or consist of multiple stationary sensors. In this paper a novel algorithm is presented for multiple-view registration under a loop closure constraint. Different from most existing methods, which use general optimization techniques, our method studies the mechanism of adjusting the poses of views in a loop and provides a highly efficient and accurate solution. We prove that translation vectors can be decoupled if the same point set is used in each view to associate the previous and subsequent views, leading to our solution for such decouplable cases. If this condition does not hold, an exact solution of translation vectors is provided when rotation parameters are given, which results in our iterative solution for general cases by updating rotation and translation alternately. In our method, the effect of the accumulated pose error in a loop can be distributed to all views efficiently through loop factors, and only a few iterations are needed. Most important of all, in each iteration our method has linear computational complexity with respect to the number of views, which is much superior to that of state-of-the-art methods. A series of experiments was conducted, involving simulation of thousands of views and real vehicle-borne sensing data that include 65 371 point pairs in 352 views. Experimental results show that our proposed method is not only stable and highly efficient but also provides competitive accuracy relative to existing methods.	[Shao, Xiaowei] Univ Tokyo, Earth Observat Data Integrat & Fusion Res Initiat, Tokyo 1138656, Japan; [Shao, Xiaowei] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing 100081, Peoples R China; [Shi, Yun] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Agri Informat, Minist Agr, Beijing 100081, Peoples R China; [Shi, Yun; Shibasaki, Ryosuke] Univ Tokyo, Ctr Spatial Informat Sci, Tokyo 1130033, Japan; [Zhao, Huijing] Peking Univ, State Key Lab Machine Percept, Beijing 100871, Peoples R China; [Li, Xuelong] Chinese Acad Sci, Xian Inst Opt & Precis Mech, Ctr Opt Imagery Anal & Learning OPTIMAL, State Key Lab Transient Opt & Photon, Xian 710119, Peoples R China	Shao, XW (reprint author), Univ Tokyo, Earth Observat Data Integrat & Fusion Res Initiat, Tokyo 1138656, Japan.	shaoxw@iis.u-tokyo.ac.jp; shiyun@caas.cn			GRENE Program (Green Network of Excellence) - Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan; National Natural Science Foundation of China [61125106]; Key Laboratory of Agri-informatics, Ministry of Agriculture in China [2012004]	This work was supported in part by the GRENE Program (Green Network of Excellence, 2011-2016) funded by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan, by the National Natural Science Foundation of China under Grant 61125106, and by the Key Laboratory of Agri-informatics, Ministry of Agriculture in China under Project 2012004. The Associate Editor for this paper was A. Amditis.	AGARWAL S, 2010, P EUR C COMP VIS, V6312, P29; Almansa-Valverde S, 2012, EXPERT SYST APPL, V39, P8835, DOI 10.1016/j.eswa.2012.02.006; Huber DF, 2003, IMAGE VISION COMPUT, V21, P637, DOI 10.1016/S0262-8856(03)00060-X; Nuchter A, 2007, J FIELD ROBOT, V24, P699, DOI 10.1002/rob.20209; Lu F, 1997, AUTON ROBOT, V4, P333, DOI 10.1023/A:1008854305733; Salvi J, 2007, IMAGE VISION COMPUT, V25, P578, DOI 10.1016/j.imavis.2006.05.012; Boughorbel F, 2010, IMAGE VISION COMPUT, V28, P124, DOI 10.1016/j.imavis.2009.05.003; Fitzgibbon AW, 2003, IMAGE VISION COMPUT, V21, P1145, DOI 10.1016/j.imavis.2003.09.004; Borrmann D, 2008, ROBOT AUTON SYST, V56, P130, DOI 10.1016/j.robot.2007.07.002; Endres F, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION (ICRA), P1691, DOI 10.1109/ICRA.2012.6225199; Cole DM, 2006, IEEE INT CONF ROBOT, P1556; Hasberg C, 2012, IEEE T INTELL TRANSP, V13, P541, DOI 10.1109/TITS.2011.2177522; Bergevin R, 1996, IEEE T PATTERN ANAL, V18, P540, DOI 10.1109/34.494643; Cummins M, 2008, INT J ROBOT RES, V27, P647, DOI 10.1177/0278364908090961; Pomerleau F, 2013, AUTON ROBOT, V34, P133, DOI 10.1007/s10514-013-9327-2; Nguyen TN, 2012, IEEE T INTELL TRANSP, V13, P154, DOI 10.1109/TITS.2011.2165705; Henry P, 2012, INT J ROBOT RES, V31, P647, DOI 10.1177/0278364911434148; Zhao HJ, 2012, IEEE T INTELL TRANSP, V13, P655, DOI 10.1109/TITS.2011.2175218; Tsuda K, 2005, J MACH LEARN RES, V6, P995; Weise T, 2011, COMPUT VIS IMAGE UND, V115, P635, DOI 10.1016/j.cviu.2010.11.023; Konolige K, 2008, IEEE T ROBOT, V24, P1066, DOI 10.1109/TRO.2008.2004832; Estrada C, 2005, IEEE T ROBOT, V21, P588, DOI 10.1109/TRO.2005.844673; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Arora R., 2009, P ADV NEUR INF PROC, V22, P55; Arun K S, 1987, IEEE Trans Pattern Anal Mach Intell, V9, P698; Biber P, 2006, IEEE INT CONF ROBOT, P2270; Borges PVK, 2013, IEEE T INTELL TRANSP, V14, P720, DOI 10.1109/TITS.2012.2235431; Edelman A, 1998, SIAM J MATRIX ANAL A, V20, P303, DOI 10.1137/S0895479895290954; LIU MJ, 2011, P IEEE C ROB AUT, P1811; Lourakis MIA, 2009, ACM T MATH SOFTWARE, V36, DOI 10.1145/1486525.1486527; Makadia A., 2006, P IEEE C COMP VIS PA, V1, P1297; Montemerlo M., 2002, P AAAI NAT C ART INT, P593; Neugebauer P. J., 1997, International Journal of Shape Modeling, V3, DOI 10.1142/S0218654397000070; Nishino K., 2008, DIGITALLY ARCHIVING, P71, DOI 10.1007/978-0-387-75807_5; Polyak BT, 2007, EUR J OPER RES, V181, P1086, DOI 10.1016/j.ejor.2005.06.076; Rusinkiewicz S., 2001, Proceedings Third International Conference on 3-D Digital Imaging and Modeling, DOI 10.1109/IM.2001.924423; Saez JM, 2011, COMPUT VIS IMAGE UND, V115, P270, DOI 10.1016/j.cviu.2010.10.004; Shao X., 2011, P IEEE RSJ C INT ROB, P2036; Shao X., 2007, P IEEE RSJ INT C INT, P2174; Shao X., 2012, P IEEE C ROB BIOM, P452; Shi Y, 2013, SENSORS-BASEL, V13, P119, DOI 10.3390/s130100119; Silva L., 2003, Proceedings Fourth International Conference on 3-D Digital Imaging and Modeling. 3DIM 2003; Smith A., 2008, P C LEARN THEOR, P517; Smith R., 1990, AUTONOMOUS ROBOT VEH, P167; Sprickerhof J., 2009, P EUR C MOB ROB ECMR, P229; STUELPNA.J, 1964, SIAM REV, V6, P422, DOI 10.1137/1006093; Tick D, 2013, IEEE T CYBERNETICS, V43, P1237, DOI 10.1109/TSMCB.2012.2227720; Triggs B., 2000, Vision Algorithms: Theory and Practice. International Workshop on Vision Algorithms. Proceedings (Lecture Notes in Computer Science Vol. 1883); Tungadi F., 2007, P AUSTR C ROB AUT, P1; Underwood JP, 2010, J FIELD ROBOT, V27, P2, DOI 10.1002/rob.20315; Williams J, 2000, IEICE T INF SYST, VE83D, P1662; ZHANG ZY, 1994, INT J COMPUT VISION, V13, P119, DOI 10.1007/BF01427149	52	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1524-9050	1558-0016		IEEE T INTELL TRANSP	IEEE Trans. Intell. Transp. Syst.	DEC	2014	15	6					2524	2538		10.1109/TITS.2014.2319352		15	Engineering, Civil; Engineering, Electrical & Electronic; Transportation Science & Technology	Engineering; Transportation	AU4IB	WOS:000345572900015		
J	Guo, L; Zhou, DJ; Goto, S				Guo, Li; Zhou, Dajiang; Goto, Satoshi			A New Reference Frame Recompression Algorithm and Its VLSI Architecture for UHDTV Video Codec	IEEE TRANSACTIONS ON MULTIMEDIA			English	Article						Embedded compression; H.264/AVC; HEVC; lossless reference frame recompression; multi-mode DPCM and averaging prediction	HIGH-DEFINITION VIDEO; COMPRESSION ALGORITHM; MOTION-ESTIMATION; H.264/AVC; SCHEME; DESIGN	Video encoders and decoders for HEVC-like compression standards require huge external memory bandwidth, which occupies a significant portion of the codec power consumption. To reduce the memory bandwidth, this paper presents a new lossless reference frame recompression algorithm along with a high-throughput hardware architecture. Firstly, hybrid spatial-domain prediction is proposed to combine the merits of DPCM scanning and averaging. The prediction is then enhanced with multiple modes to accommodate various image characteristics. Finally, efficient residual regrouping based on semi-fixed-length (SFL) coding is used to improve the compression performance. Compared to no compression, the proposed scheme can reduce data traffic by an average of 57.6% with no image quality degradation. The average compression ratio is 2.49, an improvement of at least 12.2-13.2%, relative to the state-of-the-art algorithms. By applying a reordered two-step architecture and the two optimizations, residual reuse and simplified coding mode decision, the hardware cost is similar to that of previous reference frame recompression architectures. The computational complexity increase caused by multi-mode prediction affects the HW cost slightly. This work can be implemented with 45.1 k gates for the compressor and 34.5 k gates for the decompressor at 300 MHz, enough to support a 3840 x 2160@60fps video encoder and decoder.	[Guo, Li; Zhou, Dajiang; Goto, Satoshi] Waseda Univ, Grad Sch Informat Prod & Syst, Kitakyushu, Fukuoka 8080135, Japan	Guo, L (reprint author), Shanghai Jiao Tong Univ, Dept Elect Engn, Shanghai 200240, Peoples R China.	guoli0104@gmail.com; zhou@fuji.waseda.jp; goto@waseda.jp					Ding LF, 2010, IEEE J SOLID-ST CIRC, V45, P46, DOI 10.1109/JSSC.2009.2031787; Song T, 2007, IEICE ELECTRON EXPR, V4, P121, DOI 10.1587/elex.4.121; Bao XN, 2012, IEEE T MULTIMEDIA, V14, P237, DOI 10.1109/TMM.2011.2171677; Cheng CC, 2009, IEEE T CIRC SYST VID, V19, P141, DOI 10.1109/TCSVT.2008.2009250; Chen CY, 2006, IEEE T CIRCUITS-I, V53, P578, DOI 10.1109/TCSI.2005.858488; Kim J, 2010, IEEE T CIRC SYST VID, V20, P848, DOI 10.1109/TCSVT.2010.2045923; Zhu JY, 2008, IEEE INT SYMP CIRC S, P3518; Budagavi M, 2008, INT CONF ACOUST SPEE, P1165, DOI 10.1109/ICASSP.2008.4517822; CHAO P, 2008, P IEEE INT C MULT EX, P1441; Chen TC, 2007, IEEE T CIRC SYST VID, V17, P242, DOI 10.1016/TCSVT.2006.887130; CHEN X, 2009, P IEEE INT S CIRC SY, P1069; Guo L., 2013, P EUSIPCO, P1; Ivanov Y.V., 2008, P 3 INT C DIG TEL, P168; Kuo HC, 2012, IEEE T MULTIMEDIA, V14, P500, DOI 10.1109/TMM.2012.2191945; Lee S, 2010, IEEE INT CON MULTI, P232, DOI 10.1109/ICME.2010.5582592; Lee YH, 2008, IEEE ASIAN SOLID STA, P185, DOI 10.1109/ASSCC.2008.4708759; Lee YH, 2010, IEEE INT SYMP CIRC S, P1149; Lee YX, 2008, IEEE INT SYMP CIRC S, P2586; Lee YY, 2008, IEEE INT SOC CONF, P233; Li YF, 2012, IEEE INT C COMPUT, P303, DOI 10.1109/ICCSE.2012.49; Lin YK, 2008, IEEE T CIRCUITS-I, V55, P1526, DOI 10.1109/TCSI.2008.916681; Song L., 2010, P EUSIPCO, P2017; Xiph.org Foundation, XIPH ORG VID TEST ME; Yang HT, 2009, 2009 IEEE/ACM/IFIP 7TH WORKSHOP ON EMBEDDED SYSTEMS FOR REAL-TIME MULTIMEDIA, P28, DOI 10.1109/ESTMED.2009.5336820; Yng TLB, 2008, IEEE T CONSUM ELECTR, V54, P1453, DOI 10.1109/TCE.2008.4637640; Zhou D., 2011, IEEE J SOLID-ST CIRC, V6, P777; Zhou D., 2012, P ISSCC, P224; Zhou J., 2013, P VLSIC, pC286	28	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1520-9210	1941-0077		IEEE T MULTIMEDIA	IEEE Trans. Multimedia	DEC	2014	16	8					2323	2332		10.1109/TMM.2014.2350256		10	Computer Science, Information Systems; Computer Science, Software Engineering; Telecommunications	Computer Science; Telecommunications	AU4HL	WOS:000345571300020		
J	Zhang, YJ; Chai, TY; Sun, J; Chen, XK; Wang, H				Zhang, Yajun; Chai, Tianyou; Sun, Jing; Chen, Xinkai; Wang, Hong			A Novel Estimation Algorithm Based on Data and Low-Order Models for Virtual Unmodeled Dynamics	IEEE TRANSACTIONS ON NEURAL NETWORKS AND LEARNING SYSTEMS			English	Article						Data driven; low-order linear model; nonlinear systems; virtual un-modeled dynamics	FUZZY DISTURBANCE OBSERVER; EXTREME LEARNING-MACHINE; OUTPUT-FEEDBACK CONTROL; NEURAL-NETWORKS; ADAPTIVE-CONTROL; MULTIPLE MODELS; NONLINEAR-SYSTEMS; TRACKING CONTROL; DESIGN; CLASSIFICATION	In this paper, the challenging issue of estimating virtual unmodeled dynamics is addressed. A novel estimation algorithm based on historical data and the output of low-order approximation models for virtual un-modeled dynamics is presented. In particular, the virtual un-modeled dynamics are decomposed into known and unknown parts, where only the unknown part is to be estimated. The method effectively avoids the need to use the unknown control input directly, and enables the estimation of the un-modeled dynamics with a relatively simple algorithm. Moreover, it is shown that the proposed algorithm overcomes the difficulty in obtaining the control solutions caused by the fact that the controller input is embedded in un-modeled dynamics. Finally, simulation studies are presented to demonstrate the effectiveness of the proposed method.	[Zhang, Yajun; Chai, Tianyou] Northeastern Univ, Key Lab Synthet Automat Proc Ind, Shenyang 110819, Peoples R China; [Sun, Jing] Univ Michigan, Dept Naval Architecture & Marine Engn, Ann Arbor, MI 48109 USA; [Chen, Xinkai] Shibaura Inst Technol, Dept Elect Informat Syst, Saitama 3378570, Japan; [Wang, Hong] Univ Manchester, Control Syst Ctr, Manchester M60 1QD, Lancs, England	Zhang, YJ (reprint author), Northeastern Univ, Key Lab Synthet Automat Proc Ind, Shenyang 110819, Peoples R China.	zhangyajun79@gmail.com; tychai@mail.neu.edu.cn; jingsun@umich.edu; chen@shibaura-it.ac.jp; hong.wang@manchester.ac.ak			Plant-wide Optimal Control for Complex Industrial Processes Using a Hybrid Data-driven and Model-based Approach; Funds for Creative Research Groups of China [60821063]; Chinese National Fundamental Research Program [2009CB320601]; 111 Project [B08015]; National Natural Science Foundation of China [61290323, 61333007, 61304035]	This work was supported in part by the Major International Joint Research Project: Plant-wide Optimal Control for Complex Industrial Processes Using a Hybrid Data-driven and Model-based Approach, in part by the Funds for Creative Research Groups of China under Grant 60821063, in part by the Chinese National Fundamental Research Program under Grant 2009CB320601, in part by the 111 Project under Grant B08015, in part by the National Natural Science Foundation of China under Grant 61290323, Grant 61333007, and Grant 61304035.	Adetona O, 2000, IEEE T NEURAL NETWOR, V11, P102, DOI 10.1109/72.822514; Aha D. W., 1997, ARTIF INTELL, V11, P1; JANG JSR, 1993, IEEE T SYST MAN CYB, V23, P665, DOI 10.1109/21.256541; Zhang YJ, 2013, IEEE T FUZZY SYST, V21, P989, DOI 10.1109/TFUZZ.2012.2236889; Tong SC, 2010, IEEE T FUZZY SYST, V18, P845, DOI 10.1109/TFUZZ.2010.2050326; Abdullah R, 2008, NEUROCOMPUTING, V71, P2727, DOI 10.1016/j.neucom.2007.05.016; Tong SC, 2009, IEEE T FUZZY SYST, V17, P1059, DOI 10.1109/TFUZZ.2009.2021648; Ge SS, 2003, INT J CONTROL, V76, P334, DOI 10.1080/0020717031000073063; Chai TY, 2011, IEEE T NEURAL NETWOR, V22, P2154, DOI 10.1109/TNN.2011.2167685; Wen YT, 2011, IEEE T NEURAL NETWOR, V22, P1599, DOI 10.1109/TNN.2011.2165222; Huang GB, 2012, IEEE T SYST MAN CY B, V42, P513, DOI 10.1109/TSMCB.2011.2168604; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Kim E, 2005, IEEE T FUZZY SYST, V13, P725; Liang NY, 2006, IEEE T NEURAL NETWOR, V17, P1411, DOI 10.1109/TNN.2006.880583; Yang ZJ, 2010, IEEE T CONTR SYST T, V18, P454, DOI 10.1109/TCST.2009.2022549; SPALL JC, 1993, PROCEEDINGS OF THE 32ND IEEE CONFERENCE ON DECISION AND CONTROL, VOLS 1-4, P2792, DOI 10.1109/CDC.1993.325704; Li TS, 2010, IEEE T FUZZY SYST, V18, P150, DOI 10.1109/TFUZZ.2009.2038277; SCHAAL S, 1994, IEEE CONTR SYST MAG, V14, P57, DOI 10.1109/37.257895; Hou ZS, 2013, INFORM SCIENCES, V235, P3, DOI 10.1016/j.ins.2012.07.014; Liu YS, 2009, AUTOMATICA, V45, P1891, DOI 10.1016/j.automatica.2009.04.002; Shaik FA, 2011, EXPERT SYST APPL, V38, P13043, DOI 10.1016/j.eswa.2011.04.107; Chen XK, 2004, IEEE T CONTR SYST T, V12, P569, DOI 10.1109/TCST.2004.825135; WANG LX, 1992, IEEE T NEURAL NETWOR, V3, P807, DOI 10.1109/72.159070; Chen LJ, 2001, AUTOMATICA, V37, P1245, DOI 10.1016/S0005-1098(01)00072-3; Chai T. Y., 2010, ACTA AUTOMATICA SINI, V337, P773; Chai TY, 2011, J PROCESS CONTR, V21, P351, DOI 10.1016/j.jprocont.2010.11.007; Chen LJ, 2004, IEEE T NEURAL NETWOR, V15, P663, DOI 10.1109/TNN.2004.826206; Chen XK, 2006, AUTOMATICA, V42, P427, DOI 10.1016/j.automatica.2005.10.008; Chen XK, 2000, SYST CONTROL LETT, V41, P189, DOI 10.1016/S0167-6911(00)00056-6; Deng H, 2009, J PROCESS CONTR, V19, P1392, DOI 10.1016/j.jprocont.2009.04.011; Deng H, 2008, IEEE T NEURAL NETWOR, V19, P1615, DOI 10.1109/TNN.2008.2000804; Fu Y, 2007, AUTOMATICA, V43, P1101, DOI 10.1016/j.automatica.2006.12.010; Fu Y, 2008, INT J ADAPT CONTROL, V22, P495, DOI 10.1002/acs.1007; Hou Z. S., 1994, THESIS NE U SHENGYAN; Kim E, 2003, IEEE T FUZZY SYST, V11, P399, DOI 10.1109/TFUZZ.2003.812699; Liu Y, 2012, MATH COMPUT SIMULAT, V82, P847, DOI 10.1016/j.matcom.2011.07.010; Mahmoud MS, 2002, AUTOMATICA, V38, P361, DOI 10.1016/S0005-1098(01)00253-9; NAHAS EP, 1992, COMPUT CHEM ENG, V16, P1039, DOI 10.1016/0098-1354(92)80022-2; Narendra KS, 1990, J IEEE T NEURAL NETW, V1, P4, DOI DOI 10.1109/72.80202; Safonov M. G., 1995, FEEDBACK CONTROL NON, P196, DOI DOI 10.1007/BFB0027678; SPALL JC, 1992, IEEE T AUTOMAT CONTR, V37, P332, DOI 10.1109/9.119632; Wang H, 1996, INT J SYST SCI, V27, P161, DOI 10.1080/00207729608929200; Wang H., 1999, BOUNDED DYNAMICS STO; Wang L.-X., 1994, ADAPTIVE FUZZY SYSTE; Zhang YJ, 2011, IEEE T NEURAL NETWOR, V22, P1783, DOI 10.1109/TNN.2011.2166561; Zhao WQ, 2013, IEEE T FUZZY SYST, V21, P30, DOI 10.1109/TFUZZ.2012.2200900; Zhu KY, 1999, INT J ADAPT CONTROL, V13, P183, DOI 10.1002/(SICI)1099-1115(199905)13:3<183::AID-ACS533>3.0.CO;2-W	47	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2162-237X	2162-2388		IEEE T NEUR NET LEAR	IEEE Trans. Neural Netw. Learn. Syst.	DEC	2014	25	12					2156	2166		10.1109/TNNLS.2014.2306002		11	Computer Science, Artificial Intelligence; Computer Science, Hardware & Architecture; Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	AU3MZ	WOS:000345518900003		
J	Kang, Y; Kato, S				Kang, Yoonkyung; Kato, Shinsuke			Thermal and non-thermal germicidal effects of microwave radiation on microbial agents	INDOOR AND BUILT ENVIRONMENT			English	Article						Microwave radiation; Germicidal effect; Evaporative humidifier; Cladosporium herbarum; Fusarium solani; Bacillus subtilis	BACILLUS-SUBTILIS; HYPERSENSITIVITY PNEUMONITIS; AIR; SYSTEMS; SPORES; STERILIZATION; CONTAMINATION; MICROORGANISMS; INACTIVATION; PERFORMANCE	To assess possible applications of evaporative humidifier elements of air-conditioning systems, the germicidal effect of microwave irradiation on fungal spores (e.g. Cladosporium herbarum and Fusarium solani), vegetative bacteria and bacterial spores (e.g., Bacillus subtilis) was investigated by this study. A general purpose microwave oven and a specifically assembled microwave source placed in a 2.45GHz magnetron were used. Initially, the optimal radiation output power and exposure time were determined to achieve the desired germicidal effects using both wet and dry sample filters. The study also investigated whether the germicidal effect could be a direct result of the microwave irradiation or rather a result of the radiation-induced heat. The results of our study have indicated that microbial degradation could be dependent on the fungal strain type, microwave output power, exposure time and sample moisture. Our results have also illustrated that the germicidal effect shown in the experiments could be attributed to the associated rise in temperature particularly above 60? during the microwave irradiation of the fungal buffer solutions.	[Kang, Yoonkyung] Univ Tokyo, Dept Architecture, Meguro Ku, Tokyo 1538505, Japan; [Kato, Shinsuke] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan	Kang, Y (reprint author), Univ Tokyo, Dept Architecture, Meguro Ku, Tokyo 1538505, Japan.	phycology99@gmail.com			Tokyo Electric Power Company in Japan	We appreciate suggestions by U Yanagi, M Sung and M Harada. This work was performed with the financial support of Tokyo Electric Power Company in Japan.	AHEARN DG, 1991, J IND MICROBIOL, V8, P277, DOI 10.1007/BF01576067; Noakes CJ, 2004, INDOOR BUILT ENVIRON, V13, P477, DOI 10.1177/1420326X04049343; Oliveira EA, 2010, WASTE MANAGE, V30, P2327, DOI 10.1016/j.wasman.2010.05.002; Bonetta S, 2010, ENVIRON MONIT ASSESS, V161, P473, DOI 10.1007/s10661-009-0761-8; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; RANTIOLEHTIMAKI A, 1989, ALLERGY, V44, P18, DOI 10.1111/j.1398-9995.1989.tb00440.x; Setlow P, 2006, J APPL MICROBIOL, V101, P514, DOI 10.1111/j.1365-2672.2005.02736.x; Woo IS, 2000, APPL ENVIRON MICROB, V66, P2243, DOI 10.1128/AEM.66.5.2243-2247.2000; Wang HG, 2005, SCI TECHNOL ADV MAT, V6, P921, DOI 10.1016/j.stam.2005.07.005; Celandroni F, 2004, J APPL MICROBIOL, V97, P1220, DOI 10.1111/j.1365-2672.2004.02406.x; Kozempel MF, 1998, J FOOD PROTECT, V61, P582; BURGE HA, 1980, APPL ENVIRON MICROB, V39, P840; JENG DKH, 1987, APPL ENVIRON MICROB, V53, P2133; TYNDALL RL, 1995, INDOOR AIR, V5, P171, DOI 10.1111/j.1600-0668.1995.t01-1-00003.x; BANASZAK EF, 1970, NEW ENGL J MED, V283, P271, DOI 10.1056/NEJM197008062830601; Baron S, 1996, MED MICROBIOLOGY; Begot C, 1996, J MICROBIOL METH, V25, P225, DOI 10.1016/0167-7012(95)00090-9; Bencko V, 1993, INDOOR AIR, V3, P20, DOI 10.1111/j.1600-0668.1993.t01-3-00004.x; CASASNOVAS J, 1994, J MICROWAVE POWER EE, V29, P171; Chuaybamroong P, 2010, INDOOR AIR, V20, P246, DOI 10.1111/j.1600-0668.2010.00651.x; Cole EC, 1993, EPA68WO0032; COOK HJ, 1980, ANN SCI, V37, P323, DOI 10.1080/00033798000200271; Copson DA, 1975, MICROWAVE HEATING; Fernando H, 1998, P NATL ACAD SCI USA, V95, P5550, DOI 10.1073/pnas.95.10.5550; Fink JN, 1998, INDOOR AIR, P56; FINK JN, 1976, ANN INTERN MED, V84, P406; GERHARDT P, 1989, REGULATION OF PROCARYOTIC DEVELOPMENT, P43; GOLDBLIT.SA, 1967, APPL MICROBIOL, V15, P1371; GREENGUARD Environmental Institute, 2007, METH MEAS MICR RES V; Ian S, 2012, INDOOR BUILT ENVIRON, V21, P562; Katsui N, 1995, SHASE, V61, P37; Kemp SJ, 1995, ASHRAE TRAN, V101, P305; Kim JH, 2010, ASHRAE IAQ 2010 C NO; Klanova K, 2006, INDOOR BUILT ENVIRON, V15, P81, DOI 10.1177/1420326X06062344; Kubota M, 2011, APPL THERM ENG, V31, P1482, DOI 10.1016/j.applthermaleng.2011.01.027; Papadantonakis GA, 2002, J PHYS CHEM B, V106, P7704, DOI 10.1021/jp0206491; Patel SS, 2010, J ARTIF ORGANS, V13, P24, DOI 10.1007/s10047-010-0489-9; Pieckova E, 1999, ANN AGR ENV MED, V6, P1; Singh J, 2010, INDOOR BUILT ENVIRON, V19, P40, DOI 10.1177/1420326X09358808; STOUT JE, 1986, APPL ENVIRON MICROB, V52, P396; Sung MK, 2011, HVAC&R RES, V17, P22, DOI 10.1080/10789669.2010.541540; VERISSIMO A, 1990, J HOSP INFECT, V15, P255, DOI 10.1016/0195-6701(90)90033-K; Williams JM, 2001, BIOL EFFECTS MICROWA; Wong LT, 2009, INDOOR BUILT ENVIRON, V18, P553, DOI 10.1177/1420326X09347061; Woo MH, 2012, AEROSOL AIR QUAL RES, V12, P4; Wu Y, 2010, J AEROSOL SCI, V41, P682, DOI 10.1016/j.jaerosci.2010.04.004; Yanagi U, 2007, J ENV ENG AIJ, V617, P53; Yu CWF, 2011, INDOOR BUILT ENVIRON, V20, P5, DOI 10.1177/1420326X10397780; Yu Ying, 2009, Instrument Techniques and Sensor	49	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1420-326X	1423-0070		INDOOR BUILT ENVIRON	Indoor Built Environ.	DEC	2014	23	8					1080	1091		10.1177/1420326X13490180		12	Construction & Building Technology; Engineering, Environmental; Public, Environmental & Occupational Health	Construction & Building Technology; Engineering; Public, Environmental & Occupational Health	AT9AT	WOS:000345220800003		
J	Yoshino, H; Ando, N; Kensuke, H; Hasegawa, K; Abe, K; Ikeda, K; Kato, N; Kumagai, K; Mitamura, T; Yanagi, U				Yoshino, Hiroshi; Ando, Naoya; Kensuke, Hamada; Hasegawa, Kenichi; Abe, Keiko; Ikeda, Koichi; Kato, Noriko; Kumagai, Kazukiyo; Mitamura, Teruaki; Yanagi, U.			Investigation of association between indoor environmental factors and child health problems in Japan Design of survey and outcome from preliminary cross-sectional questionnaire	INDOOR AND BUILT ENVIRONMENT			English	Article						Allergic diseases; Indoor environment; Questionnaire survey; House dust; Mould; School children	RISK-FACTORS; HOUSE-DUST; ASTHMA; EXPOSURE; SENSITIZATION; SYMPTOMS; DAMPNESS; SWEDEN; MOLD; EPIDEMIOLOGY	In Japan, there is an increase in allergic diseases such as asthma, respiratory symptom, particularly prevailing among the young generation. The reasons why the prevalence is increasing are still not yet well understood. However, it is deemed that indoor environmental factors are one of the essential sources. Therefore, an epidemiology type of survey was investigated on the 4(th) and 5(th) grade school children in Japan. The survey was divided into three phases. Phase 1 was a preliminary cross-sectional questionnaire of the prevalence of health problems. Phase 2 was a cross-sectional questionnaire survey on housing characteristics and health. Phase 3 was a field measurement for case control. This paper describes the study protocol and the outcomes from Phase 1. The prevalence of current allergic symptoms was 49.9%. Asthma and rhinitis of the children were 12.5% and 33.3%, respectively. The prevalence of several allergic symptoms among boys was significantly higher than in girls. It indicated that the environmental factors such as pollen, indoor house dust and dust mites could influence allergic symptoms. This survey reveals the ratio of children allergic symptoms in Japan and the possibility of the association between adverse health effect and indoor environmental factors.	[Yoshino, Hiroshi] Tohoku Univ, Dept Architecture & Bldg Sci, Sendai, Miyagi 9808579, Japan; [Ando, Naoya] Taisei Corp, Tokyo, Japan; [Kensuke, Hamada] Kajima Corp, Tokyo, Japan; [Hasegawa, Kenichi] Akita Prefectural Univ, Fac Syst Sci & Technol, Yurihonjo, Japan; [Abe, Keiko] Inst Environm Biol, Yokohama, Kanagawa, Japan; [Ikeda, Koichi] Nihon Univ, Coll Sci & Technol, Dept Architecture, Tokyo 101, Japan; [Kato, Noriko] Natl Inst Publ Hlth, Wako, Saitama 3510197, Japan; [Kumagai, Kazukiyo] Calif Dept Publ Hlth, Environm Hlth Lab Branch, Richmond, CA USA; [Mitamura, Teruaki] Maebashi Inst Technol, Maebashi, Gumma, Japan; [Yanagi, U.] Kogakuin Univ, Dept Architecture, Tokyo, Japan	Yoshino, H (reprint author), Tohoku Univ, Dept Architecture & Bldg Sci, Aoba Ku, 6-6-11-1201 Aoba, Sendai, Miyagi 9808579, Japan.	yoshino@sabine.pln.archi.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science & Technology in Japan; Housing Research Foundation; TOSTEM Foundation for Construction Materials Industry Promotion; Kajima Foundation	The authors would like to thank the residents who were involved in this study for their helpful cooperation. This project was conducted as one of the activities of the Research Project for Creation of Housing that Promotes Health and Well-being (Chair: Prof. Shuzo Murakami). This study was supported partly by the Grants-in-Aid for Scientific Research of the Ministry of Education, Culture, Sports, Science & Technology in Japan, the Housing Research Foundation, TOSTEM Foundation for Construction Materials Industry Promotion and the Kajima Foundation Research Grant.	Amano M, 2008, J ARCHIT PLAN, V628, P1289; [Anonymous], 2009, WHO GUID IND AIR QUA; Bornehag CG, 2005, ENVIRON HEALTH PERSP, V113, P1399, DOI 10.1289/ehp.7809; Kolarik B, 2008, ENVIRON HEALTH PERSP, V116, P98, DOI 10.1289/ehp.10498; Peters JM, 1999, AM J RESP CRIT CARE, V159, P760; Fisk WJ, 2007, INDOOR AIR, V17, P284, DOI 10.1111/j.1600-0668.2007.00475.x; Jaakkola JJK, 1999, AM J PUBLIC HEALTH, V89, P188, DOI 10.2105/AJPH.89.2.188; Buyukalaca O, 2001, APPL ENERG, V69, P269, DOI 10.1016/S0306-2619(01)00017-4; Mudarri D, 2007, INDOOR AIR, V17, P226, DOI 10.1111/j.1600-0668.2007.00474.x; Mari A, 2003, CLIN EXP ALLERGY, V33, P1429, DOI 10.1046/j.1365-2222.2003.01783.x; Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x; Squillace SP, 1997, AM J RESP CRIT CARE, V156, P1760; Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; Kavlock R, 2002, REPROD TOXICOL, V16, P453, DOI 10.1016/S0890-6238(02)00029-1; LAU S, 1989, J ALLERGY CLIN IMMUN, V84, P718, DOI 10.1016/0091-6749(89)90300-X; Holgate ST, 1999, NATURE, V402, pB2; GELBER LE, 1993, AM REV RESPIR DIS, V147, P573; Andersson MA, 1997, APPL ENVIRON MICROB, V63, P387; Nishima Sankei, 2009, Allergology International, V58, P37, DOI 10.2332/allergolint.O-08-550; Benesse Educational Research & Development Center, 2009, INV LIF TIM SCH HOUR; Bornehag CG, 2005, INDOOR AIR, V15, P48, DOI 10.1111/j.1600-0668.2005.00306.x; Bornehag CG, 2004, INDOOR AIR, V14, P59, DOI 10.1111/j.1600-0668.2004.00274.x; Chew KW, 2007, PEDIAT ALLERGY IMMUN, V18, P418; Foliaki S, 2008, INT J TUBERC LUNG D, V12, P799; Hasegawa K, 2007, P 6 INT C IND AIR QU, P275; Haverinen-Shaughnessy U, 2006, INDOOR AIR, V16, P248, DOI 10.1111/j.1600-0668.2006.00422.x; Lindgren A, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-25; Ministry of Health, 2003, OUTL HLTH WELF TREND; Ministry of Internal Affairs and Communications, 2005, SYST SOC DEM STAT; Natural Astronomical Observatory of Japan, 2003, CHRON SCI TABL; Nishima S, 2002, NIHON SHOUNI ARERUGI, V16, P207; Ogura Y, 1988, Arerugi, V37, P1057; PLATTSMILLS TAE, 1991, INT ARCH ALLER A IMM, V94, P339; Schleibinger H, 2008, INDOOR AIR, V18, P113, DOI 10.1111/j.1600-0668.2007.00513.x; Shiotsu M, 1998, J ARCHIT PLANN ENV E, V511, P45; Sugita O, 2007, INDOOR ENVIRON, V10, P137; Tsai HJ, 2007, J ASTHMA, V44, P397, DOI 10.1080/02770900701364304; Tsukioka K, 2009, JPN SOC PEDIAT ALLER, V23, P303; Tunetoshi Y, 1987, J JAPAN SOC AIR POLL, V22, P431; Yoshino H, 2002, J ENV ENG, V558, P87	41	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1420-326X	1423-0070		INDOOR BUILT ENVIRON	Indoor Built Environ.	DEC	2014	23	8					1151	1162		10.1177/1420326X13500157		12	Construction & Building Technology; Engineering, Environmental; Public, Environmental & Occupational Health	Construction & Building Technology; Engineering; Public, Environmental & Occupational Health	AT9AT	WOS:000345220800009		
J	Hiasa, S; Iwamoto, S; Endo, T; Edashige, Y				Hiasa, Shou; Iwamoto, Shinichiro; Endo, Takashi; Edashige, Yusuke			Isolation of cellulose nanofibrils from mandarin (Citrus unshiu) peel waste	INDUSTRIAL CROPS AND PRODUCTS			English	Article						Cellulose; Nanofibril; Mandarin peel waste; Citrus unshiu; Hydrothermal treatment	BY-PRODUCTS; MICROFIBRILS; FIBERS; NANOCOMPOSITES; SUSPENSIONS; RESIDUES	Cellulose obtained from mandarin (Citrus unshiu) peel waste was purified by the removal of oil, coloring substances, and pectin. Two pectin-removing methods, namely multistep and hydrothermal treatments, were investigated to compare their purification efficiencies. The multistep treatment consisted of three steps: removal of metal in pectin, depolymerization, and dissolution of pectin. In contrast, the hydrothermal treatment comprises a single step process involving a solution of 0.18 wt% hydrochloric acid. Fourier-transform infrared spectroscopy and neutral sugar content analysis of the purified cellulose from the mandarin peel waste indicated that the hydrothermal treatment was more effective for the purification of cellulose, as compared to the multistep treatment. The crystal width of the purified cellulose was determined from X-ray diffraction analysis, and it revealed a smaller crystal width (2.5 nm) than that of wood cellulose (3.9 nm). After the pectin removal, the purified cellulose from the mandarin peel waste was fibrillated by sonication to obtain cellulose nanofibrils, yielding cellulose fibers with widths of 2-3 nm, as observed by atomic force microscopy. The observed fiber width corresponded to the crystal width, indicating that the cellulose nanofibrils were completely individualized by sonication. (C) 2014 Elsevier B.V. All rights reserved.	[Hiasa, Shou; Edashige, Yusuke] Ehime Univ, United Grad Sch Agr Sci, Matsuyama, Ehime 7908566, Japan; [Hiasa, Shou; Iwamoto, Shinichiro; Endo, Takashi] Natl Inst Adv Sci & Technol AIST, Biomass Refinery Res Ctr, Higashihiroshima, Hiroshima 7390046, Japan	Endo, T (reprint author), Natl Inst Adv Sci & Technol AIST, Biomass Refinery Res Ctr, 3-11-32 Kagamiyama, Higashihiroshima, Hiroshima 7390046, Japan.	t-endo@aist.go.jp					Marin FR, 2007, FOOD CHEM, V100, P736, DOI 10.1016/j.foodchem.2005.04.040; Taboada E, 2010, FOOD CHEM, V123, P669, DOI 10.1016/j.foodchem.2010.05.030; Wang X, 2014, FOOD HYDROCOLLOID, V38, P129, DOI 10.1016/j.foodhyd.2013.12.003; Dufresne A, 1997, J APPL POLYM SCI, V64, P1185; SUGIYAMA J, 1991, MACROMOLECULES, V24, P2461, DOI 10.1021/ma00009a050; Pandey KK, 1999, J APPL POLYM SCI, V71, P1969, DOI 10.1002/(SICI)1097-4628(19990321)71:12<1969::AID-APP6>3.3.CO;2-4; Roman M, 2009, ACS SYM SER, V1017, P81; FREYWYSSLING A, 1954, SCIENCE, V119, P80, DOI 10.1126/science.119.3081.80; Rezzadori K, 2012, FOOD BIOPROD PROCESS, V90, P606, DOI 10.1016/j.fbp.2012.06.002; Saito T, 2006, BIOMACROMOLECULES, V7, P1687, DOI 10.1021/bm060154s; Lapuerta M, 2008, FUEL PROCESS TECHNOL, V89, P828, DOI 10.1016/j.fuproc.2008.02.001; Habibi Y, 2009, FOOD CHEM, V115, P423, DOI 10.1016/j.foodchem.2008.12.034; Zuluaga R, 2007, CELLULOSE, V14, P585, DOI 10.1007/s10570-007-9118-z; Agoda-Tandjawa G, 2010, CARBOHYD POLYM, V80, P677, DOI 10.1016/j.carbpol.2009.11.045; Danielski L, 2008, J SUPERCRIT FLUID, V44, P315, DOI 10.1016/j.supflu.2007.09.007; Talebnia F, 2008, BIORESOURCES, V3, P108; Yano H, 2005, ADV MATER, V17, P153, DOI 10.1002/adma.200400597; Zhang TJ, 2010, ADV FUNCT MATER, V20, P1152, DOI 10.1002/adfm.200902104; Besbes I, 2011, CARBOHYD POLYM, V86, P1198, DOI 10.1016/j.carbpol.2011.06.015; de Azeredo HMC, 2009, FOOD RES INT, V42, P1240, DOI 10.1016/j.foodres.2009.03.019; Endo T., 2009, SYNTHESIOLOGY, V2, P270; Garcia-Castello E, 2006, DESALINATION, V191, P178, DOI 10.1016/j.desal.2005.09.012; Ifuku S, 2011, SEN-I GAKKAISHI, V67, P86; Martinez M, 2010, CHEM ENG J, V162, P480, DOI 10.1016/j.cej.2010.05.048; MAY CD, 1990, CARBOHYD POLYM, V12, P79, DOI 10.1016/0144-8617(90)90105-2; MEGIAS MD, 1993, ANIM FEED SCI TECH, V43, P269; Niimura H, 2010, CELLULOSE, V17, P13, DOI 10.1007/s10570-009-9361-6; Pascual J. M., 1980, ANIMAL FEED SCI TECH, V5, P1, DOI 10.1016/0377-8401(80)90005-X; Ribitsch V, 1996, COLLOID POLYM SCI, V274, P388, DOI 10.1007/BF00654060; Scherrer P., 1918, GOTTINGER NACHRICHTE, V2, P98	30	1	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0926-6690	1872-633X		IND CROP PROD	Ind. Crop. Prod.	DEC	2014	62						280	285		10.1016/j.indcrop.2014.08.007		6	Agricultural Engineering; Agronomy	Agriculture	AU2SW	WOS:000345468800037		
J	Sasaki, C; Kushiki, Y; Asada, C; Nakamura, Y				Sasaki, Chizuru; Kushiki, Yohei; Asada, Chikako; Nakamura, Yoshitoshi			Acetone-butanol-ethanol production by separate hydrolysis and fermentation (SHF) and simultaneous saccharification and fermentation (SSF) methods using acorns and wood chips of Quercus acutissima as a carbon source	INDUSTRIAL CROPS AND PRODUCTS			English	Article						Quercus acutissima; Acorns; Wood chips; Simultaneous saccharification and fermentation; Butanol	ARUNDO-DONAX L.; CLOSTRIDIUM-ACETOBUTYLICUM; ENZYMATIC-HYDROLYSIS; SUGARCANE BAGASSE; BUTYRIC-ACID; INHIBITION; BIOMASS; WATER; SACCHAROPERBUTYLACETONICUM; DEGENERATION	We investigated the production of acetone-butanol-ethanol (ABE) from acorns (starchy material) and wood chips (cellulosic material) of Quercus acutissima through separate hydrolysis and fermentation (SHF) and simultaneous saccharification and fermentation (SSF) by Clostridium acetobutylicum NBRC13948. With acorns, 15.45 g/L of ABE was obtained in 96 h of fermentation time from the enzymatic hydrolyzate of acorns by SHF. From the SSF, it was found that ABE (16.70 g/L, 120 h) was produced without enzyme addition, given that C acetobutylicum NBRC 13948 possesses an amylolytic enzyme. With wood chips, steam explosion was used for pretreatment. In the SHF, when the enzymatic hydrolyzate of residue of water and methanol extraction after pretreatment was used as the substrate, the maximum ABE concentration, 15.29 g/L, was obtained in 120 h. From the SSF, 13.41 g/L of ABE was obtained in 144h, and it was determined that sufficient enzyme loading was 7.8 mg of protein to 1 g of dry substrate. (C) 2014 Published by Elsevier B.V.	[Sasaki, Chizuru; Kushiki, Yohei; Asada, Chikako; Nakamura, Yoshitoshi] Univ Tokushima, Inst Sci & Technol, Dept Life Syst, Tokushima 7708506, Japan	Sasaki, C (reprint author), Univ Tokushima, Inst Sci & Technol, Dept Life Syst, 2-1 Minamijosanjima Cho, Tokushima 7708506, Japan.	csasaki@bio.tokushima-u.ac.jp			ESPEC Foundation for Global Environment Research and Technology (Charitable Trust) (ESPEC Prize for the Encouragement of Environmental Studies)	Part of this study was funded by ESPEC Foundation for Global Environment Research and Technology (Charitable Trust) (ESPEC Prize for the Encouragement of Environmental Studies). We are deeply grateful to Tsutomu Ushikawa for providing the acorns used in this study.	ALFANI F, 1990, J MEMBRANE SCI, V52, P339, DOI 10.1016/S0376-7388(00)85136-4; Qureshi N, 2010, BIOMASS BIOENERG, V34, P566, DOI 10.1016/j.biombioe.2009.12.023; Klinke HB, 2004, APPL MICROBIOL BIOT, V66, P10, DOI 10.1007/s00253-004-1642-2; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P25, DOI 10.1016/S0960-8524(99)00161-3; Jang YS, 2012, BIORESOURCE TECHNOL, V123, P653, DOI 10.1016/j.biortech.2012.07.104; Chen CK, 1999, APPL ENVIRON MICROB, V65, P499; Stenberg K, 2000, BIOTECHNOL BIOENG, V68, P204, DOI [10.1002/(SICI)1097-0290(20000420)68:2<204::AID-BIT9>3.0.CO;2-4, 10.1002/(SICI)1097-0290(20000420)68:2<204::AID-BIT9>3.3.CO;2-W]; Qureshi N, 2010, BIOMASS BIOENERG, V34, P559, DOI 10.1016/j.biombioe.2009.12.024; Lee SY, 2008, BIOTECHNOL BIOENG, V101, P209, DOI 10.1002/bit.22003; Buruiana CT, 2014, IND CROP PROD, V54, P32, DOI 10.1016/j.indcrop.2014.01.003; Scordia D, 2013, IND CROP PROD, V49, P392, DOI 10.1016/j.indcrop.2013.05.031; Khullar E, 2013, IND CROP PROD, V44, P11, DOI 10.1016/j.indcrop.2012.10.015; Lu ZD, 2010, BIORESOURCE TECHNOL, V101, P3642, DOI 10.1016/j.biortech.2009.12.119; OUNINE K, 1985, APPL ENVIRON MICROB, V49, P874; Scordia D, 2012, BIOMASS BIOENERG, V39, P296, DOI 10.1016/j.biombioe.2012.01.023; Cornillot E, 1997, J BACTERIOL, V179, P5442; Tashiro Y, 2004, J BIOSCI BIOENG, V98, P263; Survase SA, 2013, IND CROP PROD, V45, P349, DOI 10.1016/j.indcrop.2012.12.049; Canellas I, 2007, AGROFOREST SYST, V70, P3, DOI 10.1007/s10457-007-9034-0; HONG J, 1981, BIOTECHNOL BIOENG, V23, P2779, DOI 10.1002/bit.260231212; Tomas CA, 2004, J BACTERIOL, V186, P2006, DOI 10.1128/JB.186.7.2006-2018.2004; Ando H, 2000, IND ENG CHEM RES, V39, P3688, DOI 10.1021/ie0000257; Sun ZJ, 2012, BIOMASS BIOENERG, V39, P39, DOI 10.1016/j.biombioe.2010.07.026; Nakamura Y, 2001, J CHEM TECHNOL BIOT, V76, P879, DOI 10.1002/jctb.465; Lee SH, 2008, J ANAL APPL PYROL, V83, P110, DOI 10.1016/j.jaap.2008.06.006; Baba SI, 2012, J BIOTECHNOL, V157, P605, DOI 10.1016/j.jbiotec.2011.06.004; DUNLOP AP, 1948, IND ENG CHEM, V40, P204, DOI 10.1021/ie50458a006; Larsson S, 1999, ENZYME MICROB TECH, V24, P151, DOI 10.1016/S0141-0229(98)00101-X; Asgher M, 2013, IND CROP PROD, V44, P488, DOI 10.1016/j.indcrop.2012.10.005; Li SY, 2011, BIORESOURCE TECHNOL, V102, P4241, DOI 10.1016/j.biortech.2010.12.078; JONES DT, 1986, MICROBIOL REV, V50, P484; Liu ZY, 2010, J IND MICROBIOL BIOT, V37, P495, DOI 10.1007/s10295-010-0695-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Garcia A, 2014, IND CROP PROD, V53, P148, DOI 10.1016/j.indcrop.2013.12.029; AOAC, 2000, OFF METH AN, V2; Asada C, 2011, CARBOHYD POLYM, V85, P196, DOI 10.1016/j.carbpol.2011.02.020; Asada C, 2011, BIORESOURCE TECHNOL, V102, P10052, DOI 10.1016/j.biortech.2011.08.020; Asada C, 2005, BIOTECHNOL BIOPROC E, V10, P346, DOI 10.1007/BF02931853; Ballesteros I, 2011, BIORESOURCE TECHNOL, V102, P6611, DOI 10.1016/j.biortech.2011.03.077; Hari KS, 2001, BIORESOURCE TECHNOL, V77, P193; Kobayashi F, 2004, J BIOSCI BIOENG, V97, P426, DOI 10.1016/S1389-1723(04)70231-5; Nakaji S., 1993, JPN J HYG, V48, P623; Okamura M., 2001, J FOREST RES, V6, P63, DOI 10.1007/BF02762489; Oshiro M, 2010, APPL MICROBIOL BIOT, V87, P1177, DOI 10.1007/s00253-010-2673-5; Sasaki C, 2012, J MATER CYCLES WASTE, V14, P234, DOI 10.1007/s10163-012-0064-y; Sasaki C, 2014, BIOSCI BIOTECH BIOCH, V78, P160, DOI 10.1080/09168451.2014.877818; Tang L, 2009, FRONT FOREST CHINA, V4, P185; VANDERWESTHUIZEN A, 1982, APPL ENVIRON MICROB, V44, P1277; Wise L. E., 1946, Paper Trade Journal, V122, P35; Yen HW, 2011, J TAIWAN INST CHEM E, V42, P902, DOI 10.1016/j.jtice.2011.05.006	50	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0926-6690	1872-633X		IND CROP PROD	Ind. Crop. Prod.	DEC	2014	62						286	292		10.1016/j.indcrop.2014.08.049		7	Agricultural Engineering; Agronomy	Agriculture	AU2SW	WOS:000345468800038		
J	Takaesu, T				Takaesu, Toshimitsu			Essential spectrum of a fermionic quantum field model	INFINITE DIMENSIONAL ANALYSIS QUANTUM PROBABILITY AND RELATED TOPICS			English	Article						Essential spectrum; Fock space; quantum field theory	YUKAWA MODEL; HAMILTONIANS	An interaction system of a fermionic quantum field is considered. The state space is defined by a tensor product space of a fermion Fock space and a Hilbert space. It is assumed that the total Hamiltonian is a self-adjoint operator on the state space and bounded from below. Then it is proven that a subset of real numbers is the essential spectrum of the total Hamiltonian. It is applied to a Yukawa interaction system, which is a system of a Dirac field coupled to a Klein-Gordon, and the HVZ theorem is obtained.	Gunma Univ, Fac Sci & Technol, Gunma 3768515, Japan	Takaesu, T (reprint author), Gunma Univ, Fac Sci & Technol, Gunma 3768515, Japan.				JSPS [24.1671]	It is a pleasure to thank Professor Tadayoshi Adachi for giving opportunities of talk in seminar and his comments. The author would also like to thank the referee for his careful review and valuable comments. This work is supported by JSPS Grant 24.1671.	Ammari Z, 2004, J FUNCT ANAL, V208, P302, DOI 10.1016/S0022-1236(03)00217-9; Arai A, 2000, J MATH ANAL APPL, V246, P189, DOI 10.1006/jmaa.2000.6782; Cycon H. L., 1987, SCHRODINGER OPERATOR; Deckert DA, 2014, COMMUN MATH PHYS, V327, P887, DOI 10.1007/s00220-013-1877-9; Frohlich J., 1973, Annales de l'Institut Henri Poincare, Section A (Physique Theorique), V19; Derezinski J, 1999, REV MATH PHYS, V11, P383; Glimm J., 1985, COLLECTED PAPERS, V1; Guillot J. C., ARXIV12093207; Hislop P. D., 1996, INTRO SPECTRAL THEOR; Takaesu T, 2011, INFIN DIMENS ANAL QU, V14, P225, DOI 10.1142/S0219025711004390; Takaesu T., 2009, J MATH PHYS, V50; Thaller B., 1992, DIRAC EQUATION	12	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-0257	1793-6306		INFIN DIMENS ANAL QU	Infin. Dimens. Anal. Quantum Probab. Relat. Top.	DEC	2014	17	4							1450024	10.1142/S0219025714500246		11	Mathematics, Applied; Physics, Mathematical; Statistics & Probability	Mathematics; Physics	AU4LJ	WOS:000345582300002		
J	Ansary, MMU; Ishihara, S; Oka, A; Kusunoki, R; Oshima, N; Yuki, T; Kawashima, K; Maegawa, H; Kashiwagi, N; Kinoshita, Y				Ansary, Md. Mesbah Uddin; Ishihara, Shunji; Oka, Akihiko; Kusunoki, Ryusaku; Oshima, Naoki; Yuki, Takafumi; Kawashima, Kousaku; Maegawa, Hidetaka; Kashiwagi, Nobuhito; Kinoshita, Yoshikazu			Apoptotic Cells Ameliorate Chronic Intestinal Inflammation by Enhancing Regulatory B-cell Function	INFLAMMATORY BOWEL DISEASES			English	Article						apoptotic cells; regulatory B cells; IL-10; phagocytosis; inflammatory bowel disease	COLLAGEN-INDUCED ARTHRITIS; CD8(+) T-CELLS; BOWEL-DISEASE; DENDRITIC CELLS; CROHNS-DISEASE; GROWTH-FACTOR; IN-VITRO; NEUTROPHIL APOPTOSIS; CYTOKINE PRODUCTION; MURINE NEUTROPHILS	Apoptosis is a programmed physiological death of unwanted cells, and handling of apoptotic cells (ACs) is thought to have profound effects on immune-mediated disorders. However, there is scant information regarding the role of ACs in intestinal inflammation, in which immune homeostasis is a major concern. To investigate this, we injected ACs into a severe combined immunodeficiency adoptive transfer model of chronic colitis in the presence and absence of cotransferred whole B or regulatory B cell (Breg)-depleted B cells. We also injected syngeneic ACs into AKR/N mice as a control and into milk fat globule-epidermal growth factor 8 knockout mice deficient of phagocytic function. Chronic colitis severity was significantly reduced in the AC as opposed to the phosphate-buffered saline group with cotransferred whole B cells. The AC-mediated effect was lost in the absence of B cells or presence of Breg-depleted B cells. In addition, ACs induced splenic B cells to secrete significantly increased levels of interleukin 10 in AKR/N mice but not milk fat globule-epidermal growth factor 8 knockout mice. Apoptotic leukocytes were induced by reactive oxygen species during granulocyte/monocyte apheresis therapy in rabbits and H2O2-induced apoptotic neutrophils ameliorated mice colitis. Our results indicate that ACs are protective only in the presence of B cells and phagocytosis of ACs induced interleukin 10 producing Bregs. Thus, the ameliorative effect seen in this study might have been exerted by AC-induced Bregs through increased production of the immunosuppressive cytokine interleukin 10, whereas an AC-mediated effect may contribute to the anti-inflammatory effect of granulocyte/monocyte apheresis as a novel therapeutic mechanism for inflammatory bowel disease.	[Ansary, Md. Mesbah Uddin; Ishihara, Shunji; Oka, Akihiko; Kusunoki, Ryusaku; Oshima, Naoki; Kawashima, Kousaku; Kinoshita, Yoshikazu] Shimane Univ, Sch Med, Dept Internal Med 2, Izumo, Shimane, Japan; [Yuki, Takafumi] Shimane Univ Hosp, Dept Gastrointestinal Endoscopy, Izumo, Shimane, Japan; [Maegawa, Hidetaka; Kashiwagi, Nobuhito] JIMRO Co Ltd, Div Res, Takasaki, Gumma, Japan	Ishihara, S (reprint author), Shimane Univ, Dept Internal Med 2, Fac Med, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	si360405@med.shimane-u.ac.jp			JIMRO Co. Ltd., Takasaki, Japan	Supported in part by JIMRO Co. Ltd., Takasaki, Japan.	ABEL EA, 1995, DERMATOL CLIN, V13, P841; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Chen YF, 2009, J IMMUNOL, V183, P1346, DOI 10.4049/jimmunol.0900948; Ginaldi L, 2000, IMMUNOL RES, V21, P31, DOI 10.1385/IR:21:1:31; Burns RC, 2001, GASTROENTEROLOGY, V121, P1428, DOI 10.1053/gast.2001.29568; Notley CA, 2011, J IMMUNOL, V186, P4967, DOI 10.4049/jimmunol.1003021; Gray M, 2007, P NATL ACAD SCI USA, V104, P14080, DOI 10.1073/pnas.0700326104; Johansson ACM, 2001, J IMMUNOL, V167, P3505; Mishima Y, 2010, IMMUNOLOGY, V131, P473, DOI 10.1111/j.1365-2567.2010.03318.x; Takeda Y, 2004, INFLAMM RES, V53, P277, DOI 10.1007/s00011-004-1253-5; Ravishankar B, 2014, P NATL ACAD SCI USA, V111, P4215, DOI 10.1073/pnas.1320924111; Ferguson TA, 2003, IMMUNOL REV, V193, P111, DOI 10.1034/j.1600-065X.2003.00042.x; Mizoguchi A, 1997, J EXP MED, V186, P1749, DOI 10.1084/jem.186.10.1749; KANNAN Y, 1991, BLOOD, V77, P1320; Unsinger J, 2010, J IMMUNOL, V184, P6766, DOI 10.4049/jimmunol.0904054; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Noguchi A, 2007, J GASTROENTEROL, V42, P947, DOI 10.1007/s00535-007-2118-9; STREILEIN JW, 1981, J EXP MED, V153, P1058, DOI 10.1084/jem.153.5.1058; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; DRANSFIELD I, 1994, J IMMUNOL, V153, P1254; Satsangi J, 1996, LANCET, V347, P1212, DOI 10.1016/S0140-6736(96)90734-5; Hibi T, 2009, DIGEST LIVER DIS, V41, P570, DOI 10.1016/j.dld.2008.11.020; SAVILL J, 1993, IMMUNOL TODAY, V14, P131, DOI 10.1016/0167-5699(93)90215-7; Ferguson TA, 2002, J IMMUNOL, V168, P5589; Morelli AE, 2003, BLOOD, V101, P611, DOI 10.1182/blood-2002-06-1769; Wei B, 2005, P NATL ACAD SCI USA, V102, P2010, DOI 10.1073/pnas.0409449102; VAUX DL, 1993, P NATL ACAD SCI USA, V90, P786, DOI 10.1073/pnas.90.3.786; Ikeda S, 2013, J AM ACAD DERMATOL, V68, P609, DOI 10.1016/j.jaad.2012.09.037; Miles K, 2012, P NATL ACAD SCI USA, V109, P887, DOI 10.1073/pnas.1109173109; Oka A, 2014, INFLAMM BOWEL DIS, V20, P315, DOI 10.1097/01.MIB.0000437983.14544.d5; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Griffith TS, 2007, J IMMUNOL, V178, P2679; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Brummel R, 2005, J IMMUNOL, V174, P2429; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; WETSEL RA, 1990, J BIOL CHEM, V265, P2435; Bijl M, 2006, ANN RHEUM DIS, V65, P57, DOI 10.1136/ard.2005.035733; Diepolder HM, 2005, J MED VIROL, V77, P209, DOI 10.1002/jmv.20437; DRANSFIELD I, 1995, BLOOD, V85, P3264; Duerr RH, 1996, INFLAMM BOWEL DIS, V2, P48, DOI 10.1002/ibd.3780020108; Finnegan A, 2003, ARTHRITIS RES THER, V5, pR18, DOI 10.1186/ar.601; Fukuchi T, 2013, J CROHNS COLITIS, V7, P803, DOI 10.1016/j.crohns.2012.12.003; Ishikawa D, 2013, MUCOSAL IMMUNOL, V6, P267, DOI 10.1038/mi.2012.67; KANNAN Y, 1992, BIOCHEM BIOPH RES CO, V186, P1050, DOI 10.1016/0006-291X(92)90853-D; Kashiwagi N, 1998, Ther Apher, V2, P134, DOI 10.1111/j.1744-9987.1998.tb00091.x; Kashiwagi N, 2002, INFLAMMATION, V26, P199, DOI 10.1023/A:1016523914161; Kosiewicz MM, 2001, J CLIN INVEST, V107, P695, DOI 10.1172/JCI10956; Linton Ludvig, 2012, Clin Transl Gastroenterol, V3, pe29, DOI 10.1038/ctg.2012.23; Marteau P, 2000, ENDOSCOPY, V32, P131; Noguchi M, 1998, GUT, V43, P203; Papadakis KA, 1999, GASTROENTEROL CLIN N, V28, P283, DOI 10.1016/S0889-8553(05)70057-1; Pettipher EA, 1988, BRIT J PHARMACOL, V98, P176; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; Ramlow W, 2005, J CLIN APHERESIS, V20, P72, DOI 10.1002/jca.20053; ROBERTS RL, 1985, BLOOD, V65, P433; Sacco Rodolfo, 2013, J Crohns Colitis, V7, pe692, DOI 10.1016/j.crohns.2013.06.012; Satsangi J, 1998, DIGEST DIS, V16, P370, DOI 10.1159/000016894; Sun E, 2004, CELL DEATH DIFFER, V11, P1258, DOI 10.1038/sj.cdd.4401500; Trott K.-R, 1994, Strahlentherapie und Onkologie, V170, P1; UEHARA K, 1993, FEBS LETT, V335, P167, DOI 10.1016/0014-5793(93)80722-7; Vecchi Maurizio, 2013, Clin Exp Gastroenterol, V6, P1, DOI 10.2147/CEG.S33275	62	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1078-0998	1536-4844		INFLAMM BOWEL DIS	Inflamm. Bowel Dis.	DEC	2014	20	12					2308	2320		10.1097/MIB.0000000000000240		13	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AU3ND	WOS:000345519400018		
J	Ito, E; Yamada, YY				Ito, Emi; Yamada, Yoshihiro Y.			Self-/conspecific discrimination and superparasitism strategy in the ovicidal parasitoid Echthrodelphax fairchildii (Hymenoptera: Dryinidae)	INSECT SCIENCE			English	Article						infanticide; ovicide; plant hopper; self-recognition; sex ratio	WASP NASONIA-VITRIPENNIS; LEPTOPILINA-HETEROTOMA HYMENOPTERA; OFFSPRING SEX-RATIO; VENTURIA-CANESCENS; PAY-OFF; CONSPECIFIC SUPERPARASITISM; SOLITARY PARASITOIDS; HOST DISCRIMINATION; EUPELMUS-VUILLETI; OXIDATIVE STRESS	Superparasitism in solitary parasitoids results in fatal competition between the immature parasitoids, and consequently only one individual can emerge. In the semisolitary ovicidal parasitoid Echthrodelphax fairchildii (Hymenoptera: Dryinidae), 2 adults can emerge under superparasitism with a short interval (<24 h) between the first and second ovipositions. We determined the female parasitoid's behavioral responses under self- and conspecific superparasitism bouts with first-to-second oviposition intervals of 2 h. The self- and conspecific superparasitizing frequencies increased up to an oviposition interval of 0.75 h, with the former remaining lower than the latter, particularly for oviposition intervals of 0.25 h, suggesting the existence of self-/conspecific discrimination. The superparasitizing frequency plateaued for oviposition intervals of 0.75 h, with no difference between self- and conspecific superparasitism. The ovicidal-probing frequency did not differ under self- and conspecific superparasitism, and was usually <20%. The females exhibited no preference for the oviposition side (i.e., ovipositing on the side with or without the first progeny) and almost always laid female eggs for any oviposition interval under self- and conspecific superparasitism. The sex ratio was not affected by the type of superparasitism, oviposition sides, or the occurrence of ovicidal probing. These observed results about the oviposition side, ovicidal probing, and sex ratios differed from the predictions obtained assuming that the females behave optimally. Possible reasons for the discrepancies are discussed: likely candidates include the high cost of selecting oviposition sides and ovicidal probing, and, for the sex ratio, the low frequency of encountering suitable hosts before superparasitism bouts.	[Ito, Emi; Yamada, Yoshihiro Y.] Mie Univ, Grad Sch Bioresources, Insect Ecol Lab, Tsu, Mie 5148507, Japan	Yamada, YY (reprint author), Mie Univ, Grad Sch Bioresources, Insect Ecol Lab, Tsu, Mie 5148507, Japan.	yamada-y@bio.mie-u.ac.jp					RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.2307/2409177; Williams JB, 2008, EXP GERONTOL, V43, P538, DOI 10.1016/j.exger.2008.02.001; ROGERS D, 1972, ENTOMOL EXP APPL, V15, P190; Yamada YY, 2003, ECOL ENTOMOL, V28, P613, DOI 10.1046/j.1365-2311.2003.00537.x; Shuker DM, 2004, P NATL ACAD SCI USA, V101, P10363, DOI 10.1073/pnas.030804101; Yamada YY, 2005, ENTOMOL EXP APPL, V114, P143, DOI 10.1111/j.1570-7458.2005.00253.x; Field SA, 1997, ECOL ENTOMOL, V22, P142, DOI 10.1046/j.1365-2311.1997.t01-1-00057.x; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Babendreier D, 2002, ENTOMOL EXP APPL, V105, P63, DOI 10.1046/j.1570-7458.2002.01034.x; Nilsson JA, 2002, P ROY SOC B-BIOL SCI, V269, P1735, DOI 10.1098/rspb.2002.2071; Takasuka K, 2011, NATURWISSENSCHAFTEN, V98, P529, DOI 10.1007/s00114-011-0797-9; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; UENO T, 1994, OIKOS, V70, P333, DOI 10.2307/3545770; CHARNOV EL, 1981, NATURE, V289, P27, DOI 10.1038/289027a0; CHARNOV E L, 1982; Cytel Inc, 2010, LX9MANUAL; Darrouzet E, 2003, ENTOMOL EXP APPL, V109, P167, DOI 10.1046/j.1570-7458.2003.00103.x; Darrouzet E, 2008, J INSECT BEHAV, V21, P181, DOI 10.1007/s10905-008-9118-3; Dawkins R., 1982, EXTENDED PHENOTYPE; Gauthier N., 1996, ENTOMOLOGIA EXPT APP, V43, P183; Godfray H.C.J., 1994, PARASITOIDS BEHAV EV; Heinsohn R, 1999, TRENDS ECOL EVOL, V14, P53, DOI 10.1016/S0169-5347(98)01545-6; HENNEMAN ML, 1995, J INSECT BEHAV, V8, P331; Hubbard SF, 1999, ANIM BEHAV, V57, P1193, DOI 10.1006/anbe.1999.1085; HUBBARD SF, 1987, J ANIM ECOL, V56, P387, DOI 10.2307/5055; HUGHES JP, 1994, J INSECT BEHAV, V7, P455, DOI 10.1007/BF02025443; Ito E, 2005, ECOL ENTOMOL, V30, P714, DOI 10.1111/j.0307-6946.2005.00748.x; Ito E., 2009, THESIS MIE U MIE JAP; KING B, 1992, J EVOLUTION BIOL, V5, P445, DOI 10.1046/j.1420-9101.1992.5030445.x; KING BH, 1991, ANIM BEHAV, V42, P23, DOI 10.1016/S0003-3472(05)80602-5; Kuno E., 1963, RES POPUL ECOL, V5, P31, DOI 10.1007/BF02518819; Lebreton S, 2010, BEHAV ECOL, V21, P107, DOI 10.1093/beheco/arp156; Lebreton S, 2009, ENTOMOL EXP APPL, V130, P28, DOI 10.1111/j.1570-7458.2008.00790.x; Netting JF, 2000, ANIM BEHAV, V60, P217, DOI 10.1006/anbe.2000.1463; Ode PJ, 2002, BIOL CONTROL, V24, P31, DOI 10.1016/S1049-9644(02)00003-8; ODONNELL S, 1995, EXPERIENTIA, V51, P749, DOI 10.1007/BF01941274; ODONNELL S, 1992, ANIM BEHAV, V44, P1021, DOI 10.1016/S0003-3472(05)80314-8; PUTTLER B, 1959, J ECON ENTOMOL, V52, P327; ROSENHEIM JA, 1994, ECOL ENTOMOL, V19, P374, DOI 10.1111/j.1365-2311.1994.tb00255.x; Segoli M, 2009, BEHAV ECOL, V20, P1262, DOI 10.1093/beheco/arp125; Sirot E, 1996, ECOL ENTOMOL, V21, P305; Sykes EM, 2007, BEHAV ECOL SOCIOBIOL, V61, P1751, DOI 10.1007/s00265-007-0407-1; Ueno T, 1996, ANIM BEHAV, V52, P875, DOI 10.1006/anbe.1996.0235; VANDIJKEN MJ, 1992, BEHAV ECOL SOCIOBIOL, V30, P77; VANSALPHEN JJ, 1990, ANNU REV ENTOMOL, V35, P59; vansBaaren J., 1999, FUNCTIONAL ECOLOGY, V13, P66; vansDijken M. J., 1987, ENTOMOLOGIA EXPT APP, V43, P183; VISSER ME, 1993, BEHAV ECOL, V4, P22; VISSER ME, 1992, ECOL ENTOMOL, V17, P76, DOI 10.1111/j.1365-2311.1992.tb01042.x; Wyatt T.D., 2003, PHEROMONES ANIMAL BE; Yamada Yoshihiro Y., 2000, Entomological Science, V3, P579; Yamada Yoshihiro Y., 2002, Entomological Science, V5, P161; Yamada YY, 1998, OIKOS, V81, P209, DOI 10.2307/3547042	53	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1672-9609	1744-7917		INSECT SCI	Insect Sci.	DEC	2014	21	6					741	749		10.1111/1744-7917.12054		9	Entomology	Entomology	AU2ME	WOS:000345451500007		
J	Hayashi, M; Haapasalo, M; Imazato, S; Lee, JI; Momoi, Y; Murakami, S; Whelton, H; Wilson, N				Hayashi, Mikako; Haapasalo, Markus; Imazato, Satoshi; Lee, Jae Il; Momoi, Yasuko; Murakami, Shinya; Whelton, Helen; Wilson, Nairn			Dentistry in the 21st century: challenges of a globalising world	INTERNATIONAL DENTAL JOURNAL			English	Article						Oral health; oral health promotion; globalising world; preventive model; quality of life	PERIODONTAL TISSUE REGENERATION; ELDERLY JAPANESE; ADULTS; CARIES; MORTALITY	Oral health is - literally - vital to good general health, not least because the mouth is the sentinel of the body. Dentistry, the Cinderella of health care, faces immense challenges of globalisation. Governments, having spent freely on everything from defence to social security, face mountains of debts which make budget cutbacks essential. Simultaneously, most developed countries have to pay increasing costs of caring for rapidly ageing populations. Dentistry is being pulled two ways: wealthy members of society demand high-end expensive treatment, much of it cosmetic rather than necessary to deal with disease, whereas many millions of poor people in developing countries cannot afford basic dental treatment and may never see a dentist. Too many governments and dentists persist with the expensive and destructive regime of drill and fill (and bill)'. International advances in care may not reach the clinician's chair because treatment guidelines and payments are set locally. An international symposium to celebrate Mikako Hayashi becoming Professor of Restorative Dentistry and Endodontology at Osaka University concluded that dentistry should move from an increasingly unaffordable curative model to a cost-effective evidence-based preventive model. The goal is to help people retain healthy natural teeth throughout their lives, as an essential part of enhancing their general health.	[Hayashi, Mikako; Imazato, Satoshi; Murakami, Shinya] Osaka Univ, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Haapasalo, Markus] Univ British Columbia, Fac Dent, Vancouver, BC V5Z 1M9, Canada; [Lee, Jae Il] Seoul Natl Univ, Sch Dent, Seoul, South Korea; [Momoi, Yasuko] Tsurumi Univ, Sch Dent Med, Yokohama, Kanagawa, Japan; [Whelton, Helen] Univ Leeds, Sch Dent, Leeds, W Yorkshire, England; [Wilson, Nairn] Kings Coll London, Inst Dent, London WC2R 2LS, England	Hayashi, M (reprint author), Osaka Univ, Dept Restorat Dent & Endodontol, Grad Sch Dent, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	mikarin@dent.osaka-u.ac.jp					Abt E, 2012, COCHRANE SYST REV, DOI [10.1002/14651858.CD003814.pub2/abstract, DOI 10.1002/14651858.CD003814.PUB2/ABSTRACT]; Axelsson P, 2004, J CLIN PERIODONTOL, V31, P749, DOI 10.1111/j.1600-051X.2004.00563.x; Ikeda E, 2008, EXPERT OPIN BIOL TH, V8, P735, DOI 10.1517/14712598.8.6.735 ; IMAZATO S, 1994, J DENT RES, V73, P1437; Murakami S, 2011, PERIODONTOL 2000, V56, P188, DOI 10.1111/j.1600-0757.2010.00365.x; Imazato S, 2009, DENT MATER J, V28, P11; Kitamura M, 2011, J DENT RES, V90, P35, DOI 10.1177/0022034510384616; Beaglehole R, 2009, ORAL HLTH ATLAS FDI, P68; Elderton R J, 1990, Adv Dent Res, V4, P4; Hayasaka K, 2013, J AM GERIATR SOC, V61, P815, DOI 10.1111/jgs.12225; Hobson R, 2008, EUR J DENT EDUC, V12, P92, DOI 10.1111/j.1600-0579.2007.00484.x; Ikebe K, 2012, COMMUNITY DENT ORAL, V40, P406, DOI 10.1111/j.1600-0528.2012.00683.x; Imazato S, 2014, DENT MATER, V30, P97, DOI 10.1016/j.dental.2013.06.003; Ito A, 2012, J DENT RES, V91, pS52, DOI 10.1177/0022034511435701; Kitamura M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002611; Momoi Y, 2012, J DENT, V40, P95, DOI 10.1016/j.jdent.2011.10.011; Shanley D B, 1997, Eur J Dent Educ, V1, P35, DOI 10.1111/j.1600-0579.1997.tb00008.x; WHO Expert Committee, 1990, WHO TECHNICAL REPORT, V794; Wilson NHF, 2009, CLIN DENT MED 2020	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0020-6539	1875-595X		INT DENT J	Int. Dent. J.	DEC	2014	64	6					333	342		10.1111/idj.12132		10	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AU4DK	WOS:000345559100011		
J	Saeki, H; Matsuzaki, H; Ito, K; Nobeyama, Y; Nakagawa, H				Saeki, Hidehisa; Matsuzaki, Hiroyuki; Ito, Keigo; Nobeyama, Yoshimasa; Nakagawa, Hidemi			Pigmented clear cell acanthoma of the finger simulating pigmented nevus	INTERNATIONAL JOURNAL OF DERMATOLOGY			English	Letter							MELANOCYTES		[Saeki, Hidehisa; Matsuzaki, Hiroyuki; Ito, Keigo; Nobeyama, Yoshimasa; Nakagawa, Hidemi] Jikei Univ, Sch Med, Dept Dermatol, Tokyo, Japan	Saeki, H (reprint author), Jikei Univ, Sch Med, Dept Dermatol, Tokyo, Japan.	saeki-der@jikei.ac.jp					FANTI PA, 1990, AM J DERMATOPATH, V12, P373, DOI 10.1097/00000372-199008000-00008; LANGER K, 1994, AM J DERMATOPATH, V16, P134, DOI 10.1097/00000372-199404000-00005; PIERARD GE, 1991, AM J DERMATOPATH, V13, P430, DOI 10.1097/00000372-199108000-00021; Scheinfeld Noah, 2007, Arch Dermatol, V143, P255, DOI 10.1001/archderm.143.2.255-d	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0011-9059	1365-4632		INT J DERMATOL	Int. J. Dermatol.	DEC	2014	53	12					E579	E581		10.1111/ijd.12542		3	Dermatology	Dermatology	AU4QC	WOS:000345595800007		
J	Unno, T; Minagawa, A; Koga, H; Uhara, H; Okuyama, R				Unno, Toshinori; Minagawa, Akane; Koga, Hiroshi; Uhara, Hisashi; Okuyama, Ryuhei			Alteration of dermoscopic features in a juvenile xanthogranuloma during follow-up of 43 months	INTERNATIONAL JOURNAL OF DERMATOLOGY			English	Letter							CLEAR-CELL HIDRADENOMA; YOUNG GIRL		[Unno, Toshinori; Minagawa, Akane; Koga, Hiroshi; Uhara, Hisashi; Okuyama, Ryuhei] Shinshu Univ, Sch Med, Dept Dermatol, Matsumoto, Nagano 390, Japan; [Unno, Toshinori] Dept Dermatol, Matsumoto, Nagano 3908621, Japan	Unno, T (reprint author), Shinshu Univ, Sch Med, Dept Dermatol, Matsumoto, Nagano 390, Japan.	0467unno@shinshu-u.ac.jp					Faulhaber D, 2000, J AM ACAD DERMATOL, V42, P693, DOI 10.1016/S0190-9622(00)90192-0; Gilaberte Yolanda, 2006, J Am Acad Dermatol, V54, P248, DOI 10.1016/j.jaad.2006.03.003; Gonul M, 2010, INDIAN J DERMATOL VE, V76, P445, DOI 10.4103/0378-6323.66573; Ozawa T, 2005, PEDIATR DERMATOL, V22, P450, DOI 10.1111/j.1525-1470.2005.00115.x; Taylor RS, 2008, FITZPATRICKS DERMATO, P1075	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0011-9059	1365-4632		INT J DERMATOL	Int. J. Dermatol.	DEC	2014	53	12					E590	E591		10.1111/ijd.12530		2	Dermatology	Dermatology	AU4QC	WOS:000345595800013		
J	Ochiai, M; Matsuo, T				Ochiai, Masaru; Matsuo, Tatsuhiro			Effect of egg white and its hydrolysate on stearoyl-CoA desaturase index and fat accumulation in rat tissues	INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION			English	Article						Egg white; fat accumulation; fat excretion; stearoyl-CoA desaturase; triacylglycerol	FOOD-INTAKE; SKELETAL-MUSCLE; OBESE RATS; PROTEIN; LEPTIN; DEFICIENCY; LIVER; MICE; ADIPOSITY; MECHANISM	We investigated the dietary effects of egg white (EW) and its hydrolysate (EWH) on fat metabolism in rats. Wistar rats were divided into casein, EW and EWH dietary groups, and fed their respective diet for 8 weeks. Dietary EW and EWH decreased food intake, body weight gain and fat accumulation in the carcass, liver, muscles and adipose tissues, but muscle weight was increased. In addition, dietary EW and EWH decreased stearoyl-CoA desaturase (SCD) indices and glucose-6-phosphate dehydrogenase activity of the liver and gastrocnemius muscle. Dietary EW also increased the fecal excretion of triacylglycerol, cholesterol and total bile acids, and decreased the serum levels of triacylglycerol and leptin. The suppressive effects of dietary EW on food intake and body fat accumulation were weakened by dietary EWH. These findings indicate that EW and EWH, especially EW, are effective in reducing body fat accumulation by regulating hepatic and muscular SCD indices.	[Ochiai, Masaru; Matsuo, Tatsuhiro] Kagawa Univ, Fac Agr, Kita Ku, Miki, Kagawa 7610795, Japan	Ochiai, M (reprint author), Kagawa Univ, Fac Agr, Kita Ku, 2393 Ikenobe, Miki, Kagawa 7610795, Japan.	x742012z@mails.cc.ehime-u.ac.jp					Prieur X, 2008, ENDOCRINOLOGY, V149, P5432, DOI 10.1210/en.2008-0498; Yu ZP, 2011, FOOD CHEM, V129, P1376, DOI 10.1016/j.foodchem.2011.05.067; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; Beppu F, 2013, LIPIDS, V48, P449, DOI 10.1007/s11745-013-3784-4; Klok MD, 2007, OBES REV, V8, P21, DOI 10.1111/j.1467-789X.2006.00270.x; Tremblay F, 2003, DIABETES, V52, P29, DOI 10.2337/diabetes.52.1.29; Ohinata K, 2009, PEPTIDES, V30, P1105, DOI 10.1016/j.peptides.2009.03.003; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Dobrzyn P, 2004, P NATL ACAD SCI USA, V101, P6409, DOI 10.1073/pnas.0401627101; Stengel A, 2013, AM J PHYSIOL-REG I, V305, pR582, DOI 10.1152/ajpregu.00598.2012; Sampath H, 2011, ANN NY ACAD SCI, V1243, P47, DOI 10.1111/j.1749-6632.2011.06303.x; DAY AP, 1993, METABOLISM, V42, P839, DOI 10.1016/0026-0495(93)90056-T; Asato L, 1996, J NUTR SCI VITAMINOL, V42, P87; de Bont A J, 1975, Proc Soc Exp Biol Med, V149, P849; Dobrzyn A, 2005, AM J PHYSIOL-ENDOC M, V288, pE599, DOI 10.1152/ajpendo.00439.2004; Dobrzyn A, 2005, OBES REV, V6, P169, DOI 10.1111/j.1467-789X.2005.00177.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Karahashi M, 2013, LIPIDS, V48, P457, DOI 10.1007/s11745-013-3786-2; KELLEY DS, 1984, BIOCHEM J, V217, P543; Matsuoka R, 2008, BIOSCI BIOTECH BIOCH, V72, P1506, DOI 10.1271/bbb.80016; MICKELSEN O, 1959, J LAB CLIN MED, V53, P282; Miyazaki M, 2004, J BIOL CHEM, V279, P35017, DOI 10.1074/jbc.M405327200; Ochiai M, 2013, J OLEO SCI, V62, P745, DOI 10.5650/jos.62.745; Ochiai M, 2014, INT J FOOD SCI NUTR, V65, P495, DOI 10.3109/09637486.2013.879288	24	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0963-7486	1465-3478		INT J FOOD SCI NUTR	Int. J. Food Sci. Nutr.	DEC	2014	65	8					948	952		10.3109/09637486.2014.937800		5	Food Science & Technology; Nutrition & Dietetics	Food Science & Technology; Nutrition & Dietetics	AU0YB	WOS:000345347000005		
J	Fukuda, F				Fukuda, Fumihiko			Anisotropic Hardening Rule for Presheared Clay under a Constant Mean-Stress Condition	INTERNATIONAL JOURNAL OF GEOMECHANICS			English	Article						Anisotropy; Clays; Elastoplasticity; Microstructures; Soil tests; Stress strain relations; Yield; Anisotropy; Clays; Elastoplasticity; Microstructures; Soil tests; Stress-strain relations; Yield	SATURATED COHESIVE SOILS; MECHANICAL-PROPERTIES; SHEAR HISTORY; SAND; ROTATION	This paper suggests that the isotropic hardening rule with a modified hardening parameter can be used to simulate anisotropic hardening behavior from both theoretical and experimental viewpoints. It is believed that the isotropic hardening rule cannot simulate anisotropic hardening behavior mainly because its yield function is expressed in terms of the principal stresses and its hardening parameter is expressed in terms of the principal plastic strains. Contrary to this belief, the first part of this paper theoretically suggests that the isotropic hardening rule with a modified hardening parameter, expressed in terms of the plastic strains in the coordinate system defined by the principal stress axes, can simulate anisotropic hardening behavior. In the second part of this paper, it is experimentally shown that the isotropic hardening rule with the modified hardening parameter can simulate the actual anisotropic hardening behavior of presheared clay. The second part also discusses the microscopic mechanism of the hardening for the presheared clay with reference to the isotropic hardening rule with the modified hardening parameter.	Hokkaido Univ, Div Field Engn Environm, Lab Soil Mech, Fac Engn,Kita Ku, Sapporo, Hokkaido 0608628, Japan	Fukuda, F (reprint author), Hokkaido Univ, Div Field Engn Environm, Lab Soil Mech, Fac Engn,Kita Ku, Kita 13,Nishi 8, Sapporo, Hokkaido 0608628, Japan.	fukuda@eng.hokudai.ac.jp					ARTHUR JRF, 1972, GEOTECHNIQUE, V22, P115; MROZ Z, 1967, J MECH PHYS SOLIDS, V15, P163, DOI 10.1016/0022-5096(67)90030-0; ARTHUR JRF, 1977, GEOTECHNIQUE, V27, P13; HIGHT DW, 1983, GEOTECHNIQUE, V33, P355; Coulomb C.A., 1776, MEMOIRES MATH PHYSIQ, V7, P343; Fukuda F, 2003, SOILS FOUND, V43, P109; Fukuda F., 1997, SOILS FOUND, V37, P139; Fukuda F., 2003, P 12 PAN AM C SOIL M, V1, P589; Fukuda F, 2008, DEFORMATION CHARACTERISTICS OF GEOMATERIALS, VOLS 1 AND 2, P581; Grammatikopoulou A., 2006, INT J GEOMECH, V6, P291, DOI DOI 10.1061/(ASCE)1532-3641(2006)6:5(291); Japanese Geotechnical Society, 1999, 05222000 JGS, P12; Jardine R.J., 1992, SOILS FOUND, V32, P111, DOI 10.3208/sandf1972.32.2_111; Karstunen M., 2005, INT J GEOMECHANICS, V5, P87, DOI DOI 10.1061/(ASCE)1532-3641(2005)5:2(87); Lin Han, 2006, International Journal of Geomechanics, V6, P55, DOI 10.1061/(ASCE)1532-3641(2006)6:1(55); Miura K., 1986, SOILS FOUND, V26, P36, DOI DOI 10.3208/SANDF1972.26.36; MROZ Z, 1981, GEOTECHNIQUE, V31, P451; Prager W., 1956, J APPL MECH, V23, P493; Roscoe K. H., 1958, GEOTECHNIQUE, V8, P22, DOI DOI 10.1680/GEOT.1958.8.1.22; Roscoe K. H., 1968, ENG PLASTICITY, P535; Sayao A., 1991, SOILS FOUND, V31, P60; Schofield A. N., 1968, CRITICAL STATE SOIL; Sekiguchi H., 1977, P 9 INT C SOIL MECH, P159; SYMES MJ, 1988, GEOTECHNIQUE, V38, P59; SYMES MJPR, 1984, GEOTECHNIQUE, V34, P11; Toyota H, 2001, SOILS FOUND, V41, P97; Toyota H, 2003, SOILS FOUND, V43, P111; Tresca H., 1864, CR HEBD ACAD SCI, V59, P754; Zhou C., 2005, INT J GEOMECH, V5, P218, DOI DOI 10.1061/(ASCE)1532-3641(2005)5:3(218)	28	0	0	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	1532-3641	1943-5622		INT J GEOMECH	Int. J. Geomech.	DEC	2014	14	6								10.1061/(ASCE)GM.1943-5622.0000371		9	Engineering, Geological	Engineering	AT9YO	WOS:000345280100004		
J	Jin, J; Allison, BZ; Zhang, Y; Wang, XY; Cichocki, A				Jin, Jing; Allison, Brendan Z.; Zhang, Yu; Wang, Xingyu; Cichocki, Andrzej			AN ERP-BASED BCI USING AN ODDBALL PARADIGM WITH DIFFERENT FACES AND REDUCED ERRORS IN CRITICAL FUNCTIONS	INTERNATIONAL JOURNAL OF NEURAL SYSTEMS			English	Article						Brain computer interface; event-related potentials; multi-faces	BRAIN-COMPUTER INTERFACE; RECOGNITION; REPETITION; POTENTIALS; FAMILIAR; SYSTEMS; DISEASE	Recent research has shown that a new face paradigm is superior to the conventional "flash only" approach that has dominated P300 brain-computer interfaces (BCIs) for over 20 years. However, these face paradigms did not study the repetition effects and the stability of evoked event related potentials (ERPs), which would decrease the performance of P300 BCI. In this paper, we explored whether a new "multi-faces (MF)" approach would yield more distinct ERPs than the conventional " single face (SF)" approach. To decrease the repetition effects and evoke large ERPs, we introduced a new stimulus approach called the "MF" approach, which shows different familiar faces randomly. Fifteen subjects participated in runs using this new approach and an established "SF" approach. The result showed that the MF pattern enlarged the N200 and N400 components, evoked stable P300 and N400, and yielded better BCI performance than the SF pattern. The MF pattern can evoke larger N200 and N400 components and more stable P300 and N400, which increase the classification accuracy compared to the face pattern.	[Jin, Jing; Zhang, Yu; Wang, Xingyu] E China Univ Sci & Technol, Key Lab Adv Control & Optimizat Chem Proc, Minist Educ, Shanghai 200237, Peoples R China; [Allison, Brendan Z.] Univ Calif San Diego, Dept Cognit Sci, Cognit Neurosci Lab, La Jolla, CA 92093 USA; [Cichocki, Andrzej] RIKEN, Brain Sci Inst, Lab Adv Brain Signal Proc, Wako, Saitama 3510198, Japan; [Cichocki, Andrzej] Polish Acad Sci, Syst Res Inst, PL-01447 Warsaw, Poland	Jin, J (reprint author), E China Univ Sci & Technol, Key Lab Adv Control & Optimizat Chem Proc, Minist Educ, Shanghai 200237, Peoples R China.	jinjingat@gmail.com; ballison@ucsd.edu; yuzhang@ecust.edu.cn; xywang@ecust.edu.cn; cia@brain.riken.jp	Cichocki, Andrzej/A-1545-2015		Grant National Natural Science Foundation of China [61203127, 61105122, 61201124, 61305028]; Shanghai Leading Academic Discipline Project [B504]; Fundamental Research Funds for the Central Universities [WG1414005, WH1314023]	This work was supported in part by the Grant National Natural Science Foundation of China, under Grant Numbers 61203127, 61105122, 61201124 and 61305028 and supported in part by Shanghai Leading Academic Discipline Project, Project Number: B504. This work was also supported by the Fundamental Research Funds for the Central Universities (WG1414005, WH1314023). We wish to thank anonymous reviewers for their helpful suggestions.	Kaestner EJ, 2011, COGN AFFECT BEHAV NE, V11, P186, DOI 10.3758/s13415-011-0023-4; Hsu WY, 2012, INT J NEURAL SYST, V22, P51, DOI 10.1142/S0129065712002979; Jin J, 2012, J NEUROSCI METH, V205, P265, DOI 10.1016/j.jneumeth.2012.01.004; Lei X, 2009, IEEE T NEUR SYS REH, V17, P521, DOI 10.1109/TNSRE.2009.2027705; Townsend G, 2010, CLIN NEUROPHYSIOL, V121, P1109, DOI 10.1016/j.clinph.2010.01.030; Kaufmann T, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056016; Kaufmann T, 2013, CLIN NEUROPHYSIOL, V124, P893, DOI 10.1016/j.clinph.2012.11.006; Ortiz-Rosario A, 2013, REV NEUROSCIENCE, V24, P537, DOI 10.1515/revneuro-2013-0032; Guger C, 2009, NEUROSCI LETT, V462, P94, DOI 10.1016/j.neulet.2009.06.045; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Jin J, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036006; Zhang Y, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026018; Zhang Y, 2014, INT J NEURAL SYST, V24, DOI 10.1142/S0129065714500038; Hoffmann U, 2008, J NEUROSCI METH, V167, P115, DOI 10.1016/j.jneumeth.2007.03.005; Jemel B, 2003, COGNITIVE BRAIN RES, V17, P431, DOI 10.1016/S0926-6410(03)00145-9; Curran T, 2007, NEUROIMAGE, V36, P464, DOI 10.1016/j.neuroimage.2006.12.016; Gonsalvez CJ, 2002, PSYCHOPHYSIOLOGY, V39, P388, DOI 10.1017/S0048577201393137; Adeli H, 2005, J ALZHEIMERS DIS, V7, P187; Itier RJ, 2002, NEUROIMAGE, V15, P353, DOI 10.1006/nimg.2001.0982; Billinger M, 2013, PRACTICAL BRAIN COMP, P333; Fazel-Rezai R., 2012, FRONT NEUROENG, V5; Guger C., 2012, FRONT NEUROSCI, V6; Jin J, 2010, BIOMED TECH, V55, P203, DOI 10.1515/BMT.2010.029; Jin J., 2012, PLOS ONE, V77; Jin J., 2010, MED BIOL ENG COMPUT, V49, P181; Kaufmann T., 2013, 5 INT BRAIN COMP INT, P136; Lopez-Gordo MA, 2012, INT J NEURAL SYST, V22, DOI 10.1142/S0129065712500098; Manyakov NV, 2012, INT J NEURAL SYST, V22, DOI 10.1142/S0129065712500220; Mikat S, 1999, P IEEE NEUR NETW SIG, P41; Miyakoshi M, 2008, INT J PSYCHOPHYSIOL, V69, P119, DOI 10.1016/j.ijpsycho.2008.03.009; Mueller-Putz G. R., 2013, INT J NEURAL SYST, V23; Onishi A., 2011, 5 INT BCI C GRAZ AUS, P191; Penney T B, 2001, Brain Res Cogn Brain Res, V10, P239; Rodriguez-Bermudez G, 2013, INT J NEURAL SYST, V23, DOI 10.1142/S0129065713500159; Rossion B., 2008, NEUROIMAGE, V39, P1957; Xanthopoulos P, 2013, ROBUST DATA MINING, P27; Ye J., 2004, NIPS; Yuan P, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026014; Zhao Q., 2013, ERAIN COMPUTER INTER, P61	39	5	5	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0129-0657	1793-6462		INT J NEURAL SYST	Int. J. Neural Syst.	DEC	2014	24	8							1450027	10.1142/S0129065714500270		14	Computer Science, Artificial Intelligence	Computer Science	AU3LN	WOS:000345514800002		
J	Cong, F; Zhou, G; Astikainen, P; Zhao, Q; Wu, Q; Nandi, AK; Hietanen, JK; Ristaniemi, T; Cichocki, A				Cong, Fengyu; Zhou, Guoxu; Astikainen, Piia; Zhao, Qibin; Wu, Qiang; Nandi, Asoke K.; Hietanen, Jari K.; Ristaniemi, Tapani; Cichocki, Andrzej			LOW-RANK APPROXIMATION BASED NON-NEGATIVE MULTI-WAY ARRAY DECOMPOSITION ON EVENT-RELATED POTENTIALS	INTERNATIONAL JOURNAL OF NEURAL SYSTEMS			English	Article						Event-related potential; low-rank approximation; multi-domain feature; non-negative canonical polyadic decomposition; non-negative tensor factorization; tensor decomposition	INDEPENDENT COMPONENT ANALYSIS; PARALLEL FACTOR-ANALYSIS; EPILEPTIC EEG SIGNALS; TENSOR FACTORIZATION; MATRIX FACTORIZATION; MISMATCH NEGATIVITY; FACIAL EXPRESSIONS; ALZHEIMERS-DISEASE; BRAIN; CLASSIFICATION	Non-negative tensor factorization (NTF) has been successfully applied to analyze event-related potentials (ERPs), and shown superiority in terms of capturing multi-domain features. However, the time-frequency representation of ERPs by higher-order tensors are usually large-scale, which prevents the popularity of most tensor factorization algorithms. To overcome this issue, we introduce a non-negative canonical polyadic decomposition (NCPD) based on low-rank approximation (LRA) and hierarchical alternating least square (HALS) techniques. We applied NCPD (LRAHALS and benchmark HALS) and CPD to extract multi-domain features of a visual ERP. The features and components extracted by LRAHALS NCPD and HALS NCPD were very similar, but LRAHALS NCPD was 70 times faster than HALS NCPD. Moreover, the desired multi-domain feature of the ERP by NCPD showed a significant group difference (control versus depressed participants) and a difference in emotion processing (fearful versus happy faces). This was more satisfactory than that by CPD, which revealed only a group difference.	[Cong, Fengyu] Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dept Biomed Engn, Dalian, Peoples R China; [Cong, Fengyu; Nandi, Asoke K.; Ristaniemi, Tapani] Univ Jyvaskyla, Dept Math Informat Technol, SF-40351 Jyvaskyla, Finland; [Zhou, Guoxu; Zhao, Qibin; Cichocki, Andrzej] RIKEN, Brain Sci Inst, Lab Adv Brain Signal Proc, Wako, Saitama, Japan; [Astikainen, Piia] Univ Jyvaskyla, Dept Psychol, SF-40351 Jyvaskyla, Finland; [Wu, Qiang] Shandong Univ, Sch Informat Sci & Engn, Jinan, Shandong, Peoples R China; [Nandi, Asoke K.] Brunel Univ, Dept Elect & Comp Engn, Uxbridge UB8 3PH, Middx, England; [Hietanen, Jari K.] Univ Tampere, Sch Social Sci & Humanities, Human Informat Proc Lab, FIN-33101 Tampere, Finland; [Cichocki, Andrzej] Polish Acad Sci, Syst Res Inst, PL-01447 Warsaw, Poland	Cong, F (reprint author), Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dept Biomed Engn, Dalian, Peoples R China.	cong@dlut.edu.cn; zhouguoxu@brain.riken.jp; piia.astikainen@jyu.fi; qbzhao@brain.riken.jp; wuqiang@sdu.edu.cn; asoke.nandi@brunel.ac.uk; jari.hietanen@uta.fi; tapani.ristaniemi@jyu.fi; cia@brain.riken.jp	Cichocki, Andrzej/A-1545-2015; Zhou, Guoxu/D-2040-2014	Zhou, Guoxu/0000-0003-1187-577X	TEKES (Finland) [40334/10]; Fundamental Research Funds for the Central Universities (China) [DUT14RC(3)037]; TEKES; Research and Innovation Office of the University of Jyvaskyla for the international mobility grant; JSPS [24700154]; National Natural Science Foundation of China [61202155]	This work was partially supported by TEKES (Finland) grant 40334/10 'Machine Learning for Future Music and Learning Technologies', and supported by the Fundamental Research Funds for the Central Universities (China, DUT14RC(3)037). A.K. Nandi would like to thank TEKES for their award of the Finland Distinguished Professorship. F. Cong thanks the Research and Innovation Office of the University of Jyvaskyla for the international mobility grant (2009, 2010) and thank Dr. Anh Huy Phan (BSI RIKEN, Japan) for helping in learning tensor decomposition. Q. Zhao was partly supported by JSPS Grants-in-Aid for Scientific Research (Grant No. 24700154) and the National Natural Science Foundation of China (Grant No. 61202155). F. Cong and G. Zhou contribute equally to this work.	Acar E., 2006, P 4 IASTED INT C BIO, P317; Acharya UR, 2011, INT J NEURAL SYST, V21, P403, DOI 10.1142/S0129065711002912; Adeli H, 2010, AUTOMATED EEG-BASED DIAGNOSIS OF NEUROLOGICAL DISORDERS: INVENTING THE FUTURE OF NEUROLOGY, P1, DOI 10.1201/9781439815328; KRUSKAL JB, 1977, LINEAR ALGEBRA APPL, V18, P95, DOI 10.1016/0024-3795(77)90069-6; Rossignol M, 2005, NEUROSCI LETT, V377, P115, DOI 10.1016/j.neulet.2004.11.091; Sankari Z, 2011, CLIN NEUROPHYSIOL, V122, P897, DOI 10.1016/j.clinph.2010.09.008; Li J, 2009, IEEE T NEUR SYS REH, V17, P107, DOI 10.1109/TNSRE.2008.2008394; Timmerman ME, 2000, BRIT J MATH STAT PSY, V53, P1, DOI 10.1348/000711000159132; Morup M, 2009, J CHEMOMETR, V23, P352, DOI 10.1002/cem.1223; CARROLL JD, 1970, PSYCHOMETRIKA, V35, P283, DOI 10.1007/BF02310791; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Acar E, 2007, BIOINFORMATICS, V23, pI10, DOI 10.1093/bioinformatics/btm210; Acar E, 2009, IEEE T KNOWL DATA EN, V21, P6, DOI 10.1109/TKDE.2008.112; Vanderperren K, 2013, PSYCHOPHYSIOLOGY, V50, P97, DOI 10.1111/j.1469-8986.2012.01405.x; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Daubechies I, 2009, P NATL ACAD SCI USA, V106, P10415, DOI 10.1073/pnas.0903525106; Cichocki A, 2008, COMPUTER, V41, P34, DOI 10.1109/MC.2008.431; Martis RJ, 2013, INT J NEURAL SYST, V23, DOI 10.1142/S0129065713500238; TUCKER LR, 1966, PSYCHOMETRIKA, V31, P279, DOI 10.1007/BF02289464; Acharya UR, 2011, INT J NEURAL SYST, V21, P199, DOI 10.1142/S0129065711002808; Morup M, 2006, NEUROIMAGE, V29, P938, DOI 10.1016/j.neuroimage.2005.08.005; Yang ZY, 2011, IEEE T IMAGE PROCESS, V20, P1112, DOI 10.1109/TIP.2010.2081678; Zhou GX, 2011, IEEE T NEURAL NETWOR, V22, P550, DOI 10.1109/TNN.2011.2109396; Zhou GX, 2012, IEEE T SIGNAL PROCES, V60, P2928, DOI 10.1109/TSP.2012.2190410; Herrera LJ, 2013, INT J NEURAL SYST, V23, DOI 10.1142/S0129065713500123; Cichocki A, 2007, INT J NEURAL SYST, V17, P431, DOI 10.1142/S0129065707001275; Cichocki A, 2007, LECT NOTES COMPUT SC, V4666, P169; Ahmadlou M, 2011, NEUROIMAGE, V58, P401, DOI 10.1016/j.neuroimage.2011.04.070; Andersson CA, 2000, CHEMOMETR INTELL LAB, V52, P1, DOI 10.1016/S0169-7439(00)00071-X; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; De Vos M, 2007, NEUROIMAGE, V37, P844, DOI 10.1016/j.neuroimage.2007.04.041; Sidiropoulos ND, 2000, J CHEMOMETR, V14, P229, DOI 10.1002/1099-128X(200005/06)14:3<229::AID-CEM587>3.3.CO;2-E; Adeli H, 2008, NEUROSCI LETT, V444, P190, DOI 10.1016/j.neulet.2008.08.008; Leppanen JM, 2007, CHILD DEV, V78, P232, DOI 10.1111/j.1467-8624.2007.00994.x; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Zhou GX, 2011, IEEE T NEURAL NETWOR, V22, P1626, DOI 10.1109/TNN.2011.2164621; Astikainen P, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-30; Astikainen P, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00557; Bro R., 1998, THESIS U AMSTERDAM H; Cichocki A., 2009, NONNEGATIVE MATRIX T; Cichocki A., 2013, J CONTROL MEAS SYST, V6, P507; Cichocki A, 2009, IEICE T FUND ELECTR, VE92A, P708, DOI 10.1587/transfun.E92.A.708; Cong F., 2012, P 2012 IEEE WORKSH M, P1; Cong F., 2012, INT J NEURAL SYST, V22, P1; Cong F., 2013, INT J NEURAL SYST, V23, P1; Cong FY, 2011, J NEUROSCI METH, V201, P269, DOI 10.1016/j.jneumeth.2011.07.015; De Vos Maarten, 2007, Comput Intell Neurosci, P58253, DOI 10.1155/2007/58253; Delorme A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030135; Faust O, 2010, INT J NEURAL SYST, V20, P159, DOI 10.1142/S0129065710002334; Harshman R. A., 1970, UCLA WORKING PAPERS, V16, P1; Hitchcock F. L., 1927, J MATH PHYS, V6, P164; Hogg R. V., 1987, ENG STAT; Kalyakin I, 2007, DEV NEUROPSYCHOL, V31, P429; Kim J., 2012, HIGH PERFORMANCE SCI, P311; Kopriva I, 2011, AM J PATHOL, V179, P547, DOI 10.1016/j.ajpath.2011.05.010; Kopriva I, 2010, J PHOTOCH PHOTOBIO B, V100, P10, DOI 10.1016/j.jphotobiol.2010.03.013; Lee H, 2007, INT J NEURAL SYST, V17, P305, DOI 10.1142/S0129065707001159; Li J, 2010, PATTERN RECOGN LETT, V31, P619, DOI 10.1016/j.patrec.2009.11.012; Luck SJ, 2005, INTRO EVENT RELATED; Makeig S, 1999, J NEUROSCI, V19, P2665; Morup M, 2007, J NEUROSCI METH, V161, P361, DOI 10.1016/j.jneumeth.2006.11.008; Naatanen R, 2011, BRAIN, V134, P3432, DOI 10.1093/brain/awr064; PHAN AH, 2010, IEICE NONLINEAR THEO, V1, P37; Phan AH, 2011, NEUROCOMPUTING, V74, P1956, DOI 10.1016/j.neucom.2010.06.031; Zhou G., 2013, TDALAB VER1 0	66	1	1	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0129-0657	1793-6462		INT J NEURAL SYST	Int. J. Neural Syst.	DEC	2014	24	8					CP2	U20	1440005	10.1142/S012906571440005X		19	Computer Science, Artificial Intelligence	Computer Science	AU3LN	WOS:000345514800001		
J	Sakamoto, S; Tanaka, E; Kameyama, A; Takizawa, T; Takizawa, S; Fujishima, S; Nara, M; Sakashita, T; Oyama, H; Ono, Y				Sakamoto, Shinji; Tanaka, Eriko; Kameyama, Akiko; Takizawa, Tohru; Takizawa, Shiho; Fujishima, Satoko; Nara, Mieko; Sakashita, Tomoe; Oyama, Hirofumi; Ono, Yutaka			The effects of suicide prevention measures reported through a psychoeducational video: A practice in Japan	INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY			English	Article						Attitude; community survey; educational activities; preventive psychiatry; suicide	DEPRESSION	Background: As the suicide rate in Japan has remained high since 1998, various suicide prevention measures have been implemented in Japanese local communities. Aims: To report our findings on the effect of a psychoeducational video as a suicide prevention measure in a Japanese rural town. Methods: Questionnaires were randomly mailed to 2,000 residents aged between 30 and 79 years. Within 4 weeks, volunteers in the town visited the residents individually and collected the questionnaires. The variables reported in this study are demographics, awareness of suicide prevention measures available in the town, whether the residents watched the video, help-seeking from advisers regarding suicidal ideation and financial problems and attitudes towards suicide. Results: We analysed data collected from 1,118 people who reported their demographics (i.e. sex, age, and job) and whether they had watched the video. By conducting a series of logistic regression and multiple regression analyses and controlling for demographic variables, we found that watching the video had substantial psychoeducational effects. Conclusion: Despite conducting a cross-sectional study, our new suicide prevention measures were considered effective for psychoeducation. However, further studies using a longitudinal design are needed.	[Sakamoto, Shinji] Nihon Univ, Dept Psychol, Coll Humanities & Sci, Tokyo 1568550, Japan; [Tanaka, Eriko; Kameyama, Akiko] Nihon Univ, Inst Humanities & Social Sci, Coll Humanities & Sci, Tokyo 1568550, Japan; [Takizawa, Tohru; Takizawa, Shiho] Hachinohe Gakuin Univ, Fac Human Hlth, Aomori, Japan; [Fujishima, Satoko; Nara, Mieko] Nanbu Town Off, Hlth & Welf Sect, Aomori, Japan; [Sakashita, Tomoe; Oyama, Hirofumi] Aomori Univ Hlth & Welf, Dept Social Welf, Fac Hlth Sci, Aomori, Japan; [Ono, Yutaka] Natl Ctr Neurol & Psychiat, Cognit Behav Therapy Ctr, Tokyo, Japan	Sakamoto, S (reprint author), Nihon Univ, Dept Psychol, Coll Humanities & Sci, 3-25-40 Sakurajyosui Setagaya Ku, Tokyo 1568550, Japan.	Jsakamoto.shinji@nihon-u.ac.jp					Sakamoto S, 2004, PSYCHIAT CLIN NEUROS, V58, P522, DOI 10.1111/j.1440-1819.2004.01295.x; Dumesnil H, 2009, PSYCHIAT SERV, V60, P1203, DOI 10.1176/appi.ps.60.9.1203; Antonucci TC, 1997, PSYCHOL AGING, V12, P189, DOI 10.1037//0882-7974.12.1.189; Conwell Y, 1996, AM J PSYCHIAT, V153, P1001; Klimes-Dougan B, 2009, CRISIS, V30, P128, DOI 10.1027/0227-5910.30.3.128; Ono Yutaka, 2004, Keio J Med, V53, P1, DOI 10.2302/kjm.53.1; Oyama H, 2006, PSYCHIAT CLIN NEUROS, V60, P110, DOI 10.1111/j.1440-1819.2006.01468.x; Sakamoto S., 2013, JAPANESE J MENTAL HL, V28, P56; Yamashita S., 2005, CRISIS, V26, P12	9	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0020-7640	1741-2854		INT J SOC PSYCHIATR	Int. J. Soc. Psychiatr.	DEC	2014	60	8					751	758		10.1177/0020764013518689		8	Psychiatry	Psychiatry	AU2OM	WOS:000345457800003		
J	Zhang, P; Kawaguchi, K; Feng, J				Zhang, Pei; Kawaguchi, Ken'ichi; Feng, Jian			Prismatic tensegrity structures with additional cables: Integral symmetric states of self-stress and cable-controlled reconfiguration procedure	INTERNATIONAL JOURNAL OF SOLIDS AND STRUCTURES			English	Article						Prismatic tensegrities; Integral symmetric prestress; Eigenvalue analysis; Reconfiguration procedure; Tangent stiffness matrix; Moore-Penrose generalized inverse	GRID STRUCTURES; FRAMEWORKS; STIFFNESS; PRESTRESS; STABILITY; MATRIX; DESIGN	A simple energy method is put forward to determine the prestress distribution for symmetric tensegrity structures with multiple states of self-stress and a class of prismatic tensegrities with additional cables are introduced to show the accuracy of presented method. For the purpose of modifying structural shape as well as mechanical properties, a cable-controlled reconfiguration procedure is subsequently proposed for these structures. By defining the length adjustments as the control parameters, the reconfiguration procedure is regarded as a quasi-static process, consisting of a sequence of equilibrium configurations with varying control parameters. Then the nonlinear iterative algorithm based on the tangent stiffness of the structure is presented to simulate and follow this reconfiguration process. By way of example, a particular class of reconfigurations coined symmetrical reconfigurations are investigated carefully and the key features as well as the potential applications are given. (C) 2014 Elsevier Ltd. All rights reserved.	[Zhang, Pei; Feng, Jian] Southeast Univ, Sch Civil Engn, Nanjing 210096, Jiangsu, Peoples R China; [Zhang, Pei; Feng, Jian] Southeast Univ, Natl Prestress Engn Res Ctr, Nanjing 210096, Jiangsu, Peoples R China; [Kawaguchi, Ken'ichi] Univ Tokyo, Dept Architecture, Meguro Ku, Tokyo 1538505, Japan; [Kawaguchi, Ken'ichi] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan	Zhang, P (reprint author), Southeast Univ, Sch Civil Engn, Nanjing 210096, Jiangsu, Peoples R China.				China Scholarship Council [2010609072]; National Natural Science Foundation of China [51278116]	The main part of this study was carried out when the first author was visiting the Institute of Industrial Science at the University of Tokyo, supported by State Scholarship Fund from China Scholarship Council (Grant No. 2010609072). The remainder work completed at Southeast University was supported by National Natural Science Foundation of China (Grant No. 51278116). The first author is grateful for financial support from both.	Fest E, 2003, J STRUCT ENG-ASCE, V129, P515, DOI 10.1061/(ASCE)0733-9445(2003)129:4(515); Juan SH, 2008, MECH MACH THEORY, V43, P859, DOI 10.1016/j.mechmachtheory.2007.06.010; Zhang JY, 2009, INT J SOLIDS STRUCT, V46, P1, DOI 10.1016/j.ijsolstr.2008.08.032; Sultan C, 2003, INT J SOLIDS STRUCT, V40, P4637, DOI 10.1016/S0020-7683(03)00267-1; Chen Y, 2012, INT J STRUCT STAB DY, V12, P213, DOI 10.1142/S0219455412500010; Skelton RE, 2001, J FRANKLIN I, V338, P255, DOI 10.1016/S0016-0032(00)00078-8; Lee S, 2014, INT J MECH SCI, V79, P38, DOI 10.1016/j.ijmecsci.2013.12.001; Fest E, 2004, J STRUCT ENG-ASCE, V130, P1454, DOI 10.1061/(ASCE)0733-9445(2004)130:10(1454); Sultan C, 2002, INT J SOLIDS STRUCT, V39, P2215, DOI 10.1016/S0020-7683(02)00100-2; Guest SD, 2006, INT J SOLIDS STRUCT, V43, P842, DOI 10.1016/j.ijsolstr.2005.03.008; Yuan XF, 2003, COMPUT STRUCT, V81, P2111, DOI 10.1016/S0045-7949(03)00254-2; Djouadi S, 1998, J AEROSPACE ENG, V11, P37, DOI 10.1061/(ASCE)0893-1321(1998)11:2(37); Sultan C, 2001, INT J SOLIDS STRUCT, V38, P5223, DOI 10.1016/S0020-7683(00)00401-7; Kangwai RD, 2000, INT J SOLIDS STRUCT, V37, P1525, DOI 10.1016/S0020-7683(98)00318-7; CALLADINE CR, 1978, INT J SOLIDS STRUCT, V14, P161, DOI 10.1016/0020-7683(78)90052-5; PELLEGRINO S, 1993, INT J SOLIDS STRUCT, V30, P3025, DOI 10.1016/0020-7683(93)90210-X; Guest SD, 2011, IMA J APPL MATH, V76, P57, DOI 10.1093/imamat/hxq065; Connelly R, 1998, AM SCI, V86, P142, DOI 10.1511/1998.2.142; Connelly R, 1995, J STRUCTURAL TOPOLOG, V21, P59; Fuller R.B., 1962, US Patent, Patent No. [no. 3,063,521, 3063521, 3,063,521]; Kawaguchi K., 2003, P IASS APCS TAIP; Kawaguchi K., 2002, P 5 INT C SPAC STRUC, V1, P1; Murakami H, 2001, INT J SOLIDS STRUCT, V38, P3615, DOI 10.1016/S0020-7683(00)00233-X; PELLEGRINO S, 1986, INT J SOLIDS STRUCT, V22, P409, DOI 10.1016/0020-7683(86)90014-4; Sultan C, 2013, INT J SOLIDS STRUCT, V50, P2180, DOI 10.1016/j.ijsolstr.2013.03.005; Sultan C, 2000, J GUID CONTROL DYNAM, V23, P1055, DOI 10.2514/2.4647; Tanaka H., 1986, SHELLS MEMBR SPACE F, V2, P55; Tibert A. G., 2011, International Journal of Space Structures, V26, DOI 10.1260/0266-3511.26.3.241; Tran HC, 2010, COMPUT STRUCT, V88, P558, DOI 10.1016/j.compstruc.2010.01.011; Vassart N., 1999, INT J SPACE STRUCTUR, V14, P147, DOI DOI 10.1260/0266351991494768)	30	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7683	1879-2146		INT J SOLIDS STRUCT	Int. J. Solids Struct.	DEC	2014	51	25-26					4294	4306		10.1016/j.ijsolstr.2014.08.014		13	Mechanics	Mechanics	AU2TM	WOS:000345470400009		
J	Su, DX; Nakano, K; Zheng, RC; Cartmell, MP				Su, Dongxu; Nakano, Kimihiko; Zheng, Rencheng; Cartmell, Matthew P.			Investigations of a Stiffness Tunable Nonlinear Vibrational Energy Harvester	INTERNATIONAL JOURNAL OF STRUCTURAL STABILITY AND DYNAMICS			English	Article						Energy harvesting; hardening type duffing oscillator; tunable stiffness		The recent potential benefit of nonlinearity has been applying in order to improve the effectiveness of energy harvesting devices. For instance, at relatively high excitation levels, both low and high-energy responses can coexist for the same parameter combinations in a hardening type Duffing oscillator, and this provides a wider bandwidth and a higher energy harvesting effectiveness under periodic excitations. However, frequency or amplitude sweeps of the excitation must be used in order to reach a desirable high-energy orbit, and this gives a limitation on practical implementation. This paper presents a stiffness tunable nonlinear vibrational energy harvester which contains a moving magnetic end mass attached to a cantilever beam, whose nonlinearity emerges from the interaction forces with two neighboring permanent magnets facing with opposing poles. The motivating hypothesis has been that the jump from the low-energy orbit to the high-energy orbit can be triggered by tuning the stiffness of the system without changing the frequency or the amplitude of the excitation. Theoretical investigations show a methodology for tuning stiffness, and experimental tests have validated that the proposed method can be used to trigger a jump to the desirable state, and hereby this can broaden the bandwidth of the energy harvester.	[Su, Dongxu] Univ Tokyo, Grad Sch Engn, Tokyo 1538904, Japan; [Nakano, Kimihiko] Univ Tokyo, Interfac Initiat Informat Studies, Tokyo 1538904, Japan; [Zheng, Rencheng] Univ Tokyo, Inst Ind Sci, Tokyo 1538904, Japan; [Cartmell, Matthew P.] Univ Sheffield, Dept Mech Engn, Sheffield S1 3JD, S Yorkshire, England	Su, DX (reprint author), Univ Tokyo, Grad Sch Engn, Tokyo 1538904, Japan.	sudx@iis.u-tokyo.ac.jp; knakano@iis.u-tokyo.ac.jp; topzrc@iis.u-tokyo.ac.jp; m.cartmell@sheffield.ac.uk			Institute of Industrial Science at University of Tokyo, Japan; China Scholarship Council (CSC) [201206050004]	The study was supported by special funding of the Institute of Industrial Science at University of Tokyo, Japan, and the first author wishes to record his profound gratitude to the China Scholarship Council (CSC) for the financial support (Grant No. 201206050004).	Challa VR, 2008, SMART MATER STRUCT, V17, DOI 10.1088/0964-1726/17/01/015035; Stanton SC, 2010, PHYSICA D, V239, P640, DOI 10.1016/j.physd.2010.01.019; Mann BP, 2010, J SOUND VIB, V329, P1215, DOI 10.1016/j.jsv.2009.11.034; Kulah H, 2008, IEEE SENS J, V8, P261, DOI 10.1109/JSEN.2008.917125; Mann BP, 2009, J SOUND VIB, V319, P515, DOI 10.1016/j.jsv.2008.06.011; Brennan MJ, 2008, J SOUND VIB, V318, P1250, DOI 10.1016/j.jsv.2008.04.032; Shahruz SM, 2006, J SOUND VIB, V292, P987, DOI 10.1016/j.jsv.2005.08.018; Mann BP, 2009, J SOUND VIB, V323, P864, DOI 10.1016/j.jsv.2009.01.012; Cottone F, 2012, SMART MATER STRUCT, V21, DOI 10.1088/0964-1726/21/3/035021; Barton DAW, 2010, J VIB ACOUST, V132, DOI 10.1115/1.4000809; Leland ES, 2006, SMART MATER STRUCT, V15, P1413, DOI 10.1088/0964-1726/15/5/030; Cottone F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.080601; Eichhorn C, 2008, P POWERMEMS 2008 MIC, P309; Green PL, 2012, J SOUND VIB, V331, P4504, DOI 10.1016/j.jsv.2012.04.035; Magnus K, 1965, VIBRATIONS; Roundy S, 2004, SMART MATER STRUCT, V13, P1131, DOI 10.1088/0964-1726/13/5/018; Shahruz S.M., 2006, J SOUND VIBRATION, V292, P449; Stanton S. C., 2009, APPL PHYS LETT, V95, P1; Tang L., 2010, J INTEL MAT SYST STR, V21, P1869; Torah R, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/12/125202; Van Blarigan L, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4729875; Zhu D., 2008, P POWERMEMS 2008 MIC, P229	22	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-4554	1793-6764		INT J STRUCT STAB DY	Int. J. Struct. Stab. Dyn.	DEC	2014	14	8			SI				1440023	10.1142/S0219455414400239		14	Engineering, Civil; Engineering, Mechanical; Mechanics	Engineering; Mechanics	AU4LY	WOS:000345583800012		
J	Yoshida, A; Imuta, A; Yamada, T; Kagata, K				Yoshida, Atsumasa; Imuta, Azusa; Yamada, Tetsuya; Kagata, Kakeru			Study on Photoacoustic Measurement Technique of Thermophysical Properties of Thick Solid Material and Human Skin	INTERNATIONAL JOURNAL OF THERMOPHYSICS			English	Article; Proceedings Paper	1st Conference on Photoacoustics and Photothermal Theory and Applications (CPPTA)	SEP 23-26, 2013	Warsaw, POLAND	Warsaw Univ Technol, Fac Elect & Informat Technol		In vivo measurement technique; Noninvasive measurement; Optical properties; Photothermal method; Thermal diffusivity; Thermal effusivity; Thick material; Thin sheet		The thermal effusivity and thermal diffusivity of thick solid materials were measured to validate a developed technique using a photoacoustic method. First, the thermal effusivity was determined by making close contact between an optically opaque sheet and the material. A titanium plate was used as the sheet with known thermophysical properties. Second, using the thermal effusivity as a known value, the thermal diffusivity was also determined by making close contact between an optically semitransparent sheet and the material. A rigid polyvinyl chloride plate was used as the thin sheet with known thermophysical and radiative properties, and a natural rubber block and an epoxy resin block were adopted as samples. The results indicated that the present technique was sufficiently accurate. The thermal effusivity and then the thermal diffusivity of human skin in vivo were measured noninvasively in the same way instead of the solid materials. The results also indicated that the present technique was sufficiently accurate for human skin.	[Yoshida, Atsumasa; Imuta, Azusa; Yamada, Tetsuya; Kagata, Kakeru] Osaka Prefecture Univ, Dept Mech Engn, Naka Ku, Sakai, Osaka 5998531, Japan	Yoshida, A (reprint author), Osaka Prefecture Univ, Dept Mech Engn, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	ayoshida@me.osakafu-u.ac.jp					Yoshida A, 2010, INT J THERMOPHYS, V31, P2019, DOI 10.1007/s10765-010-0869-7; ROSENCWAIG A, 1976, J APPL PHYS, V47, P64, DOI 10.1063/1.322296; HUANG J, 1995, PHYSIOL MEAS, V16, P213, DOI 10.1088/0967-3334/16/4/002; Japan Society of Thermophysical Properties, 1990, THERM PROP HDB, p[25, 493]; Tanasawa I., 1975, Heat Transfer - Japanese Research, V4; Tanasawa I., 1984, International Journal of Thermophysics, V5, DOI 10.1007/BF00505497; Yamada Yukio, 2008, Refrigeration, V83	7	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0195-928X	1572-9567		INT J THERMOPHYS	Int. J. Thermophys.	DEC	2014	35	12					2226	2236		10.1007/s10765-014-1788-9		11	Thermodynamics; Chemistry, Physical; Mechanics; Physics, Applied	Thermodynamics; Chemistry; Mechanics; Physics	AU1NQ	WOS:000345387900008		
J	Fukuda, H; Miyauchi, S; Tonai, M; Ono, M; Magilvy, JK; Murashima, S				Fukuda, H.; Miyauchi, S.; Tonai, M.; Ono, M.; Magilvy, J. K.; Murashima, S.			The first nurse practitioner graduate programme in Japan	INTERNATIONAL NURSING REVIEW			English	Article						Homecare; Nurse Practitioner; Nurse Practitioner Education; Nursing Homes; Super-Ageing Populations	QUALITY-OF-CARE; HEALTH-CARE	AimThis paper describes the establishment of the first Japanese nurse practitioner graduate programme and legislative activities to institutionalize nurse practitioners in Japan. BackgroundTo address the super-ageing population, Oita University of Nursing and Health Sciences initiated the first academic graduate level nurse practitioner programme in Japan, based upon the global standard defined by the International Council of Nurses. ConclusionIn 2010, Oita University of Nursing and Health Sciences graduated the first nurse practitioner. We believe that nurse practitioners will be highly valued in Japan for thoughtful nursing care to the fragile elders living in rural and urban Japan.	[Fukuda, H.] Oita Univ Nursing & Hlth Sci, Ctr Nursing Educ Res & Collaborat, Oita 8701201, Japan; [Miyauchi, S.] Oita Univ Nursing & Hlth Sci, Div Linguist, Dept Human Sci, Oita 8701201, Japan; [Tonai, M.] Oita Univ Nursing & Hlth Sci, Div Nursing Assessment, Dept Basic Nursing Sci, Oita 8701201, Japan; [Ono, M.] Oita Univ Nursing & Hlth Sci, Div Gen & Gerontol Nursing, Dept Specialized Nursing, Oita 8701201, Japan; [Murashima, S.] Oita Univ Nursing & Hlth Sci, Board Directors, Oita 8701201, Japan; [Murashima, S.] Univ Tokyo, Tokyo, Japan; [Magilvy, J. K.] Univ Colorado, Coll Nursing, Aurora, CO USA	Miyauchi, S (reprint author), Oita Univ Nursing & Hlth Sci, Div Linguist, Dept Human Sci, 2944-9 Megusuno, Oita 8701201, Japan.	miyauchi@oita-nhs.ac.jp					Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Hashimoto H, 2011, LANCET, V378, P1174, DOI 10.1016/S0140-6736(11)60987-2; Ban N, 2011, LANCET, V378, P1206, DOI 10.1016/S0140-6736(11)61189-6; Matsumoto M, 2011, LANCET, V378, pE17, DOI 10.1016/S0140-6736(11)61841-2; Ministry of Health Labour and Welfare, 2014, BAS POL AM NAT REIMB; Murata C, 2010, INT J ENV RES PUB HE, V7, P1330, DOI 10.3390/ijerph7041330; National Institute of Population and Social Security Research, 2014, FUT TREND REG POP JA; Pinkerton J A, 2000, J Am Acad Nurse Pract, V12, P211, DOI 10.1111/j.1745-7599.2000.tb00184.x; Statistics Bureau Ministry of Internal Affairs and Communications, 2010, POP JAP FIN REP 2005	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0020-8132	1466-7657		INT NURS REV	Int. Nurs. Rev.	DEC	2014	61	4					487	490		10.1111/inr.12126		4	Nursing	Nursing	AU0ZT	WOS:000345351500009		
J	Abe, M; Turale, S; Klunklin, A; Supamanee, T				Abe, M.; Turale, S.; Klunklin, A.; Supamanee, T.			Community health nurses' HIV health promotion and education programmes: a qualitative study	INTERNATIONAL NURSING REVIEW			English	Article						AIDS; Community Health Nursing; Content Analysis; Culture; Health Education; Health Promotion; HIV; Mixed Methods; Nursing	GROUNDED THEORY; THAILAND; HIV/AIDS; CARE	BackgroundGlobally, nurses practice in many settings with people with human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS), taking an increasing share of the professional burden of care and helping to reduce morbidity and mortality. International literature is sparse about Thai community nurses providing primary healthcare programmes for people with HIV. AimThis study aimed to describe background, experiences and strategies of community nurses regarding their design and delivery of programmes for people living with HIV and AIDS in Chiang Mai Province, Thailand. DesignThis study used a qualitative mixed-methods study employing a qualitative survey and in-depth interviews. MethodsTwenty community health nurses from 18 small community hospitals completed a survey comprising demographic data and 13 open-ended questions. Four of them later engaged in in-depth interviews using the same questions. Survey, interview data and field notes were analysed using interpretive content analysis. FindingsFour themes and six sub-themes portrayed participants' rich experiences and knowledge of HIV health promotion and education; challenges of daily work, discrimination and ethical issues; success through programme diversity comprising promotion of community volunteerism, networking and relationships; and holistic connections with Thai cultural traditions and Buddhism. Conclusions and implications for practiceFindings help to recognize the diversity, uniqueness and contributions of Thai community nurses regarding culturally appropriate health promotion and education programmes for people living with HIV and AIDS. Findings inform nurses and health officials in and outside of the country to complement innovation in future HIV health promotion and education programmes. LimitationsOur sample came from one province of Thailand. Findings might not be reflective of nurses elsewhere. Implications for health and nursing policyThree decades of collective experience in providing holistic and multifaceted HIV and AIDS nursing care, education and health promotion by community health nurses have the potential to effect new and existing policies and protocols on HIV community care in Thailand, but more research is required for this.	[Abe, M.] Bunkyo Hlth Serv Ctr, Tokyo, Japan; [Turale, S.] Chiang Mai Univ, Chiang Mai 50200, Thailand; [Klunklin, A.] Chiang Mai Univ, Planning Serv, Chiang Mai 50200, Thailand; [Klunklin, A.] Chiang Mai Univ, Community Serv, Chiang Mai 50200, Thailand; [Supamanee, T.] Chiang Mai Univ, Fac Nursing, Chiang Mai 50200, Thailand	Turale, S (reprint author), Chiang Mai Univ, Fac Nursing, Off Dean, Room N4-214,110 Inthawaroros Rd, Chiang Mai 50200, Thailand.	inreditor@icn.ch			Faculty of Health Sciences, Yamaguchi University Japan	We thank the community health nurses for sharing their valuable insights. This study was funded in part by the Faculty of Health Sciences, Yamaguchi University Japan.	Ainsworth M, 2003, HEALTH POLICY, V64, P13, DOI 10.1016/S0168-8510(02)00079-9; Anaya HD, 2008, J GEN INTERN MED, V23, P800, DOI 10.1007/s11606-008-0617-x; Genberg BL, 2009, SOC SCI MED, V68, P2279, DOI 10.1016/j.socscimed.2009.04.005; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Squires A, 2008, INT NURS REV, V55, P265, DOI 10.1111/j.1466-7657.2008.00652.x; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Chan K. Y., 2008, HARM REDUCT J, V5, P1; Chantavichitwong P., 2008, LANNA PUBLIC HLTH J, V4, P305; Dussault Gilles, 2006, Hum Resour Health, V4, P12, DOI 10.1186/1478-4491-4-12; Fongkaew Warunee, 2014, J Int Assoc Provid AIDS Care, V13, P69, DOI 10.1177/1545109712463734; Holloway I, 2013, QUALITATIVE RES NURS; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2013, JOINT UN PROGR HIV A; Klunklin A, 2005, J ASSOC NURSE AIDS C, V16, P24, DOI 10.1016/j.jana.2005.09.003; Klunklin A, 2006, J ASSOC NURSE AIDS C, V17, P32, DOI 10.1016/j.jana.2006.07.005; Limprasutra P., 2011, J NURSING HLTH SCI, V5, P78; Lincoln Y. S., 1985, NATURALISTIC INQUIRY; Maneesriwongul WL, 2006, JAIDS-J ACQ IMM DEF, V43, pS119, DOI 10.1097/01.qai.0000248346.79888.78; Merson M. H., 2008, LANCET, V372, P478; Ministry of Public Health, 2012, THAIL HLTH PROF 2008; Morse J. M., 2003, HDB MIXED METHODS SO, P189; Morse JM, 2014, QUAL HEALTH RES, V24, P3, DOI 10.1177/1049732313513656; Morse JM, 2009, MIXED METHOD DESIGN; Natpratan C., 1996, P 11 INT C AIDS, V11, P189; Natpratan P., 1998, EXPERIENCE FORMATION; Pitayanon S., 1997, EC HIV AIDS CASE S S, P42; Punpanich W, 2004, AIDS EDUC PREV, V16, P119, DOI 10.1521/aeap.16.3.5.119.35520; Ruxrungtham Kiat, 2001, Journal of the Medical Association of Thailand, V84, pS1; Singhanetra-Renard A., 2001, Culture, Health & Sexuality, V3, P167, DOI 10.1080/136910501750152987; Songwathana P, 2001, Health Care Women Int, V22, P263, DOI 10.1080/073993301300357197; Streubert Speziale HJ, 2011, QUALITATIVE RES NURS; Tlou SD, 2001, J ADV NURS, V36, P722; Tunnicliff SA, 2013, J CLIN NURS, V22, P3349, DOI 10.1111/jocn.12369; UNAIDS, 2000, EV 100 COND PROGR TH; UNAIDS, 2013, FACT SHEET; Weniger B G, 1991, AIDS, V5 Suppl 2, pS71	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0020-8132	1466-7657		INT NURS REV	Int. Nurs. Rev.	DEC	2014	61	4					515	524		10.1111/inr.12140		10	Nursing	Nursing	AU0ZT	WOS:000345351500013		
J	Izumi, H; Kaiho, Y; Miyazato, M; Kawamorita, N; Nakagawa, H; Arai, Y				Izumi, Hideaki; Kaiho, Yasuhiro; Miyazato, Minoru; Kawamorita, Naoki; Nakagawa, Haruo; Arai, Yoichi			Effects of phosphodiesterase type 5 inhibitor, tadalafil, on continence reflex in rats	INTERNATIONAL UROGYNECOLOGY JOURNAL			English	Article						Stress urinary incontinence; Sneeze; Striated muscle; Smooth muscle	LOWER URINARY-TRACT; BENIGN PROSTATIC HYPERPLASIA; RADICAL PROSTATECTOMY; STRIATED-MUSCLE; INCONTINENCE; SYMPTOMS; EXPRESSION; SPHINCTER; URETHRA; MEN	Introduction and hypothesis Effects of tadalafil, a phosphodiesterase type 5 inhibitor, on the urethral continence reflex induced by sneezing were investigated. Methods The amplitude of urethral pressure responses during sneezing (A-URS) and urethral baseline pressure (UBP) were measured in female rats using a microtransducer-tipped catheter. Sneeze leak-point pressure (S-LPP), defined as the lowest amount of pressure required to induce fluid leakage from the urethral orifice during sneezing, was measured in rats with stress urinary incontinence (SUI) induced by vaginal distension. Values were determined before and after tadalafil administration. Results Tadalafil dose dependently and significantly decreased A-URS and S-LPP. At the highest dose tested (6.0 mg/kg), A-URS and S-LPP decreased from 49.7 to 32.3 and from 63.9 to 44.2 cmH(2)O, respectively, whereas UBP did not significantly change. Conclusions Tadalafil attenuated the sneeze-induced urethral continence reflex by relaxing the striated muscles of the external urethral sphincter.	[Izumi, Hideaki; Kaiho, Yasuhiro; Miyazato, Minoru; Kawamorita, Naoki; Nakagawa, Haruo; Arai, Yoichi] Tohoku Univ Grad Sch Med, Dept Urol, Aoba Ku, Sendai, Miyagi 9808574, Japan	Kaiho, Y (reprint author), Tohoku Univ Grad Sch Med, Dept Urol, Aoba Ku, 1-1 Seiryomachi, Sendai, Miyagi 9808574, Japan.	kaiho@uro.med.tohoku.ac.jp			Japan Society for the Promotion of Science KAKENHI [23650317]	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 23650317.	Yokoyama O, 2013, INT J UROL, V20, P193, DOI 10.1111/j.1442-2042.2012.03130.x; Gacci M, 2010, J SEX MED, V7, P234, DOI 10.1111/j.1743-6109.2009.01471.x; ANDERSON RS, 1983, J UROLOGY, V130, P727; Kaiho Y, 2013, INT J UROL, V20, P285, DOI 10.1111/iju.12071; Fibbi B, 2010, J SEX MED, V7, P59, DOI 10.1111/j.1743-6109.2009.01511.x; Tinel H, 2006, BJU INT, V98, P1259, DOI 10.1111/j.1464-410X.2006.06501.x; Sairam K, 2002, BJU INT, V90, P836, DOI 10.1046/j.1464-4096.2002.03040.x; DELANCEY JOL, 1994, AM J OBSTET GYNECOL, V170, P1713; Damaser MS, 2003, J UROLOGY, V170, P1027, DOI 10.1097/01.ju.0000079492.09716.43; Hampel C, 1997, UROLOGY, V50, P15; Hampel C, 1997, UROLOGY, V50, P4, DOI 10.1016/S0090-4295(97)00578-5; Heesakkers JPFA, 2004, DIGESTION, V69, P93, DOI 10.1159/000077875; HERR HW, 1994, J UROLOGY, V151, P652; Ho KMT, 1998, J UROLOGY, V159, P1091, DOI 10.1016/S0022-5347(01)63841-2; Kaiho Y, 2007, AM J PHYSIOL-RENAL, V292, pF639, DOI 10.1152/ajprenal.00226.2006; Kamo I, 2003, AM J PHYSIOL-REG I, V285, pR356, DOI 10.1152/ajpregu.00010.2003.; Kamo I, 2009, LUTS, V1, pS40, DOI 10.1111/j.1757-5672.2009.00026.x; Lin AS, 1998, UROLOGY, V52, P143, DOI 10.1016/S0090-4295(98)00136-8; Lin GT, 2010, J UROLOGY, V184, P769, DOI 10.1016/j.juro.2010.03.110; Miyazato M, 2008, AM J PHYSIOL-RENAL, V295, pF264, DOI 10.1152/ajprenal.90241.2008	20	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-3462	1433-3023		INT UROGYNECOL J	Int. Urogynecol. J.	DEC	2014	25	12					1721	1727		10.1007/s00192-014-2453-3		7	Obstetrics & Gynecology; Urology & Nephrology	Obstetrics & Gynecology; Urology & Nephrology	AU0DO	WOS:000345293900018		
J	Ishida, H; Takahashi, K; Kurachi, H				Ishida, Hiromi; Takahashi, Kazuhiro; Kurachi, Hirohisa			Uterine prolapse during late pregnancy in a nulliparous woman	INTERNATIONAL UROGYNECOLOGY JOURNAL			English	Article						Uterine prolapse; Pregnancy; Nulliparous		A pregnancy that is complicated by a uterine prolapse is rare and primarily occurs in multiparous women during their first or second trimester. In the present report, we describe a case of a 31-year-old nulliparous woman who experienced sudden uterine prolapse at 38 weeks' gestation without labor pains. The cervix was congested, the cervical mucosa was partially lacerated, and bleeding was noted; the protruding cervix could not be repositioned into her vagina. Although the cervical congestion worsened over time, she still did not experience any labor pains. She was delivered by emergency cesarean section. Following delivery, the prolapse promptly improved and did not recur before her 1-month postpartum examination. To our knowledge, this is the first case where uterine prolapse occurred in a nulliparous woman during late gestation.	[Ishida, Hiromi; Takahashi, Kazuhiro; Kurachi, Hirohisa] Yamagata Univ Fac Med, Dept Obstet & Gynecol, Yamagata 9909585, Japan	Takahashi, K (reprint author), Yamagata Univ Fac Med, Dept Obstet & Gynecol, 2-2-2 Iidanishi, Yamagata 9909585, Japan.	ktaka@med.id.yamagata-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [2390308, 23592433]	This work was supported in part by a Grant-in-Aid for Scientific Research, No. 2390308 (to H. K.) and No. 23592433 (to K. T.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan	Brown HL, 1997, J NATL MED ASSOC, V89, P346; Erata Y. E., 2002, Archives of Gynecology and Obstetrics, V267, P14, DOI 10.1007/s00404-001-0256-5; Keettle WC, 1941, AM J OBSTET GYNECOL, V42, P21; Partsinevelos GA, 2008, FETAL DIAGN THER, V24, P296, DOI 10.1159/000158521; Tsikouras P, 2014, J MATERN-FETAL NEO M, V27, P297, DOI 10.3109/14767058.2013.807235	5	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-3462	1433-3023		INT UROGYNECOL J	Int. Urogynecol. J.	DEC	2014	25	12					1739	1740		10.1007/s00192-014-2457-z		2	Obstetrics & Gynecology; Urology & Nephrology	Obstetrics & Gynecology; Urology & Nephrology	AU0DO	WOS:000345293900021		
J	Yamamoto, N; Kiyosawa, T				Yamamoto, Naoto; Kiyosawa, Tomoharu			Histological effects of occlusive dressing on healing of incisional skin wounds	INTERNATIONAL WOUND JOURNAL			English	Article						2-Octyl cyanoacrylate; Hydrocolloid dressing; Incisional wounds; Occlusive dressing; Wound healing	TISSUE ADHESIVE; GAUZE DRESSINGS; CLOSURE; DERMABOND; SURGERY	Occlusive dressing is widely accepted and used to manage skin ulcers. However, with respect to its application to incisional wounds, most studies have been conducted about the clinical effects on incisional healing of surgical sites. Studies of the histological effects of occlusive dressing for incisional wounds have been few. The aim of this study was to clarify the histological effects of occlusive dressings on healing of incisional skin wounds. Rat dorsal skin was incised down to the panniculus and sutured immediately. Dressing types included 2-octyl cyanoacrylate and hydrocolloid materials as occlusive dressings and no-dressing as the open therapy. Histological examination and dermoscopic observation were performed 1, 2, 4 and 7 days after surgery. The findings from each dressing type were compared. In the open therapy group, the upper portion of the edge of incision was necrosed minimally and finally healed with wide scar formation. However, in the occlusive dressing groups, micronecrosis of the incision edge seen in the no-dressing group was not observed, healing was more rapid and the remaining scar was finer. Occlusive dressing can prevent micronecrosis of the incision edge, resulting in rapid and excellent healing. This study shows that the efficacy of and supports the use of occlusive dressing in incisional wound management.	[Yamamoto, Naoto; Kiyosawa, Tomoharu] Natl Def Med Coll, Dept Plast Surg, Tokorozawa, Saitama 3598513, Japan	Yamamoto, N (reprint author), Natl Def Med Coll, Dept Plast Surg, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	naotoyamamoto42@gmail.com			National Defense Medical College of the Ministry of Defense, Japan	This work was funded by the National Defense Medical College of the Ministry of Defense, Japan.	WINTER GD, 1963, NATURE, V197, P91, DOI 10.1038/197091b0; Holm C, 1998, EUR J SURG, V164, P179; WINTER GD, 1962, NATURE, V193, P293, DOI 10.1038/193293a0; Gennari R, 2004, SURGERY, V136, P593, DOI 10.1016/j.surg.2004.02.015; Kloeters O, 2008, WOUND REPAIR REGEN, V16, P568, DOI 10.1111/j.1524-475X.2008.00404.x; Knott PD, 2007, ANN PLAS SURG, V58, P121, DOI 10.1097/01.sap.0000232984.68797.62; Krishnamoorthy B, 2009, ANN THORAC SURG, V88, P1445, DOI 10.1016/j.athoracsur.2009.06.047; MICHIE DD, 1994, ANN PLAS SURG, V32, P57, DOI 10.1097/00000637-199401000-00011; Nipshagen MD, 2008, PLAST RECONSTR SURG, V122, P10, DOI 10.1097/PRS.0b013e318171524b; ORDMAN LJ, 1966, ARCH SURG-CHICAGO, V93, P857; Rupio PA, 1991, INT SURG, V76, P253; Toriumi DM, 1998, PLAST RECONSTR SURG, V102, P2209, DOI 10.1097/00006534-199811000-00062; WINTER G D, 1963, Nature, V200, P378, DOI 10.1038/200378a0	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-4801	1742-481X		INT WOUND J	Int. Wound J.	DEC	2014	11	6					616	621		10.1111/iwj.12016		6	Dermatology; Surgery	Dermatology; Surgery	AU3JS	WOS:000345509700010		
J	Kaneko, H; Nakatani, Y; Fujimura, K; Tanaka, M				Kaneko, Hiroki; Nakatani, Yuki; Fujimura, Koji; Tanaka, Mikiko			Development of the lateral plate mesoderm in medaka Oryzias latipes and Nile tilapia Oreochromis niloticus: insight into the diversification of pelvic fin position	JOURNAL OF ANATOMY			English	Article						lateral plate mesoderm; medaka; Nile tilapia	TROUT ONCORHYNCHUS-MYKISS; PAIRED FINS; EXPRESSION; EVOLUTION; FISHES; ROLES; HEART; DHAND	The position of the pelvic fins among teleost fishes has tended to shift rostrally during evolution. This positional shift seems to have led to the diversification of feeding behavior and allowed adaptation to new environments. To understand the developmental basis of this shift in pelvic fin position among teleosts, we investigated the embryonic development of the lateral plate mesoderm, which gives rise to the pelvic fins, at histological levels in the medaka Oryzias latipes (abdominal pelvic fins) and Nile tilapia Oreochromis niloticus (thoracic pelvic fins). Our histological analyses revealed that the lateral plate mesodermal cells expand not only ventrally but also rostrally to cover the yolk during embryogenesis of both medaka and Nile tilapia. In medaka, we also found that the lateral plate mesoderm completely covered the yolk prior to the initiation of the pelvic fin buds, whereas in Nile tilapia the pelvic fin buds appeared in the body wall from the lateral plate mesoderm at the thoracic level when the lateral plate mesodermal cells only covered one-third of the yolk. We discuss the relevance of such differences in the rate of the lateral plate mesoderm expansion on the yolk surface and the position of the pelvic fins.	[Kaneko, Hiroki; Nakatani, Yuki; Tanaka, Mikiko] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan; [Fujimura, Koji] Niigata Univ, Fac Sci, Niigata 95021, Japan	Tanaka, M (reprint author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, B-17,4259 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.	mitanaka@bio.titech.ac.jp			Inamori Foundation;  [11J40211];  [24113508];  [25291086]	We thank Norihiro Okada for use of his facilities, Keijiro Munakata for sequencing, Masato Nikaido for technical advice and NBRP medaka for the hatching enzyme. This work was supported in part by the Grant-in-Aid for JSPS Fellows (11J40211) to Y.N., and by the Grant-in-Aid for Scientific Research on Innovative Areas (24113508), the Grant-in-Aid for Scientific Research (B) (25291086) and the Inamori Foundation to M.T.	Fujimura K, 2007, DEV GROWTH DIFFER, V49, P301, DOI 10.1111/j.1440-169x.2007.00926.x; Tanaka M, 2011, EVOL DEV, V13, P382, DOI 10.1111/j.1525-142X.2011.00493.x; Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2; Standen EM, 2010, J EXP BIOL, V213, P831, DOI 10.1242/jeb.033084; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; Standen EM, 2008, J EXP BIOL, V211, P2931, DOI 10.1242/jeb.018572; Charite J, 2000, DEVELOPMENT, V127, P2461; Yelon D, 2000, DEVELOPMENT, V127, P2573; Murata Y, 2010, DEV BIOL, V347, P236, DOI 10.1016/j.ydbio.2010.07.034; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Fernandez-Teran M, 2000, DEVELOPMENT, V127, P2133; Gosline W.A., 1971, FUNCTIONAL MORPHOLOG; Greenwood P. H., 1966, Bulletin of the American Museum of Natural History, V131, P339; Harris JE, 1936, J EXP BIOL, V13, P000; Harris JE, 1938, J EXP BIOL, V15, P32; Iwamatsu T, 2006, INTEGRATED BOOK BIOL; LEUSSINK B, 1995, MECH DEVELOP, V52, P51, DOI 10.1016/0925-4773(95)00389-I; Onimaru K, 2011, DEV BIOL, V359, P124, DOI 10.1016/j.ydbio.2011.08.003; ROSEN DE, 1982, AM ZOOL, V22, P261; Tanaka M, 2005, DEV BIOL, V281, P227, DOI 10.1016/j.ydbio.2005.02.016; Westerfield M, 2000, GUIDE LAB USE ZEBRAF	21	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8782	1469-7580		J ANAT	J. Anat.	DEC	2014	225	6					659	674		10.1111/joa.12244		16	Anatomy & Morphology	Anatomy & Morphology	AU4TG	WOS:000345603700008		
J	Ishihara, M; Tokui, B; Abe, T; Ijiri, S; Adachi, S				Ishihara, M.; Tokui, B.; Abe, T.; Ijiri, S.; Adachi, S.			Seasonal changes in oocyte maturational competence, ovulatory competence and gonadotropin sensitivity of ovarian follicles in hybrid sturgeon, bester (Huso huso x Acipenser ruthenus)	JOURNAL OF APPLIED ICHTHYOLOGY			English	Article; Proceedings Paper	7th International Symposium on Sturgeons - Sturgeons, Science and Society at the Cross-Roads - Meeting the Challenges of the 21st Century	JUL 21-25, 2013	Nanaimo, CANADA	Vancouver Isl Univ, WSCS			ANNUAL REPRODUCTIVE-CYCLE; PLASMA STEROID-LEVELS; IN-VITRO; WHITE STURGEON; TRANSMONTANUS RICHARDSON; PRECOCIOUS INDUCTION; GONADAL ACTIVITY; DIFFERENT PHASES; GTH-II; TEMPERATURE	Oocyte maturation and ovulation in sturgeon species are induced by injection of hormones such as the luteinizing hormone-releasing hormone (LHRH). Appropriate timing for the LHRH injection is determined by monitoring the maturational stage of the ovarian follicles. In the present study, ovarian follicles from a group of female bester sturgeon (Huso husoxAcipenser ruthenus) were sampled continuously from September to May and incubated in 100% L-15 medium (pH 8.2) containing 17-hydroxyprogesterone or salmon pituitary extract (SPE) for 48h at 15 degrees C. After incubation, ratios of oocyte maturational competence (OMC; ability of oocytes to undergo final oocyte maturation in response to maturation-inducing steroid, MIS), ovulatory competence (OC; ability of ovarian follicles to ovulate under MIS stimulation), and GTH sensitivity (ability of ovarian follicles to respond to GTH) were examined. Almost all oocytes maintained OMC throughout the sampling period. However, OC was acquired in circa December and May. The ratio of follicles that acquired ovulatory competence showed wide variation among individuals. Most females first acquired a higher degree of ovulatory competence in May, although some only did so around December. SPE-induced oocyte maturation was relatively high throughout the entire experiment, and the ovulation rate showed a tendency similar to that of the ovulatory competence. LHRH-a injections in May successfully induced ovulation in all females. Higher hatching rates resulted in females whose ovarian follicles showed an increasing trend of ovulatory competence and GTH sensitivity for ovulation in May. These results indicate that ovulatory competence and GTH sensitivity can be used as indicators to determine the timing of LHRH injections for sturgeon.	[Ishihara, M.; Tokui, B.; Abe, T.; Ijiri, S.; Adachi, S.] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido 0418611, Japan	Adachi, S (reprint author), Hokkaido Univ, Div Marine Life Sci, Grad Sch Fisheries Sci, 3-1-1 Minato Cho, Hakodate, Hokkaido 0418611, Japan.	s-adachi@fish.hokudai.ac.jp					Amiri B. M., 2001, J AGR SCI TECHNOL, V3, P199; Lubzens E, 2010, GEN COMP ENDOCR, V165, P367, DOI 10.1016/j.ygcen.2009.05.022; Kagawa H, 1998, GEN COMP ENDOCR, V112, P80, DOI 10.1006/gcen.1998.7133; Stahl MT, 2009, J APPL ICHTHYOL, V25, P75, DOI 10.1111/j.1439-0426.2009.01334.x; MUSHIAKE K, 1994, FISHERIES SCI, V60, P647; Crespo D, 2013, GEN COMP ENDOCR, V188, P175, DOI 10.1016/j.ygcen.2013.02.031; SWANSON P, 1991, BIOL REPROD, V44, P29, DOI 10.1095/biolreprod44.1.29; Patino R, 2001, COMP BIOCHEM PHYS B, V129, P427, DOI 10.1016/S1096-4959(01)00344-X; Hanna RN, 2011, MOL CELL ENDOCRINOL, V337, P80, DOI 10.1016/j.mce.2011.02.004; Patino R, 2002, FISH PHYSIOL BIOCHEM, V26, P57, DOI 10.1023/A:1023311613987; Shimizu A, 2003, GEN COMP ENDOCR, V131, P310, DOI 10.1016/S0016-6480(03)00026-1; Conte F. S., 1988, COOPERATION EXTENSIO, V3322, P104; DEMONTALEMBERT G, 1978, ANN BIOL ANIM BIOCH, V18, P969, DOI 10.1051/rnd:19780533; Dettlaff T. A., 1993, STURGEON FISHES DEV; Dettlaff T. A., 1969, ANN EMBRYOL MORPHO S, V1, P133; DOROSHOV SI, 1984, AQUACULTURE, V38, P221, DOI 10.1016/0044-8486(84)90146-7; Fujii K., 1991, USE VITELLOGENIN LEV, P381; Goncharov BF, 2002, J APPL ICHTHYOL, V18, P368, DOI 10.1046/j.1439-0426.2002.00367.x; JALABERT B, 1978, ANN BIOL ANIM BIOCH, V18, P977, DOI 10.1051/rnd:19780534; Kagawa H, 2009, J EXP ZOOL PART A, V311A, P752, DOI 10.1002/jez.560; Lister AL, 2009, MOL REPROD DEV, V76, P1064, DOI 10.1002/mrd.21072; LUTES PB, 1987, AQUACULTURE, V66, P43, DOI 10.1016/0044-8486(87)90282-1; LUTES PB, 1985, ENVIRON BIOL FISH, V14, P87, DOI 10.1007/BF00001580; Omoto N, 2005, AQUACULTURE, V245, P287, DOI 10.1016/j.aquaculture.2004.11.008; Patino R, 2003, FISH PHYSIOL BIOCHEM, V28, P305, DOI 10.1023/B:FISH.0000030565.74702.0a; Patino R, 2003, BIOL REPROD, V68, P516, DOI 10.1095/biolreprod.102.009662; Semenkova B, 2006, J APPL ICHTHYOL, V22, P353, DOI 10.1111/j.1439-0426.2007.00983.x; SHIMIZU A, 1994, GEN COMP ENDOCR, V93, P137, DOI 10.1006/gcen.1994.1016; Skoblina M. N., 2012, RUSS J DEV BIOL, V43, P185; Smith T.I.J., 1985, Journal of the World Mariculture Society, V16, P104; Takahashi T, 2013, ZOOL SCI, V30, P239, DOI 10.2108/zsj.30.239; Thomas P, 2001, BIOL REPROD, V64, P21, DOI 10.1095/biolreprod64.1.21; ZHU Y, 1991, NIPPON SUISAN GAKK, V57, P1871	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0175-8659	1439-0426		J APPL ICHTHYOL	J. Appl. Ichthyol.	DEC	2014	30	6			SI		1141	1148		10.1111/jai.12579		8	Fisheries; Marine & Freshwater Biology	Fisheries; Marine & Freshwater Biology	AU4NO	WOS:000345588500006		
J	Hagihara, S; Yamashita, R; Yamamoto, S; Ishihara, M; Abe, T; Ijiri, S; Adachi, S				Hagihara, S.; Yamashita, R.; Yamamoto, S.; Ishihara, M.; Abe, T.; Ijiri, S.; Adachi, S.			Identification of genes involved in gonadal sex differentiation and the dimorphic expression pattern in undifferentiated gonads of Russian sturgeon Acipenser gueldenstaedtii Brandt & Ratzeburg, 1833	JOURNAL OF APPLIED ICHTHYOLOGY			English	Article; Proceedings Paper	7th International Symposium on Sturgeons - Sturgeons, Science and Society at the Cross-Roads - Meeting the Challenges of the 21st Century	JUL 21-25, 2013	Nanaimo, CANADA	Vancouver Isl Univ, WSCS			MOLECULAR-CLONING; ORYZIAS-LATIPES; PLOIDY LEVELS; ANCIENT FISH; SCAPHIRHYNCHUS; PHYLOGENY; TELEOST; MEDAKA; FOXL2; HUSO	The establishment of a sexing technique at an early developmental stage is an important issue in sturgeon aquaculture, yet the mechanism of sex differentiation in sturgeons remains poorly understood. This study aimed to identify genes involved in gonadal sex differentiation and to investigate sexually dimorphic gene expression in undifferentiated gonads. RNA-seq analyses using next-generation sequencers were carried out on undifferentiated gonads of five 9-month-old juvenile Russian sturgeon Acipenser gueldenstaedtii. A total of 45686832 (8498Mb) and 79743269 (7887Mb) quality-controlled reads were obtained using Ion PGM and HiSeq 2000 sequencers, respectively, and were assembled into 338648 contigs (N50: 532 b). tBLASTx analyses identified 26 transcripts potentially involved in gonadal differentiation. Read-mapping analyses were performed to obtain relative transcript levels (RPKM values). Multivariate analyses of the RPKM values of five transcripts (gsdf, dmrt1a, dmrt1b, foxl2 and cyp19a1a) showed that the five individuals could be separated into two distinct groups. One group, comprising two individuals, had increased levels of foxl2, hsd17b1 and cyp19a1a, suggesting differentiation into females. Alternatively, levels of gsdf were higher in the other three individuals, suggesting differentiation into males. We describe the levels of 26 transcripts potentially involved in gonadal differentiation in undifferentiated sturgeon gonads and suggest that levels of gsdf, foxl2, hsd17b1 and cyp19a1a are appropriate sexing markers for sturgeon at an early developmental stage.	[Hagihara, S.; Yamashita, R.; Yamamoto, S.; Ishihara, M.; Abe, T.; Ijiri, S.; Adachi, S.] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido 0418611, Japan	Ijiri, S (reprint author), Hokkaido Univ, Grad Sch Fisheries Sci, Div Marine Life Sci, 3-1-1 Minato Cho, Hakodate, Hokkaido 0418611, Japan.	ijiri@fish.hokudai.ac.jp					Shibata Y, 2010, GENE EXPR PATTERNS, V10, P283, DOI 10.1016/j.gep.2010.06.005; Ijiri S, 2008, BIOL REPROD, V78, P333, DOI 10.1095/biolreprod.107.064246; Nakamoto M, 2006, BIOCHEM BIOPH RES CO, V344, P353, DOI 10.1016/j.bbrc.2006.03.137; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Ye YM, 2012, FISH RES, V131, P21, DOI 10.1016/j.fishres.2012.06.022; Wang DS, 2007, MOL ENDOCRINOL, V21, P712, DOI 10.1210/me.2006-0248; Leet JK, 2011, J APPL TOXICOL, V31, P379, DOI 10.1002/jat.1682; Pikitch EK, 2005, FISH FISH, V6, P233, DOI 10.1111/j.1467-2979.2005.00190.x; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; Kobayashi Y, 2013, SEX DEV, V7, P115, DOI 10.1159/000342009; Katsu Y, 2008, ENDOCRINOLOGY, V149, P6300, DOI 10.1210/en.2008-0670; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ludwig A, 2001, GENETICS, V158, P1203; Vizziano D, 2007, DEV DYNAM, V236, P2198, DOI 10.1002/dvdy-21212; Berbejillo J, 2012, MOL REPROD DEV, V79, P504, DOI 10.1002/mrd.22053; Amberg JJ, 2010, FISH PHYSIOL BIOCHEM, V36, P923, DOI 10.1007/s10695-009-9369-8; BLACKLIDGE KH, 1993, J HERED, V84, P427; Hale MC, 2010, GENETICA, V138, P745, DOI 10.1007/s10709-010-9455-y; Rodriguez-Mari A, 2005, GENE EXPR PATTERNS, V5, P655, DOI 10.1016/j.modgep.2005.02.008; Bahmani M., 1998, SHILAT SCI MAGAZINE, V7, P1; Doukakis P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040907; Keyvanshokooh S, 2010, AQUAC RES, V41, pe1, DOI 10.1111/j.1365-2109.2009.02463.x; Koopman P, 2003, CURR BIOL, V13, pR177, DOI 10.1016/S0960-9822(03)00117-9; Schlueter PJ, 2007, DEV BIOL, V305, P377, DOI 10.1016/j.ydbio.2007.02.015; Vidotto M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-407; Wuertz S, 2006, AQUACULTURE, V258, P685, DOI 10.1016/j.aquaculture.2006.03.042; Yan H, 2012, BIOL REPROD, V87, P1; Zhou H, 2011, J APPL ICHTHYOL, V27, P484, DOI 10.1111/j.1439-0426.2010.01648.x; Zhou LY, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-36	29	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0175-8659	1439-0426		J APPL ICHTHYOL	J. Appl. Ichthyol.	DEC	2014	30	6			SI		1557	1564		10.1111/jai.12588		8	Fisheries; Marine & Freshwater Biology	Fisheries; Marine & Freshwater Biology	AU4NO	WOS:000345588500061		
J	Nemeth, E; Kortvelyesi, T; Kozisek, M; Thulstrup, PW; Christensen, HEM; Asaka, MN; Nagata, K; Gyurcsik, B				Nemeth, Eszter; Koertvelyesi, Tamas; Kozisek, Milan; Thulstrup, Peter W.; Christensen, Hans E. M.; Asaka, Masamitsu N.; Nagata, Kyosuke; Gyurcsik, Bala			Substrate binding activates the designed triple mutant of the colicin E7 metallonuclease	JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY			English	Article						Binding affinity; Calorimetry; Zinc nuclease; Substrate induced folding; Protein engineering	PROTEIN SECONDARY STRUCTURE; H-BONDING CORRECTION; NUCLEASE DOMAIN; ENDONUCLEASE DOMAIN; CRYSTAL-STRUCTURE; ZINC-FINGER; DNA-BINDING; PM6 METHOD; HNH MOTIF; DICHROISM	The nuclease domain of colicin E7 (NColE7) cleaves DNA nonspecifically. The active center is a Zn2+-containing HNH motif at the C-terminus. The N-terminal loop is essential for the catalytic activity providing opportunity for allosteric modulation of the enzyme. To identify the key residues responsible for the structural integrity of NColE7, a virtual alanine scan was performed on a semiempirical quantum chemical level within the 25 residue long N-terminal sequence (446-470). Based on the calculations the T454A/K458A/W464A-NColE7 triple mutant (TKW) was expressed and purified. According to the agarose gel electrophoresis experiments and linear dichroism spectra the catalytic activity of the TKW mutant decreased in comparison with wild-type NColE7. The distorted structure and weakened Zn2+ binding may account for this as revealed by circular dichroism spectra, mass spectrometry, fluorescence-based thermal analysis and isothermal microcalorimetric titrations. Remarkably, the substrate induced the folding of the mutant protein.	[Nemeth, Eszter; Gyurcsik, Bala] Univ Szeged, Dept Inorgan & Analyt Chem, H-6720 Szeged, Hungary; [Nemeth, Eszter; Koertvelyesi, Tamas] Univ Szeged, Dept Phys Chem & Mat Sci, H-6720 Szeged, Hungary; [Kozisek, Milan] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Gilead Sci & IOCB Res Ctr, CR-16610 Prague 6, Czech Republic; [Thulstrup, Peter W.] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Christensen, Hans E. M.] Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark; [Asaka, Masamitsu N.; Nagata, Kyosuke] Univ Tsukuba, Nagata Special Lab, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Gyurcsik, Bala] MTA SZTE Bioinorgan Chem Res Grp, H-6720 Szeged, Hungary	Gyurcsik, B (reprint author), Univ Szeged, Dept Inorgan & Analyt Chem, Dom Ter 7, H-6720 Szeged, Hungary.	gyurcsik@chem.u-szeged.hu	Kozisek, Milan/D-4234-2013		Hungarian Science Foundation [OTKA-NKTH CK80850]; European Union; State of Hungary; European Social Fund [TAMOP 4.2.4.A/2-11-1-2012-0001, TAMOP-4.2.2.C-11/1/KONV-2012-010, TAMOP-4.2.2.A-11/1/KONV-2012-0047]; CALIPSO [312284]; EU OPPC program [CZ.2.16/3.1.00/24016]	This work has received support through the Hungarian Science Foundation (OTKA-NKTH CK80850), European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4.A/2-11-1-2012-0001 'National Excellence Program', TAMOP-4.2.2.C-11/1/KONV-2012-010, TAMOP-4.2.2.A-11/1/KONV-2012-0047. The computational resources at HPC of University Szeged and financial support from the CALIPSO Programme (FP7/2007-2013, grant no 312284) is also acknowledged. B. G. and E.N. thank JSPS. M. K. was partially funded by EU OPPC program CZ.2.16/3.1.00/24016.	Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; Rezac J, 2009, J CHEM THEORY COMPUT, V5, P1749, DOI 10.1021/ct9000922; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Korth M, 2010, J CHEM THEORY COMPUT, V6, P344, DOI 10.1021/ct900541n; Sui MJ, 2002, PROTEIN SCI, V11, P2947, DOI 10.1110/ps.0220602; Stewart JJP, 1996, INT J QUANTUM CHEM, V58, P133, DOI 10.1002/(SICI)1097-461X(1996)58:2<133::AID-QUA2>3.0.CO;2-Z; Ko TP, 1999, STRUCT FOLD DES, V7, P91, DOI 10.1016/S0969-2126(99)80012-4; Stewart JJP, 2009, J MOL MODEL, V15, P765, DOI 10.1007/s00894-008-0420-y; Orlowski J, 2008, NUCLEIC ACIDS RES, V36, P3552, DOI 10.1093/nar/gkn175; Mosbahi K, 2004, J BIOL CHEM, V279, P22145, DOI 10.1074/jbc.M400402200; Samanta U, 2000, PROTEINS, V38, P288, DOI 10.1002/(SICI)1097-0134(20000215)38:3<288::AID-PROT5>3.0.CO;2-7; Blasie CA, 2002, BIOCHEMISTRY-US, V41, P15068, DOI 10.1021/bi026621h; CHAK KF, 1991, J GEN MICROBIOL, V137, P91; Cheng YS, 2002, J MOL BIOL, V324, P227, DOI 10.1016/S0022-2836(02)01092-6; Czene A, 2013, J BIOL INORG CHEM, V18, P309, DOI 10.1007/s00775-013-0975-7; Czene A, 2013, ACTA CRYSTALLOGR F, V69, P551, DOI 10.1107/S1744309113008233; Doudeva LG, 2006, PROTEIN SCI, V15, P269, DOI 10.1110/ps.051903406; Eastberg JH, 2007, BIOCHEMISTRY-US, V46, P7215, DOI 10.1021/bi700418d; FLANAGAN JM, 1992, P NATL ACAD SCI USA, V89, P748, DOI 10.1073/pnas.89.2.748; Gyurcsik B, 2011, FUTURE MED CHEM, V3, P1935, DOI [10.4155/fmc.11.139, 10.4155/FMC.11.139]; Hsia KC, 2005, CURR OPIN STRUC BIOL, V15, P126, DOI 10.1016/j.sbi.2005.01.015; Hsia KC, 2004, STRUCTURE, V12, P205, DOI 10.1016/j.str.2004.01.004; Hu HY, 2010, BIOPHYS CHEM, V151, P170, DOI 10.1016/j.bpc.2010.07.001; Huang H, 2007, J MOL BIOL, V368, P812, DOI 10.1016/j.jmb.2007.02.044; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KLAMT A, 1993, J CHEM SOC PERK T 2, P799, DOI 10.1039/p29930000799; Ku WY, 2002, NUCLEIC ACIDS RES, V30, P1670, DOI 10.1093/nar/30.7.1670; Li WF, 2008, J AM CHEM SOC, V130, P892, DOI 10.1021/ja075302g; Lin YH, 2004, BIOCHEM BIOPH RES CO, V318, P81, DOI 10.1016/j.bbrc.2004.03.184; Marrington R, 2004, BIOPHYS J, V87, P2002, DOI 10.1529/biophysj.103.035022; Mehta P, 2004, PROTEIN SCI, V13, P295, DOI 10.1110/ps.03115604; Miles AJ, 2007, SPECTROSC-INT J, V21, P245; Miles AJ, 2008, J SYNCHROTRON RADIAT, V15, P420, DOI 10.1107/S0909049508009606; Nemeth E, 2014, PROTEIN SCI, V23, P1113, DOI 10.1002/pro.2497; Shi ZH, 2005, J BIOL CHEM, V280, P24663, DOI 10.1074/jbc.M501216200; Stewart J.J., 2008, MOPAC2009; Wang YT, 2007, NUCLEIC ACIDS RES, V35, P584, DOI 10.1093/nar/gkl621; Wang YT, 2009, J AM CHEM SOC, V131, P17345, DOI 10.1021/ja907160r	38	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0949-8257	1432-1327		J BIOL INORG CHEM	J. Biol. Inorg. Chem.	DEC	2014	19	8					1295	1303		10.1007/s00775-014-1186-6		9	Biochemistry & Molecular Biology; Chemistry, Inorganic & Nuclear	Biochemistry & Molecular Biology; Chemistry	AU1TW	WOS:000345403900005		
J	Wakabayashi, H; Sakuma, K				Wakabayashi, Hidetaka; Sakuma, Kunihiro			Rehabilitation nutrition for sarcopenia with disability: a combination of both rehabilitation and nutrition care management	JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE			English	Review						Rehabilitation nutrition; Stroke; Hip fracture; Hospital-associated deconditioning; Sarcopenic dysphagia	NURSING-HOME RESIDENTS; BODY-MASS INDEX; POINT-OF-VIEW; HIP FRACTURE; OLDER-ADULTS; ELDERLY-PATIENTS; STROKE REHABILITATION; MUSCLE MASS; MALNUTRITION; DYSPHAGIA	Malnutrition and sarcopenia often occur in rehabilitation settings. The prevalence of malnutrition and sarcopenia in older patients undergoing rehabilitation is 49-67 % and 40-46.5 %, respectively. Malnutrition and sarcopenia are associated with poorer rehabilitation outcome and physical function. Therefore, a combination of both rehabilitation and nutrition care management may improve outcome in disabled elderly with malnutrition and sarcopenia. The concept of rehabilitation nutrition as a combination of both rehabilitation and nutrition care management and the International Classification of Functioning, Disability and Health guidelines are used to evaluate nutrition status and to maximize functionality in the elderly and other people with disability. Assessment of the multifactorial causes of primary and secondary sarcopenia is important because rehabilitation nutrition for sarcopenia differs depending on its etiology. Treatment of age-related sarcopenia should include resistance training and dietary supplements of amino acids. Therapy for activity-related sarcopenia includes reduced bed rest time and early mobilization and physical activity. Treatment for disease-related sarcopenia requires therapies for advanced organ failure, inflammatory disease, malignancy, or endocrine disease, while therapy for nutrition-related sarcopenia involves appropriate nutrition management to increase muscle mass. Because primary and secondary sarcopenia often coexist in people with disability, the concept of rehabilitation nutrition is useful for their treatment. Stroke, hip fracture, and hospital-associated deconditioning are major causes of disability, and inpatients of rehabilitation facilities often have malnutrition and sarcopenia. We review the concept of rehabilitation nutrition, the rehabilitation nutrition options for stroke, hip fracture, hospital-associated deconditioning, sarcopenic dysphagia, and then evaluate the amount of research interest in rehabilitation nutrition.	[Wakabayashi, Hidetaka] Yokohama City Univ, Med Ctr, Dept Rehabil Med, Minami ward, Yokohama, Kanagawa 2320024, Japan; [Sakuma, Kunihiro] Toyohashi Univ Technol, Res Ctr Phys Fitness Sports & Hlth, Toyohashi, Aichi 4418580, Japan	Wakabayashi, H (reprint author), Yokohama City Univ, Med Ctr, Dept Rehabil Med, Minami ward, 4-57 Urafune Chou, Yokohama, Kanagawa 2320024, Japan.	noventurenoglory@gmail.com		Wakabayashi, HIdetaka/0000-0002-0364-0818	Ministry of Education, Science, Culture, Sports, Science, and Technology of Japan [25350611]	All authors of this manuscript have complied with the guidelines of ethical authorship and publishing as stated in the Journal of Cachexia, Sarcopenia, and Muscle 2010;1:7-8 (von Haehling S, Morley JE, Coats AJ, and Anker SD). This work was supported by a research Grant-in-Aid for Scientific Research C (no. 25350611) from the Ministry of Education, Science, Culture, Sports, Science, and Technology of Japan.	Anbar R, 2014, CLIN NUTR, V33, P23, DOI 10.1016/j.clnu.2013.03.005; Anker SD, 2006, CLIN NUTR, V25, P311, DOI 10.1016/j.clnu.2006.01.017; Sakuma K, 2012, J CACHEXIA SARCOPENI, V3, P77, DOI 10.1007/s13539-011-0052-4; Geeganage C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000323.pub2; BLOEM BR, 1990, BRIT MED J, V300, P721; Villani AM, 2013, J CACHEXIA SARCOPENI, V4, P209, DOI 10.1007/s13539-013-0108-8; Roy N, 2007, ANN OTO RHINOL LARYN, V116, P858; Scherbakov N, 2013, INT J CARDIOL, V170, P89, DOI 10.1016/j.ijcard.2013.10.031; Ha L, 2010, CLIN NUTR, V29, P567, DOI 10.1016/j.clnu.2010.01.011; Nogueira D, 2013, CLIN INTERV AGING, V8, P221, DOI 10.2147/CIA.S39452; Charlton KE, 2010, J NUTR HEALTH AGING, V14, P622, DOI 10.1007/s12603-010-0307-3; Holland G, 2011, DIS ESOPHAGUS, V24, P476, DOI 10.1111/j.1442-2050.2011.01182.x; Ottenbacher KJ, 2014, JAMA-J AM MED ASSOC, V311, P604, DOI 10.1001/jama.2014.8; Serra-Prat M, 2011, J AM GERIATR SOC, V59, P186, DOI 10.1111/j.1532-5415.2010.03227.x; Kaiser MJ, 2010, J AM GERIATR SOC, V58, P1734, DOI 10.1111/j.1532-5415.2010.03016.x; Ensrud KE, 2013, J GERONTOL A-BIOL, V68, P1236, DOI 10.1093/gerona/glt092; Zhao L, 2014, J STROKE CEREBROVASC, V23, pE201, DOI 10.1016/j.jstrokecerebrovasdis.2013.10.002; Scherbakov N, 2011, STROKE, V42, P3646, DOI 10.1161/STROKEAHA.111.619163; Hida T, 2013, GERIATR GERONTOL INT, V13, P413, DOI 10.1111/j.1447-0594.2012.00918.x; Sakuma K, 2015, PFLUG ARCH EUR J PHY, V467, P213, DOI 10.1007/s00424-014-1527-x; Miyai I, 2011, NEUROREHAB NEURAL RE, V25, P540, DOI 10.1177/1545968311402696; Covinsky KE, 2011, JAMA-J AM MED ASSOC, V306, P1782, DOI 10.1001/jama.2011.1556; Carda S, 2013, EUR J PHYS REHAB MED, V49, P119; Davis JP, 2004, STROKE, V35, P1930, DOI 10.1161/01.STR.0000135227.10451.c9; Di Monaco M, 2011, ARCH GERONTOL GERIAT, V52, P71, DOI 10.1016/j.archger.2010.02.002; [Anonymous], 1945, NUTR REV, V3, P59; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Hoekstra JC, 2011, CLIN NUTR, V30, P455, DOI 10.1016/j.clnu.2011.01.011; Kuroda Y, 2012, J AM GERIATR SOC, V60, P1785, DOI 10.1111/j.1532-5415.2012.04123.x; Burke DT, 2014, ARCH PHYS MED REHAB, V95, P1055, DOI 10.1016/j.apmr.2014.01.019; Kawashima K, 2004, DYSPHAGIA, V19, P266, DOI 10.1007/s00455-004-0013-6; Cederholm T, 2013, EUR J PHYS REHAB MED, V49, P111; Hudson HM, 2000, DYSPHAGIA, V15, P31; Rabadi MH, 2008, NEUROLOGY, V71, P1856, DOI 10.1212/01.wnl.0000327092.39422.3c; Foley NC, 2009, J REHABIL MED, V41, P707, DOI 10.2340/16501977-0415; Kortebein P, 2009, AM J PHYS MED REHAB, V88, P66, DOI 10.1097/PHM.0b013e3181838f70; Steele CM, 1997, DYSPHAGIA, V12, P43, DOI 10.1007/PL00009517; Tamura F, 2012, DYSPHAGIA, V27, P556, DOI 10.1007/s00455-012-9407-z; Di Monaco M, 2012, ARCH GERONTOL GERIAT, V55, pE48, DOI 10.1016/j.archger.2012.05.002; Gumieiro DN, 2013, BRIT J NUTR, V109, P1657, DOI 10.1017/S0007114512003686; Feng X, 2013, J GERONTOL A-BIOL, V68, P853, DOI 10.1093/gerona/gls225; [Anonymous], 2012, ANN REP GOV MEAS PER; Scherbakov N, 2011, J CACHEXIA SARCOPENI, V2, P5, DOI 10.1007/s13539-011-0024-8; Avenell A, 2010, COCHRANE DB SYST REV, V1; Bell JJ, 2014, CLIN NUTR, V33, P1101, DOI 10.1016/j.clnu.2013.12.003; Bell JJ, 2013, J HUM NUTR DIET, V26, P519, DOI 10.1111/jhn.12040; Bell JJ, 2014, EUR J CLIN NUTR, V68, P358, DOI 10.1038/ejcn.2013.276; Durillo FTP, 2010, NUTR HOSP, V25, P676, DOI 10.3305/nh.2010.25.4.4479; English C, 2010, INT J STROKE, V5, P395, DOI 10.1111/j.1747-4949.2010.00467.x; Singh MAF, 2009, J GERONTOL A-BIOL, V64, P568, DOI 10.1093/gerona/glp002; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Franchignoni F, 2013, EUR J PHYS REHAB MED, V49, P711; Guy N, 2012, ARCH GERONTOL GERIAT, V54, P381, DOI 10.1016/j.archger.2011.04.005; Iki Masayuki, 2012, Clin Calcium, V22, P797, DOI CliCa1206797803; Invernizzi M, 2013, EUR J PHYS REHAB MED, V49, P107; Jain NB, 2008, AM J PHYS MED REHAB, V87, P21, DOI 10.1097/PHM.0b013e3181561af; Kaiser MJ, 2011, J AM GERIATR SOC, V59, P2124, DOI 10.1111/j.1532-5415.2011.03659.x; Kelly-Hayes Margaret, 2003, J Stroke Cerebrovasc Dis, V12, P119, DOI 10.1016/S1052-3057(03)00042-9; Koren-Hakim T, 2012, CLIN NUTR, V31, P917, DOI 10.1016/j.clnu.2012.03.010; Krumholz H, 2013, NEW ENGL J MED, V382, P100, DOI DOI 10.1056/NEJMP1212324; Kuroda Y, 2014, INT J SPEECH-LANG PA, V2, P20; LOPES J, 1982, AM J CLIN NUTR, V36, P602; Malafarina V, 2013, MATURITAS, V76, P123, DOI 10.1016/j.maturitas.2013.06.016; Marshall S, 2014, J HUM NUTR DIET, V27, P133, DOI 10.1111/jhn.12167; Miyanishi Keita, 2010, J Orthop Surg (Hong Kong), V18, P265; Montero-Fernandez N, 2013, EUR J PHYS REHAB MED, V49, P131; Palacios-Cena D, 2012, J AM MED DIR ASSOC, V13, P136, DOI 10.1016/j.jamda.2010.05.007; Park YH, 2013, GERIATR NURS, V34, P212, DOI 10.1016/j.gerinurse.2013.02.014; Sanchez-Rodriguez D, 2014, ARCH GERONTOL GERIAT, V59, P39, DOI 10.1016/j.archger.2014.02.009; Strakowski MM, 2002, AM J PHYS MED REHAB, V81, P77, DOI 10.1097/00002060-200201000-00016; VELDEE M S, 1992, Dysphagia, V7, P86, DOI 10.1007/BF02493439; Wakabayashi H, 2014, GERIATR GERONTOL INT, DOI [10.1111/ggi.12283, DOI 10.1111/GGI.12283]; Wakabayashi H., 2014, J FRAILTY AGING, V3, P97; Wakabayashi H, 2011, JPN J REHABIL MED, V48, P270; Wakabayashi Hidetaka, 2010, Gan To Kagaku Ryoho, V37 Suppl 2, P198; Wakabayashi Hidetaka, 2014, Curr Clin Pharmacol, V9, P171; Wakabayashi H, 2011, GEN MED, V12, P69; Wakabayashi H, 2014, J REHABIL MED, V46, P277, DOI 10.2340/16501977-1258; Wakabayashi H, 2013, J NUTR THER, V2, P100; Yaxley A, 2012, ASIA PAC J CLIN NUTR, V21, P386	80	12	12	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2190-5991	2190-6009		J CACHEXIA SARCOPENI	J. Caxhexia Sarcopenia Muscle	DEC	2014	5	4					269	277		10.1007/s13539-014-0162-x		9	Medicine, General & Internal	General & Internal Medicine	AU1WC	WOS:000345407100004		
J	Pietra, C; Takeda, Y; Tazawa-Ogata, N; Minami, M; Xia, YF; Duus, EM; Northrup, R				Pietra, Claudio; Takeda, Yasuhiro; Tazawa-Ogata, Naoko; Minami, Masashi; Xia Yuanfeng; Duus, Elizabeth Manning; Northrup, Robert			Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile	JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE			English	Article						Anamorelin HCl; Ghrelin receptor agonist; Cancer anorexia-cachexia syndrome; Body weight; Growth hormone	GROWTH-HORMONE SECRETAGOGUE; WEIGHT-LOSS; HEALTHY-VOLUNTEERS; BEARING MICE; TUMOR-GROWTH; OLDER-ADULTS; DOUBLE-BLIND; CHEMOTHERAPY; SUPPLEMENTATION; PEPTIDE	Anamorelin HCl (ANAM) is a novel, orally active, ghrelin receptor agonist in clinical development for the treatment of cancer cachexia. We report in vitro and in vivo studies evaluating the preclinical pharmacologic profile of ANAM. Fluorescent imaging plate reader and binding assays in HEK293 and baby hamster kidney cells determined the agonist and antagonist activity of ANAM, and its affinity for the ghrelin receptor. Rat pituitary cells were incubated with ANAM to evaluate its effect on growth hormone (GH) release. In vivo, rats were treated with ANAM 3, 10, or 30 mg/kg, or control orally, once daily for 6 days to evaluate the effect on food intake (FI) and body weight (BW), and once to assess GH response. In pigs, single (3.5 mg/kg) or continuous (1 mg/kg/day) ANAM doses were administered to assess GH and insulin-like growth factor (IGF-1) response. ANAM showed significant agonist and binding activity on the ghrelin receptor, and stimulated GH release in vitro. In rats, ANAM significantly and dose-dependently increased FI and BW at all dose levels compared with control, and significantly increased GH levels at 10 or 30 mg/kg doses. Increases in GH and IGF-1 levels were observed following ANAM administration in pigs. ANAM is a potent and highly specific ghrelin receptor agonist with significant appetite-enhancing activity, leading to increases in FI and BW, and a stimulatory effect on GH secretion. These results support the continued investigation of ANAM as a potential treatment of cancer anorexia-cachexia syndrome.	[Pietra, Claudio] Helsinn Healthcare SA, Res & Preclin Dept, CH-6915 Lugano, Switzerland; [Takeda, Yasuhiro; Tazawa-Ogata, Naoko; Minami, Masashi] ONO Pharmaceut Co Ltd, Discovery Res Labs, Osaka, Japan; [Xia Yuanfeng] HD Biosci, Shanghai, Peoples R China; [Duus, Elizabeth Manning; Northrup, Robert] Helsinn Therapeut Inc, Bridgewater, NJ USA	Pietra, C (reprint author), Helsinn Healthcare SA, Res & Preclin Dept, CH-6915 Lugano, Switzerland.	claudio.pietra@helsinn.com			Helsinn Healthcare SA, Lugano, Switzerland	Editorial support and medical writing assistance was provided by Eva Polk, PhD (TRM Oncology, The Hague, The Netherlands), funded by Helsinn Healthcare SA, Lugano, Switzerland. The authors are fully responsible for all content in the manuscript.	Abernethy AP, 2013, J CLIN ONCOL S, V31; Ali SA, 2013, ENDOCR REV, V34; Farris GM, 2007, TOXICOL SCI, V97, P548, DOI 10.1093/toxsci/kfm059; Andreyev HJN, 1998, EUR J CANCER, V34, P503, DOI 10.1016/S0959-8049(97)10090-9; DeBoer MD, 2007, ENDOCRINOLOGY, V148, P3004, DOI 10.1210/en.2007-0016; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI [10.1016/S1470-2045(10)70218-7, 10.1016/51470-2045(10)70218-7]; White HK, 2009, J CLIN ENDOCR METAB, V94, P1198, DOI 10.1210/jc.2008-0632; Garcia JM, 2007, ONCOLOGIST, V12, P594, DOI 10.1634/theoncologist.12-5-594; Perboni S, 2008, WORLD J GASTROENTERO, V14, P6303, DOI 10.3748/wjg.14.6303; Argiles JM, 2013, EXPERT OPIN BIOL TH, V13, P67, DOI 10.1517/14712598.2013.727390; Neary NM, 2004, J CLIN ENDOCR METAB, V89, P2832, DOI 10.1210/jc.2003-031768; Dodson S, 2011, ANNU REV MED, V62, P265, DOI 10.1146/annurev-med-061509-131248; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Suzuki H, 2013, JPN J CLIN ONCOL, V43, P695, DOI 10.1093/jjco/hyt075; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Kumar NB, 2010, CURR TREAT OPTION ON, V11, P107, DOI 10.1007/s11864-010-0127-z; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Lundholm K, 2010, CANCER-AM CANCER SOC, V116, P2044, DOI 10.1002/cncr.24917; Morozumi N, 2011, PEPTIDES, V32, P1001, DOI 10.1016/j.peptides.2011.01.021; Garcia JM, 2009, GROWTH HORM IGF RES, V19, P267, DOI 10.1016/j.ghir.2008.12.003; Hiura Y, 2012, CANCER-AM CANCER SOC, V118, P4785, DOI 10.1002/cncr.27430; Ross PJ, 2004, BRIT J CANCER, V90, P1905, DOI 10.1038/sj.bjc.6601781; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Khan AS, 2005, CANCER GENE THER, V12, P54, DOI 10.1038/sj.cgt.7700767; Velloso CP, 2008, BRIT J PHARMACOL, V154, P557, DOI 10.1038/bjp.2008.153; Garcia JM, 2013, SUPPORT CARE CANCER, V21, P129, DOI 10.1007/s00520-012-1500-1; Northrup R, 2013, SUPPORT CARE CANCER, V21, P2409, DOI 10.1007/s00520-013-1800-0; Blum R, 2006, SUPPORT CARE CANCER, V14, P593; Donohoe CL, 2011, GASTROENT RES PRACT, DOI 10.1155/2011/601434; Gong YX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007273; Guillory B, 2013, VITAM HORM, V92, P61, DOI 10.1016/B978-0-12-410473-0.00003-9; Kato Y, 2002, INTERNAL MED, V41, P7, DOI 10.2169/internalmedicine.41.7; Khan AS, 2003, MOL THER, V8, P459, DOI 10.1016/S1525-0016(03)00175-8; Koo GC, 2001, J IMMUNOL, V166, P4195; Kumor K, 2006, SUPPORT CARE CANCER, V14, P593; Nass R, 2008, ANN INTERN MED, V149, P601; Piccoli F, 2007, J CLIN ENDOCR METAB, V92, P1814, DOI 10.1210/jc.2006-2160; Reichlin S., 1998, WILLIAMS TXB ENDOCRI, P165; Temel J, 2013, EUR J CANC S2, V49; Wang W, 2006, INT J ONCOL, V28, P1393	40	13	13	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	2190-5991	2190-6009		J CACHEXIA SARCOPENI	J. Caxhexia Sarcopenia Muscle	DEC	2014	5	4					329	337		10.1007/s13539-014-0159-5		9	Medicine, General & Internal	General & Internal Medicine	AU1WC	WOS:000345407100011		
J	Uchida, H; Suzuki, T				Uchida, Hiroyuki; Suzuki, Takefumi			Dose and Dosing Frequency of Long-Acting Injectable Antipsychotics A Systematic Review of PET and SPECT Data and Clinical Implications	JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY			English	Review						antipsychotics; depot; dopamine; long-acting injection; schizophrenia	DOPAMINE-D-2 RECEPTOR OCCUPANCY; POSITRON-EMISSION-TOMOGRAPHY; MAINTENANCE TREATMENT; DOUBLE-BLIND; HALOPERIDOL DECANOATE; SCHIZOPHRENIC-PATIENTS; TREATED PATIENTS; FLUPHENAZINE DECANOATE; NEUROLEPTIC TREATMENT; C-11 RACLOPRIDE	Brain imaging data of antipsychotics have mainly been derived from oral antipsychotic drugs, which hampers our understanding of the requirement of dose/dosing frequency of long-acting injectable (LAI) antipsychotics for the maintenance treatment of schizophrenia. A systematic literature search was performed to identify positron emission tomography (PET) and single-photon emission computed tomography (SPECT) studies that assessed dopamine D-2 receptor occupancy levels with LAI antipsychotic drugs in humans, using PubMed, EMBASE, and PsycINFO (last search, February 2013). Twenty studies (15 PET and 5 SPECT studies) were identified. The most investigated drug in these PET and SPECT studies was haloperidol decanoate (44 subjects; 11 studies), followed by risperidone LAI (24 subjects; 3 studies), olanzapine pamoate (14 subject; 1 study), and fluphenazine decanoate (12 subjects; 3 studies). The data have demonstrated high and continuous D-2 receptor blockade with LAIs; the effects of LAI first-generation antipsychotics on the central nervous system may persist for several months. The prospective and cross-sectional studies showed that continuous dopamine D-2 receptor blockade above 65% (ie, the lower end of the established therapeutic window for the acute phase treatment) was not always necessary for maintenance treatment for at least some of the patients. In conclusion, because of the limited brain imaging data on LAI antipsychotics, we still do not know the best way to dose them. Still, the currently available brain imaging data raises a possibility that the dosing interval of LAI antipsychotics may be extended beyond the currently indicated range in some patients.	[Uchida, Hiroyuki; Suzuki, Takefumi] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo 1608582, Japan; [Uchida, Hiroyuki] Ctr Addict & Mental Hlth, Geriatr Mental Hlth Program, Toronto, ON, Canada; [Suzuki, Takefumi] Inokashira Hosp, Dept Psychiat, Tokyo, Japan	Uchida, H (reprint author), Keio Univ, Sch Med, Dept Neuropsychiat, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	mcn41320@biglobe.ne.jp	Uchida, Hiroyuki/I-4867-2015	Uchida, Hiroyuki/0000-0002-0628-7036	Pfizer; Astellas Pharmaceutical; Eisai; Otsuka Pharmaceutical; GlaxoSmithKline; Shiohogi; Dainippon-Sumitomo Pharma; Eli Lilly; Mochida Pharmaceutical; Meiji-Seika Pharma; Janssen Pharmaceutical; Yoshitomi Yakuhin; Dainippon-Sumitomo Phama; Novartis Pharma	Dr Uchida has received grants from Pfizer, Astellas Pharmaceutical, Eisai, Otsuka Pharmaceutical, GlaxoSmithKline, Shiohogi, Dainippon-Sumitomo Pharma, Eli Lilly, Mochida Pharmaceutical, Meiji-Seika Pharma, Janssen Pharmaceutical, and Yoshitomi Yakuhin and speaker's honoraria from Otsuka Pharmaceutical, Janssen Pharmaceutical, Novartis Pharma, Eli Lilly, Shionogi, GlaxoSmithKline, Yoshitomi Yakuhin, Dainippon-Sumitomo Pharma, and Janssen Pharmaceutical within the past 5 years. Dr Suzuki has received manuscript fees or speaker's honoraria from Dainippon-Sumitomo Phama, Astellas Pharmaceutical, Novartis Pharma, Eli Lilly, and Meiji-Seika Pharma within the past 5 years.	Kapur S, 2000, AM J PSYCHIAT, V157, P514, DOI 10.1176/appi.ajp.157.4.514; Uchida H, 2011, J CLIN PSYCHOPHARM, V31, P497, DOI 10.1097/JCP.0b013e3182214aad; Takeuchi H, 2012, SCHIZOPHR RES, V134, P219, DOI 10.1016/j.schres.2011.11.021; Leucht S, 2012, LANCET, V379, P2063, DOI 10.1016/S0140-6736(12)60239-6; Bedard AM, 2011, NEUROPSYCHOPHARMACOL, V36, P1248, DOI 10.1038/npp.2011.10; Remington G, 2006, AM J PSYCHIAT, V163, P396, DOI 10.1176/appi.ajp.163.3.396; Kane JM, 2010, AM J PSYCHIAT, V167, P181, DOI 10.1176/appi.ajp.2009.07081221; Remington G, 2005, J CLIN PSYCHOPHARM, V25, P611, DOI 10.1097/01.jcp.0000185341.55096.65; Remington G, 2011, J CLIN PSYCHIAT, V72, P1042, DOI 10.4088/JCP.09m05866yel; Nyberg S, 1998, INT J NEUROPSYCHOPH, V1, P95, DOI 10.1017/S1461145798001229; Leucht C, 2011, SCHIZOPHR RES, V127, P83, DOI 10.1016/j.schres.2010.11.020; Kapur S, 2003, PROG NEURO-PSYCHOPH, V27, P1081, DOI 10.1016/j.pnpbp.2003.09.004; Uchida H, 2011, J CLIN PSYCHOPHARM, V31, P318, DOI 10.1097/JCP.0b013e318218d339; Turrone P, 2005, BIOL PSYCHIAT, V57, P406, DOI 10.1016/j.biopsych.2004.10.023; Ng W, 2009, THER DRUG MONIT, V31, P360, DOI 10.1097/FTD.0b013e31819c7037; Kane JM, 2006, J CLIN PSYCHIAT, V67, P9; FARDE L, 1992, ARCH GEN PSYCHIAT, V49, P538; Gefvert O, 2005, INT J NEUROPSYCHOPH, V8, P27, DOI 10.1017/S1461145704004924; Schooler NR, 1997, ARCH GEN PSYCHIAT, V54, P453; Sakurai H, 2013, SCHIZOPHRENIA BULL, V39, P564, DOI 10.1093/schbul/sbr189; POST RM, 1980, LIFE SCI, V26, P1275, DOI 10.1016/0024-3205(80)90085-5; FARDE L, 1986, SCIENCE, V231, P258, DOI 10.1126/science.2867601; FARDE L, 1987, PSYCHOPHARMACOLOGY, V92, P278, DOI 10.1007/BF00210831; WOLKIN A, 1989, AM J PSYCHIAT, V146, P905; Ikai S, 2012, J CLIN PSYCHIAT, V73, P1147, DOI 10.4088/JCP.12m07638; Kane JM, 2002, AM J PSYCHIAT, V159, P554, DOI 10.1176/appi.ajp.159.4.554; Novakovic V, 2013, CLIN NEUROPHARMACOL, V36, P59, DOI 10.1097/WNF.0b013e3182854f70; BARON JC, 1989, PSYCHOPHARMACOLOGY, V99, P463, DOI 10.1007/BF00589893; CAREY RJ, 1984, PSYCHOPHARMACOLOGY, V82, P164, DOI 10.1007/BF00427766; COPPENS HJ, 1991, BIOL PSYCHIAT, V29, P629, DOI 10.1016/0006-3223(91)90132-6; Farde L, 1997, PSYCHOPHARMACOLOGY, V133, P396, DOI 10.1007/s002130050420; FARDE L, 1995, J CLIN PSYCHOPHARM, V15, pS19; HARASKOVANDERMEER C, 1993, J NEURAL TRANSM-GEN, V94, P217, DOI 10.1007/BF01277026; HOGARTY GE, 1988, ARCH GEN PSYCHIAT, V45, P797; Huttunen MO, 1996, PSYCHIATR SERV, V47, P83; INDERBITZIN LB, 1994, AM J PSYCHIAT, V151, P1753; KANE JM, 1983, ARCH GEN PSYCHIAT, V40, P893; Kasper S, 1998, PSYCHOPHARMACOLOGY, V136, P367, DOI 10.1007/s002130050579; Kuenstler U, 1999, PSYCHIAT RES-NEUROIM, V90, P31, DOI 10.1016/S0925-4927(98)00054-7; Mamo D, 2008, NEUROPSYCHOPHARMACOL, V33, P298, DOI 10.1038/sj.npp.1301409; MARDER SR, 1987, ARCH GEN PSYCHIAT, V44, P518; McEvoy JP, 2006, J CLIN PSYCHIAT, V67, P15; Mizuno Y, 2012, PROG NEURO-PSYCHOPH, V37, P182, DOI 10.1016/j.pnpbp.2011.12.013; Moriguchi S, 2013, J CLIN PSYCHOPHARM, V33, P682, DOI 10.1097/JCP.0b013e3182979a0a; Nyberg S, 1997, ARCH GEN PSYCHIAT, V54, P953; NYBERG S, 1995, INT CLIN PSYCHOPHARM, V10, P221, DOI 10.1097/00004850-199511000-00003; Nyberg S, 1996, PSYCHIAT RES-NEUROIM, V67, P163, DOI 10.1016/0925-4927(96)02921-6; NYBERG S, 1995, AM J PSYCHIAT, V152, P173; Patel MX, 2009, BR J PSYCHIAT S, V52, P1; Regenthal R, 1997, INT CLIN PSYCHOPHARM, V12, P255, DOI 10.1097/00004850-199709000-00002; Remington G, 2010, SCHIZOPHRENIA BULL, V36, P900, DOI 10.1093/schbul/sbq083; Simpson GM, 2006, J CLIN PSYCHIAT, V67, P1194; Stone JM, 2009, SCHIZOPHRENIA BULL, V35, P789, DOI 10.1093/schbul/sbn009; Tauscher J, 1997, PSYCHOPHARMACOLOGY, V133, P102, DOI 10.1007/s002130050378; Uchida H, 2008, J CLIN PSYCHIAT, V69, P1281; Uchida H, 2011, SCHIZOPHRENIA BULL, V37, P788, DOI 10.1093/schbul/sbp149	56	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-0749	1533-712X		J CLIN PSYCHOPHARM	J. Clin. Psychopharmacol.	DEC	2014	34	6					728	735		10.1097/JCP.0000000000000065		8	Pharmacology & Pharmacy; Psychiatry	Pharmacology & Pharmacy; Psychiatry	AT4TI	WOS:000344934600014		
J	Kawada, T				Kawada, Tomoyuki			Selective Serotonin Reuptake Inhibitors Exposure During Pregnancy and Neonatal Outcomes	JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY			English	Letter									Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, Tokyo 113, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 113, Japan.	kawada@nms.ac.jp					Grzeskowiak LE, 2012, J CLIN PSYCHOPHARM, V32, P615, DOI 10.1097/JCP.0b013e31826686bc; Stephansson O, 2013, JAMA-J AM MED ASSOC, V309, P48, DOI 10.1001/jama.2012.153812	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-0749	1533-712X		J CLIN PSYCHOPHARM	J. Clin. Psychopharmacol.	DEC	2014	34	6					751	751				1	Pharmacology & Pharmacy; Psychiatry	Pharmacology & Pharmacy; Psychiatry	AT4TI	WOS:000344934600022		
J	Kikuchi, YS; Ataka, K; Yagisawa, K; Omori, Y; Kanbayashi, T; Shimizu, T				Kikuchi, Yuka Sugawara; Ataka, Keiichiro; Yagisawa, Kiwamu; Omori, Yuki; Kanbayashi, Takashi; Shimizu, Tetsuo			Clozapine Administration and the Risk of Drug-Related Pure Red Cell Aplasia A Novel Case Report	JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY			English	Letter									[Kikuchi, Yuka Sugawara; Ataka, Keiichiro; Yagisawa, Kiwamu; Omori, Yuki; Kanbayashi, Takashi; Shimizu, Tetsuo] Akita Univ, Grad Sch Med, Dept Neuropsychiat, Akita 010, Japan	Kikuchi, YS (reprint author), Akita Univ, Grad Sch Med, Dept Neuropsychiat, Akita 010, Japan.	yuka@med.akita-u.ac.jp					Thompson DF, 1996, PHARMACOTHERAPY, V16, P1002; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239; Fisch P, 2000, BRIT J HAEMATOL, V111, P1010, DOI 10.1046/j.1365-2141.2000.02429.x; Lipton JM, 2013, WINTRONES CLIN HEMAT, P1421; Sawada K, 2009, HEMATOL ONCOL CLIN N, V23, P249, DOI 10.1016/j.hoc.2009.01.009	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-0749	1533-712X		J CLIN PSYCHOPHARM	J. Clin. Psychopharmacol.	DEC	2014	34	6					763	764				2	Pharmacology & Pharmacy; Psychiatry	Pharmacology & Pharmacy; Psychiatry	AT4TI	WOS:000344934600030		
J	Matsuo, Y; Uozumi, N; Matsuo, R				Matsuo, Yuko; Uozumi, Nana; Matsuo, Ryota			Photo-tropotaxis based on projection through the cerebral commissure in the terrestrial slug Limax	JOURNAL OF COMPARATIVE PHYSIOLOGY A-NEUROETHOLOGY SENSORY NEURAL AND BEHAVIORAL PHYSIOLOGY			English	Article						Tentacle; Cerebral commissure; Circling behavior; Slug; Light-evoked electrical response	SNAIL LYMNAEA-STAGNALIS; PHOTOTROPIC CIRCUS MOVEMENTS; PHOTOSENSITIVE NEURONS; ONCHIDIUM-VERRUCULATUM; DERMAL PHOTORECEPTORS; OLFACTORY CENTER; CENTRAL GANGLIA; NERVOUS-SYSTEM; HERMISSENDA; ORIENTATION	In the terrestrial slug, Limax, eyes are located at the tip of the superior tentacles. This animal has long been believed to show negative phototaxis through tropotaxis, i.e., it compares the two light intensities detected by bilateral eyes to move away from a light source. As one of the possible manifestations of such negative phototaxis, a circling movement has been observed: if one of the superior tentacles is removed, the slugs continuously move in the direction of the removed side. However, there has been no evidence demonstrating that this behavior is actually based on negative phototropotaxis. In this study, we showed that the slugs do not exhibit the circling behavior in the absence of light, and that amputation of the cerebral commissure also diminishes the circling behavior under light. We could detect light-evoked responses during electrical recording from the cut edge of the cerebral commissure. Labeling of the optic nerve with neurobiotin also revealed the presence of the commissural fibers that potentially transmit the light information to the contralateral cerebral ganglion. Our study suggests that the slug's circling behavior is based on phototropotaxis in which the light intensities detected by the bilateral eyes are compared through the cerebral commissure.	[Matsuo, Yuko; Uozumi, Nana; Matsuo, Ryota] Fukuoka Womens Univ, Int Coll Arts & Sci, Neurobiol Lab, Higashi Ku, Fukuoka 8138529, Japan	Matsuo, R (reprint author), Fukuoka Womens Univ, Int Coll Arts & Sci, Neurobiol Lab, Higashi Ku, 1-1-1 Kasumigaoka, Fukuoka 8138529, Japan.	matsuor@fwu.ac.jp			Japan Society for the promotion of science [25440181]; Yamada Science Foundation; Naito Foundation	We thank Suguru Kobayashi for his helpful advice on the electrophysiological experiments, and Takeshi Morita for his help in the measurement of the irradiance of light. This study was supported by Grants-in-Aid for KAKENHI from the Japan Society for the promotion of science (No. 25440181 to RM), the Yamada Science Foundation (to RM), and the Naito Foundation (to RM). We minimized the number of animals used, and reduced the pain of the animals by deep anesthesia (with cold Mg<SUP>2+</SUP> buffer) when sacrifice.	CROW TJ, 1980, SCIENCE, V209, P412, DOI 10.1126/science.209.4454.412; Matsuo R, 2014, J COMP NEUROL, V522, P2951, DOI 10.1002/cne.23559; CROLL RP, 1983, BIOL REV, V58, P293, DOI 10.1111/j.1469-185X.1983.tb00391.x; Gomez-Marin A, 2012, CURR OPIN NEUROBIOL, V22, P208, DOI 10.1016/j.conb.2011.11.008; Kobayashi S, 2012, J NEUROPHYSIOL, V108, P989, DOI 10.1152/jn.01137.2010; Kobayashi S, 2010, EUR J NEUROSCI, V32, P1180, DOI 10.1111/j.1460-9568.2010.07399.x; Jekely G, 2008, NATURE, V456, P395, DOI 10.1038/nature07590; Matsuo R, 2011, J EXP BIOL, V214, P879, DOI 10.1242/jeb.024562; Matsuo R, 2013, DEV NEUROBIOL, V73, P609, DOI 10.1002/dneu.22087; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; CHASE R, 1981, J COMP PHYSIOL, V143, P357; Chono K, 2002, BRAIN RES, V951, P107, DOI 10.1016/S0006-8993(02)03143-8; Crozier WJ, 1924, J GEN PHYSIOL, V7, P221, DOI 10.1085/jgp.7.2.221; Crozier WJ, 1924, J GEN PHYSIOL, V7, P151, DOI 10.1085/jgp.7.1.151; FARLEY J, 1982, J NEUROPHYSIOL, V48, P785; Friedrich A, 1998, J COMP PHYSIOL A, V183, P247, DOI 10.1007/s003590050252; GOTOW T, 1973, J COMP PHYSIOL, V83, P361, DOI 10.1007/BF00696352; GOTOW T, 1975, J COMP PHYSIOL, V99, P139; HELDMAN E, 1979, J NEUROPHYSIOL, V42, P153; HISANO N, 1972, J EXP BIOL, V57, P651; Kartelija G, 2003, COMP BIOCHEM PHYS A, V134, P483, DOI 10.1016/S1095-6433(02)00351-3; LEDERHENDLER II, 1987, BEHAV NEURAL BIOL, V47, P227, DOI 10.1016/S0163-1047(87)90370-0; Michel S, 2000, J COMP NEUROL, V425, P244, DOI 10.1002/1096-9861(20000918)425:2<244::AID-CNE7>3.0.CO;2-A; OLSON LM, 1985, J NEUROSCI, V5, P3214; Pankey S, 2010, J COMP PHYSIOL B, V180, P1205, DOI 10.1007/s00360-010-0490-x; PASIC M, 1990, COMP BIOCHEM PHYS A, V95, P73, DOI 10.1016/0300-9629(90)90012-H; Sunada H, 2010, J EXP BIOL, V213, P3409, DOI 10.1242/jeb.043521; Tuchina Oksana P., 2011, Zoological Research, V32, P403, DOI 10.3724/SP.J.1141.2011.04403; VANDUIVENBODEN YA, 1982, J COMP PHYSIOL, V149, P363; Zhukov VV, 2007, J EVOL BIOCHEM PHYS+, V43, P524, DOI 10.1134/S0022093007050118	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-7594	1432-1351		J COMP PHYSIOL A	J. Comp. Physiol. A -Neuroethol. Sens. Neural Behav. Physiol.	DEC	2014	200	12					1023	1032		10.1007/s00359-014-0954-7		10	Behavioral Sciences; Neurosciences; Physiology; Zoology	Behavioral Sciences; Neurosciences & Neurology; Physiology; Zoology	AU0SF	WOS:000345333900004		
J	Tagawa, H; Liu, YD				Tagawa, Hiroshi; Liu, Yudu			Stiffening of bolted end-plate connections with steel member assemblies	JOURNAL OF CONSTRUCTIONAL STEEL RESEARCH			English	Article						End-plate connection; Stiffener; Steel angle; Connection strength; Yield line theory; Cyclic loading; Rotation capacity; Reinforcement	EXPERIMENTAL BEHAVIOR; MOMENT CONNECTIONS; BACKING-PLATES; CYCLIC LOADS; JOINTS; BEAM	This paper presents a new stiffening method for bolted end-plate beam-column connections in which steel member assemblies of steel angles and plates are used as stiffeners. An important benefit of this method is that it can eliminate transverse stiffeners and doubler plates, thereby enabling use of the space between the column-flanges for architectural demands such as ducting. The local tensile strength was first evaluated based on the yield line theory. To examine failure behavior in the tension part of end-plate connections, three local tensile loading tests were conducted for the T-stub connection models. Then the local compressive strength was also evaluated by consideration of previous studies. Subsequently, to ascertain the stiffening method efficiency, one cyclic loading test was conducted for the real-size beam-to-column bolted end-plate connection. Accuracy of the strength formulae was demonstrated by comparing the predictions and the loading test results. The proposed method using the steel member assemblies was revealed to be effective to stiffen bolted end-plate connections. (C) 2014 Elsevier Ltd. All rights reserved.	[Tagawa, Hiroshi] Hiroshima Univ, Grad Sch Engn, Higashihiroshima 7398527, Japan; [Liu, Yudu] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648603, Japan	Tagawa, H (reprint author), Hiroshima Univ, Grad Sch Engn, Higashihiroshima 7398527, Japan.	htagawa@hiroshima-u.ac.jp	Tagawa, Hiroshi/I-7945-2015				AISC, 1993, MAN STEEL CONSTR LOA, V2; Al-Khatab Z, 2007, J CONSTR STEEL RES, V63, P1603, DOI 10.1016/j.jcsr.2007.01.012; PACKER JA, 1977, STRUCT ENG, V55, P446; Shi G, 2008, ENG STRUCT, V30, P2677, DOI 10.1016/j.engstruct.2008.02.013; MOORE DB, 1986, J CONSTR STEEL RES, V6, P95, DOI 10.1016/0143-974X(86)90001-5; Abidelah A, 2012, J CONSTR STEEL RES, V76, P13, DOI 10.1016/j.jcsr.2012.04.004; Gerami M, 2011, J CONSTR STEEL RES, V67, P690, DOI 10.1016/j.jcsr.2010.11.011; Diaz C, 2011, J CONSTR STEEL RES, V67, P1578, DOI 10.1016/j.jcsr.2011.04.002; Coelho AMG, 2007, J CONSTR STEEL RES, V63, P1228, DOI 10.1016/j.jcsr.2006.11.010; Hu JW, 2012, J CONSTR STEEL RES, V78, P45, DOI 10.1016/j.jcsr.2012.05.011; Wang JF, 2009, J CONSTR STEEL RES, V65, P925, DOI 10.1016/j.jcsr.2008.10.010; Eurocode 3, 2005, 1993182005 EN CEN 1; Grogan W, 1999, J CONSTR STEEL RES, V50, P71, DOI 10.1016/S0143-974X(98)00227-2; Gurel S, 2005, JAPAN SOC STEEL CONS, V12, P33; Harada Y, 2003, J STRUCT CONSTR ENG, V574, P197; Herrera RA, 2013, J CONSTR STEEL RES, V88, P289, DOI 10.1016/j.jcsr.2013.05.022; Hirade T, 2001, J STRUCT CONSTR ENG, V542, P179; Johansen K. W., 1962, YIELD LINE THEORY; Kukreti AR, 2006, ENG STRUCT, V28, P1483, DOI 10.1016/j.engstruct.2005.09.021; Mansfield EH, 1957, P ROY SOC LOND A MAT, P311; Piluso V, 2008, J CONSTR STEEL RES, V64, P655, DOI 10.1016/j.jcsr.2007.12.009; Shi G, 2007, ENG STRUCT, V29, P703, DOI 10.1016/j.engstruct.2006.06.016; Tagawa H, 2005, J CONSTR STEEL RES, V61, P1650, DOI 10.1016/j.jcsr.2005.04.004	23	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0143-974X	1873-5983		J CONSTR STEEL RES	J. Constr. Steel. Res.	DEC	2014	103						190	199		10.1016/j.jcsr.2014.09.005		10	Construction & Building Technology; Engineering, Civil	Construction & Building Technology; Engineering	AU3CA	WOS:000345489200017		
J	Tsukada, G; Sueyoshi, H; Kamibayashi, H; Tokuda, M; Torii, M				Tsukada, Gakuji; Sueyoshi, Hidekazu; Kamibayashi, Hiroki; Tokuda, Masayuki; Torii, Mitsuo			Bending strength of zirconia/porcelain functionally graded materials prepared using spark plasma sintering	JOURNAL OF DENTISTRY			English	Article						Functionally graded material; Spark plasma sintering; Y-TZP; Porcelain; Bending strength; Thermal stress	RESIDUAL-STRESSES; CERAMIC RESTORATIONS; DENTAL APPLICATIONS; SINGLE CROWNS; FOLLOW-UP; ZIRCONIA; PORCELAIN; PROSTHESES; FRACTURE; SYSTEM	Objectives: The purpose of this study was to fabricate functionally graded materials (FGMs) consisting of yttria-stabilised tetragonal zirconia polycrystal (Y-TZP) and porcelain using spark plasma sintering (SPS) and examine the influence of their microstructures and thermal stress on their bending strengths. Methods: Two types of four-layered Y-TZP/porcelain FGMs having a constant layer thickness and a varying layer thickness, Y-TZP/porcelain composite materials having a microstructure corresponding to each layer in FGMs and monolithic materials of Y-TZP and porcelain were fabricated by SPS. The Y-TZP/porcelain volume fraction of each layer in FGMs was varied over 100/0-70/30. Three-point bending test, X-ray diffraction, density measurement, microstructure observation, and thermal stress estimation were performed to characterise the materials. Results: The bending strength of the Y-TZP/porcelain composite materials decreased with the volume fraction of the porcelain. About FGMs, when the 100% Y-TZP layer was on the tensile stress side during the bending test, the bending strength was almost the same as that of the 100% Y-TZP monolithic material. On the other hand, when the 100% Y-TZP layer was on the compressive stress side, the bending strength of FGM having a constant layer thickness was almost the same as that of the 70% Y-TZP + 30% porcelain composite material, while the bending strength of FGM with a varying layer thickness was significantly higher than that of the 70% Y-TZP + 30% porcelain composite material. Clinical significance: The FGMs prepared and analyzed in this research can potentially be used for crowns and bridges as well as for inlays and onlays. Conclusion: The SPS method could effectively fabricate the Y-TZP/porcelain FGMs, and the bending strength results revealed that the graded structure was very efficient to raise the bending strength. (C) 2014 Elsevier Ltd. All rights reserved.	[Tsukada, Gakuji; Tokuda, Masayuki; Torii, Mitsuo] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Restorat Dent & Endodontol, Sakuragaoka, Kagoshima, Japan; [Sueyoshi, Hidekazu; Kamibayashi, Hiroki] Kagoshima Univ, Grad Sch Sci & Engn, Dept Mech Engn, Korimoto, Kagoshima, Japan	Tsukada, G (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Restorat Dent & Endodontol, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	tsukada@dent.kagoshima-u.ac.jp			 [21659439]	Shofu is acknowledged for providing the high-fusing porcelain. This research was supported by Grants-in-Aid for Scientific Research #21659439.	Ortorp A, 2012, J DENT, V40, P527, DOI 10.1016/j.jdent.2012.02.011; Yu LG, 2003, BIOMATERIALS, V24, P2695, DOI 10.1016/S0142-9612(03)00082-6; Nygren M, 2003, SOLID STATE SCI, V5, P125, DOI 10.1016/S1293-2558(02)00086-9; Denry I, 2010, MATERIALS, V3, P351, DOI 10.3390/ma3010351; Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6; Zhang Y, 2010, J DENT RES, V89, P1057, DOI 10.1177/0022034510375289; Guo HB, 2003, BIOMATERIALS, V24, P667, DOI 10.1016/S0142-9612(02)00381-2; Sailer I, 2009, INT J PROSTHODONT, V22, P553; Munir ZA, 2006, J MATER SCI, V41, P763, DOI 10.1007/s10853-006-6555-2; Suresh S, 2001, SCIENCE, V292, P2447, DOI 10.1126/science.1059716; GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0; Rekow D, 2007, J MATER SCI-MATER M, V18, P47, DOI 10.1007/s10856-006-0661-1; Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007; Bocanegra-Bernal MH, 2002, J MATER SCI, V37, P4947, DOI 10.1023/A:1021099308957; [Anonymous], 1995, R1602 JIS; BAO G, 1995, INT J SOLIDS STRUCT, V32, P2853, DOI 10.1016/0020-7683(94)00267-Z; Baldassarri M, 2012, DENT MATER, V28, P873, DOI 10.1016/j.dental.2012.04.019; Swain MV, 2009, ACTA BIOMATER, V5, P1668, DOI 10.1016/j.actbio.2008.12.016; Zhang Y, 2010, J DENT RES, V89, P417, DOI 10.1177/0022034510363245; Zhang Y, 2009, ACTA MATER, V57, P2721, DOI 10.1016/j.actamat.2009.02.037; RAVICHANDRAN KS, 1995, MAT SCI ENG A-STRUCT, V201, P269, DOI 10.1016/0921-5093(95)09773-2; Zhang Y, 2012, ACTA BIOMATER, V8, P1101, DOI 10.1016/j.actbio.2011.11.033; Napankangas R, 2008, INT J PROSTHODONT, V21, P307; White SN, 2005, J PROSTHET DENT, V94, P125, DOI 10.1016/j.prosdent.2005.05.007; Belli R, 2012, J DENT RES, V91, P316, DOI 10.1177/0022034511435100; Denry I, 2013, DENT MATER, V29, P85, DOI 10.1016/j.dental.2012.07.001; Koenig V, 2013, J DENT, V41, P1164, DOI 10.1016/j.jdent.2013.10.009; Guazzato M, 2004, INT J PROSTHODONT, V17, P142; Donovan TE, 2009, J ESTHET RESTOR DENT, V21, P4, DOI 10.1111/j.1708-8240.2008.00222.x; Guazza M, 2004, BIOMATERIALS, V25, P5045, DOI 10.1016/j.biomaterials.2004.02.036; Hungria T, 2009, ADV ENG MATER, V11, P615, DOI 10.1002/adem.200900052; Mahamood RM, 2012, P WORLD C ENG, V3, P4; Niino M., 1987, J JAPAN SOC COMPOSIT, V13, P257; SCOTT HG, 1977, J MATER SCI, V12, P311, DOI 10.1007/BF00566272; Tokita M, 2010, CERAMICS, P605; Yamashita I, 2005, J CERAM SOC JPN, V113, P530, DOI 10.2109/jcersj.113.530	36	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0300-5712	1879-176X		J DENT	J. Dent.	DEC	2014	42	12					1569	1576		10.1016/j.jdent.2014.09.012		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AU3KO	WOS:000345512200007		
J	Hatanaka, T; Kawakami, K; Uraji, M				Hatanaka, Tadashi; Kawakami, Kayoko; Uraji, Misugi			Inhibitory effect of collagen-derived tripeptides on dipeptidylpeptidase-IV activity	JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY			English	Article						Collagenase; collagen hydrolysate; diabetes; DPP-IV	PEPTIDASE-IV; DIPROTIN-A; PRO; FIBROBLASTS; TRANSPORT; MEMBRANE; GELATIN	The collagen tripeptide fragments Gly-Ala-Hyp, Gly-Pro-Ala and Gly-Pro-Hyp were generated by hydrolyzing collagen from pig-skin, cattle-skin, fish-scales and chicken-feet, respectively, with Streptomyces collagenase. Collagenase treatment increased the concentration of tripeptides in the hydrolysates by 13-15% (w/w). Of the three peptides, Gly-Pro-Hyp was a true peptidic inhibitor of dipeptidylpeptidase-IV (DPP-IV), because DPP-IV could not hydrolyze the bond between Pro-Hyp. This tripeptide was a moderately competitive inhibitor (K-i = 4.5 mM) of DPP-IV, and its level in the collagen hydrolysates could be greatly increased (4-9% [w/w]) using Streptomyces collagenase.	[Hatanaka, Tadashi; Kawakami, Kayoko; Uraji, Misugi] Okayama Prefectural Technol Ctr Agr Forestry & Fi, RIBS, Okayama 7161241, Japan	Hatanaka, T (reprint author), Okayama Prefectural Technol Ctr Agr Forestry & Fi, RIBS, 7549-1 Kibichuo Cho, Okayama 7161241, Japan.	hatanaka@bio-ribs.com					Hatanaka T, 2012, FOOD CHEM, V134, P797, DOI 10.1016/j.foodchem.2012.02.183; Aito-Inoue M, 2007, J PEPT SCI, V13, P468, DOI 10.1002/psc.870; Ramshaw JAM, 1998, J STRUCT BIOL, V122, P86, DOI 10.1006/jsbi.1998.3977; Bjelke JR, 2006, BIOCHEM J, V396, P391, DOI 10.1042/BJ20060079; Tulipano G, 2011, PEPTIDES, V32, P835, DOI 10.1016/j.peptides.2011.01.002; Li-Chan ECY, 2012, J AGR FOOD CHEM, V60, P973, DOI 10.1021/jf204720q; Satake M, 2002, BIOSCI BIOTECH BIOCH, V66, P378; BAUVOIS B, 1988, BIOCHEM J, V252, P723; RAHFELD J, 1991, BIOCHIM BIOPHYS ACTA, V1076, P314, DOI 10.1016/0167-4838(91)90284-7; LASKIN DL, 1986, J LEUKOCYTE BIOL, V39, P255; UMEZAWA H, 1984, J ANTIBIOT, V37, P422; POSTLETHWAITE AE, 1978, P NATL ACAD SCI USA, V75, P871, DOI 10.1073/pnas.75.2.871; Chaimbault P, 2000, J CHROMATOGR A, V870, P245, DOI 10.1016/S0021-9673(99)00863-8; Fujita A, 2003, BIOTECHNOL PROGR, V19, P1365, DOI 10.1021/bp030004i; POSTLETHWAITE AE, 1976, J EXP MED, V143, P1299, DOI 10.1084/jem.143.6.1299; Richard EP, 2008, MEDSCAPE J MED, V10, P171; Richter Bernd, 2008, Vasc Health Risk Manag, V4, P753; Sakurai Y, 2009, BIOSCI BIOTECH BIOCH, V73, P21, DOI 10.1271/bbb.80357; Watanabe-Kamiyama M, 2010, J AGR FOOD CHEM, V58, P835, DOI 10.1021/jf9031487	19	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1475-6366	1475-6374		J ENZYM INHIB MED CH	J. Enzym. Inhib. Med. Chem.	DEC	2014	29	6					823	828		10.3109/14756366.2013.858143		6	Biochemistry & Molecular Biology; Chemistry, Medicinal	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	AU3MR	WOS:000345518000008		
J	Hayashi, S; Ueno, N; Murase, A; Takada, J				Hayashi, Shigeo; Ueno, Naomi; Murase, Akio; Takada, Junji			Design, synthesis and structure-activity relationship studies of novel and diverse cyclooxygenase-2 inhibitors as anti-inflammatory drugs	JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY			English	Article						Carrageenan-induced oedema; COX-2/COX-1 selectivity; inflammation; NSAID; orally active COX-2 inhibitor	SELECTIVE COX-2 INHIBITOR; LYMPH-NODE METASTASIS; MOUSE PAW EDEMA; MESSENGER-RNA; BREAST-CANCER; GROWTH-FACTOR; UP-REGULATION; COLON-CANCER; COLORECTAL-CANCER; LIVER METASTASIS	Because of the pivotal role of cyclooxygenase (COX) in the inflammatory processes, non-steroidal anti-inflammatory drugs (NSAIDs) that suppress COX activities have been used clinically for the treatment of inflammatory diseases/syndromes; however, traditional NSAIDs exhibit serious side-effects such as gastrointestinal damage and hyper sensitivity owing to their COX-1 inhibition. Also, COX-2 inhibition-derived suppressive or preventive effects against initiation/proliferation/invasion/motility/recurrence/metastasis of various cancers/tumours such as colon, gastric, skin, lung, liver, pancreas, breast, prostate, cervical and ovarian cancers are significant. In this study, design, synthesis and structure-activity relationship (SAR) of various novel {2-[(2-, 3- and/or 4-substituted)-benzoyl, (bicyclic heterocycloalkanophenyl) carbonyl or cycloalkanecarbonyl]-(5- or 6-substituted)-1H-indol-3-yl}acetic acid analogues were investigated to seek and identify various chemotypes of potent and selective COX-2 inhibitors for the treatment of inflammatory diseases, resulting in the discovery of orally potent agents in the peripheral-inflammation model rats. The SARs and physicochemical properties for the analogues are described as significant findings.	[Hayashi, Shigeo; Ueno, Naomi; Murase, Akio; Takada, Junji] Pfizer Japan Inc, Pfizer Global Res & Dev, Nagoya Labs, Aichi 4702393, Japan	Hayashi, S (reprint author), Pfizer Japan Inc, Pfizer Global Res & Dev, Nagoya Labs, 5-2 Taketoyo, Aichi 4702393, Japan.	Shigeo_Hayashi@nifty.com					Ali-Fehmi R, 2003, CANCER, V98, P1423, DOI 10.1002/cncr.11650; Kiritoshi S, 2003, DIABETES, V52, P2570, DOI 10.2337/diabetes.52.10.2570; Li S, 1999, BRAIN RES, V825, P86, DOI 10.1016/S0006-8993(99)01225-1; Smith WL, 1996, J BIOL CHEM, V271, P33157; Connolly EM, 2002, BRIT J CANCER, V87, P231, DOI 10.1038/sj.bjc.6600462; Chen WS, 2001, INT J CANCER, V91, P894, DOI 10.1002/1097-0215(200102)9999:9999<894::AID-IJC1146>3.0.CO;2-#; Sanchez-Borges M, 2010, MED CLIN N AM, V94, P853, DOI 10.1016/j.mcna.2010.03.005; Dormond O, 2001, NAT MED, V7, P1041, DOI 10.1038/nm0901-1041; Romano M, 1997, MEDIAT INFLAMM, V6, P32; Hayashi S, 2012, EUR J MED CHEM, V50, P179, DOI 10.1016/j.ejmech.2012.01.053; Kawamoto T, 2002, INT J CANCER, V98, P427, DOI 10.1002/ijc.10222; Zhou HN, 2005, P NATL ACAD SCI USA, V102, P14641, DOI 10.1073/pnas.0505473102; Ku GY, 2010, CANCER TREAT REV, V36, P235, DOI 10.1016/j.ctrv.2009.12.009; Lee JL, 2003, TOXICOL APPL PHARM, V192, P294, DOI 10.1016/S0041-008X(03)00301-6; Oitate M, 2007, DRUG METAB DISPOS, V35, P1846, DOI 10.1124/dmd.107.016121; Xin B, 2007, CANCER, V110, P791, DOI 10.1002/cncr.22854; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692; Kew MC, 2011, J GASTROEN HEPATOL, V26, P144, DOI 10.1111/j.1440-1746.2010.06546.x; HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384; Burian M, 2005, PHARMACOL THERAPEUT, V107, P139, DOI 10.1016/j.pharmthera.2005.02.004; ONEILL GP, 1993, FEBS LETT, V330, P156; Chang SH, 2004, P NATL ACAD SCI USA, V101, P591, DOI 10.1073/pnas.2535911100; Riendeau D, 1997, BRIT J PHARMACOL, V121, P105, DOI 10.1038/sj.bjp.0701076; Jain S, 2006, CANCER RES, V66, P6638, DOI 10.1158/0008-5472.CAN-06-0661; Zeilhofer HU, 2007, BIOCHEM PHARMACOL, V73, P165, DOI 10.1016/j.bcp.2006.07.037; Kobayashi H, 2004, INT J CANCER, V112, P920, DOI 10.1002/ijc.20523; Radi ZA, 2006, EXP TOXICOL PATHOL, V58, P163, DOI 10.1016/j.etp.2006.06.004; KATRITZKY AR, 1985, TETRAHEDRON LETT, V26, P5935, DOI 10.1016/S0040-4039(00)98265-0; Ono K, 2002, J BONE MINER RES, V17, P774, DOI 10.1359/jbmr.2002.17.5.774; PATEL BA, 1977, J ORG CHEM, V42, P3903, DOI 10.1021/jo00444a023; Padi SSV, 2004, EUR J PHARMACOL, V491, P69, DOI 10.1016/j.ejphar.2004.03.013; Claudino RF, 2006, J PHARMACOL EXP THER, V318, P611, DOI 10.1124/jpet.106.102806; Blatteis CM, 2006, PHARMACOL THERAPEUT, V111, P194, DOI 10.1016/j.pharmthera.2005.10.013; Fritsche E, 2007, P NATL ACAD SCI USA, V104, P8851, DOI 10.1073/pnas.0701764104; Vane JR, 2003, THROMB RES, V110, P255, DOI 10.1016/S0049-3848(03)00379-7; Rimon G, 2010, P NATL ACAD SCI USA, V107, P28, DOI 10.1073/pnas.0909765106; Mougiakakos D, 2010, CANCER-AM CANCER SOC, V116, P2224, DOI 10.1002/cncr.24999; Wu KC, 2009, J GASTROEN HEPATOL, V24, P37, DOI 10.1111/j.1440-1746.2008.05753.x; Farooqui M, 2007, BRIT J CANCER, V97, P1523, DOI 10.1038/sj.bjc.6604057; Duque J, 2006, CELL SIGNAL, V18, P1262, DOI 10.1016/j.cellsig.2005.10.009; Sakai H, 2006, FEBS LETT, V580, P3368, DOI 10.1016/j.febslet.2006.05.007; Mohammed A, 2012, INT J CANCER, V131, P1951, DOI 10.1002/ijc.27456; MOYER MP, 1986, J ORG CHEM, V51, P5106, DOI 10.1021/jo00376a010; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544; Steer SA, 2003, VIRAL IMMUNOL, V16, P447, DOI 10.1089/088282403771926283; NAHM S, 1981, TETRAHEDRON LETT, V22, P3815, DOI 10.1016/S0040-4039(01)91316-4; Iwata C, 2007, CANCER RES, V67, P10181, DOI 10.1158/0008-5472.CAN-07-2366; Kelley DJ, 1997, CARCINOGENESIS, V18, P795, DOI 10.1093/carcin/18.4.795; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Gierse JK, 1996, J BIOL CHEM, V271, P15810; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Moore PF, 1996, INFLAMM RES, V45, P54, DOI 10.1007/BF02265116; Posadas I, 2004, BRIT J PHARMACOL, V142, P331, DOI 10.1038/sj.bjp.0705650; PATRIGNANI P, 1994, J PHARMACOL EXP THER, V271, P1705; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Saadi A, 2010, P NATL ACAD SCI USA, V107, P2177, DOI 10.1073/pnas.0909797107; Li GY, 2009, HEPATOLOGY, V50, P834, DOI 10.1002/hep.23052; Harrington LS, 2008, FASEB J, V22, P4005, DOI 10.1096/fj.08-107979; Mao YM, 2013, CANCER RES, V73, P3877, DOI 10.1158/0008-5472.CAN-12-4115; Tomozawa S, 1999, BRIT J CANCER, V81, P1274, DOI 10.1038/sj.bjc.6694262; Kang RY, 1996, BRIT J RHEUMATOL, V35, P711; Rozic JG, 2001, INT J CANCER, V93, P497, DOI 10.1002/ijc.1376; Sato M, 2012, RESPIROLOGY, V17, P1048, DOI 10.1111/j.1440-1843.2012.02173.x; Chenevard R, 2003, CIRCULATION, V107, P405, DOI 10.1161/01.CIR.0000051361.69808.3A; Oshima H, 2010, PATHOL INT, V60, P599, DOI 10.1111/j.1440-1827.2010.02567.x; Tsujii M, 1997, P NATL ACAD SCI USA, V94, P3336, DOI 10.1073/pnas.94.7.3336; Kim HS, 2012, BIOCHEM PHARMACOL, V83, P385, DOI 10.1016/j.bcp.2011.11.008; Limongelli V, 2010, P NATL ACAD SCI USA, V107, P5411, DOI 10.1073/pnas.0913377107; Nie DT, 2000, BIOCHEM BIOPH RES CO, V267, P245, DOI 10.1006/bbrc.1999.1840; Cline SD, 2004, P NATL ACAD SCI USA, V101, P7275, DOI 10.1073/pnas.0402252101; White WB, 2003, AM J CARDIOL, V92, P411, DOI 10.1016/S0002-9149(03)00659-3; Murono S, 2001, P NATL ACAD SCI USA, V98, P6905, DOI 10.1073/pnas.121016998; ARTIS DR, 1992, CAN J CHEM, V70, P1838, DOI 10.1139/v92-228; BACIOCCHI E, 1993, J ORG CHEM, V58, P7610, DOI 10.1021/jo00078a055; Badawi AF, 2000, BJU INT, V85, P451, DOI 10.1046/j.1464-410x.2000.00507.x; Barnes NLP, 2007, BRIT J CANCER, V96, P575, DOI 10.1038/sj.bjc.6603593; Beiche F, 1996, FEBS LETT, V390, P165, DOI 10.1016/0014-5793(96)00604-7; BELLUCCI G, 1986, J ORG CHEM, V51, P4224, DOI 10.1021/jo00372a023; Camp WL, 2011, SEMIN CUTAN MED SURG, V30, P6, DOI 10.1016/j.sder.2011.01.003; CARLING RW, 1993, J MED CHEM, V36, P3397, DOI 10.1021/jm00074a021; Chen JH, 2006, CANCER LETT, V239, P263, DOI 10.1016/j.canlet.2005.08.026; Denkert C, 2003, CANCER, V97, P2978, DOI 10.1002/cncr.11437; Fernandez-Martinez A, 2006, BIOCHEM J, V398, P371, DOI 10.1042/BJ20060780; Flockhart RJ, 2008, FASEB J, V22, P4218, DOI 10.1096/fj.08-113076; FRYE SV, 1991, J ORG CHEM, V56, P3750, DOI 10.1021/jo00011a066; FUNK CD, 1991, FASEB J, V5, P2304; LEME JG, 1973, BRIT J PHARMACOL, V48, P88; GIORDANO C, 1992, J ORG CHEM, V57, P2765, DOI 10.1021/jo00036a001; Hayashi N, 2001, HEPATOLOGY, V34, P638, DOI 10.1053/jhep.2001.28198; Hayashi S, 2011, BIOCHEM PHARMACOL, V82, P755, DOI 10.1016/j.bcp.2011.06.036; Hinz B, 2007, NAT CLIN PRACT RHEUM, V3, P552, DOI 10.1038/ncprheum0619; Hocherl K, 2002, HYPERTENSION, V40, P947, DOI 10.1161/01.HYP.0000041221.13644.B9; Hu Min, 2009, Proc Natl Acad Sci U S A, V106, P3372, DOI 10.1073/pnas.0813306106; Hussain M, 2012, PHARMACOL RES, V66, P7, DOI 10.1016/j.phrs.2012.02.003; Ivanov AI, 2002, AM J PHYSIOL-REG I, V283, pR1104, DOI 10.1152/ajpregu.00347.2002; Juttner S, 2003, CELL MICROBIOL, V5, P821, DOI 10.1046/j.1462-5822.2003.00324.x; Kim YB, 2002, CANCER, V95, P531, DOI 10.1002/cncr.10684; Kojima Fumiaki, 2006, Expert Rev Clin Immunol, V2, P277, DOI 10.1586/1744666X.2.2.277; Kokawa A, 2001, CANCER, V91, P333, DOI 10.1002/1097-0142(20010115)91:2<333::AID-CNCR1006>3.0.CO;2-N; Kowalski Marek L, 2006, Treat Respir Med, V5, P399, DOI 10.2165/00151829-200605060-00005; Krysan Kostyantyn, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P209, DOI 10.2174/187152006776930882; Laine L, 2006, J CARDIOVASC PHARM, V47, pS60, DOI 10.1097/00005344-200605001-00011; Lee S, 2010, IMMUNOLOGY, V132, P410; Liu HD, 2009, ANAT REC, V292, P1577, DOI 10.1002/ar.20940; LOMBARDINO JG, 1975, ARZNEIMITTEL-FORSCH, V25, P1629; Luong C, 1996, NAT STRUCT BIOL, V3, P927, DOI 10.1038/nsb1196-927; Mao H, 1999, P NATL ACAD SCI USA, V96, P6615, DOI 10.1073/pnas.96.12.6615; Nagatsuka I, 2002, INT J CANCER, V100, P515, DOI 10.1002/ijc.10508; Niijima M, 2002, CANCER, V94, P1565, DOI 10.1002/cncr.10358; OPAS EE, 1987, BIOCHEM PHARMACOL, V36, P547, DOI 10.1016/0006-2952(87)90365-0; Qualtrough D, 2007, INT J CANCER, V121, P734, DOI 10.1002/ijc.22755; Reddy Bandaru S., 2002, Journal of Environmental Pathology Toxicology and Oncology, V21, P155; Romanovsky AA, 2005, FRONT BIOSCI-LANDMRK, V10, P2193, DOI 10.2741/1690; Said N, 2012, LIFE SCI, V91, P522, DOI 10.1016/j.lfs.2012.03.040; Sales KJ, 2009, BBA-MOL CELL RES, V1793, P1917, DOI 10.1016/j.bbamcr.2009.09.018; Shirahama T, 2001, CANCER, V92, P188, DOI 10.1002/1097-0142(20010701)92:1<188::AID-CNCR1308>3.0.CO;2-W; Steiner AA, 2006, PLOS BIOL, V4, P1517, DOI 10.1371/journal.pbio.0040284; Sugimoto Y, 2000, PROG LIPID RES, V39, P289, DOI 10.1016/S0163-7827(00)00008-4; Tomozawa S, 2000, BRIT J CANCER, V83, P324, DOI 10.1054/bjoc.2000.1270; Uddin S, 2010, INT J CANCER, V126, P382, DOI 10.1002/ijc.24757; Urade M, 2008, JPN DENT SCI REV, V44, P57, DOI 10.1016/j.jdsr.2007.10.003; Valsecchi ME, 2009, CLIN BREAST CANCER, V9, P225, DOI 10.3816/CBC.2009.n.038; Wu KK, 2007, PROSTAG OTH LIPID M, V83, P175, DOI 10.1016/j.prostaglandins.2007.01.002; Yao M, 2004, BRIT J CANCER, V90, P712, DOI 10.1038/sj.bjc.6601489; Yuan A, 2005, INT J CANCER, V115, P545, DOI 10.1002/ijc.20898; Zhao QT, 2007, LIFE SCI, V80, P484, DOI 10.1016/j.lfs.2006.09.038	126	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1475-6366	1475-6374		J ENZYM INHIB MED CH	J. Enzym. Inhib. Med. Chem.	DEC	2014	29	6					846	867		10.3109/14756366.2013.864650		22	Biochemistry & Molecular Biology; Chemistry, Medicinal	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	AU3MR	WOS:000345518000012		
J	Ziermann, JM; Mitgutsch, C; Olsson, L				Ziermann, Janine M.; Mitgutsch, Christian; Olsson, Lennart			Analyzing Developmental Sequences With Parsimov-A Case Study of Cranial Muscle Development in Anuran Larvae	JOURNAL OF EXPERIMENTAL ZOOLOGY PART B-MOLECULAR AND DEVELOPMENTAL EVOLUTION			English	Article							FROG ELEUTHERODACTYLUS-COQUI; XENOPUS-LAEVIS ANURA; SKELETAL DEVELOPMENT; INTRASPECIFIC VARIATION; CRANIOFACIAL DEVELOPMENT; OSSIFICATION PATTERNS; AMBYSTOMA-MEXICANUM; NEURAL DEVELOPMENT; SUTURE CLOSURE; HETEROCHRONY	Parsimov is a parsimony-based method for identifying the minimum number of heterochronic event-shifts on all branches of a given phylogenetic framework to explain the developmental sequences seen in the species investigated, and has been used to investigate the evolution of developmental sequences in various animal groups. However, the biological interpretation of the results is difficult not least because Parsimov uses non-independent data resulting from event-pairing as the basis for its analyses. To test the applicability of Parsimov to a large data set, larval cranial muscle development was studied in 15 anurans, three caudates and the Australian lungfish. We analyzed the developmental sequences with Parsimov to investigate: if there are (1) heterochronies on deep branches of a cladogram indicating changes in the ancestral sequences, (2) heterochronies that can be related to larval life-history, and (3) the sensitivity of the analysis to different underlying cladograms. We discovered general patterns of cranial muscle development, such as an anterior-to-posterior gradient, an outside-in pattern and a tendency for cranial muscles to develop from their region of origin toward their insertion. We found most heterochronies on terminal branches and only a few shifts on deep branches in the cladograms indicating changes in the ancestral sequences. No changes could be related to larval life-history. The underlying cladogram clearly influenced the outcome of the analysis. We propose that Parsimov has the potential, combined with other methods, to find evolutionary important changes and to aid the biological interpretation of these changes. J. Exp. J. Exp. Zool. (Mol. Dev. Evol.) 322B: 586-606, 2014. (c) 2014 Wiley Periodicals, Inc.	[Ziermann, Janine M.] Howard Univ, Coll Med, Dept Anat, Washington, DC 20059 USA; [Mitgutsch, Christian] RIKEN Ctr Dev Biol, Lab Evolutionary Morphol, Kobe, Hyogo, Japan; [Olsson, Lennart] Univ Jena, Inst Spezielle Zool & Evolut Biol, Phylet Museum, Jena, Germany	Ziermann, JM (reprint author), Howard Univ, Coll Med, Dept Anat, 520 W St NW, Washington, DC 20059 USA.	jziermann@yahoo.de	Wilkinson, Angus/C-3408-2008	Wilkinson, Angus/0000-0003-2904-400X	Deutsche Forschungsgemeinschaft [OL 134/2-4]	Grant sponsor: Deutsche Forschungsgemeinschaft; grant number: OL 134/2-4.	Mitgutsch C, 2003, THEOR BIOSCI, V122, P204, DOI 10.1007/s12064-003-0054-7; Weisbecker V, 2010, J ZOOL SYST EVOL RES, V48, P332, DOI 10.1111/j.1439-0469.2010.00570.x; Mitgutsch C, 2011, ZOOL SCI, V28, P491, DOI 10.2108/zsj.28.491; Assis LCS, 2011, CLADISTICS, V27, P94, DOI 10.1111/j.1096-0031.2010.00317.x; Ziermann JM, 2014, J MORPHOL, V275, P398, DOI 10.1002/jmor.20223; Werneburg I, 2011, ACTA ZOOL-STOCKHOLM, V92, P75, DOI 10.1111/j.1463-6395.2009.00447.x; Harrison LB, 2008, SYST BIOL, V57, P378, DOI 10.1080/10635150802164421; Germain D, 2009, EVOL DEV, V11, P170, DOI 10.1111/j.1525-142X.2009.00318.x; Velhagen WA, 1997, SYST BIOL, V46, P204, DOI 10.2307/2413644; Chipman AD, 2000, J EXP ZOOL, V288, P352, DOI 10.1002/1097-010X(20001215)288:4<352::AID-JEZ8>3.0.CO;2-2; KLYMKOWSKY MW, 1991, METHOD CELL BIOL, V36, P419; Ziermann JM, 2013, ANAT REC, V296, P1031, DOI 10.1002/ar.22713; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Maxwell EE, 2009, EVOL DEV, V11, P109, DOI 10.1111/j.1525-142X.2008.00307.x; Wilson LAB, 2009, J ANAT, V214, P339, DOI 10.1111/j.1469-7580.2008.01031.x; Werneburg I, 2013, J ANAT, V222, P2, DOI 10.1111/j.1469-7580.2012.01509.x; Jeffery JE, 2005, SYST BIOL, V54, P230, DOI 10.1080/10635150590923227; Ericsson R, 2004, J MORPHOL, V261, P131, DOI 10.1002/jmor.10151; Ziermann JM, 2007, J MORPHOL, V268, P791, DOI 10.1002/jmor.10552; ALBERCH P, 1979, PALEOBIOLOGY, V5, P296; Smith KK, 2001, BIOL J LINN SOC, V73, P169, DOI 10.1006/bijl.2001.0535; Rager L, 2014, J MORPHOL, V275, P125, DOI 10.1002/jmor.20203; Jeffery JE, 2002, EVOL DEV, V4, P292, DOI 10.1046/j.1525-142X.2002.02018.x; Mitgutsch C, 2009, J ZOOL SYST EVOL RES, V47, P248, DOI 10.1111/j.1439-0469.2008.00502.x; TRUEB L, 1992, J MORPHOL, V214, P1, DOI 10.1002/jmor.1052140102; Sanchez-Villagra MR, 2008, EVOL DEV, V10, P519, DOI 10.1111/j.1525-142X.2008.00267.x; Poe S, 2004, EVOLUTION, V58, P1852; Jeffery JE, 2002, SYST BIOL, V51, P478, DOI 10.1080/10635150290069904; Werneburg I, 2013, ORG DIVERS EVOL, V13, P225, DOI 10.1007/s13127-012-0103-5; Klingenberg CP, 1998, BIOL REV, V73, P79, DOI 10.1017/S000632319800512X; Bininda-Emonds ORP, 2002, THEOR BIOSCI, V121, P297, DOI 10.1007/s12064-002-0016-5; Haas A, 2003, CLADISTICS, V19, P23, DOI 10.1016/S0748-3007(03)00006-9; Smith KK, 1997, EVOLUTION, V51, P1663, DOI 10.2307/2411218; Barmann EV, 2012, J MAMM EVOL, V19, P43, DOI 10.1007/s10914-011-9176-8; Bordzilovskaya N.P., 1989, DEV BIOL AXOLOTL, P201; de Beer G. R., 1940, EMBRYOS ANCESTORS; de Beer G.R., 1930, EMBRYOLOGY EVOLUTION; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Deban SM, 2002, NATURE, V420, P41, DOI 10.1038/420041a; Duellman W. E., 1994, BIOL AMPHIBIANS; Edgeworth F. H., 1935, CRANIAL MUSCLES VERT; Fritsch M, 2013, FRONTIERS IN ZOOLOGY, V10, P1; Glaesner L, 1925, NORMENTAFEL ENTWICKL; Gosner K. L., 1960, Herpetologica, V16, P183; Gould SJ, 1977, ONTOGENY PHYLOGENY; Haas A, 1999, ZOOMORPHOLOGY, V119, P23, DOI 10.1007/s004350050078; Haeckel E., 1874, Q J MICROSC SCI, V2, P142; Hall JA, 1998, J MORPHOL, V238, P179; HANKEN J, 1984, J MORPHOL, V182, P245, DOI 10.1002/jmor.1051820302; Harrington SM, 2013, EVOL DEV, V15, P344, DOI 10.1111/ede.12043; Hautier L, 2011, EVOL DEV, V13, P460, DOI 10.1111/j.1525-142X.2011.00503.x; Hoyos JM, 2012, ACTA HERPETOL, V7, P119; Koenemann S, 2002, CONTRIB ZOOL, V71, P1; Koyabu D, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-21; Kuratani S, 2005, ZOOL SCI, V22, P1, DOI 10.2108/zsj.22.1; Laurin M, 2011, SYST BIOL, V60, P630, DOI 10.1093/sysbio/syr024; Mabee PM, 1996, J MORPHOL, V227, P249, DOI 10.1002/(SICI)1097-4687(199603)227:3<249::AID-JMOR1>3.0.CO;2-1; Maglia AM, 2001, AM ZOOL, V41, P538, DOI 10.1668/0003-1569(2001)041[0538:CDOAUP]2.0.CO;2; Maxell EE, 2008, J MORPHOL, V269, P1095; Maxwell EE, 2010, ZOOLOGY, V113, P51; Mitgutsch C, 2008, ACTA ZOOL-STOCKHOLM, V89, P69, DOI 10.1111/j.1463-6395.2007.00295.x; NODEN DM, 1991, BRAIN BEHAV EVOLUT, V38, P190, DOI 10.1159/000114388; Nye HLD, 2003, DEV DYNAM, V226, P555, DOI 10.1002/dvdy.10237; Olson WM, 1998, THESIS U CALIFORNIA; RUIBAL R, 1988, COPEIA, P591; Saenz-Ponce N, 2012, P NATL ACAD SCI USA, V109, P20503, DOI 10.1073/pnas.1219307110; Salica MJ, 2011, SALAMANDRA, V47, P144; Sanchez-Villagra MR, 2009, J MORPHOL, V270, P1381, DOI 10.1002/jmor.10766; Schlosser G, 1997, BRAIN BEHAV EVOLUT, V50, P62; Schlosser G, 2001, J EXP ZOOL, V291, P282, DOI 10.1002/jez.1104; Schlosser G, 2003, ANAT EMBRYOL, V206, P215, DOI 10.1007/s00429-002-0291-4; Schlosser G, 1997, BRAIN BEHAV EVOLUT, V50, P94, DOI 10.1159/000113325; Schubert G, 2004, MORPHOLOGIE ENTWICKL, P1; Schulmeister S, 2004, EVOL DEV, V6, P50, DOI 10.1111/j.1525-142X.2004.04005.x; Sheil CA, 2005, J ZOOL, V265, P235, DOI 10.1017/S0952836904006296; Smirthwaite JJ, 2007, EVOL DEV, V9, P122; Smith KK, 1996, AM ZOOL, V36, P70; Swofford DL, 2002, PAUP PLYLOGENETIC AN; TRUEB L, 1985, S AFR J SCI, V81, P181; von Baer CE, 1828, ENTWICKLUNGSGESCHICH, V1; Werneburg I, 2009, BMC EVOL BIOL, V9, P1; Wilson LAB, 2010, ORG DIVERS EVOL, V10, P243, DOI 10.1007/s13127-010-0020-4; Ziermann JM, 2013, ACTA ZOOL-STOCKHOLM, V94, P101, DOI 10.1111/j.1463-6395.2011.00525.x; Ziermann JM, 2008, THESIS F SCHILLER U	84	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-5007	1552-5015		J EXP ZOOL PART B	J. Exp. Zool. Part B	DEC	2014	322	8					586	606		10.1002/jez.b.22566		21	Evolutionary Biology; Developmental Biology; Zoology	Evolutionary Biology; Developmental Biology; Zoology	AU2KJ	WOS:000345446800004		
J	Koyabu, D; Son, NT				Koyabu, Daisuke; Nguyen Truong Son			Patterns of Postcranial Ossification and Sequence Heterochrony in Bats: Life Histories and Developmental Trade-Offs	JOURNAL OF EXPERIMENTAL ZOOLOGY PART B-MOLECULAR AND DEVELOPMENTAL EVOLUTION			English	Article							MARSUPIAL-PLACENTAL DICHOTOMY; CRANIAL SUTURE CLOSURE; SKELETAL DEVELOPMENT; CRANIOFACIAL DEVELOPMENT; EVOLUTIONARY PATTERNS; MAMMAL PHYLOGENY; THERIAN MAMMALS; BOVINE SKELETON; LIMB; GROWTH	The recently increased interest in studies on sequence heterochrony has uncovered developmental variation between species. However, how changes in developmental program are related to shifts in life-history parameters remains largely unsolved. Here we provide the most comprehensive data to date on postcranial ossification sequence of bats and compare them to various boreoeutherian mammals with different locomotive modes. Given that bats are equipped with an elongated manus, we expected to detect characteristic heterochronies particularly related to wing development. Although heterochronies related to wing development were confirmed as predicted, unexpected heterochronies regarding the pedal digits were also found. The timing of ossification onset of pedal phalanges is earlier than other mammals. Particularly, bats deviate from others in that pedal phalanges initiate ossification earlier than manual phalanges. It is known that the foot size of new born bats is close to that of adults, and that it takes several weeks to month until the wing is developed for flight. Given that the foot is required to be firm and stable enough at the time of birth to allow continued attachment to the mother and/or cave walls, we suggest that the accelerated development of the hind foot is linked to their unique life history. Since the forelimb is not mature enough for flight at birth and requires extended postnatal time to be large enough to be fully functional, we postulate that bats invest in earlier development of the hindlimb. We conclud that energy allocation trade-offs can play a significant role in shaping the evolution of development. J. Exp. Zool. (Mol. Dev. Evol.) 322B: 607-618, 2014. (c) 2014 Wiley Periodicals, Inc.	[Koyabu, Daisuke] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan; [Nguyen Truong Son] Vietnam Acad Sci & Technol, Inst Ecol & Biol Resources, Hanoi, Vietnam	Koyabu, D (reprint author), Univ Tokyo, Univ Museum, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	koyabu@um.u-tokyo.ac.jp			Japan Society for Promotion of Science [23-4832, 25891010, 24000015]; Sasakawa Scientific Research [25-501]	Grant sponsor: Japan Society for Promotion of Science; grant numbers: 23-4832, 25891010, 24000015; grant sponsor: Sasakawa Scientific Research; grant number: 25-501.	ADAMS RA, 1992, J MAMMAL, V73, P160, DOI 10.2307/1381878; Adams RA, 2007, CELLS TISSUES ORGANS, V187, P13; Adams Rick A., 2013, P21; Agnarsson I., 2011, PLOS CURRENTS TREE L, V3, P1, DOI [10.1371/currents.RRN1212, DOI 10.1371/CURRENTS.RRN1212]; ALBERCH P, 1981, J MORPHOL, V167, P249, DOI 10.1002/jmor.1051670208; Maxwell EE, 2009, ZOOL J LINN SOC-LOND, V157, P169, DOI 10.1111/j.1096-3642.2009.00533.x; Hockman D, 2008, P NATL ACAD SCI USA, V105, P16982, DOI 10.1073/pnas.0805308105; Harrison LB, 2008, SYST BIOL, V57, P378, DOI 10.1080/10635150802164421; Sanchez-Villagra MR, 2002, J EXP ZOOL, V294, P264, DOI 10.1002/jez.10147; Hockman D, 2009, DEV DYNAM, V238, P965, DOI 10.1002/dvdy.21896; Wilson LAB, 2009, J ANAT, V214, P339, DOI 10.1111/j.1469-7580.2008.01031.x; Cretekos CJ, 2007, INT J DEV BIOL, V51, P333, DOI 10.1387/ijdb.062257cc; Hugi J, 2012, ZOOLOGY, V115, P188, DOI 10.1016/j.zool.2011.10.003; SHUBIN NH, 1986, EVOL BIOL, V20, P319; MACPHEE RDE, 1994, B AM MUS NAT HIST, P1; Smith KK, 2001, BIOL J LINN SOC, V73, P169, DOI 10.1006/bijl.2001.0535; Jeffery JE, 2002, EVOL DEV, V4, P292, DOI 10.1046/j.1525-142X.2002.02018.x; Sanchez-Villagra MR, 2008, EVOL DEV, V10, P519, DOI 10.1111/j.1525-142X.2008.00267.x; Maxwell EE, 2010, ZOOLOGY, V113, P57, DOI 10.1016/j.zool.2009.06.002; Jeffery JE, 2002, SYST BIOL, V51, P478, DOI 10.1080/10635150290069904; Goswami A, 2009, J EXP ZOOL PART B, V312B, P186, DOI 10.1002/jez.b.21283; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; Swartz SM, 1997, J MORPHOL, V234, P277, DOI 10.1002/(SICI)1097-4687(199712)234:3<277::AID-JMOR6>3.0.CO;2-6; Sears KE, 2006, P NATL ACAD SCI USA, V103, P6581, DOI 10.1073/pnas.0509716103; Hautier L, 2010, P NATL ACAD SCI USA, V107, P18903, DOI 10.1073/pnas.1010335107; LEE PC, 1986, BEHAV ECOL SOCIOBIOL, V18, P353, DOI 10.1007/BF00299666; Weisbecker V, 2008, EVOLUTION, V62, P2027, DOI 10.1111/j.1558-5646.2008.00424.x; Smith KK, 2006, DEV DYNAM, V235, P1181, DOI 10.1002/dvdy.20676; Schultz AH, 1926, Q REV BIOL, V1, P465, DOI 10.1086/394257; Alberch P, 1996, INT J DEV BIOL, V40, P845; Cretekos CJ, 2008, GENE DEV, V22, P141, DOI 10.1101/gad.1620408; Smith KK, 1997, EVOLUTION, V51, P1663, DOI 10.2307/2411218; Asher RJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-102; BEYERLEIN L, 1951, ANAT REC, V111, P49, DOI 10.1002/ar.1091110104; Catania KC, 2000, BRAIN BEHAV EVOLUT, V56, P146, DOI 10.1159/000047201; Green CV, 1933, J EXP ZOOL, V66, P351, DOI 10.1002/jez.1400660303; Hautier L, 2011, EVOL DEV, V13, P460, DOI 10.1111/j.1525-142X.2011.00503.x; Hautier L, 2013, EVOLUTION, V67, P1994, DOI 10.1111/evo.12071; JONES C, 1967, J MAMMAL, V48, P1, DOI 10.2307/1378165; Kaufman MH, 2008, ATLAS MOUSE DEV; Koyabu D, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-21; Koyabu D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4625; Kunz T. H., 1987, S ZOOL SOC LOND, V57, P79; LINDSAY FEF, 1969, BRIT VET J, V125, P422; LINDSAY FEF, 1969, BRIT VET J, V125, P101; MULLER F, 1967, Revue Suisse de Zoologie, V74, P607; Neuweiler G., 2000, BIOL BATS; Nolte MJ, 2009, ANAT REC, V292, P155, DOI 10.1002/ar.20835; Nowak R. M., 1999, WALKERS MAMMALS WORL; Nunn CL, 1998, AM NAT, V152, P82, DOI 10.1086/286151; Orr RT, 1970, BIOL BATS, P217; PATTON JT, 1995, J ANAT, V186, P175; Prochel J, 2004, J ANAT, V205, P99, DOI 10.1111/j.0021-8782.2004.00321.x; Prochel J, 2006, ZOOL SCI, V23, P427, DOI 10.2108/zsj.23.427; R Development Core Team, 2008, R LANG ENV STAT COMP; Smirthwaite JJ, 2007, EVOL DEV, V9, P122; Stockli A, 1922, THESIS U ZURICH; Strong RM, 1925, AM J ANAT, V36, P313, DOI 10.1002/aja.1000360206; Theiler K, 1972, HOUSE MOUSE; Tokita M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2298; Vaughan T. A., 1970, BIOL BATS, P98; Wang Z, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-619; Weisbecker V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-160; Weisbecker V, 2011, EVOLUTION, V65, P1323, DOI 10.1111/j.1558-5646.2011.01234.x; Wilson LAB, 2010, ORG DIVERS EVOL, V10, P243, DOI 10.1007/s13127-010-0020-4; Wilson LAB, 2014, J MAMM EVOL, V21, P257, DOI 10.1007/s10914-013-9242-5; Yoshikawa T, 1989, KAGAWA SEIBUTSU, V15, P129; Yukawa M, 1999, ANAT HISTOL EMBRYOL, V28, P319, DOI 10.1046/j.1439-0264.1999.00213.x	68	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-5007	1552-5015		J EXP ZOOL PART B	J. Exp. Zool. Part B	DEC	2014	322	8					607	618		10.1002/jez.b.22581		12	Evolutionary Biology; Developmental Biology; Zoology	Evolutionary Biology; Developmental Biology; Zoology	AU2KJ	WOS:000345446800005		
J	Yoshida, A; Ito, K; Amano, Y				Yoshida, Akira; Ito, Koichi; Amano, Yoshiharu			Energy-Saving Evaluation of SOFC Cogeneration Systems With Solar Cell and Battery	JOURNAL OF FUEL CELL SCIENCE AND TECHNOLOGY			English	Article						solid oxide fuel cell; solar energy; battery; energy saving; operational planning; optimization		The purpose of this study is to evaluate the maximum energy-saving potential of residential energy supply systems consisting of a solid oxide fuel cell (SOFC) cogeneration system (CGS) combined with a solar cell (SC) and a battery (BT), compared with a reference system (RS). This study applies an optimization theory into an operational planning problem to measure actual energy demands over the course of 1 year. Eight different types of energy supply system were compared with each other by changing the components of the SOFC-CGS, SC, BT, and RS. Meaningful numerical results are obtained, indicating the maximum potential energy savings.	[Yoshida, Akira] Waseda Univ, Grad Sch Fundamental Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Ito, Koichi] Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Amano, Yoshiharu] Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1620044, Japan	Yoshida, A (reprint author), Waseda Univ, Grad Sch Fundamental Sci & Engn, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.	yoshida@power.mech.waseda.ac.jp; k.ito8@kurenai.waseda.jp; yoshiha@waseda.jp			JSPS [24561062]	The authors would like to express their thanks to all members of Project-W, who supported this research. The authors would also like to thank the IBM academic initiative for the use of the IBM ILOG CPLEX optimizer. This work was partly supported by JSPS Grant-in-Aid for Scientific Research Grant No. 24561062.	Wakui T, 2010, ENERGY, V35, P740, DOI 10.1016/j.energy.2009.09.029; Building Research Institute, 2013, DESCR METH CALC JUDG; Fourer R., 2003, AMPL MODELING LANGUA; IBM, 2014, IBM ILOG CPLEX OPT; Shio M., 2012, J JPN SOC ENERGY RES, V34, P209; Steiglitz K., 1998, COMBINATORIAL OPTIMI; Yokoyama R., 1995, ASME, V117, P337; Yoshida A, 2013, ENERGIES, V6, P374, DOI 10.3390/en6010374	8	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	1550-624X	1551-6989		J FUEL CELL SCI TECH	J. Fuel Cell Sci. Technol.	DEC	2014	11	6							061006	10.1115/1.4028948		7	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	AU2QL	WOS:000345462800006		
J	Itoyama, R; Hashimoto, D; Chikamoto, A; Hayashi, H; Beppu, T; Baba, H				Itoyama, R.; Hashimoto, D.; Chikamoto, A.; Hayashi, H.; Beppu, T.; Baba, H.			Hepatobiliary and Pancreatic: Sigmoidal mesenterial lymph node metastasis from pancreatic cancer	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Editorial Material									[Itoyama, R.; Hashimoto, D.; Chikamoto, A.; Hayashi, H.; Beppu, T.; Baba, H.] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan	Itoyama, R (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan.							0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	DEC	2014	29	12					1953	1953		10.1111/jgh.12807		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AU0OM	WOS:000345322800005		
J	Masaki, N; Sugiyama, M; Shimada, N; Tanaka, Y; Nakamuta, M; Izumi, N; Watanabe, S; Tsubota, A; Komatsu, M; Masaki, T; Enomoto, N; Yoneda, M; Murata, K; Ito, K; Koike, K; Mizokami, M				Masaki, Naohiko; Sugiyama, Masaya; Shimada, Noritomo; Tanaka, Yasuhito; Nakamuta, Makoto; Izumi, Namiki; Watanabe, Sumio; Tsubota, Akihito; Komatsu, Masafumi; Masaki, Tsutomu; Enomoto, Nobuyuki; Yoneda, Masashi; Murata, Kazumoto; Ito, Kiyoaki; Koike, Kazuhiko; Mizokami, Masashi			Pretreatment prediction of the outcome of response-guided peginterferon-alpha and ribavirin therapy for chronic hepatitis C	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						(TA) dinucleotide repeat; chronic hepatitis C; IL28B; response-guided therapy	SIGNAL AMPLIFICATION REACTION; GENOME-WIDE ASSOCIATION; AMINO-ACID SUBSTITUTION; GENOTYPE 1 INFECTION; GENETIC-VARIATION; PLUS RIBAVIRIN; VIRUS-INFECTION; VIRAL RESPONSE; IL28B; HCV	Background and Aim: The accuracy for predicting virological outcomes of peginterferon-alpha and ribavirin therapy in patients with chronic hepatitis C is limited to approximately 80%, even with IL28B genotyping. Our in vitro study revealed that the numbers of (TA) dinucleotide repeats [(TA)n] of rs72258881, which is located in the promoter region of IL28B gene, might regulate IL28B transcription. We aimed to evaluate the usefulness of these host factors for predicting virological outcomes of this therapy in response-guided clinical settings. Methods: A nationwide, multi-center prospective study in Japan determined IL28B (rs8099917) genotype, (TA) n of rs72258881, and amino acid substitutions of hepatitis C virus and used these for multivariate analysis together with other parameters at pretreatment. Results: After enrolling 215 patients with genotype 1 and high viral load from 23 hospitals between October 2009 and February 2011, intent-to-treat analysis identified 202 patients in whom the final virological outcomes could be determined. Non-virological response by non-TT genotype was predicted with 79.7% accuracy. When combined with the (TA) n, the incidences of virological response tended to be higher in the longer (TA) n group, regardless of rs8099917 genotype. Multivariate logistic regression analysis revealed that rs8099917 non-TT genotype (P < 0.001), shorter (TA) n (P = 0.011), mutation of amino acid 70 in the virus core region (P = 0.029), and lower levels of serum albumin (P = 0.036) were independently associated with non-virological response. Conclusions: IL28B genotype and (TA) n of rs72258881 may independently affect virological outcomes of peginterferon-alpha and ribavirin as host factors, even in response-guided therapy.	[Masaki, Naohiko; Sugiyama, Masaya; Murata, Kazumoto; Ito, Kiyoaki; Mizokami, Masashi] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Chiba 2728516, Japan; [Shimada, Noritomo] Shinmatsudo Cent Gen Hosp, Div Gastroenterol & Hepatol, Chiba, Japan; [Tsubota, Akihito] Jikei Univ, Sch Med, Inst Clin Med & Res, Chiba, Japan; [Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan; [Nakamuta, Makoto] NHO Kyushu Med Ctr, Dept Gastroenterol, Fukuoka, Japan; [Izumi, Namiki] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Watanabe, Sumio] Juntendo Univ, Dept Gastroenterol, Tokyo, Japan; [Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Komatsu, Masafumi] Akita City Hosp, Dept Gastroenterol, Akita, Japan; [Masaki, Tsutomu] Kagawa Med Univ, Sch Med, Dept Gastroenterol, Kagawa, Japan; [Watanabe, Sumio] Aichi Med Univ, Div Gastroenterol, Dept Internal Med, Nagakute, Aichi, Japan	Masaki, N (reprint author), Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, 1-7-1 Kohnodai, Chiba 2728516, Japan.	nmasaki@hospk.ncgm.go.jp			National Center for Global Health and Medicine [21A113]	This study was supported by the Grant-in-Aid from the National Center for Global Health and Medicine (21A113) (N.M.). The funding source had no involvement, such as the roles of the study design, the collection, analysis, interpretation of the data, the writing of this manuscript or the decision to submit this manuscript for publication.	Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Akuta N, 2005, INTERVIROLOGY, V48, P372, DOI 10.1159/000086064; Harrison SA, 2012, HEPATOLOGY, V56, P464, DOI 10.1002/hep.25661; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Hall JG, 2000, P NATL ACAD SCI USA, V97, P8272, DOI 10.1073/pnas.140225597; Chayama K, 2012, HEPATOLOGY, V55, P742, DOI 10.1002/hep.24724; Lyamichev VI, 2000, BIOCHEMISTRY-US, V39, P9523, DOI 10.1021/bi0007829; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; Ito K, 2011, J CLIN MICROBIOL, V49, P1853, DOI 10.1128/JCM.02139-10; Akuta N, 2010, HEPATOLOGY, V52, P421, DOI 10.1002/hep.23690; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Everhart JE, 2013, HEPATOLOGY, V57, P1725, DOI 10.1002/hep.26203; European Assoc Study L, 2011, J HEPATOL, V55, P245, DOI DOI 10.1016/J.JHEP.2011.02.023]; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Guedj H, 2012, J VIRAL HEPATITIS, V19, P488, DOI 10.1111/j.1365-2893.2011.01569.x; Izumi N, 2010, HEPATOL RES, V40, P347; Manns MP., 2004, GASTROENTEROL CLIN N, V33, P11, DOI DOI 10.1016/J.GTC.2003.12.003; Ohno T, 1997, J CLIN MICROBIOL, V35, P201; Saito H, 2012, HEPATOL RES, V42, P958, DOI 10.1111/j.1872-034X.2012.01013.x; Sugiyama M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026620; TSUKIYAMAKOHARA K, 1993, VIROLOGY, V192, P430, DOI 10.1006/viro.1993.1058; World Health Organization, HEPATITIS C	33	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	DEC	2014	29	12					1996	2005		10.1111/jgh.12646		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AU0OM	WOS:000345322800012		
J	Ishikawa, D; Shimada, M; Utsunomiya, T; Morine, Y; Imura, S; Ikemoto, T; Arakawa, Y; Kanamoto, M; Iwahashi, S; Saito, Y; Yamada, S; Miyake, H				Ishikawa, Daichi; Shimada, Mitsuo; Utsunomiya, Tohru; Morine, Yuji; Imura, Satoru; Ikemoto, Tetsuya; Arakawa, Yusuke; Kanamoto, Mami; Iwahashi, Shuichi; Saito, Yu; Yamada, Shinichiro; Miyake, Hidenori			Effect of Twist and Bmi1 on intraductal papillary mucinous neoplasm of the pancreas	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						Bmi1; cancers: biology; diagnosis and therapy; epithelial-mesenchymal transition; pancreatic neoplasms: biology and therapy; Twist	EPITHELIAL-MESENCHYMAL TRANSITION; DUCTAL ADENOCARCINOMA; CANCER PROGRESSION; COLORECTAL-CANCER; STEM-CELLS; EXPRESSION; PROTEINS; OVEREXPRESSION; ONCOPROTEIN; TUMORS	Background: Intraductal papillary mucinous neoplasm (IPMN) is a well-established entity among pancreatic neoplasms that ranges from low-grade dysplasia to invasive carcinoma. Epithelial-mesenchymal transition (EMT) contributes to tumor progression in various cancers. Moreover, Notch signaling is one of the important upstream effectors of EMT promotion. Currently, it is unclear whether EMT causes pathological progression of IPMN. Aim: We evaluated the expression of EMT-promoting transcription factors Twist and B cell-specific Moloney murine leukemia virus insertion site 1 (Bmi1) in IPMN. Methods: Patients who underwent resections at our institute and its affiliated hospital were enrolled in this study (n = 35). Protein expression of EMT markers Twist, Bmi1, Jagged1, and E-cadherin in resected specimens was investigated by immunohistochemistry. Expression of these proteins was compared with the clinicopathological factors and patient survival. Results: Positive expression of Twist and Bmi1 was observed in 40.0% and 42.9% of IPMNs, respectively. Twist and Bmi1 expression was significantly higher in IPMNs with high-grade dysplasia (P < 0.05) and invasive carcinoma (P < 0.05) than that in IPMNs with low-grade dysplasia. High expression of Twist was correlated with Jagged1 expression and inversely correlated with expression of E-cadherin (P = 0.06 and P < 0.05, respectively). In survival analyses, the recurrence rate was significantly higher in the group that showed simultaneous high expression of Twist and Bmi1 (P < 0.05). Conclusions: Expression of Twist and Bmi1 is associated with aggressiveness and poor prognoses of IPMN through EMT promotion that might be induced by Notch signaling.	[Ishikawa, Daichi; Shimada, Mitsuo; Utsunomiya, Tohru; Morine, Yuji; Imura, Satoru; Ikemoto, Tetsuya; Arakawa, Yusuke; Kanamoto, Mami; Iwahashi, Shuichi; Saito, Yu; Yamada, Shinichiro; Miyake, Hidenori] Univ Tokushima, Dept Surg, Tokushima 7708503, Japan	Shimada, M (reprint author), Univ Tokushima, Dept Surg, 3-18-15 Kuramoto, Tokushima 7708503, Japan.	mitsuo.shimada@tokushima-u.ac.jp					Adsay NV, 2000, SEMIN DIAGN PATHOL, V17, P16; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Bates RC, 2005, CANCER BIOL THER, V4, P365; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Yao X, 2012, ONCOTARGETS THER, V5, P255, DOI 10.2147/OTT.S36213; Hsu KW, 2012, CARCINOGENESIS, V33, P1459, DOI 10.1093/carcin/bgs165; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Kim JH, 2004, CANCER LETT, V203, P217, DOI 10.1016/j.canlet.2003.07.009; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Bea S, 2001, CANCER RES, V61, P2409; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Silva J, 2006, CLIN CANCER RES, V12, P6929, DOI 10.1158/1078-0432.CCR-06-0788; Furukawa T, 2005, MODERN PATHOL, V18, P1034, DOI 10.1038/modpathol.3800383; Yang Z, 2007, BIOCHEM BIOPH RES CO, V358, P925, DOI 10.1016/j.bbrc.2007.05.023; Tanaka M, 2005, J GASTROENTEROL, V40, P669, DOI 10.1007/s00535-005-1646-4; Lee TK, 2006, CLIN CANCER RES, V12, P5369, DOI 10.1158/1078-0432.CCR-05-2722; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Chetty R, 2006, HUM PATHOL, V37, P212, DOI 10.1016/j.humpath.2005.11.002; Yuen HF, 2007, HISTOPATHOLOGY, V50, P648, DOI 10.1111/j.1365-2559.2007.02665.x; Tanaka M, 2004, PANCREAS, V28, P282, DOI 10.1097/00006676-200404000-00013; Semba S, 2003, PANCREAS, V26, P250, DOI 10.1097/00006676-200304000-00008; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; Hayry V, 2010, BRIT J CANCER, V102, P892, DOI 10.1038/sj.bjc.6605544; ITAI Y, 1986, RADIOLOGY, V161, P697; Jury RP, 2012, PANCREAS, V41, P611, DOI 10.1097/MPA.0b013e31823d7b36; Kim JH, 2004, BREAST, V13, P383, DOI 10.1016/j.breast.2004.02.010; Kitago M, 2004, INT J CANCER, V110, P177, DOI 10.1002/ijc.20084; Kloppel G, 1996, WHO INT HISTOLOGICAL, P1; Loftus EV, 1996, GASTROENTEROLOGY, V110, P1909, DOI 10.1053/gast.1996.v110.pm8964418; Ohhashi K, 1982, PROG DIG ENDOSC, V20, P348; Satoh K, 1996, PANCREAS, V12, P362, DOI 10.1097/00006676-199605000-00007; van Kemenade FJ, 2001, BLOOD, V97, P3896, DOI 10.1182/blood.V97.12.3896; Yan J, 2004, CELL, V117, P927	42	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	DEC	2014	29	12					2032	2037		10.1111/jgh.12652		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AU0OM	WOS:000345322800016		
J	Yoshida, Y; Ajiki, T; Ueno, K; Shinozaki, K; Murakami, S; Okazaki, T; Matsumoto, T; Matsumoto, I; Fukumoto, T; Usami, M; Ku, Y				Yoshida, Yuko; Ajiki, Tetsuo; Ueno, Kimihiko; Shinozaki, Kenta; Murakami, Sae; Okazaki, Taro; Matsumoto, Taku; Matsumoto, Ippei; Fukumoto, Takumi; Usami, Makoto; Ku, Yonson			Preoperative Bile Replacement Improves Immune Function for Jaundiced Patients Treated with External Biliary Drainage	JOURNAL OF GASTROINTESTINAL SURGERY			English	Article						Bile replacement; Obstructive jaundice; Immune function	EXPERIMENTAL OBSTRUCTIVE-JAUNDICE; MUCOSAL T-LYMPHOCYTES; SERUM DIAMINE OXIDASE; PANCREATICODUODENECTOMY; EXPRESSION; CANCER; LIVER; RISK; RATS; CHOLANGIOCARCINOMA	Although preoperative biliary drainage in jaundiced patients is controversial, external biliary drainage (EBD) is beneficial for infection control in patients with biliary cancers. When EBD is performed, additional bile replacement (BR) has the benefit of improving impaired intestinal barrier function, but the detailed mechanism remains unknown. We examined the effect of bile replacement on immune functions over the duration of BR in jaundiced patients. Fifteen patients were enrolled into this prospective study. BR was started soon after the total serum bilirubin concentration reached 5.0 mg/dl and was continued for 14 days. Drained bile was given two times orally (2 x 100 ml/day). Concanavalin A (Con A)- and phytohemagglutinin (PHA)-stimulated lymphocyte proliferation and serum diamine oxidase (DAO) activity were measured before starting and during BR. Twenty patients with EBD and no BR were analyzed as a control group. Serum liver enzymes, prothrombin time-international normalized ratio (PT-INR), and responses to Con A and PHA gradually improved over the 14 days of BR, but percentages of lymphocytes and DAO levels did not. PT-INR, and Con A and PHA responses did not improve during EBD in the control group. PT-INR significantly decreased in patients with a greater fraction of their drained bile replaced. Our results indicate that preoperative BR using as large a quantity of bile as possible is useful for improving blood coagulability and cellular immunity in patients with EBD.	[Yoshida, Yuko; Ajiki, Tetsuo; Ueno, Kimihiko; Shinozaki, Kenta; Murakami, Sae; Okazaki, Taro; Matsumoto, Taku; Matsumoto, Ippei; Fukumoto, Takumi; Ku, Yonson] Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Usami, Makoto] Kobe Univ, Div Nutr & Metab, Dept Biophys, Grad Sch Hlth Sci,Suma Ku, Kobe, Hyogo 6540102, Japan	Ajiki, T (reprint author), Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	ajiki@med.kobe-u.ac.jp					Aida T, 2014, SURGERY, V155, P124, DOI 10.1016/j.surg.2013.05.040; Iacono C, 2013, ANN SURG, V257, P191, DOI 10.1097/SLA.0b013e31826f4b0e; Nagino M, 2008, J HEPATO-BILIARY-PAN, V15, P25, DOI 10.1007/s00534-007-1277-7; DWYER JM, 1981, CLIN EXP IMMUNOL, V46, P237; Kawakami H, 2011, J GASTROENTEROL, V46, P242, DOI 10.1007/s00535-010-0298-1; Parks RW, 1996, BRIT J SURG, V83, P1345, DOI 10.1002/bjs.1800831007; Sugiura T, 2012, WORLD J SURG, V36, P2888, DOI 10.1007/s00268-012-1742-6; Sewnath ME, 2002, ANN SURG, V236, P17, DOI 10.1097/01.SLA.0000018565.87010.B8; Kiriyama S, 2013, J HEPATO-BIL-PAN SCI, V20, P24, DOI 10.1007/s00534-012-0561-3; Shoda J, 2001, AM J GASTROENTEROL, V96, P3368; Kamiya S, 2004, ANN SURG, V239, P510, DOI 10.1097/01.sla.0000118594.23874.89; Garcea G, 2010, PANCREAS, V39, P119, DOI 10.1097/MPA.0b013e3181bd65de; van der Gaag NA, 2010, NEW ENGL J MED, V362, P129, DOI 10.1056/NEJMoa0903230; Hamada Y, 2013, CLIN BIOCHEM, V46, P99, DOI 10.1016/j.clinbiochem.2012.10.013; TAKAGI K, 1994, CLIN CHIM ACTA, V226, P67, DOI 10.1016/0009-8981(94)90103-1; Nimura Y, 2008, HPB, V10, P130, DOI 10.1080/13651820801992666; BEMELMANS MHA, 1992, HEPATOLOGY, V15, P1132, DOI 10.1002/hep.1840150626; CHRISTOU NV, 1989, ANN SURG, V210, P69, DOI 10.1097/00000658-198907000-00011; Confer BD, 2013, J CLIN GASTROENTEROL, V47, P807, DOI 10.1097/MCG.0b013e3182854969; DENNING DA, 1981, AM J SURG, V141, P61, DOI 10.1016/0002-9610(81)90013-1; Fukuoka K, 2001, EUR J SURG, V167, P684; Hirazawa K, 1999, SURGERY, V126, P900, DOI 10.1067/msy.2099.100473; Matsumoto T, 2008, J GASTROENTEROL, V43, P390, DOI 10.1007/s00535-008-2173-x; Rerknimitr Rungsun, 2002, Journal of the Medical Association of Thailand, V85, pS48; Saiki S, 1999, ANN SURG, V230, P655, DOI 10.1097/00000658-199911000-00007; Sano T, 2004, SURGERY, V136, P693, DOI 10.1016/j.surg.2004.02.001; Schwartz S, 1999, PRINCIPLES SURG, V7th; Seyama Y, 2007, WORLD J GASTROENTERO, V13, P1505; SMITH RC, 1985, SURGERY, V97, P641; Srivastava S, 2001, DIGEST SURG, V18, P381, DOI 10.1159/000050178; Suzuki D, 2010, SURGERY, V148, P573, DOI 10.1016/j.surg.2010.01.017; SUZUKI H, 1994, HEPATOLOGY, V20, P1318, DOI 10.1016/0270-9139(94)90774-9; Tanaka Yoshiaki, 2003, Kurume Medical Journal, V50, P131; THOMPSON RLE, 1990, BRIT J SURG, V77, P1229, DOI 10.1002/bjs.1800771112; Yamada T, 2005, LANGENBECK ARCH SURG, V390, P421, DOI 10.1007/s00423-005-0564-5	35	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1091-255X	1873-4626		J GASTROINTEST SURG	J. Gastrointest. Surg.	DEC	2014	18	12					2095	2104		10.1007/s11605-014-2674-2		10	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AT9YX	WOS:000345281100005		
J	Lee, C; Yashiro, S; Dotson, DL; Uzdavinys, P; Iwata, S; Sansom, MSP; von Ballmoos, C; Beckstein, O; Drew, D; Cameron, AD				Lee, Chiara; Yashiro, Shoko; Dotson, David L.; Uzdavinys, Povilas; Iwata, So; Sansom, Mark S. P.; von Ballmoos, Christoph; Beckstein, Oliver; Drew, David; Cameron, Alexander D.			Crystal structure of the sodium-proton antiporter NhaA dimer and new mechanistic insights	JOURNAL OF GENERAL PHYSIOLOGY			English	Article							MEMBRANE-PROTEIN OVEREXPRESSION; X-RAY-DIFFRACTION; ESCHERICHIA-COLI; NA+/H+-ANTIPORTER; MOLECULAR-DYNAMICS; BACTERIAL-MEMBRANE; PK(A) VALUES; MACROMOLECULAR CRYSTALLOGRAPHY; DEPENDENT DIMERIZATION; PH REGULATION	Sodium-proton antiporters rapidly exchange protons and sodium ions across the membrane to regulate intracellular pH, cell volume, and sodium concentration. How ion binding and release is coupled to the conformational changes associated with transport is not clear. Here, we report a crystal form of the prototypical sodium-proton antiporter NhaA from Escherichia coli in which the protein is seen as a dimer. In this new structure, we observe a salt bridge between an essential aspartic acid (Asp163) and a conserved lysine (Lys300). An equivalent salt bridge is present in the homologous transporter NapA, but not in the only other known crystal structure of NhaA, which provides the foundation of most existing structural models of electrogenic sodium-proton antiport. Molecular dynamics simulations show that the stability of the salt bridge is weakened by sodium ions binding to Asp164 and the neighboring Asp163. This suggests that the transport mechanism involves Asp163 switching between forming a salt bridge with Lys300 and interacting with the sodium ion. pK(a) calculations suggest that Asp163 is highly unlikely to be protonated when involved in the salt bridge. As it has been previously suggested that Asp163 is one of the two residues through which proton transport occurs, these results have clear implications to the current mechanistic models of sodium-proton antiport in NhaA.	[Lee, Chiara; Yashiro, Shoko; Iwata, So; Drew, David; Cameron, Alexander D.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [Yashiro, Shoko; Iwata, So; Cameron, Alexander D.] Diamond Light Source, Membrane Prot Lab, Didcot OX11 0DE, Oxon, England; [Dotson, David L.] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Uzdavinys, Povilas; von Ballmoos, Christoph; Drew, David] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden; [Iwata, So; Cameron, Alexander D.] Rutherford Appleton Lab, Res Complex Harwell, Didcot OX11 0FA, Oxon, England; [Iwata, So] Japan Sci & Technol Agcy, ERATO, Human Crystallog Project, Sakyo Ku, Kyoto 606851, Japan; [Iwata, So] Kyoto Univ, Grad Sch Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Sansom, Mark S. P.; Beckstein, Oliver] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Cameron, Alexander D.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	Beckstein, O (reprint author), Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA.	obeckste@asu.edu; ddrew@dbb.su.se; a.cameron@warwick.ac.uk	Beckstein, Oliver/C-9095-2009; 	Beckstein, Oliver/0000-0003-1340-0831; von Ballmoos, Christoph/0000-0002-4642-6088	Wellcome Trust at the Diamond Light Source [WT089809]; National Science Foundation [OCI-1053575, MCB130177]; Royal Society; Medical Research Council [MRC_G0900990(91997)]; Swedish Research Council; Biotechnology and Biological Sciences Research Council [BB/G023425/1]; EMBO; ERATO Iwata Human Receptor Crystallography Project; Japan Science and Technology Agency; EU (European Drug Initiative for Channels and Transporters, EDICT) [201924]	We are grateful to Etana Padan, Carola Hunte, and Gunnar von Heijne for useful discussions. The authors are grateful for the use of the Membrane Protein Laboratory funded by the Wellcome Trust (WT089809) at the Diamond Light Source, where data were collected. Computer simulations were carried out on the A2C2 Saguaro supercomputer at Arizona State University.; This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant OCI-1053575 (allocation MCB130177 to O. Beckstein). This work was supported with grants from The Royal Society through the University Research Fellow scheme (to D. Drew), the Medical Research Council (MRC_G0900990(91997) to A.D. Cameron and D. Drew), the Swedish Research Council (to C. von Ballmoos and D. Drew), and the Biotechnology and Biological Sciences Research Council (BB/G023425/1 to S. Iwata). D. Drew acknowledges the support from EMBO through the EMBO Young Investigator Program. Part of the work was funded by the ERATO Iwata Human Receptor Crystallography Project, Japan Science and Technology Agency and the EU (European Drug Initiative for Channels and Transporters, EDICT grant 201924).	Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Sonoda Y, 2011, STRUCTURE, V19, P17, DOI 10.1016/j.str.2010.12.001; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Scott KA, 2008, STRUCTURE, V16, P621, DOI 10.1016/j.str.2008.01.014; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Padan E, 2009, J EXP BIOL, V212, P1593, DOI 10.1242/jeb.026708; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Drew DE, 2001, FEBS LETT, V507, P220, DOI 10.1016/S0014-5793(01)02980-5; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Jensen KP, 2006, J CHEM THEORY COMPUT, V2, P1499, DOI 10.1021/ct600252r; Padan E, 2004, BBA-BIOENERGETICS, V1658, P2, DOI 10.1016/j.bbabio.2004.04.018; Williams KA, 2000, NATURE, V403, P112, DOI 10.1038/47534; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; Dahl ACE, 2012, BIOINFORMATICS, V28, P2193, DOI 10.1093/bioinformatics/bts357; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; FAFOURNOUX P, 1994, J BIOL CHEM, V269, P2589; Goswami P, 2011, EMBO J, V30, P439, DOI 10.1038/emboj.2010.321; Stansfeld PJ, 2011, J CHEM THEORY COMPUT, V7, P1157, DOI 10.1021/ct100569y; Kozachkov L, 2013, MOL MEMBR BIOL, V30, P90, DOI 10.3109/09687688.2012.693209; Lee C, 2013, NATURE, V501, P573, DOI 10.1038/nature12484; Kumar S, 2002, BIOPHYS J, V83, P1595; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Herz K, 2009, J BIOL CHEM, V284, P6337, DOI 10.1074/jbc.M807720200; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382; Isom DG, 2011, P NATL ACAD SCI USA, V108, P5260, DOI 10.1073/pnas.1010750108; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Mager T, 2011, J BIOL CHEM, V286, P23570, DOI 10.1074/jbc.M111.230235; Hu NJ, 2011, NATURE, V478, P408, DOI 10.1038/nature10450; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Kozachkov L, 2007, BIOCHEMISTRY-US, V46, P2419, DOI 10.1021/bi602393s; Domanski J, 2010, J MEMBRANE BIOL, V236, P255, DOI 10.1007/s00232-010-9296-8; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Schushan M, 2010, J MOL BIOL, V396, P1181, DOI 10.1016/j.jmb.2009.12.055; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Screpanti E, 2006, J MOL BIOL, V362, P192, DOI 10.1016/j.jmb.07.019; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Rappolt M, 2003, BIOPHYS J, V84, P3111; Rizzo RC, 1999, J AM CHEM SOC, V121, P4827, DOI 10.1021/ja984106u; Murzyn K, 2005, BIOPHYS J, V88, P1091, DOI 10.1529/biophysj.104.048835; Cronan JE, 2003, ANNU REV MICROBIOL, V57, P203, DOI 10.1146/annurev.micro.57.030502.090851; Ulmschneider JP, 2011, J AM CHEM SOC, V133, P15487, DOI 10.1021/ja204042f; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Hilger D, 2005, BIOPHYS J, V89, P1328, DOI 10.1529/biophysj.105.062232; Rimon A, 2007, J BIOL CHEM, V282, P26810, DOI 10.1074/jbc.M704469200; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Harms MJ, 2011, P NATL ACAD SCI USA, V108, P18954, DOI 10.1073/pnas.1104808108; Ulmschneider JP, 2009, J CHEM THEORY COMPUT, V5, P1803, DOI 10.1021/ct900086b; Herz K, 2010, J BIOL CHEM, V285, P2211, DOI 10.1074/jbc.M109.047134; Appel M, 2009, J MOL BIOL, V388, P659, DOI 10.1016/j.jmb.2009.03.010; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; DeLaBarre B, 2006, ACTA CRYSTALLOGR D, V62, P923, DOI 10.1107/S0907444906012650; Galili L, 2002, BIOCHEMISTRY-US, V41, P609, DOI 10.1021/bi011655v; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kleywegt G.J., 2001, INT TABLES CRYSTALLO, P497; Kleywegt G.J., 1994, ESF CCP4 NEWSLETTER, V31, P9; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Lee C, 2014, FEBS LETT, V588, P3761, DOI 10.1016/j.febslet.2014.08.025; Maes M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.391128; Mager T, 2013, J BIOL CHEM, V288, P24666, DOI 10.1074/jbc.M113.484071; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Olkhova E, 2009, PROTEINS, V76, P548, DOI 10.1002/prot.22368; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RAETZ CRH, 1986, ANNU REV GENET, V20, P253; Scott D. W., 1992, MULTIVARIATE DENSITY; Ulmschneider MB, 2010, J AM CHEM SOC, V132, P3452, DOI 10.1021/ja909347x; Waskom M, 2014, SEABORN STAT DATA VI; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	82	5	5	ROCKEFELLER UNIV PRESS	NEW YORK	950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA	0022-1295	1540-7748		J GEN PHYSIOL	J. Gen. Physiol.	DEC	2014	144	6					529	544		10.1085/jgp.201411219		16	Physiology	Physiology	AU4FR	WOS:000345565900006		
J	Hattori, Y; Doi, K; Koide, S; Sakamoto, S				Hattori, Yasunori; Doi, Kazuteru; Koide, Satomi; Sakamoto, Sotetsu			Endoscopic Release for Severe Carpal Tunnel Syndrome in Octogenarians	JOURNAL OF HAND SURGERY-AMERICAN VOLUME			English	Article						Carpal tunnel syndrome; endoscopic carpal tunnel release; octogenarian	CLINICALLY IMPORTANT DIFFERENCE; ADVANCED DISEASE; SURGERY; OLDER; AGE; OUTCOMES; RESPONSIVENESS; QUESTIONNAIRE; INSTRUMENT; SYMPTOMS	Purpose To investigate the clinical outcomes of endoscopic carpal tunnel release for severe carpal tunnel syndrome in octogenarians compared with a younger cohort. Methods Fifty-five hands in 48 patients were enrolled in this study. There were 27 hands in 24 octogenarians and 28 hands in 24 patients in a younger group with average ages of 83 and 60 years, respectively. Postoperative follow-ups were 8.5 and 7.2 months, respectively. Clinical evaluation included documentation of subjective symptoms and Semmes-Weinstein testing before surgery, 3 months after surgery, and at final follow-up. Symptom severity and function outcomes scores and compound muscle action potential of abductor pollicis brevis as an electrophysiological assessment were evaluated before surgery and at the final follow-up. Results Nocturnal pain and paresthesias were improved in all patients. The octogenarians had poorer recovery of Semmes-Weinstein testing score and better improvement of outcomes scores than the younger group. There was no difference of the results in postoperative electrophysiological improvement between the groups. Conclusions Endoscopic release for severe carpal tunnel syndrome relieved symptoms and improved activities of daily living in octogenarians. (Copyright (C) 2014 by the American Society for Surgery of the Hand. All rights reserved.)	[Hattori, Yasunori; Doi, Kazuteru; Koide, Satomi; Sakamoto, Sotetsu] Ogori Daiichi Gen Hosp, Dept Orthoped Surg, Yamaguchi 7540002, Japan	Hattori, Y (reprint author), Ogori Daiichi Gen Hosp, Dept Orthoped Surg, 862-3 Shimogo, Yamaguchi 7540002, Japan.	yhattori@saikyo.or.jp					Ozyurekoglu T, 2006, J HAND SURG-AM, V31A, P733, DOI 10.1016/j.jhsa.2006.01.012; Nobuta S, 2005, J ORTHOP SCI, V10, P22, DOI 10.1007/s00776-004-0852-x; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Atroshi I, 1998, ACTA ORTHOP SCAND, V69, P82, DOI 10.3109/17453679809002363; Ozer K, 2013, PLAST RECONSTR SURG, V131, P1279, DOI 10.1097/PRS.0b013e31828bd6ec; Itsubo T, 2009, J ORTHOP SCI, V14, P17, DOI 10.1007/s00776-008-1290-y; Beck JD, 2013, J HAND SURG-AM, V38A, P1524, DOI 10.1016/j.jhsa.2013.05.016; Choi SJ, 1998, PLAST RECONSTR SURG, V102, P2374, DOI 10.1097/00006534-199812000-00016; CHOW J C Y, 1989, Arthroscopy, V5, P19, DOI 10.1016/0749-8063(89)90085-6; Ettema AM, 2006, PLAST RECONSTR SURG, V118, P947, DOI 10.1097/01.prs.0000232373.40248.fa; Hansen TB, 2009, J HAND SURG-EUR VOL, V34E, P660, DOI 10.1177/1753193409104563; Hobby JL, 2005, J HAND SURG-BRIT EUR, V30B, P599, DOI 10.1016/j.jhsb.2005.07.005; Imaeda T, 2007, J ORTHOP SCI, V12, P14, DOI 10.1007/s00776-006-1087-9; Leit ME, 2004, J HAND SURG-AM, V29A, P379, DOI 10.1016/j.jhsa.2004.02.003; LEVINE DW, 1993, J BONE JOINT SURG AM, V75A, P1585; Mondelli M, 2000, J HAND SURG-BRIT EUR, V25B, P128, DOI 10.1054/jhsb.2000.0361; Nagaoka M, 2006, MINIM INVAS NEUROSUR, V49, P216, DOI 10.1055/s-2006-947999; Porter P, 2002, J BONE JOINT SURG BR, V84B, P688, DOI 10.1302/0301-620X.84B5.12266; Salomon JA, 2010, LANCET, V380, P2144, DOI DOI 10.1016/S0140-6736(12)61690-0; Tomaino MM, 2001, J HAND SURG-BRIT EUR, V26, P481, DOI 10.1054/jhsb.2001.0614; Townshend DN, 2005, J HAND SURG-AM, V30A, P500, DOI 10.1016/j.jhsa.2004.11.006; Vliet MMV, 2013, PLAST RECONSTR SURG, V132, P105; Weber RA, 2005, J HAND SURG-AM, V30A, P75, DOI 10.1016/j.jhsa.2004.08.005; Wilgis EFS, 2006, J HAND SURG-BRIT EUR, V31B, P401, DOI 10.1016/j.jhsb.2006.03.165	24	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0363-5023	1531-6564		J HAND SURG-AM	J. Hand Surg.-Am. Vol.	DEC	2014	39	12					2448	2453		10.1016/j.jhsa.2014.09.018		6	Orthopedics; Surgery	Orthopedics; Surgery	AU4CX	WOS:000345557600015		
J	Hattori, Y; Doi, K; Sakamoto, S; Kumar, K; Koide, S				Hattori, Yasunori; Doi, Kazuteru; Sakamoto, Sotetsu; Kumar, Kannan; Koide, Satomi			Camitz Tendon Transfer Using Flexor Retinaculum as a Pulley in Advanced Carpal Tunnel Syndrome	JOURNAL OF HAND SURGERY-AMERICAN VOLUME			English	Article						Abductor pollicis brevis; Camitz opponensplasty; carpal tunnel syndrome	JAPANESE SOCIETY; HAND VERSION; OPPONENSPLASTY; SURGERY; VALIDATION; SECONDARY; SERIES	Purpose To report the outcomes of modified Camitz abductor plasty using the released flexor retinaculum as a pulley in patients with advanced carpal tunnel syndrome. Methods A retrospective review of 46 hands in 43 patients who underwent modified Camitz abductor plasty was performed. Active palmar abduction of thumb and pulp pinch strength were assessed. Patient-reported outcome measures were assessed using the Disabilities of the Arm, Shoulder, and Hand and Carpal Tunnel Syndrome instrument. As an electrophysiological assessment, compound muscle action potential (CMAP) from abductor pollicis brevis (APB) was investigated. Results At 3 months, active palmar abduction of thumb and pulp pinch strength significantly improved. Although pulp pinch strength further improved, active abduction of thumb did not improve at the final follow-up. Both the patient-reported outcome measures improved at 3 months and further improved at final follow-up. Approximately 75% of improved scores were obtained at the first 3 months after surgery and the balance of improved scores (25%) was obtained by the time of final follow-up. Useful recovery of postoperative APB-CMAP (amplitude > 1.8 mV) was obtained in 3 hands (7%) at 3 months after surgery and in 23 hands (50%) at final follow-up. There was no statistical significance of the postoperative results including active palmar abduction of thumb and improvement of patient-reported outcome measures at final follow-up between the hands with useful recovery of postoperative APB-CMAP and the hands without it. Conclusions Modified Camitz abductor plasty benefitted the early improvement of activity of daily living in patients with advanced carpal tunnel syndrome. It acted not only as an internal orthosis in patients who eventually recovered thenar muscle function but also as the sole palmar abductor of the thumb in patients who failed to recover useful thenar muscle function. (Copyright (C) 2014 by the American Society for Surgery of the Hand. All rights reserved.)	[Hattori, Yasunori; Doi, Kazuteru; Sakamoto, Sotetsu; Kumar, Kannan; Koide, Satomi] Ogori Daiichi Gen Hosp, Dept Orthoped Surg, Yamaguchi 7540002, Japan	Hattori, Y (reprint author), Ogori Daiichi Gen Hosp, Dept Orthoped Surg, 862-3 Shimogo, Yamaguchi 7540002, Japan.	yhattori@saikyo.or.jp					Nobuta S, 2005, J ORTHOP SCI, V10, P22, DOI 10.1007/s00776-004-0852-x; Padua L, 1996, ACTA NEUROL SCAND, V94, P343; Sorensen AA, 2013, J HAND SURG-AM, V38A, P641, DOI 10.1016/j.jhsa.2012.12.032; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; MACDOUGAL BA, 1995, PLAST RECONSTR SURG, V96, P982, DOI 10.1097/00006534-199509001-00035; Imaeda T, 2005, J ORTHOP SCI, V10, P353, DOI 10.1007/s00776-005-0917-5; Aulisa L, 1998, J HAND SURG-AM, V23A, P687, DOI 10.1016/S0363-5023(98)80056-7; Braun R M, 1978, J Hand Surg Am, V3, P488; Camitz H, 1929, ACTA CHIR SCAND, V65, P77; Choi SJ, 1998, PLAST RECONSTR SURG, V102, P2374, DOI 10.1097/00006534-199812000-00016; FOUCHER G, 1991, J HAND SURG-BRIT EUR, V16B, P56, DOI 10.1016/0266-7681(91)90128-B; Imaeda T, 2007, J ORTHOP SCI, V12, P14, DOI 10.1007/s00776-006-1087-9; Kang SW, 2012, PLAST RECONSTR SURG, V129, p761E, DOI 10.1097/PRS.0b013e318245e8ee; Kato N, 2013, J HAND SURG-BRIT EUR, V39, P632; LITTLER JW, 1967, PLAST RECONSTR SURG, V39, P74, DOI 10.1097/00006534-196701000-00009; Mondelli M, 2001, CLIN NEUROPHYSIOL, V112, P1237, DOI 10.1016/S1388-2457(01)00555-7; Naeem R, 2013, J HAND SURG-AM, V38A, P795, DOI 10.1016/j.jhsa.2013.01.027; NOLAN WB, 1992, J HAND SURG-AM, V17A, P1020; Park IJ, 2002, J KOREAN SOC SURG HA, V7, P52; Park IJ, 2010, ARCH ORTHOP TRAUM SU, V130, P829, DOI 10.1007/s00402-010-1053-z; TERRONO AL, 1993, J HAND SURG-AM, V18A, P204, DOI 10.1016/0363-5023(93)90346-5	21	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0363-5023	1531-6564		J HAND SURG-AM	J. Hand Surg.-Am. Vol.	DEC	2014	39	12					2454	2459		10.1016/j.jhsa.2014.09.008		6	Orthopedics; Surgery	Orthopedics; Surgery	AU4CX	WOS:000345557600016		
J	Pronschinske, KB; Qiu, S; Wu, C; Kato, TS; Khawaja, T; Takayama, H; Naka, Y; Templeton, DL; George, I; Farr, MA; Mancini, DM; Schulze, PC				Pronschinske, Katherine B.; Qiu, Sylvia; Wu, Christina; Kato, Tomoko S.; Khawaja, Tuba; Takayama, Hiroo; Naka, Yoshifumi; Templeton, Danielle L.; George, Isaac; Farr, Maryjane A.; Mancini, Donna M.; Schulze, P. Christian			Neutrophil gelatinase-associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist device placement	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Article						heart failure; renal function; NGAL; cystatin C; ventricular assist device	GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; CARDIAC-SURGERY; RENAL-FUNCTION; INJURY; MARKER; RISK; BIOMARKER	BACKGROUND: Progressive renal dysfunction develops in patients with advanced HF. We evaluated neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C compared with established markers of renal function in patients with heart failure (HF) because they might improve prognostic assessment of patients with HF. METHODS: Serum samples were collected from 40 patients with stable HF (age: 58 +/- 8 years, body mass index [BMI]: 28.4 +/- 6.4 kg/m(2)), 40 HF patients undergoing ventricular assist device (VAD) implantation (age: 53 +/- 11 years, BMI: 26.8 +/- 5.5 kg/m(2)), 40 patients undergoing VAD removal at cardiac transplantation, and 24 controls (age: 48 +/- 7 years, BMI: 29.4 +/- 4.2 kg/m(2)). Clinical data were collected from institutional medical records. NGAL and cystatin C levels were measured by enzyme-linked immunosorbent assay and estimated glomerular filtration rate (eGFR) calculated using the Modification of Diet in Renal Disease formula. RESULTS: Patients with stable HF showed elevated NGAL and cystatin C levels compared with controls (NGAL: 114.9 +/- 48.3 ng/mL vs 72.0 +/- 36.6 ng/mL, p < 0.0001; cystatin C: 1490.4 +/- 576.1 ng/mL vs 954.7 +/- 414.2 ng/mL, p = 0.0026). Unlike cystatin C, NGAL increased in advanced HF patients requiring VAD implantation (158.7 +/- 74.8 ng/mL, p < 0.001). On VAD support, NGAL levels decreased (127.1 +/- 80.4 ng/mL, p = 0.034). NGAL was higher in patients who developed right ventricular failure (187.8 +/- 66.0 vs 130.9 +/- 67.0 ng/rnL, p = 0.03) and irreversible renal dysfunction (190.0 +/- 73.8 ng/mL vs 133.8 +/- 54.2 ng/mL, p < 0.05), whereas cystatin C, creatinine, and eGFR were not different. NGAL correlated with eGFR (r = -0.2188, p = 0.01). CONCLUSIONS: NGAL levels correlate with HF severity and hemodynamic improvement after VAD placement. Our findings suggest a role of this novel biomarker as a marker of severity and prognosis in patients with HF. (C) 2014 International Society for Heart and Lung Transplantation. All rights reserved.	[Pronschinske, Katherine B.; Qiu, Sylvia; Wu, Christina; Khawaja, Tuba; Templeton, Danielle L.; George, Isaac; Farr, Maryjane A.; Mancini, Donna M.; Schulze, P. Christian] Columbia Univ, Med Ctr, Dept Med, Div Cardiol, New York, NY 10032 USA; [Kato, Tomoko S.] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med & Organ Transplantat, Osaka, Japan; [Takayama, Hiroo; Naka, Yoshifumi] Columbia Univ, Med Ctr, Dept Surg, Div Cardiothorac Surg, New York, NY 10032 USA	Schulze, PC (reprint author), Columbia Univ, Med Ctr, Dept Med, Div Cardiol, 622 W 168th St,PH 10,Rm 203, New York, NY 10032 USA.	pcs2121@cumc.columbia.edu			National Heart, Lung and Blood Institute [K23-HL-095742-01, P30-HL-101272-01, UL1-RR-024156, HL-073029]; Herbert and Florence Irving Scholar Award	This work was supported by grants from the National Heart, Lung and Blood Institute (K23-HL-095742-01, P30-HL-101272-01, UL1-RR-024156, HL-073029) and the Herbert and Florence Irving Scholar Award to Dr Schulze.	Murata K, 2011, CLIN J AM SOC NEPHRO, V6, P1963, DOI 10.2215/CJN.02300311; Stevenson LW, 2009, J HEART LUNG TRANSPL, V28, P535, DOI 10.1016/j.healun.2009.02.015; Lassus J, 2012, HEART FAIL REV, V17, P251, DOI 10.1007/s10741-011-9242-6; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Wagener G, 2006, ANESTHESIOLOGY, V105, P485, DOI 10.1097/00000542-200609000-00011; Sarnak MJ, 2005, ANN INTERN MED, V142, P497; Schmidt-Ott KM, 2006, CURR OPIN NEPHROL HY, V15, P442, DOI 10.1097/01.mnh.0000232886.81142.58; Koenig W, 2005, CLIN CHEM, V51, P321, DOI 10.1373/clinchem.2004.041899; Nickolas TL, 2008, ANN INTERN MED, V148, P810; Lund LH, 2010, EUR J HEART FAIL, V12, P434, DOI 10.1093/eurjhf/hfq006; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Yndestad A, 2009, EUR HEART J, V30, P1229, DOI 10.1093/eurheartj/ehp088; Malyszko J, 2008, RENAL FAILURE, V30, P625, DOI 10.1080/08860220802134607; Mishra J, 2005, LANCET, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Dent CL, 2007, CRIT CARE, V11, DOI 10.1186/cc6192; Evangelopoulos AA, 2012, INTERN MED J, V42, P517, DOI 10.1111/j.1445-5994.2011.02500.x; Lindenfeld J, 2010, J CARD FAIL, V16, pe1, DOI DOI 10.1016/J.CARDFAIL.2010.04.004; Mitsnefes MM, 2007, PEDIATR NEPHROL, V22, P101, DOI 10.1007/s00467-006-0244-x; Pokhrel Narayan, 2008, Exp Clin Cardiol, V13, P165; Ronco C, 2010, CONGEST HEART FAI S1, V16, pSvi; Ronco C, 2010, CONGEST HEART FAI S1, V16, pS1; Yanavitski Marat, 2011, Curr Heart Fail Rep, V8, P206, DOI 10.1007/s11897-011-0065-5	22	5	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	DEC	2014	33	12					1215	1222		10.1016/j.healun.2014.06.007		8	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	AU3XS	WOS:000345544600003		
J	Nishino, T; Hamano, T; Mitsunaga, Y; Shirato, I; Shirato, M; Tagata, T; Shimada, M; Yoshida, S; Mitsunaga, A				Nishino, Takayoshi; Hamano, Tetsuya; Mitsunaga, Yutaka; Shirato, Izumi; Shirato, Miho; Tagata, Tomoko; Shimada, Masahiko; Yoshida, Shuhei; Mitsunaga, Atsushi			Clinical evaluation of the Tokyo Guidelines 2013 for severity assessment of acute cholangitis	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Acute cholangitis; Bacteremia; Scoring system; Severity assessment; Tokyo Guidelines 2013	RISK-FACTORS; URGENT ERCP	BackgroundWe evaluated the severity assessment criteria for acute cholangitis (AC) of the Tokyo Guidelines 2013 (TG13) and developed a scoring system for predicting the need for urgent/early biliary drainage. MethodsWe retrospectively reviewed 66 AC cases prospectively managed based on the TG07 and divided into an urgent/early biliary drainage group (n = 30) and elective biliary drainage group (n = 36). ResultsThere were 26 mild, 27 moderate, and 13 severe cases based on the TG13. The TG13 assessment in 12 of the 17 cases requiring early biliary drainage based on the TG07 was moderate, but underestimated the other five cases as mild AC. When five predictors (blood urea nitrogen >20mg/dL, SIRS presence, platelet count <120000/L, serum albumin level <3.0g/dL, age 75 years old) were used to devise a scoring system, the receiver-operator characteristic curve of the scores showed good test performance for predicting the need for urgent/early biliary drainage. The area under the curve (AUC) was 0.95 and higher than the TG13 AUC (0.80). ConclusionsThe TG13 is practical, but some AC cases requiring urgent/early biliary drainage were underestimated as mild AC. The scoring system allows identification of high-risk AC patients and will improve the TG13.	[Nishino, Takayoshi; Mitsunaga, Yutaka; Shirato, Izumi; Shirato, Miho; Shimada, Masahiko; Yoshida, Shuhei] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Gastroenterol, Chiba 2768542, Japan; [Hamano, Tetsuya; Tagata, Tomoko; Mitsunaga, Atsushi] Tokyo Womens Med Univ, Sch Med, Dept Endoscopy, Tokyo, Japan	Nishino, T (reprint author), Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Gastroenterol, 477-96 Owada Shinden, Chiba 2768542, Japan.	tnishino@tymc.twmu.ac.jp					Miura F, 2013, J HEPATO-BIL-PAN SCI, V20, P47, DOI 10.1007/s00534-012-0563-1; Wada K, 2007, J HEPATO-BILIARY-PAN, V14, P52, DOI 10.1007/s00534-006-1156-7; Kiriyama S, 2013, J HEPATO-BIL-PAN SCI, V20, P24, DOI 10.1007/s00534-012-0561-3; Yokoe M, 2011, J HEPATO-BIL-PAN SCI, V18, P250, DOI 10.1007/s00534-010-0338-5; Tsuyuguchi T, 2012, J HEPATO-BIL-PAN SCI, V19, P557, DOI 10.1007/s00534-012-0538-2; Fujii Y, 2012, J HEPATO-BIL-PAN SCI, V19, P487, DOI 10.1007/s00534-011-0464-8; Hui CK, 2001, ALIMENT PHARM THERAP, V15, P1633, DOI 10.1046/j.1365-2036.2001.01071.x; Kiriyama S, 2012, J HEPATO-BIL-PAN SCI, V19, P548, DOI 10.1007/s00534-012-0537-3; Lai EC, 1992, NEW ENGL J MED, V326, P158; Lee BS, 2013, DIGEST DIS SCI, V58, P1091, DOI 10.1007/s10620-012-2478-8; Lee CC, 2007, AM J GASTROENTEROL, V102, P563, DOI 10.1111/j.1572-0241.2007.01095.x; LIPSETT PA, 1990, SURG CLIN N AM, V70, P1297; Nishino T, 2012, J HEPATO-BIL-PAN SCI, V19, P698, DOI 10.1007/s00534-011-0488-0; Salek J, 2009, J CLIN GASTROENTEROL, V43, P171, DOI 10.1097/MCG.0b013e318157c62c; Shinya S, 2014, J HEPATO-BIL-PAN SCI, V21, P777, DOI 10.1002/jhbp.132; Sun G, 2014, J HEPATO-BIL-PAN SCI, V21, P113, DOI 10.1002/jhbp.9	16	0	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	DEC	2014	21	12					841	849		10.1002/jhbp.189		9	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AU0YD	WOS:000345347200003		
J	Yoshidome, H; Shimizu, H; Ohtsuka, M; Yoshitomi, H; Kato, A; Furukawa, K; Miyazaki, M				Yoshidome, Hiroyuki; Shimizu, Hiroaki; Ohtsuka, Masayuki; Yoshitomi, Hideyuki; Kato, Atsushi; Furukawa, Katsunori; Miyazaki, Masaru			Pancreaticoduodenetomy combined with hepatic artery resection following preoperative hepatic arterial embolization	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Arterial invasion center dot Coil embolization center dot Curative resection center dot Pancreatic cancer	LONG-TERM SURVIVAL; ADVANCED PANCREATIC ADENOCARCINOMA; PHASE-III; CANCER; GEMCITABINE; TRIAL; CHEMORADIATION; RADIOTHERAPY; HEAD	BackgroundThe possibility of resection for locally advanced pancreatic ductal adenocarcinoma (PDAC) with involvement of hepatic or superior mesenteric artery is low. The treatment strategy for these locally advanced PDAC needs to be elucidated. MethodsWe retrospectively reviewed the medical records of 107 patients undergoing pancreaticoduodenectomy for PDAC between 2007 and 2012. Among these patients, seven patients who had unresectable PDAC because of cancer involvement of hepatic artery underwent preoperative hepatic arterial embolization and subsequent pancreaticoduodenectomy combined with resection of hepatic artery without reconstruction (PDCAR). We specifically focused on these seven patients to clarify the benefit and drawback of PDCAR. ResultsSerum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels on 1 day after hepatic arterial embolization increased, but returned to baseline before pancreaticoduodenectomy. There was no arterial embolization-related complication before surgery. Serum ALT and AST levels increased 1 day after surgery, but thereafter returned to baseline. Although postoperative morbidity such as hepatic infarction was observed in one case, there were no in-hospital deaths. The median survival time was 12.6 months and 5-year survival rate was 19%. ConclusionPreoperative hepatic arterial embolization and subsequent PDCAR might be a feasible procedure in selected patients with unresectable locally advanced PDAC with hepatic artery involvement.	[Yoshidome, Hiroyuki; Shimizu, Hiroaki; Ohtsuka, Masayuki; Yoshitomi, Hideyuki; Kato, Atsushi; Furukawa, Katsunori; Miyazaki, Masaru] Chiba Univ, Grad Sch Med, Dept Gen Surg, Chuo Ku, Chiba 2608670, Japan	Miyazaki, M (reprint author), Chiba Univ, Grad Sch Med, Dept Gen Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	masaru@faculty.chiba-u.jp					Amano H, 2009, J HEPATO-BILIARY-PAN, V16, P777, DOI 10.1007/s00534-009-0202-7; Mollberg N, 2011, ANN SURG, V254, P882, DOI 10.1097/SLA.0b013e31823ac299; Ueno H, 2013, J CLIN ONCOL, V31, P1640, DOI 10.1200/JCO.2012.43.3680; Butturini G, 2008, ARCH SURG-CHICAGO, V143, P75, DOI 10.1001/archsurg.2007.17; Schnelldorfer T, 2008, ANN SURG, V247, P456, DOI 10.1097/SLA.0b013e3181613142; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Hirano S, 2007, ANN SURG, V246, P46, DOI 10.1097/01.sla.0000258608.52615.5a; Morganti AG, 2010, ANN SURG ONCOL, V17, P194, DOI 10.1245/s10434-009-0762-4; Stitzenberg KB, 2008, ANN SURG ONCOL, V15, P1399, DOI 10.1245/s10434-008-9844-y; Conlon KC, 1996, ANN SURG, V223, P273, DOI 10.1097/00000658-199603000-00007; Siriwardana HPP, 2006, BRIT J SURG, V93, P662, DOI 10.1002/bjs.5368; Nakao A, 2012, ANN SURG, V255, P103, DOI 10.1097/SLA.0b013e318237872e; Haddock MG, 2007, J CLIN ONCOL, V25, P2567, DOI 10.1200/JCO.2006.10.2111; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Yekebas EF, 2008, ANN SURG, V247, P300, DOI 10.1097/SLA.0b013e31815aab22; Evans DB, 2008, J CLIN ONCOL, V26, P3496, DOI 10.1200/JCO.2007.15.8634; Bachellier P, 2011, J SURG ONCOL, V103, P75, DOI 10.1002/jso.21769; Bockhorn M, 2011, BRIT J SURG, V98, P86, DOI 10.1002/bjs.7270; Burris HA, 1997, J CLIN ONCOL, V15, P2403; Cunha AS, 2005, J AM COLL SURGEONS, V201, P359; Loehrer PJ, 2011, J CLIN ONCOL, V29, P4105, DOI 10.1200/JCO.2011.34.8904; Martin RCG, 2009, ARCH SURG-CHICAGO, V144, P154, DOI 10.1001/archsurg.2008.547; Sergeant G, 2013, CASE REP MED, V2013	24	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	DEC	2014	21	12					850	855		10.1002/jhbp.192		6	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AU0YD	WOS:000345347200004		
J	Kogure, K; Kojima, I; Kuwano, H; Matsuzaki, T; Yorifuji, H; Takata, K; Makuuchi, M				Kogure, Kimitaka; Kojima, Itaru; Kuwano, Hiroyuki; Matsuzaki, Toshiyuki; Yorifuji, Hiroshi; Takata, Kuniaki; Makuuchi, Masatoshi			Reconfirmation of the anatomy of the left triangular ligament and the appendix fibrosa hepatis in human livers, and its implication in abdominal surgery	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Appendix fibrosa hepatis; Human liver	PERIBILIARY VASCULAR PLEXUS; ABERRANT BILE-DUCTS; SURGICAL IMPLICATIONS; SURFACE	BackgroundThe aim of the present study was to clarify the anatomy between the left triangular ligament (LTL) and the appendix fibrosa hepatis (AFH) in order not to sever the AFH when dissecting the LTL. MethodsTotals of 43 and 27 cadaveric livers were examined macroscopically and histologically, respectively. ResultsThe LTL attached itself to the diaphragmatic surface of the AFH through almost all lengths of the AFH. This might be the reason why AFH is so often dissected together with the LTL. There were two types of relation between the LTL and the AFH; in one type, the starting point of the LTL existed on the left liver and in the other type, it was on the AFH. Twenty-five of 27 AFH included remnants of the bile duct and 12 of 25 AFH had comparatively large bile ducts, which was unexceptionally accompanied by the well-developed peribiliary vascular plexus. AFH showed a variety of shapes, such as rectangular (6/43), long triangular (4/43), short triangular (7/43), triangular plus cordlike (11/43), cordlike (12/43) and bifurcated (3/43) types. ConclusionsAs AFH sometimes includes relatively large bile ducts, it is recommended for surgeons to sever the AFH not just simply by electrocautery but by ligating its stump securely.	[Kogure, Kimitaka; Kojima, Itaru] Gunma Univ, Inst Mol & Cellular Regulat, Lab Cell Physiol, Maebashi, Gunma 3718512, Japan; [Kuwano, Hiroyuki] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gunma 3718512, Japan; [Matsuzaki, Toshiyuki] Gunma Univ, Grad Sch Med, Dept Anat & Cell Biol, Maebashi, Gunma 3718512, Japan; [Yorifuji, Hiroshi] Gunma Univ, Grad Sch Med, Dept Neuromuscular & Dev Anat, Maebashi, Gunma 3718512, Japan; [Takata, Kuniaki] Gunma Univ, Off President, Maebashi, Gunma 3718512, Japan; [Makuuchi, Masatoshi] Japanese Red Cross Med Ctr, Dept Surg, Shibuya Ku, Tokyo, Japan	Kogure, K (reprint author), Gunma Univ, Inst Mol & Cellular Regulat, Lab Cell Physiol, 3-39-15 Showamachi, Maebashi, Gunma 3718512, Japan.	kogurefm@oak.gunma-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [21659314, 23659636]	This study was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (No. 21659314, 23659636). Masako Saito, Hiroko Yamazaki, Ryuichi Aoyagi, Fujio Takahashi, Mitsuo Shikata, Yoshihiro Morimura and Masako Sin were the technicians belonging to Gunma University, Graduate School of Medicine, Maebashi, Japan. The authors are grateful to the technicians for their technical support in this study.	HEALEY JE, 1953, AMA ARCH SURG, V66, P599; CHO KJ, 1983, RADIOLOGY, V147, P357; Washington K, 1997, HUM PATHOL, V28, P791, DOI 10.1016/S0046-8177(97)90151-9; Nakanuma Y, 1997, MICROSC RES TECHNIQ, V38, P552, DOI 10.1002/(SICI)1097-0029(19970915)38:6<552::AID-JEMT2>3.0.CO;2-H; Bannister LH., 1999, 38 GRAYS ANATOMY ANA, P1795; CHAMPETIER J, 1982, ANAT CLIN, V4, P137, DOI 10.1007/BF01800623; Charpy A, 1914, TRAITED ANATOMIE HUM, V4, P117; Collins P, 1999, 38 GRAYS ANATOMY ANA, P187; Couinaud C., 1981, CONTROLLED HEPATECTO, P9; Davies DV, 1969, 34 GRAYS ANATOMY, P1518; El Gharbawy RM, 2011, CLIN ANAT, V24, P429, DOI 10.1002/ca.21117; Engel R, 1911, NOUVE RICERCHE VASI; FOSTER JH, 1962, AM J SURG, V104, P14, DOI 10.1016/0002-9610(62)90288-X; GAO XH, 1986, AM SURGEON, V52, P246; HEALEY JE, 1963, ANN NY ACAD SCI, V111, P25, DOI 10.1111/j.1749-6632.1963.tb36946.x; HOBSLEY M, 1958, BRIT J SURG, V45, P635, DOI 10.1002/bjs.18004519415; Iso Y, 1996, AM J GASTROENTEROL, V91, P2428; Kekis PB, 2000, HPB, V2, P21; Kogure K, 2007, J HEPATO-BILIARY-PAN, V14, P297, DOI 10.1007/s00534-006-1148-7; MISSEN AJB, 1969, BRIT J SURG, V56, P427, DOI 10.1002/bjs.1800560607; MURAKAMI T, 1974, Archivum Histologicum Japonicum, V37, P245; RAPANT V, 1950, ANN SURG, V132, P253; Rohen JW, 2002, COLOR ATLAS ANATOMY, P286; Takeuchi K, 2000, J JAPAN SURG ASS, V61, P2715; Toldt C, 1875, AKAD WISSENSCHAFTEN, V72, P241	25	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	DEC	2014	21	12					856	863		10.1002/jhbp.144		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AU0YD	WOS:000345347200005		
J	Saito, Y; Shimada, M; Utsunomiya, T; Ikemoto, T; Yamada, S; Morine, Y; Imura, S; Mori, H; Arakawa, Y; Kanamoto, M; Iwahashi, S; Takasu, C				Saito, Yu; Shimada, Mitsuo; Utsunomiya, Tohru; Ikemoto, Tetsuya; Yamada, Shinichiro; Morine, Yuji; Imura, Satoru; Mori, Hiroki; Arakawa, Yusuke; Kanamoto, Mami; Iwahashi, Shuichi; Takasu, Chie			Homing effect of adipose-derived stem cells to the injured liver: the shift of stromal cell-derived factor 1 expressions	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Adipose derived stem cells; C-X-C chemokine receptor type 4; Hepatic ischemia-reperfusion; Homing; Stromal derived factor-1	HEPATIC ISCHEMIA-REPERFUSION; BONE-MARROW; MYOCARDIAL-INFARCTION; ENDOTHELIAL-CELLS; IN-VITRO; MIGRATION; RATS; DIFFERENTIATION; RECEPTOR; SDF-1	BackgroundWhether systemically transplanted human adipose-derived stem cells (ADSCs) homed to the injured liver in nude mice under stress with subsequent hepatectomy (Hx) and ischemia-reperfusion (I/R) was investigated in the present study. The types of cells in the liver that were involved in the homing of ADSCs were clarified, with focus on the stromal-derived factor-1 (SDF-1)/C-X-C chemokine receptor type 4 (CXCR-4) axis. MethodsAdipose-derived stem cells were transplanted intravenously immediately after 70% Hx and I/R. ADSCs were traced by in vivo imaging for 24h after transplantation and ADSCs were histologically detected in the liver. SDF-1 and CXCR-4 expressions in the liver were evaluated by real time RT-PCR. The immunohistochemical analysis of SDF-1 was also performed to identify SDF-1 expressing cells in the liver. ResultsAdipose-derived stem cells were found in various organs immediately following transplantation and almost accumulated in remnant liver or spleen at 6h after transplantation. ADSCs were also histologically revealed in the harvested liver. Hx and I/R injury significantly enhanced SDF-1 expressions regardless of ADSCs transplantation, and only ADSC transplantation increased CXCR-4 expressions. The predominant SDF-1 positive cells in the liver were equally identified in parenchymal and non-parenchymal cells at 6h, but shifted to non-parenchymal cells at 24h after transplantation. ConclusionsSystemically transplanted ADSCs homed to the injured liver after transplantation, possibly based on the mechanisms of SDF-1/CXCR-4 axis. Therefore, systemic transplantation might be an effective and practical route for the transplantation of ADSCs.	[Saito, Yu; Shimada, Mitsuo; Utsunomiya, Tohru; Ikemoto, Tetsuya; Yamada, Shinichiro; Morine, Yuji; Imura, Satoru; Mori, Hiroki; Arakawa, Yusuke; Kanamoto, Mami; Iwahashi, Shuichi; Takasu, Chie] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Surg, Tokushima 7708503, Japan; [Takasu, Chie] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Tokushima 7708503, Japan	Saito, Y (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Surg, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	saito@clin.med.tokushima-u.ac.jp					Shi M, 2007, HAEMATOL-HEMATOL J, V92, P897, DOI 10.3324/haematol.10669; Furlani D, 2009, MICROVASC RES, V77, P370, DOI 10.1016/j.mvr.2009.02.001; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Higgins GM, 1931, ARCH PATHOL, V12, P186; Huwiler KG, 2009, ANAL BIOCHEM, V393, P95, DOI 10.1016/j.ab.2009.06.018; Sun CK, 2012, CRIT CARE MED, V40, P1279, DOI 10.1097/CCM.0b013e31823dae23; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Sengenes C, 2007, STEM CELLS, V25, P2269, DOI 10.1634/stemcells.2007-0180; Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818; Seki T, 2012, J SURG RES, V178, P63, DOI 10.1016/j.jss.2012.02.014; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Yamamoto Y, 2008, FEBS J, V275, P1260, DOI 10.1111/j.1742-4658.2008.06287.x; Cheng ZK, 2008, CARDIOVASC DRUG THER, V22, P363, DOI 10.1007/s10557-008-6110-2; Kubo N, 2012, J GASTROEN HEPATOL, V27, P165, DOI 10.1111/j.1440-1746.2011.06798.x; Baek SJ, 2011, EXP MOL MED, V43, P596, DOI 10.3858/emm.2011.43.10.069; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Banas A, 2009, J GASTROEN HEPATOL, V24, P70, DOI 10.1111/j.1440-1746.2008.05496.x; Jiang WH, 2006, PFLUG ARCH EUR J PHY, V453, P43, DOI 10.1007/s00424-006-0117-y; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Lau TT, 2011, EXPERT OPIN BIOL TH, V11, P189, DOI 10.1517/14712598.2011.546338; Cho HH, 2006, STEM CELLS DEV, V15, P853, DOI 10.1089/scd.2006.15.853; Kanazawa H, 2011, PLOS ONE, V6, P191; Kollar K, 2009, INT J CELL BIOL, V2009, P9046; Lai PH, 2008, GRAEF ARCH CLIN EXP, V246, P1707, DOI 10.1007/s00417-008-0907-3; Nagaya N, 2004, AM J PHYSIOL-HEART C, V287, P2670; Ochiya T, 2010, DIFFERENTIATION, V79, P65, DOI 10.1016/j.diff.2009.10.002; Pan GZ, 2012, J SURG RES, V178, P935, DOI 10.1016/j.jss.2012.04.070; Ra JC, 2011, STEM CELLS DEV, V20, P1297, DOI 10.1089/scd.2010.0466; Ryser MF, 2008, TISSUE ENG PT C-METH, V14, P179, DOI 10.1089/ten.tec.2007.0359; Saito Y, 2013, J SURG RES, V180, P162, DOI 10.1016/j.jss.2012.10.009; Utsunomiya T, 2011, SURG TODAY, V41, P18, DOI 10.1007/s00595-010-4415-9; Yukawa H, 2009, CELL TRANSPLANT, V18, P611	34	3	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	DEC	2014	21	12					873	880		10.1002/jhbp.147		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AU0YD	WOS:000345347200007		
J	Okuno, M; Hatano, E; Seo, S; Taura, K; Yasuchika, K; Nakajima, A; Yazawa, T; Furuyama, H; Kawamoto, H; Yagi, S; Nishitai, R; Fujikawa, T; Arimoto, A; Zaima, M; Yoshimura, T; Terajima, H; Kaihara, S; Manaka, D; Tanaka, A; Uemoto, S				Okuno, Masayuki; Hatano, Etsuro; Seo, Satoru; Taura, Kojiro; Yasuchika, Kentaro; Nakajima, Akio; Yazawa, Takefumi; Furuyama, Hiroaki; Kawamoto, Hiroshi; Yagi, Shintaro; Nishitai, Ryuta; Fujikawa, Takahisa; Arimoto, Akira; Zaima, Masazumi; Yoshimura, Tsunehiro; Terajima, Hiroaki; Kaihara, Satoshi; Manaka, Dai; Tanaka, Akira; Uemoto, Shinji			Indication for neoadjuvant chemotherapy in patients with colorectal liver metastases based on a nomogram that predicts disease-free survival	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Colorectal liver metastases; Hepatic resection; Neoadjuvant chemotherapy; Nomogram	LONG-TERM SURVIVAL; HEPATIC METASTASES; CANCER; RESECTION; HEPATECTOMY; SURGERY; 10-YEAR	BackgroundThe purpose of this study was to validate the Beppu nomogram, which predicts disease-free survival (DFS) after resection of colorectal liver metastases, and to investigate the efficacy of neoadjuvant chemotherapy based on the nomogram-predicted recurrence risk. MethodsWe retrospectively analyzed 234 patients with colorectal liver metastases who underwent a hepatic resection at eight hospitals between 2005 and 2010. ResultsThe nomogram c-index of all the patients was 0.59. The observed and the predicted 3-year DFS showed good agreement. When the patients were divided into two groups who received or did not receive pre-hepatectomy chemotherapy (PHC), the c-index of the patients who received PHC was inferior to that of the patients who did not (0.56 and 0.61, respectively). In patients who received PHC, DFS among the quintiles clustered by the nomogram score indicated no significant differences (P = 0.25), unlike in patients who did not receive PHC (P < 0.0001). Surprisingly, in patients with no risk factors for recurrence, neoadjuvant chemotherapy provided significantly lower DFS than no neoadjuvant chemotherapy (3-year DFS: 42.9% vs. 80.0%, P = 0.03). ConclusionsThe nomogram validation was shown to be moderately predictive. PHC decreased the performance of the nomogram and might produce no DFS benefit in patients with low recurrent risk.	[Okuno, Masayuki; Hatano, Etsuro; Seo, Satoru; Taura, Kojiro; Yasuchika, Kentaro; Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Dept Surg, Sakyo Ku, Kyoto 6068507, Japan; [Nakajima, Akio; Arimoto, Akira] Osaka Red Cross Hosp, Dept Surg, Osaka, Japan; [Yazawa, Takefumi; Zaima, Masazumi] Shiga Med Ctr Adults, Dept Surg, Moriyama, Shiga, Japan; [Furuyama, Hiroaki; Yoshimura, Tsunehiro] Tenri Yorozu Hosp, Dept Surg, Tenri, Nara, Japan; [Kawamoto, Hiroshi; Terajima, Hiroaki] Kitano Hosp, Dept Surg, Osaka, Japan; [Yagi, Shintaro; Kaihara, Satoshi] Kobe City Med Ctr Gen Hosp, Dept Surg, Kobe, Hyogo, Japan; [Nishitai, Ryuta; Manaka, Dai] Kyoto Katsura Hosp, Dept Surg, Kyoto, Japan; [Fujikawa, Takahisa; Tanaka, Akira] Kokura Mem Hosp, Dept Surg, Fukuoka, Japan	Hatano, E (reprint author), Kyoto Univ, Grad Sch Med, Dept Surg, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	etsu@kuhp.kyoto-u.ac.jp					Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Cummings LC, 2007, CANCER, V109, P718, DOI 10.1002/cncr.22448; Tomlinson JS, 2007, J CLIN ONCOL, V25, P4575, DOI 10.1200/JCO.2007.11.0833; STEELE G, 1989, ANN SURG, V210, P127, DOI 10.1097/00000658-198908000-00001; Lam VWT, 2012, ANN SURG ONCOL, V19, P1292, DOI 10.1245/s10434-011-2061-0; Tanaka K, 2003, BRIT J SURG, V90, P963, DOI 10.1002/bjs.4160; Van Cutsem E, 2009, ANN ONCOL, V20, P1842, DOI 10.1093/annonc/mdp233; Boostrom SY, 2009, J GASTROINTEST SURG, V13, P2003, DOI 10.1007/s11605-009-1007-3; Iasonos A, 2008, J CLIN ONCOL, V26, P1364, DOI 10.1200/JCO.2007.12.9791; Nordlinger B, 2008, LANCET, V371, P1007, DOI 10.1016/S0140-6736(08)60455-9; Tamandl D, 2011, ANN SURG ONCOL, V18, P421, DOI 10.1245/s10434-010-1317-4; Kornprat P, 2007, ANN SURG ONCOL, V14, P1151, DOI 10.1245/s10434-006-9068-y; Beppu T, 2014, ANN SURG ONCOL, V21, P405, DOI 10.1245/s10434-014-3577-x; Beppu T, 2012, J HEPATO-BIL-PAN SCI, V19, P72, DOI 10.1007/s00534-011-0460-z; desJong MC, 2009, ANN SURG, V250, P440; EISENBERG B, 1982, CANCER, V49, P1131, DOI 10.1002/1097-0142(19820315)49:6<1131::AID-CNCR2820490611>3.0.CO;2-T; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Jaeck D, 1997, BRIT J SURG, V84, P977, DOI 10.1002/bjs.1800840719; Karanjia ND, 2009, EJSO-EUR J SURG ONC, V35, P838, DOI 10.1016/j.ejso.2008.09.017; Kattan Michael W, 2002, Clin Prostate Cancer, V1, P90, DOI 10.3816/CGC.2002.n.010; Nathan H, 2010, J AM COLL SURGEONS, V210, P755, DOI 10.1016/j.jamcollsurg.2009.12.041; Pawlik TM, 2011, J GASTROINTEST SURG, V15, P410, DOI 10.1007/s11605-011-1423-z; Polterauer S, 2012, GYNECOL ONCOL, V125, P526, DOI 10.1016/j.ygyno.2012.03.030	23	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	DEC	2014	21	12					881	888		10.1002/jhbp.149		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AU0YD	WOS:000345347200008		
J	Sugawara, G; Ebata, T; Yokoyama, Y; Igami, T; Mizuno, T; Nagino, M				Sugawara, Gen; Ebata, Tomoki; Yokoyama, Yukihiro; Igami, Tsuyoshi; Mizuno, Takashi; Nagino, Masato			Management strategy for biliary stricture following laparoscopic cholecystectomy	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Bile duct injury; Biliary stricture; Laparoscopic cholecystectomy	BILE-DUCT-INJURY; HEPATIC-ARTERY INJURY; CLASSIFICATION; COMPLICATIONS; RESECTION; HEPATECTOMY; EXPERIENCE; DRAINAGE; IMPACT; CANCER	BackgroundBiliary strictures following laparoscopic cholecystectomy (Lap-C), which are often associated with vascular injuries, remain a serious problem to manage. The aim of this study was to review our experiences with postoperative biliary stricture. MethodsThis study involved 14 consecutive patients with biliary strictures that resulted from bile duct injuries during Lap-C between 1997 and 2013. Their medical records were retrospectively analyzed. ResultsPercutaneous transhepatic biliary drainage (PTBD) catheter dilatation was first attempted in eight patients, and five patients were successfully treated. Biliary re-stricture recurred in one patient after 34-month follow-up period. This patient underwent repeated catheter dilatations, which led to recurrent stricture resolution. All five patients maintained biliary tract patency over 72-month follow-up period. The remaining nine patients underwent surgical procedures, including hepaticojejunostomy in two patients, re-hepaticojejunostomy in two patients, and the remaining five patients, with biliary strictures involving the secondary biliary branch and concomitant vascular injuries underwent right hemihepatectomy with cholangiojejunostomy. There were no major postoperative complications. After 80-month follow-up period, all nine patients were alive without biliary stricture. ConclusionsPTBD catheter dilatation is recommended first for postoperative Lap-C-associated biliary strictures. In complicated injury patients with vascular injuries, right hemihepatectomy with cholangiojejunostomy should be indicated.	[Sugawara, Gen; Ebata, Tomoki; Yokoyama, Yukihiro; Igami, Tsuyoshi; Mizuno, Takashi; Nagino, Masato] Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol,Showa Ku, Nagoya, Aichi 4668550, Japan	Nagino, M (reprint author), Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol,Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	nagino@med.nagoya-u.ac.jp					Nuzzo G, 2005, ARCH SURG-CHICAGO, V140, P986, DOI 10.1001/archsurg.140.10.986; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Alves A, 2003, ANN SURG, V238, P93, DOI 10.1097/01.sla.0000074983.39297.c5; Yokoyama Y, 2010, BRIT J SURG, V97, P1260, DOI 10.1002/bjs.7084; Laurent A, 2008, ANN SURG, V248, P77, DOI 10.1097/SLA.0b013e31817b65f2; Igami T, 2010, J HEPATO-BIL-PAN SCI, V17, P449, DOI 10.1007/s00534-009-0209-0; Li J, 2008, BRIT J SURG, V95, P460, DOI 10.1002/bjs.6022; DAVIDS PHP, 1993, ANN SURG, V217, P237, DOI 10.1097/00000658-199303000-00004; Takara D, 2011, WORLD J SURG, V35, P850, DOI 10.1007/s00268-011-0990-1; Nagino M, 2006, ANN SURG, V243, P364, DOI 10.1097/01.sla.0000201482.11876.14; STRASBERG SM, 1995, J AM COLL SURGEONS, V180, P101; Sugawara G, 2013, SURGERY, V153, P200, DOI 10.1016/j.surg.2012.07.032; Flum DR, 2003, JAMA-J AM MED ASSOC, V290, P2168, DOI 10.1001/jama.290.16.2168; Grbas H, 2013, HEPATO-GASTROENTEROL, V60, P1873, DOI 10.5754/hge.121136; Walsh RM, 2007, SURGERY, V142, P450, DOI 10.1016/j.surg.2007.07.008; Kawashima H, 2013, ANN SURG, V257, P121, DOI 10.1097/SLA.0b013e318262b2e9; Sahajpal AK, 2010, ARCH SURG-CHICAGO, V145, P757, DOI 10.1001/archsurg.2010.153; Bismuth H, 2001, WORLD J SURG, V25, P1241; Draganov P, 2002, GASTROINTEST ENDOSC, V55, P680, DOI 10.1067/mge.2002.122955; Bergman JJGHM, 2001, GASTROINTEST ENDOSC, V54, P154, DOI 10.1067/mge.2001.116455; Barauskas G, 2012, MED LITH, V48, P138; Bektas H, 2007, BRIT J SURG, V94, P1119, DOI 10.1002/bjs.5752; Connor S, 2006, BRIT J SURG, V93, P158, DOI 10.1002/bjs.5266; Costamagna Guido, 2003, Gastrointest Endosc Clin N Am, V13, P635, DOI 10.1016/S1052-5157(03)00103-X; DAVIDOFF AM, 1992, ANN SURG, V215, P196, DOI 10.1097/00000658-199203000-00002; Perera MTPR, 2011, ANN SURG, V253, P553, DOI 10.1097/SLA.0b013e318208fad3; Lillemoe KD, 2000, ANN SURG, V232, P430, DOI 10.1097/00000658-200009000-00015; Misra S, 2004, J AM COLL SURGEONS, V198, P218, DOI 10.1016/j.jamcollsurg.2003.09.020; Nishio H, 1999, J Hepatobiliary Pancreat Surg, V6, P427, DOI 10.1007/s005340050145; PELLEGRINI CA, 1984, AM J SURG, V147, P175, DOI 10.1016/0002-9610(84)90054-0; Pulitano C, 2011, AM J SURG, V201, P238, DOI 10.1016/j.amjsurg.2009.07.038; Saad Nael, 2008, Tech Vasc Interv Radiol, V11, P102, DOI 10.1053/j.tvir.2008.07.004; Sarno G, 2012, BRIT J SURG, V99, P1129, DOI 10.1002/bjs.8806; Senda Y, 2009, WORLD J SURG, V33, P1459, DOI 10.1007/s00268-009-0025-3; Shimada H, 2012, SURG TODAY, V42, P1143, DOI 10.1007/s00595-012-0333-3; Thomson BNJ, 2007, WORLD J SURG, V31, P2363, DOI 10.1007/s00268-007-9234-9; Tocchi A, 1996, ANN SURG, V224, P162, DOI 10.1097/00000658-199608000-00008; Walsh RM, 2007, SURGERY, V142, P6	38	4	4	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	DEC	2014	21	12					889	895		10.1002/jhbp.151		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AU0YD	WOS:000345347200009		
J	Kubota, K; Fujita, Y; Sato, T; Sekino, Y; Hosono, K; Kobayashi, N; Fujisawa, N; Kagawa, K; Fujisawa, T; Matsuhashi, N; Tanida, E; Sakaguchi, T; Endo, I; Nakajima, A				Kubota, Kensuke; Fujita, Yuji; Sato, Takamistu; Sekino, Yusuke; Hosono, Kunihiro; Kobayashi, Noritoshi; Fujisawa, Nobutaka; Kagawa, Koji; Fujisawa, Toshio; Matsuhashi, Nobuyuki; Tanida, Emiko; Sakaguchi, Takashi; Endo, Itaru; Nakajima, Atsushi			Autoimmune pancreatitis associated with pancreatic cyst: how can we manage it?	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Autoimmune pancreatitis; Pancreatic cyst; Varix	INTERNATIONAL CONSENSUS; PORTAL-HYPERTENSION; STEROID-THERAPY; PSEUDOCYSTS; DISEASE	BackgroundAutoimmune pancreatitis (AIP) with cyst formation (ACF) is often refractory to corticosteroid treatment (CST). AimTo determine the characteristic features for the development of ACF. MethodsWe studied characteristics in AIP patients (n = 116) whether any factors might be related to ACF. Additionally, an individual database of 24 patients was compiled to investigate factors included CST effectiveness. ResultThe results of univariate analysis for type 1 AIP patients revealed significant association of ACF with the elevation of pancreatic enzymes, peripancreas vascular involvement (PVI) and varix formation at disease onset (P < 0.05), while multivariate analysis revealed only the absence of varix formation (odds ratio = 0.033, P = 0.0015) as a significant independent predictor of the development of ACF. The comparison of the characteristic features in ACF grouped by the diameter of the cysts revealed that only the effectiveness of the CST was significantly recognized in ACF measuring less than 55mm in diameter than that with patients in the group with smaller cysts (P < 0.05). ConclusionThe varix formation is an independent predictor of the development of ACF. A pooled analysis indicated that the disease process might be irreversible in AIP patients with large cystic lesions exceeding 55mm in diameter and those patients tended to show a refractory course even if CST were conducted.	[Kubota, Kensuke; Fujita, Yuji; Sato, Takamistu; Sekino, Yusuke; Hosono, Kunihiro; Kobayashi, Noritoshi; Nakajima, Atsushi] Yokohama City Univ, Grad Sch Med, Div Gastroenterol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Fujisawa, Nobutaka] Tokyo Hiroo Metroporitan Hosp, Div Gastroenterol, Shibuya, Japan; [Kagawa, Koji; Fujisawa, Toshio; Matsuhashi, Nobuyuki] NTT Kanto Med Ctr, Div Gastroenterol, Tokyo, Japan; [Tanida, Emiko] Machida Metroporitan Hosp, Div Gastroenterol, Machida, Tokyo, Japan; [Sakaguchi, Takashi] Hiratsuka City Hosp, Div Gastroenterol, Hiratsuka, Kanagawa, Japan; [Endo, Itaru] Yokohama City Univ, Div Surg, Yokohama, Kanagawa 232, Japan	Kubota, K (reprint author), Yokohama City Univ, Grad Sch Med, Div Gastroenterol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	kubotak@yokohama-cu.ac.jp			Health and Labour Sciences Research Grants for research on intractable diseases (Research on IgG4-related disease) from the Ministry of Health, Labour and Welfare of Japan	This work was supported in part by the Health and Labour Sciences Research Grants for research on intractable diseases (Research on IgG4-related disease) from the Ministry of Health, Labour and Welfare of Japan.	Kamisawa T, 2009, GUT, V58, P1504, DOI 10.1136/gut.2008.172908; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Nishimori I, 2006, PANCREAS, V32, P244, DOI 10.1097/01.mpa.0000202950.02988.07; Takase M, 1997, ARCH PATHOL LAB MED, V121, P612; Hart PA, 2013, GUT, V62, P1771, DOI 10.1136/gutjnl-2012-303617; Zen Y, 2010, AM J SURG PATHOL, V34, P1812, DOI 10.1097/PAS.0b013e3181f7266b; YEO CJ, 1990, SURG GYNECOL OBSTET, V170, P411; Kubota K, 2007, GASTROINTEST ENDOSC, V66, P1142, DOI 10.1016/j.gie.2007.06.059; Kubota K, 2010, PANCREAS, V39, pE6, DOI 10.1097/MPA.0b013e3181bc119d; Notohara K, 2003, AM J SURG PATHOL, V27, P1119, DOI 10.1097/00000478-200308000-00009; Ishikawa T, 2012, J GASTROEN HEPATOL, V27, P1790, DOI 10.1111/j.1440-1746.2012.07248.x; Kubota K, 2011, J GASTROENTEROL, V46, P834, DOI 10.1007/s00535-011-0393-y; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Beristain JL, 2008, REV ESP ENFERM DIG, V100, P652, DOI 10.4321/s1130-01082008001000011; Flack VG, 2007, ARCH PATHOL LAB MED, V131, P16; Hirano K, 2012, PANCREAS, V41, P691, DOI 10.1097/MPA.0b013e31823bcdee; Kawa S, 2001, NEW ENGL J MED, V345, P147; Kawakami H, 2008, INTERNAL MED, V47, P603, DOI 10.2169/internalmedicine.47.0731; Kitoh H, 2003, NIPPON NAIKA GAKKAI, V92, P161; Kobayashi G, 2007, J GASTROENTEROL, V42, P650, DOI 10.1007/s00535-007-2068-2; Maruyama M, 2013, INT J RHEUMATOL, V2013; Matsubayashi H, 2013, J GASTROENTEROL, V48, P942, DOI 10.1007/s00535-012-0692-y; Mina SH, 2013, JOP, V14, P502; Muraki T, 2005, J GASTROENTEROL, V40, P761, DOI 10.1007/s00535-005-1622-z; Nishimura T, 2004, J GASTROENTEROL, V39, P1005, DOI 10.1007/s00535-004-1436-4; Okamoto T, 2003, SUIZO, V18, P228; Sharon MW, 2003, WORLD J SURG, V27, P1271; Sohn JW, 2012, GUT LIVER, V6, P132, DOI 10.5009/gnl.2012.6.1.132; Takita M, 2013, PANCREAS, V42, P175, DOI 10.1097/MPA.0b013e3182546e37; Welsch T, 2006, WORLD J GASTROENTERO, V12, P5904; YOSHIDA K, 1995, DIGEST DIS SCI, V40, P1561, DOI 10.1007/BF02285209	31	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	DEC	2014	21	12					902	910		10.1002/jhbp.160		9	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AU0YD	WOS:000345347200011		
J	Hayashi, C; Ito, M; Ito, R; Murakumo, A; Yamamoto, N; Hiramatsu, N; Fox, IJ; Horiguchi, A				Hayashi, Chihiro; Ito, Masahiro; Ito, Ryoutaro; Murakumo, Akiko; Yamamoto, Naoki; Hiramatsu, Noriko; Fox, Ira J.; Horiguchi, Akihiko			Effects of edaravone, a radical scavenger, on hepatocyte transplantation	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Edaravone; Hepatocyte; Radical scavenger; Transplantation	ISCHEMIA-REPERFUSION INJURY; ARTIFICIAL CHROMOSOMES; LIVER-FAILURE; MCI-186; RAT; GENE; CONSTRUCTION; KIDNEY; CELLS; PIGS	BackgroundHepatocyte transplantation (HTx) has yielded significant improvements in liver function and survival in experimentally induced acute liver failure and liver-based metabolic disease. However, transplantation is inefficient, and it is thought that transplanted hepatocytes have a shortened lifespan because of inflammation involving excess nitric oxide (NO). The present study aimed to clarify whether edaravone, a free radical scavenger used to treat ischemic stroke, could reduce ischemic changes in hepatocyte-transplanted livers. MethodsEdaravone (3mg/kg) was administered intravenously 24h before HTx to Nagase analbuminemic rats (NARs). Hepatocytes were isolated, and 30 x 10(6) cells were injected in a 1.0-ml volume directly into the spleens of NARs. All experimental groups studied received FK506 to control rejection. Animals in Group A received medium-only; Group B received HTx only; and Group C received HTx and edaravone. Forty-eight hours after transplantation, the hepatocytes from animals were isolated and analyzed for staining with propidium iodide- and annexin-V using flow cytometry. Liver sections were also studied by immunostaining for albumin, and TUNEL. Peripheral blood serum albumin levels were measured on post-transplant days 0, 3, 5, 7, 10 and 14 using ELISA. ResultsThe edaravone-treated animals demonstrated an increased number of engrafted donor hepatocytes in the liver. The edaravone-treated liver sections also contained fewer TUNEL-positive cells and animals that received edaravone had higher serum albumin levels post-transplantation. Hepatocytes were also found to have increased in numbers 2 weeks following treatment with edaravone. ConclusionsEdaravone administration during HTx can suppress apoptosis near the transplanted cells, increasing engraftment. These studies indicate its potential usefulness for future clinical application.	[Hayashi, Chihiro; Ito, Masahiro; Ito, Ryoutaro; Murakumo, Akiko; Horiguchi, Akihiko] Fujita Hlth Univ, Dept Surg, Toyoake, Aichi 4701192, Japan; [Yamamoto, Naoki; Hiramatsu, Noriko] Fujita Hlth Univ, Inst Comprehens Med Sci, Toyoake, Aichi 4701192, Japan; [Fox, Ira J.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA	Ito, M (reprint author), Fujita Hlth Univ, Dept Surg, 1-98 Dengakugakubo,Kutukake Cho, Toyoake, Aichi 4701192, Japan.	masito@fujita-hu.ac.jp					ABE K, 1988, STROKE, V19, P480; Akao T, 2006, J HEART LUNG TRANSPL, V25, P965, DOI 10.1016/j.healun.2006.03.004; Doi K, 2004, KIDNEY INT, V65, P1714, DOI 10.1111/j.1523-1755.2004.00567.x; Kawai H, 1997, J PHARMACOL EXP THER, V281, P921; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; Ikeno M, 1998, NAT BIOTECHNOL, V16, P431, DOI 10.1038/nbt0598-431; Cai J, 2000, J HEPATOL, V33, P701, DOI 10.1016/S0168-8278(00)80299-8; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Arkadopoulos N, 1998, CELL TRANSPLANT, V7, P357, DOI 10.1016/S0963-6897(98)00027-X; DEMETRIOU AA, 1986, P NATL ACAD SCI USA, V83, P7475, DOI 10.1073/pnas.83.19.7475; desRoos WK, 1997, TRANSPLANTATION, V63, P513; Fox IJ, 1998, NEW ENGL J MED, V338, P1422, DOI 10.1056/NEJM199805143382004; IKENO M, 1994, HUM MOL GENET, V3, P1245, DOI 10.1093/hmg/3.8.1245; Ikeno M, 2002, GENES CELLS, V7, P1021, DOI 10.1046/j.1365-2443.2002.00580.x; Masaki Y, 1996, TRANSPLANT P, V28, P1885; Miyazawa K, 2014, TRANSPL P, V46, P1090, DOI 10.1016/j.transproceed.2013.11.155; Nagatani S, 2011, PANCREAS, V40, P126, DOI 10.1097/MPA.0b013e3181f7e436; Nakamura J, 1997, TRANSPLANTATION, V63, P1541, DOI 10.1097/00007890-199706150-00001; Ninomiya M, 2002, TRANSPLANTATION, V74, P1470, DOI 10.1097/01.TP.000038708.71408.1F; RUGSTAD H E, 1970, Science (Washington D C), V170, P553, DOI 10.1126/science.170.3957.553; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Suszynski Thomas M, 2014, J Diabetes Sci Technol, V8, P575, DOI 10.1177/1932296814525827; Suzuki F, 2005, TRANSPLANT INT, V18, P844, DOI 10.1111/j.1432-2277.2005.00094.x; Tahara M, 2005, TRANSPLANTATION, V80, P213, DOI 10.1097/01.TP.0000165092.07375.C9	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	DEC	2014	21	12					919	924		10.1002/jhbp.164		6	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AU0YD	WOS:000345347200013		
J	Itoi, T; Sofuni, A; Tsuchiya, T; Ijima, M; Iwashita, T				Itoi, Takao; Sofuni, Atsushi; Tsuchiya, Takayoshi; Ijima, Masashi; Iwashita, Takuji			Endoscopic ultrasonography-guided transhepatic antegrade stone removal in patients with surgically altered anatomy: case series and technical review (with videos)	JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES			English	Article						Bile duct stone; Endoscopic papillary balloon dilation; Endoscopic ultrasonography; Endoscopic ultrasonography-guided biliary drainage	EN-Y ANASTOMOSIS; BALLOON ENTEROSCOPE; MALIGNANT BILIARY; METAL STENT; OBSTRUCTION; ERCP; DRAINAGE; CHOLEDOCHODUODENOSTOMY; PLACEMENT	Recently, endoscopic ultrasonography (EUS)-guided transhepatic antegrade interventions have been introduced in patients with a surgically altered anatomy. Herein, we focused on and reviewed EUS-guided transhepatic antegrade stone removal (EUS-TASR) in patients with a surgically altered anatomy and native papilla. The basic technique of EUS-TASR involves the following steps: (1) EUS-guided needle puncture; (2) guidewire placement; (3) tract dilation; (4) balloon sphincteroplasty; (5) stone removal; and (6) stent placement if needed. Based on reports in the literature including our cases, the complete stone extraction rate is 71.4% (10/14) including five of our cases (60% success rate) at one session without serious complications. In conclusion, EUS-TASR appears to be feasible and useful in selected patients although its application may be limited depending on anatomical factors and current devices used.	[Itoi, Takao; Sofuni, Atsushi; Tsuchiya, Takayoshi] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Shinjuku Ku, Tokyo 1600023, Japan; [Ijima, Masashi] Isezaki Civilian Hosp, Dept Gastroenterol, Gunma, Japan; [Iwashita, Takuji] Gifu Univ Hosp, Dept Internal Med 1, Gifu, Japan	Itoi, T (reprint author), Tokyo Med Univ, Dept Gastroenterol & Hepatol, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	itoi@tokyo-med.ac.jp					Shimatani M, 2009, ENDOSCOPY, V41, P849, DOI 10.1055/s-0029-1215108; Park DH, 2012, GASTROINTEST ENDOSC, V75, P692, DOI 10.1016/j.gie.2011.04.013; Nguyen-Tang T, 2010, ENDOSCOPY, V42, P232, DOI 10.1055/s-0029-1243858; Artifon ELA, 2012, J CLIN GASTROENTEROL, V46, P768, DOI 10.1097/MCG.0b013e31825f264c; Itoi T, 2012, GASTROINTEST ENDOSC, V75, P870, DOI 10.1016/j.gie.2011.10.020; Tonozuka R, 2013, DIGEST ENDOSC, V25, P100, DOI 10.1111/den.12063; Park DH, 2011, GASTROINTEST ENDOSC, V74, P1276, DOI 10.1016/j.gie.2011.07.054; Dhir V, 2012, GASTROINTEST ENDOSC, V75, P354, DOI 10.1016/j.gie.2011.07.075; Weilert F, 2011, ENDOSCOPY, V43, P1105, DOI 10.1055/s-0030-1256961; Hara K, 2011, AM J GASTROENTEROL, V106, P1239, DOI 10.1038/ajg.2011.84; Iwashita T, 2013, DIGEST DIS SCI, V58, P2417, DOI 10.1007/s10620-013-2645-6; Saleem A, 2010, ENDOSCOPY, V42, P656, DOI 10.1055/s-0030-1255557; Artifon Everson L A, 2011, JOP, V12, P610; Itoi T, 2013, J HEPATO-BIL-PAN SCI, V20, P71, DOI 10.1007/s00534-012-0569-8; Itoi T, 2014, J HEPATO-BIL-PAN SCI, V21, pE4, DOI 10.1002/jhbp.43; Itoi T, 2010, AM J GASTROENTEROL, V105, P93, DOI 10.1038/ajg.2009.559; Iwashita T, 2013, DIGEST ENDOSC, V25, P84; Kawakami H, 2014, DIGEST ENDOSC, V26, P121, DOI 10.1111/den.12180; Monkemuller K, 2008, GASTROINTEST ENDOSC, V67, P992, DOI 10.1016/j.gie.2007.10.023; Sansak I, 2014, J HEPATO-BIL-PAN SCI, V21, P719, DOI 10.1002/jhbp.133; Yasuda I, 2013, DIGEST ENDOSC, V25, P376, DOI 10.1111/den.12118	21	3	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	DEC	2014	21	12					E86	E93		10.1002/jhbp.165		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AU0YD	WOS:000345347200001		
J	Yamazaki, S; Nishioka, A; Kasuya, S; Ohkura, N; Hemmi, H; Kaisho, T; Taguchi, O; Sakaguchi, S; Morita, A				Yamazaki, Sayuri; Nishioka, Akiko; Kasuya, Saori; Ohkura, Naganari; Hemmi, Hiroaki; Kaisho, Tsuneyasu; Taguchi, Osamu; Sakaguchi, Shimon; Morita, Akimichi			Homeostasis of Thymus-Derived Foxp3(+) Regulatory T Cells Is Controlled by Ultraviolet B Exposure in the Skin	JOURNAL OF IMMUNOLOGY			English	Article							MAINTAIN IMMUNE HOMEOSTASIS; DENDRITIC CELLS; LANGERHANS CELLS; INDUCED IMMUNOSUPPRESSION; IN-VIVO; EXPRESSION; INFLAMMATION; POPULATIONS; ACTIVATION; PRECURSORS	Accumulating evidence shows that immunological tolerance induced by Ag administration together with UVB irradiation is dependent on Foxp3(+) CD4(+) regulatory T (Treg) cells. However, the mechanisms by which UVB controls Treg cells in the skin are currently unclear. In this study, we have shown that exposure to UVB induced expansion of Treg cells up to 50-60% of the CD4(+) T cells in the irradiated skin. The Treg cell expansion in the skin lasted for 2 wk after exposure, which contributed to homeostasis of Treg cells in the periphery later. UVB-expanded Treg cells formed clusters with dendritic cells and proliferated in situ. Furthermore, the expanded Treg cells appeared to derive from neuropilin 1(+) thymus-derived Treg (tTreg) cells in the periphery because UVB-expanded Treg cells possessed Treg cell-specific CpG hypomethylation pattern, as seen in tTreg cells. These results collectively indicate that homeostasis of tTreg cells is controlled by UVB exposure in the skin. UVB therapy may be useful for not only inflammatory skin disorders, but also autoimmunity, transplantation, and allergy.	[Yamazaki, Sayuri; Nishioka, Akiko; Kasuya, Saori; Taguchi, Osamu; Morita, Akimichi] Nagoya City Univ, Grad Sch Med Sci, Dept Geriatr & Environm Dermatol, Nagoya, Aichi 4678601, Japan; [Ohkura, Naganari; Sakaguchi, Shimon] Osaka Univ, Dept Expt Immunol, World Premier Int Res Ctr Initiat, Immunol Frontier Res Ctr, Osaka 5650871, Japan; [Hemmi, Hiroaki; Kaisho, Tsuneyasu] Osaka Univ, Immunol Frontier Res Ctr, Lab Immune Regulat, World Premier Int Res Ctr Initiat, Osaka 5650871, Japan; [Kaisho, Tsuneyasu] RIKEN, Ctr Integrat Med Sci IMS RCAI, Lab Inflammatory Regulat, Yokohama, Kanagawa 2300045, Japan; [Taguchi, Osamu] Kochi Med Sch, Dept Ophthalmol, Nankoku, Kochi 7838505, Japan	Yamazaki, S (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Geriatr & Environm Dermatol, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	yamazas@med.nagoya-cu.ac.jp	Sakaguchi, Shimon/C-9535-2009		Japan Society for the Promotion of Science [24659182, 2339088]; Aichi Cancer Research Foundation; Lydia O'Leary Memorial Pias Dermatological Foundation; Japanese Dermatological Association of Shiseido	This work was supported by Grant-in-Aid for Challenging Exploratory Research 24659182 and Grant-in-Aid for Scientific Research B 2339088 from the Japan Society for the Promotion of Science, the Aichi Cancer Research Foundation, the Lydia O'Leary Memorial Pias Dermatological Foundation, and a Grant for Basic Dermatological Research from the Japanese Dermatological Association of Shiseido. These funding bodies played no role in study design, data collection or analysis, the decision to publish, or preparation of the manuscript.	Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Yamazaki S, 2007, BLOOD, V110, P4293, DOI 10.1182/blood-2007-05-088831; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Loser K, 2006, NAT MED, V12, P1372, DOI 10.1038/nm1518; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1081/jem.20030422; Seneschal J, 2012, IMMUNITY, V36, P873, DOI 10.1016/j.immuni.2012.03.018; Schwarz A, 2010, J INVEST DERMATOL, V130, P1419, DOI 10.1038/jid.2009.429; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Dudda JC, 2008, J EXP MED, V205, P1559, DOI 10.1084/jem.20072594; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Schwarz A, 2011, J ALLERGY CLIN IMMUN, V128, P826, DOI 10.1016/j.jaci.2011.06.005; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Soontrapa K, 2011, P NATL ACAD SCI USA, V108, P6668, DOI 10.1073/pnas.1018625108; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Yamazaki S, 2006, P NATL ACAD SCI USA, V103, P2758, DOI 10.1073/pnas.0510606103; Norval M, 2011, PHOTOCHEM PHOTOBIOL, V87, P965, DOI 10.1111/j.1751-1097.2011.00969.x; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; de Aguero MG, 2012, J CLIN INVEST, V122, P1700, DOI 10.1172/JCI59725; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Yamazaki S, 2008, J IMMUNOL, V181, P6923; Azukizawa H, 2011, EUR J IMMUNOL, V41, P1420, DOI 10.1002/eji.201040930; Abbas AK, 2013, NAT IMMUNOL, V14, P307, DOI 10.1038/ni.2554; Fehervari Z, 2004, INT IMMUNOL, V16, P1769, DOI 10.1093/intimm/dxh178; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Itoh M, 1999, J IMMUNOL, V162, P5317; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Bour-Jordan H, 2009, IMMUNOL REV, V229, P41, DOI 10.1111/j.1600-065X.2009.00775.x; Caricchio R, 2003, J IMMUNOL, V171, P5778; Chow Z, 2013, J IMMUNOL, V191, P3049, DOI 10.4049/jimmunol.1203205; Furuhashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054895; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Paiva RS, 2013, P NATL ACAD SCI USA, V110, P6494, DOI 10.1073/pnas.1221955110; Yamazaki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018833; Yamazaki S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00151	44	2	2	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	DEC 1	2014	193	11					5488	5497		10.4049/jimmunol.1400985		10	Immunology	Immunology	AU2JC	WOS:000345443000016		
J	Fujita, T; Burwitz, BJ; Chew, GM; Reed, JS; Pathak, R; Seger, E; Clayton, KL; Rini, JM; Ostrowski, MA; Ishii, N; Kuroda, MJ; Hansen, SG; Sacha, JB; Ndhlovu, LC				Fujita, Tsuyoshi; Burwitz, Benjamin J.; Chew, Glen M.; Reed, Jason S.; Pathak, Reesab; Seger, Elizabeth; Clayton, Kiera L.; Rini, James M.; Ostrowski, Mario A.; Ishii, Naoto; Kuroda, Marcelo J.; Hansen, Scott G.; Sacha, Jonah B.; Ndhlovu, Lishomwa C.			Expansion of Dysfunctional Tim-3-Expressing Effector Memory CD8(+) T Cells during Simian Immunodeficiency Virus Infection in Rhesus Macaques	JOURNAL OF IMMUNOLOGY			English	Article							CLASS-I MOLECULE; TIM-3 EXPRESSION; IMMUNE-RESPONSES; PD-1 BLOCKADE; HIV-INFECTION; ANTIRETROVIRAL THERAPY; VIRAL-INFECTION; SIV INFECTION; EXHAUSTION; VIREMIA	The T cell Ig- and mucin domain-containing molecule-3 (Tim-3) negative immune checkpoint receptor demarcates functionally exhausted CD8(+) T cells arising from chronic stimulation in viral infections like HIV. Tim-3 blockade leads to improved antiviral CD8(+) T cell responses in vitro and, therefore, represents a novel intervention strategy to restore T cell function in vivo and protect from disease progression. However, the Tim-3 pathway in the physiologically relevant rhesus macaque SIV model of AIDS remains uncharacterized. We report that Tim-3(+)CD8(+) T cell frequencies are significantly increased in lymph nodes, but not in peripheral blood, in SIV-infected animals. Tim-3(+)PD-1(+)CD8(+) T cells are similarly increased during SIV infection and positively correlate with SIV plasma viremia. Tim-3 expression was found primarily on effector memory CD8(+) T cells in all tissues examined. Tim-3(+)CD8(+) T cells have lower Ki-67 content and minimal cytokine responses to SIV compared with Tim-3(-)CD8(+) T cells. During acute-phase SIV replication, Tim-3 expression peaked on SIV-specific CD8(+) T cells by 2 wk postinfection and then rapidly diminished, irrespective of mutational escape of cognate Ag, suggesting non-TCR-driven mechanisms for Tim-3 expression. Thus, rhesus Tim-3 in SIV infection partially mimics human Tim-3 in HIV infection and may serve as a novel model for targeted studies focused on rejuvenating HIV-specific CD8(+) T cell responses.	[Fujita, Tsuyoshi; Chew, Glen M.; Ndhlovu, Lishomwa C.] Univ Hawaii, John A Burns Sch Med, Hawaii Ctr AIDS, Dept Trop Med, Honolulu, HI 96813 USA; [Fujita, Tsuyoshi; Ishii, Naoto] Tohoku Univ, Grad Sch Med, Dept Microbiol & Immunol, Sendai, Miyagi 9808575, Japan; [Burwitz, Benjamin J.; Reed, Jason S.; Pathak, Reesab; Seger, Elizabeth; Hansen, Scott G.; Sacha, Jonah B.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA; [Burwitz, Benjamin J.; Reed, Jason S.; Pathak, Reesab; Seger, Elizabeth; Hansen, Scott G.; Sacha, Jonah B.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Clayton, Kiera L.; Rini, James M.; Ostrowski, Mario A.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Kuroda, Marcelo J.] Tulane Natl Primate Res Ctr, Div Immunol, Covington, LA 70433 USA	Ndhlovu, LC (reprint author), Univ Hawaii, Dept Trop Med, Hawaii Ctr AIDS, 651 Ilalo St,BSB 325C, Honolulu, HI 96813 USA.	sacha@ohsu.edu; lndhlovu@hawaii.edu			National Institutes of Health, National Institute of Allergy and Infectious Diseases, Centers for AIDS Research [AI027757]; National Center for Research Resources [P51 OD011092, P51 OD011104]; Creative and Novel Ideas in HIV Research Program [P30 A1027763]; Office of AIDS Research, National Institute of Allergy and Infectious Diseases; International AIDS Society; Delaney AIDS Research Enterprise Grant [AI096109]	This work was supported in part by Grant AI027757 from the National Institutes of Health, National Institute of Allergy and Infectious Diseases, Centers for AIDS Research; Grants P51 OD011092 and P51 OD011104 from the National Center for Research Resources; and the Creative and Novel Ideas in HIV Research Program through a supplement to the University of California San Francisco-Gladstone Institute of Virology and Immunology Center for AIDS Research funding (P30 A1027763 to L.C.N.). This funding was made possible by collaborative efforts of the Office of AIDS Research, the National Institute of Allergy and Infectious Diseases, and the International AIDS Society. E.S. is a Silver Family Foundation Scholar. This work was also supported by Delaney AIDS Research Enterprise Grant AI096109.	Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x; Brodie SJ, 1999, NAT MED, V5, P34; Vogel TU, 2002, J VIROL, V76, P11623, DOI 10.1128/JVI.76.22.11623-11636.2002; Fukazawa Y, 2012, NAT MED, V18, P1673, DOI 10.1038/nm.2934; Ndhlovu LC, 2012, BLOOD, V119, P3734, DOI 10.1182/blood-2011-11-392951; Schietinger A, 2014, TRENDS IMMUNOL, V35, P51, DOI 10.1016/j.it.2013.10.001; Hafler DA, 2008, J EXP MED, V205, P2699, DOI 10.1084/jem.20082429; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Mothe BR, 2002, J VIROL, V76, P875, DOI 10.1128/JVI.76.2.875-884.2002; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Porichis F, 2012, CURR HIV-AIDS REP, V9, P81, DOI [10.1007/s11904-011-0106-4, 10.1007/s11904-011-0106]; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; KOUP RA, 1994, J VIROL, V68, P4650; Chiba S, 2012, NAT IMMUNOL, V13, P832, DOI 10.1038/ni.2376; Yang ZZ, 2012, J CLIN INVEST, V122, P1271, DOI 10.1172/JCI59806; Yan GM, 2011, NAT BIOTECHNOL, V29, P1019, DOI 10.1038/nbt.1992; Takamura S, 2010, J IMMUNOL, V184, P4696, DOI 10.4049/jimmunol.0903478; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Elahi S, 2011, NAT MED, V17, P989, DOI 10.1038/nm.2422; Xu HB, 2013, J LEUKOCYTE BIOL, V93, P943, DOI 10.1189/jlb.1112580; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; BORROW P, 1994, J VIROL, V68, P6103; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Hastings WD, 2009, EUR J IMMUNOL, V39, P2492, DOI 10.1002/eji.200939274; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Youngblood B, 2013, J IMMUNOL, V191, P540, DOI 10.4049/jimmunol.1203161; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Petrovas C, 2007, BLOOD, V110, P928, DOI 10.1182/blood-2007-01-069112; Matano T, 1998, J VIROL, V72, P164; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Crespo J, 2013, CURR OPIN IMMUNOL, V25, P214, DOI 10.1016/j.coi.2012.12.003; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Sacha JB, 2007, J IMMUNOL, V178, P2746; Bimber BN, 2009, J VIROL, V83, P8247, DOI 10.1128/JVI.00897-09; Burwitz BJ, 2011, J VIROL, V85, P13088, DOI 10.1128/JVI.05650-11; Dietze KK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003798; Shetty RD, 2012, J CLIN INVEST, V122, P1712, DOI 10.1172/JCI60612; Evering TH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002506; Gao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030676; Kassu A, 2011, AIDS RES HUM RETROV, V27, P1, DOI 10.1089/aid.2010.0156; Li W, 2011, J VIROL, V85, P13342, DOI 10.1128/JVI.00120-11; Mujib S, 2012, J IMMUNOL, V188, P3745, DOI 10.4049/jimmunol.1102609; Nebbia G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047648; Okagawa T, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-45; Saitoh H, 2012, TOHOKU J EXP MED, V228, P157, DOI 10.1620/tjem.228.157; Sakhdari A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040146; Sehrawat S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000882; Stekler JD, 2012, INT J STD AIDS, V23, P201, DOI 10.1258/ijsa.2011.011178; Tandon R, 2014, AIDS RES HUM RETROV, V30, P654, DOI [10.1089/AID.2014.0004, 10.1089/aid.2014.0004]; Tandon R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045733; Vali B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003454	60	3	3	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	DEC 1	2014	193	11					5576	5583		10.4049/jimmunol.1400961		8	Immunology	Immunology	AU2JC	WOS:000345443000025		
J	Watanabe, M; Terasawa, M; Miyano, K; Yanagihara, T; Uruno, T; Sanematsu, F; Nishikimi, A; Cote, JF; Sumimoto, H; Fukui, Y				Watanabe, Mayuki; Terasawa, Masao; Miyano, Kei; Yanagihara, Toyoshi; Uruno, Takehito; Sanematsu, Fumiyuki; Nishikimi, Akihiko; Cote, Jean-Francois; Sumimoto, Hideki; Fukui, Yoshinori			DOCK2 and DOCK5 Act Additively in Neutrophils To Regulate Chemotaxis, Superoxide Production, and Extracellular Trap Formation	JOURNAL OF IMMUNOLOGY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; RAC ACTIVATOR DOCK2; RHO-GTPASES; IN-VIVO; P-REX1; POLARITY; FAMILY; MIGRATION; RESPONSES; PROTEINS	Neutrophils are highly motile leukocytes that play important roles in the innate immune response to invading pathogens. Neutrophils rapidly migrate to the site of infections and kill pathogens by producing reactive oxygen species (ROS). Neutrophil chemotaxis and ROS production require activation of Rac small GTPase. DOCK2, an atypical guanine nucleotide exchange factor (GEF), is one of the major regulators of Rac in neutrophils. However, because DOCK2 deficiency does not completely abolish fMLF-induced Rac activation, other Rac GEFs may also participate in this process. In this study, we show that DOCK5 acts with DOCK2 in neutrophils to regulate multiple cellular functions. We found that fMLF- and PMA-induced Rac activation were almost completely lost in mouse neutrophils lacking both DOCK2 and DOCK5. Although beta(2) integrin-mediated adhesion occurred normally even in the absence of DOCK2 and DOCK5, mouse neutrophils lacking DOCK2 and DOCK5 exhibited a severe defect in chemotaxis and ROS production. Similar results were obtained when human neutrophils were treated with CPYPP, a small-molecule inhibitor of these DOCK GEFs. Additionally, we found that DOCK2 and DOCK5 regulate formation of neutrophil extracellular traps (NETs). Because NETs are involved in vascular inflammation and autoimmune responses, DOCK2 and DOCK5 would be a therapeutic target for controlling NET-mediated inflammatory disorders.	[Watanabe, Mayuki; Terasawa, Masao; Yanagihara, Toyoshi; Uruno, Takehito; Sanematsu, Fumiyuki; Fukui, Yoshinori] Kyushu Univ, Med Inst Bioregulat, Dept Immunobiol & Neurosci, Div Immunogenet, Fukuoka 8128582, Japan; [Miyano, Kei; Sumimoto, Hideki] Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Fukuoka 8128582, Japan; [Nishikimi, Akihiko] Kitasato Univ, Sch Sci, Dept Biosci, Sagamihara, Kanagawa 2520373, Japan; [Cote, Jean-Francois] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Fukui, Yoshinori] Kyushu Univ, Res Ctr Adv Immunol, Fukuoka 8128582, Japan	Fukui, Y (reprint author), Kyushu Univ, Med Inst Bioregulat, Dept Immunobiol & Neurosci, Div Immunogenet,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	fukui@bioreg.kyushu-u.ac.jp			Core Research for Evolutional Science and Technology program; Strategic Japanese-Swiss Cooperative Program of the Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Canadian Institute of Health Research	This work was supported by the Core Research for Evolutional Science and Technology program (to Y.F.) and the Strategic Japanese-Swiss Cooperative Program (to Y.F.) of the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research (to Y.F.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and Grants-in-Aid for Scientific Research (to Y.F.) from the Japan Society for the Promotion of Science; and by the Canadian Institute of Health Research (to J.-F.C.). M.W. is a Research Fellow of the Japan Society for the Promotion of Science. J.-F.C. is a Senior Investigator from the Fonds de RechercheSante du Quebec.	Akasaki T, 1999, J BIOL CHEM, V274, P18055, DOI 10.1074/jbc.274.25.18055; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Kunisaki Y, 2006, J CELL BIOL, V174, P647, DOI 10.1083/jcb.2006.02142; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Damoulakis G, 2014, J CELL SCI, V127, P2589, DOI 10.1242/jcs.153049; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Welch HCE, 2005, CURR BIOL, V15, P1867, DOI 10.1016/j.cub.2005.09.050; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Williams DA, 2000, BLOOD, V96, P1646; Hanawa-Suetsugu K, 2012, P NATL ACAD SCI USA, V109, P3305, DOI 10.1073/pnas.1113512109; Kim C, 2003, J IMMUNOL, V171, P4425; Harada Y, 2012, BLOOD, V119, P4451, DOI 10.1182/blood-2012-01-407098; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Laurin M, 2013, P NATL ACAD SCI USA, V110, P7434, DOI 10.1073/pnas.1213050110; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Dong XM, 2005, CURR BIOL, V15, P1874, DOI 10.1016/j.cub.2005.09.014; Vives V, 2011, J BONE MINER RES, V26, P1099, DOI 10.1002/jbmr.282; Sanui T, 2003, BLOOD, V102, P2948, DOI 10.1182/blood-2003-01-0173; Sun CX, 2004, BLOOD, V104, P3758, DOI 10.1182/blood-2004-03-0781; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gakidis MAM, 2004, J CELL BIOL, V166, P273, DOI 10.1083/jcb.200404166; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI [10.1038/nchembio.496, 10.1038/NCHEMBIO.496]; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Lawson CD, 2011, J IMMUNOL, V186, P1467, DOI 10.4049/jimmunol.1002738; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Li SJ, 2002, J IMMUNOL, V169, P5043; Filippi MD, 2004, NAT IMMUNOL, V5, P744, DOI 10.1038/ni1081; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Nishikimi A, 2012, CHEM BIOL, V19, P488, DOI 10.1016/j.chembiol.2012.03.008; Sakai Y, 2013, BLOOD, V122, P386, DOI 10.1182/blood-2012-12-475897; Sanematsu F, 2013, J BIOL CHEM, V288, P8092, DOI 10.1074/jbc.M112.410423	41	1	1	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	DEC 1	2014	193	11					5660	5667		10.4049/jimmunol.1400885		8	Immunology	Immunology	AU2JC	WOS:000345443000033		
J	Brennan, AJ; House, IG; Oliaro, J; Ramsbottom, KM; Hagn, M; Yagita, H; Trapani, JA; Voskoboinik, I				Brennan, Amelia J.; House, Imran G.; Oliaro, Jane; Ramsbottom, Kelly M.; Hagn, Magdalena; Yagita, Hideo; Trapani, Joseph A.; Voskoboinik, Ilia			A Method for Detecting Intracellular Perforin in Mouse Lymphocytes	JOURNAL OF IMMUNOLOGY			English	Article							CD8(+) T-CELLS; IMMUNOLOGICAL SYNAPSE; MEDIATED CYTOTOXICITY; KILLER-CELLS; GRANZYME-B; DIFFERENTIATION; MEMORY; DEATH; GENE; POLARIZATION	Cytotoxic lymphocytes destroy pathogen-infected and transformed cells through the cytotoxic granule exocytosis death pathway, which is dependent on the delivery of proapoptotic granzymes into the target cell cytosol by the pore-forming protein, perforin. Despite the importance of mouse models in understanding the role of cytotoxic lymphocytes in immune-mediated disease and their role in cancer immune surveillance, no reliable intracellular detection method exists for mouse perforin. Consequently, rapid, flow-based assessment of cytotoxic potential has been problematic, and complex assays of function are generally required. In this study, we have developed a novel method for detecting perforin in primary mouse cytotoxic T lymphocytes by immunofluorescence and flow cytometry. We used this new technique to validate perforin colocalization with granzyme B in cytotoxic granules polarized to the immunological synapse, and to assess the expression of perforin in cytotoxic T lymphocytes at various stages of activation. The sensitivity of this technique also allowed us to distinguish perforin levels in Prf1(+/+) and Prf1(+/-) mice. This new methodology will have broad applications and contribute to advances within the fields of lymphocyte biology, infectious disease, and cancer.	[Brennan, Amelia J.; House, Imran G.; Oliaro, Jane; Ramsbottom, Kelly M.; Hagn, Magdalena; Trapani, Joseph A.; Voskoboinik, Ilia] Peter MacCallum Canc Ctr, Canc Immunol Program, East Melbourne, Vic 3002, Australia; [House, Imran G.; Oliaro, Jane; Trapani, Joseph A.; Voskoboinik, Ilia] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 1138421, Japan; [Trapani, Joseph A.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Voskoboinik, Ilia] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia; [Voskoboinik, Ilia] Univ Melbourne, Dept Genet, Parkville, Vic 3010, Australia	Voskoboinik, I (reprint author), Peter MacCallum Canc Ctr, Canc Immunol Program, St Andrews Pl, East Melbourne, Vic 3002, Australia.	amelia.brennan@petermac.org; ilia.voskoboinik@petermac.org			National Health and Medical Research Council of Australia; Cancer Council Victoria; Australian postgraduate award; National Health and Medical Research Council of Australia fellowship	This work was supported by project and program grants from the National Health and Medical Research Council of Australia and the Cancer Council Victoria (to I.V. and J.A.T.). I.V. is supported by a National Health and Medical Research Council of Australia fellowship. I.G.H. is supported by an Australian postgraduate award.	Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Zhang J, 1999, J EXP MED, V190, P1297, DOI 10.1084/jem.190.9.1297; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Chia J, 2009, P NATL ACAD SCI USA, V106, P9809, DOI 10.1073/pnas.0903815106; Trifari S, 2013, P NATL ACAD SCI USA, V110, P18608, DOI 10.1073/pnas.1317191110; Lopez JA, 2013, BLOOD, V121, P2659, DOI 10.1182/blood-2012-07-446146; Froelich CJ, 1996, J BIOL CHEM, V271, P29073; Wakita D, 2010, EUR J IMMUNOL, V40, P1927, DOI 10.1002/eji.200940157; Johnson BJ, 2003, P NATL ACAD SCI USA, V100, P2657, DOI 10.1073/pnas.0538056100; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Shevach EM, 2006, IMMUNOL REV, V212, P60, DOI 10.1111/j.0105-2896.2006.00415.x; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Jenkins MR, 2007, J IMMUNOL, V179, P64; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Jenkins MR, 2008, J IMMUNOL, V181, P3818; Peixoto A, 2007, J EXP MED, V204, P1193, DOI 10.1084/jem.20062349; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Lopez JA, 2012, TRENDS IMMUNOL, V33, P406, DOI 10.1016/j.it.2012.04.001; Kim N, 2014, J ALLERGY CLIN IMMUN, V134, P195, DOI 10.1016/j.jaci.2014.02.018; Baschuk N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.74; Brennan AJ, 2010, CELL DEATH DIFFER, V17, P607, DOI 10.1038/cdd.2009.212; Jenkins MR, 2009, IMMUNITY, V31, P621, DOI 10.1016/j.immuni.2009.08.024; Katano H, 2005, BRIT J HAEMATOL, V128, P739, DOI 10.1111/j.1365-2141.2004.05305.x; KAWASAKI A, 1990, INT IMMUNOL, V2, P677, DOI 10.1093/intimm/2.7.677; Kelso A, 2002, INT IMMUNOL, V14, P605, DOI 10.1093/intimm/dxf028; KONISHI N, 1988, THYMUS, V12, P225; Lopez JA, 2013, J IMMUNOL, V191, P2328, DOI 10.4049/jimmunol.1301205; Pipkin ME, 2010, IMMUNOL REV, V235, P55, DOI 10.1111/j.0105-2896.2010.00905.x; Zaiss DMW, 2008, INFECT IMMUN, V76, P4609, DOI 10.1128/IAI.00563-08	37	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	DEC 1	2014	193	11					5744	5750		10.4049/jimmunol.1402207		7	Immunology	Immunology	AU2JC	WOS:000345443000041		
J	Shigehara, K; Sasagawa, T; Namiki, M				Shigehara, Kazuyoshi; Sasagawa, Toshiyuki; Namiki, Mikio			Human papillomavirus infection and pathogenesis in urothelial cells: A mini-review	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Review						Human papillomavirus; Urothelial cell; Bladder carcinoma	POLYMERASE-CHAIN-REACTION; IN-SITU HYBRIDIZATION; BILHARZIAL BLADDER-CANCER; URINARY-BLADDER; CONDYLOMA ACUMINATUM; MYCOPLASMA SPP.; VIRUS INFECTION; P53 EXPRESSION; HIGH-FREQUENCY; CARCINOMA	Several recent studies described that high-risk human papillomavirus (HPV) infection could have a potential role in the development of malignancies other than cervical cancer, such as laryngeal carcinoma, penile carcinoma, and anal carcinoma. However, the etiological role of HPV infection in the pathogenesis of urinary tract has not been clarified. Many epidemiological studies demonstrated that HPV infections frequently occur in the external genitalia through sexual contact; however, it was reported that HPV infection could also occur in the urinary tract, including the urethra and urinary bladder. Some morphological changes of cells associated with HPV infection and mild atypical cells, suspected to be intraneoplasia, were seen in HPV-positive samples obtained from the urinary tract. Some clinical studies and meta-analysis have indicated that HPV infection is likely to have a certain etiological correlation with the development of bladder carcinoma, although its prevalence may vary according to HPV type, study population, region, histological type, detection methods, and other variables. According to the results of previous studies, the prevalence of HPV greatly widely varies in cases of bladder carcinoma. Further research by caseecontrol or large-scales studies is thus required to reach a more definite conclusion. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Shigehara, Kazuyoshi] Ishikawa Prefectural Cent Hosp, Dept Urol, Kanazawa, Ishikawa 9208530, Japan; [Sasagawa, Toshiyuki] Kanazawa Med Univ, Dept Reprod & Perinatal Med, Kahoku, Ishikawa, Japan; [Namiki, Mikio] Kanazawa Univ, Grad Sch Med Sci, Dept Integrat Canc Therapy, Kanazawa, Ishikawa 9201192, Japan; [Namiki, Mikio] Kanazawa Univ, Grad Sch Med Sci, Dept Urol, Kanazawa, Ishikawa 9201192, Japan	Shigehara, K (reprint author), Ishikawa Prefectural Cent Hosp, Dept Urol, 2-1 Kuratsukihigashi, Kanazawa, Ishikawa 9208530, Japan.	kshigehara0415@yahoo.co.jp					Chan KW, 1997, J CLIN PATHOL, V50, P1018, DOI 10.1136/jcp.50.12.1018; Shai A, 2007, CANCER RES, V67, P1626, DOI 10.1158/0008-5472.CAN-06-3344; Ouhoummane N, 2013, CANCER EPIDEMIOL, V37, P807, DOI 10.1016/j.canep.2013.09.015; Rubin MA, 2001, AM J PATHOL, V159, P1211, DOI 10.1016/S0002-9440(10)62506-0; KNOWLES MA, 1992, UROL RES, V20, P297; Youshya S, 2005, J CLIN PATHOL, V58, P207, DOI 10.1136/jcp.2004.017152; Nicolau SM, 2005, UROLOGY, V65, P251, DOI 10.1016/j.urology.2004.09.031; ANWAR K, 1992, CANCER, V70, P1967, DOI 10.1002/1097-0142(19921001)70:7<1967::AID-CNCR2820700726>3.0.CO;2-8; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Westenend PJ, 2001, BJU INT, V88, P198, DOI 10.1046/j.1464-410x.2001.02230.x; LopezBeltran A, 1996, BRIT J CANCER, V73, P124, DOI 10.1038/bjc.1996.23; Tenti P, 1996, J PATHOL, V178, P65, DOI 10.1002/(SICI)1096-9896(199601)178:1<65::AID-PATH451>3.0.CO;2-W; Shigehara K, 2011, J INFECT CHEMOTHER, V17, P487, DOI 10.1007/s10156-010-0203-0; Rocco JW, 2001, EXP CELL RES, V264, P42, DOI 10.1006/excr.2000.5149; Tena-Suck ML, 2012, DIAGN CYTOPATHOL, V40, P597, DOI 10.1002/dc.21595; Lu QL, 1997, EUR UROL, V31, P428; Khaled HM, 2003, UROL ONCOL-SEMIN O I, V21, P334, DOI 10.1016/S000-0000(01)00014-0; Shigehara K, 2011, CANCER-AM CANCER SOC, V117, P2067, DOI 10.1002/cncr.25777; Aynaud O, 1998, J UROLOGY, V159, P86, DOI 10.1016/S0022-5347(01)64019-9; Li N, 2011, J INFECT DIS, V204, P217, DOI 10.1093/infdis/jir248; Moonen PMJ, 2007, EUR UROL, V52, P464, DOI 10.1016/j.eururo.2006.11.017; Kawaguchi S, 2012, J CLIN MICROBIOL, V50, P401, DOI 10.1128/JCM.05219-11; De Gaetani C, 1999, J CLIN PATHOL, V52, P103; Klaes R, 2001, INT J CANCER, V92, P276, DOI 10.1002/ijc.1174; Yavuzer D, 2011, MED ONCOL, V28, P919, DOI 10.1007/s12032-010-9540-1; Smith JS, 2008, J ADOLESCENT HEALTH, V43, pS5, DOI 10.1016/j.jadohealth.2008.07.009; Helal TEA, 2006, PATHOL ONCOL RES, V12, P173; AGLIANO AM, 1994, UROL INT, V53, P125; Barghi MR, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-102; Giuliano AR, 2007, J INFECT DIS, V196, P1146, DOI 10.1086/521629; O'Rorke MA, 2012, ORAL ONCOL, V48, P1191, DOI 10.1016/j.oraloncology.2012.06.019; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55; LopezBeltran A, 1996, PATHOL RES PRACT, V192, P154; Dunne EF, 2006, J INFECT DIS, V194, P1044, DOI 10.1086/507432; Badawi Hala, 2008, Medscape J Med, V10, P232; Barghi MR, 2012, ARCH IRAN MED, V15, P572, DOI 012159/AIM.0013; Ben Selma W, 2010, PATHOL RES PRACT, V206, P740, DOI 10.1016/j.prp.2010.06.005; Berrada N, 2013, J INFECT DEV COUNTR, V7, P586, DOI 10.3855/jidc.3068; Boucher NR, 1996, BRIT J UROL, V78, P866, DOI 10.1046/j.1464-410X.1996.25810.x; BRYANT P, 1991, BRIT J UROL, V68, P49, DOI 10.1111/j.1464-410X.1991.tb15256.x; Cai T, 2011, ONCOL REP, V25, P485, DOI 10.3892/or.2010.1083; CHANG FJ, 1994, J UROLOGY, V152, P1429; CHETSANGA C, 1992, CANCER, V69, P1208; Chrisofos M, 2004, INT J STD AIDS, V15, P836, DOI 10.1258/0956462042563783; Cooper K, 1997, J CLIN PATHOL-MOL PA, V50, P145; Diaz De Stahl T1, 2008, MINERVA UROL NEFROL, V60, P205; Fioriti D, 2003, INT J IMMUNOPATH PH, V16, P283; FURIHATA M, 1993, CANCER RES, V53, P4823; Gazzaniga P, 1998, J MED VIROL, V55, P262, DOI 10.1002/(SICI)1096-9071(199808)55:4<262::AID-JMV2>3.0.CO;2-Z; GOPALKRISHNA V, 1995, GENITOURIN MED, V71, P231; zur Hausen H, 1989, Cancer Res, V49, P4677; Jimenez-Pacheco Antonio, 2012, Korean J Urol, V53, P240, DOI 10.4111/kju.2012.53.4.240; KAMEL D, 1995, APMIS, V103, P331; Karim RZ, 2005, PATHOLOGY, V37, P176, DOI 10.1080/00313020500058615; Kawaguchi S, 2012, JPN J CLIN ONCOL, V42, P455, DOI 10.1093/jjco/hys024; KERLEY SW, 1991, MODERN PATHOL, V4, P316; Khaled HM, 2001, TUMORI, V87, P256; Kim Kun Hong, 1995, Yonsei Medical Journal, V36, P322; Kim SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093525; KITAMURA T, 1988, CANCER RES, V48, P7207; LARUE H, 1995, CLIN CANCER RES, V1, P435; Lazcano-Ponce E, 2001, SEX TRANSM DIS, V28, P277, DOI 10.1097/00007435-200105000-00007; LOPEZBELTRAN A, 1995, HISTOPATHOLOGY, V26, P565, DOI 10.1111/j.1365-2559.1995.tb00276.x; MALONEY KE, 1994, J UROLOGY, V151, P360; Mincione G. P., 1994, Pathologica (Genoa), V86, P244; Mvula M, 1996, J UROLOGY, V155, P471, DOI 10.1016/S0022-5347(01)66421-8; Nakashima K, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-43; NOEL JC, 1994, UROLOGY, V44, P671, DOI 10.1016/S0090-4295(94)80202-5; Polesel J, 2012, BRIT J CANCER, V106, P222, DOI 10.1038/bjc.2011.519; SALTZSTEIN DR, 1993, ANTICANCER RES, V13, P423; SANO T, 1995, PATHOL INT, V45, P506, DOI 10.1111/j.1440-1827.1995.tb03493.x; SHIBUTANI YF, 1992, UROLOGY, V40, P15, DOI 10.1016/0090-4295(92)90429-Z; Shigehara K, 2014, DIAGN CYTOPATHOL, V42, P491, DOI 10.1002/dc.23055; Shigehara K, 2010, INT J UROL, V17, P563, DOI 10.1111/j.1442-2042.2010.02521.x; Shigehara K, 2013, APMIS, V121, P1169, DOI 10.1111/apm.12070; Simoneau M, 1999, UROL RES, V27, P180; SINCLAIR AL, 1993, BRIT J BIOMED SCI, V50, P350; Smetana Z, 1995, CELL MOL BIOL, V41, P1017; Steinestel J, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065189, 10.1371/journal-pone.0065189]; Sur M, 2001, PATHOLOGY, V33, P17; Tekin MI, 1999, INT J UROL, V6, P184, DOI 10.1046/j.1442-2042.1999.06435.x; WILCZYNSKI SP, 1993, HUM PATHOL, V24, P96, DOI 10.1016/0046-8177(93)90068-R; YU ST, 1993, CHINESE MED J-PEKING, V106, P494	83	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	DEC	2014	20	12					741	747		10.1016/j.jiac.2014.08.033		7	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	AU4DH	WOS:000345558800001		
J	Ito, S; Horie, K; Seike, K; Yasuda, M; Tsuchiya, T; Yokoi, S; Nakano, M; Deguchi, T				Ito, Shin; Horie, Kengo; Seike, Kensaku; Yasuda, Mitsuru; Tsuchiya, Tomohiro; Yokoi, Shigeaki; Nakano, Masahiro; Deguchi, Takashi			Usefulness of quantifying leukocytes in first-voided urine to predict positivity for Chlamydia trachomatis in asymptomatic men at high risk for chlamydial infection	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Chlamydia trachomatis; Urinary leukocytes; Automated quantitative urine particle analyzers	GONOCOCCAL INFECTIONS; ESTERASE TEST; URETHRITIS; DIAGNOSIS; MALES; MICROSCOPY; SAMPLES	Chlamydia trachomatis causes acute non-gonococcal urethritis, but some infected men are asymptomatic. We examined leukocytes in uncentrifuged first-voided urine (FVU) from asymptomatic men at high risk for chlamydial infection by automated urine particle analyzers to assess whether the quantification of urinary leukocytes could predict chlamydial infection in these men. We enrolled 209 asymptomatic men, whose female sexual partners had been diagnosed as having a genital chlamydial infection. Their FVU specimens were examined for quantification of leukocytes with automated urine particle analyzers and tested for Neisseria gonorrhoeae, C. trachomatis, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum, and Ureaplasma urealyticum by nucleotide acid amplification tests. Eleven men positive for N. gonorrhoeae or M. genitalium were excluded from further analysis. In the remaining 198 men, 84 positive for C. trachomatis (42.4%) had 1.8-1666.9 white blood cells (WBCs)/mu l (median, 43.3 WBCs/mu l) in their FVU, whereas 114 negative for C. trachomatis had 0.1-1378 WBCs/mu l (median, 4.8 WBCs/mu l). A receiver operating characteristic (ROC) curve was constructed to examine the sensitivity and specificity of leukocytes counts for predicting chlamydial infection. A cut-off point of leukocyte counts of 12.5 WBCs/mu l was determined from the ROC curve, resulting in a sensitivity of 86.9% and specificity of 88.6% for predicting chlamydial infection. Leukocyte quantification in FVU by automated urine particle analyzers showed good performance in predicting the positivity and negativity for chlamydial infection in asymptomatic men. This test could potentially develop into a relevant tool for preselecting asymptomatic men prior to C. trachomatis screening. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Ito, Shin] iClinic, Taihaku Ku, Sendai, Miyagi 9820011, Japan; [Horie, Kengo; Seike, Kensaku; Yasuda, Mitsuru; Tsuchiya, Tomohiro; Yokoi, Shigeaki; Nakano, Masahiro; Deguchi, Takashi] Gifu Univ, Grad Sch Med, Dept Urol, Gifu 5011194, Japan	Deguchi, T (reprint author), Gifu Univ, Grad Sch Med, Dept Urol, 1-1 Yanagido, Gifu 5011194, Japan.	deguchit@gifu-u.ac.jp			Japan Society for the Promotion of Science (JSPS), Japan [25462509]	This work was supported in part by the Japan Society for the Promotion of Science (JSPS), Japan (Grant-in-Aid for Scientific Research (C) 25462509).	PATRICK DM, 1994, GENITOURIN MED, V70, P187; Smith R, 2003, SEX TRANSM INFECT, V79, P487, DOI 10.1136/sti.79.6.487; Manoni F, 2010, CLIN CHEM LAB MED, V48, P1107, DOI 10.1515/CCLM.2010.233; Yoshida T, 2003, J CLIN MICROBIOL, V41, P1850, DOI 10.1128/JCM.41.5.1850-1855.2003; BOWIE WR, 1978, SEX TRANSM DIS, V5, P39, DOI 10.1097/00007435-197804000-00001; Gift TL, 2008, SEX TRANSM DIS, V35, pS51, DOI [10.1097/OLQ.0b013e3181723dba, 10.1097/OLQ.01b013e3181723dba]; Grosso Shamanta, 2012, Infez Med, V20, P188; Hedin G, 2001, APMIS, V109, P595, DOI 10.1034/j.1600-0463.2001.d01-180.x; Ito S, 2014, J INFECT CHEMOTHER, V20, P143, DOI 10.1016/j.jiac.2013.07.011; Jiang T, 2011, SCAND J CLIN LAB INV, V71, P30, DOI 10.3109/00365513.2010.535011; Martin DH, 2008, SEXUALLY TRANSMITTED, P1107; MCNAGNY SE, 1992, J INFECT DIS, V165, P573; MONCADA J, 1994, SEX TRANSM DIS, V21, P8, DOI 10.1097/00007435-199401000-00003; SHAFER MA, 1989, JAMA-J AM MED ASSOC, V262, P2562, DOI 10.1001/jama.262.18.2562; SHAFER MA, 1993, JAMA-J AM MED ASSOC, V270, P2065, DOI 10.1001/jama.270.17.2065; STAMM WE, 1984, ANN INTERN MED, V100, P47; SWARTZ SL, 1979, J INFECT DIS, V140, P614; Takahashi S, 2011, J INFECT CHEMOTHER, V17, P76, DOI 10.1007/s10156-010-0083-3; Wiggins RC, 2006, INT J STD AIDS, V17, P289, DOI 10.1258/095646206776790268; Workowski Kimberly A., 2010, Morbidity and Mortality Weekly Report, V59, P1	20	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	DEC	2014	20	12					748	751		10.1016/j.jiac.2014.08.002		4	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	AU4DH	WOS:000345558800002		
J	Fujimura, S; Nakano, Y; Watanabe, A				Fujimura, Shigeru; Nakano, Yoshihisa; Watanabe, Akira			A correlation between reduced susceptibilities to vancomycin and daptomycin among the MRSA isolates selected in mutant selection window of both vancomycin and daptomycin	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Vancomycin; Vancomycin creeping; Daptomycin; Daptomycin non-susceptible; Mutant selection window	RESISTANT STAPHYLOCOCCUS-AUREUS; CLINICAL-PRACTICE GUIDELINES; INFECTIOUS-DISEASES SOCIETY; METHICILLIN-RESISTANT; BACTEREMIA; MORTALITY; COMMUNITY; CHILDREN; AMERICA; ADULTS	Guidelines for the treatment of MRSA infection, recently published by the IDSA and JSC, recommend daptomycin for sepsis and skin and soft tissue infections comparably to or more strongly than vancomycin. Meanwhile MIC creeping with an increased isolation frequency of MRSA isolates with vancomycin MIC of 2 mu g/mL has become a problem. In the present study, the MIC creeping rate of MRSA strains in the Tohoku district, Japan in 2012 was 13%, a significantly higher value than 3.3% in 2008 (P < 0.01). Of these isolates, the MIC and mutant prevention concentration (MPC) values of daptomycin and vancomycin were determined for 30 clinical isolates of MRSA in 2012. The MIC50/MIC80 values of daptomycin and vancomycin were 0.125/0.5 mu g/mL and 0.125/1 mu g/mL, respectively. The MPC50/MPC80 values of daptomycin and vancomycin were both 32/64 mu g/mL. In the present study, the mutant selection window (MSW) of daptomycin and vancomycin was >= 64 MIC. Of strains that selected in the MSW, daptomycin non-susceptible isolates accounted for 70.0%, while MRSA with vancomycin MIC of 2 mu g/mL accounted for 26.7%. On the other hand, 50% of the strains that selected in the vancomycin MSW were daptomycin non-susceptible strain. The detection rate of MRSA with vancomycin MIC of 2 mu g/mL that selected in the daptomycin MSW was 36.7%. These results showed that MRSA with vancomycin MIC of 2 mu g/mL and daptomycin non-susceptible isolates were selected by exposure to both antibiotics. Therefore, though vancomycin is frequently used for treatment of MRSA infection, both antibiotics should be selected as a first-line drug appropriately. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Fujimura, Shigeru] Tohoku Pharmaceut Univ, Div Clin Infect Dis & Chemotherapy, Sendai, Miyagi, Japan; [Fujimura, Shigeru; Nakano, Yoshihisa; Watanabe, Akira] Tohoku Univ, Inst Dev Aging & Canc, Res Div Dev Antiinfect Agents, Sendai, Miyagi 980, Japan	Fujimura, S (reprint author), 4-4-1 Komatsushima,Aoba Ku, Sendai, Miyagi 9818558, Japan.	sfuji@tohoku-pharm.ac.jp			Daiichi Sankyo Co., Ltd.: Mitsubishi Tanabe Pharma Corporation; Toyama Chemocal Co., Ltd.; Otsuka Pharmaceutical Co., Ltd.: GlaxoSmithKline K.K.; Mitsubishi Chemical Medience	Dr. A. Watanabe has received consultation fees from Daiichi Sankyo Co., Ltd.: Mitsubishi Tanabe Pharma Corporation; Toyama Chemocal Co., Ltd.; Otsuka Pharmaceutical Co., Ltd.: GlaxoSmithKline K.K.; and Mitsubishi Chemical Medience. No other disclosures were reported.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008; Sakoulas G, 2006, ANTIMICROB AGENTS CH, V50, P1581, DOI 10.1128/AAC.50.4.1581-1585.2006; Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI 10.1093/cid/cir034; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Azimian A, 2012, J CLIN MICROBIOL, V50, P3581, DOI 10.1128/JCM.01727-12; Hulten KG, 2010, INFECT CONT HOSP EP, V31, P183, DOI 10.1086/649793; Liu C, 2011, CLIN INFECT DIS, V52, pE18, DOI 10.1093/cid/ciq146; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Cui L, 2003, J CLIN MICROBIOL, V41, P5, DOI 10.1128/JCM.41.1.5-14.2003; de Niederhausern S, 2011, CURR MICROBIOL, V62, P1363, DOI 10.1007/s00284-011-9868-6; Hidayat LK, 2006, ARCH INTERN MED, V166, P2138, DOI 10.1001/archinte.166.19.2138; Holmes NE, 2013, ANTIMICROB AGENTS CH, V57, P1654, DOI 10.1128/AAC.01485-12; [Anonymous], 2013, GUID TREATM MRSA INF; Cui LZ, 2006, ANTIMICROB AGENTS CH, V50, P1079, DOI 10.1128/AAC.50.3.1079-1082.2006; Blondeau JM, 2001, ANTIMICROB AGENTS CH, V45, P433, DOI 10.1128/AAC.45.2.433-438.2001; Wang JL, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-159; Clinical and Laboratory Standards Institute, 2013, M100S23 CLIN LAB STA; Hsu LY, 2010, J MED MICROBIOL, V59, P1509, DOI 10.1099/jmm.0.022533-0; Iwao Y, 2012, J INFECT CHEMOTHER, V18, P228, DOI 10.1007/s10156-012-0379-6; Nakamura I, 2013, JPN J INFECT DIS, V66, P416; Rolo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034768; Rybak Michael, 2009, Am J Health Syst Pharm, V66, P82, DOI 10.2146/ajhp080434; Zhuo C, 2013, INT J ANTIMICROB AG, V41, P578, DOI 10.1016/j.ijantimicag.2013.02.014	25	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	DEC	2014	20	12					752	756		10.1016/j.jiac.2014.08.004		5	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	AU4DH	WOS:000345558800003		
J	Nakashima, K; Aoshima, M; Ohkuni, Y; Hoshino, E; Hashimoto, K; Otsuka, Y				Nakashima, Kei; Aoshima, Masahiro; Ohkuni, Yoshihiro; Hoshino, Eri; Hashimoto, Kohei; Otsuka, Yoshihito			Loop-mediated isothermal amplification method for diagnosing Pneumocystis pneumonia in HIV-uninfected immunocompromised patients with pulmonary infiltrates	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Pneumocystis pneumonia; Pneumocystis jirovecii; Loop-mediated isothermal amplification method	HUMAN-IMMUNODEFICIENCY-VIRUS; POLYMERASE-CHAIN-REACTION; CARINII-PNEUMONIA; RESPIRATORY SPECIMENS; INFECTED PATIENTS; INDUCED SPUTUM; JIROVECI; DNA; PCR	Loop-mediated isothermal amplification (LAMP) is becoming an established nucleic acid amplification method offering rapid, accurate, and cost-effective diagnosis of infectious diseases. We retrospectively evaluated 78 consecutive HIV-uninfected patients who underwent LAMP method for diagnosing Pneumocystis pneumonia (PCP). Diagnosis of PCP was made by the detection of Pneumocystis jirovecii (P. jirovecii) with positive LAMP or conventional staining (CS) (Grocott methenamine silver staining or Diff-Quick (TM)) on the basis of compatible clinical symptoms and radiologic findings. Additionally, we reviewed HIV-uninfected immunocompromised patients who underwent subcontract PCR as a historical control. LAMP was positive in 10 (90.9%) of 11 positive-CS patients. Among 13 negative-CS patients with positive LAMP, 11 (84.6%) had PCP, and the remaining 2 were categorized as having P. jirovecii colonization. LDH levels in negative-CS PCP were higher than in positive-CS PCP (p = 0.026). (1 -> 3)-beta-D-glucan levels in negative-CS PCP were lower than in positive-CS PCP (p = 0.011). The interval from symptom onset to diagnosis as PCP in LAMP group (3.45 +/- 1.77 days; n = 22) was shorter than in subcontract PCR group (6.90 +/- 2.28 days; n = 10; p < 0.001). As for patients without PCP, duration of unnecessary PCP treatment in LAMP group (2; 2-3 days; n = 10) was shorter than in subcontract PCR group (7; 7-12.25 days; n = 6; p = 0.003). LAMP showed higher sensitivity (95.4%) and positive predictive value (91.3%) than subcontract PCR did. Pneumocystis LAMP method is a sensitive and cost-effective diagnostic method and is easy to administer in general hospitals. In-house LAMP method would realize early diagnosis of PCP, resulting in improving PCP prognosis and reducing unnecessary PCP-specific treatment. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Nakashima, Kei; Aoshima, Masahiro; Ohkuni, Yoshihiro] Kameda Med Ctr, Dept Pulmonol, Chiba 2968602, Japan; [Hoshino, Eri] Kameda Coll Hlth Sci, Ctr Hlth Res, Clin Res Support Div, Tokyo, Japan; [Hashimoto, Kohei; Otsuka, Yoshihito] Kameda Med Ctr, Dept Lab Med, Chiba 2968602, Japan	Nakashima, K (reprint author), Kameda Med Ctr, Dept Pulmonol, 929 Higashi Cho, Chiba 2968602, Japan.	kei.7.nakashima@gmail.com					Huggett JF, 2008, THORAX, V63, P154, DOI 10.1136/thx.2007.081687; LIPSCHIK GY, 1992, LANCET, V340, P203, DOI 10.1016/0140-6736(92)90469-J; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; Azoulay E, 2009, CHEST, V135, P655, DOI 10.1378/chest.08-1309; Tasaka S, 2007, CHEST, V131, P1173, DOI 10.1378/chest.06-1467; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Asai N, 2012, J INFECT CHEMOTHER, V18, P898, DOI 10.1007/s10156-012-0441-4; Uemura N, 2008, J MED MICROBIOL, V57, P50, DOI 10.1099/jmm.0.47216-0; WAKEFIELD AE, 1991, LANCET, V337, P1378, DOI 10.1016/0140-6736(91)93062-E; Maskell NA, 2003, THORAX, V58, P594, DOI 10.1136/thorax.58.7.594; Green H, 2007, MAYO CLIN PROC, V82, P1052; Procop GW, 2004, J CLIN MICROBIOL, V42, P3333, DOI 10.1128/JCM.42.7.3333-3335.2004; LIMPER AH, 1989, AM REV RESPIR DIS, V140, P1204; Asai N, 2012, J INFECT CHEMOTHER, V18, P965, DOI 10.1007/s10156-012-0415-6; LEIBOVITZ E, 1995, J CLIN MICROBIOL, V33, P3004; Tokuda H, 2008, INTERNAL MED, V47, P915, DOI 10.2169/internalmedicine.47.0702; ZAMAN MK, 1988, AM REV RESPIR DIS, V137, P796	17	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	DEC	2014	20	12					757	761		10.1016/j.jiac.2014.08.005		5	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	AU4DH	WOS:000345558800004		
J	Kawanami, T; Mukae, H; Noguchi, S; Yamasaki, K; Akata, K; Ishimoto, H; Matsumoto, K; Morita, K; Yatera, K				Kawanami, Toshinori; Mukae, Hiroshi; Noguchi, Shingo; Yamasaki, Kei; Akata, Kentarou; Ishimoto, Hiroshi; Matsumoto, Kana; Morita, Kunihiko; Yatera, Kazuhiro			Efficacy and safety of meropenem (3 g daily) in Japanese patients with refractory respiratory infections	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Meropenem; Efficacy and safety; Respiratory infection; Plasma concentration; High dose	PNEUMONIA	Introduction: Pneumonia is the third leading cause of mortality in Japan. In 2011, the use of meropenem (MEPM) at 3 g daily was approved to treat refractory infections in Japan. However, little has been reported on the clinical efficacy and safety of this regimen in Japanese patients with refractory infections. Objectives: This study prospectively assessed the clinical efficacy and safety of MEPM (3 g daily) in Japanese patients with refractory pneumonia and/or intrapleural infections. Methods: This study was performed at our university hospital and affiliated hospitals. The plasma concentrations of MEPM before and one and four hours after MEPM administration were also evaluated. Results: A total of 48 patients were enrolled for the efficacy and safety evaluations. The response rate to MEPM (3 g daily) treatment was 90.9% (40/44). Adverse drug reactions were observed in 17 of the 48 patients (20.8%), and all improved after the cessation of MEPM. The plasma MEPM concentration one hour after administering 1 g of MEPM was 44.9 +/- 12.0 mu g/ml. A pharmacokinetic analysis revealed that the percentage of time above the MIC/24 h for an MIC of 4 mu g/ml or 8 mu g/ml was more than 50% in 12 of 13 (92%) and in nine of the 13 patients (69%), respectively, indicating sufficient efficacy of 3 g daily of MEPM. Conclusion: Treatment with MEPM (3 g daily) in Japanese patients with refractory pneumonia and/or intrapleural infections is effective, with sufficient plasma concentrations of MEPM, and the treatment has a relatively good safety profile. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Kawanami, Toshinori; Mukae, Hiroshi; Noguchi, Shingo; Yamasaki, Kei; Akata, Kentarou; Ishimoto, Hiroshi; Yatera, Kazuhiro] Univ Occupat & Environm Hlth, Dept Resp Med, Kitakyushu, Fukuoka 8078555, Japan; [Matsumoto, Kana; Morita, Kunihiko] Doshisha Womens Coll Liberal Arts, Dept Clin Pharmaceut, Kyoto, Japan	Mukae, H (reprint author), Univ Occupat & Environm Hlth, Dept Resp Med, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	hmukae@med.uoeh-u.ac.jp			Dainippon Sumitomo Pharmaceutical, Co., Ltd.	Hiroshi Mukae has received honoraria, lecture fees and research grants and Toshinori Kawanami and Kazuhiro Yatera have received honoraria and lecture fees for activities other than this study from Dainippon Sumitomo Pharmaceutical, Co., Ltd.	Alvarez-Lerma AF, 2001, J CHEMOTHER, V13, P70; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Kuti JL, 2003, J CLIN PHARMACOL, V43, P1116, DOI 10.1177/0091270003257225; MOUTON YJ, 1995, J ANTIMICROB CHEMOTH, V36, P145; Cunha BA, 1999, INT J ANTIMICROB AG, V11, P167; Sieger B, 1997, CRIT CARE MED, V25, P1663, DOI 10.1097/00003246-199710000-00015; Committee for The Japanese Respiratory Society guidelines for the management of respiratory infections, 2006, RESPIROLOGY, V11, pS79; Imajo Kenji, 2012, Jpn J Antibiot, V65, P271; Kohno Shigeru, 2013, Respir Investig, V51, P103, DOI 10.1016/j.resinv.2012.11.001; NORRBY SR, 1995, J ANTIMICROB CHEMOTH, V36, P207; Ohata Y, 2011, J INFECT CHEMOTHER, V17, P831, DOI 10.1007/s10156-011-0271-9; Okimoto N., 2013, Kawasaki Medical Journal, V39, P43; Saito A, 1999, J INFECT CHEMOTHER, V5, P110, DOI 10.1007/s101560050020; The Committee for the Japanese Respiratory Society Guideline in the Management of Respiratory Infections, 2008, JAP RESP SOC GUID MA, P24; The Japanese Respiratory Society, 2011, NURS HEALTHC ASS PNE, P21; Tokuyasu H, 2009, INTERNAL MED, V48, P129, DOI 10.2169/internalmedicine.48.1308; Yamamoto Y, 2013, J INFECT CHEMOTHER, V19, P291, DOI 10.1007/s10156-013-0552-6	17	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	DEC	2014	20	12					768	773		10.1016/j.jiac.2014.08.011		6	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	AU4DH	WOS:000345558800006		
J	Okamoto, A; Abe, A; Okamoto, M; Kobayashi, T; Inaguma, Y; Tokuda, M; Yanada, M; Morishima, S; Kanie, T; Yamamoto, Y; Tsuzuki, M; Mizuta, S; Akatsuka, Y; Yatsuya, H; Yoshikawa, T; Emi, N				Okamoto, Akinao; Abe, Akihiro; Okamoto, Masataka; Kobayashi, Tsukane; Inaguma, Yoko; Tokuda, Masutaka; Yanada, Masamitsu; Morishima, Satoko; Kanie, Tadaharu; Yamamoto, Yukiya; Tsuzuki, Motohiro; Mizuta, Shuichi; Akatsuka, Yoshiki; Yatsuya, Hiroshi; Yoshikawa, Tetsushi; Emi, Nobuhiko			A varicella outbreak in B-cell lymphoma patients receiving rituximab-containing chemotherapy	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Rituximab; Lymphoma; Nosocomial infection; Varicella; Outbreak	ZOSTER-VIRUS; PLUS RITUXIMAB; TRANSPLANTATION; INFECTION; CHOP	Varicella, characterized by a vesicular rash, occurs primarily in young children. Although older individuals can also be affected or vaccinated, outbreaks among adults are rare. We investigated a small outbreak of varicella in B-cell lymphoma patients for elucidation of risk factor of the disease. We experienced four cases of varicella after an index herpes zoster case. All varicella cases were confirmed varicella zoster virus (VZV) infection by PCR. All varicella cases occurred in diffuse large B-cell lymphoma patients receiving rituximab-containing chemotherapy. On the other hand, only three of the 18 non-varicella patients in the same room were receiving rituximab-containing chemotherapy (P = 0.005). All varicella patients had detectable serum anti-varicella zoster virus IgG antibodies before chemotherapy. Even in the presence of neutralizing antibodies to the virus, lymphoma patients treated with rituximab-containing chemotherapy can possibly become re-infected with varicella. These findings suggest that zoster patients should be strictly isolated in hematology and oncology ward, and prophylactic acyclovir should be considered for such patients when exposed to zoster/varicella. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Okamoto, Akinao; Abe, Akihiro; Okamoto, Masataka; Inaguma, Yoko; Tokuda, Masutaka; Yanada, Masamitsu; Morishima, Satoko; Kanie, Tadaharu; Yamamoto, Yukiya; Tsuzuki, Motohiro; Mizuta, Shuichi; Akatsuka, Yoshiki; Emi, Nobuhiko] Fujita Hlth Univ, Sch Med, Dept Hematol, Toyoake, Aichi 4701192, Japan; [Kobayashi, Tsukane] Fujita Hlth Univ, Sch Med, Dept Dermatol, Toyoake, Aichi 4701192, Japan; [Yatsuya, Hiroshi] Fujita Hlth Univ, Sch Med, Dept Publ Hlth, Toyoake, Aichi 4701192, Japan; [Yoshikawa, Tetsushi] Fujita Hlth Univ, Sch Med, Dept Pediat, Toyoake, Aichi 4701192, Japan	Okamoto, A (reprint author), Fujita Hlth Univ, Sch Med, Dept Hematol, 1-98 Dengakugakubo Kutsukake Cho, Toyoake, Aichi 4701192, Japan.	aokamoto@fujita-hu.ac.jp	Yamamoto, Yukiya/E-9529-2010	Yamamoto, Yukiya/0000-0002-7439-4925			Aksoy S, 2009, LEUKEMIA LYMPHOMA, V50, P357, DOI 10.1080/10428190902730219; Wilson WH, 2002, BLOOD, V99, P2685, DOI 10.1182/blood.V99.8.2685; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Pfreundschuh M, 2006, LANCET ONCOL, V7, P379, DOI 10.1016/S1470-2045(06)70664-7; Heininger U, 2006, LANCET, V368, P1365, DOI 10.1016/S0140-6736(06)69561-5; Koc Y, 2000, BIOL BLOOD MARROW TR, V6, P44, DOI 10.1016/S1083-8791(00)70051-6; Bermudez A, 2000, HAEMATOLOGICA, V85, P894; DAVISON AJ, 1986, J GEN VIROL, V67, P1759, DOI 10.1099/0022-1317-67-9-1759; Depledge DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027805; Kimura H, 2000, J CLIN MICROBIOL, V38, P2447; Leena M, 2006, SCAND J GASTROENTERO, V41, P242, DOI 10.1080/00365520500328113; Loparev VN, 2000, J CLIN MICROBIOL, V38, P3156; Niitsu N, 2010, HEMATOL ONCOL, V28, P68, DOI 10.1002/hon.940; Okamoto A, 2012, INT J HEMATOL, V96, P516, DOI 10.1007/s12185-012-1160-4; Okamoto M, 1994, Rinsho Ketsueki, V35, P635	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	DEC	2014	20	12					774	777		10.1016/j.jiac.2014.08.006		4	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	AU4DH	WOS:000345558800007		
J	Okade, H; Nakagawa, S; Sakagami, T; Hisada, H; Nomura, N; Mitsuyama, J; Yamagishi, Y; Mikamo, H				Okade, Hayato; Nakagawa, Satoshi; Sakagami, Toru; Hisada, Harumi; Nomura, Nobuhiko; Mitsuyama, Junichi; Yamagishi, Yuka; Mikamo, Hiroshige			Characterization of plasmid-mediated quinolone resistance determinants in Klebsiella pneumoniae and Escherichia coli from Tokai, Japan	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						qnr; Plasmid-mediated quinolone resistance; Klebsiella pneumoniae; Bactericidal activity	SPECTRUM BETA-LACTAMASES; HIGH PREVALENCE; SEQUENCE-ANALYSIS; MULTIPLEX PCR; QNR GENES; CTX-M; ENTEROBACTERIACEAE; ASSOCIATION; ENVIRONMENT; STRAINS	The spread of plasmid-mediated quinolone resistance (PMQR) determinants was evaluated in 150 ceftazidime or cefotaxime-resistant clinical isolates of Klebsiella pneumoniae and Escherichia coli from Tokai, Japan between 2008 and 2011. In this study, qnrB, qnrS, and aac(6')-Ib-cr genes were detected in 12 (50.0%), 4 (16.7%), and 1 (4.2%) of 24 K. pneumoniae isolates, respectively, while qnrA, aac(6')-Ib-cr, and qepA genes were detected in 1 (0.8%), 11 (8.7%), and 2 (1.6%) of 126 E. coli isolates, respectively. qnr genes were mainly found in K. pneumoniae (66.7%) and to a lesser extent in E. coli (0.8%). We determined the genetic environment of the qnrB4 gene in 24.6 kb class 1 integron structure, including aar-2, cmlA, blaOXA-10, aadA1, qacEdelta1, sul1, and blaDHA-1. In a time-kill assay, introduction of the qnrB4 or qnrS1 plasmid to the recipient E. coli strain decreased the bactericidal activities of fluoroquinolones such as ciprofloxacin, levofloxacin, and pazufloxacin. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Okade, Hayato; Mikamo, Hiroshige] Aichi Med Univ, Grad Sch Med, Dept Clin Infect Dis, Nagakute, Aichi 4801195, Japan; [Okade, Hayato; Nakagawa, Satoshi; Sakagami, Toru; Hisada, Harumi; Nomura, Nobuhiko] Toyama Chem Co Ltd, Res Labs, Toyama 9308508, Japan; [Mitsuyama, Junichi] Toyama Chem Co Ltd, Dev Div, Shinjyuku Ku, Tokyo 1600023, Japan; [Yamagishi, Yuka; Mikamo, Hiroshige] Aichi Med Univ Hosp, Dept Clin Infect Dis, Nagakute, Aichi 4801195, Japan	Okade, H (reprint author), Toyama Chem Co Ltd, Res Labs, 2-4-1 Shimookui, Toyama 9308508, Japan.	hayato_okade@toyama-chemical.co.jp			Taisho Toyama Pharmaceutical Co., Ltd; Pfizer Japan Inc; MSD Japan; GlaxoSmithKline Co., Ltd; Daiichi-Sankyo Co., Ltd; Astellas Pharma Inc; Dainippon Sumitomo Pharma Co., Ltd; Shionogi Co., Ltd	H. Okade, S. Nakagawa, T. Sakagami, H. Hisada, N. Nomura and J. Mitsuyama are the employees of the Toyama Chemical Co., Ltd. Y. Yamagishi has received grant support from Taisho Toyama Pharmaceutical Co., Ltd. H. Mikamo is a consultant to Toyama Chemical Co., Ltd, and has received grant support from Pfizer Japan Inc, MSD Japan, Taisho Toyama Pharmaceutical Co., Ltd, GlaxoSmithKline Co., Ltd, Daiichi-Sankyo Co., Ltd, Astellas Pharma Inc, Dainippon Sumitomo Pharma Co., Ltd, and Shionogi & Co., Ltd.	Veldman K, 2011, J ANTIMICROB CHEMOTH, V66, P1278, DOI 10.1093/jac/dkr084; Eckert C, 2006, J ANTIMICROB CHEMOTH, V57, P14, DOI 10.1093/jac/dki398; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Tamang MD, 2008, ANTIMICROB AGENTS CH, V52, P4159, DOI 10.1128/AAC.01633-07; Pallecchi L, 2009, ANTIMICROB AGENTS CH, V53, P2632, DOI 10.1128/AAC.01722-08; Cattoir V, 2007, J ANTIMICROB CHEMOTH, V60, P394, DOI 10.1093/jac/dkm204; Yang H, 2008, ANTIMICROB AGENTS CH, V52, P4268, DOI 10.1128/AAC.00830-08; Toleman MA, 2006, MICROBIOL MOL BIOL R, V70, P296, DOI 10.1128/MMBR.00048-05; Jouini A, 2007, J ANTIMICROB CHEMOTH, V60, P1137, DOI 10.1093/jac/dkm316; Ode T, 2009, INT J ANTIMICROB AG, V34, P347, DOI 10.1016/j.ijantimicag.2009.05.007; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Jacoby GA, 2011, ANTIMICROB AGENTS CH, V55, P4979, DOI 10.1128/AAC.05187-11; Clinical and laboratory standard institute, 2014, M100S24 CLIN LAB STA; Clinical and Laboratory Standards Institute, 2012, M07A9 CLIN LAB STAND; Jakobsen L, 2012, J ANTIMICROB CHEMOTH, V67, P2438, DOI 10.1093/jac/dks224; Jeong HS, 2011, KOREAN J LAB MED, V31, P257, DOI 10.3343/kjlm.2011.31.4.257; Jones CH, 2009, ANTIMICROB AGENTS CH, V53, P465, DOI 10.1128/AAC.00883-08; Jones GL, 2008, J ANTIMICROB CHEMOTH, V62, P1245, DOI 10.1093/jac/dkn406; Kanamori H, 2011, J ANTIMICROB CHEMOTH, V66, P2255, DOI 10.1093/jac/dkr283; Kanamori H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037967; Kim HK, 2009, J AM COLL CARDIOL, V53, P2009, DOI 10.1016/j.jacc.2009.01.066; Leuthner KD, 2010, ANTIMICROB AGENTS CH, V54, P3799, DOI 10.1128/AAC.00452-10; Lopes ACS, 2010, MEM I OSWALDO CRUZ, V105, P163, DOI 10.1590/S0074-02762010000200009; Richter SN, 2010, INT J ANTIMICROB AG, V35, P578, DOI 10.1016/j.ijantimicag.2010.02.015; Saga T, 2007, INT J ANTIMICROB AG, V29, P738, DOI 10.1016/j.ijantimicag.2007.01.010	26	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	DEC	2014	20	12					778	783		10.1016/j.jiac.2014.08.018		6	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	AU4DH	WOS:000345558800008		
J	Mizushima, D; Tanuma, J; Dung, NT; Dung, NH; Trung, NV; Lam, NT; Gatanaga, H; Kikuchi, Y; Kinh, NV; Oka, S				Mizushima, Daisuke; Tanuma, Junko; Nguyen Thi Dung; Nguyen Hoai Dung; Nguyen Vu Trung; Nguyen Tien Lam; Gatanaga, Hiroyuki; Kikuchi, Yoshimi; Nguyen Van Kinh; Oka, Shinichi			Low body weight and tenofovir use are risk factors for renal dysfunction in Vietnamese HIV-infected patients. A prospective 18-month observation study	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Renal dysfunction; Human immunodeficiency virus; Tenofovir; Vietnamese; Low body weight	CHRONIC KIDNEY-DISEASE; ANTIRETROVIRAL THERAPY; DISOPROXIL FUMARATE; INCOMPLETE REVERSIBILITY; FAILURE; COHORT; IMPAIRMENT; EPIDEMIC; EXPOSURE; DECLINE	Background: The use of tenofovir has been rapidly increasing in Vietnam. Several studies identified low body weight as a risk factor for tenofovir-induced nephrotoxicity. However, little is known about the impact of tenofovir on renal function in HIV-infected Vietnamese with generally low weight. Methods: An observational single-center cohort of adult HIV-infected patients on antiretroviral therapy at National Hospital of Tropical Diseases, Hanoi. Patients on tenofovir or with creatinine clearance <= 60 ml/min at baseline were excluded. The incidence of renal dysfunction was compared between patients who switched to tenofovir and those who did not. Renal dysfunction was defined as 25% decline of creatinine clearance from baseline. Time to renal dysfunction was analyzed by the Kaplan-Meier method between the two groups. The Cox hazard model was used to determine risk factors for renal dysfunction in uni- and multivariate analyses. Results: Of 556 patients enrolled in this study, 403 were non-tenofovir group while 153 were the tenofovir-switched group. Renal dysfunction occurred at a higher rate in the tenofovir-switched group (92.5 per 1000 person-years) than the non-tenofovir group (47.8 per 1000 person-years)(p = 0.023, Log-rank test). Multivariate analysis confirmed that tenofovir use, low body weight and glucosuria were significant risk factors for renal dysfunction (hazard ratio = 1.980; 95% confidential interval, 1.094-3.582, HR = 1.057; 95% CI, 1.016-1.098, HR = 5.202; 95% CI, 1.245-21.738, respectively). Conclusions: Tenofovir use, low body weight and glucosuria were significant risk factors for renal dysfunction. We suggest close monitoring of renal function in patients with these risk factors even in resource-limited setting. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Mizushima, Daisuke; Tanuma, Junko; Gatanaga, Hiroyuki; Kikuchi, Yoshimi; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo 1620052, Japan; [Mizushima, Daisuke; Gatanaga, Hiroyuki; Oka, Shinichi] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan; [Nguyen Thi Dung; Nguyen Hoai Dung; Nguyen Vu Trung; Nguyen Tien Lam; Nguyen Van Kinh] Natl Hosp Trop Dis, Hanoi, Vietnam	Mizushima, D (reprint author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1620052, Japan.	dmizushi@acc.ncgm.go.jp			Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)	The authors thank Ms. Keiko Saito and Ms. Nguyen Thi Huyen for the excellent assistance. The authors also thank all the clinical staff at the National Hospital of Tropical Diseases for their help in the completion of this study. Financial support for this study was provided by Japan Initiative for Global Research Network on Infectious Diseases (J-GRID).	Choi AI, 2010, KIDNEY INT, V78, P478, DOI 10.1038/ki.2010.171; Bonjoch A, 2012, ANTIVIR RES, V96, P65, DOI 10.1016/j.antiviral.2012.07.009; Jose S, 2014, J INFECT DIS, V210, P363, DOI 10.1093/infdis/jiu107; Kalayjian RC, 2012, AIDS, V26, P1907, DOI 10.1097/QAD.0b013e328357f5ed; Wever K, 2010, JAIDS-J ACQ IMM DEF, V55, P78, DOI 10.1097/QAI.0b013e3181d05579; Gallant JE, 2009, AIDS, V23, P1971, DOI 10.1097/QAD.0b013e32832c96e9; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Wyatt CM, 2007, AIDS, V21, P2101; Schwartz EJ, 2005, J AM SOC NEPHROL, V16, P2412, DOI 10.1681/ASN.2005040340; Mocroft A, 2007, AIDS, V21, P1119, DOI 10.1097/QAD.0b013e3280f774ee; Chaisiri K, 2010, CURR HIV RES, V8, P504, DOI 10.2174/157016210793499259; Van Rompay KKA, 2008, ANTIMICROB AGENTS CH, V52, P3144, DOI 10.1128/AAC.00350-08; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Deti EK, 2010, HIV MED, V11, P308, DOI 10.1111/j.1468-1293.2009.00780.x; Franceschini N, 2005, KIDNEY INT, V67, P1526, DOI 10.1111/j.1523-1755.2005.00232.x; Menezes AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026042; Mizushima D, 2013, PLOS ONE, V8; Mwafongo A, 2014, AIDS, V28, P1135, DOI 10.1097/QAD.0000000000000202; Nishijima T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022661; Peters L, 2012, AIDS, V26, P1917, DOI 10.1097/QAD.0b013e3283574e71; Wyatt CM, 2006, AIDS, V20, P561, DOI 10.1097/01.aids.0000210610.52836.07; Yoshino M, 2012, J INFECT CHEMOTHER, V18, P169, DOI 10.1007/s10156-011-0310-6	22	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	DEC	2014	20	12					784	788		10.1016/j.jiac.2014.08.015		5	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	AU4DH	WOS:000345558800009		
J	Nakamura, Y; Sugawara, T; Ohkusa, Y; Taniguchi, K; Miyazaki, C; Momoi, M; Okabe, N				Nakamura, Yuuki; Sugawara, Tamie; Ohkusa, Yasushi; Taniguchi, Kiyosu; Miyazaki, Chiaki; Momoi, Mariko; Okabe, Nobuhiko			Abnormal behavior during influenza in Japan during the last seven seasons: 2006-2007 to 2012-2013	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Abnormal behavior; Influenza; Oseltamivir; Antiviral drug		A few mortalities and cases of severe abnormal behavior have been reported after oseltamivir administration for influenza, thus increasing medical and public concerns regarding the drug's safety. We investigated the association between oseltamivir and abnormal behavior for seven years. All outpatient clinics and hospitals all over the country were requested to report severe abnormal behavior that could have resulted in a fatality if nobody intervened, such as abrupt running outside the home or intention of jumping off a building. The survey was performed prospectively between the 2007-2008 and 2012-2013 seasons, and retrospectively for the 2006-2007 season. As the result of the investigation, eight-hundred fifty-eight cases were reported and among of them 95.7% were positive by the influenza rapid diagnosis test. The epidemic curve of severe abnormal behavior showed a pattern similar to influenza-like illness. The same pattern was observed regardless of age group, gender, or timing of the incidents after waking. Consequently, specific association between the types of medications used or the types of antiviral and abnormal behavior was not observed clearly. The reported abnormal behaviors include fatal cases that would have died if nobody had stopped. This suggested that patients with influenza should be observed with caution for possible abnormal behavior whether taking oseltamivir or other neuraminidase inhibitor anti-influenza drugs. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Nakamura, Yuuki; Sugawara, Tamie; Ohkusa, Yasushi; Taniguchi, Kiyosu; Okabe, Nobuhiko] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo 1628640, Japan; [Nakamura, Yuuki] Nihon Univ, Grad Sch Pharm, Tokyo 102, Japan; [Taniguchi, Kiyosu] Natl Hosp Org Mie Natl Hosp, Kyoto, Japan; [Miyazaki, Chiaki] Fukuoka Welf Ctr Disabled, Fukuoka, Japan; [Momoi, Mariko] Int Univ Hlth & Welf, Tokyo, Japan; [Okabe, Nobuhiko] Kawasaki City Inst Publ Hlth, Kawasaki, Kanagawa, Japan	Ohkusa, Y (reprint author), Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	ohkusa@nih.go.jp			Health and Labor Sciences Research Grant from the Ministry of Health, Labour and Wealth [H19-Special Urgent-Assignment-002, H20-Pharmaceuticals and Medical Devices-Assignment-029, H21-Pharmaceuticals and Medical Devices-Assignment-032, H22-Pharmaceuticals and Medical Devices-Assignment-023]; Health and Labor Sciences Research Grant from the Ministry of Health, Labour and Wealth. [H23-Global Health-Assignment-005, H24-Global Health-Assignment-001, H25-Global Health-Assignment-002]	We appreciate all doctors who reported a large number of abnormal behavior cases and Dr. Tim Uyeki, CDC, for his helpful comments. This research was financially supported by a Health and Labor Sciences Research Grant from the Ministry of Health, Labour and Wealth (H19-Special Urgent-Assignment-002 in 2007, H20-Pharmaceuticals and Medical Devices-Assignment-029 in 2008, H21-Pharmaceuticals and Medical Devices-Assignment-032 in 2009, H22-Pharmaceuticals and Medical Devices-Assignment-023 in 2010, H23-Global Health-Assignment-005 in 2011, H24-Global Health-Assignment-001 in 2012, and H25-Global Health-Assignment-002 in 2013).	Fujita T, 2010, JPN J PHARMACOEPIDEM, V15, P73; Fujita T, 2007, NIHON SYOUNIKAGAKKAI, V111, P1559; Greene WH, 1998, ECONOMETRIC ANAL, P250; Hama R, 2005, JAP SOC PED INF DIS; Morita H, 2007, INFECT IMMUN CHILD, V19, P455; Nariai A, 2008, INFECT IMMUN CHILD, V20, P148; Takahashi K, 2007, INFECT IMMUN CHILD, V19, P473; Takamiya H., 2007, INFECT IMMUN CHILD, V19, P479; Tanabe T, 2007, INFECT IMMUN CHILD, V19, P463; Tominaga M, 2007, INFECT IMMUN CHILD, V19, P468; Yokota S, 2007, NIHON SYOUNIKAGAKKAI, V111, P1545	11	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	DEC	2014	20	12					789	793		10.1016/j.jiac.2014.08.016		5	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	AU4DH	WOS:000345558800010		
J	Takahashi, Y; Ishiwada, N; Hishiki, H; Tanaka, J; Akeda, Y; Shimojo, N; Oishi, K; Kohno, Y				Takahashi, Yoshiko; Ishiwada, Naruhiko; Hishiki, Haruka; Tanaka, Junko; Akeda, Yukihiro; Shimojo, Naoki; Oishi, Kazunori; Kohno, Yoichi			IgG levels against 13-valent pneumococcal conjugate vaccine serotypes in non pneumococcal conjugate vaccine immunized healthy Japanese and intravenous immunoglobulin preparations	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Pneumococcal conjugate vaccine; Intravenous immunoglobulin preparations; Invasive pneumococcal disease; Opsonophagocytic killing assay; Serotype-specific IgG antibody	STREPTOCOCCUS-PNEUMONIAE; ANTIBODIES; INFANTS; IMMUNOGENICITY; PREVENTION; DISEASE; ASSAY	No studies showed specific antibody levels against all serotypes covered by 13-valent pneumococcal conjugate vaccine (PCV13) among polyclonal intravenous immunoglobulin (IVIG) products. Our study aimed to assess whether we could expect the efficacy of IVIG therapy for invasive pneumococcal disease (IPD) and to clarify the age group which should be recommended for IVIG therapy in case of IPD. Serotype-specific immunoglobulin G (IgG) levels against PCV13 serotypes were measured in four IVIGs which were produced from Japanese donors who were not immunized with any pneumococcal conjugate vaccines (PCVs), and in the serum of 160 non-PCV immunized Japanese subjects, by enzyme-linked immunosorbent assay. The functional opsonic activities of the IVIGs against serotypes 6B and 19A were assessed by a multiplexed opsonophagocytic killing assay. Japanese infants aged <2 years had a geometric mean IgG concentration of <0.35 mu g/ml against several serotypes. Serotype-specific IgG concentrations varied among IVIGs. In general, IgG antibodies against serotypes 6A, 14 and 19A were higher in each IVIG. Although opsonization indices also varied among preparations, each IVIG had the ability to opsonize both serotypes 6B and 19A. This study suggests that routine immunization with PCV is important for prevention of IPD, especially for children <2 years old and IVIGs might be effective for IPD patients. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Takahashi, Yoshiko; Hishiki, Haruka; Tanaka, Junko; Shimojo, Naoki; Kohno, Yoichi] Chiba Univ, Grad Sch Med, Dept Pediat, Chiba 2608670, Japan; [Ishiwada, Naruhiko] Chiba Univ Hosp, Div Control & Treatment Infect Dis, Chiba, Japan; [Akeda, Yukihiro; Oishi, Kazunori] Osaka Univ, Int Res Ctr Infect Dis, Microbial Dis Res Inst, Osaka, Japan; [Oishi, Kazunori] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan	Takahashi, Y (reprint author), Chiba Univ, Grad Sch Med, Dept Pediat, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	honda-sag@umin.ac.jp			Ministry of Health, Labor and Welfare of Japan [H24-Sinko-Ippan-003]	This work was supported by research grants from the Ministry of Health, Labor and Welfare of Japan (H24-Sinko-Ippan-003). We obtained the pneumococcal strains used for MOPA from BEI Resources. We thank Tao Yu and Yumi Hattori for technical assistance in the measurement of the serotype-specific IgG and OIs and Yasunori Sato who advised us on statistical analyses. We are also grateful to Hideki Uchikawa, Yuzaburo Inoue, other pediatricians at Chiba University and the participants in the Chiba Paediatric Infectious Disease Meeting, who gave us valuable advice about conducting this study.	Rodenburg GD, 2010, EMERG INFECT DIS, V16, P816, DOI 10.3201/eid1605.091223; Spijkerman J, 2013, JAMA-J AM MED ASSOC, V310, P930, DOI 10.1001/jama.2013.228052; Davidson RN, 2001, CLIN MICROBIOL INFEC, V7, P657, DOI 10.1046/j.1198-743x.2001.00355.x; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Chiba N, 2010, EPIDEMIOL INFECT, V138, P61, DOI 10.1017/S0950268809990239; Concepcion NF, 2001, CLIN DIAGN LAB IMMUN, V8, P266, DOI 10.1128/CDLI.8.2.266-272.2001; Busse PJ, 2002, J ALLERGY CLIN IMMUN, V109, P1001, DOI 10.1067/mai.2002.124999; Mikolajczyk MG, 2004, CLIN DIAGN LAB IMMUN, V11, P1158, DOI 10.1128/CDLI.11.6.1158-1164.2004; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Burton RL, 2006, CLIN VACCINE IMMUNOL, V13, P1004, DOI 10.1128/CVI.00112-06; CRUMRINE MH, 1979, INFECT IMMUN, V25, P960; Elberse KEM, 2011, VACCINE, V29, P1029, DOI 10.1016/j.vaccine.2010.11.054; El-Nawawy A, 2005, J TROP PEDIATRICS, V51, P271, DOI 10.1093/tropej/fmi011; Holmlund E, 2006, VACCINE, V24, P57, DOI 10.1016/j.vaccine.2005.07.055; Janeway C.e.a, 2005, IMMUNOBIOLOGY IMMUNE; LAGERGARD T, 1983, ACTA PATH MICRO IM C, V91, P371; Masuda K, 2002, PEDIATR INT, V44, P376, DOI 10.1046/j.1442-200X.2002.01587.x; MUSHER DM, 1990, J INFECT DIS, V161, P736; Shinjoh Masayoshi, 2012, Kansenshogaku Zasshi, V86, P582; Togashi T, 2013, PEDIATR INFECT DIS J, V32, P984, DOI 10.1097/INF.0b013e318293007e; World Health Organization Expert Committee on Biological Standardization, 2005, WHO TECH REP SER, V927, P64	21	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	DEC	2014	20	12					794	798		10.1016/j.jiac.2014.08.027		5	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	AU4DH	WOS:000345558800011		
J	Ikematsu, H; Kawai, N; Iwaki, N; Kashiwagi, S				Ikematsu, Hideyuki; Kawai, Naoki; Iwaki, Norio; Kashiwagi, Seizaburo			Continued effectiveness of laninamivir octanate hydrate for influenza treatment in Japan: Comparison between the 2011-2012 and 2012-2013 influenza seasons	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Long-acting neuraminidase inhibitor; Laninamivir; Efficacy; IC50	OCTANOATE HYDRATE; POSTMARKETING SURVEILLANCE; CLINICAL-TRIAL; DOUBLE-BLIND; OSELTAMIVIR; MULTICENTER	The clinical effectiveness of Laninamivir octanoate hydrate (laninamivir) was investigated in the Japanese 2012-2013 influenza season for comparison with that of the Japanese 2011-2012 influenza season. A total of 235 patients were enrolled, of whom 210 were evaluated for the duration of fever and other symptoms. The median durations of fever for A(H3N2) were 32.0 and 38.0 h and the median durations of symptoms for the A(H3N2) were 102.0 and 84.0 h for patients aged under 10 and 10 years or older, respectively. All four influenza B patients were 10 years or older, and their median duration of fever was 43.0 h and the median duration of symptoms was 71.0 h. There was no significant difference in the duration of fever or symptoms between the two seasons. The rates of patients A(H3N2) virus positive at day 5 were 37.2% (16/43) and 12.8% (18/141) for those aged under 10 years and 10 years or older, respectively. The virus positive rate was significantly higher for the patients under 10 years than for the patients aged 10 years or older (p < 0.0001). No significant change in IC50 value was found between days 1 and 5. Adverse drug reactions were reported by 2 of the 231 patients (0.87%), but neither was serious. These results suggest that laninamivir continued to be effective against influenza A(H3N2) with no safety issues and that it is unlikely that the clinical use of laninamivir will lead to virus resistance. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Ikematsu, Hideyuki; Kawai, Naoki; Iwaki, Norio; Kashiwagi, Seizaburo] Japan Phys Assoc, Tokyo 1000003, Japan	Ikematsu, H (reprint author), Japan Phys Assoc, Chiyoda Ku, 1-2-2 Sumitomosyouzitakehashi Bld 13F, Tokyo 1000003, Japan.	ikematsu@gray.plala.or.jp			Daiichi Sankyo Company, Limited	This investigation was sponsored by Daiichi Sankyo Company, Limited.	Kohno S, 2011, ANTIMICROB AGENTS CH, V55, P2803, DOI [10.1128/AAC.01718-10, 10.1128/AAC.00360-11]; Kawai N, 2005, CLIN INFECT DIS, V40, P1309, DOI 10.1086/429241; Watanabe A, 2010, CLIN INFECT DIS, V51, P1167, DOI 10.1086/656802; Kawai N, 2009, J INFECTION, V59, P207, DOI 10.1016/j.jinf.2009.07.002; Kawai N, 2009, CLIN INFECT DIS, V49, P1828, DOI 10.1086/648424; Kawai N, 2006, CLIN INFECT DIS, V43, P439, DOI 10.1086/505868; Yamashita M, 2009, ANTIMICROB AGENTS CH, V53, P186, DOI 10.1128/AAC.00333-08; Zambon M, 2001, ANTIVIR RES, V49, P147, DOI 10.1016/S0166-3542(01)00124-3; Kawai N, 2007, J INFECTION, V55, P267, DOI 10.1016/j.jinf.2007.05.176; Ikematsu H, 2014, J INFECT CHEMOTHER, V20, P77, DOI 10.1016/j.jiac.2013.07.002; Sugaya N, 2010, ANTIMICROB AGENTS CH, V54, P2575, DOI 10.1128/AAC.01755-09; Ikematsu H, 2014, J INFECT CHEMOTHER, V20, P81, DOI 10.1016/j.jiac.2013.07.013; Kashiwagi S, 2012, INT J ANTIMICROB AG, V40, P381, DOI 10.1016/j.ijantimicag.2012.06.017; [Anonymous], 2009, WKLY EPIDEMIOL REC, V46, P481; Ikematsu H, 2012, J INFECT CHEMOTHER, V18, P529, DOI 10.1007/s10156-012-0377-8; Kashiwagi S, 2013, J INFECT CHEMOTHER, V19, P223, DOI 10.1007/s10156-012-0481-9; Kawai N, 2014, INFLUENZA TREATMENT, P26; Yates PJ, 2013, ANTIMICROB AGENTS CH, V57, P1677, DOI 10.1128/AAC.02145-12	18	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	DEC	2014	20	12					799	803		10.1016/j.jiac.2014.08.023		5	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	AU4DH	WOS:000345558800012		
J	Hagiya, H; Kokeguchi, S; Ogawa, H; Terasaka, T; Kimura, K; Waseda, K; Hanayama, Y; Oda, K; Mori, H; Miyoshi, T; Otsuka, F				Hagiya, Hideharu; Kokeguchi, Susumu; Ogawa, Hiroko; Terasaka, Tomohiro; Kimura, Kosuke; Waseda, Koichi; Hanayama, Yoshihisa; Oda, Kaori; Mori, Hisatoshi; Miyoshi, Toru; Otsuka, Fumio			Aortic vascular graft infection caused by Cardiobacterium valvarum: A case report	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Infective endocarditis; Infective aneurysm; Aortic vascular graft; Cardiobacterium; Septic embolism; Hyperglobulinemia	ENDOCARDITIS; BACTERIA; VALVE; IDENTIFICATION; HOMINIS	A 53-year-old man with a past medical history of total arch replacement surgery and severe aortic regurgitation presented with a 1-month history of persistent general malaise, anorexia, body weight loss and night sweats. His recent history included gingival hyperplasia for 6 years, gingivitis after tooth extraction 3 years before, prolonged inflammatory status for 4 months, fundal hemorrhage and leg tenderness for 2 months. A pathogen was detected from blood culture, but conventional microbiological examination failed to identify the pathogen. The organism was eventually identified as Cardiobacterium valvarum by 16S rRNA analysis, and the patient was diagnosed with infective endocarditis and prosthetic vascular graft infection. The patient received intravenous antibiotic therapy using a combination of ceftriaxone and levofloxacin for 5 weeks and was discharged with a good clinical course. C. valvarum is a rare human pathogen in clinical settings. Only 10 cases have been reported to date worldwide, and therefore, the clinical characteristics of C. valvarum infection are not fully known. This is a first well-described case of C. valvarum infection in Japan, and further, a first report of aortic prosthetic vascular graft infection worldwide. Identification of C. valvarum is usually difficult due to its phenotypic characteristics, and molecular approaches would be required for both clinicians and microbiologists to facilitate more reliable diagnosis and uncover its clinical picture more clearly. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Hagiya, Hideharu; Ogawa, Hiroko; Terasaka, Tomohiro; Kimura, Kosuke; Waseda, Koichi; Hanayama, Yoshihisa; Oda, Kaori; Mori, Hisatoshi; Otsuka, Fumio] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gen Med, Okayama, Japan; [Kokeguchi, Susumu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Microbiol, Okayama, Japan; [Miyoshi, Toru] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiol, Okayama, Japan	Hagiya, H (reprint author), 2-5-1 Shikata Cho,Kitaku, Okayama 7008558, Japan.	e_dai_for_all@hotmail.com					Abraham R, 2012, J MED MICROBIOL, V61, P1625, DOI 10.1099/jmm.0.043208-0; Ashimoto A, 1996, ORAL MICROBIOL IMMUN, V11, P266, DOI 10.1111/j.1399-302X.1996.tb00180.x; Ward C, 2000, HEART, V83, P81, DOI 10.1136/heart.83.1.81; Selton-Suty C, 2012, CLIN INFECT DIS, V54, P1230, DOI 10.1093/cid/cis199; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Tleyjeh IM, 2005, JAMA-J AM MED ASSOC, V293, P3022, DOI 10.1001/jama.293.24.3022; Berbari EF, 1997, MAYO CLIN PROC, V72, P532; Fedak PWM, 2002, CIRCULATION, V106, P900, DOI 10.1161/01.CIR.0000027905.26586.E8; Brouqui P, 2001, CLIN MICROBIOL REV, V14, P177, DOI 10.1128/CMR.14.1.177-207.2001; Bothelo E, 2006, J CLIN MICROBIOL, V44, P657, DOI 10.1128/JCM.44.2.657-658.2006; Chambers ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063181; Chen M, 2011, J MED MICROBIOL, V60, P522, DOI 10.1099/jmm.0.025353-0; Choudhury S, 2013, J CLIN MICROBIOL, V51, P1996, DOI 10.1128/JCM.00480-13; Citron DM, 2005, J CLIN MICROBIOL, V43, P2485, DOI 10.1128/JCM.43.5.2485-2488.2005; Ferreiros E, 2006, AM HEART J, V151, P545, DOI 10.1016/j.ahj.2005.04.008; Geissdörfer Walter, 2007, J Clin Microbiol, V45, P2324, DOI 10.1128/JCM.00400-07; Gonzalez JB, 2007, INFECT DIS CLIN PRAC, V15, P364, DOI 10.1097/IPC.0b013e3181342f74; Han XY, 2004, J CLIN MICROBIOL, V42, P1590, DOI 10.1128/JCM.42.4.1590-1595.2004; Han XY, 2005, J CLIN MICROBIOL, V43, P2370, DOI 10.1128/JCM.43.5.2370-2374.2005; Hoffman MJ, 2010, INFECTION, V38, P245, DOI 10.1007/s15010-010-0004-5; Hoover SE, 2005, ANN INTERN MED, V142, P229; Kugler KC, 1999, DIAGN MICR INFEC DIS, V34, P73, DOI 10.1016/S0732-8893(98)00165-5; Prisant L Michael, 2002, J Clin Hypertens (Greenwich), V4, P310, DOI 10.1111/j.1524-6175.2002.01095.x; Samarasinghe Y P, 2004, Heart, V90, P16, DOI 10.1136/heart.90.1.16; SLOTNICK IJ, 1964, ANTON VAN LEE J M S, V30, P261, DOI 10.1007/BF02046732; Vanerkova M, 2010, J MED MICROBIOL, V59, P231, DOI 10.1099/jmm.0.012948-0; Wallet F, 2011, JPN J INFECT DIS, V64, P327	27	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	DEC	2014	20	12					804	809		10.1016/j.jiac.2014.07.008		6	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	AU4DH	WOS:000345558800013		
J	Urakami, T; Hamada, Y; Magarihuchi, H; Yamakuchi, H; Aoki, Y				Urakami, Tosiharu; Hamada, Yohei; Magarihuchi, Hiroki; Yamakuchi, Hiroki; Aoki, Yosuke			Enterococcal endocarditis complicated with ruptured infected-intracranial aneurysm: With pharmacokinetic-pharmacodynamic documentation in proof of the successful antimicrobial treatment	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						Endocarditis; Enterococcus; Infected intracranial aneurysm; Ampicillin; Pharmacokinetics-pharmacodynamics (PK-PD)	ASSOCIATION; MANAGEMENT; STATEMENT; DIAGNOSIS; COMMITTEE	A 74-year-old man presented with sudden onset of aphasia and apraxia. Magnetic resonance image (MRI) of the brain disclosed a left frontal hemorrhage. The concomitant low grade fever suggestive of infection was unresponsive to cefazolin 1 g q12h, and refractory to piperacillin (PIPC) 2 g q8h. Blood culture grew enterococci, establishing together with echocardiography the diagnosis of infective endocarditis. The angiography revealed cerebral hemorrhage to have resulted from the rupture of the infected intracranial aneurysm. The antimicrobial therapy was switched to ampicillin (ABPC) 2 g q4h plus gentamicin (GM) 60 mg q8h. The positive blood culture was subsequently identified Enterococcus faecium to which the minimum inhibitory concentration (MIC) of PIPC, and ABPC was 16 mcg/mL, and 4 mcg/mL, respectively. The peak concentration of serum ABPC was 83.1, median 50.8, and trough 25.8 mcg/mL. Thus, the percent time > MIC for ABPC was 100%, and the time > minimum bactericidal concentration (MBC) as well. On the other hand, time > MIC for PIPC, was found nearly 30% in retrospective analysis using population pharmacokinetics. The neurological deficit of the patient was completely restored to the normal status after 4-weeks' antimicrobial therapy with ABPC plus GM, then he underwent cardiac surgery for valvular replacement, where microbiological culture of the resected valve was negative. The constellation of the clinical, pharmacological and microbiological outcome in our case provides scientific evidence that the antibiotic therapy given to our case is the best available strategy as an antimicrobial treatment of severe enterococcal endocarditis complicated by disseminated lesion as infected intracranial aneurysm. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Urakami, Tosiharu; Hamada, Yohei; Magarihuchi, Hiroki; Yamakuchi, Hiroki; Aoki, Yosuke] Saga Univ, Med Ctr, Div Infect Dis & Hosp Epidemiol, Saga, Japan; [Aoki, Yosuke] Saga Univ, Fac Med, Depatment Int Med, Saga, Japan	Aoki, Y (reprint author), 5-1-1 Nabeshima, Saga 8498501, Japan.	aokiy3@cc.saga-u.ac.jp					Peters PJ, 2006, LANCET INFECT DIS, V6, P742, DOI 10.1016/S1473-3099(06)70631-4; Durante-Mangoni E, 2008, ARCH INTERN MED, V168, P2095, DOI 10.1001/archinte.168.19.2095; Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564; Craig WA, 1998, CLIN INFECT DIS, V26, P1, DOI 10.1086/516284; Betrosian AP, 2009, EXPERT OPIN DRUG MET, V5, P1099, DOI 10.1517/17425250903145251; Mundy LM, 2000, CLIN MICROBIOL REV, V13, P513, DOI 10.1128/CMR.13.4.513-522.2000; Stone JR, 2012, CARDIOVASC PATHOL, V21, P2, DOI 10.1016/j.carpath.2011.01.001; Ducruet AF, 2010, NEUROSURG REV, V33, P37, DOI 10.1007/s10143-009-0233-1; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Aoki Y, 2011, J INFECT CHEMOTHER, V17, P407, DOI 10.1007/s10156-010-0119-8; Bulitta JB, 2007, ANTIMICROB AGENTS CH, V51, P2497, DOI 10.1128/AAC.01477-06; Gilmore MS, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P301; Hessen MT, 2000, INFECT DIS CLIN N AM, V14, P265, DOI 10.1016/S0891-5520(05)70247-6; JOLY V, 1987, ANTIMICROB AGENTS CH, V31, P1632; Mainardi JL, 2010, ANTIBIOGRAM, P127; MEGRAN DW, 1992, CLIN INFECT DIS, V15, P63; SAWCHUK RJ, 1976, J PHARMACOKINET BIOP, V4, P183, DOI 10.1007/BF01086153; Speight Trevor M, 1997, AVERYS DRUG TREATMEN, P1639; Thummel Kenneth E, 1996, AG GILMAN GOODMAN GI, P1917; Wayne PA, 2010, M100S20 CLSI	20	0	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	DEC	2014	20	12					810	813		10.1016/j.jiac.2014.07.011		4	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	AU4DH	WOS:000345558800014		
J	Mizuno, Y; Yamaguchi, T; Matsumoto, T				Mizuno, Yasutaka; Yamaguchi, Tetsuo; Matsumoto, Tetsuya			A first case of New Delhi metallo-beta-lactamase-7 in an Escherichia coli ST648 isolate in Japan	JOURNAL OF INFECTION AND CHEMOTHERAPY			English	Article						NDM-7; Escherichia coli; ST648 isolate; Screening; Travellers; Japan	METALLO-BETA-LACTAMASE; ENTEROBACTERIACEAE; IDENTIFICATION; CARBAPENEMASE; VARIANT	We report a first identification case of an Escherichia coli ST648 isolate producing a variant New Delhi metallo-beta-lactamase (NDM) -7 in Japan, which was recovered from a patient hospitalized in India. Although the first isolate, NDM-1, was identified in Japan in 2010, NDM-producing bacteria have only been isolated from seven patients to date, and no other variant of NDM producing organism has been reported yet. The emergence of NDM variants in Enterobacteriaceae is of great concern, and the use of rigorous screening tests and preventive measures against infection is imperative. (C) 2014, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.	[Mizuno, Yasutaka] Tokyo Med Univ, Dept Infect Dis, Shinjuku Ku, Tokyo 1600023, Japan; [Yamaguchi, Tetsuo; Matsumoto, Tetsuya] Tokyo Med Univ, Dept Microbiol, Shinjuku Ku, Tokyo 1600023, Japan	Mizuno, Y (reprint author), Tokyo Med Univ, Dept Infect Dis, Shinjuku Ku, 6-7-1 Nishi Shinjuku, Tokyo 1600023, Japan.	mizuno@tokyo-med.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [25461522]	We are indebted to Mrs. Yoshizumi Ayumi of Toho University, Tokyo, Japan, for the assistance of conjugation experiments in this study. This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant-in-Aid for Scientific Research (C), Grant Number 25461522.	Hornsey M, 2011, ANTIMICROB AGENTS CH, V55, P5952, DOI 10.1128/AAC.05108-11; Kaase M, 2011, J ANTIMICROB CHEMOTH, V66, P1260, DOI 10.1093/jac/dkr135; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Nordmann P, 2012, ANTIMICROB AGENTS CH, V56, P2184, DOI 10.1128/AAC.05961-11; Tada T, 2013, ANTIMICROB AGENTS CH, V57, P2394, DOI 10.1128/AAC.02553-12; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Mushtaq S, 2011, J ANTIMICROB CHEMOTH, V66, P2002, DOI 10.1093/jac/dkr226; Arakawa Y, 2000, J CLIN MICROBIOL, V38, P40; Williamson DA, 2012, INT J ANTIMICROB AG, V39, P529, DOI 10.1016/j.ijantimicag.2012.02.017; Chihara S, 2011, CLIN INFECT DIS, V52, P153, DOI 10.1093/cid/ciq054; Glupczynski Y, 2007, J CLIN MICROBIOL, V45, P501, DOI 10.1128/JCM.02221-06; Cuzon G, 2013, PLOS ONE, V8, P1; Yan JJ, 2001, ANTIMICROB AGENTS CH, V45, P2224, DOI 10.1128/AAC.45.8.2224-2228.2001	14	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-321X	1437-7780		J INFECT CHEMOTHER	J. Infect. Chemother.	DEC	2014	20	12					814	816		10.1016/j.jiac.2014.08.009		3	Infectious Diseases; Pharmacology & Pharmacy	Infectious Diseases; Pharmacology & Pharmacy	AU4DH	WOS:000345558800015		
J	Obinata, H; Gutkind, S; Stitham, J; Okuno, T; Yokomizo, T; Hwa, J; Hla, T				Obinata, Hideru; Gutkind, Sarah; Stitham, Jeremiah; Okuno, Toshiaki; Yokomizo, Takehiko; Hwa, John; Hla, Timothy			Individual variation of human S1P(1) coding sequence leads to heterogeneity in receptor function and drug interactions	JOURNAL OF LIPID RESEARCH			English	Article						sphingosine phosphate; drug therapy; cell signaling; endocytosis; genetics; sphingosine 1-phosphate receptor; single nucleotide polymorphism	PROTEIN-COUPLED RECEPTOR; SPHINGOSINE 1-PHOSPHATE; SPROUTING ANGIOGENESIS; VASCULAR DEVELOPMENT; LYMPHOCYTE EGRESS; SPHINGOSINE-1-PHOSPHATE; EDG-1; PHOSPHORYLATION; INTERNALIZATION; LIPOPROTEINS	Sphingosine 1-phosphate receptor 1 (S1P(1)), an abundantly-expressed G protein-coupled receptor which regulates key vascular and immune responses, is a therapeutic target in autoimmune diseases. Fingolimod/Gilenya (FTY720), an oral medication for relapsing-remitting multiple sclerosis, targets S1P(1) receptors on immune and neural cells to suppress neuroinflammation. However, suppression of endothelial S1P(1) receptors is associated with cardiac and vascular adverse effects. Here we report the genetic variations of the S1P(1) coding region from exon sequencing of >12,000 individuals and their functional consequences. We conducted functional analyses of 14 nonsynonymous single nucleotide polymorphisms (SNPs) of the S1PR1 gene. One SNP mutant (Arg(120) to Pro) failed to transmit sphingosine 1-phosphate (S1P)-induced intracellular signals such as calcium increase and activation of p44/42 MAPK and Akt. Two other mutants (Ile(45) to Thr and Gly(305) to Cys) showed normal intracellular signals but impaired S1P-induced endocytosis, which made the receptor resistant to FTY720-induced degradation. Another SNP mutant (Arg(13) to Gly) demonstrated protection from coronary artery disease in a high cardiovascular risk population. Individuals with this mutation showed a significantly lower percentage of multi-vessel coronary obstruction in a risk factor-matched case-control study. This study suggests that individual genetic variations of S1P(1) can influence receptor function and, therefore, infer differential disease risks and interaction with S1P(1)-targeted therapeutics.	[Obinata, Hideru; Gutkind, Sarah; Hla, Timothy] Cornell Univ, Weill Cornell Med Coll, Dept Pathol & Lab Med, Ctr Vasc Biol, New York, NY 10065 USA; [Stitham, Jeremiah; Hwa, John] Yale Univ, Sect Cardiovasc Med, Yale Cardiovasc Res Ctr, Dept Internal Med,Sch Med, New Haven, CT 06510 USA; [Okuno, Toshiaki; Yokomizo, Takehiko] Juntendo Univ, Dept Biochem, Sch Med, Tokyo 1138421, Japan	Hla, T (reprint author), Cornell Univ, Weill Cornell Med Coll, Dept Pathol & Lab Med, Ctr Vasc Biol, New York, NY 10065 USA.	tih2002@med.cornell.edu			National Institutes of Health [HL89934, HL117798]; National Heart, Lung, and Blood Institute [HL102923]; WHI Sequencing Project [HL102924]; Broad GO Sequencing Project [HL102925]; Seattle GO Sequencing Project [HL102926]; Heart GO Sequencing Project [HL103010]	This work was supported by National Institutes of Health Grants HL89934 and HL117798 to T.H., and the National Heart, Lung, and Blood Institute Grand Opportunity Exome Sequencing Project and its ongoing studies, which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL102923), the WHI Sequencing Project (HL102924), the Broad GO Sequencing Project (HL102925), the Seattle GO Sequencing Project (HL102926), and the Heart GO Sequencing Project (HL103010).	Christoffersen C, 2011, P NATL ACAD SCI USA, V108, P9613, DOI 10.1073/pnas.1103187108; Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460; Bielawski J, 2009, METHODS MOL BIOL, V579, P443, DOI 10.1007/978-1-60761-322-0_22; Koyrakh L, 2005, AM J TRANSPLANT, V5, P529, DOI 10.1111/j.1600-6143.2005.00754.x; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Lee MJ, 2001, MOL CELL, V8, P693, DOI 10.1016/S1097-2765(01)00324-0; Sanchez T, 2003, J BIOL CHEM, V278, P47281, DOI 10.1074/jbc.M306896200; Hla T, 2008, BBA-MOL CELL BIOL L, V1781, P477, DOI 10.1016/j.bbalip.2008.07.003; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Soto AG, 2010, J BIOL CHEM, V285, P18781, DOI 10.1074/jbc.M110.111088; Garris CS, 2013, NAT IMMUNOL, V14, P1166, DOI 10.1038/ni.2730; Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; Jung B, 2012, DEV CELL, V23, P600, DOI 10.1016/j.devcel.2012.07.015; Ben Shoham A, 2012, DEVELOPMENT, V139, P3859, DOI 10.1242/dev.078550; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; Liu CH, 1999, MOL BIOL CELL, V10, P1179; Rosen H, 2013, ANNU REV BIOCHEM, V82, P637, DOI 10.1146/annurev-biochem-062411-130916; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Watterson KR, 2002, J BIOL CHEM, V277, P5767, DOI 10.1074/jbc.M110647200; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Gaengel K, 2012, DEV CELL, V23, P587, DOI 10.1016/j.devcel.2012.08.005; Thangada S, 2010, J EXP MED, V207, P1475, DOI 10.1084/jem.20091343; Argraves KM, 2007, J LIPID RES, V48, P2325, DOI 10.1194/jlr.R700011-JLR200; Oo ML, 2011, J CLIN INVEST, V121, P2290, DOI 10.1172/JCI45403; Bigaud M, 2014, BBA-MOL CELL BIOL L, V1841, P745, DOI 10.1016/j.bbalip.2013.11.001; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Parrill AL, 2000, J BIOL CHEM, V275, P39379, DOI 10.1074/jbc.M007680200; Camerer E, 2009, J CLIN INVEST, V119, P1871, DOI 10.1172/JCI38575; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Nofer JR, 2004, J CLIN INVEST, V113, P569, DOI 10.1172/JCI200418004; HELENIUS A, 1994, MOL BIOL CELL, V5, P253; Obinata H, 2012, SEMIN IMMUNOPATHOL, V34, P73, DOI 10.1007/s00281-011-0287-3; Hanson MA, 2012, SCIENCE, V335, P851, DOI 10.1126/science.1215904; Okajima F, 2009, ENDOCR J, V56, P317, DOI 10.1507/endocrj.K08E-228; Pace CN, 1998, BIOPHYS J, V75, P422; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; Blaho VA, 2011, CHEM REV, V111, P6299, DOI 10.1021/cr200273u; Aratake Y, 2012, FASEB J, V26, P4068, DOI 10.1096/fj.12-212050; Arehart E, 2008, CIRC RES, V102, P986, DOI 10.1161/CIRCRESAHA.107.165936; Kohno T, 2002, FASEB J, V16, P983, DOI 10.1096/fj.01-0809com; Lee MJ, 1996, J BIOL CHEM, V271, P11272; Obinata Hideru, 2012, Methods Mol Biol, V874, P69, DOI 10.1007/978-1-61779-800-9_6; Obinata H, 2012, CHEM BIOL, V19, P1080, DOI 10.1016/j.chembiol.2012.09.002; Poti F, 2014, CARDIOVASC RES, V103, P395, DOI 10.1093/cvr/cvu136; Sun XG, 2010, J ALLERGY CLIN IMMUN, V126, P241, DOI 10.1016/j.jaci.2010.04.036; Windh RT, 1999, J BIOL CHEM, V274, P27351, DOI 10.1074/jbc.274.39.27351	47	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0022-2275	1539-7262		J LIPID RES	J. Lipid Res.	DEC	2014	55	12					2665	2675		10.1194/jlr.P054163		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AU3NH	WOS:000345519900022		
J	Sano, M; Yasukawa, H; Hata, H				Sano, Masaaki; Yasukawa, Hironori; Hata, Hiroki			Directional stability of a ship in close proximity to channel wall	JOURNAL OF MARINE SCIENCE AND TECHNOLOGY			English	Article						Directional stability; Equilibrium condition; Bank effect; Shallow water effect		Ship maneuvering motions are affected by so-called bank suction forces when proceeding in close proximity to channel wall. In fact, some rudder angles would be required to maintain the course and proper rudder activities are needed to be directionally stable. The authors conducted captive model tests in a channel with variations in water depth, off-centerline displacement, ship speed, hull drift angle and rudder angle. The shallow water and bank effects on the hydrodynamic force characteristics were investigated. Based on the regression mathematical model, the rudder angle and hull drift angle required at equilibrium conditions were estimated and the limiting off-centerline displacement for safe operation was proposed. Directional stability in the channel was also studied based on the eigenvalue analysis and dynamic maneuvering motion simulations. The stable/unstable zone for course keeping according to control system characteristics would be important for the maneuvering operation.	[Sano, Masaaki; Yasukawa, Hironori] Hiroshima Univ, Grad Sch Engn, Hiroshima 7398527, Japan; [Hata, Hiroki] Hiroshima Univ, Grad Sch Engn, Grade Masters Program 2, Higashihiroshima 724, Japan	Sano, M (reprint author), Hiroshima Univ, Grad Sch Engn, 1-4-1 Kagamiyama, Hiroshima 7398527, Japan.	masaaki-sano@hiroshima-u.ac.jp	Sano, Masaaki/D-6906-2011				Eloot K, 2007, ARCH CIV MECH ENG, V7, P91; NEWMAN JN, 1992, J ENG MATH, V26, P51, DOI 10.1007/BF00043225; Ch'ng P. W., 1993, INT SHIPBUILD PROG, V40, P7; Eda H, 1971, T SOC NAVAL ARCHITEC, V79, P71; Fujino M, 1970, INT SHIPBUILD PROGR, V17, P45; Fujino M, 1968, INT SHIPBUILD PROGR, V15, P279; Lataire E, 2008, P 27 S NAV HYDR SEOU, V2, P511; Li DQ, 2003, P INT C MAR SIM SHIP, V3, P803; Newman JN, 1977, MARINE HYDRODYNAMICS, P132; Norrbin NH, 1985, P 26 PIANC INT NAV C, P167; Norrbin N.H., 1974, P 10 S NAV HYDR CAMB, P71; Sano M, 2012, P INT C MAR SIM SHIP; Vantorre M, 2003, P INT C MAR SIM SHIP, V3, P815; Yasukawa H, 2009, P INT C SHIP MAN SHA, P127; Zou L, 2011, P 2 INT C SHIP MAN S, P413	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0948-4280	1437-8213		J MAR SCI TECH-JAPAN	J. Mar. Sci. Technol.	DEC	2014	19	4					376	393		10.1007/s00773-014-0271-4		18	Engineering, Marine; Engineering, Civil	Engineering	AU1NS	WOS:000345388100003		
J	Maki, A; Umeda, N; Renilson, M; Ueta, T				Maki, Atsuo; Umeda, Naoya; Renilson, Martin; Ueta, Tetsushi			Analytical methods to predict the surf-riding threshold and the wave-blocking threshold in astern seas	JOURNAL OF MARINE SCIENCE AND TECHNOLOGY			English	Article						Surf-riding; Wave-blocking; Analytical formula; Nonlinear dynamics	SHIP	For the safe design and operation of high-speed craft, it is important to predict the behavior of these craft in following and astern quartering seas as it is well known that serious problems can occur when a vessel is forced by the waves to travel at wave speed. The surf-riding threshold is the lower speed limit above which the vessel will be forced to travel at wave speed (usually on the face of the wave) which is generally accepted to be a prerequisite for broaching. While a vessel travelling below this speed will experience significant changes in its longitudinal speed in the wave, it will not be forced to travel at wave speed. For high-speed craft, the wave-blocking threshold also becomes important. This is the upper speed, below which the vessel will also be forced to travel at wave speed (usually on the back of the wave) and is related to the possibility of bow diving. By the application of a polynomial approximation to the wave-induced surge force, including the nonlinear surge equation, an analytical formula to predict both the surf-riding and the wave-blocking thresholds is proposed. Comparative results of the surf-riding threshold and wave-blocking threshold predicted utilizing the proposed formula and the thresholds predicted using numerical bifurcation analysis indicate fairly good agreement. In addition, previously proposed analytical formulae are examined. It is concluded that predictions of these thresholds obtained using the analytical formulae based on a continuous piecewise linear approximation and Melnikov's method agree well when used to predict these thresholds with predictions obtained from numerical bifurcation analysis and those obtained experimentally using free-running models. As a result, it is considered that these two calculation methods could be recommended for the early design stage tool for avoiding broaching and bow diving.	[Maki, Atsuo] Kobe Univ, Grad Sch Maritime Sci, Higashinada Ku, Kobe, Hyogo 6580022, Japan; [Umeda, Naoya] Osaka Univ, Grad Sch Engn, Dept Naval Architecture & Ocean Engn, Suita, Osaka 5650971, Japan; [Renilson, Martin] Higher Coll Technol, Abu Dhabi, U Arab Emirates; [Ueta, Tetsushi] Univ Tokushima, Ctr Adv Informat Technol, Tokushima 7708506, Japan	Maki, A (reprint author), Minist Def, Tech Res & Dev Inst, Naval Syst Res Ctr, Meguro Ku, 2-2-1 Nakameguro, Tokyo 1538630, Japan.	atsuo_maki@yahoo.co.jp			US Office of Naval Research [0014-06-1-0646]; Japan Society for Promotion of Science [24360355]	The work was supported by the US Office of Naval Research Contract No. 0014-06-1-0646 under the administration of Dr. Patrick Purtell. This research was partly supported by a Grant-in-Aid for Scientific Research of the Japan Society for Promotion of Science (No. 24360355). The authors express their sincere gratitude to the above organization. Further, the authors are grateful to John Kecsmar from Ad Hoc Marine Designs Ltd. for his comprehensive review for preparing his paper as an expert in small craft technology and native English speaker.	Maki A, 2010, J MAR SCI TECH-JAPAN, V15, P218, DOI 10.1007/s00773-010-0085-y; [Anonymous], 2005, SLF4841 IMO, P1; Hannon M, 2000, NAV 2000 INT C SHIP; Hannon M, 1999, 5 INT C FAST SEA TRA; HOLMES PJ, 1980, SIAM J APPL MATH, V38, P65, DOI 10.1137/0138005; Kan M, 1990, J SOC NAVAL ARCHIT J, V167, P81; Maki A, 2009, P 10 INT SHIP STAB W, P429; Maki A, 2008, J MARINE SCI TECHNOL, V14, P80; Maki A, 2010, J MAR SCI TECH-JAPAN, V15, P102, DOI 10.1007/s00773-009-0076-z; Renilson MR, 2000, P 7 INT C STAB SHIPS, P511; Renilson MR, 1982, T RINA; Renilson MR, 1997, P 4 INT C FAST SEA T, P463; Spyrou KJ, 2001, P 5 INT WORKSH STAB; Spyrou KJ, 1996, J SHIP RES, V40, P326; Umeda N, 1990, P 4 INT C STAB SHIPS, P336; Umeda N, 1999, J MAR SCI TECHNOL, V4, P16, DOI 10.1007/s007730050003; Umeda N, 2008, J JAPAN SOC NAVAL AR, V8, P123; Umeda N, 1999, J MAR SCI TECHNOL, V4, P45, DOI 10.1007/s007730050006	18	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0948-4280	1437-8213		J MAR SCI TECH-JAPAN	J. Mar. Sci. Technol.	DEC	2014	19	4					415	424		10.1007/s00773-014-0257-2		10	Engineering, Marine; Engineering, Civil	Engineering	AU1NS	WOS:000345388100006		
J	Mitsuyuki, T; Hiekata, K; Yamato, H				Mitsuyuki, Taiga; Hiekata, Kazuo; Yamato, Hiroyuki			Design of production strategy considering the cutting peak demand of electricity in the shipbuilding industry	JOURNAL OF MARINE SCIENCE AND TECHNOLOGY			English	Article						Discrete event simulation; Production strategy; Scheduling; Genetic algorithm	PROJECT; ITERATIONS	This paper proposes a methodology to design production strategy considering the cutting peak demand of electricity in shipyard using the discrete event simulator and technique of genetic algorithm. First, the proposed methodology defines an organization model, product model, constraints and production strategy. The organization model is composed of workers and facilities that are defined by their amount of skill, cost and electricity consumption. The product model is defined by workflow. Work plan is calculated by a discrete event simulator that considers the constraints of electricity and work area size. The production strategy consists of the weights of nine dispatching rules. In the developed process simulator, simulation results change according to the parameters of the production strategy. In addition, an adequate production strategy is designed automatically using this process simulator and a random key-based genetic algorithm for minimizing the total cost in performing all activities. This proposed methodology was applied to several sample scenarios of assembly planning considering the cutting peak demand of electricity in shipyard. Results show that this methodology can construct a work plan that will help cut the peak demand of electricity by adequately changing the production strategy. Furthermore, this methodology also evaluates the organizational performance of the change of production strategy while considering the difference of work area size.	[Mitsuyuki, Taiga] Univ Tokyo, Grad Sch Engn, Kashiwa, Chiba 2778563, Japan; [Hiekata, Kazuo; Yamato, Hiroyuki] Univ Tokyo, Grad Sch Frontier Sci, Tokyo, Japan	Mitsuyuki, T (reprint author), Univ Tokyo, Grad Sch Engn, 5-1-5 Kashiwano Ha, Kashiwa, Chiba 2778563, Japan.	mitsuyuki@is.k.u-tokyo.ac.jp					Levitt RE, 1999, MANAGE SCI, V45, P1479, DOI 10.1287/mnsc.45.11.1479; Lankhorst MM, 2004, ADV ENG INFORM, V18, P205, DOI 10.1016/j.aei.2005.01.005; Kolisch R, 2006, EUR J OPER RES, V174, P23, DOI 10.1016/j.ejor.2005.01.065; [Anonymous], 2004, BPMN VER1 0; Merkle D, 2002, IEEE T EVOLUT COMPUT, V6, P333, DOI 10.1109/TEVC.2002.802450; Kunz JC, 1998, COMMUN ACM, V41, P84, DOI 10.1145/287831.287844; Luh PB, 1999, EUR J OPER RES, V113, P575, DOI 10.1016/S0377-2217(98)00027-7; Unger D, 2011, J ENG DESIGN, V22, P689, DOI 10.1080/09544828.2010.524886; Bean J. C., 1994, ORSA Journal on Computing, V6; BLACKSTONE JH, 1982, INT J PROD RES, V20, P27, DOI 10.1080/00207548208947745; Brown Ross, 2011, Business Process Management Journal, V17, DOI 10.1108/14637151111136414; Evans JR, 2002, TOTAL QUALITY MANAGE; Hai R, 2011, ADV ENG INFORM, V25, P748, DOI 10.1016/j.aei.2011.05.002; Hartmann S, 1998, NAV RES LOG, V45, P733, DOI 10.1002/(SICI)1520-6750(199810)45:7<733::AID-NAV5>3.3.CO;2-7; Hassan K, 2013, J SHIP PROD DES, V29, P105, DOI 10.5957/JSPD.29.3.120021; Hattan M, 1994, TASK ORIENTED QC APP; IBM, FILENET BUS PROC MAN; Jin Y., 1996, COMPUTATIONAL MATH O, V2, P171, DOI DOI 10.1007/BF00127273; Kaji K, 2010, P 19 ISPE INT C CONC, V1, P51; Kajiwara H, 2010, P INT C MAR TECHNOL, V1, P189; Kajiwara H, 2009, P INT C COMPUT APPL, V1, P149; Moser BR, 2012, THESIS U TOKYO; Suzuki Y, 2012, ADV ENG INFORM, V26, P763, DOI 10.1016/j.aei.2012.06.002; Tyson RB, 2001, IEEE T ENG MANAGE, V48, P292	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0948-4280	1437-8213		J MAR SCI TECH-JAPAN	J. Mar. Sci. Technol.	DEC	2014	19	4					425	437		10.1007/s00773-014-0261-6		13	Engineering, Marine; Engineering, Civil	Engineering	AU1NS	WOS:000345388100007		
J	Adachi, M; Kosaka, H; Fukuda, T; Ohashi, S; Harumi, K				Adachi, Masaki; Kosaka, Hiroyuki; Fukuda, Tetsugo; Ohashi, Shota; Harumi, Kazuyoshi			Economic analysis of trans-ocean LNG-fueled container ship	JOURNAL OF MARINE SCIENCE AND TECHNOLOGY			English	Article						LNG; Container ship; LNG fuel tank; Discount cash flow method (DCFM); Net present value (NPV)		This paper proposes concepts and economic analysis of 9,300 TEU (Twenty-foot Equivalent Unit) trans-ocean container ship fueled by LNG, sailing between Asia and Europe, based on the design of existing container ship fueled by bunker oil. For a quantitative comparison, three projects complying with IMO Tier III NOx emission regulation are made: oil-fueled ship with selective catalystic reduction (SCR), LNG-fueled ship with low-speed diesel engine directly coupled to the propulsion system, and LNG-fueled ship with medium-speed diesel electrical propulsion system. Moreover, parameters for the economic analysis study are evaluated by the market research and the general information: initial shipbuilding cost, freight revenue, operation expenditure, and fuel cost. Economic analysis by discount cash flow method shows that the project of LNG low-speed diesel ship is more attractive investment than the project of the oil-fueled ship with SCR. Supposing that life time is 20 years, net present value of each LNG ship is larger than that of the oil-ship at the end of the projects. Moreover, refund time to payback initial cost for the LNG ship is shorter. This result is confirmed by the market price of LNG.	[Adachi, Masaki; Kosaka, Hiroyuki; Fukuda, Tetsugo; Ohashi, Shota; Harumi, Kazuyoshi] NMRI, Tokyo 1810004, Japan	Adachi, M (reprint author), NMRI, 6-38-1 Shinkawa, Tokyo 1810004, Japan.	mada@nmri.go.jp			JSTRA (Japan Ship Technology Research Association); Nippon Foundation	This study was carried out based on our investigation study called "The feasibility study of Trans-ocean LNG Fueled Container Ship'', which was sponsored by JSTRA (Japan Ship Technology Research Association) and basically financed by the Nippon Foundation in the 2011 year's support work called "Phase 2 Framework for Energy Efficiency Optimization of International Seaborne Trade ". We would like to thank both associations for their support.	ABS, 2011, GUIDE PROP AUX SYST; Adachi M, 2012, P JIME 82 ANN M, P39; MYERS SC, 1984, INTERFACES, V14, P126, DOI 10.1287/inte.14.1.126; Baumgart M, 2010, LNG FUELED VESSELS N; Chang D, 2008, GASTECH 2008; Clarkson Research Services, 2011, WORLD SHIP MON, V18; Deal AL, 2013, LIQUEFIED NATURAL GA; DNV, 2010, TRIAL TAK ENV EC PER; DNV, 2011, QUANT 9000 2 STROK L; EPA, 2009, PROP DES EM CONTR AR, P21; Gerdsmeyer KD, 2006, GASTECH 2006; IEA, 2012, EN PRIC TAX; IMF, 2011, PRIM COMM PRIC; IMO, 1993, INT COD CONSTR EQ SH; IMO, 2010, 1318 IMO BLG; MOF Japan, 2012, TRAD STAT JAP; Ocean Commerce Ltd, 2011, INT TRANSP HDB; Stopford M., 2009, MARITIME EC; UNCTAD, 1997, REV MAR TRANSP	19	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0948-4280	1437-8213		J MAR SCI TECH-JAPAN	J. Mar. Sci. Technol.	DEC	2014	19	4					470	478		10.1007/s00773-014-0262-5		9	Engineering, Marine; Engineering, Civil	Engineering	AU1NS	WOS:000345388100011		
J	Kanehira, M; Akimoto, H				Kanehira, Makoto; Akimoto, Hiromichi			Numerical analysis of righting moment for heeling of a wing with heel angles in the surface effect	JOURNAL OF MARINE SCIENCE AND TECHNOLOGY			English	Article						WISES; Surface effect; Ground effect; Heel; Righting moment		A wing-in-surface-effect-ship (WISES) is a high-speed transportation system that utilizes the enhanced lift-to-drag ratio which occurs in the proximity of the water surface. Unlike conventional aircraft and ships, a WISES experiences a righting moment against heeling from the surface. In this study, we analyzed the flow around a wing that has heel angles in the surface effect using Reynolds-averaged Navier-Stokes (RaNS) simulations and experiments. We compared our numerical results with the measurements obtained in the wind tunnel tests to confirm the validity of the computational approach under several conditions. To detect the righting moment for heeling without the effect of a boundary layer, we implemented a towing tank experiment and compared the results. In the towing tank experiment, we towed a wing model above flat plates in the water. Our results showed that a righting moment is generated for a wing that has heel angles in the surface effect. The righting moment is not proportional to the heel angle. In addition, the moment increases with decrease of the trailing edge altitude. Furthermore, we found that the addition of endplates enhances the righting moment.	[Kanehira, Makoto; Akimoto, Hiromichi] Univ Tokyo, Grad Sch Engn, Dept Syst Innovat, Meguro Ku, Tokyo 1530041, Japan	Kanehira, M (reprint author), Univ Tokyo, Grad Sch Engn, Dept Syst Innovat, Meguro Ku, 4-6-1 Komaba, Tokyo 1530041, Japan.	kanehira@iis.u-tokyo.ac.jp					Abbott I. H., 1959, THEORY WING SECTIONS; Akimoto H, 2002, P 3 INT EUR HIGH PER, P3; Akimoto H, 2007, P 9 INT C FAST SEA T, P258; Akimoto Hiromichi, 2010, International Journal of Aerodynamics, V1, DOI 10.1504/IJAD.2010.031698; Akimoto H, 2000, P 3 INT C HIGH PERF, P1; Kanai M, 1991, J SOC NAVAL ARCHIT J, V170, P73; Kim HJ, 2009, J MAR SCI TECHNOL, V14, P39, DOI 10.1007/s00773-008-0020-7; Maskalik AI, 1998, RTO AVT S FLUID DYN; Mizutani N., 1993, J SOC NAVAL ARCHITEC, V1993, P35, DOI [10.2534/jjasnaoe1968.1993.174_35, DOI 10.2534/JJASNAOE1968.1993.174_35]; NISSHO-ELECTRIC-WORKS Co. Ltd, LMC3520 NISSH EL WOR; Watanabe K, 2002, J SOC NAVAL ARCHIT J, V192, P257; Zhukov VI, 1997, P INT C WING IN GROU	12	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0948-4280	1437-8213		J MAR SCI TECH-JAPAN	J. Mar. Sci. Technol.	DEC	2014	19	4					493	502		10.1007/s00773-014-0263-4		10	Engineering, Marine; Engineering, Civil	Engineering	AU1NS	WOS:000345388100013		
J	Yamada, S; Yamamoto, A; Kasuga, T				Yamada, Shinya; Yamamoto, Akiko; Kasuga, Toshihiro			Poly(L-lactic acid)/vaterite composite coatings on metallic magnesium	JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE			English	Article							POLY(LACTIC ACID) COMPOSITES; ORTHOPEDIC IMPLANTS; TETRAZOLIUM SALT; CELL VIABILITY; IN-VITRO; ALLOYS; BONE; BIOMATERIALS; ADHESION; CORROSION	Poly(l-lactic acid)/vaterite composite materials were coated onto metallic magnesium substrates to control rapid degradation and to improve biocompatibility. Two types of composites were prepared by adding 30 and 60 wt% of vaterite to poly(l-lactic acid) (PLLA). The composite coating layer that contained 30 wt% vaterite in the PLLA matrix had almost no pores on the surface and suppressed the initial rapid degradation of the Mg substrate. After immersion in a culture medium for 7 days, pores of 0.5-1.0 mu m in diameter formed on the surface. The composite coating layer that contained 60 wt% vaterite with pores of 1.0-2.0 mu m in diameter on the surface did not suppress the degradation of the Mg substrate. During immersion, the pH of the media near the composite coating surfaces was maintained at 7.4-7.5 because of the degradation of PLLA and because the vaterite particles dissolved in the solution. Proliferation of murine osteoblast-like cells (MC3T3-E1) on the substrates was improved using composite coatings. Cells on the coating that contained 60 wt% vaterite had significantly higher proliferation than those on a bare Mg substrate. Our coating provides the optimum combination to suppress the initial Mg degradation and to promote cell growth on the coating surface by adjusting the vaterite content in the composite.	[Yamada, Shinya; Kasuga, Toshihiro] Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan; [Yamamoto, Akiko] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitechton MANA, Biomat Unit, Biomet Grp,Nanolife Field, Tsukuba, Ibaraki 3050044, Japan	Kasuga, T (reprint author), Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	kasuga.toshihiro@nitech.ac.jp			Institute of Ceramics Research and Education (ICRE), Nagoya Institute of Technology	The authors thank Dr. Hirotaka Maeda for helpful discussions. This work was supported in part by the Institute of Ceramics Research and Education (ICRE), Nagoya Institute of Technology.	Mueller WD, 2010, ACTA BIOMATER, V6, P1749, DOI 10.1016/j.actbio.2009.12.048; Tominaga H, 1999, ANAL COMMUN, V36, P47, DOI 10.1039/a809656b; Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2; Song YW, 2008, MATER LETT, V62, P3276, DOI 10.1016/j.matlet.2008.02.048; Maeda H, 2006, BIOMATERIALS, V27, P1216, DOI 10.1016/j.biomaterials.2005.08.010; Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X; Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003; Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001; Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006; Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049; Yamamoto A, 2009, MAT SCI ENG C-BIO S, V29, P1559, DOI 10.1016/j.msec.2008.12.015; Maeda H, 2002, J MATER RES, V17, P727, DOI 10.1557/JMR.2002.0104; Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028; Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E; Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035; Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9; Wong HM, 2010, BIOMATERIALS, V31, P2084, DOI 10.1016/j.biomaterials.2009.11.111; Xu LP, 2012, COLLOID SURFACE B, V93, P67, DOI 10.1016/j.colsurfb.2011.12.009; Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270; Schubert DW, 2003, MATER RES INNOV, V7, P314, DOI 10.1007/s10019-003-0270-2; Yamasaki Y, 2002, J BIOMED MATER RES, V62, P99, DOI 10.1002/jbm.10220; Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4; Kasuga T, 2003, BIOMATERIALS, V24, P3247, DOI 10.1016/S0142-9612(03)00190-X; Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9; Kohn DH, 2002, J BIOMED MATER RES, V60, P292, DOI 10.1002/jbm.10050; Hiromoto S, 2009, ELECTROCHIM ACTA, V54, P7085, DOI 10.1016/j.electacta.2009.07.033; Arnett TR, 2008, J NUTR, V138, P4155; CHEN HL, 1995, POLYMER, V36, P4355, DOI 10.1016/0032-3861(95)92235-7	28	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0957-4530	1573-4838		J MATER SCI-MATER M	J. Mater. Sci.-Mater. Med.	DEC	2014	25	12					2639	2647		10.1007/s10856-014-5302-5		9	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AU5KA	WOS:000345644300004		
J	Murakami, T; Ibi, K; Kuraishi, T; Hattori, S; Kai, C; Ishiguro, N; Yanai, T				Murakami, Tomoaki; Ibi, Kanata; Kuraishi, Takeshi; Hattori, Shosaku; Kai, Chieko; Ishiguro, Naotaka; Yanai, Tokuma			Failure of heterogeneous amyloid-enhancing factor in geriatric squirrel monkeys (Saimiri boliviensis)	JOURNAL OF MEDICAL PRIMATOLOGY			English	Article						AA amyloidosis; amyloid A; amyloid; cattle; chicken; chimpanzee; transmission	SYSTEMIC AA-AMYLOIDOSIS; SECONDARY AMYLOIDOSIS; MACACA-MULATTA; INDUCTION; FIBRILS; TRANSMISSION; MACAQUES; ANIMALS	BackgroundCross-species transmission of AA amyloidosis between primates and other animals has not been previously reported. MethodsEight geriatric squirrel monkeys were intravenously administered chimpanzee, bovine, or chicken amyloid fibrils and simultaneously received inflammatory stimulation. ResultsAA amyloid deposition was not detected in any of the monkeys histopathologically or immunohistochemically. ConclusionsThese results suggest that heterogeneous AA amyloidosis may not be easily transmitted into primates.	[Murakami, Tomoaki] Tokyo Univ Agr & Technol, Lab Vet Toxicol, Fuchu, Tokyo 1838509, Japan; [Ibi, Kanata; Yanai, Tokuma] Gifu Univ, Dept Vet Med, Lab Vet Pathol, Gifu, Japan; [Kuraishi, Takeshi; Hattori, Shosaku; Kai, Chieko] Univ Tokyo, Inst Med Sci, Amami Lab Injurious Anim, Kagoshima, Japan; [Kai, Chieko] Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Minato Ku, Tokyo 108, Japan; [Ishiguro, Naotaka] Gifu Univ, Dept Vet Med, Lab Food & Environm Hyg, Gifu, Japan	Murakami, T (reprint author), Tokyo Univ Agr & Technol, Fac Agr, Dept Vet Med, Lab Vet Toxicol, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	mrkmt@cc.tuat.ac.jp	Murakami, Tomoaki/D-4654-2015	Murakami, Tomoaki/0000-0002-5706-7842	Ministry of Health, Labor, and Welfare of Japan; Institute of Medical Science; University of Tokyo; Hokkaido University Center of Zoonosis Control	This study was supported in part by a Grant-in-Aid (Emerging infection) for scientific research from the Ministry of Health, Labor, and Welfare of Japan. This study was also supported in part by a Grant-in-Aid for scientific research from the Institute of Medical Science, The University of Tokyo, and the Hokkaido University Center of Zoonosis Control.	JAKOB W, 1971, VET PATHOL, V8, P292; Ludlage E, 2005, VET PATHOL, V42, P117, DOI 10.1354/vp.42-2-117; Cui D, 2008, AMYLOID, V15, P77, DOI 10.1080/13506120802005833; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; PRAS M, 1968, J CLIN INVEST, V47, P924; Bacciarini LN, 2004, VET PATHOL, V41, P229, DOI 10.1354/vp.41-3-229; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Murakami T, 2014, VET PATHOL, V51, P363, DOI 10.1177/0300985813511128; Murakami T, 2013, AMYLOID, V20, P80, DOI 10.3109/13506129.2013.783474; Cray C, 2009, COMPARATIVE MED, V59, P517; MCADAM KPWJ, 1976, J EXP MED, V144, P1121, DOI 10.1084/jem.144.4.1121; Arslan HH, 2007, B VET I PULAWY, V51, P655; BANKS KL, 1967, J AM VET MED ASSOC, V151, P839; Hubbard GB, 2001, J MED PRIMATOL, V30, P260, DOI 10.1034/j.1600-0684.2001.d01-58.x; Hukkanen RR, 2006, COMPARATIVE MED, V56, P119; ISHIHARA T, 1973, ACTA PATHOL JAPON, V23, P439; Kisilevsky R, 1999, AMYLOID, V6, P98, DOI 10.3109/13506129909007309; Liu Y, 2007, SCAND J IMMUNOL, V66, P495, DOI 10.1111/j.1365-3083.2007.02005.x; MacGuire JG, 2009, COMPARATIVE MED, V59, P168; Murakami T, 2011, AMYLOID, V18, P112, DOI 10.3109/13506129.2011.582901; Naumenko ES, 2003, B EXP BIOL MED+, V136, P80, DOI 10.1023/A:1026005416942; Obici L, 2009, ARTHRIT CARE RES, V61, P1435, DOI 10.1002/art.24735; SUZUKI T, 1980, ACTA PATHOL JAPON, V30, P549	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0047-2565	1600-0684		J MED PRIMATOL	J. Med. Primatol.	DEC	2014	43	6					488	491		10.1111/jmp.12136		4	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	AT8ZL	WOS:000345217400006		
J	Ota, D; Kanayama, M; Matsui, Y; Ito, K; Maeda, N; Kutomi, G; Hirata, K; Torigoe, T; Sato, N; Takaoka, A; Chambers, AF; Morimoto, J; Uede, T				Ota, Daichi; Kanayama, Masashi; Matsui, Yutaka; Ito, Koyu; Maeda, Naoyoshi; Kutomi, Goro; Hirata, Koichi; Torigoe, Toshihiko; Sato, Noriyuki; Takaoka, Akinori; Chambers, Ann F.; Morimoto, Junko; Uede, Toshimitsu			Tumor-alpha 9 beta 1 integrin-mediated signaling induces breast cancer growth and lymphatic metastasis via the recruitment of cancer-associated fibroblasts	JOURNAL OF MOLECULAR MEDICINE-JMM			English	Article						Osteopontin; alpha 9 beta 1 integrin; Tumor microenvironment; Cancer-associated fibroblasts; Breast cancer	PROMOTE TUMOR-GROWTH; STROMAL FIBROBLASTS; TENASCIN-C; OSTEOPONTIN; ALPHA(9)BETA(1); MODEL; INTEGRIN-ALPHA-9-BETA-1; MICROENVIRONMENT; EXPRESSION; REGULATOR	Tumor-derived matricellular proteins such as osteopontin (OPN) and tenascin-C (TN-C) have been implicated in tumor growth and metastasis. However, the molecular basis of how these proteins contribute to tumor progression remains to be elucidated. Importantly, these matricellular proteins are known to interact with alpha 9 beta 1 integrin. Therefore, we hypothesized that tumor-derived alpha 9 beta 1 integrin may contribute to tumor progression. To clarify the roles of alpha 9 beta 1 integrin in tumor growth and lymphatic metastasis, we used an inhibitory anti-human alpha 9 beta 1 integrin antibody (anti-h alpha 9 beta 1 antibody) and a alpha 9 beta 1 integrin-positive human breast cancer cell line, MDA-MB-231 luc-D3H2LN (D3H2LN), in vitro functional assays, and an in vivo orthotopic xenotransplantation model. In this study, we demonstrated that tumor, but not host alpha 9 beta 1 integrin, contributes to tumor growth, lymphatic metastasis, recruitment of cancer-associated fibroblasts (CAFs), and host-derived OPN production. We also found that CAFs contributed to tumor growth, lymphatic metastasis, and host-derived OPN levels. Consistent with those findings, tumor volume was well-correlated with numbers of CAFs and levels of host-derived OPN. Furthermore, it was shown that the inoculation of D3H2LN cells into mammary fat pads with mouse embryonic fibroblasts (MEFs), obtained from wild type, but not OPN knock-out mice, resulted in enhancement of tumor growth, thus indicating that CAF-derived OPN enhanced tumor growth. These results suggested that tumor alpha 9 beta 1-mediated signaling plays a pivotal role in generating unique primary tumor tissue microenvironments, which favor lymphatic metastasis and tumor growth.	[Ota, Daichi; Matsui, Yutaka; Ito, Koyu; Uede, Toshimitsu] Hokkaido Univ, Inst Med Genet, Dept Matrix Med, Kita Ku, Sapporo, Hokkaido 0600815, Japan; [Kanayama, Masashi; Maeda, Naoyoshi] Hokkaido Univ, Inst Med Genet, Div Mol Immunol, Kita Ku, Sapporo, Hokkaido 0600815, Japan; [Kutomi, Goro; Hirata, Koichi] Sapporo Med Univ, Sapporo Med Univ Hosp, Dept Surg 1, Chuo Ku, Sapporo, Hokkaido 0608543, Japan; [Torigoe, Toshihiko; Sato, Noriyuki] Sapporo Med Univ, Dept Pathol 1, Sch Med, Sapporo, Hokkaido 0608556, Japan; [Takaoka, Akinori] Hokkaido Univ, Inst Med Genet, Div Signaling Canc & Immunol, Kita Ku, Sapporo, Hokkaido 0600815, Japan; [Chambers, Ann F.] Univ Western Ontario, London Reg Canc Program, Dept Oncol, London, ON N6A 4L6, Canada; [Chambers, Ann F.] Univ Western Ontario, London Reg Canc Program, Dept Pathol, London, ON N6A 4L6, Canada; [Chambers, Ann F.] Univ Western Ontario, London Reg Canc Program, Dept Med Biophys, London, ON N6A 4L6, Canada; [Morimoto, Junko] Univ Tokushima, Inst Enzyme Res, Tokushima 7708503, Japan	Ota, D (reprint author), Hokkaido Univ, Inst Med Genet, Dept Matrix Med, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0600815, Japan.	dai-o@igm.hokudai.ac.jp; uedetoshimitsu@icloud.com	Chambers, Ann/L-6285-2015	Chambers, Ann/0000-0002-9509-5123	Ministry of Education, Culture, Science, Sports, and Technology of Japan [21390113]	We thank Chiemi Kimura and Orie Yamamori (Hokkaido University) for excellent technical assistance, and Tetsuro Nakamura (Gene Techono Science Corporation, Sapporo, Japan) for valuable suggestion about the use of anti-h alpha 9 beta 1 antibody and for valuable discussions during course of experiments. This study was supported by grant-in-aids from the Ministry of Education, Culture, Science, Sports, and Technology of Japan (21390113(B)) to Toshimitsu Uede.	Anborgh PH, 2009, CLIN CHEM, V55, P895, DOI 10.1373/clinchem.2008.117465; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Neufert C, 2013, J CLIN INVEST, V123, P1428, DOI 10.1172/JCI63748; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; Ijichi H, 2011, J CLIN INVEST, V121, P4106, DOI 10.1172/JCI42754; Hutti JE, 2012, CANCER RES, V72, P3260, DOI 10.1158/0008-5472.CAN-11-4141; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Tyan SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015313; Saldanha-Gama RF, 2010, BBA-MOL CELL RES, V1803, P848, DOI 10.1016/j.bbamcr.2010.03.012; Farnsworth RH, 2014, ONCOGENE, V33, P3496, DOI 10.1038/onc.2013.304; Elkabets M, 2011, J CLIN INVEST, V121, P784, DOI 10.1172/JCI43757; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Ross EA, 2006, BLOOD, V107, P1178; Vlahakis NE, 2005, J BIOL CHEM, V280, P4544, DOI 10.1074/jbc.M412816200; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; O'Connell JT, 2011, P NATL ACAD SCI USA, V108, P16002, DOI 10.1073/pnas.1109493108; Uede T, 2011, PATHOL INT, V61, P265, DOI 10.1111/j.1440-1827.2011.02649.x; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Allen MD, 2011, J PATHOL, V223, P646, DOI 10.1002/path.2833; Anderberg C, 2009, CANCER RES, V69, P369, DOI 10.1158/0008-5472.CAN-08-2724; Pena C, 2013, CANCER RES, V73, P1287, DOI 10.1158/0008-5472.CAN-12-1875; Pazolli E, 2012, CANCER RES, V72, P2251, DOI 10.1158/0008-5472.CAN-11-3386; CHONG HC, 2012, J ONCOL, P51089; Feng F, 2000, BREAST CANCER RES TR, V63, P71, DOI 10.1023/A:1006466516192; Hugo HJ, 2012, CANC MICROENVIRON, V5, P83, DOI DOI 10.1007/S12307-012-0098-7; Kanayama M, 2011, J IMMUNOL, V187, P5851, DOI 10.4049/jimmunol.1101524; Kidd S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030563; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Taniwaki K, 2007, CANCER RES, V67, P4311, DOI 10.1158/0008-5472.CAN-06-4761; Vantyghem SA, 2005, CLIN EXP METASTAS, V22, P351, DOI 10.1007/s10585-005-0745-1; YOKOSAKI Y, 1994, J BIOL CHEM, V269, P26691	33	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2716	1432-1440		J MOL MED	J. Mol. Med.	DEC	2014	92	12					1271	1281		10.1007/s00109-014-1183-9		11	Genetics & Heredity; Medicine, Research & Experimental	Genetics & Heredity; Research & Experimental Medicine	AU5KF	WOS:000345644900006		
J	Takahashi, A; Fukusumi, Y; Yamazaki, M; Kayaba, M; Kitazawa, Y; Tomita, M; Kawachi, H				Takahashi, Aya; Fukusumi, Yoshiyasu; Yamazaki, Mihoko; Kayaba, Mutsumi; Kitazawa, Yukina; Tomita, Masayuki; Kawachi, Hiroshi			Angiotensin II type 1 receptor blockade ameliorates proteinuria in puromycin aminonucleoside nephropathy by inhibiting the reduction of NEPH1 and nephrin	JOURNAL OF NEPHROLOGY			English	Article						ARB; Podocyte; Slit diaphragm; NEPH1; Nephrin	SLIT DIAPHRAGM; DEVELOPING GLOMERULI; RENAL-FAILURE; EXPRESSION; RATS; PODOCYTE; MODEL; PERMEABILITY; ANTIBODY; BARRIER	The precise pathogenic mechanism and role of angiotensin II (Ang II) action in the development of proteinuria in minimal change nephrotic syndrome (MCNS) is uncertain. The glomerular expressions of the slit diaphragm (SD) molecules nephrin, podocin and NEPH1 in rat puromycin aminonucleoside (PAN) nephropathy, a mimic of MCNS, were analyzed. The effects of Ang II receptor blockade (ARB) (irbesartan 15 mg/kg body weight/day) on proteinuria and on the expression of the SD molecules were analyzed. mRNA expressions of nephrin, podocin and NEPH1 were decreased to an undetectable level at 1 h. The staining of these SD molecules shifted to a discontinuous pattern, and their intensity was reduced. NEPH1 staining was reduced to an undetectable level on day 10. ARB treatment ameliorated the peak value of proteinuria (237.6 +/- A 97.0 vs. 359.0 +/- A 63.3 mg/day, p < 0.05), and prevented the decrease in the mRNA expression of the SD molecules (nephrin 66.96 %, podocin 60.40 %, NEPH1 77.87 % of normal level). The immunofluorescence staining of NEPH1 was restored by ARB. ARB treatment enhanced the expression of NEPH1 of normal rats. Dysfunction of the SD molecules including NEPH1 is a crucial initiation event of PAN nephropathy. ARB treatment ameliorates proteinuria in PAN nephropathy by inhibiting the reduction of NEPH1 and nephrin. Ang II action regulates the expression of NEPH1 and nephrin in not only the pathological but also physiological state.	[Takahashi, Aya; Fukusumi, Yoshiyasu; Yamazaki, Mihoko; Kayaba, Mutsumi; Kitazawa, Yukina; Tomita, Masayuki; Kawachi, Hiroshi] Niigata Univ, Grad Sch Med & Dent Sci, Inst Nephrol, Dept Cell Biol,Chuo Ku, Niigata 9518510, Japan	Kawachi, H (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Inst Nephrol, Dept Cell Biol,Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	kawachi@med.niigata-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23390224, 23591186, 24790839]	This work was supported by Grant-Aids for Scientific Research (B: 23390224 to H. Kawachi, and C: 23591186 to Y. Tomita) and Grant-Aid for Young Sciences (B: 24790839 to Y. Fukusumi) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors would like to express their gratitude to Ms. Tomoyo Kobayashi and Ms. Erina Kowada for their technical support.	Garovic VD, 2007, NEPHROL DIAL TRANSPL, V22, P1136, DOI 10.1093/ndt/gfl711; Benigni A, 2001, J AM SOC NEPHROL, V12, P941; Hidaka T, 2008, AM J PATHOL, V172, P603, DOI 10.2353/ajpath.2008.070196; Ruggenenti P, 1999, LANCET, V354, P359, DOI 10.1016/S0140-6736(98)10363-X; ORIKASA M, 1988, J IMMUNOL, V141, P807; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Pavenstadt H, 2000, AM J PHYSIOL-RENAL, V278, pF173; Fukuda A, 2010, NEPHROLOGY, V15, P321, DOI 10.1111/j.1440-1797.2009.01256.x; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI1200318242; Arif E, 2014, J BIOL CHEM, V289, P9502, DOI 10.1074/jbc.M113.505743; Quack I, 2006, P NATL ACAD SCI USA, V103, P14110, DOI 10.1073/pnas.0602587103; Kawachi H, 2003, J AM SOC NEPHROL, V14, P46, DOI 10.1097/01.ASN.0000037401.02391.76; Bonnet F, 2001, DIABETOLOGIA, V44, P874; Sugimoto H, 2003, J BIOL CHEM, V278, P12605, DOI 10.1074/jbc.C300012200; Macconi D, 2000, J AM SOC NEPHROL, V11, P477; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Goodfriend TL, 1996, NEW ENGL J MED, V334, P1649; Kawachi H, 2000, CLIN EXP NEPHROL, V4, P161, DOI 10.1007/s101570070017; KAWACHI H, 1992, CLIN EXP IMMUNOL, V88, P399; Kawachi H, 1997, AM J PHYSIOL-RENAL, V273, pF984; Kawachi H, 2009, J NEPHROL, V22, P450; Kawachi H, 2000, KIDNEY INT, V57, P1949, DOI 10.1046/j.1523-1755.2000.00044.x; LAFAYETTE RA, 1992, J CLIN INVEST, V90, P766, DOI 10.1172/JCI115949; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; Otaki Y, 2008, AM J PHYSIOL-RENAL, V295, pF1376, DOI 10.1152/ajprenal.00075.2008; REMUZZI A, 1993, J AM SOC NEPHROL, V4, P40; Suzuki K, 2007, AM J PATHOL, V170, P1841, DOI 10.2353/ajpath.2007.060484; Ruggenenti P, 1997, LANCET, V349, P1857; Tryggvason K, 2003, J INTERN MED, V254, P216, DOI 10.1046/j.1365-2796.2003.01207.x	30	0	1	WICHTIG EDITORE	MILAN	72/74 VIA FRIULI, 20135 MILAN, ITALY	1121-8428	1724-6059		J NEPHROL	J. Nephrol.	DEC	2014	27	6					627	634		10.1007/s40620-014-0147-z		8	Urology & Nephrology	Urology & Nephrology	AU1RB	WOS:000345396800004		
J	Shirai, S; Yabe, I; Kano, T; Shimizu, Y; Sasamori, T; Sato, K; Hirotani, M; Nonaka, T; Takahashi, I; Matsushima, M; Minami, N; Nakamichi, K; Saijo, M; Hatanaka, KC; Shiga, T; Tanaka, S; Sasaki, H				Shirai, Shinichi; Yabe, Ichiro; Kano, Takahiro; Shimizu, Yuka; Sasamori, Toru; Sato, Kazunori; Hirotani, Makoto; Nonaka, Takayuki; Takahashi, Ikuko; Matsushima, Masaaki; Minami, Naoya; Nakamichi, Kazuo; Saijo, Masayuki; Hatanaka, Kanako C.; Shiga, Tohru; Tanaka, Shinya; Sasaki, Hidenao			Usefulness of C-11-methionine-positron emission tomography for the diagnosis of progressive multifocal leukoencephalopathy	JOURNAL OF NEUROLOGY			English	Article						Progressive multifocal leukoencephalopathy; C-11-methionine-positron emission tomography; F-18-fluorodeoxyglucose-positron emission tomography; Mefloquine	PATIENT	Progressive multifocal leukoencephalopathy (PML) is a subacute demyelinating disease of the brain caused by the JC virus that occurs mainly in immunocompromised patients. The prognosis is very poor. As the lesion looks like non- specific leukoencephalopathy, making a diagnosis at the early stage is very difficult. We report three PML cases in which there was a mismatch between C-11-methionine-positron emission tomography (MET-PET) uptake and F-18-fluorodeoxyglucose-positron emission tomography (FDG-PET) uptake. All three cases demonstrated the hyper-uptake of MET around the white matter lesions and hypo-uptake of FDG inside the lesions. We speculate that the infection had ended inside the white matter lesions of these patients, while JC virus infection was ongoing around the lesions, resulting in the increase of methionine metabolism, and the glucose metabolism was reduced or intermediate because inflammatory cells infiltrate PML lesions rarely. Two patients who were diagnosed and treated with mefloquine while the JC virus was at a low level in the cerebrospinal fluid are still alive. We suggest the usefulness of MET-PET for the early diagnosis of PML and early treatment with mefloquine.	[Shirai, Shinichi; Yabe, Ichiro; Kano, Takahiro; Shimizu, Yuka; Sasamori, Toru; Sato, Kazunori; Hirotani, Makoto; Takahashi, Ikuko; Matsushima, Masaaki; Sasaki, Hidenao] Hokkaido Univ, Grad Sch Med, Dept Neurol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Nonaka, Takayuki; Minami, Naoya] Hokkaido Med Ctr, Dept Neurol, Sapporo, Hokkaido, Japan; [Nakamichi, Kazuo; Saijo, Masayuki] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan; [Hatanaka, Kanako C.] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Hokkaido 060, Japan; [Shiga, Tohru] Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Sapporo, Hokkaido 0608638, Japan; [Tanaka, Shinya] Hokkaido Univ, Grad Sch Med, Dept Canc Pathol, Sapporo, Hokkaido 0608638, Japan	Yabe, I (reprint author), Hokkaido Univ, Grad Sch Med, Dept Neurol, Kita Ku, N15 W7, Sapporo, Hokkaido 0608638, Japan.	yabe@med.hokudai.ac.jp	Tanaka, Shinya/D-3586-2011		Ministry of Health, Labor, and Welfare of Japan [H24-AIDS-Wakate-002]; Research Committee of Prion Disease and Slow Virus Infection from the Ministry of Health, Labor, and Welfare of Japan [H23-Nanchi-Ippan-013]	This work was partly supported by Grants-in-Aid for Research on HIV/AIDS (H24-AIDS-Wakate-002) and the Research Committee of Prion Disease and Slow Virus Infection (H23-Nanchi-Ippan-013) from the Ministry of Health, Labor, and Welfare of Japan.	Shishido-Hara Y, 2010, ACTA NEUROPATHOL, V120, P403, DOI 10.1007/s00401-010-0694-x; Beppu M, 2012, INTERNAL MED, V51, P1245, DOI 10.2169/internalmedicine.51.6810; Herholz K, 1998, NEUROLOGY, V50, P1316; Hartung HP, 2009, LANCET NEUROL, V8, P28, DOI 10.1016/S1474-4422(08)70281-3; Hirata K, 2012, ACTA RADIOL, V53, P1155, DOI 10.1258/ar.2012.120382; Kishida S, 2010, INTERNAL MED, V49, P2509, DOI 10.2169/internalmedicine.49.3227; Ochi H, 1996, Rinsho Shinkeigaku, V36, P858	7	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	DEC	2014	261	12					2314	2318		10.1007/s00415-014-7500-y		5	Clinical Neurology	Neurosciences & Neurology	AU1MD	WOS:000345383800007		
J	Masuda, H; Asahina, M; Oide, T; Wakita, H; Sekiguchi, Y; Araki, N; Kuwabara, S				Masuda, Hiroki; Asahina, Masato; Oide, Takashi; Wakita, Hiromasa; Sekiguchi, Yukari; Araki, Nobuyuki; Kuwabara, Satoshi			Antemortem detection of colonic alpha-synuclein pathology in a patient with pure autonomic failure	JOURNAL OF NEUROLOGY			English	Letter							PARKINSONS-DISEASE		[Masuda, Hiroki; Asahina, Masato; Wakita, Hiromasa; Sekiguchi, Yukari; Araki, Nobuyuki; Kuwabara, Satoshi] Chiba Univ, Grad Sch Med, Dept Neurol, Chuo Ku, Chiba 2608670, Japan; [Oide, Takashi] Chiba Univ, Grad Sch Med, Dept Diagnost Pathol, Chiba 2608670, Japan	Masuda, H (reprint author), Chiba Univ, Grad Sch Med, Dept Neurol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	hiroki_masuda@msn.com					Hawkes CH, 2010, PARKINSONISM RELAT D, V16, P79, DOI 10.1016/j.parkreldis.2009.08.007; Koike H, 2013, J NEUROL NEUROSUR PS, V84, P98, DOI 10.1136/jnnp-2012-302833; Visanji NP, 2014, MOVEMENT DISORD, V29, P444, DOI 10.1002/mds.25789; Garland Emily M, 2013, Handb Clin Neurol, V117, P243, DOI 10.1016/B978-0-444-53491-0.00020-1; Sugiyama A, 2014, AMYLOID, V21, P218, DOI 10.3109/13506129.2014.935321	5	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	DEC	2014	261	12					2451	2452		10.1007/s00415-014-7529-y		2	Clinical Neurology	Neurosciences & Neurology	AU1MD	WOS:000345383800026		
J	Yamamoto, M; Kawabe, T; Sato, Y; Higuchi, Y; Nariai, T; Watanabe, S; Kasuya, H				Yamamoto, Masaaki; Kawabe, Takuya; Sato, Yasunori; Higuchi, Yoshinori; Nariai, Tadashi; Watanabe, Shinya; Kasuya, Hidetoshi			Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors	JOURNAL OF NEUROSURGERY			English	Article						brain metastases; radiation therapy; radiosurgery; Gamma Knife; tumor number; stereotactic radiosurgery	GAMMA-KNIFE RADIOSURGERY; CLINICAL ARTICLE; COMPETING RISKS; RADIATION-THERAPY; PROPENSITY SCORE; IRRADIATION; MANAGEMENT; JLGK0901	Object. Although stereotactic radiosurgery (SRS) alone is not a standard treatment for patients with 4-5 tumors or more, a recent trend has been for patients with 5 or more, or even 10 of more, tumors to undergo SRS alone. The aim of this study was to reappraise whether the treatment results for SRS alone for patients with 10 or more tumors differ from those for patients with 2-9 tumors. Methods. This was an institutional review board approved, retrospective cohort study that gathered data from the Katsuta Hospital Mito GammaHouse prospectively accuniulated database. Data were collected for 2553 patients who consecutively had undergone Gamma Knife SRS alone, without whole-brain radiotherapy (WBRT), for newly diagnosed (mostly) or recurrent (uncommonly) brain metastases during 1998-2011. Of these 2553 patients, 739 (28.9%) with a single tumor were excluded, leaving 1814 with multiple metastases in the study. These 1814 patients were divided into 2 groups: those with 2-9 tumors (Group A, 1254 patients) and those with 10 or more tumors (Group B, 560 patients). Because of considerable bias in pre-SRS Clinical factors between groups A and B, a case-matched study, which used the propensity score matching method, was conducted for clinical factors (i.e., age, sex, primary tumor state, extracerebral metastases, Karnofsky Performance Status, neurological symptoms, prior procedures [surgery and WBRT], volume of the largest tumor, and peripheral doses). Ultimately, 720 patients (360 in each group) were selected. The standard Kaplan-Meier method was used to determine post-SRS survival times and post-SRS neurological death free survival times. Competing risk analysis was applied to estimate cumulative incidence for local recurrence, repeat SRS for new lesions, neurological deterioration, and SRS-induced complications. Results. Post-SRS median survival times did not differ significantly between the 2 groups (6.8 months for Group A vs 6.0 months for Group B; hazard ratio [HR] 1.133, 95% CI 0.974-1.319, p = 0.10). Furthermore, rates of neurological death were very similar: 10.0% for group A and 9.4% for group B (p = 0.89); neurological death free survival times did not differ significantly between the 2 groups (HR 1.073,95% CI 0.649-1.771, p = 0.78). The cumulative incidence of local recurrence (BR 0.425, 95% CI 0.0.181-0.990, p = 0.04) and repeat SRS for new lesions (HR 0.732, 95% CI 0.554-0.870, p = 0.03) were significantly lower for Group B than for Group A patients. No significant differences between the groups were found for cumulative incidence for neurological deterioration (HR 0.994,95% CI 0.607-1.469, p = 0.80) or SRS-related complications (HR 0.541,95% CI 0.138-2.112, p = 0.38). Conclusions. Post-SRS treatment results (i.e., median survival time; neurological death free survival times; and cumulative incidence for local recurrence, repeat SRS for new lesions, neurological deterioration, and SRS-related complications) were not inferior (neither less effective nor less safe) for patients in Group B than for those in Group A. We conclude that carefully selected patients with 10 or more tumors are not unfavorable candidates for SRS alone. A randomized controlled trial should be conducted to test this hypothesis.	[Yamamoto, Masaaki; Kawabe, Takuya; Watanabe, Shinya] Katsuta Hosp Mito GammaHouse, Hitachinaka, Ibaraki 3120011, Japan; [Yamamoto, Masaaki; Kasuya, Hidetoshi] Tokyo Womens Med Univ, Med Ctr East, Dept Neurosurg, Tokyo, Japan; [Kawabe, Takuya] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Neurosurg, Kyoto, Japan; [Sato, Yasunori] Chiba Univ, Grad Sch Med, Clin Res Ctr, Chiba, Japan; [Higuchi, Yoshinori] Chiba Univ, Grad Sch Med, Dept Neurosurg, Chiba, Japan; [Nariai, Tadashi] Tokyo Med & Dent Univ, Sch Med, Grad Sch, Dept Neurosurg, Tokyo 113, Japan; [Watanabe, Shinya] Univ Tsukuba, Fac Med, Dept Neurosurg, Tsukuba, Ibaraki, Japan	Yamamoto, M (reprint author), Katsuta Hosp Mito GammaHouse, 5125-2 Nakane, Hitachinaka, Ibaraki 3120011, Japan.	bcd06275@nifty.com					Serizawa T, 2010, J NEURO-ONCOL, V98, P163, DOI 10.1007/s11060-010-0169-x; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Yamamoto M, 2013, J NEURO-ONCOL, V111, P327, DOI 10.1007/s11060-012-1019-9; Gaspar L, 1997, INT J RADIAT ONCOL, V37, P745, DOI 10.1016/S0360-3016(96)00619-0; Kim CH, 2008, J KOREAN NEUROSURG S, V44, P358, DOI 10.3340/jkns.2008.44.6.358; Rava P, 2013, J NEUROSURG, V119, P457, DOI 10.3171/2013.4.JNS121751; STURM V, 1987, INT J RADIAT ONCOL, V13, P279; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Knisely JPS, 2010, J NEUROSURG, V113, P84, DOI 10.3171/2010.8.GKS10999; Grandhi R, 2012, J NEUROSURG, V117, P237, DOI 10.3171/2012.4.JNS11870; Yamamoto M, 2013, J NEUROSURG, V118, P1258, DOI 10.3171/2013.3.JNS121900; Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102; Aoyama H, 2006, JAMA-J AM MED ASSOC, V295, P2483, DOI 10.1001/jama.295.21.2483; Bakoyannis G, 2012, STAT METHODS MED RES, V21, P257, DOI 10.1177/0962280210394479; Yamamoto M, 2014, LANCET ONCOL, V15, P387, DOI 10.1016/S1470-2045(14)70061-0; Chang WS, 2010, J NEUROSURG, V113, P73, DOI 10.3171/2010.8.GKS10994; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Linskey ME, 2010, J NEURO-ONCOL, V96, P45, DOI 10.1007/s11060-009-0073-4; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Hanssens P, 2011, J NEUROSURG, V115, P499, DOI 10.3171/2011.4.JNS101832; Hayashi M, 2007, Neuroradiol J, V20, P481; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karlsson B, 2009, J NEUROSURG, V111, P449, DOI 10.3171/2008.10.JNS08214; Karnofsky D, 1949, EVALUATION CHEMOTHER, P191; Parsons LS, REDUCING BIAS PROPEN; Radiation Therapy Oncology Group, COOP GROUP COMM TOX; Serizawa T, 2010, J NEUROSURG, V113, P48, DOI 10.3171/2010.8.GKS10838; Suzuki S, 2000, J NEUROSURG, V93, P30; Tsao May N, 2012, Pract Radiat Oncol, V2, P210, DOI 10.1016/j.prro.2011.12.004; Yamamoto M, 2012, PROG NEUROL SURG, V25, P261, DOI 10.1159/000331199; Yamamoto M, 2013, INT J RADIAT ONCOL, V85, P53, DOI 10.1016/j.ijrobp.2012.04.018; Yamamoto M, 1998, RADIOSURG, V2, P94; Yamamoto M, 2012, INT J RADIAT ONCOL, V83, P1399, DOI 10.1016/j.ijrobp.2011.10.018; Yamamoto M, 2002, INT J RADIAT ONCOL, V53, P1279, DOI 10.1016/S0360-3016(02)02855-9	35	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2014	121			S			16	25		10.3171/2014.8.GKS141421		10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AU3CS	WOS:000345491000003		
J	Serizawa, T; Higuchi, Y; Nagano, O; Matsuda, S; Ono, J; Saeki, N; Hirai, T; Miyakawa, A; Shibamoto, Y				Serizawa, Toru; Higuchi, Yoshinori; Nagano, Osamu; Matsuda, Shinji; Ono, Junichi; Saeki, Naokatsu; Hirai, Tatsuo; Miyakawa, Akifumi; Shibamoto, Yuta			A new grading system focusing on neurological outcomes for brain metastases treated with stereotactic radiosurgery: the modified Basic Score for Brain Metastases	JOURNAL OF NEUROSURGERY			English	Article						brain metastases; preservation of neurological function; prevention of neurological death; stereotactic radiosurgery; Gamma Knife surgery	GAMMA-KNIFE SURGERY; RADIATION-THERAPY; PROGNOSTIC-FACTORS; TUMORS; RADIOTHERAPY; JLGK0901; INDEXES; RPA	Object. The Basic Score for Brain Metastases (BSBM) proposed by Lorenzoni and colleagues is one of the best grading systems for predicting survival periods after stereotactic radiosurgery (SRS) for brain metastases. However, it includes no brain factors and cannot predict neurological outcomes, such as preservation of neurological function and prevention of neurological death. Herein, the authors propose a modified BSBM, adding 4 brain factors to the original BSBM, enabling prediction of neurological outcomes, as well as of overall survival, in patients undergoing SRS. Methods. To serve as neurological prognostic scores (NPSs), the authors scored 4 significant brain factors for both preservation of neurological function (qualitative survival) and prevention of neurological death (neurological survival) as 0 or 1 as described in the following: > 10 brain tumors = 0 or <= 10 = 1, total tumor volume > 15 cm(3) = 0 or <= 15 cm(3) = 1, MRI findings of localized meningeal dissemination (yes =0 or no = 1), and neurological symptoms (yes = 0 or no = 1). According to the sum of NPSs, patients were classified into 2 subgroups: Subgroup A with a total NPS of 3 or 4 and Subgroup B with an NPS of 0, 1, or 2. The authors defined the modified BSBM according to the NPS subgroup classification applied to the original BSBM groups. The validity of this modified BSBM in 2838 consecutive patients with brain metastases treated with SRS was verified. Results. Patients included 1868 with cancer of the lung (including 1604 with non-small cell lung cancer), 355 of the gastrointestinal tract, 305 of the breast, 176 of the urogenital tract, and 134 with other cancers. Subgroup A had 2089 patients and Subgroup B 749. Median overall survival times were 2.6 months in BSBM 0 (382 patients), 5.7 in BSBM 1(1143), 11.4 in BSBM 2 (1011) and 21.7 in BSBM 3 (302), and pairwise differences between the BSBM groups were statistically significant (all p < 0.0001). One-year qualitative survival rates were 64.6% (modified BSBM OA, 204 patients), 45.0% (OB, 178), 82.5% (1A, 825), 63.3% (1B, 318), 86.4% (2A, 792), 73.7% (2B, 219), 91.4% (3A, 268), and 73.5% (3B, 34). One-year neurological survival rates were 82.6% (OA), 52.4% (OB), 90.5% (1A), 78.1% (1B), 91.1% (2A), 83.2% (2B), 93.9% (3A), and 76.3% (3B), where A and B identify the subgroup. Statistically significant differences in both qualitative and neurological survivals between Subgroups A and B were detected in all BSBM groups. Conclusions. The authors' new index, the modified BSBM, was found to be excellent for predicting neurological outcomes, independently of life expectancy, in SRS-treated patients with brain metastases.	[Serizawa, Toru] Tsukiji Neurol Clin, Tokyo Gamma Unit Ctr, Tokyo 1040045, Japan; [Higuchi, Yoshinori; Saeki, Naokatsu] Chiba Univ, Grad Sch Med, Dept Cerebral & Neurol Surg, Chiba, Japan; [Nagano, Osamu; Matsuda, Shinji; Ono, Junichi] Chiba Cardiovasc Ctr, Ichihara, Chiba, Japan; [Hirai, Tatsuo] Fujieda Heisei Mem Hosp, Heisei Gamma Unit Ctr, Fujieda, Shizuoka, Japan; [Miyakawa, Akifumi; Shibamoto, Yuta] Nagoya City Univ, Grad Sch Med Sci, Dept Radiol, Nagoya, Aichi, Japan; [Miyakawa, Akifumi; Shibamoto, Yuta] Nagoya City Univ, Sch Med, Nagoya, Aichi 467, Japan	Serizawa, T (reprint author), Tsukiji Neurol Clin, Tokyo Gamma Unit Ctr, Chuou Ku, 1-9-9 Tsukiji, Tokyo 1040045, Japan.	gamma-knife.serizawa@nifty.com					Serizawa T, 2010, J NEURO-ONCOL, V98, P163, DOI 10.1007/s11060-010-0169-x; Higuchi Y, 2009, INT J RADIAT ONCOL, V74, P1543, DOI 10.1016/j.ijrobp.2008.10.035; Yamamoto M, 2013, J NEURO-ONCOL, V111, P327, DOI 10.1007/s11060-012-1019-9; Lorenzoni J, 2004, INT J RADIAT ONCOL, V60, P218, DOI 10.1016/j.ijrobp.2004.02.017; Gaspar L, 1997, INT J RADIAT ONCOL, V37, P745, DOI 10.1016/S0360-3016(96)00619-0; Golden DW, 2008, J NEUROSURG, V109, P77, DOI 10.3171/JNS/2008/109/12/S13; Weltman E, 2000, INT J RADIAT ONCOL, V46, P1155, DOI 10.1016/S0360-3016(99)00549-0; COX DR, 1972, J R STAT SOC B, V34, P187; Aoyama H, 2006, JAMA-J AM MED ASSOC, V295, P2483, DOI 10.1001/jama.295.21.2483; Yamamoto M, 2014, LANCET ONCOL, V15, P387, DOI 10.1016/S1470-2045(14)70061-0; Sperduto PW, 2010, INT J RADIAT ONCOL, V77, P655, DOI 10.1016/j.ijrobp.2009.08.025; Sperduto PW, 2008, INT J RADIAT ONCOL, V70, P510, DOI 10.1016/j.ijrobp.2007.06.074; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karnofsky D, 1949, EVALUATION CHEMOTHER, P191; Serizawa T, 2000, J NEUROSURG, V93, P32; Serizawa T, 2010, J NEUROSURG, V113, P48, DOI 10.3171/2010.8.GKS10838; Serizawa T, 2012, J NEUROSURG, V117, P31, DOI 10.3171/2012.8.GKS12710; Serizawa T, 2005, ACTA NEUROCHIR, V147, P721, DOI 10.1007/s00701-005-0540-4; Serizawa T, 2008, J NEUROSURG, V109, P118, DOI 10.3171/JNS/2008/109/12/S18; Serizawa T, 2006, J NEUROSURG, V105, P86; Yamamoto M, 2002, INT J RADIAT ONCOL, V53, P1279, DOI 10.1016/S0360-3016(02)02855-9; Yomo S, 2012, J NEURO-ONCOL, V109, P159, DOI 10.1007/s11060-012-0882-8	22	3	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2014	121			S			35	43		10.3171/2014.7.GKS14980		9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AU3CS	WOS:000345491000005		
J	Kono, K; Terada, T				Kono, Kenichi; Terada, Tomoaki			Encephaloduroarteriosynangiosis for cerebral proliferative angiopathy with cerebral ischemia	JOURNAL OF NEUROSURGERY			English	Article						arteriovenous malformation; cerebral ischemia; cerebral proliferative angiopathy; encephaloduroarteriosynangiosis; epilepsy; vascular disorders	VASCULAR MALFORMATION	Cerebral proliferative angiopathy (CPA) is a rare clinical entity. This disorder is characterized by diffuse vascular abnormalities with intermingled normal brain parenchyma, and is differentiated from classic arteriovenous malformations. The management of CPA in patients presenting with nonhemorrhagic neurological deficits due to cerebral ischemia is challenging and controversial. The authors report a case of adult CPA with cerebral ischemia in which neurological deficits were improved after encephaloduroarteriosynangiosis (EDAS). A 28-year-old man presented with epilepsy. Magnetic resonance imaging and angiography showed a diffuse vascular network (CPA) in the right hemisphere. Antiepileptic medications were administered. Four years after the initial onset of epilepsy, the patient's left-hand grip strength gradually decreased over the course of 1 year. The MRI studies showed no infarcts, but technetium-99m-labeled ethyl cysteinate dimer (Tc-99m-ECD) SPECT studies obtained with acetazolamide challenge demonstrated hypoperfusion and severely impaired cerebrovascular reactivity over the affected hemisphere. This suggested that the patient's neurological deficits were associated with cerebral ischemia. The authors performed EDAS for cerebral ischemia, and the patient's hand grip strength gradually improved after the operation. Follow-up angiography studies obtained 7 months after the operation showed profound neovascularization through the superficial temporal artery and the middle meningeal artery. A SPECT study showed slight improvement of hypoperfusion at the focal region around the right motor area, indicating clinical improvement from the operation. The authors conclude that EDAS may be a treatment option for CPA-related hypoperfusion.	[Kono, Kenichi; Terada, Tomoaki] Wakayama Rosin Hosp, Dept Neurosurg, Wakayama 6408505, Japan	Kono, K (reprint author), Wakayama Rosin Hosp, Dept Neurosurg, 93-1 Kinomoto, Wakayama 6408505, Japan.	vyr01450@gmail.com		Kono, Kenichi/0000-0003-0006-076X			SUZUKI J, 1983, STROKE, V14, P104; Smith ER, 2005, SKULL BASE-INTERD AP, V15, P15, DOI 10.1055/s-2005-868160; Lasjaunias PL, 2008, STROKE, V39, P878, DOI 10.1161/STROKEAHA.107.493080; Doria-Netto HL, 2010, ARQ NEURO-PSIQUIAT, V68, P300, DOI 10.1590/S0004-282X2010000200027; Ducreux D, 2002, EUR RADIOL, V12, P2717, DOI 10.1007/s00330-001-1293-y; Eesa M, 2009, CAN J NEUROL SCI, V36, P135; Eesa M, 2009, CAN J NEUROL SCI, V36, P242; Ellis MJ, 2011, J NEUROSURG-PEDIATR, V7, P15, DOI 10.3171/2010.10.PEDS10388; Fierstra J, 2011, J NEUROSURG-PEDIATR, V8, P310, DOI 10.3171/2011.6.PEDS1170; Gold JJ, 2013, CASE REP NEUROL MED, V2013; Hong KS, 2010, J NEUROL NEUROSUR PS, V81, P36, DOI 10.1136/jnnp.2009.183277; Khan A, 2013, J PAEDIATR CHILD H, V49, P504, DOI 10.1111/jpc.12233; Kimiwada T, 2013, J STROKE CEREBROVASC, V22, P1432, DOI 10.1016/j.jstrokecerebrovasdis.2013.05.038; Maekawa H, 2012, INTERV NEURORADIOL, V18, P309; Marks MP, 2012, J NEUROINTERV SURG, V4, DOI 10.1136/neurintsurg-2011-010027; Vargas MC, 2011, J COMPUT ASSIST TOMO, V35, P33, DOI 10.1097/RCT.0b013e3181ff1e79	16	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2014	121	6					1411	1415		10.3171/2014.7.JNS132793		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AU3CP	WOS:000345490700018		
J	Yamada, S; Fukuhara, N; Horiguchi, K; Yamaguchi-Okada, M; Nishioka, H; Takeshita, A; Takeuchi, Y; Ito, J; Inoshita, N				Yamada, Shozo; Fukuhara, Noriaki; Horiguchi, Kentaro; Yamaguchi-Okada, Mitsuo; Nishioka, Hiroshi; Takeshita, Akira; Takeuchi, Yasuhiro; Ito, Junko; Inoshita, Naoko			Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases	JOURNAL OF NEUROSURGERY			English	Article						hyperthyroidism; somatostatin analogs; pituitary surgery; syndrome of inappropriate TSH secretion; transsphenoidal surgery; thyrotropin-secreting pituitary adenoma	OF-THE-LITERATURE; THYROID-HORMONE; FOLLOW-UP; OCTREOTIDE; DIAGNOSIS; SURGERY; TUMOR; CURE; SENSITIVITY; EXPERIENCE	Object. The aim of this study was to analyze clinicopathological characteristics and treatment outcomes in a large single-center clinical series of cases of thyrotropin (TSH)-secreting pituitary adenomas. Methods. The authors retrospectively reviewed clinical, pathological, and treatment characteristics of 90 consecutive cases of TSH-secreting pituitary adenomas treated with transsphenoidal surgery between December 1991 and May 2013. The patient group included 47 females and 43 males (median age 42 years, range 11-74 years). Results. Sixteen tumors (18%) were microadenomas and 74 (82%) were macroadenomas. Microadenomas were significantly more frequent in the more recent half of our case series (12 of 45 cases) (p = 0.0274). Cavernous sinus invasion was confirmed in 21 patients (23%). In 67 cases (74%), the tumors were firm elastic or hard in consistency. Acromegaly and hyperprolactinemia were observed, respectively, in 14 (16%) and 11(12%) of the 90 cases. Euthyroidism was achieved in 40 (83%) of 48 patients and tumor shrinkage was found in 24(55%) of 44 patients following preoperative somatostatin analog treatment. Conventional transsphenoidal surgery, extended transsphenoidal surgery, and a simultaneous combined supra- and infrasellar approach were performed in 85, 2, and 3 patients, respectively. Total removal with endocrinological remission was achieved in 76 (84%) of 90 patients, including all 16 (100%) patients with microadenomas, 60 (81%) of the 74 with macroadenomas, and 8 (38%) of the 21 with cavernous sinus invasion. None of these 76 patients experienced tumor recurrence during a median follow-up period of 2.8 years. Stratifying by Knosp grade, total removal with endocrinological remission was achieved in 34 of 36 patients with Knosp Grade 0 tumors, all 24 of those with Grade 1 tumors, 12 of the 14 with Grade 2 tumors, 6 of the 8 with Grade 3 tumors, and none of the 8 with Grade 4 tumors. Cavernous sinus invasion and tumor size were significant independent predictors of surgical outcome. Immunoreactivity for growth hormone, prolactin, or both hormones was present in 32, 9, and 24 patients, respectively. The Ki-67 labeling index was less than 3% in 71(97%) of 73 tumors for which it was obtained and 3% or more in 2. Postsurgery pituitary dysfunction was found in 15 patients (17%) and delayed hyponatremia was seen in 9. Conclusions. TSH-secreting adenomas, particularly those in the microadenoma stage, have increased in frequency over the past 5 years. The high surgical success rate achieved in this series is due to relatively early diagnosis and relatively small tumor size. In addition, the surgical strategies used, such as extracapsular removal of hard or solid adenomas, aggressive resction of tumors with cavernous sinus invasion, or extended transsphenoidal surgery or a simultaneous combined approach for large/giant multilobulated adenomas, also may improve remission rate with a minimal incidence of complications.	[Yamada, Shozo; Fukuhara, Noriaki; Horiguchi, Kentaro; Yamaguchi-Okada, Mitsuo; Nishioka, Hiroshi] Toranomon Gen Hosp, Dept Hypothalam & Pituitary Surg, Tokyo 1058470, Japan; [Takeshita, Akira; Takeuchi, Yasuhiro] Toranomon Gen Hosp, Dept Endocrinol, Tokyo 1058470, Japan; [Ito, Junko] Toranomon Gen Hosp, Dept Pediat, Tokyo 1058470, Japan; [Inoshita, Naoko] Toranomon Gen Hosp, Dept Pathol, Tokyo 1058470, Japan; [Yamada, Shozo; Nishioka, Hiroshi; Takeshita, Akira; Takeuchi, Yasuhiro] Okinaka Mem Inst Med Res, Tokyo, Japan	Yamada, S (reprint author), Toranomon Gen Hosp, Dept Hypothalam & Pituitary Surg, Minato Ku, 2-2-2 Toranomon, Tokyo 1058470, Japan.	syamadays11@hotmail.com					Yamada S, 2011, EUR J ENDOCRINOL, V165, P873, DOI 10.1530/EJE-11-0657; KNOSP E, 1993, NEUROSURGERY, V33, P610; Giustina A, 2010, J CLIN ENDOCR METAB, V95, P3141, DOI 10.1210/jc.2009-2670; Sudhakar N, 2004, BRIT J NEUROSURG, V18, P507, DOI 10.1080/02688690400012459; Refetoff S, 2007, BEST PRACT RES CL EN, V21, P277, DOI 10.1016/j.beem.2007.03.005; Wang EL, 2009, ENDOCR PATHOL, V20, P209, DOI 10.1007/s12022-009-9094-y; LUNDIN P, 1992, J COMPUT ASSIST TOMO, V16, P519, DOI 10.1097/00004728-199207000-00004; Beck-Peccoz Paolo, 2002, Pituitary, V5, P83, DOI 10.1023/A:1022360414062; Beck-Peccoz P, THYROID DIS MANAGER; BeckPeccoz P, 1996, ENDOCR REV, V17, P610, DOI 10.1210/er.17.6.610; Beck-Peccoz P, 2009, BEST PRACT RES CL EN, V23, P597, DOI 10.1016/j.beem.2009.05.006; Bertholon-Gregoire M, 1999, EUR J ENDOCRINOL, V140, P519, DOI 10.1530/eje.0.1400519; Brucker-Davis F, 1999, J CLIN ENDOCR METAB, V84, P476, DOI 10.1210/jc.84.2.476; Clarke MJ, 2008, J NEUROSURG, V109, P17, DOI 10.3171/JNS/2008/109/7/0017; de Aguiar PHP, 2010, NEUROL RES, V32, P1060, DOI 10.1179/016164110X12670144737855; Elston MS, 2010, INTERN MED J, V40, P214, DOI 10.1111/j.1445-5994.2009.02107.x; EZZAT S, 1995, ENDOCR PATHOL, V6, P125, DOI 10.1007/BF02739875; Gatto F, 2011, PITUITARY, V14, P141, DOI 10.1007/s11102-010-0271-2; Horiguchi K, 2007, ENDOCR J, V54, P371, DOI 10.1507/endocrj.K06-177; Kamitani M, 2013, J JAPAN THYROID ASS, V4, P129; Kerr J, 2008, CURR OPIN ENDOCRINOL, V15, P359, DOI 10.1097/MED.0b013e3283060a56; Laws Edward R, 2006, Pituitary, V9, P313, DOI 10.1007/s11102-006-0411-x; Losa M, 1999, Pituitary, V2, P127, DOI 10.1023/A:1009987530852; Losa M, 2008, MINERVA ENDOCRINOL, V33, P329; Ma WB, 2003, HORM RES, V59, P257, DOI 10.1159/000070227; Macchia E, 2009, J ENDOCRINOL INVEST, V32, P773, DOI 10.3275/6479; MINDERMANN T, 1993, J NEUROSURG, V79, P521, DOI 10.3171/jns.1993.79.4.0521; Ness-Abramof R, 2007, PITUITARY, V10, P307, DOI 10.1007/s11102-007-0020-3; Nishioka H, 2008, NEUROL MED-CHIR, V48, P311, DOI 10.2176/nmc.48.311; Nishioka H, 2012, WORLD NEUROSURG, V77, P533, DOI 10.1016/j.wneu.2011.07.013; Onnestam L, 2013, J CLIN ENDOCR METAB, V98, P626, DOI 10.1210/jc.2012-3362; Sanno N, 2001, J NEURO-ONCOL, V54, P179, DOI 10.1023/A:1012917701756; Sanno N, 2000, J NEUROSURG, V93, P194, DOI 10.3171/jns.2000.93.2.0194; Shimatsu A, 1999, ENDOCR J, V46, P113, DOI 10.1507/endocrj.46.113; Socin HV, 2003, EUR J ENDOCRINOL, V148, P433, DOI 10.1530/eje.0.1480433; Taylor TJ, 2000, THYROID, V10, P1001, DOI 10.1089/thy.2000.10.1001; van Varsseveld NC, 2014, CLIN ENDOCRINOL, V80, P395, DOI 10.1111/cen.12290; Zhao WW, 2012, WIEN KLIN WOCHENSCHR, V124, P678, DOI 10.1007/s00508-012-0216-z	38	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2014	121	6					1462	1473		10.3171/2014.7.JNS1471		12	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AU3CP	WOS:000345490700026		
J	Yamaya, S; Ozawa, H; Kanno, H; Kishimoto, KN; Sekiguchi, A; Tateda, S; Yahata, K; Ito, K; Shimokawa, H; Itoi, E				Yamaya, Seiji; Ozawa, Hiroshi; Kanno, Haruo; Kishimoto, Koshi N.; Sekiguchi, Akira; Tateda, Satoshi; Yahata, Kenichiro; Ito, Kenta; Shimokawa, Hiroaki; Itoi, Eiji			Low-energy extracorporeal shock wave therapy promotes vascular endothelial growth factor expression and improves locomotor recovery after spinal cord injury	JOURNAL OF NEUROSURGERY			English	Article						spinal cord injury; shock wave; VEGF; Flt-1; neuroprotection	ISCHEMIA-REPERFUSION INJURY; PIGS IN-VIVO; NITRIC-OXIDE; ANTIINFLAMMATORY ACTION; MYOCARDIAL-ISCHEMIA; PERMEABILITY FACTOR; SEGMENTAL DEFECT; ARTERY-DISEASE; NERVOUS-SYSTEM; VEGF	Object. Extracorporeal shock wave therapy (ESWT) is widely used for the clinical treatment of various human diseases. Recent studies have demonstrated that low-energy ESWT upregulates the expression of vascular endothelial growth factor (VEGF) and promotes angiogenesis and functional recovery in myocardial infarction and peripheral artery disease. Many previous reports suggested that VEGF produces a neuroprotective effect to reduce secondary neural tissue damage after spinal cord injury (SCI). The purpose of the present study was to investigate whether low-energy ESWT promotes VEGF expression and neuroprotection and improves locomotor recovery after SCI. Methods. Sixty adult female Sprague-Dawley rats were randomly divided into 4 groups: sham group (laminectomy only), sham-SW group (low-energy ESWT applied after laminectomy), SCI group (SCI only), and SCI-SW group (low-energy ESWT applied after SCI). Thoracic spinal cord contusion injury was inflicted using an impactor. Low-energy ESWT was applied to the injured spinal cord 3 times a week for 3 weeks. Locomotor function was evaluated using the Basso, Beattie, and Bresnahan (BBB) Scale (open field locomotor score) at different time points over 42 days after SCI. Hematoxylin and eosin staining Was performed to assess neural tissue damage in the spinal cord. Neuronal loss was investigated by immunostaining for NeuN. The mRNA expressions of VEGF and its receptor, Flt-1, in the spinal cord were assessed using real-time polymerase chain reaction. Immunostaining for VEGF was performed to evaluate VEGF protein expression in the spinal cord. Results. In both the sham and sham-SW groups, no animals showed locomotor impairment on BBB scoring. Histological analysis of H & E and NeuN stainings in the sham-SW group confirmed that no neural tissue damage was induced by the low-energy ESWT. Importantly, animals in the SCI-SW group demonstrated significantly better locomotor improvement than those in the SCI group at 7, 35, and 42 days after injury (p < 0.05). The number of NeuN-positive cells in the SCI-SW group was significantly higher than that in the SCI group at 42 days after injury (p < 0.05). In addition, mRNA expressions of VEGF and Flt-1 were significantly increased in the SCI-SW group compared with the SCI group at 7 days after injury (p < 0.05). The expression of VEGF protein in the SCI-SW group was significantly higher than that in the SCI group at 7 days (p < 0.01). Conclusions. The present study showed that low-energy ESWT significantly increased expressions of VEGF and Flt-1 in the spinal cord without any detrimental effect. Furthermore, it significantly reduced neuronal loss in damaged neural tissue and improved locomotor function after SCI. These results suggested that low-energy ESWT enhances the neuroprotective effect of VEGF in reducing secondary injury and leads to better locomotor recovery following SCI. This study provides the first evidence that low-energy ESWT can be a safe and promising therapeutic strategy for SCI.	[Yamaya, Seiji; Ozawa, Hiroshi; Kanno, Haruo; Kishimoto, Koshi N.; Sekiguchi, Akira; Tateda, Satoshi; Yahata, Kenichiro; Itoi, Eiji] Tohoku Univ, Grad Sch Med, Dept Orthopaed Surg, Sendai, Miyagi 9808574, Japan; [Ito, Kenta; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 9808574, Japan	Kanno, H (reprint author), Tohoku Univ, Grad Sch Med, Dept Orthopaed Surg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	kanno-h@isis.ocn.ne.jp			Japan Society for the Promotion of Science [10312563]; Japanese Ministry of Health, Labor and Welfare, Tokyo, Japan [H21-rinsyokenkyuippan-012]	The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper. This work was supported by a Grant-in-Aid for Scientific Research (C) (No. 10312563) from the Japan Society for the Promotion of Science and by Grants-in-Aid from the Japanese Ministry of Health, Labor and Welfare, Tokyo, Japan (H21-rinsyokenkyuippan-012).	Stojadinovic A, 2008, ANGIOGENESIS, V11, P369, DOI 10.1007/s10456-008-9120-6; Haupt G, 1997, J UROLOGY, V158, P4, DOI 10.1097/00005392-199707000-00003; SEIDL M, 1994, ULTRASONICS, V32, P397, DOI 10.1016/0041-624X(94)90111-2; Pan PJ, 2003, ARCH PHYS MED REHAB, V84, P988, DOI 10.1016/S0003-9993(03)00010-8; Gotte G, 2002, FEBS LETT, V520, P153, DOI 10.1016/S0014-5793(02)02807-7; Rompe JD, 2005, J ORTHOP RES, V23, P931, DOI 10.1016/j.orthres.2004.09.003; Basso DM, 2004, J NEUROTRAUM, V21, P395, DOI 10.1089/089771504323004548; Kikuchi Y, 2010, CIRC J, V74, P589, DOI 10.1253/circj.CJ-09-1028; CONNOLLY DT, 1989, J BIOL CHEM, V264, P20017; Ogunshola OO, 2002, J BIOL CHEM, V277, P11410, DOI 10.1074/jbc.M111085200; Uwatoku T, 2007, CORONARY ARTERY DIS, V18, P397, DOI 10.1097/MCA.0b013e328089f19b; Luo ZY, 1997, ANN THORAC SURG, V64, P993, DOI 10.1016/S0003-4975(97)00715-7; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Yan XY, 2008, ANN PLAS SURG, V61, P646, DOI 10.1097/SAP.0b013e318172ba1f; Oi K, 2008, TOHOKU J EXP MED, V214, P151, DOI 10.1620/tjem.214.151; Serizawa F, 2012, CIRC J, V76, P1486, DOI 10.1253/circj.CJ-11-1216; Fukumoto Y, 2006, CORONARY ARTERY DIS, V17, P63, DOI 10.1097/00019501-200602000-00011; Ciampa AR, 2005, FEBS LETT, V579, P6839, DOI 10.1016/j.febslet.2005.11.023; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Cacchio A, 2009, J BONE JOINT SURG AM, V91A, P2589, DOI 10.2106/JBJS.H.00841; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Liu Y, 2010, NEUROBIOL DIS, V37, P384, DOI 10.1016/j.nbd.2009.10.018; Wang FS, 2003, BONE, V32, P387, DOI 10.1016/S8756-3282(03)00029-2; Al-Abbad H, 2013, FOOT ANKLE INT, V34, P33, DOI 10.1177/1071100712464354; Wang FS, 2001, BIOCHEM BIOPH RES CO, V287, P648, DOI 10.1006/bbrc.2001.5654; Chen YJ, 2004, J ORTHOPAED RES, V22, P526, DOI 10.1016/j.orthres.2003.10.005; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Fisher AB, 2001, AM J PHYSIOL-LUNG C, V281, pL529; Rosenstein JM, 2004, EXP NEUROL, V187, P246, DOI 10.1016/j.expneurol.2004.01.022; Mariotto S, 2005, NITRIC OXIDE-BIOL CH, V12, P89, DOI 10.1016/j.niox.2004.12.005; Nishida T, 2004, CIRCULATION, V110, P3055, DOI 10.1161/01.CIR.0000148849.51177.97; Ito K, 2011, AM J CARDIOVASC DRUG, V11, P295, DOI 10.2165/11592760-000000000-00000; Facchiano F, 2002, J NEUROSURG, V97, P161, DOI 10.3171/jns.2002.97.1.0161; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Wang CJ, 2003, J ORTHOPAED RES, V21, P984, DOI 10.1016/S0736-0266(03)00104-9; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; APFEL RE, 1982, BRIT J CANCER, V45, P140; Bartholdi D, 1997, EUR J NEUROSCI, V9, P2549, DOI 10.1111/j.1460-9568.1997.tb01684.x; Brockington A, 2004, NEUROPATH APPL NEURO, V30, P427, DOI 10.1111/j.1365-2990.2004.00600.x; Fuchs G J, 1989, Arch Esp Urol, V42 Suppl 1, P83; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Hayashi D, 2012, WOUND REPAIR REGEN, V20, P887, DOI 10.1111/j.1524-475X.2012.00851.x; Herrera JJ, 2009, J NEUROTRAUM, V26, P995, DOI 10.1089/neu.2008-0779; Ito K, 2009, TOHOKU J EXP MED, V219, P1, DOI 10.1620/tjem.219.1; Ito Y, 2010, CORONARY ARTERY DIS, V21, P304, DOI 10.1097/MCA.0b013e32833aec62; Karatas A, 2008, SPINAL CORD, V46, P627, DOI 10.1038/sc.2008.31; Karimi-Abdolrezaee S, 2010, J NEUROSCI, V30, P1657, DOI 10.1523/JNEUROSCI.3111-09.2010; Kishimoto KN, 2009, CELL BIOL INT, V33, P1222, DOI 10.1016/j.cellbi.2009.06.009; Lee TC, 2007, J CLIN NEUROSCI, V14, P873, DOI 10.1016/j.jocn.2006.11.007; Mariotto S, 2009, CURR MED CHEM, V16, P2366; Rompe JD, 1998, J BONE JOINT SURG BR, V80B, P546, DOI 10.1302/0301-620X.80B3.8434; Salem S, 2010, UROL RES, V38, P135, DOI 10.1007/s00240-009-0247-8; Savas S, 2008, SPINAL CORD, V46, P113, DOI 10.1038/sj.sc.3102066; Serizawa F, 2011, EUR J VASC ENDOVASC, V42, P254, DOI 10.1016/j.ejvs.2011.02.029; Svensson B, 2002, J CEREBR BLOOD F MET, V22, P1170; VALCHANOU VD, 1991, INT ORTHOP, V15, P181; Vaquero J, 1999, J NEUROSURG, V90, P220, DOI 10.3171/spi.1999.90.2.0220; Widenfalk J, 2003, NEUROSCIENCE, V120, P951, DOI 10.1016/S0306-4522(03)00399-3; Zachary I, 2005, NEUROSIGNALS, V14, P207, DOI 10.1159/000088637	62	1	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2014	121	6					1514	1525		10.3171/2014.8.JNS132562		12	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AU3CP	WOS:000345490700034		
J	Shinojima, N; Nakamura, H; Tasaki, M; Kameno, K; Anai, S; Iyama, K; Ando, Y; Seto, H; Kuratsu, J				Shinojima, Naoki; Nakamura, Hideo; Tasaki, Masayoshi; Kameno, Kouki; Anai, Shigeo; Iyama, Ken-ichi; Ando, Yukio; Seto, Hiroshi; Kuratsu, Jun-ichi			A patient with medulloblastoma in its early developmental stage	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						medulloblastoma; intratumoral hemorrhage; tumor development; genetic subgroup; heterogeneity; oncology	CHEMOTHERAPY; CELLS	Medulloblastoma is the most frequent malignant brain tumor of the posterior fossa in children and is considered an embryonal tumor. It has been suggested that medulloblastomas be categorized into 4 distinct molecular subgroups-WNT (DKK1), SHH (SFRP1), Group 3 (NPR3), or Group 4 (KCNA1)-since each subgroup is distinct and there is no overlap. The authors report on a 13-year-old boy with medulloblastoma. He presented with sudden-onset nausea and vomiting due to intratumoral hemorrhage. The medulloblastoma was thought to be in an early developmental stage because the tumor volume was extremely small. Immunohistochemical analysis showed that the tumor was mainly composed of DKK1- and NPR3-positive areas. The individual areas of the tumor stained only for DKK1 or NPR3, with no overlap-that is, DKK1 and NPR3 expression were mutually exclusive. Samples obtained by laser microdissection of individual areas and subjected to mass spectrometry confirmed that the expression patterns of proteins were different. Fluorescence in situ hybridization for chromosome 6 showed there were 2 distinct types of cells that exhibited monosomy or disomy of chromosome 6. These results demonstrated that distinct subtypes of medulloblastoma may be present within a single tumor, an observation that has not been previously reported. Our findings in this case indicate that early-stage medulloblastoma may include more than 1 distinct subtype and hint at factors involved in the origin and development of medulloblastomas.	[Shinojima, Naoki; Nakamura, Hideo; Kameno, Kouki; Anai, Shigeo; Kuratsu, Jun-ichi] Kumamoto Univ Hosp, Dept Neurosurg, Kumamoto 8608556, Japan; [Tasaki, Masayoshi; Ando, Yukio] Kumamoto Univ Hosp, Dept Neurol, Kumamoto 8608556, Japan; [Iyama, Ken-ichi] Kumamoto Univ Hosp, Dept Surg Pathol, Kumamoto 8608556, Japan; [Seto, Hiroshi] Izumi Gen Med Ctr, Div Neurosurg, Kagoshima, Japan; [Tasaki, Masayoshi] Kumamoto Univ, Grad Sch Med Sci, Dept Immunol & Hematol, Div Informat Clin Sci, Kumamoto, Japan	Shinojima, N (reprint author), Kumamoto Univ Hosp, Dept Neurosurg, 1-1-1 Honjo Chuo Ku, Kumamoto 8608556, Japan.	nshinojima@fc.kuh.kumamoto-u.ac.jp			Japan Society for the Promotion of Science [25462272]	This work was supported by a Grant-in-Aid for Scientific Research (grant no. 25462272) from the Japan Society for the Promotion of Science.	Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Kuroda N, 2008, HISTOL HISTOPATHOL, V23, P1517; Vrana JA, 2009, BLOOD, V114, P4957, DOI 10.1182/blood-2009-07-230722; Rutkowski S, 2005, NEW ENGL J MED, V352, P978, DOI 10.1056/NEJMoa042176; Kawamura T, 2010, J PROTEOMICS, V73, P1089, DOI 10.1016/j.jprot.2009.11.011; Packer RJ, 2006, J CLIN ONCOL, V24, P4202, DOI 10.1200/JCO.2006.06.4980; Shinojima N, 2013, CANCER RES, V73, P2333, DOI 10.1158/0008-5472.CAN-12-3086; Tasaki M, 2013, INT J CARDIOL, V170, P69, DOI 10.1016/j.ijcard.2013.10.033; Claveria C, 2013, NATURE, V500, P39, DOI 10.1038/nature12389; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Shinojima N, 2003, CANCER RES, V63, P6962; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.500084-MCP200; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Fukai J, 2002, CHILD NERV SYST, V18, P356, DOI 10.1007/s00381-002-0601-4; Fruehwald-Pallamar J, 2011, NEURORADIOLOGY, V53, P387, DOI 10.1007/s00234-010-0829-8; YOKOTA J, 1988, ONCOGENE, V2, P607	17	2	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	DEC	2014	14	6					615	620		10.3171/2014.8.PEDS13590		6	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	AU3CL	WOS:000345490300007		
J	Takenaka, S; Mukai, Y; Hosono, N; Tateishi, K; Fuji, T				Takenaka, Shota; Mukai, Yoshihiro; Hosono, Noboru; Tateishi, Kosuke; Fuji, Takeshi			Vertebral osteolytic defect due to cellulose particles derived from gauze fibers after posterior lumbar interbody fusion	JOURNAL OF NEUROSURGERY-SPINE			English	Article						osteolysis; cyst; posterior lumbar interbody fusion; particle-induced; pseudarthrosis	CYSTS	Vertebral cystic lesions may be observed in pseudarthroses after lumbar fusion surgery. The authors report a rare case of pseudarthrosis after spinal fusion, accompanied by an expanding vertebral osteolytic defect induced by cellulose particles. A male patient originally presented at the age of 69 years with leg and low-back pain caused by a lumbar isthmic spondylolisthesis. He underwent a posterior lumbar interbody fusion, and his neurological symptoms and pain resolved within a year but recurred 14 months after surgery. Radiological imaging demonstrated a cystic lesion on the inferior endplate of L-5 and the superior endplate of S-1, which rapidly enlarged into a vertebral osteolytic defect. The patient underwent revision surgery, and his low-back pain resolved. A histopathological examination demonstrated foreign body type multinucleated giant cells, containing 10-mu m particles, in the sample collected just below the defect. Micro Fourier transform infrared spectroscopy revealed that the foreign particles were cellulosic, presumably originating from cotton gauze fibers that had contaminated the interbody cages used during the initial surgery. Vertebral osteolytic defects that occur after interbody fusion are generally presumed to be the result of infection. This case suggests that some instances of vertebral osteolytic defects may be aseptically induced by foreign particles. Hence, this possibility should be carefully considered in such cases, to help prevent contamination of the morselized bone used for autologous grafts by foreign materials, such as gauze fibers.	[Takenaka, Shota; Mukai, Yoshihiro; Hosono, Noboru; Tateishi, Kosuke; Fuji, Takeshi] Osaka Hosp, Japan Community Hlth Care Org, Osaka 5530003, Japan	Takenaka, S (reprint author), Osaka Hosp, Japan Community Hlth Care Org, 4-2-78 Fukushima, Osaka 5530003, Japan.	show@yb3.so-net.ne.jp			Showa-Ika-Kogyo; Century Medical	Dr. Fuji reports a consultant relationship with Daiichi-Sankyo and receipt of royalties from Showa-Ika-Kogyo and Century Medical.	Ollivere B, 2012, J BONE JOINT SURG BR, V94B, P10, DOI 10.1302/0301-620X.94B1.28047; SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111; Brantigan JW, 2000, SPINE, V25, P1437, DOI 10.1097/00007632-200006010-00017; Etminan M, 2002, ORTHOP CLIN N AM, V33, P381, DOI 10.1016/S0030-5898(02)00005-6; Jiya T, 2009, SPINE, V34, P233, DOI 10.1097/BRS.0b013e318194ed00; Durr HR, 2004, ACTA ORTHOP SCAND, V75, P554, DOI 10.1080/00016470410001411; Frost A, 2012, EUR SPINE J, V21, P449, DOI 10.1007/s00586-011-2002-4; Fujibayashi S, 2012, SPINE, V37, pE1197, DOI 10.1097/BRS.0b013e31825d26d7; Goodman Stuart B, 2013, Instr Course Lect, V62, P201; Griffiths P. R., 2007, FOURIER TRANSFORM IN, P1; Izumida S, 1986, J JPN ORTHOP ASSOC, V60, P391; Kubo T, 1999, J BIOMED MATER RES, V45, P363, DOI 10.1002/(SICI)1097-4636(19990615)45:4<363::AID-JBM11>3.0.CO;2-3; Punt IM, 2012, SPINE, V37, P150, DOI 10.1097/BRS.0b013e3182154c22	13	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	DEC	2014	21	6					877	881		10.3171/2014.8.SPINE14196		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AU3CJ	WOS:000345490100006		
J	Yokosuka, J; Takai, K; Komori, T; Taniguchi, M				Yokosuka, Junichi; Takai, Keisuke; Komori, Takashi; Taniguchi, Makoto			Superficial siderosis: bleeding from the bone marrow after laminectomy for spinal tumor removal	JOURNAL OF NEUROSURGERY-SPINE			English	Article						superficial siderosis; bleeding source; bone marrow; spinal surgery; neuroradiology; oncology	CENTRAL-NERVOUS-SYSTEM; OF-THE-LITERATURE	Superficial siderosis of the CNS is a rare disease characterized by the deposition of hemosiderin in the subpial layers of the CNS as the result of chronic subarachnoid bleeding. The arrest of bleeding is important for preventing the progression of this disease; however, the exact source of bleeding remains unknown in most cases because of a lack of objective surgical data. The authors of this report have described a unique case of superficial siderosis following cervical laminectomy and autograft fusion for the removal of a spinal schwannoma; the bleeding source was verified by intraoperative and histopathological findings. The patient exhibited no obvious neurological deficits, such as hearing loss or cerebellar ataxia, when the superficial siderosis was diagnosed, although there were the social impairments associated with schizophrenia. During repair surgery, the bleeding source was revealed as the bone marrow vasculature of the remaining vertebral arch, and not the fragile vessels at the dural defect or the residual tumor. Chronic bleeding was stopped before the onset of irreversible neurological deficits in this case. Bone marrow exposed to the intrathecal space may represent a chronic bleeding source in patients with superficial siderosis following CNS surgery including laminectomy or craniotomy. The following recommendations have been proposed for superficial siderosis of the CNS from both a preventative and a therapeutic perspective: 1) During CNS surgery, neurosurgeons should make every effort to prevent exposing bone marrow to the intrathecal space to avoid the risk of chronic subarachnoid bleeding. 2) In the case of a large dural defect and pseudomeningocele following CNS surgery, bone marrow around the dural defect should be considered as the bleeding source of superficial siderosis, and such cases should undergo revision surgery before the progression of this disease.	[Yokosuka, Junichi; Takai, Keisuke; Taniguchi, Makoto] Tokyo Metropolitan Neurol Hosp, Dept Neurosurg, Fuchu, Tokyo 1830042, Japan; [Komori, Takashi] Tokyo Metropolitan Neurol Hosp, Dept Lab Med & Pathol, Fuchu, Tokyo 1830042, Japan	Takai, K (reprint author), Tokyo Metropolitan Neurol Hosp, Dept Neurosurg, 2-6-1 Musashidai, Fuchu, Tokyo 1830042, Japan.	takai-nsu@umin.ac.jp					Levy M, 2007, NAT CLIN PRACT NEURO, V3, P54, DOI 10.1038/ncpneuro0356; Kumar N, 2006, NEUROLOGY, V66, P1144, DOI 10.1212/01.wnl.0000208510.76323.5b; Schievink WI, 2011, J NEUROSURG-SPINE, V15, P433, DOI 10.3171/2011.5.SPINE10890; Cohen-Gadol AA, 2005, J NEUROSURG-SPINE, V2, P206, DOI 10.3171/spi.2005.2.2.0206; Egawa S, 2013, J NEUROSURG-SPINE, V18, P388, DOI 10.3171/2013.1.SPINE12649; Levy M, 2012, STROKE, V43, P120, DOI 10.1161/STROKEAHA.111.628032; Posti JP, 2011, ACTA NEUROCHIR, V153, P2067, DOI 10.1007/s00701-011-1116-0	7	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	DEC	2014	21	6					905	908		10.3171/2014.8.SPINE13328		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AU3CJ	WOS:000345490100011		
J	Maruo, K; Moriyama, T; Tachibana, T; Inoue, S; Arizumi, F; Daimon, T; Yoshiya, S				Maruo, Keishi; Moriyama, Tokuhide; Tachibana, Toshiya; Inoue, Shinichi; Arizumi, Fumihiro; Daimon, Takashi; Yoshiya, Shinichi			The impact of dynamic factors on surgical outcomes after double-door laminoplasty for ossification of the posterior longitudinal ligament of the cervical spine	JOURNAL OF NEUROSURGERY-SPINE			English	Article						ossification of the posterior longitudinal ligament; cervical spine; laminoplasty; dynamic factors; surgical outcomes; C2-7 range of motion	ANTERIOR DECOMPRESSION; SPONDYLOTIC MYELOPATHY; FUSION; LAMINECTOMY; STRATEGY; ETIOLOGY; COHORT	Object. Laminoplasty is the preferred operation for most patients with cervical myelopathy due to multilevel ossification of the posterior longitudinal ligament (OPLL). Recent studies have demonstrated several significant risk factors for poor clinical outcomes after laminoplasty, including older age, lower preoperative Japanese Orthopaedic Association (JOA) score, postoperative change in cervical alignment, cervical kyphosis, and high occupying ratio of the OPLL (that is, the ratio of the greatest anteroposterior thickness of the OPLL to the anteroposterior diameter of the spinal canal at the same level on a lateral image). However, the impact of dynamic factors on clinical outcomes is unclear. The purpose of this study is to assess the impact of dynamic factors on the clinical outcome after laminoplasty for cervical myelopathy due to OPLL. Methods. A consecutive series of patients who underwent laminoplasty for cervical myelopathy due to OPLL between 2003 and 2009 was retrospectively reviewed. The indication for laminoplasty at the authors' hospital included preoperative straight or lordotic alignment of the cervical spine and an occupying ratio of OPLL less than 60%. The JOA score and recovery rate were used to evaluate clinical outcomes. A poor clinical outcome was defined as a recovery rate of less than 50%. Patient factors examined along with outcome included age, preoperative JOA score, preoperative somatosensory evoked potentials, preoperative inotor evoked potentials, body mass index, and presence of high intensity on MRI. Radiographic measures included the preoperative C2-7 lordotic angle, preoperative C2-7 range of motion (ROM), preoperative segmental ROM at the level of myelopathy, and the occupying ratio of OPLL. Results. There were 45 patients (33 males and 12 females). The mean follow-up period was 4 years (range 2-6.8 years). The mean patient age was 66.9 years (range 50-85 years). The mean JOA score significantly increased from 9.1 before surgery to 13.1 at the final follow-up. The mean recovery rate was 51.2%. Nineteen patients (42%) had a recovery rate of less than 50%. Patient factors were not associated with surgical outcomes. Only the preoperative C2-7 ROM was significantly greater in the poor surgical outcome group (23.1 degrees vs 14.1 degrees). Receiver operating characteristic curve analysis showed that the optimal preoperative C2-7 ROM cutoff was 20 degrees. Logistic regression analysis revealed that patients with a preoperative C2-7 ROM of greater than 20 degrees had a 4.6 times higher risk (p = 0.021) of a poor clinical outcome, indicating that dynamic factors may have an impact on the surgical outcome of laminoplasty. Conclusions. Fusion surgery may be a useful strategy in patients with preoperative hypermobility of the cervical spine.	[Maruo, Keishi; Moriyama, Tokuhide; Tachibana, Toshiya; Inoue, Shinichi; Arizumi, Fumihiro; Yoshiya, Shinichi] Hyogo Coll Med, Dept Orthopaed Surg, Nishinomiya, Hyogo 6638501, Japan; [Daimon, Takashi] Hyogo Coll Med, Dept Biostat, Nishinomiya, Hyogo 6638501, Japan	Maruo, K (reprint author), Hyogo Coll Med, Dept Biostat, Dept Orthopaed Surg, Mukogawa Cho 1-1, Nishinomiya, Hyogo 6638501, Japan.	kmaruo@hyo-med.ac.jp					Chen Y, 2009, INT ORTHOP, V33, P1075, DOI 10.1007/s00264-008-0609-9; Iwasaki M, 2007, SPINE, V32, P647, DOI 10.1097/01.brs.0000257560.91147.86; Ogawa Y, 2005, J NEUROSURG-SPINE, V3, P198, DOI 10.3171/spi.2005.3.3.0198; Holly LT, 2009, J NEUROSURG-SPINE, V11, P112, DOI 10.3171/2009.1.SPINE08718; Chang H, 2012, J BONE JOINT SURG BR, V94B, P946, DOI 10.1302/0301-620X.94B7.29018; Matsunaga S, 2004, J NEUROSURG, V100, P245, DOI 10.3171/spi.2004.100.3.0245; Iwasaki M, 2007, SPINE, V32, P654, DOI 10.1097/01.brs.0000257566.91177.cb; Matsunaga S, 2012, SPINE, V37, pE309, DOI 10.1097/BRS.0b013e318241ad33; Matsumoto M, 2012, SPINE, V37, pE303, DOI 10.1097/BRS.0b013e318239cca0; Lee SE, 2013, J NEUROSURG-SPINE, V18, P465, DOI 10.3171/2013.1.SPINE12779; Li H, 2008, EUR SPINE J, V17, P1277, DOI 10.1007/s00586-008-0740-8; Matsunaga S, 2008, SPINE, V33, P2648, DOI 10.1097/BRS.0b013e31817f988c; Masaki Y, 2007, J SPINAL DISORD TECH, V20, P7, DOI 10.1097/01.bsd.0000211260.28497.35; Fujiyoshi T, 2010, J CLIN NEUROSCI, V17, P320, DOI 10.1016/j.jocn.2009.06.023; HIRABAYASHI K, 1981, SPINE, V6, P354, DOI 10.1097/00007632-198107000-00005; Chiba K, 2006, SPINE, V31, P2998, DOI 10.1097/01.brs.0000250307.78987.6b; Tani T, 2002, SPINE, V27, P2491, DOI 10.1097/01.BRS.0000031270.69596.4E; Sakai K, 2012, SPINE, V37, P367, DOI 10.1097/BRS.0b013e31821f4a51; Azuma Y, 2010, J SPINAL DISORD TECH, V23, P166, DOI 10.1097/BSD.0b013e31819e9066; Cardoso MJ, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.1.FOCUS10278; Fujimura Y, 1998, ARCH ORTHOP TRAUM SU, V117, P471, DOI 10.1007/s004020050296; Fujiyoshi T, 2008, SPINE, V33, pE990, DOI 10.1097/BRS.0b013e318188b300; Houten JK, 2003, NEUROSURGERY, V52, P1081, DOI 10.1227/01.NEU.0000057746.74779.55; Matsunaga S, 1999, SPINE, V24, P937, DOI 10.1097/00007632-199905150-00002; Takahashi J, 2008, SPINE, V33, pE15, DOI 10.1097/BRS.0b013e31815e5dae; YOSHIDA M, 1992, SPINE, V17, P491, DOI 10.1097/00007632-199205000-00004	26	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	DEC	2014	21	6					938	943		10.3171/2014.8.SPINE131197		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AU3CJ	WOS:000345490100017		
J	Ishizaki, H; Nakano, H; Nakano, T; Shikama, N				Ishizaki, Hiroshi; Nakano, Hideyuki; Nakano, Toshiya; Shikama, Nobuyuki			Evidence of equatorial Rossby wave propagation obtained by deep mooring observations in the western Pacific Ocean	JOURNAL OF OCEANOGRAPHY			English	Article						Vertically propagating equatorial annual Rossby waves; Multi-cell structure of pressure; Pacific deep layer; Melanesian Basin; Mooring observation; High-resolution simulation; Harmonic analysis; Decomposition of Rossby wave into a set of meridional modes	NORTH PACIFIC; CIRCULATION; CURRENTS	We investigated long-term zonal flow (U) oscillations in the deep layer in the western Pacific Ocean by comparing measurements obtained from deep mooring observations near the equator with a high-resolution model. For the comparison, we used mooring data at 2,000 m and below north and south of the equator obtained from preceding studies. In our model results, vertically propagating equatorial annual Rossby waves were detected in the velocity and pressure anomaly (P-a) fields. P-a had a multi-cell meridional structure symmetric about the equator. The corresponding meridional distribution of U, averaged along the wave propagation, was the same as that previously obtained from Argo float data, suggesting the existence of the multicell structure in P-a in the real ocean. A harmonic analysis of the simulated U indicated that the equatorial annual Rossby waves excited over the central and eastern equatorial Pacific propagated down to below 2,000 m in the western equatorial Pacific. Decomposition of the annual U harmonics indicated that the multi-cell structure in pressure was not a manifestation of a single meridional mode but a composite of several lowest meridional modes, suggesting that the cell widths may change according to relative mode intensities. The mooring data north and south of the equator was consistent with the simulated multi-cell structure in P-a of the equatorial Rossby waves, although some discrepancies remained. We consider that the observed variation in U is a manifestation of the Rossby wave propagation in the real ocean. The present study is the first to recognize the existence of equatorial annual Rossby waves below 2,000 m in the western Pacific Ocean from direct current observations.	[Ishizaki, Hiroshi; Nakano, Hideyuki; Nakano, Toshiya; Shikama, Nobuyuki] Meteorol Res Inst, Oceanog & Geochem Res Dept, Tsukuba, Ibaraki 3050052, Japan; [Nakano, Toshiya] Japan Meteorol Agcy, Global Environm & Marine Dept, Tokyo, Japan	Ishizaki, H (reprint author), Meteorol Res Inst, Oceanog & Geochem Res Dept, 1-1 Nagamine, Tsukuba, Ibaraki 3050052, Japan.	hishizak@mri-jma.go.jp			MRI	The authors express their gratitude to Mr. K. Ishikawa, and the officers and crew of the R/V Ryofu-maru and R/V Keifu-maru, Japan Meteorological Agency, for their help in planning the mooring system and their onboard work of setting and recovering the system. The authors thank the members of the Oceanographic Research Department, Meteorological Research Institute (MRI), for their helpful suggestions and discussion on data analyses. The authors are much grateful to Dr. Yanagimoto for his offer of the mooring data by Kawabe et al. (2006). The analysis of the data much reinforced our opinion. The authors also thank Reviewers very much for their constructive comments and suggestions to make the present paper more convincing. This study was funded by the ordinary budget of MRI.	Cravatte S, 2012, J PHYS OCEANOGR, V42, P1475, DOI 10.1175/JPO-D-11-0206.1; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; KESSLER WS, 1993, J PHYS OCEANOGR, V23, P1192, DOI 10.1175/1520-0485(1993)023<1192:TAWDRW>2.0.CO;2; Kawabe M, 2003, DEEP-SEA RES PT I, V50, P631, DOI 10.1016/S0967-0637(03)00040-2; Kawabe M, 2010, J OCEANOGR, V66, P389; PHILANDER SGH, 1978, REV GEOPHYS, V16, P15, DOI 10.1029/RG016i001p00015; Ishizaki H, 2012, J OCEANOGR, V68, P929, DOI 10.1007/s10872-012-0145-5; Kawabe M, 2006, DEEP-SEA RES PT I, V53, P942, DOI 10.1016/j.dsr.2006.03.003; Komaki K, 2007, LA MER, V45, P15; LUKAS R, 1985, J PHYS OCEANOGR, V15, P55, DOI 10.1175/1520-0485(1985)015<0055:TARWIT>2.0.CO;2; Marin F, 2010, J PHYS OCEANOGR, V40, P915, DOI 10.1175/2009JPO4318.1; MCCREARY JP, 1984, J MAR RES, V42, P395; Nakano H, 2008, CLIVAR EXCHANGES, V13, P11; Perez RC, 2005, J PHYS OCEANOGR, V35, P666, DOI 10.1175/JPO2714.1; Thierry V, 2006, OCEAN DYNAM, V56, P581, DOI 10.1007/s10236-005-0045-y; WUNSCH C, 1977, J PHYS OCEANOGR, V7, P497, DOI 10.1175/1520-0485(1977)007<0497:ROAEOT>2.0.CO;2	16	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	DEC	2014	70	6					463	488		10.1007/s10872-014-0247-3		26	Oceanography	Oceanography	AU1PM	WOS:000345392600001		
J	Kodama, T; Shimizu, Y; Ichikawa, T; Hiroe, Y; Kusaka, A; Morita, H; Shimizu, M; Hidaka, K				Kodama, Taketoshi; Shimizu, Yugo; Ichikawa, Tadafumi; Hiroe, Yutaka; Kusaka, Akira; Morita, Hiroshi; Shimizu, Manabu; Hidaka, Kiyotaka			Seasonal and spatial contrast in the surface layer nutrient content around the Kuroshio along 138 degrees E, observed between 2002 and 2013	JOURNAL OF OCEANOGRAPHY			English	Article						Nutrient; Nitrate; Phosphate; Silicate; Kuroshio; Seasonal variation; Long-term observation; Western boundary current	WESTERN NORTH PACIFIC; EAST CHINA SEA; SARDINE SARDINOPS-MELANOSTICTUS; MIXED-LAYER; CHLOROPHYLL-A; UNITED-STATES; VARIABILITY; SOUTH; ENVIRONMENTS; DEPTH	Seasonal and spatial contrasts of nitrate ? nitrite (N + N) concentrations in the slope area (the inshore area to the Kuroshio), Kuroshio and subtropical gyre areas were described by using data sets carried out along the O-line (138 degrees E) between 34 degrees 45/N and 30 degrees N over 11 years (2002-2013). The mean concentration of N + N in the surface mixed layer during winter was elevated to 4.8 +/- 2.7, 1.5 +/- 1.6 and 0.7 +/- 0.4 lM in the slope, Kuroshio and subtropical gyre areas, respectively, while it was depleted to <0.1 lM in all areas during summer. Applying regression analyses to the data, a significant negative correlation between N + N concentration and temperature was found at any depths above 1000 m in both summer and winter in these areas, except for the summer surface depletive layers. The analyses also showed that the diffusive upward flux and the depth difference between the surface mixed layer and the 15-mu M nitrate-isoconcentration depth were important factors to induce the seasonal contrast between winter and summer and horizontal contrast among the slope, Kuroshio and gyre areas in the N + N concentration in the surface mixed layer. Since the nitrate-isoconcentration depth is much shallower in the slope area than in the other two areas, the developing wintertime mixed layer reaches to the nitrate-rich water in the slope area, and that leads to a several micromolar increase in the surface N + N concentration there.	[Kodama, Taketoshi; Shimizu, Yugo; Ichikawa, Tadafumi; Hiroe, Yutaka; Kusaka, Akira; Morita, Hiroshi; Shimizu, Manabu; Hidaka, Kiyotaka] Natl Res Inst Fisheries Sci, Fisheries Res Agcy, Kanazawa Ku, Yokohama, Kanagawa 2368648, Japan	Kodama, T (reprint author), Japan Sea Natl Fisheries Res Inst, Fisheries Res Agcy, 1-5939-22 Suido Cho, Niigata 9518121, Japan.	takekodama@affrc.go.jp		Kodama, Taketoshi/0000-0001-8031-7881	Ministry of Agriculture, Forestry and Fisheries, Japan	We thank the captains, officers, crew members, and scientists of the R/V Soyo-maru cruise for their cooperation at the sea. We are grateful to Prof. A. Shiomoto, Drs. T. Udagawa and T. Tokunaga for nutrient analysis and Ms. K. Yamada for the Chl a analysis. We thank the anonymous reviewers for their careful reading of our manuscript and their many insightful comments and suggestions. We would like to thank Japan Scientific Texts for the English language review. This work was financially supported by the Ministry of Agriculture, Forestry and Fisheries, Japan through a research project entitled "Development of Technologies for Mitigation and Adaptation to Climate Change in Agriculture, Forestry and Fisheries."	BRZEZINSKI MA, 1985, J PHYCOL, V21, P347; Yasuda I, 2003, J OCEANOGR, V59, P389, DOI 10.1023/A:1025580313836; Shiozaki T, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006934; Cavender-Bares KK, 2001, DEEP-SEA RES PT I, V48, P2373, DOI 10.1016/S0967-0637(01)00027-9; Kodama T, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006814; Furuya K, 2003, DEEP-SEA RES PT II, V50, P367, DOI 10.1016/S0967-0645(02)00460-5; Chen CTA, 2008, J OCEANOGR, V64, P737, DOI 10.1007/s10872-008-0062-9; Kaneko H, 2013, GEOPHYS RES LETT, V40, P3123, DOI 10.1002/grl.50613; Sugisaki Hiroya, 2010, P330; OSBORN TR, 1980, J PHYS OCEANOGR, V10, P83, DOI 10.1175/1520-0485(1980)010<0083:EOTLRO>2.0.CO;2; Wu LX, 2012, NAT CLIM CHANGE, V2, P161, DOI 10.1038/NCLIMATE1353; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985; Nishikawa H, 2011, FISH OCEANOGR, V20, P570, DOI 10.1111/j.1365-2419.2011.00603.x; LEE TN, 1991, J GEOPHYS RES-OCEANS, V96, P22191, DOI 10.1029/91JC02450; Guo XY, 2013, BIOGEOSCIENCES, V10, P6403, DOI 10.5194/bg-10-6403-2013; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Atkinson LP, 1996, J GEOPHYS RES-OCEANS, V101, P20565, DOI 10.1029/96JC00690; ATKINSON LP, 1978, B MAR SCI, V28, P667; Atkinson LP, 1985, COASTAL ESTUARINE SC, P77; Hidaka K, 2010, J OCEANOGR, V66, P741, DOI 10.1007/s10872-010-0061-5; HOLM-HANSEN OSMUND, 1965, J CONS CONS PERMS INTE EXPLOR MER, V30, P3; Hydes D. M., 2010, ICPO PUBLICATION SER, V134; Japan River Association, 2007, DAT CHRON RAINF RIV; Kaneko H, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052419; Kawai H, 1972, KUROSHIO ITS PHYSICA, P235; Levitus S, 1982, 13 NOAA, P173; Limsakul A, 2001, PROG OCEANOGR, V49, P129, DOI 10.1016/S0079-6611(01)00019-2; Limsakul A, 2002, DEEP-SEA RES PT II, V49, P5487, DOI 10.1016/S0967-0645(02)00208-4; Longhurst R, 2007, ECOLOGICAL GEOGRAPHY; Nishikawa H, 2008, FISH OCEANOGR, V17, P411, DOI 10.1111/j.1365-2419.2008.00487.x; Nishikawa H, 2013, MAR ECOL PROG SER, V487, P217, DOI 10.3354/meps10201; Nitani H, 1972, KUROSHIO ITS PHYS AS, P129; SUZUKI R, 1990, Journal of the Oceanographical Society of Japan, V46, P190, DOI 10.1007/BF02125580; Takasuka A, 2008, MAR ECOL PROG SER, V366, P231, DOI 10.3354/meps07514; Takasuka A, 2008, MAR ECOL PROG SER, V360, P211, DOI 10.3354/meps07407; Watanabe YW, 2005, J OCEANOGR, V61, P1011, DOI 10.1007/s10872-006-0017-y	36	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	DEC	2014	70	6					489	503		10.1007/s10872-014-0245-5		15	Oceanography	Oceanography	AU1PM	WOS:000345392600002		
J	Oka, E; Uehara, K; Nakano, T; Suga, T; Yanagimoto, D; Kouketsu, S; Itoh, S; Katsura, S; Talley, LD				Oka, Eitarou; Uehara, Kazuyuki; Nakano, Toshiya; Suga, Toshio; Yanagimoto, Daigo; Kouketsu, Shinya; Itoh, Sachihiko; Katsura, Shota; Talley, Lynne D.			Synoptic observation of Central Mode Water in its formation region in spring 2003	JOURNAL OF OCEANOGRAPHY			English	Article						Central Mode Water; Formation; Fronts; Mesoscale eddies; Decadal variability	PACIFIC INTERMEDIATE WATER; SUBTROPICAL NORTH PACIFIC; WINTER MIXED-LAYER; INTERANNUAL VARIABILITY; HYDROGRAPHIC STRUCTURE; TRANSITION REGION; MESOSCALE EDDIES; CIRCULATION; ZONE; FRONTS	Hydrographic data east of Japan from five research cruises and Argo profiling floats in spring 2003 have been analyzed to examine the relationship of the formation of Central Mode Water (CMW) and Transition Region Mode Water (TRMW) in late winter 2003 to thermohaline fronts and mesoscale eddies. TRMW and the denser variety of CMW (D-CMW) were formed continuously just south of the subarctic frontal zone between 155 degrees E and 165 degrees W with little relation to eddies, suggesting that the absence of the permanent thermocline and halocline in this area is essential for the formation. The lighter variety of CMW (L-CMW) was formed south of the Kuroshio bifurcation front and east of 165 degrees E, partly in an anticyclonic eddy associated with the Kuroshio Extension. Some portion of D-CMW and L-CMW likely had been subducted to the permanent pycnocline by crossing southward the Kuroshio bifurcation front and the Kuroshio Extension front, respectively. In contrast, the formation of these waters in the western regions was inactive and was significantly different from that described previously using multiyear Argo float data. West of 155 degrees E, TRMW and D-CMW were formed only in two anticyclonic eddies that had been detached from the Kuroshio Extension 1-2 years ago. L-CMW was hardly formed west of 165 degrees E, which might be related to the upstream Kuroshio Extension being in its stable state characterized by low regional eddy activity.	[Oka, Eitarou; Yanagimoto, Daigo; Itoh, Sachihiko; Katsura, Shota] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan; [Uehara, Kazuyuki] Tokai Univ, Sch Marine Sci & Technol, Dept Marine Sci, Shizuoka 4248610, Japan; [Nakano, Toshiya] Japan Meteorol Agcy, Global Environm & Marine Dept, Tokyo 1008122, Japan; [Suga, Toshio] Tohoku Univ, Grad Sch Sci, Dept Geophys, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Suga, Toshio; Kouketsu, Shinya] Japan Agcy Marine Earth Sci & Technol, Res Inst Global Change, Yokosuka, Kanagawa 2370061, Japan; [Talley, Lynne D.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	Oka, E (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan.	eoka@aori.u-tokyo.ac.jp			Japan Society for Promotion of Science (KAKENHI) [21340133, 25287118]; Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [22106007, 25121502]	The authors are grateful to the captain, crew, and scientists participating in the R/V Kofu-maru 0304 cruise, the R/V Seifu-maru 0304 cruise, and the R/V Ryofu-maru 0306 cruise of the Japan Meteorological Agency, the R/V Hakuho-maru KH-03-1 cruise of the Ocean Research Institute, The University of Tokyo, and the R/V Shoyo-maru FY2003 1st research cruise of the Fisheries Research Agency for their efforts in conducting the CTD and XCTD measurements. They also thank Tsuyoshi Ohira for his assistance in preparing the Argo float data and two anonymous reviewers for their helpful comments. The Argo float data used in this study were collected and made freely available by the International Argo Project and the national programs that contribute to it (http://www.argo.ucsd.edu, http://argo.jcommops.org). This study was initiated in 2005 when E.O. was sent from Institute of Observational Research for Global Change, Japan Agency for Marine-Earth Science and Technology to Scripps Institution of Oceanography (SIO) as a visiting scholar. He thanks the late Nobuo Suginohara and Nobuyuki Shikama for giving him an opportunity to visit SIO. This study is supported by the Japan Society for Promotion of Science (KAKENHI, Grant-in-Aid for Scientific Research (B), No. 21340133 and 25287118) and the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT; Grant-in-Aid for Scientific Research on Innovative Areas under Grant No. 22106007 and 25121502). Comments from participants at the "Research Meetings on Air-Sea Interaction" in 2011-2013 held as a part of the Collaborative Research Program of Hydrospheric Atmospheric Research Center, Nagoya University and at the research meeting "North Pacific Ocean Circulation and the Changes" in 2013 supported by the Atmosphere and Ocean Research Institute, The University of Tokyo and the Marine Meteorological Society of Japan were helpful.	Kouketsu S, 2012, J OCEANOGR, V68, P63, DOI 10.1007/s10872-011-0049-9; Oka E, 2007, J OCEANOGR, V63, P293, DOI 10.1007/s10872-007-0029-2; TALLEY LD, 1993, J PHYS OCEANOGR, V23, P517, DOI 10.1175/1520-0485(1993)023<0517:DAFONP>2.0.CO;2; Tomita H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049902; Yasuda T, 1997, J PHYS OCEANOGR, V27, P858, DOI 10.1175/1520-0485(1997)027<0858:DCITMW>2.0.CO;2; Qiu B, 2007, J PHYS OCEANOGR, V37, P982, DOI 10.1175/JPO3097.1; Roemmich D, 2009, OCEANOGRAPHY, V22, P46; Itoh S, 2010, J PHYS OCEANOGR, V40, P2624, DOI 10.1175/2010JPO4475.1; MASUZAWA J, 1969, DEEP-SEA RES, V16, P463, DOI 10.1016/0011-7471(69)90034-5; Yasuda I, 1996, J PHYS OCEANOGR, V26, P448, DOI 10.1175/1520-0485(1996)026<0448:DAMONP>2.0.CO;2; Yasuda I, 2003, J OCEANOGR, V59, P389, DOI 10.1023/A:1025580313836; Ishii M, 2001, MAR CHEM, V75, P17, DOI 10.1016/S0304-4203(01)00023-8; Kobashi F, 2012, J OCEANOGR, V68, P21, DOI 10.1007/s10872-011-0083-7; Qiu B, 2011, J PHYS OCEANOGR, V41, P503, DOI 10.1175/2010JPO4575.1; SUGA T, 1989, J PHYS OCEANOGR, V19, P1605, DOI 10.1175/1520-0485(1989)019<1605:SMWITS>2.0.CO;2; ZHANG RC, 1993, J GEOPHYS RES-OCEANS, V98, P967, DOI 10.1029/92JC01854; Isoguchi O, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003080; Qiu B, 2005, J PHYS OCEANOGR, V35, P2090, DOI 10.1175/JPO2807.1; TALLEY LD, 1988, J PHYS OCEANOGR, V18, P89, DOI 10.1175/1520-0485(1988)018<0089:PVDITN>2.0.CO;2; Midorikawa T, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003095; Oka E, 2009, J OCEANOGR, V65, P151, DOI 10.1007/s10872-009-0015-y; Sugimoto S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021410; Yamashita Y, 2009, LIMNOL OCEANOGR, V54, P598, DOI 10.4319/lo.2009.54.2.0598; Suga T, 2004, J PHYS OCEANOGR, V34, P3, DOI 10.1175/1520-0485(2004)034<0003:TNPCOW>2.0.CO;2; Shiozaki T, 2014, J GEOPHYS RES-OCEANS, V119, P253, DOI 10.1002/2013JC009187; Ladd C, 2000, J PHYS OCEANOGR, V30, P868, DOI 10.1175/1520-0485(2000)030<0868:FMFNPC>2.0.CO;2; Itoh S, 2010, J PHYS OCEANOGR, V40, P1018, DOI 10.1175/2009JPO4265.1; Oka E, 2012, J OCEANOGR, V68, P5, DOI 10.1007/s10872-011-0032-5; Hanawa K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019904; Oka E, 2011, J PHYS OCEANOGR, V41, P666, DOI 10.1175/2011JPO4501.1; Yuan XJ, 1996, J GEOPHYS RES-OCEANS, V101, P16491, DOI 10.1029/96JC01249; Yasuda I, 1997, J GEOPHYS RES-OCEANS, V102, P893, DOI 10.1029/96JC02938; Oka E, 2011, J PHYS OCEANOGR, V41, P113, DOI 10.1175/2010JPO4419.1; Suga T, 1997, J PHYS OCEANOGR, V27, P140, DOI 10.1175/1520-0485(1997)027<0140:TDITNP>2.0.CO;2; MIZUNO K, 1983, J PHYS OCEANOGR, V13, P1847, DOI 10.1175/1520-0485(1983)013<1847:AAIVIT>2.0.CO;2; Rossi V, 2013, DEEP-SEA RES PT I, V80, P37, DOI 10.1016/j.dsr.2013.05.015; Ducet N, 2000, J GEOPHYS RES-OCEANS, V105, P19477, DOI 10.1029/2000JC900063; Aoyama M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031964; de Boyer Montegut C, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002378; Freeland H. J., 2010, ESA PUBLICATION WPP, V2, DOI [10.5270/OceanObs09.cwp.32, DOI 10.5270/OCEANOBS09.CWP.32]; HUANG RX, 1994, J PHYS OCEANOGR, V24, P1608, DOI 10.1175/1520-0485(1994)024<1608:TDSOTW>2.0.CO;2; Itoh S, 2011, J OCEANOGR, V67, P281, DOI 10.1007/s10872-011-0027-2; Japan Meteorological Agency, 2005, 94 JAP MET AG; Kawabe M, 2005, KH031 U TOK OC RES I; Kawai H, 1972, KUROSHIO ITS PHYSICA, P235; Komaki K, 2009, DEEP-SEA RES PT I, V56, P305, DOI 10.1016/j.dsr.2008.10.006; Kono T, 1997, DEEP-SEA RES PT I, V44, P689, DOI 10.1016/S0967-0637(96)00107-0; LEVINE ER, 1983, J GEOPHYS RES-OC ATM, V88, P9617, DOI 10.1029/JC088iC14p09617; Mecking S, 2001, J GEOPHYS RES-OCEANS, V106, P22179, DOI 10.1029/2001JC000846; Nakamura H, 1996, J OCEANOGR, V52, P171, DOI 10.1007/BF02235668; Ohtani K, 1989, UMI TO SORA, V65, P63; Ohtani K, 1971, B FAC FISH HOKKAIDO, V22, P58; Oka E, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037540; Oka E, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018581; Oka E, 2005, J PHYS OCEANOGR, V35, P1997, DOI 10.1175/JPO2811.1; Qiu B, 2006, J PHYS OCEANOGR, V36, P1365, DOI 10.1175/JPO2918.1; Reid JL, 1965, J HOPKINS OCCANOGRAP, V2; RODEN GI, 1972, J GEOPHYS RES, V77, P7175, DOI 10.1029/JC077i036p07175; RODEN GI, 1970, J GEOPHYS RES, V75, P1097, DOI 10.1029/JC075i006p01097; Saitoi H, 2007, J OCEANOGR, V63, P589, DOI 10.1007/s10872-007-0052-3; Saito H, 2011, J PHYS OCEANOGR, V41, P1639, DOI 10.1175/2011JPO4346.1; SPALL MA, 1995, J GEOPHYS RES-OCEANS, V100, P2543, DOI 10.1029/94JC02860; Stabeno PJ, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2007JC004705; Sugiura J, 1958, GEOPHYS MAG, V28, P399; TOMOSADA A, 1986, DEEP-SEA RES, V33, P1475, DOI 10.1016/0198-0149(86)90063-4; Tsujino H, 2004, J PHYS OCEANOGR, V34, P399, DOI 10.1175/1520-0485(2004)034<0399:FACOMW>2.0.CO;2; Uehara K, 2004, FY2003 FISH RES AG; YASUDA I, 1992, DEEP-SEA RES, V39, pS131	68	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	DEC	2014	70	6					521	534		10.1007/s10872-014-0248-2		14	Oceanography	Oceanography	AU1PM	WOS:000345392600004		
J	Miyazawa, Y; Yamashita, N; Taniyasu, S; Yamazaki, E; Guo, XY; Varlamov, SM; Miyama, T				Miyazawa, Yasumasa; Yamashita, Nobuyoshi; Taniyasu, Sachi; Yamazaki, Eriko; Guo, Xinyu; Varlamov, Sergey M.; Miyama, Toru			Oceanic dispersion simulation of perfluoroalkyl substances in the Western North Pacific associated with the Great East Japan Earthquake of 2011	JOURNAL OF OCEANOGRAPHY			English	Article						Perfluoroalkyl substances; Great East Japan Earthquake 2011; Oceanic dispersion; In-situ observation; Numerical simulation; Ocean reanalysis	PERFLUORINATED ACIDS; PERFLUOROOCTANE SULFONATE; FRONTAL EDDY; FUKUSHIMA; WATER; CIRCULATION; SHELF; MODEL; LAYER	The Great East Japan Earthquake on 11 March 2011, followed by the tsunami and fire, resulted in serious environmental problems in and around Japan. A huge amount of material was discharged into the ocean after the tremendous flood damage of the tsunami. A monitoring survey of the perfluoroalkyl substances (PFAs) found evidence showing an abrupt increase in the PFA concentration in the ocean east of Japan in 2011 after the earthquake. To confirm the anomalous input of two typical PFAs, perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS), from the Japanese coast into the ocean, associated with the earthquake, we conducted a series of chemical tracer simulations using an eddy-resolving ocean reanalysis product: JCOPE2. The simulation model involves processes representing the emission of PFAs from the land triggered by the tsunami flood, advection of the polluted waters, and decay of the concentration by the background oceanic turbulence. Comparison of the PFOA simulation results with the observation confirms a spike-like input of PFOA into the Western North Pacific after the earthquake. Advection and diffusion by the Kuroshio Extension and the mesoscale eddies play a key role in the dilution of the concentration. Optimization of unknown simulation parameters leads to an estimation of the total amount of the anomalous PFOA emission. In contrast, the PFOS simulations are not able to explain the observed distribution, suggesting possible differences in the oceanic transport processes between PFOS and PFOA.	[Miyazawa, Yasumasa; Guo, Xinyu; Varlamov, Sergey M.; Miyama, Toru] Japan Agcy Marine Earth Sci & Technol, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Yamashita, Nobuyoshi; Taniyasu, Sachi; Yamazaki, Eriko] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058569, Japan; [Guo, Xinyu] Ehime Univ, Matsuyama, Ehime 7908577, Japan	Miyazawa, Y (reprint author), Japan Agcy Marine Earth Sci & Technol, Kanazawa Ku, 3173-25 Showa Machi, Yokohama, Kanagawa 2360001, Japan.	miyazawa@jamstec.go.jp	Miyazawa, Yasumasa/J-3196-2014; Miyama, Toru/A-3824-2009	Miyazawa, Yasumasa/0000-0002-0107-6272; Miyama, Toru/0000-0002-6400-0312			Menemenlis D, 2005, MON WEATHER REV, V133, P1224, DOI 10.1175/MWR2912.1; Miyazawa Y, 2013, BIOGEOSCIENCES, V10, P2349, DOI 10.5194/bg-10-2349-2013; Yamashita N, 2008, CHEMOSPHERE, V70, P1247, DOI 10.1016/j.chemosphere.2007.07.079; Mellor G, 2004, J PHYS OCEANOGR, V34, P693, DOI 10.1175/2517.1; Nakata H, 2006, ENVIRON SCI TECHNOL, V40, P4916, DOI 10.1021/es0603195; LEE TN, 1981, DEEP-SEA RES, V28, P347, DOI 10.1016/0198-0149(81)90004-2; Kasai A, 2002, J MARINE SYST, V37, P185, DOI 10.1016/S0924-7963(02)00201-4; Miyazawa Y, 2009, J OCEANOGR, V65, P737; Yamashita N, 2004, ENVIRON SCI TECHNOL, V38, P5522, DOI 10.1021/es0492541; Nakanishi M, 2009, J METEOROL SOC JPN, V87, P895, DOI 10.2151/jmsj.87.895; Giesy JP, 2001, ENVIRON SCI TECHNOL, V35, P1339, DOI 10.1021/es001834k; Masumoto Y, 2012, ELEMENTS, V8, P207, DOI 10.2113/gselements.8.3.207; Miyazawa Y, 2012, CONT SHELF RES, V50-51, P16, DOI 10.1016/j.csr.2012.09.002; Furuichi N, 2012, J OCEANOGR, V68, P285, DOI 10.1007/s10872-011-0095-3; Yamashita N, 2005, MAR POLLUT BULL, V51, P658, DOI 10.1016/j.marpolbul.2005.04.026; Nakajima H., 2011, B GEOSPATIAL INFORM, V59, P55; Showstack R, 2011, EOS T AM GEOPHYS UN, V92, P306; Smagorinsky J., 1963, MON WEATHER REV, V91, P99, DOI [DOI 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.C0;2, 10.1175/1520-0493(1963)091&LT;0099:GCEWTP&GT;2.3.CO;2(1963)]; Yamazaki E, 2012, ORGANOHALOG COMPD, V74, P103; Yoshida K., 1955, REC OCEANOGR WORKS J, V2, P8	20	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0916-8370	1573-868X		J OCEANOGR	J. Oceanogr.	DEC	2014	70	6					535	547		10.1007/s10872-014-0250-8		13	Oceanography	Oceanography	AU1PM	WOS:000345392600005		
J	Kimakura, M; Usui, T; Yokoo, S; Nakagawa, S; Yamagami, S; Amano, S				Kimakura, Mikiko; Usui, Tomohiko; Yokoo, Seiichi; Nakagawa, Suguru; Yamagami, Satoru; Amano, Shiro			Toxicity of Topical Antifungal Agents to Stratified Human Cultivated Corneal Epithelial Sheets	JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS			English	Article							BENZALKONIUM CHLORIDE; CELLS; VORICONAZOLE	Purpose: Prolonged use of topical antifungal agents may compromise corneal epithelial integrity. Here, we used an in vitro model of human stratified corneal epithelium to compare the ocular toxicity profiles of 4 different antifungal eye drops. Methods: Human corneal epithelial cell sheets were cultured in a serum-free medium containing 0.1% micafungin, 1% voriconazole, 5% pimaricin, 0.1% amphotericin B, or controls (saline or 5% glucose). Cell viability and barrier function were measured by WST-1 assay and carboxyfluorescein permeability assay, respectively. Cell migration was measured on a wound healing assay. Results: WST-1 assay and carboxyfluorescein permeability assay revealed that amphotericin B was the most toxic drug, followed by pimaricin, micafungin, and voriconazole. Cell migration on a wound healing assay was decreased in the following order, amphotericin B, pimaricin, micafungin, and voriconazole. Conclusions: Topical micafungin and voriconazole appeared to be the least toxic to the corneal epithelium. Drug prescription should consider not only fungal species and susceptibility but also ocular toxicity and stage of treatment.	[Kimakura, Mikiko; Usui, Tomohiko; Yokoo, Seiichi; Nakagawa, Suguru; Yamagami, Satoru; Amano, Shiro] Univ Tokyo, Sch Med, Dept Ophthalmol, Tokyo 11386556, Japan	Usui, T (reprint author), Univ Tokyo, Sch Med, Dept Ophthalmol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 11386556, Japan.	tomohiko-tky@umin.ac.jp					Al-Badriyeh D, 2009, ANN PHARMACOTHER, V43, P2103, DOI 10.1345/aph.1M318; Nakagawa S, 2012, INVEST OPHTH VIS SCI, V53, P5154, DOI 10.1167/iovs.12-9685; Yokoo S, 2008, INVEST OPHTH VIS SCI, V49, P2438, DOI 10.1167/iovs.06-1448; Kernt M, 2009, TOXICOLOGY, V258, P84, DOI 10.1016/j.tox.2009.01.008; Nakashima M, 2008, J OCUL PHARMACOL TH, V24, P43, DOI 10.1089/jop.2007.0006; Bhartiya P, 2007, CLIN EXP OPHTHALMOL, V35, P124, DOI 10.1111/j.1442-9071.2006.01405.x; Doucet O, 2006, TOXICOL IN VITRO, V20, P499, DOI 10.1016/j.tiv.2005.09.005; Guenoun JM, 2005, INVEST OPHTH VIS SCI, V46, P4594, DOI 10.1167/iovs.05-0776; Jeu L, 2003, CLIN THER, V25, P1321, DOI 10.1016/S0149-2918(03)80126-1; Kahook MY, 2010, J OCUL PHARMACOL TH, V26, P259, DOI 10.1089/jop.2010.0003; DeRosa AJ, 1998, INT OPHTHALMOL CLIN, V38, P15, DOI 10.1097/00004397-199803840-00004; FOSTER CS, 1981, ARCH OPHTHALMOL-CHIC, V99, P1081; Khoh-Reiter S, 2009, BMC OPHTHALMOL, V9, DOI 10.1186/1471-2415-9-5; Lamers ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022865; Maesaki S, 2000, ANTIMICROB AGENTS CH, V44, P1728, DOI 10.1128/AAC.44.6.1728-1730.2000; Mahdy RA, 2010, J OCUL PHARMACOL TH, V26, P281, DOI 10.1089/jop.2010.0005; Nakamura T, 2007, BIOL PHARM BULL, V30, P2360, DOI 10.1248/bpb.30.2360; Pauly A, 2009, INVEST OPHTH VIS SCI, V50, P1644, DOI 10.1167/iovs.08-2992; Srinivasan M, 2004, Curr Opin Ophthalmol, V15, P321, DOI 10.1097/00055735-200408000-00008	19	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1080-7683	1557-7732		J OCUL PHARMACOL TH	J. Ocular Pharmacol. Ther.	DEC 1	2014	30	10					810	814		10.1089/jop.2014.0044		5	Ophthalmology; Pharmacology & Pharmacy	Ophthalmology; Pharmacology & Pharmacy	AU6AL	WOS:000345684400004		
J	Sanuki, T; Watanabe, T; Kurata, S; Ayuse, T				Sanuki, Takuro; Watanabe, Toshihiro; Kurata, Shinji; Ayuse, Takao			Perioperative Management of Tooth Extractions for a Patient With Hereditary Angioedema	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							INHIBITOR	Hereditary angioedema (HAE) is a rare genetic disorder that causes a deficiency in or dysfunction of C1 esterase inhibitor (C1-INH) and is clinically characterized by sudden and recurrent attacks of angioedema. Although almost any part of the body can be affected, HAE is of greatest concern and can be life-threatening when the upper airway is involved, particularly the larynx (laryngeal attack). HAE attacks can be triggered by physical or psychological stress or can arise spontaneously without any apparent trigger. Dental treatments and routine oral surgical procedures, such as tooth extraction, abound with factors that can trigger an attack of HAE. Indeed, several cases of death resulting from HAE attacks have been reported after such procedures. Therefore, patients with HAE are of special concern in dentistry and require precautionary preparations before treatment. This report describes the successful management of tooth extractions in a patient with HAE who was at high risk of an HAE-induced laryngeal attack. (C) 2014 American Association of Oral and Maxillofacial Surgeons	[Sanuki, Takuro; Ayuse, Takao] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Physiol, Unit Translat Med, Nagasaki 8528588, Japan; [Watanabe, Toshihiro; Kurata, Shinji] Nagasaki Univ Hosp, Dept Dent Anesthesiol, Nagasaki, Japan	Sanuki, T (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Physiol, Unit Translat Med, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.	sanuki@nagasaki-u.ac.jp					Amemiya K, 2006, J JPN DENT SOC ANEST, V34, P164; Grant JA, 2012, ALLERGY ASTHMA PROC, V33, P348, DOI 10.2500/aap.2012.33.3585; Longhurst HJ, 2007, CLIN EXP IMMUNOL, V147, P11, DOI 10.1111/j.1365-2249.2006.03256.x; Cicardi M, 2012, ALLERGY, V67, P147, DOI 10.1111/j.1398-9995.2011.02751.x; Bork K, 2003, J AM DENT ASSOC, V134, P1088; Cardona Lourdes Pastó, 2010, Appl Clin Genet, V3, P133, DOI 10.2147/TACG.S9275; Ghazi Aasia, 2013, Biologics, V7, P103, DOI 10.2147/BTT.S27566; Papamanthos Mattheos, 2010, J Oral Maxillofac Res, V1, pe9, DOI 10.5037/jomr.2010.1109; Van Sickels NJ, 2010, ORAL SURG ORAL MED O, V109, P168, DOI 10.1016/j.tripleo.2009.09.031	9	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	DEC	2014	72	12								10.1016/j.joms.2014.08.026		3	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AT9BX	WOS:000345223900011		
J	Shintaku, H; Ohura, T				Shintaku, Haruo; Ohura, Toshihiro			Sapropterin Is Safe and Effective in Patients less than 4-Years-Old with BH4-Responsive Phenylalanine Hydroxylase Deficiency	JOURNAL OF PEDIATRICS			English	Article							TERM-FOLLOW-UP; TETRAHYDROBIOPTERIN	Objective To assess the safety and efficacy of tetrahydrobiopterin therapy with sapropterin to treat tetrahydrobiopterin (BH4)-responsive phenylalanine hydroxylase (PAH) deficiency in children aged <4 years compared with those aged >= 4 years. Study design We analyzed a longitudinal follow-up study conducted in all patients with BH4-responsive PAH deficiency throughout Japan. At the end of 2011, 43 patients were receiving sapropterin, of whom 21 were aged <4 years at the initiation of treatment. The starting dose of sapropterin was >= 10 mg/kg/day in 11 of these 21 patients. The duration of follow-up was >= 4 years in 6 of those 11 patients; 3 of these 6 were followed for >= 10 years. Nine patients were receiving sapropterin monotherapy at the end of 2011. Results Serum phenylalanine level was maintained within the recommended optimal control range in all 21 patients who started sapropterin treatment before age 4 years. Only 1 nonserious adverse drug reaction occurred, an elevated alanine aminotransferase level in 1 patient. No significant abnormal behavior related to nerve disorders was reported. Conclusion Sapropterin therapy initiated before age 4 years was effective in maintaining serum phenylalanine level within the favorable range and was safe in Japanese patients with BH4-responsive PAH deficiency.	[Shintaku, Haruo] Osaka City Univ, Dept Pediat, Sch Med, Osaka 5458585, Japan; [Ohura, Toshihiro] Tohoku Univ, Sch Med, Dept Pediat, Sendai, Miyagi 980, Japan	Shintaku, H (reprint author), Osaka City Univ, Dept Pediat, Grad Sch Med, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	shintakuh@med.osaka-cu.ac.jp			Ministry of Health, Labour and Welfare, Japan [14427732]; Daiichi Sankyo	Supported by the Ministry of Health, Labour and Welfare, Japan (grant 14427732 to H.S. to produce the manuscript). H.S. received the data of postmarketing surveillance of Biopten for BH<INF>4</INF>-responsive hyperphenylalaninemia. H.S. and T.O. received consultant, travel, and lecture fees from Daiichi Sankyo. The authors declare no conflict of interest.	Shintaku H, 2004, PEDIATR RES, V55, P425, DOI 10.1203/01.PDR.0000111283.91564.7E; Kure S, 1999, J PEDIATR-US, V135, P375, DOI 10.1016/S0022-3476(99)70138-1; Keil S, 2013, PEDIATRICS, V131, pE1881, DOI 10.1542/peds.2012-3291; Leuret O, 2012, J INHERIT METAB DIS, V35, P975, DOI 10.1007/s10545-012-9464-3; Shintaku H, 2013, BRAIN DEV-JPN, V35, P406, DOI 10.1016/j.braindev.2012.06.010; Shintaku H, 2002, CURR DRUG METAB, V3, P123, DOI 10.2174/1389200024605145	6	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	DEC	2014	165	6					1241	1244		10.1016/j.jpeds.2014.08.003		4	Pediatrics	Pediatrics	AU3PS	WOS:000345526500033		
J	Kajihara, Y; Kanemitsu, Y; Nishihara, M; Okamoto, R; Izumi, M				Kajihara, Yasuhiro; Kanemitsu, Yurie; Nishihara, Mika; Okamoto, Ryo; Izumi, Masayuki			Efficient synthesis of polypeptide-alpha-thioester by the method combining polypeptide expression and chemical activation for the semi-synthesis of interferon-gamma having oligosaccharides	JOURNAL OF PEPTIDE SCIENCE			English	Article						peptide expression; chemical conversion; semi-synthesis; peptide-alpha-thioester	LIGATION; PEPTIDES; PROTEINS; GLYCOSYLATION	In order to synthesize interferon- glycoform having an oligosaccharide at the 97 position by a semi-synthetic method, interferon--polypeptide-(1-94)--hydrazide was prepared by the specific Cys-cyanylation of polypeptide-(1-94)-Cys-His(6) expressed from E. coli and subsequent hydrazinolysis in 22% yield (two steps). This polypeptide--hydrazide was then converted into corresponding polypeptide--thioester under NaNO2/acid conditions followed by thiolysis in 83% yield. Copyright (c) 2014 European Peptide Society and John Wiley & Sons, Ltd.	[Kajihara, Yasuhiro; Kanemitsu, Yurie; Nishihara, Mika; Okamoto, Ryo; Izumi, Masayuki] Osaka Univ, Dept Chem, Toyonaka, Osaka 5600043, Japan	Kajihara, Y (reprint author), Osaka Univ, Dept Chem, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan.	kajihara@chem.sci.osaka-u.ac.jp	Izumi, Masayuki/C-6230-2008	Izumi, Masayuki/0000-0001-6486-9678	Japan Society for the Promotion of Science [A 23245037]	This work was supported by Financial support from the Japan Society for the Promotion of Science (No. A 23245037).	Unverzagt C, 2013, CHEM SOC REV, V42, P4408, DOI 10.1039/c3cs35485g; Hackenberger CPR, 2008, ANGEW CHEM INT EDIT, V47, P10030, DOI 10.1002/anie.200801313; Adams AL, 2013, ANGEW CHEM INT EDIT, V52, P13062, DOI 10.1002/anie.201304997; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Noren CJ, 2000, ANGEW CHEM INT EDIT, V39, P450; Shah NH, 2014, CHEM SCI, V5, P446, DOI 10.1039/c3sc52951g; Fang GM, 2011, ANGEW CHEM INT EDIT, V50, P7645, DOI 10.1002/anie.201100996; Kang J, 2010, ORG BIOMOL CHEM, V8, P1993, DOI 10.1039/b925075a; CURLING EMA, 1990, BIOCHEM J, V272, P333; DEGANI Y, 1974, BIOCHEMISTRY-US, V13, P1, DOI 10.1021/bi00698a001; Kang J, 2009, ORG BIOMOL CHEM, V7, P4918, DOI 10.1039/b913886b; Lis Y-M, 2012, ACS CHEM BIOL, V7, P1015; Sareneva T, 1996, EUR J BIOCHEM, V242, P191, DOI 10.1111/j.1432-1033.1996.0191r.x; Wang P, 1998, TETRAHEDRON LETT, V39, P8719, DOI 10.1016/S0040-4039(98)01917-0; Wus J, 1998, ANAL BIOCHEM, V258, P268; Wus W, 2004, J PROTEOME RES, V3, P770	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1075-2617	1099-1387		J PEPT SCI	J. Pept. Sci.	DEC	2014	20	12					958	963		10.1002/psc.2709		6	Biochemistry & Molecular Biology; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	AU3ML	WOS:000345517400008		
J	Sato, Y; Murata, M; Sasahara, J; Hayashi, S; Ishii, K; Mitsuda, N				Sato, Y.; Murata, M.; Sasahara, J.; Hayashi, S.; Ishii, K.; Mitsuda, N.			A case of fetal hyperthyroidism treated with maternal administration of methimazole	JOURNAL OF PERINATOLOGY			English	Article							GRAVES-DISEASE; NEONATAL HYPERTHYROIDISM; THYROID-FUNCTION; PREGNANCY; PROPYLTHIOURACIL; MANAGEMENT; DIAGNOSIS	Prenatal ultrasonography of a pregnant woman with a past history of total thyroidectomy for Graves' disease detected fetal tachycardia, fetal growth restriction and oligohydramnios at 30 weeks gestation. Because a high titer of thyroid-stimulating hormone receptor antibody was noted in maternal serum and the fetal goiter was detected on ultrasonography, fetal hyperthyroidism was strongly suspected and subsequently confirmed with cordocentesis at 31 weeks gestation. After treatment of fetal hyperthyroidism through oral maternal administration of methimazole (MMI) starting at 33 weeks gestation, fetal heart rate and amniotic fluid volume returned to normal ranges. Complete resolution of the fetal goiter was observed at 35 weeks gestation. A male infant was born at 35 weeks 6 days gestation via cesarean section in the absence of thyrotoxic findings; however, cord blood chemical analysis at birth indicated iatrogenic fetal hypothyroidism. In the present report, maternal therapy using MMI to resolve symptoms of fetal thyrotoxicosis, including fetal tachycardia and oligohydramnios, was successfully conducted.	[Sato, Y.] Osaka Prefectural Hosp Org, Osaka Med Ctr, Dept Maternal Fetal Med, Izumi, Osaka 5941101, Japan; [Sato, Y.] Res Inst Maternal & Child Hlth, Izumi, Osaka 5941101, Japan	Sato, Y (reprint author), Osaka Prefectural Hosp Org, Osaka Med Ctr, Dept Maternal Fetal Med, 840 Murodo Cho, Izumi, Osaka 5941101, Japan.	yuka910@mch.pref.osaka.jp					MOORE TR, 1990, AM J OBSTET GYNECOL, V162, P1168; Nakamura H, 2007, J CLIN ENDOCR METAB, V92, P2157, DOI 10.1210/jc.2006-2135; Mortimer RH, 1997, J CLIN ENDOCR METAB, V82, P3099, DOI 10.1210/jc.82.9.3099; Polak M, 2010, HORM RES PAEDIAT, V74, P1, DOI 10.1159/000297595; Luton D, 2005, J CLIN ENDOCR METAB, V90, P6093, DOI 10.1210/jc.2004-2555; Rivkees SA, 2013, J CLIN ENDOCR METAB, V98, P4332, DOI 10.1210/jc.2013-3549; Zimmerman D, 1999, THYROID, V9, P727, DOI 10.1089/thy.1999.9.727; Laurberg P, 2009, EUR J ENDOCRINOL, V160, P1, DOI 10.1530/EJE-08-0663; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; Huel C, 2009, ULTRASOUND OBST GYN, V33, P412, DOI 10.1002/uog.6315; Aslam M, 2008, SOUTH MED J, V101, P840, DOI 10.1097/SMJ.0b013e31817dae27; Bahn Rebecca S, 2009, Thyroid, V19, P673, DOI 10.1089/thy.2009.0169; Guibourdenche J, 2001, ANN CLIN BIOCHEM, V38, P520, DOI 10.1258/0004563011901334; Heckel S, 1997, FETAL DIAGN THER, V12, P54; Nachum Z, 2003, AM J OBSTET GYNECOL, V189, P159, DOI 10.1067/mob.2003.321; Ranzini AC, 2001, J ULTRAS MED, V20, P613; Spremovic-Radjenovic S, 2012, J CLIN ENDOCR METAB, V97, P4014, DOI 10.1210/jc.2012-1392; WENSTROM KD, 1990, OBSTET GYNECOL, V76, P513; ZAKARIJA M, 1986, J CLIN ENDOCR METAB, V62, P368	19	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0743-8346	1476-5543		J PERINATOL	J. Perinatol.	DEC	2014	34	12					945	947		10.1038/jp.2014.163		3	Obstetrics & Gynecology; Pediatrics	Obstetrics & Gynecology; Pediatrics	AU3AS	WOS:000345486000015		
J	Ichibangase, T; Imai, K				Ichibangase, Tomoko; Imai, Kazuhiro			Straightforward proteomic analysis reveals real dynamics of proteins in cells	JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS			English	Review						Proteomics; Top-down; Fluorogenic derivatization; HPLC separation; Bioinformatics	CHROMATOGRAPHY/TANDEM MASS-SPECTROMETRY; ACUTE-PHASE RESPONSE; FLUOROGENIC DERIVATIZATION; LIQUID-CHROMATOGRAPHY; CANCER CELL; IDENTIFICATION; INTERLEUKIN-6; EXPRESSION; SEPARATION; ELEGANS	To reveal real dynamics of proteins in cells, we have developed a novel type of straightforward proteomic analysis named FD-LC-MS/MS. This technique consists of fluorogenic derivatization (FD) of intact proteins, followed by high performance liquid chromatographic (LC) separation, detection and quantification of the derivatized proteins, isolation of the subject proteins, enzymatic digestion of the isolated proteins, and identification of the proteins using HPLC and MS/MS with a database-searching algorithm. The method is uncomplicated, sensitive, reproducible, and easily quantifies and identifies intact proteins in tissues and cells. Additionally, in contrast to other proteomic approaches, our method does not require any pretreatment steps, such as precipitation and clean-up, except for the derivatization, resulting in high reproducibility and the same or higher detectability than that of other methods. In this article, after a brief review of other types of proteomic analyses, we introduce the development and application of the FD-LC-MS/MS method. We also discuss the features and perspectives of this method. (C) 2014 Elsevier B.V. All rights reserved.	[Ichibangase, Tomoko; Imai, Kazuhiro] Musashino Univ, Pharmaceut Sci Res Inst, Nishitokyo, Tokyo, Japan	Imai, K (reprint author), Musashino Univ, Pharmaceut Sci Res Inst, 1-1-20 Shinmachi, Nishitokyo, Tokyo, Japan.	k-imai@musashino-u.ac.jp					Koshiyama A, 2013, BIOMED CHROMATOGR, V27, P440, DOI 10.1002/bmc.2811; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Zhang YY, 2013, CHEM REV, V113, P2343, DOI 10.1021/cr3003533; Koshiyama A, 2011, J CHROMATOGR A, V1218, P3447, DOI 10.1016/j.chroma.2011.03.070; Ichibangase T, 2008, BIOMED CHROMATOGR, V22, P232, DOI 10.1002/bmc.931; Ichibangase T, 2009, BIOMED CHROMATOGR, V23, P480, DOI 10.1002/bmc.1139; HEINRICH PC, 1990, BIOCHEM J, V265, P621; Langley SR, 2013, CARDIOVASC RES, V97, P612, DOI 10.1093/cvr/cvs346; Asamoto H, 2008, J CHROMATOGR A, V1208, P147, DOI 10.1016/j.chroma.2008.08.078; Ichibangase T, 2013, BIOMED CHROMATOGR, V27, P1520, DOI 10.1002/bmc.2952; Ichibangase T, 2007, J PROTEOME RES, V6, P2841, DOI 10.1021/pr070094c; Ichibangase T, 2012, BIOL PHARM BULL, V35, P1393; Ichibangase T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045483; Ichibangase T, 2009, J PROTEOME RES, V8, P2129, DOI 10.1021/pr801004s; Imai K, 2008, BIOMED CHROMATOGR, V22, P1304, DOI 10.1002/bmc.1102; Imai K, 2011, BIOMED CHROMATOGR, V25, P59, DOI 10.1002/bmc.1541; Josic D., 2010, CURRENT PROTOCOLS PR; Koshiyama A., 2013, QUANTITATIVE PROTEOM, P1; Masuda M, 2004, ANAL CHEM, V76, P728, DOI 10.1021/ac034840i; Masuda M, 2005, BIOMED CHROMATOGR, V19, P556, DOI 10.1002/bmc.479; MEHDI H, 1991, GENE, V108, P293, DOI 10.1016/0378-1119(91)90449-L; Nakata K, 2012, CYTOKINE, V59, P317, DOI 10.1016/j.cyto.2012.04.025; Toriumi C, 2003, ANAL CHEM, V75, P3725, DOI 10.1021/ac020693x; Yadav AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024442; YANG FM, 1983, P NATL ACAD SCI-BIOL, V80, P5875, DOI 10.1073/pnas.80.19.5875	25	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0731-7085	1873-264X		J PHARMACEUT BIOMED	J. Pharm. Biomed. Anal.	DEC	2014	101				SI		31	39		10.1016/j.jpba.2014.05.036		9	Chemistry, Analytical; Pharmacology & Pharmacy	Chemistry; Pharmacology & Pharmacy	AU3AA	WOS:000345484200003		
J	Hayama, T; Yoshida, H; Yamaguchi, M; Nohta, H				Hayama, Tadashi; Yoshida, Hideyuki; Yamaguchi, Masatoshi; Nohta, Hitoshi			Fluorous affinity-based separation techniques for the analysis of biogenic and related molecules	JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS			English	Review						Perfluoroallcyl; Specific affinity; Biogenic and related compounds; Fluorous solid-phase extraction; Fluorous liquid chromatography	INITIATOR MASS-SPECTROMETRY; HYDROPHILIC-INTERACTION CHROMATOGRAPHY; PERFORMANCE LIQUID-CHROMATOGRAPHY; STATIONARY PHASES; SELECTIVE ENRICHMENT; MIXTURE SYNTHESIS; TAGGING STRATEGY; CHEMICAL BIOLOGY; HIGHLY EFFICIENT; BONDED PHASES	Perfluoroalkyl-containing compounds have a unique 'fluorous' property that refers to the remarkably specific affinity they share. Fluorous compounds can be easily isolated from non-fluorous species on the perfluoroalkyl-functionalized stationary phases used in fluorous solid-phase extraction and fluorous liquid chromatography by means of fluorous-fluorous interactions (fluorophilicity). Recently, this unique specificity has been applied to the highly selective enrichment and analysis of different classes of biogenic and related compounds in complex samples. Because the biogenic compounds are generally not 'fluorous', they must be derivatized with appropriate perfluoroalkyl group-containing reagent in order to utilize fluorous interaction. In this review, we introduce the application of fluorous affinity techniques including derivatization methods to biogenic sample analysis. (C) 2014 Elsevier B.V. All rights reserved.	[Hayama, Tadashi; Yoshida, Hideyuki; Yamaguchi, Masatoshi; Nohta, Hitoshi] Fukuoka Univ, Fac Pharmaceut Sci, Fukuoka 8140180, Japan	Nohta, H (reprint author), Fukuoka Univ, Fac Pharmaceut Sci, 8-19-1 Nanakuma, Fukuoka 8140180, Japan.	nohta@fukuoka-u.ac.jp					Lanucara F, 2013, MASS SPECTROM REV, V32, P27, DOI 10.1002/mas.21348; Yan ZH, 2013, J CHROMATOGR A, V1321, P21, DOI 10.1016/j.chroma.2013.10.067; Wang D, 2008, LANGMUIR, V24, P1080, DOI 10.1021/la702038t; Hayama T, 2010, RAPID COMMUN MASS SP, V24, P2868, DOI 10.1002/rcm.4710; Lau C, 2004, TOXICOL APPL PHARM, V198, P231, DOI 10.1016/j.taap.2003.11.031; Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; Wang D, 2009, J COLLOID INTERF SCI, V331, P90, DOI 10.1016/j.jcis.2008.11.010; Lai CZ, 2010, ANAL CHEM, V82, P7634, DOI 10.1021/ac1013767; DANIELSON ND, 1991, J CHROMATOGR, V544, P187, DOI 10.1016/S0021-9673(01)83985-6; Sakaguchi Y, 2011, J CHROMATOGR A, V1218, P5581, DOI 10.1016/j.chroma.2011.05.076; Greving MP, 2011, ANAL CHEM, V83, P2, DOI 10.1021/ac101565f; Daley AB, 2011, ANAL CHEM, V83, P1688, DOI 10.1021/ac102827t; Van Eeckhaut A, 2009, J CHROMATOGR B, V877, P2198, DOI 10.1016/j.jchromb.2009.01.003; Matta A, 2010, MASS SPECTROM REV, V29, P945, DOI 10.1002/mas.20296; ALPERT AJ, 1990, J CHROMATOGR, V499, P177, DOI 10.1016/S0021-9673(00)96972-3; Louie MW, 2011, INORG CHEM, V50, P9465, DOI 10.1021/ic201143f; Cametti M, 2012, CHEM SOC REV, V41, P31, DOI 10.1039/c1cs15084g; Miriyala B, 2012, TOP CURR CHEM, V308, P105, DOI 10.1007/128_2011_247; Hayama T, 2012, ANAL CHEM, V84, P8407, DOI 10.1021/ac3020092; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Todoroki K, 2013, J SEP SCI, V36, P232, DOI 10.1002/jssc.201200692; Liu L, 2013, CARBOHYD RES, V369, P14, DOI 10.1016/j.carres.2012.12.015; Zhang W, 2008, J FLUORINE CHEM, V129, P910, DOI 10.1016/j.jfluchem.2008.07.001; ALPERT AJ, 1994, J CHROMATOGR A, V676, P191, DOI 10.1016/0021-9673(94)00467-6; Bell DS, 2005, J CHROMATOGR A, V1073, P99, DOI 10.1016/j.chroma.2004.08.163; Liu T, 2006, MOL CELL PROTEOMICS, V5, P2167, DOI 10.1074/mcp.T600039-MCP200; Pucci V, 2009, J PHARMACEUT BIOMED, V50, P867, DOI 10.1016/j.jpba.2009.05.037; Miura T, 2004, J ORG CHEM, V69, P5348, DOI 10.1021/jo049425k; Zhang W, 2006, TETRAHEDRON, V62, P11837, DOI 10.1016/j.tet.2006.08.051; Song ZQ, 2012, CHEM COMMUN, V48, P3339, DOI 10.1039/c2cc00027j; Stokvis E, 2005, RAPID COMMUN MASS SP, V19, P401, DOI 10.1002/rcm.1790; Poole CF, 2007, CHROMATOGRAPHIA, V65, P127, DOI 10.1365/s10337-006-0131-4; Gerssen A, 2009, ANAL BIOANAL CHEM, V394, P1213, DOI 10.1007/s00216-009-2790-0; Kim JK, 2011, ANAL CHEM, V83, P157, DOI 10.1021/ac102080d; Zhang W, 2009, CHEM REV, V109, P749, DOI 10.1021/cr800412s; Sturm RM, 2013, ANAL METHODS-UK, V5, P1623, DOI 10.1039/c3ay26067d; Matuszewski BK, 2003, ANAL CHEM, V75, P3019, DOI 10.1021/ac020361s; Buszewski B, 2012, ANAL BIOANAL CHEM, V402, P231, DOI 10.1007/s00216-011-5308-5; Zhang F, 2009, J ORG CHEM, V74, P2594, DOI 10.1021/jo9000993; BERENDSEN GE, 1980, ANAL CHEM, V52, P1990, DOI 10.1021/ac50062a056; BILLIET HAH, 1981, J CHROMATOGR, V218, P443, DOI 10.1016/S0021-9673(00)82070-1; Boswell PG, 2008, ANAL CHEM, V80, P2084, DOI 10.1021/ac702161c; Brittain SM, 2005, NAT BIOTECHNOL, V23, P463, DOI 10.1038/nbt1076; Chen LD, 2011, J AM CHEM SOC, V133, P20869, DOI 10.1021/ja207680e; Collet BYM, 2009, J FLUORINE CHEM, V130, P1042, DOI 10.1016/j.jfluchem.2009.09.005; Curran DP, 2008, SCIENCE, V321, P1645, DOI 10.1126/science.1158721; Curran DP, 2012, NAT CHEM, V4, P124, DOI [10.1038/nchem.1233, 10.1038/NCHEM.1233]; Fusstero S., 2012, TOP CURR CHEM, V308, P45; Gladysz J.A., 2004, HDB FLUOROUS CHEM; Go EP, 2007, J PROTEOME RES, V6, P1492, DOI 10.1021/pr060608s; Jiang ZX, 2014, MOL DIVERS, V18, P203, DOI 10.1007/s11030-013-9503-5; Ko KS, 2005, J AM CHEM SOC, V127, P13162, DOI 10.1021/ja054811k; Kolmel D.K., 2013, BIOMOL CHEM, V11, P3954; Li J, 2013, ANAL CHEM, V85, P5499, DOI 10.1021/ac4006233; Lin G., 2010, ANAL CHEM, V82, P9671; Luo ZY, 2001, SCIENCE, V291, P1766, DOI 10.1126/science.1057567; Marchetti N, 2012, ANAL CHEM, V84, P7138, DOI 10.1021/ac301442m; Marin A, 2006, J PHARMACEUT BIOMED, V40, P262, DOI 10.1016/j.jpba.2005.07.028; Mirzaei H, 2008, PROTEOMICS, V8, P1516, DOI 10.1002/pmic.200700363; Mizuno M, 2003, CHEM COMMUN, P972, DOI 10.1039/b300682d; Ohyama K, 2011, CLIN CHEM, V57, P905, DOI 10.1373/clinchem.2010.157776; Plavina T, 2007, J PROTEOME RES, V6, P662, DOI 10.1021/pr060413k; Qian JA, 2011, J MASS SPECTROM, V46, P1, DOI 10.1002/jms.1854; SADEK PC, 1984, J CHROMATOGR, V288, P25, DOI 10.1016/S0021-9673(01)93679-9; Saeed A, 2013, ANAL CHEM, V85, P8979, DOI 10.1021/ac4015484; Sakaguchi Y, 2009, ANAL CHEM, V81, P5039, DOI 10.1021/ac9005952; Sakaguchi Y, 2011, J PHARMACEUT BIOMED, V55, P176, DOI 10.1016/j.jpba.2011.01.011; Song EH, 2009, FUTURE MED CHEM, V1, P889, DOI [10.4155/fmc.09.76, 10.4155/FMC.09.76]; Song ZQ, 2009, ORG LETT, V11, P4882, DOI 10.1021/ol901955y; Stockholm Convention on Persistent Organic Pollutants, 2009, STOCKH CONV PERS ORG; Takayose M, 2012, ANALYST, V137, P2762, DOI 10.1039/c2an15936h; Todoroki K, 2013, ANAL BIOANAL CHEM, V405, P8121, DOI 10.1007/s00216-013-7207-4; Todoroki K, 2011, J CHROMATOGR B, V879, P1325, DOI 10.1016/j.jchromb.2010.11.038; Todoroki K, 2009, ANAL BIOANAL CHEM, V394, P321, DOI 10.1007/s00216-009-2704-1; Todoroki K, 2010, ANAL BIOANAL CHEM, V397, P2409, DOI 10.1007/s00216-010-3813-6; Turowski M, 2001, J CHROMATOGR A, V911, P177, DOI 10.1016/S0021-9673(00)01193-6; Uneyama K., 2006, ORGANOFLUORINE CHEM; United States Environmental Protection Agency (U. S. EPA), 2005, DRAFT RISK ASS POT H; Woo HK, 2008, NAT PROTOC, V3, P1341, DOI 10.1038/nprot.2008.110; Xu ZP, 2013, ANALYST, V138, P611, DOI 10.1039/c2an36473e; Yang B, 2010, EUR J ORG CHEM, P1290, DOI 10.1002/ejoc.200901155; Ying WT, 2009, RAPID COMMUN MASS SP, V23, P4019, DOI 10.1002/rcm.4343; Yoder NC, 2006, CURR OPIN CHEM BIOL, V10, P576, DOI 10.1016/j.cbpa.2006.10.007; Zhang W, 2004, CURR OPIN DRUG DISC, V7, P784; Zhang W, 2002, J AM CHEM SOC, V124, P10443, DOI 10.1021/ja026947d	85	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0731-7085	1873-264X		J PHARMACEUT BIOMED	J. Pharm. Biomed. Anal.	DEC	2014	101				SI		151	160		10.1016/j.jpba.2014.04.035		10	Chemistry, Analytical; Pharmacology & Pharmacy	Chemistry; Pharmacology & Pharmacy	AU3AA	WOS:000345484200012		
J	Ishihara, T; Kaneko, K; Ishihara, T; Mizushima, T				Ishihara, Tsutomu; Kaneko, Kohei; Ishihara, Tomoaki; Mizushima, Tohru			Development of Biodegradable Nanoparticles for Liver-Specific Ribavirin Delivery	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						polymeric drug carrier; nanoparticles; controlled release; site-specific delivery; hepatocytes; polymer biodegradation; encapsulation	PERFORMANCE LIQUID-CHROMATOGRAPHY; ANTIVIRAL ACTIVITY; HEPATITIS-C; ARABINOGALACTAN; VIRUS; PHARMACOKINETICS; NUCLEOSIDE; CONJUGATE; MECHANISM; IMPROVES	Ribavirin is an antiviral drug used for the treatment of chronic hepatitis C. However, ribavirin induces severe side effects such as hemolytic anemia. In this study, we prepared biodegradable nanoparticles as ribavirin carriers to modulate the pharmacokinetics of the drug. The nanoparticles encapsulating ribavirin monophosphate (RMP) were prepared from the blend of poly(d,l-lactic acid) homopolymer and arabinogalactan (AG)-poly(l-lysine) conjugate by using the solvent diffusion method in the presence of iron (III). RMP was efficiently and stably embedded in the nanoparticles and gradually released for 37 days in phosphate-buffered saline at 37 degrees C. The coating of AG on the nanoparticles surfaces was verified by measuring the zeta potentials and performing an aggregation test of the nanoparticles using galactose-binding lectin. Moreover, the nanoparticles were efficiently internalized in cultured HepG2 cells. Ribavirin was drastically accumulated to the liver of mice after intravenous administration of the RMP-loaded nanoparticles, after which the ribavirin content gradually decreased for at least 7 days. Our results indicated successful development of nanoparticles with dual functions, targeting to the liver and sustained release of ribavirin, and suggested that the present strategy could help to advance the clinical application of ribavirin as a therapeutic agent for chronic hepatitis C. (c) 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 103:4005-4011, 2014	[Ishihara, Tsutomu; Kaneko, Kohei] Nihon Univ, Dept Chem Biol & Appl Chem, Coll Engn, Fukushima 9638642, Japan; [Ishihara, Tomoaki; Mizushima, Tohru] Keio Univ, Dept Analyt Chem, Fac Pharm, Tokyo 1058512, Japan	Ishihara, T (reprint author), Nihon Univ, Dept Chem Biol & Appl Chem, Coll Engn, Fukushima 9638642, Japan.	ishihara@chem.ce.nihon-u.ac.jp			Nihon University; Japan Society for the Promotion of Science [22500410]	This study was supported by the Nihon University Multidisciplinary Research Grant for 2011-2012, and Grant-in-Aid for Scientific Research (No. 22500410) from the Japan Society for the Promotion of Science. The authors thank Naoko Takasaki, Yoshinori Maeda, Takahiro Otiai, Naoto Kobayashi, Satomi Ohno, Sayuri Ohuchi, and Fumie Hashimoto for their technical assistance with the experiments.	ALLEN LB, 1978, J MED CHEM, V21, P742, DOI 10.1021/jm00206a005; ALPINI G, 1994, HEPATOLOGY, V20, P494, DOI 10.1016/0270-9139(94)90203-8; Yasuno S, 1997, BIOSCI BIOTECH BIOCH, V61, P1944; Mishra N, 2013, BIOMED RES INT, DOI 10.1155/2013/382184; Elgart A, 2010, BIOMACROMOLECULES, V11, P1972, DOI 10.1021/bm100298r; Romero EL, 1999, FEBS LETT, V448, P193, DOI 10.1016/S0014-5793(99)00364-6; Ishihara T, 2011, J CONTROL RELEASE, V155, P34, DOI 10.1016/j.jconrel.2010.10.014; Chimalakonda KC, 2007, BIOCONJUGATE CHEM, V18, P2097, DOI 10.1021/bc700193d; Kaneo Y, 2000, INT J PHARM, V201, P59, DOI 10.1016/S0378-5173(00)00405-1; Pathak A, 2008, INT J NANOMED, V3, P31; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Russmann S, 2006, CURR MED CHEM, V13, P3351, DOI 10.2174/092986706778773059; DiStefano G, 1997, BIOCHEM PHARMACOL, V54, P357; Loregian A, 2007, J CHROMATOGR B, V856, P358, DOI 10.1016/j.jchromb.2007.05.039; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; Poelstra K, 2012, J CONTROL RELEASE, V161, P188, DOI 10.1016/j.jconrel.2012.02.011; Matthews SJ, 2012, CLIN THER, V34, P1857, DOI 10.1016/j.clinthera.2012.07.011; Mori K, 2013, HEPATOLOGY, V58, P1236, DOI 10.1002/hep.26421; Bijsterbosch MK, 2001, MOL PHARMACOL, V60, P521; Brochot E, 2010, ANTIVIR THER, V15, P687, DOI 10.3851/IMP1609; Cerenzia MT, 1996, HEPATOLOGY, V23, P657, DOI 10.1002/hep.510230401; FIUME L, 1980, FEBS LETT, V116, P185, DOI 10.1016/0014-5793(80)80639-9; Fiume L, 1997, J VIRAL HEPATITIS, V4, P363, DOI 10.1046/j.1365-2893.1997.00067.x; Inoue Y, 2004, ANTIMICROB AGENTS CH, V48, P3813, DOI 10.1128/ACC.48.10.3813-3816.2004; Ishihara T, 2009, INT J PHARM, V365, P200, DOI 10.1016/j.ijpharm.2008.08.030; Ishihara T, 2009, J PHARMACOL EXP THER, V329, P412, DOI 10.1124/jpet.108.150276; Ishihara T, 2010, EXPERT OPIN DRUG DEL, V7, P565, DOI 10.1517/17425241003713486; Ishihara T, 2010, INT J PHARMACEUT, V385, P170, DOI 10.1016/j.ijpharm.2009.10.025; Ishihara T, 2008, PHARM RES-DORDR, V25, P1686, DOI 10.1007/s11095-008-9549-8; Levy GA, 2006, HEPATOLOGY, V43, P581, DOI 10.1002/hep.21072; Matsuo Y, 2009, CELL IMMUNOL, V260, P33, DOI 10.1016/j.cellimm.2009.07.004; Park JU, 1999, PREP BIOCHEM BIOTECH, V29, P353, DOI 10.1080/10826069908544934; Pawlotsky JM, 2013, ADV PHARMACOL, V67, P169, DOI 10.1016/B978-0-12-405880-4.00005-6; Sakai T, 2011, INVEST OPHTH VIS SCI, V52, P1516, DOI 10.1167/iovs.10-5676; Shah SM, 2013, CARBOHYD RES, V367, P41, DOI 10.1016/j.carres.2012.11.025; Thitinan S, 2009, INT J PHARM, V369, P121, DOI 10.1016/j.ijpharm.2008.11.027; Virovic Lucija, 2005, Expert Opin Drug Deliv, V2, P707, DOI 10.1517/17425247.2.4.707	38	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	DEC	2014	103	12					4005	4011		10.1002/jps.24219		7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AU0UO	WOS:000345340500021		
J	Kawase, A; Sakata, M; Yada, N; Nakasaka, M; Shimizu, T; Kato, Y; Iwaki, M				Kawase, Atsushi; Sakata, Misato; Yada, Nagisa; Nakasaka, Misaki; Shimizu, Takuya; Kato, Yukio; Iwaki, Masahiro			Decreased Radixin Function for ATP-Binding Cassette Transporters in Liver in Adjuvant-Induced Arthritis Rats	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						ABC transporters; active transport; disease states; efflux pumps; elimination; membrane transport; MRP; multidrug resistance transporters; P-glycoprotein	RESISTANCE-ASSOCIATED PROTEIN-2; CANALICULAR MRP2 LOCALIZATION; INTRACELLULAR REDOX STATUS; P-GLYCOPROTEIN; GLUTATHIONE DEPLETION; SMALL-INTESTINE; ERM PROTEINS; IN-VIVO; EXPRESSION; EZRIN	Pathophysiological changes are associated with alterations in the expression and function of numerous ADME-related proteins. We have previously demonstrated that the membrane localization of ATP-binding cassette (ABC) transporters in liver was decreased without change of total expression levels in adjuvant-induced arthritis (AA) in rats. Ezrin/radixin/moesin (ERM) proteins are involved in localization of some ABC transporters in canalicular membrane. The mRNA levels of radixin decreased significantly in liver but not kidney, small intestine, and brain. The mRNA levels of ezrin and moesin did not change in AA. The membrane localization of radixin was reduced in liver of AA and the ratios of activated radixin (p-radixin) to total radixin were decreased in AA, although the protein levels of radixin did not change in homogenate and membrane protein. To clarify whether AA affects the linker functions of ERM proteins, we examined the interactions between ERM proteins and ABC transporters. The interactions between radixin and ABC transporters were decreased in AA. In vitro studies using human hepatoma HepG2 cells showed that interleukin-1 decreased the mRNA levels of radixin and colocalization of radixin and Mrp2. Our results show that the decreased radixin functions affect the interaction between radixin and ABC transporters in inflammation. (c) 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 103:4058-4065, 2014	[Kawase, Atsushi; Sakata, Misato; Yada, Nagisa; Nakasaka, Misaki; Iwaki, Masahiro] Kinki Univ, Sch Pharm, Dept Pharm, Osaka 5778502, Japan; [Shimizu, Takuya; Kato, Yukio] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Pharm, Kanazawa, Ishikawa 9201192, Japan	Iwaki, M (reprint author), Kinki Univ, Sch Pharm, Dept Pharm, Osaka 5778502, Japan.	iwaki@phar.kindai.ac.jp	KATO, Yukio/D-8396-2015		JSPS KAKENHI [26860119]; "Antiaging" Project for Private Universities; Ministry of Education, Culture, Sports, Science, and Technology	This work was supported by JSPS KAKENHI Grant Number 26860119 and the "Antiaging" Project for Private Universities, with a matching fund subsidy from Ministry of Education, Culture, Sports, Science, and Technology. We wish to thank Dr. Tomoko Sugiura in Pharmaceutical and Health Sciences, Kanazawa University, for useful advices.	Simons PC, 1998, BIOCHEM BIOPH RES CO, V253, P561, DOI 10.1006/bbrc.1998.9823; Pietromonaco SF, 1998, J BIOL CHEM, V273, P7594, DOI 10.1074/jbc.273.13.7594; GARY R, 1995, MOL BIOL CELL, V6, P1061; Schmitt M, 2000, BIOL CHEM, V381, P487, DOI 10.1515/BC.2000.063; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Yonemura S, 2002, J CELL SCI, V115, P2569; Sekine S, 2012, BBA-MOL BASIS DIS, V1822, P980, DOI 10.1016/j.bbadis.2012.01.015; Wang W, 2006, GASTROENTEROLOGY, V131, P878, DOI 10.1053/j.gastro2006.06.013; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Fouassier L, 2001, HEPATOLOGY, V33, P166, DOI 10.1053/jhep.2001.21143; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Sukhai M, 2001, INFLAMM RES, V50, P362, DOI 10.1007/PL00000257; Sukhai M, 2000, J PHARM PHARM SCI, V3, P268; Kikuchi S, 2002, NAT GENET, V31, P320, DOI 10.1038/ng905; Nakano T, 2013, AM J PHYSIOL-GASTR L, V305, pG807, DOI 10.1152/ajpgi.00187.2013; Saeki J, 2011, BIOCHEM PHARMACOL, V81, P178, DOI 10.1016/j.bcp.2010.09.016; SATO N, 1992, J CELL SCI, V103, P131; Cai X, 2006, N-S ARCH PHARMACOL, V373, P140, DOI 10.1007/s00210-006-0062-5; Cressman AM, 2012, EXPERT REV CLIN PHAR, V5, P69, DOI [10.1586/ecp.11.66, 10.1586/ECP.11.66]; He XJ, 2012, EUR J PHARM SCI, V46, P426, DOI 10.1016/j.ejps.2012.03.006; Ji B, 2004, FREE RADICAL BIO MED, V37, P1718, DOI 10.1016/j.freeradbiomed.2004.08.020; Kano T, 2011, J PHARM SCI-US, V100, P5308, DOI 10.1002/jps.22718; Kawase A, 2013, XENOBIOTICA, V43, P246, DOI 10.3109/00498254.2012.710350; Kawase A, 2014, J PHARM SCI-US, V103, P2556, DOI 10.1002/jps.24043; Kawase A, 2007, DRUG METAB DISPOS, V35, P256, DOI 10.1124/dmd.106.011536; Kawase A, 2008, DRUG METAB PHARMACOK, V23, P196, DOI 10.2133/dmpk.23.196; Kobori T, 2013, J PHARM SCI-US, V102, P1095, DOI 10.1002/jps.23441; Kobori T, 2013, J PHARM SCI-US, V102, P1670, DOI 10.1002/jps.23503; Sekine S, 2011, BBA-MOL BASIS DIS, V1812, P1427, DOI 10.1016/j.bbadis.2011.07.015; Sekine S, 2008, AM J PHYSIOL-GASTR L, V295, pG1035, DOI 10.1152/ajpgi.90404.2008; Suda J, 2011, AM J PHYSIOL-CELL PH, V300, pC416, DOI 10.1152/ajpcell.00467.2010; Uno S, 2009, BIOPHARM DRUG DISPOS, V30, P49, DOI 10.1002/bdd.639; Uno S, 2007, DRUG METAB PHARMACOK, V22, P313, DOI 10.2133/dmpk.22.313; Williams R C Jr, 1992, J Rheumatol Suppl, V32, P42; Yano K, 2013, J PHARM SCI-US, V102, P2875, DOI 10.1002/jps.23637	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	DEC	2014	103	12					4058	4065		10.1002/jps.24210		8	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AU0UO	WOS:000345340500027		
J	Yasui, S; Badal, MMR; Kobayashi, S; Mishima, M				Yasui, Shinro; Badal, Md. Mizanur Rahman; Kobayashi, Shinjiro; Mishima, Masaaki			Combination of LFP-TRIR spectroscopy and DFT computation as a tool to determine the intermediate during the photooxidation of triarylphosphine	JOURNAL OF PHYSICAL ORGANIC CHEMISTRY			English	Article						laser flash photolysis; time-resolved IR; DFT; triarylphosphine; radical cation	PHOTOINDUCED ELECTRON-TRANSFER; RADICAL CATIONS; SINGLET OXYGEN; SCALE FACTORS; BASIS-SET; PHOSPHADIOXIRANE; PHOTOOXYGENATION; REACTIVITY; PHOTOLYSIS; ATMOSPHERE	Laser flash photolysis-time-resolved infrared spectroscopy (LFP-TRIR) was performed on an acetonitrile or dichloromethane solution of triarylphosphines, Ar3P, in air. A transient spectrum consisting of several absorption bands appeared in the region of 1050-1300cm(-1) on the TRIR on a microsecond timescale, which disappeared on a millisecond timescale. To identify the observed transient intermediate, the IR spectra of possible intermediates of the photoreaction were simulated by theoretical calculations based on density functional theory (DFT). The IR spectrum simulated for the phosphine peroxidic radical cation, (Ar3P+OO center dot), well predicted the observed IR spectrum, showing that (Ar3P+OO center dot) is formed as a transient intermediate upon the LFP of Ar3P in air. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Yasui, Shinro] Tezukayama Gakuin Univ, Fac Contemporary Human Life Sci, Nara 6318585, Japan; [Badal, Md. Mizanur Rahman; Kobayashi, Shinjiro; Mishima, Masaaki] Kyushu Univ, Inst Mat Chem & Engn, Higashi Ku, Fukuoka 8128581, Japan	Yasui, S (reprint author), Tezukayama Gakuin Univ, Fac Contemporary Human Life Sci, Nara 6318585, Japan.	yasui@tezukayama-u.ac.jp					Akasaka T., 1993, QUIM NOVA, V16, P325; Somasundaram N, 1996, J ORG CHEM, V61, P2895, DOI 10.1021/jo951990n; Merrick JP, 2007, J PHYS CHEM A, V111, P11683, DOI 10.1021/jp073974n; Andersson MP, 2005, J PHYS CHEM A, V109, P2937, DOI 10.1021/jp045733a; Halls MD, 2001, THEOR CHEM ACC, V105, P413, DOI 10.1007/s002140000204; Yasui S, 2005, J ORG CHEM, V70, P1276, DOI 10.1021/jo0490321; Foresman J. B., 1996, EXPLORING CHEM ELECT, V64, pChap; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gao RM, 2001, ORG LETT, V3, P3719, DOI 10.1021/ol010195v; Ho DG, 2003, SCIENCE, V302, P259, DOI 10.1126/science.1089145; Keepyung K., 1993, J AM CHEM SOC, V115, P4879; MIZUNO K, 1995, J ORG CHEM, V60, P2935, DOI 10.1021/jo00114a056; Nakamura M, 2000, J CHEM SOC PERK T 2, P1447, DOI 10.1039/b001617i; Pouchert C. J., 1975, ALDRICH LIB INFRARED, V45, P444; Smith AL, 1982, COBLENTZ SOC DESK BO, P1; STEICHEN DS, 1981, J AM CHEM SOC, V103, P1855, DOI 10.1021/ja00397a054; Stein S.E., NIST STANDARD REFERE, V69, P20899; TSUJI S, 1993, J ORG CHEM, V58, P5055, DOI 10.1021/jo00071a012; Yasui S, 2013, CHEM LETT, V42, P866, DOI 10.1246/cl.130258; Yasui S, 2011, PHOSPHORUS SULFUR, V186, P838, DOI 10.1080/10426507.2010.524182; Yasui S, 2014, B CHEM SOC JPN, V87, P988, DOI 10.1246/bcsj.20140100; Yasui S, 2013, CHEM LETT, V42, P1478, DOI 10.1246/cl.130748; Yasui S, 2008, J PHYS ORG CHEM, V21, P541, DOI 10.1002/poc.1313; Yasui S, 2010, PHOSPHORUS SULFUR, V185, P1025, DOI 10.1080/10426501003772201; Yasui S, 1999, J CHEM SOC PERK T 2, P855, DOI 10.1039/a807722c; Yasui S, 2006, ORG BIOMOL CHEM, V4, P2969, DOI 10.1039/b606857j	26	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-3230	1099-1395		J PHYS ORG CHEM	J. Phys. Org. Chem.	DEC	2014	27	12					967	972		10.1002/poc.3383		6	Chemistry, Organic; Chemistry, Physical	Chemistry	AU1EG	WOS:000345363200007		
J	Totsuji, H				Totsuji, Hiroo			Behavior of dust particles in cylindrical discharges: Structure formation, mixture and void, effect of gravity	JOURNAL OF PLASMA PHYSICS			English	Article							PLASMAS; MICROGRAVITY	Theoretical and numerical works on dusty plasmas with cylindrical symmetry are presented. The main purpose has been to investigate behavior of dust particles in strongly coupled dusty plasmas which are expected to be realized in the planned experiments by PK-4 on the International Space Station and experiments by PK-4J, a similar apparatus constructed in Japan. The distribution of dust particles is analyzed on the basis of the drift-diffusion equations and, with the effect of discreteness taken into account, structure formations are numerically simulated.	[Totsuji, Hiroo] JAXA, ISAS, ISS Sci Project Off, Tsukuba, Ibaraki 3058505, Japan; [Totsuji, Hiroo] Okayama Univ, Okayama 7008530, Japan	Totsuji, H (reprint author), JAXA, ISAS, ISS Sci Project Off, Tsukuba, Ibaraki 3058505, Japan.	totsuji-09@t.okadai.jp					Thomas HM, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/3/033036; Fortov VE, 2005, PHYS REP, V421, P1, DOI 10.1016/j.physrep.2005.08.007; Morfill GE, 1999, PHYS REV LETT, V83, P1598, DOI 10.1103/PhysRevLett.83.1598; Morfill GE, 2009, REV MOD PHYS, V81, P1353, DOI 10.1103/RevModPhys.81.1353; Fortov V, 2005, PLASMA PHYS CONTR F, V47, pB537, DOI 10.1088/0741-3335/47/12B/S39; HAMAGUCHI S, 1994, J CHEM PHYS, V101, P9876, DOI 10.1063/1.467954; Mitic S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.125002; ROSENFELD Y, 1994, PHYS REV E, V49, P4425, DOI 10.1103/PhysRevE.49.4425; Totsuji H, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.045401; Totsuji H, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036406; Totsuji H, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.015401	11	2	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0022-3778	1469-7807		J PLASMA PHYS	J. Plasma Phys.	DEC	2014	80		6		SI		843	848		10.1017/S0022377814000294		6	Physics, Fluids & Plasmas	Physics	AW0EP	WOS:000345963700010		
J	Saitou, Y; Ishihara, O				Saitou, Yoshifumi; Ishihara, Osamu			Tempest in a glass tube: A helical vortex formation in a complex plasma	JOURNAL OF PLASMA PHYSICS			English	Article							MAGNETIC-FIELD; DUST; MICROGRAVITY; DISCHARGE; PARTICLES; BEHAVIOR; ROTATION	A collective behavior of dust particles in a complex plasma with a magnetic field (up to 4 kG) is investigated. Dust particles form a dust disk which is rotating in a horizontal plane pushed by ions rotating with the E x B drift as a trigger force. The thickness of the disk is determined by controlling the experimental conditions. The disk rotates in a horizontal plane and forms a two-dimensional thin structure when the pressure p(Ar) is relatively high. The dust particles are ejected from near the disk center and form a rotation in the vertical plane and, hence, forms a helical vortex when the disk is thick for relatively low p(Ar). The reason the dust disk has the different thickness is due to the neutral pressure. Under a higher (lower) neutral gas pressure, the disk becomes two (three) dimensional due to the influence of the neutral drag force.	[Saitou, Yoshifumi] Utsunomiya Univ, Fac Engn, Utsunomiya, Tochigi 3218585, Japan; [Ishihara, Osamu] Yokohama Natl Univ, Fac Engn, Yokohama, Kanagawa 2408501, Japan; [Ishihara, Osamu] Chubu Univ, Sci & Technol Res Inst, Kasugai, Aichi 4878501, Japan	Saitou, Y (reprint author), Utsunomiya Univ, Fac Engn, Utsunomiya, Tochigi 3218585, Japan.	saitou@cc.utsunomiya-u.ac.jp			Asian Office of Aerospace R D [FA2386-12-1-4077]; JSPS [23244110, 2424409401, 24654188]	The authors acknowledge the fruitful discussion with Professor Yoshiharu Nakamura of Yokohama National University and Dr. Alex A. Samarian of the University of Sydney. This work is supported by the Asian Office of Aerospace R & D FA2386-12-1-4077, JSPS Grant-in-Aid for Scientific Research (A) 23244110 and 2424409401, and JSPS Grant-in-Aid for Challenging Exploratory Research 24654188.	Uchida G, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.155002; Tsytovich VN, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/343; Mikikian M, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/319; Karasev VY, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.066403; Sato N, 2001, PHYS PLASMAS, V8, P1786, DOI 10.1063/1.1342229; Einstein A, 1926, NATURWISSENSCHAFTEN, V14, P223; Ishihara O, 2001, IEEE T PLASMA SCI, V29, P179, DOI 10.1109/27.923689; Konopka U, 2000, PHYS REV E, V61, P1890, DOI 10.1103/PhysRevE.61.1890; Carstensen J, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3063059; Morfill GE, 1999, PHYS REV LETT, V83, P1598, DOI 10.1103/PhysRevLett.83.1598; Molotkov VI, 1999, J EXP THEOR PHYS+, V89, P477, DOI 10.1134/1.559006; Thomas E, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/12/124034; Chung TH, 1999, J KOREAN PHYS SOC, V34, P24; Couedel L, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.026403; Farokhi B, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3143032; Greenspan H. P., 1968, THEORY ROTATING FLUI; Mamun AA, 1998, J PLASMA PHYS, V59, P575, DOI 10.1017/S002237789800645X; NAKAMURA Y, 2008, PHYS PLASMAS, V79; Reichstein T, 2010, IEEE T PLASMA SCI, V38, P814, DOI 10.1109/TPS.2009.2038700; SAITOU Y, 2013, PHYS REV LETT, V118; SAITOU Y, 2014, JPS C P, V1; Yeo LY, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2345590	22	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0022-3778	1469-7807		J PLASMA PHYS	J. Plasma Phys.	DEC	2014	80		6		SI		869	876		10.1017/S0022377814000518		8	Physics, Fluids & Plasmas	Physics	AW0EP	WOS:000345963700014		
J	Sakamoto, M; Kimura, Y; Ishii, D; Nakaoki, T				Sakamoto, Manato; Kimura, Yuuki; Ishii, Daisuke; Nakaoki, Takahiko			Biosynthesis of Poly(3-hydroxyalkanoate) from Amino Acids in Medium with Nitrogen, Phosphate, and Magnesium, or Some Combination of These Nutrients	JOURNAL OF POLYMERS AND THE ENVIRONMENT			English	Article						Biosynthesis; Poly(3-hydroxybutyrate); Amino acid; Phosphate-free medium; R. eutropha	ALCALIGENES-EUTROPHUS; RALSTONIA-EUTROPHA; POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYVALERATE); PSEUDOMONAS; GLYCEROL; POLYHYDROXYALKANOATES; POLY(3-HYDROXYBUTYRATE); TRIACYLGLYCEROLS; CULTURE; PHB	Twenty natural amino acids were investigated as carbon sources for biosynthesis of poly(3-hydroxyalkanoate) (PHA) by Ralstonia eutropha in media free of inorganic nitrogen, phosphate, or magnesium. First, the effect of limiting nitrogen, phosphate, and magnesium was investigated on the metabolism of l-leucine. Nitrogen-limited media have been widely used to stimulate PHA accumulation, but phosphate-free media lead to higher accumulation. This is because amino acids can act as nitrogen sources, leading to preferential cell growth over PHA accumulation. Magnesium-free conditions don't show a significant effect on accumulation of PHA. When Ralstonia eutropha was cultivated in the presence of natural amino acids l-leucine, l-isoleucine, l-phenylalanine, and l-tyrosine in media free of nitrogen, phosphate, and magnesium, the PHA content was high, over 40 % of dry weight. Accumulation of PHA on supplementation with mixed substrates of l-leucine and various other amino acids was investigated in nitrogen-, phosphate-, and magnesium-free medium. Culturing with most mixed substrates led to accumulation of PHA, but some led to low or no PHA yield in spite of high PHA yield when metabolized from l-leucine alone. l-cysteine as a sole carbon source showed a unique feature, in that cell growth was significantly preferred over PHA accumulation. A mixed substrate of l-leucine and l-cysteine provided high PHA accumulation because of the combination of PHA accumulation due to l-leucine and cell growth due to l-cysteine. When glucose was used instead of l-leucine in a mixed substrate with l-cysteine, the PHA content was much lower because l-cysteine acts as an inhibitor of glucose metabolism. These results showed that the precise combination of carbon sources is an important factor in accumulation of PHA.	[Sakamoto, Manato; Kimura, Yuuki; Ishii, Daisuke; Nakaoki, Takahiko] Ryukoku Univ, Dept Chem Mat, Otsu, Shiga 5202194, Japan	Nakaoki, T (reprint author), Ryukoku Univ, Dept Chem Mat, Otsu, Shiga 5202194, Japan.	nakaoki@rins.ryukoku.ac.jp			MEXT [24550179]; Ryukoku University	This work was partially supported by a Grant-in-Aid for Scientific Research, MEXT (No. 24550179). In addition, financial support from a research fund at Ryukoku University is gratefully acknowledged.	Ashby RD, 1998, APPL MICROBIOL BIOT, V49, P431; DOI Y, 1988, APPL MICROBIOL BIOT, V28, P330; MITOMO H, 1993, MACROMOLECULES, V26, P5809, DOI 10.1021/ma00073a041; Cavalheiro JMBT, 2009, PROCESS BIOCHEM, V44, P509, DOI 10.1016/j.procbio.2009.01.008; Cromwick AM, 1996, APPL MICROBIOL BIOT, V46, P464, DOI 10.1007/s002530050845; YOSHIE N, 1995, MACROMOLECULES, V28, P6516, DOI 10.1021/ma00123a018; ANDERSON AJ, 1990, MICROBIOL REV, V54, P450; Ryu HW, 1997, BIOTECHNOL BIOENG, V55, P28; Mothes G, 2007, ENG LIFE SCI, V7, P475, DOI 10.1002/elsc.200620210; Yoshie N, 1999, MACROMOL CHEM PHYSIC, V200, P977, DOI 10.1002/(SICI)1521-3935(19990501)200:5<977::AID-MACP977>3.0.CO;2-Y; Ashby RD, 2005, BIOMACROMOLECULES, V6, P2106, DOI 10.1021/bm058005h; Brandl H, 1990, Adv Biochem Eng Biotechnol, V41, P77; Doi Y, 1987, J CHEM SOC CHEM COMM, P1635; Doi Y, 1990, MICROBIAL POLYESTERS; FUJITA M, 1993, INT J BIOL MACROMOL, V15, P253, DOI 10.1016/0141-8130(93)90046-O; Fujita M, 1994, MACROMOL CHEM PHYS, V195, P3699; Hee WR, 1997, BIOTECHNOL BIOENG, V55, P28; HOLMES PA, 1985, PHYS TECHNOL, V16, P32, DOI 10.1088/0305-4624/16/1/305; HUIJBERTS GNM, 1992, APPL ENVIRON MICROB, V58, P536; Kimura H, 2003, B CHEM SOC JPN, V76, P1775, DOI 10.1246/bcsj.76.1775; Longan S, 2003, BIOTECHNOL LETT, V25, P1415; Miura T, 2013, J POLYM ENVIRON, V21, P760, DOI 10.1007/s10924-013-0588-9; NAKAMURA K, 1992, INT J BIOL MACROMOL, V14, P117, DOI 10.1016/0141-8130(92)90008-V; NAKAMURA K, 1992, INT J BIOL MACROMOL, V14, P321, DOI 10.1016/S0141-8130(05)80072-8; Solaiman DKY, 2002, CURR MICROBIOL, V44, P189, DOI 10.1007/s00284-001-0086-5; Solaiman DKY, 2001, APPL MICROBIOL BIOT, V56, P664; Squio CR, 2003, APPL MICROBIOL BIOT, V61, P257, DOI 10.1007/s00253-003-1258-y; Yoshie N, 1993, MACROMOLECULES, V26, P5809; Zhu CJ, 2010, BIOTECHNOL PROGR, V26, P424, DOI 10.1002/btpr.355	29	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1566-2543	1572-8900		J POLYM ENVIRON	J. Polym. Environ.	DEC	2014	22	4					488	493		10.1007/s10924-014-0656-9		6	Engineering, Environmental; Polymer Science	Engineering; Polymer Science	AU4OQ	WOS:000345591300008		
J	Miyazaki, K; Sato, H; Watanabe, T; Nakatani, H				Miyazaki, Kensuke; Sato, Hiroaki; Watanabe, Taiki; Nakatani, Hisayuki			Photodegradation of Herbaceous Lignin and Unsaturated Polyester with a Novel TiO2 Photocatalyst System	JOURNAL OF POLYMERS AND THE ENVIRONMENT			English	Article						Lignin; Photocatalyst; Methyl linoleate; Unsaturated polyester	POLYPROPYLENE; DEGRADATION; OXIDE); CHEMILUMINESCENCE; OXIDATION	Photodegradation of a herbaceous lignin and unsaturated polyester was carried out with a novel TiO2/polyethylene oxide (PEO) + methyl linoleate (ML) photocatalyst system. The lignin and unsaturated polyester photodegradation ratios were 51 and 40 %, respectively, showing that the TiO2/PEO + ML had high photocatalyst activity. The ML center dot produced by the TiO2 photocatalyst was able to attack the lignin and unsaturated polyester because of its hydrophobic molecular structure and worked well as the initiator. In order to study the detailed mechanism of photodegradation with the TiO2/PEO + ML, the chloroform soluble fraction of the photodegraded unsaturated polyester was characterized with H-1-NMR measurement. The result showed that the TiO2/PEO + ML preferentially cleaved carbon-carbon bond.	[Miyazaki, Kensuke; Sato, Hiroaki; Watanabe, Taiki; Nakatani, Hisayuki] Kitami Inst Technol, Dept Biotechnol & Environm Chem, Kitami, Hokkaido 0908507, Japan	Nakatani, H (reprint author), Kitami Inst Technol, Dept Biotechnol & Environm Chem, 165 Koen Cho, Kitami, Hokkaido 0908507, Japan.	nakatani@chem.kitami-it.ac.jp			Environment Research and Technology Development Fund from Ministry of the Environment, Government of Japan [3K123020]	This work was supported by the Environment Research and Technology Development Fund, No 3K123020 from Ministry of the Environment, Government of Japan.	Weng JK, 2008, CURR OPIN BIOTECH, V19, P166, DOI 10.1016/j.copbio.2008.02.014; Broska R, 1999, POLYM DEGRAD STABIL, V63, P231, DOI 10.1016/S0141-3910(98)00097-4; Vijayalakshmi SP, 2006, J APPL POLYM SCI, V100, P3997, DOI 10.1002/app.23190; Pouteau C, 2003, POLYM DEGRAD STABIL, V81, P9, DOI 10.1016/S0141-3910(03)00057-0; Cox BJ, 2011, POLYM DEGRAD STABIL, V96, P426, DOI 10.1016/j.polymdegradstab.2011.01.011; Mishra S, 2003, COMPOS SCI TECHNOL, V63, P1377, DOI 10.1016/S0266-3538(03)00084-8; Nakatani H, 2013, J APPL POLYM SCI, V129, P3490, DOI 10.1002/app.39101; Eriksson P, 2002, POLYM DEGRAD STABIL, V78, P183, DOI 10.1016/S0141-3910(02)00132-5; Gallet G, 2002, POLYMER, V43, P1081, DOI 10.1016/S0032-3861(01)00677-2; Chen XP, 2012, RSC ADV, V2, P6504, DOI 10.1039/c2ra20617j; Wambua P, 2003, COMPOS SCI TECHNOL, V63, P1259, DOI 10.1016/S0266-3538(03)00096-4; Dahm A, 2004, IND ENG CHEM RES, V43, P7996, DOI 10.1021/ie0498302; Li C, 2000, CELLULOSE, V7, P369, DOI 10.1023/A:1009298008276; Miyata Y, 2013, J POLYM ENVIRON, V21, P115, DOI 10.1007/s10924-012-0465-y; Miyazaki K, 2009, POLYM DEGRAD STABIL, V94, P2114, DOI 10.1016/j.polymdegradstab.2009.10.001; Miyazaki K, 2010, POLYM DEGRAD STABIL, V95, P1557, DOI 10.1016/j.polymdegradstab.2010.06.009	16	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1566-2543	1572-8900		J POLYM ENVIRON	J. Polym. Environ.	DEC	2014	22	4					494	500		10.1007/s10924-014-0657-8		7	Engineering, Environmental; Polymer Science	Engineering; Polymer Science	AU4OQ	WOS:000345591300009		
J	Whitney, DE; Luo, JX; Heller, DA				Whitney, Daniel E.; Luo, Jianxi; Heller, Daniel A.			The benefits and constraints of temporary sourcing diversification in supply chain disruption and recovery	JOURNAL OF PURCHASING AND SUPPLY MANAGEMENT			English	Article						Supply chain disruption; Disaster; Risk management; Temporary diversification; Single-sourcing; Product specificity; Asset specificity; Case studies	MANAGEMENT; RISKS; IMPACT; PERFORMANCE; INFORMATION; STRATEGIES; NETWORKS; SECTORS; FIRMS	Sourcing diversification is the preferred hedge to supply chain disruption risks, but many companies insist on single-sourcing for long-term strategic benefits. For rare-but-catastrophic disruptions of fortified supply chains, temporary sourcing diversification has been seen as a desirable response strategy. However, little is known about the conditions to temporary sourcing diversification and the situations where it is applicable. Our fieldwork and comparison of two disaster recoveries at Aisin Seiki and Riken Corporation shows that while temporary sourcing diversification worked in the Aisin Seiki case, it was impossible at Riken due to the high degree of specificity required in the design and manufacturing methods of the disrupted product item, suggesting product and process specificity limits recovery alternatives. Unawareness of such constraints to temporary sourcing diversification may result in over-optimism regarding its feasibility and insufficient disaster preparedness. In addition, the case of Riken's recovery from an earthquake in 2007 is systematically documented in this paper for the first time. (c) 2014 Elsevier Ltd. All rights reserved.	[Whitney, Daniel E.] MIT, Engn Syst Div, Cambridge, MA 02139 USA; [Luo, Jianxi] Singapore Univ Technol & Design, Singapore 138682, Singapore; [Heller, Daniel A.] Yokohama Natl Univ, Coll Business Adm, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan	Luo, JX (reprint author), Singapore Univ Technol & Design, 20 Dover Dr, Singapore 138682, Singapore.	dwhitney@mit.edu; luo@sutd.edu.sg; daheller@ynu.ac.jp					Allbusiness, 2007, DESP RIK RINGS SHORT; Altay N, 2010, J SUPPLY CHAIN MANAG, V46, P59, DOI 10.1111/j.1745-493X.2010.03206.x; Narasimhan R, 2009, J OPER MANAG, V27, P114, DOI 10.1016/j.jom.2009.02.001; Giannakis M, 2011, J PURCH SUPPLY MANAG, V17, P23, DOI 10.1016/j.pursup.2010.05.001; Song JS, 1996, MANAGE SCI, V42, P1409, DOI 10.1287/mnsc.42.10.1409; Liker JK, 2004, HARVARD BUS REV, V82, P104; Tomlin B, 2006, MANAGE SCI, V52, P639, DOI 10.1287/mnsc.11060.0515; Lamming R, 2000, INT J OPER PROD MAN, V20, P675, DOI 10.1108/01443570010321667; Ellis SC, 2011, J SUPPLY CHAIN MANAG, V47, P65, DOI 10.1111/j.1745-493X.2011.03217.x; Hoffmann P, 2013, J PURCH SUPPLY MANAG, V19, P199, DOI 10.1016/j.pursup.2013.06.002; Zsidisin GA, 2010, J BUS LOGIST, V31, P1; Nishiguchi T, 1998, SLOAN MANAGE REV, V40, P49; Barratt M, 2011, J OPER MANAG, V29, P329, DOI 10.1016/j.jom.2010.06.002; Knemeyer AM, 2009, J OPER MANAG, V27, P141, DOI 10.1016/j.jom.2008.06.002; Dada M, 2007, M&SOM-MANUF SERV OP, V9, P9, DOI 10.1287/msom.1060.0128; Bode C, 2011, ACAD MANAGE J, V54, P833; Wang YM, 2010, M&SOM-MANUF SERV OP, V12, P489, DOI 10.1287/msom.1090.0279; Simchi-Levi D, 2014, HARVARD BUS REV, V92, P96; Chopra S, 2007, NAV RES LOG, V54, P544, DOI 10.1002/nav.20228; Kleindorfer PR, 2005, PROD OPER MANAG, V14, P53; Tomlin B, 2009, NAV RES LOG, V56, P318, DOI 10.1002/nav.20344; Speier C, 2011, J OPER MANAG, V29, P721, DOI 10.1016/j.jom.2011.06.003; Costantino N, 2010, J PURCH SUPPLY MANAG, V16, P27, DOI 10.1016/j.pursup.2009.08.001; Luo JX, 2012, IND CORP CHANGE, V21, P1307, DOI 10.1093/icc/dts007; Braunscheidel MJ, 2009, J OPER MANAG, V27, P119, DOI 10.1016/j.jom.2008.09.006; Arup N.A., 2007, ARUP REC REP JUL 16; Asanumi B., 1989, J JAPANESE INT EC, V3, P1, DOI DOI 10.1016/0889-1583(89)90029-4; Baldwin C.Y., 2000, DESIGN RULES; Chopra S., 2014, MIT SLOAN MANAGE REV, V55, p[72, 80]; Chozik A., 2007, WALL STREET J; Courtland R., 2011, IEEE SPECTRUM; Fine C. H., 1999, LOGISTICS INFORM AGE, P31; Fujimoto T, 2007, COMPETING BE REALLY; Fujimoto T., 2001, INT J AUTOMOTIVE TEC, V1, P1; Global Risk Miyamoto, 2007, 2007 NIIG CHUEST OKI; Hopp W. J., 2004, Manufacturing & Service Operations Management, V6, DOI 10.1287/msom.1030.0028; IRC, 1999, REP PROD T 200 AUT C; IRC, 2008, REP PROD T 200 AUT C; Kakihara M., 2002, Journal of Global Information Technology Management (JGITM), V5; Kleindorfer P. R., 2004, STRATEGIES BUILDING, P288; MacDuffie J. P., 2008, TECHNOLOGICAL ORG BA; MACDUFFIE JP, 1995, IND LABOR RELAT REV, V48, P197, DOI 10.2307/2524483; Miles M., 1994, QUALITATIVE DATA ANA; Nakamoto M., 2007, FINANCIAL TIMES; Nishiguchi T, 2000, KNOWLEDGE CREATION: A SOURCE OF VALUE, P199; Reitman V., 1997, WALL STREET J; Revilla E, 2014, J BUS RES, V67, P1123, DOI 10.1016/j.jbusres.2013.05.021; Sako M, 1992, PRICES QUALITY TRUST; Schoenherr T, 2012, INT J PROD RES, V50, P4556, DOI 10.1080/00207543.2011.613870; Schweikhart S.B., 1988, J OPERATIONS MANAGEM, V7, P93; SHEFFI Y, 2007, RESILIENT ENTERPRISE; Sridharan UV, 2005, SUPPLY CHAIN MANAG, V10, P313, DOI 10.1108/13598540510612785; Tomlin B., 2005, Manufacturing & Service Operations Management, V7, DOI 10.1287/msom.1040.0063; Tracey M, 2013, J PURCH SUPPLY MANAG, V19, P98, DOI 10.1016/j.pursup.2013.02.004; Treece J.B., 1997, AUTOMOTIVE NEWS; Wagner SM, 2012, IEEE T ENG MANAGE, V59, P52, DOI 10.1109/TEM.2010.2087762; Wang Y., 2010, HDB INTEGRATED RISK, P79; Watts D., 2003, 6 DEGREES SCI CONNEC; Whitney D. E., 1993, Research in Engineering Design, V5, DOI 10.1007/BF01608394; Williamson EO, 1981, AM J SOCIOL, V87, P548; WILLIAMSON O.E., 1985, EC I CAPITALISM FIRM; Womack JP, 1990, MACHINE CHANGED WORL; Yin R.K., 2009, CASE STUDY RES DESIG	63	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1478-4092	1873-6505		J PURCH SUPPLY MANAG	J. Purch. Supply Manag.	DEC	2014	20	4					238	250		10.1016/j.pursup.2014.06.001		13	Management	Business & Economics	AU2WZ	WOS:000345476600003		
J	Ikeda, H; Kubo, T; Kuriyama, K; Takahashi, M				Ikeda, Hiroki; Kubo, Tomohide; Kuriyama, Kenichi; Takahashi, Masaya			Self-awakening improves alertness in the morning and during the day after partial sleep deprivation	JOURNAL OF SLEEP RESEARCH			English	Article						daytime sleepiness; forced awakening; sleep inertia	PSYCHOMOTOR VIGILANCE; DAYTIME SLEEPINESS; WAKEFULNESS TEST; MENSTRUAL-CYCLE; LATENCY TEST; TIME; INERTIA; MAINTENANCE; VALIDITY; RISK	The ability to awaken at a predetermined time without an alarm is known as self-awakening. Self-awakening improves morning alertness by eliminating sleep inertia; however, the effects of self-awakening on daytime alertness and alertness that has deteriorated as a result of sleep loss are unknown. The aim of this study was to determine the effects of self-awakening on both morning and daytime alertness after partial sleep deprivation. Fifteen healthy males without the habit of self-awakening participated in a cross-over trial including forced awakening and self-awakening conditions. In each condition, participants' sleep was restricted to 5h per night in their homes for 4 consecutive days. They completed a psychomotor vigilance task and subjective ratings of sleepiness immediately upon awakening each morning. On the fourth day, participants completed subjective ratings of sleepiness, a psychomotor vigilance task and sleep latency tests in the laboratory seven times at 1-h intervals during the day. The response speed on the psychomotor vigilance task, in the morning and during the day, was higher in the self-awakening than the forced awakening condition. Our results showed that self-awakening improved alertness (assessed by response speeds) by reducing sleep inertia and alleviated daytime sleepiness heightened by partial sleep deprivation.	[Ikeda, Hiroki; Kuriyama, Kenichi] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Adult Mental Hlth, Kodaira, Tokyo 1878502, Japan; [Kubo, Tomohide; Takahashi, Masaya] Natl Inst Occupat Safety & Hlth, Hlth Adm & Psychosocial Factor Res Grp, Kawasaki, Kanagawa, Japan	Ikeda, H (reprint author), Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.	hikeda@ncnp.go.jp; kenichik@ncnp.go.jp			Japan Society for the Promotion of Science [09J03662]; Japan Science and Technology (JST) Corporation; Japan Foundation for Neuroscience and Mental Health; Takeda Science Foundation	This study was supported by a Grant-in-Aid for fellows from the Japan Society for the Promotion of Science (no. 09J03662), a grant from the Core Research for Evolutional Science and Technology (CREST) programme from the Japan Science and Technology (JST) Corporation, a grant from the Japan Foundation for Neuroscience and Mental Health and a grant from the Takeda Science Foundation.	Melamed S, 2002, SLEEP, V25, P315; Basner M, 2011, SLEEP, V34, P581; Wells AS, 1998, J APPL PHYSIOL, V84, P507; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; ISHIHARA K, 1984, PERCEPT MOTOR SKILL, V59, P863; Jewett ME, 1999, SLEEP, V22, P171; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; Tassi P, 2000, SLEEP MED REV, V4, P341, DOI 10.1053/smrv.2000.0098; DINGES DF, 1985, BEHAV RES METH INS C, V17, P37, DOI 10.3758/BF03200895; Drummond SPA, 2005, SLEEP, V28, P1059; Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; MONK TH, 1987, SLEEP, V10, P343; Born J, 1999, NATURE, V397, P29, DOI 10.1038/16166; Sullivan SS, 2008, CHEST, V134, P854, DOI 10.1378/chest.08-0822; Scheer FAJL, 2008, J BIOL RHYTHM, V23, P353, DOI 10.1177/0748730408318081; Aritake S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-153; BELL CR, 1980, PERCEPT MOTOR SKILL, V50, P503; Blagrove M, 1998, J SLEEP RES, V7, P233, DOI 10.1046/j.1365-2869.1998.00119.x; Cavallero C., 2003, SLEEP RES ONLINE, V5, P89; Dagan Y, 1997, J PSYCHOSOM RES, V42, P577, DOI 10.1016/S0022-3999(97)00013-5; HAMPSON E, 1988, BEHAV NEUROSCI, V102, P456, DOI 10.1037/0735-7044.102.3.456; HAWKINS J, 1989, PERCEPT MOTOR SKILL, V69, P507; Hayashi M, 2010, INT REV NEUROBIOL, V93, P109, DOI 10.1016/S0074-7742(10)93005-5; Honma M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012923; Ikeda H, 2010, BIOL PSYCHOL, V83, P15, DOI 10.1016/j.biopsycho.2009.09.008; Ikeda H, 2008, SLEEP BIOL RHYTHMS, V6, P256, DOI 10.1111/j.1479-8425.2008.00366.x; Kaida K, 2005, IND HEALTH, V43, P179, DOI 10.2486/indhealth.43.179; kerstedt T, 1990, INT J NEUROSCI, V52, P29, DOI [10.3109/00207459008994241, DOI 10.3109/00207459008994241]; LAVIE P, 1979, PERCEPT MOTOR SKILL, V49, P447; Luboshitzky R, 2001, CHRONOBIOL INT, V18, P513, DOI 10.1081/CBI-100103973; Manber R, 1996, SLEEP, V19, P432; Manber R, 1997, HEALTH PSYCHOL, V16, P209; Matsuura N, 2002, PSYCHIAT CLIN NEUROS, V56, P223, DOI 10.1046/j.1440-1819.2002.00973.x; Matsuura N, 2009, SLEEP BIOL RHYTHMS, V7, P172, DOI 10.1111/j.1479-8425.2009.00398.x; Miccoli L, 2008, CHRONOBIOL INT, V25, P725, DOI 10.1080/07420520802397228; Moorcroft WH, 1997, SLEEP, V20, P40; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Rechtschaffen A., 1968, MANUAL STANDARDIZED; SANGAL RB, 1992, CHEST, V101, P898, DOI 10.1378/chest.101.4.898; Shibui K, 2000, BIOL PSYCHIAT, V48, P1062, DOI 10.1016/S0006-3223(00)00912-4; Stampi C, 1995, WORK STRESS, V9, P368, DOI 10.1080/02678379508256574; STEPANSKI E, 1988, SLEEP, V11, P54	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1105	1365-2869		J SLEEP RES	J. Sleep Res.	DEC	2014	23	6					673	680		10.1111/jsr.12176		8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AU4OK	WOS:000345590700009		
J	Nakamura, K; Sakurai, M; Miura, K; Morikawa, Y; Nagasawa, SY; Ishizaki, M; Kido, T; Naruse, Y; Nakashima, M; Nogawa, K; Suwazono, Y; Nakagawa, H				Nakamura, Koshi; Sakurai, Masaru; Miura, Katsuyuki; Morikawa, Yuko; Nagasawa, Shin-Ya; Ishizaki, Masao; Kido, Teruhiko; Naruse, Yuchi; Nakashima, Motoko; Nogawa, Kazuhiro; Suwazono, Yasushi; Nakagawa, Hideaki			Overall sleep status and high sensitivity C-reactive protein: a prospective study in Japanese factory workers	JOURNAL OF SLEEP RESEARCH			English	Article						high-sensitivity C-reactive protein; inflammation; Pittsburgh Sleep Quality Index; prospective study; sleep	CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; QUALITY INDEX; SYSTEMIC INFLAMMATION; WHITEHALL II; DURATION; BIOMARKERS; WOMEN; COAGULATION; RISK	We investigated the relation between overall sleep status based on the modified Pittsburgh Sleep Quality Index (PSQI) global score and subsequent changes in serum high-sensitivity C-reactive protein (hsCRP) in a population of Japanese factory workers, who were predominantly female. A total of 991 Japanese with inflammation classified as low cardiovascular risk (baseline hsCRP<1.0mgL(-1)) were grouped according to the presence or absence of unfavourable sleep, defined as a modified PSQI global score>5.5 points. The subsequent changes in hsCRP after 3years were then compared in the two groups. Analysis of covariance incorporating log-transformed baseline hsCRP, age, sex, lifestyle and physical and biochemical profiles was used to compare the geometric means of hsCRP at year 3 in each sleep status group. A logistic regression model incorporating the same variables was used to calculate the odds ratios for development of inflammation with a medium-to-high cardiovascular risk (hsCRP at year 31.0mgL(-1)) comparing the presence or absence of unfavourable sleep habits. The multivariate-adjusted geometric mean of hsCRP at year 3 was significantly higher in subjects with unfavourable sleep habits compared with those with a normal pattern (0.275 versus 0.242mgL(-1)). The multivariate-adjusted odds ratio for developing increased and potentially pathogenic levels of inflammation due to unfavourable sleep was 2.08 (95% confidence interval=1.29-3.35). There was a significant linear trend for the development of increased inflammation across the modified PSQI global scores (P=0.04). Unfavourable sleep is associated with activation of low-grade systemic inflammation.	[Nakamura, Koshi; Sakurai, Masaru; Morikawa, Yuko; Nagasawa, Shin-Ya; Nakagawa, Hideaki] Kanazawa Med Univ, Dept Epidemiol & Publ Hlth, Uchinada, Ishikawa 9200293, Japan; [Miura, Katsuyuki] Shiga Univ Med Sci, Ctr Epidemiol Res Asia, Dept Publ Hlth, Otsu, Shiga 52021, Japan; [Ishizaki, Masao] Kanazawa Med Univ, Dept Social & Environm Med, Uchinada, Ishikawa 9200293, Japan; [Kido, Teruhiko] Kanazawa Univ, Coll Med Pharmaceut & Hlth Sci, Sch Hlth Sci, Kanazawa, Ishikawa, Japan; [Naruse, Yuchi] Toyama Univ, Sch Nursing, Dept Human Sci & Fundamental Nursing, Toyama 930, Japan; [Nakashima, Motoko] Kanazawa Med Univ, Sch Nursing, Uchinada, Ishikawa 9200293, Japan; [Nogawa, Kazuhiro; Suwazono, Yasushi] Chiba Univ, Grad Sch Med, Dept Occupat & Environm Med, Chiba, Japan	Nakamura, K (reprint author), Kanazawa Med Univ, Dept Epidemiol & Publ Hlth, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.	knaka@kanazawa-med.ac.jp			Japan Society for the Promotion of Science [23590817]; Ministry of Health, Labour and Welfare, Health and Labour Sciences Research Grants, Japan [H17-Kenkou-007, H18-Junkankitou (Seishuu)-Ippan-012, H19-Junkankitou (Seishuu)-Ippan-021, H20-Junkankitou (Seishuu)-Ippan-013, H22-Junkankitou (Seishuu)-Ippan-005, H23-Junkankitou (Seishuu)-Ippan-005]; Japan Arteriosclerosis Prevention Fund	The study was supported by a Grant-in-Aid from the Japan Society for the Promotion of Science [Scientific Research (C) 23590817)], from the Ministry of Health, Labour and Welfare, Health and Labour Sciences Research Grants, Japan (H17-Kenkou-007, H18-Junkankitou (Seishuu)-Ippan-012, H19-Junkankitou (Seishuu)-Ippan-021, H20-Junkankitou (Seishuu)-Ippan-013, H22-Junkankitou (Seishuu)-Ippan-005 and H23-Junkankitou (Seishuu)-Ippan-005) and from the Japan Arteriosclerosis Prevention Fund.	Ferrie JE, 2013, AM J EPIDEMIOL, V178, P956, DOI 10.1093/aje/kwt072; Irwin M, 2003, BRAIN BEHAV IMMUN, V17, P365, DOI 10.1016/S0889-1591(03)00031-X; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Prather AA, 2013, J PSYCHIATR RES, V47, P1228, DOI [10.1016/j.jpsychires.2013.05.004, 10.1016/j.psychires.2013.05.004]; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Morikawa Y, 2013, ALCOHOL ALCOHOLISM, V48, P202, DOI 10.1093/alcalc/ags128; Chandola T, 2010, SLEEP, V33, P739; Ray P, 1997, FEBS LETT, V409, P79, DOI 10.1016/S0014-5793(97)00487-0; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Okun ML, 2009, BRAIN BEHAV IMMUN, V23, P351, DOI 10.1016/j.bbi.2008.10.008; Hoevenaar-Blom MP, 2011, SLEEP, V34, P1487, DOI 10.5665/sleep.1382; Dowd JB, 2011, ANN EPIDEMIOL, V21, P799, DOI 10.1016/j.annepidem.2011.07.004; Westerlund A, 2013, EUR J EPIDEMIOL, V28, P463, DOI 10.1007/s10654-013-9802-2; Sasaki S, 2000, J NUTR SCI VITAMINOL, V46, P285; Irwin MR, 2010, BRAIN BEHAV IMMUN, V24, P54, DOI 10.1016/j.bbi.2009.06.001; Suarez EC, 2008, BRAIN BEHAV IMMUN, V22, P960, DOI 10.1016/j.bbi.2008.01.011; Newman AB, 2000, J AM GERIATR SOC, V48, P115; Deshpande R, 1997, AM J REPROD IMMUNOL, V38, P46; Arima H, 2008, ARTERIOSCL THROM VAS, V28, P1385, DOI 10.1161/ATVBAHA.107.157164; Bush AL, 2012, PSYCHIAT RES, V199, P24, DOI 10.1016/j.psychres.2012.03.045; Koh JM, 2005, OSTEOPOROSIS INT, V16, P1263, DOI 10.1007/s00198-005-1840-5; O'Connor MF, 2007, AM J PHYSIOL-REG I, V293, pR145, DOI 10.1152/ajpregu.00752.2006; Doi Y, 2000, PSYCHIAT RES, V97, P165, DOI 10.1016/S0165-1781(00)00232-8; Patel SR, 2009, SLEEP, V32, P200; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Doi Y, 1998, JAPANESE J PSYCHIAT, V13, P755; Kashiwagi A, 2012, DIABETOL INT, V3, P8, DOI DOI 10.1007/S13340-012-0069-8; Matthews KA, 2010, SLEEP, V33, P1649; Ross R, 1999, NEW ENGL J MED, V340, P115; Sasaki S, 1998, J Epidemiol, V8, P203; Seino Y, 2010, DIABETOL INT, V1, P2, DOI 10.1007/s13340-010-0006-7; Sekikawa A, 2005, INT J EPIDEMIOL, V34, P173, DOI 10.1093/ije/dyh285; Teramoto Tamio, 2013, J Atheroscler Thromb, V20, P517; vansLeeuwen W. M., 2009, PLOS ONE, V4, pe4589; Walsh B., 2001, PRINCIPLES PRACTICE, P982	38	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1105	1365-2869		J SLEEP RES	J. Sleep Res.	DEC	2014	23	6					717	727		10.1111/jsr.12182		11	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AU4OK	WOS:000345590700014		
J	Guler, NK; Ekicibil, A; Ozcelik, B; Onar, K; Yakinci, ME; Okazaki, H; Takeya, H; Takano, Y				Guler, Nilay Kantarci; Ekicibil, Ahmet; Ozcelik, Bekir; Onar, Kubra; Yakinci, M. Eyyuphan; Okazaki, H.; Takeya, H.; Takano, Y.			The Annealing Effects in the Iron-Based Superconductor FeTe0.8Se0.2 Prepared by the Self-Flux Method	JOURNAL OF SUPERCONDUCTIVITY AND NOVEL MAGNETISM			English	Article						Iron-based superconductors; SEM; XRD; Magnetization; Magnetic hysteresis	ANISOTROPY; CRYSTALS	FeTe0.8Se0.2 single crystals as-cast and post-annealed were prepared by the self-flux method. We have investigated the structural properties of samples by using the XRD, scanning electron microscope (SEM), energy dispersive X-ray (EDX), and magnetic techniques. The SEM results clearly demonstrate that Te ions are quite well substituted for Se ions in the FeSe lattice for the samples. From the XRD and EDX spectra of the both samples, it has been concluded that the post-annealing causes no change in the tetragonal structure of FeTe0.8Se0.2. According to M-H measurements, the perfect diamagnetism has been observed only in low field at 5 and 10 K temperatures. The trend of the magnetization versus temperature curves, measured under a magnetic field of 10 Oe, also support our conclusion about diamagnetic contribution in FeTe0.8Se0.2 single crystal explored in this study. The as-cast and post-annealed samples show the onset of diamagnetism at temperatures, T-c.on(mag), 12.45 and 13.27 K, respectively. In addition, those curves indicate that the high field value and some impurities reveal ferromagnetic interactions.	[Guler, Nilay Kantarci; Ekicibil, Ahmet; Ozcelik, Bekir] Cukurova Univ, Fac Sci & Letters, Dept Phys, Adana, Turkey; [Onar, Kubra; Yakinci, M. Eyyuphan] Inonu Univ, Fac Sci & Arts, Dept Phys, Malatya, Turkey; [Okazaki, H.; Takeya, H.; Takano, Y.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan	Ozcelik, B (reprint author), Cukurova Univ, Fac Sci & Letters, Dept Phys, Adana, Turkey.	ozcelik@cu.edu.tr			TUBITAK (The Scientific and Technological Research Council of Turkey) [112T767]	This work is supported by the TUBITAK (The Scientific and Technological Research Council of Turkey) under grant contract no. 112T767	Noji T, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.084711; Noji T, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.054708; Mizuguchi Y, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.074712; BEAN CP, 1964, REV MOD PHYS, V36, P31, DOI 10.1103/RevModPhys.36.31; Fang MH, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.224503; Hsu FC, 2008, P NATL ACAD SCI USA, V105, P14262, DOI 10.1073/pnas.0807325105; Wang AF, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.060512; Yeh KW, 2009, CRYST GROWTH DES, V9, P4847, DOI 10.1021/cg900675e; Fang MH, 2013, J PHYS CONF SER, V449, DOI 10.1088/1742-6596/449/1/012015; Hamada K, 2013, PHYSCS PROC, V45, P81, DOI 10.1016/j.phpro.2013.04.057; Heng D.C., 2013, CHINESE PHYS B, V22; Imaizumi M, 2011, PHYSICA C, V471, P614, DOI 10.1016/j.physc.2011.05.009; KRAMER EJ, 1973, J APPL PHYS, V44, P1360, DOI 10.1063/1.1662353; Maziopa A.K., 2011, J PHYS CONDENS MATT, V23; Mizuguchi Y, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3058720; Ohno M, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.044704; Sarma G., 1963, PHYS CHEM SOLIDS, V24, P1029; Wang HD, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/47004; Yeh KW, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/37002; Zhuang JC, 2013, J LOW TEMP PHYS, V172, P113, DOI 10.1007/s10909-012-0846-6	20	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1557-1939	1557-1947		J SUPERCOND NOV MAGN	J. Supercond. Nov. Magn	DEC	2014	27	12					2691	2697		10.1007/s10948-014-2797-4		7	Physics, Applied; Physics, Condensed Matter	Physics	AU0BC	WOS:000345287100007		
J	Tang, SP; Wang, DL; Zhang, XP; Zhang, QJ; Li, C; Ma, YW; Oguro, H; Awaji, S; Watanabe, K				Tang, Shaopu; Wang, Dongliang; Zhang, Xianping; Zhang, Qianjun; Li, Chen; Ma, Yanwei; Oguro, Hidetoshi; Awaji, Satoshi; Watanabe, Kazuo			Improved Transport J(c) in MgB2 Tapes by Graphene Doping	JOURNAL OF SUPERCONDUCTIVITY AND NOVEL MAGNETISM			English	Article						Transport J(c); MgB2 tapes; Graphene doping	CRITICAL-CURRENT DENSITY; UPPER CRITICAL-FIELD; SUPERCONDUCTING PROPERTIES; MAGNESIUM DIBORIDE; CARBON; WIRES	Graphene is a special form of carbon which can effectively enhance the critical current density Jc of MgB2. In this work, a systematic investigation on the impact of sintering conditions and doping level was carried out for graphene-doped MgB2 tapes. It is found that an appropriate addition level, i. e., 8 at% in this work, is very critical to obtain a high Jc in graphene-doped samples. The critical field and pinning force are improved obviously due to the graphene doping. The magnetic Jc of samples sintered at 800 degrees C with 8 at% graphene doping reached 1.78 x 10(4) A/cm(2), at 5 T, 20 K. At the same time, the transport Jc was up to 2.38 x10(4) A/cm(2) at 10 T, 4.2 K. The lattice distortion caused by C substitution and residual C at the grain boundaries were thought to be the major factors affecting the Jc of graphene-doped MgB2 samples.	[Tang, Shaopu; Wang, Dongliang; Zhang, Xianping; Zhang, Qianjun; Li, Chen; Ma, Yanwei] Chinese Acad Sci, Inst Elect Engn, Key Lab Appl Superconduct, Beijing 100190, Peoples R China; [Oguro, Hidetoshi; Awaji, Satoshi; Watanabe, Kazuo] Tohoku Univ, Inst Mat Res, High Field Lab Superconducting Mat, Sendai, Miyagi 9808577, Japan	Ma, YW (reprint author), Chinese Acad Sci, Inst Elect Engn, Key Lab Appl Superconduct, POB 2703, Beijing 100190, Peoples R China.	ywma@mail.iee.ac.cn	Awaji, Satoshi/A-8130-2011; Watanabe, Kazuo/C-2819-2011; Oguro, Hidetoshi/D-7279-2015		National Natural Science Foundation of China [51025726, 51202243, 51104136]; National '973' Program [2011CBA00105]	This work is partially supported by the National Natural Science Foundation of China (Grant Nos. 51025726, 51202243, and 51104136) and the National '973' Program (Grant No. 2011CBA00105).	Zhang XP, 2007, SUPERCOND SCI TECH, V20, P1198, DOI 10.1088/0953-2048/20/12/021; Lee S, 2003, PHYSICA C, V397, P7, DOI 10.1016/S0921-4534(03)01296-6; Dou SX, 2002, APPL PHYS LETT, V81, P3419, DOI 10.1063/1.1517398; Senkowicz BJ, 2008, SUPERCOND SCI TECH, V21, DOI 10.1088/0953-2048/21/3/035009; Senkowicz BJ, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1920428; Bugoslavsky Y, 2001, NATURE, V410, P563, DOI 10.1038/35069029; Serquis A, 2003, APPL PHYS LETT, V82, P2847, DOI 10.1063/1.1571231; Mikheenko P, 2007, SUPERCOND SCI TECH, V20, pS264, DOI 10.1088/0953-2048/20/9/S22; De Silva KSB, 2011, SCRIPTA MATER, V65, P634, DOI 10.1016/j.scriptamat.2011.06.047; De Silva K.SB., 2013, IEEE T APPL SUPERCON, V23, P1; Dou S.X., 2007, PHYS REV LETT, V98, P4; Dou SX, 2003, APPL PHYS LETT, V83, P4996, DOI 10.1063/1.1634378; Gao Z.S., 2007, J APPL PHYS, V102, P4; Hassler W, 2008, SUPERCOND SCI TECH, V21, DOI 10.1088/0953-2048/21/6/062001; Jun BH, 2008, PHYSICA C, V468, P1825, DOI 10.1016/j.physc.2008.05.152; Kim JH, 2007, IEEE T APPL SUPERCON, V17, P2907, DOI 10.1109/TASC.2007.898831; Eisterer M, 2007, SUPERCOND SCI TECH, V20, pR47, DOI 10.1088/0953-2048/20/12/R01; Lee S, 2003, SUPERCOND SCI TECH, V16, P213, DOI 10.1088/0953-2048/16/2/316; Li W.X., 2008, J APPL PHYS, V103, P5; Ma YW, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2173635; Nagamatsu J, 2001, NATURE, V410, P63, DOI 10.1038/35065039; Soltanian S, 2003, PHYSICA C, V390, P185, DOI 10.1016/S0921-4534(03)00960-2; Tarantini C., 2006, PHYS REV B, V73, P11; Wilke R.H.T., 2004, PHYS REV LETT, V92, P4; Xu AX, 2007, PHYSICA C, V466, P190, DOI 10.1016/j.physc.2007.07.005; Xu X, 2010, SUPERCOND SCI TECH, V23, DOI 10.1088/0953-2048/23/8/085003; Yamamoto A., 2005, APPL PHYS LETT, V86, P3; Zhang XP, 2008, PHYSICA C, V468, P1809, DOI 10.1016/j.physc.2008.05.090	28	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1557-1939	1557-1947		J SUPERCOND NOV MAGN	J. Supercond. Nov. Magn	DEC	2014	27	12					2699	2705		10.1007/s10948-014-2804-9		7	Physics, Applied; Physics, Condensed Matter	Physics	AU0BC	WOS:000345287100008		
J	Sasaki, T; Kuniyasu, H; Luo, Y; Fujiwara, R; Kitayoshi, M; Tanabe, E; Kato, D; Shinya, S; Fujii, K; Ohmori, H; Yamashita, Y				Sasaki, Takamitsu; Kuniyasu, Hiroki; Luo, Yi; Fujiwara, Rina; Kitayoshi, Misaho; Tanabe, Eriko; Kato, Daisuke; Shinya, Satoshi; Fujii, Kiyomu; Ohmori, Hitoshi; Yamashita, Yuichi			Serum CD10 is associated with liver metastasis in colorectal cancer	JOURNAL OF SURGICAL RESEARCH			English	Article						Colorectal cancer; CD10; Liver metastasis; Serum marker	ANGIOTENSIN-CONVERTING ENZYME; METHIONINE-ENKEPHALIN; ENDOPEPTIDASE-24.11 ENKEPHALINASE; EXPRESSION; CARCINOMA; DIFFERENTIATION; GENERATION; INHIBITION; INCREASES; GROWTH	Introduction: Colorectal cancer (CRC) is the third leading cause of cancer death in Japan. CD10 expression is closely associated with liver metastasis. In the present study, we explored the possibility of serum CD10 as a marker of liver metastasis in CRC. Methodology: BALB/c mouse with subcutaneous tumor of syngeneic CT26 CRC cells were examined serum CD10. In 84 CRC patients and patients undergoing hemodialysis, serum CD10 was examined. CD10 concentration was measured by enzyme- linked immunosorbent assay. Results: In a mouse subcutaneous tumor model, serum CD10 correlated with the weight of the tumors. Serum CD10 was examined in 84 patients with CRC. The serum levels of CD10 were higher in patients with more advanced cancer stages. Patients with liver metastasis showed the highest levels of serum CD10 among all patients. Importantly, patients with high serum CD10 levels had metachronous liver metastasis. Healthy volunteers showed low levels of CD10; however, serum CD10 levels in patients undergoing hemodialysis showed levels as high as those with stage II and III CRC. A cutoff of serum CD10 set to > 1000 pg/mL showed 70% sensitivity and 93% specificity for liver metastasis in CRC. This cutoff included all cases of metachronous liver metastasis. Conclusions: With the exclusion of mimicking factors, serum CD10 levels might serve as a useful marker of synchronous and metachronous liver metastasis in CRC. (C) 2014 Elsevier Inc.All rights reserved.	[Sasaki, Takamitsu; Kato, Daisuke; Shinya, Satoshi; Yamashita, Yuichi] Fukuoka Univ, Sch Med, Dept Surg Gastroenterol, Fukuoka 81401, Japan; [Kuniyasu, Hiroki; Luo, Yi; Fujiwara, Rina; Kitayoshi, Misaho; Tanabe, Eriko; Fujii, Kiyomu; Ohmori, Hitoshi] Nara Med Univ, Dept Mol Pathol, Kashihara, Nara 6348521, Japan	Kuniyasu, H (reprint author), Nara Med Univ, Dept Mol Pathol, 840 Shijo Cho, Kashihara, Nara 6348521, Japan.	cooninh@zb4.so-net.ne.jp			Japan Society for the Promotion of Science, Japan [13253395]	This work was supported in part by Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science, Japan (No. 13253395). T. S. contributed to data collection, writing the article, and obtaining funding; H.K. contributed to conception and design and obtaining funding; Y.L. and S.S. contributed to data collection and interpretation; R.F., M.K., E.T., and D.K. contributed to data collection; K.F. and H.O. contributed to critical revision of the article; Y.Y. contributed to approving the final version of the manuscript.	Ono M, 1996, CANCER, V78, P1179, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1179::AID-CNCR3>3.0.CO;2-5; Yao T, 2002, PATHOLOGY, V34, P556, DOI 10.1080/0031302021000035965; Tajima Y, 2006, CLIN CANCER RES, V12, P6469, DOI 10.1158/1078-0432.CCR-06-1339; Maguer-Satta V, 2011, STEM CELLS, V29, P389, DOI 10.1002/stem.592; Kuniyasu H, 2010, GUT, V59, P348, DOI 10.1136/gut.2009.178376; Fujimoto Y, 2005, DIS COLON RECTUM, V48, P1883, DOI 10.1007/s10350-005-0141-6; DIRENZO MF, 1995, CLIN CANCER RES, V1, P147; Luo Y, 2009, PATHOBIOLOGY, V76, P267, DOI 10.1159/000228903; Ohji Y, 2007, ONCOL REP, V17, P525; Fujita S, 2007, ANTICANCER RES, V27, P3307; Boyella VD, 2008, ANN HEPATOL, V7, P221; Cezard JP, 2001, GASTROENTEROLOGY, V120, P799, DOI 10.1053/gast.2001.22544; Cruden NLM, 2004, HYPERTENSION, V44, P913, DOI 10.1161/01.HYP.0000146483.78994.56; DESCHODTLANCKMAN M, 1989, LIFE SCI, V45, P133, DOI 10.1016/0024-3205(89)90287-7; Fong Y, 1996, SEMIN SURG ONCOL, V12, P219, DOI 10.1002/(SICI)1098-2388(199607/08)12:4<219::AID-SSU3>3.0.CO;2-8; Ishida H, 2000, ONCOL REP, V7, P1229; Ismaili N, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-154; Jaglowski JR, 2005, CANCER CHEMOTH PHARM, V56, P97, DOI 10.1007/s00280-004-0929-4; Martin-Kleiner I, 2003, INT IMMUNOPHARMACOL, V3, P707, DOI 10.1016/S1567-5769(03)00058-4; Miron N, 2012, J GASTROINTEST LIVER, V21, P413; Nicoll J, 2005, MED HYPOTHESES, V65, P1099, DOI 10.1016/j.mehy.2005.06.019; Ohmori H, 2009, CANCER SCI, V100, P497, DOI 10.1111/j.1349-7006.2008.01073.x; Purkiss SF, 1998, EUR J SURG, V164, P803, DOI 10.1080/110241598750005192; Raasch W, 2005, J HYPERTENS, V23, P1597, DOI 10.1097/01.hjh.0000173395.42794.cd; Rysz J, 2006, ARCH IMMUNOL THER EX, V54, P209, DOI 10.1007/s00005-006-0023-1; Scholzen TE, 2007, ENDOCRINOLOGY, V148, P2793, DOI 10.1210/en.2006-1765; SHIPP MA, 1989, P NATL ACAD SCI USA, V86, P297, DOI 10.1073/pnas.86.1.297; Singhal P, 2001, ADV EXP MED BIOL, V493, P127; Sobin LH, 2009, UICC TNM CLASSIFICAT; SPIVEY JR, 1994, AM J GASTROENTEROL, V89, P2028; Tudoric N, 2000, PEPTIDES, V21, P359, DOI 10.1016/S0196-9781(00)00151-0; Wakao F, 2013, CANC STAT JAPAN; WERFEL T, 1991, J IMMUNOL, V147, P3909; Zagon IS, 2005, NEUROPEPTIDES, V39, P495, DOI 10.1016/j.npep.2005.07.001	34	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	DEC	2014	192	2					390	394		10.1016/j.jss.2014.05.071		5	Surgery	Surgery	AU2BA	WOS:000345419900024		
J	Nanashima, A; Abo, T; Arai, J; Tominaga, T; Takagi, K; Mochinaga, K; Furukawa, K; Nagayasu, T				Nanashima, Atsushi; Abo, Takafumi; Arai, Junichi; Tominaga, Tetsuro; Takagi, Katsunori; Mochinaga, Koji; Furukawa, Katsuro; Nagayasu, Takeshi			Prediction of portal pressure from intraoperative ultrasonography	JOURNAL OF SURGICAL RESEARCH			English	Article						Hepatectomy; Intraoperative ultrasonography; Doppler-portal pressure	HEPATIC FUNCTIONAL RESERVE; SERUM HYALURONATE; VEIN EMBOLIZATION; MAJOR HEPATECTOMY; LIVER-FUNCTION; HYPERTENSION; VOLUME; SCINTIGRAPHY; CIRRHOSIS; VARICES	Background: Portal hypertension is a major risk factor for hepatic failure or bleeding in patients who have undergone hepatectomy, but it cannot be measured indirectly. We attempted to evaluate the intraoperative ultrasonography parameters that correlate with portal pressure (PP) in patients undergoing hepatectomy. Methods: We examined 30 patients in whom PP was directly measured during surgery. The background liver conditions included chronic viral liver disease in seven patients, chemotherapy- associated steatohepatitis in four patients, fatty liver in one patient, hepatolithiasis in one patient, obstructive jaundice in one patient, and a normal liver in 16 patients. A multivariate logistic analysis and linear regression analysis were conducted to develop a predictive formula for PP. Results: The mean PP was 10.4 +/- 4.1 mm Hg. The PP tended to be increased in patients with chronic viral hepatitis. A univariate analysis identified the association of the six following parameters with PP: the platelet count and the maximum (max), minimum (min), endodiastolic, peak- systolic, and mean velocity in the portal vein (PV) flow. Using multiple linear regression analysis, the predictive formula using the PV max and min was as follows: Y (estimated PP) = 18.235 - 0.120 X (PV max.[ m/ s]) - 0.364 X (PV min). The calculated PP (10.44 +/- 2.61 mm Hg) was nearly the same as the actual PP (10.43 +/- 4.07 mm Hg). However, there was no significant relationship between the calculated PP and the intraoperative blood loss and post hepatectomy morbidity. Conclusions: This formula, which uses ultrasonographic Doppler flow parameters, appears to be useful for predicting PP. (C) 2014 Elsevier Inc.All rights reserved.	[Nanashima, Atsushi; Abo, Takafumi; Arai, Junichi; Tominaga, Tetsuro; Takagi, Katsunori; Mochinaga, Koji; Furukawa, Katsuro; Nagayasu, Takeshi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg Oncol, Nagasaki 8528501, Japan	Nanashima, A (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg Oncol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	a-nanasm@nagasaki-u.ac.jp					Al- usafi SA, 2012, INT J HEPATOL, V2012; Alempijevic T, 2012, TURK J GASTROENTEROL, V23, P239, DOI 10.4318/tjg.2012.0463; Shneider BL, 2012, J PEDIATR GASTR NUTR, V55, P567, DOI 10.1097/MPG.0b013e31826eb0cf; Cucchetti A, 2009, ANN SURG, V250, P922, DOI 10.1097/SLA.0b013e3181b977a5; Kubota K, 1997, HEPATOLOGY, V26, P1176; Yachida S, 2000, WORLD J SURG, V24, P359; Sporea I, 2013, MED ULTRASON, V15, P111; Ling LF, 2012, JACC-CARDIOVASC IMAG, V5, P747, DOI 10.1016/j.jcmg.2011.08.026; Mitsumori A, 1998, EUR J NUCL MED, V25, P1377, DOI 10.1007/s002590050311; Schneider PD, 2004, SURG CLIN N AM, V84, P355, DOI 10.1016/S0039-6109(03)00224-X; Poon RT, 2004, ANN SURG, V240, P698, DOI 10.1097/01.sla.0000141195.66155.0c; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Thalheimer U, 2005, DIGEST LIVER DIS, V37, P601, DOI 10.1016/j.dld.2005.02.009; Nanashima A, 2010, J HEPATO-BIL-PAN SCI, V17, P871, DOI 10.1007/s00534-010-0281-5; Chelliah S Timothy, 2011, Indian J Radiol Imaging, V21, P291, DOI 10.4103/0971-3026.90693; Gibo Masaki, 2007, Radiat Med, V25, P164, DOI 10.1007/s11604-007-0120-z; Hayashi H, 2012, J GASTROENTEROL, V47, P1336, DOI 10.1007/s00535-012-0599-7; Ikeda N, 2013, HEPATOL RES; Lim LG, 2009, WORLD J GASTROENTERO, V15, P3823, DOI 10.3748/wjg.15.3823; Maleux G, 2011, J VASC INTERV RADIOL, V22, P1553, DOI 10.1016/j.jvir.2011.08.003; Min Yang Won, 2012, Clin Mol Hepatol, V18, P178, DOI 10.3350/cmh.2012.18.2.178; Mizuguchi T, 2004, WORLD J SURG, V28, P971, DOI 10.1007/s00268-004-7389-1; Nanashima A, 2010, J SURG RES, V164, pE235, DOI 10.1016/j.jss.2010.06.003; Nanashima A, 2006, DIGEST DIS SCI, V51, P1190, DOI 10.1007/s10620-006-8031-x; Shimura T, 2007, J SURG ONCOL, V96, P438, DOI 10.1002/jso.20829; TAKASAKI T, 1980, INT SURG, V65, P309; Wiechowska-Kozlowska A, 2009, TRANSPL P, V41, P3082, DOI 10.1016/j.transproceed.2009.07.095; Zhang L, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-84	28	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	DEC	2014	192	2					395	401		10.1016/j.jss.2014.05.069		7	Surgery	Surgery	AU2BA	WOS:000345419900025		
J	Ito, R; Ishii, Y; Wakiyama, S; Shiba, H; Fujioka, S; Misawa, T; Ishida, Y; Hano, H; Yanaga, K				Ito, Ryusuke; Ishii, Yuji; Wakiyama, Shigeki; Shiba, Hiroaki; Fujioka, Shuichi; Misawa, Takeyuki; Ishida, Yuichi; Hano, Hiroshi; Yanaga, Katsuhiko			Prognostic significance of receptor for advanced glycation end products expression in hepatocellular carcinoma after hepatectomy	JOURNAL OF SURGICAL RESEARCH			English	Article						RAGE; Hepatocellular carcinoma; Hepatectomy	SQUAMOUS-CELL CARCINOMA; NEURITE OUTGROWTH; CANCER-CELLS; RAGE; AMPHOTERIN; LIVER; BLOCKADE; DISEASE; LIGAND; MICE	Background: The receptor for advanced glycation end products (RAGE) is recognized to be responsible for cancer progression in several human cancers. In this study, we investigated the clinical impact of RAGE expression in patients with hepatocellular carcinoma (HCC) after hepatectomy. Materials and methods: Sixty-five consecutive patients who underwent initial hepatectomy for HCC were investigated. The relationships between immunohistochemical expression of RAGE and clinicopathologic features, clinical outcome (overall survival [OS], and disease-free survival [DFS]) were evaluated. Results: The cytoplasmic expression of RAGE in HCC cells was observed in 46 patients (70.8%) and correlated with histologic grade (poorly differentiated versus moderately differentiated HCC, P = 0.021). Five-year OS in RAGE-positive and RAGE-negative groups were 72% and 94%, respectively, whereas 5-y DFS were 29% and 55%, respectively. There were significant differences between OS and DFS (P = 0.018 and 0.031, respectively). Multivariate analysis indicated that RAGE was an independent predictor for both OS and DFS (P = 0.048 and 0.032, respectively). Conclusions: Our data suggest for the first time a positive correlation between RAGE expression and poor therapeutic outcome. Furthermore, RAGE downregulation may provide a novel therapeutic target for HCC. (C) 2014 Elsevier Inc. All rights reserved.	[Ito, Ryusuke; Ishii, Yuji; Wakiyama, Shigeki; Shiba, Hiroaki; Fujioka, Shuichi; Misawa, Takeyuki; Ishida, Yuichi; Yanaga, Katsuhiko] Jikei Univ, Sch Med, Dept Surg, Tokyo 1058461, Japan; [Hano, Hiroshi] Jikei Univ, Sch Med, Dept Pathol, Tokyo 1058461, Japan	Ito, R (reprint author), Jikei Univ, Sch Med, Dept Surg, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	fwkv0705@mb.infoweb.ne.jp			Japan Society for the Promotion of Science [18591525]	This work was supported in part by Grant- in-Aid for Scientific Research from Japan Society for the Promotion of Science (no.18591525).	Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Llovet JM, 2005, J GASTROENTEROL, V40, P225, DOI 10.1007/s00535-005-1566-3; Huttunen HJ, 2004, J INTERN MED, V255, P351, DOI 10.1111/j.1365-2796.2003.01301.x; Logsdon CD, 2007, CURR MOL MED, V7, P777, DOI 10.2174/156652407783220697; Takada M, 2004, HEPATO-GASTROENTEROL, V51, P928; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Ishiguro H, 2005, PROSTATE, V64, P92, DOI 10.1002/pros.20219; Hiwatashi K, 2008, ANN SURG ONCOL, V15, P923, DOI 10.1245/s10434-007-9698-8; Hirata K, 2003, HEPATO-GASTROENTEROL, V50, P1205; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; Kuniyasu H, 2002, J PATHOL, V196, P163, DOI 10.1002/path.1031; Hyogo H, 2008, CURR PHARM DESIGN, V14, P969, DOI 10.2174/138161208784139701; Fiuza C, 2003, BLOOD, V101, P2652, DOI 10.1182/blood-2002-05-1300; Hayashi M, 1999, AM J ROENTGENOL, V172, P969; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; GUESDON JL, 1979, J HISTOCHEM CYTOCHEM, V27, P1131; Basta G, 2011, LIVER TRANSPLANT, V17, P633, DOI 10.1002/lt.22306; Taguchi A, 2000, NATURE, V405, P354; HORI O, 1995, J BIOL CHEM, V270, P25752; Kuniyasu H, 2003, ONCOL REP, V10, P445; Tateno T, 2009, ANN SURG ONCOL, V16, P440, DOI 10.1245/s10434-008-0237-z; Zeng S, 2004, HEPATOLOGY, V39, P422, DOI 10.1002/hep.20045; Asayama Y, 2008, AM J ROENTGENOL, V190, pW28, DOI 10.2214/AJR.07.2117; Bartling B, 2005, CARCINOGENESIS, V26, P293, DOI 10.1093/carcin/bgh333; Chuma Makoto, 2004, Keio Journal of Medicine, V53, P90, DOI 10.2302/kjm.53.90; Du Yan S, 1997, Proc Natl Acad Sci U S A, V94, P5296, DOI 10.1073/pnas.94.10.5296; Ekong U, 2006, J GASTROEN HEPATOL, V21, P682, DOI 10.1111/j.1440-1746.2006.04225.x; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Miyata T, 1996, J CLIN INVEST, V98, P1088, DOI 10.1172/JCI118889; Riehl A, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-12; Sasahira T, 2007, HISTOPATHOLOGY, V51, P166, DOI 10.1111/j.1365-2559.2007.02739.x; Takada M, 2001, HEPATO-GASTROENTEROL, V48, P1577; Wamke R, 1980, J HISTOCHEM CYTOCHEM, V28, P771	37	4	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	DEC	2014	192	2					503	508		10.1016/j.jss.2014.06.028		6	Surgery	Surgery	AU2BA	WOS:000345419900039		
J	Watari, K				Watari, Koji			Evaluation of thermal conductivity of grains and fillers by using thermoreflectance technique-Si3N4, AlN, SiC-	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Review						Si3N4; AlN; SiC; Thermal conductivity; Grain; Filler; Ceramics; Thermoreflectance technique	SILICON-NITRIDE; MICROSTRUCTURAL CHARACTERIZATION; MICROMETER SCALE; BOUNDARY PHASE; CERAMICS; MICROSCOPY; DIFFUSIVITY	In order to clarify thermal conductivity mechanism of ceramics and composites, their local thermal information is very significant. Present work reviewed thermal characterization of non-oxide ceramics at the micrometer scale, and concentrated especially the conductivity of individual grain by a thermal microscope, using thermoreflectance technique and periodic heating. Strong thermal anisotropy was found into very large beta-Si3N4 grain for developed ceramic. Furthermore, non-homogenous distribution of the conductivity of AlN and SiC ceramics was quantitatively demonstrated in term of thermal conductivity map. Based on the results, the author also discussed high conductivity of AlN and SiC ceramics fabricated with high-purity powders and effective sintering aids, and Si3N4 ceramic involving elongated grains with highly orientation. (C) 2014 The Ceramic Society of Japan. All rights reserved.	Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan	Watari, K (reprint author), Natl Inst Adv Ind Sci & Technol, AIST Tsukuba Cent 2,1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	koji-watari@aist.go.jp					Watari K, 2002, J MATER RES, V17, P2940, DOI 10.1557/JMR.2002.0426; SLACK GA, 1973, J PHYS CHEM SOLIDS, V34, P321, DOI 10.1016/0022-3697(73)90092-9; Nakano H, 2004, J EUR CERAM SOC, V24, P3685, DOI 10.1016/j.jeurceramsoc.2003.12.019; Watari K, 2001, J CERAM SOC JPN, V109, pS7, DOI 10.2109/jcersj.109.S7; Zhou Y, 2011, ADV MATER, V23, P4563, DOI 10.1002/adma.201102462; Kume S, 2009, J AM CERAM SOC, V92, pS153, DOI 10.1111/j.1551-2916.2008.02650.x; Nakano H, 2002, J AM CERAM SOC, V85, P3093; Fabbri L, 1996, J MATER SCI, V31, P5429, DOI 10.1007/BF01159313; Hatori K, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2130333; Hirao K, 1996, J AM CERAM SOC, V79, P2485, DOI 10.1111/j.1151-2916.1996.tb09002.x; Hirosaki N., 1996, J AM CERAM SOC, V79, P2978; Hirosaki N, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.134110; Kitayama M, 2001, J AM CERAM SOC, V84, P353; Lee SK, 2008, J CERAM SOC JPN, V116, P1260, DOI 10.2109/jcersj2.116.1260; Lee S-K., 2007, J SOC INORG MAT JPN, V14, P429; Li BC, 1999, J EUR CERAM SOC, V19, P1631, DOI 10.1016/S0955-2219(98)00258-1; Pelissonnier C., 1995, 4 EUR CER, V3, P413; POTTIER L, 1994, APPL PHYS LETT, V64, P1618, DOI 10.1063/1.111856; ROGER JP, 1987, THIN SOLID FILMS, V155, P165, DOI 10.1016/0040-6090(87)90462-7; Takeda K., 1986, ADV CERAM MATER, V1, P162; Watari K, 1999, J MATER RES, V14, P1538, DOI 10.1557/JMR.1999.0206; Yamada I., 2008, NETSU BASSEI, V22, P172, DOI 10.2963/jjtp.22.172; Yamada I., 2009, J SOC POWDER TECH JA, V46, P20	23	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	DEC	2014	122	1432					967	970		10.2109/jcersj2.122.967		4	Materials Science, Ceramics	Materials Science	AU3RB	WOS:000345530200001		
J	Morito, H				Morito, Haruhiko			Low-temperature synthesis of Si and Si-based compounds using Na	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Review						Sodium; Silicon; Phase diagram; Crystal growth; Purification; Silicon carbide; Ternary compound	METALLURGICAL-GRADE SILICON; MECHANICAL-PROPERTIES; CARBIDE CERAMICS; BORON REMOVAL; FABRICATION; SODIUM; FLUX; WOOD	Low-temperature solution growth of Si crystals using Na was demonstrated based on the Na-Si binary phase diagram. Single crystals, films, porous bulk samples, and helical microtubes of Si crystals were prepared from a Na-Si solution by Na evaporation. Dissolution and crystallization of Si in a Na melt reduced the impurity content in the Si crystals. Low-temperature synthesis and morphology control of porous SiC ceramics using Na were also performed and a new ternary compound, Na8B74.5Si17.5, was synthesized. (C) 2014 The Ceramic Society of Japan. All rights reserved.	Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan	Morito, H (reprint author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	morito@tagen.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [20860016, 22656160]; Japan Science and Technology Agency	I would like to thank Prof. H. Yamane, Dr. T. Yamada, Dr. T. Ikeda, and Dr. M. Uchikoshi for supporting my study. Financial support was provided in part by a Grant-in-Aid for Young Scientists (Start-up) (No. 20860016); Challenging Exploratory Research grant (No. 22656160) from the Ministry of Education, Culture, Sports, Science and Technology; and a Grant-in-Aid for Research Seeds Quest Program (Lower Carbon Society) from the Japan Science and Technology Agency.	Adler J, 2005, INT J APPL CERAM TEC, V2, P429, DOI 10.1111/j.1744-7402.2005.02044.x; Safarian J, 2012, ENRGY PROCED, V20, P88, DOI 10.1016/j.egypro.2012.03.011; TRUMBORE FA, 1960, AT&T TECH J, V39, P205; Greil P, 1998, J EUR CERAM SOC, V18, P1975, DOI 10.1016/S0955-2219(98)00155-1; Xu FM, 2014, SEP SCI TECHNOL, V49, P305, DOI 10.1080/01496395.2013.817423; Chi WG, 2004, CERAM INT, V30, P869, DOI 10.1016/j.ceramint.2003.10.006; Ma Y, 2008, CERAM INT, V34, P253, DOI 10.1016/j.ceramint.2006.08.018; Hu L, 2013, METALL MATER TRANS B, V44, P828, DOI 10.1007/s11663-013-9850-8; Yoshikawa T, 2009, J CRYST GROWTH, V311, P776, DOI 10.1016/j.jcrysgro.2008.09.095; Greil P, 1998, J EUR CERAM SOC, V18, P1961, DOI 10.1016/S0955-2219(98)00156-3; Zhu SM, 2005, MATER LETT, V59, P595, DOI 10.1016/j.matlet.2004.11.003; Morito H, 2013, SEP PURIF TECHNOL, V118, P723, DOI 10.1016/j.seppur.2013.08.022; Ramachandran GK, 1999, J SOLID STATE CHEM, V145, P716, DOI 10.1006/jssc.1999.8295; Cros C., 1970, J SOLID STATE CHEM, V2, P570, DOI 10.1016/0022-4596(70)90053-8; DAWLESS RK, 1988, J CRYST GROWTH, V89, P68, DOI 10.1016/0022-0248(88)90073-5; Eom JH, 2009, J MATER SCI, V44, P4482, DOI 10.1007/s10853-009-3638-x; Eom JH, 2010, J AM CERAM SOC, V93, P2463, DOI 10.1111/j.1551-2916.2010.03812.x; HOHMANN E, 1948, Z ANORG CHEM, V257, P113, DOI 10.1002/zaac.19482570113; Jin YJ, 2010, J MATER SCI, V45, P282, DOI 10.1007/s10853-009-3993-7; Yamane H, 2008, J CERAM SOC JPN, V116, P163, DOI 10.2109/jcersj2.116.163; Kawamura F, 2008, J AM CERAM SOC, V91, P51, DOI 10.1111/j.1551-2916.2007.02021.x; Li-xin Z., 2011, T NONFERR METAL SOC, V21, P1185; Morito H, 2009, J ALLOY COMPD, V480, P723, DOI 10.1016/j.jallcom.2009.02.036; Morito H, 2008, MATER TRANS, V49, P1929, DOI 10.2320/matertrans.MAW200859; Morito H, 2010, ANGEW CHEM INT EDIT, V49, P3638, DOI 10.1002/anie.200907271; Morito H, 2010, DALTON T, V39, P10197, DOI 10.1039/c0dt00801j; Morito H, 2012, J CRYST GROWTH, V355, P109, DOI 10.1016/j.jcrysgro.2012.06.032; Morito H, 2012, SILICON-NETH, V4, P121, DOI 10.1007/s12633-011-9105-8; Suzuki Y, 2009, J ALLOY COMPD, V486, P70, DOI 10.1016/j.jallcom.2009.06.157; WITTE J, 1964, Z ANORG ALLG CHEM, V327, P260, DOI 10.1002/zaac.19643270319; Yamane H, 2009, J CERAM SOC JPN, V117, P1021, DOI 10.2109/jcersj2.117.1021; Kawamura F, 2007, J CERAM SOC JPN, V115, P74, DOI 10.2109/jcersj.115.74; Yamane H, 2011, J EUR CERAM SOC, V31, P409, DOI 10.1016/j.jeurceramsoc.2010.10.025	33	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	DEC	2014	122	1432					971	975		10.2109/jcersj2.122.971		5	Materials Science, Ceramics	Materials Science	AU3RB	WOS:000345530200002		
J	Widiatmoko, P; Khaemba, DN; Lenggoro, IW				Widiatmoko, Pramujo; Khaemba, Doris N.; Lenggoro, I. Wuled			Preparation of LiMn2O4 particles by glucose-assisted combustion method	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Spray drying; Metal oxide; Saccharide; Complex; Submicron; Powder	LITHIUM-ION BATTERIES; LOW-TEMPERATURE ROUTE; NANOCRYSTALLINE LIMN2O4; CATHODE MATERIAL; SPINEL LIMN2O4; THERMAL-DECOMPOSITION; RAMAN-SPECTRA; CITRATE ROUTE; COMPLEXES; PERFORMANCE	Lithium manganese oxide (LiMn2O4) powders with particle sizes in the range of 100-600nm have been synthesized through glucose-assisted combustion synthesis. The presence of glucose increases the stability of the precursor solution, purity of the heat-treated powders, and decreasing on size of the synthesized particle. The formation of complex metal salts-glucose in the precursor solution and effect of the methods for preparing solid precursors on the final product were investigated. (C) 2014 The Ceramic Society of Japan. All rights reserved.	[Widiatmoko, Pramujo; Lenggoro, I. Wuled] Tokyo Univ Agr & Technol, Grad Sch Bio Applicat & Syst Engn, Koganei, Tokyo 1848588, Japan; [Khaemba, Doris N.; Lenggoro, I. Wuled] Tokyo Univ Agr & Technol, Dept Chem Engn, Koganei, Tokyo 1848588, Japan; [Khaemba, Doris N.] Univ Leeds, Sch Mech Engn, Leeds LS2 9JT, W Yorkshire, England	Lenggoro, IW (reprint author), Tokyo Univ Agr & Technol, Grad Sch Bio Applicat & Syst Engn, Koganei, Tokyo 1848588, Japan.	wuled.@cc.tuat.ac.jp	Lenggoro, Wuled/B-8629-2009	Lenggoro, Wuled/0000-0002-0048-8486	Ministry of Education, Culture, Sports, Science & Technology (Japan) [26420761, 23246132, 10304403]; Ministry of Education and Culture (Indonesia)	The present study was partially supported by the Ministry of Education, Culture, Sports, Science & Technology (Japan) with Grant-in-Aid for Scientific Research through the Japan Society for the Promotion of Science (IWL, No. 26420761, 23246132, 10304403), and by a doctoral scholarship from the Ministry of Education and Culture (Indonesia) (PW). The authors are grateful to Drs. H. Kamiya, M. Iijima, and M. Tsukada for measurement facilities and for valuable supports.	ANGYAL SJ, 1974, TETRAHEDRON, V30, P1695; Soderholm S, 1999, J RAMAN SPECTROSC, V30, P1009, DOI 10.1002/(SICI)1097-4555(199911)30:11<1009::AID-JRS436>3.0.CO;2-#; Raja MW, 2007, MATER RES BULL, V42, P1499, DOI 10.1016/j.materresbull.2006.11.002; Lu CZ, 2006, J PHYS CHEM SOLIDS, V67, P756, DOI 10.1016/j.jpcs.2005.11.008; Kovacheva D, 2002, J MATER CHEM, V12, P1184, DOI 10.1039/b107669h; Gyurcsik B, 2000, COORDIN CHEM REV, V203, P81, DOI 10.1016/S0010-8545(99)00183-6; Wang XN, 2003, J CRYST GROWTH, V256, P123, DOI 10.1016/S0022-0248(03)01289-2; Fortunato G, 2001, J MATER CHEM, V11, P905, DOI 10.1039/b007306g; Wu XM, 2004, MATER CHEM PHYS, V84, P182, DOI 10.1016/j.matchemphys.2003.11.020; Le Barc'H N, 2001, FOOD CHEM, V74, P119, DOI 10.1016/S0308-8146(01)00139-X; Dominko R, 2003, ELECTROCHIM ACTA, V48, P3709, DOI 10.1016/S0013-4686(03)00522-X; Gao T, 2009, INORG CHEM, V48, P6242, DOI 10.1021/ic900565m; Fey GTK, 2006, MATER CHEM PHYS, V99, P451, DOI 10.1016/j.matchemphys.2005.11.022; Zhou XY, 2013, CERAM INT, V39, P4783, DOI 10.1016/j.ceramint.2012.11.068; Patil KC, 1997, CURR OPIN SOLID ST M, V2, P158, DOI 10.1016/S1359-0286(97)80060-5; Fritsch S, 1996, J AM CERAM SOC, V79, P1761, DOI 10.1111/j.1151-2916.1996.tb07993.x; Zhang Y, 2004, SOLID STATE IONICS, V171, P25, DOI 10.1016/j.ssi.2004.04.008; Choy JH, 1999, J POWER SOURCES, V77, P1, DOI 10.1016/S0378-7753(98)00157-8; DIEFALLAH EM, 1992, THERMOCHIM ACTA, V202, P1, DOI 10.1016/0040-6031(92)85144-K; Du K, 2003, J ALLOY COMPD, V352, P250, DOI 10.1016/S0925-8388(02)01165-9; Fournier P, 2005, J SOLUTION CHEM, V34, P881, DOI 10.1007/s10953-005-6251-x; Kumar VG, 2003, CHEM MATER, V15, P4211, DOI 10.1021/cm030104j; Liang YY, 2005, J ELECTROCHEM SOC, V152, pA2030, DOI 10.1149/1.2030063; Moon J, 1999, J MATER RES, V14, P4594, DOI 10.1557/JMR.1999.0622; Mukhopadhyay A, 2000, CARBOHYD RES, V324, P30, DOI 10.1016/S0008-6215(99)00277-3; Mukhopadhyay A, 2000, CARBOHYD RES, V328, P103, DOI 10.1016/S0008-6215(00)00084-7; Murugan A. V., 2005, J SOLID STATE ELECTR, V10, P104; Orsi F., 1973, J THERM ANAL, V5, P6; Park HB, 2001, J POWER SOURCES, V92, P124, DOI 10.1016/S0378-7753(00)00512-7; Prabaharan SRS, 1998, SOLID STATE IONICS, V112, P25, DOI 10.1016/S0167-2738(98)00219-7; RAO CP, 1991, INORG CHIM ACTA, V186, P11, DOI 10.1016/S0020-1693(00)87923-2; Ren M, 2007, ANAL BIOANAL CHEM, V387, P879, DOI 10.1007/s00216-006-1047-4; Selvasekarapandian S, 2006, SPECTROCHIM ACTA A, V65, P1234, DOI 10.1016/j.saa.2006.02.026; Shen PZ, 2006, J POWER SOURCES, V158, P608, DOI 10.1016/j.jpowsour.2005.09.051; Tong YH, 2006, MATER LETT, V60, P2578, DOI 10.1016/j.matlet.2005.12.150; Tsumura T, 1996, THERMOCHIM ACTA, V278, P135, DOI 10.1016/0040-6031(95)02759-9; Tsumura T, 1996, SOLID STATE IONICS, V90, P197, DOI 10.1016/S0167-2738(96)00404-3; TSUMURA T, 1993, J MATER CHEM, V3, P995, DOI 10.1039/jm9930300995; Tsumura T, 1997, SOLID STATE IONICS, V104, P35, DOI 10.1016/S0167-2738(97)00417-7; Wan CY, 2010, POWDER TECHNOL, V199, P154, DOI 10.1016/j.powtec.2009.12.017; Wu HM, 2005, PHYSICA B, V369, P221, DOI 10.1016/j.physb.2005.08.017	41	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	DEC	2014	122	1432					976	981		10.2109/jcersj2.122.976		6	Materials Science, Ceramics	Materials Science	AU3RB	WOS:000345530200003		
J	Zhang, D; Kambe, S; Tashiro, A; Ohba, Y; Mizuguchi, H; Ito, K; Kakizaki, S; Okita, Y				Zhang, Dan; Kambe, Shiro; Tashiro, Akihiro; Ohba, Yasushi; Mizuguchi, Hitoshi; Ito, Kazunori; Kakizaki, Shinya; Okita, Yasuo			Novel measuring and correction method of oxygen content in La2-xSrxCuOy superconductors with the dissolved oxygen sensor	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						DO sensor; Oxygen content; Cu valence	CU-VALENCE; OXIDES	It is known that Cu valence of cuprate superconductors govern transition temperature (T-c). For La2-xSrxCuOy, when x = 0.15, that is, v is 2.15, the highest T-c around 40 K is achieved. The v value is determined both by strontium and oxygen content. So far, coulometry and iodometry have been used for determining oxygen content. However, chemical analysis usually requires much experience. The purpose of this research is to develop a novel measuring method of oxygen content in cuprate superconductors with a newly developed dissolved oxygen (DO) sensor and to discuss correction method. Signal received from the DO sensor is sent to PC automatically without any external power supply. Oxygen content obtained with DO sensor was compared with iodometry. It was found that this method is reliable enough to determine oxygen content in La2-xSrxCuOy, and is called dissolved oxygen (DO) method. (C) 2014 The Ceramic Society of Japan. All rights reserved.	[Zhang, Dan; Kambe, Shiro; Tashiro, Akihiro; Ohba, Yasushi] Yamagata Univ, Grad Sch Sci & Engn, Organ Mat Program, Yonezawa, Yamagata 9928510, Japan; [Mizuguchi, Hitoshi; Ito, Kazunori; Kakizaki, Shinya; Okita, Yasuo] DKK TOA YAMAGATA Corp, Shinjo, Yamagata 9960053, Japan	Zhang, D (reprint author), Yamagata Univ, Grad Sch Sci & Engn, Organ Mat Program, 4-3-16 Johnan, Yonezawa, Yamagata 9928510, Japan.	zhangdan168@163.com					Karppinen M, 2002, J MATER CHEM, V12, P1761, DOI 10.1039/b200770n; TAKAGI H, 1989, PHYS REV B, V40, P2254, DOI 10.1103/PhysRevB.40.2254; CAVA RJ, 1990, PHYSICA C, V165, P419, DOI 10.1016/0921-4534(90)90376-P; Chen M, 2000, APPL SURF SCI, V158, P134, DOI 10.1016/S0169-4332(99)00601-7; Karppinen M, 1996, SUPERCOND SCI TECH, V9, P121, DOI 10.1088/0953-2048/9/3/001; Fukuoka A, 1996, PHYSICA C, V265, P13, DOI 10.1016/0921-4534(96)00288-2; Kambe S., 1999, ADV SUPERCONDUCTIVIT, P423; KANBE S, 1987, CHEM LETT, P547, DOI 10.1246/cl.1987.547; MURAKOSHI Y, 1991, PHYSICA C, V178, P71, DOI 10.1016/0921-4534(91)90159-V; Yasukawa Y, 2002, APPL PHYS LETT, V81, P502, DOI 10.1063/1.1490146	10	1	1	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	DEC	2014	122	1432					989	994		10.2109/jcersj2.122.989		6	Materials Science, Ceramics	Materials Science	AU3RB	WOS:000345530200005		
J	Terasaka, S; Kamitakahara, M; Yokoi, T; Ioku, K				Terasaka, Sota; Kamitakahara, Masanobu; Yokoi, Taishi; Ioku, Koji			Effect of preparation temperature on the ability of bone char to remove fluoride ion and organic contaminants	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Bone char; Hydroxyapatite; Char; Fluoride; Organic contaminants	SYNTHETIC HYDROXYAPATITE; AQUEOUS-SOLUTION; WATER-SUPPLIES; DEFLUORIDATION; ADSORPTION	The excessive intake of fluoride ion (F-) from drinking water causes dental and skeletal disorders and thus methods for the removal of F- from water are desired. A method for removing organic contaminants from water is also desired. Bone char is a composite material composed of char and hydroxyapatite (HA). Bone char can remove F- because of the HA in the bone char. It is expected that bone char containing small grain size HA will remove F- effectively because of its high surface area. Additionally, the char in bone char can remove organic matter from contaminated water, and controlling the amount of char in bone char is also important. Bone char is fabricated by heating porcine bone at 200-600 degrees C for 1 h under a limited oxygen supply. The grain size of HA in these samples increases with an increase in heating temperature. The amount of organic matter and char in these samples decreases with an increase in heating temperature. Bone char with a controlled HA grain size and the amount of char was fabricated by changing the heating temperature. Their ability to remove F- and methylene blue (MB), as a model organic contaminant, was evaluated by immersing the samples in F--containing and MB-containing solutions. The sample prepared at 400 degrees C was able to remove most of the F- and less than 1.5 mg.dm(-3) F- remained, which is within the World Health Organization recommended level for drinking water. Additionally, the sample prepared at 400 degrees C was also able to remove most of the MB. Bone char can thus be used to remove F- and organic contaminants. (C) 2014 The Ceramic Society of Japan. All rights reserved.	[Terasaka, Sota; Kamitakahara, Masanobu] Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Yokoi, Taishi; Ioku, Koji] Keio Univ, Fac Econ, Kohoku Ku, Yokohama, Kanagawa 2238521, Japan	Kamitakahara, M (reprint author), Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, 6-6-20 Aoba, Sendai, Miyagi 9808579, Japan.	kamitaka@mail.kankyo.tohoku.ac.jp					HOLDEN JL, 1995, J BONE MINER RES, V10, P1400; Leyva-Ramos R, 2010, CHEM ENG J, V158, P458, DOI 10.1016/j.cej.2010.01.019; Dorozhkin SV, 2007, J MATER SCI, V42, P1061, DOI 10.1007/s10853-006-1467-8; Kawasaki N, 2009, J OLEO SCI, V58, P529, DOI 10.5650/jos.58.529; Sternitzke V, 2012, ENVIRON SCI TECHNOL, V46, P802, DOI 10.1021/es202750t; Abe I, 2004, J COLLOID INTERF SCI, V275, P35, DOI 10.1016/j.jcis.2003.12.031; Girgis BS, 2002, MICROPOR MESOPOR MAT, V52, P105, DOI 10.1016/S1387-1811(01)00481-4; FRANT MS, 1968, ANAL CHEM, V40, P1169, DOI 10.1021/ac60263a005; Gao S, 2009, J FLUORINE CHEM, V130, P550, DOI 10.1016/j.jfluchem.2009.03.007; Sundaram CS, 2008, J HAZARD MATER, V155, P206, DOI 10.1016/j.jhazmat.2007.11.048; CHRISTOFFERSEN J, 1991, WATER RES, V25, P227, DOI 10.1016/0043-1354(91)90033-M; LAMBERT SD, 1995, WATER RES, V29, P2421, DOI 10.1016/0043-1354(95)00057-R; LARSEN MJ, 1994, ARCH ORAL BIOL, V39, P807, DOI 10.1016/0003-9969(94)90010-8; Medellin-Castillo NA, 2007, IND ENG CHEM RES, V46, P9205, DOI 10.1021/ie070023n; Miguel G.S., 2006, J CHEM TECHNOL BIOT, V81, P1685; Motoyama A., 2012, J JAPAN SOC CIVIL EN, V68, pIII_517; Onishi A, 2008, J THERM ANAL CALORIM, V92, P87, DOI 10.1007/s10973-007-8741-0	17	2	2	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	DEC	2014	122	1432					995	999		10.2109/jcersj2.122.995		5	Materials Science, Ceramics	Materials Science	AU3RB	WOS:000345530200006		
J	Siribudhaiwan, N; Atarashi, D; Nito, N; Miyauchi, M; Koibuchi, K; Sakai, E				Siribudhaiwan, Norrarat; Atarashi, Daiki; Nito, Nobukazu; Miyauchi, Masahiro; Koibuchi, Kiyoshi; Sakai, Etsuo			Hydration of blended cement with high alite content	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Blended cement; Blast-furnace slag; Fly ash; Cement hydration; Calorimeter; Heat liberation; High alite cement		We have produced a trial high alite cement in a cement plant and have researched the hydration reaction of the high alite cement with blended materials. The high alite blended cement has a higher heat of reaction and produces a more hydrated product than ordinary Portland cement, as confirmed by heat liberation from a calorimeter. The amount of Ca(OH)(2) (or CH) was confirmed to be higher than that of ordinary Portland cement. In this research, we focused on measuring the properties of blended high alite cement in the early hydration period. Results were obtained for hydrated samples at up to 28 days to ascertain the possibility of using high alite cement and its potential improvement in blending. (C) 2014 The Ceramic Society of Japan. All rights reserved.	[Siribudhaiwan, Norrarat] Grad Sch Sci & Engn, Tokyo Inst Technol, Dept Met & Ceram Sci, Meguro Ku, Tokyo 1528552, Japan; [Atarashi, Daiki; Nito, Nobukazu; Miyauchi, Masahiro; Koibuchi, Kiyoshi; Sakai, Etsuo] DC Corp, Dept Dev, Kawasaki, Kanagawa 2100854, Japan	Siribudhaiwan, N (reprint author), Grad Sch Sci & Engn, Tokyo Inst Technol, Dept Met & Ceram Sci, Meguro Ku, 2-12-1 O Okayama, Tokyo 1528552, Japan.	snorrarat87@gmail.com	Miyauchi, Masahiro/O-3535-2015				Ghosh S. N., 1991, CEMENT CONCRETE SC 1, VI, P314; Imoto H., 2002, CEM SCI CONCR TECHNO, V56, P42; Japan Society of Civil Engineers (JSCE), 2009, CONCRETE LIB, V132, P316; Japan Society of Civil Engineers (JSCE), 2005, CONCRETE LIB, V125, P48; Sakai E., 2010, P INT S CEM CONCR IS, VII, P1439; Taylor H. F. W., 1997, CEMENT CHEM; Walter AG, 1990, CEMENT CONCRETE RES, V20, P778; Wesselsky A, 2009, CEMENT CONCRETE RES, V39, P973, DOI 10.1016/j.cemconres.2009.07.013	8	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	DEC	2014	122	1432					1004	1009		10.2109/jcersj2.122.1004		6	Materials Science, Ceramics	Materials Science	AU3RB	WOS:000345530200008		
J	Yamada, S; Ota, Y; Nakamura, J; Sakka, Y; Kasuga, T				Yamada, Shinya; Ota, Yoshio; Nakamura, Jin; Sakka, Yoshio; Kasuga, Toshihiro			Preparation of siloxane-containing vaterite doped with magnesium	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Calcium carbonate; Vaterite; ion release; Magnesium; Siloxane	GUIDED BONE REGENERATION; CALCIUM-CARBONATE POLYMORPHS; IN-VITRO; BICARBONATE SOLUTION; PHOSPHATE CERAMICS; FT-IR; TRANSFORMATION; IONS; MEMBRANES; KINETICS	Siloxane-containing vaterite doped with magnesium (MgSiV) was prepared by a carbonation process for application in bone regeneration. Ca(OH)(2), aminopropyltriethoxysilane (APTES) and Mg(OH)(2) were mixed with a solvent consisting of methanol and distilled water under CO2 gas. After the mixture was aged, the translucent precursor gel was dried, resulting in the formation of MgSiV particles containing 2.0 wt% magnesium and 2.8 wt% silicon. The MgSiV consists of distorted spherical particles with diameters of approximately 1.3 mu m and a thickness of approximately 0.6 mu m while the siloxane-containing vaterite without magnesium (SiV) was spherical with a diameter of approximately 1.5 mu m. X-ray diffraction (XRD) analysis suggests the incorporation of magnesium into the vaterite structure. Fourier transform infrared spectroscopy (FTIR) indicated the presence of amorphous calcium carbonate (ACC) while the magnesium and the siloxane formed Si-O-Mg bonds. After heating the MgSiV at 500 degrees C, the magnesium removed from the vaterite structure formed Si-O-Mg bonds with the siloxane. The MgSiV released Ca2+, Mg2+ and Si4+ ions into a Tris buffer solution. The amount of Ca2+ ion dissolved in the Tris buffer solution increased within the initial 12 h and subsequently decreased with time because of the formation of precipitates. (C) 2014 The Ceramic Society of Japan. All rights reserved.	[Yamada, Shinya; Ota, Yoshio] Yabashi Ind Co Ltd, Ogaki, Gifu 5032213, Japan; [Nakamura, Jin; Sakka, Yoshio] Natl Inst Mat Sci, Mat Proc Unit, Adv Key Technol Div, Tsukuba, Ibaraki 3050047, Japan; [Kasuga, Toshihiro] Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan	Kasuga, T (reprint author), Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	kasuga.toshihiro@nitech.ac.jp			Institute of Ceramics Research and Education (ICRE), Nagoya Institute of Technology	This work was supported in part by the Institute of Ceramics Research and Education (ICRE), Nagoya Institute of Technology.	Alonso R. P., 2007, J MATER SCI, V42, P595; KITANO Y, 1962, B CHEM SOC JPN, V35, P1973, DOI 10.1246/bcsj.35.1973; Maeda H, 2006, BIOMATERIALS, V27, P1216, DOI 10.1016/j.biomaterials.2005.08.010; Saboori A, 2009, MAT SCI ENG C-BIO S, V29, P335, DOI 10.1016/j.msec.2008.07.004; Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z; Obata A, 2009, ACTA BIOMATER, V5, P57, DOI 10.1016/j.actbio.2008.08.004; Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006; Maier JAM, 2004, BBA-MOL BASIS DIS, V1689, P6, DOI 10.1016/j.bbadis.2004.02.004; Madejova J, 2003, VIB SPECTROSC, V31, P1, DOI 10.1016/S0924-2031(02)00065-6; Vagenas NV, 2003, TALANTA, V59, P831, DOI 10.1016/S0039-9140(02)00638-0; Kitamura M, 2001, J COLLOID INTERF SCI, V236, P318, DOI 10.1006/jcis.2000.7398; Wang JW, 2009, AM MINERAL, V94, P380, DOI 10.2138/am.2009.2939; ANDERSEN FA, 1991, ACTA CHEM SCAND, V45, P1018, DOI 10.3891/acta.chem.scand.45-1018; Politi Y, 2010, CHEM MATER, V22, P161, DOI 10.1021/cm902674h; RAO MS, 1973, B CHEM SOC JPN, V46, P1414, DOI 10.1246/bcsj.46.1414; Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270; Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503; Obata A, 2010, ACTA BIOMATER, V6, P1248, DOI 10.1016/j.actbio.2009.11.013; Morse JW, 1997, GEOLOGY, V25, P85, DOI 10.1130/0091-7613(1997)025<0085:IOTAMC>2.3.CO;2; Madejova J, 1998, SPECTROCHIM ACTA A, V54, P1397, DOI 10.1016/S1386-1425(98)00040-7; Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404; Nakamura J, 2013, J MATER CHEM B, V1, P4446, DOI 10.1039/c3tb20589d; Kim JY, 2009, J COLLOID INTERF SCI, V329, P114, DOI 10.1016/j.jcis.2008.09.031; BISCHOFF JL, 1968, J GEOPHYS RES, V73, P3315, DOI 10.1029/JB073i010p03315; BISH DL, 1988, J APPL CRYSTALLOGR, V21, P86, DOI 10.1107/S0021889887009415; Bottcher ME, 1997, SOLID STATE IONICS, V101, P1379, DOI 10.1016/S0167-2738(97)00235-X; Falini G, 2009, CRYST GROWTH DES, V9, P2065, DOI 10.1021/cg8002959; Falini G, 1996, CHEM COMMUN, P1037, DOI 10.1039/cc9960001037; Finch AA, 2007, MINERAL MAG, V71, P539, DOI 10.1180/minmag.2007.071.5.539; Hench L.L., 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611; JARCHO M, 1981, CLIN ORTHOP RELAT R, P259; KITANO Y, 1979, GEOCHEM J, V13, P181; LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81; MUCCI A, 1986, GEOCHIM COSMOCHIM AC, V50, P2255, DOI 10.1016/0016-7037(86)90080-3; Nebel H, 2008, Z ANORG ALLG CHEM, V634, P1439, DOI 10.1002/zaac.200800134; SAWADA K, 1990, J CRYST GROWTH, V106, P393, DOI 10.1016/0022-0248(90)90084-X; Tokuda S, 2009, ACTA BIOMATER, V5, P1163, DOI 10.1016/j.actbio.2008.10.005; Wakita T, 2009, MATER TRANS, V50, P1737, DOI 10.2320/matertrans.MF200912; WINTER M, 1981, BIOMATERIALS, V2, P159, DOI 10.1016/0142-9612(81)90043-0; Xu X, 2006, J PHYS CHEM B, V110, P2764, DOI 10.1021/jp055712w; Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134; Zhang Z., 2002, J CRYST GROWTH, V343, P62	42	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	DEC	2014	122	1432					1010	1015		10.2109/jcersj2.122.1010		6	Materials Science, Ceramics	Materials Science	AU3RB	WOS:000345530200009		
J	Yanagida, T; Watanabe, K; Fujimoto, Y; Uritani, A; Yagi, H; Yanagitani, T				Yanagida, Takayuki; Watanabe, Kenichi; Fujimoto, Yutaka; Uritani, Akira; Yagi, Hideki; Yanagitani, Takagimi			Scintillation properties of composite ceramic YAG and its capability on pulse shape descrimination	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Composite ceramic; YAG; Scintillator; Pulse shape discrimination; Gamma-ray	RAY; COLLIMATORS	Transparent ceramic composite of non-doped and Ce-doped YAG was prepared by Konoshima Chemical with the vacuum sintering technique and investigated on pulse shape discrimination capability for functional collimator. Scintillation responses such as X-ray induced radioluminescence and decay time profiles of non-doped and Ce-doped YAG were evaluated. Pulse shape discrimination capability of the composite ceramic was evaluated by Cs-137 662 keV gamma-ray irradiation. As a result, clear separation of gamma-ray events at non-doped or Ce-doped YAG layers was observed in two dimensional histogram by using signal processing with two different shaping times. (C) 2014 The Ceramic Society of Japan. All rights reserved.	[Yanagida, Takayuki] Kyushu Inst Technol, Aizu Wakamatsu, Kitakyushu 8080196, Japan; [Watanabe, Kenichi; Fujimoto, Yutaka; Uritani, Akira] Nagoya Univ, Nagoya, Aichi 4648603, Japan; [Yagi, Hideki; Yanagitani, Takagimi] Konoshima Chem, Mitoya, Kagawa 7691103, Japan	Yanagida, T (reprint author), Kyushu Inst Technol, 2-4 Hibikino, Aizu Wakamatsu, Kitakyushu 8080196, Japan.	yanagida@lsse.kyutech.ac.jp	Yanagida, Takayuki/F-1814-2014	Yanagida, Takayuki/0000-0002-4298-5886	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government (MEXT) [26249147]; JST A-step; Collaborative Research Program of Institute for Chemical Research, Kyoto University [2014-31]	This work was mainly supported by a Grant in Aid for Scientific Research (A)-26249147 from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government (MEXT) and partially by JST A-step. Partial assistance from Nippon Sheet Glass Foundation for Materials Science and Engineering, Tokuyama Science foundation, Iketani Science and Technology Foundation, Hitachi Metals Materials Science Foundation, Mazda Foundation, JFE 21st century Foundation, and The Asahi Glass Foundation, the Cooperative Research Project of Research Institute of Electronics, Shizuoka University and Collaborative Research Program of Institute for Chemical Research, Kyoto University (2014-31) are also gratefully acknowledged.	Totsuka D, 2011, NUCL INSTRUM METH A, V659, P399, DOI 10.1016/j.nima.2011.08.014; Liu WB, 2014, CERAM INT, V40, P8879, DOI 10.1016/j.ceramint.2013.12.152; Yanagida T, 2013, OPT MATER, V35, P1987, DOI 10.1016/j.optmat.2012.11.002; Yanagida T, 2013, OPT MATER, V35, P2480, DOI 10.1016/j.optmat.2013.07.002; Yanagida T, 2010, IEEE T NUCL SCI, V57, P1492, DOI 10.1109/TNS.2009.2032265; Watanabe K, 2011, NUCL INSTRUM METH A, V652, P582, DOI 10.1016/j.nima.2011.01.153; Liu WB, 2012, J ALLOY COMPD, V527, P66, DOI 10.1016/j.jallcom.2012.02.161; Yagi H, 2005, LASER PHYS, V15, P1338; BORTFELD TR, 1994, INT J RADIAT ONCOL, V28, P723; Yanagida T, 2005, IEEE T NUCL SCI, V52, P1836, DOI 10.1109/TNS.2005.856757; Fujimoto Y, 2014, OPT MATER, V36, P1926, DOI 10.1016/j.optmat.2014.06.019; Yanagida T, 2013, RADIAT MEAS, V55, P99, DOI 10.1016/j.radmeas.2012.05.014; Kokubun M, 2004, IEEE T NUCL SCI, V51, P1991, DOI 10.1109/TNS.2004.832921; Chukalina M, 2007, SPECTROCHIM ACTA B, V62, P544, DOI 10.1016/j.sab.2007.02.020; Ito T., 2006, IEEE T NUCL SCI, V53, P2983; Lee P C, 1997, Med Dosim, V22, P59, DOI 10.1016/S0958-3947(96)00149-5; Lemeshev DO, 2012, GLASS CERAM+, V69, P178, DOI 10.1007/s10717-012-9440-2; Petrashen P, 2001, NUCL INSTRUM METH A, V467, P358, DOI 10.1016/S0168-9002(01)00324-2; Prasad S C, 1996, Med Dosim, V21, P105, DOI 10.1016/0958-3947(96)00024-6; Takahashi H, 2006, IEEE T NUCL SCI, V53, P2404, DOI 10.1109/TNS.2006.878575; Yanagida T, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.056202; Yanagida T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.076401	22	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	DEC	2014	122	1432					1016	1019		10.2109/jcersj2.122.1016		4	Materials Science, Ceramics	Materials Science	AU3RB	WOS:000345530200010		
J	Yamashita, M; Matsumoto, S; Akai, T; Sugita, H; Imoto, Y; Komai, T; Sakanakura, H				Yamashita, Masaru; Matsumoto, Sachiko; Akai, Tomoko; Sugita, Hajime; Imoto, Yukari; Komai, Takeshi; Sakanakura, Hirofumi			Leaching behavior of cathode ray tube (CRT) glasses	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Lead silicate glass; Chemical durability; CRT glass; Leaching; Environmental safety	LEAD SILICATE-GLASSES; FUNNEL GLASS; ACID-SOLUTIONS; RECOVERY; RELEASE; WATER	The leaching behavior of cathode ray tube (CRT) funnel and neck glasses were compared in 0.001 N HCl and 0.001 N NaOH at 70 and 90 degrees C. We measured the weight loss and leached amount of each component and observed the surface changes by scanning electron microscopy (SEM). In acid solution funnel glass showed t(1/2)-dependent leaching, whereas neck glass only demonstrated congruent dissolution after 8 weeks. In basic solutions leaching behavior was almost equivalent for both types of glass. Dissolution halted after one or two weeks as a result of the deposition of a protective layer. This layer was formed by saturation of Pb and was subsequently dissolvable by refreshing the leachant solution. (C) 2014 The Ceramic Society of Japan. All rights reserved.	[Yamashita, Masaru; Matsumoto, Sachiko; Akai, Tomoko] Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, Adv Glass Grp, Ikeda, Osaka 5638577, Japan; [Sugita, Hajime; Imoto, Yukari; Komai, Takeshi] Natl Inst Adv Ind Sci & Technol, Inst Georesources & Environm, Tsukuba, Ibaraki 3058569, Japan; [Komai, Takeshi] Tohoku Univ, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Sakanakura, Hirofumi] Natl Inst Environm Studies, Ctr Mat Cycles & Waste Management Res, Tsukuba, Ibaraki 3058506, Japan	Yamashita, M (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, Adv Glass Grp, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan.	m-yamashita1@ni.aist.go.jp					Ahmed AA, 1997, GLASS TECHNOL, V38, P171; Andreola F, 2005, WASTE MANAGE, V25, P183, DOI 10.1016/j.wasman.2004.12.007; Dondi M, 2009, WASTE MANAGE, V29, P1945, DOI 10.1016/j.wasman.2008.12.003; Mizuno M, 2005, J AM CERAM SOC, V88, P2908, DOI 10.1111/j.1551-2916.2005.00508.x; Yamashita M, 2010, J HAZARD MATER, V184, P58, DOI 10.1016/j.jhazmat.2010.08.002; Rahimi RA, 2009, J NON-CRYST SOLIDS, V355, P169, DOI 10.1016/j.jnoncrysol.2008.11.001; Okada T, 2013, WASTE MANAGE, V33, P1758, DOI 10.1016/j.wasman.2013.04.009; [Anonymous], 1981, NUCL WAST MAT HDB TE; Chen MJ, 2009, J HAZARD MATER, V161, P1109, DOI 10.1016/j.jhazmat.2008.04.084; Okada T, 2012, J SOC INF DISPLAY, V20, P508, DOI 10.1002/jsid.113; Mear F, 2006, WASTE MANAGE, V26, P1468, DOI 10.1016/j.wasman.2005.11.017; HENCH LL, 1978, J NON-CRYST SOLIDS, V28, P83, DOI 10.1016/0022-3093(78)90077-7; [Anonymous], ANN REP HOM APPL REC, P23; Musson SE, 2000, ENVIRON SCI TECHNOL, V34, P4376, DOI 10.1021/es0009020; Bertoncello R, 2004, APPL PHYS A-MATER, V79, P193, DOI 10.1007/s00339-004-2651-9; Bonnet C, 2003, J NON-CRYST SOLIDS, V323, P214, DOI 10.1016/S0022-3093(03)00279-5; Cailleteau C, 2008, J NON-CRYST SOLIDS, V354, P117, DOI 10.1016/j.jnoncrysol.2007.07.063; Carmona N, 2005, MATER CHEM PHYS, V94, P92, DOI 10.1016/j.matchemphys.2005.04.026; DSouza A, 1996, PHYS CHEM GLASSES, V37, P79; Guadagnino E, 2002, GLASS TECHNOL, V43, P63; Keith A, 2008, J ENVIRON SCI HEAL A, V43, P1717, DOI 10.1080/10934520802330305; LEHMAN RL, 1992, J AM CERAM SOC, V75, P2194, DOI 10.1111/j.1151-2916.1992.tb04483.x; Ling TC, 2012, J HAZARD MATER, V199, P321, DOI 10.1016/j.jhazmat.2011.11.019; Maschio S., 2013, J WASTE MANAGEMENT, V2013, P8; Mostaghel S, 2010, WASTE MANAGE, V30, P140, DOI 10.1016/j.wasman.2009.09.025; Munzenberg C. S., 1998, J NONCRYST SOLIDS, V238, P83; Yot PG, 2009, J HAZARD MATER, V172, P117, DOI 10.1016/j.jhazmat.2009.06.137	27	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	DEC	2014	122	1432					1020	1027		10.2109/jcersj2.122.1020		8	Materials Science, Ceramics	Materials Science	AU3RB	WOS:000345530200011		
J	Paul, C; Reich, K; Gottlieb, AB; Mrowietz, U; Philipp, S; Nakayama, J; Harfst, E; Guettner, A; Papavassilis, C				Paul, C.; Reich, K.; Gottlieb, A. B.; Mrowietz, U.; Philipp, S.; Nakayama, J.; Harfst, E.; Guettner, A.; Papavassilis, C.		CAIN457A2211 Study Grp	Secukinumab improves hand, foot and nail lesions in moderate-to-severe plaque psoriasis: subanalysis of a randomized, double-blind, placebo-controlled, regimen-finding phase 2 trial	JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY			English	Article							PALMOPLANTAR PSORIASIS; EFFICACY; THERAPY; USTEKINUMAB; SAFETY; ETANERCEPT; ADALIMUMAB	BackgroundPsoriasis affecting sites such as the hands, feet and nails can be particularly difficult to treat. There are limited data on the efficacy of biological agents to treat these specific localizations. ObjectiveThis analysis of a phase 2 regimen-finding study evaluated the efficacy of secukinumab in subjects with moderate-to-severe psoriasis and non-pustular involvement of the hands, feet and/or nails. MethodsSubjects were randomized (1:2:2:1) to one of three subcutaneous secukinumab 150-mg induction regimens [Single (Week 0), Monthly (Weeks 0, 4, 8), Early (Weeks 0, 1, 2, 4)] or placebo. In the subgroup (n=131) with hand and/or foot psoriasis [baseline 5-point hand/foot Investigator's Global Assessment (IGA) score 2], efficacy was assessed as percentage of subjects achieving an IGA response [a score of 0 (clear) or 1 (minimal) and an improvement of 2 points on the 5-point hand/foot scale vs. baseline] at Week 12. In the subgroup (n=304) with fingernail psoriasis (baseline composite score 1), efficacy was assessed as mean percentage change from baseline to Week 12 in a composite score. ResultsAt Week 12, a markedly higher percentage of subjects with hand and/or foot psoriasis achieved an IGA response with the Early regimen vs. placebo (54.3% vs. 19.2%, P=0.005). The composite fingernail score improved with the Early and Monthly regimens, but worsened with placebo [percentage mean change from baseline (SE): -19.1% (6.12) and -10.6% (7.06) vs. 14.4% (11.92); P=0.010 vs. placebo for Early, P=0.027 for Monthly). Secukinumab was well tolerated. ConclusionSecukinumab demonstrated a beneficial effect on psoriasis of the hands/feet/nails in this short-term assessment.	[Paul, C.] Univ Toulouse 3, F-31062 Toulouse, France; [Reich, K.] Dermatologikum Hamburg, Hamburg, Germany; [Gottlieb, A. B.] Tufts Med Ctr, Dept Dermatol, Boston, MA USA; [Mrowietz, U.] Univ Med Ctr Schleswig Holstein, Dept Dermatol, Psoriasis Ctr, Kiel, Germany; [Philipp, S.] Charite, Dept Dermatol, D-13353 Berlin, Germany; [Nakayama, J.] Fukuoka Univ Hosp, Dept Dermatol, Fukuoka, Japan; [Harfst, E.; Guettner, A.; Papavassilis, C.] Novartis Pharma AG, Basel, Switzerland	Paul, C (reprint author), Univ Toulouse 3, F-31062 Toulouse, France.	paul.c@chu-toulouse.fr			Novartis Pharma AG	Funded by Novartis Pharma AG; ClinicalTrials.gov number: NCT00941031	Herrier RN, 2011, AM J HEALTH-SYST PH, V68, P795, DOI 10.2146/ajhp100227; Wozel G, 2008, CLIN DERMATOL, V26, P448, DOI 10.1016/j.clindermatol.2007.10.026; Rich P, 2013, BRIT J DERMATOL, V168, P402, DOI 10.1111/bjd.12112; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238; Leonardi C, 2011, ARCH DERMATOL, V147, P429, DOI 10.1001/archdermatol.2010.384; Lebwohl M, 2003, LANCET, V361, P1197, DOI 10.1016/S0140-6736(03)12954-6; Luger TA, 2009, J EUR ACAD DERMATOL, V23, P896, DOI 10.1111/j.1468-3083.2009.03211.x; Pettey AA, 2003, J AM ACAD DERMATOL, V49, P271, DOI 10.1067/S0190-9622(03)01479-8; Jacobson CC, 2011, J AM ACAD DERMATOL, V65, P870, DOI 10.1016/j.jaad.2009.05.047; Papp KA, 2013, BRIT J DERMATOL, V168, P412, DOI 10.1111/bjd.12110; Christophers E, 2013, J DERMATOL TREAT, V24, P193, DOI 10.3109/09546634.2012.697112; Rigopoulos D, 2010, J EUR ACAD DERMATOL, V24, P530, DOI 10.1111/j.1468-3083.2009.03453.x; Rigopoulos D, 2011, DERMATOLOGY, V223, P325, DOI 10.1159/000334482; Au SC, 2013, J DERMATOL TREAT, V24, P179, DOI 10.3109/09546634.2012.672710; desJong EM, 1996, DERMATOLOGY, V193, P300; desVries AC, 2013, COCHRANE DB SYST REV, V1; DisLernia V, 2010, DERMATOL ONLINE J, V16, P8; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Livideanu CB, 2010, DERMATOLOGY, V221, P321, DOI 10.1159/000320961; Menter A, 2008, J AM ACAD DERMATOL, V58, P826, DOI 10.1016/j.jaad.2008.02.039; Ortonne JP, 2013, BRIT J DERMATOL, V168, P1080, DOI 10.1111/bjd.12060; Radtke Marc A, 2011, Patient Relat Outcome Meas, V2, P1, DOI 10.2147/PROM.S14861; Reich K, 2009, J EUR ACAD DERMATOL, V23, P15, DOI 10.1111/j.1468-3083.2009.03364.x	23	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0926-9959	1468-3083		J EUR ACAD DERMATOL	J. Eur. Acad. Dermatol. Venereol.	DEC	2014	28	12					1670	1675		10.1111/jdv.12359		6	Dermatology	Dermatology	AU0YS	WOS:000345348800009		
J	Imafuku, S; Nakayama, J; Higa, K; Furue, M; Takahara, M; Katayama, I; Tani, M				Imafuku, S.; Nakayama, J.; Higa, K.; Furue, M.; Takahara, M.; Katayama, I.; Tani, M.			One-year follow-up of zoster-associated pain in 764 immunocompetent patients with acute herpes zoster treated with famciclovir (FAMILIAR study)	JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY			English	Article							PLACEBO-CONTROLLED TRIAL; POSTHERPETIC NEURALGIA; ORAL ACYCLOVIR; CLINICAL-TRIAL; DOUBLE-BLIND; METAANALYSIS; MANAGEMENT; EFFICACY; THERAPY	BackgroundHerpes zoster (HZ), a reactivation of varicella zoster virus manifested by skin blisters and neuralgia, can lead to postherpetic neuralgia in 10-20% of affected subjects. MethodIn this study, a cohort of 764 patients with HZ was treated with 1500mg/day of famciclovir for 7days, and zoster-associated pain (ZAP) was monitored monthly thereafter for up to 12months until pain resolution was achieved. Patients were questioned monthly by telephone, and pain was recorded using a numerical rating scale (NRS, 0-10). Key resultsA total of 751 of 764 (98.3%) patients completed follow-up. The percentage of patients with ZAP was 12.4% at day 90, 7.1% at 6months and 4.0% at 1year. After the third month, the NRS were 3 or less in most of the remaining patients with ZAP. Stratified analysis revealed significant persistence of ZAP in patients aged 50years and in those aged 65years, and in patients with either moderate-to-severe skin symptoms or severe pain at the initial consultation. Stratified analyses unexpectedly showed patients who commenced famciclovir at 0-2days after onset of the eruption had a higher prevalence of ZAP at day 90 than those treated at 3-5days or 6days after rash onset (P=0.0164, log-rank test). On further analysis, a higher proportion of patients (45.4%) treated at 0-2days had moderate to severe symptoms compared with those treated at 3-5days (40.5%) or 6days (37.0%) (P=0.0987, Cochran-Armitage test). Conclusion & InferenceThis study, with an exceptionally high follow-up rate, revealed several new findings, including the influence of disease severity on the delay between the onset of symptoms and seeking medical attention. Six adverse drug reactions were reported in five of 721 patients in the safety analysis, including two severe cases of vomiting and convulsions.	[Imafuku, S.; Nakayama, J.] Fukuoka Univ, Dept Dermatol, Fukuoka 81401, Japan; [Higa, K.] Fukuoka Univ, Dept Anesthesiol, Fukuoka 81401, Japan; [Furue, M.; Takahara, M.] Kyushu Univ, Dept Dermatol, Fukuoka 812, Japan; [Katayama, I.; Tani, M.] Osaka Univ, Dept Dermatol, Osaka, Japan	Imafuku, S (reprint author), Fukuoka Univ, Dept Dermatol, Fukuoka 81401, Japan.	dermatologist@mac.com			Asahi Kasei Pharma Corporation in Japan; Maruho Co., Ltd. in Japan	This study was sponsored by Asahi Kasei Pharma Corporation, which obtained manufacturing and marketing approval of famciclovir (Famvir (R) 250 mg tablets) in Japan, and Maruho Co., Ltd., the designated distributor of famciclovir in Japan.	Dworkin RH, 2003, NEUROLOGY, V60, P1274; DEGREEF H, 1994, INT J ANTIMICROB AG, V4, P241, DOI 10.1016/0924-8579(94)90024-8; Tyring SK, 2000, ARCH FAM MED, V9, P863, DOI 10.1001/archfami.9.9.863; Imafuku S, 2008, INT J DERMATOL, V47, P36, DOI 10.1111/j.1365-4632.2007.03548.x; Shafran SD, 2004, J CLIN VIROL, V29, P248, DOI 10.1016/S1386-6532(03)00164-1; Arani RB, 2001, STAT MED, V20, P2429, DOI 10.1002/sim.851.abs; Aunhachoke K, 2011, INT J DERMATOL, V50, P428, DOI 10.1111/j.1365-4632.2010.04715.x; BOYD MR, 1987, ANTIMICROB AGENTS CH, V31, P1238; Desmond RA, 2002, J PAIN SYMPTOM MANAG, V23, P510, DOI 10.1016/S0885-3924(02)00393-7; Dworkin RH, 1997, ANTIVIR RES, V33, P73, DOI 10.1016/S0166-3542(96)01007-8; Dworkin RH, 2007, CLIN INFECT DIS, V44, pS1, DOI 10.1086/510206; Dworkin RH, 1998, J INFECT DIS, V178, pS76, DOI 10.1086/514260; Jackson JL, 1997, ARCH INTERN MED, V157, P909, DOI 10.1001/archinte.157.8.909; Li QF, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006866.pub2; Lukas K, 2012, Z GESUNDH WISS, V20, P441; McDonald EM, 2012, ANTIVIR THER, V17, P255, DOI 10.3851/IMP2011; Shen Meng-Chuan, 2004, Journal of Microbiology Immunology and Infection, V37, P75; TYRING S, 1995, ANN INTERN MED, V123, P89; Tyring SK, 1996, SEMIN DERMATOL, V15, P27; Wassilew S, 2005, J EUR ACAD DERMATOL, V19, P47; Wood MJ, 1996, CLIN INFECT DIS, V22, P341	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0926-9959	1468-3083		J EUR ACAD DERMATOL	J. Eur. Acad. Dermatol. Venereol.	DEC	2014	28	12					1716	1722		10.1111/jdv.12379		7	Dermatology	Dermatology	AU0YS	WOS:000345348800016		
J	Taniguchi, T; Asano, Y; Tamaki, Z; Akamata, K; Aozasa, N; Noda, S; Takahashi, T; Ichimura, Y; Toyama, T; Sugita, M; Sumida, H; Kuwano, Y; Miyazaki, M; Yanaba, K; Sato, S				Taniguchi, T.; Asano, Y.; Tamaki, Z.; Akamata, K.; Aozasa, N.; Noda, S.; Takahashi, T.; Ichimura, Y.; Toyama, T.; Sugita, M.; Sumida, H.; Kuwano, Y.; Miyazaki, M.; Yanaba, K.; Sato, S.			Histological features of localized scleroderma 'en coup de sabre': a study of 16 cases	JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY			English	Article							MORPHEA; EPIDEMIOLOGY; DERMATITIS; LINES	BackgroundEarly lesions of localized scleroderma are histologically characterized by perivascular lymphocytic infiltrate in the reticular dermis and swollen endothelial cells. However, there have been few information regarding histological features other than these findings in localized scleroderma. ObjectiveSince en coup de sabre (ECDS) is a certain subset of localized scleroderma with a relatively uniform clinical manifestation, we focused on this disease subset and evaluated its histopathological features. MethodsA total of 16 patients with ECDS were retrospectively evaluated on the basis of clinical and histological findings. ResultsRegardless of clinical manifestations, vacuolar degeneration was found in all of the ECDS patients. Importantly, keratinocyte necroses were restricted to early and active ECDS lesions. In early ECDS patients (disease duration of <3years), moderate to severe perivascular and/or periappendageal lymphocytic infiltrate and vacuolar changes in follicular epithelium were more prominent, whereas epidermal atrophy was less frequently observed, than in late ECDS patients (disease duration of 6years). ConclusionVacuolar degeneration at the dermoepidermal junction is a common histological feature in ECDS and perivascular and/or periappendageal lymphocytic infiltrate and vacuolar degeneration of follicular epithelium are characteristic especially in early ECDS, further supporting a canonical idea that the elimination of mutated epidermal cells by immune surveillance contributes to tissue damage and resultant fibrosis in localized scleroderma.	[Taniguchi, T.; Asano, Y.; Tamaki, Z.; Akamata, K.; Aozasa, N.; Noda, S.; Takahashi, T.; Ichimura, Y.; Toyama, T.; Sugita, M.; Sumida, H.; Kuwano, Y.; Miyazaki, M.; Yanaba, K.; Sato, S.] Univ Tokyo Grad Sch Med, Dept Dermatol, Tokyo, Japan	Asano, Y (reprint author), Univ Tokyo Grad Sch Med, Dept Dermatol, Tokyo, Japan.	yasano-tky@umin.ac.jp					Fett N, 2011, J AM ACAD DERMATOL, V64, P217, DOI 10.1016/j.jaad.2010.05.045; Christen-Zaech S, 2008, J AM ACAD DERMATOL, V59, P385, DOI 10.1016/j.jaad.2008.05.005; Kurzinski K, 2011, CYTOKINE, V55, P157, DOI 10.1016/j.cyto.2011.04.001; Peterson LS, 1997, J RHEUMATOL, V24, P73; McNiff JM, 1999, AM J DERMATOPATH, V21, P315, DOI 10.1097/00000372-199908000-00001; Zulian F, 2006, RHEUMATOLOGY, V45, P614, DOI 10.1093/rheumatology/kei251; BOLOGNIA JL, 1994, J AM ACAD DERMATOL, V31, P157; FALANGA V, 1989, MED CLIN N AM, V73, P1143; Ghoreishi M, 2012, EXP DERMATOL, V21, P417, DOI 10.1111/j.1600-0625.2012.01475.x; PETERSON LS, 1995, MAYO CLIN PROC, V70, P1068; Santini SM, 2011, PLOS ONE, V6; Sontheimer RD, 2009, J INVEST DERMATOL, V129, P1088, DOI [10.1038/sj.jid.2009.42, 10.1038/jid.2009.42]; Succaria F, 2013, J EUR ACAD DERMATOL, V27, pE191, DOI 10.1111/j.1468-3083.2012.04581.x; Weibel L, 2008, BRIT J DERMATOL, V159, P175, DOI 10.1111/j.1365-2133.2008.08647.x; Wenzel J, 2008, J INVEST DERMATOL, V128, P2392, DOI 10.1038/jid.2008.96	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0926-9959	1468-3083		J EUR ACAD DERMATOL	J. Eur. Acad. Dermatol. Venereol.	DEC	2014	28	12					1805	1810		10.1111/jdv.12280		6	Dermatology	Dermatology	AU0YS	WOS:000345348800029		
J	Sugiura, K; Haruna, K; Suga, Y; Akiyama, M				Sugiura, K.; Haruna, K.; Suga, Y.; Akiyama, M.			Generalized pustular psoriasis caused by deficiency of interleukin-36 receptor antagonist successfully treated with granulocyte and monocyte adsorption apheresis	JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY			English	Letter									[Sugiura, K.; Akiyama, M.] Nagoya Univ Grad Sch Med, Dept Dermatol, Nagoya, Aichi, Japan; [Haruna, K.; Suga, Y.] Juntendo Univ Urayasu Hosp, Dept Dermatol, Urayasu, Japan	Sugiura, K (reprint author), Nagoya Univ Grad Sch Med, Dept Dermatol, Nagoya, Aichi, Japan.	kazusugi@med.nagoya-u.ac.jp	Sugiura, Kazumitsu /M-8913-2014	Sugiura, Kazumitsu /0000-0002-5207-4592			Sugiura K, 2013, J INVEST DERMATOL, V133, P2514, DOI 10.1038/jid.2013.230; Ikeda S, 2013, J AM ACAD DERMATOL, V68, P609, DOI 10.1016/j.jaad.2012.09.037; Cowen EW, 2012, ARCH DERMATOL, V148, P381, DOI 10.1001/archdermatol.2011.3014; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Suzuki A, 2012, THER APHER DIAL, V16, P445, DOI 10.1111/j.1744-9987.2012.01109.x	5	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0926-9959	1468-3083		J EUR ACAD DERMATOL	J. Eur. Acad. Dermatol. Venereol.	DEC	2014	28	12					1835	1836		10.1111/jdv.12383		2	Dermatology	Dermatology	AU0YS	WOS:000345348800038		
J	Tang, XH; Tang, CZ; Su, H; Luo, HN; Nakamura, T; Yatani, H				Tang, Xuehua; Tang, Chengzhong; Su, Han; Luo, Huinan; Nakamura, Takashi; Yatani, Hirofumi			The effects of repeated heat-pressing on the mechanical properties and microstructure of IPS e.max Press	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						IPS e.max Press; Repeated heat-pressing; Mechanical properties; Microstructure	DISILICATE GLASS-CERAMICS; FIXED PARTIAL DENTURES; FRACTURE-TOUGHNESS; FLEXURAL STRENGTH; ZIRCONIA FRAMEWORKS; VENEERING CERAMICS; DENTAL CERAMICS; SURVIVAL RATES; SINGLE CROWNS; PART I	Objectives: We evaluated the effects of repeated heat-pressing on the mechanical properties and microstructure of IFS e.max Press. Methods: A total of 20 specimens were fabricated including 10 heat-pressed once and another 10 heat-pressed twice. The density, porosity, and surface roughness (Ra) were evaluated. Three-point flexural strength following the ISO 6872 and Vickers hardness were measured, and fracture toughness (K-IC) was calculated. Specimens were characterized using X-ray diffraction (XRD) and scanning electron microscopy (SEM). Results: Compared to a single heat-press treatment, the density decreased and porosity increased after two heat-pressing events. A significant difference in density was observed. The flexural strength, Vickers hardness and fracture toughness significantly decreased after two heat-pressing events. The XRD patterns show that the intensity of the crystalline phase better corresponds to lithium disilicate (Li2Si2O5) after two heat-presses than only one. The SEM images detailed the interlocking microstructure of rod-shaped Li2Si2O5 crystals after one heat-press. These became oriented after two heat-presses, and the crystal size became larger. Conclusion: This study showed that repeated heat-pressing was detrimental to the density, porosity, strength, hardness, and toughness of IPS e.max Press. (C) 2014 Elsevier Ltd. All rights reserved.	[Tang, Xuehua; Tang, Chengzhong; Su, Han; Luo, Huinan] Nanjing Univ, Sch Med, Jinling Hosp, Dept Stomatol, Nanjing 210002, Jiangsu, Peoples R China; [Tang, Xuehua; Nakamura, Takashi; Yatani, Hirofumi] Osaka Univ, Grad Sch Dent, Dept Fixed Prosthodont, Osaka 5650871, Japan	Tang, XH (reprint author), 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	t-xuehua2008@hotmail.com					Akar G.C., 2014, J PROSTHET DENT; Albakry Mohammad, 2004, J Prosthodont, V13, P141, DOI 10.1111/j.1532-849X.2004.04025.x; Yoshimura HN, 2012, CERAM INT, V38, P4715, DOI 10.1016/j.ceramint.2012.02.056; Sola-Ruiz MF, 2013, INT J PROSTHODONT, V26, P175, DOI 10.11607/ijp.3045; Pjetursson BE, 2007, CLIN ORAL IMPLAN RES, V18, P73, DOI 10.1111/j.1600-0501.2007.01467.x; [Anonymous], 2008, 6872 ISO; Tang XH, 2012, J DENT, V40, P372, DOI 10.1016/j.jdent.2012.01.014; Heintze SD, 2011, DENT MATER, V27, pE10, DOI 10.1016/j.dental.2010.09.004; Schmitter M, 2012, J DENT, V40, P154, DOI 10.1016/j.jdent.2011.12.007; Valenti M, 2009, QUINTESSENCE INT, V40, P573; Tang XH, 2012, J DENT, V40, P913, DOI 10.1016/j.jdent.2012.07.009; Wen G, 2007, ACTA MATER, V55, P3583, DOI 10.1016/j.actamat.2007.02.009; Albakry M, 2004, J BIOMED MATER RES B, V71B, P99, DOI 10.1002/jbm.b.30066; Guazzato M, 2004, DENT MATER, V20, P441, DOI 10.1016/j.dental.2003.05.003; Kim MJ, 2012, J DENT, V40, P979, DOI 10.1016/j.jdent.2012.08.004; Albakry M, 2003, J DENT, V31, P181, DOI 10.1016/S0300-5712(03)00025-3; Pieger S, 2014, J PROSTHET DENT, V112, P22, DOI 10.1016/j.prosdent.2014.01.005; Apel E, 2008, J MECH BEHAV BIOMED, V1, P313, DOI 10.1016/j.jmbbm.2007.11.005; Wang F, 2010, MATER DESIGN, V31, P3270, DOI 10.1016/j.matdes.2010.02.013; Zheng X, 2008, ACTA MATER, V56, P549, DOI 10.1016/j.actamat.2007.10.024; Zhang Y, 2013, DENT MATER, V29, P1201, DOI 10.1016/j.dental.2013.09.004; Gehrt M, 2013, CLIN ORAL INVEST, V17, P275, DOI 10.1007/s00784-012-0700-x; Zhong HB, 2011, CERAM INT, V37, P2459, DOI 10.1016/j.ceramint.2011.03.037; Marquardt P, 2006, QUINTESSENCE INT, V37, P253; Pollington S, 2012, J DENT, V40, P1006, DOI 10.1016/j.jdent.2012.08.010; Cattell MJ, 2002, J DENT, V30, P161, DOI 10.1016/S0300-5712(02)00013-1; Chavan NM, 2011, SURF COAT TECH, V205, P4798, DOI 10.1016/j.surfcoat.2011.04.063; Cheng JS, 2010, J ALLOY COMPD, V507, P531, DOI 10.1016/j.jallcom.2010.08.011; Chung KH, 2009, J ORAL REHABIL, V36, P132, DOI 10.1111/j.1365-2842.2008.01909.x; Della Bona A, 2008, J AM DENT ASSOC, V139, p8S; Esquivel-Upshaw JF, 2006, INT J PROSTHODONT, V19, P391; Fernandes HR, 2010, J EUR CERAM SOC, V30, P2017, DOI 10.1016/j.jeurceramsoc.2010.04.017; Kang Suk-Ho, 2013, Restor Dent Endod, V38, P134, DOI 10.5395/rde.2013.38.3.134; Raigrodski A.J., 2012, J PROSTHET DENT, V107, P170; Sax C, 2011, Int J Comput Dent, V14, P183; Steeger Bianca, 2010, Int J Comput Dent, V13, P101; Suputtamongkol K, 2010, WEAR, V269, P317, DOI 10.1016/j.wear.2010.04.015; Theocharopoulos A., 2012, J DENT, V41, P561; Tulyaganov DU, 2009, CERAM INT, V35, P3013, DOI 10.1016/j.ceramint.2009.04.002; Wang R.R., 2013, INT J ORAL SCI, V13; Wang X.D., 2014, J DENT; Wolfart Stefan, 2009, Dent Mater, V25, pe63, DOI 10.1016/j.dental.2009.05.003; Yang Y, 2009, MAT SCI ENG A-STRUCT, V508, P161, DOI 10.1016/j.msea.2008.12.040; Yuan K, 2013, J NON-CRYST SOLIDS, V362, P7, DOI 10.1016/j.jnoncrysol.2012.11.010	44	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	DEC	2014	40						390	396		10.1016/j.jmbbm.2014.09.016		7	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	AU2SU	WOS:000345468700038		
J	Fukushima, R; Kubota, N				Fukushima, Ryoki; Kubota, Naoki			Quenched Large Deviations for Multidimensional Random Walk in Random Environment with Holding Times	JOURNAL OF THEORETICAL PROBABILITY			English	Article						Random walk in random environment; Holding times; Large deviations	LYAPOUNOV EXPONENTS; PERCOLATION	We consider a random walk in random environment with random holding times, that is, the random walk jumping to one of its nearest neighbors with some transition probability after a random holding time. Both the transition probabilities and the laws of the holding times are randomly distributed over the integer lattice. Our main result is a quenched large deviation principle for the position of the random walk. The rate function is given by the Legendre transform of the so-called Lyapunov exponents for the Laplace transform of the first passage time. By using this representation, we derive some asymptotics of the rate function in some special cases.	[Fukushima, Ryoki] Tokyo Inst Technol, Dept Math, Tokyo 1528551, Japan; [Kubota, Naoki] Nihon Univ, Grad Sch Sci & Technol, Dept Math, Tokyo 1018308, Japan	Fukushima, R (reprint author), Kyoto Univ, Math Sci Res Inst, Kyoto 6068502, Japan.	ryoki@kurims.kyoto-u.ac.jp			JSPS [22840019]	The first author was supported by JSPS Grant-in-Aid for Research Activity Start-up 22840019.	COX JT, 1981, ANN PROBAB, V9, P583, DOI 10.1214/aop/1176994364; Kosygina E, 2006, COMMUN PUR APPL MATH, V59, P1489, DOI 10.1002/cpa.20137; Bingham N.H., 1989, ENCY MATH ITS APPL, V27; Dembo A, 2004, ANN PROBAB, V32, P996; Flury M, 2007, STOCH PROC APPL, V117, P596, DOI 10.1016/j.spa.2006.09.006; KESTEN H, 1986, LECT NOTES MATH, V1180, P125; Kosygina E, 2011, PROBAB THEORY REL, V150, P43, DOI 10.1007/s00440-010-0266-y; Petrov V. V., 1995, OXFORD STUDIES PROBA, V4; Rassoul-Agha F, 2011, ANN I H POINCARE-PR, V47, P214, DOI 10.1214/10-AIHP369; Rosenbluth J.M., 2006, THESIS NEW YORK U AN; Ross S., 1996, WILEY SERIES PROBABI; SZNITMAN AS, 1994, COMMUN PUR APPL MATH, V47, P1655, DOI 10.1002/cpa.3160471205; Varadhan SRS, 2003, COMMUN PUR APPL MATH, V56, P1222, DOI 10.1002/cpa.10093; Yilmaz A, 2009, COMMUN PUR APPL MATH, V62, P1033; Zerner MPW, 1998, ANN PROBAB, V26, P1446, DOI 10.1214/aop/1022855870; Zerner MPW, 1998, ANN APPL PROBAB, V8, P246	16	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0894-9840	1572-9230		J THEOR PROBAB	J. Theor. Probab.	DEC	2014	27	4					1140	1166		10.1007/s10959-013-0514-z		27	Statistics & Probability	Mathematics	AU0BF	WOS:000345287400005		
J	Okamura, K				Okamura, Kazuki			Singularity Results for Functional Equations Driven by Linear Fractional Transformations	JOURNAL OF THEORETICAL PROBABILITY			English	Article						De Rham's functional equations; Singular measures; Stationary measures		We consider functional equations driven by linear fractional transformations, which are special cases of de Rham's functional equations. We consider Hausdorff dimension of the measure whose distribution function is the solution. We give a necessary and sufficient condition for singularity. We also show that they have a relationship with stationary measures.	Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan	Okamura, K (reprint author), Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Komaba 3-8-1, Tokyo 1538914, Japan.	kazukio@ms.u-tokyo.ac.jp					Berg L, 2000, Z ANAL ANWEND, V19, P227; Azuma K., 1967, TOHOKU MATH J, V19, P357, DOI 10.2748/tmj/1178243286; DERHAM G, 1956, REND SEM MAT U POLIT, V16, P101; Furstenberg Harry, 1963, T AM MATH SOC, V108, P377, DOI 10.1090/S0002-9947-1; Hata M., 1985, JAPAN J APPL MATH, V2, P381; Kawamura K, 2011, P JPN ACAD A-MATH, V87, P162, DOI 10.3792/pjaa.87.162; Kruppel M., 2009, ROSTOCK MATH K, V64, P57; Okamura K., PREPRINT; PINCUS S, 1983, ANN PROBAB, V11, P931, DOI 10.1214/aop/1176993442; Pincus S., 1994, J THEOR PROB, V7, P199, DOI 10.1007/BF02213368; Protasov VY, 2004, IZV MATH+, V68, P567, DOI 10.1070/IM2004v068n03ABEH000489	11	1	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0894-9840	1572-9230		J THEOR PROBAB	J. Theor. Probab.	DEC	2014	27	4					1316	1328		10.1007/s10959-013-0516-x		13	Statistics & Probability	Mathematics	AU0BF	WOS:000345287400012		
J	Waki, H; Oikawa, A; Kato, M; Takahashi, S; Kojima, Y; Ono, F				Waki, Hiroyuki; Oikawa, Ayato; Kato, Masahiko; Takahashi, Satoru; Kojima, Yoshitaka; Ono, Fumio			Evaluation of the Accuracy of Young's Moduli of Thermal Barrier Coatings Determined on the Basis of Composite Beam Theory	JOURNAL OF THERMAL SPRAY TECHNOLOGY			English	Review						bending; composite beam; elastic modulus; MCrAlY; thermal barrier coating; yttria-stabilized zirconia	YTTRIA-STABILIZED ZIRCONIA; MECHANICAL-PROPERTIES; ELASTIC PROPERTIES; DEFORMATION-BEHAVIOR; SPRAY PARAMETERS; DEPOSITION; SYSTEMS	The Young's modulus of thermal barrier coating (TBC) is an important mechanical property as it is required for calculating the parameters of material mechanics in the TBC system. In this study, we investigated the accuracy of the Young's modulus of TBC calculated using the composite beam theory. Generally, both the Young's modulus and the thickness of TBC are approximately one order of magnitude lower than those of the substrate. Consequently, the Young's modulus of the TBC calculated on the basis of the composite beam theory is considerably sensitive to experimental errors. In order to improve the accuracy of the composite beam method, methods that make use of coating strain, substrate strain, or deflection were compared. The methods with low sensitivity to experimental errors were determined through sensitivity analysis. Further, the effectiveness of the methods with low sensitivity was confirmed experimentally.	[Waki, Hiroyuki] Iwate Univ, Dept Mech Engn, Morioka, Iwate 0208551, Japan; [Oikawa, Ayato] Iwate Univ, Grad Sch Engn, Morioka, Iwate 0208551, Japan; [Kato, Masahiko] Hiroshima Univ, Dept Mech Syst Engn, Higashihiroshima, Hiroshima 7398527, Japan; [Takahashi, Satoru] Tokyo Metropolitan Univ, Dept Mech Engn, Hachioji, Tokyo 1920397, Japan; [Kojima, Yoshitaka] Hitachi Ltd, Hitachi Res Lab, Hitachi, Ibaraki 3178511, Japan; [Ono, Fumio] Osaka Sci & Technol Ctr, New Mat Ctr, Nishi Ku, Osaka 5500004, Japan	Waki, H (reprint author), Iwate Univ, Dept Mech Engn, 4-3-5 Ueda, Morioka, Iwate 0208551, Japan.	waki@iwate-u.ac.jp			Ministry of Economy, Trade, and Industry (METI) of Japan	This research was financially supported by the Ministry of Economy, Trade, and Industry (METI) of Japan.	Matsumoto M, 2008, SURF COAT TECH, V202, P3507, DOI 10.1016/j.surfcoat.2007.12.035; Waki H, 2009, J THERM SPRAY TECHN, V18, P500, DOI 10.1007/s11666-009-9402-6; Waki H, 2004, MAT SCI ENG A-STRUCT, V374, P129, DOI 10.1016/j.msea.2004.02.040; Arai M., 2003, Journal of the Society of Materials Science, Japan, V52; Arai M., 2009, T JAPAN SOC MECH E A, V75, P697; Beghini M, 2001, EXP MECH, V41, P293, DOI 10.1007/BF02323922; Beghini M, 2001, EXP MECH, V41, P305, DOI 10.1007/BF02323923; Cruse TA, 1997, J THERM SPRAY TECHN, V6, P57, DOI 10.1007/BF02646313; Hasegawa M, 2006, INT J APPL CERAM TEC, V3, P293, DOI 10.1111/j.1744-7402.2006.02085.x; Itoh Y, 2005, J ENG GAS TURB POWER, V127, P807, DOI 10.1115/1.1688766; Itoh Y., 1995, Journal of the Society of Materials Science, Japan, V44; Kucuk A, 2000, MAT SCI ENG A-STRUCT, V284, P29, DOI 10.1016/S0921-5093(00)00799-1; Ma XQ, 2001, J MATER SCI, V36, P5633, DOI 10.1023/A:1012573801510; Margadant N, 2006, SURF COAT TECH, V200, P2805, DOI 10.1016/j.surfcoat.2005.02.201; Okazaki Masakazu, 2008, Journal of the Society of Materials Science, Japan, V57, DOI 10.2472/jsms.57.1121; Patsias S, 2006, MAT SCI ENG A-STRUCT, V442, P504, DOI 10.1016/j.msea.2006.04.129; Rejda EF, 1999, SURF COAT TECH, V113, P218, DOI 10.1016/S0257-8972(98)00843-3; Rybicki EF, 1995, J THERM SPRAY TECHN, V4, P377, DOI 10.1007/BF02648639; Saeidi S, 2011, J THERM SPRAY TECHN, V20, P1231, DOI 10.1007/s11666-011-9666-5; Tang F, 2006, SCRIPTA MATER, V54, P1587, DOI 10.1016/j.scriptamat.2006.01.021; Timoshenko S.P., 1972, MECH MATER, P142; Waki Hiroyuki, 2010, Journal of Solid Mechanics and Materials Engineering, V4, DOI 10.1299/jmmp.4.274; Waki H., 2010, T JPN SOC MECH ENG A, V76, P151; Zhang XC, 2013, ACTA MATER, V61, P1037, DOI 10.1016/j.actamat.2012.09.020; Zotov N, 2009, SURF COAT TECH, V203, P2064, DOI 10.1016/j.surfcoat.2009.02.008	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9630	1544-1016		J THERM SPRAY TECHN	J. Therm. Spray Technol.	DEC	2014	23	8					1291	1301		10.1007/s11666-014-0145-7		11	Materials Science, Coatings & Films	Materials Science	AU1QI	WOS:000345394800007		
J	Naoe, K; Nishiki, M; Sato, K				Naoe, Kazuaki; Nishiki, Masashi; Sato, Keishi			Microstructure and Electron Energy-Loss Spectroscopy Analysis of Interface Between Cu Substrate and Al2O3 Film Formed by Aerosol Deposition Method	JOURNAL OF THERMAL SPRAY TECHNOLOGY			English	Review						aerosol deposition method; alumina; bonding mechanism; electron energy-loss spectroscopy; metal-ceramic interface	THICK-FILMS; ROOM-TEMPERATURE; PB(ZR,TI)O-3; POWDER	Aerosol deposition method is a technique to form dense films by impacting solid particles on a substrate at room temperature. To clarify the bonding mechanism between AD films and substrates, TEM observation and electron energy-loss spectroscopy (EELS) analysis of the interface between Al2O3 AD films and Cu substrates were conducted. The Al2O3 film was directly adhered to the Cu substrate without any void or crack. The film was composed of randomly oriented alpha-Al2O3 crystal grains of about 10-20 nm large. At the Al2O3/Cu interface, the lattice fringes of the film were recognized, and no interfacial layer with nanometer-order thickness could be found. EELS spectra near O-K edge obtained at the interface had the pre-peak feature at around 528 eV. According to previously reported experiments and theoretical calculations, this suggests interactions between Cu and O in Al2O3 at the interface. It is inferred that not only the anchoring effect but also the ionic bonding and covalent bonding that originates from the Cu-O interactions contribute to the bonding between Al2O3 AD films and Cu substrates.	[Naoe, Kazuaki; Nishiki, Masashi] Hitachi Ltd, Yokohama Res Lab, Yokohama, Kanagawa, Japan; [Sato, Keishi] Hitachi Ltd, Informat & Telecommun Syst Co, Tokyo, Japan	Naoe, K (reprint author), Hitachi Ltd, Yokohama Res Lab, Yokohama, Kanagawa, Japan.	kazuaki.naoe.ym@hitachi.com					Akedo J, 2005, JPN J APPL PHYS 1, V44, P7072, DOI 10.1143/JJAP.44.7072; Akedo J, 2002, JPN J APPL PHYS 1, V41, P6980, DOI 10.1143/JJAP.41.6980; Akedo J, 1999, JPN J APPL PHYS 1, V38, P5397, DOI 10.1143/JJAP.38.5397; Yoon WH, 2010, J AM CERAM SOC, V93, P2125, DOI 10.1111/j.1551-2916.2010.03674.x; Akedo J, 2008, J THERM SPRAY TECHN, V17, P181, DOI 10.1007/s11666-008-9163-7; Nam SM, 2004, JPN J APPL PHYS 1, V43, P5414, DOI 10.1143/JJAP.43.5414; Akedo J, 2006, J AM CERAM SOC, V89, P1834, DOI 10.1111/j.1551-2916.2006.01030.x; Fukumoto M., 2009, FUNCT MAT, V29, P24; Imanaka Y, 2004, ELEC COMP C, P1614; Ito Y, 1999, APPL PHYS LETT, V75, P3793, DOI 10.1063/1.125458; Kim YH, 2011, CERAM INT, V37, P1859, DOI 10.1016/j.ceramint.2011.02.014; Mizoguchi T, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.235408; Nakada M, 2005, J CRYST GROWTH, V275, pE1275, DOI 10.1016/j.jcrysgro.2004.11.083; Nakada M, 2005, JPN J APPL PHYS 2, V44, pL1088, DOI 10.1143/JJAP.44.L1088; Naoe K, 2014, J CERAM SOC JPN, V122, P110, DOI 10.2109/jcersj2.122.110; Naoe K, 2013, J THERM SPRAY TECHN, V22, P1267, DOI 10.1007/s11666-013-0031-8; Sakamaki R, 2008, J CERAM SOC JPN, V116, P1299, DOI 10.2109/jcersj2.116.1299; Sasaki T., 2003, Science and Technology of Advanced Materials, V4, DOI 10.1016/j.stam.2003.12.003; Wang Y.-Y., 2012, P 5 AS THERM SPRAY C, P79; Xiong Y, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2928218	20	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9630	1544-1016		J THERM SPRAY TECHN	J. Therm. Spray Technol.	DEC	2014	23	8					1333	1338		10.1007/s11666-014-0172-4		6	Materials Science, Coatings & Films	Materials Science	AU1QI	WOS:000345394800011		
J	Seto, N; Endo, K; Sakamoto, N; Hirose, S; Akedo, J				Seto, Naoki; Endo, Kazuteru; Sakamoto, Nobuo; Hirose, Shingo; Akedo, Jun			Hard alpha-Al2O3 Film Coating on Industrial Roller Using Aerosol Deposition Method	JOURNAL OF THERMAL SPRAY TECHNOLOGY			English	Review						aerosol deposition method; alpha-Al2O3 film; chemical stability; industrial roller; wear	ROOM-TEMPERATURE; PHASE-STABILITY; THICK-FILMS; ALUMINA	It is well known that alpha-Al2O3 forms very hard, highly insulating, smooth films. There is demand for the use of such films instead of conventional hard, smooth films; For example, industrial rollers such as calendering rollers etc. are always required to have a harder and smoother surface than conventional rollers. Therefore, this work investigated the specification of alpha-Al2O3 films, e.g., their wear resistance and chemical stability, using various tests. This paper also discusses whether alpha-Al2O3 film can take the place of Cr plating film as a hard, smooth film by comparing their wear resistance and chemical stability.	[Seto, Naoki; Sakamoto, Nobuo; Hirose, Shingo; Akedo, Jun] Natl Inst Adv Ind Sci & Technol, Adv Mfg Res Inst, Integrat Proc Technol Grp, Tsukuba, Ibaraki, Japan; [Endo, Kazuteru] Honda Seiki Co Ltd, Sendai, Miyagi, Japan	Seto, N (reprint author), Natl Inst Adv Ind Sci & Technol, Adv Mfg Res Inst, Integrat Proc Technol Grp, Tsukuba, Ibaraki, Japan.	naoki-seto@aist.go.jp					Akedo J., 1999, JPN J APPL PHYS, V38-9B, P5297; Wang Y, 2000, WEAR, V237, P176, DOI 10.1016/S0043-1648(99)00323-3; Picas JA, 2006, WEAR, V261, P477, DOI 10.1016/j.wear.2005.12.005; Akedo J, 2008, J THERM SPRAY TECHN, V17, P181, DOI 10.1007/s11666-008-9163-7; Lausmann GA, 1996, SURF COAT TECH, V86-7, P814, DOI 10.1016/S0257-8972(96)02973-8; Navinsek B, 1999, SURF COAT TECH, V116, P476, DOI 10.1016/S0257-8972(99)00145-0; Nam SM, 2004, JPN J APPL PHYS 1, V43, P5414, DOI 10.1143/JJAP.43.5414; Akedo J, 2006, J AM CERAM SOC, V89, P1834, DOI 10.1111/j.1551-2916.2006.01030.x; [Anonymous], 2371 JIS Z; Leushake U, 1997, SURF COAT TECH, V94-5, P131, DOI 10.1016/S0257-8972(97)00490-8; ARAI T, 1987, THIN SOLID FILMS, V154, P387, DOI 10.1016/0040-6090(87)90381-6; Chraska P, 1997, J THERM SPRAY TECHN, V6, P320, DOI 10.1007/s11666-997-0066-9; Munro M., 1999, J AM CERAM SOC, V80, P1919; Taschner C, 1998, SURF COAT TECH, V108, P257, DOI 10.1016/S0257-8972(98)00561-1; Wen HL, 2000, J CRYST GROWTH, V208, P696, DOI 10.1016/S0022-0248(99)00436-4	15	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9630	1544-1016		J THERM SPRAY TECHN	J. Therm. Spray Technol.	DEC	2014	23	8					1373	1381		10.1007/s11666-014-0135-9		9	Materials Science, Coatings & Films	Materials Science	AU1QI	WOS:000345394800015		
J	Tsao, MS; Travis, WD; Brambilla, E; Nicholson, AG; Noguchi, M; Hirsch, FR				Tsao, Ming-Sound; Travis, William D.; Brambilla, Elisabeth; Nicholson, Andrew G.; Noguchi, Masayuki; Hirsch, Fred R.		IASLC Pathology Comm	Forty Years of the International Association for Study of Lung Cancer Pathology Committee	JOURNAL OF THORACIC ONCOLOGY			English	Review						World Health Organization classification; Histopathology; Molecular pathology; Epidermal growth factor receptor; Anaplastic lymphoma kinase	RESPIRATORY SOCIETY CLASSIFICATION; PULMONARY NEUROENDOCRINE TUMORS; MULTIDISCIPLINARY CLASSIFICATION; ADENOCARCINOMA CLASSIFICATION; BRONCHIOLOALVEOLAR CARCINOMA; BRONCHIAL EPITHELIUM; CELL-CARCINOMA; GENE; IDENTIFICATION; DIAGNOSIS	Lung cancer classification during the last four decades has undergone major changes and evolution, mostly lead by pathologists who were actively involved in the International Association for the Study of Lung Cancer (IASLC) Pathology Committee. The Committee members have led the development and writing of the second (1981), third (1999 and 2004), and fourth (2015) editions of the World Health Organization classifications on lung tumors. Committee members were responsible for defining and refining the classifications of small-cell carcinoma and adenocarcinoma subtypes that are relevant to their clinical behavior. Particularly notable was development of the 2011 IASLC/American Thoracic Society/European Respiratory Society international, multidisciplinary lung adenocarcinoma classification. The multidisciplinary approach that represents the IASLC culture in research, education, and practice in clinical management of lung cancer patients have paved the way for integrating pathology practice into the new era of personalized cancer care.	[Tsao, Ming-Sound] Princess Margaret Canc Ctr, Univ Hlth Network, Dept Pathol, Toronto, ON, Canada; [Tsao, Ming-Sound] Univ Toronto, Toronto, ON, Canada; [Travis, William D.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Brambilla, Elisabeth] Univ Grenoble 1, CHU Albert Michallon, INSERM, U823,Dept Anat & Pathol Cytol, Grenoble, France; [Nicholson, Andrew G.] Royal Brompton Hosp, Dept Histopathol, London SW3 6LY, England; [Noguchi, Masayuki] Univ Tsukuba, Fac Med, Dept Pathol, Tsukuba, Ibaraki, Japan; [Hirsch, Fred R.] Univ Colorado, Ctr Canc, Dept Pathol, Aurora, CO USA; [Hirsch, Fred R.] Univ Colorado Denver, Div Med Oncol, Aurora, CO USA	Tsao, MS (reprint author), Princess Margaret Canc Ctr, Univ Hlth Network, Dept Pathol, Toronto, ON, Canada.	ming.tsao@uhn.ca					Travis William D, 2011, Proc Am Thorac Soc, V8, P381, DOI 10.1513/pats.201107-042ST; Toyooka S, 2001, MOL CANCER THER, V1, P61; Lindeman NI, 2013, J THORAC ONCOL, V8, P823, DOI 10.1097/JTO.0b013e318290868f; Van Schil PE, 2012, EUR RESPIR J, V39, P478, DOI 10.1183/09031936.00027511; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Debelenko LV, 1997, HUM MOL GENET, V6, P2285, DOI 10.1093/hmg/6.13.2285; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Onuki N, 1999, CANCER, V85, P600, DOI 10.1002/(SICI)1097-0142(19990201)85:3<600::AID-CNCR10>3.0.CO;2-W; Travis WD, 2006, J THORAC ONCOL, V1, pS13, DOI 10.1097/01243894-200611001-00004; He P, 2004, HUM PATHOL, V35, P1196, DOI 10.1016/j.humpath.2004.06.014; Nicholson SA, 2002, AM J SURG PATHOL, V26, P1184, DOI 10.1097/01.PAS.0000022995.91977.CD; Austin JHM, 2013, RADIOLOGY, V266, P62, DOI 10.1148/radiol.12120240; ROGGLI VL, 1985, HUM PATHOL, V16, P569, DOI 10.1016/S0046-8177(85)80106-4; Travis WD, 2005, J CLIN ONCOL, V23, P3279, DOI 10.1200/JCO.2005.15.778; Miller VA, 2004, J CLIN ONCOL, V22, P1103, DOI 10.1200/JCO.2004.08.158; Miller VA, 2005, J CLIN ONCOL, V23, P3288, DOI 10.1200/JCO.2005.19.240; Travis WD, 2013, ARCH PATHOL LAB MED, V137, P685, DOI 10.5858/arpa.2012-0264-RA; Travis WD, 2011, EUR RESPIR J, V38, P239, DOI 10.1183/09031936.00026711; BRAMBILLA E, 1992, HUM PATHOL, V23, P993, DOI 10.1016/0046-8177(92)90260-A; NOGUCHI M, 1995, CANCER, V75, P2844, DOI 10.1002/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#; Pelosi G, 2014, J THORAC ONCOL, V9, P273, DOI 10.1097/JTO.0000000000000092; RADICE PA, 1982, CANCER, V50, P2894, DOI 10.1002/1097-0142(19821215)50:12<2894::AID-CNCR2820501232>3.0.CO;2-G; Travis WD, 2013, ARCH PATHOL LAB MED, V137, P668, DOI 10.5858/arpa.2012-0263-RA; Thunnissen E, 2012, MODERN PATHOL, V25, P1574, DOI 10.1038/modpathol.2012.106; Travis WD, 1998, HUM PATHOL, V29, P272, DOI 10.1016/S0046-8177(98)90047-8; Beasley MB, 2000, HUM PATHOL, V31, P1255, DOI 10.1053/hupa.2000.19294; Beasley MB, 2003, HUM PATHOL, V34, P136, DOI 10.1053/hupa.2003.8; AUERBACH O, 1979, NEW ENGL J MED, V300, P381, DOI 10.1056/NEJM197902223000801; BEPLER G, 1989, CANCER, V64, P74, DOI 10.1002/1097-0142(19890701)64:1<74::AID-CNCR2820640113>3.0.CO;2-Q; Burke L, 2005, CLIN CANCER RES, V11, P232; Burke L, 1998, CANCER RES, V58, P2533; Debelenko LV, 2000, GENE CHROMOSOME CANC, V28, P58, DOI 10.1002/(SICI)1098-2264(200005)28:1<58::AID-GCC7>3.0.CO;2-2; Dodds L, 1986, J NATL CANCER I, V77, P53; GAZDAR AF, 1985, CANCER RES, V45, P2924; GUINEE DG, 1995, CARCINOGENESIS, V16, P993, DOI 10.1093/carcin/16.5.993; HIRSCH FR, 1988, CANCER, V62, P973, DOI 10.1002/1097-0142(19880901)62:5<973::AID-CNCR2820620521>3.0.CO;2-O; KANHOUWA SB, 1976, ACTA CYTOL, V20, P229; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lim E, 2008, J THORAC ONCOL, V3, P1194, DOI 10.1097/JTO.0b013e3181861d7b; MATTHEWS MJ, 1980, EUR J CANCER, V16, P527, DOI 10.1016/0014-2964(80)90232-7; MORO D, 1994, CANCER, V73, P2734, DOI 10.1002/1097-0142(19940601)73:11<2734::AID-CNCR2820731114>3.0.CO;2-4; OSWALD NC, 1971, THORAX, V26, P623, DOI 10.1136/thx.26.6.623; Park IW, 1999, J NATL CANCER I, V91, P1863, DOI 10.1093/jnci/91.21.1863; Travis W, 2004, PATHOLOGY GENETICS T; Travis WD, 1999, SOBIN PATHOLOGISTS 1; Tsao MS, 2013, IASLC ATLAS ALK TEST; World Health Organization, 1981, HIST TYP LUNG TUM; WU AH, 1986, J NATL CANCER I, V77, P53; YESNER R, 1985, NEW ENGL J MED, V312, P652	50	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	DEC	2014	9	12					1740	1749		10.1097/JTO.0000000000000356		10	Oncology; Respiratory System	Oncology; Respiratory System	AU4DR	WOS:000345559900003		
J	Kinoshita, T; Ohtsuka, T; Hato, T; Goto, T; Kamiyama, I; Tajima, A; Emoto, K; Hayashi, Y; Kohno, M				Kinoshita, Tomonari; Ohtsuka, Takashi; Hato, Tai; Goto, Taichiro; Kamiyama, Ikuo; Tajima, Atsushi; Emoto, Katsura; Hayashi, Yuichiro; Kohno, Mitsutomo			Prognostic Factors Based on Clinicopathological Data Among the Patients with Resected Peripheral Squamous Cell Carcinomas of the Lung	JOURNAL OF THORACIC ONCOLOGY			English	Article						Peripheral squamous cell carcinoma; Pleural invasion; Vascular invasion	ADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIAL; ANTIGEN SCC; CANCER; RECURRENCE; FEATURES; ADENOCARCINOMA; LOBECTOMY; TEGAFUR; URACIL	Introduction: Although the incidence of peripheral squamous cell carcinomas (p-SqCCs) of the lung has increased over recent years, clinicopathological factors influencing prognosis of resected p-SqCCs remain unclear. Methods: We examined 280 patients who underwent complete resection of SqCCs and analyzed the clinicopathological features in relation to their overall survival (OS) and recurrence-free survival (RFS) according to the primary location. Results: Multivariate analysis of all stages of p-SqCCs patients revealed that high serum squamous cell carcinoma antigen (SCC) level (OS; p < 0.01, RFS; p < 0.01), vascular invasion (OS; p < 0.01, RFS; p < 0.01), pleural invasion (OS; p = 0.03, RFS; p = 0.01), nodal metastasis (OS; p = 0.02) and complication with lung disease (OS; p < 0.01) were independently unfavorable prognostic factors. Among stage I p-SqCCs patients, high serum SCC level (OS; p < 0.01, RFS; p < 0.01), vascular invasion (RFS; p < 0.01) and pleural invasion (RFS; p = 0.01) were also strongly correlated with poor prognosis independently. When we reevaluated the survival rate, T1 p-SqCCs with high serum SCC level or vascular invasion can be upgraded to T2a. Patients with stage IB had a significantly poorer prognosis than stage IA (5-year RFS; 61.4 % versus 76.6 %, p < 0.05). Conclusion: High serum SCC level, pleural and vascular invasions were independent poor prognostic factors for completely resected p-SqCCs. T1 p-SqCCs with high serum SCC level or vascular invasion should be upgraded to T2a, which accurately reflect survival status among patients with p-SqCCs.	[Kinoshita, Tomonari; Ohtsuka, Takashi; Hato, Tai; Goto, Taichiro; Kamiyama, Ikuo; Kohno, Mitsutomo] Keio Univ, Sch Med, Dept Surg, Div Gen Thorac Surg, Tokyo 1608582, Japan; [Tajima, Atsushi] Saiseikai Utsunomiya Hosp, Dept Gen Thorac Surg, Utsunomiya, Tochigi, Japan; [Emoto, Katsura; Hayashi, Yuichiro] Keio Univ, Sch Med, Dept Pathol, Tokyo 1608582, Japan	Kinoshita, T (reprint author), Keio Univ, Sch Med, Dept Surg, Div Gen Thorac Surg,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	t.kinoshita@a7.keio.jp	Emoto, Katsura/D-5543-2014				Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kawase A, 2013, J THORAC ONCOL, V8, P606, DOI 10.1097/JTO.0b013e31828632b8; Shimada Y, 2012, J THORAC ONCOL, V7, P1263, DOI 10.1097/JTO.0b013e31825cca6e; Kaseda K, 2013, CANCER SCI, V104, P1262, DOI 10.1111/cas.12219; Travis WD, 2011, CLIN CHEST MED, V32, P669, DOI 10.1016/j.ccm.2011.08.005; Watanabe S, 2001, EUR J CARDIO-THORAC, V20, P1007, DOI 10.1016/S1010-7940(01)00954-X; Hamada C, 2005, J CLIN ONCOL, V23, P4999, DOI 10.1200/JCO.2005.09.017; AUERBACH O, 1961, NEW ENGL J MED, V265, P253, DOI 10.1056/NEJM196108102650601; SHIMOSATO Y, 1980, AM J SURG PATHOL, V4, P365, DOI 10.1097/00000478-198008000-00005; Kato H, 2004, NEW ENGL J MED, V350, P1713, DOI 10.1056/NEJMoa032792; Chansky K, 2009, J THORAC ONCOL, V4, P792, DOI 10.1097/JTO.0b013e3181a7716e; Asamura H, 1996, J THORAC CARDIOV SUR, V111, P1125, DOI 10.1016/S0022-5223(96)70213-1; Funai K, 2003, AM J SURG PATHOL, V27, P978, DOI 10.1097/00000478-200307000-00013; HOLMES CE, 1995, ANN THORAC SURG, V60, P615; Ginsberg RJ, 1995, ANN THORAC SURG, V60, P622; Kagohashi K, 2008, MED ONCOL, V25, P187, DOI 10.1007/s12032-007-9021-3; KUHLMAN JE, 1988, RADIOLOGY, V167, P379; Nagashima T, 2013, ANN THORAC CARDIOVAS, V19, P351, DOI 10.5761/atcs.oa.12.01843; Ohta Y, 2001, J THORAC CARDIOV SUR, V122, P900, DOI 10.1067/mtc.2001.117626; Saijo T, 2006, LUNG CANCER-J IASLC, V52, P37, DOI 10.1016/j.lungcan.2005.12.006; Sakurai H, 2004, ANN THORAC SURG, V78, P222, DOI 10.1016/j.athoracsur.2004.01.029; Takeuchi Susumu, 2003, Ann Thorac Cardiovasc Surg, V9, P98; Tas F, 2000, J EXP CLIN CANC RES, V19, P477; THOMAS PA, 1987, J THORAC CARDIOV SUR, V94, P349	24	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	DEC	2014	9	12					1779	1787		10.1097/JTO.0000000000000338		9	Oncology; Respiratory System	Oncology; Respiratory System	AU4DR	WOS:000345559900007		
J	Inoue, A; Sugawara, S; Harada, M; Kobayashi, K; Kozuki, T; Kuyama, S; Maemondo, M; Asahina, H; Hisamoto, A; Nakagawa, T; Hotta, K; Nukiwa, T				Inoue, Akira; Sugawara, Shunichi; Harada, Masao; Kobayashi, Kunihiko; Kozuki, Toshiyuki; Kuyama, Shoichi; Maemondo, Makoto; Asahina, Hajime; Hisamoto, Akiko; Nakagawa, Taku; Hotta, Katsuyuki; Nukiwa, Toshihiro			Phase II Study of Amrubicin Combined with Carboplatin for Thymic Carcinoma and Invasive Thymoma North Japan Lung Cancer Group Study 0803	JOURNAL OF THORACIC ONCOLOGY			English	Article						Thymic carcinoma; Invasive thymoma; Chemotherapy; Amrubicin; Phase II	CELL LUNG-CANCER; ELDERLY-PATIENTS; CHEMOTHERAPY; CISPLATIN; TRIAL; COMBINATION; DOXORUBICIN; PACLITAXEL	Background: There has been no standard chemotherapy for advanced or recurrent thymic malignancies including thymic carcinoma (TC) and invasive thymoma (IT), though platinum and anthracycline have been reported as effective agents for the treatment of these diseases. The objective of this study was to evaluate the efficacy and safety of the combination of amrubicin (AMR), a new anthracycline agent, and carboplatin (CBDCA) in patients with advanced thymic malignancies. Methods: Patients with histologically confirmed thymic malignancies received AMR (35 mg/m(2), days 1-3) and CBDCA (area under the curve 4.0, day 1) every 3 weeks. Patients who had received previous chemotherapy were treated with a reduced dose of AMR (30 mg/m2). The primary end point was objective response rate (ORR), and secondary endpoints were progression-free survival, overall survival, and toxicity profile. Results: From December 2008 to October 2012, 51 patients (33 TC and 18 IT) were enrolled. The median number of treatment cycles was four in each group. The ORR and progression-free survival were 30% (95% confidence interval, 14-46) and 7.6 months in the TC group, and 17% (95% confidence interval, 0-34) and 7.6 months in the IT group, respectively. The ORR of TC patients without previous chemotherapy (n = 19) was 42%. Although grade 3 or 4 hematological toxicities were common including neutropenia (82%) and febrile neutropenia (22%), these were transient and manageable. Nonhematological toxicities were moderate and no treatment-related death was observed. Conclusions: The combination of AMR with CBDCA was active for TC with acceptable toxicity, although it was not effective for IT. Further investigation of this regimen for advanced TC is warranted.	[Inoue, Akira] Tohoku Univ Hosp, Dept Resp Med, Sendai, Miyagi 9808574, Japan; [Sugawara, Shunichi] Sendai Kousei Hosp, Dept Pulm Med, Sendai, Miyagi, Japan; [Harada, Masao] Hokkaido Canc Ctr, Dept Resp Med, Sapporo, Hokkaido, Japan; [Kobayashi, Kunihiko] Saitama Univ, Int Med Ctr, Dept Resp Med, Saitama 3388570, Japan; [Kozuki, Toshiyuki] Shikoku Canc Ctr, Dept Resp Med, Matsuyama, Ehime, Japan; [Kuyama, Shoichi] Iwakuni Med Ctr, Dept Resp Med, Iwakuni, Japan; [Maemondo, Makoto] Miyagi Canc Ctr, Dept Resp Med, Natori, Miyagi 9811293, Japan; [Asahina, Hajime] Hokkaido Univ, Sch Med, Dept Med 1, Sapporo, Hokkaido 060, Japan; [Hisamoto, Akiko; Hotta, Katsuyuki] Okayama Univ, Grad Sch Med, Dept Hematol Oncol & Resp Med, Okayama 7008530, Japan; [Nakagawa, Taku] Senboku Kumiai Gen Hosp, Dept Thorac Surg, Daisen, Japan; [Nukiwa, Toshihiro] South Miyagi Med Ctr, Sendai, Miyagi, Japan	Inoue, A (reprint author), Tohoku Univ Hosp, Dept Resp Med, Aoba Ku, 1-1 Seiryocho, Sendai, Miyagi 9808574, Japan.	akinoue@idac.tohoku.ac.jp					Lemma GL, 2011, J CLIN ONCOL, V29, P2060, DOI 10.1200/JCO.2010.32.9607; Okuma Y, 2013, LUNG CANCER, V80, P75, DOI 10.1016/j.lungcan.2012.12.012; Eng TY, 2004, INT J RADIAT ONCOL, V59, P654, DOI 10.1016/j.ijrobp.2003.11.021; FORNASIERO A, 1991, CANCER, V68, P30, DOI 10.1002/1097-0142(19910701)68:1<30::AID-CNCR2820680106>3.0.CO;2-4; LOEHRER PJ, 1994, J CLIN ONCOL, V12, P1164; Socinski MA, 2012, J CLIN ONCOL, V30, P2055, DOI 10.1200/JCO.2011.39.5848; Force J, 2011, J THORAC ONCOL, V6, P1267, DOI 10.1097/JTO.0b013e3182199be2; Inoue A, 2010, ANN ONCOL, V21, P800, DOI 10.1093/annonc/mdp384; Inoue A, 2006, J THORAC ONCOL, V1, P551, DOI 10.1097/01243894-200607000-00009; Kawashima Yosuke, 2014, Respir Investig, V52, P190, DOI 10.1016/j.resinv.2013.12.005; Marx A, 2004, PATHOLOGY GENETICS T; NCCN Clinical Practice Guidelines in Oncology, 2014, THYM THYM CARC VERS; Okuma Y, 2011, LUNG CANCER, V74, P492, DOI 10.1016/j.lungcan.2011.05.013; Schmitt J, 2010, J THORAC ONCOL, V5, pS357, DOI 10.1097/JTO.0b013e3181f21129; Yana T, 2007, INVEST NEW DRUG, V25, P253, DOI 10.1007/s10637-006-9012-9; Yoh K, 2003, CANCER, V98, P926, DOI 10.1002/cncr.11606	16	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	DEC	2014	9	12					1805	1809		10.1097/JTO.0000000000000362		5	Oncology; Respiratory System	Oncology; Respiratory System	AU4DR	WOS:000345559900011		
J	Toyokawa, G; Hirai, F; Inamasu, E; Yoshida, T; Nosaki, K; Takenaka, T; Yamaguchi, M; Seto, T; Takenoyama, M; Ichinose, Y				Toyokawa, Gouji; Hirai, Fumihiko; Inamasu, Eiko; Yoshida, Tsukihisa; Nosaki, Kaname; Takenaka, Tomoyoshi; Yamaguchi, Masafumi; Seto, Takashi; Takenoyama, Mitsuhiro; Ichinose, Yukito			Secondary Mutations at I1171 in the ALK Gene Confer Resistance to Both Crizotinib and Alectinib	JOURNAL OF THORACIC ONCOLOGY			English	Article							LUNG-CANCER; INHIBITORS; MUTANTS		[Toyokawa, Gouji; Hirai, Fumihiko; Inamasu, Eiko; Yoshida, Tsukihisa; Nosaki, Kaname; Takenaka, Tomoyoshi; Yamaguchi, Masafumi; Seto, Takashi; Takenoyama, Mitsuhiro; Ichinose, Yukito] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka 8111395, Japan	Toyokawa, G (reprint author), Kyushu Natl Canc Ctr, Dept Thorac Oncol, Minami Ku, 3-1-1 Notame, Fukuoka 8111395, Japan.	gouji104kawa@gmail.com					Camidge DR, 2012, NAT REV CLIN ONCOL, V9, P268, DOI 10.1038/nrclinonc.2012.43; Ceccon M, 2013, MOL CANCER RES, V11, P122, DOI 10.1158/1541-7786.MCR-12-0569; Ou SHI, 2014, J THORAC ONCOL, V9, P549, DOI 10.1097/JTO.0000000000000094; Kodama T, 2014, CANCER LETT, V351, P215, DOI 10.1016/j.canlet.2014.05.020; Friboulet L, 2014, CANCER DISCOV, V4, P662, DOI 10.1158/2159-8290.CD-13-0846; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Sakamoto H, 2011, CANCER CELL, V19, P679, DOI 10.1016/j.ccr.2011.04.004; Zhang S, 2011, CHEM BIOL DRUG DES, V78, P999, DOI 10.1111/j.1747-0285.2011.01239.x	8	4	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	DEC	2014	9	12					E86	E87		10.1097/JTO.0000000000000358		2	Oncology; Respiratory System	Oncology; Respiratory System	AU4DR	WOS:000345559900001		
J	Terahara, K; Ishii, H; Nomura, T; Takahashi, N; Takeda, A; Shiino, T; Tsunetsugu-Yokota, Y; Matano, T				Terahara, Kazutaka; Ishii, Hiroshi; Nomura, Takushi; Takahashi, Naofumi; Takeda, Akiko; Shiino, Teiichiro; Tsunetsugu-Yokota, Yasuko; Matano, Tetsuro			Vaccine-Induced CD107a(+) CD4(+) T Cells Are Resistant to Depletion following AIDS Virus Infection	JOURNAL OF VIROLOGY			English	Article							CHRONIC VIRAL-INFECTION; CELLULAR IMMUNE-RESPONSES; HIV-1/SIV CHIMERIC VIRUS; LYMPHOCYTE-BASED CONTROL; IMMUNODEFICIENCY-VIRUS; RHESUS MACAQUES; CD8-T-CELL MEMORY; CD4-T-CELL HELP; SIV INFECTION; SENDAI-VIRUS	CD4(+) T-cell responses are crucial for effective antibody and CD8(+) T-cell induction following virus infection. However, virus-specific CD4(+) T cells can be preferential targets for human immunodeficiency virus (HIV) infection. HIV-specific CD4(+) T-cell induction by vaccination may thus result in enhancement of virus replication following infection. In the present study, we show that vaccine-elicited CD4(+) T cells expressing CD107a are relatively resistant to depletion in a macaque AIDS model. Comparison of virus-specific CD107a, macrophage inflammatory protein-1 beta, gamma interferon, tumor necrosis factor alpha, and interleukin-2 responses in CD4(+) T cells of vaccinated macaques prechallenge and 1 week postchallenge showed a significant reduction in the CD107a-but not the CD107a(+) subset after virus exposure. Those vaccinees that failed to control viremia showed a more marked reduction and exhibited significantly higher viral loads at week 1 than unvaccinated animals. Our results indicate that vaccine-induced CD107a(-) CD4(+) T cells are depleted following virus infection, suggesting a rationale for avoiding virus-specific CD107a(-) CD4(+) T-cell induction in HIV vaccine design. IMPORTANCE Induction of effective antibody and/or CD8(+) T-cell responses is a principal vaccine strategy against human immunodeficiency virus (HIV) infection. CD4(+) T-cell responses are crucial for effective antibody and CD8(+) T-cell induction. However, virus-specific CD4(+) T cells can be preferential targets for HIV infection. Here, we show that vaccine-induced virus-specific CD107a(-) CD4(+) T cells are largely depleted following infection in a macaque AIDS model. While CD4(+) T-cell responses are important in viral control, our results indicate that virus-specific CD107a(-) CD4(+) T-cell induction by vaccination may not lead to efficient CD4(+) T-cell responses following infection but rather be detrimental and accelerate viral replication in the acute phase. This suggests that HIV vaccine design should avoid virus-specific CD107a(-) CD4(+) T-cell induction. Conversely, this study found that vaccine-induced CD107a(-) CD4(+) T cells are relatively resistant to depletion following virus challenge, implying that induction of these cells may be an alternative approach toward HIV control.	[Terahara, Kazutaka; Tsunetsugu-Yokota, Yasuko] Natl Inst Infect Dis, Dept Immunol, Tokyo, Japan; [Ishii, Hiroshi; Nomura, Takushi; Takahashi, Naofumi; Takeda, Akiko; Shiino, Teiichiro; Matano, Tetsuro] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Matano, Tetsuro] Univ Tokyo, Inst Med Sci, Tokyo, Japan	Matano, T (reprint author), Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan.	tmatano@nih.go.jp			Ministry of Education, Culture, Sports, Science, and Technology in Japan; Ministry of Health, Labor, and Welfare in Japan	This work was supported by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology in Japan and grants-in-aid from the Ministry of Health, Labor, and Welfare in Japan.	Veazey RS, 2000, J VIROL, V74, P57; MATLOUBIAN M, 1994, J VIROL, V68, P8056; Ranasinghe S, 2013, NAT MED, V19, P930, DOI 10.1038/nm.3229; Schieffer M, 2014, J VIROL, V88, P7357, DOI 10.1128/JVI.00728-14; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Jellison ER, 2005, J IMMUNOL, V174, P614; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Casazza JP, 2006, J EXP MED, V203, P2865, DOI 10.1081/jem.20052246; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Matano T, 2004, J EXP MED, V199, P1709, DOI 10.1084/jem.20040432; Yamamoto T, 2009, J VIROL, V83, P5514, DOI 10.1128/JVI.00145-09; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/01.aids.0000096870.36052.b6; KOUP RA, 1994, J VIROL, V68, P4650; Zheng N, 2009, J VIROL, V83, P7668, DOI 10.1128/JVI.00513-09; Kawada M, 2007, J VIROL, V81, P5202, DOI 10.1128/JVI.02881-06; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Soghoian DZ, 2010, EXPERT REV VACCINES, V9, P1453, DOI [10.1586/erv.10.132, 10.1586/ERV.10.132]; BORROW P, 1994, J VIROL, V68, P6103; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Matano T, 2001, J VIROL, V75, P11891, DOI 10.1128/JVI.75.23.11891-11896.2001; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Nomura T, 2012, J VIROL, V86, P6481, DOI 10.1128/JVI.07077-11; Iwamoto N, 2014, J VIROL, V88, P425, DOI 10.1128/JVI.02634-13; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Takeda A, 2003, J VIROL, V77, P9710, DOI 10.1128/JVI.77.17.9710-9715.2003; Kawada M, 2008, J VIROL, V82, P10199, DOI 10.1128/JVI.01103-08; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Streeck H, 2013, NAT MED, V19, P143, DOI 10.1038/nm.3054; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Matano T, 1998, J VIROL, V72, P164; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Tsukamoto T, 2009, J VIROL, V83, P9339, DOI 10.1128/JVI.01120-09; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152; HOU S, 1992, J IMMUNOL, V149, P1319; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Nakane T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073453; Soghoian DZ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003165; Takahashi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054300	54	3	3	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	DEC	2014	88	24					14232	14240		10.1128/JVI.02032-14		9	Virology	Virology	AU0CZ	WOS:000345292100028		
J	Lo, TH; Tseng, KY; Tsao, WS; Yang, CY; Hsieh, SL; Chiu, AWH; Takai, T; Mak, TW; Tarng, DC; Chen, NJ				Lo, Tzu-Han; Tseng, Kai-Yu; Tsao, Wen-Shan; Yang, Chih-Ya; Hsieh, Shie-Liang; Chiu, Allen Wen-Hsiang; Takai, Toshiyuki; Mak, Tak W.; Tarng, Der-Cherng; Chen, Nien-Jung			TREM-1 regulates macrophage polarization in ureteral obstruction	KIDNEY INTERNATIONAL			English	Article						chronic kidney disease; fibrosis; immunology and pathology; macrophages; obstructive nephropathy	INNATE IMMUNITY; SEPTIC SHOCK; RENAL INJURY; INFLAMMATION; ACTIVATION; EXPRESSION; DISEASE; CELLS; NEPHROPATHY; FIBROSIS	Chronic kidney disease (CKD) is an emerging worldwide public health problem. Inflammatory cell infiltration and activation during the early stages in injured kidneys is a common pathologic feature of CKD. Here, we determined whether an important inflammatory regulator, triggering receptor expressed on myeloid cells (TREM)-1, is upregulated in renal tissues collected from mouse ureteral obstruction-induced nephritis. TREM-1 is crucial for modulating macrophage polarization, and has a pivotal role in mediating tubular injury and interstitial collagen deposition in obstructive nephritis. Lysates from nephritic kidneys triggered a TREM-1-dependent M1 polarization ex vivo, consistent with the observation that granulocyte-macrophage colony-stimulating factor (GM-CSF)-derived M1 macrophages express higher levels of TREM-1 in comparison with M-CSF-derived cells. Moreover, agonistic TREM-1 crosslink significantly strengthens the inductions of iNOS and GMCSF in M1 cells. These observations are validated by a strong clinical correlation between infiltrating TREM-1-expressing/iNOS-positive macrophages and renal injury in human obstructive nephropathy. Thus, TREM-1 may be a potential diagnostic and therapeutic target in human kidney disease.	[Lo, Tzu-Han; Tarng, Der-Cherng] Natl Yang Ming Univ, Sch Med, Inst Physiol, Taipei 112, Taiwan; [Tseng, Kai-Yu; Tsao, Wen-Shan; Yang, Chih-Ya; Hsieh, Shie-Liang; Chen, Nien-Jung] Natl Yang Ming Univ, Sch Life Sci, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Yang, Chih-Ya; Hsieh, Shie-Liang] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Hsieh, Shie-Liang; Tarng, Der-Cherng] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Hsieh, Shie-Liang; Chen, Nien-Jung] Natl Yang Ming Univ, Inflammat & Immun Res Ctr, Taipei 112, Taiwan; [Hsieh, Shie-Liang; Tarng, Der-Cherng] Taipei Vet Gen Hosp, Ctr Immunol, Taipei, Taiwan; [Hsieh, Shie-Liang] Taipei Med Univ, Coll Med Sci & Technol, Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Chiu, Allen Wen-Hsiang] Natl Yang Ming Univ, Sch Med, Dept Urol, Taipei 112, Taiwan; [Takai, Toshiyuki] Tohoku Univ, Inst Dev Aging & Canc, Dept Expt Immunol, Sendai, Miyagi 980, Japan; [Mak, Tak W.] Univ Toronto, Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada; [Mak, Tak W.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; [Tarng, Der-Cherng] Taipei Vet Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan	Mak, TW (reprint author), Univ Toronto, Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Univ Ave,Room 7-706, Toronto, ON M5G 2C1, Canada.	tmak@uhnresearch.ca; dctarng@vghtpe.gov.tw; njchen@ym.edu.tw			National Science Council [NSC97-2320-B010-032-MY2, NSC99-2320-B10-003-MY3, NSC102-2320-B -010-015, NSC 99-2314-B-010-004-MY3, NSC 102-2314-B-010-004-MY3]; Taipei Veterans General Hospital [V97S5-001, V98S5-008, V99S5-002, V100E4-003, V101E4-001, V102E4-001]; Yen Tjing Ling Medical Foundation [CI-100-10]; Ministry of Education, Aim for the Top University Plan in Taiwan [98A-C-D117]; Bureau of Health Promotion, Department of Health [DOH98-HP-1110]; Canadian Institute of Health Research; Leukemia Lymphoma Society; Terry Fox Cancer Research Foundation	This work was supported by grants to NJC from the National Science Council (NSC97-2320-B010-032-MY2; NSC99-2320-B10-003-MY3; NSC102-2320-B -010-015)), Taipei Veterans General Hospital (V97S5-001; V98S5-008; V99S5-002; V100E4-003), Yen Tjing Ling Medical Foundation (CI-100-10), and a grant (98A-C-D117) from the Ministry of Education, Aim for the Top University Plan in Taiwan. DCT is supported by grants from the National Science Council (NSC 99-2314-B-010-004-MY3; NSC 102-2314-B-010-004-MY3), Taipei Veterans General Hospital (V101E4-001; V102E4-001), and Bureau of Health Promotion, Department of Health (DOH98-HP-1110). TWM is supported by grants from the Canadian Institute of Health Research, the Leukemia Lymphoma Society, the Canadian Institute of Health Research, and the Terry Fox Cancer Research Foundation.	STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Haselmayer P, 2007, BLOOD, V110, P1029, DOI 10.1182/blood-2007-01-069195; Gibot S, 2006, INFECT IMMUN, V74, P2823, DOI 10.1128/IAI.74.5.2823-2830.2006; Sharif O, 2008, IMMUNOBIOLOGY, V213, P701, DOI 10.1016/j.imbio.2008.07.008; Klesney-Tait J, 2013, J CLIN INVEST, V123, P138, DOI 10.1172/JCI64181; Lin YT, 2014, INFECT IMMUN, V82, P1335, DOI 10.1128/IAI.01347-13; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schiffer L, 2008, J IMMUNOL, V180, P1938; Schenk M, 2007, J CLIN INVEST, V117, P3097, DOI 10.1172/JCI30602; Lanier LL, 2009, IMMUNOL REV, V227, P150, DOI 10.1111/j.1600-065X.2008.00720.x; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Dumont P, 2008, LAB INVEST, V88, P896, DOI 10.1038/labinvest.2008.54; Benoit M, 2008, J IMMUNOL, V181, P3733; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; TSUNAWAKI S, 1988, NATURE, V334, P260, DOI 10.1038/334260a0; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Kuai J, 2009, RHEUMATOLOGY, V48, P1352, DOI 10.1093/rheumatology/kep235; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245; Lopez-Novoa JM, 2010, PHARMACOL THERAPEUT, V128, P61, DOI 10.1016/j.pharmthera.2010.05.006; Gibot S, 2004, NEW ENGL J MED, V350, P451, DOI 10.1056/NEJMoa031544; Wu J, 2012, CANCER RES, V72, P3977, DOI 10.1158/0008-5472.CAN-12-0938; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Wu MF, 2013, BLOOD, V121, P95, DOI 10.1182/blood-2012-05-430090; Vielhauer V, 2010, SEMIN NEPHROL, V30, P318, DOI 10.1016/j.semnephrol.2010.03.006; Wang Y, 2008, AM J PATHOL, V172, P1491, DOI 10.2353/ajpath.2008.070825; Cao Q, 2014, KIDNEY INT, V85, P794, DOI 10.1038/ki.2013.341; Chang NCA, 2001, J BIOL CHEM, V276, P17497, DOI 10.1074/jbc.M010417200; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; McVicar DW, 1998, J BIOL CHEM, V273, P32934, DOI 10.1074/jbc.273.49.32934; Raes Geert, 2002, Dev Immunol, V9, P151, DOI 10.1080/1044667031000137629; Tammaro A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082498; te Witt R, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-255	37	4	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0085-2538	1523-1755		KIDNEY INT	Kidney Int.	DEC	2014	86	6					1174	1186		10.1038/ki.2014.205		13	Urology & Nephrology	Urology & Nephrology	AU4ZN	WOS:000345616900016		
J	Kobayashi, H; Akamatsu, Y; Kumagai, K; Kusayama, Y; Ishigatsubo, R; Muramatsu, S; Saito, T				Kobayashi, Hideo; Akamatsu, Yasushi; Kumagai, Ken; Kusayama, Yoshihiro; Ishigatsubo, Ryo; Muramatsu, Shuntaro; Saito, Tomoyuki			The surgical epicondylar axis is a consistent reference of the distal femur in the coronal and axial planes	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Computed tomography (CT); Mechanical axis; Gender differences; Surgical epicondylar axis (SEA); Total knee arthroplasty	TOTAL KNEE ARTHROPLASTY; TRANSEPICONDYLAR AXIS; ROTATIONAL ALIGNMENT; ANATOMIC VARIATIONS; FEMALE KNEE; REPLACEMENT; MORPHOLOGY; LANDMARKS; COMPONENT	Various rotational landmarks including the surgical epicondylar axis (SEA) are used for preoperative planning and intra-operative reference of total knee arthroplasty (TKA) in the axial plane. The aim of the study was to elucidate the relationships between the SEA and other femoral anatomical landmarks, including the mechanical axis, distal and posterior knee joints, the trochlear groove, and the anterior femoral condyle, in both the coronal and axial planes. Angular and linear measurements were taken of sixty femora using Orthomap3D, which has a tool to analyse computed tomography image data that makes it possible to measure three-dimensional distances and angles precisely. The inter- and intra-observer reliabilities of these measurements were evaluated. Comparisons were made according to height, weight, body mass index, and gender. The angle between the mechanical axis and the SEA was 90.2A degrees (95 % CI 90.0A degrees-90.4A degrees). There was a significant correlation for each linear measurement between the SEA and the distal/posterior knee joint line and for each linear measurement between the SEA and the anterior medial/lateral femoral condyle. A significant difference was observed between genders in the linear measurements. Significant correlations were found between height and weight and linear parameters. Knowledge of the relationships between the SEA and other femoral anatomical landmarks is useful in preoperative planning, intra-operative landmark, and postoperative assessment of TKA. The SEA is a consistent parameter of femoral alignment in the coronal plane and a stable reference for femoral rotation in the axial plane. III.	[Kobayashi, Hideo; Akamatsu, Yasushi; Kumagai, Ken; Kusayama, Yoshihiro; Ishigatsubo, Ryo; Muramatsu, Shuntaro; Saito, Tomoyuki] Yokohama City Univ, Grad Sch Med, Dept Orthopaed Surg, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan	Kobayashi, H (reprint author), Yokohama City Univ, Grad Sch Med, Dept Orthopaed Surg, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	hi-deo@live.jp					Jenny JY, 2004, ACTA ORTHOP SCAND, V75, P74, DOI 10.1080/00016470410001708150; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; BERGER RA, 1993, CLIN ORTHOP RELAT R, P40; Conley S, 2007, J AM ACAD ORTHOP SUR, V15, pS31; Victor J, 2009, ORTHOP TRAUMATOL-SUR, V95, P365, DOI 10.1016/j.otsr.2009.04.011; Barrack RL, 2001, CLIN ORTHOP RELAT R, P46; Fehring TK, 2009, J BONE JOINT SURG AM, V91A, P2335, DOI 10.2106/JBJS.H.00834; JEFFERY RS, 1991, J BONE JOINT SURG BR, V73, P709; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lustig S, 2008, KNEE SURG SPORT TR A, V16, P674, DOI 10.1007/s00167-008-0551-9; YOSHIOKA Y, 1987, J BONE JOINT SURG AM, V69A, P873; Merchant AC, 2008, CLIN ORTHOP RELAT R, V466, P3059, DOI 10.1007/s11999-008-0536-5; Yoshino N, 2001, J ARTHROPLASTY, V16, P493, DOI 10.1054/arth.2001.23621; Griffin FM, 2000, J ARTHROPLASTY, V15, P354, DOI 10.1016/S0883-5403(00)90739-3; Servien E, 2008, KNEE SURG SPORT TR A, V16, P263, DOI 10.1007/s00167-007-0449-y; Pfitzner T, 2012, ORTHOPEDICS, V35, P45, DOI 10.3928/01477447-20120919-57; Eckhoff DG, 2003, J BONE JOINT SURG AM, V85A, P97; Colle F, 2012, KNEE SURG SPORT TR A, V20, P552, DOI 10.1007/s00167-011-1604-z; Oussedik S, 2012, CLIN ORTHOP RELAT R, V470, P3227, DOI 10.1007/s11999-012-2515-0; Poilvache PL, 1996, CLIN ORTHOP RELAT R, P35; Li K, 2012, J ORTHOP RES, V30, P686, DOI 10.1002/jor.21575; Matziolis G, 2011, ARCH ORTHOP TRAUM SU, V131, P163, DOI 10.1007/s00402-010-1113-4; BRATTSTROM HAKAN, 1964, ACTA ORTHOP SCAND, VSuppl. 68, P1; Kawahara S, 2012, KNEE SURG SPORT TR A, V20, P2073, DOI 10.1007/s00167-011-1826-0; Lombardi Adolph V Jr, 2009, J Bone Joint Surg Am, V91 Suppl 5, P52, DOI 10.2106/JBJS.I.00403; Luksanapruksa Panya, 2012, Journal of the Medical Association of Thailand, V95, P526; Luyckx T, 2013, KNEE SURG SPORT TR A, V21, P2331, DOI 10.1007/s00167-012-2306-x; Pietsch M, 2013, KNEE SURG SPORT TR A, V21, P2220, DOI 10.1007/s00167-013-2624-7; Stiehl JB, 1995, J ARTHROPLASTY, V10, P785, DOI 10.1016/S0883-5403(05)80075-0; Urabe K, 2008, J Orthop Surg (Hong Kong), V16, P312; Yue B, 2011, KNEE SURG SPORT TR A, V19, P80, DOI 10.1007/s00167-010-1139-8	31	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	DEC	2014	22	12					2947	2953		10.1007/s00167-014-2867-y		7	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AU0TA	WOS:000345336200009		
J	Nishikawa, M; Owaki, H; Kaneshiro, S; Fuji, T				Nishikawa, Masataka; Owaki, Hajime; Kaneshiro, Shoichi; Fuji, Takeshi			Preoperative morphometric differences in the distal femur are based on skeletal size in Japanese patients undergoing total knee arthroplasty	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Morphometry; Japanese; Distal femur; Total knee arthroplasty	FEMORAL ROTATIONAL ALIGNMENT; FEMALE KNEE; ANTHROPOMETRIC MEASUREMENTS; ANTEROPOSTERIOR AXIS; ANATOMIC VARIATIONS; DESIGN; REPLACEMENT; POPULATION; IMPLANTS; FLEXION	The objectives of this study were to measure the morphometric parameters of preoperative distal femurs to determine the differences by diagnosis and gender after accounting for skeletal size. One-hundred and seventy-nine Japanese patients who underwent total knee arthroplasty (TKA) (25 males and 154 females) were assessed. The anteroposterior length (AP), mediolateral width (ML), aspect ratio (AR), surgical epicondylar axis (SEA) to posterior condylar axis (PCA) angle, and Whiteside to SEA angle were measured on preoperative computed tomography scans. The AP/ML, AR/ML, SEA/PCA, and Whiteside/PCA relationships were evaluated and compared by patient diagnosis and gender. The results were also compared with the sizes of 10 currently available TKA implants in Japan. The mean AP, ML, AR, SEA/PCA angle, and Whiteside/PCA angle were 58.8 mm, 64.7 mm, 0.91, external rotation (ER) 3.5A degrees, and ER 1.6A degrees, respectively. AP and AR each were significantly correlated with ML (p < 0.001). AP, ML, and AR were not significantly different between patients diagnosed with osteoarthritis and rheumatoid arthritis. AP/ML and AR/ML were significantly correlated within each diagnosis (p < 0.001), but the analysis of covariance showed no significant differences between the diagnoses. AP and ML were significantly longer (p < 0.001) in males (63.6, 72.7 mm) than in females (58.1, 63.4 mm), while AR was smaller in males (0.88 vs. 0.92), with significant correlations for AP/ML (male: p < 0.010, female: p < 0.001) and AR/ML (male: p = 0.002, female: p < 0.001) in each gender. However, the analysis of covariance showed no significant differences between gender in the AP/ML and AR/MR correlations. The AP/ML ratio of our data was similar to the size variations of the 10 TKA implants, but the AR/ML ratio was quite different from almost all the implants. No differences in preoperative femur morphometry were found between patients with different diagnoses, but the gender difference in AR was related to the difference in skeletal size between males and females. Case series with no comparison groups, Level IV.	[Nishikawa, Masataka; Owaki, Hajime; Kaneshiro, Shoichi; Fuji, Takeshi] Japan Community Hlth Care Org Osaka Hosp, Dept Orthopaed Surg, Fukushima Ku, Osaka 5530003, Japan; [Owaki, Hajime] Japan Community Hlth Care Org Osaka Hosp, Dept Rheumatol, Osaka 5530003, Japan	Nishikawa, M (reprint author), Japan Community Hlth Care Org Osaka Hosp, Dept Orthopaed Surg, Fukushima Ku, 4-2-78 Fukushima, Osaka 5530003, Japan.	ni4kawa-ma@umin.ac.jp					Akagi M, 2000, J BONE JOINT SURG AM, V82A, P1626; Conley S, 2007, J AM ACAD ORTHOP SUR, V15, pS31; Nam D, 2013, J ARTHROPLASTY, V28, P798, DOI 10.1016/j.arth.2012.09.016; Greene KA, 2007, J ARTHROPLASTY, V22, P27, DOI 10.1016/j.arth.2007.05.019; Cheng FB, 2009, KNEE, V16, P341, DOI 10.1016/j.knee.2008.12.019; Merchant AC, 2008, CLIN ORTHOP RELAT R, V466, P3059, DOI 10.1007/s11999-008-0536-5; Yue B, 2011, J ARTHROPLASTY, V26, P124, DOI 10.1016/j.arth.2009.11.020; Yoshino N, 2001, J ARTHROPLASTY, V16, P493, DOI 10.1054/arth.2001.23621; Gillespie RJ, 2011, J BONE JOINT SURG BR, V93B, P357, DOI 10.1302/0301-620X.93B3.24708; MacDonald SJ, 2008, CLIN ORTHOP RELAT R, V466, P2612, DOI 10.1007/s11999-008-0430-1; ARIMA J, 1995, J BONE JOINT SURG AM, V77, P1331; Hitt K, 2003, J BONE JOINT SURG AM, V85A, P115; Kim D, 2012, KNEE SURG SPORT TR A, V20, P337, DOI 10.1007/s00167-011-1750-3; Mahfouz M. R., 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P447, DOI 10.1080/10255840701552093; Bellemans J, 2010, CLIN ORTHOP RELAT R, V468, P29, DOI 10.1007/s11999-009-1016-2; Bonnin MP, 2013, KNEE SURG SPORT TR A, V21, P2314, DOI 10.1007/s00167-013-2443-x; Booth RE, 2006, ORTHOPEDICS, V29, P768; Booth RE, 2006, ORTHOPEDICS, V29, P836; Chin Kingsley R, 2002, J Knee Surg, V15, P213; Clarke HD, 2008, CLIN ORTHOP RELAT R, V466, P2711, DOI 10.1007/s11999-008-0454-6; Emerson RH, 2008, CLIN ORTHOP RELAT R, V466, P2706, DOI 10.1007/s11999-008-0431-0; Ho WP, 2006, KNEE, V13, P12, DOI 10.1016/j.knee.2005.05.002; Hosaka K, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-251; Iorio Richard, 2007, J Surg Orthop Adv, V16, P164; Lonner JH, 2008, CLIN ORTHOP RELAT R, V466, P2724, DOI 10.1007/s11999-008-0415-0; Low FH, 2000, P I MECH ENG H, V214, P301, DOI 10.1243/0954411001535796; Miyazaki Y, 2011, J ARTHROPLASTY, V26, P1038, DOI 10.1016/j.arth.2010.08.015; Smitowicz M, 2006, ORTOP TRAUMATOL REHA, V8, P219; Tanavalee A, 2011, KNEE, V18, P483, DOI 10.1016/j.knee.2010.10.005; Urabe Ken, 2003, J Knee Surg, V16, P27; Vaidya SV, 2000, J ARTHROPLASTY, V15, P79, DOI 10.1016/S0883-5403(00)91285-3; WANG SW, 1992, CHINESE MED J-PEKING, V105, P227; WHITESIDE LA, 1995, CLIN ORTHOP RELAT R, P168	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	DEC	2014	22	12					2962	2968		10.1007/s00167-014-3253-5		7	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AU0TA	WOS:000345336200011		
J	Tsukeoka, T; Tsuneizumi, Y; Lee, TH				Tsukeoka, Tadashi; Tsuneizumi, Yoshikazu; Lee, Tae Hyun			Accuracy of the second metatarsal as a landmark for the extramedullary tibial cutting guide in total knee arthroplasty	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Total knee arthroplasty; Second metatarsal; Extramedullary cutting guide; Alignment	MANUAL INSTRUMENTATION; ALIGNMENT; REPLACEMENT	The purpose of this study was to evaluate the accuracy of the second metatarsal (MT2) as a landmark for proximal tibial cutting in total knee arthroplasty (TKA). It was hypothesized that the accuracy of the MT2 is not high, especially in rheumatoid arthritis (RA) patients whose foot joints are apt to be involved. Computer simulation studies on 48 RA knees and 45 osteoarthritis (OA) knees were performed. The deviations from the mechanical axis (MA) of the tibia when the guide rod was pointed toward the base of the MT2 or the distal part of the MT2 were measured. The mean deviation from MA was 0.8A degrees A A +/- A 2.1A degrees valgus (range 8.1A degrees-6.3A degrees valgus) and 1.2A degrees A A +/- A 2.9A degrees valgus (range 11.6A degrees-7.9A degrees valgus) at the base of the MT2, and at the distal part of the MT2, respectively. The outlier rate when using the base of the MT2 was lower than when using the distal part of the MT2 (12.9 vs 32.3 %, p = 0.0032). The outlier rate was equivalent in OA and RA patients (n.s.). However, foot involvement in RA patients demonstrated a trend toward significance (base of MT2 p = 0.078, distal part of MT2 p = 0.068). The major clinical relevance was to raise caution about using the MT2. Surgeons should aim toward the base of the MT2, but avoid using it in RA patients with foot involvement. The accuracy of the MT2 is not high and it should be used only to supplement other landmarks. II.	[Tsukeoka, Tadashi; Tsuneizumi, Yoshikazu; Lee, Tae Hyun] Chiba Rehabil Ctr, Dept Orthopaed Surg, Midori Ku, Chiba 2660005, Japan	Tsukeoka, T (reprint author), Chiba Rehabil Ctr, Dept Orthopaed Surg, Midori Ku, 1-45-2 Hondacho, Chiba 2660005, Japan.	mdddd940@ybb.ne.jp					Akagi M, 2004, CLIN ORTHOP RELAT R, P213, DOI 10.1097/01.blo.0000118442.93383.16; Cinotti G, 2013, ACTA ORTHOP, V84, P275, DOI 10.3109/17453674.2013.792032; Conteduca F, 2013, KNEE SURG SPORT TR A, V21, P2194, DOI 10.1007/s00167-012-2098-z; Schneider M, 2007, J ARTHROPLASTY, V22, P219, DOI 10.1016/j.arth.2006.04.023; Iorio R, 2013, KNEE SURG SPORT TR A, V21, P2296, DOI 10.1007/s00167-012-2005-7; Ng VY, 2012, CLIN ORTHOP RELAT R, V470, P99, DOI 10.1007/s11999-011-1996-6; JEFFERY RS, 1991, J BONE JOINT SURG BR, V73, P709; Fukagawa S, 2011, J ORTHOP RES, V29, P919, DOI 10.1002/jor.21335; Dennis D A, 1993, J Arthroplasty, V8, P43, DOI 10.1016/S0883-5403(06)80106-3; LOTKE PA, 1977, J BONE JOINT SURG AM, V59, P77; LARSEN A, 1977, ACTA RADIOL DIAGN, V18, P481; Mizu-Uchi H, 2006, J BONE JOINT SURG AM, V88A, P2632, DOI 10.2106/JBJS.E.01288; BARGREN JH, 1983, CLIN ORTHOP RELAT R, P178; Erdem M, 2014, KNEE SURG SPORT TR A, DOI [10.1007/s00167-014-2957-x, DOI 10.1007/S00167-014-2957-X]; Rajadhyaksha Amar D, 2009, Am J Orthop (Belle Mead NJ), V38, pE68; Tsukeoka T, 2013, J ARTHROPLASTY, V28, P1094, DOI 10.1016/j.arth.2012.12.008; Tsukeoka T, 2014, KNEE, V21, P283, DOI 10.1016/j.knee.2012.09.002	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	DEC	2014	22	12					2969	2974		10.1007/s00167-014-3254-4		6	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AU0TA	WOS:000345336200012		
J	Kuriyama, S; Hyakuna, K; Inoue, S; Tanaka, Y; Tamaki, Y; Ito, H; Matsuda, S				Kuriyama, Shinichi; Hyakuna, Katsufumi; Inoue, Satoshi; Tanaka, Yasuyuki; Tamaki, Yasuyuki; Ito, Hiromu; Matsuda, Shuichi			Is a "sulcus cut" technique effective for determining the level of distal femoral resection in total knee arthroplasty?	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Total knee arthroplasty; Femoral sulcus; Distal femoral resection; Joint line; Computer simulation	JOINT LINE-POSITION; ROTATIONAL ALIGNMENT; CARTILAGE THICKNESS; CUTTING ERRORS; VALGUS KNEE; FEMUR; ELEVATION; COMPONENT; ANATOMY; AXIS	Determining the level of distal femoral resection is crucial when performing total knee arthroplasty (TKA). However, variations in distal femoral resection are encountered unexpectedly. A "sulcus cut" technique is sometimes used to determine the level of distal femoral resection, but its effectiveness has not been evaluated. The aim of this study was to examine the reliability of the sulcus cut technique using computer simulation for preoperative planning. This study group comprised 40 knees in 34 patients (22 women, 12 men) scheduled for TKA. The preoperative planning software of a computed tomography (CT)-based navigation system was used. We determined the resected level of the femur so that the bone-implant interface of the femoral component was adjusted to the deepest subchondral bone of the trochlear groove in coronal CT images. We then measured each perpendicular distance from the resected surface of the proximal femur to the most distal point of the lateral and medial femoral condyles. The mean distances of the distal-lateral and distal-medial condylar resections from the femoral sulcus were 7 mm (+/- 1 mm) and 8 mm (+/- 1 mm), respectively. The resection level did not differ significantly between men and women or between different component sizes. There was a slightly positive correlation between the femoral mechanical and anatomical axis angle and the distance of the distal-lateral condylar resection from the femoral sulcus. The sulcus cut technique can be used to determine the desirable level of the distal femoral resection in TKA. Case series, Level IV.	[Kuriyama, Shinichi; Ito, Hiromu; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Kyoto 6068507, Japan; [Hyakuna, Katsufumi; Inoue, Satoshi; Tanaka, Yasuyuki; Tamaki, Yasuyuki] Japanese Red Cross Soc Wakayama Med Ctr, Dept Orthopaed Surg, Wakayama, Japan	Kuriyama, S (reprint author), Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	kuriyama@kuhp.kyoto-u.ac.jp					Adam C, 1998, J ANAT, V193, P203, DOI 10.1046/j.1469-7580.1998.19320203.x; BERGER RA, 1993, CLIN ORTHOP RELAT R, P40; Matsuda S, 2004, J ORTHOPAED RES, V22, P104, DOI 10.1016/S0736-0266(03)00134-7; Bedard M, 2011, CLIN ORTHOP RELAT R, V469, P2346, DOI 10.1007/s11999-011-1889-8; Jawhar A, 2013, KNEE SURG SPORT TR A, V21, P2355, DOI 10.1007/s00167-013-2580-2; Babazadeh S, 2011, J BONE JOINT SURG BR, V93B, P1223, DOI 10.1302/0301-620X.93B9.26950; Plaskos C, 2002, J ARTHROPLASTY, V17, P698, DOI 10.1054/arth.2002.33564; Partington PF, 1999, CLIN ORTHOP RELAT R, P165; Baier C, 2014, INT ORTHOP, V38, P243, DOI 10.1007/s00264-013-2140-x; Sahin N, 2012, KNEE SURG SPORT TR A, V20, P565, DOI 10.1007/s00167-011-1606-x; Iacono F, 2013, KNEE SURG SPORT TR A, V21, P2725, DOI 10.1007/s00167-012-2113-4; Parratte S, 2008, J BONE JOINT SURG AM, V90A, P184; Konig C, 2010, J ORTHOP RES, V28, P1, DOI 10.1002/jor.20952; Fornalski S, 2012, CLIN BIOMECH, V27, P824, DOI 10.1016/j.clinbiomech.2012.05.009; ARIMA J, 1995, J BONE JOINT SURG AM, V77, P1331; Griffin FM, 2000, J ARTHROPLASTY, V15, P354, DOI 10.1016/S0883-5403(00)90739-3; Babazadeh S, 2014, J ARTHROPLASTY, V29, P950, DOI 10.1016/j.arth.2013.09.036; Pang HN, 2013, KNEE SURG SPORT TR A, V21, P2363, DOI 10.1007/s00167-013-2390-6; ATESHIAN GA, 1991, J BIOMECH, V24, P761, DOI 10.1016/0021-9290(91)90340-S; Bae Dae Kyung, 2012, Knee Surg Sports Traumatol Arthrosc, V20, P2039; Eckhoff DG, 1996, J ARTHROPLASTY, V11, P163, DOI 10.1016/S0883-5403(05)80011-7; ELIAS SG, 1990, CLIN ORTHOP RELAT R, P98; Hwang BH, 2013, CLIN ORTHOP RELAT R, V471, P606, DOI 10.1007/s11999-012-2634-7; Iacono F, 2014, KNEE SURG SPORT TR A, V22, P3034, DOI 10.1007/s00167-013-2809-0; Lee HJ, 2011, KNEE SURG SPORT TR A, V19, P2027, DOI 10.1007/s00167-011-1468-2; LEWIS P, 1994, CLIN ORTHOP RELAT R, P11; Lingaraj K, 2009, KNEE SURG SPORT TR A, V17, P499, DOI 10.1007/s00167-008-0719-3; MARTIN JW, 1990, CLIN ORTHOP RELAT R, P146; Nakahara H, 2012, J ARTHROPLASTY, V27, P1119, DOI 10.1016/j.arth.2011.09.018; Otani T, 1993, J Arthroplasty, V8, P503; Pietsch M, 2013, KNEE SURG SPORT TR A, V21, P2220, DOI 10.1007/s00167-013-2624-7; Romero J, 2009, CLIN ORTHOP RELAT R, V468, P1279; Servien E, 2007, KNEE SURG SPORT TR A, V16, P263; Tigani D, 2010, KNEE SURG SPORT TR A, V18, P1304, DOI 10.1007/s00167-010-1124-2; Vince KG, 2012, J BONE JOINT SURG BR, V94B, P103, DOI 10.1302/0301-620X.94B11.30793; WASIELEWSKI RC, 1994, CLIN ORTHOP RELAT R, P31	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	DEC	2014	22	12					3060	3066		10.1007/s00167-014-3217-9		7	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AU0TA	WOS:000345336200025		
J	Ishii, Y; Noguchi, H; Sato, J; Todoroki, K; Toyabe, S				Ishii, Yoshinori; Noguchi, Hideo; Sato, Junko; Todoroki, Koji; Toyabe, Shin-ichi			Retention of the posterior cruciate ligament does not affect femoral rotational alignment in TKA using a gap-balance technique	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						PCL retention; Femoral rotational alignment; TKA; Gap-balance technique	TOTAL KNEE ARTHROPLASTY; LOWER-EXTREMITY ALIGNMENT; COMPONENT ROTATION; CORONAL LAXITY; BEARING; POSITION; JOINT; AXIS	Previous studies have evaluated the ability of the gap technique to achieve accurate rotational placement in both posterior cruciate ligament (PCL)-retaining and PCL-substituting total knee arthroplasty (TKA). The purpose of the present study was to determine (1) the accuracy of this technique in degrees and (2) whether retention of the PCL affects the rotational alignment of the femoral component relative to the transepicondylar axis during TKA. The hypothesis of this study was that retention of the PCL does not affect the femoral rotational alignment in TKA using a gap-balancing technique because both procedures are reported to have good long-term clinical outcomes. The femoral rotation angle (FRA) relative to the transepicondylar axis was examined in 206 patients who underwent primary TKA using either PCL-retaining (104 knees) or PCL-substituting (102 knees) prostheses to determine the effect of PCL retention on FRA. Quantitative three-dimensional computed tomography was used to assess the FRA in both groups. All values are expressed as median (25th percentile, 75th percentile). Postoperative FRA in the PCL-retaining group was -1.1A degrees (-2.8A degrees, 2.2A degrees) and in the PCL-substituting group was -0.1A degrees (-2.5A degrees, 2.8A degrees). The groups were not statistically different. One outlier was found in the PCL-retaining group, and none was found in the PCL-substituting group. The gap technique reliably allows accurate rotational alignment of the femoral component during TKA despite the retention of the PCL. Therapeutic study, Level II.	[Ishii, Yoshinori; Noguchi, Hideo; Sato, Junko; Todoroki, Koji] Ishii Orthopaed & Rehabil Clin, Gyoda, Saitama 3610037, Japan; [Toyabe, Shin-ichi] Niigata Univ, Med & Dent Hosp, Dept Med Informat, Niigata 9518520, Japan	Ishii, Y (reprint author), Ishii Orthopaed & Rehabil Clin, 1089 Shimo Oshi, Gyoda, Saitama 3610037, Japan.	ishii@sakitama.or.jp					Siston RA, 2006, CLIN ORTHOP RELAT R, P65, DOI 10.1097/01.blo.0000229335.36900.a0; Katz MA, 2001, J ARTHROPLASTY, V16, P301, DOI 10.1054/arth.2001.21456; Buechel FF, 2001, CLIN ORTHOP RELAT R, P41; Dennis DA, 2010, CLIN ORTHOP RELAT R, V468, P102, DOI 10.1007/s11999-009-1112-3; Walde TA, 2010, KNEE, V17, P381, DOI 10.1016/j.knee.2009.12.001; Ishii Y, 2011, KNEE SURG SPORT TR A, V19, P2002, DOI 10.1007/s00167-011-1395-2; Schnurr C, 2009, INT ORTHOP, V33, P1561, DOI 10.1007/s00264-008-0656-2; Kobayashi K, 2009, J BIOMECH, V42, P2818, DOI 10.1016/j.jbiomech.2009.08.022; Sato T, 2004, J ARTHROPLASTY, V19, P620, DOI 10.1016/j.arth.2003.12.063; Heesterbeek PJC, 2009, CLIN ORTHOP RELAT R, V467, P1015, DOI 10.1007/s11999-008-0539-2; Matziolis G, 2007, J BONE JOINT SURG AM, V89A, P236, DOI 10.2106/JBJS.F.00386; Yau WP, 2007, J ARTHROPLASTY, V22, P1042, DOI 10.1016/j.arth.2006.12.043; Ariumi A, 2010, J ORTHOP SCI, V15, P64, DOI 10.1007/s00776-009-1414-z; Christensen CP, 2013, J ARTHROPLASTY, V28, P1528, DOI 10.1016/j.arth.2013.01.008; GIRGIS FG, 1975, CLIN ORTHOP RELAT R, P216; Ishii Y, 2011, J ARTHROPLASTY, V26, P255, DOI 10.1016/j.arth.2010.05.023; Ishii Y, 2005, J ORTHOP SCI, V10, P496, DOI 10.1007/s00776-005-0935-3; Jordan LR, 2005, CLIN ORTHOP RELAT R, P111, DOI 10.1097/01.blo.0000172302.74414.34; Kaipel M, 2013, J ARTHROPLASTY, V28, P1103, DOI 10.1016/j.arth.2013.02.031; Matsuda Y, 2005, J ORTHOP SCI, V10, P37, DOI 10.1007/s00776-004-0863-7; Sato T, 2007, J ARTHROPLASTY, V22, P560, DOI 10.1016/j.arth.2006.06.020; Schroer WC, 2013, J ARTHROPLASTY, V28, P116, DOI 10.1016/j.arth.2013.04.056; Stiehl JB, 1996, CLIN ORTHOP RELAT R, P47; Vaidya SV, 2013, INDIAN J ORTHOP, V47, P40, DOI 10.4103/0019-5413.106898; Witoolkollachit Polawat, 2008, Journal of the Medical Association of Thailand, V91, P1051	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	DEC	2014	22	12					3121	3126		10.1007/s00167-014-3218-8		6	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AU0TA	WOS:000345336200032		
J	Tashiro, Y; Matsuda, S; Okazaki, K; Mizu-uchi, H; Kuwashima, U; Iwamoto, Y				Tashiro, Yasutaka; Matsuda, Shuichi; Okazaki, Ken; Mizu-uchi, Hideki; Kuwashima, Umito; Iwamoto, Yukihide			The coronal alignment after medial unicompartmental knee arthroplasty can be predicted: usefulness of full-length valgus stress radiography for evaluating correctability	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Unicompartmental knee arthroplasty; Valgus stress radiography; Tibia first cut technique; Correctability; Coronal alignment	LOWER-EXTREMITY ALIGNMENT; FOLLOW-UP; WORK-UP; REPLACEMENT; ARTHRITIS; MINIMUM; WEAR; INCLINATION; RELIABILITY; SURVIVAL	We aimed to clarify whether the coronal alignment after medial unicompartmental knee arthroplasty (UKA) is predictable using preoperative full-length valgus stress radiography. Thirty-seven consecutive patients with a mean age of 71.5 +/- A 7.0 years awaiting medial UKA were recruited. Full-length weight-bearing radiographs of the lower limbs were obtained pre- and postoperatively. Preoperative full-length valgus stress radiography in the supine position was also performed, and the transition of the hip-knee-ankle angle (HKAA) and the weight-bearing ratio were assessed. The tibia first cut technique was used, and the distal femur was cut parallel to the cutting surface of the proximal tibia during surgery. The mean postoperative HKAA was 2.0A degrees A A +/- A 2.1A degrees varus, and the mean weight-bearing ratio was 43.1 +/- A 7.7 %; each of these parameters demonstrated significantly strong correlations with the values on the preoperative valgus stress radiographs (p < 0.01), while the correlation between the postoperative alignment and the preoperative standing alignment without stress was moderate (p < 0.01). The postoperative alignment was slightly undercorrected compared to that observed on the valgus stress radiographs (p < 0.05), and no knees exhibited evident overcorrection compared to that on the valgus stress radiographs. Preoperative valgus stress radiography is useful for evaluating the correctability of varus deformities and predicting the postoperative coronal alignment. For clinical relevance, performing preoperative valgus stress radiography would help to more precisely select patients and, when combined with the tibia first cut technique, aid in achieving the expected knee alignment and avoid severe undercorrection or overcorrection. Diagnostic study, Level II.	[Tashiro, Yasutaka; Okazaki, Ken; Mizu-uchi, Hideki; Kuwashima, Umito; Iwamoto, Yukihide] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, Fukuoka 8128582, Japan; [Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Kyoto 6068507, Japan	Tashiro, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, Fukuoka 8128582, Japan.	11yasu@med.kyushu-u.ac.jp			JSPS [26861197]	This study was supported by JSPS Kakenhi Grant No. 26861197.	INSALL JN, 1989, CLIN ORTHOP RELAT R, P13; Simpson DJ, 2009, MED ENG PHYS, V31, P752, DOI 10.1016/j.medengphy.2009.02.004; Aleto TJ, 2008, J ARTHROPLASTY, V23, P159, DOI 10.1016/j.arth.2007.03.020; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037//0033-2909.86.2.420; Deschamps G, 2011, ORTHOP TRAUMATOL-SUR, V97, P648, DOI 10.1016/j.otsr.2011.08.003; Berger RA, 1999, CLIN ORTHOP RELAT R, P50; KOZINN SC, 1989, J BONE JOINT SURG AM, V71A, P145; Bruni D, 2012, CLIN ORTHOP RELAT R, V470, P1442, DOI 10.1007/s11999-012-2246-2; Berger RA, 2005, J BONE JOINT SURG AM, V87A, P999, DOI 10.2106/JBJS.C.00568; Sawatari T, 2005, J ORTHOP RES, V23, P549, DOI 10.1016/j.orthres.2004.06.007; Cartier P, 1996, J ARTHROPLASTY, V11, P782, DOI 10.1016/S0883-5403(96)80177-X; GIBSON PH, 1986, J BONE JOINT SURG BR, V68, P608; Kerens B, 2013, BONE JOINT J, V95B, P1204, DOI 10.1302/0301-620X.95B9.31085; MORELAND JR, 1987, J BONE JOINT SURG AM, V69A, P745; Squire MW, 1999, CLIN ORTHOP RELAT R, P61; Dudley TE, 2008, CLIN ORTHOP RELAT R, V466, P1666, DOI 10.1007/s11999-008-0279-3; Matsuda S, 2003, J ARTHROPLASTY, V18, P56, DOI 10.1054/arth.2003.50002; LEVINE AM, 1982, J BONE JOINT SURG AM, V64, P1158; Keene G, 2006, J BONE JOINT SURG BR, V88B, P44, DOI 10.1302/0301-620X.88B1.16266; Svard UCG, 2001, J BONE JOINT SURG BR, V83B, P191, DOI 10.1302/0301-620X.83B2.10966; Bruni D, 2010, KNEE SURG SPORT TR A, V18, P710, DOI 10.1007/s00167-009-0895-9; Waldstein W, 2013, CLIN ORTHOP RELAT R, V471, P3998, DOI 10.1007/s11999-013-3212-3; Murray DW, 1998, J BONE JOINT SURG BR, V80B, P983, DOI 10.1302/0301-620X.80B6.8177; Argenson JNA, 2006, CLIN ORTHOP RELAT R, P137, DOI 10.1097/01.blo.0000229358.19867.60; Hernigou P, 2004, CLIN ORTHOP RELAT R, P161, DOI 10.1097/01.blo.0000128285.90459.12; ten Ham AM, 2013, KNEE SURG SPORT TR A, V21, P2447, DOI 10.1007/s00167-012-2021-7; Ariumi A, 2010, J ORTHOP SCI, V15, P64, DOI 10.1007/s00776-009-1414-z; BARTLEY RE, 1994, CLIN ORTHOP RELAT R, P18; Emerson Roger H Jr, 2007, Orthopedics, V30, P32; Jamali Amir A, 2009, Am J Orthop (Belle Mead NJ), V38, P17; Kawahara S, 2012, CLIN ORTHOP RELAT R, V470, P1177, DOI 10.1007/s11999-011-2138-x; KENNEDY WR, 1987, CLIN ORTHOP RELAT R, P278; Marx RG, 2011, KNEE SURG SPORT TR A, V19, P1693, DOI 10.1007/s00167-011-1467-3; Matsuda S, 2013, CLIN ORTHOP RELAT R, V471, P4004, DOI 10.1007/s11999-013-3262-6; Scott CEH, 2013, BONE JOINT J, V95B, P1339, DOI 10.1302/0301-620X.95B10.31644; Shetty GM, 2014, KNEE, V21, P544, DOI 10.1016/j.knee.2013.09.008; Whiteside LA, 2005, J ARTHROPLASTY, V20, P2, DOI 10.1016/j.arth.2005.03.029; Zambianchi F, 2014, KNEE SURG SPORT TR A, DOI [10.1007/s00167-014-2958-9, DOI 10.1007/S00167-014-2958-9]	38	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	DEC	2014	22	12					3142	3149		10.1007/s00167-014-3248-2		8	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AU0TA	WOS:000345336200035		
J	Tazawa, M; Sohmiya, M; Wada, N; Defi, IR; Shirakura, K				Tazawa, Masayuki; Sohmiya, Makoto; Wada, Naoki; Defi, Irma Ruslina; Shirakura, Kenji			Toe-out angle changes after total knee arthroplasty in patients with varus knee osteoarthritis	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Three-dimensional motion analysis; Toe-out angle; Total knee arthroplasty; Varus knee osteoarthritis	FOOT PROGRESSION ANGLE; LOWER-LIMB ALIGNMENT; ADDUCTION MOMENT; STATIC ALIGNMENT; GAIT ANALYSIS; WALKING; LOAD; PAIN; INDIVIDUALS; NAVIGATION	Toeing-out is a commonly proposed kinematic variable that has been suggested to reduce external knee adduction moment. Analyses of the toe-out angle after total knee arthroplasty (TKA) are useful for obtaining a proper understanding of the abnormal gait caused by varus knee osteoarthritis (OA), as well as performing rehabilitation after arthroplasty. Changes in the toe-out angle after arthroplasty have not yet been defined or analysed. The study population consisted of 32 knees in 32 patients with varus knee OA who underwent TKA. The femorotibial angle was evaluated on standing anteroposterior radiographs before and after arthroplasty. The subjects underwent three-dimensional motion capture analyses to measure gait parameters (walking speed, cadence, stride length, step length, step width and the relative length of the single-limb support (SLS) percentage of one gait cycle) and the maximal hip adduction angle in the stance phase, the trunk lean angle in the coronal plane and the toe-out angle before and 4 weeks after arthroplasty. The femorotibial angle on the side of arthroplasty improved after surgery. Among the measured gait parameters, only the SLS percentage increased significantly. The hip adduction angle and toe-out angle on the side of arthroplasty increased significantly after surgery. The knee alignment and hip adduction angle in the coronal plane and SLS phase were normalized after arthroplasty. The increase in the toe-out angle after arthroplasty may be attributable to the restoration of a normal knee alignment. These findings contribute to obtaining a proper understanding of the abnormal gait caused by varus knee OA and are useful for orthopaedic surgeons and rehabilitation therapists when treating patients after arthroplasty. Prospective study, Level II.	[Tazawa, Masayuki; Defi, Irma Ruslina; Shirakura, Kenji] Gunma Univ, Grad Sch Med, Dept Rehabil Med, Maebashi, Gunma 3718511, Japan; [Sohmiya, Makoto; Wada, Naoki] Gunma Univ Hosp, Div Rehabil Med, Maebashi, Gunma 3718511, Japan; [Defi, Irma Ruslina] Padjadjaran State Univ, Hasan Sadikin Gen Hosp, Fac Med, Dept Phys Med & Rehabil, Bandung 40161, Indonesia	Tazawa, M (reprint author), Gunma Univ, Grad Sch Med, Dept Rehabil Med, 3-39-22 Showa, Maebashi, Gunma 3718511, Japan.	m09702047@gunma-u.ac.jp					Andrews M, 1996, J ORTHOPAED RES, V14, P289, DOI 10.1002/jor.1100140218; Guo M, 2007, GAIT POSTURE, V26, P436, DOI 10.1016/j.gaitpost.2006.10.008; Elbaz A, 2012, KNEE, V19, P32, DOI 10.1016/j.knee.2010.12.004; Huang TW, 2011, J BONE JOINT SURG AM, V93A, P1197, DOI 10.2106/JBJS.J.00325; Rutherford DJ, 2008, OSTEOARTHR CARTILAGE, V16, P883, DOI 10.1016/j.joca.2007.11.012; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Carse B, 2013, PHYSIOTHERAPY, V99, P347, DOI 10.1016/j.physio.2013.03.001; Wada M, 2001, RHEUMATOLOGY, V40, P499, DOI 10.1093/rheumatology/40.5.499; McKean KA, 2007, CLIN BIOMECH, V22, P400, DOI 10.1016/j.clinbiomech.2006.11.006; Mundermann A, 2005, ARTHRITIS RHEUM, V52, P2835, DOI 10.1002/art.21262; Hunt MA, 2008, OSTEOARTHR CARTILAGE, V16, P591, DOI 10.1016/j.joca.2007.10.017; Hunt MA, 2010, ARTHRIT CARE RES, V62, P1426, DOI 10.1002/acr.20248; Jackson BD, 2004, RHEUMATOLOGY, V43, P311, DOI 10.1093/rheumatology/keh002; Chang A, 2007, ANN RHEUM DIS, V66, P1271, DOI 10.1136/ard.2006.062927; McClelland JA, 2011, KNEE, V18, P151, DOI 10.1016/j.knee.2010.04.005; Hunt MA, 2006, J BIOMECH, V39, P2213, DOI 10.1016/j.jbiomech.2005.07.002; Hurwitz DE, 2002, J ORTHOPAED RES, V20, P101, DOI 10.1016/S0736-0266(01)00081-X; Catani F, 2012, KNEE SURG SPORT TR A, V20, P546, DOI 10.1007/s00167-011-1602-1; Yoshida Y, 2008, CLIN BIOMECH, V23, P320, DOI 10.1016/j.clinbiomech.2007.10.008; Konig A, 2000, J ARTHROPLASTY, V15, P289, DOI 10.1016/S0883-5403(00)90532-1; Siston RA, 2007, J BIOMECH, V40, P728, DOI 10.1016/j.jbiomech.2007.01.006; Chandler JT, 2004, J ARTHROPLASTY, V19, P211, DOI 10.1016/j.arth.2003.09.007; Bechard DJ, 2012, ARTHRIT CARE RES, V64, P525, DOI 10.1002/acr.21584; BERMAN AT, 1991, CLIN ORTHOP RELAT R, P106; Chang QZ, 2011, J ORTHOP SCI, V16, P382, DOI 10.1007/s00776-011-0066-y; Lynn SK, 2008, CLIN BIOMECH, V23, P779, DOI 10.1016/j.clinbiomech.2008.01.012; Niki Y, 2012, KNEE SURG SPORT TR A, V20, P2022, DOI 10.1007/s00167-011-1813-5; Solak AS, 2005, J ARTHROPLASTY, V20, P745, DOI 10.1016/j.arth.2004.10.019; TERAUCHI M, 1995, CLIN ORTHOP RELAT R, P141	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	DEC	2014	22	12					3168	3173		10.1007/s00167-014-2841-8		6	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AU0TA	WOS:000345336200039		
J	Okamoto, S; Okazaki, K; Mitsuyasu, H; Matsuda, S; Mizu-uchi, H; Hamai, S; Tashiro, Y; Iwamoto, Y				Okamoto, Shigetoshi; Okazaki, Ken; Mitsuyasu, Hiroaki; Matsuda, Shuichi; Mizu-uchi, Hideki; Hamai, Satoshi; Tashiro, Yasutaka; Iwamoto, Yukihide			Extension gap needs more than 1-mm laxity after implantation to avoid post-operative flexion contracture in total knee arthroplasty	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Total knee arthroplasty; Flexion contracture; Extension gap; Soft-tissue tension	NATURAL-HISTORY; DEFORMITY; ACCURACY; OUTCOMES	In total knee arthroplasty (TKA), a high soft-tissue tension in extension at the time of operation would cause a post-operative flexion contracture. However, how tight the extension gap should be during surgery to avoid a post-operative flexion contracture remains unclear. The hypothesis is that some laxity in the intraoperative extension gap is necessary to avoid the post-operative flexion contracture. A posterior-stabilized TKA was performed for 75 osteoarthritic knees with a varus deformity. The intraoperative extension gap was measured using a tensor device that provides the gap length and the angle between the femoral component and the tibial cut surface. The medial component gap was defined as the gap calculated by subtracting the selected thickness of the tibial component, including the polyethylene liner, from the extension gap at the medial side. Then, the patients were divided into three groups according to the medial component gap, and post-operative extension angle measured 1 year after the surgery was compared between each groups. One year post-operatively, a flexion contracture of more than 5A degrees was found in 0/34 patients when the medial component gap was more than 1 mm, in 2/26 (8 %) patients when the gap was between 0 and 1 mm, and in 3/15 (20 %) patients when the gap was < 0 mm. Three factors were associated significantly with the post-operative extension angle: age, preoperative extension angle, and medial component gap. The intraoperative extension gap is related to the post-operative extension angle. Surgeons should leave more than 1-mm laxity after the implantation to avoid the post-operative flexion contracture. As a clinical relevance, this study clarified the optimal extension gap to avoid the post-operative flexion contracture. Prospective comparative study, Level II.	[Okamoto, Shigetoshi; Okazaki, Ken; Mitsuyasu, Hiroaki; Mizu-uchi, Hideki; Hamai, Satoshi; Tashiro, Yasutaka; Iwamoto, Yukihide] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, Fukuoka 8128582, Japan; [Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Kyoto 6068507, Japan	Okazaki, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	okazaki@med.kyushu-u.ac.jp					Anania A, 2013, INT ORTHOP, V37, P1917, DOI 10.1007/s00264-013-1993-3; McPherson E J, 1994, J Arthroplasty, V9, P499, DOI 10.1016/0883-5403(94)90096-5; Dennis DA, 2010, CLIN ORTHOP RELAT R, V468, P102, DOI 10.1007/s11999-009-1112-3; Aunan E, 2012, ARCH ORTHOP TRAUM SU, V132, P1173, DOI 10.1007/s00402-012-1536-1; Smith CK, 2010, J ARTHROPLASTY, V25, P1137, DOI 10.1016/j.arth.2009.05.030; Yagishita K, 2003, J ARTHROPLASTY, V18, P313, DOI 10.1054/arth.2003.50088; GOGIA PP, 1987, PHYS THER, V67, P192; Okamoto S, 2013, CLIN ORTHOP RELAT R, V471, P1334, DOI 10.1007/s11999-012-2745-1; Matsumoto T, 2007, KNEE SURG SPORT TR A, V15, P1013, DOI 10.1007/s00167-007-0331-y; Griffin FM, 2000, J ARTHROPLASTY, V15, P970, DOI 10.1054/arth.2000.6503; Muratsu H, 2010, CLIN BIOMECH, V25, P926, DOI 10.1016/j.clinbiomech.2010.06.020; TEW M, 1987, J BONE JOINT SURG BR, V69, P395; Magit D, 2007, J AM ACAD ORTHOP SUR, V15, P682; Ritter MA, 2007, J ARTHROPLASTY, V22, P1092, DOI 10.1016/j.arth.2006.11.009; Bengs BC, 2006, J ARTHROPLASTY, V21, P161, DOI 10.1016/j.arth.2005.06.008; Song SJ, 2014, J ARTHROPLASTY, V29, P360, DOI 10.1016/j.arth.2013.06.023; Pang HN, 2011, KNEE SURG SPORT TR A, V19, P1496, DOI 10.1007/s00167-011-1483-3; Lavernia C, 2008, J ARTHROPLASTY, V23, P85, DOI 10.1016/j.arth.2008.05.019; Asano H, 2008, KNEE SURG SPORT TR A, V16, P999, DOI 10.1007/s00167-008-0591-1; Edwards JZ, 2004, J ARTHROPLASTY, V19, P369, DOI 10.1016/j.arth.2003.12.001; Goudie Stuart T, 2011, Orthopedics, V34, pe855, DOI 10.3928/01477447-20111021-18; Koh IJ, 2013, J ARTHROPLASTY, V28, P585, DOI 10.1016/j.arth.2012.07.014; Lam LO, 2003, KNEE, V10, P181, DOI 10.1016/S0968-0160(02)00102-3; Mihalko WM, 2003, J BONE JOINT SURG AM, V85A, P132; Mitsuyasu H, 2011, J BONE JOINT SURG BR, V93B, P1210, DOI 10.1302/0301-620X.93B9.25822; Schroer WC, 2013, J ARTHROPLASTY, V28, P116, DOI 10.1016/j.arth.2013.04.056	26	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	DEC	2014	22	12					3174	3180		10.1007/s00167-014-2858-z		7	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AU0TA	WOS:000345336200040		
J	Choi, D; Lim, GS; Piao, YL; Choi, OY; Cho, KA; Park, CB; Chang, YC; Song, YI; Lee, MK; Cho, H				Choi, Dubok; Lim, Geum-Sook; Piao, Yu Lan; Choi, On-You; Cho, Ki-An; Park, Choon-Bae; Chang, Young-Cheol; Song, Young-Il; Lee, Myung-Koo; Cho, Hoon			Characterization, stability, and antioxidant activity of Salicornia herbaciea seed oil	KOREAN JOURNAL OF CHEMICAL ENGINEERING			English	Article						Salicornia herbaciea; Seed Oil; Fatty Acids; Stability; Antioxidant Activity	VIRGIN OLIVE OIL; VEGETABLE-OILS; FATTY-ACIDS; OXIDATIVE STABILITY; PHENOLIC-COMPOUNDS; STORAGE; PHYTOSTEROLS; COMPONENTS; STEROLS; PLANT	We investigated the physicochemical properties, chemical composition, stability and antioxidant activity from seed oil of Salicornia herbaciea grown in Korea. The density, refractive index, acid value, peroxide value, iodine value, saponification value, and unsaponifiable matter of oil were 0.91mg/mL, 1.48 at 20 A degrees C, 1.89mg KOH/g oil, 10.20 mEq/kg oil, 1.08 g I/g oil, 216.21 mg KOH/g oil, and 2.60%, respectively. The major fatty acids were linoleic acid (43.73%), oleic acid (19.81%), arachidic acid (13.52%), and palmitic acid (11.84%), respectively. The oil contained high levels of alpha-tocopherol (249.2 mg/kg oil), followed by delta-tocopherol (89.3 mg/kg), and gamma-tocopherol (75.6 mg/kg oil). The oil was found to have high levels of beta-sitosterol (94.5mg/kg oil) and stigmasterol (65.7mg/kg oil), respectively. The total phenol, chlorophyll and beta-carotene content of oil was 15.2, 94.5, and 8.2 mg/kg oil, respectively. The oil had good oxidative stability during 60 days of storage in a dark area at 50 A degrees C. The maximum degradation rates of the oil were observed at 242.3 A degrees C (9.5%/min), 382.6 A degrees C (5.2%/min), and 440.7 A degrees C (1.3%/min), respectively, where the rate of the weight decrease increased to a maximum up to this point. The ABTS radical scavenging activity of the oil was increased from 50.2 to 71.8% when the oil concentration extracted by methanol was increased from 100 to 300 mu g/mL. This study suggests that S. herbaciea seed oil has potential use in functional foods, cosmetics or pharmaceuticals.	[Choi, Dubok; Lee, Myung-Koo] Chungbuk Natl Univ, Dept Pharm, Coll Pharm, Cheongju 361763, South Korea; [Lim, Geum-Sook] Chonnam Natl Univ, Grad Sch, Interdisciplinary Program Perfume & Cosmet, Kwangju 500757, South Korea; [Piao, Yu Lan; Cho, Hoon] Chosun Univ, Dept Biochem Polymer Sci & Engn, Kwangju 501759, South Korea; [Choi, On-You; Cho, Ki-An] Shinchon E&C R&D, Biochem Lab, Kwangju 500010, South Korea; [Choi, On-You; Cho, Ki-An] Chodang Univ, Dept Med Management, Jeonnam 534800, South Korea; [Park, Choon-Bae] Wonkwang Univ, Dept Informat & Commun Engn, Iksan 570749, South Korea; [Chang, Young-Cheol] Muroran Inst Technol, Div Appl Sci, Biosyst Course, Muroran, Hokkaido 0508585, Japan; [Song, Young-Il] Chosun Univ, Leaders Ind Univ Cooperat LINC, Kwangju 501759, South Korea	Cho, H (reprint author), Chosun Univ, Dept Biochem Polymer Sci & Engn, Kwangju 501759, South Korea.	hcho@chosun.ac.kr		Chang, Young-Cheol/0000-0002-6197-5974	Chosun University	This study was supported by research funds from Chosun University, 2013.	A. O. C. S, 1990, OFF TENT METH AM OIL; Koski A, 2003, EUR FOOD RES TECHNOL, V217, P110, DOI 10.1007/s00217-003-0721-4; Anwar F, 2006, J AM OIL CHEM SOC, V83, P323, DOI 10.1007/s11746-006-1207-x; Ramadan MF, 2006, J FOOD COMPOS ANAL, V19, P838, DOI 10.1016/j.jfca.2006.02.013; Li CM, 2011, J AGR FOOD CHEM, V59, P12493, DOI 10.1021/jf203760k; Rhee MH, 2009, J MED PLANTS RES, V3, P548; Miraliakbari H, 2008, FOOD CHEM, V111, P421, DOI 10.1016/j.foodchem.2008.04.008; Gutierrez F, 2000, J AGR FOOD CHEM, V48, P1106, DOI 10.1021/jf9907337; Morello JR, 2004, FOOD CHEM, V85, P357, DOI 10.1016/j.foodchem.2003.07.012; LIANG TM, 1992, BIOCHEM J, V285, P557; Awad AB, 2000, J NUTR, V130, P2127; Siger A, 2008, J FOOD LIPIDS, V15, P137, DOI 10.1111/j.1745-4522.2007.00107.x; Santos JCO, 2004, J THERM ANAL CALORIM, V75, P419, DOI 10.1023/B:JTAN.0000027128.62480.db; Nehdi I, 2010, IND CROP PROD, V32, P360, DOI 10.1016/j.indcrop.2010.05.016; Tsimidou MZ, 2005, FOOD CHEM, V93, P377, DOI 10.1016/j.foodchem.2004.09.033; Goodrum JW, 2002, BIOMASS BIOENERG, V22, P205, DOI 10.1016/S0961-9534(01)00074-5; Frega N, 1999, J AM OIL CHEM SOC, V76, P325, DOI 10.1007/s11746-999-0239-4; Ostlund RE, 2002, ANNU REV NUTR, V22, P533, DOI 10.1146/annurev.nutr.22.020702.075220; Kang S, 2011, FOOD SCI BIOTECHNOL, V20, P115, DOI 10.1007/s10068-011-0016-7; [Anonymous], 1991, ANAL PROPERTIES OIL; Dugo G, 2004, FOOD CHEM, V87, P639, DOI [10.1016/j.foodchem.2003.12.035, 10.1016/j.foochem.2003.12.035]; Nasri N, 2005, PHYTOCHEMISTRY, V66, P1729, DOI 10.1016/j.phytochem.2005.05.023; Chang NW, 1998, LIPIDS, V33, P481, DOI 10.1007/s11745-998-0231-9; Weber DJ, 2007, J ARID ENVIRON, V68, P315, DOI 10.1016/j.jaridenv.2006.05.010; Okogeri O, 2002, J AGR FOOD CHEM, V50, P1077, DOI 10.1021/jf010895e; Canabate-Diaz B, 2007, FOOD CHEM, V102, P593, DOI 10.1016/j.foodchem.2006.05.038; AUSTENFELD FA, 1986, PHYSIOL PLANTARUM, V68, P446, DOI 10.1111/j.1399-3054.1986.tb03380.x; Babu SVV, 2010, EUR J PHARMACOL, V626, P262, DOI 10.1016/j.ejphar.2009.09.037; Basu HN, 2001, J AM OIL CHEM SOC, V78, P665, DOI 10.1007/s11746-001-0324-x; Belitz H. D., 1999, VEGETABLE OIL FOOD C; Castelo-Branco V. N., 2009, LIPID TECHNOL, V2, P152; Choi O. Y., 2011, Korea Patent, Patent No. [10-1022137, 101022137]; Choi O. Y., 2011, Korea Patent, Patent No. [10-1022133, 101022133]; Eganathan P, 2006, IND CROP PROD, V23, P177, DOI 10.1016/j.indcrop.2004.05.007; Farooq Anwar, 2002, Journal of Agricultural and Food Chemistry, V50, P4210, DOI 10.1021/jf0114132; Fireston D., 2006, PHYS CHEM CHARACTERI; Glenn E. P., 1998, Scientific American, V279, P56; Jo Y. C., 2002, KOREAN J MED CROP SC, V10, P93; Jung BM, 2008, J KOREAN SOC FOOD SC, V37, P148, DOI 10.3746/jkfn.2008.37.2.148; Marcelo G. M., 2012, ANAIS ANN BRAZILIAN, V84, P865; Mellerup J., 2007, US Patent, Patent No. [7,288,278, 7288278]; Moros J, 2009, FOOD CHEM, V114, P1529, DOI 10.1016/j.foodchem.2008.11.040; Rohman A, 2011, FOOD ANAL METHOD, V4, P155, DOI 10.1007/s12161-010-9156-2; Rossell J. B., 1991, APPL SCI; Santos JCO, 2005, J THERM ANAL CALORIM, V79, P283, DOI 10.1007/s10973-005-0050-x; Shin K. S., 2002, KOREAN J PLANT RES, V15, P216; Solis-Fuentes JA, 2010, BIORESOURCE TECHNOL, V101, P799, DOI 10.1016/j.biortech.2009.08.031; Song H. S., 2007, KOREAN J FOOD NUTR, V20, P150; Stiti N., 2002, Rivista Italiana delle Sostanze Grasse, V79, P357; Stuchlik Milan, 2002, Biomedical Papers (Olomouc), V146, P3; Sung JH, 2009, BIOSCI BIOTECH BIOCH, V73, P552, DOI 10.1271/bbb.80601; Vles R. O., 1989, NUTR CHARACTERISTICS	52	0	0	KOREAN INSTITUTE CHEMICAL  ENGINEERS	SEOUL	F.5, 119, ANAM-RO, SEONGBUK-GU, SEOUL 136-075, SOUTH KOREA	0256-1115	1975-7220		KOREAN J CHEM ENG	Korean J. Chem. Eng.	DEC	2014	31	12					2221	2228		10.1007/s11814-014-0163-7		8	Chemistry, Multidisciplinary; Engineering, Chemical	Chemistry; Engineering	AU4NN	WOS:000345588400016		
J	Kabara, M; Kawabe, J; Matsuki, M; Hira, Y; Minoshima, A; Shimamura, K; Yamauchi, A; Aonuma, T; Nishimura, M; Saito, Y; Takehara, N; Hasebe, N				Kabara, Maki; Kawabe, Jun-ichi; Matsuki, Motoki; Hira, Yoshiki; Minoshima, Akiho; Shimamura, Kohei; Yamauchi, Atsushi; Aonuma, Tatsuya; Nishimura, Masato; Saito, Yukihiro; Takehara, Naofumi; Hasebe, Naoyuki			Immortalized multipotent pericytes derived from the vasa vasorum in the injured vasculature. A cellular tool for studies of vascular remodeling and regeneration	LABORATORY INVESTIGATION			English	Article							ENDOTHELIAL PROGENITOR CELLS; MESENCHYMAL STEM-CELLS; SKELETAL-MUSCLE; NEOVASCULARIZATION; DIFFERENTIATION; ANTIGEN; IDENTIFICATION; PARTICIPATE; TISSUES; AORTAS	Adventitial microvessels, vasa vasorum in the vessel walls, have an active role in the vascular remodeling, although its mechanisms are still unclear. It has been reported that microvascular pericytes (PCs) possess mesenchymal plasticity. Therefore, microvessels would serve as a systemic reservoir of stem cells and contribute to the tissues remodeling. However, most aspects of the biology of multipotent PCs (mPCs), in particular of pathological nnicrovessels are still obscure because of the lack of appropriate methods to detect and isolate these cells. In order to examine the characteristics of mPCs, we established immortalized cells residing in adventitial capillary growing at the injured vascular walls. We recently developed in vivo angiogenesis to observe adventitial microvessels using collagen-coated tube (CCT), which also can be used as an adventitial microvessel-rich tissue. By using the CCT, CD146- or NG2-positive cells were isolated from the adventitial microvessels in the injured arteries of mice harboring a temperature-sensitive SV40 T-antigen gene. Several capillary-derived endothelial cells (cECs) and PCs (cPCs) cell lines were established. cECs and cPCs maintain a number of key endothelial and PC features. Co-incubation of cPCs with cECs formed capillary-like structure in Matrigel. Three out of six cPC lines, termed capillary mPCs demonstrated both mesenchymal stem cell- and neuronal stem cell-like phenotypes, differentiating effectively into adipocytes, osteoblasts, as well as schwann cells. mPCs differentiated to ECs and PCs, and formed capillary-like structure on their own. Transplanted Ds Red-expressing mPCs were resident in the capillary and muscle fibers and promoted angiogenesis and myogenesis in damaged skeletal muscle. Adventitial mPCs possess transdifferentiation potential with unique phenotypes, including the reconstitution of capillary-like structures. Their phenotype would contribute to the pathological angiogenesis associated with vascular remodeling. These cell lines also provide a reproducible cellular tool for high-throughput studies on angiogenesis, vascular remodeling, and regeneration as well.	[Kabara, Maki; Matsuki, Motoki; Minoshima, Akiho; Shimamura, Kohei; Yamauchi, Atsushi; Aonuma, Tatsuya; Nishimura, Masato; Hasebe, Naoyuki] Asahikawa Med Univ, Dept Med, Div Cardiovasc Resp & Neurol, Asahikawa, Hokkaido 0788510, Japan; [Kawabe, Jun-ichi; Takehara, Naofumi; Hasebe, Naoyuki] Asahikawa Med Univ, Dept Cardiovasc Regenerat & Innovat, Asahikawa, Hokkaido 0788510, Japan; [Hira, Yoshiki] Asahikawa Med Univ, Dept Anat, Asahikawa, Hokkaido 0788510, Japan; [Saito, Yukihiro] Asahikawa Med Univ, Dept Vasc Surg, Asahikawa, Hokkaido 0788510, Japan	Kawabe, J (reprint author), Asahikawa Med Univ, Dept Cardiovasc Regenerat & Innovat, Higashi 2-1-1, Asahikawa, Hokkaido 0788510, Japan.	kawabeju@asahikawa-med.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan [22590820, 25461121]; Akiyama Life Science Foundation; Suhara Memorial Foundation; Mitsubishi Pharma Research Foundation	We thank K Kanno, A Oda, S Takahashi, Y Horikawa, and E Shinokawa for laboratory assistance, and Y. Segawa for secretarial assistance. Funding for this study was provided by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan (22590820, 25461121); a grant from The Akiyama Life Science Foundation, Suhara Memorial Foundation, and Mitsubishi Pharma Research Foundation.	Campagnolo P, 2010, CIRCULATION, V121, P1735, DOI 10.1161/CIRCULATIONAHA.109.899252; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909; Majesky MW, 2011, ARTERIOSCL THROM VAS, V31, P1530, DOI 10.1161/ATVBAHA.110.221549; Bautch VL, 2011, NAT MED, V17, P1437, DOI 10.1038/nm.2539; Shimizu F, 2008, J CELL PHYSIOL, V217, P388, DOI 10.1002/jcp.21508; Naito H, 2012, EMBO J, V31, P842, DOI 10.1038/emboj.2011.465; Birbrair A, 2013, AM J PHYSIOL-CELL PH, V305, pC1098, DOI 10.1152/ajpcell.00171.2013; Corselli M, 2012, STEM CELLS DEV, V21, P1299, DOI 10.1089/scd.2011.0200; Tintut Y, 2003, CIRCULATION, V108, P2505, DOI 10.1161/01.CIR.0000096485.64373.C5; Doyle B, 2007, J AM COLL CARDIOL, V49, P2073, DOI 10.1016/j.jacc.2007.01.089; Wilkinson FL, 2007, J PATHOL, V211, P362, DOI 10.1002/path.2114; Tilki D, 2009, TRENDS MOL MED, V15, P501, DOI 10.1016/j.molmed.2009.09.004; Obinata M, 1997, GENES CELLS, V2, P235, DOI 10.1046/j.1365-2443.1997.1160314.x; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; Kawabe J, 2010, ARTERIOSCL THROM VAS, V30, P464, DOI 10.1161/ATVBAHA.109.193730; Mulligan-Kehoe MJ, 2010, AM J PHYSIOL-HEART C, V298, pH295, DOI 10.1152/ajpheart.00884.2009; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Pasquinelli G, 2007, STEM CELLS, V25, P1627, DOI 10.1634/stemcells.2006-0731; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Takahashi Y, 2013, SCIENCE, V341, P860, DOI 10.1126/science.1230717; Middleton J, 2005, J PATHOL, V206, P260, DOI 10.1002/path.1788; Tanaka K, 2011, ATHEROSCLEROSIS, V215, P366, DOI 10.1016/j.atherosclerosis.2011.01.016; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Chang L, 2013, CIRC J, V77, P11, DOI 10.1253/circj.CJ-12-1393; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; LAITINEN L, 1987, HISTOCHEM J, V19, P225, DOI 10.1007/BF01680633; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tigges U, 2013, J VASC RES, V50, P134, DOI 10.1159/000345524; Zorzi P, 2010, J LEUKOCYTE BIOL, V88, P1051, DOI 10.1189/jlb.0310178; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Crisan M, 2012, J CELL MOL MED, V16, P2851, DOI 10.1111/j.1582-4934.2012.01617.x; Langheinrich AC, 2006, ARTERIOSCL THROM VAS, V26, P347, DOI 10.1161/01.ATV.0000196565.38679.6d; Aburakawa Y, 2013, CIRC J, V77, P1053, DOI 10.1253/circj.CJ-12-0897; Asanome A, 2014, BIOCHEM BIOPH RES CO, V443, P150, DOI 10.1016/j.bbrc.2013.11.070; Bardin N, 1996, BIOCHEM BIOPH RES CO, V218, P210, DOI 10.1006/bbrc.1996.0037; Birbrair A, 2013, STEM CELL RES, V10, P67, DOI 10.1016/j.scr.2012.09.003; Chen W.C.W., 2013, STEM CELLS INT, V2013; Hildebrandt HA, 2008, ATHEROSCLEROSIS, V199, P47, DOI 10.1016/j.atherosclerosis.2007.09.015; Kawabe J, 2014, BIOMED RES INT, DOI 10.1155/2014/701571; Kondo T, 2003, CELL STRUCT FUNCT, V28, P145; Kovacic JC, 2009, STEM CELL RES, V2, P2, DOI 10.1016/j.scr.2008.05.005; Murray IR, 2013, CELL MOL LIFE SCI, V71, P1353; Shimabukuro Michio, 2013, J Med Invest, V60, P1; Tang ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1867; Yamauchi A, 2013, AM J PHYSIOL-HEART C, V305, pH1158, DOI 10.1152/ajpheart.00965.2012	47	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	DEC	2014	94	12					1340	1354		10.1038/labinvest.2014.121		15	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	AU4AT	WOS:000345552200003		
J	Yasuda, K; Torigoe, T; Mariya, T; Asano, T; Kuroda, T; Matsuzaki, J; Ikeda, K; Yamauchi, M; Emori, M; Asanuma, H; Hasegawa, T; Saito, T; Hirohashi, Y; Sato, N				Yasuda, Kazuyo; Torigoe, Toshihiko; Mariya, Tasuku; Asano, Takuya; Kuroda, Takafumi; Matsuzaki, Junichi; Ikeda, Kanae; Yamauchi, Makoto; Emori, Makoto; Asanuma, Hiroko; Hasegawa, Tadashi; Saito, Tsuyoshi; Hirohashi, Yoshihiko; Sato, Noriyuki			Fibroblasts induce expression of FGF4 in ovarian cancer stem-like cells/cancer-initiating cells and upregulate their tumor initiation capacity	LABORATORY INVESTIGATION			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; STROMAL FIBROBLASTS; GENE; AMPLIFICATION; ESTABLISHMENT; PROGNOSIS; GROWTH	Cancer stem-like cells (CSCs)/cancer-initiating cells (CICs) are defined as a small population of cells within cancer that contribute to cancer initiation and progression. Cancer-associated fibroblasts (CAFs) are stromal fibroblasts surrounding tumor cells, and they have important roles in tumor growth and tumor progression. It has been suggested that stromal fibroblasts and CSCs/CICs might mutually cooperate to enhance their growth and tunnorigenic capacity. In this study, we investigated the effects of fibroblasts on tumor-initiating capacity and stem-like properties of ovarian CSCs/CICs. CSCs/CICs were isolated from the ovarian carcinoma cell line HTBoA as aldehyde dehydrogenase 1 high (ALDH1(high)) population by the ALDEFLUOR assay. Histological examination of tumor tissues derived from ALDH1(high) cells revealed few fibrous stroma, whereas those derived from fibroblast-mixed ALDH1(high) cells showed abundant fibrous stroma formation. In vivo tumor-initiating capacity and in vitro sphere-forming capacity of ALDH1(high) cells were enhanced in the presence of fibroblasts. Gene expression analysis revealed that fibroblast-mixed ALDH1(high) cells had enhanced expression of fibroblast growth factor 4 (FGF4) as well as sternness-associated genes such as SOX2 and POU5F1. Sphere-forming capacity of ALDH1(high) cells was suppressed by small-interfering RNA (siRNA)-mediated knockdown of FGFR2, the receptor for FGF4 which was expressed preferentially in ALDH1(high) cells. Taken together, the results indicate that interaction of fibroblasts with ovarian CSCs/CICs enhanced tumor-initiating capacity and stem-like properties through autocrine and paracrine FGF4-FGFR2 signaling.	[Yasuda, Kazuyo; Torigoe, Toshihiko; Mariya, Tasuku; Asano, Takuya; Matsuzaki, Junichi; Emori, Makoto; Hirohashi, Yoshihiko; Sato, Noriyuki] Sapporo Med Univ, Dept Pathol, Sch Med, Sapporo, Hokkaido 0608556, Japan; [Mariya, Tasuku; Asano, Takuya; Kuroda, Takafumi; Saito, Tsuyoshi] Sapporo Med Univ, Dept Obstet & Gynecol, Sch Med, Sapporo, Hokkaido 0608556, Japan; [Ikeda, Kanae; Yamauchi, Makoto] Sapporo Med Univ, Dept Plast & Reconstruct Surg, Sch Med, Sapporo, Hokkaido 0608556, Japan; [Asanuma, Hiroko; Hasegawa, Tadashi] Sapporo Med Univ, Dept Surg Pathol, Sch Med, Sapporo, Hokkaido 0608556, Japan	Yasuda, K (reprint author), Sapporo Med Univ, Dept Pathol, Sch Med, Chuo Ku, South 1 West 17, Sapporo, Hokkaido 0608556, Japan.	yasudasann@gmail.com			Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; Sagawa Foundation for Promotion of Cancer Research; Suharakinennzaidann	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to NS, TT, JM and YH), program for developing the supporting system for upgrading education and research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to NS) and Takeda Science Foundation (to YH), Sagawa Foundation for Promotion of Cancer Research (to YH) and Suharakinennzaidann (to YH).	Tsuyada A, 2012, CANCER RES, V72, P2768, DOI 10.1158/0008-5472.CAN-11-3567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Wang YC, 2012, AM J PATHOL, V180, P1159, DOI 10.1016/j.ajpath.2011.11.015; Aboussekhra A, 2011, INT J DEV BIOL, V55, P841, DOI 10.1387/ijdb.113362aa; Allen M, 2011, J PATHOL, V223, P162, DOI 10.1002/path.2803; Brooks AN, 2012, CLIN CANCER RES, V18, P1855, DOI 10.1158/1078-0432.CCR-11-0699; Kawase A, 2008, INT J CANCER, V123, P1053, DOI 10.1002/ijc.23611; JAAKKOLA S, 1993, INT J CANCER, V54, P378, DOI 10.1002/ijc.2910540305; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Giannoni E, 2010, CANCER RES, V70, P6945, DOI 10.1158/0008-5472.CAN-10-0785; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Jordan NV, 2011, CELL CYCLE, V10, P2865, DOI 10.4161/cc.10.17.17188; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Park CY, 2009, MOL THER, V17, P219, DOI 10.1038/mt.2008.254; Abate-Shen C, 2007, CANCER CELL, V12, P495, DOI 10.1016/j.ccr.2007.11.021; Nishizawa S, 2012, CANCER RES, V72, P2844, DOI 10.1158/0008-5472.CAN-11-3062; Arao T, 2012, HEPATOLOGY, V57, P1407; Behrens P, 2001, INT J MOL MED, V8, P149; Chao CL, 2012, LAB INVEST, V92, P420, DOI 10.1038/labinvest.2011.185; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Hirohashi Y, 2010, IMMUNOTHERAPY-UK, V2, P201, DOI [10.2217/imt.10.10, 10.2217/IMT.10.10]; ISHIWATA I, 1988, GYNECOL ONCOL, V30, P35, DOI 10.1016/0090-8258(88)90043-1; Katoh M, 2005, INT J ONCOL, V27, P281; Kuroda T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065158; SAKAMOTO H, 1986, P NATL ACAD SCI USA, V83, P3997, DOI 10.1073/pnas.83.11.3997; Sigurdsson V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023833; SZEPETOWSKI P, 1992, ONCOGENE, V7, P751; Torigoe T, 2012, PATHOL INT, V62, P303, DOI 10.1111/j.1440-1827.2012.02789.x; Yamamoto H, 2000, ONCOGENE, V19, P3805, DOI 10.1038/sj.onc.1203752; Yasuda K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068187; Zaharieva BM, 2003, J PATHOL, V201, P603, DOI 10.1002/path.1481	35	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	DEC	2014	94	12					1355	1369		10.1038/labinvest.2014.122		15	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	AU4AT	WOS:000345552200004		
J	Kennedy, LL; Hargrove, LA; Graf, AB; Francis, TC; Hodges, KM; Nguyen, QP; Ueno, Y; Greene, JF; Meng, FY; Huynh, VD; Francis, HL				Kennedy, Lindsey L.; Hargrove, Laura A.; Graf, Allyson B.; Francis, Taylor C.; Hodges, Kyle M.; Nguyen, Quy P.; Ueno, Yoshi; Greene, John F.; Meng, Fanyin; Huynh, Victoria D.; Francis, Heather L.			Inhibition of mast cell-derived histamine secretion by cromolyn sodium treatment decreases biliary hyperplasia in cholestatic rodents	LABORATORY INVESTIGATION			English	Article							CHOLANGIOCYTE PROLIFERATION; HISTIDINE-DECARBOXYLASE; LIVER-DISEASE; RAT-LIVER; ACTIVATION; BILE; PRURITUS; PATHWAY; GROWTH; EXPRESSION	Cholangiopathies are characterized by dysregulation of the balance between biliary growth and loss. We have shown that histamine (HA) stimulates biliary growth via autocrine mechanisms. To evaluate the paracrine effects of mast cell (MC) stabilization on biliary proliferation, sham or BDL rats were treated by IP-implanted osmotic pumps filled with saline or cromolyn sodium (24 mg/kg BW/day (inhibits MC histamine release)) for 1 week. Serum, liver blocks and cholangiocytes were collected. Histidine decarboxylase (HDC) expression was measured using real-time PCR in cholangiocytes. Intrahepatic bile duct mass (IBDM) was evaluated by IHC for CK-19. MC number was determined using toluidine blue staining and correlated to IBDM. Proliferation was evaluated by PCNA expression in liver sections and purified cholangiocytes. We assessed apoptosis using real-time PCR and IHC for BAX. Expression of MC stem factor receptor, c-kit, and the proteases chymase and tryptase were measured by real-time PCR. HA levels were measured in serum by EIA. In vitro, MCs and cholangiocytes were treated with 0.1% BSA (basal) or cromolyn (25 mu M) for up to 48 h prior to assessing HDC expression, HA levels and chymase and tryptase expression. Supernatants from MCs treated with or without cromolyn were added to cholangiocytes before measuring (i) proliferation by MU assays, (ii) HDC gene expression by real-time PCR and (iii) HA release by EIA. In vivo, cromolyn treatment decreased BDL-induced: (i) IBDM, MC number, and biliary proliferation; (ii) HDC and MC marker expression; and (iii) HA levels. Cromolyn treatment increased cholangiocyte apoptosis. In vitro, cromolyn decreased HA release and chymase and tryptase expression in MCs but not in cholangiocytes. Cromolyn-treated MC supernatants decreased biliary proliferation and HA release. These studies provide evidence that MC histamine is key to biliary proliferation and may be a therapeutic target for the treatment of cholangiopathies.	[Kennedy, Lindsey L.; Graf, Allyson B.; Nguyen, Quy P.; Meng, Fanyin; Francis, Heather L.] Cent Texas Vet Hlth Care Syst, Digest Dis Res Ctr, Temple, TX USA; [Hargrove, Laura A.; Hodges, Kyle M.; Greene, John F.; Meng, Fanyin; Francis, Heather L.] Scott & White Mem Hosp & Clin, Scott & White Digest Dis Res Ctr, Temple, TX USA; [Francis, Taylor C.; Meng, Fanyin; Huynh, Victoria D.; Francis, Heather L.] Texas A&M Hlth Sci Ctr, Dept Med, Temple, TX USA; [Ueno, Yoshi] Japan Sci & Technol Corp, CREST, Tokyo, Japan	Francis, HL (reprint author), Scott & White Healthcare, Cent Texas Vet Hlth Care Syst, Digest Dis Res Ctr, Olin E Teague Med Ctr, 1901 South 1st St,Bldg 205,1R60, Temple, TX 76504 USA.	hfrancis@medicine.tamhsc.edu			Career Development Award from the Veteran's Affairs [IK2 BX001760]; Primary Sclerosing Cholangitis Foundation; VA Merit award	This work was supported by a Career Development Award from the Veteran's Affairs (IK2 BX001760) and funds from the Primary Sclerosing Cholangitis Foundation to Dr Francis and a VA Merit award to Dr Meng.	Akiyoshi H, 1998, J HEPATOL, V29, P112, DOI 10.1016/S0168-8278(98)80185-2; Albamonte MI, 2013, HUM REPROD, V28, P698, DOI 10.1093/humrep/des453; Alpini G, 2002, GASTROENTEROLOGY, V123, P1226, DOI 10.1053/gast.2002.36055; Francis H, 2004, J HEPATOL, V41, P528, DOI 10.1016/j.jhep.2004.06.009; Francis H, 2012, GUT, V61, P753, DOI 10.1136/gutjnl-2011-300007; Glaser S, 2014, GASTROENTEROLOGY, V146, P1795, DOI 10.1053/j.gastro.2014.02.030; SPERR WR, 1994, BLOOD, V84, P3876; GALLI SJ, 1994, ADV IMMUNOL, V55, P1; Rao KN, 2008, ANN NY ACAD SCI, V1143, P83, DOI 10.1196/annals.1443.023; Ueno Y, 2003, LIVER INT, V23, P449, DOI 10.1111/j.1478-3231.2003.00876.x; Jeziorska M, 1997, J PATHOL, V182, P115, DOI 10.1002/(SICI)1096-9896(199705)182:1<115::AID-PATH806>3.0.CO;2-9; Kim CE, 2012, J CONTROL RELEASE, V157, P190, DOI 10.1016/j.jconrel.2011.09.066; Francis H, 2007, LAB INVEST, V87, P473, DOI 10.1038/labinvest.3700533; Gaudio E, 2006, GASTROENTEROLOGY, V130, P1270, DOI 10.1053/j.gastro.2005.12.034; Francis H, 2008, AM J PHYSIOL-CELL PH, V295, pC499, DOI 10.1152/ajpcell.00369.2007; De Morrow S, 2008, AM J PHYSIOL-GASTR L, V294, pG506, DOI 10.1152/ajpgi.00304.2007; Beaven MA, 2009, EUR J IMMUNOL, V39, P11, DOI 10.1002/eji.200838899; LeSage G, 2001, LIVER, V21, P73, DOI 10.1034/j.1600-0676.2001.021002073.x; Bolier R, 2013, CLIN LIVER DIS, V17, P319, DOI 10.1016/j.cld.2012.11.006; Alvaro D, 2007, GASTROENTEROLOGY, V132, P415, DOI 10.1053/j.gastro.2006.07.023; Francis HL, 2012, LAB INVEST, V92, P282, DOI 10.1038/labinvest.2011.158; Alpini G, 1997, AM J PHYSIOL-GASTR L, V272, pG289; Brower GL, 2002, AM J PHYSIOL-HEART C, V283, pH518, DOI 10.1152/ajpheart.00218.2000; Gaudio E, 2006, AM J PHYSIOL-GASTR L, V291, pG307, DOI 10.1152/ajpgi.00507.2005; Alpini G, 1996, GASTROENTEROLOGY, V110, P1636, DOI 10.1053/gast.1996.v110.pm8613073; QUIST RG, 1991, GASTROENTEROLOGY, V101, P446; Bischoff SC, 2009, SEMIN IMMUNOPATHOL, V31, P185, DOI 10.1007/s00281-009-0165-4; Melillo RM, 2010, ONCOGENE, V29, P6203, DOI 10.1038/onc.2010.348; BARDADIN KA, 1986, J PATHOL, V149, P315, DOI 10.1002/path.1711490408; Bunchorntavakul C, 2012, CLIN LIVER DIS, V16, P331, DOI 10.1016/j.cld.2012.03.010; Chan A, 2001, IMMUNOL CELL BIOL, V79, P35, DOI 10.1046/j.1440-1711.2001.00974.x; FARRELL DJ, 1995, HEPATOLOGY, V22, P1175, DOI 10.1016/0270-9139(95)90627-4; GALLI SJ, 1993, AM J PATHOL, V142, P965; GITTLEN SD, 1990, GUT, V31, P96, DOI 10.1136/gut.31.1.96; Glaser S, 2010, AM J PHYSIOL-GASTR L, V299, pG769, DOI 10.1152/ajpgi.00237.2010; HERZIG DJ, 1975, J PHARMACOL EXP THER, V194, P457; IRANI AA, 1986, P NATL ACAD SCI USA, V83, P4464, DOI 10.1073/pnas.83.12.4464; ISHIZAKA T, 1993, CURR OPIN IMMUNOL, V5, P937, DOI 10.1016/0952-7915(93)90109-6; Islam M A, 2014, Mymensingh Med J, V23, P213; Janssen LJ, 1998, EUR RESPIR J, V12, P50, DOI 10.1183/09031936.98.12010050; Kim HH, 2014, TOXICOL APPL PHARM, V274, P455, DOI 10.1016/j.taap.2013.12.006; Koda W, 2000, LAB INVEST, V80, P1007, DOI 10.1038/labinvest.3780106; Liu De-zhao, 2012, Zhonghua Yi Xue Za Zhi, V92, P2597; Marzioni M, 2005, GASTROENTEROLOGY, V128, P121, DOI 10.1053/j.gastro.2004.10.002; Matsunaga Y, 2000, LIVER, V20, P152, DOI 10.1034/j.1600-0676.2000.020002152.x; Meng FY, 2014, AM J PATHOL, V184, P662, DOI 10.1016/j.ajpath.2013.11.008; Minagawa N, 2007, GASTROENTEROLOGY, V133, P1592, DOI 10.1053/j.gastro.2007.08.020; MURPHY S, 1987, DRUG INTEL CLIN PHAR, V21, P22; Nakamura A, 1997, AM J GASTROENTEROL, V92, P2245; Nemmar A, 2004, CIRCULATION, V110, P1670, DOI 10.1161/01.CIR.0000142053.13921.21; Park SM, 2012, GUT LIVER, V6, P295, DOI 10.5009/gnl.2012.6.3.295; PATELLA V, 1995, J IMMUNOL, V154, P2855; ROSENTHA.J, 1965, P NATL ACAD SCI USA, V54, P152, DOI 10.1073/pnas.54.1.152; RUTENBUR.AM, 1969, J HISTOCHEM CYTOCHEM, V17, P517; Schaefer B, 2012, PEDIATR NEPHROL, V27, P829, DOI 10.1007/s00467-011-2058-8; Shiohara M, 2005, CHEM IMMUNOL ALLERGY, V87, P1; Stoyanova Irina Ivanova, 2004, Rom J Gastroenterol, V13, P203; Traver E, 2010, NEUROGASTROENT MOTIL, V22, pE34, DOI 10.1111/j.1365-2982.2009.01377.x; Vessal G, 2010, NEPHROL DIAL TRANSPL, V25, P1541, DOI 10.1093/ndt/gfp628; Volcheck GW, 1998, POSTGRAD MED, V104, P127; Xue J.L., 2010, CURR PROTOC MICROBIO; Yamashiro M, 1998, VIRCHOWS ARCH, V433, P471, DOI 10.1007/s004280050276	62	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	DEC	2014	94	12					1406	1418		10.1038/labinvest.2014.129		13	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	AU4AT	WOS:000345552200008		
J	Leydon, C; Imaizumi, M; Yang, D; Thibeault, SL; Fried, MP				Leydon, Ciara; Imaizumi, Mitsuyoshi; Yang, David; Thibeault, Susan L.; Fried, Marvin P.			Structural and Functional Vocal Fold Epithelial Integrity Following Injury	LARYNGOSCOPE			English	Article						Vocal fold; surgery; epithelium; basement membrane; permeability	BASEMENT-MEMBRANE ZONE; LARYNGOPHARYNGEAL REFLUX; BENIGN LESIONS; MODEL; LARYNX; REGENERATION; DEFENSES; DISEASE; MUCOSA; PEPSIN	Objectives/HypothesisAn intact epithelium is an important part of vocal fold defense. Damage to the epithelium can compromise vocal fold homeostasis and protection of the host tissue from viral and bacterial invasion. Elucidating the effects of damage on epithelial architectural and barrier integrity provides insight into the role of epithelium in protecting vocal folds. Using an animal model, we evaluated the time course of structural and functional epithelial restoration following injury. Study DesignProspective, controlled animal study. MethodsForty rats underwent surgery to remove vocal fold mucosa unilaterally. Larynges were harvested at five time intervals between 3 to 90 days postinjury and were prepared for histological and permeability analyses. ResultsRapid restoration of structural integrity was demonstrated by return of a multilayerd epithelium, intercellular junctions, and basement membrane at 5 days postinjury. Atypical epithelial permeability was observed up to 5 weeks postinjury. ConclusionRestoration of epithelial barrier integrity lags epithelial structural restoration. Consequently, epithelial regeneration cannot be equated with return of functional barrier integrity. Rather, ongoing leakiness of regenerated epithelium indicates that vocal folds remain at risk for damage, pathogen invasion, and remodeling postinjury. Level of EvidenceN/A. Laryngoscope, 124:2764-2769, 2014	[Leydon, Ciara; Thibeault, Susan L.] Univ Wisconsin, Dept Surg, Div Otolaryngol Head & Neck Surg, Madison, WI 53705 USA; [Yang, David] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53705 USA; [Fried, Marvin P.] Albert Einstein Coll Med, Dept Otolaryngol Head & Neck Surg, Bronx, NY USA; [Fried, Marvin P.] Montefiore Med Ctr, Bronx, NY 10467 USA; [Imaizumi, Mitsuyoshi] Fukushima Med Univ, Dept Otolaryngol, Fukushima, Japan	Leydon, C (reprint author), Univ Wisconsin, 5105 WIMR,1111 Highland Ave, Madison, WI 53705 USA.	leydon@surgery.wisc.edu			American Laryngological Voice Research and Education Foundation (ALVRE); National Institutes of Health (NIH) [NIDCD R03 DC011355, R01 DC012773]	This work was supported by grants from the American Laryngological Voice Research and Education Foundation (ALVRE) (M.P.F.) and National Institutes of Health (NIH) (NIDCD R03 DC011355 (C.L.) and R01 DC012773 (C.L., S.L.T.)). The authors have no other funding, financial relationships, or conflicts of interest to disclose.	Ling CY, 2010, WOUND REPAIR REGEN, V18, P89, DOI 10.1111/j.1524-475X.2009.00550.x; Dupuit F, 2000, AM J PHYSIOL-LUNG C, V278, pL165; KOTBY MN, 1988, ACTA OTO-LARYNGOL, V105, P477, DOI 10.3109/00016488809119505; Branski RC, 2005, ANN OTO RHINOL LARYN, V114, P19; Puchelle Edith, 2006, Proc Am Thorac Soc, V3, P726, DOI 10.1513/pats.200605-126SF; Myer L, 2005, LANCET INFECT DIS, V5, P786, DOI 10.1016/S1473-3099(05)70298-X; Roh JL, 2006, ARCH OTOLARYNGOL, V132, P995, DOI 10.1001/archotol.132.9.995; Thibeault SL, 2002, J VOICE, V16, P96, DOI 10.1016/S0892-1997(02)00078-4; Doorbar J, 2005, J CLIN VIROL, V32, pS7, DOI 10.1016/j.jcv.2004.12.006; Cho SH, 2000, ANN OTO RHINOL LARYN, V109, P658; DesBentzmann S, 2000, LAB INVEST, V80, P209; DIKKERS FG, 1993, ACTA OTO-LARYNGOL, V113, P98, DOI 10.3109/00016489309135774; DIKKERS FG, 1995, ANN OTO RHINOL LARYN, V104, P698; Erickson E, 2010, LARYNGOSCOPE, V120, P1569, DOI 10.1002/lary.20983; Zhang QR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034017; Fisher KV, 2001, J APPL PHYSIOL, V91, P1401; Gill GA, 2005, ANN OTO RHINOL LARYN, V114, P913; Gill GA, 2005, J CLIN PATHOL, V58, P1265, DOI 10.1136/jcp.2004.016972; Isik ACU, 2004, J OTOLARYNGOL, V33, P382; Johnston N, 2003, ANN OTO RHINOL LARYN, V112, P481; Levendoski EE, 2014, J SPEECH LANG HEAR R, V57, P1679, DOI 10.1044/2014_JSLHR-S-13-0283; Martins Regina Helena Garcia, 2009, Braz J Otorhinolaryngol, V75, P116; Pastuszek Piotr, 2003, Polish Journal of Pathology, V54, P61; Plotkowski MC, 1999, AM J RESP CELL MOL, V20, P880; Rousseau B, 2004, ANN OTO RHINOL LARYN, V113, P767; Schneider B, 2002, ORL J OTO-RHINO-LARY, V64, P324, DOI 10.1159/000066086; SHIN T, 1994, EUR ARCH OTO-RHINO-L, V251, P67; Suzuki T, 2002, ANN OTO RHINOL LARYN, V111, P684; WOO P, 1994, LARYNGOSCOPE, V104, P1084	29	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	DEC	2014	124	12					2764	2769		10.1002/lary.24818		6	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	AU0WZ	WOS:000345344200026		
J	Hiwatashi, N; Hirano, S; Mizuta, M; Tateya, I; Kanemaru, S; Nakamura, T; Ito, J				Hiwatashi, Nao; Hirano, Shigeru; Mizuta, Masanobu; Tateya, Ichiro; Kanemaru, Shin-ichi; Nakamura, Tatsuo; Ito, Juichi			Adipose-Derived Stem Cells Versus Bone Marrow-Derived Stem Cells for Vocal Fold Regeneration	LARYNGOSCOPE			English	Article						Mesenchymal stromal cell; vocal fold scarring; adipose tissue; bone marrow; wound healing; extracellular matrix	FIBROBLAST-GROWTH-FACTOR; STROMAL CELLS; HISTOLOGIC CHARACTERIZATION; HYALURONIC-ACID; TISSUE; SCAR; INJECTION; COLLAGEN	Objectives/HypothesisVocal fold scarring presents therapeutic challenges. Recently, cell therapy with mesenchymal stromal cells has become a promising approach. The aim of this study was to compare the therapeutic potential of adipose-derived stem cells (ASC) with bone marrow-derived stem cells (BMSC) for vocal fold regeneration. Study DesignProspective animal experiments with controls. MethodsThe vocal folds of Sprague-Dawley rats were unilaterally injured. Two months after injury, rats were treated with a local injection of ASC (ASC group), BMSC (BMSC group), or saline (sham-treated group). The GFP-labeled ASC and BMSC were extracted from CAG-EGFP rats. Larynges were harvested for histological and immunohistochemical examinations 1 and 3 months posttransplantation and for quantitative real-time polymerase chain reaction (PCR) 1 month posttransplantation. ResultsAfter 1 month, no surviving cells from the transplant were detected. Histological examination showed significantly increased hyaluronic acid (HA) and decreased dense collagen deposition in both ASC and BMSC groups compared to shams 1 and 3 months after treatment. Real-time PCR revealed that hyaluronan synthase 1 (Has1) and Has2 were upregulated in only the ASC group compared with the sham-treated group. Fibroblast growth factor 2 (basic) (Fgf2), hepatocyte growth factor (Hgf) and Has3 were upregulated in both cell transplantation groups. ASC seemed to upregulate Hgf more than did BMSC. ConclusionsThe regenerative effects of ASC and BMSC transplantation were found to be similar for the restoration. It is suggested that ASC might have more potential because of better recovery of HA, a superior antifibrotic effect, and the upregulation of Hgf. Level of EvidenceN/A. Laryngoscope, 124:E461-E469, 2014	[Hiwatashi, Nao; Hirano, Shigeru; Mizuta, Masanobu; Tateya, Ichiro; Kanemaru, Shin-ichi; Ito, Juichi] Kyoto Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Kyoto 6068507, Japan; [Nakamura, Tatsuo] Kyoto Univ, Inst Frontier Med Sci, Dept Bioartificial Organs, Kyoto 6068507, Japan; [Kanemaru, Shin-ichi] Kitano Hosp, Tazuke Kofukai Med Res Inst, Dept Otolaryngol Head & Neck Surg, Osaka, Japan; [Kanemaru, Shin-ichi] Fdn Biomed Res & Innovat, Dept Regenerat Treatment Tympan Membrane, Dept Otolaryngol, Kobe, Hyogo, Japan; [Mizuta, Masanobu] Vanderbilt Univ, Dept Otolaryngol, Nashville, TN 37235 USA	Hirano, S (reprint author), Kyoto Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan.	hirano@ent.kuhp.kyoto-u.ac.jp			Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO)	This study was supported by the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO). The authors have no other funding, financial relationships, or conflicts of interest to disclose.	MCGEE GS, 1988, J SURG RES, V45, P145, DOI 10.1016/0022-4804(88)90034-0; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762; Matsumoto K, 1997, BIOCHEM BIOPH RES CO, V239, P639, DOI 10.1006/bbrc.1997.7517; Chan RW, 2001, OTOLARYNG HEAD NECK, V124, P607, DOI 10.1067/mhn.2001.115906; Gray SD, 2000, ANN OTO RHINOL LARYN, V109, P77; Rousseau B, 2003, LARYNGOSCOPE, V113, P620, DOI 10.1097/00005537-200304000-00007; Svensson B, 2011, LARYNGOSCOPE, V121, P2185, DOI 10.1002/lary.22143; Kahan BD, 2003, NAT REV IMMUNOL, V3, P831, DOI 10.1038/nri1204; Sataloff RT, 1997, J VOICE, V11, P238; Romanov YA, 2003, STEM CELLS, V21, P105, DOI 10.1634/stemcells.21-1-105; Suehiro A, 2010, ANN OTO RHINOL LARYN, V119, P690; Hirano S, 2009, J VOICE, V23, P399, DOI 10.1016/j.jvoice.2007.12.002; Kanemaru SI, 2003, ANN OTO RHINOL LARYN, V112, P915; Remacle M, 2000, ANN OTO RHINOL LARYN, V109, P141; HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3; Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Liechty KW, 2000, NAT MED, V6, P1282; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; Hertegard S, 2006, LARYNGOSCOPE, V116, P1248, DOI 10.1097/01.mlg.0000224548.68499.35; Friedrich G, 2013, EUR ARCH OTO-RHINO-L, V270, P2491, DOI 10.1007/s00405-013-2498-9; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Lee BJ, 2006, CELLS TISSUES ORGANS, V184, P198, DOI 10.1159/000099627; Xu W, 2011, ANN OTO RHINOL LARYN, V120, P123; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Kanemaru S, 2005, ANN OTO RHINOL LARYN, V114, P907; Kishimoto Y, 2010, LARYNGOSCOPE, V120, P108, DOI 10.1002/lary.20642; Kumai Y, 2010, LARYNGOSCOPE, V120, P330, DOI 10.1002/lary.20753; LesBlanc K., 2003, CYTOTHERAPY, V5, P485; Ohno S, 2012, LARYNGOSCOPE, V122, P2503, DOI 10.1002/lary.23543; Tateya T, 2005, ANN OTO RHINOL LARYN, V114, P183; Tsunoda Koichi, 2005, Laryngoscope, V115, P1, DOI 10.1097/01.mlg.0000183966.72921.31	35	1	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	DEC	2014	124	12					E461	E469		10.1002/lary.24816		9	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	AU0WZ	WOS:000345344200003		
J	Yao, WP; Li, BW; Cao, LH; Zheng, FL; Huang, TW; Xiao, CZ; Skoric, MM				Yao, Weipeng; Li, Baiwen; Cao, Lihua; Zheng, Fanglan; Huang, Taiwu; Xiao, Chengzhuo; Skoric, Milos M.			Generation of monoenergetic proton beams by a combined scheme with an overdense hydrocarbon target and an underdense plasma gas irradiated by ultra-intense laser pulse	LASER AND PARTICLE BEAMS			English	Article						Combined acceleration mechanism; Hydrocarbon target; Optimized injection process; Particle-in-cell; Proton acceleration	SOLIDS	An optimization scheme for the generation of monoenergetic proton beams by using an overdense hydrocarbon target, followed by an underdense plasma gas, irradiated by an ultra-intense laser pulse is presented. The scheme is based on a combination of a radiation pressure acceleration mechanism and a laser wakefield acceleration mechanism, and is verified by one-dimensional relativistic particle-in-cell (1D PIC) simulations. As compared to the pure hydrogen (H) target, protons in the hydrocarbon target can be pre-accelerated to higher energy and compressed in space due to the existence of the heavy carbon atoms, which provides a better injection process for the successive laser wakefield acceleration in the underdense plasma gas, resulting in the generation of a monoenergetic, tens-of-GeV proton beam. Additionally, for the first time, it is found that the use of the hydrocarbon target can reduce the requirement for laser intensity to generate proton beams with the same energy in this combined scheme, as compared to the use of the pure H target.	[Yao, Weipeng] China Acad Engn Phys, Grad Sch, Beijing, Peoples R China; [Li, Baiwen; Cao, Lihua] Inst Appl Phys & Computat Math, Beijing 100088, Peoples R China; [Cao, Lihua; Zheng, Fanglan; Huang, Taiwu; Xiao, Chengzhuo] Peking Univ, CAPT, Minist Educ, Key Lab HEDP, Beijing 100871, Peoples R China; [Skoric, Milos M.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Li, BW (reprint author), Inst Appl Phys & Computat Math, POB 8009, Beijing 100088, Peoples R China.	li_baiwen@iapcm.ac.cn			NSFC [11475029, 11375032, 11175030]; Science and Technology Foundation of CAEP [2011A0102008]; 973 project [61319403]	The project was sponsored by the NSFC (Grants No. 11475029, No. 11375032, and No. 11175030), the Science and Technology Foundation of CAEP (Grant No. 2011A0102008), and the 973 project (Grant No. 61319403). W. P. Yao would like to thank S. L. Yang and K. Q. Pan for valuable discussions.	Snavely RA, 2000, PHYS REV LETT, V85, P2945, DOI 10.1103/PhysRevLett.85.2945; Borghesi M, 2006, FUSION SCI TECHNOL, V49, P412; Bulanov SV, 2002, PHYS LETT A, V299, P240, DOI 10.1016/S0375-9601(02)00521-2; Robinson APL, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/1/013021; Borghesi M, 2003, REV SCI INSTRUM, V74, P1688, DOI 10.1063/1.1534390; Esirkepov T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.175003; Liu TC, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/2/025026; Zhang XM, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2817087; Clark EL, 2000, PHYS REV LETT, V84, P670, DOI 10.1103/PhysRevLett.84.670; Yan XQ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.135003; Roth M, 2001, PHYS REV LETT, V86, P436, DOI 10.1103/PhysRevLett.86.436; Maksimchuk A, 2000, PHYS REV LETT, V84, P4108, DOI 10.1103/PhysRevLett.84.4108; Brantov AV, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2404928; Chen M, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.3019105; Qiao B, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3577573; Qiao B, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/12/124009; Qiao B, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.145002; SHEARER JW, 1973, PHYS REV A, V8, P1582, DOI 10.1103/PhysRevA.8.1582; Shen BF, 2009, PHYS REV SPEC TOP-AC, V12, DOI 10.1103/PhysRevSTAB.12.121301; Wilks SC, 2001, PHYS PLASMAS, V8, P542, DOI 10.1063/1.1333697; Yu LL, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/045021; Zheng FL, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3684658	22	2	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0263-0346	1469-803X		LASER PART BEAMS	Laser Part. Beams	DEC	2014	32	4					583	589		10.1017/S0263034614000561		7	Physics, Applied	Physics	AU2KP	WOS:000345447500011		
J	Oguri, Y; Kondo, K; Hasegawa, J				Oguri, Y.; Kondo, K.; Hasegawa, J.			Numerical research on the ion-beam-driven hydrodynamic motion of fissile targets for nuclear safety studies	LASER AND PARTICLE BEAMS			English	Article						Equation of state; Fissile material; Heavy-ion stopping power; Hydrodynamic simulation; Nuclear safety assessment	EQUATION-OF-STATE; ENERGY-LOSS; PLASMA TARGET; DENSE MATTER	As a method to evaluate high-temperature equation of state (EOS) data of fissile materials precisely and safely, we numerically examined an experimental setup based on a sub-range fissile target and a high-intensity shortpulsed heavy-ion beam. As an example, we calculated one-dimensional hydrodynamic motion of a uranium target with rho = 0.03 rho(solid) (rho(solid) equivalent to solid density = 19.05 g/cm(3)) induced by a pulsed Na-23(+) beam with a duration of 2 ns and a peak power of 5 GW/mm(2). The projectile stopping power was calculated using a density-and temperature-dependent dielectric response function. To heat the target uniformly, we optimized the experimental condition so that the energy deposition could occur almost at the top of the Bragg peak. The energy deposition inhomogeneity could be reduced to +/- 5% by adjusting the incident energy and the target thickness to be 2.02 MeV/u and 180 mu m, respectively. The target could be heated homogeneously up to kT = 7 eV well before the arrival of the rarefaction waves at the center of the target. In principle, the EOS data can be evaluated by iteratively adjusting the data embedded in the hydro code until the measured hydrodynamic motion is reproduced by the calculation. This method is consistent with the conditions of nuclear nonproliferation, because a very small amount of fissile material is enough to perform the experiment, and no shock compression occurs in the target.	[Oguri, Y.; Kondo, K.] Tokyo Inst Technol, Nucl Reactors Res Lab, Tokyo 1528550, Japan; [Hasegawa, J.] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Atsugi, Kanagawa, Japan	Oguri, Y (reprint author), Tokyo Inst Technol, Nucl Reactors Res Lab, Meguro Ku, Ookayama 2-12-1, Tokyo 1528550, Japan.	yoguri@nr.titech.ac.jp					Grisham LR, 2004, PHYS PLASMAS, V11, P5727, DOI 10.1063/1.1806137; HOFFMANN DHH, 1990, PHYS REV A, V42, P2313, DOI 10.1103/PhysRevA.42.2313; MORE RM, 1988, PHYS FLUIDS, V31, P3059, DOI 10.1063/1.866963; Lomonosov IV, 2007, LASER PART BEAMS, V25, P567, DOI 10.1017/S0263034607000687; Iosilevskiy I, 2005, J NUCL MATER, V344, P30, DOI 10.1016/j.jnucmat.2005.04.011; RAGAN CE, 1982, PHYS REV A, V25, P3360, DOI 10.1103/PhysRevA.25.3360; Belyaev G, 1996, PHYS REV E, V53, P2701, DOI 10.1103/PhysRevE.53.2701; Hasegawa J, 2001, NUCL INSTRUM METH A, V464, P237, DOI 10.1016/S0168-9002(01)00040-7; Oguri Y, 2014, NUCL INSTRUM METH A, V733, P4, DOI 10.1016/j.nima.2013.05.104; Armijo J, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051507; Hoffmann DHH, 2002, PHYS PLASMAS, V9, P3651, DOI 10.1063/1.1498260; ARISTA NR, 1984, PHYS REV A, V29, P1471, DOI 10.1103/PhysRevA.29.1471; Morita K, 1998, NUCL ENG DES, V183, P177, DOI 10.1016/S0029-5493(98)00175-7; Sakumi A, 2001, NUCL INSTRUM METH A, V464, P231, DOI 10.1016/S0168-9002(01)00039-0; Barnard JJ, 2007, NUCL INSTRUM METH A, V577, P275, DOI 10.1016/j.nima.2007.02.062; Pflieger R, 2011, J APPL PHYS, V109, DOI 10.1063/1.3533439; Buddemeier BR, 2011, LLNLTR512111; Committee on High Energy Density Plasma Physics of the National Research Council, 2003, FRONT HIGH EN DENS P; Friedman A, 2013, LLNLTR627254; GARDES D, 1992, PHYS REV A, V46, P5101, DOI 10.1103/PhysRevA.46.5101; Gnanadhas L, 2011, NUCL ENG DES, V241, P3839, DOI 10.1016/j.nucengdes.2011.06.054; Heller A., 2004, SCI TECHNOL REV, P4; Hofmann P.L., 1970, LECTURE SERIES FAST, VII; Iosilevskiy I., 2002, ARXIV10054192; Logan B.G., 2004, UCRLTR208767 LAWR LI; Lyon S. P., 1992, LAUR923407; Medalia J., 2013, COMPREHENSIVE NUCL T; RAMIS R, 1988, COMPUT PHYS COMMUN, V49, P475, DOI 10.1016/0010-4655(88)90008-2; Ronchi C, 2004, EQUATION STATE URANI; Roy P K, 2005, PHYS REV LETT, V95; Salzmann D., 1998, ATOMIC PHYS HOT PLAS; Seidl PA, 2013, PHYS REV SPEC TOP-AC, V16, DOI 10.1103/PhysRevSTAB.16.024701; Tahir NA, 2009, LASER PART BEAMS, V27, P9, DOI 10.1017/S0263034609000020	33	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0263-0346	1469-803X		LASER PART BEAMS	Laser Part. Beams	DEC	2014	32	4					665	670		10.1017/S0263034614000706		6	Physics, Applied	Physics	AU2KP	WOS:000345447500021		
J	Kawai, H; Matsushita, H; Suzuki, R; Sheng, Y; Lu, J; Matsuzawa, H; Yahata, T; Tsuma-Kaneko, M; Tsukamoto, H; Kawada, H; Ogawa, Y; Ando, K				Kawai, Hidetsugu; Matsushita, Hiromichi; Suzuki, Rikio; Sheng, Yin; Lu, Jun; Matsuzawa, Hideyuki; Yahata, Takashi; Tsuma-Kaneko, Mitsuyo; Tsukamoto, Hideo; Kawada, Hiroshi; Ogawa, Yoshiaki; Ando, Kiyoshi			Functional analysis of the SEPT9-ABL1 chimeric fusion gene derived from T-prolymphocytic leukemia	LEUKEMIA RESEARCH			English	Article						SEPT9-ABL1; ABL1 fusion gene; Tyrosine kinase inhibitors	ACUTE LYMPHOBLASTIC-LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; TYROSINE KINASE INHIBITORS; SEPTIN GENE; BCR-ABL; C-ABL; EXPRESSION; FAMILY; CANCER; TUMORS	We analyzed the function of a SEPT9-ABL1 fusion identified in a case of T-prolymphocytic leukemia with tyrosine kinase inhibitor (TKI) resistance. Five isoforms with different N-termini, including SEPT9a-ABL1, SEPT9b-ABL1, SEPT9d-ABL1, SEPT9e-ABL1 and SEPT9f-ABL1, were detected in the leukemic cells. All isoforms except SEPT9d-ABL1 are localized in the cytoplasm, undergo autophosphorylation and phosphorylate the downstream targets, STAT-5 and Crkl, and provided IL-3-independence and in vivo invasiveness to 32D cells. Additionally, these SEPT9-ABL1 isoforms were resistant to TKIs in vitro and in vivo, in comparison to BCR-ABL1. These findings demonstrated that SEPT9-ABL1 had oncogenic activity and conferred resistance to TKIs. (C) 2014 Elsevier Ltd. All rights reserved.	[Kawai, Hidetsugu; Matsushita, Hiromichi; Sheng, Yin; Lu, Jun; Yahata, Takashi; Tsuma-Kaneko, Mitsuyo; Kawada, Hiroshi; Ando, Kiyoshi] Tokai Univ, Sch Med, Res Ctr Canc Stem Cell, Isehara, Kanagawa 2591193, Japan; [Kawai, Hidetsugu; Tsuma-Kaneko, Mitsuyo; Kawada, Hiroshi; Ogawa, Yoshiaki; Ando, Kiyoshi] Tokai Univ, Sch Med, Dept Hematol Oncol, Isehara, Kanagawa 2591193, Japan; [Matsushita, Hiromichi] Tokai Univ, Sch Med, Dept Lab Med, Isehara, Kanagawa 2591193, Japan; [Matsuzawa, Hideyuki; Tsukamoto, Hideo] Tokai Univ, Sch Med, Support Ctr Med Res & Educ, Isehara, Kanagawa 2591193, Japan; [Matsushita, Hiromichi; Ando, Kiyoshi] Tokai Univ, Inst Med Res, Isehara, Kanagawa 2591193, Japan	Matsushita, H (reprint author), Tokai Univ, Sch Med, Dept Lab Med, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	hmatsu@is.icc.u-tokai.ac.jp; andok@keyaki.cc.u-tokai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24390248, 24591411]; Tokai University School of Medicine Project Research in Japan	We thank Dr. Warren S. Pear (University of Pennsylvania) for providing the MIGR1 retroviral vector, Dr. Toshio Kitamura (The University of Tokyo) for providing the PLAT-gp packaging cells, and Ms. Akemi Kamijo, Ms. Katsuko Naito, Ms. Yoshiko Ito and Mr. Masayuki Tanaka (Biological Science Support Center, Tokai University) for their professional technical assistance. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Nos. 24390248 and 24591411), Tokai University School of Medicine Project Research in Japan.	Amir Sharon, 2007, Cancer Biol Ther, V6, P1926; Montagna C, 2003, CANCER RES, V63, P2179; Vigneri P, 2001, NAT MED, V7, P228, DOI 10.1038/84683; Connolly D, 2011, BIOL CHEM, V392, P725, DOI 10.1515/BC.2011.073; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; MCWHIRTER JR, 1991, MOL CELL BIOL, V11, P1553; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Chacko AD, 2012, CELL ONCOL, V35, P85, DOI 10.1007/s13402-011-0066-0; Quintas-Cardama A, 2008, LEUKEMIA, V22, P1117, DOI 10.1038/leu.2008.80; Luo FR, 2006, CLIN CANCER RES, V12, P7180, DOI 10.1158/1078-0432.CCR-06-1112; Scott M, 2006, INT J CANCER, V118, P1325, DOI 10.1002/ijc.21486; Pear WS, 1998, BLOOD, V92, P3780; Warsch W, 2012, ONCOTARGET, V3, P1669; Cilloni D, 2012, CLIN CANCER RES, V18, P930, DOI 10.1158/1078-0432.CCR-10-1613; Graux C, 2004, NAT GENET, V36, P1084, DOI 10.1038/ng1425; Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; Feller SM, 1998, J CELL PHYSIOL, V177, P535, DOI 10.1002/(SICI)1097-4652(199812)177:4<535::AID-JCP5>3.0.CO;2-E; Harada Y, 2013, BLOOD, V121, P3434, DOI 10.1182/blood-2012-06-434423; Quintas-Cardama A, 2009, BLOOD, V113, P1619, DOI 10.1182/blood-2008-03-144790; Golan M, 2013, CELL CYCLE, V12, P2297, DOI 10.4161/cc.25379; Gonzalez ME, 2009, CELL SIGNAL, V21, P477, DOI 10.1016/j.cellsig.2008.11.007; Tomita O, 2014, LEUKEMIA RES, V38, P361, DOI 10.1016/j.leukres.2013.11.017; Burrows JF, 2003, J PATHOL, V201, P581, DOI 10.1002/path.1484; Cerveira N, 2011, BIOL CHEM, V392, P713, DOI 10.1515/BC.2011.072; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Connolly D, 2014, BIOL CHEM, V395, P157, DOI 10.1515/hsz-2013-0247; De Braekeleer E, 2011, EUR J HAEMATOL, V86, P361, DOI 10.1111/j.1600-0609.2011.01586.x; Deenik W, 2009, LEUKEMIA, V23, P627, DOI 10.1038/leu.2008.318; De Keersmaecker K, 2005, BLOOD, V105, P4849, DOI 10.1182/blood-2004-12-4897; Dietrich D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084225; Gancheva K, 2013, MOL CYTOGENET, V6, DOI 10.1186/1755-8166-6-39; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Landsverk ML, 2009, HUM MOL GENET, V18, P1200, DOI 10.1093/hmg/ddp014; Mustjoki S, 2009, HAEMATOL-HEMATOL J, V94, P1469, DOI 10.3324/haematol.2009.008094; Peterson EA, 2007, MAMM GENOME, V18, P796, DOI 10.1007/s00335-007-9065-x; Russell SEH, 2000, CANCER RES, V60, P4729; Scott M, 2005, ONCOGENE, V24, P4688, DOI 10.1038/sj.onc.1208574; Soverini S, 2011, ONCOLOGIST, V16, P868, DOI 10.1634/theoncologist.2010-0388; Suzuki Rikio, 2014, Leuk Res Rep, V3, P54, DOI 10.1016/j.lrr.2014.06.004; Warsch W, 2013, CELL CYCLE, V12, P1813, DOI 10.4161/cc.25116; Wasserkort R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-398	41	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2126			LEUKEMIA RES	Leuk. Res.	DEC	2014	38	12					1451	1459		10.1016/j.leukres.2014.08.015		9	Oncology; Hematology	Oncology; Hematology	AU4YN	WOS:000345614400013		
J	Yamazaki, T; Kadokura, M; Mutoh, Y; Sakamoto, T; Okazaki, M; Mitsumoto, A; Kawashima, Y; Kudo, N				Yamazaki, Tohru; Kadokura, Makiko; Mutoh, Yuki; Sakamoto, Takeshi; Okazaki, Mari; Mitsumoto, Atsushi; Kawashima, Yoichi; Kudo, Naomi			Inducing Effect of Clofibric Acid on Stearoyl-CoA Desaturase in Intestinal Mucosa of Rats	LIPIDS			English	Article						Stearoyl-CoA desaturase; Clofibric acid; Intestinal mucosa; Rat	PEROXISOMAL BETA-OXIDATION; MICROSOMAL 1-ACYLGLYCEROPHOSPHOCHOLINE ACYLTRANSFERASE; PROLIFERATOR-ACTIVATED RECEPTORS; ADIPOSE TRIGLYCERIDE LIPASE; CIS-VACCENIC ACID; GENE-EXPRESSION; BINDING-PROTEIN; CHAIN ELONGATION; UP-REGULATION; FATTY-ACIDS	Fibrates have been reported to elevate the hepatic proportion of oleic acid (18:1n-9) through inducing stearoyl-CoA desaturase (SCD). Despite abundant studies on the regulation of SCD in the liver, little is known about this issue in the small intestine. The present study aimed to investigate the effect of clofibric acid on the fatty acid profile, particularly monounsaturated fatty acids (MUFA), and the SCD expression in intestinal mucosa. Treatment of rats with a diet containing 0.5 % (w/w) clofibric acid for 7 days changed the MUFA profile of total lipids in intestinal mucosa; the proportion of 18:1n-9 was significantly increased, whereas those of palmitoleic (16:1n-7) and cis-vaccenic (18:1n-7) acids were not changed. Upon the treatment with clofibric acid, SCD was induced and the gene expression of SCD1, SCD2, and fatty acid elongase (Elovl) 6 was up-regulated, but that of Elovl5 was unaffected. Fat-free diet feeding for 28 days increased the proportions of 16:1n-7 and 18:1n-7, but did not effectively change that of 18:1n-9, in intestinal mucosa. Fat-free diet feeding up-regulated the gene expression of SCD1, but not that of SCD2, Elovl6, or Elovl5. These results indicate that intestinal mucosa significantly changes its MUFA profile in response to challenges by clofibric acid and a fat-free diet and suggest that up-regulation of the gene expression of SCD along with Elovl6 is indispensable to elevate the proportion of 18:1n-9 in intestinal mucosa.	[Yamazaki, Tohru; Kadokura, Makiko; Mutoh, Yuki; Sakamoto, Takeshi; Okazaki, Mari; Kawashima, Yoichi; Kudo, Naomi] Josai Univ, Sch Pharmaceut Sci, Sakado, Saitama 3500295, Japan; [Mitsumoto, Atsushi] Josai Int Univ, Fac Pharmaceut Sci, Togane, Chiba 2838555, Japan	Kawashima, Y (reprint author), Josai Univ, Sch Pharmaceut Sci, 1-1 Keyakidai, Sakado, Saitama 3500295, Japan.	ykawash@josai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was partially supported by a Grant-in-Aid for Scientific Research from Ministry of Education, Culture, Sports, Science and Technology of Japan.	MARSH JB, 1962, BIOCHIM BIOPHYS ACTA, V60, P320, DOI 10.1016/0006-3002(62)90407-9; Tripathy S, 2013, J LIPID RES, V54, P71, DOI 10.1194/jlr.M028787; Jump DB, 2008, CURR OPIN LIPIDOL, V19, P242, DOI 10.1097/MOL.0b013e3282ffaf6a; Tabor DE, 1999, J BIOL CHEM, V274, P20603, DOI 10.1074/jbc.274.29.20603; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; Marx N, 2004, CIRC RES, V94, P1168, DOI 10.1161/01.RES.0000127122.22685.0A; Obrowsky S, 2013, J LIPID RES, V54, P425, DOI 10.1194/jlr.M031716; Ling PR, 2010, PROSTAG LEUKOTR ESS, V83, P229, DOI 10.1016/j.plefa.2010.07.004; Hodson L, 2013, PROG LIPID RES, V52, P15, DOI 10.1016/j.plipres.2012.08.002; Braun A, 2009, INFLAMM BOWEL DIS, V15, P1705, DOI 10.1002/ibd.20993; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; KAWASHIMA Y, 1983, BIOCHIM BIOPHYS ACTA, V754, P21, DOI 10.1016/0005-2760(83)90077-2; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Marks KA, 2013, GENES NUTR, V8, P317, DOI 10.1007/s12263-012-0325-3; NTAMBI JM, 1992, J BIOL CHEM, V267, P10925; Block R, 2012, PROSTAG LEUKOTR ESS, V86, P175, DOI 10.1016/j.plefa.2012.02.009; Uchida A, 2011, BBA-MOL CELL BIOL L, V1811, P170, DOI 10.1016/j.bbalip.2010.12.011; Miller CW, 1996, P NATL ACAD SCI USA, V93, P9443, DOI 10.1073/pnas.93.18.9443; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Brown JD, 2007, CIRCULATION, V115, P518, DOI 10.1161/CIRCULATIONAHA.104.475673; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Staels B, 1998, CIRCULATION, V98, P2088; Kota BP, 2005, PHARMACOL RES, V51, P85, DOI 10.1016/j.phrs.2004.07.012; CATALA A, 1986, ACTA PHYSIOL PHARM L, V36, P19; CHRISTIANSEN EN, 1986, BIOCHEM J, V237, P293; Ehehalt R, 2004, BBA-MOL CELL BIOL L, V1682, P63, DOI 10.1016/j.bbalip.2004.01.009; Ferrer R, 2010, BIOCHEM PHARMACOL, V80, P431, DOI 10.1016/j.bcp.2010.04.033; GARG ML, 1988, BIOCHIM BIOPHYS ACTA, V958, P139, DOI 10.1016/0005-2760(88)90256-1; Guillou H, 2002, LIPIDS, V37, P981, DOI 10.1007/s11745-006-0990-3; Hebbachi AM, 2008, J BIOL CHEM, V283, P4866, DOI 10.1074/jbc.M709471200; Hirose A, 2011, J PHARMACOL SCI, V116, P362, DOI 10.1254/jphs.11020FP; Karahashi M, 2013, J PHARMACOL SCI, V123, P356, DOI 10.1254/jphs.13149FP; Karahashi M, 2013, LIPIDS, V48, P457, DOI 10.1007/s11745-013-3786-2; KATOH H, 1987, BIOCHIM BIOPHYS ACTA, V920, P171; KAWASHIMA Y, 1985, BIOCHIM BIOPHYS ACTA, V837, P222; KAWASHIMA Y, 1986, BIOCHIM BIOPHYS ACTA, V875, P549; KAWASHIMA Y, 1982, BIOCHIM BIOPHYS ACTA, V713, P622; KAWASHIMA Y, 1989, BIOCHIM BIOPHYS ACTA, V1005, P123, DOI 10.1016/0005-2760(89)90177-X; KAWASHIMA Y, 1990, J BIOL CHEM, V265, P9170; KAWASHIMA Y, 1985, TOXICOL APPL PHARM, V78, P363, DOI 10.1016/0041-008X(85)90241-8; KAWASHIMA Y, 1989, BIOCHIM BIOPHYS ACTA, V1006, P214, DOI 10.1016/0005-2760(89)90199-9; Kimura R, 2011, BIOCHEM BIOPH RES CO, V410, P1, DOI 10.1016/j.bbrc.2011.05.057; Kudo N, 2003, LIPIDS, V38, P531, DOI 10.1007/s11745-003-1338-8; MIHARA K, 1990, J BIOCHEM-TOKYO, V108, P1022; Murase T, 2001, BBA-MOL CELL BIOL L, V1530, P15, DOI 10.1016/S1388-1981(00)00162-1; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; SHIMAKAT.T, 1972, J BIOCHEM-TOKYO, V72, P1163; STRITTMA.P, 1974, P NATL ACAD SCI USA, V71, P4565, DOI 10.1073/pnas.71.11.4565; Toyama T, 2007, J PHARMACOL SCI, V103, P383, DOI 10.1254/jphs.FP0061124; ULLMAN D, 1971, BIOCHIM BIOPHYS ACTA, V248, P61, DOI 10.1016/0005-2760(71)90075-0; Valasek MA, 2007, J LIPID RES, V48, P2725, DOI 10.1194/jlr.M700345-JLR200; Yamazaki T, 2012, BIOL PHARM BULL, V35, P116; Yamazaki T, 2012, BIOL PHARM BULL, V35, P1509	56	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0024-4201	1558-9307		LIPIDS	Lipids	DEC	2014	49	12					1203	1214		10.1007/s11745-014-3965-9		12	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	AU2BX	WOS:000345422100003		
J	Yamashita, S; Abe, A; Nakagawa, K; Kinoshita, M; Miyazawa, T				Yamashita, Shinji; Abe, Akihiro; Nakagawa, Kiyotaka; Kinoshita, Mikio; Miyazawa, Teruo			Separation and Detection of Plasmalogen in Marine Invertebrates by High-Performance Liquid Chromatography with Evaporative Light-Scattering Detection	LIPIDS			English	Article						HPLC-ELSD; EtnGpl subclass; Plasmalogen; Diradylglycerol; Marine invertebrate; TLC; LC-MS	THIN-LAYER CHROMATOGRAPHY; RAT-BRAIN; QUANTITATIVE DETERMINATION; ETHER PHOSPHOLIPIDS; ALZHEIMER-DISEASE; RAPID SEPARATION; BLOOD-PLASMA; FATTY-ACIDS; LC-MS/MS; ETHANOLAMINE	We have developed a new method for determining ethanolamine plasmalogen contents in marine invertebrates. This quantification method involves derivatization of ethanolamine glycerophospholipid (EtnGpl) subclasses, alkenylacyl (plasmalogen), diacyl, and alkylacyl subclasses, by enzyme treatment and acetylation, followed by separation and detection by high-performance liquid chromatography (HPLC) with evaporative light-scattering detection (ELSD). This method enabled complete separation of the subclasses, and the limit of detection for plasmalogen was 200 ng (260 pmol). The peak area of plasmalogen by ELSD was unaffected by the degree of unsaturated fatty acids in EtnGpl, in contrast to ultraviolet (UV) detection. Thus, this method enables accurate determination of plasmalogen contents in various species containing marine products possessing abundant polyunsaturated fatty acids (PUFA). The method developed here was applied to marine invertebrates available in Japan. The examined marine invertebrates showed a wide range of plasmalogen contents ranging from 19 to 504 mu mol/100 g wet wt. The plasmalogen levels in samples except those of class Cephalopoda and Crustacea were more than 60 mol% of EtnGpl.	[Yamashita, Shinji; Kinoshita, Mikio] Obihiro Univ Agr & Vet Med, Dept Food Sci, Obihiro, Hokkaido 0808555, Japan; [Abe, Akihiro; Nakagawa, Kiyotaka; Miyazawa, Teruo] Tohoku Univ, Grad Sch Agr Sci, Food & Biodynam Chem Lab, Sendai, Miyagi 9818555, Japan; [Miyazawa, Teruo] Tohoku Univ, New Ind Creat Hatchery Ctr NICHe, Food & Biotechnol Innovat Project, Sendai, Miyagi 9800845, Japan	Miyazawa, T (reprint author), Tohoku Univ, Grad Sch Agr Sci, Food & Biodynam Chem Lab, Sendai, Miyagi 9818555, Japan.	miyazawa@m.tohoku.ac.jp					Andre A, 2006, BRAIN RES, V1085, P28, DOI 10.1016/j.brainres.2006.02.067; Sugawara T, 1999, LIPIDS, V34, P1231, DOI 10.1007/s11745-999-0476-3; Zoeller RA, 1999, BIOCHEM J, V338, P769, DOI 10.1042/0264-6021:3380769; Guan ZZ, 1999, J NEUROPATH EXP NEUR, V58, P740, DOI 10.1097/00005072-199907000-00008; CHRISTIE WW, 1985, J LIPID RES, V26, P507; Yamashita S, 2014, J OLEO SCI, V63, P423, DOI 10.5650/jos.ess13188; Kimura T, 2004, J AGR FOOD CHEM, V52, P1415, DOI 10.1021/jf0306901; Ingrand SS, 2000, ANAL BIOCHEM, V280, P65; GOTTFRIED EL, 1962, J BIOL CHEM, V237, P329; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Shoji N, 2010, J LIPID RES, V51, P2445, DOI 10.1194/jlr.D004564; Kraffe E, 2004, LIPIDS, V39, P59, DOI 10.1007/s11745-004-1202-x; Higuchi O, 2006, J LIPID RES, V47, P964, DOI 10.1194/jlr.M500348-JLR200; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; GINSBERG L, 1995, BRAIN RES, V698, P223, DOI 10.1016/0006-8993(95)00931-F; Nakagawa K, 2006, J AGR FOOD CHEM, V54, P2479, DOI 10.1021/jf051823g; BLANK ML, 1992, J NUTR, V122, P1656; Brouwers JFHM, 1999, J LIPID RES, V40, P164; CHAPELLE S, 1987, COMP BIOCHEM PHYS B, V88, P1, DOI 10.1016/0305-0491(87)90068-X; Dembitskii VM, 1976, MAR BIOL, V5, P68; Dembitskii VM, 1979, BIOL MORYA, V5, P86; DEMBITSKY VM, 1988, J CHROMATOGR, V436, P467, DOI 10.1016/S0021-9673(00)94606-5; FOGERTY AC, 1991, INT J FOOD SCI TECH, V26, P363; Folch J, 1957, J BIOL CHEM, V20, P337; Guan ZZ, 2001, ANAL BIOCHEM, V297, P137, DOI 10.1006/abio.2001.5303; HACK MH, 1977, J CHROMATOGR, V135, P229, DOI 10.1016/S0021-9673(00)86326-8; Hara H, 2003, BRIT J NUTR, V90, P29, DOI 10.1079/BJN2003879; HAYASHI A, 1991, BIOCHIM BIOPHYS ACTA, V1083, P179, DOI 10.1016/0005-2760(91)90040-O; Hoffman-Kuczynski B, 2004, NEUROCHEM RES, V29, P843, DOI 10.1023/B:NERE.0000018859.23881.f9; Jeong BY, 1996, LIPIDS, V31, P9, DOI 10.1007/BF02522404; JOSEPH J D, 1982, Progress in Lipid Research, V21, P109, DOI 10.1016/0163-7827(82)90002-9; KATZ I, 1966, J LIPID RES, V7, P170; KEENAN RW, 1968, ANAL BIOCHEM, V23, P555, DOI 10.1016/0003-2697(68)90246-7; LUTZKE BS, 1990, J LIPID RES, V31, P2127; MacPherson JC, 1998, LIPIDS, V33, P931, DOI 10.1007/s11745-998-0290-y; MAHADEVA.V, 1967, J LIPID RES, V8, P2; MEYER H, 1979, BIOCHIM BIOPHYS ACTA, V573, P464, DOI 10.1016/0005-2760(79)90221-2; MORRISON WR, 1964, J LIPID RES, V5, P600; MOSCATELLI EA, 1978, LIPIDS, V13, P294, DOI 10.1007/BF02533674; NAKAGAWA Y, 1982, BIOCHIM BIOPHYS ACTA, V712, P667; NAKAGAWA Y, 1983, J LIPID RES, V24, P1268; Nishimukai M, 2003, LIPIDS, V38, P1227, DOI 10.1007/s11745-003-1183-9; NORTON WT, 1971, J LIPID RES, V12, P84; POCOCK DME, 1969, COMP BIOCHEM PHYSIOL, V30, P133, DOI 10.1016/0010-406X(69)91307-3; PRIES C, 1965, BIOCHIM BIOPHYS ACTA, V98, P329, DOI 10.1016/0005-2760(65)90124-4; RAPPORT MM, 1960, J BIOL CHEM, V235, P1953; RENKONEN O, 1966, BIOCHIM BIOPHYS ACTA, V125, P288, DOI 10.1016/0005-2760(66)90070-1; Sargent JR, 1989, MARINE BIOGENIC LIPI, VI, P175; VASKOVSKY VE, 1975, J CHROMATOGR, V115, P645, DOI 10.1016/S0021-9673(01)98976-9; Wells K, 1995, NEUROCHEM RES, V20, P1329, DOI 10.1007/BF00992508; WELLS MA, 1966, BIOCHEMISTRY-US, V5, P3405, DOI 10.1021/bi00875a004; WELLS MA, 1967, BIOCHEMISTRY-US, V6, P3169, DOI 10.1021/bi00862a026	52	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0024-4201	1558-9307		LIPIDS	Lipids	DEC	2014	49	12					1261	1273		10.1007/s11745-014-3957-9		13	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	AU2BX	WOS:000345422100009		
J	Hammad, A; Kaido, T; Ogawa, K; Fujimoto, Y; Tomiyama, K; Mori, A; Uemura, T; Uemoto, S				Hammad, Ahmed; Kaido, Toshimi; Ogawa, Kohei; Fujimoto, Yasuhiro; Tomiyama, Koji; Mori, Akira; Uemura, Tadahiro; Uemoto, Shinji			Perioperative Changes in Nutritional Parameters and Impact of Graft Size in Patients Undergoing Adult Living Donor Liver Transplantation	LIVER TRANSPLANTATION			English	Article							ENTERAL NUTRITION; DISEASE; METABOLISM; CIRRHOSIS; REGENERATION; SARCOPENIA; STRATEGY; AMMONIA; BARRIER	Derangements of various serum biochemical nutritional/metabolic parameters are common in patients with end-stage liver disease who undergo liver transplantation (LT). The aim of this study was to explain the benefit of LT with respect to parameter changes and to examine the impact of the graft-to-recipient weight ratio (GRWR) on such changes. We investigated each parameter's course in 208 adult recipients for 1 year after living donor LT and analyzed changes in the parameters with a GRWR of 0.8% as the cutoff point. Bonferroni corrections were applied to account for multiple testing. Liver disease-induced high pretransplant ammonia and tyrosine levels and low branched-chain amino acids to tyrosine ratio (BTR) and zinc levels normalized within 2 weeks after transplantation, and the total lymphocyte count (TLC) normalized within 2 months, whereas low pretransplant prealbumin levels took 1 year to normalize. Branched-chain amino acids (BCAA), zinc, and TLC levels transiently dropped shortly after transplantation and then were corrected later. An accelerated recovery of ammonia and tyrosine levels and the BTR were found with larger grafts, especially early after transplantation, whereas zinc, prealbumin, BCAA, and TLC levels recovered regardless of the graft size. In conclusion, graft size had little effect on the recovery of nutritional/metabolic parameters except for ammonia and tyrosine levels. Liver Transpl 20:1486-1496, 2014. (c) 2014 AASLD.	[Hammad, Ahmed; Kaido, Toshimi; Ogawa, Kohei; Fujimoto, Yasuhiro; Tomiyama, Koji; Mori, Akira; Uemura, Tadahiro; Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Div Hepatobiliary Pancreat & Transplant Surg, Dept Surg, Kyoto 6068507, Japan; [Hammad, Ahmed] Mansoura Univ, Dept Surg, Mansoura, Egypt	Kaido, T (reprint author), Kyoto Univ, Grad Sch Med, Div Hepatobiliary Pancreat & Transplant Surg, Dept Surg,Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	kaido@kuhp.kyoto-u.ac.jp					Umeda Y, 2008, TRANSPLANTATION, V86, P673, DOI 10.1097/TP.0b013e318181e02d; Yoshizumi T, 2008, LIVER TRANSPLANT, V14, P1007, DOI 10.1002/lt.21462; Shenkin A, 2006, CLIN CHEM, V52, P2177, DOI 10.1373/clinchem.2006.077412; Iwasaki M, 2004, TRANSPLANTATION, V78, P1501, DOI 10.1097/01.TP.0000140499.23683.0D; Morioka D, 2007, ANN SURG, V245, P315, DOI 10.1097/01.sla.0000236600.24667.a4; Kaido T, 2013, AM J TRANSPLANT, V13, P1549, DOI 10.1111/ajt.12221; Michitaka K, 2010, HEPATOL RES, V40, P393, DOI 10.1111/j.1872-034X.2009.00614.x; Raut V, 2011, SURG TODAY, V41, P317, DOI 10.1007/s00595-010-4437-3; Montano-Loza AJ, 2014, WORLD J GASTROENTERO, V20, P8061, DOI 10.3748/wjg.v20.i25.8061; BLAND JM, 1995, BRIT MED J, V310, P170; Hori T, 2012, CLIN TRANSPLANT, V26, pE324, DOI 10.1111/j.1399-0012.2012.01664.x; Stickel F, 2008, NUTR REV, V66, P47, DOI 10.1111/j.1753-4887.2007.00005.x; Plauth M, 2006, CLIN NUTR, V25, P285, DOI 10.1016/j.clnu.2006.01.018; Holecek M, 2013, NUTRITION, V29, P1186, DOI 10.1016/j.nut.2013.01.022; Yoshida R, 2012, J HEPATO-BIL-PAN SCI, V19, P438, DOI 10.1007/s00534-011-0459-5; Inomata Y, 2000, TRANSPLANTATION, V69, P258, DOI 10.1097/00007890-200001270-00011; Egawa H, 2008, J HEPATO-BILIARY-PAN, V15, P131, DOI 10.1007/s00534-007-1298-2; Goldbecker A, 2010, J CEREBR BLOOD F MET, V30, P1384, DOI 10.1038/jcbfm.2010.22; Humar A, 2004, LIVER TRANSPLANT, V10, P374, DOI 10.1002/lt.20096; Inomata Y, 1996, TRANSPLANTATION, V61, P247, DOI 10.1097/00007890-199601270-00015; KAIDO T, 2010, HEPATO-GASTROENTEROL, V58, P1489; KAIDO T, 2010, HEPATO-GASTROENTEROL, V58, P1522; Kaido T, 2011, TRANSPL P, V43, P2391, DOI 10.1016/j.transproceed.2011.05.037; Marchesini G, 1996, HEPATOLOGY, V23, P1084; Nagai S, 2014, HEPATOLOGY, V59, P35, DOI 10.1002/hep.26536; Peng CJ, 2010, HEPATOB PANCREAT DIS, V9, P135; Pescovitz MD, 1996, CLIN TRANSPLANT, V10, P256; SHANBHOGUE RLK, 1987, METABOLISM, V36, P1047, DOI 10.1016/0026-0495(87)90024-2; Shimomura Y, 2004, HEPATOL RES S, V30S, P3, DOI 10.1016/j.hepres.2004.09.001; Takada Y, 2006, LIVER TRANSPLANT, V12, P912, DOI 10.1002/lt.20642; Tietge UJF, 2003, TRANSPLANT INT, V16, P1, DOI 10.1007/s00147-002-0484-z; Urano E, 2014, HEPATOL RES, V44, P1102, DOI 10.1111/hepr.12263	32	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1527-6465	1527-6473		LIVER TRANSPLANT	Liver Transplant.	DEC	2014	20	12					1486	1496		10.1002/lt.23992		11	Gastroenterology & Hepatology; Surgery; Transplantation	Gastroenterology & Hepatology; Surgery; Transplantation	AU5AN	WOS:000345619600008		
J	Ninomiya, M; Aishima, S; Yoshizumi, T; Ikegami, T; Wang, HL; Harimoto, N; Ito, S; Uchiyama, H; Soejima, Y; Kawanaka, H; Shirabe, K; Maehara, Y				Ninomiya, Mizuki; Aishima, Shinichi; Yoshizumi, Tomoharu; Ikegami, Toru; Wang, Huanlin; Harimoto, Norifumi; Ito, Shinji; Uchiyama, Hideaki; Soejima, Yuji; Kawanaka, Hirofumi; Shirabe, Ken; Maehara, Yoshihiko			Different Histological Sequelae of Immune-Mediated Graft Dysfunction After Interferon Treatment in Transplanted Dual Grafts From Living Donors	LIVER TRANSPLANTATION			English	Letter							HEPATITIS-C; LIVER-TRANSPLANTATION		[Ninomiya, Mizuki; Yoshizumi, Tomoharu; Ikegami, Toru; Harimoto, Norifumi; Ito, Shinji; Kawanaka, Hirofumi; Shirabe, Ken; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan; [Wang, Huanlin] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 8128582, Japan; [Aishima, Shinichi] Saga Univ, Dept Pathol & Microbiol, Saga 840, Japan; [Uchiyama, Hideaki] Fukuoka City Hosp Org, Fukuoka City Hosp, Dept Surg, Fukuoka, Japan; [Soejima, Yuji] Matsuyama Red Cross Hosp, Dept Surg, Matsuyama, Ehime, Japan	Ninomiya, M (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan.	nino-m@surg2.med.kyushu-u.ac.jp					Ikegami T, 2014, J HEPATOL, V60, P894, DOI 10.1016/j.jhep.2013.10.037; Levitsky J, 2012, GASTROENTEROLOGY, V142, P1132; Motomura T, 2011, AM J TRANSPLANT, V11, P1325, DOI 10.1111/j.1600-6143.2011.03537.x; Selzner N, 2011, J HEPATOL, V55, P207, DOI 10.1016/j.jhep.2010.11.012	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1527-6465	1527-6473		LIVER TRANSPLANT	Liver Transplant.	DEC	2014	20	12					1520	1522		10.1002/lt.23996		3	Gastroenterology & Hepatology; Surgery; Transplantation	Gastroenterology & Hepatology; Surgery; Transplantation	AU5AN	WOS:000345619600011		
J	Furuta, T; Yamaguchi, M; Nakagami, R; Akahane, M; Minami, M; Ohtomo, K; Fujii, H				Furuta, Toshihiro; Yamaguchi, Masayuki; Nakagami, Ryutaro; Akahane, Masaaki; Minami, Manabu; Ohtomo, Kuni; Fujii, Hirofumi			Delayed hepatic signal recovery on ferucarbotran-enhanced magnetic resonance images in a rat model with regional liver irradiation	MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE			English	Article						Magnetic resonance imaging; Kupffer cells; Radiation; Rats; SPIO	SUPERPARAMAGNETIC IRON-OXIDE; MR; INJURY; CLEARANCE; PARTICLES	To determine whether superparamagnetic iron oxide (SPIO)-enhanced magnetic resonance (MR) imaging could demonstrate signal recovery delay in irradiated areas of rat livers. We also investigated the relationship between MR imaging and histological findings. Twelve rats received 20 mu mol iron/kg of SPIO followed by X-irradiation to the right upper abdomen 4 h later. Radiation doses were 0, 50 and 70 Gy. Hepatic signals were assessed on unenhanced T (2) (*) -weighted images for up to 7 days using a 9.4-Tesla scanner. The livers were excised on day 7 and examined histologically. Normalized relative signal intensity of 70 Gy-irradiated right liver lobe (2.36 +/- A 0.22) and 50 Gy-irradiated right liver lobe (2.37 +/- A 0.46) was significantly lower than that of the non-irradiated right liver lobe (4.04 +/- A 0.28) on day 7, respectively (p < 0.05). Pearson product-moment correlation coefficient between relative intensity of the liver and the number of hepatic iron deposits was -0.588 (p < 0.01). Superparamagnetic iron oxide-enhanced MR imaging could demonstrate signal recovery delay in irradiated areas of rat livers. It seems that the signal recovery delay in irradiated areas was due to SPIO-derived iron deposition. Hepatic signal recovery could be a novel diagnostic marker for delineation of irradiated areas.	[Furuta, Toshihiro; Yamaguchi, Masayuki; Nakagami, Ryutaro; Fujii, Hirofumi] Natl Canc Ctr Hosp East, Div Funct Imaging, Res Ctr Innovat Oncol, Kashiwa, Chiba 2778577, Japan; [Furuta, Toshihiro] Univ Tokyo, Inst Med Sci, Dept Radiol, Res Hosp, Tokyo, Japan; [Nakagami, Ryutaro] Tokyo Metropolitan Univ, Dept Radiol Sci, Grad Sch Human Hlth Sci, Tokyo 158, Japan; [Akahane, Masaaki; Ohtomo, Kuni] Univ Tokyo, Dept Radiol, Grad Sch Med, Tokyo, Japan; [Minami, Manabu] Univ Tsukuba, Dept Radiol, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan	Yamaguchi, M (reprint author), Natl Canc Ctr Hosp East, Div Funct Imaging, Res Ctr Innovat Oncol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	tfuruta-tky@umin.ac.jp; masyamag@east.ncc.go.jp			Health and Labour Sciences Research Grants for the Third Term Comprehensive 10-year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare in Japan [21-5]; Foundation for Promotion of Cancer Research in Japan; Japan Radiological Society	This work was partially supported by the Health and Labour Sciences Research Grants for the Third Term Comprehensive 10-year Strategy for Cancer Control (21-5) from the Ministry of Health, Labour and Welfare in Japan, a grant from Foundation for Promotion of Cancer Research in Japan, and a grant from Japan Radiological Society. Toshihiro Furuta, MD, PhD was a recipient of a Research Resident Fellowship from the Foundation for Promotion of Cancer Research in Japan. Ryutaro Nakagami, MS is a research fellow of the Japan Society for the Promotion of Science.	Mori K, 2009, RADIOLOGY, V251, P557, DOI 10.1148/radiol.2512081161; HAMM B, 1994, JMRI-J MAGN RESON IM, V4, P659, DOI 10.1002/jmri.1880040508; Briley-Saebo KC, 2006, INVEST RADIOL, V41, P560, DOI 10.1097/01.rli.0000221321.90261.09; CLEMENT O, 1992, RADIOLOGY, V185, P163; Furuta T, 2013, MAGN RESON MATER PHY, V26, P313, DOI 10.1007/s10334-012-0354-3; HEBARD DW, 1980, RADIAT RES, V81, P441, DOI 10.2307/3575202; Lawaczeck R, 1997, ACTA RADIOL, V38, P584; Masui T, 1996, ACTA RADIOL, V37, P665; Mitsuda M, 2013, MAGN RESON MED SCI, V12, P95, DOI 10.2463/mrms.2012-0038; Morimoto N, 1999, JMRI-J MAGN RESON IM, V9, P573, DOI 10.1002/(SICI)1522-2586(199904)9:4<573::AID-JMRI11>3.0.CO;2-C; Yoshioka H, 2000, MAGN RESON IMAGING, V18, P1079, DOI 10.1016/S0730-725X(00)00192-2	11	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0968-5243	1352-8661		MAGN RESON MATER PHY	Magn. Reson. Mat. Phys. Biol. Med.	DEC	2014	27	6					501	508		10.1007/s10334-014-0434-7		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AU1XE	WOS:000345410000004		
J	Lee, VY; Ito, Y; Sekiguchi, A				Lee, Vladimir Ya.; Ito, Yuki; Sekiguchi, Akira			Reactivity of a spirobis(pentagerma[1.1.1]-propellane)	MAIN GROUP METAL CHEMISTRY			English	Article						cluster; germanium; inverted tetrahedral geometry; [1.1.1]propellane; tetraradicaloid; X-ray diffraction	CHEMISTRY; ATOMS; BOND	The specific reactivity of the tetraradicaloid derivative spirobis(pentagerma[1.1.1]propellane) toward the halogenating reagents (CCl4 and I-2) is reported.	[Lee, Vladimir Ya.; Ito, Yuki; Sekiguchi, Akira] Univ Tsukuba, Dept Chem, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan	Lee, VY (reprint author), Univ Tsukuba, Dept Chem, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan.	leevya@chem.tsukuba.ac.jp; sekiguch@chem.tsukuba.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan [23655027, 24245007, 24550038, 90143164]	Ministry of Education, Science, Sports, and Culture of Japan (Grant/Award Number: '23655027', '24245007', '24550038', '90143164').	SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; Drost C, 2002, MAIN GROUP MET CHEM, V25, P93; Nied D, 2010, J AM CHEM SOC, V132, P10264, DOI 10.1021/ja104810u; Ito Y, 2013, J AM CHEM SOC, V135, P6770, DOI 10.1021/ja401650q; WIBERG KB, 1989, CHEM REV, V89, P975, DOI 10.1021/cr00095a001; Levin MD, 2000, CHEM REV, V100, P169, DOI 10.1021/cr990094z; Coppens P, 2005, ANGEW CHEM INT EDIT, V44, P6810, DOI 10.1002/anie.200501734; Lee V. Y., 2010, ORGANOMETALLIC COMPO; Messerschmidt M, 2005, ANGEW CHEM INT EDIT, V44, P3925, DOI 10.1002/anie.200500169; Nied D, 2011, CHEM SOC REV, V40, P3455, DOI 10.1039/c0cs00210k; Nied D, 2009, ANGEW CHEM INT EDIT, V48, P1411, DOI 10.1002/anie.200805289; Nied D, 2010, ORGANOMETALLICS, V29, P6028, DOI 10.1021/om100779b; Nied D, 2011, ORGANOMETALLICS, V30, P1419, DOI 10.1021/om100977z; Richards AF, 2004, ORGANOMETALLICS, V23, P4009, DOI 10.1021/om0497137; Shaik S, 2009, NAT CHEM, V1, P443, DOI [10.1038/nchem.327, 10.1038/NCHEM.327]; Sheldrick G. M., 1997, SHELXL 97 PROGRAM CR; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Silverstein R. M., 2005, SPECTROMETRIC IDENTI; SITA LR, 1991, J AM CHEM SOC, V113, P5070, DOI 10.1021/ja00013a058; SITA LR, 1989, J AM CHEM SOC, V111, P6454, DOI 10.1021/ja00198a085; SITA LR, 1992, J AM CHEM SOC, V114, P7024, DOI 10.1021/ja00044a011; Wu W, 2009, ANGEW CHEM INT EDIT, V48, P1407, DOI 10.1002/anie.200804965	22	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0792-1241	2191-0219		MAIN GROUP MET CHEM	Main Group Met. Chem.	DEC	2014	37	5-6					149	151		10.1515/mgmc-2014-0017		3	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	AU3JY	WOS:000345510200007		
J	Song, X; Wang, L; Niinomi, M; Nakai, M; Liu, Y; Zhu, MY				Song, Xiu; Wang, Lei; Niinomi, Mitsuo; Nakai, Masaaki; Liu, Yang; Zhu, Miaoyong			Microstructure and fatigue behaviors of a biomedical Ti-Nb-Ta-Zr alloy with trace CeO2 additions	MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES MICROSTRUCTURE AND PROCESSING			English	Article						beta-type Ti alloy; CeO2 additions; Microstructure; Fatigue properties; Young's modulus	RIGIDITY TITANIUM-ALLOY; MECHANICAL-PROPERTIES; OXYGEN-CONTENT; ELASTIC PROPERTIES; YOUNGS MODULUS; CYTOTOXICITY; TI-29NB-13TA-4.6ZR; MARTENSITE; FIXATION; STRAIN	The new p-type Ti-29Nb-13Ta-4.6Zr (TNTZ) alloy containing trace amounts of CeO2 additions has been designed as a biomedical implant with improved fatigue properties achieved by keeping Young's modulus to a low value. The results show that the microstructure is refined by the addition of CeO2; the p grain size becomes a little larger when Ce content increases from 0.05% to 0.10%. This occurs because dispersed CeO2 particles can act as nucleation sites for p grains; thus, the effect of rare earth oxides on microstructure refinement mainly depends on the size and dispersion of the rare earth oxides. Young's moduli of TNTZ with CeO(2)additions are maintained as low as those of TNTZ without CeO2, while the fatigue limit is highly improved. The 0.10% Ce alloy exhibits the best fatigue strength among the experimental alloys; its fatigue strength is increased by 66.7% compared to that of pure TNTZ. The mechanism by which rare earth oxides affect fatigue performance is dominated by dispersion strengthening. The stiff rare earth oxides can hinder the movement of dislocations, resulting in resistance to the formation of fatigue cracks. Rare earth oxides also change the crack propagation direction and the crack propagation route, effectively decreasing the crack propagation rate. (C) 2014 Elsevier B.V. All rights reserved.	[Song, Xiu; Wang, Lei; Liu, Yang; Zhu, Miaoyong] Northeastern Univ, Sch Met & Mat, Key Lab Anisotropy & Texture Mat, Minist Educ, Shenyang 110819, Peoples R China; [Niinomi, Mitsuo; Nakai, Masaaki] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan	Wang, L (reprint author), Northeastern Univ, Sch Met & Mat, Key Lab Anisotropy & Texture Mat, 3-11 Wenhua Rd, Shenyang 110819, Peoples R China.	wanglei@mail.neu.edu.cn	Nakai, Masaaki/C-1919-2009; Niinomi, Mitsuo/B-5965-2011		Fundamental Research Funds for the Central Universities [N100702001, N120310001]; Doctoral Fund of Liaoning Province, China [20131036]; National Natural Science Foundation of China [51301037]	This research work was financially supported by Fundamental Research Funds for the Central Universities (N100702001, N120310001), the Doctoral Fund of Liaoning Province, China (20131036) and the National Natural Science Foundation of China (51301037).	Andelman T, 2010, NANOSCALE RES LETT, V5, P263, DOI 10.1007/s11671-009-9445-0; Atri RR, 1999, MAT SCI ENG A-STRUCT, V271, P150, DOI 10.1016/S0921-5093(99)00198-7; Li QL, 2013, J ALLOY COMPD, V562, P25, DOI 10.1016/j.jallcom.2013.02.016; Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037; Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3; Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970; Hanada S, 2013, MAT SCI ENG A-STRUCT, V588, P403, DOI 10.1016/j.msea.2013.09.053; Geng F, 2011, MAT SCI ENG A-STRUCT, V528, P5435, DOI 10.1016/j.msea.2011.03.064; Jung TK, 2013, MAT SCI ENG C-MATER, V33, P1629, DOI 10.1016/j.msec.2012.12.072; Miura K, 2011, ACTA BIOMATER, V7, P2320, DOI 10.1016/j.actbio.2011.02.008; Cimpean A, 2012, MAT SCI ENG C-MATER, V32, P1554, DOI 10.1016/j.msec.2012.04.042; Hollander DA, 2006, BIOMATERIALS, V27, P955, DOI 10.1016/j.biomaterials.2005.07.041; Wei QQ, 2011, MATER DESIGN, V32, P2934, DOI 10.1016/j.matdes.2010.11.049; Guo QH, 2010, MATER DESIGN, V31, P4842, DOI 10.1016/j.matdes.2010.05.047; Sumitomo N, 2008, J MATER SCI-MATER M, V19, P1581, DOI 10.1007/s10856-008-3372-y; Bernal S, 2006, J ALLOY COMPD, V408, P496, DOI 10.1016/j.jallcom.2004.12.090; Courcot E, 2010, J EUR CERAM SOC, V30, P1911, DOI 10.1016/j.jeurceramsoc.2010.02.012; Dai SJ, 2013, T NONFERR METAL SOC, V23, P1299, DOI 10.1016/S1003-6326(13)62597-2; Hao YL, 2006, MAT SCI ENG A-STRUCT, V441, P112, DOI 10.1016/j.msea.2006.09.051; Hung VV, 2011, PHYSICA B, V406, P4014, DOI 10.1016/j.physb.2011.07.012; Ke YB, 2010, MAT SCI ENG A-STRUCT, V528, P220, DOI 10.1016/j.msea.2010.09.011; LAIRD C, 1981, MATER SCI ENG, V50, P127, DOI 10.1016/0025-5416(81)90093-8; Nakai M, 2009, MATER TRANS, V50, P2716, DOI 10.2320/matertrans.MA200904; Narita K, 2012, J MECH BEHAV BIOMED, V9, P207, DOI 10.1016/j.jmbbm.2012.01.011; Niinomi M, 2005, MAT SCI ENG C-BIO S, V25, P417, DOI 10.1016/j.msec.2005.01.024; Sakaguchi N., 2005, MAT SCI ENG C, V25, P63; Wang LQ, 2009, J ALLOY COMPD, V469, P512, DOI 10.1016/j.jallcom.2008.02.032; Yang QX, 2006, J RARE EARTH, V24, P471, DOI 10.1016/S1002-0721(06)60146-4; Zheng CY, 2007, MAT SCI ENG C-BIO S, V27, P824, DOI 10.1016/j.msec.2006.09.021	29	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0921-5093	1873-4936		MAT SCI ENG A-STRUCT	Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.	DEC 1	2014	619						112	118		10.1016/j.msea.2014.09.069		7	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Science & Technology - Other Topics; Materials Science; Metallurgy & Metallurgical Engineering	AU2TD	WOS:000345469500013		
J	Mentek, R; Hippo, D; Gelloz, B; Koshida, N				Mentek, Romain; Hippo, Daihei; Gelloz, Bernard; Koshida, Nobuyoshi			Photovoltaic effect with high open circuit voltage observed in electrochemically prepared nanocrystalline silicon membranes	MATERIALS SCIENCE AND ENGINEERING B-ADVANCED FUNCTIONAL SOLID-STATE MATERIALS			English	Article						Solar cell; Electrochemical etching; Nanocrystalline porous silicon; Wide-gap material; Membrane cells	EMITTING POROUS SILICON; SOLAR-CELLS; QUANTUM EFFICIENCY; ELECTROLUMINESCENCE; STABILIZATION; PHOTODETECTORS; FABRICATION; ABSORPTION; CHEMISTRY; SUBSTRATE	We have investigated photovoltaic effect in electrochemically etched nanocrystalline porous silicon (nc-PSi) thin layer for potential application as a wide-gap absorber for solar cells. The free-standing nc-PSi layer with a pn junction structure shows a photovoltaic effect with a large open circuit voltage in excess of 0.87 V. Comparison with single doped material in different top contact configurations clearly indicates that the original junction remains in the porosified material and plays a major role in the observed photovoltaic effect, while the contributions from the contacts are negligible. The effects of additional processing of the material including chemical etching as well as annealing of the material in an inert atmosphere suggests a strong contribution from the hydrogenated surface in the observed photoconductive characteristics. Replacement of interfacial hydrogen by more stable organic molecules appears to be a promising approach toward stabilization of the material for practical application. (c) 2014 Elsevier B.V. All rights reserved.	[Mentek, Romain; Hippo, Daihei; Koshida, Nobuyoshi] Tokyo Univ Agr & Technol, Grad Sch Engn, Dept Elect & Informat Engn, Koganei, Tokyo 1848588, Japan; [Gelloz, Bernard] Nagoya Univ, Grad Sch Engn, Dept Appl Phys, Nagoya, Aichi 4648603, Japan	Mentek, R (reprint author), Tokyo Univ Agr & Technol, Grad Sch Engn, Dept Elect & Informat Engn, Koganei, Tokyo 1848588, Japan.	mentek@cc.tuat.ac.jp			New Energy and Industrial Technology Development Organization (NEDO, Japan)	This work has been partially supported by the New Energy and Industrial Technology Development Organization (NEDO, Japan).	KOSHIDA N, 1992, APPL PHYS LETT, V60, P347, DOI 10.1063/1.106652; Yerokhov VY, 1999, RENEW SUST ENERG REV, V3, P291, DOI 10.1016/S1364-0321(99)00005-2; Bisi O, 2000, SURF SCI REP, V38, P1, DOI 10.1016/S0167-5729(99)00012-6; Okamoto H, 2011, CHEM-EUR J, V17, P9864, DOI 10.1002/chem.201100641; Kovalev D, 1996, J APPL PHYS, V80, P5978, DOI 10.1063/1.363595; Buriak JM, 2002, CHEM REV, V102, P1271, DOI 10.1021/cr000064s; SMESTAD G, 1992, SOL ENERG MAT SOL C, V26, P277, DOI 10.1016/0927-0248(92)90047-S; Rajabi M, 2009, J POROUS MAT, V16, P513, DOI 10.1007/s10934-008-9226-7; Kislyuk VV, 2008, J NANOSCI NANOTECHNO, V8, P131, DOI 10.1166/jnn.2008.N16; Gelloz B, 2003, APPL PHYS LETT, V83, P2342, DOI 10.1063/1.1613812; Boukherroub R, 2000, PHYS STATUS SOLIDI A, V182, P117, DOI 10.1002/1521-396X(200011)182:1<117::AID-PSSA117>3.0.CO;2-3; STEINER P, 1993, APPL PHYS LETT, V62, P2700, DOI 10.1063/1.109236; LINNROS J, 1995, APPL PHYS LETT, V66, P3048, DOI 10.1063/1.114273; Perez-Wurfl I, 2012, SOL ENERG MAT SOL C, V100, P65, DOI 10.1016/j.solmat.2011.02.029; Meillaud F, 2006, SOL ENERG MAT SOL C, V90, P2952, DOI 10.1016/j.solmat.2006.06.002; Ramizy A, 2011, APPL SURF SCI, V257, P6112, DOI 10.1016/j.apsusc.2011.02.013; LEHMANN V, 1991, APPL PHYS LETT, V58, P856, DOI 10.1063/1.104512; Stalmans L, 1998, PROG PHOTOVOLTAICS, V6, P233, DOI 10.1002/(SICI)1099-159X(199807/08)6:4<233::AID-PIP207>3.0.CO;2-D; Green MA, 2002, PHYSICA E, V14, P65, DOI 10.1016/S1386-9477(02)00361-2; Balagurov LA, 2000, MAT SCI ENG B-SOLID, V69, P127, DOI 10.1016/S0921-5107(99)00230-5; von Behren J, 1998, SOLID STATE COMMUN, V105, P317, DOI 10.1016/S0038-1098(97)10099-0; CANHAM LT, 1990, APPL PHYS LETT, V57, P1046, DOI 10.1063/1.103561; MENNA P, 1995, SOL ENERG MAT SOL C, V37, P13, DOI 10.1016/0927-0248(94)00193-6; Loper P, 2012, ADV MATER, V24, P3124, DOI 10.1002/adma.201200539; BUSTARRET E, 1995, THIN SOLID FILMS, V255, P234, DOI 10.1016/0040-6090(94)05661-V; Bywalez R, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-76; Canham L.T., 1997, PROPERTIES POROUS SI, V18; Chan MH, 1996, J APPL PHYS, V79, P3273, DOI 10.1063/1.361216; Gelloz B., 2003, HDB LUMINESCENCE DIS, P128; GIEBEL G, 1995, PHYS STATUS SOLIDI A, V151, P355, DOI 10.1002/pssa.2211510212; Halimaoui A, 1997, PROPERTIES POROUS SI, P12; Hoeymissen J.V., 2011, PHYS STATUS SOLIDI A, V208, P1433; Kore L, 1999, SOL ENERG MAT SOL C, V57, P31, DOI 10.1016/S0927-0248(98)00164-0; Koshida N, 2003, MAT SCI ENG R, V40, P169, DOI 10.1016/S0927-796X(02)00135-3; Kurokawa Y., 2009, P 24 EUR PHOT SOL EN, P398; Liu CY, 2010, NANOSCALE RES LETT, V5, P1253, DOI 10.1007/s11671-010-9632-z; Mentek R, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.02BP05; Mentek R, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.04DG22; Palsule C, 1997, SOL ENERG MAT SOL C, V46, P261, DOI 10.1016/S0927-0248(97)00004-4; PULSFORD NJ, 1993, J LUMIN, V57, P181, DOI 10.1016/0022-2313(93)90129-B; Torres-Costa V, 2007, MAT SCI ENG C-BIO S, V27, P954, DOI 10.1016/j.msec.2006.06.026; TSAI CC, 1993, APPL PHYS LETT, V62, P2818, DOI 10.1063/1.109220; WALTENBURG HN, 1995, CHEM REV, V95, P1589; Yamada S, 2010, IEEE PHOT SPEC CONF, P766	44	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-5107	1873-4944		MATER SCI ENG B-ADV	Mater. Sci. Eng. B-Adv. Funct. Solid-State Mater.	DEC	2014	190						33	40		10.1016/j.mseb.2014.09.005		8	Materials Science, Multidisciplinary; Physics, Condensed Matter	Materials Science; Physics	AU2UQ	WOS:000345473300006		
J	Ozaki, K; Matin, A; Numata, Y; Akai, D; Sawada, K; Ishida, M				Ozaki, Katsuya; Matin, Abdul; Numata, Yasuyuki; Akai, Daisuke; Sawada, Kazuaki; Ishida, Makoto			Fabrication and characterization of a smart epitaxial piezoelectric micromachined ultrasonic transducer	MATERIALS SCIENCE AND ENGINEERING B-ADVANCED FUNCTIONAL SOLID-STATE MATERIALS			English	Article						Ultrasonic transducer; PMUT; Epitaxy; Pressure mapping; Finite element analysis; Medical diagnosis	THIN-FILMS; SENSITIVITY; DIAPHRAGMS; OPERATION; ARRAYS; CMUT	A novel piezoelectric micromachined ultrasonic transducer (pMUT) array was designed and fabricated using epitaxially grown functional Pb(Zr0.52Ti0.48)O-3 (PZT) thin film on Si(1 1 1)/gamma-Al2O3(1 1 1)/SrRuO3(1 1 1) substrate for biomedical applications. The crystallographic orientation of PZT film was controlled by the incorporation of epitaxial gamma-Al2O3 film on Si substrate. Modal shape of pMUT was analyzed employing advanced 3D finite element modeling taking the crystallographic anisotropy of materials and the properties of immersed medium (air or water) into account. Eigenfrequency with mode shapes has shown to have significant influence on transmitting-receiving characteristics of pMUT. Modal shapes of pMUT were also quantitatively determined using Laser Doppler Vibratometry (LDV). An excellent correlation was obtained between computational and experimental results. A significantly high sensitivity of 3.9 mu V/kPa was obtained in an under-water ultrasonic wave transmission experiment conducted using fabricated pMUT as wave transmitter and a commercial transducer as receiver at a fundamental frequency of 1.20 MHz. Advanced FE computation thus serves as a tool to a priori optimize device structure for the successful transmission of ultrasonic waves with sufficient power to generate high resolution 3D imaging. (c) 2014 Elsevier B.V. All rights reserved.	[Ozaki, Katsuya; Numata, Yasuyuki; Sawada, Kazuaki; Ishida, Makoto] Toyohashi Univ Technol, Dept Elect & Elect Informat Engn, Toyohashi, Aichi 4418580, Japan; [Matin, Abdul] Bangladesh Univ Engn & Tech, Dept Glass & Ceram Engn, Dhaka 1000, Bangladesh; [Akai, Daisuke; Sawada, Kazuaki; Ishida, Makoto] Toyohashi Univ Technol, Elect Inspired Interdisciplinary Res Inst EIIRIS, Toyohashi, Aichi 4418580, Japan	Matin, A (reprint author), Bangladesh Univ Engn & Tech, Dept Glass & Ceram Engn, Dhaka 1000, Bangladesh.	matin.md.a@gmail.com	Akai, Daisuke/A-5951-2012	Akai, Daisuke/0000-0003-1178-1255			Ahrens O, 2002, IEEE T ULTRASON FERR, V49, P1321, DOI 10.1109/TUFFC.2002.1041549; Akai D, 2006, SENSOR MATER, V18, P161; Akai D., 2011, TRANSDUCERS 2011 - 2011 16th International Solid-State Sensors, Actuators and Microsystems Conference, DOI 10.1109/TRANSDUCERS.2011.5969159; Akasheh F, 2004, SENSOR ACTUAT A-PHYS, V111, P275, DOI 10.1016/j.sna.2003.11.022; Caronti A, 2002, IEEE T ULTRASON FERR, V49, P159, DOI 10.1109/58.985700; MO JH, 1990, IEEE T ELECTRON DEV, V37, P134, DOI 10.1109/16.43810; Dausch DE, 2008, IEEE T ULTRASON FERR, V55, P2484, DOI 10.1109/TUFFC.956; Hong E, 2006, IEEE T ULTRASON FERR, V53, P697; Muralt P, 2005, IEEE T ULTRASON FERR, V52, P2276, DOI 10.1109/TUFFC.2005.1563270; Khuri-Yakub BT, 2009, IEEE SPECTRUM, V46, P44, DOI 10.1109/MSPEC.2009.4907385; Ergun AS, 2005, IEEE T ULTRASON FERR, V52, P2242, DOI 10.1109/TUFFC.2005.1563267; ANDERSON MJ, 1995, J ACOUST SOC AM, V97, P262, DOI 10.1121/1.412310; Oralkan O, 2002, IEEE T ULTRASON FERR, V49, P1596, DOI 10.1109/TUFFC.2002.1049742; Percin G, 1998, APPL PHYS LETT, V72, P1397, DOI 10.1063/1.121067; Ladabaum I, 1998, IEEE T ULTRASON FERR, V45, P678, DOI 10.1109/58.677612; Bernstein J., 1997, IEEE T ULTRASON FERR, P960; Buigas M, 2005, ULTRASONICS, V43, P383, DOI 10.1016/j.ultras.2004.07.006; Caronti A, 2006, MICROELECTRON J, V37, P770, DOI 10.1016/j.mejo.2005.10.012; HIETANEN J, 1993, MEAS SCI TECHNOL, V4, P1138, DOI 10.1088/0957-0233/4/10/018; Huang YL, 2006, IEEE T ULTRASON FERR, V53, P1918, DOI 10.1109/TUFFC.2006.125; Khuri-Yakub B.T., 2001, J MICROMECH MICROENG, V21, P54004; Matin M., 2013, IEEE SENSORS, P77; Matin MA, 2011, COMP MATER SCI, V50, P2311, DOI 10.1016/j.commatsci.2011.02.041; Mills D.M., 2004, IEEE ULTR S, P384; MSC Software, 2007, MSC SOFTWARE, VXXIII; Muralt P., 2001, IEEE ULTRASON S, P907; Numata Y., 2012, THESIS TOYOHASHI U T; Oralkan O., 1999, P IEEE ULTR S, P1141; Percin G, 2002, IEEE T ULTRASON FERR, V49, P585, DOI 10.1109/TUFFC.2002.1002457; Percin G., 1997, P IEEE ULTR S, V2, P959; Percin G, 2002, IEEE T ULTRASON FERR, V49, P573, DOI 10.1109/TUFFC.2002.1002456; Reynolds P., 2001, ULTRASONICS INT; Smyth K.M., 2012, THESIS MIT; Wang Y.F., 2010, 3 INT C BIOM ENG INF, P666; Yamashita K, 2002, SENSOR ACTUAT A-PHYS, V97-8, P302, DOI 10.1016/S0924-4247(02)00037-7; 2007, MSC SOFTWARE, VE	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-5107	1873-4944		MATER SCI ENG B-ADV	Mater. Sci. Eng. B-Adv. Funct. Solid-State Mater.	DEC	2014	190						41	46		10.1016/j.mseb.2014.08.002		6	Materials Science, Multidisciplinary; Physics, Condensed Matter	Materials Science; Physics	AU2UQ	WOS:000345473300007		
J	Hoshi, H; Tanaka, S; Miyoshi, T				Hoshi, Hajime; Tanaka, Shumpei; Miyoshi, Takashi			Pt-graphene electrodes for dye-sensitized solar cells	MATERIALS SCIENCE AND ENGINEERING B-ADVANCED FUNCTIONAL SOLID-STATE MATERIALS			English	Article						Dye-sensitized solar cell; Graphene; Nanoparticle	COUNTER ELECTRODES; LOW-COST; EFFICIENCY; CONVERSION; FILMS; LIGHT	A simple paste method for fabricating graphene films with Pt nanoparticles was developed. First, graphene pastes with Pt nanoparticles were prepared from commercially available graphene. The resulting films of graphene nanoplatelet aggregates with Pt nanoparticles (Pt-GNA) contained Pt nanoparticles distributed over the entire three-dimensional surface of the GNA. Then, the catalytic activity for the I-3(-)/I- redox reaction was evaluated by cyclic voltammetry. The GNA electrode exhibited higher activity than a graphene nanoplatelet electrode because of its higher effective surface area. Addition of Pt nanoparticles to the electrodes improved the catalytic activity. In particular, a large Faradaic current for the I-3(-)/I- reaction was observed for the Pt-GNA electrode. As the counter electrodes of dye-sensitized solar cells (DSSCs), their performance was consistent with the cyclic voltammetry results. In particular, the DSSC performance of the Pt-GNA electrode was superior to that of the Pt electrodes commonly used in DSSCs. (c) 2014 Elsevier B.V. All rights reserved.	[Hoshi, Hajime; Tanaka, Shumpei; Miyoshi, Takashi] Tokyo Univ Sci, Dept Appl Chem, Yamaguchi 7560884, Japan	Hoshi, H (reprint author), Tokyo Univ Sci, Dept Appl Chem, 1-1-1 Daigaku Dori, Yamaguchi 7560884, Japan.	hoshi@ed.tus.ac.jp					Adachi T, 2013, MATER LETT, V94, P15, DOI 10.1016/j.matlet.2012.11.123; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Menshykau D, 2008, ELECTROANAL, V20, P2387, DOI 10.1002/elan.200804334; Suzuki K, 2003, CHEM LETT, V32, P28, DOI 10.1246/cl.2003.28; NAZEERUDDIN MK, 1993, J AM CHEM SOC, V115, P6382, DOI 10.1021/ja00067a063; Roy-Mayhew JD, 2010, ACS NANO, V4, P6203, DOI 10.1021/nn1016428; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Zhang DW, 2011, CARBON, V49, P5382, DOI 10.1016/j.carbon.2011.08.005; Gratzel M, 2004, J PHOTOCH PHOTOBIO A, V164, P3, DOI 10.1016/j.jphotochem.2004.02.023; Hauch A, 2001, ELECTROCHIM ACTA, V46, P3457, DOI 10.1016/S0013-4686(01)00540-0; Kavan L, 2011, ACS NANO, V5, P165, DOI 10.1021/nn102353h; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Choi H, 2011, J MATER CHEM, V21, P7548, DOI 10.1039/c1jm11145k; Gratzel C, 2013, MATER TODAY, V16, P11, DOI 10.1016/j.mattod.2013.01.020; Hong WJ, 2008, ELECTROCHEM COMMUN, V10, P1555, DOI 10.1016/j.elecom.2008.08.007; Papageorgiou N, 1997, J ELECTROCHEM SOC, V144, P876, DOI 10.1149/1.1837502; Kay A, 1996, SOL ENERG MAT SOL C, V44, P99, DOI 10.1016/0927-0248(96)00063-3; Imoto K, 2003, SOL ENERG MAT SOL C, V79, P459, DOI 10.1016/S0927-0248(03)00021-7; Chiba Y, 2006, JPN J APPL PHYS 2, V45, pL638, DOI 10.1143/JJAP.45.L638	21	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-5107	1873-4944		MATER SCI ENG B-ADV	Mater. Sci. Eng. B-Adv. Funct. Solid-State Mater.	DEC	2014	190						47	51		10.1016/j.mseb.2014.09.003		5	Materials Science, Multidisciplinary; Physics, Condensed Matter	Materials Science; Physics	AU2UQ	WOS:000345473300008		
J	Abrams, M				Abrams, Michael			BIG HOLOGRAMS FROM TINY ANTENNAS	MECHANICAL ENGINEERING			English	Editorial Material									ASME ORG, Chiba, Japan	Abrams, M (reprint author), ASME ORG, Chiba, Japan.							0	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0025-6501	1943-5649		MECH ENG	Mech. Eng.	DEC	2014	136	12					14	14				1	Engineering, Mechanical	Engineering	AT9SN	WOS:000345266500009		
J	Horiuchi, Y; Ohno, T; Hoshino, M; Shin, KC; Murakami, H; Tsunematsu, M; Watanabe, Y				Horiuchi, Yu; Ohno, Tetsuji; Hoshino, Mihoko; Shin, Ki-Cheol; Murakami, Hiroyasu; Tsunematsu, Maiko; Watanabe, Yasushi			Geochemical prospecting for rare earth elements using termite mound materials	MINERALIUM DEPOSITA			English	Article						Termite mounds; Rare earth elements; Geochemical prospecting; South Africa; Blockspruit; Portable XRF	GOLD; SOILS	The Blockspruit fluorite prospect, located in North West State of the Republic of South Africa, occurs within an actinolite rock zone that was emplaced into the Kenkelbos-type granite of Proterozoic age. There are a large number of termite mounds in the prospect. For geochemical prospecting for rare earth elements (REEs), in total, 200 samples of termite mound material were collected from actinolite rock and granite zones in the prospect. Geochemical analyses of these termite mound materials were conducted by two methods: portable X-ray fluorescence (XRF) spectrometry and inductively coupled plasma-mass spectrometry (ICP-MS). Comparison of the two methods broadly indicates positive correlations of REEs (La, Ce, Pr, Nd, and Y), in particular Y and La having a strong correlation. As the result of modal abundance analyses, the actinolite rock at surface mainly consists of ferro-actinolite (89.89 wt%) and includes xenotime (0.26 wt%) and monazite (0.21 wt%) grains as REE minerals. Termite mound materials from actinolite rock also contain xenotime (0.27 wt%) and monazite (0.41 wt%) grains. In addition, termite mound materials from the actinolite rock zone have high hematite and Fe silicate contents compared to those from granite zone. These relationships suggest that REE minerals in termite mound materials originate form actinolite rock. Geochemical anomaly maps of Y, La, and Fe concentrations drawn based on the result of the portable XRF analyses show that high concentrations of these elements trend from SW to NE which broadly correspond to occurrences of actinolite body. These results indicate that termite mounds are an effective tool for REE geochemical prospection in the study area for both light REEs and Y, but a more detailed survey is required to establish the distribution of the actinolite rock body.	[Horiuchi, Yu; Ohno, Tetsuji; Hoshino, Mihoko; Tsunematsu, Maiko; Watanabe, Yasushi] AIST, Geol Survey Japan, Tsukuba, Ibaraki 3058567, Japan; [Shin, Ki-Cheol] Res Inst Human & Nat, Kyoto, Japan; [Murakami, Hiroyasu] AIST, Interdisciplinary Res Ctr Catalyt Chem, Tsukuba, Ibaraki 3058567, Japan	Hoshino, M (reprint author), AIST, Geol Survey Japan, Higashi 1-1-1, Tsukuba, Ibaraki 3058567, Japan.	hoshino-m@aist.go.jp					GLEESON CF, 1989, J GEOCHEM EXPLOR, V31, P253, DOI 10.1016/0375-6742(89)90105-2; BROOKS RR, 1982, J GEOCHEM EXPLOR, V17, P109, DOI 10.1016/0375-6742(82)90028-0; Crocker IT, 1988, HANDBOOK, V11; Crocker IT, 2001, MEMOIR, V90, P115; FERRAR P, 1982, OECOLOGIA, V52, P125, DOI 10.1007/BF00349021; Hoshino M, 2013, RARE EARTHS, V62, P94; LEROUX JP, 1991, J GEOCHEM EXPLOR, V41, P341, DOI 10.1016/0375-6742(91)90007-H; Sarala P, 2013, MINERAL DEPOSIT RESEARCH FOR A HIGH-TECH WORLD, VOLS. 1-4, P437; WATSON JP, 1972, SOIL SCI, V113, P317, DOI 10.1097/00010694-197205000-00004; West WF, 1970, CHAMBER MINES J, V12, P32	10	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0026-4598	1432-1866		MINER DEPOSITA	Miner. Depos.	DEC	2014	49	8			SI		1013	1023		10.1007/s00126-014-0550-3		11	Geochemistry & Geophysics; Mineralogy	Geochemistry & Geophysics; Mineralogy	AU1OZ	WOS:000345391200008		
J	Szczesniak, M; Yoneda, M; Sato, H; Makalowska, I; Kyuwa, S; Sugano, S; Suzuki, Y; Makalowski, W; Kai, C				Szczesniak, Michal; Yoneda, Misako; Sato, Hiroki; Makalowska, Izabela; Kyuwa, Shigeru; Sugano, Sumio; Suzuki, Yutaka; Makalowski, Wojciech; Kai, Chieko			Characterization of the mitochondrial genome of Rousettus leschenaulti	MITOCHONDRIAL DNA			English	Article						Fruit bats phylogeny; next generation sequencing; Rousettus leschenaulti mitochondrion	FOSSIL	We present a complete sequence of mitochondrial genome of echolocating megabat Rousettus leschenaulti (16,704 nt, GenBank record KC702803) and provide its annotation. We also show that phylogenetic analysis based on mitochondrial genomes of eighteen bat species, including R. leschenaulti, supports division of Chiroptera into Yinpterochiroptera and Yangochiroptera.	[Szczesniak, Michal; Makalowska, Izabela] Adam Mickiewicz Univ, Lab Bioinformat, Poznan, Poland; [Yoneda, Misako; Sato, Hiroki; Kai, Chieko] Univ Tokyo, Inst Med Sci, Tokyo 1088639, Japan; [Kyuwa, Shigeru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomed Sci, Tokyo 1088639, Japan; [Sugano, Sumio; Suzuki, Yutaka; Makalowski, Wojciech] Univ Tokyo, Dept Med Genome Sci, Chiba, Japan; [Makalowski, Wojciech] Univ Munster, Inst Bioinformat, D-48149 Munster, Germany	Kai, C (reprint author), Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	ckai@ims.u-tokyo.ac.jp			Ministry of Education, Science, Culture, and Sports, Japan; Project "EVOLGEN'' [247633]	This study was supported by Grant-in-Aid from the Ministry of Education, Science, Culture, and Sports, Japan and partially by the FP7-People-2009-IRSES Project "EVOLGEN'' No. 247633. The authors declare no conflict of interest.	Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; Springer MS, 2001, P NATL ACAD SCI USA, V98, P6241, DOI 10.1073/pnas.111551998; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Fernandez-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514; Van den Bussche RA, 2004, J MAMMAL, V85, P321, DOI 10.1644/1545-1542(2004)085<0321:PRARCF>2.0.CO;2	5	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1940-1736	1940-1744		MITOCHONDR DNA	Mitochondrial DNA	DEC	2014	25	6					443	444		10.3109/19401736.2013.809451		2	Genetics & Heredity	Genetics & Heredity	AU0IP	WOS:000345307000016		
J	Sako-Kubota, K; Tanaka, N; Nagae, S; Meng, WX; Takeichi, M				Sako-Kubota, Kyoko; Tanaka, Nobutoshi; Nagae, Shigenori; Meng, Wenxiang; Takeichi, Masatoshi			Minus end-directed motor KIFC3 suppresses E-cadherin degradation by recruiting USP47 to adherens junctions	MOLECULAR BIOLOGY OF THE CELL			English	Article							CELL-CELL CONTACTS; MICROTUBULE PLUS-END; N-CADHERIN; UBIQUITIN; P120-CATENIN; ENDOCYTOSIS; PROTEINS; ADHESION; DOMAIN; BETA	The adherens junction (AJ) plays a crucial role in maintaining cell-cell adhesion in epithelial tissues. Previous studies show that KIFC3, a minus end-directed kinesin motor, moves into AJs via microtubules that grow from clusters of CAMSAP3 (also known as Nezha), a protein that binds microtubule minus ends. The function of junction-associated KIFC3, however, remains to be elucidated. Here we find that KIFC3 binds the ubiquitin-specific protease USP47, a protease that removes ubiquitin chains from substrates and hence inhibits proteasome-mediated proteolysis, and recruits it to AJs. Depletion of KIFC3 or USP47 promotes cleavage of E-cadherin at a juxtamembrane region of the cytoplasmic domain, resulting in the production of a 90-kDa fragment and the internalization of E-cadherin. This cleavage depends on the E3 ubiquitin protein ligase Hakai and is inhibited by proteasome inhibitors. Ecadherin ubiquitination consistently increases after depletion of KIFC3 or USP47. These findings suggest that KIFC3 suppresses the ubiquitination and resultant degradation of E-cadherin by recruiting USP47 to AJs, a process that may be involved in maintaining stable cell-cell adhesion in epithelial sheets.	[Sako-Kubota, Kyoko; Tanaka, Nobutoshi; Nagae, Shigenori; Meng, Wenxiang; Takeichi, Masatoshi] RIKEN, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan; [Meng, Wenxiang] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China	Takeichi, M (reprint author), RIKEN, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan.	takeichi@cdb.riken.jp	Takeichi, Masatoshi/G-5903-2012	Takeichi, Masatoshi/0000-0002-9931-3378	Japan Society for Promotion of Science [20002009, 2522110]	We thank N. Hirokawa for KIFC3 cDNA, G. Melino for USP47 cDNA, K. Shinmyozu (Center for Developmental Biology Mass Spectrometry Analysis Unit) for mass spectrometric analysis, Y. Fujita for discussion, and K. Nagata for critical reading of the manuscript. We are also grateful to M. Nomura-Harata, H. Saitou, Y. Inoue, and H. Sylvain for their technical support, as well as to other members of our laboratory for discussion. This work was supported by Grant-in-Aid for Specially Promoted Research 20002009 and Grant-in-Aid for Scientific Research (S) 2522110 from the Japan Society for Promotion of Science to M.T.	Baines AJ, 2009, MOL BIOL EVOL, V26, P2005, DOI 10.1093/molbev/msp115; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; Ronzitti G, 2004, BRIT J CANCER, V90, P1100, DOI 10.1038/sj.bjc.6601640; Peschiaroli A, 2010, ONCOGENE, V29, P1384, DOI 10.1038/onc.2009.430; Nekrasova OE, 2011, J CELL BIOL, V195, P1185, DOI 10.1083/jcb.201106057; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Shen Y, 2008, J BIOL CHEM, V283, P5127, DOI 10.1074/jbc.M703300200; Stehbens SJ, 2006, J CELL SCI, V119, P1801, DOI 10.1242/jcs.02903; Miyashita Y, 2007, J BIOL CHEM, V282, P11540, DOI 10.1074/jbc.M608351200; Xiao K, 2007, BBA-MOL CELL RES, V1773, P8, DOI 10.1016/j.bbamcr.2006.07.005; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Tsukamoto T, 1999, J BIOL CHEM, V274, P24579, DOI 10.1074/jbc.274.35.24579; Kim H, 2012, BBA-MOL BASIS DIS, V1822, P509, DOI 10.1016/j.bbadis.2011.12.015; Parsons JL, 2011, MOL CELL, V41, P609, DOI 10.1016/j.molcel.2011.02.016; Yang JY, 2006, MOL CELL BIOL, V26, P7269, DOI 10.1128/MCB.00172-06; Janda E, 2006, ONCOGENE, V25, P7117, DOI 10.1038/sj.onc.1209701; Nanes BA, 2012, J CELL BIOL, V199, P365, DOI 10.1083/jcb.201205029; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Tanaka N, 2012, P NATL ACAD SCI USA, V109, P20029, DOI 10.1073/pnas.1218017109; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Steinhusen U, 2001, J BIOL CHEM, V276, P4972, DOI 10.1074/jbc.M006102200; Takeichi M, 2014, NAT REV MOL CELL BIO, V15, P397, DOI 10.1038/nrm3802; Schaefer A, 2012, BIOCHEM J, V442, P13, DOI 10.1042/BJ20111815; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019; Nagae S, 2013, GENES CELLS, V18, P387, DOI 10.1111/gtc.12044; Zhang Z, 2013, GENE DEV, V27, P1581, DOI 10.1101/gad.211037.112; Ligon LA, 2007, TRAFFIC, V8, P808, DOI 10.1111/j.1600-0854.2007.00574.x; Tanno H, 2013, J BIOCHEM, V153, P497, DOI 10.1093/jb/mvt028; Bellett G, 2009, CELL MOTIL CYTOSKEL, V66, P893, DOI 10.1002/cm.20393; Buus R, 2009, CURR BIOL, V19, P1463, DOI 10.1016/j.cub.2009.07.040; Delva E, 2009, TRAFFIC, V10, P259, DOI 10.1111/j.1600-0854.2008.00862.x; Hartsock A, 2012, PLOS ONE, V7; Mary S, 2002, MOL BIOL CELL, V13, P285, DOI 10.1091/mbc.01-07-0337; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Noda Y, 2001, J CELL BIOL, V155, P77, DOI 10.1083/jcb.200108042; Saitoh M, 2009, BIOCHEM BIOPH RES CO, V381, P560, DOI 10.1016/j.bbrc.2009.02.098; Shiraishi K, 2005, J IMMUNOL, V175, P1014; Starck JL, 2009, ASTRON ASTROPHYS, V504, P641, DOI 10.1051/0004-6361/200811388; Swaminathan G, 2012, ONCOGENE, V31, P376, DOI 10.1038/onc.2011.242; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Wirtz-Peitz F, 2009, CURR OPIN GENET DEV, V19, P350, DOI 10.1016/j.gde.2009.04.011; Ye Y, 2013, ONCOGENE, V32, P1702, DOI 10.1038/onc.2012.180	46	0	0	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	DEC 1	2014	25	24					3851	3860		10.1091/mbc.E14-07-1245		10	Cell Biology	Cell Biology	AU4EY	WOS:000345563700002		
J	Hosomi, K; Sakaguchi, Y; Kohda, T; Gotoh, K; Motooka, D; Nakamura, S; Umeda, K; Iida, T; Kozaki, S; Mukamoto, M				Hosomi, Koji; Sakaguchi, Yoshihiko; Kohda, Tomoko; Gotoh, Kazuyoshi; Motooka, Daisuke; Nakamura, Shota; Umeda, Kaoru; Iida, Tetsuya; Kozaki, Shunji; Mukamoto, Masafumi			Complete nucleotide sequence of a plasmid containing the botulinum neurotoxin gene in Clostridium botulinum type B strain 111 isolated from an infant patient in Japan	MOLECULAR GENETICS AND GENOMICS			English	Article						Infant botulism; Plasmid; Nucleotide sequence; Subtype B2 neurotoxin	INCREASE TOXIN ABSORPTION; C-TERMINAL HALF; ESCHERICHIA-COLI; GENOME SEQUENCE; HEAVY-CHAIN; RECOMBINATION; PHAGE; TOXIGENICITY; MECHANISMS; PROTEINS	Botulinum neurotoxins (BoNTs) are highly potent toxins that are produced by Clostridium botulinum. We determined the complete nucleotide sequence of a plasmid containing the botulinum neurotoxin gene in C. botulinum type B strain 111 in order to obtain an insight into the toxigenicity and evolution of the bont gene in C. botulinum. Group I C. botulinum type B strain 111 was isolated from the first case of infant botulism in Japan in 1995. In previous studies, botulinum neurotoxin subtype B2 (BoNT/B2) produced by strain 111 exhibited different antigenic properties from those of authentic BoNT/B1 produced by strain Okra. We have recently shown that the isolates of strain 111 that lost toxigenicity were cured of the plasmid containing the bont/B2 gene. In the present study, the plasmid (named pCB111) was circular 265,575 bp double-stranded DNA and contained 332 predicted open reading frames (ORFs). 85 gene products of these ORFs could be functionally assigned on the basis of sequence homology to known proteins. The bont/B2 complex genes were located on pCB111 and some gene products may be involved in the conjugative plasmid transfer and horizontal transfer of bont genes. pCB111 was similar to previously identified plasmids containing bont/B1, /B5, or/A3 complex genes in other group I C. botulinum strains. It was suggested that these plasmids had been derived from a common ancestor and had played important roles for the bont gene transfer between C. botulinum.	[Hosomi, Koji; Kohda, Tomoko; Kozaki, Shunji; Mukamoto, Masafumi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Vet Sci, Osaka 5988531, Japan; [Sakaguchi, Yoshihiko] Miyazaki Univ, Interdisciplinary Res Org, Miyazaki, Japan; [Gotoh, Kazuyoshi; Motooka, Daisuke; Nakamura, Shota; Iida, Tetsuya] Osaka Univ, Microbial Dis Res Inst, Dept Infect Metagen, Suita, Osaka 565, Japan; [Umeda, Kaoru] Osaka City Inst Publ Hlth & Environm Sci, Dept Microbiol, Osaka 543, Japan	Mukamoto, M (reprint author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Vet Sci, 1-58 Rinku Orai Kita, Osaka 5988531, Japan.	mukamoto@vet.osakafu-u.ac.jp					Alouf JE, 1999, STRUCTURAL GENOMIC F, P174; Kozaki S, 1998, INFECT IMMUN, V66, P4811; Umeda K, 2013, INFECT GENET EVOL, V16, P298, DOI 10.1016/j.meegid.2013.02.022; Fujinaga Y, 2009, TOXICON, V54, P583, DOI 10.1016/j.toxicon.2008.11.014; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; Sebaihia M, 2007, GENOME RES, V17, P1082, DOI 10.1101/gr.6282807; CORNET F, 1994, J BACTERIOL, V176, P3188; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66; Yamakawa K, 1997, J CLIN MICROBIOL, V35, P2163; Huber KE, 2002, NATURE, V417, P656, DOI 10.1038/nature00782; Nakayama K, 2000, MOL MICROBIOL, V38, P213, DOI 10.1046/j.1365-2958.2000.02135.x; Hielm S, 1998, APPL ENVIRON MICROB, V64, P703; Sakaguchi Y, 2005, P NATL ACAD SCI USA, V102, P17472, DOI 10.1073/pnas.0505503102; Kohda T, 2007, MICROB PATHOGENESIS, V42, P72, DOI 10.1016/j.micpath.2006.10.006; LAMANNA C, 1947, J BACTERIOL, V54, P575; Umeda K, 2009, J CLIN MICROBIOL, V47, P2720, DOI 10.1128/JCM.00077-09; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Hill KK, 2013, CURR TOP MICROBIOL, V364, P1, DOI 10.1007/978-3-642-33570-9_1; Das B, 2013, TRENDS MICROBIOL, V21, P23, DOI 10.1016/j.tim.2012.10.003; Zielenkiewicz U, 2001, ACTA BIOCHIM POL, V48, P1003; Matsumura T, 2008, CELL MICROBIOL, V10, P355, DOI 10.1111/j.1462-5822.2007.01048.x; Raffestin S, 2004, ANAEROBE, V10, P93, DOI 10.1016/j.anerobe.2004.01.001; SUGIYAMA H, 1980, MICROBIOL REV, V44, P419; Barash JR, 2013, J INFECT DIS, V209, P183, DOI DOI 10.1093/INFDIS/JIT449; Dover N, 2013, J INFECT DIS, V209, P192, DOI DOI 10.1093/INFDIS/JIT450; EDMOND BJ, 1977, TEX MED, V73, P85; EKLUND MW, 1971, SCIENCE, V172, P480, DOI 10.1126/science.172.3982.480; Fox CK, 2005, PEDIATR NEUROL, V32, P149, DOI 10.1016/j.pediatrneurol.2004.10.001; Hill KK, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-66; Ihara H, 2003, BBA-GENE STRUCT EXPR, V1625, P19, DOI 10.1016/S0167-4781(02)00537-7; Kakinuma H, 1996, ACTA PAEDIATR JAPON, V38, P541; Montecucco C, 1995, Q REV BIOPHYS, V28, P423; Ohtsubo Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-376; Peck MW, 2009, ADV MICROB PHYSL, V55, P320, DOI [10.1016/S0065-2911(09)05503-9, DOI 10.1016/S0065-2911(09)05503-9]; Smith T, 2007, PLOS ONE, V12, pe1271, DOI [DOI 10.1371/J0URNAL.P0NE.0001271, 10.1371/journal.pone.0001271]; Umeda K, 2012, MICROBIOL IMMUNOL, V56, P338, DOI 10.1111/j.1348-0421.2012.00441.x; Yamaichi Y, 2000, P NATL ACAD SCI USA, V97, P14656, DOI 10.1073/pnas.97.26.14656; Ye Q, 2004, APPL ENVIRON MICROB, V70, P5595, DOI 10.1128/AEM.70.9.5595-5602.2004	39	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-4615	1617-4623		MOL GENET GENOMICS	Mol. Genet. Genomics	DEC	2014	289	6					1267	1274		10.1007/s00438-014-0887-4		8	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	AU0RW	WOS:000345332800020		
J	Viborg, AH; Fredslund, F; Katayama, T; Nielsen, SK; Svensson, B; Kitaoka, M; Lo Leggio, L; Abou Hachem, M				Viborg, Alexander Holm; Fredslund, Folmer; Katayama, Takane; Nielsen, Stinne Kirketerp; Svensson, Birte; Kitaoka, Motomitsu; Lo Leggio, Leila; Abou Hachem, Maher			A beta 1-6/beta 1-3 galactosidase from Bifidobacterium animalis subsp lactis Bl-04 gives insight into sub-specificities of beta-galactoside catabolism within Bifidobacterium	MOLECULAR MICROBIOLOGY			English	Article							HUMAN-MILK OLIGOSACCHARIDES; HUMAN GUT MICROBIOTA; PROBIOTIC STRAINS; ESCHERICHIA-COLI; OPERON INDUCER; FERMENTED MILK; MARSUPIAL-MILK; DOUBLE-BLIND; LACTOBACILLUS; GALACTOOLIGOSACCHARIDES	The Bifidobacterium genus harbours several health promoting members of the gut microbiota. Bifidobacteria display metabolic specialization by preferentially utilizing dietary or host-derived -galactosides. This study investigates the biochemistry and structure of a glycoside hydrolase family 42 (GH42) -galactosidase from the probiotic Bifidobacterium animalis subsp. lactisBl-04 (BlGal42A). BlGal42A displays a preference for undecorated 1-6 and 1-3 linked galactosides and populates a phylogenetic cluster with close bifidobacterial homologues implicated in the utilization of N-acetyl substituted 1-3 galactosides from human milk and mucin. A long loop containing an invariant tryptophan in GH42, proposed to bind substrate at subsite +1, is identified here as specificity signature within this clade of bifidobacterial enzymes. Galactose binding at the subsite -1 of the active site induced conformational changes resulting in an extra polar interaction and the ordering of a flexible loop that narrows the active site. The amino acid sequence of this loop provides an additional specificity signature within this GH42 clade. The phylogenetic relatedness of enzymes targeting 1-6 and 1-3 galactosides likely reflects structural differences between these substrates and 1-4 galactosides, containing an axial galactosidic bond. These data advance our molecular understanding of the evolution of sub-specificities that support metabolic specialization in the gut niche.	[Viborg, Alexander Holm; Fredslund, Folmer; Svensson, Birte; Abou Hachem, Maher] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Katayama, Takane] Ishikawa Prefectural Univ, Nonoichi, Ishikawa 9218836, Japan; [Nielsen, Stinne Kirketerp; Lo Leggio, Leila] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen O, Denmark; [Kitaoka, Motomitsu] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	Lo Leggio, L (reprint author), Univ Copenhagen, Dept Chem, DK-2100 Copenhagen O, Denmark.	leila@chem.ku.dk; maha@bio.dtu.dk	Lo Leggio, Leila/B-4287-2015	Lo Leggio, Leila/0000-0002-5135-0882	Danish Strategic Research Council; The Technical University of Denmark; The Idella Foundation; Scandinavia-Japan Sasakawa Foundation; The Danish Ministry of Higher Education and Science through Instrument Center DANSCATT; European Community's Seventh Framework Programme under BioStruct-X [283570]	This work is supported by the FoSu grant from the Danish Strategic Research Council to the project 'Gene discovery and molecular interactions in prebiotics/probiotics systems. Focus on carbohydrate prebiotics', and a PhD stipend (AHV) from The Technical University of Denmark. The Idella Foundation and the Scandinavia-Japan Sasakawa Foundation funded travel support to Japan (AHV). The Danish Ministry of Higher Education and Science through the Instrument Center DANSCATT and the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (grant agreement No283570) funded travel to synchrotrons.	Andersen JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-312; Andersen JM, 2011, P NATL ACAD SCI USA, V108, P17785, DOI 10.1073/pnas.1114152108; Masco L, 2005, INT J FOOD MICROBIOL, V102, P221, DOI 10.1016/j.ijfoodmicro.2004.11.018; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Turroni F, 2009, APPL ENVIRON MICROB, V75, P1534, DOI 10.1128/AEM.02216-08; Han NS, 2012, BIOTECHNOL ADV, V30, P1268, DOI 10.1016/j.biotechadv.2011.11.003; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Lee JH, 2010, MICROBIOL MOL BIOL R, V74, P378, DOI 10.1128/MMBR.00004-10; Gibson GR, 2004, NUTR RES REV, V17, P259, DOI 10.1079/NRR200479; Ventura M, 2007, INT J FOOD MICROBIOL, V120, P2, DOI 10.1016/j.ijfoodmicro.2007.06.011; Hidaka M, 2002, J MOL BIOL, V322, P79, DOI 10.1016/S0022-2836(02)00746-5; Maksimainen M, 2012, FEBS J, V279, P1788, DOI 10.1111/j.1742-4658.2012.08555.x; Nishimoto M, 2009, CARBOHYD RES, V344, P2573, DOI 10.1016/j.carres.2009.09.031; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Cardelle-Cobas A, 2011, INT J FOOD MICROBIOL, V149, P81, DOI 10.1016/j.ijfoodmicro.2011.05.026; Garrido D, 2013, FOOD MICROBIOL, V33, P262, DOI 10.1016/j.fm.2012.10.003; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Morgan XC, 2013, TRENDS GENET, V29, P51, DOI 10.1016/j.tig.2012.09.005; MCNEIL M, 1984, ANNU REV BIOCHEM, V53, P625; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Guyonnet D, 2009, J DIG DIS, V10, P61, DOI 10.1111/j.1751-2980.2008.00366.x; Vincken JP, 2003, PLANT PHYSIOL, V132, P1781, DOI 10.1104/pp.103.022350; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Marteau P, 2002, ALIMENT PHARM THERAP, V16, P587, DOI 10.1046/j.1365-2036.2002.01188.x; Urashima T, 2001, GLYCOCONJUGATE J, V18, P357, DOI 10.1023/A:1014881913541; Meile L, 1997, SYST APPL MICROBIOL, V20, P57; Wheatley RW, 2013, J BIOL CHEM, V288, P12993, DOI 10.1074/jbc.M113.455436; Loquasto JR, 2013, APPL ENVIRON MICROB, V79, P6903, DOI 10.1128/AEM.01777-13; Jensen PH, 2010, FEBS J, V277, P81, DOI 10.1111/j.1742-4658.2009.07429.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; Urashima T, 2013, BIOSCI BIOTECH BIOCH, V77, P455, DOI 10.1271/bbb.120810; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Yoshida E, 2012, GLYCOBIOLOGY, V22, P361, DOI 10.1093/glycob/cwr116; Bunkoczi G, 2011, ACTA CRYSTALLOGR D, V67, P303, DOI 10.1107/S0907444910051218; Rizzardini G, 2012, BRIT J NUTR, V107, P876, DOI 10.1017/S000711451100420X; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Barrangou R, 2009, J BACTERIOL, V191, P4144, DOI 10.1128/JB.00155-09; Hinz SWA, 2004, APPL MICROBIOL BIOT, V66, P276, DOI 10.1007/s00253-004-1745-9; Ernst HA, 2006, J MOL BIOL, V358, P1106, DOI 10.1016/j.jmb.2006.02.056; Pokusaeva K, 2011, GENES NUTR, V6, P285, DOI 10.1007/s12263-010-0206-6; Cantarel BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028742; COLLINS JG, 1981, CARBOHYD RES, V92, P136; Davis LMG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025200; Goulas T, 2009, APPL MICROBIOL BIOT, V82, P1079, DOI 10.1007/s00253-008-1795-5; Huber RE, 2003, BIOCHEMISTRY-US, V42, P1796, DOI 10.1021/bi0270642; Juers DH, 2001, BIOCHEMISTRY-US, V40, P14781, DOI 10.1021/bi011727i; Le Nours J, 2009, PROTEINS, V75, P977, DOI 10.1002/prot.22310; MESSER M, 1980, CARBOHYD RES, V83, P327, DOI 10.1016/S0008-6215(00)84545-0; Nakajima M, 2009, J BIOL CHEM, V284, P19220, DOI 10.1074/jbc.M109.007666; Nihira T, 2007, ANAL BIOCHEM, V371, P259, DOI 10.1016/j.ab.2007.07.012; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2101, DOI 10.1271/bbb.70320; Peacock KS, 2013, J AGR FOOD CHEM, V61, P12612, DOI 10.1021/jf403789r; Peric-Hassler L, 2010, CARBOHYD RES, V345, P1781, DOI 10.1016/j.carres.2010.05.026; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Turroni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036957; Turroni Francesca, 2011, Gut Microbes, V2, P183; Van Laere KMJ, 2000, APPL ENVIRON MICROB, V66, P1379, DOI 10.1128/AEM.66.4.1379-1384.2000; Viborg AH, 2014, GLYCOBIOLOGY, V24, P208, DOI 10.1093/glycob/cwt104; Wall R, 2008, ISME J, V2, P83, DOI 10.1038/ismej.2007.69	64	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0950-382X	1365-2958		MOL MICROBIOL	Mol. Microbiol.	DEC	2014	94	5					1024	1040		10.1111/mmi.12815		17	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	AU4PX	WOS:000345595100004		
J	Hemmi, S; Kurokawa, K; Nagai, T; Murakami, T; Sunada, Y				Hemmi, Shoji; Kurokawa, Katsumi; Nagai, Taiji; Murakami, Tatsufumi; Sunada, Yoshihide			A NOVEL METHOD TO MEASURE SENSORY NERVE CONDUCTION OF THE SUPRACLAVICULAR NERVE	MUSCLE & NERVE			English	Article						clavicle; sensory nerve action potential; sensory nerve conduction; sternoclavicular joint; supraclavicular nerve	MIDSHAFT CLAVICLE FRACTURES; ENTRAPMENT; FIXATION	Introduction: In this report we describe a reliable method for recording sensory nerve action potentials (SNAPs) of the supraclavicular nerve. Methods: Supraclavicular SNAPs were recorded by placing a surface active electrode at the posterior border of the sternocleidomastoid muscle at a distance of 6 cm from the sternoclavicular joint. The nerve was stimulated at the lower border of the clavicle 4.5 cm lateral to the sternoclavicular joint. Results: Supraclavicular SNAPs were recorded bilaterally from 20 healthy volunteers. Mean onset latency was 1.0 +/- 0.2 ms, and mean peak latency was 1.4 +/- 0.3 ms. Mean baseline-to-peak amplitude for the SNAPs was 6.1 +/- 2.2 mu V, and mean maximum conduction velocity was 59.8 +/- 6.2 m/s. The mean percentage of side-to-side difference in amplitude was 12.9 +/- 11.0%. Conclusions: Supraclavicular SNAPs could be obtained in all normal subjects. Assessment of supraclavicular nerve conduction is very useful in the diagnosis of supraclavicular neuropathy Muscle Nerve 50: 1005-1007, 2014	[Hemmi, Shoji; Kurokawa, Katsumi; Nagai, Taiji; Murakami, Tatsufumi; Sunada, Yoshihide] Kawasaki Med Univ, Dept Neurol, Kurashiki, Okayama 7010192, Japan	Hemmi, S (reprint author), Kawasaki Med Univ, Dept Neurol, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	shojihemmi@yahoo.co.jp					Shen WJ, 1999, INJURY, V30, P497, DOI 10.1016/S0020-1383(99)00140-0; Canadian Orthopaedic Trauma Society, 2007, J BONE JOINT SURG AM, V89, P1, DOI [10.2106/JBJS.F.00020, DOI 10.2106/JBJS.F.00020]; Douchamps F, 2012, JOINT BONE SPINE, V79, P88, DOI 10.1016/j.jbspin.2011.09.009; Havet E, 2007, SURG RADIOL ANAT, V29, P605, DOI 10.1007/s00276-007-0258-5; Lee HJ, 2004, MUSCLE NERVE, V29, P878, DOI 10.1002/mus.20023; Mehta A, 1997, INJURY, V28, P491, DOI 10.1016/S0020-1383(97)00041-7; Nathe T, 2011, CLIN ORTHOP RELAT R, V469, P890, DOI 10.1007/s11999-010-1608-x; O'Neill K, 2012, J ORTHOP TRAUMA, V26, pE63, DOI 10.1097/BOT.0b013e31822c0796; Oh SJ, 2003, CLIN ELECTROMYOGRAPH, P25; Strauss EJ, 2007, J SHOULDER ELB SURG, V16, P280, DOI 10.1016/j.jse.2006.08.012; Therimadasamy A, 2012, MUSCLE NERVE, V45, P603, DOI 10.1002/mus.23237; Tubbs RS, 2006, CLIN ANAT, V19, P599, DOI 10.1002/ca.20208	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0148-639X	1097-4598		MUSCLE NERVE	Muscle Nerve	DEC	2014	50	6					1005	1007		10.1002/mus.24335		3	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AU3IX	WOS:000345507100020		
J	Yao, ZS; Mito, M; Kamachi, T; Shiota, Y; Yoshizawa, K; Azuma, N; Miyazaki, Y; Takahashi, K; Zhang, KR; Nakanishi, T; Kang, S; Kanegawa, S; Sato, O				Yao, Zi-Shuo; Mito, Masaki; Kamachi, Takashi; Shiota, Yoshihito; Yoshizawa, Kazunari; Azuma, Nobuaki; Miyazaki, Yuji; Takahashi, Kazuyuki; Zhang, Kuirun; Nakanishi, Takumi; Kang, Soonchul; Kanegawa, Shinji; Sato, Osamu			Molecular motor-driven abrupt anisotropic shape change in a single crystal of a Ni complex	NATURE CHEMISTRY			English	Article							NEGATIVE THERMAL-EXPANSION; FRAMEWORK MATERIAL; MACHINES; MOTION; TEMPERATURE; ENVIRONMENT; MUSCLE; ANALOG; LIGHT	Many molecular machines with controllable molecular-scale motors have been developed. However, transmitting molecular movement to the macroscopic scale remains a formidable challenge. Here we report a single crystal of a Ni complex whose shape changes abruptly and reversibly in response to thermal changes at around room temperature. Variable-temperature single-crystal X-ray diffraction studies show that the crystalline shape change is induced by an unusual 90 degrees rotation of uniaxially aligned oxalate molecules. The oxalate dianions behave as molecular-scale rotors, with their movement propagated through the entire crystalline material via intermolecular hydrogen bonding. Consequently, the subnanometrescale changes in the oxalate molecules are instantly amplified to a micrometre-scale contraction or expansion of the crystal, accompanied by a thermal hysteresis loop. The shape change in the crystal was clearly detected under an optical microscope. The large directional deformation and prompt response suggest a role for this material in microscale or nanoscale thermal actuators.	[Yao, Zi-Shuo; Zhang, Kuirun; Nakanishi, Takumi; Kang, Soonchul; Kanegawa, Shinji; Sato, Osamu] Kyushu Univ, Inst Mat Chem & Engn, Fukuoka 8168580, Japan; [Mito, Masaki] Kyushu Inst Technol, Fac Engn, Kitakyushu, Fukuoka 8048550, Japan; [Kamachi, Takashi; Shiota, Yoshihito; Yoshizawa, Kazunari] Kyushu Univ, Inst Mat Chem & Engn, Nishi Ku, Fukuoka 8190395, Japan; [Azuma, Nobuaki; Miyazaki, Yuji] Osaka Univ, Grad Sch Sci, Res Ctr Struct Thermodynam, Toyonaka, Osaka 5600043, Japan; [Takahashi, Kazuyuki] Kobe Univ, Grad Sch Sci, Dept Chem, Kobe, Hyogo 6578501, Japan	Sato, O (reprint author), Kyushu Univ, Inst Mat Chem & Engn, 6-1 Kasuga Koen, Fukuoka 8168580, Japan.	sato@cm.kyushu-u.ac.jp	Takahashi, Kazuyuki/G-1756-2011; Kang, Soonchul/N-9537-2015	Takahashi, Kazuyuki/0000-0002-1776-4416; Kang, Soonchul/0000-0003-2580-7241	MEXT (Japan) [26104528]; China Scholarship Council	This work was supported by a KAKEN on Innovative Areas ('Soft Molecular Systems' Area 2503, No. 26104528) from MEXT (Japan). Z-S.Y. thanks the China Scholarship Council for support.	Garcia-Garibay MA, 2007, ANGEW CHEM INT EDIT, V46, P8945, DOI 10.1002/anie.200702443; Hosono N, 2010, SCIENCE, V330, P808, DOI 10.1126/science.1195302; Steiner T, 2002, ANGEW CHEM INT EDIT, V41, P48, DOI 10.1002/1521-3773(20020104)41:1<48::AID-ANIE48>3.0.CO;2-U; Sokolov AN, 2008, P NATL ACAD SCI USA, V105, P1794, DOI 10.1073/pnas.0706117105; Yu YL, 2003, NATURE, V425, P145, DOI 10.1038/425145a; Das D, 2010, NAT MATER, V9, P36, DOI [10.1038/nmat2583, 10.1038/NMAT2583]; Goodwin AL, 2005, J AM CHEM SOC, V127, P17980, DOI 10.1021/ja056460f; Browne WR, 2006, NAT NANOTECHNOL, V1, P25, DOI 10.1038/nnano.2006.45; Wu Y, 2008, ANGEW CHEM INT EDIT, V47, P8929, DOI 10.1002/anie.200803925; Badjic JD, 2004, SCIENCE, V303, P1845, DOI 10.1126/science.1094791; Padmanabhan M, 2008, J MOL STRUCT, V885, P36, DOI 10.1016/j.molstruc.2007.10.012; Birkedal H, 2002, ANGEW CHEM INT EDIT, V41, P754, DOI 10.1002/1521-3773(20020301)41:5<754::AID-ANIE754>3.0.CO;2-R; Shen XY, 2013, NAT CHEM, V5, P1035, DOI [10.1038/nchem.1780, 10.1038/NCHEM.1780]; Fortes AD, 2011, SCIENCE, V331, P742, DOI 10.1126/science.1198640; Margadonna S, 2004, J AM CHEM SOC, V126, P15390, DOI 10.1021/ja044959o; Nath NK, 2014, CRYSTENGCOMM, V16, P1850, DOI 10.1039/c3ce41313f; Horike S, 2009, NAT CHEM, V1, P695, DOI [10.1038/nchem.444, 10.1038/NCHEM.444]; Iamsaard S, 2014, NAT CHEM, V6, P229, DOI [10.1038/nchem.1859, 10.1038/NCHEM.1859]; Coskun A, 2012, CHEM SOC REV, V41, P19, DOI 10.1039/c1cs15262a; LANGE CW, 1992, J AM CHEM SOC, V114, P4220, DOI 10.1021/ja00037a027; KUME Y, 1992, J PHYS CHEM SOLIDS, V53, P1297, DOI 10.1016/0022-3697(92)90249-D; Ma MM, 2013, SCIENCE, V339, P186, DOI 10.1126/science.1230262; Goodwin AL, 2010, NAT MATER, V9, P7, DOI 10.1038/nmat2597; Irie M, 2008, B CHEM SOC JPN, V81, P917, DOI 10.1246/bcsj.81.917; Vogelsberg CS, 2012, CHEM SOC REV, V41, P1892, DOI 10.1039/c1cs15197e; van Delden RA, 2002, P NATL ACAD SCI USA, V99, P4945, DOI 10.1073/pnas.062660699; Bruns CJ, 2013, NAT NANOTECHNOL, V8, P9, DOI 10.1038/nnano.2012.239; Chen CL, 2005, ANGEW CHEM INT EDIT, V44, P6673, DOI 10.1002/anie.200502309; Kobatake S, 2007, NATURE, V446, P778, DOI 10.1038/nature05669; Du GY, 2012, ANGEW CHEM INT EDIT, V51, P12504, DOI 10.1002/anie.201206571; Kay ER, 2007, ANGEW CHEM INT EDIT, V46, P72, DOI 10.1002/anie.200504313; Hayami S, 2001, J AM CHEM SOC, V123, P11644, DOI 10.1021/ja0017920; Goodwin AL, 2008, SCIENCE, V319, P794, DOI 10.1126/science.1151442; Eelkema R, 2006, NATURE, V440, P163, DOI 10.1038/440163a; Vukotic VN, 2012, NAT CHEM, V4, P456, DOI [10.1038/nchem.1354, 10.1038/NCHEM.1354]; Ichikawa M, 1996, J MOL STRUCT, V378, P17, DOI 10.1016/0022-2860(95)09144-0; Zhou HL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3534	37	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1755-4330	1755-4349		NAT CHEM	Nat. Chem.	DEC	2014	6	12					1079	1083		10.1038/NCHEM.2092		5	Chemistry, Multidisciplinary	Chemistry	AU2EN	WOS:000345429200015		
J	Totoki, Y; Tatsuno, K; Covington, KR; Ueda, H; Creighton, CJ; Kato, M; Tsuji, S; Donehower, LA; Slagle, BL; Nakamura, H; Yamamoto, S; Shinbrot, E; Hama, N; Lehmkuhl, M; Hosoda, F; Arai, Y; Walker, K; Dahdouli, M; Gotoh, K; Nagae, G; Gingras, MC; Muzny, DM; Ojima, H; Shimada, K; Midorikawa, Y; Goss, JA; Cotton, R; Hayashi, A; Shibahara, J; Ishikawa, S; Guiteau, J; Tanaka, M; Urushidate, T; Ohashi, S; Okada, N; Doddapaneni, H; Wang, M; Zhu, YM; Dinh, H; Okusaka, T; Kokudo, N; Kosuge, T; Takayama, T; Fukayama, M; Gibbs, RA; Wheeler, DA; Aburatani, H; Shibata, T				Totoki, Yasushi; Tatsuno, Kenji; Covington, Kyle R.; Ueda, Hiroki; Creighton, Chad J.; Kato, Mamoru; Tsuji, Shingo; Donehower, Lawrence A.; Slagle, Betty L.; Nakamura, Hiromi; Yamamoto, Shogo; Shinbrot, Eve; Hama, Natsuko; Lehmkuhl, Megan; Hosoda, Fumie; Arai, Yasuhito; Walker, Kim; Dahdouli, Mahmoud; Gotoh, Kengo; Nagae, Genta; Gingras, Marie-Claude; Muzny, Donna M.; Ojima, Hidenori; Shimada, Kazuaki; Midorikawa, Yutaka; Goss, John A.; Cotton, Ronald; Hayashi, Akimasa; Shibahara, Junji; Ishikawa, Shumpei; Guiteau, Jacfranz; Tanaka, Mariko; Urushidate, Tomoko; Ohashi, Shoko; Okada, Naoko; Doddapaneni, Harsha; Wang, Min; Zhu, Yiming; Huyen Dinh; Okusaka, Takuji; Kokudo, Norihiro; Kosuge, Tomoo; Takayama, Tadatoshi; Fukayama, Masashi; Gibbs, Richard A.; Wheeler, David A.; Aburatani, Hiroyuki; Shibata, Tatsuhiro			Trans-ancestry mutational landscape of hepatocellular carcinoma genomes	NATURE GENETICS			English	Article							SOMATIC MUTATIONS; CANCER GENOME; SUSCEPTIBILITY LOCUS; RECURRENT MUTATIONS; ACTIVATOR PROTEIN; WIDE ASSOCIATION; TELOMERASE; COMPLEX; TUMORS; GENES	Diverse epidemiological factors are associated with hepatocellular carcinoma (HCC) prevalence in different populations. However, the global landscape of the genetic changes in HCC genomes underpinning different epidemiological and ancestral backgrounds still remains uncharted. Here a collection of data from 503 liver cancer genomes from different populations uncovered 30 candidate driver genes and 11 core pathway modules. Furthermore, a collaboration of two large-scale cancer genome projects comparatively analyzed the trans-ancestry substitution signatures in 608 liver cancer cases and identified unique mutational signatures that predominantly contribute to Asian cases. This work elucidates previously unexplored ancestry-associated mutational processes in HCC development. A combination of hotspot TERT promoter mutation, TERT focal amplification and viral genome integration occurs in more than 68% of cases, implicating TERT as a central and ancestry-independent node of hepatocarcinogenesis. Newly identified alterations in genes encoding metabolic enzymes, chromatin remodelers and a high proportion of mTOR pathway activations offer potential therapeutic and diagnostic opportunities.	[Totoki, Yasushi; Kato, Mamoru; Nakamura, Hiromi; Hama, Natsuko; Hosoda, Fumie; Arai, Yasuhito; Urushidate, Tomoko; Ohashi, Shoko; Okada, Naoko; Shibata, Tatsuhiro] Natl Canc Ctr, Res Inst, Div Canc Genom, Tokyo 104, Japan; [Tatsuno, Kenji; Ueda, Hiroki; Tsuji, Shingo; Yamamoto, Shogo; Gotoh, Kengo; Nagae, Genta; Hayashi, Akimasa; Aburatani, Hiroyuki] Univ Tokyo, Adv Sci & Technol Res Ctr, Genome Sci Div, Tokyo 113, Japan; [Covington, Kyle R.; Creighton, Chad J.; Shinbrot, Eve; Lehmkuhl, Megan; Walker, Kim; Dahdouli, Mahmoud; Gingras, Marie-Claude; Muzny, Donna M.; Doddapaneni, Harsha; Wang, Min; Zhu, Yiming; Huyen Dinh; Gibbs, Richard A.; Wheeler, David A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Creighton, Chad J.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Donehower, Lawrence A.; Slagle, Betty L.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Ojima, Hidenori] Natl Canc Ctr, Res Inst, Div Mol Pathol, Tokyo 104, Japan; [Shimada, Kazuaki; Kosuge, Tomoo] Natl Canc Ctr, Hepatobiliary & Pancreat Surg Div, Tokyo, Japan; [Midorikawa, Yutaka; Takayama, Tadatoshi] Nihon Univ, Sch Med, Dept Digest Surg, Tokyo, Japan; [Goss, John A.; Cotton, Ronald; Guiteau, Jacfranz] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA; [Hayashi, Akimasa; Shibahara, Junji; Ishikawa, Shumpei; Tanaka, Mariko; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan; [Okusaka, Takuji] Natl Canc Ctr, Hepatobiliary & Pancreat Oncol Div, Tokyo, Japan; [Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan; [Shibata, Tatsuhiro] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan	Wheeler, DA (reprint author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.	wheeler@bcm.edu; haburata-tky@umin.ac.jp; tashibat@ncc.go.jp	Tatsuno, Kenji/B-1765-2008		Ministry of Health, Labour and Welfare of Japan; US National Human Genome Research Institute (NHGRI) [5U541-IG003273]; National Cancer Institute (NCI) [HHSN261201000053C, P30 CA125123]; National Institute of Biomedical Innovation (NIBIO, Japan); National Cancer Center Research and Development Funds (Japan) [23-A-8]	This study was supported by Grants-in-Aid from the Ministry of Health, Labour and Welfare of Japan for the third-term Comprehensive 10-Year Strategy for Cancer Control, grants from the US National Human Genome Research Institute (NHGRI; 5U541-IG003273) and National Cancer Institute (NCI; HHSN261201000053C and P30 CA125123), the Program for Promotion of Fundamental Studies in Health Sciences from the National Institute of Biomedical Innovation (NIBIO, Japan) and the National Cancer Center Research and Development Funds (23-A-8, Japan). The National Cancer Center Biobank is supported by the National Cancer Center Research and Development Fund, Japan. The supercomputing resource SHIROKANE was provided by the Human Genome Center at the University of Tokyo (http://sc.hgc.jp/shirokane.html).	Kan ZY, 2013, GENOME RES, V23, P1422, DOI 10.1101/gr.154492.113; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; Tanaka K, 2000, CANCER RES, V60, P5106; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Keng VW, 2013, HEPATOLOGY, V57, P120, DOI 10.1002/hep.26004; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Pai R, 2008, CANCER RES, V68, P5086, DOI 10.1158/0008-5472.CAN-07-2325; Yu J, 2013, SEMIN CANCER BIOL, V23, P483, DOI 10.1016/j.semcancer.2013.07.003; Li YH, 2014, CANCER RES, V74, P1639, DOI 10.1158/0008-5472.CAN-13-3568; Tetsu O, 1999, NATURE, V398, P422; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Eissenberg JC, 2005, MOL CELL BIOL, V25, P6559, DOI 10.1128/MCB.25.15.6559-6569.2005; Wang K, 2013, HEPATOLOGY, V58, P706, DOI 10.1002/hep.26402; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Hood RL, 2012, AM J HUM GENET, V90, P308, DOI 10.1016/j.ajhg.2011.12.001; GOEDDE HW, 1983, AM J HUM GENET, V35, P769; Augustine MM, 2014, SURG ONCOL CLIN N AM, V23, P171, DOI 10.1016/j.soc.2013.10.001; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; EI-Serag H.B, 2012, GASTROENTEROLOGY, V142, P1264; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Monroy MA, 2003, MOL ENDOCRINOL, V17, P2519, DOI 10.1210/me.2003-0208; Nault JC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3218; Nelson RA, 2009, AM J MED GENET A, V149A, P2265, DOI 10.1002/ajmg.a.33014; Poon S.L., 2013, SCI TRANSL MED, V5; Song LN, 2008, J BIOL CHEM, V283, P25988, DOI 10.1074/jbc.M800325200	39	18	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2014	46	12					1267	1273		10.1038/ng.3126		7	Genetics & Heredity	Genetics & Heredity	AU3YU	WOS:000345547300007		
J	von Mentzer, A; Connor, TR; Wieler, LH; Semmler, T; Iguchi, A; Thomson, NR; Rasko, DA; Joffre, E; Corander, J; Pickard, D; Wiklund, G; Svennerholm, AM; Sjoling, A; Dougan, G				von Mentzer, Astrid; Connor, Thomas R.; Wieler, Lothar H.; Semmler, Torsten; Iguchi, Atsushi; Thomson, Nicholas R.; Rasko, David A.; Joffre, Enrique; Corander, Jukka; Pickard, Derek; Wiklund, Gudrun; Svennerholm, Ann-Mari; Sjoling, Asa; Dougan, Gordon			Identification of enterotoxigenic Escherichia coli (ETEC) clades with long-term global distribution	NATURE GENETICS			English	Article							COLONIZATION FACTOR; VIRULENCE FACTORS; STRAINS; DIARRHEA; TRANSMISSION; EPIDEMIOLOGY; EXPRESSION; EVOLUTION; COUNTRIES; PLASMIDS	Enterotoxigenic Escherichia coli (ETEC), a major cause of infectious diarrhea, produce heat-stable and/or heat-labile enterotoxins and at least 25 different colonization factors that target the intestinal mucosa. The genes encoding the enterotoxins and most of the colonization factors are located on plasmids found across diverse E. coli serogroups. Whole-genome sequencing of a representative collection of ETEC isolated between 1980 and 2011 identified globally distributed lineages characterized by distinct colonization factor and enterotoxin profiles. Contrary to current notions, these relatively recently emerged lineages might harbor chromosome and plasmid combinations that optimize fitness and transmissibility. These data have implications for understanding, tracking and possibly preventing ETEC disease.	[von Mentzer, Astrid; Joffre, Enrique; Wiklund, Gudrun; Svennerholm, Ann-Mari; Sjoling, Asa] Univ Gothenburg, Sahlgrenska Acad, Dept Microbiol & Immunol, Gothenburg, Sweden; [von Mentzer, Astrid; Connor, Thomas R.; Thomson, Nicholas R.; Pickard, Derek; Dougan, Gordon] Wellcome Trust Sanger Inst, Hinxton, England; [Connor, Thomas R.] Cardiff Univ, Sch Biosci, Organisms & Environm Div, Cardiff CF10 3AX, S Glam, Wales; [Wieler, Lothar H.; Semmler, Torsten] Free Univ Berlin, Ctr Infect Med, Inst Microbiol & Epizoot, Berlin, Germany; [Iguchi, Atsushi] Miyazaki Univ, Interdisciplinary Res Org, Miyazaki, Japan; [Rasko, David A.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Corander, Jukka] Univ Helsinki, Dept Math & Stat, Helsinki, Finland; [Sjoling, Asa] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	von Mentzer, A (reprint author), Univ Gothenburg, Sahlgrenska Acad, Dept Microbiol & Immunol, Gothenburg, Sweden.	astrid.von.mentzer@gu.se; ann-mari.svennerholm@microbio.gu.se; asa.sjoling@ki.se; gdl@sanger.ac.uk		Connor, Thomas/0000-0003-2394-6504; David, Rasko/0000-0002-7337-7154	Wellcome Trust [098051]; Swedish Research Council [2012-3464, 2011-3435]; Swedish Strategic Foundation [SB12-0072]; European Research Council [239784]	This work was supported by the Wellcome Trust (grant 098051), the Swedish Research Council (grants 2012-3464 and 2011-3435), the Swedish Strategic Foundation (grant SB12-0072) and the European Research Council (grant 239784).	Svennerholm AM, 2012, EXPERT REV VACCINES, V11, P495, DOI [10.1586/erv.12.12, 10.1586/ERV.12.12]; Okoro CK, 2012, NAT GENET, V44, P1215, DOI 10.1038/ng.2423; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369; HERZER PJ, 1990, J BACTERIOL, V172, P6175; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Pupo GM, 1997, INFECT IMMUN, V65, P2685; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Isidean SD, 2011, VACCINE, V29, P6167, DOI 10.1016/j.vaccine.2011.06.084; Sahl JW, 2011, INFECT IMMUN, V79, P950, DOI 10.1128/IAI.00932-10; Wolf MK, 1997, CLIN MICROBIOL REV, V10, P569; Sabui S, 2010, J MED MICROBIOL, V59, P770, DOI 10.1099/jmm.0.017582-0; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Froehlich B, 2005, J BACTERIOL, V187, P6509, DOI 10.1128/JB187.18.6509-6516.2005; Darsley MJ, 2012, CLIN VACCINE IMMUNOL, V19, P1921, DOI 10.1128/CVI.00364-12; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Didelot X, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r118; Walker CLF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-220; Grossman L.C, 2010, J BACTERIOL, V192, P5822; Lasaro MA, 2009, FEMS IMMUNOL MED MIC, V55, P93, DOI 10.1111/j.1574-695X.2008.00506.x; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Regua-Mangia AH, 2004, FEMS IMMUNOL MED MIC, V40, P155, DOI 10.1016/S0928-8244(03)00308-0; Rodrigues J, 1996, INFECT IMMUN, V64, P2680; Sahl JW, 2012, INFECT IMMUN, V80, P1232, DOI 10.1128/IAI.06138-11; SMITH HW, 1973, P ROY SOC MED, V66, P272; Steinsland H, 2010, J CLIN MICROBIOL, V48, P2916, DOI 10.1128/JCM.02432-09; Steinsland H, 2004, J CLIN MICROBIOL, V42, P3100, DOI 10.1128/JCM.42.7.3100-3107.2004; Turner SM, 2006, J CLIN MICROBIOL, V44, P4528, DOI 10.1128/JCM.01474-06; Valvatne H, 2002, APMIS, V110, P665, DOI 10.1034/j.1600-0463.2002.1100911.x; World Health Organization, 2009, DIARRH DIS	32	5	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2014	46	12					1321	1326		10.1038/ng.3145		6	Genetics & Heredity	Genetics & Heredity	AU3YU	WOS:000345547300013		
J	Dunstan, SJ; Hue, NT; Han, B; Li, Z; Tram, TTB; Sim, KS; Parry, CM; Chinh, NT; Vinh, H; Lan, NPH; Thieu, NTV; Vinh, PV; Koirala, S; Dongol, S; Arjyal, A; Karkey, A; Shilpakar, O; Dolecek, C; Foo, JN; Phuong, LT; Lanh, MN; Do, T; Aung, T; Hon, DN; Teo, YY; Hibberd, ML; Anders, KL; Okada, Y; Raychaudhuri, S; Simmons, CP; Baker, S; de Bakker, PIW; Basnyat, B; Hien, TT; Farrar, JJ; Khor, CC				Dunstan, Sarah J.; Nguyen Thi Hue; Buhm Han; Li, Zheng; Trinh Thi Bich Tram; Sim, Kar Seng; Parry, Christopher M.; Nguyen Tran Chinh; Ha Vinh; Nguyen Phu Huong Lan; Nga Tran Vu Thieu; Phat Voong Vinh; Koirala, Samir; Dongol, Sabina; Arjyal, Amit; Karkey, Abhilasha; Shilpakar, Olita; Dolecek, Christiane; Foo, Jia Nee; Le Thi Phuong; Mai Ngoc Lanh; Tan Do; Aung, Tin; Do Nu Hon; Teo, Yik Ying; Hibberd, Martin L.; Anders, Katherine L.; Okada, Yukinori; Raychaudhuri, Soumya; Simmons, Cameron P.; Baker, Stephen; de Bakker, Paul I. W.; Basnyat, Buddha; Tran Tinh Hien; Farrar, Jeremy J.; Khor, Chiea Chuen			Variation at HLA-DRB1 is associated with resistance to enteric fever	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TYPHOID-FEVER; COMMON VARIANTS; SUSCEPTIBILITY LOCI; CLASS-II; HLA; SALMONELLA; DISEASE; REGION; HIV-1	Enteric fever affects more than 25 million people annually and results from systemic infection with Salmonella enterica serovar Typhi or Paratyphi pathovars A, B or C-1. We conducted a genome-wide association study of 432 individuals with blood culture-confirmed enteric fever and 2,011 controls from Vietnam. We observed strong association at rs7765379 (odds ratio (OR) for the minor allele = 0.18, P = 4.5 x 10(-10)), a marker mapping to the H LA class II region, in proximity to HLA-DQB1 and HLA-DRB1. We replicated this association in 595 enteric fever cases and 386 controls from Nepal and also in a second independent collection of 151 cases and 668 controls from Vietnam. Imputation-based fine-mapping across the extended MHC region showed that the classical HLA-DRB1*04:05 allele (OR = 0.14, P = 2.60 x 10(-11)) could entirely explain the association at rs7765379, thus implicating HLA-DRB1 as a major contributor to resistance against enteric fever, presumably through antigen presentation.	[Dunstan, Sarah J.; Nguyen Thi Hue; Trinh Thi Bich Tram; Parry, Christopher M.; Nga Tran Vu Thieu; Phat Voong Vinh; Dolecek, Christiane; Anders, Katherine L.; Simmons, Cameron P.; Baker, Stephen; Tran Tinh Hien; Farrar, Jeremy J.] Hosp Trop Dis, Oxford Univ Clin Res Unit, Ho Chi Minh City, Vietnam; [Dunstan, Sarah J.; Dolecek, Christiane; Anders, Katherine L.; Simmons, Cameron P.; Baker, Stephen; Farrar, Jeremy J.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Dunstan, Sarah J.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Nossal Inst Global Hlth, Melbourne, Vic, Australia; [Nguyen Thi Hue] Vietnam Natl Univ, Univ Sci, Fac Biol, Ho Chi Minh City, Vietnam; [Buhm Han] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Buhm Han; Raychaudhuri, Soumya] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Genet, Boston, MA 02115 USA; [Buhm Han; Raychaudhuri, Soumya] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Buhm Han; Raychaudhuri, Soumya] Partners Ctr Personalized Genet Med, Boston, MA USA; [Li, Zheng; Sim, Kar Seng; Foo, Jia Nee; Hibberd, Martin L.; Khor, Chiea Chuen] Genome Inst Singapore, Singapore, Singapore; [Parry, Christopher M.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Nguyen Tran Chinh; Ha Vinh; Nguyen Phu Huong Lan] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Koirala, Samir; Dongol, Sabina; Arjyal, Amit; Karkey, Abhilasha; Shilpakar, Olita; Basnyat, Buddha] Patan Hosp, Patan Acad Hlth Sci, Oxford Univ Clin Res Unit Nepal, Patan, Nepal; [Le Thi Phuong; Mai Ngoc Lanh] Dong Thap Prov Hosp, Cao Lanh, Vietnam; [Tan Do; Do Nu Hon] Vietnam Natl Inst Ophthalmol, Hanoi, Vietnam; [Aung, Tin; Khor, Chiea Chuen] Singapore Eye Res Inst, Singapore, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Teo, Yik Ying; Khor, Chiea Chuen] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Hibberd, Martin L.; Baker, Stephen] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Okada, Yukinori] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Genet & Dis Divers, Tokyo, Japan; [Okada, Yukinori] RIKEN Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Raychaudhuri, Soumya] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England; [Simmons, Cameron P.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Med Genet, Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands; [Khor, Chiea Chuen] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore 117595, Singapore; [Khor, Chiea Chuen] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore	Dunstan, SJ (reprint author), Hosp Trop Dis, Oxford Univ Clin Res Unit, Ho Chi Minh City, Vietnam.	sarah.dunstan@unimelb.edu.au; khorcc@gis.a-star.edu.sg	de Bakker, Paul/B-8730-2009; 	de Bakker, Paul/0000-0001-7735-7858; Dunstan, Sarah/0000-0001-7873-933X; Li, Zheng/0000-0002-7060-2213; Simmons, Cameron P./0000-0002-9039-7392; Farrar, Jeremy/0000-0002-2700-623X	Wellcome Trust, UK, Major Overseas Program in Viet Nam [089276/Z/09/Z]; Biomedical Research Council, Agency for Science, Technology and Research, Singapore; Wellcome Trust and the Royal Society [100087/Z/12/Z]; Netherlands Organization for Scientific Research (Vernieuwingsimpuls VIDI Award NWO) [016.126.354]	This work was supported by the Wellcome Trust, UK as part of their Major Overseas Program in Viet Nam (089276/Z/09/Z) and by the Biomedical Research Council, Agency for Science, Technology and Research, Singapore. S.B. is a Sir Henry Dale Fellow, jointly funded by the Wellcome Trust and the Royal Society (100087/Z/12/Z). P.I.W.d.B. acknowledges support from the Netherlands Organization for Scientific Research (Vernieuwingsimpuls VIDI Award NWO project number 016.126.354).	de Bakker PIW, 2010, NAT GENET, V42, P731, DOI 10.1038/ng0910-731; Freudenberg J, 2011, ARTHRITIS RHEUM-US, V63, P884, DOI 10.1002/art.30235; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Thye T, 2012, NAT GENET, V44, P257, DOI 10.1038/ng.1080; Cheminay C, 2005, J IMMUNOL, V174, P2892; Pillai NE, 2014, HUM MOL GENET, V23, P4443, DOI 10.1093/hmg/ddu149; Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Huang L, 2009, AM J HUM GENET, V85, P692, DOI 10.1016/j.ajhg.2009.09.017; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; Sfriso P, 2010, J LEUKOCYTE BIOL, V87, P385, DOI 10.1189/jlb.0709517; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Karlsson EK, 2014, NAT REV GENET, V15, P379, DOI 10.1038/nrg3734; Yamazaki K, 2013, GASTROENTEROLOGY, V144, P781, DOI 10.1053/j.gastro.2012.12.021; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Dunstan SJ, 2001, J INFECT DIS, V183, P261, DOI 10.1086/317940; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Karki S, 2013, CLIN INFECT DIS, V57, pE167, DOI 10.1093/cid/cit563; de Jong R, 1998, SCIENCE, V280, P1435; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Gockel I, 2014, NAT GENET, V46, P901, DOI 10.1038/ng.3029; Jantsch J, 2011, IMMUNOL REV, V240, P185, DOI 10.1111/j.1600-065X.2010.00981.x; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; McGregor AC, 2013, CURR OPIN INFECT DIS, V26, P254, DOI 10.1097/QCO.0b013e32835fb829; Buckle GC, 2010, J GLOB HLTH, V2; CVJETANO.B, 1971, B WORLD HEALTH ORGAN, V45, P53; Dharmana E, 2002, EUR J IMMUNOGENET, V29, P297, DOI 10.1046/j.1365-2370.2002.00318.x; Dunstan SJ, 2001, J INFECT DIS, V183, P1156, DOI 10.1086/319289; Dunstan SJ, 2007, HUM GENET, V122, P51, DOI 10.1007/s00439-007-0372-9; Fakiola M, 2013, NAT GENET, V45, P208, DOI 10.1038/ng.2518; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Khor CC, 2012, TRENDS GENET, V28, P233, DOI 10.1016/j.tig.2012.02.001; Kingsley RA, 2013, MBIO, V4, DOI 10.1128/mBio.00565-13; Malik-Kale P, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00125; Okada Y, 2014, HUM MOL GENET, V23, P6916, DOI 10.1093/hmg/ddu387; van den Bergh ETAM, 1999, TROP MED INT HEALTH, V4, P211; Wong VK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084567	43	6	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2014	46	12					1333	1336		10.1038/ng.3143		4	Genetics & Heredity	Genetics & Heredity	AU3YU	WOS:000345547300015		
J	Hirano, Y; Yasuma, T; Mizutani, T; Fowler, BJ; Tarallo, V; Yasuma, R; Kim, Y; Bastos-Carvalho, A; Kerur, N; Gelfand, BD; Bogdanovich, S; He, SK; Zhang, XH; Nozaki, M; Ijima, R; Kaneko, H; Ogura, Y; Terasaki, H; Nagai, H; Haro, I; Nunez, G; Ambati, BK; Hinton, DR; Ambati, J				Hirano, Yoshio; Yasuma, Tetsuhiro; Mizutani, Takeshi; Fowler, Benjamin J.; Tarallo, Valeria; Yasuma, Reo; Kim, Younghee; Bastos-Carvalho, Ana; Kerur, Nagaraj; Gelfand, Bradley D.; Bogdanovich, Sasha; He, Shikun; Zhang, Xiaohui; Nozaki, Miho; Ijima, Ryo; Kaneko, Hiroki; Ogura, Yuichiro; Terasaki, Hiroko; Nagai, Hiroshi; Haro, Isao; Nunez, Gabriel; Ambati, Balamurali K.; Hinton, David R.; Ambati, Jayakrishna			IL-18 is not therapeutic for neovascular age-related macular degeneration	NATURE MEDICINE			English	Letter							NLRP3 INFLAMMASOME; INTERLEUKIN-18; ANGIOGENESIS; MICE; DYSFUNCTION; INHIBITION; INDUCTION; MODELS; TARGET		[Hirano, Yoshio; Yasuma, Tetsuhiro; Fowler, Benjamin J.; Tarallo, Valeria; Yasuma, Reo; Kim, Younghee; Bastos-Carvalho, Ana; Kerur, Nagaraj; Gelfand, Bradley D.; Bogdanovich, Sasha; Ambati, Jayakrishna] Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA; [Mizutani, Takeshi; Nozaki, Miho; Ogura, Yuichiro] Nagoya City Univ, Grad Sch Med Sci, Dept Ophthalmol & Visual Sci, Nagoya, Aichi, Japan; [Tarallo, Valeria] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, I-80125 Naples, Italy; [Gelfand, Bradley D.] Univ Kentucky, Dept Biomed Engn, Lexington, KY USA; [Gelfand, Bradley D.] Univ Kentucky, Dept Microbiol Immunol & Human Genet, Lexington, KY USA; [He, Shikun; Hinton, David R.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [He, Shikun; Hinton, David R.] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA; [Zhang, Xiaohui; Ambati, Balamurali K.] Univ Utah, Sch Med, Dept Ophthalmol & Visual Sci, Moran Eye Ctr, Salt Lake City, UT USA; [Ijima, Ryo; Kaneko, Hiroki; Terasaki, Hiroko] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi 4648601, Japan; [Nagai, Hiroshi] Kobe Univ, Sch Med, Div Dermatol, Chuo Ku, Kobe, Hyogo 650, Japan; [Haro, Isao] Wakayama Med Univ, Dept Urol, Wakayama, Japan; [Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Nunez, Gabriel] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA; [Ambati, Balamurali K.] Vet Affairs Salt Lake City Healthcare Syst, Dept Ophthalmol, Salt Lake City, UT USA; [Ambati, Jayakrishna] Univ Kentucky, Dept Physiol, Lexington, KY USA	Hirano, Y (reprint author), Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA.	jamba2@email.uky.edu	Kaneko, Hiroki/O-7695-2015	Tarallo, Valeria/0000-0002-6920-4402; Kaneko, Hiroki/0000-0003-0731-6465			ABRAMI L, 1995, PFLUG ARCH EUR J PHY, V430, P447, DOI 10.1007/BF00373921; Ambati J, 2013, NAT REV IMMUNOL, V13, P438, DOI 10.1038/nri3459; Lavalette S, 2011, AM J PATHOL, V178, P2416, DOI 10.1016/j.ajpath.2011.01.013; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Woldbaek PR, 2005, AM J PHYSIOL-HEART C, V289, pH708, DOI 10.1152/ajpheart.01179.2004; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Platis A, 2008, PERFUSION-UK, V23, P237, DOI 10.1177/0267659108101511; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Grossniklaus HE, 2010, PROG RETIN EYE RES, V29, P500, DOI 10.1016/j.preteyeres.2010.05.003; Park CC, 2001, J IMMUNOL, V167, P1644; Tseng WA, 2013, INVEST OPHTH VIS SCI, V54, P110, DOI 10.1167/iovs.12-10655; Wahlsten D, 2003, J NEUROBIOL, V54, P283, DOI 10.1002/neu.10173; Reinhardt C, 2012, NATURE, V483, P627, DOI 10.1038/nature10893; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; DOBSON DE, 1990, CELL, V61, P223, DOI 10.1016/0092-8674(90)90803-M; Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Yu QL, 2009, AM J PHYSIOL-HEART C, V297, pH76, DOI 10.1152/ajpheart.01285.2008; Rofagha S, 2013, OPHTHALMOLOGY, V120, P2292, DOI 10.1016/j.ophtha.2013.03.046; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Chan C.-C., 2013, INVEST OPHTH VIS SCI, V54, P315; Coughlin CM, 1998, J CLIN INVEST, V101, P1441, DOI 10.1172/JCI1555; Doyle SL, 2014, SCI TRANSL MED, V6; Hosohara K, 2002, CLIN DIAGN LAB IMMUN, V9, P777, DOI 10.1128/CDLI.9.4.777-783.2002; Mallat Z, 2002, CIRC RES, V91, P441, DOI 10.1161/01.RES.0000033592.11674.D8; Park S, 2007, CELL MOL IMMUNOL, V4, P329; Zhu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094743	29	4	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2014	20	12					1372	1375		10.1038/nm.3671		4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AU7ZZ	WOS:000345817900006		
J	Schubert, D; Bode, C; Kenefeck, R; Hou, TZ; Wing, JB; Kennedy, A; Bulashevska, A; Petersen, BS; Schaffer, AA; Gruning, BA; Unger, S; Frede, N; Baumann, U; Witte, T; Schmidt, RE; Dueckers, G; Niehues, T; Seneviratne, S; Kanariou, M; Speckmann, C; Ehl, S; Rensing-Ehl, A; Warnatz, K; Rakhmanov, M; Thimme, R; Hasselblatt, P; Emmerich, F; Cathomen, T; Backofen, R; Fisch, P; Seidl, M; May, A; Schmitt-Graeff, A; Ikemizu, S; Salzer, U; Franke, A; Sakaguchi, S; Walker, LSK; Sansom, DM; Grimbacher, B				Schubert, Desiree; Bode, Claudia; Kenefeck, Rupert; Hou, Tie Zheng; Wing, James B.; Kennedy, Alan; Bulashevska, Alla; Petersen, Britt-Sabina; Schaeffer, Alejandro A.; Gruening, Bjoern A.; Unger, Susanne; Frede, Natalie; Baumann, Ulrich; Witte, Torsten; Schmidt, Reinhold E.; Dueckers, Gregor; Niehues, Tim; Seneviratne, Suranjith; Kanariou, Maria; Speckmann, Carsten; Ehl, Stephan; Rensing-Ehl, Anne; Warnatz, Klaus; Rakhmanov, Mirzokhid; Thimme, Robert; Hasselblatt, Peter; Emmerich, Florian; Cathomen, Toni; Backofen, Rolf; Fisch, Paul; Seidl, Maximilian; May, Annette; Schmitt-Graeff, Annette; Ikemizu, Shinji; Salzer, Ulrich; Franke, Andre; Sakaguchi, Shimon; Walker, Lucy S. K.; Sansom, David M.; Grimbacher, Bodo			Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations	NATURE MEDICINE			English	Article							REGULATORY T-CELLS; COMMON VARIABLE IMMUNODEFICIENCY; GERMLINE MUTATIONS; CLINICAL-PICTURE; ANTIGEN 4; AUTOIMMUNITY; TOLERANCE; FOXP3; MICE; HOMEOSTASIS	The protein cytotoxic T lymphocyte antigen-4 (CTLA-4) is an essential negative regulator of immune responses, and its loss causes fatal autoimmunity in mice. We studied a large family in which five individuals presented with a complex, autosomal dominant immune dysregulation syndrome characterized by hypogammaglobulinemia, recurrent infections and multiple autoimmune clinical features. We identified a heterozygous nonsense mutation in exon 1 of CTLA4. Screening of 71 unrelated patients with comparable clinical phenotypes identified five additional families (nine individuals) with previously undescribed splice site and missense mutations in CTLA4. Clinical penetrance was incomplete (eight adults of a total of 19 genetically proven CTLA4 mutation carriers were considered unaffected). However, CTLA-4 protein expression was decreased in regulatory T cells (T-reg cells) in both patients and carriers with CTLA4 mutations. Whereas T-reg cells were generally present at elevated numbers in these individuals, their suppressive function, CTLA-4 ligand binding and transendocytosis of CD80 were impaired. Mutations in CTLA4 were also associated with decreased circulating B cell numbers. Taken together, mutations in CTLA4 resulting in CTLA-4 haploinsufficiency or impaired ligand binding result in disrupted T and B cell homeostasis and a complex immune dysregulation syndrome.	[Schubert, Desiree; Bode, Claudia; Bulashevska, Alla; Unger, Susanne; Frede, Natalie; Speckmann, Carsten; Ehl, Stephan; Rensing-Ehl, Anne; Warnatz, Klaus; Rakhmanov, Mirzokhid; Cathomen, Toni; Salzer, Ulrich; Grimbacher, Bodo] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany; [Schubert, Desiree] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79106 Freiburg, Germany; [Kenefeck, Rupert; Hou, Tie Zheng; Kennedy, Alan; Seneviratne, Suranjith; Walker, Lucy S. K.; Sansom, David M.; Grimbacher, Bodo] UCL, Inst Immun & Transplantat, London, England; [Wing, James B.; Sakaguchi, Shimon] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Osaka, Japan; [Petersen, Britt-Sabina; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Schaeffer, Alejandro A.] NIH, Natl Lib Med, Bethesda, MD 20892 USA; [Gruening, Bjoern A.; Backofen, Rolf] Univ Freiburg, Dept Comp Sci, D-79106 Freiburg, Germany; [Baumann, Ulrich; Witte, Torsten; Schmidt, Reinhold E.] Hannover Med Sch, Dept Pediat Pulmonol Allergy & Neonatol, Hannover, Germany; [Dueckers, Gregor; Niehues, Tim] HELIOS Childrens Hosp, Krefeld, Germany; [Kanariou, Maria] Aghia Sophia Childrens Hosp, Dept Immunol & Histocompatibil, Athens, Greece; [Thimme, Robert; Hasselblatt, Peter] Univ Med Ctr Freiburg, Clin Internal Med 2, Freiburg, Germany; [Emmerich, Florian; Cathomen, Toni] Univ Med Ctr Freiburg, Inst Cell & Gene Therapy, Freiburg, Germany; [Fisch, Paul; Seidl, Maximilian; May, Annette; Schmitt-Graeff, Annette] Univ Med Ctr Freiburg, Dept Pathol, Freiburg, Germany; [Ikemizu, Shinji] Kumamoto Univ, Div Struct Biol, Kumamoto, Japan	Grimbacher, B (reprint author), Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany.	bodo.grimbacher@uniklinik-freiburg.de	HOU, TIEZHENG/B-4848-2015; Sakaguchi, Shimon/C-9535-2009; Petersen, Britt-Sabina/I-1671-2012; 	Petersen, Britt-Sabina/0000-0001-9022-9017; Gruning, Bjorn/0000-0002-3079-6586; Cathomen, Toni/0000-0002-7757-4630; Ehl, Stephan/0000-0002-9265-2721	Bundesministerium fur Bildung und Forschung, grant: Integriertes Forschungs und Behandlungszentrum/Center for Chronic Immunodeficiencies [01EO1303]; Bildung und Forschung, grant Systems Biology E:med/SysInflame [012X1306F]; Deutsches Zentrum fur Infelctionsforschung [8000805-3]; Excellence Initiative of the German Research Foundation [GSC-4]; Intramural Research Program of the US National Institutes of Health, National Library of Medicine; DFG [CRC 992]; UK Medical Research Council; Wellcome Trust; Diabetes UK; Japan Society for the Promotion of ScienceYoung Scientist B grant; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency	We thank the patients and their relatives for their participation in this study. We thank F. Atschekzei, S. Kock, A. Gaa, S. Glatzel and M. Stenzel for technical assistance, and D. Comtesse, R. Weinert, R. Wieland, M. Schuler and N. Verma for their excellent and dedicated patient care. This research was funded by the Bundesministerium fur Bildung und Forschung with the following grants: Integriertes Forschungs und Behandlungszentrum/Center for Chronic Immunodeficiencies 01EO1303, Systems Biology E:med/SysInflame: 012X1306F; the Deutsches Zentrum fur Infelctionsforschung #8000805-3 and in part by the Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School) and by the Intramural Research Program of the US National Institutes of Health, National Library of Medicine. We also thank the German Crohn's and Colitis Foundation for support of the exome sequencing and the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Inflammation at Interfaces' B.A.G. is funded by the DFG CRC 992 Medical Epigenetics, L.S.K.W. by a UK Medical Research Council Senior Fellowship, T.Z.H. by the Wellcome Trust, R.K. by Diabetes UK, J.B.W. by a Japan Society for the Promotion of ScienceYoung Scientist B grant and S.S. by the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Japan Science and Technology Agency.	Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jou ST, 2006, INT J IMMUNOGENET, V33, P361, DOI 10.1111/j.1744-313X.2006.00627.x; Chen K, 2013, AM J HUM GENET, V93, P812, DOI 10.1016/j.ajhg.2013.09.009; Resnick ES, 2012, CURR OPIN ALLERGY CL, V12, P595, DOI 10.1097/ACI.0b013e32835914b9; Walker LSK, 2013, J AUTOIMMUN, V45, P49, DOI 10.1016/j.jaut.2013.06.006; Wing K, 2011, TRENDS IMMUNOL, V32, P428, DOI 10.1016/j.it.2011.06.002; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wofsy D, 2012, ARTHRITIS RHEUM-US, V64, P3660, DOI 10.1002/art.34624; Chambers CA, 1996, IMMUNOL REV, V153, P27, DOI 10.1111/j.1600-065X.1996.tb00919.x; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Bachmann MF, 1999, J IMMUNOL, V163, P1128; Lucas CL, 2014, NAT IMMUNOL, V15, P88, DOI 10.1038/ni.2771; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Gathmann B, 2014, J ALLERGY CLIN IMMUN, V134, P116, DOI 10.1016/j.jaci.2013.12.1077; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Tabares P, 2014, EUR J IMMUNOL, V44, P1225, DOI 10.1002/eji.201343967; Angulo I, 2013, SCIENCE, V342, P866, DOI 10.1126/science.1243292; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Atzeni F, 2013, AUTOIMMUN REV, V12, P1115, DOI 10.1016/j.autrev.2013.06.011; Rudd CE, 2008, NAT REV IMMUNOL, V8, P153, DOI 10.1038/nri2253; Walker LSK, 2011, NAT REV IMMUNOL, V11, P852, DOI 10.1038/nri3108; Vincenti F, 2005, NEW ENGL J MED, V353, P770, DOI 10.1056/NEJMoa050085; Yong PFK, 2011, ADV IMMUNOL, V111, P47, DOI 10.1016/B978-0-12-385991-4.00002-7; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Schmidt EM, 2009, J IMMUNOL, V182, P274; Friedline RH, 2009, J EXP MED, V206, P421, DOI 10.1084/jem.20081811; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; Bacchetta R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00077; Barzaghi F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00211; Boomer JS, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002436; Bour-Jordan H, 2009, IMMUNOL REV, V229, P41, DOI 10.1111/j.1600-065X.2009.00775.x; Homann D, 2006, J VIROL, V80, P270, DOI 10.1128/JVI.80.1.270-280.2006; Keir ME, 2005, IMMUNOL REV, V204, P128, DOI 10.1111/j.0105-2896.2005.00242.x; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Ochs HD, 2005, IMMUNOL REV, V203, P156, DOI 10.1111/j.0105-2896.2005.00231.x; Riewaldt J, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00141; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303	45	30	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2014	20	12					1410	1416		10.1038/nm.3746		7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AU7ZZ	WOS:000345817900016		
J	Kikuchi, R; Nakamura, K; MacLauchlan, S; Ngo, DTM; Shimizu, I; Fuster, JJ; Katanasaka, Y; Yoshida, S; Qiu, Y; Yamaguchi, TP; Matsushita, T; Murohara, T; Gokce, N; Bates, DO; Hamburg, NM; Walsh, K				Kikuchi, Ryosuke; Nakamura, Kazuto; MacLauchlan, Susan; Doan Thi-Minh Ngo; Shimizu, Ippei; Fuster, Jose Javier; Katanasaka, Yasufumi; Yoshida, Sumiko; Qiu, Yan; Yamaguchi, Terry P.; Matsushita, Tadashi; Murohara, Toyoaki; Gokce, Noyan; Bates, David O.; Hamburg, Naomi M.; Walsh, Kenneth			An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease	NATURE MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INTERMITTENT CLAUDICATION; SKELETAL-MUSCLE; SPLICE VARIANT; PHASE-II; ANGIOGENESIS; INFLAMMATION; ASSOCIATION; MECHANISMS; VEGF(165)B	Peripheral artery disease (PAD) generates tissue ischemia through arterial occlusions and insufficient collateral vessel formation. Vascular insufficiency in PAD occurs despite higher circulating levels of vascular endothelial growth factor A (VEGF-A)1,2, a key regulator of angiogenesis. Here we show that clinical PAD is associated with elevated levels of an antiangiogenic VEGF-A splice isoform (VEGF-A(165)b) and a corresponding reduction in levels of the proangiogenic VEGF-A(165)a splice isoform. In mice, VEGF-A(165)b expression was upregulated by conditions associated with impaired limb revascularization, including leptin deficiency, diet-induced obesity, genetic ablation of the secreted frizzled-related protein 5 (Sfrp5) adipokine and transgenic overexpression of Wnt5a in myeloid cells. In a mouse model of PAD, delivery of VEGF-A(165)b inhibited revascularization of ischemic hind limbs, Whereas treatment with an isoform-specific neutralizing antibody reversed impaired revascularization caused by metabolic dysfunction or perturbations in the Wnt5a-Sfrp5 regulatory system. These results indicate that inflammation-driven expression of the antiangiogenic VEGF-A isoform can contribute to impaired collateralization in ischemic cardiovascular disease.	[Kikuchi, Ryosuke; Nakamura, Kazuto; MacLauchlan, Susan; Shimizu, Ippei; Fuster, Jose Javier; Katanasaka, Yasufumi; Yoshida, Sumiko; Hamburg, Naomi M.; Walsh, Kenneth] Boston Univ, Sch Med, Boston, MA 02118 USA; [Kikuchi, Ryosuke; Nakamura, Kazuto; MacLauchlan, Susan; Doan Thi-Minh Ngo; Shimizu, Ippei; Fuster, Jose Javier; Katanasaka, Yasufumi; Yoshida, Sumiko; Gokce, Noyan; Hamburg, Naomi M.; Walsh, Kenneth] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Kikuchi, Ryosuke] Nagoya Univ Hosp, Dept Med Tech, Nagoya, Aichi, Japan; [Doan Thi-Minh Ngo; Gokce, Noyan] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Qiu, Yan; Bates, David O.] Univ Bristol, Sch Physiol & Pharmacol, Microvasc Res Labs, Bristol, Avon, England; [Yamaguchi, Terry P.] NCI, Canc & Dev Biol Lab, NIH, Frederick, MD 21701 USA; [Matsushita, Tadashi] Nagoya Univ Hosp, Dept Clin Lab, Nagoya, Aichi, Japan; [Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan; [Bates, David O.] Univ Nottingham, Sch Med, Queens Med Ctr, Div Canc & Stem Cells, Nottingham, England; [Hamburg, Naomi M.] Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA	Walsh, K (reprint author), Boston Univ, Sch Med, Boston, MA 02118 USA.	kxwalsh@bu.edu	Murohara, Toyoaki/M-4958-2014		US National Institutes of Health (NIH) [HL102874, AG34972, HL68758, HL126141]; Uehara Memorial Foundation; NIH [HL102299, HL109790, HL081587, HL1145675]; British Heart Foundation [PG/13/47130337, PG/08/054/25272]; Wellcome Trust; Cancer Research UK; Medical Research Council	This work was supported by US National Institutes of Health (NIH) grants HL102874, AG34972, HL68758 and HL126141 to K.W. R.K. is supported by the Uehara Memorial Foundation and the Grant-in-Aid for Young Scientists B. N.M.H. is supported by NIH grants HL102299 and HL109790, and N.G. is supported by NIH grants HL081587 and HL1145675. D.O.B. is supported by the British Heart Foundation PG/13/47130337 and PG/08/054/25272, the Wellcome Trust, Cancer Research UK and the Medical Research Council. We are grateful to S.M. Eswarappa and P.L. Fox, Department of Cellular and Molecular Medicine, The Lerner Research Institute, Cleveland Clinic, for providing Ax-specific antibody and recombinant VEGF-Ax protein.	Rajagopalan S, 2003, CIRCULATION, V108, P1933, DOI 10.1161/01.CIR.0000093398.16124.29; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Schiekofer S, 2005, ARTERIOSCL THROM VAS, V25, P1603, DOI 10.1161/01.ATV.0000171994.89106.ca; Blann AD, 2002, CLIN SCI, V102, P187, DOI 10.1042/CS20010178; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Jones WS, 2012, VASC MED, V17, P94, DOI 10.1177/1358863X11436334; Duscha BD, 2011, ARTERIOSCL THROM VAS, V31, P2742, DOI 10.1161/ATVBAHA.111.230441; McDermott MM, 2007, J AM COLL CARDIOL, V50, P897, DOI 10.1016/j.jacc.2007.05.017; Kawamura H, 2008, CANCER RES, V68, P4683, DOI 10.1158/0008-5472.CAN-07-6577; Stefater JA, 2011, NATURE, V474, P511, DOI 10.1038/nature10085; Bates DO, 2002, CANCER RES, V62, P4123; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Eswarappa SM, 2014, CELL, V157, P1605, DOI 10.1016/j.cell.2014.04.033; Marso SP, 2006, J AM COLL CARDIOL, V47, P921, DOI 10.1016/j.jacc.2005.09.065; Makin AJ, 2003, CLIN SCI, V104, P397, DOI 10.1042/CS20020182; Anderson PL, 2004, J VASC SURG, V39, P1200, DOI 10.1016/j.jvs.2004.02.039; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Bates DO, 2012, CLIN CANCER RES, V18, P6384, DOI 10.1158/1078-0432.CCR-12-2223; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Hamburg NM, 2011, CIRCULATION, V123, P87, DOI 10.1161/CIRCULATIONAHA.109.881888; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Vidula H, 2008, ANN INTERN MED, V148, P85; Makinen K, 2002, MOL THER, V6, P127, DOI 10.1006/mthe.2002.0638; Dokun AO, 2011, CIRC RES, V109, P246, DOI 10.1161/CIRCRESAHA.111.249953; Findley CM, 2008, J AM COLL CARDIOL, V52, P387, DOI 10.1016/j.jacc.2008.02.045; Merdzhanova G, 2010, ONCOGENE, V29, P5392, DOI 10.1038/onc.2010.281; Suarez SC, 2006, CELL MOL LIFE SCI, V63, P2067, DOI 10.1007/s00018-006-6254-9	29	6	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2014	20	12					1464	1471		10.1038/nm.3703		8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AU7ZZ	WOS:000345817900023		
J	Herry, C; Johansen, JP				Herry, Cyril; Johansen, Joshua P.			Encoding of fear learning and memory in distributed neuronal circuits	NATURE NEUROSCIENCE			English	Review							MEDIAL PREFRONTAL CORTEX; ANTERIOR-CINGULATE-CORTEX; AMYGDALA INHIBITORY CIRCUITS; PERIAQUEDUCTAL GRAY; CONDITIONED FEAR; LATERAL AMYGDALA; BASOLATERAL AMYGDALA; PYRAMIDAL CELLS; GENICULATE-BODY; CENTRAL NUCLEUS	How sensory information is transformed by learning into adaptive behaviors is a fundamental question in neuroscience. Studies of auditory fear conditioning have revealed much about the formation and expression of emotional memories and have provided important insights into this question. Classical work focused on the amygdala as a central structure for fear conditioning. Recent advances, however, have identified new circuits and neural coding strategies mediating fear learning and the expression of fear behaviors. One area of research has identified key brain regions and neuronal coding mechanisms that regulate the formation, specificity and strength of fear memories. Other work has discovered critical circuits and neuronal dynamics by which fear memories are expressed through a medial prefrontal cortex pathway and coordinated activity across interconnected brain regions. Here we review these recent advances alongside prior work to provide a working model of the extended circuits and neuronal coding mechanisms mediating fear learning and memory.	[Herry, Cyril] INSERM, Neuroctr Magendie, U862, Bordeaux, France; [Johansen, Joshua P.] RIKEN Brain Sci Inst, Lab Neural Circuitry Memory, Wako, Saitama, Japan; [Johansen, Joshua P.] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan	Johansen, JP (reprint author), RIKEN Brain Sci Inst, Lab Neural Circuitry Memory, Wako, Saitama, Japan.	cyril.herry@inserm.fr; jjohans@brain.riken.jp			French National Research Agency [ANR-2010-BLAN-1442-01, ANR-10-EQPX-08 OPTOPATH, LABEX BRAIN ANR 10-LABX-43]; European Research Council under the European Union's Seventh Framework Program (FP7)/ERC [281168]; Conseil Regional d'Aquitaine; MEXT (Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS)); Strategic Research Program for Brain Sciences [11041047];  [25710003];  [25116531]	We thank T.C. Bienvenu, R.R. Rozeske and J. Ormond for helpful comments on the manuscript. This work was supported by grants to C.H. from the French National Research Agency (ANR-2010-BLAN-1442-01; ANR-10-EQPX-08 OPTOPATH; LABEX BRAIN ANR 10-LABX-43), the European Research Council under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC grant agreement no. 281168, the Conseil Regional d'Aquitaine, and by grants to J.P.J. from MEXT (Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS)), Strategic Research Program for Brain Sciences (11041047) and Grants-in-Aid for Scientific Research (25710003, 25116531).	Viviani D, 2011, SCIENCE, V333, P104, DOI 10.1126/science.1201043; LeDoux JE, 2014, P NATL ACAD SCI USA, V111, P2871, DOI 10.1073/pnas.1400335111; AITKIN LM, 1973, J NEUROPHYSIOL, V36, P275; Roesch MR, 2010, J NEUROSCI, V30, P2464, DOI 10.1523/JNEUROSCI.5781-09.2010; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Weinberger NM, 2011, HEARING RES, V274, P61, DOI 10.1016/j.heares.2010.03.093; Tully K, 2007, P NATL ACAD SCI USA, V104, P14146, DOI 10.1073/pnas.0704621104; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Quirk GJ, 2003, J NEUROSCI, V23, P8800; Wolff SBE, 2014, NATURE, V509, P453, DOI 10.1038/nature13258; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Bajic D, 1999, J COMP NEUROL, V405, P359; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Likhtik E, 2005, J NEUROSCI, V25, P7429, DOI 10.1523/JNEUROSCI.2314-05.2005; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Courtin J, 2014, NATURE, V505, P92, DOI 10.1038/nature12755; Corcoran KA, 2007, J NEUROSCI, V27, P840, DOI 10.1523/JNEUROSCI.5327-06.2007; Massi L, 2012, J NEUROSCI, V32, P16496, DOI 10.1523/JNEUROSCI.3475-12.2012; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Gross CT, 2012, NAT REV NEUROSCI, V13, P651, DOI 10.1038/nrn3301; Sotres-Bayon F, 2012, NEURON, V76, P804, DOI 10.1016/j.neuron.2012.09.028; Livneh U, 2012, NEURON, V75, P133, DOI 10.1016/j.neuron.2012.05.016; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Furlong TM, 2010, BEHAV NEUROSCI, V124, P574, DOI 10.1037/a0020739; Fanselow MS, 1998, NEURON, V20, P625, DOI 10.1016/S0896-6273(00)81002-8; Grace AA, 2002, PHYSIOL BEHAV, V77, P489, DOI 10.1016/S0031-9384(02)00909-5; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037//0735-7044.107.3.444; Carlen M, 2012, MOL PSYCHIATR, V17, P537, DOI 10.1038/mp.2011.31; CAMPEAU S, 1995, J NEUROSCI, V15, P2312; BOLLES RC, 1980, BEHAV BRAIN SCI, V3, P291; Lanuza E, 2004, NEUROSCIENCE, V125, P305, DOI 10.1016/j.neuroscience.2003.12.034; McNally GP, 2011, TRENDS NEUROSCI, V34, P283, DOI 10.1016/j.tins.2011.03.005; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Shi CJ, 1999, J NEUROSCI, V19, P420; Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Weinberger NM, 2007, LEARN MEMORY, V14, P1, DOI 10.1101/lm.421807; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Schafe GE, 2005, J NEUROSCI, V25, P10010, DOI 10.1523/JNEUROSCI.3307-05.2005; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; Morrison SE, 2010, CURR OPIN NEUROBIOL, V20, P221, DOI 10.1016/j.conb.2010.02.007; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037//0033-295X.87.6.532; Goosens KA, 2003, NEURON, V40, P1013, DOI 10.1016/S0896-6273(03)00728-1; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Kayser C, 2009, NEURON, V61, P597, DOI 10.1016/j.neuron.2009.01.008; Goosens KA, 2003, BEHAV NEUROSCI, V117, P738, DOI 10.1037/0735-7044.117.4.738; Johansen JP, 2012, BIOL PSYCHIAT, V71, P1053, DOI 10.1016/j.biopsych.2011.10.023; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Kim EJ, 2013, P NATL ACAD SCI USA, V110, P14795, DOI 10.1073/pnas.1310845110; Duvarci S, 2014, NEURON, V82, P966, DOI 10.1016/j.neuron.2014.04.042; Penzo MA, 2014, J NEUROSCI, V34, P2432, DOI 10.1523/JNEUROSCI.4166-13.2014; Baeg EH, 2001, CEREB CORTEX, V11, P441, DOI 10.1093/cercor/11.5.441; UWANO T, 1995, NEUROSCIENCE, V68, P339, DOI 10.1016/0306-4522(95)00125-3; Heidbreder CA, 2003, NEUROSCI BIOBEHAV R, V27, P555, DOI 10.1016/j.neubiorev.2003.09.003; Han JH, 2008, LEARN MEMORY, V15, P443, DOI 10.1101/lm.993608; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Likhtik E, 2014, NAT NEUROSCI, V17, P106, DOI 10.1038/nn.3582; Johansen JP, 2004, NAT NEUROSCI, V7, P398, DOI 10.1038/nn1207; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Adhikari A, 2011, NEURON, V71, P898, DOI 10.1016/j.neuron.2011.07.027; McHugh SB, 2014, J NEUROSCI, V34, P9024, DOI 10.1523/JNEUROSCI.4465-13.2014; Amano T, 2011, J NEUROSCI, V31, P15481, DOI 10.1523/JNEUROSCI.3410-11.2011; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Huxter JR, 2008, NAT NEUROSCI, V11, P587, DOI 10.1038/nn.2106; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; McNally GP, 2006, BEHAV NEUROSCI, V120, P313, DOI 10.1037/0735-7044.120.2.313; Popa D, 2010, P NATL ACAD SCI USA, V107, P6516, DOI 10.1073/pnas.0913016107; Bienvenu TCM, 2012, NEURON, V74, P1059, DOI 10.1016/j.neuron.2012.04.022; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006; Li HH, 2013, NAT NEUROSCI, V16, P332, DOI 10.1038/nn.3322; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Tye KM, 2010, J NEUROSCI, V30, P116, DOI 10.1523/JNEUROSCI.4240-09.2010; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Schultz W, 2013, CURR OPIN NEUROBIOL, V23, P229, DOI 10.1016/j.conb.2012.11.012; Sacco T, 2010, SCIENCE, V329, P649, DOI 10.1126/science.1183165; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Petrovich GD, 1997, BRAIN RES, V763, P247, DOI 10.1016/S0006-8993(96)01361-3; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Brunzell DH, 2001, BEHAV NEUROSCI, V115, P365, DOI 10.1037//0735-7044.115.2.365; CALFORD MB, 1981, J NEUROPHYSIOL, V45, P1013; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Pezze MA, 2004, PROG NEUROBIOL, V74, P301, DOI 10.1016/j.pneurobio.2004.009.004; Zimmerman JM, 2007, LEARN MEMORY, V14, P634, DOI 10.1101/lm.607207; Johansen JP, 2010, NAT NEUROSCI, V13, P979, DOI 10.1038/nn.2594; Antunes R, 2010, J NEUROSCI, V30, P9782, DOI 10.1523/JNEUROSCI.1037-10.2010; Boatman JA, 2006, EUR J NEUROSCI, V24, P894, DOI 10.1111/j.1460-9568.2006.04965.x; DISCALA G, 1987, PHYSIOL BEHAV, V40, P55, DOI 10.1016/0031-9384(87)90185-5; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; HELMSTETTER FJ, 1994, J NEUROSCI, V14, P7099; Johansen J.P., 2010, SOC NEUR ABSTR, V914, P15; Johansen J.P., P NATL ACAD IN PRESS; Kholodar-Smith DB, 2008, BEHAV NEUROSCI, V122, P1178, DOI 10.1037/a0012902; Klavir O, 2013, NEURON, V80, P1290, DOI 10.1016/j.neuron.2013.09.035; Klavir O, 2012, J NEUROSCI, V32, P8589, DOI 10.1523/JNEUROSCI.6481-11.2012; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Linke R, 2000, CEREB CORTEX, V10, P753, DOI 10.1093/cercor/10.8.753; Maren S, 2001, J NEUROSCI, V21, part. no.; Maroun M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035853; McDonald AJ, 2005, BRAIN RES, V1035, P32, DOI 10.1016/j.brainres.2004.11.052; Parsons RG, 2006, NEUROSCIENCE, V141, P1163, DOI 10.1016/j.neuroscience.2006.04.078; Rescorla R. A, 1972, CLASSICAL CONDITIONI; Roy M, 2014, NAT NEUROSCI, V17, P1607, DOI 10.1038/nn.3832; RYUGO DK, 1978, BEHAV BIOL, V22, P275, DOI 10.1016/S0091-6773(78)92351-9; Senn V, 2014, NEURON, V81, P428, DOI 10.1016/j.neuron.2013.11.006; Shabel SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027797; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Tang JR, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-6; Watabe AM, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-11; YOUNG SL, 1992, J EXP PSYCHOL ANIM B, V18, P400, DOI 10.1037/0097-7403.18.4.400	119	23	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2014	17	12					1644	1654		10.1038/nn.3869		11	Neurosciences	Neurosciences & Neurology	AU2ZY	WOS:000345484000009		
J	Trimarco, A; Forese, MG; Alfieri, V; Lucente, A; Brambilla, P; Dina, G; Pieragostino, D; Sacchetta, P; Urade, Y; Boizet-Bonhoure, B; Boneschi, FM; Quattrini, A; Taveggia, C				Trimarco, Amelia; Forese, Maria Grazia; Alfieri, Valentina; Lucente, Alessandra; Brambilla, Paola; Dina, Giorgia; Pieragostino, Damiana; Sacchetta, Paolo; Urade, Yoshihiro; Boizet-Bonhoure, Brigitte; Boneschi, Filippo Martinelli; Quattrini, Angelo; Taveggia, Carla			Prostaglandin D2 synthase/GPR44: a signaling axis in PNS myelination	NATURE NEUROSCIENCE			English	Article							PROTEIN-COUPLED RECEPTOR; PERIPHERAL NERVOUS-SYSTEM; SCHWANN-CELL MYELINATION; LIPOCALIN-TYPE; BETA-TRACE; DIFFERENTIATION; NEUREGULIN-1; GPR126; DEMYELINATION; ACTIVATION	Neuregulin 1 type III is processed following regulated intramembrane proteolysis, which allows communication from the plasma membrane to the nucleus. We found that the intracellular domain of neuregulin 1 type III upregulated the prostaglandin D2 synthase (L-pgds, also known as Ptgds) gene, which, together with the G protein-coupled receptor Gpr44, forms a previously unknown pathway in PNS myelination. Neuronal L-PGDS is secreted and produces the PGD2 prostanoid, a ligand of Gpr44. We found that mice lacking L-PGDS were hypomyelinated. Consistent with this, specific inhibition of L-PGDS activity impaired in vitro myelination and caused myelin damage. Furthermore, in vivo ablation and in vitro knockdown of glial Gpr44 impaired myelination. Finally, we identified Nfatc4, a key transcription factor for myelination, as one of the downstream effectors of PGD2 activity in Schwann cells. Thus, L-PGDS and Gpr44 are previously unknown components of an axo-glial interaction that controls PNS myelination and possibly myelin maintenance.	[Trimarco, Amelia; Forese, Maria Grazia; Alfieri, Valentina; Lucente, Alessandra; Brambilla, Paola; Dina, Giorgia; Boneschi, Filippo Martinelli; Quattrini, Angelo; Taveggia, Carla] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy; [Trimarco, Amelia; Forese, Maria Grazia; Alfieri, Valentina; Lucente, Alessandra; Brambilla, Paola; Dina, Giorgia; Boneschi, Filippo Martinelli; Quattrini, Angelo; Taveggia, Carla] Ist Sci San Raffaele, INSPE, I-20132 Milan, Italy; [Pieragostino, Damiana; Sacchetta, Paolo] Univ G DAnnunzio, Dept Expt & Clin Sci, Chieti, Italy; [Urade, Yoshihiro] Univ Tsukuba, Int Inst Integrat Sleep Med, Ibaraki, Japan; [Boizet-Bonhoure, Brigitte] CNRS, Inst Genet Humaine, UPR1142, Montpellier, France	Taveggia, C (reprint author), Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy.	taveggia.carla@hsr.it			Italian Minister of Health [GR08-35]; European Marie Curie Reintegration Grant [IRG 239430-2008]; Agence Nationale pour la Recherche (ANRblanc programme); Italian Fondazione Italiana Sderbsi Multipla	We thank V. Marzano and A. Urbani for shotgun mass spectrometry analyses, F. Clarelli for heat map and statistical analyses, G. Fitzgerald (University of Pennsylvania) for providing Gpr44<SUP>-/-</SUP> mice, P. Podini for excellent technical assistance with electron microscopy analyses, and P. Del Boccio for LC-MS/MS analyses. We are grateful to M. Buono, S. Previtali and A. Bolino for critical reading of the manuscript and suggestions, and L. Massimino for artwork. Part of this work was carried out in ALEMBIC, an advanced microscopy laboratory at the San Raffaele Scientific Institute. M.G.F. conducted this study in partial fulfillment for her Ph.D. in Molecular and Cellular Neuroscience, San Raffaele University. This study was supported by the Italian Minister of Health (award number GR08-35, C.T.), the European Marie Curie Reintegration Grant (award number IRG 239430-2008, CT.) and the Agence Nationale pour la Recherche (ANRblanc programme, B.B.B) C.T. is also supported by Italian Fondazione Italiana Sderbsi Multipla.	Ragolia L, 2005, J BIOL CHEM, V280, P29946, DOI 10.1074/jbc.M502927200; Comley LH, 2011, HUM MOL GENET, V20, P2406, DOI 10.1093/hmg/ddr147; Taketomi Y, 2013, NAT IMMUNOL, V14, P554, DOI 10.1038/ni.2586; Subra C, 2010, J LIPID RES, V51, P2105, DOI 10.1194/jlr.M003657; Hirahara Y, 2013, GLIA, V61, P420, DOI 10.1002/glia.22445; Birchmeier C, 2008, GLIA, V56, P1491, DOI 10.1002/glia.20753; Mohri I, 2006, J NEUROSCI, V26, P4383, DOI 10.1523/JNEUROSCI.4531-05.2006; Kanekiyo T, 2007, P NATL ACAD SCI USA, V104, P6412, DOI 10.1073/pnas.0701585104; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; La Marca R, 2011, NAT NEUROSCI, V14, P857, DOI 10.1038/nn.2849; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Monje PV, 2008, J BIOL CHEM, V283, P34087, DOI 10.1074/jbc.M802318200; Qu WM, 2006, P NATL ACAD SCI USA, V103, P17949, DOI 10.1073/pnas.0608581103; Monk KR, 2011, DEVELOPMENT, V138, P2673, DOI 10.1242/dev.062224; Kipanyula MJ, 2013, J NEUROSCI RES, V91, P105, DOI 10.1002/jnr.23131; Lal M, 2011, PHYSIOLOGY, V26, P34, DOI 10.1152/physiol.00028.2010; Moniot B, 2009, DEVELOPMENT, V136, P1813, DOI 10.1242/dev.032631; Mogha A, 2013, J NEUROSCI, V33, P17976, DOI 10.1523/JNEUROSCI.1809-13.2013; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Urade Y, 2000, VITAM HORM, V58, P89, DOI 10.1016/S0083-6729(00)58022-4; Glenn TD, 2013, DEVELOPMENT, V140, P3167, DOI 10.1242/dev.093401; Newbern JM, 2011, NEURON, V69, P91, DOI 10.1016/j.neuron.2010.12.003; Bao JX, 2003, J CELL BIOL, V161, P1133, DOI 10.1083/jcb.200212085; Kostenis E, 2006, TRENDS MOL MED, V12, P148, DOI 10.1016/j.molmed.2006.02.005; Bao JX, 2004, NAT NEUROSCI, V7, P1250, DOI 10.1038/nn1342; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Ganfornina MD, 2010, GLIA, V58, P1320, DOI 10.1002/glia.21010; Nagata N, 2009, FEBS J, V276, P7146, DOI 10.1111/j.1742-4658.2009.07426.x; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Kao SC, 2009, SCIENCE, V323, P651, DOI 10.1126/science.1166562; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Beuckmann CT, 1996, J NEUROSCI, V16, P6119; Beuckmann CT, 2000, J COMP NEUROL, V428, P62, DOI 10.1002/1096-9861(20001204)428:1<62::AID-CNE6>3.0.CO;2-E; Chen YF, 2010, J MED BIOL ENG, V30, P1; Evans SF, 2011, J BIOL CHEM, V286, P29556, DOI 10.1074/jbc.M111.219675; Giacomelli S, 1996, BBA-MOL CELL RES, V1310, P269, DOI 10.1016/0167-4889(95)00182-4; Grimwood S, 2005, NEUROPHARMACOLOGY, V48, P1002, DOI 10.1016/j.neuropharm.2005.01.016; Harizi H, 2013, BIOMED RES INT; Haskew-Layton RE, 2013, J NEUROCHEM, V124, P536, DOI 10.1111/jnc.12107; Hennen S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004350; Irikura D, 2009, J BIOL CHEM, V284, P7623, DOI 10.1074/jbc.M808593200; Kerr BJ, 2008, GLIA, V56, P436, DOI 10.1002/glia.20630; Nicholson JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050021; RAFF MC, 1978, CELL, V15, P813, DOI 10.1016/0092-8674(78)90266-0; Samy ET, 2000, ENDOCRINOLOGY, V141, P710, DOI 10.1210/en.141.2.710; Tin A, 2013, NEPHROL DIAL TRANSPL, V28, P1497, DOI 10.1093/ndt/gfs591; Tootle TL, 2013, INT J BIOCHEM CELL B, V45, P1629, DOI 10.1016/j.biocel.2013.05.008; Urade Y, 2002, PROSTAG OTH LIPID M, V68-9, P375, DOI 10.1016/S0090-6980(02)00042-4; VESIN MF, 1995, J NEUROSCI, V15, P470	50	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2014	17	12					1682	1692		10.1038/nn.3857		11	Neurosciences	Neurosciences & Neurology	AU2ZY	WOS:000345484000015		
J	Villanueva, MT				Villanueva, M. Teresa			TUMOUR IMMUNOLOGY The new midfielders in the tumour microenvironment	NATURE REVIEWS IMMUNOLOGY			English	News Item									Nat Reviews Canc, Tokyo, Japan	Villanueva, MT (reprint author), Nat Reviews Canc, Tokyo, Japan.							0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1474-1733	1474-1741		NAT REV IMMUNOL	Nat. Rev. Immunol.	DEC	2014	14	12								10.1038/nri3781		1	Immunology	Immunology	AU4FW	WOS:000345566400006		
J	Hanel, R; Stepputtis, D; Bonhommeau, S; Castonguay, M; Schaber, M; Wysujack, K; Vobach, M; Miller, MJ				Hanel, Reinhold; Stepputtis, Daniel; Bonhommeau, Sylvain; Castonguay, Martin; Schaber, Matthias; Wysujack, Klaus; Vobach, Michael; Miller, Michael J.			Low larval abundance in the Sargasso Sea: new evidence about reduced recruitment of the Atlantic eels	NATURWISSENSCHAFTEN			English	Article						Anguilliformes; Anguillidae; Spawning area; Eel larvae; Population declines	ANGUILLA-ANGUILLA L.; ST-LAWRENCE-RIVER; FRESH-WATER EELS; EUROPEAN EEL; JAPANESE EEL; SPECIES ASSEMBLAGES; NORTH-ATLANTIC; MARINE SNOW; AMERICAN EEL; LEPTOCEPHALI	The European eel Anguilla anguilla has shown decreased recruitment in recent decades. Despite increasing efforts to establish species recovery measures, it is unclear if the decline was caused by reduced numbers of reproductive-stage silver eels reaching the spawning area, low early larval survival, or increased larval mortality during migration to recruitment areas. To determine if larval abundances in the spawning area significantly changed over the past three decades, a plankton trawl sampling survey for anguillid leptocephali was conducted in March and April 2011 in the spawning area of the European eel that was designed to directly compare to collections made in the same way in 1983 and 1985. The catch rates of most anguilliform leptocephali were lower in 2011, possibly because of the slightly smaller plankton trawl used, but the relative abundances of European eel and American eel, Anguilla rostrata, leptocephali were much lower in 2011 than in 1983 and 1985 when compared to catches of other common leptocephali. The leptocephali assemblage was the same in 2011 as in previous years, but small larvae of mesopelagic snipe eels, Nemichthys scolopaceus, which spawn sympatrically with anguillid eels, were less abundant. Temperature fronts in the spawning area were also poorly defined compared to previous years. Although the causes for low anguillid larval abundances in 2011 are unclear, the fact that there are presently fewer European and American eel larvae in the spawning area than during previous time periods indicates that decreased larval abundance and lower eventual recruitment begin within the spawning area.	[Hanel, Reinhold; Wysujack, Klaus; Vobach, Michael] Thunen Inst Fisheries Ecol, D-22767 Hamburg, Germany; [Stepputtis, Daniel] Thunen Inst Balt Sea Fisheries, D-18069 Rostock, Germany; [Bonhommeau, Sylvain] IFREMER, Ctr Mediterranean & Trop Res, F-34200 Sete, France; [Castonguay, Martin] Fisheries & Oceans Canada, Maurice Lamontagne Inst, Mont Joli, PQ G5H 3Z4, Canada; [Schaber, Matthias] Thunen Inst Sea Fisheries, D-22767 Hamburg, Germany; [Miller, Michael J.] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan	Hanel, R (reprint author), Thunen Inst Fisheries Ecol, Palmaille 9, D-22767 Hamburg, Germany.	reinhold.hanel@ti.bund.de	Bonhommeau, Sylvain/P-8654-2014	Bonhommeau, Sylvain/0000-0002-0882-5918	German Federal Ministry of Food and Agriculture	We thank the captain and crew of the R/V Walther Herwig III for assistance during the cruise and the other scientists and technicians, Tagried Kurwie, Manfred Trenk, Tina Blancke, and Olav Giere, who helped sort the IKMT plankton samples and provide other types of assistance. This study was financed by the German Federal Ministry of Food and Agriculture.	Aarestrup K, 2009, SCIENCE, V325, P1660, DOI 10.1126/science.1178120; Palstra AP, 2007, J EXP MAR BIOL ECOL, V352, P244, DOI 10.1016/j.jembe.2007.08.003; Chassignet EP, 2009, OCEANOGRAPHY, V22, P64, DOI 10.5670/oceanog.2009; MILLER MJ, 1995, MAR ECOL PROG SER, V121, P11, DOI 10.3354/meps121011; Wippelhauser GS, 1996, B MAR SCI, V59, P298; Miller MJ, 2009, AM FISH S S, V69, P231; KLECKNER RC, 1988, J MAR RES, V46, P647, DOI 10.1357/002224088785113469; Haro A, 2000, FISHERIES, V25, P7, DOI 10.1577/1548-8446(2000)025<0007:PDOTAE>2.0.CO;2; Acou A, 2011, FRESHWATER BIOL, V56, P952, DOI 10.1111/j.1365-2427.2010.02540.x; Dekker W, 2003, FISHERIES MANAG ECOL, V10, P365, DOI 10.1111/j.1365-2400.2003.00352.x; Friedland KD, 2007, ICES J MAR SCI, V64, P519, DOI 10.1093/icesjms/fsm022; Tsukamoto K, 2009, MAR BIOL, V156, P835, DOI 10.1007/s00227-008-1123-8; Miller MJ, 2002, MAR ECOL PROG SER, V235, P279, DOI 10.3354/meps235279; Miyazaki S, 2011, MAR BIOL, V158, P2555, DOI 10.1007/s00227-011-1756-x; Dekker W, 1998, B FR PECHE PISCIC, P199, DOI 10.1051/kmae:1998045; Knights B, 2003, SCI TOTAL ENVIRON, V310, P237, DOI 10.1016/S0048-9697(02)00644-7; MILLER MJ, 1994, J MAR RES, V52, P743, DOI 10.1357/0022240943076948; BAST HD, 1990, HELGOLANDER MEERESUN, V44, P353, DOI 10.1007/BF02365472; Shanks AL, 1997, MAR ECOL PROG SER, V156, P75, DOI 10.3354/meps156075; Govoni JJ, 2010, SCI MAR, V74, P339, DOI 10.3989/scimar.2010.74n2339; Belpaire C, 2007, ICES J MAR SCI, V64, P1423, DOI 10.1093/icesjms/fsm121; Miller MJ, 2007, MAR ECOL PROG SER, V344, P197, DOI 10.3354/meps06923; Riemann L, 2011, MAR ECOL PROG SER, V426, P57, DOI 10.3354/meps09001; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Bonhommeau S, 2008, FISH OCEANOGR, V17, P32, DOI 10.1111/j.1365-2419.2007.00453.x; Andersen NG, 2011, MAR ECOL PROG SER, V426, P71, DOI 10.3354/meps09047; Kiorboe T, 2000, LIMNOL OCEANOGR, V45, P479; Robinet TT, 2002, ECOTOXICOLOGY, V11, P265, DOI 10.1023/A:1016352305382; McCleave JD, 2008, MAR BIOL, V155, P249, DOI 10.1007/s00227-008-1026-8; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Tsukamoto K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1174; Feunteun E, 2002, ECOL ENG, V18, P575, DOI 10.1016/S0925-8574(02)00021-6; Baltazar-Soares M, 2014, CURR BIOL, V24, P104, DOI 10.1016/j.cub.2013.11.031; Kimura S, 2001, FISH OCEANOGR, V10, P51, DOI 10.1046/j.1365-2419.2001.00159.x; Miller MJ, 2013, MAR BIODIVERS, V43, P493, DOI 10.1007/s12526-013-0170-7; Kettle AJ, 2011, FISH FISH, V12, P380, DOI 10.1111/j.1467-2979.2010.00400.x; Miller MJ, 2015, BIOL REV, V90, P1035, DOI 10.1111/brv.12144; McCleave JD, 1998, J MAR BIOL ASSOC UK, V78, P285; OTAKE T, 1993, MAR ECOL PROG SER, V92, P27, DOI 10.3354/meps092027; SCHOTH M, 1982, HELGOLANDER MEERESUN, V35, P309, DOI 10.1007/BF02006139; Mochioka N, 1996, MAR BIOL, V125, P447; Tsukamoto K, 2009, J FISH BIOL, V74, P1833, DOI 10.1111/j.1095-8649.2009.02242.x; Riemann L, 2010, BIOL LETTERS, V6, P819, DOI 10.1098/rsbl.2010.0411; Tsukamoto Katsumi, 2009, P21; ALLDREDGE AL, 1988, PROG OCEANOGR, V20, P41, DOI 10.1016/0079-6611(88)90053-5; Geeraerts C, 2010, ECOTOXICOLOGY, V19, P239, DOI 10.1007/s10646-009-0424-0; Chow S, 2009, FISHERIES SCI, V75, P257, DOI 10.1007/s12562-008-0017-5; CASTONGUAY M, 1987, J PLANKTON RES, V9, P195, DOI 10.1093/plankt/9.1.195; Miller MJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0826; Kirk RS, 2003, FISHERIES MANAG ECOL, V10, P385, DOI 10.1111/j.1365-2400.2003.00355.x; Munk P, 2010, P ROY SOC B-BIOL SCI, V277, P3593, DOI 10.1098/rspb.2010.0900; Kim H, 2007, ICES J MAR SCI, V64, P1387, DOI 10.1093/icesjms/fsm091; Bonhommeau S, 2010, FISH FISH, V11, P289, DOI 10.1111/j.1467-2979.2010.00362.x; TESCH FW, 1990, INT REV GES HYDROBIO, V75, P845, DOI 10.1002/iroh.19900750629; Bonhommeau S, 2008, MAR ECOL PROG SER, V373, P71, DOI 10.3354/meps07696; Manabe R, 2011, MAR ECOL PROG SER, V437, P229, DOI 10.3354/meps09266; Aoyama Jun, 2009, Aqua-Bioscience Monographs, V2, P1; Arribas C, 2012, ESTUAR COAST SHELF S, V107, P46, DOI 10.1016/j.ecss.2012.04.024; Astrom M, 2007, ICES J MAR SCI, V64, P1491, DOI 10.1093/icesjms/fsm122; Belpaire CGJ, 2009, ECOL FRESHW FISH, V18, P197, DOI 10.1111/j.1600-0633.2008.00337.x; Bohlke E. B., 1989, FISHES W N ATLANTI 9, V2, P657; Casselman JM, 2003, EEL BIOLOGY, P255; Castonguay Martin, 1994, Fisheries Oceanography, V3, P197, DOI 10.1111/j.1365-2419.1994.tb00097.x; CASTONGUAY M, 1994, CAN J FISH AQUAT SCI, V51, P479, DOI 10.1139/f94-050; CITES, 2006, 22 M AN COMM LIM PER, P38; Clevestam PD, 2011, J FISH BIOL, V78, P1073, DOI 10.1111/j.1095-8649.2011.02920.x; Couillard CM, 1997, CAN J FISH AQUAT SCI, V54, P1916, DOI 10.1139/cjfas-54-8-1916; Dekker W, 2003, FISHERIES, V28, P28, DOI DOI 10.1577/1548-8446-28-12; Durif CMF, 2011, P ROY SOC B-BIOL SCI, V278, P464, DOI 10.1098/rspb.2010.1547; ERIKSEN CC, 1991, J GEOPHYS RES-OCEANS, V96, P8569, DOI 10.1029/90JC02531; EU, 2007, OFFICIAL J EUROPEA L, V248, P17; Frankowski J, 2010, MOL ECOL RESOUR, V10, P173, DOI 10.1111/j.1755-0998.2009.02698.x; HALLIWELL GR, 1991, J GEOPHYS RES-OCEANS, V96, P8553, DOI 10.1029/91JC00100; ICES, 2013, JOINT EIFAAC ICES WO; Itakura H, 2014, LANDSC ECOL ENG; Jacob E, 2009, ICES J MAR SCI, V66, P358; Kettle AJ, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000589; Kurogi H, 2011, FISHERIES SCI, V77, P199, DOI 10.1007/s12562-010-0318-3; Marohn L, 2013, J SEA RES, V77, P100, DOI 10.1016/j.seares.2012.10.006; McCleave JD, 2003, EEL BIOLOGY, P141; McCleave JD, 1987, AM FISH SOC S SERIES, V1, P286; Miller MJ, 2011, COAST MAR SCI, V35, P277; Miller MJ, 2002, ENVIRON BIOL FISH, V63, P235, DOI 10.1023/A:1014311429809; Polyakov IV, 2005, J CLIMATE, V18, P4562, DOI 10.1175/JCLI3548.1; Prigge E, 2013, ICES J MAR SCI, V70, P309, DOI 10.1093/icesjms/fss188; Schmidt J., 1922, Philosophical Transactions of the Royal Society London B, V211, P179; Tesch F. W., 2003, EEL; TESCH F W, 1986, Vie et Milieu, V36, P255; Trautner JH, 2013, J APPL ICHTHYOL, V29, P912, DOI 10.1111/jai.12233; Tsukamoto K, 2013, FISHERIES SCI, V79, P407, DOI 10.1007/s12562-013-0611-z; Ullman DS, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003601; van den Thillart G, 2009, FISH FISHERIES SER, V30; van Ginneken V, 2005, COMP BIOCHEM PHYS C, V140, P97, DOI 10.1016/j.cca.2005.01.011; WELLER RA, 1991, J GEOPHYS RES-OCEANS, V96, P8501, DOI 10.1029/90JC01868; Wysujack K, 2014, MAR FRESHW IN PRESS	95	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-1042	1432-1904		NATURWISSENSCHAFTEN	Naturwissenschaften	DEC	2014	101	12					1041	1054		10.1007/s00114-014-1243-6		14	Multidisciplinary Sciences	Science & Technology - Other Topics	AU0EQ	WOS:000345296800005		
J	Obulesu, M; Lakshmi, MJ				Obulesu, M.; Lakshmi, M. Jhansi			Apoptosis in Alzheimer's Disease: An Understanding of the Physiology, Pathology and Therapeutic Avenues	NEUROCHEMICAL RESEARCH			English	Article						Alzheimer's disease; Apoptosis; Neuroprotection; Mitochondria; Endoplasmic reticulum; Animal model	ENDOPLASMIC-RETICULUM STRESS; AMYLOID PRECURSOR PROTEIN; BETA-INDUCED APOPTOSIS; CELL-DEATH; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; INTRACELLULAR DOMAIN; PC12 CELLS; TRANSCRIPTION FACTOR; CALORIE RESTRICTION	Alzheimer's disease (AD) is a devastative neurodegenerative disorder with complex etiology. Apoptosis, a biological process that plays an essential role in normal physiology to oust a few cells and contribute to the normal growth, when impaired or influenced by various factors such as Bcl2, Bax, caspases, amyloid beta, tumor necrosis factor-alpha, amyloid precursor protein intracellular C-terminal domain, reactive oxygen species, perturbation of enzymes leads to deleterious neurodegenerative disorders like AD. There are diverse pathways that provoke manifold events in mitochondria and endoplasmic reticulum (ER) to execute the process of cell death. This review summarizes the crucial apoptotic mechanisms occurring in both mitochondria and ER. It gives substantial summary of the diverse mechanisms studied in vivo and in vitro. A brief account on neuroprotection of several bioactive components, flavonoids and antioxidants of plants against apoptotic events of both mitochondria and ER in both in vitro and in vivo has been discussed. In light of this, the burgeoning need to develop animal models to study the efficacy of various therapeutic effects has been accentuated.	[Obulesu, M.] Univ Tsukuba, Dept Mat Sci, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan; [Lakshmi, M. Jhansi] Cent Food Technol Res Inst, Dept Biochem, Mysore 570013, Karnataka, India	Obulesu, M (reprint author), Univ Tsukuba, Dept Mat Sci, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan.	mobulesu@gmail.com					Alvarez S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016100; Wright JW, 2010, EXP NEUROL, V223, P326, DOI 10.1016/j.expneurol.2009.09.012; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Katayama T, 2004, J CHEM NEUROANAT, V28, P67, DOI 10.1016/j.jchemneu.2003.12.004; Verkhratsky A, 2005, PHYSIOL REV, V85, P201, DOI 10.1152/physrev.00004.2004; Kell DB, 2010, ARCH TOXICOL, V84, P825, DOI 10.1007/s00204-010-0577-x; Song J, 2014, INT J MOL SCI, V15, P2119, DOI 10.3390/ijms15022119; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Sun XL, 2011, J BIOL CHEM, V286, P9049, DOI 10.1074/jbc.M110.177519; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Le YY, 2001, J NEUROSCI, V21; Obulesu M, 2011, INT J NEUROSCI, V121, P229, DOI 10.3109/00207454.2010.551432; Gamba P, 2011, AGING CELL, V10, P403, DOI 10.1111/j.1474-9726.2011.00681.x; El-Guendy N, 2003, EXP CELL RES, V283, P51, DOI 10.1016/S0014-4827(02)00016-2; Anekonda TS, 2006, BRAIN RES REV, V52, P316, DOI 10.1016/j.brainresrev.2006.04.004; Obulesu M, 2011, ACTA NEUROL SCAND, V124, P295, DOI 10.1111/j.1600-0404.2010.01483.x; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Obulesu M, 2014, INT J NEUROSCI, V124, P227, DOI 10.3109/00207454.2013.831852; Obulesu M, 2011, NEUROCHEM INT, V59, P535, DOI 10.1016/j.neuint.2011.04.004; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Qin WP, 2008, ANN NY ACAD SCI, V1147, P335, DOI 10.1196/annals.1427.024; Li X, 2000, EXP CELL RES, V255, P125, DOI 10.1006/excr.1999.4796; Oules B, 2012, J NEUROSCI, V32, P11820, DOI 10.1523/JNEUROSCI.0875-12.2012; Ramirez C, 2011, J ALZHEIMERS DIS, V24, P161, DOI 10.3233/JAD-2010-101653; Cavallucci V, 2011, CURR PHARM DESIGN, V17, P215; Bianco F, 2005, J IMMUNOL, V174, P7268; Kim R, 2005, BIOCHEM BIOPH RES CO, V333, P336, DOI 10.1016/j.bbrc.2005.04.161; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809; Hong YK, 2011, J ETHNOPHARMACOL, V134, P1028, DOI 10.1016/j.jep.2011.02.012; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Hashimoto Y, 2009, MOL BIOL CELL, V20, P2864, DOI 10.1091/mbc.E09-02-0168; Lu J, 2011, BRAIN, V134, P783, DOI 10.1093/brain/awq376; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; Viviani B, 2004, TOXICOL LETT, V149, P85, DOI 10.1016/j.toxlet.2003.12.022; Ueki S, 2008, J IMMUNOL, V181, P7689; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Luciano F, 2005, J BIOL CHEM, V280, P15825, DOI 10.1074/jbc.M413062200; Ozaki T, 2006, BIOCHEM BIOPH RES CO, V351, P57, DOI 10.1016/j.bbrc.2006.09.162; Rathmell JC, 2002, NAT IMMUNOL, V3, P932, DOI 10.1038/ni834; Jayanthi S, 2005, P NATL ACAD SCI USA, V102, P868, DOI 10.1073/pnas.0404990102; Anekonda TS, 2011, J ALZHEIMERS DIS, V23, P21, DOI 10.3233/JAD-2010-101287; Choi JH, 2010, EXP MOL MED, V42, P811, DOI 10.3858/emm.2010.42.12.084; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Morelli A, 2003, MOL BIOL CELL, V14, P2655, DOI 10.1091/mbc.02-04-0061; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Moreira PI, 2005, ANN NY ACAD SCI, V1043, P545, DOI 10.1196/annals.1338.062; Pidgeon GP, 2002, CANCER RES, V62, P2721; Geng J, 2012, ADV HEALTHC MATER, V1, P332, DOI 10.1002/adhm.201200067; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Copani A, 2002, J NEUROSCI, V22, P3963; Julien C, 2009, J NEUROPATH EXP NEUR, V68, P48, DOI 10.1097/NEN.0b013e3181922348; Parvathenani LK, 2003, J BIOL CHEM, V278, P13309, DOI 10.1074/jbc.M209478200; Eckert A, 2003, ANN NY ACAD SCI, V1010, P604, DOI 10.1196/annals.1299.113; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Lambertsen KL, 2007, NEUROSCIENCE, V144, P934, DOI 10.1016/j.neuroscience.2006.10.046; Lee HP, 2009, EXPERT REV NEUROTHER, V9, P1615, DOI [10.1586/ern.09.86, 10.1586/ERN.09.86]; Ermak G, 2001, J BIOL CHEM, V276, P38787, DOI 10.1074/jbc.M102829200; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Hong SY, 2012, MOLECULES, V17, P10831, DOI 10.3390/molecules170910831; Sponne I, 2004, MOL CELL NEUROSCI, V25, P95, DOI 10.1016/j.mcn.2003.09.017; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Nakaya T, 2006, GENES CELLS, V11, P633, DOI 10.1111/j.1365-2443.2006.00968.x; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Chen X, 2011, NEUROSCIENCE, V178, P159, DOI 10.1016/j.neuroscience.2011.01.024; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Ye L, 2013, J NEUROCHEM, V125, P897, DOI 10.1111/jnc.12263; Maestre C, 2008, EMBO J, V27, P2736, DOI 10.1038/emboj.2008.195; Azmi NH, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-177; Chang KA, 2010, BMB REP, V43, P656, DOI 10.5483/BMBRep.2010.43.10.656; Chen CH, 2011, INT J NEUROPSYCHOPH, V15, P1; Cui B, 2013, MED HYPOTHESES, V81, P623, DOI 10.1016/j.mehy.2013.07.017; Farooqui AA, 2004, BRAIN RES REV, V45, P179, DOI 10.1016/j.brainresv.2004.03.002; Figiel I, 2007, BRAIN RES, V1131, P17, DOI 10.1016/j.brainres.2006.10.095; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Gatta V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015965; Ha S, 2011, NEUROBIOL AGING, V32, P2287, DOI 10.1016/j.neurobiolaging.2010.01.003; Hashimoto Y, 2003, J PHARMACOL EXP THER, V306, P889, DOI 10.1124/jpet.103.051383; Hengartner M O, 2000, Symp Soc Exp Biol, V52, P1; Hoarau JJ, 2010, CNS NEUROL DISORD-DR, V10, P25; Jahanshahi M, 2013, ANAT SCI INT, V88, P217, DOI 10.1007/s12565-013-0188-8; Kariya S, 2005, J MOL NEUROSCI, V25, P165, DOI 10.1385/JMN:25:2:165; Kataoka S., 1996, ONCOLOGIST, V1, P399; Kim EA, 2014, CELL MOL NEUROBIOL, V34, P963, DOI 10.1007/s10571-014-0080-7; Kim IK, 2013, FREE RADICAL RES, V47, P836, DOI 10.3109/10715762.2013.833330; Kim JK, 2010, J KOREAN MED SCI, V25, P1492, DOI 10.3346/jkms.2010.25.10.1492; Lauterbach EC, 2010, J NEUROPSYCH CLIN N, V22, P8, DOI 10.1176/appi.neuropsych.22.1.8; Le Bras Morgane, 2006, Med Chem, V2, P1; Lee C., 2013, OXID MED CELL LONGEV, V2013; Li CH, 2011, CELL MOL IMMUNOL, V8, P67, DOI 10.1038/cmi.2010.55; Li WW, 2011, MUTAT RES-FUND MOL M, V708, P1, DOI 10.1016/j.mrfmmm.2010.12.017; Lin HY, 2007, BBA-MOL CELL RES, V1773, P1073, DOI 10.1016/j.bbamcr.2007.04.008; Magisetty Obulesu, 2009, J Clin Med Res, V1, P212, DOI 10.4021/jocmr2009.09.1265; Malik M, 2011, NEUROCHEM RES, V36, P754, DOI 10.1007/s11064-010-0395-9; Menendez-Gonzalez M, 2011, CURR PHARM DESIGN, V17, P508; Mishra M, 2010, J CELL MOL MED, V15, P2462; Morrison BE, 2007, CELL MOL LIFE SCI, V64, P2258, DOI 10.1007/s00018-007-7035-9; Nakayama K, 2008, NEUROSCI LETT, V444, P127, DOI 10.1016/j.neulet.2008.08.034; Niikura T, 2003, EUR J NEUROSCI, V17, P1150, DOI 10.1046/j.1460-9568.2003.02553.x; North A, 2002, PHYSIOL REV, V82, P1013; Obulesu M, 2011, NEUROCHEM RES, V36, P1329, DOI 10.1007/s11064-011-0475-5; Obulesu M, 2011, J Neurosci Rural Pract, V2, P56, DOI 10.4103/0976-3147.80102; Obulesu M, 2010, INT J NEUROSCI, V120, P397, DOI 10.3109/00207450903411133; Obulesu M, 2010, INT J NEUROSCI, V120, P531, DOI 10.3109/00207451003760080; Pislar AH, 2013, NEUROMOL MED, V15, P623, DOI 10.1007/s12017-013-8247-9; Radi E, 2014, J ALZHEIMERS DIS, V42, pS125, DOI 10.3233/JAD-132738; Sakai Kenji, 2013, Brain Nerve, V65, P461; Saraiva LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015230; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; Shimoke K, 2011, METHOD ENZYMOL, V490, P53, DOI 10.1016/B978-0-12-385114-7.00003-9; Simon D, 2011, CNS NEUROL DISORD-DR, V10, P208; Sureda FX, 2011, CURR PHARM DESIGN, V17, P230; Szewczyk B, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00033; Tillement L, 2011, NEURODEGENER DIS, V8, P331, DOI 10.1159/000323264; Tsai FM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-15; Vasileiou E, 2010, HIPPOKRATIA, V14, P155; Vazquez MC, 2009, J CELL PHYSIOL, V220, P136, DOI 10.1002/jcp.21743; Wang JW, 2004, INT J MOL MED, V14, P627; Xu Y, 2007, CELL DEATH DIFFER, V14, P79, DOI 10.1038/sj.cdd.4401928; Yamamoto Y, 2011, PLOS ONE, V6; Zapala B, 2010, PHARMACOL REP, V62, P767; Zhang H, 2011, APOPTOSIS, V16, P808, DOI 10.1007/s10495-011-0608-y; Zhang JH, 2003, AGEING RES REV, V2, P357, DOI 10.1016/S1568-1637(03)00026-6; Zhou Y, 2011, EXP TOXICOL PATHOL, V64, P673	125	4	4	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	DEC	2014	39	12					2301	2312		10.1007/s11064-014-1454-4		12	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	AU5KL	WOS:000345645700003		
J	Imafuku, M; Hakuno, Y; Uchida-Ota, M; Yamamoto, J; Minagawa, Y				Imafuku, Masahiro; Hakuno, Yoko; Uchida-Ota, Mariko; Yamamoto, Jun-ichi; Minagawa, Yasuyo			"Mom called me!" Behavioral and prefrontal responses of infants to self-names spoken by their mothers	NEUROIMAGE			English	Article						Self-name; Infants; Mother's voice; Near-infrared spectroscopy; The medial prefrontal cortex (mPFC)	TRANSCRANIAL FUNCTIONAL BRAIN; SUBJECTS OWN NAME; OPTICAL TOPOGRAPHY; SOCIAL COGNITION; RIGHT-HEMISPHERE; RECOGNITION; FAMILIARITY; PERCEPTION; VOICES; SPEECH	Development of a sense of self is a fundamental process needed for human social interaction. Although functional neuroimaging studies have revealed the importance of medial prefrontal cortex (mPFC) in self-referencing, how this function develops in infancy remains poorly understood. To determine the cerebral basis underlying processing of self-related stimuli, we used behavioral measures and functional multi-channel near-infrared spectroscopy (fNIRS) to measure prefrontal cortical responses in 6-month-old infants hearing their own names. We also investigated the influence of a mother's voice on name perception in infants - an ability that plays a crucial role in the recognition of social signals. Experiment 1 measured the behavioral preferences of infants for their own names and for other names, spoken either by their mothers or by strangers. Results showed that infants significantly preferred their own name to other names, regardless of speaker type. Experiment 2 examined hemodynamic responses to the same four conditions in the prefrontal cortex. Compared with other names, hearing their own names, especially when spoken by their mother, elicited greater activity in the infant's dorsal mPFC. Furthermore, the magnitude of the cerebral response correlated with the degree of behavioral preference only when involving their mother's voice. These findings suggest that, particularly in the context of their mothers' voice, the dorsal mPFC of infants is already sensitive to social signals related to self at 6 months. At the same time, familiarity and affection related processing are also discussed as possible factors modulating dorsal mPFC activation at this age. (C) 2014 Elsevier Inc. All rights reserved.	[Imafuku, Masahiro; Hakuno, Yoko; Yamamoto, Jun-ichi; Minagawa, Yasuyo] Keio Univ, Fac Letters, Dept Psychol, Minato Ku, Tokyo 1088345, Japan; [Imafuku, Masahiro] Kyoto Univ, Grad Sch Educ, Sakyo Ku, Kyoto 6068501, Japan; [Uchida-Ota, Mariko] Keio Univ, Grad Sch Human Relat, Minato Ku, Tokyo 1088345, Japan; [Minagawa, Yasuyo] Ecole Normale Super, Inst Etud Cognit, F-75005 Paris, France	Minagawa, Y (reprint author), Keio Univ, Fac Letters, Dept Psychol, Minato Ku, 2-15-45 Mita, Tokyo 1088345, Japan.	myasuyo@bea.hi-ho.ne.jp			Global Center of Excellence (GCOE) program at Keio University;  [24118508];  [24300105]	This work was supported by the Global Center of Excellence (GCOE) program at Keio University, Grant-in-Aid for Scientific Research (KAKENHI) (B) (Project No. 24118508) and Grant-in-Aid for Scientific Research on Innovation Areas (Project No. 24300105) to YM. Part of this work was the undergraduate thesis of the first author. We would like to thank all the children and their parents who participated in this research at Keio Baby Lab. We also thank S. Ishii for assistance with the experiments, M. Myowa-Yamakoshi and lab members of Kyoto University for the helpful suggestions, I. Imahori for proof reading and R. Wu for helpful comments on earlier drafts of this paper.	Taga G, 2003, P NATL ACAD SCI USA, V100, P10722, DOI 10.1073/pnas.1932552100; Osterling JA, 2002, DEV PSYCHOPATHOL, V14, P239; Holeckova I, 2006, BRAIN RES, V1082, P142, DOI 10.1016/j.brainres.2006.01.089; Bortfeld H, 2005, PSYCHOL SCI, V16, P298, DOI 10.1111/j.0956-7976.2005.01531.x; BARKOVICH AJ, 1988, RADIOLOGY, V166, P173; Seth AK, 2008, TRENDS COGN SCI, V12, P314, DOI 10.1016/j.tics.2008.04.008; Okamoto M, 2005, NEUROIMAGE, V26, P18, DOI 10.1016/j.neuroimage.2005.01.018; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4; NELSON DGK, 1995, INFANT BEHAV DEV, V18, P111; Naoi N, 2012, NEUROIMAGE, V59, P1735, DOI 10.1016/j.neuroimage.2011.07.093; Kovacs AM, 2010, SCIENCE, V330, P1830, DOI 10.1126/science.1190792; Keenan JP, 2001, NATURE, V409, P305, DOI 10.1038/35053167; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Skinner EI, 2007, NEUROPSYCHOLOGIA, V45, P2163, DOI 10.1016/j.neuropsychologia.2007.03.007; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Frith U, 2001, NEURON, V32, P969, DOI 10.1016/S0896-6273(01)00552-9; Tsuzuki D, 2007, NEUROIMAGE, V34, P1506, DOI 10.1016/j.neuroimage.2006.10.043; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Kampe KKW, 2003, J NEUROSCI, V23, P5258; Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Pena M, 2003, P NATL ACAD SCI USA, V100, P11702, DOI 10.1073/pnas.1934290100; DECASPER AJ, 1980, SCIENCE, V208, P1174, DOI 10.1126/science.7375928; Nakamura K, 2001, NEUROPSYCHOLOGIA, V39, P1047, DOI 10.1016/S0028-3932(01)00037-9; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Minagawa-Kawai Y, 2009, CEREB CORTEX, V19, P284, DOI 10.1093/cercor/bhn081; Fossati P, 2003, AM J PSYCHIAT, V160, P1938, DOI 10.1176/appi.ajp.160.11.1938; Perrin F, 2005, NEUROPSYCHOLOGIA, V43, P12, DOI 10.1016/j.neuropsychologia.2004.07.002; Nadig AS, 2007, ARCH PEDIAT ADOL MED, V161, P378, DOI 10.1001/archpedi.161.4.378; Barker B.A., 2004, COGNITION, V94, P45; Beauchemin M., 2010, CEREB CORTEX, V21, P1705; Csibra G., 2010, MIND LANG, V25, P141, DOI DOI 10.1111/J.1468-0017.2009.01384.X; Dan H, 2013, BRAIN LANG, V126, P208, DOI 10.1016/j.bandl.2013.05.007; Dehaene-Lambertz G., 2009, BRAIN LANG, V114, P53; Fukui Y, 2003, APPL OPTICS, V42, P2881, DOI 10.1364/AO.42.002881; Grossmann T, 2013, FRONT HUM NEUROSCI, V7, P1; Grossmann T, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00201; Hakuno Y., 2012, CARLS SERIES ADV RES, V5, P177; Hoehla S., 2011, DEV COGN NEUROSCI, V2, P81; Holeckova I, 2008, BRAIN RES, V1189, P152, DOI 10.1016/j.brainres.2007.10.091; Ikuzawa M., 2002, KYOTO SCALE PSYCHOL; Jasper H.H., 1958, CLIN NEUROPHYSIOL, V10, P367; Kanakogi Y., 2011, NAT COMMUN, V2, P1, DOI DOI 10.1038/NCOMMS1342; Lebedeva GC, 2010, INFANT BEHAV DEV, V33, P419, DOI 10.1016/j.infbeh.2010.04.006; MANDEL DR, 1995, PSYCHOL SCI, V6, P314, DOI 10.1111/j.1467-9280.1995.tb00517.x; Matsui M, 2014, NEUROSCI RES, V80, P55, DOI 10.1016/j.neures.2014.01.003; Montague DPF, 2002, CHILD DEV, V73, P1339, DOI 10.1111/1467-8624.00475; Neisser U., 1988, PHILOS PSYCHOL, V1, P35, DOI [10.1080/09515088808572924, DOI 10.1080/09515088808572924]; Parise E., 2010, PLOS ONE, V5, P1; Purhonen M, 2005, COGNITIVE BRAIN RES, V24, P627, DOI 10.1016/j.cogbrainres.2005.03.012; Sassa Y, 2007, NEUROIMAGE, V37, P985, DOI 10.1016/j.neuroimage.2007.05.059; Sato Y, 2007, NEUROREPORT, V18, P2001; Uchida-Ota M., 2011, CARLS SERIES ADV RES, V5, P137	53	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	DEC	2014	103						476	484		10.1016/j.neuroimage.2014.08.034		9	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AU1PR	WOS:000345393100047		
J	Tada, Y; Makino, H; Furukawa, H; Shimada, K; Wada, K; Liang, EI; Murakami, S; Kudo, M; Kung, DK; Hasan, DM; Kitazato, KT; Nagahiro, S; Lawton, MT; Hashimoto, T				Tada, Yoshiteru; Makino, Hiroshi; Furukawa, Hajime; Shimada, Kenji; Wada, Kosuke; Liang, Elena I.; Murakami, Shako; Kudo, Mari; Kung, David K.; Hasan, David M.; Kitazato, Keiko T.; Nagahiro, Shinji; Lawton, Michael T.; Hashimoto, Tomoki			Roles of Estrogen in the Formation of Intracranial Aneurysms in Ovariectomized Female Mice	NEUROSURGERY			English	Article						Animal model; Estrogen; Inflammation; Intracranial aneurysm; Nitric oxide; Stroke	RECEPTOR-BETA; PHARMACOLOGICAL STABILIZATION; SUBARACHNOID HEMORRHAGE; DECREASING INCIDENCE; CEREBRAL ANEURYSMS; PROMISING AGENT; S-NITROSYLATION; ER-BETA; DEFICIENCY; RUPTURE	BACKGROUND: Epidemiological studies have indicated that postmenopausal women have a higher incidence of intracranial aneurysms than men in the same age group. OBJECTIVE: To investigate whether estrogen or estrogen receptors (ERs) mediate protective effects against the formation of intracranial aneurysms. METHODS: Intracranial aneurysms were induced in mice by combining a single injection of elastase into the cerebrospinal fluid with deoxycorticosterone acetate salt hypertension. The mice were treated with estrogen (17 beta-estradiol), an ER alpha agonist (propyl pyrazole triol), and an ER beta agonist (diarylpropionitrile) with and without a nitric oxide synthase inhibitor. RESULTS: The ovariectomized female mice had a significantly higher incidence of aneurysms than the male mice, which was consistent with findings in previous epidemiological studies. In ovariectomized female mice, an ER beta agonist, but not an ER alpha agonist or 17 beta-estradiol, significantly reduced the incidence of aneurysms. The protective effect of the ER beta agonist was absent in the ovariectomized ER beta knockout mice. The protective effect of the ER beta agonist was negated by treatment with a nitric oxide synthase inhibitor. CONCLUSION: The effects of sex, menopause, and estrogen treatment observed in this animal study were consistent with previous epidemiological findings. Stimulation of estrogen receptor-beta was protective against the formation of intracranial aneurysms in ovariectomized female mice.	[Tada, Yoshiteru; Makino, Hiroshi; Furukawa, Hajime; Shimada, Kenji; Wada, Kosuke; Liang, Elena I.; Murakami, Shako; Kudo, Mari; Hashimoto, Tomoki] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94110 USA; [Tada, Yoshiteru; Shimada, Kenji; Hasan, David M.; Lawton, Michael T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94110 USA; [Kung, David K.] Univ Iowa Hosp & Clin, Dept Neurosurg, Iowa City, IA 52242 USA; [Kitazato, Keiko T.; Nagahiro, Shinji] Univ Tokushima, Sch Med, Dept Neurosurg, Tokushima 770, Japan	Hashimoto, T (reprint author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, 1001 Potrero Ave,3C-38, San Francisco, CA 94110 USA.	hashimot@anesthesia.ucsf.edu			National Institutes of Health/National Institute of Neurological Disorders and Stroke [R01NS055876, R01NS082280, K08NS082363]; American Heart Association [11GRNT6380003]; Brain Aneurysm Foundation Shirley Dudek Demmer Chair of Research	The project described was supported by R01NS055876 (Dr Hashimoto), R01NS082280 (Dr Hashimoto), and K08NS082363 (Dr Hasan) from the National Institutes of Health/National Institute of Neurological Disorders and Stroke, American Heart Association Grant-in-Aid 11GRNT6380003 (Dr Hashimoto), and the Brain Aneurysm Foundation Shirley Dudek Demmer Chair of Research (Drs Hashimoto and Shimada). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke, National Institutes of Health, the American Heart Association, and the Brain Aneurysm Foundation. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Hendrix SL, 2006, CIRCULATION, V113, P2425, DOI 10.1161/CIRCULATIONAHA.105.594077; Jamous MA, 2005, J NEUROSURG, V103, P1046, DOI 10.3171/jns.2005.103.6.1046; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Hasan DM, 2011, STROKE, V42, P3156, DOI 10.1161/STROKEAHA.111.619411; Frasor J, 2003, ENDOCRINOLOGY, V144, P3159, DOI 10.1210/en.2002-0143; Hashimoto T, 2006, NEUROL RES, V28, P372, DOI 10.1179/016164106X14973; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Jamous MA, 2005, J NEUROSURG, V103, P1052, DOI 10.3171/jns.2005.103.6.1052; Menghini VV, 1998, NEUROLOGY, V51, P405; Leitman DC, 2010, CURR OPIN PHARMACOL, V10, P629, DOI 10.1016/j.coph.2010.09.009; STOBER T, 1985, J NEUROL, V232, P67, DOI 10.1007/BF00313903; Lin J, 2009, CIRCULATION, V120, P245, DOI 10.1161/CIRCULATIONAHA.109.868729; Tiwari-Woodruff S, 2007, P NATL ACAD SCI USA, V104, P14813, DOI 10.1073/pnas.0703783104; Krause DN, 2006, J APPL PHYSIOL, V101, P1252, DOI 10.1152/japplphysiol.01095.2005; Nuki Y, 2009, HYPERTENSION, V54, P1337, DOI 10.1161/HYPERTENSIONAHA.109.138297; Suzuki S, 2007, P NATL ACAD SCI USA, V104, P6013, DOI 10.1073/pnas.0610394104; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Toutain CE, 2009, ARTERIOSCL THROM VAS, V29, P1543, DOI 10.1161/ATVBAHA.109.192849; Sun JH, 2006, CIRC RES, V98, P403, DOI 10.1161/01.RES.0000202707.79018.0a; Harrod CG, 2006, MED HYPOTHESES, V66, P736, DOI 10.1016/j.mehy.2005.09.051; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Becker C, 2010, NEW ENGL J MED, V362, P752, DOI 10.1056/NEJMe0912847; Cheng J, 2009, STEROIDS, V75, P754; Eden SV, 2008, NEUROLOGY, V71, P731, DOI 10.1212/01.wnl.0000319690.82357.44; Galea E, 2002, NEUROREPORT, V13, P1469, DOI 10.1097/00001756-200208070-00024; Hess DT, 2009, CIRCULATION, V120, P190, DOI 10.1161/CIRCULATIONAHA.109.876607; Kanematsu Y, 2011, STROKE, V42, P173, DOI 10.1161/STROKEAHA.110.590976; Makino H, 2012, STROKE, V43, P2450, DOI 10.1161/STROKEAHA.112.659821; Nuedling S, 2001, FEBS LETT, V502, P103, DOI 10.1016/S0014-5793(01)02675-8; Tada Y, 2011, ACTA NEUROCHIR SUPPL, V111, P31, DOI 10.1007/978-3-7091-0693-8_6; Tamura T, 2009, J HYPERTENS, V27, P1284, DOI 10.1097/HJH.0b013e328329d1a7; Tsutsumi S, 2008, J ENDOCRINOL, V199, P267, DOI 10.1677/JOE-07-0292; Tymianski M, 2011, STROKE, V42, P3003, DOI 10.1161/STROKEAHA.111.626762	33	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	DEC	2014	75	6					690	695		10.1227/NEU.0000000000000528		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AU2FK	WOS:000345431600031		
J	Ochi, K; Horiuchi, Y				Ochi, Kensuke; Horiuchi, Yukio			Fascicular Constrictions in Spontaneous Anterior Interosseous Nerve Palsy and Spontaneous Posterior Interosseous Nerve Palsy	NEUROSURGERY			English	Letter							SURGICAL-TREATMENT		[Ochi, Kensuke] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Ochi, Kensuke; Horiuchi, Yukio] Kawasaki Municipal Kawasaki Hosp, Dept Orthopaed Surg, Kawasaki, Kanagawa, Japan	Ochi, K (reprint author), Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan.						Nagano A, 2003, J BONE JOINT SURG BR, V85B, P313, DOI 10.1302/0301-620X.85B3.14147; Haussmann P, 1996, ORTHOP CLIN N AM, V27, P339; Pan YW, 2014, NEUROSURGERY, V75, P10, DOI 10.1227/NEU.0000000000000350; Ochi K, 2011, J BONE JOINT SURG BR, V93B, P217, DOI 10.1302/0301-620X.93B2.24748; Ochi K, 2012, J PLAST SURG HAND SU, V46, P19, DOI 10.3109/2000656X.2011.634558; Nakamichi K, 2007, J ULTRAS MED, V26, P683; Kodama A, 2014, J HAND SURG EUR; Ochi K, 2013, J PLAST SURG HAND SU, V47, P213, DOI 10.3109/2000656X.2012.753079; Okinaga S., 2011, JPN J ELBOW SOC, V18, pS71	9	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	DEC	2014	75	6					R737	E738		10.1227/NEU.0000000000000546		3	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AU2FK	WOS:000345431600005		
J	Tominaga, M; Naito, H; Morisaki, Y; Chujo, Y				Tominaga, Masato; Naito, Hirofumi; Morisaki, Yasuhiro; Chujo, Yoshiki			Colour-tunable aggregation-induced emission of trifunctional o-carborane dyes	NEW JOURNAL OF CHEMISTRY			English	Article							SOLID-STATE; PHOTOLUMINESCENCE; DERIVATIVES; BORON; FLUOROPHORES; POLYMERS; LUMINESCENCE; FLUORESCENCE; SUBSTITUENT; MOLECULES	o-Carborane compounds possessing emissive pi-electron systems at the Cl and B9 (and/or B12) positions exhibit dual emission, i.e., normal emission and aggregation-induced emission (AIE). Appropriate control of the emission intensity ratio for these dyes results in colour-tunable emission from blue to orange via white.	[Tominaga, Masato; Naito, Hirofumi; Morisaki, Yasuhiro; Chujo, Yoshiki] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158510, Japan	Morisaki, Y (reprint author), Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158510, Japan.	ymo@chujo.synchem.kyoto-u.ac.jp; chujo@chujo.synchem.kyoto-u.ac.jp			Japan Society for the Promotion of Science [24655102, 24102013]; Shorai Foundation for Science and Technology; Japan Society for the Promotion of Science for Young Scientists [12J03404]	This work was supported by Grant-in-Aid for Exploratory Research (No. 24655102) and Grant-in-Aid for Scientific Research on Innovative Areas "Element-Blocks" (No. 24102013) from the Japan Society for the Promotion of Science. Financial support from The Shorai Foundation for Science and Technology is also gratefully acknowledged. M.T. appreciates Research Fellowships (No. 12J03404) from the Japan Society for the Promotion of Science for Young Scientists.	BREGADZE VI, 1992, CHEM REV, V92, P209, DOI 10.1021/cr00010a002; Liu J, 2009, J INORG ORGANOMET P, V19, P249, DOI 10.1007/s10904-009-9282-8; Weber L, 2013, DALTON T, V42, P2266, DOI 10.1039/c2dt32378h; Kokado K, 2011, J ORG CHEM, V76, P316, DOI 10.1021/jo101999b; Yuan WZ, 2009, MACROMOLECULES, V42, P9400, DOI 10.1021/ma9012169; Wee KR, 2012, ANGEW CHEM INT EDIT, V51, P2677, DOI 10.1002/anie.201109069; Oliva JM, 2005, J AM CHEM SOC, V127, P13538, DOI 10.1021/ja052091b; Dash BP, 2011, NEW J CHEM, V35, P1955, DOI 10.1039/c1nj20228f; Zaumseil J, 2007, CHEM REV, V107, P1296, DOI 10.1021/cr0501543; Gonzalez-Campo A, 2008, MACROMOLECULES, V41, P8458, DOI 10.1021/ma801483c; Liu SJ, 2010, ORG ELECTRON, V11, P613, DOI 10.1016/j.orgel.2009.12.026; Wee KR, 2013, ANGEW CHEM INT EDIT, V52, P9682, DOI 10.1002/anie.201304321; Kokado K, 2009, MACROMOLECULES, V42, P1418, DOI 10.1021/ma8027358; Heng LP, 2008, LANGMUIR, V24, P2157, DOI 10.1021/la702888v; Dash BP, 2011, INORG CHEM, V50, P5485, DOI 10.1021/ic200010q; Wee KR, 2012, J AM CHEM SOC, V134, P17982, DOI 10.1021/ja3066623; Ohta K, 2005, INORG CHEM, V44, P8569, DOI 10.1021/ic0509736; Zhang GF, 2012, CHEM COMMUN, V48, P7711, DOI 10.1039/c2cc33218c; Peterson JJ, 2011, ACS APPL MATER INTER, V3, P1796, DOI 10.1021/am2000856; Yoshii R, 2013, CHEM-EUR J, V19, P4506, DOI 10.1002/chem.201203703; Ferrer-Ugalde A, 2012, CHEM-EUR J, V18, P544, DOI 10.1002/chem.201101881; Teixidor F, 2005, J AM CHEM SOC, V127, P10158, DOI 10.1021/ja052981; Weber L, 2012, CHEM-EUR J, V18, P8347, DOI 10.1002/chem.201200390; Li Z, 2005, J PHYS CHEM B, V109, P10061, DOI 10.1021/jp0503462; Peterson JJ, 2009, MACROMOLECULES, V42, P8594, DOI 10.1021/ma901703r; Spokoyny AM, 2011, NAT CHEM, V3, P590, DOI [10.1038/nchem.1088, 10.1038/NCHEM.1088]; Issa F, 2011, CHEM REV, V111, P5701, DOI 10.1021/cr2000866; Fox MA, 2002, J MATER CHEM, V12, P1301, DOI 10.1039/b108721e; Lu HG, 2012, J MATER CHEM, V22, P9890, DOI 10.1039/c2jm30258f; Llop J, 2002, J ORGANOMET CHEM, V657, P232, DOI 10.1016/S0022-328X(02)01637-6; Tominaga M, 2013, MACROMOL RAPID COMM, V34, P1357, DOI 10.1002/marc.201300368; Davis AR, 2012, ACS MACRO LETT, V1, P469, DOI 10.1021/mz300037u; Ferrer-Ugalde A, 2013, CHEM-EUR J, V19, P17021, DOI 10.1002/chem.201302493; Cheng YJ, 2009, CHEM REV, V109, P5868, DOI 10.1021/cr900182s; Wang ZK, 2013, J AM CHEM SOC, V135, P8238, DOI 10.1021/ja312581r; Anthony JE, 2006, CHEM REV, V106, P5028, DOI 10.1021/cr050966z; Dash B.P., 2011, BORON SCI NEW TECHNO, P675, DOI DOI 10.1201/B11199-34; Fan X, 2008, CHEM COMMUN, P2989, DOI 10.1039/b803539c; Ferrer-Ugalde A, 2014, CHEM-EUR J, V20, P9940, DOI 10.1002/chem.201402396; Grimes R. N., CARBORANES, P301; Luo JD, 2001, CHEM COMMUN, P1740, DOI 10.1039/b105159h; Skotheim T. A., 1997, HDB CONDUCTING POLYM; Sonogashira K., 2002, HDB ORGANOPALLADIUM, P493, DOI DOI 10.1002/04712I2466.CH22; Lerouge F, 2011, DALTON T, V40, P7541, DOI 10.1039/c1dt10309a; Tohda Y., 1975, TETRAHEDRON LETT, V16, P4467	45	4	4	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1144-0546	1369-9261		NEW J CHEM	New J. Chem.	DEC	2014	38	12					5686	5690		10.1039/c4nj00955j		5	Chemistry, Multidisciplinary	Chemistry	AU3AI	WOS:000345485000002		
J	Tatsumi, Y; Fujinaga, N; Kasuno, M; Morimoto, M; Yokojima, S; Nakamura, S; Uchida, K				Tatsumi, Yuto; Fujinaga, Noriko; Kasuno, Megumi; Morimoto, Masakazu; Yokojima, Satoshi; Nakamura, Shinichiro; Uchida, Kingo			A photo- and halochromic multicolor switching system consisting of diarylethene and malachite green moieties	NEW JOURNAL OF CHEMISTRY			English	Article							SINGLE-CRYSTALLINE PHASE; NONDESTRUCTIVE READOUT; FUSED DITHIENYLETHENE; MOLECULAR SWITCHES; QUANTUM YIELDS; PHOTOCHROMISM; DERIVATIVES; FLUORESCENCE; REACTIVITY	A diarylethene with an attached malachite green moiety was synthesized. The diarylethene moiety undergoes reversible cyclization and cycloreversion reactions upon alternate irradiation with UV (313 nm) and visible (435 nm) light, while the malachite green moiety reversibly changes between neutral, monocationic, and dicationic states up to the proton concentration. The photochromic and halochromic reactions could be controlled, and this provided a multi-reversible system with six states. The cyclization and cycloreversion quantum yields of the diarylethene moiety were dependent on the states of the malachite green moiety.	[Tatsumi, Yuto; Fujinaga, Noriko; Kasuno, Megumi; Uchida, Kingo] Ryukoku Univ, Fac Sci & Technol, Dept Chem Mat, Otsu, Shiga 5202194, Japan; [Morimoto, Masakazu] Rikkyo Univ, Dept Chem, Toshima Ku, Tokyo 1718501, Japan; [Morimoto, Masakazu] Rikkyo Univ, Res Ctr Smart Mol, Toshima Ku, Tokyo 1718501, Japan; [Yokojima, Satoshi] Tokyo Univ Pharm & Life Sci, Sch Pharm, Hachioji, Tokyo 1920392, Japan; [Nakamura, Shinichiro] RIKEN Res Cluster Innovat, Nakamura Lab, Wako, Saitama 3510198, Japan	Kasuno, M (reprint author), Ryukoku Univ, Fac Sci & Technol, Dept Chem Mat, Otsu, Shiga 5202194, Japan.	uchida@rins.ryukoku.ac.jp	Morimoto, Masakazu/F-3232-2013	Morimoto, Masakazu/0000-0002-7494-0404	MEXT-Supported Program for the Strategic Research Foundation at Private Universities	The authors are also grateful to Zeon Co., Ltd, for providing the octafluorocyclopentene to synthesize compound 1A. This work was supported by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities.	Morimoto M, 2003, J AM CHEM SOC, V125, P11080, DOI 10.1021/ja035277o; Kobatake S, 1999, J AM CHEM SOC, V121, P2380, DOI 10.1021/ja983717j; SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; IRIE M, 1988, J ORG CHEM, V53, P803, DOI 10.1021/jo00239a022; Raymo FM, 2002, ADV MATER, V14, P401, DOI 10.1002/1521-4095(20020318)14:6<401::AID-ADMA401>3.0.CO;2-F; Higashiguchi K, 2003, ANGEW CHEM INT EDIT, V42, P3537, DOI 10.1002/anie.200351751; Pu SZ, 2012, J MATER CHEM, V22, P3517, DOI 10.1039/c2jm15262b; Sumi T, 2014, CHEM COMMUN, V50, P3928, DOI 10.1039/c4cc00396a; Pu SZ, 2013, J MATER CHEM C, V1, P4726, DOI 10.1039/c3tc30804a; Irie M, 2002, NATURE, V420, P759, DOI 10.1038/420759a; Irie M, 2000, CHEM REV, V100, P1685, DOI 10.1021/cr980069d; Irie M, 1995, J ORG CHEM, V60, P8305, DOI 10.1021/jo00130a035; Suzuki K, 2012, CHEM COMMUN, V48, P765, DOI 10.1039/c1cc16516j; de Silva AP, 1997, CHEM REV, V97, P1515, DOI 10.1021/cr960386p; IRIE M, 1994, J AM CHEM SOC, V116, P9894, DOI 10.1021/ja00101a010; Stojanovic MN, 2002, J AM CHEM SOC, V124, P3555, DOI 10.1021/ja016756v; IRIE M, 1986, MACROMOLECULES, V19, P2476, DOI 10.1021/ma00164a003; Massaad J, 2012, CHEM-EUR J, V18, P6568, DOI 10.1002/chem.201103896; Pu SZ, 2013, CHEM COMMUN, V49, P8036, DOI 10.1039/c3cc44348e; Perrier A, 2012, ACCOUNTS CHEM RES, V45, P1173, DOI 10.1021/ar200214k; Uchida K, 2001, TETRAHEDRON, V57, P4559, DOI 10.1016/S0040-4020(01)00389-1; Liu G, 2013, ORG LETT, V15, P980, DOI 10.1021/ol400188h; Higashiguchi K, 2005, J AM CHEM SOC, V127, P8922, DOI 10.1021/ja051467i; Brown G. H., 1971, PHOTOCHROMISM; Crano J. C., 1999, ORGANIC PHOTOCHROMIC, V1; Duerr H., 2003, PHOTOCHROMISM MOL SY; Feringa BL, 2011, MOLECULAR SWITCHES, VOL 1, 2ND EDITION, P1, DOI 10.1002/9783527634408; Fukaminato T, 2003, J PHYS CHEM B, V107, P8372, DOI 10.1021/jp034624d; Irie M, 1999, CHEM COMMUN, P747, DOI 10.1039/a809410a; Kawai SH, 1999, EUR J ORG CHEM, P2359; KAWAI SH, 1995, CHEM-EUR J, V1, P285, DOI 10.1002/chem.19950010505; Kobatake S, 1999, J AM CHEM SOC, V121, P8450, DOI 10.1021/ja991013j; Kobatake S, 2002, CHEM COMMUN, P2804, DOI 10.1039/b208419h; Liu HH, 2012, J PHYS CHEM A, V116, P9900, DOI 10.1021/jp3070163; Lund H., 1931, THEORY HALOCHROMISM; Nishikawa N, 2013, LANGMUIR, V29, P8164, DOI 10.1021/la4014834; Odo Y, 2006, CHEM-EUR J, V12, P4283, DOI 10.1002/chem.200501292; Roque A, 2003, J AM CHEM SOC, V125, P987, DOI 10.1021/ja0287276; Peters A, 2000, ADV MATER OPT ELECTR, V10, P245, DOI 10.1002/1099-0712(200011/12)10:6<245::AID-AMO422>3.0.CO;2-O; Pina F, 1997, J AM CHEM SOC, V119, P5556, DOI 10.1021/ja9704646; Samat A, 2001, TETRAHEDRON, V57, P7349, DOI 10.1016/S0040-4020(01)00693-7; Sevez G, 2010, PHOTOCH PHOTOBIO SCI, V9, P131, DOI 10.1039/b9pp00127a; Sheldrick G. M., 1997, SHELXL 97 PROGRAM CR; Kobatake S, 2007, CHEM COMMUN, P1698, DOI 10.1039/b700177k; Uchida K, 2005, CHEM-EUR J, V11, P534, DOI 10.1002/chem.200400575; UCHIDA M, 1993, J AM CHEM SOC, V115, P6442, DOI 10.1021/ja00067a082; Yamaguchi T, 2014, J PHYS CHEM A, V118, P134, DOI 10.1021/jp411190d; YOKOYAMA Y, 1991, J CHEM SOC CHEM COMM, P1722, DOI 10.1039/c39910001722; Yumoto K, 2008, ORG LETT, V10, P2051, DOI 10.1021/ol8005216	49	0	0	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1144-0546	1369-9261		NEW J CHEM	New J. Chem.	DEC	2014	38	12					5706	5714		10.1039/c4nj00434e		9	Chemistry, Multidisciplinary	Chemistry	AU3AI	WOS:000345485000006		
J	Sato, H; Ochi, M; Kato, M; Tamura, K; Yamagishi, A				Sato, Hisako; Ochi, Miwa; Kato, Masaru; Tamura, Kenji; Yamagishi, Akihiko			Energy transfer in hybrid Langmuir-Blodgett films of iridium complexes and synthetic saponite: dependence of transfer efficiency on the interlayer distance	NEW JOURNAL OF CHEMISTRY			English	Article							CATIONIC PORPHYRIN COMPLEXES; SIZE-MATCHING RULE; CLAY SURFACE; RUTHENIUM(II) COMPLEXES; ALKYLAMMONIUM CATION; TRIDENTATE LIGANDS; ORIENTATION FACTOR; ROOM-TEMPERATURE; METAL-COMPLEXES; EXCITED-STATES	Multi-layered hybrid films comprised of amphiphilic cationic iridium(III) complexes and the exfoliated layers of synthetic saponite were prepared by the modified Langmuir-Blodgett method. Two iridium(III) complexes, [Ir(dfppy)(2)(dc9bpy)](+) (dfppyH = 2-(4',6'-difluorophenyl)pyridine; dc9bpy = 4,4'-dinonyl-2,2'-bipyridine) and [Ir(dfppy)(2)(dc9bpy)(+) (piqH = 1-phenyisoquinoline), were used as blue (donor) and red emitters (acceptor), respectively. A non-luminescent hybrid layer of stearylammonium and synthetic saponite was deposited in a layer-by-layer manner to vary the distance between the donor and acceptor layers. Energy transfer was analysed according to the Forster-type mechanism with a focus on the dependence of its efficiency on the interlayer distance.	[Sato, Hisako; Ochi, Miwa] Ehime Univ, Grad Sch Sci & Engn, Dept Chem, Matsuyama, Ehime 7908577, Japan; [Kato, Masaru] Hokkaido Univ, Grad Sch Environm Sci, Div Environm Mat Sci, Sapporo, Hokkaido 0600810, Japan; [Tamura, Kenji] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Yamagishi, Akihiko] Toho Univ, Dept Chem, Chiba 2748510, Japan	Sato, H (reprint author), Ehime Univ, Grad Sch Sci & Engn, Dept Chem, Matsuyama, Ehime 7908577, Japan.	sato.hisako.my@ehime-u.ac.jp	Kato,  Masaru/H-6801-2012	Kato,  Masaru/0000-0002-2845-3525	MEXT KAKENHI [23350069, 26288039, 23655200]; Nippon Sheet Glass Foundation of Materials and Science and Engineering of Japan; JST A-STEP [AS2421179M]	We thank Prof. Takafumi Kitazawa (Toho University) for suggestions. This work has been financially supported by the MEXT KAKENHI Grant-Aid-for Scientific Research (B) Number 23350069, 26288039, Grant-in-Aid for Exploratory Research Number 23655200 and Nippon Sheet Glass Foundation of Materials and Science and Engineering of Japan and JST A-STEP Number AS2421179M.	Aiello D, 2011, NEW J CHEM, V35, P141, DOI 10.1039/c0nj00533a; Sato H, 2014, NEW J CHEM, V38, P132, DOI 10.1039/c3nj00879g; KING KA, 1985, J AM CHEM SOC, V107, P1431, DOI 10.1021/ja00291a064; Yui T, 2013, LANGMUIR, V29, P10705, DOI 10.1021/la4019212; Hecht S, 2001, ANGEW CHEM INT EDIT, V40, P74, DOI 10.1002/1521-3773(20010105)40:1<74::AID-ANIE74>3.0.CO;2-C; Tian N, 2010, EUR J INORG CHEM, P4875, DOI 10.1002/ejic.201000610; Odobel F, 2013, ENERG ENVIRON SCI, V6, P2041, DOI 10.1039/c3ee24229c; Waki M, 2011, ANGEW CHEM INT EDIT, V50, P11667, DOI 10.1002/anie.201104063; Medlycott EA, 2005, CHEM SOC REV, V34, P133, DOI 10.1039/b316486c; Takagi S, 2006, LANGMUIR, V22, P1406, DOI 10.1021/la052911y; Eguchi M, 2014, TETRAHEDRON LETT, V55, P2662, DOI 10.1016/j.tetlet.2014.03.027; Ishida Y, 2011, J AM CHEM SOC, V133, P14280, DOI 10.1021/ja204425u; Ishida Y, 2012, J PHYS CHEM C, V116, P7879, DOI 10.1021/jp300842f; Xie ZG, 2010, J AM CHEM SOC, V132, P922, DOI 10.1021/ja909629f; Frischmann PD, 2013, CHEM SOC REV, V42, P1847, DOI 10.1039/c2cs35223k; Sajoto T, 2009, J AM CHEM SOC, V131, P9813, DOI 10.1021/ja903317w; DeRosa MC, 2003, INORG CHEM, V42, P4864, DOI 10.1021/ic026230r; Ishida Y, 2012, ACS APPL MATER INTER, V4, P811, DOI 10.1021/am201465a; Mori K, 2011, J PHYS CHEM C, V115, P21358, DOI 10.1021/jp208357e; Tsuboyama A, 2003, J AM CHEM SOC, V125, P12971, DOI 10.1021/ja034732d; Ladouceur S, 2010, INORG CHEM, V49, P5625, DOI 10.1021/ic100521t; Collini E, 2013, CHEM SOC REV, V42, P4932, DOI 10.1039/c3cs35444j; Calzaferri G, 2011, CHEMPHYSCHEM, V12, P580, DOI 10.1002/cphc.201000947; Lowry MS, 2006, CHEM-EUR J, V12, P7970, DOI 10.1002/chem.200600618; Ward MD, 2013, CHEM SOC REV, V42, P1619, DOI 10.1039/c2cs35123d; Dey D, 2013, J PHOTOCH PHOTOBIO A, V252, P174, DOI 10.1016/j.jphotochem.2012.12.003; Roldan-Carmona C, 2011, PHYS CHEM CHEM PHYS, V13, P2834, DOI 10.1039/c0cp01683g; Yang J, 2012, CHEM SOC REV, V41, P4808, DOI 10.1039/c2cs35022j; Umemura Y, 2002, J AM CHEM SOC, V124, P992, DOI 10.1021/ja016005t; Morimoto K, 2012, NEW J CHEM, V36, P2467, DOI 10.1039/c2nj40351j; OGAWA M, 1995, CHEM REV, V95, P399, DOI 10.1021/cr00034a005; Tamayo AB, 2005, INORG CHEM, V44, P8723, DOI 10.1021/ic050970t; Tamayo AB, 2003, J AM CHEM SOC, V125, P7377, DOI 10.1021/ja034537z; Seth D, 2005, CHEM PHYS LETT, V401, P546, DOI 10.1016/j.cplett.2004.11.119; Sasai R, 2009, J PHYS CHEM C, V113, P415, DOI 10.1021/jp805201n; Ishida Y, 2012, J PHYS CHEM A, V116, P12065, DOI 10.1021/jp309502j; Hoertz PG, 2005, INORG CHEM, V44, P6828, DOI 10.1021/ic050779j; Sato H, 2010, NEW J CHEM, V34, P617, DOI 10.1039/b9nj00714h; Verma S, 2012, J PHYS CHEM LETT, V3, P1877, DOI 10.1021/jz300639q; Sato H, 2011, NEW J CHEM, V35, P394, DOI 10.1039/c0nj00534g; Balaban TS, 2005, ACCOUNTS CHEM RES, V38, P612, DOI 10.1021/ar040211z; Barbieri A, 2012, COORDIN CHEM REV, V256, P1732, DOI 10.1016/j.ccr.2012.02.006; Bolink HJ, 2010, LANGMUIR, V26, P11461, DOI 10.1021/la100956w; Bujadk J., 2010, J PHYS CHEM-US, V114, P1246; Clemente-Leon M, 2010, LANGMUIR, V26, P1316, DOI 10.1021/la902513z; DeRosa MC, 2004, J AM CHEM SOC, V126, P7619, DOI 10.1021/ja049872h; Greenwell H. C., 2010, GREEN CHEM, V12, P685; Hussain SA, 2010, SPECTROCHIM ACTA A, V75, P664, DOI 10.1016/j.saa.2009.11.037; Kuroda T, 2010, J PHYS CHEM C, V114, P983, DOI 10.1021/jp910341f; Loura LMS, 2012, INT J MOL SCI, V13, P15252, DOI 10.3390/ijms131115252; Medlycott EA, 2006, COORDIN CHEM REV, V250, P1763, DOI 10.1016/j.ccr.2006.02.015; Richter B, 1999, J CHEM PHYS, V111, P5191, DOI 10.1063/1.479773; Sato H, 2014, APPL CLAY SCI, V97-98, P84, DOI 10.1016/j.clay.2014.05.008; Sato H, 2007, J PHOTOCH PHOTOBIO C, V8, P67, DOI 10.1016/j.jphotochemrev.2007.04.001; Sato H, 2005, J PHYS CHEM B, V109, P18935, DOI 10.1021/jp053541p; Schoonheydt RA, 2014, APPL CLAY SCI, V96, P9, DOI 10.1016/j.clay.2014.04.010; Shichi T., 2000, J PHOTOCH PHOTOBIO C, V1, P113, DOI 10.1016/S1389-5567(00)00008-3; Shimada T, 2012, J PHYS CHEM B, V116, P4484, DOI 10.1021/jp2098894; Takagi S, 2002, J PHYS CHEM B, V106, P5455, DOI 10.1021/jp0200977; Tamura K., 1999, LANGMUIR, V15, P6915, DOI 10.1021/la981396j; Umemura Y, 2005, LANGMUIR, V21, P4520, DOI 10.1021/la0469497	61	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1144-0546	1369-9261		NEW J CHEM	New J. Chem.	DEC	2014	38	12					5715	5720		10.1039/c4nj00818a		6	Chemistry, Multidisciplinary	Chemistry	AU3AI	WOS:000345485000007		
J	Guo, XZ; Cai, XB; Song, J; Zhu, Y; Nakanishi, K; Kanamori, K; Yang, H				Guo, Xingzhong; Cai, Xiaobo; Song, Jie; Zhu, Yang; Nakanishi, Kazuki; Kanamori, Kazuyoshi; Yang, Hui			Facile synthesis of monolithic mayenite with well-defined macropores via an epoxide-mediated sol-gel process accompanied by phase separation	NEW JOURNAL OF CHEMISTRY			English	Article							HIERARCHICALLY POROUS MATERIALS; MICROPOROUS CRYSTAL; MESOSTRUCTURED SKELETONS; INORGANIC ELECTRIDE; TITANIUM-OXIDES; 12CAO-CENTER-DOT-7AL(2)O(3); AEROGELS; ANIONS; TIO2; ION	Monolithic mayenite with well-defined macropores has been successfully synthesized from ionic precursors via a sol-gel process accompanied by phase separation. The addition of propylene oxide (PO) to the starting solution leads to homogenous gelation and modifies the gel skeleton, whereas the addition of poly(ethylene oxide) (PEO) induces phase separation. Glycol acts as a chelating agent to suppress the precipitation of Ca2+ ions, and formamide works as a drying control chemical additive to enhance the drying behavior. Appropriate amounts of solvents, PEO, and PO allow the formation of calcium aluminate gets with co-continuous macroporous structure. The reaction mechanism of the sol-gel process of the Ca-Al-O system is also investigated by TG-DSC, FT-IR and NMR. The dried gels are amorphous and the crystalline phase Ca12Al14O32Cl2 forms after heat-treatment at 1000 degrees C in air, while the macroporous structure is preserved. The resultant monoliths before and after heat-treatment possess both high porosity and smooth and dense skeletons.	[Guo, Xingzhong; Cai, Xiaobo; Song, Jie; Yang, Hui] Zhejiang Univ, Dept Mat Sci & Engn, Hangzhou 310027, Zhejiang, Peoples R China; [Zhu, Yang; Nakanishi, Kazuki; Kanamori, Kazuyoshi] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan	Yang, H (reprint author), Zhejiang Univ, Dept Mat Sci & Engn, Hangzhou 310027, Zhejiang, Peoples R China.	yanghui@zju.edu.cn	Nakanishi, Kazuki/A-1814-2012; Kanamori, Kazuyoshi/A-5561-2011		National Natural Science Foundation of China [51372225]; Zhejiang Provincial Natural Science Foundation of China [LY13B010001]	This work is supported by the National Natural Science Foundation of China (51372225) and Zhejiang Provincial Natural Science Foundation of China (LY13B010001).	Matsuishi S, 2003, SCIENCE, V301, P626, DOI 10.1126/science.1083842; Sushko PV, 2007, J AM CHEM SOC, V129, P942, DOI 10.1021/ja066177w; Gash AE, 2001, J NON-CRYST SOLIDS, V285, P22, DOI 10.1016/S0022-3093(01)00427-6; Li J, 2005, CHEM MATER, V17, P2771, DOI 10.1021/cm0500354; Hasegawa G, 2011, CHEM MATER, V23, P5208, DOI 10.1021/cm2021438; Li WY, 2013, J SOL-GEL SCI TECHN, V67, P639, DOI 10.1007/s10971-013-3123-5; Guo XZ, 2013, J SOL-GEL SCI TECHN, V67, P406, DOI 10.1007/s10971-013-3094-6; Nakanishi K, 2007, ACCOUNTS CHEM RES, V40, P863, DOI 10.1021/ar600034p; Guo XZ, 2013, J POROUS MAT, V20, P1477, DOI 10.1007/s10934-013-9733-z; Guo XZ, 2014, J EUR CERAM SOC, V34, P817, DOI 10.1016/j.jeurceramsoc.2013.08.016; Gash AE, 2003, CHEM MATER, V15, P3268, DOI 10.1021/cm034211p; Rao AV, 1999, MATER CHEM PHYS, V60, P268; Kido Y, 2012, CHEM MATER, V24, P2071, DOI 10.1021/cm300495j; Tokudome Y, 2007, CHEM MATER, V19, P3393, DOI 10.1021/cm063051p; Toda Y, 2007, ADV MATER, V19, P3564, DOI 10.1002/adma.200700663; Hasegawa G, 2010, J AM CERAM SOC, V93, P3110, DOI 10.1111/j.1551-2916.2010.03831.x; Dorin RM, 2014, CHEM MATER, V26, P339, DOI 10.1021/cm4024056; Konishi J, 2006, CHEM MATER, V18, P6069, DOI 10.1021/cm0617485; Nakanishi K, 1997, J POROUS MAT, V4, P67, DOI 10.1023/A:1009627216939; Gash AE, 2001, CHEM MATER, V13, P999, DOI 10.1021/cm0007611; Lee DK, 2009, PHYS CHEM CHEM PHYS, V11, P3105, DOI 10.1039/b818474g; Hayashi K, 2002, J AM CHEM SOC, V124, P738, DOI 10.1021/ja016112n; CALZADA ML, 1995, J AM CERAM SOC, V78, P1802, DOI 10.1111/j.1151-2916.1995.tb08892.x; Matsuishi S, 2009, CHEM MATER, V21, P2589, DOI 10.1021/cm9007987; HOSONO H, 1987, INORG CHEM, V26, P1192, DOI 10.1021/ic00255a003; Sushko PV, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.126401; Hayashi K, 2002, NATURE, V419, P462, DOI 10.1038/nature01053; Konishi J, 2008, CHEM MATER, V20, P2165, DOI 10.1021/cm703351d; Bartl H., 1970, NEUES JB MINER MONAT, P547; KARLIK SJ, 1983, INORG CHEM, V22, P525, DOI 10.1021/ic00145a031; Gash AE, 2004, J NON-CRYST SOLIDS, V350, P145, DOI 10.1016/j.jnoncrysol.2004.06.030; Guo X. Z., 2013, J EUR CERAM SOC, V15, P3268; Hasegawa G, 2013, CHEM MATER, V25, P3504, DOI 10.1021/cm401933a; Imlach J. A., 1971, CEMENT CONCRETE RES, V1, P57, DOI 10.1016/0008-8846(71)90083-4; JEEVARATNAM J, 1964, J AM CERAM SOC, V47, P105, DOI 10.1111/j.1151-2916.1964.tb15669.x; Kawamoto K., 2008, P S ORG IN HYBR MAT, V1007, P63; Kitada A, 2012, J AM CHEM SOC, V134, P10894, DOI 10.1021/ja302083n; Konishi J, 2006, CHEM MATER, V18, P864, DOI 10.1021/cm052155h; Kubicki JD, 1999, J PHYS CHEM A, V103, P903, DOI 10.1021/jp983462w; Kurashige K, 2006, CRYST GROWTH DES, V6, P1602, DOI 10.1021/cg0600290; Li WY, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/4/045007; Li ZY, 2004, ANGEW CHEM INT EDIT, V43, P6479, DOI 10.1002/anie.200461200; Matsuishi S, 2005, J AM CHEM SOC, V127, P12454, DOI 10.1021/ja053568m; Miyakawa M, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2735280; Miyakawa M, 2003, ADV MATER, V15, P1100, DOI 10.1002/adma.200304925; Nurse R.W., 1965, BRIT CERAM T, V64, P323; Ozawa K., 2011, J CERAM SOC JPN, V119, P469; Sun JQ, 2010, ACTA PHYS-CHIM SIN, V26, P795, DOI 10.3866/PKU.WHXB20100241; Toda, 2011, ACS NANO, V5, P1907; Toda Y, 2004, ADV MATER, V16, P685, DOI 10.1002/adma.200306484; Tokudome Y, 2011, J SOL-GEL SCI TECHN, V57, P269, DOI 10.1007/s10971-010-2184-y; Ude SN, 2014, CERAM INT, V40, P1117, DOI 10.1016/j.ceramint.2013.06.112; Viart N, 1996, J NON-CRYST SOLIDS, V195, P223, DOI 10.1016/0022-3093(95)00540-4; Zahedi M, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/3/035404	54	5	5	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1144-0546	1369-9261		NEW J CHEM	New J. Chem.	DEC	2014	38	12					5832	5839		10.1039/c4nj00898g		8	Chemistry, Multidisciplinary	Chemistry	AU3AI	WOS:000345485000022		
J	Guo, LM; Ida, S; Daio, T; Hagiwara, H; Ishihara, T				Guo, Limin; Ida, Shintaro; Daio, Takashi; Hagiwara, Hidehisa; Ishihara, Tatsumi			In situ carbonization of a soft-template to directly synthesize crystalline mesoporous metal oxides with high surface areas	NEW JOURNAL OF CHEMISTRY			English	Article							PHOTOCATALYTIC ACTIVITY; TANTALUM OXIDE; ELECTROCHEMICAL PERFORMANCE; WATER; TA3N5; TAON; NANOCOMPOSITE; MESOSTRUCTURE; DECOMPOSITION; HYDROGEN	High-surface-area crystalline mesoporous d(0) metal oxides such as Ta2O5, Nb2O5, and TiO2 were synthesized via a one-pot method using pluronic triblock copolymer P-123 as a structure directing agent. Mesostructure stability during metal oxide crystallization via high temperature calcination is difficult to maintain in such synthesis. In this study, two heat treatments were proven to play a key role in achieving this goal. The first one is the intermediate heat treatment that preconsolidates the mesostructure and partially decomposes P-123 into carbon-rich species. The second heat treatment relies on high temperature calcination under an inert atmosphere to simultaneously form carbon wrapping on the metal oxides in situ and achieve crystallization of metal oxides. These two treatments successfully restricted the porous structure collapse and crystal size growth during high temperature crystallization. The as-synthesized crystalline mesoporous metal oxides show disordered mesoporous structures consisting of polycrystals. Notably, the commonly used P-123 surfactant without the sp(2)-hybridized carbon forms much amorphous carbon in situ, which effectively restricts mass transfer during crystallization and thus successfully prevents crystal size growth. The as-synthesized crystalline mesoporous Ta2O5, Nb2O5, and TiO2 displayed surface areas of 117.0, 125, and 76.2 m(2) g(-1), respectively, and pore sizes of 5.4, 8.1, and 13.9 nm, respectively. Crystal sizes amounted to 19, 28, and 34 nm for mesoporous Ta2O5, Nb2O5, and TiO2, respectively. Porous and crystal structures of the as-synthesized samples are characterized using X-ray diffraction, thermogravimetric-differential thermal analysis, scanning electron microscopy, transmission electron microscopy, X-ray photoelectron spectroscopy, and N-2 sorption techniques. The photocatalytic performance of the as-synthesized crystalline mesoporous Ta2O5 is also evaluated. Using NiOx as a cocatalyst, the as-prepared crystalline mesoporous Ta2O5 showed stable overall water splitting under Xe lamp irradiation (full arc). When the light intensity is fixed at 0.17-0.18 W cm(-2), the highest H-2 evolution rate is 709.1 mu mol g(-1) h(-1).	[Guo, Limin; Ishihara, Tatsumi] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, Fukuoka 8190395, Japan; [Ida, Shintaro; Hagiwara, Hidehisa] Kyushu Univ, Dept Appl Chem, Nishi Ku, Fukuoka 8190395, Japan; [Daio, Takashi] Kyushu Univ, Int Res Ctr Hydrogen Energy, Nishi Ku, Fukuoka 8190395, Japan	Guo, LM (reprint author), Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	lmguo1982@gmail.com; ishihara@cstf.kyushu-u.ac.jp	Guo, Limin/K-4199-2012		International Institute for Carbon-Neutral Energy Research (WPI-I<SUP>2</SUP>CNER); MEXT (Japan) [26810125]; Kyushu University; Ministry of Education, Culture, Sports, Science and Technology (MEXT)	This work was supported by the International Institute for Carbon-Neutral Energy Research (WPI-I<SUP>2</SUP>CNER), which was established by the World Premier International Research Centre Initiative (WPI), the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Grants-in-Aid: 26810125 from MEXT (Japan). Kyushu University offered the financial support for English editing.	Abellan G, 2012, CHEM COMMUN, V48, P11416, DOI 10.1039/c2cc35750j; Grosso D, 2004, NAT MATER, V3, P787, DOI 10.1038/nmat1206; Walcarius A, 2013, CHEM SOC REV, V42, P4098, DOI 10.1039/c2cs35322a; Lee J, 2008, NAT MATER, V7, P222, DOI 10.1038/nmat2111; Guo LM, 2013, ACS APPL MATER INTER, V5, P11080, DOI 10.1021/am4032778; Yu CC, 2008, ADV FUNCT MATER, V18, P1544, DOI 10.1002/adfm.200701052; Noda Y, 2008, CHEM MATER, V20, P5361, DOI 10.1021/cm703202n; Ren Y, 2012, CHEM SOC REV, V41, P4909, DOI 10.1039/c2cs35086f; Shi JL, 2013, CHEM REV, V113, P2139, DOI 10.1021/cr3002752; Lorencon E, 2009, ACS APPL MATER INTER, V1, P2104, DOI 10.1021/am900424m; Takata T, 1997, CHEM MATER, V9, P1063, DOI 10.1021/cm960612b; Zhang RY, 2012, NANO TODAY, V7, P344, DOI 10.1016/j.nantod.2012.06.012; Nakajima K, 2005, CHEM LETT, V34, P394, DOI 10.1246/cl.2005.394; Bresser D, 2014, CHEMPHYSCHEM, V15, P2177, DOI 10.1002/cphc.201400092; Tiemann M, 2008, CHEM MATER, V20, P961, DOI 10.1021/cm702050s; Takahara Y, 2001, CHEM MATER, V13, P1194, DOI 10.1021/cm000572i; Yang PD, 1998, NATURE, V396, P152; Kudo A, 2009, CHEM SOC REV, V38, P253, DOI 10.1039/b800489g; Ren Y, 2010, J AM CHEM SOC, V132, P996, DOI 10.1021/ja905488x; Ma SSK, 2012, J AM CHEM SOC, V134, P19993, DOI 10.1021/ja3095747; Chun WJ, 2003, J PHYS CHEM B, V107, P1798, DOI 10.1021/jp027593f; Brinker CJ, 1999, ADV MATER, V11, P579, DOI 10.1002/(SICI)1521-4095(199905)11:7<579::AID-ADMA579>3.0.CO;2-R; Brezesinski K, 2010, J AM CHEM SOC, V132, P6982, DOI 10.1021/ja9106385; Takata T, 1998, CATAL TODAY, V44, P17, DOI 10.1016/S0920-5861(98)00170-9; Kondo JN, 2004, CHEM MATER, V16, P4304, DOI 10.1021/cm030355s; Maeda K, 2013, CHEM-EUR J, V19, P4986, DOI 10.1002/chem.201300158; Katou T, 2003, ANGEW CHEM INT EDIT, V42, P2382, DOI 10.1002/anie.200250263; Guo LM, 2009, NEW J CHEM, V33, P1926, DOI 10.1039/b906776k; Guo LM, 2014, COLLOID SURFACE A, V451, P136, DOI 10.1016/j.colsurfa.2014.03.059; Hagiwara H, 2013, CATALYSTS, V3, P614, DOI 10.3390/catal3030614; Hisatomi T, 2010, CHEM MATER, V22, P3854, DOI 10.1021/cm903583f; Jiao F., 2008, ANGEW CHEM INT EDIT, V47, P97119; Reitz C, 2011, NANO RES, V4, P414, DOI 10.1007/s12274-011-0096-y; Suchomski C, 2012, CHEM MATER, V24, P155, DOI 10.1021/cm2026043; Wang Y, 2013, INT J ELECTROCHEM SC, V8, P8077; Wu JM, 2012, BEILSTEIN J NANOTECH, V3, P123, DOI 10.3762/bjnano.3.13	36	3	3	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1144-0546	1369-9261		NEW J CHEM	New J. Chem.	DEC	2014	38	12					5846	5855		10.1039/c4nj01034e		10	Chemistry, Multidisciplinary	Chemistry	AU3AI	WOS:000345485000024		
J	Zhao, JL; Tomiyasu, H; Ni, XL; Zeng, X; Elsegood, MRJ; Redshaw, C; Rahman, S; Georghiou, PE; Yamato, T				Zhao, Jiang-Lin; Tomiyasu, Hirotsugu; Ni, Xin-Long; Zeng, Xi; Elsegood, Mark R. J.; Redshaw, Carl; Rahman, Shofiur; Georghiou, Paris E.; Yamato, Takehiko			Synthesis and evaluation of a novel ionophore based on a thiacalix[4]arene derivative bearing imidazole units	NEW JOURNAL OF CHEMISTRY			English	Article							MAGNETITE NANOPARTICLES; EXTRACTION PROPERTIES; CYCLIC POLYETHERS; DICHROMATE ANION; FUNNEL COMPLEXES; METAL-CATIONS; ACTIVE-SITES; RECOGNITION; FLUORESCENT; COPPER(II)	O-Alkylation of the flexible thiacalix[4]arene 1 with 2-chloromethyl-1-methyl-1H-imidazole 2 in the presence of Na2CO3 or K2CO3 afforded mono-O-alkylation product 3 in 29-51% yield, along with recovery of the starting compound. In contrast, the same reaction in the presence of Cs2CO3 gave only one pure stereoisomer, namely 1,3-alternate-4; other possible isomers were not observed. Alkali metal salts such as Na2CO3 and Cs2CO3 can play an important role in the conformer distribution via a template effect. The conformations of the receptors, mono-O-alkylation product 3 and that of 1,3-alternate-4, have been confirmed by X-ray crystallography. Furthermore, the complexation properties of the receptor 1,3-alternate-4 toward selected alkali/transition metal cations are reported. The two-phase solvent extraction data indicated that 1,3-alternate-4 exhibited a stronger extraction efficiency for transition metals over alkali metals. The dichromate anion extraction ability of 1,3-alternate-4 showed that it could serve as an efficient extractor of HCr2O7-/Cr2O72- anions at low pH.	[Zhao, Jiang-Lin; Tomiyasu, Hirotsugu; Yamato, Takehiko] Saga Univ, Fac Sci & Engn, Dept Appl Chem, Saga 8408502, Japan; [Ni, Xin-Long; Zeng, Xi] Guizhou Univ, Key Lab Macrocycl & Supramol Chem Guizhou Prov, Guiyang 550025, Guizhou, Peoples R China; [Elsegood, Mark R. J.] Univ Loughborough, Dept Chem, Loughborough LE11 3TU, Leics, England; [Redshaw, Carl] Univ Hull, Dept Chem, Kingston Upon Hull HU6 7RX, Yorks, England; [Rahman, Shofiur; Georghiou, Paris E.] Mem Univ Newfoundland, Dept Chem, St John, NF A1B 3X7, Canada	Yamato, T (reprint author), Saga Univ, Fac Sci & Engn, Dept Appl Chem, Honjo Machi 1, Saga 8408502, Japan.	yamatot@cc.saga-u.ac.jp	Redshaw, Carl/C-5644-2009	Redshaw, Carl/0000-0002-2090-1688	OTEC at Saga University; International Cooperation Projects of Guizhou Province [20137002]; Royal Society of Chemistry; EPSRC	This work was performed under the Cooperative Research Program of "Network Joint Research Center for Materials and Devices (Institute for Materials Chemistry and Engineering, Kyushu University)". We would like to thank the OTEC at Saga University and the International Cooperation Projects of Guizhou Province (No. 20137002), The Royal Society of Chemistry for financial support and the EPSRC for an overseas travel grant to C.R. The computational work has been assisted by the use of computing resources provided by WestGrid and Compute/Calcul Canada. We thank Dr Grigory Shamov, Westgrid/U. Manitoba for support.	de Silva N, 2010, NAT CHEM, V2, P1062, DOI [10.1038/nchem.860, 10.1038/NCHEM.860]; PEDERSEN CJ, 1970, J AM CHEM SOC, V92, P391, DOI 10.1021/ja00705a606; Goyal N, 2003, ADV ENVIRON RES, V7, P311, DOI 10.1016/S1093-0191(02)00004-7; Bayrakci M, 2009, TETRAHEDRON, V65, P7963, DOI 10.1016/j.tet.2009.07.062; PEDERSEN CJ, 1967, J AM CHEM SOC, V89, P7017, DOI 10.1021/ja01002a035; Kim HN, 2012, CHEM SOC REV, V41, P3210, DOI 10.1039/c1cs15245a; Sayin S, 2011, TETRAHEDRON, V67, P3743, DOI 10.1016/j.tet.2011.03.012; Rodik RV, 2009, CURR MED CHEM, V16, P1630; Schuhle DT, 2011, COORDIN CHEM REV, V255, P2727, DOI 10.1016/j.ccr.2011.04.005; Rondelez Y, 2000, CHEM-EUR J, V6, P4218, DOI 10.1002/1521-3765(20001117)6:22<4218::AID-CHEM4218>3.3.CO;2-M; Qureshi I, 2009, J HAZARD MATER, V164, P675, DOI 10.1016/j.jhazmat.2008.08.076; Oliveri CG, 2006, J AM CHEM SOC, V128, P16286, DOI 10.1021/ja0661010; Cao YD, 2003, TETRAHEDRON LETT, V44, P4751, DOI 10.1016/S0040-4039(03)01074-8; Raji C, 1998, WATER RES, V32, P3772, DOI 10.1016/S0043-1354(98)00150-X; Seneque O, 2000, J AM CHEM SOC, V122, P6183, DOI 10.1021/ja000185+; Bayrakci M, 2009, J INCL PHENOM MACRO, V63, P241, DOI 10.1007/s10847-008-9513-6; Roundhill DM, 2002, CHEM SOC REV, V31, P60, DOI 10.1039/b003141k; Torok I, 1998, J INORG BIOCHEM, V71, P7, DOI 10.1016/S0162-0134(98)10027-2; Licen S, 2013, SUPRAMOL CHEM, V25, P631, DOI 10.1080/10610278.2013.824576; Sayin S, 2013, MAT SCI ENG C-MATER, V33, P2433, DOI 10.1016/j.msec.2013.02.004; Ni XL, 2013, ORG BIOMOL CHEM, V11, P5435, DOI 10.1039/c3ob40601f; Tabakci M, 2007, TETRAHEDRON, V63, P6861, DOI 10.1016/j.tet.2007.04.060; [Anonymous], 2008, SAINT APEX 2 SOFTW C; Kumagai H, 1997, TETRAHEDRON LETT, V38, P3971, DOI 10.1016/S0040-4039(97)00792-2; PEDERSEN CJ, 1967, J AM CHEM SOC, V89, P2495, DOI 10.1021/ja00986a052; Baldini L, 2007, CHEM SOC REV, V36, P254, DOI 10.1039/b603082n; Bozkurt S, 2009, J HAZARD MATER, V165, P974, DOI 10.1016/j.jhazmat.2008.10.096; Brewster RE, 2004, CURR ORG CHEM, V8, P867, DOI 10.2174/1385272043370401; Cao YD, 2003, J CHEM RES-S, P489; Cao YD, 2004, INORG CHIM ACTA, V357, P316, DOI 10.1016/S0020-1693(03)00469-9; Clainche L. L., 2000, INORG CHEM, V39, P3436; Darbost U, 2004, EUR J INORG CHEM, P4371, DOI 10.1002/ejic.200400619; Darbost U, 2007, CHEM-EUR J, V13, P2078, DOI 10.1002/chem.200601040; Frausto da Silva J.J.R., 2001, BIOL CHEM ELEMENTS I; Frisch M.J., 2013, GAUSSIAN 09 REVISION; Gattuso G, 2006, SUPRAMOL CHEM, V18, P235, DOI 10.1080/10610270500450333; Hajipour AR, 2009, POLYM ADVAN TECHNOL, V20, P1050, DOI 10.1002/pat.1362; HARROWFIELD JM, 1991, J CHEM SOC CHEM COMM, P1159, DOI 10.1039/c39910001159; Israeli Y, 2004, MAGN RESON CHEM, V42, P573, DOI 10.1002/mrc.1387; Liu Y, 2008, SUPRAMOL CHEM, V20, P419, DOI 10.1080/10610270701291650; Ludwig R, 2005, MICROCHIM ACTA, V152, P1, DOI 10.1007/s00604-005-0422-8; Neelakantan MA, 2004, IRAN J CHEM CHEM ENG, V23, P97; Oh SW, 2005, FASEB J, V19, P1335, DOI 10.1096/fj.04-2098fje; Olsher U, 1996, PURE APPL CHEM, V68, P1195, DOI 10.1351/pac199668061195; Osz K, 2002, INORG CHIM ACTA, V339, P373, DOI 10.1016/S0020-1693(02)00954-4; Rondelez Y, 2002, J AM CHEM SOC, V124, P1334, DOI 10.1021/ja0161958; Salorinne K, 2008, J INCL PHENOM MACRO, V61, P11, DOI 10.1007/s10847-008-9411-y; Sansone F, 2003, ORG BIOMOL CHEM, V1, P1802, DOI 10.1039/b301595e; Seneque O, 2005, J AM CHEM SOC, V127, P14833, DOI 10.1021/ja053620e; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Solangi IB, 2013, SEP PURIF TECHNOL, V118, P470, DOI 10.1016/j.seppur.2013.07.037; SOLOMON EI, 1992, CHEM REV, V92, P521, DOI 10.1021/cr00012a003; Tabakci B, 2012, J APPL POLYM SCI, V125, P1012, DOI 10.1002/app.36344; Tabakci M, 2003, J INCL PHENOM MACRO, V45, P265; Vicens J., 1995, CALIXARENES 50 ANNIV; Willans CE, 2009, ORG BIOMOL CHEM, V7, P2756, DOI 10.1039/b904148f; Yamato T, 1998, CAN J CHEM, V76, P989, DOI 10.1139/cjc-76-7-989; Yilmaz A, 2002, TETRAHEDRON, V58, P7735, DOI 10.1016/S0040-4020(02)00837-2; Zadmard R, 2006, ANGEW CHEM INT EDIT, V45, P2703, DOI 10.1002/anie.200502946	59	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1144-0546	1369-9261		NEW J CHEM	New J. Chem.	DEC	2014	38	12					6041	6049		10.1039/c4nj01099j		9	Chemistry, Multidisciplinary	Chemistry	AU3AI	WOS:000345485000048		
J	Muratsugu, S; Nishihara, H				Muratsugu, Satoshi; Nishihara, Hiroshi			pi-Conjugation modification of photochromic and redox-active dimethyldihydropyrene by phenyl- and ethynyl-terpyridines and Ru(bis-terpyridine) complexes	NEW JOURNAL OF CHEMISTRY			English	Article							METACYCLOPHANEDIENE VALENCE ISOMERIZATION; CROSS-COUPLING REACTIONS; DES TRANS-15,16-DIMETHYL-DIHYDROPYRENS; ELECTROCHEMICAL REDUCTION; ELECTRONIC COMMUNICATION; MEASURING AROMATICITY; RING CURRENT; DIHYDROPYRENE; DERIVATIVES; SWITCHES	Two pi-conjugated dimethyldihydropyrene (DHP)-bis-terpyridine ligands (2 and 3) were prepared, in which two terpyridine moieties were connected at the 4 and 9 positions of DHP (1) via phenyl and ethynyl linkers, respectively. The nature of the pi-conjugated linkers influenced the valence orbitals of the DHP moiety, which shifted the redox potentials of the DHP moiety and the absorption spectra. In 3 with an ethynyl linker, the redox potentials of the DHP moiety were shifted in the positive direction and the absorption band was largely red-shifted compared with 1. In 2 with a phenyl linker, the shifts in the redox potentials of the DHP moiety and in the absorption band were moderate. These results were supported by valence orbital energies calculated using time-dependent density functional theory, which enabled the assignment of the four main transitions in each spectrum for the first time. The fluorescence intensity of 3 was larger than that of 2, which was photoisomerisable. Two dinuclear Ru(bis-terpyridine) complexes (4 and 5) were prepared from 2 and 3, and their redox and photochemical properties were investigated.	[Muratsugu, Satoshi; Nishihara, Hiroshi] Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Muratsugu, Satoshi] Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Muratsugu, S (reprint author), Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	smuratsugu@chem.nagoya-u.ac.jp; nisihara@chem.s.u-tokyo.ac.jp	Nishihara, Hiroshi/B-4755-2012		MEXT of Japan [20245013, 21108002, 22108534, 2107]; Japan Society for the Promotion of Science for Young Scientists	The authors thank Professor Masahiro Ehara at the Institute for Molecular Science for helpful discussions about TD-DFT calculations. This work was supported by a Grant-in-Aid for Scientific Research from MEXT of Japan [Nos. 20245013, 21108002, and 22108534, area 2107 (Coordination Programming)], and a Research Fellowship from the Japan Society for the Promotion of Science for Young Scientists. The computational studies were carried out using the Research Centre for Computational Science, Okazaki, Japan.	Williams RV, 2012, J AM CHEM SOC, V134, P16742, DOI 10.1021/ja306868r; Straight SD, 2005, J AM CHEM SOC, V127, P9403, DOI 10.1021/ja051218u; Zhang PR, 2012, ORGANOMETALLICS, V31, P8121, DOI 10.1021/om3007008; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Vila N, 2011, INORG CHEM, V50, P10581, DOI 10.1021/ic2003904; Liddell PA, 2004, J AM CHEM SOC, V126, P4803, DOI 10.1021/ja039800a; Andreasson J, 2007, J PHYS CHEM C, V111, P14274, DOI 10.1021/jp074429p; Nishimori Y, 2009, CHEM-ASIAN J, V4, P1361, DOI 10.1002/asia.200900072; Mitchell RH, 2006, J ORG CHEM, V71, P327, DOI 10.1021/jo052153g; Yanai T, 2004, CHEM PHYS LETT, V393, P51, DOI 10.1016/j.cplett.2004.06.011; Grosshenny V, 1997, J ORG CHEM, V62, P1491, DOI 10.1021/jo962068w; ALTOMARE A, 1994, J APPL CRYSTALLOGR, V27, P435, DOI 10.1107/S002188989400021X; Roldan D, 2013, J AM CHEM SOC, V135, P5974, DOI 10.1021/ja401484j; Cossi M, 2003, J COMPUT CHEM, V24, P669, DOI 10.1002/jcc.10189; Barone V, 1998, J PHYS CHEM A, V102, P1995, DOI 10.1021/jp9716997; Williams RV, 2002, J AM CHEM SOC, V124, P13495, DOI 10.1021/ja020595t; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Sheepwash MAL, 2002, J AM CHEM SOC, V124, P4693, DOI 10.1021/ja017229e; Ziessel R, 2004, INORG CHEM, V43, P4262, DOI 10.1021/ic049822d; Sheepwash MAL, 2003, PHOTOCH PHOTOBIO SCI, V2, P104, DOI 10.1039/b208952a; Andreasson J, 2007, ANGEW CHEM INT EDIT, V46, P958, DOI 10.1002/anie.200603856; Aspley CJ, 2001, NEW J CHEM, V25, P1136, DOI 10.1039/b103062k; Mitchell RH, 2004, ORG LETT, V6, P1729, DOI 10.1021/ol049590m; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Andreasson J, 2004, J AM CHEM SOC, V126, P15926, DOI 10.1021/ja045577l; Ayub K, 2008, J ORG CHEM, V73, P451, DOI 10.1021/jo7019459; BENNISTON AC, 1994, ANGEW CHEM INT EDIT, V33, P1884, DOI 10.1002/anie.199418841; BERGER RM, 1988, INORG CHEM, V27, P4245, DOI 10.1021/ic00296a032; BLATTMAN.HR, 1967, HELV CHIM ACTA, V50, P68, DOI 10.1002/hlca.19670500112; BLATTMAN.HR, 1970, TETRAHEDRON, V26, P5885, DOI 10.1016/0040-4020(70)80025-4; BLATTMAN.HR, 1965, J AM CHEM SOC, V87, P130, DOI 10.1021/ja01079a031; BOEKELHE.V, 1972, TETRAHEDRON LETT, P575; Coulson D.R., 1972, INORG SYNTH, V13, P121, DOI 10.1002/9780470132449.ch23; Dunning Jr T.H., 1976, MODERN THEORETICAL C, V3, P1; Farrugia L. J., 1999, J APPL CRYSTALLOGR, V32, P837, DOI DOI 10.1107/S0021889899006020; Frisch M J, 2010, GAUSSIAN 09 REVISION; FRY AJ, 1983, ACTA CHEM SCAND B, V37, P445, DOI 10.3891/acta.chem.scand.37b-0445; FRY AJ, 1974, TETRAHEDRON LETT, P445; FRY AJ, 1985, TETRAHEDRON LETT, V26, P4879, DOI 10.1016/S0040-4039(00)94975-X; Galletta M, 2005, CHEM COMMUN, P4222, DOI 10.1039/b507196h; GERSON F, 1964, HELV CHIM ACTA, V47, P1123, DOI 10.1002/hlca.19640470503; Harriman A, 2000, ANGEW CHEM INT EDIT, V39, P4287, DOI 10.1002/1521-3773(20001201)39:23<4287::AID-ANIE4287>3.0.CO;2-0; Harriman A, 2005, DALTON T, P2925, DOI 10.1039/b506818e; Hissler M, 1998, ANGEW CHEM INT EDIT, V37, P1717, DOI 10.1002/(SICI)1521-3773(19980703)37:12<1717::AID-ANIE1717>3.0.CO;2-T; Kimball DB, 2002, J ORG CHEM, V67, P8798, DOI 10.1021/jo020462q; KLEVENS HB, 1949, J CHEM PHYS, V17, P470, DOI 10.1063/1.1747291; Laali KK, 2008, J ORG CHEM, V73, P457, DOI 10.1021/jo701932j; Marsella MJ, 2000, ORG LETT, V2, P2979, DOI 10.1021/ol006293i; Mitchell RH, 1999, EUR J ORG CHEM, P2695; Mitchell RH, 2007, J ORG CHEM, V72, P7939, DOI 10.1021/jo0712392; MITCHELL RH, 1995, J AM CHEM SOC, V117, P1514, DOI 10.1021/ja00110a008; Mitchell RH, 2003, J AM CHEM SOC, V125, P2974, DOI 10.1021/ja0288136; Mitchell RH, 2005, J AM CHEM SOC, V127, P16251, DOI 10.1021/ja055356v; Mitchell RH, 2001, TETRAHEDRON, V57, P3689, DOI 10.1016/S0040-4020(01)00233-2; Mitchell RH, 2012, CHEM COMMUN, V48, P8144, DOI 10.1039/c2cc33518b; Mitchell RH, 2003, J AM CHEM SOC, V125, P7581, DOI 10.1021/ja034807d; Mitchell RH, 1999, J AM CHEM SOC, V121, P2601, DOI 10.1021/ja983848k; Mitchell RH, 2004, J ORG CHEM, V69, P549, DOI 10.1021/jo0354589; Mitchell RH, 2009, J AM CHEM SOC, V131, P189, DOI 10.1021/ja806427n; MURAKAMI S, 1988, NIPPON KAGAKU KAISHI, P221; Muratsugu S, 2013, CHEM-EUR J, V19, P17314, DOI 10.1002/chem.201303456; Muratsugu S, 2008, J AM CHEM SOC, V130, P7204, DOI 10.1021/ja8016494; Murphy RS, 1999, CHEM COMMUN, P2097; Pal S, 2013, RSC ADV, V3, P3739, DOI 10.1039/c3ra23089a; Kishida M, 2013, CHEM LETT, V42, P361, DOI 10.1246/cl.121264; Sheldrick G.M., 1997, SHELXL97 PROGRAM REF; Williams RV, 2005, J AM CHEM SOC, V127, P16207, DOI 10.1021/ja054553r; Williams RV, 1998, J ORG CHEM, V63, P3125, DOI 10.1021/jo972230a; Zhang PR, 2011, ORGANOMETALLICS, V30, P5396, DOI 10.1021/om200575t	69	2	2	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1144-0546	1369-9261		NEW J CHEM	New J. Chem.	DEC	2014	38	12					6114	6124		10.1039/c4nj01462f		11	Chemistry, Multidisciplinary	Chemistry	AU3AI	WOS:000345485000057		
J	Gorelenkov, NN; Pinches, SD; Toi, K				Gorelenkov, N. N.; Pinches, S. D.; Toi, K.			Energetic particle physics in fusion research in preparation for burning plasma experiments	NUCLEAR FUSION			English	Review						energetic particles; burning plasmas; toroidal fusion devices; Alfven instabilities	TOROIDAL ALFVEN EIGENMODES; ION-CYCLOTRON EMISSION; JOINT EUROPEAN TORUS; LARGE HELICAL DEVICE; DEUTERIUM-TRITIUM EXPERIMENTS; KINETIC BALLOONING MODES; NEUTRAL BEAM INJECTION; DIII-D TOKAMAK; FAST MAGNETOACOUSTIC EIGENMODES; COLLECTIVE THOMSON SCATTERING	The area of energetic particle (EP) physics in fusion research has been actively and extensively researched in recent decades. The progress achieved in advancing and understanding EP physics has been substantial since the last comprehensive review on this topic by Heidbrink and Sadler (1994 Nucl. Fusion 34 535). That review coincided with the start of deuterium-tritium (DT) experiments on the Tokamak Fusion Test Reactor (TFTR) and full scale fusion alphas physics studies. Fusion research in recent years has been influenced by EP physics in many ways including the limitations imposed by the 'sea' of Alfven eigenmodes (AEs), in particular by the toroidicity-induced AE (TAE) modes and reversed shear AEs (RSAEs). In the present paper we attempt a broad review of the progress that has been made in EP physics in tokamaks and spherical tori since the first DT experiments on TFTR and JET (Joint European Torus), including stellarator/helical devices. Introductory discussions on the basic ingredients of EP physics, i.e., particle orbits in STs, fundamental diagnostic techniques of EPs and instabilities, wave particle resonances and others, are given to help understanding of the advanced topics of EP physics. At the end we cover important and interesting physics issues related to the burning plasma experiments such as ITER (International Thermonuclear Experimental Reactor).	[Gorelenkov, N. N.] Princeton Univ, Princeton Plasma Phys Lab, Princeton, NJ 08543 USA; [Pinches, S. D.] ITER Org, F-13115 St Paul Les Durance, France; [Toi, K.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Gorelenkov, NN (reprint author), Princeton Univ, Princeton Plasma Phys Lab, POB 451, Princeton, NJ 08543 USA.				JSPS [21360457, 24360386]; U S DOE [DE-AC02-09CH11466]	The work on this review is supported in part (KT) by the Grant-in-Aid for Scientific Research from JSPS (grant no's 21360457 and 24360386) and in part (NNG) under contract number DE-AC02-09CH11466 with the U S DOE. The views and opinions expressed herein do not necessarily reflect those of the ITER organization.	Abel IG, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3237026; Albergante M, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/9/094016; ANDERSON D, 1994, NUCL FUSION, V34, P217, DOI 10.1088/0029-5515/34/2/I05; ANDERSON D, 1991, PLASMA PHYS CONTR F, V33, P455, DOI 10.1088/0741-3335/33/5/005; BUSSAC MN, 1975, PHYS REV LETT, V35, P1638, DOI 10.1103/PhysRevLett.35.1638; Nielsen SK, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/6/063014; ROSENBLUTH MN, 1975, PHYS REV LETT, V34, P1428, DOI 10.1103/PhysRevLett.34.1428; Todo Y, 1998, PHYS PLASMAS, V5, P1321, DOI 10.1063/1.872791; Bortolon A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.265008; PORCELLI F, 1994, PHYS PLASMAS, V1, P470, DOI 10.1063/1.870792; GOLDSTON RJ, 1981, PHYS REV LETT, V47, P647, DOI 10.1103/PhysRevLett.47.647; Salewski M, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/6/063019; Estrada-Mila C, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2364149; Berk HL, 1996, PHYS REV LETT, V76, P1256, DOI 10.1103/PhysRevLett.76.1256; Chavdarovski I, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/11/115001; Hellesen C, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/8/085013; Kiptily VG, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/8/084001; Bass EM, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3509106; ROSENBLUTH MN, 1992, PHYS REV LETT, V68, P596, DOI 10.1103/PhysRevLett.68.596; Kondoh T, 1997, J NUCL MATER, V241, P564, DOI 10.1016/S0022-3115(96)00565-X; FISCH NJ, 1992, PHYS REV LETT, V69, P612, DOI 10.1103/PhysRevLett.69.612; Heidbrink WW, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.245002; Ghantous K, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4752011; Fu GY, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.185002; COPPI B, 1986, PHYS REV LETT, V57, P2272, DOI 10.1103/PhysRevLett.57.2272; BEIDLER CD, 1994, PLASMA PHYS CONTR F, V36, P317, DOI 10.1088/0741-3335/36/2/007; BERNSTEIN IB, 1957, PHYS REV, V108, P546, DOI 10.1103/PhysRev.108.546; Spong DA, 2003, PHYS PLASMAS, V10, P3217, DOI 10.1063/1.1590316; SPONG DA, 1992, PHYS FLUIDS B-PLASMA, V4, P3316, DOI 10.1063/1.860386; Candy J, 2003, J COMPUT PHYS, V186, P545, DOI 10.1016/S0021-9991(03)00079-2; Chen L, 2001, PHYS PLASMAS, V8, P4713, DOI 10.1063/1.1406939; Kiptily VG, 2005, NUCL FUSION, V45, pL21, DOI 10.1088/0029-5515/45/5/L01; Cooper WA, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/7/072002; CHEN L, 1984, PHYS REV LETT, V52, P1122, DOI 10.1103/PhysRevLett.52.1122; BERNSTEIN IB, 1958, PROC R SOC LON SER-A, V244, P17, DOI 10.1098/rspa.1958.0023; Doyle EJ, 2007, NUCL FUSION, V47, pS18, DOI 10.1088/0029-5515/47/6/S02; Chen L, 2007, NUCL FUSION, V47, pS727, DOI 10.1088/0029-5515/47/10/S20; Berk HL, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/3/035007; Evans TE, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/2/024002; Casati A, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/8/085012; Kimura H, 1998, NUCL FUSION, V38, P1303, DOI 10.1088/0029-5515/38/9/304; Maraschek M, 1997, PHYS REV LETT, V79, P4186, DOI 10.1103/PhysRevLett.79.4186; Sharapov SE, 2001, PHYS LETT A, V289, P127, DOI 10.1016/S0375-9601(01)00588-6; FISCH NJ, 1987, REV MOD PHYS, V59, P175, DOI 10.1103/RevModPhys.59.175; Lilley MK, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3486535; HASEGAWA A, 1975, PHYS REV LETT, V35, P370, DOI 10.1103/PhysRevLett.35.370; Sasaki M, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/8/085017; Nazikian R, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.185001; Patel A, 2004, REV SCI INSTRUM, V75, P4944, DOI 10.1063/1.1808915; Heidbrink WW, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/9/093006; Qiu ZY, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/9/095003; TANI K, 1981, J PHYS SOC JPN, V50, P1726, DOI 10.1143/JPSJ.50.1726; Mishchenko A, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3207878; Lauber P, 2013, PHYS REP, V533, P33, DOI 10.1016/j.physrep.2013.07.001; Gorelenkov NN, 2007, PHYS LETT A, V370, P70, DOI 10.1016/j.physleta.2007.05.113; Angioni C, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/5/055013; Gorelenkov NN, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3097920; BERK HL, 1995, PHYS PLASMAS, V2, P3401, DOI 10.1063/1.871174; Bowden GW, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4879802; HEIDBRINK WW, 1994, NUCL FUSION, V34, P535, DOI 10.1088/0029-5515/34/4/I07; Shinohara K, 2001, NUCL FUSION, V41, P603, DOI 10.1088/0029-5515/41/5/313; Konies A, 2008, AIP CONF PROC, V1069, P133, DOI 10.1063/1.3033696; Kallne J, 2000, PHYS REV LETT, V85, P1246, DOI 10.1103/PhysRevLett.85.1246; McClements KG, 2002, NUCL FUSION, V42, P1155, DOI 10.1088/0029-5515/42/9/314; Bertram J, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/5/055009; Tardocchi M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.205002; Sharapov SE, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/10/104022; Hu B, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2364147; ROME JA, 1995, NUCL FUSION, V35, P195, DOI 10.1088/0029-5515/35/2/I09; BEIDLER C, 1990, FUSION TECHNOL, V17, P148; Schaffer MJ, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/10/103028; Popovich P, 2006, COMPUT PHYS COMMUN, V175, P250, DOI 10.1016/j.cpc.2006.04.001; MIKHAILOVSKII AB, 1975, ZH EKSP TEOR FIZ+, V68, P1772; Berk HL, 2006, NUCL FUSION, V46, pS888, DOI 10.1088/0029-5515/46/10/S04; Hender TC, 2007, NUCL FUSION, V47, pS128, DOI 10.1088/0029-5515/47/6/S03; Lin L, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4798397; Todo Y, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/9/094018; Fu GY, 2011, J PLASMA PHYS, V77, P457, DOI 10.1017/S0022377810000619; Michael CA, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/9/095007; Spong DA, 2001, NUCL FUSION, V41, P711, DOI 10.1088/0029-5515/41/6/305; Fasoli A, 2007, NUCL FUSION, V47, pS264, DOI 10.1088/0029-5515/47/6/S05; Heidbrink WW, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2838239; Pinches SD, 1998, COMPUT PHYS COMMUN, V111, P133, DOI 10.1016/S0010-4655(98)00034-4; Stutman D, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.115002; Takechi M, 1999, PHYS REV LETT, V83, P312, DOI 10.1103/PhysRevLett.83.312; Fisch NJ, 2010, J PLASMA PHYS, V76, P627, DOI 10.1017/S0022377809990857; Belova EV, 2003, PHYS PLASMAS, V10, P3240, DOI 10.1063/1.1592155; HEIDBRINK WW, 1993, PHYS REV LETT, V71, P855, DOI 10.1103/PhysRevLett.71.855; Sharapov SE, 2002, PHYS PLASMAS, V9, P2027, DOI 10.1063/1.1448346; Boswell CJ, 2006, PHYS LETT A, V358, P154, DOI 10.1016/j.physleta.2006.05.030; Fetterman AJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.205003; Menard JE, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.095002; Fu GY, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2203604; Spong DA, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3313818; Clark DS, 2000, PHYS PLASMAS, V7, P2923, DOI 10.1063/1.874143; Fisch NJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.225001; Garcia-Munoz M, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/12/123008; Salewski M, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/10/103008; Ogawa K, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/5/053012; Salewski M, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/3/035006; Kiptily VG, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/6/065030; Kiptily VG, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.115001; Ichimura M, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/3/035012; Hellesen C, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/113009; FISCH NJ, 1994, NUCL FUSION, V34, P1541, DOI 10.1088/0029-5515/34/12/I01; Crocker NA, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/10/105001; Classen IGJ, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/12/124018; Matsunaga G, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/8/084003; Testa D, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/8/084010; Chen W, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/8/084008; Deng CB, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.025003; Gorelenkov NN, 2005, NUCL FUSION, V45, P226, DOI 10.1088/0029-5515/45/4/002; Kramer GJ, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/12/123018; Nazikian R, 2001, PHYS PLASMAS, V8, P1840, DOI 10.1063/1.1362534; Pinches SD, 2004, PLASMA PHYS CONTR F, V46, pS47, DOI 10.1088/0741-3335/46/7/S04; FISCH NJ, 1995, PHYS PLASMAS, V2, P2375, DOI 10.1063/1.871454; MCGUIRE K, 1983, PHYS REV LETT, V50, P891, DOI 10.1103/PhysRevLett.50.891; Ido T, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/7/073046; METT RR, 1992, PHYS FLUIDS B-PLASMA, V4, P2885, DOI 10.1063/1.860459; Isobe M, 2006, NUCL FUSION, V46, pS918, DOI 10.1088/0029-5515/46/10/S08; Berk HL, 1996, PHYS PLASMAS, V3, P1827, DOI 10.1063/1.871978; Nielsen SK, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/9/092001; FISCH NJ, 1992, NUCL FUSION, V32, P549, DOI 10.1088/0029-5515/32/4/I02; Spong DA, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1887172; Kiptily VG, 2006, PLASMA PHYS CONTR F, V48, pR59, DOI 10.1088/0741-3335/48/8/R01; Spong DA, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3575626; Tobias BJ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.075003; GAFFEY JD, 1976, J PLASMA PHYS, V16, P149; Kiptily VG, 2002, NUCL FUSION, V42, P999, DOI 10.1088/0029-5515/42/8/308; Lesur M, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3234249; CARY JR, 1988, PHYS FLUIDS, V31, P1586, DOI 10.1063/1.866698; Gorelenkov NN, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/5/055014; Jarvis ON, 1996, NUCL FUSION, V36, P1513, DOI 10.1088/0029-5515/36/11/I06; Chung JN, 2005, PLASMA PHYS CONTR F, V47, P919, DOI 10.1088/0741-3335/47/6/012; Fisch NJ, 2000, NUCL FUSION, V40, P1095, DOI 10.1088/0029-5515/40/6/307; Kramer GJ, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/2/025013; Smolyakov AI, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/5/054002; Fu GY, 1996, PHYS PLASMAS, V3, P4036, DOI 10.1063/1.871537; Berk HL, 1997, PHYS LETT A, V234, P213, DOI 10.1016/S0375-9601(97)00523-9; Kramer GJ, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/10/103029; KOLESNICHENKO YI, 1980, NUCL FUSION, V20, P727, DOI 10.1088/0029-5515/20/6/008; Lin Z, 1998, SCIENCE, V281, P1835, DOI 10.1126/science.281.5384.1835; Lauber P, 2007, J COMPUT PHYS, V226, P447, DOI 10.1016/j.jcp.2007.04.019; BRIGUGLIO S, 1995, PHYS PLASMAS, V2, P3711, DOI 10.1063/1.871071; Gorelenkov NN, 1999, PHYS PLASMAS, V6, P2802, DOI 10.1063/1.873545; ADAMS JM, 1993, NUCL INSTRUM METH A, V329, P277, DOI 10.1016/0168-9002(93)90947-G; Konies A, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3274921; CANDY J, 1994, PHYS PLASMAS, V1, P356, DOI 10.1063/1.870838; Krasilnikov AV, 1997, REV SCI INSTRUM, V68, P553, DOI 10.1063/1.1147651; Gryaznevich MP, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/8/084003; Kolesnichenko YI, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2789558; Sykes A, 1997, PHYS PLASMAS, V4, P1665, DOI 10.1063/1.872271; Heidbrink WW, 2007, PLASMA PHYS CONTR F, V49, P1457, DOI 10.1088/0741-3335/49/9/008; Aymar R, 2001, NUCL FUSION, V41, P1301, DOI 10.1088/0029-5515/41/10/301; Todo Y, 2003, PHYS PLASMAS, V10, P2888, DOI 10.1063/1.1580122; Bass EM, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4773177; Basu R, 2003, PHYS PLASMAS, V10, P2696, DOI 10.1063/1.1578075; Jones OM, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/8/085009; FASOLI A, 1995, PHYS REV LETT, V75, P645, DOI 10.1103/PhysRevLett.75.645; Miller RL, 1998, PHYS PLASMAS, V5, P973, DOI 10.1063/1.872666; SPONG DA, 1994, PHYS PLASMAS, V1, P1503, DOI 10.1063/1.870700; Gorelenkov NN, 2003, NUCL FUSION, V43, P594, DOI 10.1088/0029-5515/43/7/313; Chen Y, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3490213; APPERT K, 1982, PLASMA PHYS CONTR F, V24, P1147, DOI 10.1088/0032-1028/24/9/010; Asunta O, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/9/094014; Bader A, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/9/094019; Basiuk V, 2004, NUCL FUSION, V44, P181, DOI 10.1088/0029-5515/44/1/020; Bass E., 2013, B AM PHYS SOC; BEIDLER CD, 1987, PHYS REV LETT, V58, P1745, DOI 10.1103/PhysRevLett.58.1745; Belikov V S, 1969, SOV PHYS JETP, V28, P1172; Belikov V. S., 1968, Zhurnal Eksperimental'noi i Teoreticheskoi Fiziki, V55; Belova E., B AM PHYS SOC; Belova E., 2012, P 24 INT C FUS EN SA; Berk H., 2012, 5 INT SUMM SCH AIX P, P29; Berk H., 1998, 841 IFSR U TEX; BERK HL, 1992, PHYS FLUIDS B-PLASMA, V4, P1806, DOI 10.1063/1.860455; Berk HL, 1997, PLASMA PHYS REP, V23, P778; Berk HL, 1995, NUCL FUSION, V35, P1661, DOI 10.1088/0029-5515/35/12/I30; Berk HL, 1998, PHYS LETT A, V238, P408; BERK HL, 1993, PHYS FLUIDS B-PLASMA, V5, P3969, DOI 10.1063/1.860617; Berk HL, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.185002; BETTI R, 1991, PHYS FLUIDS B-PLASMA, V3, P1865, DOI 10.1063/1.859655; BIGLARI H, 1991, PHYS REV LETT, V67, P3681, DOI 10.1103/PhysRevLett.67.3681; Bindslev H, 1999, PHYS REV LETT, V83, P3206, DOI 10.1103/PhysRevLett.83.3206; Bindslev H, 2007, PLASMA PHYS CONTR F, V49, pB551, DOI 10.1088/0741-3335/49/12B/S52; Bindslev H, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.205005; BOOZER AH, 1980, PHYS FLUIDS, V23, P904, DOI 10.1063/1.863080; Bortolon A., 2010, B AM PHYS SOC; Breizman B. N., 2006, AIP C P THEOR FUS PL, V871; BREIZMAN BN, 1995, PLASMA PHYS CONTR F, V37, P1057, DOI 10.1088/0741-3335/37/10/001; Breizman BN, 2003, PHYS PLASMAS, V10, P3649, DOI 10.1063/1.1597495; Breizman BN, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2130692; Briguglio S, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2710208; BRYSK H, 1973, PLASMA PHYS CONTR F, V15, P611, DOI 10.1088/0032-1028/15/7/001; BUDNY RV, 1994, NUCL FUSION, V34, P1247, DOI 10.1088/0029-5515/34/9/I06; Budny RV, 2002, NUCL FUSION, V42, P1383, DOI 10.1088/0029-5515/42/12/305; Burbaumer H, 2000, FUSION TECHNOL, V37, P131; Burbaumer H, 1999, FUSION TECHNOL, V35, P280; Candy J, 1996, PHYS LETT A, V215, P299, DOI 10.1016/0375-9601(96)00197-1; Candy J, 1997, PHYS PLASMAS, V4, P2597, DOI 10.1063/1.872348; Carlsson J, 2001, PHYS PLASMAS, V8, P4725, DOI 10.1063/1.1412008; Cauffman S, 1995, NUCL FUSION, V35, P1597, DOI 10.1088/0029-5515/35/12/I22; Cesario R, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/7/075034; CHANG CS, 1990, PHYS FLUIDS B-PLASMA, V2, P310, DOI 10.1063/1.859319; Chang ZY, 1996, PHYS REV LETT, V76, P1071, DOI 10.1103/PhysRevLett.76.1071; Chapman IT, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/1/013001; Chapman IT, 2007, PLASMA PHYS CONTR F, V49, pB385, DOI 10.1088/0741-3335/49/12B/S35; Chen L, 2014, REV MOD PHYS UNPUB; Chen SY, 2012, CHINESE PHYS LETT, V29, DOI 10.1088/0256-307X/29/2/025203; CHENG CZ, 1985, ANN PHYS-NEW YORK, V161, P21, DOI 10.1016/0003-4916(85)90335-5; CHENG CZ, 1992, PHYS REP, V211, P1, DOI 10.1016/0370-1573(92)90166-W; CHENG CZ, 1986, PHYS FLUIDS, V29, P3695, DOI 10.1063/1.865801; Cheng CZ, 1995, NUCL FUSION, V35, P1639, DOI 10.1088/0029-5515/35/12/I28; CHENG CZ, 1991, J GEOPHYS RES, V96, P21159, DOI 10.1029/91JA01981; CHU MS, 1992, PHYS FLUIDS B-PLASMA, V4, P3713, DOI 10.1063/1.860327; Classen IGJ, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3483214; Cooper WA, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/2/024001; COOPER WA, 1992, PLASMA PHYS CONTR F, V34, P1011; Cooper WA, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/2/024002; COPPI B, 1986, PHYS FLUIDS, V29, P4060, DOI 10.1063/1.865749; Coppi B, 1997, ANN PHYS-NEW YORK, V261, P117, DOI 10.1006/aphy.1997.5719; CORDEY JG, 1981, NUCL FUSION, V21, P581, DOI 10.1088/0029-5515/21/5/007; COTTRELL GA, 1993, NUCL FUSION, V33, P1365, DOI 10.1088/0029-5515/33/9/I10; Cottrell GA, 2000, PHYS REV LETT, V84, P2397, DOI 10.1103/PhysRevLett.84.2397; Crocker NA, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2993182; Crocker NA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.045002; Crocker NA, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/4/043017; Dannert T, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2936886; DARROW DS, 1995, REV SCI INSTRUM, V66, P476, DOI 10.1063/1.1146484; Darrow DS, 2004, REV SCI INSTRUM, V75, P3566, DOI 10.1063/1.1788876; de Cambrier A., 1982, P 3 JOINT VAR GREN I, P161; de Cambrier A., 1982, PLASMA PHYS, V893; Delgado-Aparicio L., 2014, PHYS PLASMAS UNPUB; DENDY RO, 1994, FUSION TECHNOL, V25, P334; Dendy RO, 1995, NUCL FUSION, V35, P1733, DOI 10.1088/0029-5515/35/12/I38; Dimits AM, 2001, NUCL FUSION, V41, P1725, DOI 10.1088/0029-5515/41/11/322; Donne AJH, 2007, NUCL FUSION, V47, pS337, DOI 10.1088/0029-5515/47/6/S07; Doyle E., 2007, NUCL FUSION, V47, P518; Du X. D., 2013, 13 IAEA TECHN M EN P; DURST RD, 1992, PHYS FLUIDS B-PLASMA, V4, P3707, DOI 10.1063/1.860326; Edlund EM, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/11/115003; Edlund EM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.165003; Edlund EM, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3086869; Guimaraes ZO, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/7/074012; ENGELMANN F, 1992, PLASMA PHYS CONTR F, V34, P881; Eremin DY, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3277261; Ericsson G, 2001, REV SCI INSTRUM, V72, P759, DOI 10.1063/1.1321738; Fasoli A, 2002, PLASMA PHYS CONTR F, V44, pB159, DOI 10.1088/0741-3335/44/12B/312; Fasoli A, 1995, NUCL FUSION, V35, P1485, DOI 10.1088/0029-5515/35/12/I09; Fasoli A, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/7/075015; Fasoli A, 1998, PHYS REV LETT, V81, P5564, DOI 10.1103/PhysRevLett.81.5564; Fasoli A, 1996, PHYS REV LETT, V76, P1067, DOI 10.1103/PhysRevLett.76.1067; Federici G, 2006, PHYS SCRIPTA, VT124, P1, DOI 10.1088/0031-8949/2006/T124/001; Figueiredo ACA, 2005, IEEE T PLASMA SCI, V33, P468, DOI 10.1109/TPS.2005.845390; Fisher RK, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/12/123015; Fredrickson E, 2003, NUCL FUSION, V43, P1258, DOI 10.1088/0029-5515/43/10/029; Fredrickson ED, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.145001; Fredrickson ED, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/1/013006; Fredrickson ED, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/9/093007; Fredrickson ED, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2768038; Fredrickson ED, 2006, NUCL FUSION, V46, pS926, DOI 10.1088/0029-5515/46/10/S09; FU GY, 1993, PHYS FLUIDS B-PLASMA, V5, P4040, DOI 10.1063/1.860572; Fu GY, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1995007; FU GY, 1992, PHYS FLUIDS B-PLASMA, V4, P3722, DOI 10.1063/1.860328; FU GY, 1995, PHYS REV LETT, V75, P2336, DOI 10.1103/PhysRevLett.75.2336; Fu GY, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2196246; Fukuyama Y., 1999, P 6 IAEA TECHN COMM, P61; Fulop T, 1998, NUCL FUSION, V38, P761, DOI 10.1088/0029-5515/38/5/309; Fulop T, 2000, PHYS PLASMAS, V7, P1479, DOI 10.1063/1.873967; Fulop T, 1997, NUCL FUSION, V37, P1281, DOI 10.1088/0029-5515/37/9/I08; FURTH HP, 1970, PHYS FLUIDS, V13, P3020, DOI 10.1063/1.1692896; Ganesh R., 2012, 5 ITER INT SUMM SCH, P91; Garcia-Munoz M, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/10/103013; Garcia-Munoz M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.185002; Gates DA, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.205003; Geiger B, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/6/065010; Giacomelli L, 2005, NUCL FUSION, V45, P1191, DOI 10.1088/0029-5515/45/9/019; Giancarli L, 2010, FUSION ENG DES, V85, P1829, DOI 10.1016/j.fusengdes.2010.06.005; GOEDBLOED JP, 1975, PHYS FLUIDS, V18, P1258, DOI 10.1063/1.861012; GOEDBLOED JP, 1993, PLASMA PHYS CONTR F, V35, pB277, DOI 10.1088/0741-3335/35/SB/023; Goedbloed JP, 1998, PHYS PLASMAS, V5, P3143, DOI 10.1063/1.873041; Goldston R., 1981, PLASMA J PHYS, V26, P283; GOLOBORODKO VY, 1984, NUCL FUSION, V24, P627, DOI 10.1088/0029-5515/24/5/009; Goloborodko VY, 1997, NUCL FUSION, V37, P771, DOI 10.1088/0029-5515/37/6/I05; Gorelenkov N., 1991, PHYS SCR, V45, P163; Gorelenkov N., 1995, PLASMA PHYS REP, V21, P451; Gorelenkov N. N., 1992, Soviet Journal of Plasma Physics, V18; Gorelenkov N., 1992, FIZ PLASMY, V18, P555; Gorelenkov N., 2006, B AM SOC, V51, P183; Gorelenkov N N, 2008, 4287 PPPL; Gorelenkov NN, 2007, PLASMA PHYS CONTR F, V49, pB371, DOI 10.1088/0741-3335/49/12B/S34; Gorelenkov NN, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.3027512; Gorelenkov NN, 1999, PHYS PLASMAS, V6, P629, DOI 10.1063/1.873216; Gorelenkov NN, 2006, PLASMA PHYS CONTR F, V48, P1255, DOI 10.1088/0741-3335/48/8/013; Gorelenkov NN, 2000, NUCL FUSION, V40, P1311, DOI 10.1088/0029-5515/40/7/303; GORELENKOV NN, 1995, PHYS PLASMAS, V2, P1961, DOI 10.1063/1.871281; Gorelenkov NN, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3640691; Gorelenkov NN, 1998, PHYS PLASMAS, V5, P3389, DOI 10.1063/1.873052; Gorelenkov NN, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/1/015007; Gorelenkov NN, 1997, NUCL FUSION, V37, P1053, DOI 10.1088/0029-5515/37/8/I02; Gorelenkov NN, 2003, NUCL FUSION, V43, P228, DOI 10.1088/0029-5515/43/4/302; Gorelenkov NN, 1995, NUCL FUSION, V35, P1743, DOI 10.1088/0029-5515/35/12/I39; Gorelenkov NN, 2003, PHYS PLASMAS, V10, P713, DOI 10.1063/1.1539471; Greene G., 1990, P 17 EUR C CONTR B 4, V14B, P1540; Greene G., 1990, P 17 EUR C CONTR FUS, P1540; Grimm R., 1976, METHOD COMPUT PHYS, V16, P253; Gunter S., 2010, FUS EN P 23 INT C DA; Gunter S., 2006, P 21 INT C FUS EN CH; Gupta DK, 2004, REV SCI INSTRUM, V75, P3493, DOI 10.1063/1.1787951; Gusev V., 1998, P INT C PLASM PHYS 2, V22C, P576; Hammet G., 1983, THESIS PRINCETON U; Haney S., 1990, FUSION TECHNOL, V18, P609; Hastie R., 1969, PLASMA PHYS CONTROLL, V1, P389; Hauff T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.075004; Haverkort JW, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/2/025005; Hawryluk RJ, 1999, PHILOS T R SOC A, V357, P443, DOI 10.1098/rsta.1999.0336; Heeter R., 1999, THESIS PRINCETON U; Heidbrink WW, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/8/085028; HEIDBRINK WW, 1991, NUCL FUSION, V31, P1635, DOI 10.1088/0029-5515/31/9/002; Heidbrink WW, 2004, PLASMA PHYS CONTR F, V46, P1855, DOI 10.1088/0741-3335/46/12/005; Heidbrink WW, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3478739; Heidbrink WW, 2003, NUCL FUSION, V43, P883, DOI 10.1088/0029-5515/43/9/312; Heidbrink WW, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.175001; Heidbrink WW, 2006, NUCL FUSION, V46, P324, DOI 10.1088/0029-5515/46/2/016; Heidbrink WW, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/12/125001; HEIKKINEN JA, 1995, PHYS PLASMAS, V2, P3724, DOI 10.1063/1.871072; Hellsten T, 2003, PHYS PLASMAS, V10, P4371, DOI 10.1063/1.1617315; HIRSHMAN SP, 1991, J COMPUT PHYS, V96, P99, DOI 10.1016/0021-9991(91)90267-O; Holties HA, 1997, PHYS PLASMAS, V4, P709, DOI 10.1063/1.872165; Howard J, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2219433; HUYSMANS GTA, 1995, PHYS PLASMAS, V2, P1605, DOI 10.1063/1.871310; HUYSMANS GTA, 1993, PHYS FLUIDS B-PLASMA, V5, P1545, DOI 10.1063/1.860894; Ido T, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/12/124025; Ido T., 2012, 18 INT STELL HEL WOR; Ishikawa M, 2007, NUCL FUSION, V47, P849, DOI 10.1088/0029-5515/47/8/016; Isobe M, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/8/084007; ITER Final Design Report, 1999, ITER DOC SER, V14; Ito T, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3223845; Jenko F, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.239502; Joffrin E, 2003, NUCL FUSION, V43, P1167, DOI 10.1088/0029-5515/43/10/018; Johnson MG, 2008, NUCL INSTRUM METH A, V591, P417, DOI 10.1016/j.nima.2008.03.010; Kaye SM, 2005, NUCL FUSION, V45, pS168, DOI 10.1088/0029-5515/45/10/S14; Kim J, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4733550; Kimura H., 1996, P 16 INT C PLASM PHY; KIPTILYJ VG, 1990, FUSION TECHNOL, V18, P583; Kleiber R., 2006, THEORY FUSION PLASMA, V871, P136; Kolesnichenko Y., 1996, P 23 EUR C CONTR FUS, V20C, P331; Kolesnichenko Y., 1996, P 23 EUR C CONTR FUS, P331; Kolesnichenko Y., 1996, P 16 INT C FUS EN MO, V2, P487; Kolesnichenko Y. I., 1967, SOV ATOM ENERGY, V23, P1028, DOI 10.1007/BF01120459; Kolesnichenko Ya.I., 1967, Atomnaya Energiya, V23; Kolesnichenko YI, 2002, PHYS PLASMAS, V9, P2639, DOI 10.1063/1.1475685; KOLESNICHENKO YI, 1991, NUCL FUSION, V31, P1479, DOI 10.1088/0029-5515/31/8/005; Kolesnichenko YI, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/2/024007; KOLESNICHENKO YI, 1992, NUCL FUSION, V32, P449, DOI 10.1088/0029-5515/32/3/I08; Kolesnichenko YI, 2000, NUCL FUSION, V40, P1419, DOI 10.1088/0029-5515/40/7/311; Kolesnichenko YI, 1999, PHYS PLASMAS, V6, P1117, DOI 10.1063/1.873358; Kolesnichenko YI, 2001, PHYS PLASMAS, V8, P491, DOI 10.1063/1.1339228; Kolesnichenko YI, 2000, NUCL FUSION, V40, P1325, DOI 10.1088/0029-5515/40/7/304; Kolesnichenko YI, 2004, FUSION SCI TECHNOL, V46, P54; Kolesnichenko YI, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/8/084017; Kolesnichenko YI, 1998, NUCL FUSION, V38, P1871, DOI 10.1088/0029-5515/38/12/311; Kolesnichenko YI, 1998, PHYS PLASMAS, V5, P2963, DOI 10.1063/1.873021; Kolesnichenko YI, 1996, NUCL FUSION, V36, P159, DOI 10.1088/0029-5515/36/2/I04; KOLESNICHENKO YI, 1994, FUSION TECHNOL, V25, P84; Kolesnichenko YI, 2004, PHYS PLASMAS, V11, P158, DOI 10.1063/1.1629694; Konies A., 2012, P 24 INT C FUS EN SA; Konovalov S V, 2001, P 28 EPS C CONTR F A, V25A, P613; Konovalov SV, 2004, PHYS PLASMAS, V11, P4531, DOI 10.1063/1.1779226; Korablev L.V., 1968, Zhurnal Eksperimental'noi i Teoreticheskoi Fiziki, V54; Korablev L.V., 1967, Zhurnal Eksperimental'noi i Teoreticheskoi Fiziki, V53; KORABLEV LV, 1968, SOV PHYS JETP-USSR, V26, P922; Korablev L., 1968, SOV PHYS JETP, V27, P499; Korotkov AA, 2000, PHYS PLASMAS, V7, P957, DOI 10.1063/1.873894; Korotkov AA, 1997, NUCL FUSION, V37, P35, DOI 10.1088/0029-5515/37/1/I05; Kramer GJ, 2000, NUCL FUSION, V40, P1383, DOI 10.1088/0029-5515/40/7/308; Kramer GJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.015001; Kramer GJ, 2004, PLASMA PHYS CONTR F, V46, pL23, DOI 10.1088/0741-3335/46/11/L01; Krasilnikov AV, 1999, NUCL FUSION, V39, P1111, DOI 10.1088/0029-5515/39/9/305; Ku LP, 2008, FUSION SCI TECHNOL, V54, P673; Kubo S, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3481165; Kusama Y, 1998, NUCL FUSION, V38, P1215, DOI 10.1088/0029-5515/38/8/308; Kuvshinov B. N., 1992, Soviet Journal of Plasma Physics, V18; Lauber P, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/8/084002; Lauber P, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/9/094007; Lazarus EA, 2006, PLASMA PHYS CONTR F, V48, pL65, DOI 10.1088/0741-3335/48/8/L01; Lesur M, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/9/094004; Lesur M, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3500224; Luo Y, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2794320; MAHAJAN SM, 1984, PHYS FLUIDS, V27, P2238, DOI 10.1063/1.864878; Mandrekas J., 1991, FUSION TECHNOL, V19, P1307; Manfredi G, 1997, PHYS PLASMAS, V4, P628, DOI 10.1063/1.872159; Marchenko VS, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3577568; Masuda S, 1997, NUCL FUSION, V37, P53, DOI 10.1088/0029-5515/37/1/I12; Matsunaga G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.045001; McClements KG, 1999, PLASMA PHYS CONTR F, V41, P661, DOI 10.1088/0741-3335/41/5/307; McClements KG, 1996, PHYS PLASMAS, V3, P543, DOI 10.1063/1.871881; McClements KG, 1999, PHYS REV LETT, V82, P2099, DOI 10.1103/PhysRevLett.82.2099; McClements KG, 1997, NUCL FUSION, V37, P473, DOI 10.1088/0029-5515/37/4/I05; MCGUIRE K, 1990, PHYS FLUIDS B-PLASMA, V2, P1287, DOI 10.1063/1.859544; Medley SS, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2823259; Medley SS, 1996, REV SCI INSTRUM, V67, P3122, DOI 10.1063/1.1147419; MEDLEY SS, 1985, REV SCI INSTRUM, V56, P975, DOI 10.1063/1.1138009; Medley SS, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/1/013014; Medley SS, 1996, PLASMA PHYS CONTR F, V38, P1779, DOI 10.1088/0741-3335/38/10/006; Medley SS, 1998, NUCL FUSION, V38, P1283, DOI 10.1088/0029-5515/38/9/303; Melnikov AV, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/8/084023; Menard JE, 2007, NUCL FUSION, V47, pS645, DOI 10.1088/0029-5515/47/10/S13; Merle A., 2012, THESIS ECOLE POLYTEC; Mikhailovskii A., 1975, REV PLASMA PHYS, P70; Mikhailovskii A., 1986, REV PLASMA PHYS, P103; Mikhailovskii AB, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1877519; Mikhailovskii AB, 1999, PLASMA PHYS REP, V25, P838; Mikhailovskii A.B., 1975, SOV PHYS JETP, V41, P890; MIKHAILO.AB, 1973, NUCL FUSION, V13, P259, DOI 10.1088/0029-5515/13/2/015; Morozov A., 1966, REV PLASMA PHYS, P101; Moseev D, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/10/105004; Murakami S, 2006, NUCL FUSION, V46, pS425, DOI 10.1088/0029-5515/46/7/S05; Muscatello CM, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/2/025006; Mutoh T, 2003, NUCL FUSION, V43, P738, DOI 10.1088/0029-5515/43/8/315; Mynick HE, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2177643; Nabais F, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2096527; Nagaoka K, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.065005; Nakajima N, 1996, PHYS PLASMAS, V3, P4545, DOI 10.1063/1.872077; Nakajima N, 1996, PHYS PLASMAS, V3, P4556, DOI 10.1063/1.872071; NAKAJIMA N, 1992, PHYS FLUIDS B-PLASMA, V4, P1115, DOI 10.1063/1.860119; Nazikian R, 2006, PHYS REV LETT, V96, DOI [10.1103/PhysRevLett.96.105006, 10.1103/PhysRevLett.105006]; Nazikian R, 1997, PHYS REV LETT, V78, P2976, DOI 10.1103/PhysRevLett.78.2976; Nazikian R, 1998, PHYS PLASMAS, V5, P1703, DOI 10.1063/1.872818; Neilson G.H, 2002, J PLASMA FUSION RES, V78, P214, DOI 10.1585/jspf.78.214; Ogawa K, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/9/094013; Ogawa K, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/8/084005; Okabayashi M., 2012, PHYS PLASMAS, V18; Okabayashi M, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/12/125003; Ono M., 1997, FUSION ENERGY 1996, V2, P71; Osakabe M., 2011, 12 IAEA TM EN PART M, VO-3; Osakabe M, 2010, FUSION SCI TECHNOL, V58, P131; Osakabe M., 2006, Nuclear Fusion, V46, DOI 10.1088/0029-5515/46/10/S07; PARKER RR, 1993, PLASMA PHYS CONTR F, V35, pB23, DOI 10.1088/0741-3335/35/SB/002; Peng M.-K., 2000, PHYS PLASMAS, V7, P1681; Penn G, 1998, PHYS PLASMAS, V5, P2513, DOI 10.1063/1.872935; Petrov M., 1995, B AM PHYS SOC, V40, P1869; Petrov M., 1996, P 23 EUR C CONTR FUS, p[20C, 63]; Petrov MP, 1995, NUCL FUSION, V35, P1437, DOI 10.1088/0029-5515/35/12/I03; Petrov MP, 1999, PHYS PLASMAS, V6, P2430, DOI 10.1063/1.873539; Pinches S., 2012, P 24 INT C FUS EN SA; Pinches SD, 2006, NUCL FUSION, V46, pS904, DOI 10.1088/0029-5515/46/10/S06; Podesta M, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3080724; PUTVINSKII SV, 1982, JETP LETT+, V36, P397; Putvinskii S. V., 1988, Soviet Journal of Plasma Physics, V14; Putvinskii S. V., 1984, Soviet Journal of Plasma Physics, V10; Putvinskij S., 1993, REV PLASMA PHYS, P239; Qiu ZY, 2011, PLASMA SCI TECHNOL, V13, P257, DOI 10.1088/1009-0630/13/3/01; Rebhan E, 1997, NUCL FUSION, V37, P251, DOI 10.1088/0029-5515/37/2/I10; Redi M., 1994, PLASMA PHYS CONTROL, V36, P317; Rewoldt G, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2089247; Ronchi E, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/3/035008; Saibene G, 2007, NUCL FUSION, V47, P969, DOI 10.1088/0029-5515/47/8/031; Saida T, 2004, NUCL FUSION, V44, P488, DOI 10.1088/0029-5515/44/4/002; Saito K, 2009, FUSION ENG DES, V84, P1676, DOI 10.1016/j.fusengdes.2008.12.053; Saito K, 2013, PLASMA SCI TECHNOL, V15, P209, DOI 10.1088/1009-0630/15/3/03; Sandquist, 2007, PHYS PLASMAS, V14; Santoro RA, 1996, PHYS PLASMAS, V3, P2349, DOI 10.1063/1.871918; Schneller M, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/10/103019; SCHWAB C, 1993, PHYS FLUIDS B-PLASMA, V5, P3195, DOI 10.1063/1.860656; Sharapov SE, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.165001; Sharapov SE, 2006, NUCL FUSION, V46, pS868, DOI 10.1088/0029-5515/46/10/S02; Sharapov SE, 2004, PHYS PLASMAS, V11, P2286, DOI 10.1063/1.1690303; Sharapov SE, 1999, NUCL FUSION, V39, P373, DOI 10.1088/0029-5515/39/3/307; Smirnova MS, 2001, PHYS PLASMAS, V8, P5204, DOI 10.1063/1.1400793; Smith HM, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/7/075001; Snipes JA, 2004, PLASMA PHYS CONTR F, V46, P611, DOI 10.1088/0741-3335/46/4/003; Snipes JA, 2007, FUSION SCI TECHNOL, V51, P437; SOLTWISCH H, 1992, PLASMA PHYS CONTR F, V34, P1669, DOI 10.1088/0741-3335/34/12/001; Spong D., 2006, FUS EN P 21 INT C CH; Spong DA, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4747505; Spong DA, 1995, NUCL FUSION, V35, P1687, DOI 10.1088/0029-5515/35/12/I33; Spong DA, 1997, PLASMA PHYS REP, V23, P483; Stacey W., 2007, FUSION SCI TECHNOL, V52, P30; Staebler G., 2008, PHYS PLASMAS, V15; STIX TH, 1975, NUCL FUSION, V15, P737, DOI 10.1088/0029-5515/15/5/003; STRAIT EJ, 1994, PLASMA PHYS CONTR F, V36, P1211, DOI 10.1088/0741-3335/36/7/008; Stratton BC, 1996, NUCL FUSION, V36, P1586, DOI 10.1088/0029-5515/36/11/I12; Sun YW, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2044467; Sykes A, 2001, PHYS PLASMAS, V8, P2101, DOI 10.1063/1.1352595; Takechi M, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1938973; Talmadge JN, 2001, PHYS PLASMAS, V8, P5165, DOI 10.1063/1.1415071; Tani K, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/1/013012; Terry, 2008, PHYS PLASMAS, V15; Testa D., 2004, JET P 23 S FUS TECHN; Testa D, 2001, NUCL FUSION, V41, P809, DOI 10.1088/0029-5515/41/7/101; Testa D, 1999, PHYS PLASMAS, V6, P3498, DOI 10.1063/1.873632; Testa D, 2000, NUCL FUSION, V40, P975, DOI 10.1088/0029-5515/40/5/310; Testa D, 2005, NUCL FUSION, V45, P907, DOI 10.1088/0029-5515/45/8/019; Timofeev A., 1986, REV PLASMA PHYS, V9, P265; Tobias B, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3460456; Tobita K, 2003, PLASMA PHYS CONTR F, V45, P133, DOI 10.1088/0741-3335/45/2/305; Todo Y, 2010, FUSION SCI TECHNOL, V58, P277; Toi K., 2011, 12 IAEA TM EN PART M, VO-4; Toi K., 2013, PLASMA FUSION RES, V8; ZONCA F, 1992, PHYS REV LETT, V68, P592, DOI 10.1103/PhysRevLett.68.592; VEDENOV AA, 1961, NUCL FUSION, V1, P82, DOI 10.1088/0029-5515/1/2/003; Zonca F, 1996, PHYS PLASMAS, V3, P323, DOI 10.1063/1.871857; Zonca F, 1996, PLASMA PHYS CONTR F, V38, P2011, DOI 10.1088/0741-3335/38/11/011; Darrow DS, 1996, NUCL FUSION, V36, P509, DOI 10.1088/0029-5515/36/4/I10; Wang H, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4774410; Weller A, 2001, PHYS PLASMAS, V8, P931, DOI 10.1063/1.1346633; Van Zeeland MA, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/3/035009; van der Holst B, 2000, PHYS PLASMAS, V7, P4208, DOI 10.1063/1.1308084; WHITE RB, 1984, PHYS FLUIDS, V27, P2455, DOI 10.1063/1.864527; TSAI ST, 1993, PHYS FLUIDS B-PLASMA, V5, P3284, DOI 10.1063/1.860624; VALEO EJ, 1994, PHYS REV LETT, V73, P3536, DOI 10.1103/PhysRevLett.73.3536; YUSHMANOV PN, 1990, NUCL FUSION, V30, P1999, DOI 10.1088/0029-5515/30/10/001; Zonca F, 1999, PHYS PLASMAS, V6, P1917, DOI 10.1063/1.873449; Zonca F, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/8/085009; Wong KL, 2000, PHYS REV LETT, V85, P996, DOI 10.1103/PhysRevLett.85.996; Toi K, 2000, NUCL FUSION, V40, P1349, DOI 10.1088/0029-5515/40/7/306; Van Zeeland MA, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/5/055001; WESSON JA, 1986, PLASMA PHYS CONTR F, V28, P243, DOI 10.1088/0741-3335/28/1A/022; Zhang HS, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3498761; Toi K, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/2/024008; Fisch NJ, 1999, PLASMA PHYS CONTR F, V41, pA221, DOI 10.1088/0741-3335/41/3A/015; Yamamoto S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.245001; TURNBULL AD, 1993, PHYS FLUIDS B-PLASMA, V5, P2546, DOI 10.1063/1.860742; Toi K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.145003; WONG KL, 1991, PHYS REV LETT, V66, P1874, DOI 10.1103/PhysRevLett.66.1874; Tournianski MR, 2005, PLASMA PHYS CONTR F, V47, P671, DOI 10.1088/0741-3335/47/5/001; Vlad G, 1999, RIV NUOVO CIMENTO, V22, P1, DOI 10.1007/BF02874568; Herrmann MC, 1997, PHYS REV LETT, V79, P1495, DOI 10.1103/PhysRevLett.79.1495; WONG KL, 1984, NUCL FUSION, V24, P615, DOI 10.1088/0029-5515/24/5/008; Zonca F, 2007, NUCL FUSION, V47, P1588, DOI 10.1088/0029-5515/47/11/022; Yamada H, 2001, NUCL FUSION, V41, P901, DOI 10.1088/0029-5515/41/7/311; Fisch NJ, 1995, NUCL FUSION, V35, P1753, DOI 10.1088/0029-5515/35/12/I40; Toi K, 2004, PLASMA PHYS CONTR F, V46, pS1, DOI 10.1088/0741-3335/46/7/S01; Tritz K., 2012, B AM PHYS SOC; Tsai S., 1994, PHYS FLUIDS B-PLASMA, V5, P3284; Van Zeeland MA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.135001; Vann RGL, 2003, PHYS PLASMAS, V10, P623, DOI 10.1063/1.1539854; Van Oost G, 2008, FUSION SCI TECHNOL, V53, P16; Van Zeeland MA, 2006, NUCL FUSION, V46, pS880, DOI [10.1088/0029-5515/46/10/S03, 10.1088/0029-5515/46110/S03]; Van Zeeland MA, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/4/045006; Van Zeeland MA, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2436489; Villard L, 1997, NUCL FUSION, V37, P351, DOI 10.1088/0029-5515/37/3/I05; Vlad G, 2006, NUCL FUSION, V46, P1, DOI 10.1088/0029-5515/46/1/001; Waltz RE, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4802808; Wang ZT, 2007, NUCL FUSION, V47, P1307, DOI 10.1088/0029-5515/47/9/030; Wesson J., 1997, TOKAMAKS; White RB, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/4/045012; WHITE RB, 1988, PHYS REV LETT, V60, P2038, DOI 10.1103/PhysRevLett.60.2038; White R.B., 2006, THEORY TOROIDALLY CO; White RB, 1998, PHYS REV E, V58, P1774, DOI 10.1103/PhysRevE.58.1774; Wolle B, 1999, PHYS REP, V312, P1, DOI 10.1016/S0370-1573(98)00084-2; Wong KL, 1999, PLASMA PHYS CONTR F, V41, pR1, DOI 10.1088/0741-3335/41/1/001; Wong KL, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.085002; Wong KL, 1996, PHYS REV LETT, V76, P2286, DOI 10.1103/PhysRevLett.76.2286; Yakovenko YV, 2007, PLASMA PHYS CONTR F, V49, P535, DOI 10.1088/0741-3335/49/4/015; Yamamoto S, 2005, NUCL FUSION, V45, P326, DOI 10.1088/0029-5515/45/5/003; Yan LW, 2001, CHINESE PHYS LETT, V18, P1227, DOI 10.1088/0256-307X/18/9/323; Yavorskij V., 2002, FUS EN P 19 INT C LY; Yavorskij VA, 2002, NUCL FUSION, V42, P1210, DOI 10.1088/0029-5515/42/10/306; Yu JH, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3118626; Yu LM, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3190158; Yushmanov, 1983, NUCL FUSION, V23, P1599; Yushmanov, 1990, REV PLASMA PHYS, P55; Zaitsev FS, 2007, PLASMA PHYS CONTR F, V49, P1747, DOI 10.1088/0741-3335/49/11/001; Zakharov LE, 2004, FUSION ENG DES, V72, P149, DOI 10.1016/j.fusengdes.2004.07.015; Zalesny J, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3601136; Zarzoso D, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3680633; Zhang WL, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3379471; Zhang WL, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.239501; Zonca F, 2002, PHYS PLASMAS, V9, P4939, DOI 10.1063/1.1519241; ZONCA F, 1993, PLASMA PHYS CONTR F, V35, pB307, DOI 10.1088/0741-3335/35/SB/025; Zweben SJ, 2000, NUCL FUSION, V40, P91, DOI 10.1088/0029-5515/40/1/307	573	10	10	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	DEC	2014	54	12							125001	10.1088/0029-5515/54/12/125001		79	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	AU4KN	WOS:000345579800029		
J	Hu, ZQ; Wang, ZX; Wei, L; Li, JQ; Kishimoto, Y				Hu, Z. Q.; Wang, Z. X.; Wei, L.; Li, J. Q.; Kishimoto, Y.			Nonlinear mutual destabilization of the tearing mode and ion temperature gradient mode	NUCLEAR FUSION			English	Article						tearing mode; plasma turbulence; gyrofluid simulations	MAGNETIC ISLAND DYNAMICS; ZONAL FLOWS; SLAB GEOMETRY; DIII-D; TURBULENCE; TRANSPORT; SIMULATIONS; INSTABILITY; EVOLUTION; TOKAMAK	Multiscale interactions between the tearing mode (TM) and ion temperature gradient (ITG) turbulence are studied numerically using a self-consistent gyrofluid model in slab geometry. It is found that the multiscale system goes through five distinct phases and is then saturated in a dynamic quasi-steady state. During the nonlinear evolution, the macroscale TM and the microscale ITG turbulence can mutually destabilize each other. On the one hand, the fluctuation level of the turbulence is greatly raised when the magnetic island grows beyond a threshold. The contributions of different scale fluctuations to heat conductivity are calculated. Although the macroscale long wavelength TM plays a dominant role in inducing heat transport in comparison with micro turbulence, the secondary harmonics of the TM have a considerable effect on causing heat pinch. On the other hand, the island growth is significantly enhanced through increasing the ITG as the island width increases above a critical value or the island propagating velocity is reduced below a critical value. The underlying mechanisms of the mutual destabilizations are identified. In addition, the generation of zonal flows and the associated turbulent transport in the multiscale interaction process are analysed in detail.	[Hu, Z. Q.; Wang, Z. X.; Wei, L.] Dalian Univ Technol, Sch Phys & Optoelect Technol, Minist Educ, Key Lab Mat Modificat Beams, Dalian 116024, Peoples R China; [Li, J. Q.; Kishimoto, Y.] Kyoto Univ, Grad Sch Energy Sci, Uji, Kyoto 6110011, Japan; [Kishimoto, Y.] Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan	Hu, ZQ (reprint author), Dalian Univ Technol, Sch Phys & Optoelect Technol, Minist Educ, Key Lab Mat Modificat Beams, Dalian 116024, Peoples R China.	zxwang@dlut.edu.cn			NMCSFP [2014GB124001, 2013GB111000]; NSFC [11275043, 11322549, 11305027]; JSPS [26400531]; JSPS A3 Foresight Programme;  [2013M541218];  [2014T70239]	ZQH thanks Dr A. Ishizawa for useful discussions. This work is supported by NMCSFP with nos 2014GB124001 and 2013GB111000, NSFC with nos 11275043, 11322549 and 11305027, and China Postdoctoral Science Foundation funded project nos 2013M541218 and 2014T70239. This study was partially supported by a grant-in-aid from JSPS (no 26400531) and by JSPS A3 Foresight Programme entitled 'Study on critical physics issues specific to steady state sustainment of high-performance plasmas'. The simulation was carried out using the cluster of the PSI&APD group with the assistance of W. Hu in computation.	Wang ZX, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3166600; Waelbroeck FL, 1997, PHYS REV LETT, V78, P1703, DOI 10.1103/PhysRevLett.78.1703; Hornsby WA, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3467502; Terry PW, 2000, REV MOD PHYS, V72, P109, DOI 10.1103/RevModPhys.72.109; La Haye RJ, 1998, NUCL FUSION, V38, P987, DOI 10.1088/0029-5515/38/7/303; Buttery RJ, 2003, NUCL FUSION, V43, P69, DOI 10.1088/0029-5515/43/2/301; Wilson HR, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/11/115007; LEE GS, 1986, PHYS FLUIDS, V29, P3291, DOI 10.1063/1.865846; Li JQ, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/9/095007; Diamond PH, 2005, PLASMA PHYS CONTR F, V47, pR35, DOI 10.1088/0741-3335/47/5/R01; La Haye RJ, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2180747; Hender TC, 2007, NUCL FUSION, V47, pS128, DOI 10.1088/0029-5515/47/6/S03; Waelbroeck FL, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/10/104025; CHANG Z, 1995, PHYS REV LETT, V74, P4663, DOI 10.1103/PhysRevLett.74.4663; Ishizawa A, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4739291; Horton W, 1999, REV MOD PHYS, V71, P735, DOI 10.1103/RevModPhys.71.735; Militello F, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2917915; Li JQ, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4865378; Maraschek M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.025005; FURTH HP, 1963, PHYS FLUIDS, V6, P459, DOI 10.1063/1.1706761; McDevitt CJ, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2177585; HAMMETT GW, 1990, PHYS REV LETT, V64, P3019, DOI 10.1103/PhysRevLett.64.3019; Miki K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.145003; Lin Z, 1998, SCIENCE, V281, P1835, DOI 10.1126/science.281.5384.1835; Fitzpatrick R, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1833391; Burrell KH, 1997, PHYS PLASMAS, V4, P1499, DOI 10.1063/1.872367; Wang ZX, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.015004; Yu Q, 2000, PHYS REV LETT, V85, P2949, DOI 10.1103/PhysRevLett.85.2949; Fitzpatrick R, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1833375; Gormezano C, 2007, NUCL FUSION, V47, pS285, DOI 10.1088/0029-5515/47/6/S06; HAMMETT GW, 1993, PLASMA PHYS CONTR F, V35, P973, DOI 10.1088/0741-3335/35/8/006; Hornsby WA, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/5/054008; Isayama A, 2001, NUCL FUSION, V41, P761, DOI 10.1088/0029-5515/41/6/312; Ishizawa A, 2007, NUCL FUSION, V47, P1540, DOI 10.1088/0029-5515/47/11/016; Ishizawa A., 2013, COMMUNICATION; Itoh SI, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.045003; Li JQ, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3698111; Muraglia M, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/5/055016; Popov AM, 2002, PHYS PLASMAS, V9, P4205, DOI 10.1063/1.1505842; Qu W.X., 1985, PLASMA REPORT UWPR 8; SCOTT BD, 1985, PHYS FLUIDS, V28, P275, DOI 10.1063/1.865197; SMOLYAKOV AI, 1993, PLASMA PHYS CONTR F, V35, P657, DOI 10.1088/0741-3335/35/6/002; Waelbroeck F.L., 2013, COMMUNICATION; Wang ZX, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3551521; Wang ZX, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4731720	45	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	DEC	2014	54	12							123018	10.1088/0029-5515/54/12/123018		11	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	AU4KN	WOS:000345579800024		
J	Matsuyama, A; Yagi, M; Kagei, Y; Nakajima, N				Matsuyama, A.; Yagi, M.; Kagei, Y.; Nakajima, N.			Drift resonance effect on stochastic runaway electron orbit in the presence of low-order magnetic perturbations	NUCLEAR FUSION			English	Article						runaway electron; disruption; tokamak; MHD	RELATIVISTIC-PARTICLES; CURRENT TERMINATION; OPERATIONAL LIMITS; MAJOR DISRUPTIONS; TOKAMAK PLASMAS; MHD STABILITY; CHAPTER 3; SIMULATION; DIFFUSION; FIELDS	During major disruptions, an induced loop voltage accelerates runaway electrons (REs) towards high energy, being in the order of 1-100MeV in present tokamaks and ITER. The stochastization mechanisms of such high-energy RE drift orbits are investigated by three-dimensional (3D) orbit following in tokamak plasmas. Drift resonance is shown to play an important role in determining the onset of stochastic drift orbits for different electron energies, particularly in cases with low-order perturbations that have radially global eigenfunctions of the scale of the plasma minor radius. The drift resonance due to the coupling between the cross-field drift motion with radially global modes yields a secondary island structure in the RE drift orbit, where the width of the secondary drift islands shows a square-root dependence on the relativistic gamma factor gamma. Only for highly relativistic REs (gamma >> 1), the widths of secondary drift islands are comparable with those of magnetic islands due to the primary resonance, thus the stochastic threshold becoming sensitive to the RE energy. Because of poloidal asymmetry due to toroidicity, the threshold becomes sensitive not only to the relative amplitude but also to the phase difference between the modes. In this paper, some examples of 3D orbit-following calculations are presented for analytic models of magnetic perturbations with multiple toroidal mode numbers, for both possibilities that the drift resonance enhances and suppresses the stochastization being illustrated.	[Matsuyama, A.; Yagi, M.] Japan Atom Energy Agcy, Rokkasho, Aomori 0393212, Japan; [Kagei, Y.] Res Org Informat Sci & Technol, Tokai, Ibaraki 3191106, Japan; [Nakajima, N.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Matsuyama, A (reprint author), Japan Atom Energy Agcy, Rokkasho, Aomori 0393212, Japan.	matsuyama.akinobu@jaea.go.jp			MEXT KAKENHI [23246163, 26820404, 23561009]	One of the authors (AM) would like to thank S. Tokuda and T. Takizuka for their useful comments relating to this work. Helpful remarks from reviewers are also acknowledged. This work was carried out using the HELIOS supercomputer system at the Computational Simulation Centre of International Fusion Energy Research Centre (IFERC-CSC), Aomori, Japan, under the Broader Approach collaboration between Euratom and Japan, implemented by Fusion for Energy and JAEA. This work was supported in part by Grants-in-Aid for Scientific Research (MEXT KAKENHI Grant No. 23246163, 26820404, and 23561009).	Abdullaev SS, 2010, CONTRIB PLASM PHYS, V50, P929, DOI 10.1002/ctpp.200900045; Abdullaev SS, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4736718; Martin-Solis JR, 2000, PHYS PLASMAS, V7, P3369; Guan XY, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3476268; Riccardo V, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/12/124018; Rosenbluth MN, 1997, NUCL FUSION, V37, P1355, DOI 10.1088/0029-5515/37/10/I03; MYNICK HE, 1980, PHYS FLUIDS, V23, P1229, DOI 10.1063/1.863102; Izzo VA, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/6/063032; Cary JR, 2009, REV MOD PHYS, V81, P693, DOI 10.1103/RevModPhys.81.693; BOOZER AH, 1984, PHYS FLUIDS, V27, P2441, DOI 10.1063/1.864525; Sovinec CR, 2004, J COMPUT PHYS, V195, P355, DOI 10.1016/j.jcp.2003.10.004; Feher T, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/3/035014; Yoshino R, 1997, PLASMA PHYS CONTR F, V39, P313, DOI 10.1088/0741-3335/39/2/008; WHITE RB, 1984, PHYS FLUIDS, V27, P2455, DOI 10.1063/1.864527; Lehnen M, 2009, J NUCL MATER, V390-91, P740, DOI 10.1016/j.jnucmat.2009.01.200; Smith H, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2358110; Yoshino R, 2000, NUCL FUSION, V40, P1293, DOI 10.1088/0029-5515/40/7/302; Hender TC, 2007, NUCL FUSION, V47, pS128, DOI 10.1088/0029-5515/47/6/S03; Finken KH, 2006, NUCL FUSION, V46, pS139, DOI 10.1088/0029-5515/46/4/S04; Eriksson LG, 2003, COMPUT PHYS COMMUN, V154, P175, DOI 10.1016/S0010-4655(03)00293-5; Forster M, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4755787; Izzo VA, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/9/095002; Zhou RJ, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4795740; Papp G, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/12/123017; Hollmann EM, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/8/083004; Helander P, 2002, PLASMA PHYS CONTR F, V44, pB247, DOI 10.1088/0741-3335/44/12B/318; Yoshino R, 1999, NUCL FUSION, V39, P151, DOI 10.1088/0029-5515/39/2/302; MYRA JR, 1992, PHYS FLUIDS B-PLASMA, V4, P176, DOI 10.1063/1.860431; Hollmann EM, 2011, J NUCL MATER, V415, pS27, DOI 10.1016/j.jnucmat.2010.10.009; Plyusnin VV, 2006, NUCL FUSION, V46, P277, DOI 10.1088/0029-5515/46/2/011; Eriksson LG, 2004, PHYS REV LETT, V92, DOI [10.1103/PhysRevLett.92.235004, 10.1103/PhysRevLett.92.205004]; Papp G, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/9/095004; Boozer AH, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/8/084002; deRover M, 1996, PHYS PLASMAS, V3, P4478, DOI 10.1063/1.871582; deRover M, 1996, PHYS PLASMAS, V3, P4468, DOI 10.1063/1.872066; Finken KH, 2007, NUCL FUSION, V47, P91, DOI 10.1088/0029-5515/47/2/004; Forster M, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/8/083016; Gal K, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/5/055006; Gill RD, 2000, NUCL FUSION, V40, P163, DOI 10.1088/0029-5515/40/2/302; Mirnov S, 1999, NUCL FUSION, V39, P2251, DOI 10.1088/0029-5515/39/12/303; Hairer E., 2006, GEOMETRIC NUMERICAL; Harvey RW, 2000, PHYS PLASMAS, V7, P4590, DOI 10.1063/1.1312816; Hauff T, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3243494; Helander P, 2000, PHYS PLASMAS, V7, P4106, DOI 10.1063/1.1289892; JAYAKUMAR R, 1993, PHYS LETT A, V172, P447, DOI 10.1016/0375-9601(93)90237-T; Kolesnichenko YI, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/11/115006; Konovalov S. V., 1988, Soviet Journal of Plasma Physics, V14; KONOVALOV SV, 1990, FUSION TECHNOL, V18, P397; Lichtenberg A J, 1992, REGULAR CHAOTIC DYNA; Matsuyama A., 2014, JPS C P, V1; MYNICK HE, 1993, PHYS FLUIDS B-PLASMA, V5, P1471, DOI 10.1063/1.860886; MYNICK HE, 1993, PHYS FLUIDS B-PLASMA, V5, P2460, DOI 10.1063/1.860731; MYNICK HE, 1981, PHYS FLUIDS, V24, P695, DOI 10.1063/1.863433; MYRA JR, 1993, PHYS FLUIDS B-PLASMA, V5, P1160, DOI 10.1063/1.860906; Papp G, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/12/125008; Papp G, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/4/043004; Putvinski S, 1993, REV PLASMA PHYS, V18; Smith HM, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/12/124008; Tamai H, 2002, NUCL FUSION, V42, P290, DOI 10.1088/0029-5515/42/3/309; Tokuda S, 1999, NUCL FUSION, V39, P1123, DOI 10.1088/0029-5515/39/9/306; White RB, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/4/045012; White RB, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4791661; Wingen A, 2006, NUCL FUSION, V46, P941, DOI 10.1088/0029-5515/46/11/008	63	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	DEC	2014	54	12							123007	10.1088/0029-5515/54/12/123007		14	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	AU4KN	WOS:000345579800013		
J	Shimada, M; Hirooka, Y				Shimada, Michiya; Hirooka, Yoshi			Actively convected liquid metal divertor	NUCLEAR FUSION			English	Article						divertor; heat load; liquid metal	LITHIUM	The use of actively convected liquid metals with j x B force is proposed to facilitate heat handling by the divertor, a challenging issue associated with magnetic fusion experiments such as ITER. This issue will be aggravated even more for DEMO and power reactors because the divertor heat load will be significantly higher and yet the use of copper would not be allowed as the heat sink material. Instead, reduced activation ferritic/martensitic steel alloys with heat conductivities substantially lower than that of copper, will be used as the structural materials. The present proposal is to fill the lower part of the vacuum vessel with liquid metals with relatively low melting points and low chemical activities including Ga and Sn. The divertor modules, equipped with electrodes and cooling tubes, are immersed in the liquid metal. The electrode, placed in the middle of the liquid metal, can be biased positively or negatively with respect to the module. The j x B force due to the current between the electrode and the module provides a rotating motion for the liquid metal around the electrodes. The rise in liquid temperature at the separatrix hit point can be maintained at acceptable levels from the operation point of view. As the rotation speed increases, the current in the liquid metal is expected to decrease due to the v x B electromotive force. This rotating motion in the poloidal plane will reduce the divertor heat load significantly. Another important benefit of the convected liquid metal divertor is the fast recovery from unmitigated disruptions. Also, the liquid metal divertor concept eliminates the erosion problem.	[Shimada, Michiya] Japan Atom Energy Agcy, Rokkasho, Aomori 0393212, Japan; [Hirooka, Yoshi] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Shimada, M (reprint author), Japan Atom Energy Agcy, 2-166 Oaza Obuchi Aza Omotedate, Rokkasho, Aomori 0393212, Japan.	shimada.michiya@jaea.go.jp; michiya.shimada@gmail.com			JSPS KAKENHI [26630475]	The authors would like to appreciate fruitful discussions with many scientists and engineers of JAEA, IFERC, NIFS and other Japanese universities and industries, especially Professor S. Konishi and Professor A. Fukuyama of Kyoto University, Professor Y. Ueda of Osaka University, Professor S. Takamura of Aichi Institute of Technology, Dr S. Matsuda of Tokyo Institute of Technology, Dr M. Ono, Dr M. Zarnstroff and Professor R. Goldstone of PPPL, Dr G. Jackson of GA, Professor O. Motojima and Dr A. Loarte of ITER Organization, Dr H. Takase and Dr K. Shinya of Toshiba, Dr J. van Dam of USDoE, Dr K. Shimizu, Dr H. Tanigawa, Dr K. Tobita, Dr N. Asakura, Dr S. Sengoku and Dr M. Yagi of JAEA. The cooperation of Mr K. Yamada of Seinan Kogyo is appreciated. One of the Authors (M.S.) would like to thank Professor N. Nakajima of IFERC, Dr K. Ushigusa, Dr T. Nishitani and Dr M. Mori of JAEA for the encouragement throughout this work. This work was supported by JSPS KAKENHI Grant Number 26630475.	Surla V, 2010, THIN SOLID FILMS, V518, P6663, DOI 10.1016/j.tsf.2010.03.063; MIRNOV SV, 1992, J NUCL MATER, V196, P45, DOI 10.1016/S0022-3115(06)80010-3; Mukhovatov V, 2007, NUCL FUSION, V47, pS404, DOI 10.1088/0029-5515/47/6/S09; Jaworski MA, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.094503; Klimov N, 2011, J NUCL MATER, V415, pS59, DOI 10.1016/j.jnucmat.2011.01.013; Coenen JW, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/8/083008; Cottrell GA, 2006, FUSION SCI TECHNOL, V50, P89; Ruzic DN, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/10/102002; BATTEZZATI L, 1989, ACTA METALL MATER, V37, P1791, DOI 10.1016/0001-6160(89)90064-3; Loarte A, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/3/033007; Asakura N, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/12/123013; Badger B., 1974, UWMAK I A WISCONSIN; Davis J.W., 1998, NUCL MAT, V258-263, P308; Fiflis P., 2013, NUCL MATER, V438, P224; Hirooka Y, 2005, J NUCL MATER, V337, P585, DOI [10.1016/j.jnucmat.2004.09.065, 10.1016/j.jnucmat.2004.03.065]; Lehnen M., 2012, IAEA FUSION ENERGY C; Maki K., 1986, IAEA TECDOC 373, P87; Mirnov SV, 2006, FUSION ENG DES, V81, P113, DOI 10.1016/j.fusengdes.2005.10.003; Ono M, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/3/037001; Pitts RA, 2013, J NUCL MATER, V438, pS48, DOI 10.1016/j.jnucmat.2013.01.008; Shimada M., 2014, PROC 41ST EPS CONF O; Sugihara M., 2012, PROC IAEA FUSION ENE; Tamura S, 2005, NUCL MATER, V307-311, P735; Tamura S., 2005, NUCL MAT, V337-339, P1043; Tobita K, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/7/075029; Zohm H, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073019	26	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	DEC	2014	54	12							122002	10.1088/0029-5515/54/12/122002		7	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	AU4KN	WOS:000345579800002		
J	Uchida, S; Naitoh, M; Suzuki, H; Okada, H; Konishi, S				Uchida, Shunsuke; Naitoh, Masanori; Suzuki, Hiroaki; Okada, Hidetoshi; Konishi, Satoshi			EVALUATION OF ACCUMULATED FISSION PRODUCTS IN THE CONTAMINATED WATER AT THE FUKUSHIMA DAIICHI NUCLEAR POWER PLANT	NUCLEAR TECHNOLOGY			English	Article						nuclear accident; source term; contaminated water	TRITIUM	El As a result of the mass balance analysis for fission products (FP s) in the contaminated water accumulated in the Fukushima Daiichi nuclear power plant in the aftermath of the accident, it was concluded that the short-term cesium source was 50% of the total amount of cesium accumulated in the reactor, which was estimated with the SAMPSON severe accident analysis code, while the short-term source of tritium was 26% of the total tritium that was released during the UO2 fuel meltdown. The FP concentrations in the contaminated water during the 2 yr since the accident were determined by short-term FP sources, while their saturated concentrations, due to a balance between the release from the reactor and the cleanup, were determined by long-term FP sources A multinuclei removal system, ALPS, has been operated at the plant to clean up the contaminated water to reduce FP concentrations to a level that is permitted for release to the environment. Tritium concentration in the contaminated water decreased a little during the 2 yr since the accident primarily from dilution by mixing groundwater rather than intentional removal. Industrialscale removal of tritium from the huge amount of contaminated water is almost impossible using isotopic separation methods. Storage of tritiated water for a long period presents a high risk for leakage to the environment. As the most realistic procedure, the authors propose that the tritium be diluted with plenty of seawater to the natural background level and then be released into the ocean with continuous monitoring at the release point.	[Uchida, Shunsuke; Naitoh, Masanori; Suzuki, Hiroaki; Okada, Hidetoshi] Inst Appl Energy, Minato Ku, Tokyo 1050001, Japan; [Konishi, Satoshi] Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan	Uchida, S (reprint author), Inst Appl Energy, Minato Ku, 1-14-2 Nishi Shimbashi, Tokyo 1050001, Japan.	suchida@iae.or.jp					[Anonymous], 2012, MULTI NUCLIDE REMOVA; [Anonymous], 2011, REPORT OF THE JAPANE; Asakura Y, 2012, J NUCL SCI TECHNOL, V49, P1018, DOI 10.1080/00223131.2012.723177; CROFF A. G., 1980, ORNL 5621; FLUSS MJ, 1972, PHYS REV C, V6, P2252, DOI 10.1103/PhysRevC.6.2252; KANI Y., 2013, PROC WASTE MANAGEMEN; LIDO D. R., 2006, CRC HDB CHEM PHYS; MIYANO H., 2012, PROC 3RD INT CONF NU; NAITOH M., 2013, PROC 15TH INT TOPL M; Singh VP, 2010, RADIAT PROT DOSIM, V142, P153, DOI 10.1093/rpd/ncq219; UCHIDA S., 2013, PROC INT CONF PROPER; Ujita H, 1999, J NUCL SCI TECHNOL, V36, P1076, DOI 10.3327/jnst.36.1076; WANIGARATNE S., 2013, CHRONIC DISEASES AND, V33, P4	13	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	0029-5450	1943-7471		NUCL TECHNOL	Nucl. Technol.	DEC	2014	188	3					252	265				14	Nuclear Science & Technology	Nuclear Science & Technology	AU3CC	WOS:000345489400003		
J	Yamada, F; Fukano, Y; Nishi, H; Konomura, M				Yamada, Fumiaki; Fukano, Yoshitaka; Nishi, Hiroshi; Konomura, Mamoru			DEVELOPMENT OF NATURAL CIRCULATION ANALYTICAL MODEL IN SUPER-COPD CODE AND EVALUATION OF CORE COOLING CAPABILITY IN MONJU DURING A STATION BLACKOUT	NUCLEAR TECHNOLOGY			English	Article						Monju; station blackout; thermal hydraulics		The capability of natural circulation for core cooling has been evaluated in detail for a station blackout (SBO) event induced by an earthquake and a subsequent tsunami hit. The evaluation was prompted by the accident at the Fukushima Daiichi nuclear power station of Tokyo Electric Power Company. The plant dynamics computer code Super-COPD was used for the evaluation, which has been validated by analyses of preliminary test results on the natural circulation in Monju. As a result, it was concluded that natural circulation of the sodium coolant will enable the decay heat from the core to be removed under such an SBO condition.	[Yamada, Fumiaki; Fukano, Yoshitaka; Nishi, Hiroshi; Konomura, Mamoru] Japan Atom Energy Agcy, Plant Safety Evaluat Grp, Anal & Evaluat Dept, FBR Safety Technol Ctr,Tsuruga Head Off, Shiraki Tsuruga, Fukui 9191279, Japan	Yamada, F (reprint author), Japan Atom Energy Agcy, Plant Safety Evaluat Grp, Anal & Evaluat Dept, FBR Safety Technol Ctr,Tsuruga Head Off, Shiraki Tsuruga, Fukui 9191279, Japan.	yamada.fumiaki@jaea.go.jp					[Anonymous], 1963, MECH PHYS PROP AUSTR; LYON RN, 1951, CHEM ENG PROG, V47, P75; Mochizuki H, 2009, NUCL ENG DES, V239, P295, DOI 10.1016/j.nucengdes.2008.10.013; DWYER O. E., 1966, RECENT DEV LIQUID ME; GOLDEN G. H., 1967, ANL7323; HILBERT R. F., 1973, GEAP13967; HIYAMA T., 2012, T JPN SOC MECH ENG-B, V78, P787; Hoe RJ, 1957, T ASME, V79, P899; IHARA H., 1995, 95014 JAERI; International Atomic Energy Agency, 2006, IAEATECDOC1531; Japan Atomic Energy Agency FBR Plant Engineering Center, 2011, 2011004 JAEA FBR PLA, P55; MOCHIZUKI H., 2008, P ICAPP 08 AN CA US, P1650; MORI Y., 1965, T JSME REPORT, P31; NAKAI S., 1988, TECHNICAL REV, P68; SAWADA M, 1990, NUCL ENG DES, V120, P341, DOI 10.1016/0029-5493(90)90385-B; SCHROCK V. E., 1959, TID14639 US AT EN CO; Seban R.A., 1951, Transactions of the ASME, V73; TANJI M., 1986, TECHNICAL REV, V23; YAMADA F., 2010, 2010023 JAEA; YAMADA F., 2010, P 3 JOINT US EUR FLU	20	2	2	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	0029-5450	1943-7471		NUCL TECHNOL	Nucl. Technol.	DEC	2014	188	3					292	321				30	Nuclear Science & Technology	Nuclear Science & Technology	AU3CC	WOS:000345489400006		
J	Tada, Y; Kawano, Y; Maeda, I; Yoshizaki, T; Sunami, A; Yokoyama, Y; Matsumoto, H; Hida, A; Komatsu, T; Togo, F				Tada, Yuki; Kawano, Yukari; Maeda, Izumi; Yoshizaki, Takahiro; Sunami, Ayaka; Yokoyama, Yuri; Matsumoto, Harumi; Hida, Azumi; Komatsu, Taiki; Togo, Fumiharu			Association of Body Mass Index with Lifestyle and Rotating Shift Work in Japanese Female Nurses	OBESITY			English	Article							AUTONOMIC NERVOUS-SYSTEM; HEART-RATE-VARIABILITY; SHORT-SLEEP DURATION; OBESITY; WEIGHT; RHYTHM; LEPTIN	ObjectiveHigher body mass index (BMI) values have been reported in rotating shift workers compared with regular daytime workers. This study examines the relationship between work schedule and BMI, and considers whether lifestyle habits could explain the relationship. MethodsJapanese female nurses (1179 day workers and 1579 rotating shift workers, aged 20-59) were studied using self-administered questionnaires. The questionnaires assessed height, weight, and dietary intake, physical activity, and sleep (lifestyle) habits. ResultsThe BMI of shift workers was significantly higher than that of day workers. Shift workers consumed significantly higher amounts of sugar-sweetened beverages and slept for significantly shorter durations on nights between days on the day shift compared with day workersfactors which were also independently associated with higher BMI. In addition, multivariable linear regression coefficients for BMI showed a significant correlation with rotating shift work (=0.051), after controlling for lifestyle habits. ConclusionsHigher consumption of sugar-sweetened beverages and shorter sleep duration were associated with rotating shift work and higher BMI. This should be taken into consideration in preventing obesity in real-life shift work situations. Other shift work-related factors, such as abnormal timing of meals and/or sleep, should also be identified.	[Tada, Yuki; Kawano, Yukari; Maeda, Izumi; Hida, Azumi] Tokyo Univ Agr, Dept Nutr Sci, Fac Appl Biosci, Tokyo, Japan; [Yoshizaki, Takahiro; Sunami, Ayaka; Yokoyama, Yuri] Tokyo Univ Agr, Grad Sch Agr, Tokyo, Japan; [Yoshizaki, Takahiro] Toyo Univ, Fac Food & Nutr Sci, Tokyo, Japan; [Matsumoto, Harumi] Showagakuin Jr Coll, Healthcare Nutr Course, Ichikawa, Chiba, Japan; [Komatsu, Taiki] Tokyo Univ Technol, Sch Hlth Sci, Dept Phys Therapy, Tokyo, Japan; [Togo, Fumiharu] Univ Tokyo, Grad Sch Educ, Educ Physiol Lab, Tokyo 1138654, Japan	Togo, F (reprint author), Univ Tokyo, Grad Sch Educ, Educ Physiol Lab, Tokyo 1138654, Japan.	y3tada@nodai.ac.jp; tougou@p.u-tokyo.ac.jp			Japan Society for the Promotion of Science [20800085, 22500690]	Funding agencies: This study was supported by grants from the Japan Society for the Promotion of Science (Grant-in-Aid for start-up 20800085, Scientific Research [C] 22500690).	Cappuccio FP, 2008, SLEEP, V31, P619; [Anonymous], 2000, WHO TECH REP SER, V894, P1; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Nawaz H, 2001, AM J PREV MED, V20, P294, DOI 10.1016/S0749-3797(01)00293-8; Smith P, 2013, APPL NURS RES, V26, P24, DOI 10.1016/j.apnr.2012.10.001; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Mullington JM, 2003, J NEUROENDOCRINOL, V15, P851, DOI 10.1046/j.1365-2826.2003.01069.x; Atkinson G, 2008, SPORTS MED, V38, P671, DOI 10.2165/00007256-200838080-00005; St-Onge MP, 2011, AM J CLIN NUTR, V94, P410, DOI 10.3945/ajcn.111.013904; Rayner DV, 2001, J MOL MED-JMM, V79, P8, DOI 10.1007/s001090100198; Galli G, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2012.33; Kim MJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1204; Ministry of Health Labor and Welfare, 2011, RES 2010 NAT HLTH NU; Murase N, 2002, J HLTH WELFARE STAT, V49, P1; Takahashi K., 2001, Japanese Journal of Nutrition, V59, P221; Yoshida C, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-78; Yoshizaki T., 2010, Journal of Japanese Society of Nutrition and Food Science, V63, P161; Yoshizaki T, 2013, J BIOL RHYTHM, V28, P227, DOI 10.1177/0748730413489957; Yoshizaki T, 2013, EUR J APPL PHYSIOL, V113, P2603, DOI 10.1007/s00421-013-2702-z; Yoshizaki T, 2013, PHYSIOL BEHAV, V118, P122, DOI 10.1016/j.physbeh.2013.05.010	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1930-7381	1930-739X		OBESITY	Obesity	DEC	2014	22	12					2489	2493		10.1002/oby.20908		5	Endocrinology & Metabolism; Nutrition & Dietetics	Endocrinology & Metabolism; Nutrition & Dietetics	AU1XA	WOS:000345409500006		
J	Tajima, Y; Watanabe, M				Tajima, Yusuke; Watanabe, Mamoru			Seasonal variation of genital morphology and sperm removal in Ischnura asiatica (Odonata: Coenagrionidae)	ODONATOLOGICA			English	Article						Dragonfly; damselfly; Zygoptera; bivoltine; interrupted copulation; male-female coevolution; penis head; spermatozoa number	COPULATION ZYGOPTERA COENAGRIONIDAE; DISPLACEMENT ABILITY; FEMALE; CALOPTERYGIDAE; PRECEDENCE; STORAGE; BRAUER; FERTILIZATION; OVIPOSITION; COMPETITION	During copulation, Ischnura asiatica (Brauer, 1865) males remove the sperm of the females' previous mates from the spermatheca by stimulating vaginal sensilla thereby inducing sperm ejection. Because a wider penis head stimulates the vaginal sensilla more intensely, larger males with wider penis heads can remove much more sperm from the spermatheca. There are two distinct body sizes for spring (large) and summer (small) generations of I. asiatica. In the present study we show that in spring, males have wider penis heads and females have a higher number of vaginal sensilla as compared to summer adults, suggesting that mating males remove more spermathecal sperm in spring than in summer. However, interrupted copulation experiments showed that females of the spring generation had a higher number of spermatozoa in both sperm storage organs than those of the summer generation. Solitary females of the spring generation also had higher numbers of spermatozoa stored than those of the summer generation, suggesting that spring females might have larger sperm storage organs than summer females. Although the removal rate of bursal sperm was almost the same between generations, the removal rate of spermathecal sperm in the summer generation was slightly higher than that in the spring generation. Consequently, spermatozoa derived from previously mated males have a higher probability of remaining in the sperm storage organs in spring- than in summer-generation females. The size of sperm storage organs in females might be critical to understanding sperm displacement. This aspect of female anatomy has not been previously considered in studies of sperm competition in odonates.	[Tajima, Yusuke; Watanabe, Mamoru] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Watanabe, M (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	watanabe@kankyo.envr.tsukuba.ac.jp					Stoks R, 2012, ANNU REV ENTOMOL, V57, P249, DOI 10.1146/annurev-ento-120710-100557; Cordoba-Aguilar A, 2005, J EVOLUTION BIOL, V18, P132, DOI 10.1111/j.1420-9101.2004.00796.x; WAAGE JK, 1979, SCIENCE, V203, P916, DOI 10.1126/science.203.4383.916; Cordoba-Aguilar A, 2006, PHYSIOL ENTOMOL, V31, P146, DOI 10.1111/j.1365-3032.2005.00498.x; Cordoba-Aguilar A, 2003, J ZOOL, V261, P381, DOI 10.1017/S0952836903004357; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; CORDERO A, 1992, BEHAV ECOL SOCIOBIOL, V30, P261, DOI 10.1007/BF00166711; Cordoba-Aguilar A, 2009, BIOL J LINN SOC, V96, P815, DOI 10.1111/j.1095-8312.2008.01164.x; Cordoba-Aguilar A, 2003, ODONATOLOGICA, V32, P205; FINCKE OM, 1984, BEHAV ECOL SOCIOBIOL, V14, P235, DOI 10.1007/BF00299623; MILLER P L, 1987, Odonatologica, V16, P37; MILLER P L, 1981, Odonatologica, V10, P201; Naraoka H., 1976, New Entomologist Ueda, V25, P27; Naraoka Hirozi, 1994, Gekkan-Mushi, V279, P18; Nava-Bolanos A, 2012, ETHOLOGY, V118, P203, DOI 10.1111/j.1439-0310.2011.02000.x; R DEVELOPMENT CORE TEAM, 2011, LANG ENV STAT COMP; Robinson JV, 1997, BIOL J LINN SOC, V60, P187, DOI 10.1006/bijl.1996.0098; Sakurai T, 1998, APPL ENTOMOL ZOOL, V33, P363; Sawada K, 1998, ODONATOLOGICA, V27, P425; Sawada K., 1995, Odonatologica, V24, P237; SIVAJOTHY MT, 1989, BEHAV ECOL SOCIOBIOL, V24, P39, DOI 10.1007/BF00300116; SivaJothy MT, 1996, BEHAV ECOL SOCIOBIOL, V39, P389, DOI 10.1007/s002650050305; Tajima Y, 2010, ODONATOLOGICA, V39, P253; Tajima Y, 2009, ODONATOLOGICA, V38, P141; Tajima Y, 2013, ODONATOLOGICA, V42, P229; WAAGE JK, 1986, BIOL J LINN SOC, V28, P285, DOI 10.1111/j.1095-8312.1986.tb01758.x	26	0	0	SOC INT ODONATOLOGICA	BILTHOVEN	PO BOX 256, 3720 AG BILTHOVEN, NETHERLANDS	0375-0183			ODONATOLOGICA	Odonatologica	DEC 1	2014	43	3-4					213	226				14	Entomology	Entomology	AU3WA	WOS:000345540300006		
J	Sawada, K; Yamahira, K; Kuriwada, T				Sawada, Kouji; Yamahira, Kazunori; Kuriwada, Takashi			Interpopulation variation in female color-type frequency of Ischnura senegalensis in Okinawa Island, Japan (Odonata: Coenagrionidae)	ODONATOLOGICA			English	Article						Dragonfly; damselfly; Zygoptera; female-limited polychromatism; local population; Ryukyu Archipelago	POPULATION DIVERGENCE; POLYMORPHISM; INHERITANCE; DIMORPHISM; DAMSELFLIES; RAMBUR	Ischnura senegalensis (Rambur, 1842) has two female color-types: gynochromes, which are brown, and androchromes, which are green and similar in appearance to conspecific males. Ischnura senegalensis females from Okinawa Island, a small island in the Ryukyu Archipelago, Japan, show color-type frequencies that vary greatly, even among adjacent local populations. For example, androchrome frequencies were very low (0-4.3 %) in northern populations of the island. However, in the southern populations androchrome frequencies were high and ranged widely (0-67.2%). Periodical surveys from 2011 to 2013 of two adjacent southern populations revealed that the frequency of color-type remained constant over time. To our knowledge, this is the first study of temporally stable and extremely high interpopulation variation in female color-type frequency in Odonata. We discuss possible reasons for the evolution of such high interpopulation variation in color-type frequency.	[Sawada, Kouji] Fukuoka High Sch, Hakata Ku, Fukuoka, Japan; [Yamahira, Kazunori] Univ Ryukyus, Trop Biosphere Res Ctr, Nishihara, Okinawa 90301, Japan; [Kuriwada, Takashi] Kagoshima Univ, Fac Educ, Kagoshima 890, Japan	Sawada, K (reprint author), Fukuoka High Sch, Hakata Ku, 1-29-1 Katakasu, Fukuoka, Japan.	kouji.senegalensis@gmail.com; yamahira@lab.u-ryukyu.ac.jp; kuriwada@edu.kagoshima-u.ac.jp			Collaborative Research of Tropical Biosphere Research Center, University of the Ryukyus	We thank Tsuguo Kohama, Okinawa Prefectural Agricultural Research Center, for providing field information. We are also grateful to Atsushi Irimoto, Daigo Kakazu, Junpei Kihara, Shun Kobayashi, Kageoki Kuba, Takahiro Maeda, Kouhei Okuda, Kana Otaka, Maya Sakai, Kanako Sakumoto, and Hiroaki Ui, University of the Ryukyus, for supporting our fieldwork. This study was partly supported by the Collaborative Research of Tropical Biosphere Research Center, University of the Ryukyus.	Abbott JK, 2008, MOL ECOL, V17, P1597, DOI 10.1111/j.1365-294X.2007.03641.x; Andres JA, 1999, HEREDITY, V82, P328, DOI 10.1038/sj.hdy.6884930; Iserbyt A, 2010, J ZOOL, V282, P256, DOI 10.1111/j.1469-7998.2010.00735.x; Sanchez-Guillen RA, 2005, BIOL J LINN SOC, V85, P471, DOI 10.1111/j.1095-8312.2005.00506.x; Sanchez-Guillen RA, 2011, HEREDITY, V107, P513, DOI 10.1038/hdy.2011.36; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; CORDERO A, 1990, HEREDITY, V64, P341, DOI 10.1038/hdy.1990.42; Fincke Ola M., 2005, International Journal of Odonatology, V8, P183; JOHNSON C, 1966, HEREDITY, V21, P453, DOI 10.1038/hdy.1966.44; JOHNSON C, 1964, GENETICS, V49, P513; R Core Team, 2012, R LANG ENV STAT COMP; ROBERTSON HM, 1985, ANIM BEHAV, V33, P805, DOI 10.1016/S0003-3472(85)80013-0; Sawada K, 1998, ODONATOLOGICA, V27, P425; Sawada K., 1995, Odonatologica, V24, P237; Svensson EI, 2005, J EVOLUTION BIOL, V18, P1503, DOI 10.1111/j.1420-9101.2005.00946.x; TAKAHASHI Y., 2011, BMC EVOLUTIONARY BIO, V11; Takahashi Y, 2014, HEREDITY, V112, P391, DOI 10.1038/hdy.2013.117; Wellenreuther M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020440	18	1	1	SOC INT ODONATOLOGICA	BILTHOVEN	PO BOX 256, 3720 AG BILTHOVEN, NETHERLANDS	0375-0183			ODONATOLOGICA	Odonatologica	DEC 1	2014	43	3-4					227	235				9	Entomology	Entomology	AU3WA	WOS:000345540300007		
J	Matsushita, M; Kitoh, H; Mishima, K; Nishida, Y; Ishiguro, N				Matsushita, Masaki; Kitoh, Hiroshi; Mishima, Kenichi; Nishida, Yoshihiro; Ishiguro, Naoki			A case of severe proximal focal femoral deficiency with overlapping phenotypes of Al-Awadi-Raas-Rothschild syndrome and Fuhrmann syndrome	PEDIATRIC RADIOLOGY			English	Article						Proximal focal femoral deficiency; Al-Awadi-Raas-Rothschild syndrome; Fuhrmann syndrome; WNT7A; Molecular analysis; Radiography; Child	PHOCOMELIA-SYNDROME; WNT7A	Proximal focal femoral deficiency (PFFD) is a heterogeneous disorder characterized by various degrees of femoral deficiencies and associated anomalies of the pelvis and lower limbs. The etiology of the disease has not been determined. We report on a 3-year-old boy with severe PFFD, who showed almost completely absent femora and fibulae, malformed pelvis and ectrodactyly of the left foot. These features were partially overlapped with those of Al-Awadi-Raas-Rothschild syndrome or Fuhrmann syndrome, both of which are caused by WNT7A mutations. Molecular analysis of our case, however, demonstrated no disease-causing mutations in the WNT7A gene.	[Matsushita, Masaki; Kitoh, Hiroshi; Mishima, Kenichi; Nishida, Yoshihiro; Ishiguro, Naoki] Nagoya Univ Grad Sch Med, Dept Orthopaed Surg, Showa Ku, Nagoya, Aichi 4668550, Japan	Kitoh, H (reprint author), Nagoya Univ Grad Sch Med, Dept Orthopaed Surg, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	hkitoh@med.nagoya-u.ac.jp					Aitken GT, 1969, PROXIMAL FEMORAL FOC, P1; AlQattan MM, 2013, GENE, V527, P371, DOI 10.1016/j.gene.2013.05.023; Woods CG, 2006, AM J HUM GENET, V79, P402, DOI 10.1086/506332; DAENTL DL, 1975, J PEDIATR-US, V86, P107, DOI 10.1016/S0022-3476(75)80718-9; EPPS CH, 1983, J BONE JOINT SURG AM, V65, P867; Kantaputra PN, 2005, AM J MED GENET A, V132A, P63, DOI 10.1002/ajmg.a.30261; LENZ W, 1993, HUM GENET, V91, P347; Shyy W, 2009, CLIN ORTHOP RELAT R, V467, P1201, DOI 10.1007/s11999-008-0701-x	8	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0301-0449	1432-1998		PEDIATR RADIOL	Pediatr. Radiol.	DEC	2014	44	12					1617	1619		10.1007/s00247-014-3013-1		3	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	AU0SA	WOS:000345333300015		
J	Krishnan, A; Samtani, R; Dhanantwari, P; Lee, E; Yamada, S; Shiota, K; Donofrio, MT; Leatherbury, L; Lo, CW				Krishnan, Anita; Samtani, Rajeev; Dhanantwari, Preeta; Lee, Elaine; Yamada, Shigehito; Shiota, Kohei; Donofrio, Mary T.; Leatherbury, Linda; Lo, Cecilia W.			A detailed comparison of mouse and human cardiac development	PEDIATRIC RESEARCH			English	Article							CONGENITAL HEART-DISEASE; OUTFLOW TRACT; ARTERIAL TRUNKS; SEPTATION; MICE; ORGANOGENESIS; TRUNCUS; EMBRYOS; CHICK	BACKGROUND: Mouse mutants are used to model human congenital cardiovascular disease. Few studies exist comparing normal cardiovascular development in mice vs. humans. We carried out a systematic comparative analysis of mouse and human fetal cardiovascular development. METHODS: Episcopic fluorescence image capture (EFIC) was performed on 66 wild-type mouse embryos from embryonic day (E) 9.5 to birth; 2-dimensional and 3-dimensional datasets were compared with EFIC and magnetic resonance images from a study of 52 human fetuses (Carnegie stage 13-23). RESULTS: Time course of atrial, ventricular, and outflow septation were outlined and followed a similar sequence in both species. Bilateral venae cavae and prominent atrial appendages were seen in the mouse fetus; in human fetuses, atrial appendages were small, and a single right superior vena cava was present. In contrast to humans with separate pulmonary vein orifices, a pulmonary venous confluence with one orifice enters the left atrium in mice. CONCLUSION: The cardiac developmental sequences observed in mouse and human fetuses are comparable, with minor differences in atrial and venous morphology. These comparisons of mouse and human cardiac development strongly support that mouse morphogenesis is a good model for human development.	[Krishnan, Anita; Samtani, Rajeev; Lee, Elaine; Leatherbury, Linda; Lo, Cecilia W.] NHLBI, Dev Biol Lab, NIH, Bethesda, MD 20892 USA; [Krishnan, Anita; Donofrio, Mary T.; Leatherbury, Linda] Childrens Natl Med Ctr, Childrens Natl Heart Inst, Washington, DC 20010 USA; [Samtani, Rajeev] George Washington Univ, Sch Med, Washington, DC USA; [Dhanantwari, Preeta] Schneider Childrens Hosp, Div Pediat Cardiol, New Hyde Pk, NY USA; [Lee, Elaine] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Yamada, Shigehito; Shiota, Kohei] Kyoto Univ, Grad Sch Med, Congenital Anomaly Res Ctr, Kyoto, Japan; [Lo, Cecilia W.] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA USA	Krishnan, A (reprint author), NHLBI, Dev Biol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	akrishna@childrensnational.org			United States National Institutes of Health [ZO1-HL005701]; Japanese Ministry of Education, Culture, Sports, Science, and Technology [19390050]; Japanese Ministry of Health, Labor, and Welfare [17A-6]; Japan Science Technology Agency (BIRD grant); Kyoto University Foundation; intramural Center of Genetics and Developmental Biology, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD	This work was supported by United States National Institutes of Health grant ZO1-HL005701. The Kyoto collection was supported by the Japanese Ministry of Education, Culture, Sports, Science, and Technology (grant 19390050); Japanese Ministry of Health, Labor, and Welfare (grant 17A-6); and Japan Science Technology Agency (BIRD grant). S.Y. was supported by Kyoto University Foundation. L.L. had a subgrant from the intramural Center of Genetics and Developmental Biology, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD.	Anderson RH, 2003, HEART, V89, P1110, DOI 10.1136/heart.89.9.1110; Shen Y, 2005, PHYSIOL GENOMICS, V24, P23, DOI 10.1152/physiolgenomics.00129.2005; DeLaughter DM, 2011, BIRTH DEFECTS RES A, V91, P511, DOI 10.1002/bdra.20809; Moorman A, 2003, HEART, V89, P806, DOI 10.1136/heart.89.7.806; Restivo A, 2006, ANAT REC PART A, V288A, P936, DOI 10.1002/ar.a.20367; Sedmera D, 2011, CARDIOVASC RES, V91, P252, DOI 10.1093/cvr/cvr062; Dhanantwari P, 2009, CIRCULATION, V120, P343, DOI 10.1161/CIRCULATIONAHA.108.796698; Bajolle F, 2008, DEV BIOL, V313, P25, DOI 10.1016/j.ydbio.2007.09.023; Webb S, 1996, ANAT EMBRYOL, V194, P37; McElhinney DB, 2009, CIRCULATION, V120, P1482, DOI 10.1161/CIRCULATIONAHA.109.848994; Sizarov A, 2012, J ANAT, V220, P336, DOI 10.1111/j.1469-7580.2012.01474.x; Webb S, 1998, CIRC RES, V82, P645; MITCHELL SC, 1971, CIRCULATION, V43, P323; Anderson RH, 2003, HEART, V89, P949, DOI 10.1136/heart.89.8.949; Wessels A, 2003, PHYSIOL GENOMICS, V15, P165, DOI 10.1152/physiolgenomics.00033.2003; Weninger WJ, 2002, NAT GENET, V30, P59, DOI 10.1038/ng785; BARTELINGS MM, 1989, INT J CARDIOL, V22, P289, DOI 10.1016/0167-5273(89)90270-2; BENSHACHAR G, 1985, CIRC RES, V57, P759; Keyte A, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.04.005; Kramer TC, 1942, AM J ANAT, V71, P343, DOI 10.1002/aja.1000710303; Liu X, 2012, CIRCULATION, V126; MacGrogan D, 2010, CURR TOP DEV BIOL, V92, P333, DOI 10.1016/S0070-2153(10)92011-5; NISHIMUR.H, 1968, TERATOLOGY, V1, P281, DOI 10.1002/tera.1420010306; ORTSLLORCA F, 1982, J ANAT, V134, P41; Rosenthal Julie, 2004, Birth Defects Res C Embryo Today, V72, P213, DOI 10.1002/bdrc.20023; SHAKIBI JG, 1972, LAB ANIM SCI, V22, P668; Sissman N J, 1970, Am J Cardiol, V25, P141, DOI 10.1016/0002-9149(70)90575-8; Tonge M, 1869, PHILOS T ROY SOC LON, V159, P387, DOI 10.1098/rstl.1869.0013; VUILLEMIN M, 1989, AM J ANAT, V184, P114, DOI 10.1002/aja.1001840203; VUILLEMIN M, 1989, AM J ANAT, V184, P101, DOI 10.1002/aja.1001840202; Webb S, 2003, J ANAT, V202, P327	31	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0031-3998	1530-0447		PEDIATR RES	Pediatr. Res.	DEC	2014	76	6					500	507		10.1038/pr.2014.128		8	Pediatrics	Pediatrics	AU3XZ	WOS:000345545200001		
J	Fang, H; Liu, X; Ramirez, J; Choudhury, N; Kubo, M; Im, HK; Konkashbaev, A; Cox, NJ; Ratain, MJ; Nakamura, Y; O'Donnell, PH				Fang, H.; Liu, X.; Ramirez, J.; Choudhury, N.; Kubo, M.; Im, H. K.; Konkashbaev, A.; Cox, N. J.; Ratain, M. J.; Nakamura, Y.; O'Donnell, P. H.			Establishment of CYP2D6 reference samples by multiple validated genotyping platforms	PHARMACOGENOMICS JOURNAL			English	Article							HUMAN CYTOCHROME-P450 2D6; COPY NUMBER VARIATION; ASSOCIATION; POPULATION; PHENOTYPE; ALLELE; IMPLEMENTATION; DEBRISOQUINE; ARRANGEMENTS; POLYMORPHISM	Cytochrome P450 2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6 (CYP2D6)), a highly polymorphic drug-metabolizing enzyme, is involved in the metabolism of one-quarter of the most commonly prescribed medications. Here we have applied multiple genotyping methods and Sanger sequencing to assign precise and reproducible CYP2D6 genotypes, including copy numbers, for 48 HapMap samples. Furthermore, by analyzing a set of 50 human liver microsomes using endoxifen formation from N-desmethyl-tamoxifen as the phenotype of interest, we observed a significant positive correlation between CYP2D6 genotype-assigned activity score and endoxifen formation rate (r(s)= 0.68 by rank correlation test, P=5.3 x 10(-8)), which corroborated the genotype-phenotype prediction derived from our genotyping methodologies. In the future, these 48 publicly available HapMap samples characterized by multiple substantiated CYP2D6 genotyping platforms could serve as a reference resource for assay development, validation, quality control and proficiency testing for other CYP2D6 genotyping projects and for programs pursuing clinical pharmacogenomic testing implementation.	[Fang, H.; Cox, N. J.; Ratain, M. J.; Nakamura, Y.; O'Donnell, P. H.] Univ Chicago, Comm Clin Pharmacol & Pharmacogen, Chicago, IL 60637 USA; [Fang, H.; Liu, X.; Ramirez, J.; Choudhury, N.; Ratain, M. J.; Nakamura, Y.; O'Donnell, P. H.] Univ Chicago, Sect Hematol Oncol, Chicago, IL 60637 USA; [Kubo, M.] RIKEN Ctr Genom Med, Yokohama, Kanagawa, Japan; [Im, H. K.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Konkashbaev, A.; Cox, N. J.] Univ Chicago, Dept Med, Sect Genet Med, Chicago, IL 60637 USA; [Cox, N. J.; Ratain, M. J.; Nakamura, Y.; O'Donnell, P. H.] Univ Chicago, Ctr Personalized Therapeut, Chicago, IL 60637 USA; [Nakamura, Y.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA	O'Donnell, PH (reprint author), Univ Chicago, Dept Med, 5841 S Maryland Ave,Mail Code 2115, Chicago, IL 60637 USA.	podonnel@medicine.bsd.uchicago.edu			NIH [3N01-DK-9-2310, K12 CA139160, K23 GM100288-01A1, T32 GM007019]; Conquer Cancer Foundation of ASCO; NIH (Pharmacogenomics of Anticancer Agents Research Group) [U01GM061393]	We acknowledge the help of Dr R Stephanie Huang and Bonnie LaCroix from the Pharmacogenomics of Anticancer Agents Cell Core and the kind remarks from Dr Kazuma Kiyotani. We also thank the Liver Tissue Procurement and Distribution System (NIH contract 3N01-DK-9-2310) and the Cooperative Human Tissue Network for providing the liver samples. This work is supported by NIH U01GM061393 (Pharmacogenomics of Anticancer Agents Research Group; to YN, MJR and NJC) and NIH K12 CA139160 and K23 GM100288-01A1 (to PHO). HF is supported by a NIH T32 GM007019 training grant in Clinical Pharmacology and Pharmacogenomics. MJR is a recipient of a Conquer Cancer Foundation of ASCO Translational Research Professorship, in memory of Merrill J Egorin, MD. Any opinions, findings and conclusions expressed in this material are those of the authors and do not necessarily reflect those of the American Society of Clinical Oncology or the Conquer Cancer Foundation.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Zhou SF, 2009, CLIN PHARMACOKINET, V48, P761, DOI 10.2165/11318070-000000000-00000; Antunes MV, 2013, J PHARMACEUT BIOMED, V76, P13, DOI 10.1016/j.jpba.2012.12.005; Crews KR, 2012, CLIN PHARMACOL THER, V91, P321, DOI 10.1038/clpt.2011.287; O'Donnell PH, 2012, CLIN PHARMACOL THER, V92, P446, DOI 10.1038/clpt.2012.117; BROLY F, 1991, DNA CELL BIOL, V10, P545, DOI 10.1089/dna.1991.10.545; Kramer WE, 2009, PHARMACOGENET GENOM, V19, P813, DOI 10.1097/FPC.0b013e3283317b95; Qian JC, 2013, PHARMACOGENOMICS, V14, P1731, DOI 10.2217/pgs.13.160; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Zanger UM, 2004, N-S ARCH PHARMACOL, V369, P23, DOI 10.1007/s00210-003-0832-2; Gaedigk A, 2013, INT REV PSYCHIATR, V25, P534, DOI 10.3109/09540261.2013.825581; Bradford LD, 2002, PHARMACOGENOMICS, V3, P229, DOI 10.1517/14622416.3.2.229; STEEN VM, 1995, PHARMACOGENETICS, V5, P215, DOI 10.1097/00008571-199508000-00005; Gaedigk A, 2010, PHARMACOGENOMICS, V11, P43, DOI [10.2217/pgs.09.133, 10.2217/PGS.09.133]; Gaedigk A, 2006, DRUG METAB DISPOS, V34, P563, DOI 10.1124/dmd.105.008292; Zhou SF, 2009, CLIN PHARMACOKINET, V48, P689, DOI 10.2165/11318030-000000000-00000; BOX GEP, 1964, J ROY STAT SOC B, V26, P211; Fukuda Tsuyoshi, 2005, Drug Metab Pharmacokinet, V20, P345, DOI 10.2133/dmpk.20.345; Heller T, 2006, THER DRUG MONIT, V28, P673, DOI 10.1097/01.ftd.0000246764.67129.2a; Hosono N, 2009, CLIN CHEM, V55, P1546, DOI 10.1373/clinchem.2009.123620; Hosono N, 2008, HUM MUTAT, V29, P182, DOI 10.1002//humu.20609; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Kim J, 2012, PHARMACOGENOMICS, V13, P963, DOI [10.2217/pgs.12.58, 10.2217/PGS.12.58]; Pratt VM, 2010, J MOL DIAGN, V12, P835, DOI 10.2353/jmoldx.2010.100090; R Development Core Team, 2011, LANG ENV STAT COMP; Ramirez J, 2007, DRUG METAB DISPOS, V35, P2149, DOI 10.1124/dmd.107.015446; Ripley BD, 2002, MODERN APPL STAT S; Sachse C, 1998, PHARMACOGENETICS, V8, P181; Sim SC, 2012, PHARMACOGENET GENOM, V22, P692, DOI 10.1097/FPC.0b013e3283546d3c	29	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1470-269X	1473-1150		PHARMACOGENOMICS J	Pharmacogenomics J.	DEC	2014	14	6					564	572		10.1038/tpj.2014.27		9	Genetics & Heredity; Pharmacology & Pharmacy	Genetics & Heredity; Pharmacology & Pharmacy	AU3EK	WOS:000345495200010		
J	Ting, CC; Fukuda, M; Watanabe, T; Sanaoka, A; Mitani, A; Noguchi, T				Ting, Chun-Chan; Fukuda, Mitsuo; Watanabe, Tomohisa; Sanaoka, Atsushi; Mitani, Akio; Noguchi, Toshihide			Morphological Alterations of Periodontal Pocket Epithelium Following Nd:YAG Laser Irradiation	PHOTOMEDICINE AND LASER SURGERY			English	Article							ND-YAG LASER; SCANNING-ELECTRON-MICROSCOPY; SUBGINGIVAL IRRIGATION; ATTACHMENT PROCEDURE; SURGICAL-PROCEDURES; BACTERIAL INVASION; HUMAN GINGIVA; IN-VITRO; BACTEREMIA; HUMANS	Objective: The purpose of this in vivo study was to examine morphologic alterations in the periodontal pocket epithelium with presence or absence of clinical inflammation following the use of the Neodymium: Yttrium-Aluminum-Garnet (Nd:YAG) laser irradiation. Background data: Subgingival Nd:YAG laser irradiation has been proposed as an alternative technique for treatment of chronic periodontitis. Several published studies have reported the clinical outcomes of such treatment. Methods: Twenty patients, diagnosed with moderate chronic periodontitis, were selected for the study. A total of 32 sites was identified and divided into a control (n=18) and laser-treated test groups (n=14). Probing depth (PD) and bleeding on probing (BOP) were recorded for all sites. Test sites were irradiated with an Nd:YAG laser using parameters of 2 W, 200 mJ pulse energy, and 10 pps delivered through a 320 mu m diameter tip. Total laser treatment time ranged from 1 to 2 min. Following treatment, all specimens were harvested via biopsy and processed for scanning electron microscopy (SEM) and histologic examination. Results: Control group specimens, depending upon initial PD, exhibited either a relatively smooth and intact epithelium with little desquamation (PD <= 3 mm), or increasing degrees of epithelial desquamation and leukocytic infiltration at a PD of >= 4 mm. In the laser-treated test group, the specimens with PD <= 3 mm that were BOP negative (-) exhibited a thin layer of epithelium that was disrupted. In the specimens with initial PD of >= 4 mm, complete removal of the epithelium whose extent and degree were increasing, was observed in the inflamed portion, while epithelium remained in the uninflamed portion. Conclusions: The SEM and histologic findings demonstrated the feasibility of ablating pocket epithelium with an Nd:YAG laser irradiation using parameters of 2 W of power (200 mJ, 10 pps). Furthermore, the presence or absence of clinical inflammation appeared to have an impact on the degree of laser-mediated epithelial ablation.	[Ting, Chun-Chan; Fukuda, Mitsuo; Watanabe, Tomohisa; Sanaoka, Atsushi; Mitani, Akio; Noguchi, Toshihide] Aichi Gakuin Univ, Sch Dent, Dept Periodontol, Nagoya, Aichi 464, Japan; [Ting, Chun-Chan] Kaohsiung Med Univ, Sch Dent, Coll Dent Med, Kaohsiung 80708, Taiwan	Ting, CC (reprint author), Kaohsiung Med Univ, Sch Dent, Coll Dent Med, 100 Shihcyuan 1st Rd, Kaohsiung 80708, Taiwan.	ccting@kmu.edu.tw		Fukuda, Mistuo/0000-0002-6584-6758	Strategic Research Aichi-Gakuin University (AGU)-Platform Formation from The Ministry of Education, Science, Sport and Culture of Japan	This work was supported by Strategic Research Aichi-Gakuin University (AGU)-Platform Formation (2008-2012) from The Ministry of Education, Science, Sport and Culture of Japan.	American Academy of Periodontology, 2008, STAT REG US DENT LEA; Kinane DF, 2005, J CLIN PERIODONTOL, V32, P708, DOI 10.1111/j.1600-051X.2005.00741.x; Romanos GE, 2004, PHOTOMED LASER SURG, V22, P177, DOI 10.1089/1549541041438597; GOLD SI, 1994, J CLIN PERIODONTOL, V21, P391, DOI 10.1111/j.1600-051X.1994.tb00735.x; WHITE JM, 1991, LASER SURG MED, V11, P455, DOI 10.1002/lsm.1900110511; Miyazaki A, 2003, J PERIODONTOL, V74, P175, DOI 10.1902/jop.2003.74.2.175; Daly CG, 2001, J PERIODONTOL, V72, P210, DOI 10.1902/jop.2001.72.2.210; Fine DH, 1996, J AM DENT ASSOC, V127, P641; CONNER HD, 1967, J PERIODONTOL, V38, P466; Takai S, 2005, ORAL SURG ORAL MED O, V99, P292, DOI 10.1016/j.tripleo.2004.10.022; Aoki A, 2004, PERIODONTOL 2000, V36, P59, DOI 10.1111/j.1600-0757.2004.03679.x; ADRIAENS PA, 1988, J PERIODONTOL, V59, P493; Yukna RA, 2007, INT J PERIODONT REST, V27, P577; LOFTHUS JE, 1991, J PERIODONTOL, V62, P602; TAKARADA H, 1974, J PERIODONTOL, V45, P155; Assaf M, 2007, PHOTOMED LASER SURG, V25, P250, DOI 10.1089/pho.2006.2067; BALTCH AL, 1982, AM HEART J, V104, P1335, DOI 10.1016/0002-8703(82)90164-8; COBB CM, 1992, J PERIODONTOL, V63, P701; Dajani AS, 1997, J AM DENT ASSOC, V128, P1142; Food and Drug Administration 510(k), 2004, SUMM SAF EFF INF PER; Fukuda M, 1994, JPN J CONSERV DENT, V37, P711; GOLDMAN H M, 1961, Oral Surg Oral Med Oral Pathol, V14, P925, DOI 10.1016/0030-4220(61)90004-4; Gregg R H, 1998, Dent Today, V17, P86; Gregg R H, 1998, Dent Today, V17, P88; Ben Hatit Y, 1996, J Clin Laser Med Surg, V14, P137; HEIMDAHL A, 1990, J CLIN MICROBIOL, V28, P2205; ISRAEL M, 1995, J PERIODONTOL, V66, P197; ITO K, 1993, J PERIODONTOL, V64, P547; KAPLAN GB, 1977, J PERIODONTOL, V48, P634; Liu CM, 1999, J PERIODONTOL, V70, P1276, DOI 10.1902/jop.1999.70.11.1276; LONGMAN LP, 1991, J MED MICROBIOL, V34, P33; Neill M E, 1997, Pract Periodontics Aesthet Dent, V9, P1; Noguchi Toshihide, 2005, J Int Acad Periodontol, V7, P8; Perry DA, 1997, LASER SURG MED, V20, P39, DOI 10.1002/(SICI)1096-9101(1997)20:1<39::AID-LSM6>3.0.CO;2-#; Qadri T, 2011, LASER MED SCI, V26, P763, DOI 10.1007/s10103-010-0807-8; Qadri T, 2010, J PERIODONTOL, V81, P1161, DOI 10.1902/jop.2010.090700; RAMFJORD S, 1951, J Periodontol, V22, P67; REINHARDT RA, 1982, J PERIODONTOL, V53, P96; SAGLIE R, 1977, J PERIODONTOL, V48, P105; SAGLIE R, 1982, J PERIODONTAL RES, V17, P284, DOI 10.1111/j.1600-0765.1982.tb01155.x; SAGLIE R, 1982, J PERIODONTOL, V53, P217, DOI 10.1902/jop.1982.53.4.217; SHAFIK SS, 1988, J PERIODONTOL, V59, P535; Sulewski J G, 2000, Dent Clin North Am, V44, P717; TAKARADA H, 1974, J PERIODONTOL, V45, P30; Vitkov L, 2002, FEMS MICROBIOL LETT, V211, P239, DOI 10.1111/j.1574-6968.2002.tb11231.x; Vitkov L, 2005, ORAL MICROBIOL IMMUN, V20, P317, DOI 10.1111/j.1399-302X.2005.00233.x; Vitkov L, 2005, ULTRASTRUCT PATHOL, V29, P121, DOI 10.1080/01913120590916832; WAKI MY, 1990, J PERIODONTOL, V61, P405; Walker CB, 1996, PERIODONTOL 2000, V10, P12, DOI 10.1111/j.1600-0757.1996.tb00066.x; YUKNA RA, 1976, J PERIODONTOL, V47, P696; YUKNA RA, 1976, J PERIODONTOL, V47, P701	51	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1549-5418	1557-8550		PHOTOMED LASER SURG	Photomed. Laser Surg.	DEC 1	2014	32	12					649	657		10.1089/pho.2014.3793		9	Surgery	Surgery	AW1SS	WOS:000346070800002		
J	Emoto, T; Kashihara, M; Abeyratne, UR; Kawata, I; Jinnouchi, O; Akutagawa, M; Konaka, S; Kinouchi, Y				Emoto, Takahiro; Kashihara, Masato; Abeyratne, Udantha R.; Kawata, Ikuji; Jinnouchi, Osamu; Akutagawa, Masatake; Konaka, Shinsuke; Kinouchi, Yohsuke			Signal shape feature for automatic snore and breathing sounds classification	PHYSIOLOGICAL MEASUREMENT			English	Article						breathing; snore; signal shape and classification	OBSTRUCTIVE SLEEP-APNEA	Snore analysis techniques have recently been developed for sleep studies. Most snore analysis techniques require reliable methods for the automatic classification of snore and breathing sounds in the sound recording. In this study we focus on this problem and propose an automated method to classify snore and breathing sounds based on the novel feature, 'positive/negative amplitude ratio (PNAR)', to measure the shape of the sound signal. The performance of the proposed method was evaluated using snore and breathing recordings (snore: 22 643 episodes and breathing: 4664 episodes) from 40 subjects. Receiver operating characteristic (ROC) analysis showed that the proposed method achieved 0.923 sensitivity with 0.918 specificity for snore and breathing sound classification on test data. PNAR has substantial potential as a feature in the front end of a non-contact snore/breathing-based technology for sleep studies.	[Emoto, Takahiro; Akutagawa, Masatake; Konaka, Shinsuke; Kinouchi, Yohsuke] Univ Tokushima, Inst Sci & Technol, Tokushima, Japan; [Kashihara, Masato] Univ Tokushima, Grad Sch Adv Technol & Sci, Tokushima, Japan; [Abeyratne, Udantha R.] Univ Queensland, Sch Info Tech & Elect Engn, Brisbane, Qld 4072, Australia; [Kawata, Ikuji; Jinnouchi, Osamu] Anan kyoei Hosp, Dept Otorhinolaryngol, Anan, Tokushima, Japan	Emoto, T (reprint author), Univ Tokushima, Inst Sci & Technol, Tokushima, Japan.	emoto@ee.tokushima-u.ac.jp; udantha@itee.uq.edu.au		Abeyratne, Udantha/0000-0003-0137-7996	Australian Research Council [DP120100141]; Japan Society for the Promotion of Science [24700498]	The authors would like to acknowledge the Australian Research Council (grant no. DP120100141) and Japan Society for the Promotion of Science (grant no. 24700498) for partially supporting this work.	Abeyratne UR, 2013, PHYSIOL MEAS, V34, P99, DOI 10.1088/0967-3334/34/2/99; Abeyratne UR, 2005, PHYSIOL MEAS, V26, P779, DOI 10.1088/0967-3334/26/5/016; Cavusoglu M, 2007, PHYSIOL MEAS, V28, P841, DOI 10.1088/0967-3334/28/8/007; de Silva S, 2012, PHYSIOL MEAS, V33, P587, DOI 10.1088/0967-3334/33/4/587; Karunajeewa AS, 2011, PHYSIOL MEAS, V32, P83, DOI 10.1088/0967-3334/32/1/006; Pevernagie D, 2010, SLEEP MED REV, V14, P131, DOI 10.1016/j.smrv.2009.06.002; Karunajeewa AS, 2008, PHYSIOL MEAS, V29, P227, DOI 10.1088/0967-3334/29/2/006; Zhang T, 2001, IEEE T SPEECH AUDI P, V9, P441, DOI 10.1109/89.917689; Yadollahi A, 2010, MED ENG PHYS, V32, P985, DOI 10.1016/j.medengphy.2010.06.013; Fiz JA, 1996, EUR RESPIR J, V9, P2365, DOI 10.1183/09031936.96.09112365; Cavusoglu M, 2008, PHYSIOL MEAS, V29, P879, DOI 10.1088/0967-3334/29/8/003; Emoto T, 2012, PHYSIOL MEAS, V33, P1675, DOI 10.1088/0967-3334/33/10/1675; Emoto T., 2011, Journal of Medical Engineering & Technology, V35, P425, DOI 10.3109/03091902.2011.626838; Franklin KA, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-63; IYER VK, 1989, IEEE T BIO-MED ENG, V36, P1133, DOI 10.1109/10.40821; PALOMAKI H, 1992, NEUROLOGY, V42, P75; Powell S, 2010, CLIN OTOLARYNGOL, V35, P418, DOI 10.1111/j.1749-4486.2010.02168.x; Sello S, 2008, BIOMED SIGNAL PROCES, V3, P181, DOI 10.1016/j.bspc.2008.02.002; STROLLO PJ, 1993, SLEEP, V16, P403; ZHANG T, 1999, ACOUST SPEECH SIG PR, P3001	20	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0967-3334	1361-6579		PHYSIOL MEAS	Physiol. Meas.	DEC	2014	35	12					2489	2499		10.1088/0967-3334/35/12/2489		11	Biophysics; Engineering, Biomedical; Physiology	Biophysics; Engineering; Physiology	AU4FX	WOS:000345566500014		
J	da Silva, JAT; Zeng, SJ; Cardoso, JC; Dobranszki, J; Kerbauy, GB				da Silva, Jaime A. Teixeira; Zeng, Songjun; Cardoso, Jean Carlos; Dobranszki, Judit; Kerbauy, Gilberto Barbante			In vitro flowering of Dendrobium	PLANT CELL TISSUE AND ORGAN CULTURE			English	Review						Culture medium; Cytokinin; Environmental conditions; Flowering induction; Hormone; Orchidaceae	MADAME THONG-IN; ORCHID; ARABIDOPSIS; INDUCTION; GROWTH; EXPRESSION; DURATION; CULTURES; SMILE; COLOR	Dendrobium plants are the most frequently used orchids to study the process of in vitro flowering. Among the various environmental cues and plant growth regulators employed thus far, cytokinins have shown the most prominent effects on the transition from vegetative to reproductive stage. A clear correlation between flowering establishment and enhancement of endogenous cytokinins has been observed. However, the experimental utilization of a large amount of different Dendrobium species and hybrids, combined with a large diversity of variable media types and media compositions make interpretation of flowering control in the in vitro environment difficult. The combination of a specific model Dendrobium in vitro regeneration system or protocol with a simple, but well defined culture medium, could contributed, to some degree, to reaching a clearer consensus about the physiological and molecular mechanisms controlling the Dendrobium flowering phase change.	[da Silva, Jaime A. Teixeira] Miki Cho Post Off, Miki, Kagawa 7610799, Japan; [Zeng, Songjun] Chinese Acad Sci, Key Lab South China Agr Plant Genet & Breeding, South China Bot Garden, Guangzhou 510650, Guangdong, Peoples R China; [Cardoso, Jean Carlos] Univ Fed Sao Carlos, Ctr Ciencias Agr, Dept Rural Dev, BR-13600970 Araras City, Brazil; [Dobranszki, Judit] Univ Debrecen, Res Inst Nyiregyhaza, H-4400 Nyiregyhaza, Hungary; [Kerbauy, Gilberto Barbante] Univ Sao Paulo, Inst Biosci, Dept Bot, Sao Paulo, Brazil	da Silva, JAT (reprint author), Miki Cho Post Off, POB 7,Ikenobe 3011-2, Miki, Kagawa 7610799, Japan.	jaimetex@yahoo.com; zengsongjun@scib.ac.cn; jeancardosoctv@gmail.com; dobranszki@freemail.hu; kerbauy@usp.br					Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Petroni K, 2011, PLANT SCI, V181, P219, DOI 10.1016/j.plantsci.2011.05.009; Rademacher W, 2000, ANNU REV PLANT PHYS, V51, P501, DOI 10.1146/annurev.arplant.51.1.501; Yoshida N, 2001, PLANT CELL, V13, P2471, DOI 10.1105/tpc.13.11.2471; Campos KO, 2004, J PLANT PHYSIOL, V161, P1385, DOI 10.1016/j.jplph.2004.07.008; CHAUDHURY AM, 1993, PLANT J, V4, P907, DOI 10.1046/j.1365-313X.1993.04060907.x; Arditti J, 1966, ORCHID REV, V74, P208; Cardoso JC, 2012, HORTIC BRAS, V30, P561, DOI 10.1590/S0102-05362012000300035; Cen XiuFen, 2010, Agricultural Science & Technology - Hunan, V11, P75; Chia Tet Fatt, 1999, Lindleyana, V14, P60; Deb CR, 2009, J PLANT BIOCHEM BIOT, V18, P241; Ding LH, 2013, PLANT CELL PHYSIOL, V54, P595, DOI 10.1093/pcp/pct026; Ferreira WD, 2006, J PLANT PHYSIOL, V163, P1126, DOI 10.1016/j.jplph.2005.07.012; Ferreira WM, 2003, THESIS U SAO PAULO; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; [关萍 GUAN Ping], 2009, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V20, P205; Hee KH, 2007, PLANT CELL REP, V26, P2055, DOI 10.1007/s00299-007-0421-9; Hossain MM, 2013, J PLANT BIOCHEM BIOT, V22, P157, DOI 10.1007/s13562-012-0124-3; LIANG S, 2012, COMP FUNCT GENOM; Lin M, 2011, HORTSCIENCE, V46, P406; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nambiar N, 2012, AJCS, V6, P225; Sim GE, 2007, PLANT CELL REP, V26, P383, DOI 10.1007/s00299-006-0242-2; Sim GE, 2008, PLANT CELL REP, V27, P1281, DOI 10.1007/s00299-008-0551-8; Sudhakaran S, 2006, FLORICULTURE ORNAMEN, VII, P336; TE-CHATO S, 2009, J AGR TECHNOL, V5, P157; Tee CS, 2008, BIOL PLANTARUM, V52, P723, DOI 10.1007/s10535-008-0139-8; da Silva JAT, 2014, CRIT REV BIOTECHNOL, V34, P56, DOI 10.3109/07388551.2013.807219; da Silva JAT, 2014, SCI HORTIC-AMSTERDAM, V175, P74, DOI 10.1016/j.scienta.2014.05.008; TEIXEIRA DA SILVA J.A., 2012, ASIAN AUSTRALASIAN J, V6, P121; Vaz APA, 2008, FLORICULTURE ORNAMEN, VV, P421; Wang AiHua, 2014, Guizhou Agricultural Sciences, V42, P34; Wang GY, 1997, SCI CHINA SER C, V40, P35, DOI 10.1007/BF02879105; Wang Guang-Yuan, 1995, Acta Botanica Sinica, V37, P374; Wang ZH, 2009, SCI HORTIC-AMSTERDAM, V122, P328, DOI 10.1016/j.scienta.2009.05.018; [王再花 WANG ZaiHua], 2006, [植物生理学通讯, Plant Physiology Communications], V42, P1143; Wen YF, 1999, PLANT PHYSIOL, V35, P296; Wood HP, 2006, DENDROBIUMS; [吴高杰 Wu Gaojie], 2013, [热带作物学报, Chinese Journal of Tropical Crops], V34, P451; Wu XM, 2003, PLANT MOL BIOL, V51, P959, DOI 10.1023/A:1023050110077; Yen CYT, 2008, HORTSCIENCE, V43, P1765; Yu H, 2000, PLANT CELL REP, V19, P926, DOI 10.1007/s002990000227; Zhao DK, 2012, SUBTROPICAL PLANT SC, V41, P48; [赵银河 Zhao Yinhe], 2013, [种子, Seed], V32, P16	44	4	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6857	1573-5044		PLANT CELL TISS ORG	Plant Cell Tissue Organ Cult.	DEC	2014	119	3					447	456		10.1007/s11240-014-0561-x		10	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	AT6YU	WOS:000345083800001		
J	Pansuksan, K; Mii, M; Supaibulwatana, K				Pansuksan, Kanoktip; Mii, Masahiro; Supaibulwatana, Kanyaratt			Phytochemical alteration and new occurring compounds in hairy root cultures of Mitracarpus hirtus L. induced by phenylurea cytokinin (CPPU)	PLANT CELL TISSUE AND ORGAN CULTURE			English	Article						Mitracarpus hirtus; Agrobacterium rhizogenes; Hairy root; rol gene; Elicitor; CPPU; GC-MS	AGROBACTERIUM-RHIZOGENES; METHYL JASMONATE; ANTIBACTERIAL ACTIVITY; SECONDARY METABOLITES; CHEMICAL-COMPOSITION; ENHANCED PRODUCTION; PLANT-REGENERATION; SHOOT REGENERATION; ARTEMISIA-ANNUA; BIOSYNTHESIS	Hairy root cultures of Mitracarpus hirtus L. were obtained after transforming leaf-disc explants with wild strain Agrobacterium rhizogenes A13. The root cultures of M. hirtus showed high efficiency of shoot formation in both transformed and non-transformed cultures when illuminated with light. However, transformed hairy root proliferation was approximately 3.8-5 times higher than the control in both solidified and liquid plant growth regulator free media. Putatively transformed roots were identified by the presence of the rol gene via PCR. Integration of the rol gene into the plant genome was confirmed via Southern blot analysis after 5 months with no detection in non-transformed roots. In addition, the effect of 2-chloro-4-pyridyl-N-phenylurea (CPPU), a synthetic cytokinin, when applied as an elicitor for hairy root cultures of M. hirtus was investigated. The 24-day-old hairy root cultures of high root proliferation line R107-3, were incubated for 48 h in media supplemented with 0 or 5 mg l(-1) CPPU. The methanolic extracts of root tissues were subsequently analyzed for biochemical constituents using Gas Chromatography Mass Spectrometry (GC-MS). The alteration of plant secondary metabolites produced after CPPU treatment was analyzed. Compared to the control (with quality higher than 80 %), six unique compounds were found, five original compounds absent, 11 with increased, and five with decreased contents. Increased contents of two metabolites, chrysophanol and 2-methoxy-4-vinylphenol, showed pharmaceutical potential. CPPU was also found to elicit the alkaloid compound, Eseroline, 7-bromo-, methylcarbamate (ester), which could not be detected in the non-treated sample. The findings of this study demonstrate the establishment of transgenic hairy root of M. hirtus and the application of CPPU as an elicitor to induce variations in plant secondary metabolite that shows its potential to apply for bio-reactor system.	[Pansuksan, Kanoktip; Supaibulwatana, Kanyaratt] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand; [Pansuksan, Kanoktip; Mii, Masahiro] Chiba Univ, Grad Sch Hort, Lab Plant Cell Technol, Matsudo, Chiba 2718510, Japan	Supaibulwatana, K (reprint author), Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand.	kanyaratt.sup@mahidol.ac.th			Mahidol University; "Strategic Consortia for Capacity Building of University Faculties and Staff of Thailand Research Fund'' from the Commission on Higher Education (CHE), Thailand; Excellent International Student Scholarship at Chiba University Program from Japanese government through Chiba University	This work was supported by Mahidol University and a partial Grant by the "Strategic Consortia for Capacity Building of University Faculties and Staff of Thailand Research Fund'' from the Commission on Higher Education (CHE), Thailand. The authors are grateful for partial support of the Excellent International Student Scholarship at Chiba University Program from the Japanese government through Chiba University. This research work was conducted under the collaboration of Mahidol University and Chiba University for the double degree program of K. Pansuksan.	Abere TA, 2007, TROP J PHARM RES, V6, P849; Akutsu M, 2004, MOL BREEDING, V13, P69, DOI 10.1023/B:MOLB.0000012860.29731.9c; ANDERSON JA, 1985, PHYTOCHEMISTRY, V25, P103, DOI 10.1016/S0031-9422(00)94510-2; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Bourgaud F, 2001, PLANT SCI, V161, P839, DOI 10.1016/S0168-9452(01)00490-3; Silici S, 2005, J ETHNOPHARMACOL, V99, P69, DOI 10.1016/j.jep.2005.01.046; Moubayidin L, 2009, TRENDS PLANT SCI, V14, P557, DOI 10.1016/j.tplants.2009.06.010; Martin D, 2002, PLANT PHYSIOL, V129, P1003, DOI 10.1104/pp.011001; Chang L, 2013, J EXP BOT, V64, P5021, DOI 10.1093/jxb/ert291; Farah Adriana, 2006, Brazilian Journal of Plant Physiology, V18, P23, DOI 10.1590/S1677-04202006000100003; Ohara A, 2000, PLANT CELL REP, V19, P563, DOI 10.1007/s002990050774; Caspeta L, 2005, BIOTECHNOL PROGR, V21, P735, DOI 10.1021/bp049604n; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Amoo SO, 2012, PLANT CELL TISS ORG, V111, P345, DOI 10.1007/s11240-012-0200-3; Roy S, 2010, WORLD J MICROB BIOT, V26, P85, DOI 10.1007/s11274-009-0146-8; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; Srivastava S, 2007, CRIT REV BIOTECHNOL, V27, P29, DOI 10.1080/07388550601173918; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Pichersky E, 2002, CURR OPIN PLANT BIOL, V5, P237, DOI 10.1016/S1369-5266(02)00251-0; Burkill HM, 1970, USEFUL PLANTS W TROP, V4; Cimanga R. K., 2004, Journal of Natural Remedies, V4, P17; Crozier A, 2006, PLANT SECONDARY META, V1, P372; Daimon H, 1984, PLANT TISSUE CULTURE, V7, P31; Doyle JJ, 1990, FOCUS, V12, P13; Emam SS, 2009, J APPL SCI RES, V5, P2315; Emery RJN, 2000, PLANT PHYSIOL, V123, P1593, DOI 10.1104/pp.123.4.1593; Gao B, 2011, MOLECULES, V16, P4082, DOI 10.3390/molecules16054082; Hoshino Y, 1998, PLANT CELL REP, V17, P256, DOI 10.1007/s002990050388; Hosokawa K, 1997, PLANT CELL TISS ORG, V51, P137, DOI 10.1023/A:1005962913491; Kalaivani C. S., 2012, International Journal of Medicinal and Aromatic Plants, V2, P69; Kim OT, 2013, PLANT CELL TISS ORG, V112, P87, DOI 10.1007/s11240-012-0218-6; Kiyokawa S, 1992, PLANT TISSUE CULT LE, V9, P94; Liu Y, 2005, J INTEGR PLANT BIOL, V47, P769, DOI 10.1111/j.1744-7909.2005.00111.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ni CH, 2012, ARCH PHARM RES, V35, P887, DOI 10.1007/s12272-012-0514-z; Owolabi MS, 2013, AM J ESS OILS NAT PR, V1, P4; Pal A, 2013, FOOD TECHNOL BIOTECH, V51, P26; Pansuksan K, 2014, PLANT CELL TISS ORG, V117, P381, DOI 10.1007/s11240-014-0447-y; PELEG H, 1992, J AGR FOOD CHEM, V40, P764, DOI 10.1021/jf00017a011; Quevedo C, 2010, BIOTECHNOL LETT, V32, P997, DOI 10.1007/s10529-010-0250-8; Sa G, 2001, PLANT SCI, V160, P691, DOI DOI 10.1016/S0168-9452(00)00453-2; SAITOU T, 1992, PLANT PHYSIOL, V99, P1336, DOI 10.1104/pp.99.4.1336; Saniewski M, 1998, J PLANT GROWTH REGUL, V17, P121, DOI 10.1007/PL00007024; Satdive RK, 2007, J BIOTECHNOL, V128, P281, DOI 10.1016/j.jbiotec.2006.10.009; Tatsuo K, 2011, PLANT CELL PHYSL, V42, P677; Theboral J, 2014, PLANT CELL TISS ORG, V117, P477, DOI 10.1007/s11240-014-0450-3; Wang JW, 2001, BIOTECHNOL LETT, V23, P857, DOI 10.1023/A:1010535001943; Wink M, 1998, ALKALOIDS, P11; Xie DY, 2000, PLANT CELL TISS ORG, V63, P161, DOI 10.1023/A:1006438919841; Zhai DD, 2010, PHYTOMEDICINE, V17, P856, DOI 10.1016/j.phymed.2010.02.008; Zhai DD, 2010, CHINESE CHEM LETT, V21, P590, DOI 10.1016/j.cclet.2010.01.034; Zhang L, 2005, NATURAL PRODUCTS DRU, P197	52	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6857	1573-5044		PLANT CELL TISS ORG	Plant Cell Tissue Organ Cult.	DEC	2014	119	3					523	532		10.1007/s11240-014-0552-y		10	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	AT6YU	WOS:000345083800008		
J	Maharjan, PM; Dilkes, BP; Fujioka, S; Pencik, A; Ljung, K; Burow, M; Halkier, BA; Choe, S				Maharjan, Puna M.; Dilkes, Brian P.; Fujioka, Shozo; Pencik, Ales; Ljung, Karin; Burow, Meike; Halkier, Barbara A.; Choe, Sunghwa			Arabidopsis gulliver1/superroot2-7 identifies a metabolic basis for auxin and brassinosteroid synergy	PLANT JOURNAL			English	Article						Arabidopsisthaliana; brassinazole; cytochrome P450; whole genome resequencing; picloram	GLUCOSINOLATE BIOSYNTHESIS; SIGNAL-TRANSDUCTION; PLANT DEVELOPMENT; HOMEOSTASIS; TRYPTOPHAN; THALIANA; PATHWAY; CYTOCHROME-P450; CYP83B1; GROWTH	Phytohormone homeostasis is essential for proper growth and development of plants. To understand the growth mechanisms mediated by hormonal levels, we isolated a gulliver1 (gul1) mutant that had tall stature in the presence of both brassinazole and the light. The gul1 phenotype depended on functional BR biosynthesis; the genetic introduction of dwarf4, a BR biosynthetic mutation, masked the long hypocotyl phenotype of gul1. Furthermore, BR biosynthesis was dramatically enhanced, such that the level of 22-hydroxy campesterol was 5.8-fold greater in gul1. Molecular cloning revealed that gul1 was a missense mutation, resulting in a glycine to arginine change at amino acid 116 in SUPERROOT2 (CYP83B1), which converts indole acetaldoxime to an S-alkyl thiohydroximate adduct in the indole glucosinolate pathway. Auxin metabolite profiling coupled with quantitative reverse transcription polymerase chain reaction (RT-PCR) analysis of auxin biosynthetic genes revealed that gul1/sur2-7 activated multiple alternative branches of tryptophan-dependent auxin biosynthetic pathways. Furthermore, exogenous treatment of gul1/sur2-7 with BRs caused adventitious roots from hypocotyls, indicative of an increased response to BRs relative to wild-type. Different from severe alleles of sur2, gul1/sur2-7 lacked high-auxin' phenotypes that include stunted growth and callus-like disintegration of hypocotyl tissues. The auxin level in gul1/sur2-7 was only 1.6-fold greater than in the wild-type, whereas it was 4.2-fold in a severe allele like sur2-8. Differences in auxin content may account for the range of phenotypes observed among the sur2 alleles. This unusual allele provides long-sought evidence for a synergistic interaction between auxin and BRs in promoting growth in Arabidopsis at the level of their biosynthetic enzymes.	[Maharjan, Puna M.; Choe, Sunghwa] Seoul Natl Univ, Sch Biol Sci, Coll Nat Sci, Seoul 151747, South Korea; [Dilkes, Brian P.] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Fujioka, Shozo] RIKEN Adv Sci Inst, Saitama 3510198, Japan; [Pencik, Ales; Ljung, Karin] Swedish Univ Agr Sci, Umea Plant Sci Ctr, Dept Forest Genet & Plant Physiol, SE-90183 Umea, Sweden; [Burow, Meike; Halkier, Barbara A.] Univ Copenhagen, Dept Plant & Environm Sci, DynaMo Ctr Excellence, Fac Sci, DK-1871 Frederiksberg C, Denmark; [Choe, Sunghwa] Seoul Natl Univ, Plant Genom & Breeding Inst, Seoul 151921, South Korea; [Choe, Sunghwa] Adv Inst Convergence Technol, Convergence Res Ctr Funct Plant Prod, Suwon 443270, Gyeonggi Do, South Korea	Choe, S (reprint author), Seoul Natl Univ, Sch Biol Sci, Coll Nat Sci, Seoul 151747, South Korea.	shchoe@snu.ac.kr	Dilkes, Brian/C-9293-2012; Halkier, Barbara/H-3196-2014; Burow, Meike/A-6949-2010	Dilkes, Brian/0000-0003-2799-954X; Halkier, Barbara/0000-0002-3742-702X; Burow, Meike/0000-0002-2350-985X	Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center) [PJ008051]; Cooperative Research Program for Agriculture Science & Technology Development - Rural Development Administration [PJ906910]; Technology Development Program for Agriculture and Forestry, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea [110033-5]; BK21 Research Fellowships by Ministry of Education, Science and Technology, Republic of Korea; Ministry of Education, Culture, Sports, Science and Technology of Japan [19380069, 23380066]; Swedish Governmental Agency for Innovation Systems (VINNOVA); Swedish Research Council (VR); Kempe Foundation; S.D.G.	We would like to thank J. Chory for the gift of bzr1-D and 35Spro: BES1-GFP seeds, J. Bender for atr4 seeds, R. Granbom for IAA measurement, and S. Takatsuto for supplying deuterium-labeled internal standards. This research was supported, by grants from the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center No. PJ008051); the Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ906910), funded by the Rural Development Administration; the Technology Development Program (110033-5) for Agriculture and Forestry, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea (to S.C.); the BK21 Research Fellowships (to P.M.M.) funded by the Ministry of Education, Science and Technology, Republic of Korea; a Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (19380069 and 23380066 to S.F.); S.D.G. and the Swedish Governmental Agency for Innovation Systems (VINNOVA), the Swedish Research Council (VR), and the Kempe Foundation (to K.L. and A.P.).	Ulmasov T, 1997, PLANT CELL, V9, P1963; Mikkelsen MD, 2004, PLANT J, V37, P770, DOI 10.1111/j.1365-313X.2004.02002.x; Kliebenstein DJ, 2001, GENETICS, V159, P359; Franklin KA, 2011, P NATL ACAD SCI USA, V108, P20231, DOI 10.1073/pnas.1110682108; Nafisi M, 2007, PLANT CELL, V19, P2039, DOI 10.1105/tpc.107.051383; Barlier I, 2000, P NATL ACAD SCI USA, V97, P14819, DOI 10.1073/pnas.260502697; Seo M, 1998, PLANT PHYSIOL, V116, P687, DOI 10.1104/pp.116.2.687; Sun Y, 2010, DEV CELL, V19, P765, DOI 10.1016/j.devcel.2010.10.010; Maharjan PM, 2011, J PLANT BIOL, V54, P425, DOI 10.1007/s12374-011-9183-6; Vert G, 2008, P NATL ACAD SCI USA, V105, P9829, DOI 10.1073/pnas.0803996105; CHAVADEJ S, 1994, P NATL ACAD SCI USA, V91, P2166, DOI 10.1073/pnas.91.6.2166; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Won C, 2011, P NATL ACAD SCI USA, V108, P18518, DOI 10.1073/pnas.1108436108; Novak O, 2012, PLANT J, V72, P523, DOI 10.1111/j.1365-313X.2012.05085.x; Chung Y, 2013, CRIT REV PLANT SCI, V32, P396, DOI 10.1080/07352689.2013.797856; Choe S, 2001, PLANT J, V26, P573, DOI 10.1046/j.1365-313x.2001.01055.x; Bak S, 2001, PLANT CELL, V13, P101, DOI 10.1105/tpc.13.1.101; BOERJAN W, 1995, PLANT CELL, V7, P1405, DOI 10.1105/tpc.7.9.1405; Andersen SU, 2008, PLANT CELL, V20, P88, DOI 10.1105/tpc.107.054676; Maharjan PM, 2011, J PLANT BIOL, V54, P126, DOI 10.1007/s12374-010-9138-3; Delarue M, 1998, PLANT J, V14, P603, DOI 10.1046/j.1365-313X.1998.00163.x; Smolen G, 2002, GENETICS, V160, P323; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306; Bak S, 2001, PLANT PHYSIOL, V127, P108, DOI 10.1104/pp.127.1.108; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; Mikkelsen MD, 2000, J BIOL CHEM, V275, P33712, DOI 10.1074/jbc.M001667200; Sugawara S, 2009, P NATL ACAD SCI USA, V106, P5430, DOI 10.1073/pnas.0811226106; Ljung K, 2013, DEVELOPMENT, V140, P943, DOI 10.1242/dev.086363; Hull AK, 2000, P NATL ACAD SCI USA, V97, P2379, DOI 10.1073/pnas.040569997; Li L, 2005, PLANT CELL, V17, P2738, DOI 10.1105/tpc.105.034397; Mano Y, 2012, J EXP BOT, V63, P2853, DOI 10.1093/jxb/ers091; Chung Y, 2011, PLANT J, V66, P564, DOI 10.1111/j.1365-313X.2011.04513.x; Fujioka S, 2002, PLANT PHYSIOL, V130, P930, DOI 10.1104/pp.008722; Goda H, 2004, PLANT PHYSIOL, V134, P1555, DOI 10.1104/pp.103.034736; ARTECA RN, 1988, J PLANT PHYSIOL, V133, P430; Bao F, 2004, PLANT PHYSIOL, V135, P1864; CERANA R, 1983, PHYSIOL PLANTARUM, V59, P23, DOI 10.1111/j.1399-3054.1983.tb06565.x; Clouse SD, 1997, PHYSIOL PLANTARUM, V100, P702, DOI 10.1034/j.1399-3054.1997.1000334.x; DesLuca V., 1989, P NATL ACAD SCI USA, V86, P2582; EUN JS, 1989, PLANT CELL PHYSIOL, V30, P807; Hoecker U, 2004, PLANTA, V219, P195, DOI 10.1007/s00425-004-1211-z; Kim B, 2013, PLANT CELL REP, V32, P1139, DOI 10.1007/s00299-012-1381-2; Morant M, 2010, MOL PLANT, V3, P192, DOI 10.1093/mp/ssp098; Nemhauser J. L., 2004, PLoS Biology, V2, P0020258, DOI 10.1371/journal.pbio.0020258; Strader LC, 2008, NAT CHEM BIOL, V4, P337, DOI 10.1038/nchembio0608-337; Wagner D, 1997, PLANT CELL, V9, P731; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083	49	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	DEC	2014	80	5					797	808		10.1111/tpj.12678		12	Plant Sciences	Plant Sciences	AU3KI	WOS:000345511500005		
J	Huang, CL; Ho, CW; Chiang, YC; Shigemoto, Y; Hsu, TW; Hwang, CC; Ge, XJ; Chen, C; Wu, TH; Chou, CH; Huang, HJ; Gojobori, T; Osada, N; Chiang, TY				Huang, Chao-Li; Ho, Chuan-Wen; Chiang, Yu-Chung; Shigemoto, Yasumasa; Hsu, Tsai-Wen; Hwang, Chi-Chuan; Ge, Xue-Jun; Chen, Charles; Wu, Tai-Han; Chou, Chang-Hung; Huang, Hao-Jen; Gojobori, Takashi; Osada, Naoki; Chiang, Tzen-Yuh			Adaptive divergence with gene flow in incipient speciation of Miscanthus floridulus/sinensis complex (Poaceae)	PLANT JOURNAL			English	Article						incipient speciation; Miscanthus; gene flow; diversifying selection; outlier loci; parapatric speciation; local adaptation	MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; NUCLEOTIDE-SEQUENCE; MAXIMUM-LIKELIHOOD; INTERGENIC SPACERS; DNA POLYMORPHISM; SELECTION; EVOLUTION; SINENSIS; LOCI	Young incipient species provide ideal materials for untangling the process of ecological speciation in the presence of gene flow. The Miscanthus floridulus/sinensis complex exhibits diverse phenotypic and ecological differences despite recent divergence (approximately 1.59million years ago). To elucidate the process of genetic differentiation during early stages of ecological speciation, we analyzed genomic divergence in the Miscanthus complex using 72 randomly selected genes from a newly assembled transcriptome. In this study, rampant gene flow was detected between species, estimated as M=3.36x10(-9) to 1.20x10(-6), resulting in contradicting phylogenies across loci. Nevertheless, beast analyses revealed the species identity and the effects of extrinsic cohesive forces that counteracted the non-stop introgression. As expected, early in speciation with gene flow, only 3-13 loci were highly diverged; two to five outliers (approximately 2.78-6.94% of the genome) were characterized by strong linkage disequilibrium, and asymmetrically distributed among ecotypes, indicating footprints of diversifying selection. In conclusion, ecological speciation of incipient species of Miscanthus probably followed the parapatric model, whereas allopatric speciation cannot be completely ruled out, especially between the geographically isolated northern and southern M.sinensis, for which no significant gene flow across oceanic barriers was detected. Divergence between local ecotypes in early-stage speciation began at a few genomic regions under the influence of natural selection and divergence hitchhiking that overcame gene flow.	[Huang, Chao-Li; Ho, Chuan-Wen; Wu, Tai-Han; Huang, Hao-Jen; Chiang, Tzen-Yuh] Natl Cheng Kung Univ, Dept Life Sci, Tainan 701, Taiwan; [Ho, Chuan-Wen] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 804, Taiwan; [Shigemoto, Yasumasa] Fujitsu Ltd, Life Sci Syst Div, Ota Ku, Tokyo 1448588, Japan; [Hsu, Tsai-Wen] Endem Species Res Inst, High Altitude Expt Stn, Nantou 552, Taiwan; [Hwang, Chi-Chuan] Natl Cheng Kung Univ, Dept Engn Sci, Tainan 701, Taiwan; [Hwang, Chi-Chuan] Natl Cheng Kung Univ, Supercomp Res Ctr, Tainan 701, Taiwan; [Ge, Xue-Jun] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou 510650, Peoples R China; [Chen, Charles] Int Maize & Wheat Improvement Ctr, Mexico City, DF, Mexico; [Chou, Chang-Hung] China Med Univ, Res Ctr Biodivers, Taichung 404, Taiwan; [Chou, Chang-Hung] China Med Univ, Grad Inst Ecol & Evolutionary Biol, Taichung 404, Taiwan; [Gojobori, Takashi; Osada, Naoki] Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Gojobori, Takashi] King Abdullah Univ Sci & Technol, Biol & Environm Sci & Engn Div, Computat Biosci Res Ctr, Thuwal 239556900, Saudi Arabia	Gojobori, T (reprint author), Natl Inst Genet, Mishima, Shizuoka 4118540, Japan.	tgojobor@nig.ac.jp; nosada@nig.ac.jp; tychiang@mail.ncku.edu.tw	Hwang, Chi-Chuan/A-8237-2010; Chiang, Yu-Chung/E-9143-2011		International Research Intensive Centers of Excellence of Taiwan; Supercomputing Research Center of National Cheng Kung University; Aim for the Top University Project of National Cheng Kung University	The work is supported by the International Research Intensive Centers of Excellence of Taiwan, the Supercomputing Research Center of National Cheng Kung University, and the Aim for the Top University Project of National Cheng Kung University. We thank Peter Raven (President Emeritus of Missouri Botanical Garden) for his valuable comments.	Barling A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-864; Lowry DB, 2012, BIOL J LINN SOC, V106, P241, DOI 10.1111/j.1095-8312.2012.01867.x; Woerner AE, 2007, BIOINFORMATICS, V23, P1851, DOI 10.1093/bioinformatics/btm253; Kane NC, 2009, EVOLUTION, V63, P2061, DOI 10.1111/j.1558-5646.2009.00703.x; Scopece G, 2010, TAXON, V59, P1367; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Fay JC, 2000, GENETICS, V155, P1405; Strasburg JL, 2009, MOL BIOL EVOL, V26, P1341, DOI 10.1093/molbev/msp043; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Huang S, 2001, MOL ECOL, V10, P2669, DOI 10.1046/j.0962-1083.2001.01395.x; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; FU YX, 1993, GENETICS, V133, P693; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Pan YB, 2000, GENETICA, V108, P285, DOI 10.1023/A:1004191625603; Pritchard JK, 2000, GENETICS, V155, P945; Kilian B, 2007, MOL BIOL EVOL, V24, P2657, DOI 10.1093/molbev/msm192; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Aldous DJ, 2001, STAT SCI, V16, P23, DOI 10.1214/ss/998929474; Andrew RL, 2013, EVOLUTION, V67, P2468, DOI 10.1111/evo.12106; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Dohleman FG, 2009, PLANT PHYSIOL, V150, P2104, DOI 10.1104/pp.109.139162; Lin JZ, 2002, GENETICS, V162, P2007; Feder JL, 2012, TRENDS GENET, V28, P342, DOI 10.1016/j.tig.2012.03.009; Papadopulos AST, 2011, P NATL ACAD SCI USA, V108, P13188, DOI 10.1073/pnas.1106085108; Noor MAF, 1999, HEREDITY, V83, P503, DOI 10.1038/sj.hdy.6886320; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Feder JL, 2012, PHILOS T R SOC B, V367, P461, DOI 10.1098/rstb.2011.0256; Swaminathan K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-142; Minder AM, 2008, MOL ECOL, V17, P1552, DOI 10.1111/j.1365-294X.2008.03709.x; Hahn MW, 2012, PHILOS T R SOC B, V367, P374, DOI 10.1098/rstb.2011.0188; TAJIMA F, 1989, GENETICS, V123, P585; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; Frajman B, 2009, SYST BIOL, V58, P328, DOI 10.1093/sysbio/syp030; Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Lowry DB, 2008, PHILOS T R SOC B, V363, P3009, DOI 10.1098/rstb.2008.0064; Hodkinson TR, 2002, J PLANT RES, V115, P381, DOI 10.1007/s10265-002-0049-3; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hoskin CJ, 2005, NATURE, V437, P1353, DOI 10.1038/nature04004; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148/6/36; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Nichols R, 2001, TRENDS ECOL EVOL, V16, P358, DOI 10.1016/S0169-5347(01)02203-0; Strasburg JL, 2011, MOL ECOL, V20, P2353, DOI 10.1111/j.1365-294X.2011.05048.x; Christian DG, 2008, IND CROP PROD, V28, P320, DOI 10.1016/j.indcrop.2008.02.009; Falush D, 2003, GENETICS, V164, P1567; Penaloza-Ramirez JM, 2010, ANN BOT-LONDON, V105, P389, DOI 10.1093/aob/mcp301; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Pettengill JB, 2012, EVOLUTION, V66, P1210, DOI 10.1111/j.1558-5646.2011.01521.x; Rayburn AL, 2009, PLANT MOL BIOL REP, V27, P184, DOI 10.1007/s11105-008-0070-3; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Bomblies K, 2005, MOL BIOL EVOL, V22, P1082, DOI 10.1093/molbev/msi095; Brower A. V. Z., 2010, GENETICA, V139, P589; Chiang TY, 2006, TAXON, V55, P31; Chiang YC, 2003, AM J BOT, V90, P561, DOI 10.3732/ajb.90.4.561; Chou Chang-Hung, 2001, Weed Biology and Management, V1, P81, DOI 10.1046/j.1445-6664.2001.00018.x; Clifton-Brown J., 2010, ENERGY CROPS, P301; Clifton-Brown John, 2008, P273, DOI 10.1007/978-0-387-70805-8_10; Coyne J. A., 2004, SPECIATION; Doyle J. L. ., 1987, PHYTOCHEMISTRY B, V19, P11; EXCOFFIER L, 1992, GENETICS, V131, P479; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Glowacka K, 2015, GCB BIOENERGY, V7, P386, DOI 10.1111/gcbb.12166; Hey J, 2009, MOL BIOL EVOL, V27, P905; Ho CW, 2011, AM J BOT, V98, pE201, DOI 10.3732/ajb.1100071; Hsu T. W., 2013, TAIWAN WIND PLANT DA; Jensen JD, 2010, GENOME BIOL EVOL, V2, P371, DOI 10.1093/gbe/evq028; LEE Y. N., 1964, Bot. Mag., V77, P122; Li X, 2013, GENES GENOM, V35, P13, DOI 10.1007/s13258-013-0063-y; Ma XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033821; McGaugh SE, 2012, PHILOS T R SOC B, V367, P422, DOI 10.1098/rstb.2011.0250; Muir G, 2012, EVOLUTION, V66, P1447, DOI 10.1111/j.1558-5646.2011.01529.x; Nadeau NJ, 2011, PHILOS T R SOC B, V367, P343, DOI [10.1098/rstb.2011.0198, DOI 10.1098/RSTB.2011.0198]; Nosil P., 2011, PHILOS T R SOC B, V367, P332; Nosil P., 2008, TRENDS ECOL EVOL, V24, P145, DOI DOI 10.1016/J.TREE.2008.10.011; Osada N, 2005, GENETICS, V169, P259, DOI 10.1534/genetics.104.029231; Paun O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-113; Poczai P, 2010, MOL BIOL REP, V37, P1897, DOI 10.1007/s11033-009-9630-3; Scally L., 2001, ORIGINS TAXONOMY MIS; Schmickl R, 2011, P NATL ACAD SCI USA, V108, P14192, DOI 10.1073/pnas.1104212108; Sousa VC, 2011, MOL ECOL, V20, P3956, DOI 10.1111/j.1365-294X.2011.05247.x; Strasburg J. L., 2011, PHIL T R SOC B, V367, P364; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Via S, 2012, PHILOS T R SOC B, V367, P451, DOI 10.1098/rstb.2011.0260; Wang WK, 2010, NEW PHYTOL, V188, P488, DOI 10.1111/j.1469-8137.2010.03383.x; Wright KM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001497; Wu WL, 2003, AM J BOT, V90, P1513, DOI 10.3732/ajb.90.10.1513; Xu WZ, 2013, BIOCHEM SYST ECOL, V48, P174, DOI 10.1016/j.bse.2012.11.024; Yule G. V., 1924, Philosophical Transactions of the Royal Society London B, V213, P21; Zhou RC, 2007, MOL BIOL EVOL, V24, P2746, DOI 10.1093/molbev/msm209	90	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	DEC	2014	80	5					834	847		10.1111/tpj.12676		14	Plant Sciences	Plant Sciences	AU3KI	WOS:000345511500008		
J	Okuda, K; Shoki, H; Arai, M; Shikanai, T; Small, I; Nakamura, T				Okuda, Kenji; Shoki, Harumi; Arai, Miho; Shikanai, Toshiharu; Small, Ian; Nakamura, Takahiro			Quantitative analysis of motifs contributing to the interaction between PLS-subfamily members and their target RNA sequences in plastid RNA editing	PLANT JOURNAL			English	Article						pentatricopeptide repeat; RNA editing; chloroplast; Arabidopsis thaliana; protein-RNA interaction	PENTATRICOPEPTIDE REPEAT PROTEIN; CIS-ACTING ELEMENTS; SITE RECOGNITION; ARABIDOPSIS MITOCHONDRIA; MESSENGER-RNA; IDENTIFICATION; BINDING; CHLOROPLASTS; TRANSCRIPTS; ORGANELLES	In plant organelles, RNA editing alters specific cytidine residues to uridine in transcripts. Target cytidines are specifically recognized by pentatricopeptide repeat (PPR) proteins of the PLS subfamily, which have additional C-terminal E or E-DYW motifs. Recent insilico analysis proposed a model for site recognition by PLS-subfamily PPR proteins, with a correspondence of one PPR motif to one nucleotide, and with the C-terminal last Smotif aligning with the nucleotide at position -4 with respect to the editing site. Here, we present quantitative biochemical data on site recognition by four PLS-subfamily proteins: CRR28 and OTP85 are DYW-class members, whereas CRR21 and OTP80 are E-class members. The minimal RNA segments required for high-affinity binding by these PPR proteins were experimentally determined. The results were generally consistent with the insilico-based model; however, we clarified that several PPR motifs, including the C-terminal L2 and Smotifs of CRR21 and OTP80, are dispensable for the RNA binding, suggesting distinct contributions of each PPR motif to site recognition. We also demonstrate that the DYW motif interacts with the target C and its 5 proximal region (from -3 to 0), whereas the Emotif is not involved in binding.	[Okuda, Kenji; Shoki, Harumi; Arai, Miho] Chuo Univ, Dept Life Sci, Fac Sci & Engn, Bunkyo Ku, Tokyo 1128551, Japan; [Shikanai, Toshiharu] Kyoto Univ, Grad Sch Sci, Dept Bot, Sakyo Ku, Kyoto 6068502, Japan; [Small, Ian] Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, Crawley, WA 6009, Australia; [Nakamura, Takahiro] Kyushu Univ, Fac Agr, Fukuoka 8128581, Japan	Nakamura, T (reprint author), Kyushu Univ, Fac Agr, Fukuoka 8128581, Japan.	tnaka@agr.kyushu-u.ac.jp	Small, Ian/C-1168-2008	Small, Ian/0000-0001-5300-1216	Japan Society for the Promotion of Science [23710220, 25650054]; Japan Science and Technology Agency [AS221Z03416]; Kato Memorial Bioscience Foundation; Australian Research Council [CE0561495]; Japanese Society of Plant Physiologists	We would like to dedicate this article to Dr Kenji Okuda who sadly passed away in November 2013. We are grateful to Prof. Mamoru Sugita and Prof. Hiroyuki Koike for their encouraging support for this study. This work was supported by a Grant-in-Aid from the Japan Society for the Promotion of Science (23710220 and 25650054), grants from the Japan Science and Technology Agency (AS221Z03416), the Kato Memorial Bioscience Foundation and the Australian Research Council (CE0561495), and a fellowship from the Japanese Society of Plant Physiologists to K.O. The authors have no conflicts of interest to declare.	Anant S, 2000, MOL CELL BIOL, V20, P1982, DOI 10.1128/MCB.20.6.1982-1992.2000; Prikryl J, 2011, P NATL ACAD SCI USA, V108, P415, DOI 10.1073/pnas.1012076108; Boussardon C, 2012, PLANT CELL, V24, P3684, DOI 10.1105/tpc.112.099507; Hammani K, 2011, J BIOL CHEM, V286, P21361, DOI 10.1074/jbc.M111.230516; Sun T, 2013, P NATL ACAD SCI USA, V110, pE1169, DOI 10.1073/pnas.1220162110; Kobayashi K, 2012, NUCLEIC ACIDS RES, V40, P2712, DOI 10.1093/nar/gkr1084; Boussardon C, 2014, NEW PHYTOL, V203, P1090, DOI 10.1111/nph.12928; Ruwe H, 2013, FEBS LETT, V587, P1429, DOI 10.1016/j.febslet.2013.03.022; Bentolila S, 2008, GENETICS, V178, P1693, DOI 10.1534/genetics.107.073585; Salone V, 2007, FEBS LETT, V581, P4132, DOI 10.1016/j.febslet.2007.07.075; Fujii S, 2011, P NATL ACAD SCI USA, V108, P1723, DOI 10.1073/pnas.1007667108; Zhang F, 2014, P NATL ACAD SCI USA, V111, P2023, DOI 10.1073/pnas.1316183111; Colcombet J, 2013, RNA BIOL, V10, P1557, DOI 10.4161/rna.26128; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Toda T, 2012, PLANT J, V72, P450, DOI 10.1111/j.1365-313X.2012.05091.x; Miyamoto T, 2004, P NATL ACAD SCI USA, V101, P48, DOI 10.1073/pnas.0307163101; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; Farre JC, 2001, MOL CELL BIOL, V21, P6731, DOI 10.1128/MCB.21.20.6731-6737.2001; Okuda K, 2012, NUCLEIC ACIDS RES, V40, P5052, DOI 10.1093/nar/gks164; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Yagi Y, 2013, RNA BIOL, V10, P1419, DOI 10.4161/rna.24908; Emanuelsson O, 1999, PROTEIN SCI, V8, P978; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; Bock R, 1996, EMBO J, V15, P5052; Bentolila S, 2012, P NATL ACAD SCI USA, V109, pE1453, DOI 10.1073/pnas.1121465109; Nakamura T, 2012, PLANT CELL PHYSIOL, V53, P1171, DOI 10.1093/pcp/pcs069; O'Toole N, 2008, MOL BIOL EVOL, V25, P1120, DOI 10.1093/molbev/msn057; Zehrmann A, 2008, MITOCHONDRION, V8, P319, DOI 10.1016/j.mito.2008.07.003; Fujii S, 2011, NEW PHYTOL, V191, P37, DOI 10.1111/j.1469-8137.2011.03746.x; Chaudhuri S, 1996, EMBO J, V15, P5958; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Yagi Y, 2014, PLANT J, V78, P772, DOI 10.1111/tpj.12377; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Bentolila S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003584; Bock R, 2000, BIOCHIMIE, V82, P549, DOI 10.1016/S0300-9084(00)00610-6; Bock R, 1997, RNA, V3, P1194; Castandet B, 2011, BIOCHEMISTRY-MOSCOW+, V76, P924, DOI 10.1134/S0006297911080086; Chateigner-Boutin AL, 2010, RNA BIOL, V7, P213; Chateigner-Boutin AL, 2013, PLANT J, V74, P935, DOI 10.1111/tpj.12180; Chateigner-Boutin AL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm640; Fujii S, 2013, PLANT CELL, V25, P3079, DOI 10.1105/tpc.113.112193; Hayes ML, 2007, RNA, V13, P281, DOI 10.1261/rna.295607; Hermann M, 1999, P NATL ACAD SCI USA, V96, P4856, DOI 10.1073/pnas.96.9.4856; KOBAYASHI Y, 2007, NUCLEIC ACIDS RES, V36, P311, DOI 10.1093/nar/gkm1026; Miyamoto T, 2002, MOL CELL BIOL, V22, P6726, DOI 10.1128/MCB.22.19.6726-6734.2002; Okuda K, 2006, J BIOL CHEM, V281, P37661, DOI 10.1074/jbc.M608184200; Rudinger M, 2011, RNA, V17, P2058, DOI 10.1261/rna.02962911; Rudinger M, 2012, J MOL EVOL, V74, P37, DOI 10.1007/s00239-012-9486-3; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Takenaka M, 2004, NUCLEIC ACIDS RES, V32, P4137, DOI 10.1093/nar/gkh763; Takenaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065343; Tasaki E, 2010, PLANT J, V62, P560, DOI 10.1111/j.1365-313X.2010.04175.x; Tillich M, 2009, P NATL ACAD SCI USA, V106, P6002, DOI 10.1073/pnas.0808529106; Williams-Carrier R, 2008, RNA, V14, P1930, DOI 10.1261/rna.1077708; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286	57	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	DEC	2014	80	5					870	882		10.1111/tpj.12687		13	Plant Sciences	Plant Sciences	AU3KI	WOS:000345511500011		
J	Nakashima, M; Yamazaki, S; Yue, J; Nakagaki, K				Nakashima, Motomu; Yamazaki, Shingo; Yue, Janice; Nakagaki, Kohei			Simulation analysis of paddling motions in a single kayak: Development of a comprehensive dynamic model of a paddler, paddle and hull	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Kayak; paddling motion; simulation; modeling		The objective of this study was to develop a comprehensive dynamic model of the paddler, paddle and hull for a simulation analysis of the paddling motion in a single kayak. In the development of the model, a similar simulation model, not for the kayak, but for human swimming, was utilized. The paddler was represented as a series of 21 truncated elliptic cones. The paddle was represented as three truncated elliptic cones for the two blades and shaft. For the hull, an extension of the original simulation model to represent the detailed three-dimensional hull shape was carried out. In the extended hull model, the thin elliptic plate was replaced by a plate with a detailed cross-sectional shape. The paddler, paddle and hull in the model were connected by means of virtual springs and dampers. The geometries of the paddler, paddle and hull were acquired based on the experiments that measured them. The joint motion of the paddler was measured by means of motion analysis as well. By inputting the acquired data, simulation of the paddling motion was conducted. From the results, it was confirmed that the joint motion acquired in the experiment was successfully input into the simulation. It was also confirmed that the paddler, paddle and the hull were successfully connected by the virtual springs and dampers. In the simulation, the averaged velocity of the hull in the propulsive direction was 3.40 m/s, which was 11% lower than the actual value of 3.8 m/s.	[Nakashima, Motomu] Tokyo Inst Technol, Dept Mech & Control Engn, Tokyo 1528552, Japan; [Yamazaki, Shingo] Tokyo Inst Technol, Dept Mech & Environm Informat, Tokyo 1528552, Japan; [Yue, Janice] Natl Univ Singapore, Dept Biomed Engn, Singapore 117548, Singapore; [Nakagaki, Kohei] Japan Inst Sports Sci, Dept Sports Sci, Tokyo, Japan	Nakashima, M (reprint author), Tokyo Inst Technol, Dept Mech & Control Engn, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528552, Japan.	motomu@mech.titech.ac.jp					AITKEN DA, 1992, INT J SPORT BIOMECH, V8, P165; Baker J, 1999, INT S BIOM SPORTS, P53; Gomes B, 2011, ISBS C P 27 JUN 1 JU, P259; Hoerner S. F., 1965, FLUID DYNAMICS DRAG, P3; Jackson PS, 1992, P 11 AUSTR FLUID MEC, P1197; Kendal SJ, 1992, INT J SPORT BIOMECH, V8, P223; Lopez CL, 2011, REV ANDAL MED DEPORT, V4, P91; Mann R, 1983, SCI P 1 INT SOC BIOM, P145; Nakashima M, 2010, J AERO AQUA BIOMECH, V1, P11; Nakashima Motomu, 2010, Journal of Biomechanical Science and Engineering, V5, DOI 10.1299/jbse.5.380; Nakashima M., 2007, J FLUID SCI TECHNOLO, V2, P56, DOI 10.1299/jfst.2.56; Sumner D, 2003, SPORTS ENG, V6, P11	12	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	DEC	2014	228	4					259	269		10.1177/1754337114537620		11	Engineering, Mechanical; Sport Sciences	Engineering; Sport Sciences	AU0UY	WOS:000345341400005		
J	Watanabe, R; Minagawa, Y; Noji, H				Watanabe, Rikiya; Minagawa, Yoshihiro; Noji, Hiroyuki			Thermodynamic analysis of F-1-ATPase rotary catalysis using high-speed imaging	PROTEIN SCIENCE			English	Article						single-molecule biophysics; temperature dependence; molecular motor protein; F-1-ATPase; FoF1-ATP synthase	TEMPERATURE-SENSITIVE REACTION; ELASTIC POWER TRANSMISSION; SINGLE-MOLECULE; ESCHERICHIA-COLI; ATP SYNTHASE; TORQUE GENERATION; ENERGY LANDSCAPES; PHOSPHATE RELEASE; ROTATION; F-1	F-1-ATPase (F-1) is a rotary motor protein fueled by ATP hydrolysis. Although the mechanism for coupling rotation and catalysis has been well studied, the molecular details of individual reaction steps remain elusive. In this study, we performed high-speed imaging of F-1 rotation at various temperatures using the total internal reflection dark-field (TIRDF) illumination system, which allows resolution of the F-1 catalytic reaction into elementary reaction steps with a high temporal resolution of 72 mu s. At a high concentration of ATP, F-1 rotation comprised distinct 80 degrees and 40 degrees substeps. The 80 degrees substep, which exhibited significant temperature dependence, is triggered by the temperature-sensitive reaction, whereas the 40 degrees substep is triggered by ATP hydrolysis and the release of inorganic phosphate (P-i). Then, we conducted Arrhenius analysis of the reaction rates to obtain the thermodynamic parameters for individual reaction steps, that is, ATP binding, ATP hydrolysis, P-i release, and TS reaction. Although all reaction steps exhibited similar activation free energy values, G(double dagger)=53-56 kJ mol(-1), the contributions of the enthalpy (H-double dagger), and entropy (S-double dagger) terms were significantly different; the reaction steps that induce tight subunit packing, for example, ATP binding and TS reaction, showed high positive values of both H-double dagger and S-double dagger. The results may reflect modulation of the excluded volume as a function of subunit packing tightness at individual reaction steps, leading to a gain or loss in water entropy.	[Watanabe, Rikiya; Minagawa, Yoshihiro; Noji, Hiroyuki] Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan; [Watanabe, Rikiya] JST, PRESTO, Bunkyo Ku, Tokyo 1138656, Japan	Noji, H (reprint author), Univ Tokyo, Dept Appl Chem, Sch Engn, Tokyo 1138656, Japan.	hnoji@appchem.t.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [00343111, 30540108]; Precursory Research for Embryonic Science from Japan Science and Technology Agency	Grant sponsor: The Ministry of Education, Culture, Sports, Science and Technology, Japan; Grant numbers: 00343111; 30540108; Grant sponsor: Precursory Research for Embryonic Science from the Japan Science and Technology Agency.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ALSHAWI MK, 1990, J BIOL CHEM, V265, P4402; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yoshidome T, 2011, J AM CHEM SOC, V133, P4030, DOI 10.1021/ja109594y; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; Okazaki K, 2011, STRUCTURE, V19, P588, DOI 10.1016/j.str.2011.01.013; Watanabe R, 2010, NAT CHEM BIOL, V6, P814, DOI [10.1038/nchembio.443, 10.1038/NCHEMBIO.443]; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Tanigawara M, 2012, BIOPHYS J, V103, P970, DOI 10.1016/j.bpj.2012.06.054; Masaike T, 2008, NAT STRUCT MOL BIOL, V15, P1326, DOI 10.1038/nsmb.1510; Watanabe R, 2012, NAT CHEM BIOL, V8, P86, DOI 10.1038/nchembio.715; Hayashi S, 2012, J AM CHEM SOC, V134, P8447, DOI 10.1021/ja211027m; Ueno H, 2010, BIOPHYS J, V98, P2014, DOI 10.1016/j.bpj.2010.01.011; Miyashita O, 2003, P NATL ACAD SCI USA, V100, P12570, DOI 10.1073/pnas.2135471100; Yoshidome T, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4734298; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Martin JL, 2014, P NATL ACAD SCI USA, V111, P3715, DOI 10.1073/pnas.1317784111; Spetzler D, 2009, BIOCHEMISTRY-US, V48, P7979, DOI 10.1021/bi9008215; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; Okazaki K, 2006, P NATL ACAD SCI USA, V103, P11844, DOI 10.1073/pnas.0604375103; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032; Weber J, 2010, NAT CHEM BIOL, V6, P794, DOI 10.1038/nchembio.458; Watanabe R, 2013, BIOPHYS J, V105, P2385, DOI 10.1016/j.bpj.2013.09.050; Sielaff H, 2008, P NATL ACAD SCI USA, V105, P17760, DOI 10.1073/pnas.0807683105; Mukherjee S, 2011, P NATL ACAD SCI USA, V108, P20550, DOI 10.1073/pnas.1117024108; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Arai HC, 2014, BIOPHYS J, V107, P156, DOI 10.1016/j.bpj.2014.05.016; Sekiya M, 2010, J BIOL CHEM, V285, P42058, DOI 10.1074/jbc.M110.176701; Bilyard T, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0023; ELLINGTON AD, 1987, J THEOR BIOL, V127, P491, DOI 10.1016/S0022-5193(87)80145-5; Enoki S, 2009, J BIOL CHEM, V284, P23169, DOI 10.1074/jbc.M109.026401; Furuike S, 2008, BIOPHYS J, V95, P761, DOI 10.1529/biophysj.107.123307; HARRIS DA, 1981, BIOCHIM BIOPHYS ACTA, V635, P412, DOI 10.1016/0005-2728(81)90039-6; Hornung T, 2008, BBA-BIOENERGETICS, V1777, P579, DOI 10.1016/j.bbabio.2008.04.016; Li ZQ, 2001, COMP BIOCHEM PHYS B, V128, P325, DOI 10.1016/S1096-4959(00)00330-4; Lowry DS, 2005, BIOCHEMISTRY-US, V44, P7275, DOI 10.1021/bi047293j; Sekiya M, 2009, J BIOL CHEM, V284, P22401, DOI 10.1074/jbc.M109.009019; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Spetzler D, 2006, BIOCHEMISTRY-US, V45, P3117, DOI 10.1021/bi052363n; Toyabe S, 2010, PHYS REV LETT, V104; Usukura E, 2012, J BIOL CHEM, V287, P1884, DOI 10.1074/jbc.M111.305938; WANG ZY, 1993, J BIOL CHEM, V268, P20785; Watanabe R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4486; Watanabe R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04962; Watanabe R, 2008, EMBO REP, V9, P84, DOI 10.1038/sj.embor.7401135; YOSHIDA M, 1975, J BIOL CHEM, V250, P7910	52	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	DEC	2014	23	12					1773	1779		10.1002/pro.2559		7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AU0QW	WOS:000345329800012		
J	Ohno, Y; Nishio, M; Koyama, H; Seki, S; Yoshikawa, T; Matsumoto, S; Obara, M; van Cauteren, M; Sugimura, K				Ohno, Yoshiharu; Nishio, Mizuho; Koyama, Hisanobu; Seki, Shinichiro; Yoshikawa, Takeshi; Matsumoto, Sumiaki; Obara, Makoto; van Cauteren, Marc; Sugimura, Kazuro			Asthma: Comparison of Dynamic Oxygen-enhanced MR Imaging and Quantitative Thin-Section CT for Evaluation of Clinical Treatment	RADIOLOGY			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; FUNCTIONAL LOSS ASSESSMENT; HYPERPOLARIZED HE-3 MRI; AIRWAY WALL THICKNESS; COMPUTED-TOMOGRAPHY; STAGE CLASSIFICATION; MAGNETIC-RESONANCE; LUNG DENSITOMETRY; VENTILATION; SEVERITY	Purpose: To compare the use of dynamic oxygen-enhanced magnetic resonance (MR) imaging with the use of quantitatively assessed computed tomography (CT) for assessment of clinical stage and evaluation of pulmonary functional change due to treatment in patients with asthma. Materials and Methods: The institutional review board of Kobe University Hospital approved this study, and written informed consent was obtained from each subject. Thirty consecutive patients with asthma (17 men and 13 women; age range, 27-78 years) underwent dynamic oxygen-enhanced MR imaging, multidetector CT, and assessment of forced expiratory volume in 1 second. All patients were classified as having one of four stages of asthma according to the guidelines of the National Asthma Education and Prevention Program. Relative enhancement ratio (RER) and wash-in time maps were generated by means of pixel-by-pixel analyses. Regions of interest were placed on images of the lung in all sections, and all measurements were averaged to determine mean RER and mean wash-in time for each subject. Percentage of airway wall area and mean lung density were determined at quantitative CT. For comparison of the modalities for assessment of clinical stage, indexes of subjects at all clinical stages were compared by means of the Tukey honestly significant difference test. Evaluation of pulmonary functional improvement was assessed by correlating improvement of each index with that of forced expiratory volume. Results: Mean wash-in time was significantly different among patients with asthma of different clinical stages (P < .05), but significant differences between mean RER and percentage of airway wall area were observed for a limited number of clinical stages (P,.05). Improvement of mean RER (r = 0.63, P = .0002) and mean wash-in time (r = 20.75, P < .0001) was significantly correlated with forced expiratory volume. Conclusion: Dynamic oxygen-enhanced MR imaging has potential as a tool for assessment of clinical stage and evaluation of pulmonary functional change due to treatment in patients with asthma. (C) RSNA, 2014	[Ohno, Yoshiharu; Nishio, Mizuho; Yoshikawa, Takeshi; Matsumoto, Sumiaki; Sugimura, Kazuro] Kobe Univ, Grad Sch, Adv Biomed Imaging Res Ctr, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Ohno, Yoshiharu; Nishio, Mizuho; Yoshikawa, Takeshi; Matsumoto, Sumiaki] Kobe Univ, Grad Sch, Dept Radiol, Div Funct & Diagnost Imaging Res,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Koyama, Hisanobu; Seki, Shinichiro] Kobe Univ, Grad Sch, Dept Radiol, Div Radiol,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Obara, Makoto; van Cauteren, Marc] Philips Elect Japan, Tokyo, Japan	Ohno, Y (reprint author), Kobe Univ, Grad Sch, Adv Biomed Imaging Res Ctr, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	yosirad@kobe-u.ac.jp			Philips Healthcare; Philips Electronics Japan	Supported by Philips Healthcare and Philips Electronics Japan.	Liard R, 2000, EUR RESPIR J, V16, P615, DOI 10.1034/j.1399-3003.2000.16d08.x; Harris RS, 2006, AM J RESP CRIT CARE, V174, P245, DOI 10.1164/rccm.200510-1634OC; [Anonymous], 1987, AM REV RESP DIS, V136, P1285; Camargo Carlos A Jr, 2009, Proc Am Thorac Soc, V6, P357, DOI 10.1513/pats.P09ST2; Altes TA, 2001, J MAGN RESON IMAGING, V13, P378, DOI 10.1002/jmri.1054; Ohno Y, 2002, MAGNET RESON MED, V47, P1139, DOI 10.1002/mrm.10168; Ueda T, 2006, J ALLERGY CLIN IMMUN, V118, P1019, DOI 10.1016/j.jaci.2006.07.032; Hoesein FAAM, 2011, THORAX, V66, P782, DOI 10.1136/thx.2010.145995; Kim WW, 2012, AM J ROENTGENOL, V199, P975, DOI 10.2214/AJR.11.7624; Samee S, 2003, J ALLERGY CLIN IMMUN, V111, P1205, DOI 10.1067/mai.2003.1544; de Lange EE, 2006, CHEST, V130, P1055, DOI 10.1378/chest.130.4.1055; Hasegawa M, 2006, AM J RESP CRIT CARE, V173, P1309, DOI 10.1164/rccm.200601-037OC; Niimi A, 2000, AM J RESP CRIT CARE, V162, P1518; [Anonymous], 1991, AM REV RESP DIS, V144, P1202; Gevenois PA, 1996, AM J ROENTGENOL, V167, P1169; Ohno Y, 2008, AM J RESP CRIT CARE, V177, P1095, DOI 10.1164/rccm.200709-1322OC; Edelman RR, 1996, NAT MED, V2, P1236, DOI 10.1038/nm1196-1236; Biernacki W, 1997, EUR RESPIR J, V10, P2455, DOI 10.1183/09031936.97.10112455; BLAND JM, 1986, LANCET, V1, P307; Chae EJ, 2010, INVEST RADIOL, V45, P354, DOI 10.1097/RLI.0b013e3181dfdae0; Denlinger LC, 2007, J ALLERGY CLIN IMMUN, V119, P12; Denlinger LC, 2007, J ALLERGY CLIN IMMUN, V119, P3, DOI 10.1016/j.jaci.2006.10.015; Fain SB, 2008, ACAD RADIOL, V15, P753, DOI 10.1016/j.acra.2007.10.019; Fujita J, 1999, ANN NUCL MED, V13, P247; Mitsunobu F, 2001, THORAX, V56, P851, DOI 10.1136/thorax.56.11.851; NEWMAN KB, 1994, CHEST, V106, P105, DOI 10.1378/chest.106.1.105; Niimi A, 2003, AM J RESP CRIT CARE, V168, P983, DOI 10.1164/rccm.200211.1268OC; Ohno Y, 2008, AM J ROENTGENOL, V190, pW93, DOI 10.2214/AJR.07.2511; Ohno Y, 2011, EUR J RADIOL, V77, P85, DOI 10.1016/j.ejrad.2009.06.027; Role of the pharmacist in improving asthma care, 1995, AM J HLTH SYST PHARM, V52, P1411; Weinberger SE, 1998, PRINCIPLES PULMONARY, P75	31	1	1	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	DEC	2014	273	3					907	916		10.1148/radiol.14132660		10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AU3LQ	WOS:000345515100029		
J	Talebizadeh, P; Babaie, M; Brown, R; Rahimzadeh, H; Ristovski, Z; Arai, M				Talebizadeh, P.; Babaie, M.; Brown, R.; Rahimzadeh, H.; Ristovski, Z.; Arai, M.			The role of non-thermal plasma technique in NOx treatment: A review	RENEWABLE & SUSTAINABLE ENERGY REVIEWS			English	Review						Non-thermal plasma (NTP); Nitrogen oxides removal; Diesel engines; Catalyst; Emission treatment; Pollution	DIESEL-ENGINE EXHAUST; DIELECTRIC-BARRIER DISCHARGE; COMPRESSION IGNITION ENGINES; CORONA DISCHARGE; NITROGEN-OXIDES; NITRIC-OXIDE; ATMOSPHERIC-PRESSURE; PULSED CORONA; HETEROGENEOUS CATALYSIS; INDUSTRIAL APPLICATIONS	Non-thermal plasma (NTP) has been introduced over the past several years as a promising method for nitrogen oxide (NOx) removal. The intent, when using NTP, is to selectively transfer input electrical energy to the electrons, and to not expend this in heating the entire gas stream, which generates free radicals through collisions, and promotes the desired chemical changes in the exhaust gases. The generated active species react with the pollutant molecules and decompose them. This paper reviews and summarizes relevant literature regarding various aspects of the application of NTP technology on NOx removal from exhaust gases. A comprehensive description of available scientific literature on NOx removal using NTP technology is presented, including various types of NIP, e.g. dielectric barrier discharge, corona discharge and electron beam. Furthermore, the combination of NTP with catalyst and adsorbent for better NOx removal efficiency is presented in detail. The removal of NOx from both simulated gases and real diesel engines is also considered in this review paper. As NTP is a new technique and is not yet commercialized, there is a need for more studies to be performed in this field. (C) 2014 Elsevier Ltd. All rights reserved.	[Talebizadeh, P.; Rahimzadeh, H.] Amirkabir Univ Technol, Dept Mech Engn, Tehran, Iran; [Babaie, M.; Brown, R.; Ristovski, Z.] Queensland Univ Technol, Biofuel Engine Res Facil, Brisbane, Qld 4001, Australia; [Arai, M.] Gunma Univ, Dept Mech Syst Engn, Kiryu, Gumma 376, Japan	Rahimzadeh, H (reprint author), Amirkabir Univ Technol, Dept Mech Engn, Tehran, Iran.	rahimzad@aut.ac.ir	Ristovski, Zoran/D-3308-2009	Ristovski, Zoran/0000-0001-6066-6638			Ahlfont K, 1999, PULSED POWER TECHNOL; Akiyama H., 2007, DIELECTR ELECT INSUL, V14, P1051; Vinh TQ, 2012, J MECH SCI TECHNOL, V26, P1921, DOI 10.1007/s12206-012-0402-y; Epling WS, 2004, CATAL REV, V46, P163, DOI 10.1081/CR-200031932; Gomez-Garcia MA, 2005, ENVIRON INT, V31, P445, DOI 10.1016/j.envint.2004.09.006; Vinogradov J, 2008, ENERGY, V33, P480, DOI 10.1016/j.energy.2007.06.004; Mizuno A, 2007, PLASMA PHYS CONTR F, V49, pA1, DOI 10.1088/0741-3335/49/5A/S01; Yamamoto T, 2000, IEEE T IND APPL, V36, P923, DOI 10.1109/28.845073; Wang T, 2012, PLASMA CHEM PLASMA P, V32, P1189, DOI 10.1007/s11090-012-9399-3; Rajanikanth BS, 2004, PLASMA SCI TECHNOL, V6, P2411, DOI 10.1088/1009-0630/6/4/013; Kim HH, 2005, APPL CATAL B-ENVIRON, V56, P213, DOI 10.1016/j.apcatb.2004.09.008; Rajanikanth BS, 2001, FUEL PROCESS TECHNOL, V74, P177, DOI 10.1016/S0378-3820(01)00238-7; Penetrante BM, 1999, PURE APPL CHEM, V71, P1829, DOI 10.1351/pac199971101829; Magureanu M, 2007, STUD SURF SCI CATAL, V171, P361; Roy S, 2009, APPL ENERG, V86, P2283, DOI 10.1016/j.apenergy.2009.03.022; Mizuno A, 1998, COMBUST SCI TECHNOL, V133, P49, DOI 10.1080/00102209808952026; Rajanikanth BS, 2008, PLASMA SCI TECHNOL, V10, P198, DOI 10.1088/1009-0630/10/2/12; Roy S, 2009, CHEM REV, V109, P4054, DOI 10.1021/cr800496f; Devahasdin S, 2003, J PHOTOCH PHOTOBIO A, V156, P161, DOI 10.1016/S1010-6030(03)00005-4; Rajanikanth BS, 2004, PLASMA SCI TECHNOL, V6, P2475, DOI 10.1088/1009-0630/6/5/009; Tendero C, 2006, SPECTROCHIM ACTA B, V61, P2, DOI 10.1016/j.sab.2005.10.003; Fang Z, 2007, J PHYS D APPL PHYS, V40, P1401, DOI 10.1088/0022-3727/40/5/013; [Anonymous], 2000, PLASMA EXHAUST TREAT; ELIASSON B, 1987, J PHYS D APPL PHYS, V20, P1421, DOI 10.1088/0022-3727/20/11/010; Matsumoto T, 2010, IEEE T PLASMA SCI, V38, P2639, DOI 10.1109/TPS.2010.2045903; Jolibois J, 2012, J ELECTROSTAT, V70, P300, DOI 10.1016/j.elstat.2012.03.011; Fridman A, 2005, J PHYS D APPL PHYS, V38, pR1, DOI 10.1088/0022-3727/38/2/R01; Yamamoto T, 2003, IEEE T IND APPL, V39, P1608, DOI 10.1109/TIA.2003.818988; Vandenbroucke AM, 2011, J HAZARD MATER, V195, P30, DOI 10.1016/j.jhazmat.2011.08.060; Kossyi IA, 1992, PLASMA SOURCES SCI T, V1, P207, DOI 10.1088/0963-0252/1/3/011; Malik MA, 2011, J HAZARD MATER, V197, P220, DOI 10.1016/j.jhazmat.2011.09.079; Johnson TV, 2009, INT J ENGINE RES, V10, P275, DOI 10.1243/14680874JER04009; Babaie M, 2013, IEEE T PLASMA SCI, V41, P2349, DOI 10.1109/TPS.2013.2270015; Sathiamoorthy G, 1999, IND ENG CHEM RES, V38, P1844, DOI 10.1021/ie980544y; Narula CK, 2005, INT J APPL CERAM TEC, V2, P452, DOI 10.1111/j.1744-7402.2005.02046.x; He XX, 2010, CATAL COMMUN, V12, P165, DOI 10.1016/j.catcom.2010.09.016; Huttunen JT, 2003, CHEMOSPHERE, V52, P609, DOI 10.1016/S0045-6535(03)00243-1; Chaloulakou A, 2008, ATMOS ENVIRON, V42, P454, DOI 10.1016/j.atmosenv.2007.09.067; Holzer F, 2002, APPL CATAL B-ENVIRON, V38, P163, DOI 10.1016/S0926-3373(02)00040-1; Rajanikanth BS, 2008, PLASMA SCI TECHNOL, V10, P307, DOI 10.1088/1009-0630/10/3/08; Kogelschatz U, 1999, PURE APPL CHEM, V71, P1819, DOI 10.1351/pac199971101819; Palash SM, 2013, RENEW SUST ENERG REV, V23, P473, DOI 10.1016/j.rser.2013.03.003; Mok YS, 2006, FUEL PROCESS TECHNOL, V87, P591, DOI 10.1016/j.fuproc.2005.10.007; Rajanikanth BS, 2009, FUEL PROCESS TECHNOL, V90, P343, DOI 10.1016/j.fuproc.2008.10.004; Gomez E, 2009, J HAZARD MATER, V161, P614, DOI 10.1016/j.jhazmat.2008.04.017; Futamura S, 2001, IEEE T IND APPL, V37, P978, DOI 10.1109/28.936387; Takaki K, 2008, VACUUM, V83, P128, DOI 10.1016/j.vacuum.2008.03.047; CHANG JS, 1991, IEEE T PLASMA SCI, V19, P1152, DOI 10.1109/27.125038; Kim HH, 2004, PLASMA PROCESS POLYM, V1, P91, DOI 10.1002/ppap.200400028; Roland U, 2005, APPL CATAL B-ENVIRON, V58, P217, DOI 10.1016/j.apcatb.2004.11.024; van Setten BAAL, 2001, CATAL REV, V43, P489, DOI 10.1081/CR-120001810; Namihira T, 2000, IEEE T PLASMA SCI, V28, P434, DOI 10.1109/27.848102; ATKINSON R, 1989, J PHYS CHEM REF DATA, V18, P881; LIKENS GE, 1972, ENVIRONMENT, V14, P33; Pauleta SR, 2013, COORDIN CHEM REV, V257, P332, DOI 10.1016/j.ccr.2012.05.026; Iglesias-Juez A, 2003, J CATAL, V217, P310, DOI 10.1016/S0021-9517(03)00055-1; Arai M, 2007, INT J ENGINE RES, V8, P477, DOI 10.1243/14680874JER01507; Arai M, 2004, COMBUST SCI TECHNOL, V176, P1653, DOI 10.1080/00102200490487535; Atkinson R, 1997, J PHYS CHEM REF, pS1329; Auciello O, 1989, PLASMA DIAGNOSTICS D; BEHBAHANI HF, 1982, COMBUST SCI TECHNOL, V27, P123, DOI 10.1080/00102208208946981; Bhasavanish D., 1993, P 9 IEEE PULS POW C, P441; Bhatt NM, 2013, INT J EMERGING TECHN, V3, P134; Chang J, 2000, IEEE T DIALECTR ELEC, V7, P602; Chen HL, 2008, APPL CATAL B-ENVIRON, V85, P1, DOI 10.1016/j.apcatb.2008.06.021; Chmielewski AG, 2001, MOD POWER SYST, V5, P54; Fridman A, 2008, PLASMA CHEMISTRY, P1, DOI 10.1017/CBO9780511546075; Gieshoff J., 2001, SAE TECHNICAL PAPER; Gu W, 2013, ENERGIES, V6, P4394, DOI 10.3390/en6094394; Guibet J.C., 1999, FUELS ENGINES TECHNO; Han Z, 1996, SAE T, V105, P837; Hariri MH, 1994, SCI IRAN, V1, P257; Heeb NV, 2008, ATMOS ENVIRON, V42, P2543, DOI 10.1016/j.atmosenv.2007.12.008; Hoard J, 2000, 2000012895 SAE; Hoard J, 1998, SAE TECHNICAL PAPER; Jaffre Y-N, 2009, P 2 INT MULT ENG TEC; Jelles SJ, 1999, THESIS DELFT U TECHN; Jeong K, 2011, ENERGIES, V4, P2049, DOI 10.3390/en4112049; Johnson TV, 2006, US DEP EN DIES ENG E; Jolibois J, 2011, J PHYS C SER, P301; Kobayashi Y, 2008, COMBUST FLAME, V154, P346, DOI 10.1016/j.combustflame.2008.03.022; Koenig JQ, 2000, HLTH EFFECTS NITROGE, P165; Koga H, 2006, REV AUTOMOT ENG, V27, P61; Kogelschatz U, 2003, PLASMA CHEM PLASMA P, V23, P1, DOI 10.1023/A:1022470901385; Konuma M., 1992, FILM DEPOSITION PLAS; Masuda S, 1977, RADIAT PHYS CHEM, V1981, P223; Matsumoto T., 2009, P PULS POW C PPC 09, P1035; McAdams R, 2001, J PHYS D APPL PHYS, V34, P2810, DOI 10.1088/0022-3727/34/18/315; Meloni R, 2013, ENERGIES, V6, P4331, DOI 10.3390/en6094331; Mohapatro S, 2011, PLASMA SCI TECHNOL, V13; Mok YS, 2004, FUEL PROCESS TECHNOL, V86, P303, DOI 10.1016/j.fuproc.2004.05.004; Mueller G., 2011, Proceedings of the 2011 18th IEEE International Conference on IEEE Pulsed Power (PPC 2011), DOI 10.1109/PPC.2011.6191691; Namihira T, 2001, IEEE T PLASMA SCI, V29, P592, DOI 10.1109/27.940952; Panel NRCDISCHE, 1981, HLTH EFF EXP DIES EX; Penetrante BM, 1996, APPL PHYS LETT, V68, P3719, DOI 10.1063/1.115984; Penetrante BM, 1995, P 10 IEEE INT PULS P, V1, P144; PENETRANTE BM, 1995, IEEE T PLASMA SCI, V23, P679, DOI 10.1109/27.467990; Penetrante BM, 2000, NOX REDUCTION ELECT; PENETRANTE BM, 1995, PHYS LETT A, V209, P69, DOI 10.1016/0375-9601(95)00789-4; Penetrante BM, 1995, P IEEE PULS POW C AL, P144; Penetrante BM, 1997, P 11 IEEE PULS POW C, V1, P91; Penetrarite BM, 1994, ELECT BEAM ELECT DIS; Prasad R, 2010, REV DIESEL SOOT EMIS; Prasad R., 2010, Bulletin of Chemical Reaction Engineering and Catalysis, V5, P69; Puchkarev V, 1999, P 12 IEEE INT PULS P, V1, P511; Puchkarev V, 1998, SAE TECHNICAL PAPER; Radoiu MT, 2004, RADIAT PHYS CHEM, V69, P113, DOI 10.1016/S0969-806X(03)00455-9; Radojevic M, 1998, ENVIRON POLLUT, V102, P685, DOI 10.1016/S0269-7491(98)80099-7; Rajanikanth BS, 2003, PLASMA SCI TECHNOL, V5, P1825, DOI 10.1088/1009-0630/5/3/012; Rajanikanth BS, 2005, PLASMA SCI TECHNOL, V7, P2943, DOI 10.1088/1009-0630/7/4/015; Rajanikanth BS, 2002, PLASMA SCI TECHNOL, V4, P1399, DOI 10.1088/1009-0630/4/4/010; Rajanikanth BS, 2007, IEEE T DIELECT EL IN, V14, P302, DOI 10.1109/TDEI.2007.344608; Rajanikanth BS, 2006, PLASMA SCI TECHNOL, V8, P202, DOI 10.1088/1009-0630/8/2/17; Ravi V, 2003, FUEL PROCESS TECHNOL, V81, P187, DOI 10.1016/S0378-3820(03)00013-4; Ravi V, 2003, PLASMA SCI TECHNOL, V5, P2057, DOI 10.1088/1009-0630/5/6/007; Riess J., 1998, NOX NITROGEN OXIDES; Roland U, 2005, APPL CATAL B-ENVIRON, V58, P227, DOI 10.1016/j.apcatb.2004.11.025; Saito M, 2006, JSME INT J B-FLUID T, V49, P1282, DOI 10.1299/jsmeb.49.1282; Schuetzle D, 1986, FUNDAMENTALS APPL CH; Sher E., 1998, HDB AIR POLLUTION IN; Skalska K, 2010, SCI TOTAL ENVIRON, V408, P3976, DOI 10.1016/j.scitotenv.2010.06.001; Slone R, 1998, SAE TECHNICAL PAPER; Smith KA, 1997, GLOBAL CHANGE BIOL, V3, P327, DOI 10.1046/j.1365-2486.1997.00100.x; Srinivasan AD, 2007, IEEE IND APPLIC SOC, P1893; Srinivasan AD, 2009, EL JOINT C BOST U JU; Srinivasan AD, 2007, IEEE T IND APPL, V43, P1507, DOI 10.1109/TIA.2007.908186; Stratakis GA, 2004, THESIS U THESSALY GR; Subrahmanyam C, 2006, APPL CATAL B-ENVIRON, V65, P157, DOI 10.1016/j.apcatb.2006.02.024; Subrahmanyam C, 2006, APPL CATAL B-ENVIRON, V65, P150, DOI 10.1016/j.apcatb.2006.01.006; Takaki K, 2009, IEEJ T FUNDAM MAT, V129, P62; Javed MT, 2007, J ENVIRON MANAGE, V83, P251, DOI 10.1016/j.jenvman.2006.03.006; Thagard SM, 2010, IEEE T IND APPL, V46, P2165, DOI 10.1109/TIA.2010.2071230; Tonks L, 1929, PHYS REV, V33; Tudor V, 2005, INT J HEAT MASS TRAN, V48, P4428, DOI 10.1016/j.ijheatmasstransfer.2005.05.011; TUNNICLIFFE WS, 1994, LANCET, V344, P1733, DOI 10.1016/S0140-6736(94)92886-X; Vinh TQ, 2012, J ENERGY INST, V85, P163, DOI 10.1179/1743967112Z.00000000015; Vinogradov J, 2007, ENERGY, V32, P174, DOI 10.1016/j.energy.2006.04.011; Wang C, 2011, VACUUM, V86, P960, DOI DOI 10.1016/J.VACUUM.2011.06.027; West B, 2004, SAE TECHNICAL PAPER, P3023; Whealton JH, 1997, NONTHERMAL PLASMA EX; Winands GJJ, 2007, THESIS TU EINDHOVEN; Xu DY, 2003, J PHYS D APPL PHYS, V36, P1583, DOI 10.1088/0022-3727/36/13/324; YAGIELA J A, 1991, Anesthesia Progress, V38, P1; Yamamoto T, 1999, IEEE IAS ANN M PHOEN, P1495; Yao S, 2007, AICHE J, V53, P1891, DOI 10.1002/aic.11202; Yao S, 2009, RECENT PATENTS CHEM, V2, P67; Zhao GB, 2004, IND ENG CHEM RES, V43, P2315, DOI 10.1021/ie049934c	147	7	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1364-0321			RENEW SUST ENERG REV	Renew. Sust. Energ. Rev.	DEC	2014	40						886	901		10.1016/j.rser.2014.07.194		16	Energy & Fuels	Energy & Fuels	AU2UT	WOS:000345473600071		
J	Mizuno, E				Mizuno, Emi			Overview of wind energy policy and development in Japan	RENEWABLE & SUSTAINABLE ENERGY REVIEWS			English	Review						Wind energy; Japan; Policy; Trend		This article reviews the history and current issues of wind energy development in Japan and considers the role of policy and future direction of wind energy. Past policy with its weak market focus did not increase wind energy share in Japan. The situation surrounding wind and other renewable energy changed dramatically after the Great East Earthquake and Tsunami and the subsequent Fukushima Nuclear Plant Accident in early 2011. The new Feed-in Tariff regime was introduced and the Electricity Sector Reform is slowly progressing. Although wind energy has much larger potential than other renewables in Japan, the FIT has not increased wind installation to date, and the number of bottlenecks has hindered large-scale market deployment of wind. The limited grid capacity, the current electricity market structure, and grid operating practices by the existing Electricity Power Companies have constrained the grid access of wind projects. A layer of regulations related to development permits increases lead-time, project uncertainty, and risk premiums. Difficulty in terms of social acceptance is also high due to some of the past mistakes which did not address local community concerns. Cost of wind energy is also high, compared with other countries, due to lack of economies of scale and other reasons. Japan needs to implement a more comprehensive policy package to address numerous bottlenecks and risks to increase wind energy share in its energy mix. (C) 2014 Elsevier Ltd. All rights reserved.	Deliotte Touche Tohmatsu LLC, Chiyoda Ku, Tokyo 1000005, Japan	Mizuno, E (reprint author), Deliotte Touche Tohmatsu LLC, Chiyoda Ku, 3-3-1 Marunouchi, Tokyo 1000005, Japan.	e.mizuno@almn.mit.edu					Cabinet Office (CAO), 2011, REP POW GEN COST COM; EDMC, 2013, EDMC HDB EN EC STAT; Energy Data and Modeling Center (EDMC), 2011, EDMC HDB EN EC STAT, P2011; Federation of electric power companies of Japan, 2013, GRID CONN CAP PV EIN; Fraunhofer IWES, 2013, REL CLIM CAUS FAIL W; GWEC, 2012, GLOB WIND STAT 2011; International Energy Agency (IEA), 2013, RD D STAT; International Energy Agency Wind Implementing Agreement (IEA Wind), 2011, IEA WIND 2010 ANN RE; International Renewable Energy Agency, 2012, REN EN TECHN COST AN, VI; Japan Society of Industrial Machinery Manufacturers (JSIMM), 2012, SURV REP WIND POW RE; Japan Wind Power Association (JWPA), 2013, REN EN 2012 EXH FOR; JWPA, 2013, FY 2012 JWPA ACT REP; JWPA, 2012, REN EN 2012 EXH FOR; JWPA, 2013, IEA WIND TASK 28 M T; JWPA wind energy cost comparison between Europe and Japan, 2012, MAT AUT STUD GROUP 1; METI, 2013, BUDG REQ FY 2014; METI/ANRE, 2011, EL SURV STAT FY 2010; METI/ANRE, 2013, INV COMM GEN RES EN; METI/ANRE, 2012, RPS SYST ACCR FAC FY; METI/ANRE, 2013, FY 2012 FEED TAR LEV; METI/ANRE, 2013, MEAS GRID ACC LARG S; METI/ANRE, 2013, REN EN INST REC END; METI/ANRE, 2012, EL SURV STAT FY 2011; METI/ANRE, 2013, FY 2013 BUDG EN RES; METI/ANRE, 2011, FY2010 REP SURV REN; METI/ANRE, 2001, GEN EN UT VOL AGR NE; METI/ANRE, 2012, FIT CERT EX REN POW; METI/ANRE, 2011, REP SURV WIND EN POT; METI/ANRE, 2013, FUT REN EN JAP WIND; Ministry of Economy Trade and Industry (METI), 2009, STRAT TECHN ROADM; Ministry of the Environment (MOE), 2011, FY2010 REP SURV REN; Ministry of the Environment (MOE), 1997, WIND EN DEV MAN; MOE, 2013, OFFHS WIND EN DEM PR; National Policy Unit (NPU), 2011, REN EN POT VAR MIN; Navigant Research A BTM Wind Report: World Market Update 2012, 2013, NAV RES BTM WIND REP; NEDO, 2012, STAT NEDO SUPP WIND; NEDO, 2012, FY 2010 REP SURV ACC; NEDO, 2011, REP SURV ACC FAIL WI; NEF, 2012, TXB FY 2012 WIND EN; New Energy and Industrial Technology Development Organization (NEDO), 2012, PROJ ACT WIND OC EN; Nikkei, 2013, FORT PORT FUNCT ON F; Nikkei, 2013, AGR REACH GOV PREF L; Yamazaki T., 2012, US JAP REN BUS RT DE; Yamazaki T, 2012, US JAP REN BUS RT	44	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1364-0321			RENEW SUST ENERG REV	Renew. Sust. Energ. Rev.	DEC	2014	40						999	1018		10.1016/j.rser.2014.07.184		20	Energy & Fuels	Energy & Fuels	AU2UT	WOS:000345473600079		
J	Kaneko, K; Takagi, N				Kaneko, K.; Takagi, N.			Accurate Ultrasonographic Prediction of Progesterone Concentrations Greater than 1 ng/ml in Holstein lactating dairy cows	REPRODUCTION IN DOMESTIC ANIMALS			English	Article							CORPUS-LUTEUM SIZE; BLOOD-FLOW; CORPORA-LUTEA; REPRODUCTIVE MANAGEMENT; OVARIAN STRUCTURES; ESTROUS-CYCLE; LOCAL CHANGES; HEIFERS; PROSTAGLANDIN-F2-ALPHA; ULTRASOUND	To develop an ultrasonographic assay for determining plasma progesterone concentration (P-4) as < 1 ng/ml or >= 1 ng/ml, the corpus luteum (CL) area and P4 were measured in 1094 multiparous Holstein cows. The area-measuring function and frozen images were used to outline and measure CL imaged via ultrasonography, and CL area was estimated as a polygon of a continuation straight line. A significant correlation was found between CL area and P4 (p < 0.001), and this analysis resulted in the following correlation equation: y = -0.35 + 1.02x (r = 0.81). According to the correlation equation, a CL area of 1.3 cm(2) indicated a P4 of 1 ng/ml. Based on this relationship, each animal was categorized into one of six groups, groups differed based on CL area, and the area ranges were as follows: < 1.3 cm(2) (Group A), 1.3-2.2 cm(2) (Group B), 2.3-3.2 cm(2) (Group C), 3.3-4.2 cm(2) (Group D), 4.3-5.2 cm(2) (Group E) and > 5.2 cm(2) (Group F). For each group, the proportion of cows whose P4 was 1 ng/ml or more was 1.5% in Group A, 83.3% in Group B, 76.6% in Group C, 96.6% in Group D, 99.2% in Group E and 100% in Group F. There was a significant difference between Group A and the other five groups, and between Groups B or C and Groups D, E or F (p < 0.005). These results indicate that a functional CL does not exist when the CL area is less than 1.3 cm(2) and that it exists when the CL area is 3.3 cm(2) or more.	[Kaneko, K.] Azabu Univ, Dept Vet Obstet & Gynecol, Chuo Ku, Sagamihara, Kanagawa 2525201, Japan; [Takagi, N.] Komagatake Ohnuma Vet Clin, Sapporo, Hokkaido, Japan	Kaneko, K (reprint author), Azabu Univ, Chuo Ku, 1-17-71 Fu Chinobe, Sagamihara, Kanagawa 2525201, Japan.	kaneko@azabu-u.ac.jp					Acosta TJ, 2002, BIOL REPROD, V66, P651, DOI 10.1095/biolreprod66.3.651; Aldrich SL, 1995, J ANIM SCI, V73, P3712; KASTELIC JP, 1990, THERIOGENOLOGY, V34, P487, DOI 10.1016/0093-691X(90)90006-F; Silva E, 2007, J DAIRY SCI, V90, P3255, DOI 10.3168/jds.2006-779; Kaneko K, 2008, J VET MED SCI, V70, P77, DOI 10.1292/jvms.70.77; Miyamoto A, 2006, J REPROD DEVELOP, V52, P153, DOI 10.1262/jrd.17087; Acosta TJ, 2003, REPRODUCTION, V125, P759, DOI 10.1530/rep.0.1250759; Claycomb RW, 1998, BIOSENS BIOELECTRON, V13, P1173, DOI 10.1016/S0956-5663(98)00080-3; Sartori R, 2002, J DAIRY SCI, V85, P2813, DOI 10.3168/jds.S0022-0302(02)74368-3; Aungier SPM, 2012, J DAIRY SCI, V95, P2452, DOI 10.3168/jds.2011-4653; ASSEY RJ, 1993, THERIOGENOLOGY, V39, P1321, DOI 10.1016/0093-691X(93)90234-V; Hanzen C, 2000, VET J, V159, P161, DOI 10.1053/tvjl.1999.0398; Kaneko K., 2004, Journal of the Japan Veterinary Medical Association, V57, P431; KASTELIC JP, 1990, THERIOGENOLOGY, V33, P1269, DOI 10.1016/0093-691X(90)90045-U; Luttgenau J, 2011, ANIM REPROD SCI, V125, P20, DOI 10.1016/j.anireprosci.2011.02.002; Mann GE, 2009, ANIM REPROD SCI, V115, P296, DOI 10.1016/j.anireprosci.2008.11.006; Matsui M, 2009, VET J, V181, P232, DOI 10.1016/j.tvjl.2008.02.027; NEBEL RL, 1988, J DAIRY SCI, V71, P1682, DOI 10.3168/jds.S0022-0302(88)79733-7; Ostergaard S, 2005, THERIOGENOLOGY, V64, P819, DOI 10.1016/j.theriogenology.2004.10.022; PETER AT, 1987, THERIOGENOLOGY, V27, P593, DOI 10.1016/0093-691X(87)90054-9; Petersson KJ, 2008, PREV VET MED, V86, P153, DOI 10.1016/j.prevetmed.2008.04.001; PIETERSE MC, 1990, VET REC, V126, P552; RAJAMAHENDRAN R, 1993, CAN VET J, V34, P349; Rekwot PI, 2004, VET J, V167, P67, DOI 10.1016/S1090-0233(02)00266-6; Robinson RS, 2005, DOMEST ANIM ENDOCRIN, V28, P285, DOI 10.1016/j.domaniend.2004.10.003; Samarutel J, 2008, J DAIRY RES, V75, P485, DOI 10.1017/S0022029908003610; Singh J, 1997, J REPROD FERTIL, V109, P35; SON CH, 1995, REPROD DOMEST ANIM, V30, P97, DOI 10.1111/j.1439-0531.1995.tb00612.x; Tallam SK, 2001, THERIOGENOLOGY, V56, P91, DOI 10.1016/S0093-691X(01)00545-3; Tenhagen BA, 2000, J VET MED A, V47, P213, DOI 10.1046/j.1439-0442.2000.00281.x	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0936-6768	1439-0531		REPROD DOMEST ANIM	Reprod. Domest. Anim.	DEC	2014	49	6					985	988		10.1111/rda.12418		4	Agriculture, Dairy & Animal Science; Reproductive Biology; Veterinary Sciences	Agriculture; Reproductive Biology; Veterinary Sciences	AU0IE	WOS:000345305900020		
J	Cato, S				Cato, Susumu			Common preference, non-consequential features, and collective decision making	REVIEW OF ECONOMIC DESIGN			English	Article						Non-consequentialism; Arrow's impossibility theorem; Collective decision making; Welfarism	NON-WELFARIST METHOD; PARETO PRINCIPLE; SOCIAL CHOICE; IMPOSSIBILITY THEOREMS; OPPORTUNITIES; RIGHTS	This paper examines an extended framework of Arrovian social choice theory. We consider two classes of values: consequential values and non-consequential values. Each individual has a comprehensive preference based on the two. Non-consequential values are assumed to be homogeneous among individuals. It is shown that a social ordering function satisfying Arrovian conditions must be non-consequential: a social comprehensive preference gives unequivocal priority to non-consequential values. We clarify the role of common preferences over non-consequential features.	Univ Tokyo, Inst Social Sci, Bunkyo Ku, Tokyo 1130033, Japan	Cato, S (reprint author), Univ Tokyo, Inst Social Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	susumu.cato@gmail.com					HAMMOND PJ, 1976, ECONOMETRICA, V44, P793, DOI 10.2307/1913445; Fleurbaey M, 2005, J ECON THEORY, V124, P22, DOI 10.1016/j.jet.2004.05.009; Fleurbaey M, 2003, J POLIT ECON, V111, P1382, DOI 10.1086/378533; Kaplow L, 2001, J POLIT ECON, V109, P281, DOI 10.1086/319553; SEN A, 1979, ECON J, V89, P537, DOI 10.2307/2231867; Black D, 1948, J POLIT ECON, V56, P23, DOI 10.1086/256633; Fleurbaey M, 2005, SOC CHOICE WELFARE, V24, P311, DOI 10.1007/s00355-003-0306-y; Pettit P, 2000, PHILOS QUART, V50, P175, DOI 10.1111/1467-9213.00178; Arrow K. J., 1951, SOCIAL CHOICE INDIVI; Blackorby C, 2005, SOC CHOICE WELFARE, V24, P253, DOI 10.1007/s00355-003-0301-3; BLAU JH, 1957, ECONOMETRICA, V25, P302, DOI 10.2307/1910256; Cato S, 2011, THEOR DECIS, V71, P503, DOI 10.1007/s11238-011-9261-8; Cato S, 2012, SOC CHOICE WELFARE, V39, P869, DOI 10.1007/s00355-011-0564-z; Cato S, 2014, THEOR DECIS, V76, P511, DOI 10.1007/s11238-013-9384-1; Dworkin R., 1977, TAKING RIGHTS SERIOU; FISHBURN PC, 1976, J COMB THEORY B, V20, P153, DOI 10.1016/0095-8956(76)90008-3; Gaertner W, 2002, HDB SOCIAL CHOICE WE, V1, P131, DOI 10.1016/S1574-0110(02)80007-8; Gotoh R, 2005, INT J ECON THEORY, V1, P21, DOI 10.1111/j.1742-7363.2005.00003.x; GRAVEL N, 1994, AM ECON REV, V84, P454; Hansson B., 1973, THEOR DECIS, V4, P25, DOI 10.1007/BF00133397; Iwata Y, 2009, SOC CHOICE WELFARE, V32, P513, DOI 10.1007/s00355-008-0338-4; Kaplow L, 2004, J POLIT ECON, V112, P249, DOI 10.1086/381865; KAPLOW LOUIS, 2002, FAIRNESS VERSUS WELF; KELSEY D, 1987, OXFORD ECON PAP, V39, P301; Maskin ES, 1995, CHOICE WELFARE DEV, P100; PATTANAIK PK, 1994, AM ECON REV, V84, P435; Pattanaik PK, 1996, OXFORD ECON PAP, V48, P194; Perfit D, 1984, REASONS PERSONS; Rawls J., 1971, THEORY JUSTICE; Sakai T, 2006, SOC CHOICE WELFARE, V26, P435, DOI 10.1007/s00355-005-0028-4; Scheffler S., 1982, REJECTION CONSEQUENT; Sen A, 1970, COLLECTIVE CHOICE SO; SEN A, 1977, ECONOMETRICA, V45, P1539, DOI 10.2307/1913949; Sen AK, 1986, SOCIAL CHOICE PUBLIC, P29; Suzumura K, 1999, SOC CHOICE WELFARE, V16, P17, DOI 10.1007/s003550050129; Suzumura K, 2008, DISCUSSION PAPER SER; Suzumura K, 2001, J ECON THEORY, V101, P423, DOI 10.1006/jeth.2000.2747; Suzumura K, 2004, SOC CHOICE WELFARE, V22, P237, DOI 10.1007/s00355-003-0284-0; Yoshihara N, 2008, RATIONAL CHOICE SOCI, P43, DOI 10.1007/978-3-540-79832-3_4	39	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1434-4742	1434-4750		REV ECON DES	Rev. Econ. Des.	DEC	2014	18	4					265	287		10.1007/s10058-014-0164-3		23	Economics	Business & Economics	AU5KU	WOS:000345646600002		
J	Khaerudini, DS; Guan, GQ; Zhang, P; Hao, XG; Abudula, A				Khaerudini, Deni S.; Guan, Guoqing; Zhang, Peng; Hao, Xiaogang; Abudula, Abuliti			Prospects of oxide ionic conductivity bismuth vanadate-based solid electrolytes	REVIEWS IN CHEMICAL ENGINEERING			English	Review						BiMeVOx; ionic conductivity; oxide ion conductor; SOFC structure	SUBSTITUTED BI4V2O11; FUEL-CELLS; ELECTRICAL-PROPERTIES; CRYSTAL-STRUCTURE; IMPEDANCE SPECTROSCOPY; BILAYERED ELECTROLYTES; PHASE STABILIZATION; AURIVILLIUS PHASES; OXYGEN SEPARATION; ANION TRANSPORT	The benefits of lowering the operation temperature of solid oxide fuel cells (SOFCs) have attracted great attention worldwide. There has been an enormous effort in the literature for the improvement of the electrolyte materials working at lower temperatures. The family of BiMeVOx (Bi-bismuth, Me-dopant metal, V-vanadium, Ox-oxide) materials has been found to have specific properties as oxide ion conductor (electrolyte) for low operation temperature. These materials exhibit uniquely structural features rather different from those of other solid electrolytes. It is possible to use these as the electrolyte in SOFCs. This article attempts to review the main structural and electrochemical characteristics of BiMeVOx materials in order to show a guideline for designing novel BiMeVOx-based electrolyte for low-temperature SOFCs. The prospects and challenges for the application of these materials as the electrolyte are discussed.	[Khaerudini, Deni S.; Guan, Guoqing; Zhang, Peng; Abudula, Abuliti] Hirosaki Univ, Grad Sch Sci & Technol, Hirosaki, Aomori 0368560, Japan; [Guan, Guoqing; Abudula, Abuliti] Hirosaki Univ, NJRISE, Aomori 0300813, Japan; [Hao, Xiaogang] Taiyuan Univ Technol, Dept Chem Engn, Taiyuan 030024, Peoples R China	Guan, GQ (reprint author), Hirosaki Univ, Grad Sch Sci & Technol, 1 Bunkyocho, Hirosaki, Aomori 0368560, Japan.	guan@cc.hirosaki-u.ac.jp; abuliti@cc.hirosaki-u.ac.jp	Guan, Guoqing/K-6555-2013		Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; State Scholarship Fund of China Scholarship Council	Deni S. Khaerudini gratefully acknowledges the scholarship from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and P. Zhang gratefully acknowledges the scholarship from the State Scholarship Fund of China Scholarship Council.	Ahn JS, 2010, J ELECTROCHEM SOC, V157, pB376, DOI 10.1149/1.3276503; Al-Areqi NAS, 2014, PHASE TRANSIT, V87, P96, DOI 10.1080/01411594.2013.783914; Jung DW, 2010, ACTA MATER, V58, P355, DOI 10.1016/j.actamat.2009.08.072; SUBBARAO EC, 1962, J AM CERAM SOC, V45, P166, DOI 10.1111/j.1151-2916.1962.tb11113.x; Holtappels P, 2000, SOLID STATE IONICS, V135, P675, DOI 10.1016/S0167-2738(00)00379-9; Huang PN, 1996, J ELECTROCHEM SOC, V143, P1644, DOI 10.1149/1.1836692; IHARADA T, 1991, SOLID STATE IONICS, V48, P257, DOI 10.1016/0167-2738(91)90040-I; Zhen Q, 2007, J RARE EARTH, V25, P199, DOI 10.1016/S1002-0721(07)60073-8; Wachsman ED, 1997, J ELECTROCHEM SOC, V144, P233, DOI 10.1149/1.1837390; ABRAHAM F, 1990, SOLID STATE IONICS, V40-1, P934, DOI 10.1016/0167-2738(90)90157-M; Steele BCH, 2001, J MATER SCI, V36, P1053, DOI 10.1023/A:1004853019349; ISHIHARA T, 1995, SOLID STATE IONICS, V79, P147, DOI 10.1016/0167-2738(95)00054-A; Goodenough JB, 2003, ANNU REV MATER RES, V33, P91, DOI 10.1146/annurev.matsci.33.022802.091651; Shuk P, 1996, SOLID STATE IONICS, V89, P179, DOI 10.1016/0167-2738(96)00348-7; [Anonymous], 1993, IN CRYST STRUCT DAT; Boivin JC, 1998, SOLID STATE IONICS, V113, P639, DOI 10.1016/S0167-2738(98)00330-0; Roy M, 2014, J THERM ANAL CALORIM, V115, P1265, DOI 10.1007/s10973-013-3361-3; Abrahams I, 2003, SOLID STATE IONICS, V157, P139, DOI 10.1016/S0167-2738(02)00201-1; KILNER JA, 1982, SOLID STATE IONICS, V6, P253, DOI 10.1016/0167-2738(82)90046-7; Dezanneau G, 2006, SOLID STATE IONICS, V177, P3117, DOI 10.1016/j.ssi.2006.07.044; Kim SK, 1997, SOLID STATE IONICS, V104, P295, DOI 10.1016/S0167-2738(97)00435-9; Satto C, 1999, MATER RES BULL, V34, P655, DOI 10.1016/S0025-5408(99)00058-6; Lazure S, 1996, SOLID STATE IONICS, V90, P117, DOI 10.1016/S0167-2738(96)00412-2; Guillodo M, 2003, SOLID STATE IONICS, V164, P87, DOI 10.1016/S0167-2738(03)00306-0; Abrahams I, 2002, J MATER CHEM, V12, P3351, DOI 10.1039/b203992n; Knauth P, 2002, J AM CERAM SOC, V85, P1654; Xia CR, 2002, ADV MATER, V14, P521, DOI 10.1002/1521-4095(20020404)14:7<521::AID-ADMA521>3.3.CO;2-3; JOUBERT O, 1992, MATER RES BULL, V27, P1235, DOI 10.1016/0025-5408(92)90231-N; Lee CK, 1996, SOLID STATE IONICS, V86-8, P235, DOI 10.1016/0167-2738(96)00132-4; Guillodo M, 2001, J EUR CERAM SOC, V21, P2331, DOI 10.1016/S0955-2219(01)00214-X; Pirovano C, 2003, SOLID STATE IONICS, V159, P181, DOI 10.1016/S0167-2738(03)00078-X; Chmielowiec J, 2008, J ALLOY COMPD, V451, P676, DOI 10.1016/j.jallcom.2007.04.192; Tu YC, 2014, RSC ADV, V4, P19925, DOI 10.1039/c4ra01862a; ABRAHAM F, 1988, SOLID STATE IONICS, V28, P529, DOI 10.1016/S0167-2738(88)80096-1; AMBEGAOKAR V, 1971, PHYS REV B-SOLID ST, V4, P2612, DOI 10.1103/PhysRevB.4.2612; Sammes NM, 1999, J EUR CERAM SOC, V19, P1801, DOI 10.1016/S0955-2219(99)00009-6; Huve M, 1996, J MATER CHEM, V6, P1339, DOI 10.1039/jm9960601339; Paydar MH, 2004, J MATER SCI, V39, P1357, DOI 10.1023/B:JMSC.0000013896.02030.9d; GOODENOUGH JB, 1992, MAT SCI ENG B-SOLID, V12, P357, DOI 10.1016/0921-5107(92)90006-U; Marques FMB, 2006, SOLID STATE IONICS, V177, P1697, DOI 10.1016/j.ssi.2006.04.036; Boivin JC, 1998, CHEM MATER, V10, P2870, DOI 10.1021/cm980236q; Lofberg A, 2006, CATAL TODAY, V112, P8, DOI 10.1016/j.cattod.2005.11.042; Kendall KR, 1996, CHEM MATER, V8, P642, DOI 10.1021/cm9503083; Krok F, 1999, SOLID STATE IONICS, V119, P139, DOI 10.1016/S0167-2738(98)00495-0; VERKERK MJ, 1982, SOLID STATE IONICS, V6, P159, DOI 10.1016/0167-2738(82)90083-2; Krok F, 2000, SOLID STATE IONICS, V136, P119, DOI 10.1016/S0167-2738(00)00360-X; Sabolsky EM, 2012, MATER LETT, V76, P47, DOI 10.1016/j.matlet.2012.02.048; Baranovskii SD, 1998, J NON-CRYST SOLIDS, V227, P158, DOI 10.1016/S0022-3093(98)00031-3; GOODENOUGH JB, 1992, SOLID STATE IONICS, V52, P105, DOI 10.1016/0167-2738(92)90096-8; Krok F, 1998, SOLID STATE IONICS, V111, P37, DOI 10.1016/S0167-2738(98)00188-X; Lee KT, 2012, J POWER SOURCES, V205, P122, DOI 10.1016/j.jpowsour.2012.01.040; Mairesse G, 1999, CR ACAD SCI II C, V2, P651, DOI 10.1016/S1387-1609(00)88579-5; Boivin JC, 2001, INT J INORG MATER, V3, P1261, DOI 10.1016/S1466-6049(01)00118-0; Krok F, 1996, SOLID STATE IONICS, V86-8, P261, DOI 10.1016/0167-2738(96)00102-6; Fleig J, 2002, SOLID STATE IONICS, V150, P181, DOI 10.1016/S0167-2738(02)00274-6; Dieterle L, 2011, ADV ENERGY MATER, V1, P249, DOI 10.1002/aenm.201000036; Baranovskii SD, 2002, PHYS STATUS SOLIDI B, V230, P281, DOI 10.1002/1521-3951(200203)230:1<281::AID-PSSB281>3.0.CO;2-W; ABOUKAIS A, 1993, CHEM MATER, V5, P1819, DOI 10.1021/cm00036a021; Kreuer KD, 2003, ANNU REV MATER RES, V33, P333, DOI 10.1146/annurev.matsci.33.022802.091825; Beg S, 2014, J ALLOY COMPD, V586, P302, DOI 10.1016/j.jallcom.2013.10.061; KILNER JA, 1983, SOLID STATE IONICS, V8, P201, DOI 10.1016/0167-2738(83)90017-6; Lee CK, 1999, SOLID STATE IONICS, V117, P301, DOI 10.1016/S0167-2738(98)00416-0; Vyazovkin S, 1997, J COMPUT CHEM, V18, P393, DOI 10.1002/(SICI)1096-987X(199702)18:3<393::AID-JCC9>3.0.CO;2-P; BOUKAMP BA, 1993, ELECTROCHIM ACTA, V38, P1817, DOI 10.1016/0013-4686(93)80303-H; Steele BCH, 2001, NATURE, V414, P345, DOI 10.1038/35104620; Emel'yanova YV, 2006, RUSS J PHYS CHEM+, V80, P1725, DOI 10.1134/S0036024406110057; Baranovski S., 2006, CHARGE TRANSPORT DIS; Baranovskii SD, 1997, FUTURE DIRECTIONS TH, P32; Baranovskii SD, 2006, SPRINGER HDB ELECT P, P161, DOI 10.1007/978-0-387-29185-7_9; Beg S, 2014, IONICS, V20, P269, DOI 10.1007/s11581-013-0933-y; Bluementhal RN, 1973, J ELECTROCHEM SOC, V120, P1230; Boukamp BA, 2000, SOLID STATE IONICS, V136, P75, DOI 10.1016/S0167-2738(00)00354-4; Bush AA, 1986, RUSS J INORG CHEM, V31, P769; Dell RM, 1978, OXYGEN ION CONDUCTOR, P291; Delmaire F, 2000, PHYS CHEM CHEM PHYS, V2, P4477, DOI 10.1039/b003644g; Fuierer P, 2014, J EUR CERAM SOC, V34, P943, DOI 10.1016/j.jeurceramsoc.2013.10.016; Godinho MJ, 2003, MATER LETT, V57, P2540, DOI 10.1016/S0167-577X(02)01308-3; Hummel RE, 2011, ELECTRONIC PROPERTIES OF MATERIALS, FOURTH EDITION, P1, DOI 10.1007/978-1-4419-8164-6; Joshi RS, 2009, J ALLOY COMPD, V471, P461, DOI 10.1016/j.jallcom.2008.03.143; Joubert O, 1993, MATER SCI FORUM, V133/136, P795; JOUBERT O, 1994, MATER RES BULL, V29, P175, DOI 10.1016/0025-5408(94)90138-4; Kaur G, 2014, INDIAN J PURE AP PHY, V52, P262; Khaerudini DS, 2014, J ALLOY COMPD, V589, P29, DOI 10.1016/j.jallcom.2013.11.162; Kilner J.A., 1981, NONSTOICHIOMETRIC OX, P233; Kudo T., 1990, SOLID STATE IONICS; LAZURE S, 1995, J MATER CHEM, V5, P1395, DOI 10.1039/jm9950501395; LEE CK, 1993, SOLID STATE IONICS, V62, P193, DOI 10.1016/0167-2738(93)90372-A; Lee CK, 1996, J MATER CHEM, V6, P331, DOI 10.1039/jm9960600331; LEE CK, 1994, J MATER CHEM, V4, P1441, DOI 10.1039/jm9940401441; MAIRESSE G, 1993, NATO ADV SCI INST SE, V250, P271; Matskevich NI, 2014, J ALLOY COMPD, V582, P253, DOI 10.1016/j.jallcom.2013.07.135; Minh NQ, 1995, SCI TECHNOLOGY CERAM, DOI Elsevier; Nimat RK, 2007, MAT SCI ENG B-SOLID, V137, P93, DOI 10.1016/j.mseb.2006.10.011; PERNOT E, 1994, SOLID STATE IONICS, V70, P259, DOI 10.1016/0167-2738(94)90320-4; Qui L, 1997, J MATER CHEM, V7, P249; REISELHUBER K, 1993, ELECTROCHIM ACTA, V38, P969, DOI 10.1016/0013-4686(93)87016-7; Roy M, 2014, J INTEGR SCI TECHNOL, V2, P49; Sadykov V, 2013, SOLID STATE IONICS, V251, P34, DOI 10.1016/j.ssi.2013.03.016; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Shao GQ, 2012, SOLID STATE IONICS, V219, P20, DOI 10.1016/j.ssi.2012.05.001; SHARMA V, 1992, SOLID STATE IONICS, V58, P359, DOI 10.1016/0167-2738(92)90141-B; Simmer SP, 1997, J AM CERAM SOC, V80, P2563; Skinner S. J., 2003, MATER TODAY, V6, P30, DOI DOI 10.1016/S1369-7021(03)00332-8; Steele BCH, 2000, EUR FUEL CELL NEWS, V7, P16; Steele B.C.H., 1989, HIGH CONDUCTIVITY SO, P402; STEELE BCH, 1994, J POWER SOURCES, V49, P1, DOI 10.1016/0378-7753(93)01789-K; Tuller H.L., 1981, NONSTOICHIOMETRIC OX, P271; VANNIER RN, 1995, SOLID STATE IONICS, V80, P11, DOI 10.1016/0167-2738(95)00123-N; VANNIER RN, 1994, SOLID STATE IONICS, V70, P248, DOI 10.1016/0167-2738(94)90318-2; HARDCASTLE FD, 1991, J SOLID STATE CHEM, V90, P194, DOI 10.1016/0022-4596(91)90135-5; West AR, 1984, SOLID STATE CHEM ITS; Yamamoto O, 2000, ELECTROCHIM ACTA, V45, P2423, DOI 10.1016/S0013-4686(00)00330-3; YAN J, 1995, SOLID STATE IONICS, V81, P225, DOI 10.1016/0167-2738(95)00187-B; Yaremchenko A, 2002, MATER CHEM PHYS, V77, P552	114	2	2	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0167-8299	2191-0235		REV CHEM ENG	Rev. Chem. Eng.	DEC	2014	30	6					539	551		10.1515/revce-2014-0020		13	Engineering, Chemical	Engineering	AU3KA	WOS:000345510400001		
J	Standaert, L; Adriaens, C; Radaelli, E; Van Keymeulen, A; Blanpain, C; Hirose, T; Nakagawa, S; Marine, JC				Standaert, Laura; Adriaens, Carmen; Radaelli, Enrico; Van Keymeulen, Alexandra; Blanpain, Cedric; Hirose, Tetsuro; Nakagawa, Shinichi; Marine, Jean-Christophe			The long noncoding RNA Neat1 is required for mammary gland development and lactation	RNA			English	Article						NEAT1; long noncoding RNA; paraspeckles; mammary gland development	NUCLEAR RETENTION; MALAT1; MICE; TRANSCRIPTION; PARASPECKLES; EXPRESSION; COMPONENT; BODIES; BODY	The lncRNA Neat1 is an essential architectural component of paraspeckle nuclear bodies. Although cell-based studies identified Neat1-paraspeckles as key regulators of gene expression through retention of hyperdited mRNAs and/or transcription factors, it is unclear under which specific physiological conditions paraspeckles are formed in vivo and whether they have any biological relevance. Herein, we show that paraspeckles are assembled in luminal epithelial cells during mammary gland development. Importantly, genetic ablation of Neat1 results in aberrant mammary gland morphogenesis and lactation defects. We provide evidence that the lactation defect is caused by a decreased ability of Neat1-mutant cells to sustain high rates of proliferation during lobular-alveolar development. This study is the first to assign an important biological function to the lncRNA Neat1 and to link it to the presence of paraspeckles nuclear bodies in vivo.	[Standaert, Laura; Adriaens, Carmen; Marine, Jean-Christophe] VIB, Lab Mol Canc Biol, Ctr Biol Dis, B-3000 Louvain, Belgium; [Standaert, Laura; Adriaens, Carmen; Marine, Jean-Christophe] KULeuven, Lab Mol Canc Biol, Ctr Human Genet, B-3000 Louvain, Belgium; [Radaelli, Enrico] VIB, Histopathol Lab, Ctr Biol Dis, B-3000 Louvain, Belgium; [Radaelli, Enrico] KULeuven, Histopathol Lab, Ctr Human Genet, B-3000 Louvain, Belgium; [Van Keymeulen, Alexandra; Blanpain, Cedric] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium; [Hirose, Tetsuro] Hokkaido Univ, Inst Med Genet, Sapporo, Hokkaido 0600815, Japan; [Nakagawa, Shinichi] RIKEN, RNA Biol Lab, Saitama 3510198, Japan	Marine, JC (reprint author), VIB, Lab Mol Canc Biol, Ctr Biol Dis, B-3000 Louvain, Belgium.	jeanchristophe.marine@cme.vib-kuleuven.be	Nakagawa, Shinichi/I-4192-2014; Marine, Jean Christophe/J-2237-2015		Fund for Scientific Research Flanders (FWO)	We thank N. Hubbard, R.D. Cardiff, and A.D. Borowsky from the UC Davis Center for Comparative Medicine for their advice on mammary gland processing and staining. We also thank Odessa Van Goethem and Greet Bervoets from the Chris Marine lab for their excellent technical support. This work was supported by a grant from the Fund for Scientific Research Flanders (FWO) to L.S.	Nakagawa S, 2011, J CELL BIOL, V193, P31, DOI 10.1083/jcb.201011110; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Mao YTS, 2011, NAT CELL BIOL, V13, P95, DOI 10.1038/ncb2140; Nakagawa S, 2012, CELL MOL LIFE SCI, V69, P3027, DOI 10.1007/s00018-012-0973-x; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Imamura K, 2014, MOL CELL, V53, P393, DOI 10.1016/j.molcel.2014.01.009; Naganuma T, 2012, EMBO J, V31, P4020, DOI 10.1038/emboj.2012.251; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Passon DM, 2012, P NATL ACAD SCI USA, V109, P4846, DOI 10.1073/pnas.1120792109; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Nakagawa S, 2012, RNA, V18, P1487, DOI 10.1261/rna.033217.112; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Cowin P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003251; Fox AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000687; Hirose T, 2014, MOL BIOL CELL, V25, P169, DOI 10.1091/mbc.E13-09-0558; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Li LJ, 2014, TRENDS CELL BIOL, V24, P594, DOI 10.1016/j.tcb.2014.06.003	21	6	6	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1355-8382	1469-9001		RNA	RNA	DEC	2014	20	12					1844	1849		10.1261/rna.047332.114		6	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT9TQ	WOS:000345269400002		
J	Hitosugi, M; Kirinoki, M; Ishii, K; Morita, S; Furukawa, S; Chigusa, Y				Hitosugi, Masahito; Kirinoki, Masashi; Ishii, Kanto; Morita, Satomu; Furukawa, Satoshi; Chigusa, Yuichi			The importance of collecting live fly larvae from a severely decomposed human cadaver in winter. Case report	ROMANIAN JOURNAL OF LEGAL MEDICINE			English	Article						fly larvae; winter; severely decomposed cadaver; forensic entomology; postmortem interval; autopsy	POSTMORTEM INTERVAL; REMAINS; DIPTERA	A severely decomposed cadaver was found in a snow-covered mountain forest on January 31, 2010. The cadaver, later identified as a 24-year-old Japanese man, was hanging from under a tree and consisted mainly of skeletal remains. At autopsy, dozens of larvae were observed around the inner cavity of the knee joint, and entomologically they were identified as the third instar larvae of the family Piophilidae (Diptera). It is interesting that the larvae were found alive at the autopsy in January when snow is present. The entomological information supports the information that the man had died around September 8 with the following reason: the location where the victim was found was too cold for the flies to have deposited their eggs; at the man's death, the ambient temperature was enough high for flies to deposit their eggs; according to the gradual decrease of the ambient temperature, the larvae penetrated into deep lesion with feeding. This is a valuable case demonstrating that live larvae can be obtained from a severely decomposed cadaver found in winter and can support the information about the time of death. This report also validated the importance of collecting Piophilidae flies of severely decomposed cadavers in winter.	[Hitosugi, Masahito; Morita, Satomu; Furukawa, Satoshi] Shiga Univ Med Sci, Dept Legal Med, Otsu, Shiga 5202192, Japan; [Kirinoki, Masashi; Chigusa, Yuichi] Dokkyo Med Univ, Sch Med, Dept Trop Med & Parasitol, Mibu, Tochigi 3210293, Japan; [Ishii, Kanto] Dokkyo Med Univ, Sch Med, Dept Legal Med, Mibu, Tochigi 3210293, Japan	Hitosugi, M (reprint author), Shiga Univ Med Sci, Dept Legal Med, Otsu, Shiga 5202192, Japan.						Aggarwal AD, ANIL AGGRAWALS INTER, V6; Anderson Gail S., 2001, P143; Martin-Vega D, 2011, FORENSIC SCI INT, V212, P1, DOI 10.1016/j.forsciint.2011.06.016; Benecke M, 1998, J FORENSIC SCI, V43, P797; Martin-Vega D, 2011, J FORENSIC SCI, V56, P1654, DOI 10.1111/j.1556-4029.2011.01839.x; Chigusa Yuichi, 2006, Leg Med (Tokyo), V8, P62, DOI 10.1016/j.legalmed.2005.06.005; Eberhardt TL, 2007, FORENSIC SCI INT, V176, P217; GOFF ML, 1991, J FORENSIC SCI, V36, P607; Hitosugi M, 2007, ACTA CRIM JAPON, V73, P31; Huntington TE, 2007, J FORENSIC SCI, V52, P453, DOI 10.1111/j.1556-4029.2007.00385.x; Kirinoki Masashi, 2010, Medical Entomology and Zoology, V61, P115; Knight B, 1996, FORENSIC PATHOLOGY; Rodriguez WC, 1993, SPITZ FISHERS MEDICO, P65; Smith K.G.V., 1986, MANUAL FORENSIC ENTO, VBritish Museum; Thevan K, 2010, J FORENSIC SCI, V55, P1656, DOI 10.1111/j.1556-4029.2010.01485.x; ZIFFREN SE, 1953, ANN SURG, V138, P932, DOI 10.1097/00000658-195312000-00023	16	0	0	ROMANIAN LEGAL MED SOC	BUCHAREST	SOS VITAN-BIRZESTI 9, BUCHAREST, 75669, ROMANIA	1221-8618			ROM J LEG MED	Rom. J. Leg. Med.	DEC	2014	22	4					253	256		10.4323/rjlm.2014.253		4	Medicine, Legal	Legal Medicine	AU4BK	WOS:000345553800011		
J	Ota, K; Takeuchi, T; Harada, S; Edogawa, S; Kojima, Y; Inoue, T; Higuchi, K				Ota, Kazuhiro; Takeuchi, Toshihisa; Harada, Satoshi; Edogawa, Shoko; Kojima, Yuichi; Inoue, Takuya; Higuchi, Kazuhide			A novel endoscopic submucosal dissection technique for proton pump inhibitor-refractory gastroesophageal reflux disease	SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY			English	Article						endoscopic submucosal dissection; gastroesophageal reflux disease; proton pump inhibitor	FOLLOW-UP; ENDOLUMINAL GASTROPLICATION; MULTICENTER TRIAL; STRETTA PROCEDURE; GERD; SYMPTOMS	Objectives: Although drug treatment is the usual first-line therapy for gastroesophageal reflux disease (GERD), not all patients receive satisfactory relief from drug therapy, alone. We developed an endoscopic fundoplication technique using endoscopic submucosal dissection (ESD); the technique is referred to as ESD for GERD (ESD-G). This study investigated the safety and efficacy of this novel technique in patients with drug-refractory GERD. Patients and methods: ESD-G narrows the hiatal opening through ESD of the esophagogastric junction (EGJ) mucosa. For safety reasons, the range of mucosal resection was limited to half (1/2 or 1/4 + 1/4) of the circumference of the EGJ lumen. ESD-G was performed on 13 patients with proton pump inhibitor (PPI)-refractory GERD. GERD symptoms, PPI dose, and 24-h esophageal pH monitoring results were compared before and 6 months after the procedure. Results. In 12 cases, symptoms significantly improved after ESD-G. Five patients demonstrated improved esophagitis, three were able to discontinue PPI therapy, and three were able to reduce their PPI dosage following surgery. The esophageal pH <4 holding time ratio was also decreased after ESD-G. Conclusions. ESD-G may be useful for PPI-refractory GERD patients.	[Ota, Kazuhiro; Takeuchi, Toshihisa; Harada, Satoshi; Edogawa, Shoko; Kojima, Yuichi; Inoue, Takuya; Higuchi, Kazuhide] Osaka Med Coll, Dept Internal Med 2, Takatsuki, Osaka 5698686, Japan	Ota, K (reprint author), Osaka Med Coll, Dept Internal Med 2, Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	clash_kaz@yahoo.co.jp			Osaka Medical Research Foundation for Incurable Diseases	This work was supported by a grant from the Osaka Medical Research Foundation for Incurable Diseases.	Corley DA, 2003, GASTROENTEROLOGY, V125, P668, DOI 10.1016/S0016-5085(03)01052-7; Kusano M, 2004, J GASTROENTEROL, V39, P888, DOI 10.1007/s00535-004-1417-7; Hoteya S, 2013, DIGESTION, V87, P29, DOI 10.1159/000343934; Mizuta H, 2009, DIS ESOPHAGUS, V22, P626, DOI 10.1111/j.1442-2050.2009.00954.x; CADIERE GB, 1994, BRIT J SURG, V81, P400, DOI 10.1002/bjs.1800810327; Deviere J, 2005, GASTROENTEROLOGY, V128, P532, DOI 10.1053/j.gastro.2004.12.005; Fennerty MB, 2003, GASTROINTEST ENDOSC, V57, P390, DOI 10.1067/mge.2003.114; Fockens Paul, 2003, Gastrointest Endosc Clin N Am, V13, P179, DOI 10.1016/S1052-5157(02)00112-5; Higuchi K, 2007, J GASTROENTEROL, V42, P205, DOI 10.1007/s00535-006-1944-5; Higuchi K, 2007, J GASTROENTEROL, V42, P325, DOI 10.1007/s00535-007-2005-4; Honda Kuniomi, 2012, World J Gastrointest Pathophysiol, V3, P44, DOI 10.4291/wjgp.v3.i2.44; Kozarek RA, 1997, GASTROINTEST ENDOSC, V46, P527, DOI 10.1016/S0016-5107(97)70008-7; Louis Hubert, 2003, Gastrointest Endosc Clin N Am, V13, P191, DOI 10.1016/S1052-5157(02)00115-0; Montgomery M, 2006, SCAND J GASTROENTERO, V41, P1382, DOI 10.1080/00365520600735738; NISSEN R, 1956, Schweiz Med Wochenschr, V86, P590; Ozawa S, 2009, J GASTROENTEROL, V44, P675, DOI 10.1007/s00535-009-0064-4; Pleskow D, 2004, GASTROINTEST ENDOSC, V59, P163, DOI 10.1016/S0016-5107(03)02542-2; Schiefke I, 2005, ENDOSCOPY, V37, P700, DOI 10.1055/s-870128; Triadafilopoulos G, 2002, GASTROINTEST ENDOSC, V55, P149, DOI 10.1067/mge.2002.121227	19	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0036-5521	1502-7708		SCAND J GASTROENTERO	Scand. J. Gastroenterol.	DEC	2014	49	12					1409	1413		10.3109/00365521.2014.978815		5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AU4TE	WOS:000345603500002		
J	Ohshio, Y; Hanaoka, J; Kontani, K; Teramoto, K				Ohshio, Y.; Hanaoka, J.; Kontani, K.; Teramoto, K.			Tranilast Inhibits the Function of Cancer-Associated Fibroblasts Responsible for the Induction of Immune Suppressor Cell Types	SCANDINAVIAN JOURNAL OF IMMUNOLOGY			English	Article							REGULATORY T-CELLS; TUMOR-ASSOCIATED FIBROBLASTS; MURINE BREAST-CANCER; FACTOR-BETA RELEASE; ACTIVATION PROTEIN; STROMAL FIBROBLASTS; COLLAGEN-SYNTHESIS; PROLIFERATION; GROWTH; PROGRESSION	Cancer-associated fibroblasts (CAFs) are the dominant stromal component in the tumour microenvironment (TME), playing critical roles in generation of pro-tumourigenic TME; however, their contribution to suppression of antitumour immune responses has not been fully understood. To elucidate the interaction between CAFs and immune suppressor cells, we examined whether inhibition of CAFs function would impair the induction of immune suppressor cell types in vitro. In this study, we applied an anti-allergic and antifibrotic agent tranilast, which is used clinically, and evaluated a potential of tranilast to serve as a CAFs inhibitor. CAFs that had been isolated from E.G7 or LLC1 tumour-bearing mice were cultured in the presence of tranilast, and thereafter, CAFs functions on the secretion of some soluble factors as well as the induction of immune suppressor cells were evaluated. As a result, tranilast inhibited the proliferation of CAFs and reduced the levels of stromal cell-derived factor-1, prostaglandin E-2 and transforming growth factor-1 from CAFs in a dose-dependent manner. On the other hand, tranilast exerted no inhibitory effects on immune cells at doses under 100m. The induction of regulatory T cells and myeloid-derived suppressor cells from their progenitor cells was suppressed in the medium that CAFs had been cultured in the presence of tranilast; however, these findings were not observed when those progenitor cells were cultured in the medium containing tranilast alone. These data demonstrate that tranilast inhibits CAFs function, which is responsible for the induction of immune suppressor cells, and possesses a potential to serve as a specific CAFs inhibitor.	[Ohshio, Y.; Hanaoka, J.] Shiga Univ Med Sci, Dept Surg, Otsu, Shiga 5202192, Japan; [Kontani, K.] Kagawa Univ, Fac Med, Dept Thorac Breast & Endocrine Surg, Takamatsu, Kagawa 760, Japan; [Teramoto, K.] Shiga Univ Med Sci, Dept Med Oncol, Otsu, Shiga 5202192, Japan	Teramoto, K (reprint author), Shiga Univ Med Sci, Dept Med Oncol, Otsu, Shiga 5202192, Japan.	teramoto@belle.shiga-med.ac.jp			Ministry of Education, Science, and Culture of Japan [20591666]; Shiga University of Medical Science [1515503I, 1515503ZC]	The authors thank staff in Central Research Laboratory in Shiga University of Medical Science for their technical supports. This work was supported by grant-in-aid for the scientific research from the Ministry of Education, Science, and Culture of Japan (to K.T., No. 20591666) and grants from Shiga University of Medical Science (to Y.O., No. 1515503I, 1515503ZC).	Rogosnitzky M, 2012, ANTICANCER RES, V32, P2471; Loeffler M, 2006, J CLIN INVEST, V116, P1955, DOI 10.1172/JCI26532; Wen YA, 2010, CANCER SCI, V101, P2325, DOI 10.1111/j.1349-7006.2010.01695.x; Hoechst B, 2008, GASTROENTEROLOGY, V135, P234, DOI [10.1053/j.gastro.2008.03.020, 10.1053/i.gastro.2008.03.020]; SUZAWA H, 1992, JPN J PHARMACOL, V60, P85, DOI 10.1254/jjp.60.85; Lee J, 2005, CANCER RES, V65, P11156, DOI 10.1158/0008-5472.CAN-05-2805; Pan PY, 2008, BLOOD, V111, P219, DOI 10.1182/blood-2007-04-086835; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Kobayashi N, 2007, CLIN CANCER RES, V13, P902, DOI 10.1158/1078-0432.CCR-06-2363; Melani C, 2007, CANCER RES, V67, P11438, DOI 10.1158/0008-5472.CAN-07-1882; Harper J, 2014, SEMIN CANCER BIOL, V25, P69, DOI 10.1016/j.semcancer.2013.12.005; Mandruzzato S, 2009, J IMMUNOL, V182, P6562, DOI 10.4049/jimmunol.0803831; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Mao Y, 2013, CANCER METAST REV, V32, P303, DOI 10.1007/s10555-012-9415-3; Wu MH, 2011, CLIN CANCER RES, V17, P1306, DOI 10.1158/1078-0432.CCR-10-1824; Shime H, 2002, J CLIN ENDOCR METAB, V87, P5610, DOI 10.1210/jc.2002-020444; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Tran E, 2013, J EXP MED, V210, P1125, DOI 10.1084/jem.20130110; Jedeszko C, 2009, CANCER RES, V69, P9148, DOI 10.1158/0008-5472.CAN-09-1043; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Kinoshita T, 2013, CANCER SCI, V104, P409, DOI 10.1111/cas.12099; Barnas Jennifer L, 2010, Cancer Microenviron, V3, P29, DOI 10.1007/s12307-010-0044-5; Chakrabarti R, 2009, ANTI-CANCER DRUG, V20, P334, DOI 10.1097/CAD.0b013e328327994e; Ding Zhen-Yu, 2012, Cancer Microenviron, V5, P333, DOI 10.1007/s12307-012-0107-x; Hattori T, 2004, EUR J PHARMACOL, V498, P79, DOI 10.1016/j.ejphar.2004.07.061; Hiroi Makoto, 2002, Journal of Nippon Medical School, V69, P224, DOI 10.1272/jnms.69.224; Isaji M, 2000, CORNEA, V19, P364, DOI 10.1097/00003226-200005000-00021; Izumi K, 2009, PROSTATE, V69, P1222, DOI 10.1002/pros.20975; Karagoz B, 2010, MED ONCOL, V27, P29, DOI 10.1007/s12032-008-9165-9; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Murata T, 2011, CANCER RES, V71, P6633, DOI 10.1158/0008-5472.CAN-11-0034; Ohshio Y, 2013, ONCOL REP, V30, P1000, DOI 10.3892/or.2013.2505; Oshima T, 2000, CURR EYE RES, V20, P283, DOI 10.1076/0271-3683(200004)20:4;1-5;FT283; Platten M, 2001, INT J CANCER, V93, P53, DOI 10.1002/ijc.1289; SCANLAN MJ, 1994, P NATL ACAD SCI USA, V91, P5657, DOI 10.1073/pnas.91.12.5657; Subramaniam V, 2010, ANTI-CANCER DRUG, V21, P351, DOI 10.1097/CAD.0b013e328334992c; SUZAWA H, 1992, JPN J PHARMACOL, V60, P91, DOI 10.1254/jjp.60.91; TANAKA K, 1994, ATHEROSCLEROSIS, V107, P179, DOI 10.1016/0021-9150(94)90019-1; Yashiro M, 2003, ANTICANCER RES, V23, P3899; Yasukawa T, 2002, OPHTHALMIC RES, V34, P206, DOI 10.1159/000063884	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-9475	1365-3083		SCAND J IMMUNOL	Scand. J. Immunol.	DEC	2014	80	6					408	416		10.1111/sji.12242		9	Immunology	Immunology	AU5EK	WOS:000345629800004		
J	Yamamichi, F; Shigemura, K; Behnsawy, HM; Meligy, FY; Huang, WC; Li, XY; Yamanaka, K; Hanioka, K; Miyake, H; Tanaka, K; Kawabata, M; Shirakawa, T; Fujisawa, M				Yamamichi, Fukashi; Shigemura, Katsumi; Behnsawy, Hosny M.; Meligy, Fatma Y.; Huang, Wen-Chin; Li, Xiangyan; Yamanaka, Kunito; Hanioka, Keisuke; Miyake, Hideaki; Tanaka, Kazushi; Kawabata, Masato; Shirakawa, Toshiro; Fujisawa, Masato			Sonic hedgehog and androgen signaling in tumor and stromal compartments drives epithelial-mesenchymal transition in prostate cancer	SCANDINAVIAN JOURNAL OF UROLOGY			English	Article						androgens; epithelial-mesenchymal transition; prostate cancer; prostate epithelial and stroma; sonic hedgehog	CELLS; GROWTH; EXPRESSION; PATHWAY; BONE; INHIBITION; CARCINOMA; RECEPTOR; METASTASIS; SPARC	Objective. Sonic hedgehog (Shh) signaling, androgens and epithelial-mesenchymal transition (EMT) are related to prostate cancer (PCa) progression. The aim of this study was to investigate how Shh and androgen [dihydrotestosterone (DHT)] signaling act in prostate epithelial and stromal compartments and whether this signaling pathway drives EMT and promotes PCa progression. Material and methods. LNCaP, normal prostate fibroblast (NPF) and cancer-associated prostate fibroblast (CPF) cells were studied with DHT and/or the Shh signaling inhibitor cyclopamine. Real-time reverse transcription-polymerase chain reaction (RT-PCR) was performed to evaluate the expressions of a potential Shh target gene, osteonectin (ON) and EMT-associated markers (E-cadherin, N-cadherin and vimentin). Immunohistochemical studies using PCa prostatectomy samples were performed to assess the expression levels of ON, Gli-1, androgen receptor, Shh, E-cadherin, N-cadherin and vimentin. Results. While DHT enhanced cell proliferation in CPF more than LNCaP or NPF, cyclopamine inhibited cell proliferation enhanced by DHT in CPF. Real-time RT-PCR showed whereas both Shh and DHT induced N-cadherin and vimentin, DHT also induced the expression of osteonectin in LNCaP and cyclopamine blocked these expressions in osteonectin, N-cadherin and vimentin (p = 0.0084, 0.0002 and 0.0373, respectively). Immunohistochemistry showed that high expression of stromal, but, not epithelial, ON was significantly correlated with serum prostate-specific antigen (PSA) (p = 0.031), and high expression of Gli-1 and low expression of stromal ON with PSA recurrence (p = 0.0114 and p = 0.0005, respectively). Conclusions. Shh and androgen signaling in prostate tumor and stromal compartments drives EMT, and thus may play some role in PCa progression. Cyclopamine may be one therapeutic strategy for PCa.	[Yamamichi, Fukashi; Shigemura, Katsumi; Behnsawy, Hosny M.; Miyake, Hideaki; Tanaka, Kazushi; Shirakawa, Toshiro; Fujisawa, Masato] Kobe Univ, Grad Sch Med, Dept Urol, Kobe, Hyogo 6500017, Japan; [Meligy, Fatma Y.; Yamanaka, Kunito] Kobe Univ, Grad Sch Med, Infect Ctr, Kobe, Hyogo 6500017, Japan; [Kawabata, Masato; Shirakawa, Toshiro] Cedars Sinai Med Ctr, Dept Med, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Huang, Wen-Chin; Li, Xiangyan] Akashi Municipal Hosp, Dept Urol, Akashi, Hyogo, Japan; [Hanioka, Keisuke] Akashi Municipal Hosp, Dept Pathol, Akashi, Hyogo, Japan; [Behnsawy, Hosny M.] Assiut Univ, Fac Med, Dept Urol, Assiut, Egypt; [Meligy, Fatma Y.] Assiut Univ, Fac Med, Dept Histol, Assiut, Egypt	Shigemura, K (reprint author), Kobe Univ, Grad Sch Med, Dept Urol, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	yutoshunta@hotmail.co.jp					Bellovin DI, 2005, CANCER RES, V65, P10938, DOI 10.1158/0008.CAN-05-1947; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; El Khatib M, 2013, HEPATOLOGY, V57, P1035, DOI 10.1002/hep.26147; Koeneman KS, 1999, PROSTATE, V39, P246; Jacob K, 1999, CANCER RES, V59, P4453; Shigemura K, 2011, PROSTATE, V71, P1711, DOI 10.1002/pros.21388; Hay ED, 1995, ACTA ANAT, V154, P8; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Barnett P, 2011, BIOCHEM BIOPH RES CO, V404, P34, DOI 10.1016/j.bbrc.2010.11.044; Lehmann C, 2012, INT J ONCOL, V41, P1932, DOI 10.3892/ijo.2012.1654; Mimeault M, 2007, MOL CANCER THER, V6, P967, DOI 10.1158/1535-7163.MCT-06-0648; Chen M, 2009, CELL CYCLE, V8, P149, DOI 10.4161/cc.8.1.7532; Chen NY, 2007, CANCER RES, V67, P6544, DOI 10.1158/0008-5472.CAN-07-1330; Oue T, 2010, J PEDIATR SURG, V45, P387, DOI 10.1016/j.jpedsurg.2009.10.081; Bozkurt SU, 2009, APMIS, V117, P651, DOI 10.1111/j.1600-0463.2009.02516.x; Datta S, 2006, CELL MOL LIFE SCI, V63, P435, DOI 10.1007/s00018-005-5389-4; Gos Monika, 2009, Postepy Biochem, V55, P121; Hsieh CL, 2004, CANCER GENE THER, V11, P148, DOI 10.1038/sj.cgt.7700665; Inoue T, 2005, UROLOGY, V66, P332, DOI 10.1016/j.urology.2005.02.028; Lauth M, 2007, CURR OPIN INVEST DR, V8, P457; Maitah MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016068; Podhajcer OL, 2008, CANCER METAST REV, V27, P523, DOI 10.1007/s10555-008-9135-x; Rosano L, 2005, CANCER RES, V65, P11649, DOI 10.1158/0008-5472.CAN-05-2123; Sanchez P, 2005, CANCER RES, V65, P2990; Sethi Seema, 2010, Am J Transl Res, V3, P90; Shigemura K, 2009, PROSTATE, V69, P949, DOI 10.1002/pros.20944; Yang AD, 2006, CANCER RES, V66, P46, DOI 10.1158/0008-5471CAN-05-3086	27	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	2168-1805	2168-1813		SCAND J UROL	Scand. J. Urol.	DEC	2014	48	6					523	532		10.3109/21681805.2014.898336		10	Urology & Nephrology	Urology & Nephrology	AU3KK	WOS:000345511700005		
J	Ito, M; Ishikawa, K; Nishida, N				Ito, Makoto; Ishikawa, Kazuaki; Nishida, Naohisa			Distinctive erosional and depositional structures formed at a canyon mouth: A lower Pleistocene deep-water succession in the Kazusa forearc basin on the Boso Peninsula, Japan	SEDIMENTOLOGY			English	Article						Backset bedding; canyon mouth; fluid-mud deposits; mud drapes; scours; submarine fan; tractional structures; turbidity currents	SEDIMENT-GRAVITY FLOWS; DENSITY TURBIDITY CURRENTS; NORTHEAST ATLANTIC MARGIN; SOUTH-CENTRAL PYRENEES; LOBE TRANSITION ZONES; HYDRAULIC JUMPS; CONTINENTAL SHELVES; OTADAI FORMATION; FAN TRANSITION; SUBMARINE-FAN	The canyon mouth is an important component of submarine-fan systems and is thought to play a significant role in the transformation of turbidity currents. However, the depositional and erosional structures that characterize canyon mouths have received less attention than other components of submarine-fan systems. This study investigates the facies organization and geometry of turbidites that are interpreted to have developed at a canyon mouth in the early Pleistocene Kazusa forearc basin on the Boso Peninsula, Japan. The canyon-mouth deposits have the following distinctive features: (i) The turbidite succession is thinner than both the canyon-fill and submarine-fan successions and is represented by amalgamation of sandstones and pebbly sandstones as a result of bypassing of turbidity currents. (ii) Sandstone beds and bedsets show an overall lenticular geometry and are commonly overlain by mud drapes, which are massive and contain fewer bioturbation structures than do the hemipelagic muddy deposits. (iii) The mud drapes have a microstructure characterized by aggregates of clay particles, which show features similar to those of fluid-mud deposits, and are interpreted to represent deposition from fluid mud developed from turbidity current clouds. (iv) Large-scale erosional surfaces are infilled with thick-bedded to very thick-bedded turbidites, which show lithofacies quite similar to those of the surrounding deposits, and are considered to be equivalent to scours. (v) Concave-up erosional surfaces, some of which face in the upslope direction, are overlain by backset bedding, which is associated with many mud clasts. (vi) Tractional structures, some of which are equivalent to coarse-grained sediment waves, were also developed, and were overlain locally by mud drapes, in association with mud drape-filled scours, cut and fill structures and backset bedding. The combination of these outcrop-scale erosional and depositional structures, together with the microstructure of the mud drapes, can be used to identify canyon-mouth deposits in ancient deep-water successions.	[Ito, Makoto] Chiba Univ, Dept Earth Sci, Chiba 2638522, Japan; [Ishikawa, Kazuaki] Idemitsu Oil & Gas Co Ltd, Chiyoda Ku, Tokyo 1008321, Japan; [Nishida, Naohisa] Geol Survey Japan, Inst Geol & Geoinformat, AIST, Ibaraki 3058567, Japan	Ito, M (reprint author), Chiba Univ, Dept Earth Sci, Chiba 2638522, Japan.	mito@faculty.chiba-u.jp			Japan Society for the Promotion of Science [22540465]; Chiba University	This research was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (no. 22540465) and a research grant from Chiba University. An early version of the manuscript received the benefit of many constructive comments and suggestions by journal referees (D.M. Hodgson, I. Kane, and R.B. Wynn), as well as the Associate Editor (P. Talling), and the Editor (S. Rice).	Ito M, 2008, J SEDIMENT RES, V78, P668, DOI 10.2110/jsr.2008.076; GARCIA M, 1989, SCIENCE, V245, P393, DOI 10.1126/science.245.4916.393; Piper DJW, 2001, AAPG BULL, V85, P1407; Macdonald HA, 2011, J GEOL SOC LONDON, V168, P319, DOI 10.1144/0016-76492010-036; Fildani A, 2006, SEDIMENTOLOGY, V53, P1265, DOI 10.1111/j.1365-3091.2006.00812.x; Brunt RL, 2013, MAR PETROL GEOL, V41, P206, DOI 10.1016/j.marpetgeo.2012.02.007; POSTMA G, 1985, J SEDIMENT PETROL, V55, P874; Smith DP, 2007, MAR GEOL, V236, P79, DOI 10.1016/j.margeo.2006.09.024; Macdonald HA, 2011, GEOSPHERE, V7, P845, DOI 10.1130/GES00611.1; Wright LD, 2006, CONT SHELF RES, V26, P2092, DOI 10.1016/j.csr.2006.07.008; Covault JA, 2014, SEDIMENTOLOGY, V61, P1031, DOI 10.1111/sed.12084; HIRAYAMA J, 1977, SEDIMENTOLOGY, V24, P747, DOI 10.1111/j.1365-3091.1977.tb01914.x; Macquaker JHS, 2010, GEOLOGY, V38, P947, DOI 10.1130/G31093.1; Talling PJ, 2012, SEDIMENTOLOGY, V59, P1937, DOI 10.1111/j.1365-3091.2012.01353.x; Kostic S, 2006, J HYDRAUL RES, V44, P631; Gardner MH, 2003, MAR PETROL GEOL, V20, P757, DOI 10.1016/j.marpetgeo.2003.07.004; JOPLING AV, 1966, J SEDIMENT PETROL, V36, P821; Grabowski RC, 2011, EARTH-SCI REV, V105, P101, DOI 10.1016/j.earscirev.2011.01.008; Baas JH, 2009, J SEDIMENT RES, V79, P162, DOI 10.2110/jsr.2009.025; Talling PJ, 2007, NATURE, V450, P541, DOI 10.1038/nature06313; Ito M, 1998, GEOLOGY, V26, P939, DOI 10.1130/0091-7613(1998)026<0939:COCUOT>2.3.CO;2; Sumner EJ, 2013, GEOPHYS RES LETT, V40, P5904, DOI 10.1002/2013GL057862; Morris SA, 1998, SEDIMENTOLOGY, V45, P365; Sumner EJ, 2012, SEDIMENTOLOGY, V59, P1850, DOI 10.1111/j.1365-3091.2012.01329.x; Russell HAJ, 2003, J SEDIMENT RES, V73, P887, DOI 10.1306/041103730887; Weaver PPE, 2000, SEDIMENTOLOGY, V47, P239, DOI 10.1046/j.1365-3091.2000.0470s1239.x; Wynn RB, 2002, MAR GEOL, V192, P59, DOI 10.1016/S0025-3227(02)00549-2; Lang J, 2013, SEDIMENT GEOL, V296, P36, DOI 10.1016/j.sedgeo.2013.08.005; Wynn RB, 2002, AAPG BULL, V86, P1441; ITO M, 1992, SEDIMENT GEOL, V80, P67, DOI 10.1016/0037-0738(92)90032-M; NORMARK WR, 1979, SEDIMENTOLOGY, V26, P749, DOI 10.1111/j.1365-3091.1979.tb00971.x; Cartigny MJB, 2013, J SEDIMENT RES, V83, P1047, DOI 10.2110/jsr.2013.71; Kneller BC, 2003, J SEDIMENT RES, V73, P706, DOI 10.1306/031103730706; MUTTI E, 1977, SEDIMENTOLOGY, V24, P107, DOI 10.1111/j.1365-3091.1977.tb00122.x; Carling PA, 2002, SEDIMENTOLOGY, V49, P1269, DOI 10.1046/j.1365-3091.2002.00496.x; Clark J.D., 1996, SUBMARINE CHANNELS P; Cornamusini G, 2004, GEOL SOC SPEC PUBL, V222, P261, DOI 10.1144/GSL.SP.2004.222.01.14; Dickhudt PJ, 2011, CONT SHELF RES, V31, pS3, DOI 10.1016/j.csr.2010.02.008; Duarte JC, 2010, MAR GEOL, V271, P236, DOI 10.1016/j.margeo.2010.02.017; GARCIA MH, 1993, J HYDRAUL ENG-ASCE, V119, P1094; Gray TE, 2005, SEDIMENTOLOGY, V52, P467, DOI 10.1111/j.1365-3091.2005.00705.x; Heinio P., 2009, GEOLOGICAL SOC AM B, V121, P698, DOI DOI 10.1130/B26190.1; Hill PS, 2007, SPEC PUBL INT ASS SE, V37, P49, DOI 10.1002/9781444304398.ch2; Ito M, 2010, SEDIMENT GEOL, V226, P1, DOI 10.1016/j.sedgeo.2010.02.006; Ito M., 1988, FAN DELTAS SEDIMENTO, P400; Ito M., 2006, 17 INT SED C 2006 FU, P1; Ito M, 2006, J SEDIMENT RES, V76, P1274, DOI 10.2110/jsr.2006.093; Kane IA, 2009, J SEDIMENT RES, V79, P643, DOI 10.2110/jsr.2009.072; Katsura Y., 1984, SCI REPORT I GEOSCIE, VB5, P69; Kenyon NH, 2002, MAR GEOL, V184, P69, DOI 10.1016/S0025-3227(01)00282-1; KOMAR PD, 1971, GEOL SOC AM BULL, V82, P1477, DOI 10.1130/0016-7606(1971)82[1477:HJITC]2.0.CO;2; Lee SE, 2002, MAR GEOL, V185, P363, DOI 10.1016/S0025-3227(01)00298-5; LINK MH, 1984, AAPG BULL, V68, P850; LOWE DR, 1982, J SEDIMENT PETROL, V52, P279; Macdonald RG, 2009, SEDIMENTOLOGY, V56, P1346, DOI 10.1111/j.1365-3091.2008.01037.x; Malinverno A., 1988, GEOL SOC AM SPEC PAP, V229, P59; MILLINGTON JJ, 1995, J SEDIMENT RES B, V65, P443; Morris W., 2000, DEEP WATER RESERVOIR, P606; Mulder T, 2001, MAR GEOL, V175, P221, DOI 10.1016/S0025-3227(01)00114-1; Mutti E., 1987, MARINE CLASTIC SEDIM, P1; Mutti E., 1991, SEISMIC FACIES SEDIM, P75; Nishida N, 2013, MAR GEOL, V337, P1, DOI 10.1016/j.margeo.2012.12.006; Normark W.R., 1991, SPEC PUBL SOC EC PAL, V46, P207, DOI DOI 10.2110/PEC.91.09.0207; Partheniades E, 2009, COHESIVE SEDIMENTS IN OPEN CHANNELS: PROPERTIES, TRANSPORT, AND APPLICATIONS, P1; Sato T., 1957, J GEOL SOC JAPAN, V63, P100; SMITH ND, 1972, J SEDIMENT PETROL, V42, P378; Stevenson CJ, 2014, SEDIMENTOLOGY, V61, P1120, DOI 10.1111/sed.12091; Stow DAV, 1998, GEOL SOC SPEC PUBL, V129, P317, DOI 10.1144/GSL.SP.1998.129.01.19; WALKER RG, 1985, J SEDIMENT PETROL, V55, P279; Waltham D, 2004, J SEDIMENT RES, V74, P129, DOI 10.1306/062303740129; Warrick JA, 2009, GEOL SOC AM SPEC PAP, V454, P53, DOI 10.1130/2009.2454(2.3); Watanabe K., 1987, ED EARTH SCI, V40, P79; WEIRICH FH, 1988, NATURE, V332, P626, DOI 10.1038/332626a0; Winterwerp JC, 1997, J HYDRAUL ENG-ASCE, V123, P512, DOI 10.1061/(ASCE)0733-9429(1997)123:6(512)	74	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0037-0746	1365-3091		SEDIMENTOLOGY	Sedimentology	DEC	2014	61	7					2042	2062		10.1111/sed.12128		21	Geology	Geology	AU4GO	WOS:000345568500007		
J	Perillo, MM; Best, JL; Yokokawa, M; Sekiguchi, T; Takagawa, T; Garcia, MH				Perillo, Mauricio M.; Best, James L.; Yokokawa, Miwa; Sekiguchi, Tomohiro; Takagawa, Tomohiro; Garcia, Marcelo H.			A unified model for bedform development and equilibrium under unidirectional, oscillatory and combined-flows	SEDIMENTOLOGY			English	Article						Bedform; combined-flows; development; equilibrium; oscillatory; unidirectional	FIXED RIPPLED BED; SMALL-SCALE BEDFORMS; SAND RIPPLES; APPARENT ROUGHNESS; EMPIRICAL-MODEL; FINE SAND; WAVES; CURRENTS; BOTTOM; DUNES	The development of bedforms under unidirectional, oscillatory and combined-flows results from temporal changes in sediment transport, flow and morphological response. In such flows, the bedform characteristics (for example, height, wavelength and shape) change over time, from their initiation to equilibrium with the imposed conditions, even if the flow conditions remain unchanged. These variations in bedform morphology during development are reflected in the sedimentary structures preserved in the rock record. Hence, understanding the time and morphological development in which bedforms evolve to an equilibrium stage is critical for informed reconstruction of the ancient sedimentary record. This article presents results from a laboratory flume study on bedform development and equilibrium development time conducted under purely unidirectional, purely oscillatory and combined-flow conditions, which aimed to test and extend an empirical model developed in past work solely for unidirectional ripples. The present results yield a unified model for bedform development and equilibrium under unidirectional, oscillatory and combined-flows. The experimental results show that the processes of bedform genesis and growth are common to all types of flows, and can be characterized into four stages: (i) incipient bedforms; (ii) growing bedforms; (iii) stabilizing bedforms; and (iv) fully developed bedforms. Furthermore, the development path of bedform; growth exhibits the same general trend for different flow types (for example, unidirectional, oscillatory and combined-flows), bedform size (for example, small versus large ripples), bedform shape (for example, symmetrical or rounded), bedform planform geometry (for example, two-dimensional versus three-dimensional), flow velocities and sediment grain sizes. The equilibrium time for a wide range of bed configurations was determined and found to be inversely proportional to the sediment transport flux occurring for that flow condition.	[Perillo, Mauricio M.; Best, James L.; Garcia, Marcelo H.] Univ Illinois, Dept Geol, Urbana, IL 61801 USA; [Perillo, Mauricio M.; Best, James L.; Garcia, Marcelo H.] Univ Illinois, Ven Te Chow Hydrosyst Lab, Urbana, IL 61801 USA; [Best, James L.] Univ Illinois, Dept Geog, Urbana, IL 61801 USA; [Best, James L.] Univ Illinois, Dept Geog Informat Sci, Urbana, IL 61801 USA; [Best, James L.] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA; [Yokokawa, Miwa] Osaka Inst Technol, Fac Informat Sci & Technol, Lab Geoenvironm, Osaka 5730196, Japan; [Sekiguchi, Tomohiro] Univ Tsukuba, Ctr Res Isotopes & Environm Dynam, Tsukuba, Ibaraki 3058577, Japan; [Takagawa, Tomohiro] Asia Pacific Ctr Coastal Disaster Res, Port & Airport Res Inst, Yokosuka, Kanagawa 2390826, Japan	Perillo, MM (reprint author), Univ Texas Austin, Jackson Sch Geosci, 2225 Speedway,Stop C1160, Austin, TX 78712 USA.	mmperillo@utexas.edu		Perillo, Mauricio/0000-0003-0507-436X	DURIP Program ONR [N00014-01-1-0540]	The authors would like to acknowledge the support of Erik van Dusen, Scott David and Yoshitsugu Hasegawa for their assistance in the laboratory. We are very grateful to Francisco Pedocchi, Jaco Baas, Eric Prokocki and Frank Engel for many useful discussions during the course of this work. The Large Oscillating Water Sediment Tunnel was built with support from the DURIP Program ONR grant N00014-01-1-0540. In addition, the completion of this work was made possible by the Leighton Graduate Student Research Award to MMP, established and supported by Dr. Morris W. Leighton. We also acknowledge the valuable comments by Editor Stephen Rice, Associate Editor David Mohrig, Paul Myrow and Brandon McElroy.	Admiraal D, 2006, J HYDRAUL RES, V44, P437; ARNOTT RW, 1990, J SEDIMENT PETROL, V60, P211; Baas JH, 1999, SEDIMENTOLOGY, V46, P123, DOI 10.1046/j.1365-3091.1999.00206.x; BAAS JH, 1994, SEDIMENTOLOGY, V41, P185, DOI 10.1111/j.1365-3091.1994.tb01400.x; BAGNOLD RA, 1946, PROC R SOC LON SER-A, V187, P1, DOI 10.1098/rspa.1946.0062; O'Donoghue T, 2006, COAST ENG, V53, P997, DOI 10.1016/j.coastaleng.2006.06.008; Carstensen S, 2010, J FLUID MECH, V646, P169, DOI 10.1017/S0022112009992825; SOUTHARD JB, 1991, ANNU REV EARTH PL SC, V19, P423, DOI 10.1146/annurev.earth.19.1.423; RUBIN DM, 1982, SEDIMENTOLOGY, V29, P121, DOI 10.1111/j.1365-3091.1982.tb01714.x; Best JL, 2001, J VISUAL-JAPAN, V4, P373; O'Donoghue T, 2001, COAST ENG, V44, P101, DOI 10.1016/S0378-3839(01)00025-4; PAOLA C, 1991, SEDIMENTOLOGY, V38, P553, DOI 10.1111/j.1365-3091.1991.tb01008.x; Doucette JS, 2006, SEDIMENTOLOGY, V53, P581, DOI 10.1111/j.1365-3091.2006.00774.x; Leclair SF, 2001, J SEDIMENT RES, V71, P713, DOI 10.1306/2DC40962-0E47-11D7-8643000102C1865D; WILSON IG, 1972, SEDIMENTOLOGY, V19, P173, DOI 10.1111/j.1365-3091.1972.tb00020.x; Dumas S, 2005, J SEDIMENT RES, V75, P501, DOI 10.2110/jsr.2005.039; Venditti JG, 2005, SEDIMENTOLOGY, V52, P1343, DOI 10.1111/j.1365-3091.2005.00748.x; Coleman SE, 2003, J HYDRAUL ENG-ASCE, V129, P956, DOI 10.1061/(ASCE)0733-9429(2003)129:12(956); ASHLEY GM, 1990, J SEDIMENT PETROL, V60, P160; Baas J. H., 1993, THESIS UTRECHT U; BAAS JH, 1993, TERRA NOVA, V5, P29, DOI 10.1111/j.1365-3121.1993.tb00223.x; BEST JL, 1993, TURBULENCE, P61; Best J.L, 1996, ADV FLUVIAL DYNAMICS, P67; Calantoni J, 2013, J COASTAL RES, P1497, DOI 10.2112/SI65-253.1; Carling PA, 1999, J SEDIMENT RES, V69, P534; Catano-Lopera YA, 2006, COAST ENG, V53, P767, DOI 10.1016/j.coastaleng.2006.03.007; Claude N., 2012, GEOMORPHOLOGY, V179, P4057; Coleman J.M., 1969, SEDIMENT GEOL, V3, P129, DOI DOI 10.1016/0037-0738(69)90010-4; DAVIES AG, 1988, J GEOPHYS RES-OCEANS, V93, P491, DOI 10.1029/JC093iC01p00491; Dinehart RL, 2002, J HYDROL, V258, P25, DOI 10.1016/S0022-1694(01)00558-3; Faraci C, 2002, COAST ENG, V47, P35, DOI 10.1016/S0378-3839(02)00097-2; Fredsoe J, 1999, COAST ENG, V38, P177, DOI 10.1016/S0378-3839(99)00047-2; Garcia M.H, 2008, SEDIMENTATION ENG PR; Gee D., 1974, 223 U CAL HYDR ENG L; Harms J.C., 1975, SEPM SHORT COURSE, V2, P161; Lamb MP, 2012, GEOLOGY, V40, P827, DOI 10.1130/G33093.1; Landry B. J., 2007, P COAS SED, V1, P2191; LECKIE D, 1988, J SEDIMENT PETROL, V58, P607; Leeder M. R., 1983, INT ASS SEDIMENTOL S, V6, P584; Lofquist K. E. B., 1978, 785 US ARM CORPS ENG; Mathisen PP, 1996, J GEOPHYS RES-OCEANS, V101, P16543, DOI 10.1029/96JC00955; Mathisen PP, 1999, J GEOPHYS RES-OCEANS, V104, P18447, DOI 10.1029/1999JC900114; Mathisen PP, 1996, J GEOPHYS RES-OCEANS, V101, P16533, DOI 10.1029/96JC00954; OOST AP, 1994, SEDIMENTOLOGY, V41, P883, DOI 10.1111/j.1365-3091.1994.tb01430.x; Pedocchi F., 2009, J GEOPHYS RES, V144; Pedocchi F., 2009, THESIS U ILLINOIS UR; Perillo M. M, 2013, THESIS U ILLINOIS UR; Prins A., 1971, DOMINANT DISCHARGE C; Simons D. B., 1965, BEDLOAD EQUATION RIP; Sutherland A. J., 1965, 655 CAL I TECHN DIV, V65-5; Wijbenga J. H. A., 1990, Q785 DELFT HYDR LAB; Yalin M. S., 1975, P 16 C INT ASS HYDR, V2, P212; Yokokawa M., 1995, EARTH PLANETARY SC D, V29, P1	53	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0037-0746	1365-3091		SEDIMENTOLOGY	Sedimentology	DEC	2014	61	7					2063	2085		10.1111/sed.12129		23	Geology	Geology	AU4GO	WOS:000345568500008		
J	Kuwabara, K; Vogt, S; Watabe, M; Komiya, A				Kuwabara, Ko; Vogt, Sonja; Watabe, Motoki; Komiya, Asuka			Trust, Cohesion, and Cooperation After Early Versus Late Trust Violations in Two-Person Exchange: The Role of Generalized Trust in the United States and Japan	SOCIAL PSYCHOLOGY QUARTERLY			English	Article						generalized trust; trust violation; cooperation; solidarity; social dilemma; culture	SOCIAL-EXCHANGE; CULTURAL-DIFFERENCES; RECIPROCITY; COMMITMENT; UNCERTAINTY; SOLIDARITY; EMOTION; BREACH; RISK; GAME	We examine how the timing of trust violations affects cooperation and solidarity, including trust and relational cohesion. Past studies that used repeated Prisoner's Dilemmas suggest that trust violations are more harmful when they occur in early rather than later interactions. We argue that this effect of early trust violations depends on cultural and individual differences in generalized trust. A laboratory study from high- and low-trust cultures (the United States vs. Japan) supported our claim. First, early trust violations were more harmful than late trust violations, but only for Americans; the pattern reversed for Japanese. Second, these patterns were mediated by individual differences in generalized trust. Finally, generalized trust also moderated the effect of trust violations in the United States but not Japan. By demonstrating that generalized trust is not only lower but also less important in low-trust cultures, our research advances our understanding of how culture affects the development of solidarity in exchange relations.	[Kuwabara, Ko] Columbia Univ, New York, NY 10027 USA; [Vogt, Sonja] Univ Zurich, CH-8006 Zurich, Switzerland; [Watabe, Motoki] Monash Univ, Sch Business, Neurobusiness Lab, Bandar Sunway Township, Malaysia; [Komiya, Asuka] Kochi Tech Univ, Kochi, Japan	Kuwabara, K (reprint author), Columbia Univ, Columbia Business Sch, 703 Uris Hall,3022 Broadway, New York, NY 10027 USA.	kk2558@columbia.edu					Macy MW, 2002, P NATL ACAD SCI USA, V99, P7214, DOI 10.1073/pnas.082097399; Hagen JM, 1998, ACAD MANAGE REV, V23, P589, DOI 10.5465/AMR.1998.926628; Branzei O, 2007, ORGAN BEHAV HUM DEC, V104, P61, DOI 10.1016/j.obhdp.2006.11.002; Na J, 2010, P NATL ACAD SCI USA, V107, P6192, DOI 10.1073/pnas.1001911107; Lawler EJ, 1996, AM SOCIOL REV, V61, P89, DOI 10.2307/2096408; Lount RB, 2008, PERS SOC PSYCHOL B, V34, P1601, DOI 10.1177/0146167208324512; Cook KS, 2005, SOC PSYCHOL QUART, V68, P121; Molm LD, 2009, SOCIOL THEOR, V27, P1, DOI 10.1111/j.1467-9558.2009.00336.x; Schug J, 2010, PSYCHOL SCI, V21, P1471, DOI 10.1177/0956797610382786; Miller AS, 2003, SOC PSYCHOL QUART, V66, P62, DOI 10.2307/3090141; Molm LD, 2007, AM J SOCIOL, V113, P205, DOI 10.1086/517900; Molm LD, 2007, SOC PSYCHOL QUART, V70, P199; Mcknight DH, 1998, ACAD MANAGE REV, V23, P473, DOI 10.5465/AMR.1998.926622; Zhao XS, 2010, J CONSUM RES, V37, P197, DOI 10.1086/651257; Lawler EJ, 1998, AM SOCIOL REV, V63, P871, DOI 10.2307/2657506; Yamagishi T, 2008, PSYCHOL SCI, V19, P579, DOI 10.1111/j.1467-9280.2008.02126.x; Leung AKY, 2011, J PERS SOC PSYCHOL, V100, P507, DOI 10.1037/a0022151; Lawler EJ, 2000, AM J SOCIOL, V106, P616, DOI 10.1086/318965; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185; Buchan NR, 2002, AM J SOCIOL, V108, P168, DOI 10.1086/344546; Schilke O, 2013, P NATL ACAD SCI USA, V110, P15236, DOI 10.1073/pnas.1314857110; Weber JM, 2005, RES ORGAN BEHAV, V26, P75, DOI 10.1016/S0191-3085(04)26003-8; Yuki M, 2005, PERS SOC PSYCHOL B, V31, P48, DOI 10.1177/0146167204271305; Yamagishi T, 2003, RUSSELL SAGE TRUST, V6, P352; Yamagishi T, 1998, AM J SOCIOL, V104, P165, DOI 10.1086/210005; ARONSON E, 1965, J EXP SOC PSYCHOL, V1, P156, DOI 10.1016/0022-1031(65)90043-0; Blau Peter M, 1964, EXCHANGE POWER SOCIA; Bottom William P., 2002, ORGAN SCI, V13, P487; Brent Simpson, 2007, SOC NETWORKS, V30, P1; Ko Kuwabara, 2011, AM SOCIOL REV, V76, P560; Ko Kuwabara, 2008, SOCIAL PSYCHOL Q, V70, P461; KOMORITA SS, 1967, J PERS SOC PSYCHOL, V6, P349, DOI 10.1037/h0024736; Kurzban R, 2001, PERS SOC PSYCHOL B, V27, P1662, DOI 10.1177/01461672012712009; Kuwabara K, 2012, SOC FORCES, V91, P253, DOI 10.1093/sf/sos063; Lawler EJ, 2001, AM J SOCIOL, V107, P321, DOI 10.1086/324071; Lewicki Roy J., 1996, TRUST ORG FRONTIERS, P114; Linda Babcock, 2003, WOMEN DONT ASK NEGOT; Molm LD, 2006, SOC FORCES, V84, P2331, DOI 10.1353/sof.2006.0100; Molm Linda D., 2000, AM J SOCIOL, V105, P1296; Peter Kollock, 1994, AM J SOCIOL, V100, P313; Schaefer DA, 2009, SOC PSYCHOL QUART, V72, P384; Toshio Yamagishi, 1994, MOTIV EMOTION, V18, P9; Toshio Yamagishi, 1988, J EXPT SOCIAL PSYCHO, V24, P530; Uslaner Eric M., 2002, MORAL FDN TRUST	44	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0190-2725	1939-8999		SOC PSYCHOL QUART	Soc. Psychol. Q.	DEC	2014	77	4					344	360		10.1177/0190272514546757		17	Psychology, Social	Psychology	AU4PI	WOS:000345593300002		
J	Nakane, R; Shuto, Y; Sukegawa, H; Wen, ZC; Yamamoto, S; Mitani, S; Tanaka, M; Inomata, K; Sugahara, S				Nakane, R.; Shuto, Y.; Sukegawa, H.; Wen, Z. C.; Yamamoto, S.; Mitani, S.; Tanaka, M.; Inomata, K.; Sugahara, S.			Fabrication of pseudo-spin-MOSFETs using a multi-project wafer CMOS chip	SOLID-STATE ELECTRONICS			English	Article						Spin-transistors; More-than-Moore research; Monolithic integration of CMOS; Functional device	ELECTRONICS	We demonstrate monolithic integration of pseudo-spin-MOSFETs (PS-MOSFETs) using vendor-made MOSFETs fabricated in a low-cost multi-project wafer (MPW) product and lab-made magnetic tunnel junctions (MTJs) formed on the topmost passivatiop film of the MPW chip. The tunneling magneto-resistance (TMR) ratio of the fabricated MTJs strongly depends on the surface roughness of the passivation film. Nevertheless, after the chip surface was atomically flattened by SiO2 deposition on it and successive chemical-mechanical polish (CMP) process for the surface, the fabricated MTJs on the chip exhibits a sufficiently large TMR ratio (>140%) adaptable to the PS-MOSFET application. The implemented PS-MOSFETs show clear modulation of the output current controlled by the magnetization configuration of the MTJs, and a maximum magnetocurrent ratio of 90% is achieved. These magnetocurrent behaviour is quantitatively consistent with those predicted by HSPICE simulations. The developed integration technique using a MPW CMOS chip would also be applied to monolithic integration of CMOS devices/circuits and other various functional devices/materials, which would open the door for exploring CMOS-based new functional hybrid circuits. (C) 2014 Elsevier Ltd. All rights reserved.	[Nakane, R.; Tanaka, M.] Univ Tokyo, Dept Elect Engn & Informat Syst, Tokyo, Japan; [Shuto, Y.; Yamamoto, S.; Sugahara, S.] Tokyo Inst Technol, Imaging Sci & Engn Lab, Yokohama, Kanagawa 227, Japan; [Shuto, Y.] Kanagawa Acad Sci & Technol, Kawasaki, Kanagawa, Japan; [Sukegawa, H.; Wen, Z. C.; Mitani, S.; Inomata, K.] Natl Inst Mat Sci, Magnet Mat Ctr, Tsukuba, Ibaraki, Japan; [Nakane, R.; Shuto, Y.; Sukegawa, H.; Wen, Z. C.; Yamamoto, S.; Mitani, S.; Tanaka, M.; Inomata, K.; Sugahara, S.] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Nakane, R (reprint author), Univ Tokyo, Dept Elect Engn & Informat Syst, Tokyo, Japan.	nakane@cryst.t.u-tokyo.ac.jp	SUKEGAWA, Hiroaki/H-3001-2011				Abe K, 2010, 2010 INT C SOL STAT; Sugahara S, 2010, P IEEE, V98, P2124, DOI 10.1109/JPROC.2010.2064272; Yamamoto S, 2011, ELECTRON LETT, V47, P1027, DOI 10.1049/el.2011.1807; Yamamoto S, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.043001; Shuto Y, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.013003; Tanaka M, 2007, IEEE T ELECTRON DEV, V54, P961, DOI 10.1109/TED.2007.894375; Matsunaga S, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.023004; Matsunaga S, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.091301; Shuto Y, 2012, MEM WORKSH IMW IEEE, P4; Shuto Y, 2012, EL DEV M IEDM IEEE I; Shuto Y, 2009, J APPL PHYS, V105, DOI 10.1063/1.3076895; Sugahara S, 2005, IEE P-CIRC DEV SYST, V152, P355, DOI 10.1049/ip-cds:20045196; Wen ZC, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3587640; Yamamoto S, 2012, SEM C DRESD GREN ISC, P17	14	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-1101	1879-2405		SOLID STATE ELECTRON	Solid-State Electron.	DEC	2014	102						52	58		10.1016/j.sse.2014.06.004		7	Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	AU2ZD	WOS:000345482000007		
J	Morita, Y; Mori, T; Migita, S; Mizubayashi, W; Tanabe, A; Fukuda, K; Matsukawa, T; Endo, K; O'uchi, S; Liu, YX; Masahara, M; Ota, H				Morita, Yukinori; Mori, Takahiro; Migita, Shinji; Mizubayashi, Wataru; Tanabe, Akihito; Fukuda, Koichi; Matsukawa, Takashi; Endo, Kazuhiko; O'uchi, Shin-ichi; Liu, Yongxun; Masahara, Meishoku; Ota, Hiroyuki			Performance evaluation of parallel electric field tunnel field-effect transistor by a distributed-element circuit model	SOLID-STATE ELECTRONICS			English	Article						Tunnel FET; Epitaxial growth; Distributed-element circuit; Parallel plate tunneling		The performance of parallel electric field tunnel field-effect transistors (TFETs), in which band-to-band tunneling (BTBT) was initiated in-line to the gate electric field was evaluated. The TFET was fabricated by inserting an epitaxially-grown parallel-plate tunnel capacitor between heavily doped source wells and gate insulators. Analysis using a distributed-element circuit model indicated there should be a limit of the drain current caused by the self-voltage-drop effect in the ultrathin channel layer. (C) 2014 Elsevier Ltd. All rights reserved.	[Morita, Yukinori; Mori, Takahiro; Migita, Shinji; Mizubayashi, Wataru; Tanabe, Akihito; Fukuda, Koichi; Matsukawa, Takashi; Endo, Kazuhiko; O'uchi, Shin-ichi; Liu, Yongxun; Masahara, Meishoku; Ota, Hiroyuki] Natl Inst Adv Ind Sci & Technol, Green Nanoelect Ctr, Nanoelect Res Inst, Tsukuba West SCR, Tsukuba, Ibaraki 3058569, Japan	Morita, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Green Nanoelect Ctr, Nanoelect Res Inst, Tsukuba West SCR, 16-1 Onogawa, Tsukuba, Ibaraki 3058569, Japan.	y.morita@aist.go.jp	Mori, Takahiro/D-2038-2014		Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy (CSTP)	The work was supported by the Japan Society for the Promotion of Science (JSPS) through the First Program, "Development of Core Technologies for Green Nanoelectronics" initiated by the Council for Science and Technology Policy (CSTP).	Ionescu AM, 2011, NATURE, V479, P329, DOI 10.1038/nature10679; Asra R, 2011, IEEE T ELECTRON DEV, V58, P1855, DOI 10.1109/TED.2011.2140322; Seabaugh AC, 2010, P IEEE, V98, P2095, DOI 10.1109/JPROC.2010.2070470; Choi WY, 2007, IEEE ELECTR DEVICE L, V28, P743, DOI 10.1109/LED.2007.901273; Appenzeller J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.196805; Fuketa H., 2011, IEDM, V559, DOI [10.1109/IEDM.2011.6131609, DOI 10.1109/IEDM.2011.6131609]; Hu C, 2008, VLSI TSA 2008, V2008, P14; Ionescu AM, 2011, IEDM; Jeon K, 2010, S VLSI TECH, P121, DOI 10.1109/VLSIT.2010.5556195; Kim S. H., 2009, S VLSI TECHN, P178; Li R, 2012, PHYS STATUS SOLIDI C, V9, DOI 10.1002/pssc.201100241; Mori T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.06GF14; Mori T, 2013, APPL PHYS EXPRESS, V7; Morita Y, 2012, IEEE SOI C; Morita Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.04CC25; Silvaco Inc, ATLAS US MAN	16	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-1101	1879-2405		SOLID STATE ELECTRON	Solid-State Electron.	DEC	2014	102						82	86		10.1016/j.sse.2014.06.007		5	Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	AU2ZD	WOS:000345482000011		
J	Yoshida, T; Kobayashi, K; Otsuji, T; Suemitsu, T				Yoshida, Tomohiro; Kobayashi, Kengo; Otsuji, Taiichi; Suemitsu, Tetsuya			Impact of T-gate stem height on parasitic gate delay time in InGaAs-HEMTs	SOLID-STATE ELECTRONICS			English	Article						InGaAs; HEMTs; T-gate; Delay time analysis		The impact of the stem height of T-gate electrodes on the parasitic gate delay time in InGaAs high electron mobility transistors (HEMTs) is studied. Since T-gates with higher stem height make the parasitic gate capacitance smaller, the higher stem height is expected to minimize the parasitic gate delay. However, a systematic study using the devices with different stem height of T-gates reveals that the parasitic gate delay time decreases with the parasitic gate capacitance only at a drain voltage around the knee voltage and it becomes less sensitive to the parasitic capacitance by the T-gate when the device is operated in the deep saturation region at high drain bias voltage. This result suggests a design strategy for T-gate electrodes so that the tradeoff between the gate resistance and gate capacitance must be considered seriously in the devices for low-voltage applications, while one has more flexibility to use the T-gate electrode with a large head in the devices for high-voltage applications. (C) 2014 Elsevier Ltd. All rights reserved.	[Yoshida, Tomohiro; Kobayashi, Kengo; Otsuji, Taiichi; Suemitsu, Tetsuya] Tohoku Univ, Elect Commun Res Inst, Aoba Ku, Sendai, Miyagi 9808577, Japan	Yoshida, T (reprint author), Tohoku Univ, Elect Commun Res Inst, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	tomohiro@riec.tohoku.ac.jp			Research Institute of Electrical Communication (RIEC) of Tohoku University	A part of this work was financially supported by the Research Institute of Electrical Communication (RIEC) of Tohoku University. The device fabrication was carried out at the Laboratory for Nanoelectronics and Spintronics at RIEC.	Akagawa K, 2011, PHYS STATUS SOLIDI C, V8, DOI 10.1002/pssc.201000475; Fukuda S, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.04C086; Suemitsu T, 2004, IEEE ELECTR DEVICE L, V25, P669, DOI 10.1109/LED.2004.834910; DAMBRINE G, 1988, IEEE T MICROW THEORY, V36, P1151, DOI 10.1109/22.3650; Kim D.-H., 2011, IEDM, P319; Leuther A., 2011, 23 INT C IND PHOSPH, P1; Ohgishi A, 2003, JPN J APPL PHYS 2, V42, pL1090, DOI 10.1143/JJAP.42.L1090; Kobayashi K, 2013, PHYS STATUS SOLIDI C, V10, P790, DOI 10.1002/pssc.201200609; Yoshida T, 2012, PHYS STATUS SOLIDI C, V9, DOI 10.1002/pssc.201100272	9	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-1101	1879-2405		SOLID STATE ELECTRON	Solid-State Electron.	DEC	2014	102						93	97		10.1016/j.sse.2014.06.005		5	Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	AU2ZD	WOS:000345482000013		
J	Naganawa, T; Baad-Hansen, L; Ando, T; Svensson, P				Naganawa, Takuya; Baad-Hansen, Lene; Ando, Tomohiro; Svensson, Peter			Effect of a reversal mirror condition on orofacial mechanical sensitivity	SOMATOSENSORY AND MOTOR RESEARCH			English	Article						Orofacial pain; quantitative sensory test; reversal; somatosensory sensitivity; touch	RUBBER-HAND ILLUSION; NEUROPATHIC PAIN; TACTILE PERCEPTION; OWN FACE; TOUCH; HYPERALGESIA; THRESHOLDS; CAPSAICIN; PROTOCOL; HUMANS	The aim of this study was to investigate whether watching one's own face being touched in a reversal mirror condition modulates orofacial somatosensory sensitivity. A total of 37 healthy volunteers participated in a pilot study, the main study, and a control experiment. In the main experiment, 16 participants received seven different intensities of pinprick stimuli in the right infraorbital region. The perceived stimulus intensity was rated on a 0-50-100 numerical rating scale (NRS). In addition, the pinprick threshold (PiPT) was evaluated in the same region using an electronic von Frey device. During stimuli, participants were watching their own face in two different conditions (normal and reversal mirror) in randomized order. Subjective experiences during each condition were assessed with a questionnaire containing nine statements. The participants rated their level of agreement with the statements using a 7-item Likert scale. There were significant main effects on NRS scores of stimulus forces (p<0.001) and experimental condition (p<0.001). Post hoc analyses showed that stimulation with higher force levels induced significantly higher NRS scores (p<0.001), but interestingly, there were significantly lower NRS scores in the reversal mirror condition than in the normal mirror condition (p<0.001). There was no significant main effect of experimental condition on PiPT (p = 0.184). The experimental condition influenced the response to several statements significantly (p<0.001). The somatosensory sensitivity may be impaired when the location of stimulation is not in accordance with the perception. In conclusion, hypoesthetic effects of a reversal mirror were present for fixed force measures but not for threshold measures. Further studies are now needed to describe the potential implications for other somatosensory modalities and orofacial pain conditions.	[Naganawa, Takuya; Baad-Hansen, Lene; Svensson, Peter] Aarhus Univ, Dept Dent, Sect Clin Oral Physiol, DK-8000 Aarhus C, Denmark; [Naganawa, Takuya; Ando, Tomohiro] Tokyo Womens Med Univ, Sch Med, Dept Oral & Maxillofacial Surg, Tokyo, Japan; [Svensson, Peter] Aarhus Univ Hosp, Ctr Funct Integrat Neurosci, Mind Lab, DK-8000 Aarhus, Denmark	Naganawa, T (reprint author), Aarhus Univ, Dept Dent, Sect Clin Oral Physiol, Vennelyst Blvd 9, DK-8000 Aarhus C, Denmark.	tanaganawa@gmail.com			Danish Dental Association	The Danish Dental Association is acknowledged for their support of the study.	Press C, 2004, EXP BRAIN RES, V154, P238, DOI 10.1007/s00221-003-1651-x; Azanon E, 2008, CURR BIOL, V18, P1044, DOI 10.1016/j.cub.2008.06.045; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Baad-Hansen L, 2013, PAIN, V154, P1287, DOI 10.1016/j.pain.2013.04.005; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Svensson P, 2011, J ORAL REHABIL, V38, P366, DOI 10.1111/j.1365-2842.2010.02196.x; Yarnitsky D, 1997, MUSCLE NERVE, V20, P198; Kammers MPM, 2009, NEUROPSYCHOLOGIA, V47, P204, DOI 10.1016/j.neuropsychologia.2008.07.028; Cardini F, 2012, EMOTION, V12, P980, DOI 10.1037/a0027351; Magerl W, 1998, PAIN, V74, P257, DOI 10.1016/S0304-3959(97)00177-2; Kennett S, 2001, CURR BIOL, V11, P1188, DOI 10.1016/S0960-9822(01)00327-X; Moseley GL, 2008, PAIN, V138, P7, DOI 10.1016/j.pain.2008.06.026; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Baumgartner U, 2002, PAIN, V96, P141, DOI 10.1016/S0304-3959(01)00438-9; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Cardini F, 2011, J COGNITIVE NEUROSCI, V23, P503, DOI 10.1162/jocn.2010.21484; Pigg M, 2010, PAIN, V148, P220, DOI 10.1016/j.pain.2009.10.024; Riemer M, 2013, EXP BRAIN RES, V229, P383, DOI 10.1007/s00221-012-3374-3; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559; Sforza A, 2010, SOC NEUROSCI-UK, V5, P148, DOI 10.1080/17470910903205503; Serino A, 2008, PSYCHOL SCI, V19, P434, DOI 10.1111/j.1467-9280.2008.02105.x; Hansson P, 2007, PAIN, V129, P256, DOI 10.1016/j.pain.2007.03.030; Haggard P, 2007, EXP BRAIN RES, V180, P187, DOI 10.1007/s00221-007-0971-7; Baad-Hansen L, 2003, J OROFAC PAIN, V17, P333; Baad-Hansen L, 2013, CLIN J PAIN, V29, P518, DOI 10.1097/AJP.0b013e318268e4e7; CHAN AW, 1992, J NEUROL NEUROSUR PS, V55, P56, DOI 10.1136/jnnp.55.1.56; Darwin C., 1872, EXPRESSION EMOTIONS; Gallace A, 2011, PAIN, V152, P1418, DOI 10.1016/j.pain.2011.02.029; Gallace A, 2008, CONSCIOUS COGN, V17, P370, DOI 10.1016/j.concog.2007.01.005; Gallace A, 2010, PSYCHE-STUTTGART, V16, P30; Gallace A, 2008, EXP BRAIN RES, V191, P171, DOI 10.1007/s00221-008-1510-x; Haans A, 2012, ACTA PSYCHOL, V141, P169, DOI 10.1016/j.actpsy.2012.07.016; Hofle M, 2012, PAIN, V153, P1074, DOI 10.1016/j.pain.2012.02.010; Hubscher M, 2008, J ALTERN COMPLEM MED, V14, P1011, DOI 10.1089/acm.2008.0173; Lu SY, 2013, EUR J ORAL SCI, V121, P29, DOI 10.1111/eos.12014; Moseley GL, 2008, CURR BIOL, V18, pR1047, DOI 10.1016/j.cub.2008.09.031; Serino A, 2009, CORTEX, V45, P602, DOI 10.1016/j.cortex.2008.03.008; Svensson P, 1998, PAIN, V74, P93, DOI 10.1016/S0304-3959(97)00156-5; Tajadura-Jimenez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040682; Tajadura-Jimenez A, 2014, J EXP PSYCHOL GEN, V143, P736, DOI 10.1037/a0033171; Taylor-Clarke M, 2002, CURR BIOL, V12, P233, DOI 10.1016/S0960-9822(01)00681-9; YARNITSKY D, 1990, PAIN, V40, P85, DOI 10.1016/0304-3959(90)91055-N; Ziegler M, 1934, AM J PSYCHOL, V46, P47	44	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0899-0220			SOMATOSENS MOT RES	Somatosens. Mot. Res.	DEC	2014	31	4					191	197		10.3109/08990220.2014.914484		7	Neurosciences	Neurosciences & Neurology	AU0YJ	WOS:000345347800004		
J	Takahashi, M; Uchida, N; Yoshida, M; Liang, N; Nakazawa, K; Sekikawa, K; Inamizu, T; Hamada, H				Takahashi, Makoto; Uchida, Natsuko; Yoshida, Mami; Liang, Nan; Nakazawa, Kimitaka; Sekikawa, Kiyokazu; Inamizu, Tsutomu; Hamada, Hironobu			Phase-dependent modulation of corticospinal excitability during the observation of the initial phase of gait	SOMATOSENSORY AND MOTOR RESEARCH			English	Article						Action observation; initial phase of gait; transcranial magnetic stimulation	TRANSCRANIAL MAGNETIC STIMULATION; EVOKED MOTOR-RESPONSES; HUMAN WALKING; MUSCLES; CORTEX; LOCOMOTION; MOVEMENT; HUMANS; LIMB; HAND	This study was undertaken to identify the temporal characteristics of corticospinal excitability of tibialis anterior muscle during the observation of the initial phase of gait. For this purpose, using transcranial magnetic stimulation, we recorded motor evoked potentials (MEPs) during the observation of the second step of an actor's first three steps of gait initiation with (complex gait) or without (normal gait) an obstacle and unstable surface. The results demonstrate that (1) MEPs during the observation of the initial phase of normal gait were significantly increased only at early swing phase, but not other phases (mid-swing, heel contact, mid-stance, and heel off) and (2) MEPs during the observation of the initial phase of complex gait were significantly increased at early swing and also at mid-swing and heel contact phases. These findings provide the first evidence that corticospinal excitability during the observation of gait, especially the initial phase, is modulated in phase- and motor-demanded-dependent manners.	[Takahashi, Makoto; Liang, Nan; Sekikawa, Kiyokazu; Inamizu, Tsutomu; Hamada, Hironobu] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima 7348551, Japan; [Uchida, Natsuko; Yoshida, Mami] Hiroshima Univ, Fac Med, Inst Hlth Sci, Hiroshima 7348551, Japan; [Nakazawa, Kimitaka] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan	Takahashi, M (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	mako2@hiroshima-u.ac.jp			Japan Society for the Promotion of Science	This study was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.	Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; den Otter AR, 2004, GAIT POSTURE, V19, P270, DOI 10.1016/S0966-6362(03)00071-7; Schubert M, 1999, EXP BRAIN RES, V126, P583, DOI 10.1007/s002210050767; Capaday C, 1999, J NEUROPHYSIOL, V81, P129; Schubert M, 1997, EXP BRAIN RES, V115, P234, DOI 10.1007/PL00005693; Petersen NT, 2001, J PHYSIOL-LONDON, V537, P651, DOI 10.1111/j.1469-7793.2001.00651.x; Wang JJ, 2009, J NEURAL TRANSM, V116, P1087, DOI 10.1007/s00702-009-0269-y; Montagna M, 2005, EUR J NEUROSCI, V22, P1513, DOI 10.1111/j.1460-9568.2005.04336.x; Christensen LOD, 2001, J PHYSIOL-LONDON, V531, P545, DOI 10.1111/j.1469-7793.2001.0545i.x; ARMSTRONG DM, 1988, J PHYSIOL-LONDON, V405, P1; Petersen TH, 2012, J PHYSIOL-LONDON, V590, P2443, DOI 10.1113/jphysiol.2012.227397; Nakazawa K, 2004, J APPL PHYSIOL, V96, P604, DOI 10.1152/japplphysiol.00670.2003; PATLA AE, 1993, GAIT POSTURE, V1, P45, DOI 10.1016/0966-6362(93)90042-Y; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608; Wagner J, 2008, EXP BRAIN RES, V191, P247, DOI 10.1007/s00221-008-1520-8; DREW T, 1988, BRAIN RES, V457, P181, DOI 10.1016/0006-8993(88)90073-X; BELOOZEROVA IN, 1993, J PHYSIOL-LONDON, V461, P1; Borroni P, 2005, BRAIN RES, V1065, P115, DOI 10.1016/j.brainres.2005.10.034; WIDAJEWICZ W, 1994, J NEUROPHYSIOL, V72, P2070; Christensen LOD, 2000, PROG NEUROBIOL, V62, P251, DOI 10.1016/S0301-0082(00)00007-1; Takahashi M, 2008, NEUROREPORT, V19, P727, DOI 10.1097/WNR.0b013e3282fd0dc3	22	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0899-0220			SOMATOSENS MOT RES	Somatosens. Mot. Res.	DEC	2014	31	4					209	213		10.3109/08990220.2014.923392		5	Neurosciences	Neurosciences & Neurology	AU0YJ	WOS:000345347800007		
J	Nakano, H; Miyasaka, T; Ogino, T; Naito, A				Nakano, Haruki; Miyasaka, Takuji; Ogino, Toshihiko; Naito, Akira			Facilitation between extensor carpi radialis and pronator teres in humans: A study using a post-stimulus time histogram method	SOMATOSENSORY AND MOTOR RESEARCH			English	Article						Group I afferents; monosynaptic facilitation; post-stimulus time histogram method	BICEPS-BRACHII MOTONEURONS; GROUP-I AFFERENTS; ELECTRICAL-STIMULATION; RECIPROCAL INHIBITION; H-REFLEXES; MUSCLES; PROJECTIONS; PATTERN; FOREARM; FLEXOR	Group I muscle afferents modulate the excitability of motor neurons through excitatory and inhibitory spinal reflexes. Spinal reflex relationships between various muscle pairs are well described in experimental animals but not in the human upper limb, which exhibits a fine control of movement. In the present study, spinal reflexes between the extensor carpi radialis (ECR) and pronator teres (PT) muscles were examined in healthy human subjects using a post-stimulus time histogram method. Electrical stimulation of low-threshold afferents of ECR nerves increased the motor neuron excitability in 31 of 76 PT motor units (MUs) in all eight subjects tested, while stimulation of low-threshold afferents of PT nerves increased the motor neuron excitability in 36 of 102 ECR MUs in all 10 subjects. The estimated central synaptic delay was almost equivalent to that of homonymous facilitation. Mechanical stimulation (MS) of ECR facilitated 16 of 30 PT MUs in all five subjects tested, while MS of PT facilitated 17 of 30 ECR MUs in all six subjects. These results suggest excitatory reflex (facilitation) between PT and ECR. Group I afferents should mediate the facilitation through a monosynaptic path.	[Nakano, Haruki] Osaka Med Coll, Dept Rehabil Med, Takatsuki, Osaka 5698686, Japan; [Miyasaka, Takuji] Teikyo Univ, Dept Judo Therapy, Utsunomiya, Tochigi, Japan; [Ogino, Toshihiko] Hokushin Higashi Hosp, Sapporo, Hokkaido, Japan; [Naito, Akira] Yamagata Univ, Sch Med, Dept Anat, Yamagata 99023, Japan	Nakano, H (reprint author), Osaka Med Coll, Dept Rehabil Med, 2-7 Daigakumadhi, Takatsuki, Osaka 5698686, Japan.	hnakano@rio.odn.ne.jp			Japanese Ministry of Education, Science, Sport and Culture [17590146, 25461326]; Yamagata Health Support Society	This work was partly supported by Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Science, Sport and Culture (17590146, 25461326) and Grant from the Yamagata Health Support Society.	ELLAWAY PH, 1978, ELECTROEN CLIN NEURO, V45, P302, DOI 10.1016/0013-4694(78)90017-2; Morita H, 1998, J NEUROPHYSIOL, V80, P610; Wargon I, 2006, EXP BRAIN RES, V168, P203, DOI 10.1007/s00221-005-0088-9; CAVALLARI P, 1989, EXP BRAIN RES, V78, P465; STEPHENS JA, 1976, NATURE, V263, P343, DOI 10.1038/263343a0; KATZ R, 1991, J PHYSIOL-LONDON, V437, P269; Barry BK, 2008, EXP BRAIN RES, V190, P347, DOI 10.1007/s00221-008-1479-5; BURKE D, 1983, J PHYSIOL-LONDON, V339, P535; AYMARD C, 1995, J PHYSIOL-LONDON, V487, P221; BALDISSERA F, 1983, ELECTROMYOGR CLIN NE, V23, P197; BIRNBAUM A, 1982, ELECTROEN CLIN NEURO, V54, P469, DOI 10.1016/0013-4694(82)90211-5; Caicoya AG, 1999, J PHYSIOL-LONDON, V518, P825, DOI 10.1111/j.1469-7793.1999.0825p.x; CAVALLARI P, 1992, EXP BRAIN RES, V91, P311; DAY BL, 1984, J PHYSIOL-LONDON, V349, P519; FOURNIER E, 1986, J PHYSIOL-LONDON, V377, P143; FRITZ N, 1989, J PHYSIOL-LONDON, V419, P321; Fujii H, 2007, J ELECTROMYOGR KINES, V17, P80, DOI 10.1016/j.jelekin.2005.11.013; JENKINS DB, 2008, HOLLINSHEADS FUNCTIO; Lloyd DPC, 1943, J NEUROPHYSIOL, V6, P317; Lourenco G, 2007, EXP BRAIN RES, V178, P267, DOI 10.1007/s00221-006-0729-7; LUNDBERG A, 1960, ACTA PHYSIOL SCAND, V49, P155, DOI 10.1111/j.1748-1716.1960.tb01939.x; MIYASAKA T, 2007, TOHOKU J EXP MED, V212, p115S; Naito Akira, 2004, Anatomical Science International, V79, P11, DOI 10.1111/j.1447-073x.2004.00064.x; Naito A, 1996, EXP BRAIN RES, V111, P483; NAITO A, 2012, EMG METHODS EVALUATI, P259; Naito A, 1998, EXP BRAIN RES, V121, P99, DOI 10.1007/s002210050441; NAKANO H, 2006, CLIN NEUROPHYSIOL, V117, pS160; PIERROTDESEILLI.E, 2005, THE CIRCUITRY OF THE, P1; ROSSI A, 1995, NEUROSCI LETT, V191, P205, DOI 10.1016/0304-3940(95)11583-I; Sagae M, 2010, J ELECTROMYOGR KINES, V20, P1178, DOI 10.1016/j.jelekin.2010.06.003; STANDRING S, 2005, GRAYS ANATOMY, P879; Suzuki K, 2012, J CLIN NEUROPHYSIOL, V29, P472, DOI 10.1097/WNP.0b013e31826bdd48; VANBOXTEL A, 1986, J NEUROPHYSIOL, V55, P551	33	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0899-0220			SOMATOSENS MOT RES	Somatosens. Mot. Res.	DEC	2014	31	4					214	220		10.3109/08990220.2014.928615		7	Neurosciences	Neurosciences & Neurology	AU0YJ	WOS:000345347800008		
J	Koyama, S; Tanabe, S; Ishikawa, T; Itoh, S; Kubota, S; Sakurai, H; Kanada, Y				Koyama, Soichiro; Tanabe, Shigeo; Ishikawa, Takuma; Itoh, Syunpei; Kubota, Shinji; Sakurai, Hiroaki; Kanada, Yoshikiyo			Time-dependent effects of neuromuscular electrical stimulation on changes in spinal excitability are dependent on stimulation frequency: A preliminary study in healthy adults	SOMATOSENSORY AND MOTOR RESEARCH			English	Article						Neuromuscular electrical stimulation; spinal excitability; stimulation frequency	RECIPROCAL IA INHIBITION; RECURRENT INHIBITION; CORD-INJURY; SPASTICITY; STROKE; REFLEX; MOTONEURONS; MUSCLES; FACILITATION; EXTENSOR	Neuromuscular electrical stimulation (NMES) can be used as treatment for spasticity. The present study examined differences in time-dependent effects of NMES depending on stimulation frequency. Forty healthy subjects were separated into four groups (no-stim, NMES of 50, 100, and 200 Hz). The un-conditioned H-reflex amplitude and the H-reflex conditioning-test paradigm were used to measure the effectiveness on monosynaptic Ia excitation of motoneurons in the soleus (SOL) muscle, disynaptic reciprocal Ia inhibition from tibialis anterior (TA) to SOL, and presynaptic inhibition of SOL Ia afferents. Each trial consisted of a 30-min period of NMES applied to the deep peroneal nerve followed by a 30-min period with no stimulation to measure prolonged effects. Measurements were performed periodically. Stimulation applied at all frequencies produced a significant reduction in monosynaptic Ia excitation of motoneurons in the SOL muscle, however, only stimulation with 50 Hz showed prolonged reduction after NMES. NMES frequency did not affect the amount of disynaptic reciprocal Ia inhibition and presynaptic inhibition of Ia afferents. The results show a frequency-dependent effect of NMES on the monosynaptic Ia excitation of motoneurons. This result has implications for selecting the optimal NMES frequency for treatment in patients with spasticity.	[Koyama, Soichiro] Kawamura Hosp, Dept Rehabil, Gifu, Japan; [Tanabe, Shigeo; Ishikawa, Takuma; Itoh, Syunpei; Sakurai, Hiroaki; Kanada, Yoshikiyo] Fujita Hlth Univ, Sch Hlth Sci, Fac Rehabil, Toyoake, Aichi, Japan; [Kubota, Shinji] Hiroshima Univ, Human Motor Control Lab, Div Human Sci, Grad Sch Integrated Arts & Sci, Hiroshima, Japan	Tanabe, S (reprint author), Fujita Hlth Univ, 98-1 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	tanabe@2005.jukuin.keio.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22700556]	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid for Scientific Research No. 22700556).	Burke D, 2001, CLIN NEUROPHYSIOL, V112, P1575, DOI 10.1016/S1388-2457(01)00595-8; Ng SSM, 2007, STROKE, V38, P2953, DOI 10.1161/STROKEAHA.107.490318; LEVIN MF, 1992, ELECTROEN CLIN NEURO, V85, P131, DOI 10.1016/0168-5597(92)90079-Q; MIZUNO Y, 1971, J NEUROPHYSIOL, V34, P1010; Crone C, 2003, BRAIN, V126, P495, DOI 10.1093/brain/awg036; Thompson AK, 2006, EXP BRAIN RES, V170, P216, DOI 10.1007/s00221-005-0203-y; HULTBORN H, 1987, J PHYSIOL-LONDON, V389, P729; Bennett DJ, 2001, J NEUROPHYSIOL, V86, P1972; Crone C, 1999, EXP BRAIN RES, V124, P265, DOI 10.1007/s002210050621; Bakhtiary AH, 2008, CLIN REHABIL, V22, P418, DOI 10.1177/0269215507084008; Mang CS, 2010, EXP BRAIN RES, V203, P11, DOI 10.1007/s00221-010-2202-x; Hardy SG, 2002, PHYS THER, V82, P354; Weerdesteyn V, 2008, J REHABIL RES DEV, V45, P1195, DOI 10.1682/JRRD.2007.09.0145; Perez MA, 2003, J NEUROSCI, V23, P2014; Yamaguchi T, 2013, J ELECTROMYOGR KINES, V23, P190, DOI 10.1016/j.jelekin.2012.08.007; CRONE C, 1990, EXP BRAIN RES, V81, P35; CURTIS DR, 1960, J PHYSIOL-LONDON, V150, P374; DELWAIDE PJ, 1988, J NEUROL NEUROSUR PS, V51, P1546, DOI 10.1136/jnnp.51.12.1546; GOULET C, 1994, ARCH PHYS MED REHAB, V75, P1132, DOI 10.1016/0003-9993(94)90090-6; Goulet C G, 1997, Electromyogr Clin Neurophysiol, V37, P335; Kasai T, 1998, BRAIN RES, V792, P159, DOI 10.1016/S0006-8993(98)00204-2; KATZ R, 1982, BRAIN, V105, P103, DOI 10.1093/brain/105.1.103; Kubota S, 2013, NEUROMODULATION, V16, P251, DOI 10.1111/j.1525-1403.2012.00511.x; Nielsen JB, 2007, ACTA PHYSL, V189, P170; ROBICHAUD JA, 1992, PHYS THER, V72, P176; SHEFNER JM, 1992, NEUROLOGY, V42, P2162; TANAKA R, 1974, EXP BRAIN RES, V21, P529; Thompson AK, 2011, EXP BRAIN RES, V210, P143, DOI 10.1007/s00221-011-2607-1; Thompson AK, 2009, NEUROREHAB NEURAL RE, V23, P133, DOI 10.1177/1545968308321067	29	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0899-0220			SOMATOSENS MOT RES	Somatosens. Mot. Res.	DEC	2014	31	4					221	226		10.3109/08990220.2014.931279		6	Neurosciences	Neurosciences & Neurology	AU0YJ	WOS:000345347800009		
J	Nagata, K; Yoshimura, N; Hashizume, H; Muraki, S; Ishimoto, Y; Yamada, H; Takiguchi, N; Nakagawa, Y; Minamide, A; Oka, H; Kawaguchi, H; Nakamura, K; Akune, T; Yoshida, M				Nagata, Keiji; Yoshimura, Noriko; Hashizume, Hiroshi; Muraki, Shigeyuki; Ishimoto, Yuyu; Yamada, Hiroshi; Takiguchi, Noboru; Nakagawa, Yukihiro; Minamide, Akihito; Oka, Hiroyuki; Kawaguchi, Hiroshi; Nakamura, Kozo; Akune, Toni; Yoshida, Munehito			The prevalence of cervical myelopathy among subjects with narrow cervical spinal canal in a population-based magnetic resonance imaging study: the Wakayama Spine Study	SPINE JOURNAL			English	Article						Cervical spine; Spinal canal stenosis; Cervical myelopathy; Magnetic resonance imaging; Population-based cohort; Epidemiology	PHYSICAL PERFORMANCE; SPONDYLOSIS; MANIFESTATIONS; ASSOCIATION; STENOSIS; COHORT; JAPAN; RATIO; SIGNS; CORD	BACKGROUND CONTEXT: A narrow cervical spinal canal (CSC) is a well-known risk factor for cervical myelopathy (CM). However, no epidemiologic data of the CSC based on a population-based cohort are available. PURPOSE: The purpose of the study was to investigate the age-related differences in CSC diameters on plain radiographs and to examine the associated magnetic resonance imaging (MRI) abnormalities including cervical cord compression and increased signal intensity (ISI) as well as the clinical CM with the narrow CSC. STUDY DESIGN/SETTING: This was a cross-sectional study. PARTICIPANT SAMPLE: Data were obtained from the baseline survey of the Wakayama Spine Study that was performed from 2008 to 2010 in a western part of Japan. Finally, a total of 959 subjects (319 men and 640 women; mean age, 66.4 years) were included. OUTCOME MEASURES: The outcome measures included in the study were the CSC diameter at C5 level on plain radiographs, cervical cord compression and ISI on sagittal T2-weighted MRI, and physical signs related to CM (eg, the Hoffmann reflex, hyperreflexia of the patellar tendon, the Babinski reflex, sensory and motor function, and bowel/bladder symptoms). METHODS: The age-related differences of CSC diameters in men and women were investigated by descriptive statistics. The prevalence of MRI abnormalities and clinical CM was compared among the groups divided by the CSC diameter (less than 13, 13-15, and 15 mm or more). In addition, a logistic regression analysis was performed to determine the association of the CSC diameter with cervical cord compression/clinical CM after overall adjustment for age, sex, and body mass index. RESULTS: The CSC diameter was narrower with increasing age in both men and women. The prevalence of cervical cord compression, ISI, and the clinical CM was significantly higher in the narrower CSC group. The prevalence of cervical cord compression, ISI, and CM among subjects with CSC diameter less than 13 mm was 38.0%, 5.4%, and 10.1%, respectively. In the logistic model, the CSC diameter was a significant predictive factor for the clinical CM (p<.0001). CONCLUSIONS: This study firstly confirmed the age-related differences in CSC diameters and the significant association of the narrow CSC diameter with CM in a population-based cohort. (C) 2014 Elsevier Inc. All rights reserved.	[Nagata, Keiji; Hashizume, Hiroshi; Ishimoto, Yuyu; Yamada, Hiroshi; Takiguchi, Noboru; Nakagawa, Yukihiro; Minamide, Akihito; Yoshida, Munehito] Wakayama Med Univ, Dept Orthopaed Surg, Wakayama 6418510, Japan; [Yoshimura, Noriko; Oka, Hiroyuki] Univ Tokyo, Grad Sch Med, 22nd Century Med & Res Ctr, Dept Joint Dis Res,Bunkyo Ku, Tokyo 1138654, Japan; [Muraki, Shigeyuki; Akune, Toni] Univ Tokyo, Fac Med, 22nd Century Med & Res Ctr, Dept Clin Motor Syst Med,Bunkyo Ku, Tokyo 1138654, Japan; [Kawaguchi, Hiroshi] Japan Community Hlth Care Org, Tokyo Shinjuku Med Ctr, Shinjuku Ku, Tokyo 1608402, Japan; [Nakamura, Kozo] Rehabil Serv Bur, Natl Rehabil Ctr Persons Disabil, Tokorozawa, Saitama 3598555, Japan	Hashizume, H (reprint author), Wakayama Med Univ, Dept Orthopaed Surg, 811-1 Kimidera, Wakayama 6418510, Japan.	hashizum@wakayama-med.ac.jp			Japan Orthopedics and Traumatology Foundation [255]; Ministry of Education, Culture, Sports, Science and Technology [B23390172, B20390182, 08033011-00262]; Wakayama Prefecture [B-23004, B-24001]; Ministry of Health, Labour and Welfare in Japan [C20591737, H23-Cho-jyu-002];  [C20591774];  [C22591639];  [C25462305];  [A18689031]	KNag: Grant: Grant No.255 for young investigator from Japan Orthopedics and Traumatology Foundation (B, Paid directly to institution). NY: Grant: Grant-in-Aid for Scientific Research B23390172 and B20390182 (E, Paid directly to institution), Collaborating Research with NSF 08033011-00262 from the Ministry of Education, Culture, Sports, Science and Technology (E, Paid directly to institution). HH: Grant: The consigned research fund of Wakayama Prefecture Nos. B-23004 and B-24001 (C, Paid directly to institution). SM: Grant: Grant-in-Aid for Scientific Research C20591774 (D, Paid directly to institution). YI: Nothing to disclose. HY: Grant: Grant-in-Aid for Scientific Research C22591639 and C25462305 (E: Paid directly to institution). NT: Nothing to disclose. YN: Nothing to disclose. AM: Nothing to disclose. HO: Grant: Grant-in-Aid for Scientific Research for young scientists A18689031 (D, Paid directly to institution). HK: Nothing to disclose. KNak: Nothing to disclose. TA: Grant: Grant-in-Aid for Scientific Research C20591737 and H23-Cho-jyu-002 from the Ministry of Health, Labour and Welfare in Japan (E, Paid directly to institution). MY: Nothing to disclose.	MURONE I, 1974, J BONE JOINT SURG BR, VB 56, P30; Hukuda S, 2002, SPINE, V27, P250, DOI 10.1097/00007632-200202010-00009; ARNOLD JG, 1955, ANN SURG, V141, P872, DOI 10.1097/00000658-195514160-00013; Kato F, 2012, EUR SPINE J, V21, P1499, DOI 10.1007/s00586-012-2176-4; Matsumoto M, 2000, SPINE, V25, P677, DOI 10.1097/00007632-200003150-00005; EISMONT FJ, 1984, SPINE, V9, P663, DOI 10.1097/00007632-198410000-00001; Goto S, 2010, J ORTHOP SCI, V15, P97, DOI 10.1007/s00776-009-1427-7; Blackley HR, 1999, J BONE JOINT SURG BR, V81B, P110, DOI 10.1302/0301-620X.81B1.9001; PAVLOV H, 1987, RADIOLOGY, V164, P771; Countee R W, 1979, J Natl Med Assoc, V71, P257; Harrop JS, 2007, NEUROSURGERY, V60, P14, DOI 10.1227/01.NEU.0000215380.71097.EC; Houten JK, 2008, J NEUROSURG-SPINE, V9, P237, DOI 10.3171/SPI/2008/9/9/237; Ishimoto Y, 2012, OSTEOARTHR CARTILAGE, V20, P1103, DOI 10.1016/j.joca.2012.06.018; Ministry of Health Labour and Welfare, REP NAT HLTH NUTR SU; Nagata K, 2012, SPINE, V37, P1892, DOI 10.1097/BRS.0b013e31825a2619; PORTER RW, 1980, SPINE, V5, P99, DOI 10.1097/00007632-198003000-00003; Rhee JM, 2009, SPINE, V34, P890, DOI 10.1097/BRS.0b013e31819c944b; Sung RD, 2001, SPINE, V26, P67, DOI 10.1097/00007632-200101010-00013; WOLF BERNARD S., 1956, JOUR MT SINAI HOSP, V23, P283	19	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	DEC	2014	14	12					2811	2817		10.1016/j.spinee.2014.03.051		7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	AU2EQ	WOS:000345429500005		
J	Aach, M; Cruciger, O; Sczesny-Kaiser, M; Hoffken, O; Meindl, RC; Tegenthoff, M; Schwenkreis, P; Sankai, Y; Schildhauer, TA				Aach, Mirko; Cruciger, Oliver; Sczesny-Kaiser, Matthias; Hoeffken, Oliver; Meindl, Renate Ch.; Tegenthoff, Martin; Schwenkreis, Peter; Sankai, Yoshiyuki; Schildhauer, Thomas A.			Voluntary driven exoskeleton as a new tool for rehabilitation in chronic spinal cord injury: a pilot study	SPINE JOURNAL			English	Article						Exoskeleton; Treadmill training; Rehabilitation; Paraplegia; Hybrid assistive limb; Spinal cord injury	PARAPLEGIC PATIENTS; GAIT; INDIVIDUALS; IMPROVEMENT; ORTHOSIS	BACKGROUND CONTEXT: Treadmill training after traumatic spinal cord injury (SCI) has become an established therapy to improve walking capabilities. The hybrid assistive limb (HAL) exoskeleton has been developed to support motor function and is tailored to the patients' voluntary drive. PURPOSE: To determine whether locomotor training with the exoskeleton HAL is safe and can increase functional mobility in chronic paraplegic patients after SCI. DESIGN: A single case experimental A-B (pre-post) design study by repeated assessments of the same patients. The subjects performed 90 days (five times per week) of HAL exoskeleton body weight supported treadmill training with variable gait speed and body weight support. PATIENT SAMPLE: Eight patients with chronic SCI classified by the American Spinal Injury Association (ASIA) Impairment Scale (AIS) consisting of ASIA A (zones of partial preservation [ZPP] L3 S1), n=4; ASIA B (with motor ZPP L3-S1), n=1; and ASIA C/D, n=3, who received full rehabilitation in the acute and subacute phases of SCI. OUTCOME MEASURES: Functional measures included treadmill-associated walking distance, speed, and time, with additional analysis of functional improvements using the 10-m walk test (10MWT), timed-up and go test (TUG test), 6-minute walk test (6MWT), and the walking index for SCI II (WISCI II) score. Secondary physiologic measures including the AIS with the lower extremity motor score (LEMS), the spinal spasticity (Ashworth scale), and the lower extremity circumferences. METHODS: Subjects performed standardized functional testing before and after the 90 days of intervention. RESULTS: Highly significant improvements of HAL-associated walking time, distance, and speed were noticed. Furthermore, significant improvements have been especially shown in the functional abilities without the exoskeleton for over-ground walking obtained in the 6MWT, TUG test, and the 10MWT, including an increase in the WISCI II score of three patients. Muscle strength (LEMS) increased in all patients accompanied by a gain of the lower limb circumferences. A conversion in the AIS was ascertained in one patient (ASIA B to ASIA C). One patient reported a decrease of spinal spasticity. CONCLUSIONS: Hybrid assistive limb exoskeleton training results in improved over-ground walking and leads to the assumption of a beneficial effect on ambulatory mobility. However, evaluation in larger clinical trials is required. (C) 2014 Elsevier Inc. All rights reserved.	[Aach, Mirko; Cruciger, Oliver; Meindl, Renate Ch.] BG Univ Hosp Bergmannsheil, Dept Spinal Cord Injuries, D-44797 Bochum, Germany; [Sczesny-Kaiser, Matthias; Hoeffken, Oliver; Tegenthoff, Martin; Schwenkreis, Peter] BG Univ Hosp Bergmannsheil, Dept Neurol, D-44797 Bochum, Germany; [Sankai, Yoshiyuki] Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki 3050006, Japan; [Schildhauer, Thomas A.] BG Univ Hosp Bergmannsheil, Dept Gen & Trauma Surg, D-44797 Bochum, Germany	Aach, M (reprint author), BG Univ Hosp Bergmannsheil, Dept Spinal Cord Injuries, Burkle de la Camp Pl 1, D-44789 Bochum, Germany.	bergmannsheil@bergmannsheil.de			BG University Hospital Bergmannsheil, Bochum	There has been no monetary study funding. The study was supported by a grant and has been supervised by the staff of BG University Hospital Bergmannsheil, Bochum.	van Hedel HJ, 2005, ARCH PHYS MED REHAB, V86, P190, DOI 10.1016/j.apmr.2004.02.010; Nascimento LR, 2012, REV BRAS FISIOTER, V16, P122; FINCH L, 1991, PHYS THER, V71, P842; Wirz M, 2005, ARCH PHYS MED REHAB, V86, P672, DOI 10.1016/j.apmr.2004.08.004; van Hedel H, 2006, SPINAL CORD, V44, P352, DOI 10.1038/sj.sc.3101853; WATERS RL, 1994, ARCH PHYS MED REHAB, V75, P756; Hornby TG, 2005, PHYS THER, V85, P52; Colombo G, 2001, SPINAL CORD, V39, P252, DOI 10.1038/sj.sc.3101154; Colombo G, 2000, J REHABIL RES DEV, V37, P693; Morawietz C, 2013, ARCH PHYS MED REHAB, V94, P2297, DOI 10.1016/j.apmr.2013.06.023; Harada ND, 1999, ARCH PHYS MED REHAB, V80, P837, DOI 10.1016/S0003-9993(99)90236-8; Dietz V, 1998, SPINAL CORD, V36, P380, DOI 10.1038/sj.sc.3100590; Ditunno JF, 2001, SPINAL CORD, V39, P654; Eng JJ, 2007, TOP SPINAL CORD INJ, V13, P1, DOI DOI 10.1310/SCI1301-1; Finch L, 1991, PHYS THER, V71, P855; Gittler MS, 2002, ARCH PHYS MED REHAB, V83, pS65, DOI 10.1053/apmr.2002.32160; Hornby TG, 2005, TOPICS SPINAL CORD I, V11, P1, DOI DOI 10.1310/14O9-AD7M-FXX9-1G2J; Kawamoto H, 2002, P INT C COMP HAND PE, V2398, P196; Kawamoto H, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-141; Mehrholz J, 2012, COCHRANE DATABASE SY, V11; Myeong OK, 2007, ARCH PHYS MED REHAB, V88, P762; Nooijen CFJ, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-36; PIEPMEIER JM, 1988, J NEUROSURG, V69, P399, DOI 10.3171/jns.1988.69.3.0399; Schwartz I, 2011, SPINAL CORD, V49, P1062, DOI 10.1038/sc.2011.59; Suzuki K, 2007, ADV ROBOTICS, V21, P383; Winchester Patricia, 2006, Phys Med Rehabil Clin N Am, V17, P159, DOI 10.1016/j.pmr.2005.10.008; Yamawaki K, 2011, 6TH WORLD CONGRESS OF THE INTERNATIONAL SOCIETY OF PHYSICAL AND REHABILITATION MEDICINE, P66	27	5	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	DEC	2014	14	12					2847	2853		10.1016/j.spinee.2014.03.042		7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	AU2EQ	WOS:000345429500011		
J	Kusabiraki, S; Tsubata, S				Kusabiraki, Shohei; Tsubata, Shinichi			Two karate kids with pediatric idiopathic intervertebral disc calcification	SPINE JOURNAL			English	Editorial Material									[Kusabiraki, Shohei; Tsubata, Shinichi] Toyama Red Cross Hosp, Dept Pediat, Toyama, Japan	Kusabiraki, S (reprint author), Toyama Red Cross Hosp, Dept Pediat, 2-1-58 Ushijumahonmachi, Toyama, Japan.						EYRING EJ, 1964, J BONE JOINT SURG AM, V46, P1432; GIRODIAS JB, 1991, PEDIATR RADIOL, V21, P541, DOI 10.1007/BF02012591	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	DEC	2014	14	12					3048	3048		10.1016/j.spinee.2014.06.029		1	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	AU2EQ	WOS:000345429500039		
J	Okada, S; Saito, T; Kawano, O; Hayashida, M; Matsumoto, Y; Harimaya, K; Iwamoto, Y				Okada, Seiji; Saito, Takeyuki; Kawano, Osamu; Hayashida, Mitsumasa; Matsumoto, Yoshihiro; Harimaya, Katsumi; Iwamoto, Yukihide			Sequential changes of ascending myelopathy after spinal cord injury on magnetic resonance imaging: a case report of neurologic deterioration from paraplegia to tetraplegia	SPINE JOURNAL			English	Article						Spinal cord injury; Neurologic deterioration; Ascending myelopathy; Magnetic resonance image; Spinal cord swelling; Spinal venous drainage		BACKGROUND CONTEXT: Marked neurologic deterioration within a few days of traumatic spinal cord injury, known as subacute posttraumatic ascending myelopathy, is rare. Although several hypotheses regarding the pathogenesis of this condition have been proposed, the details remain elusive. PURPOSE: To report a case of ascending myelopathy in which a series of magnetic resonance images (MRIs) taken through the course of the illness helped follow the course of the disease and discuss possible pathogenesis. STUDY DESIGN: Case report and review of the literature. PATIENT SAMPLE: A 75-year-old woman involved in a motor vehicle collision sustained a fracture dislocation of T7-T8 with complete paraplegia below T8. METHODS: Neurologic examination and radiologic imaging taken by various means. RESULTS: Posterior surgical stabilization was performed 18 hours after the injury. Both the surgical and postsurgical courses were uneventful. Four days after the injury, however, the patient reported feeling a tingling sensation in the right-hand fingers and gradually suffered from motor weakness of the upper extremities, deteriorating within a few hours to complete tetraplegia and ventilator dependence. Subsequent cervicothoracic MRI showed abrupt cord swelling with abnormal areas of signal intensity in the cervical and upper thoracic spinal cord during the interval between the onset of tingling and the development of motor paralysis in the arms. On the 20th postsurgical day, an area of hypointensity within the region of high intensity was observed on T2-weighted MRIs, indicating intramedullary spinal cord hemorrhage. CONCLUSIONS: Our MRI findings suggest that systemically increased intraspinal pressure resulting from the impairment of spinal venous drainage is involved in the pathogenesis of ascending myelopathy. Although ascending myelopathy is often thought to be partly reversible, persisting increase of the intraspinal pressure may result in intramedullary hemorrhage and irreversible neurologic deficit. (C) 2014 Elsevier Inc. All rights reserved.	[Okada, Seiji; Saito, Takeyuki; Hayashida, Mitsumasa; Matsumoto, Yoshihiro; Harimaya, Katsumi; Iwamoto, Yukihide] Kyushu Univ, Grad Sch Med Sci, Dept Orthoped Surg, Higashi Ku, Fukuoka 8128582, Japan; [Kawano, Osamu] Spinal Injuries Ctr, Dept Orthoped Surg, Iizuka, Fukuoka 8208508, Japan	Okada, S (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Orthoped Surg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	seokada@ortho.med.kyushu-u.ac.jp					Aito S, 1999, SPINAL CORD, V37, P617, DOI 10.1038/sj.sc.3100872; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Harrop JS, 2001, SPINE, V26, P340, DOI 10.1097/00007632-200102150-00008; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Al-Ghatany M, 2005, J NEUROSURG-SPINE, V2, P619, DOI 10.3171/spi.2005.2.5.0619; Belanger E, 2000, J NEUROSURG, V93, P294, DOI 10.3171/spi.2000.93.2.0294; Krings T, 2007, NEUROIMAG CLIN N AM, V17, P57, DOI 10.1016/j.nic.2007.01.001; Kumar Atin, 2010, Emerg Radiol, V17, P249, DOI 10.1007/s10140-009-0832-8; Meagher TM, 2012, SPINAL CORD, V50, P638, DOI 10.1038/sc.2011.133; Nagata S, 2006, SURG NEUROL, V65, P563, DOI 10.1016/j.surneu.2005.09.018; Planner AC, 2008, SPINAL CORD, V46, P140, DOI 10.1038/sj.sc.3102056; Schmidt BJ, 2006, SPINAL CORD, V44, P322, DOI 10.1038/sj.sc.3101801; YABLON IG, 1989, SPINE, V14, P1084, DOI 10.1097/00007632-198910000-00010	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	DEC	2014	14	12					E9	E14		10.1016/j.spinee.2014.08.449		6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	AU2EQ	WOS:000345429500002		
J	Watanabe-Susaki, K; Takada, H; Enomoto, K; Miwata, K; Ishimine, H; Intoh, A; Ohtaka, M; Nakanishi, M; Sugino, H; Asashima, M; Kurisaki, A				Watanabe-Susaki, Kanako; Takada, Hitomi; Enomoto, Kei; Miwata, Kyoko; Ishimine, Hisako; Intoh, Atsushi; Ohtaka, Manami; Nakanishi, Mahito; Sugino, Hiromu; Asashima, Makoto; Kurisaki, Akira			Biosynthesis of Ribosomal RNA in Nucleoli Regulates Pluripotency and Differentiation Ability of Pluripotent Stem Cells	STEM CELLS			English	Article						Fibrillarin; Ribosomal RNA; Embryonic stem cells; Pluripotency; Nucleoli; Differentiation	HUMAN FIBRILLARIN; POLYMERASE-I; MOUSE; EXPRESSION; PROTEIN; P53; TRANSCRIPTION; DNA; PROLIFERATION; NUCLEOSTEMIN	Pluripotent stem cells have been shown to have unique nuclear properties, for example, hyperdynamic chromatin and large, condensed nucleoli. However, the contribution of the latter unique nucleolar character to pluripotency has not been well understood. Here, we show that fibrillarin (FBL), a critical methyltransferase for ribosomal RNA (rRNA) processing in nucleoli, is one of the proteins highly expressed in pluripotent embryonic stem (ES) cells. Stable expression of FBL in ES cells prolonged the pluripotent state of mouse ES cells cultured in the absence of leukemia inhibitory factor (LIF). Analyses using deletion mutants and a point mutant revealed that the methyltransferase activity of FBL regulates stem cell pluripotency. Knockdown of this gene led to significant delays in rRNA processing, growth inhibition, and apoptosis in mouse ES cells. Interestingly, both partial knockdown of FBL and treatment with actinomycin D, an inhibitor of rRNA synthesis, induced the expression of differentiation markers in the presence of LIF and promoted stem cell differentiation into neuronal lineages. Moreover, we identified p53 signaling as the regulatory pathway for pluripotency and differentiation of ES cells. These results suggest that proper activity of rRNA production in nucleoli is a novel factor for the regulation of pluripotency and differentiation ability of ES cells. Stem Cells2014;32:3099-3111	[Watanabe-Susaki, Kanako; Takada, Hitomi; Miwata, Kyoko; Ishimine, Hisako; Ohtaka, Manami; Nakanishi, Mahito; Sugino, Hiromu; Asashima, Makoto; Kurisaki, Akira] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki 3058562, Japan; [Enomoto, Kei] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Meguro Ku, Tokyo 113, Japan; [Intoh, Atsushi; Asashima, Makoto] Univ Tokyo, Dept Life Sci Biol, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan; [Asashima, Makoto] Japan Sci & Technol Agcy JST, ICORP Organ Regenerat Project, Meguro Ku, Tokyo, Japan; [Asashima, Makoto] Univ Tsukuba, Life Sci Ctr Tsukuba Adv Res Alliance TARA, Tsukuba, Ibaraki, Japan; [Kurisaki, Akira] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	Kurisaki, A (reprint author), Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Higashi 1-1-1, Tsukuba, Ibaraki 3058562, Japan.	akikuri@hotmail.com			JST PRESTO; Ministry of Health, Labor, and Welfare of Japan;  [17510165];  [20610008]	The plasmid vectors (pPthC and pCAGGS-Cre) and the mouse ES cell line EBRTcH3 were kind gifts from Drs. Niwa and Masui (RIKEN, Japan). The expression vector pCAG-IP was generously given by Dr. Koide (Kanazawa University, Japan). Expression vectors of FBL (pcDNA3.1(+)-FBL and the deletion mutants) were kind gift from Dr. Takahashi (Tokyo University of Agriculture and Technology, Japan). Plat-E cells were kindly provided from Dr. Kitamura (University of Tokyo, Japan). KUM9 cells were generously provided from Dr. Umezawa (NCCHD, Japan) via JCRB cell bank (Osaka, Japan). This work was supported by JST PRESTO, Grant-in-Aid for Scientific Research (17510165 and 20610008), and Grant-in-Aid from the Ministry of Health, Labor, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abujarour R, 2010, STEM CELLS, V28, P1487, DOI 10.1002/stem.472; Aittaleb M, 2004, J BIOL CHEM, V279, P41822, DOI 10.1074/jbc.M406209200; ALTMANN GG, 1982, J CELL SCI, V56, P83; Qu J, 2012, J CELL BIOL, V197, P731, DOI 10.1083/jcb.201103071; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Zhang Q, 2014, SCIENCE, V343, P298, DOI 10.1126/science.1246384; Intoh A, 2009, BIOMED CHROMATOGR, V23, P607, DOI 10.1002/bmc.1159; Shaw PJ, 1995, ANNU REV CELL DEV BI, V11, P93, DOI 10.1146/annurev.cellbio.11.1.93; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; ARMSTRONG JF, 1995, CURR BIOL, V5, P931, DOI 10.1016/S0960-9822(95)00183-7; Vlachos A, 2008, BRIT J HAEMATOL, V142, P859, DOI 10.1111/j.1365-2141.2008.07269.x; TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Ganapathi KA, 2008, BRIT J HAEMATOL, V141, P376, DOI 10.1111/j.1365-2141.2008.07095.x; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Derenzini M, 2000, J PATHOL, V191, P181, DOI 10.1002/(SICI)1096-9896(200006)191:2<181::AID-PATH607>3.0.CO;2-V; SCHMID P, 1991, DEVELOPMENT, V113, P857; Yanagida M, 2004, J BIOL CHEM, V279, P1607, DOI 10.1074/jbc.M305604200; ROGEL A, 1985, MOL CELL BIOL, V5, P2851; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Nomura J, 2009, STEM CELLS, V27, P1066, DOI 10.1002/stem.44; Morgado-Palacin L, 2012, CELL CYCLE, V11, P503, DOI 10.4161/cc.11.3.19002; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Suzuki A, 2012, CANCER SCI, V103, P632, DOI 10.1111/j.1349-7006.2012.02219.x; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Newton K, 2003, MOL CELL BIOL, V23, P8519, DOI 10.1128/MCB.23.23.8519-8527.2003; Mora-Castilla S, 2010, CELL DEATH DIFFER, V17, P1025, DOI 10.1038/cdd.2009.204; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; ARIS JP, 1991, P NATL ACAD SCI USA, V88, P931, DOI 10.1073/pnas.88.3.931; Baker NE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058266; HADJICHRISTODOULOU A, 1985, Cyprus Agricultural Research Institute Technical Bulletin, P1; Hayashi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098586; Kapoor M, 1998, P NATL ACAD SCI USA, V95, P2834, DOI 10.1073/pnas.95.6.2834; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; MEEK DW, 1990, EMBO J, V9, P3253; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mosgoeller W, 2004, MOL BIOL INTELL UNIT, P10; Nakamoto K, 2001, AM J PATHOL, V159, P1363, DOI 10.1016/S0002-9440(10)62523-0; SCHIMMANG T, 1989, EMBO J, V8, P4015; Smeenk L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017574; Wang BB, 2006, BIOCHEM BIOPH RES CO, V347, P1129, DOI 10.1016/j.bbrc.2006.07.020; Wang HM, 2000, EMBO J, V19, P317, DOI 10.1093/emboj/19.3.317; Yoshida-Koide U, 2004, BIOCHEM BIOPH RES CO, V313, P475, DOI 10.1016/j.bbrc.2003.11.138; Zavala G, 1997, BIOL CELL, V89, P245, DOI 10.1016/S0248-4900(97)82312-X	50	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	DEC	2014	32	12					3099	3111		10.1002/stem.1825		13	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	AU4PL	WOS:000345593700007		
J	Asai, S; Otsuru, S; Candela, ME; Cantley, L; Uchibe, K; Hofmann, TJ; Zhang, K; Wapner, KL; Soslowsky, LJ; Horwitz, EM; Enomoto-Iwamoto, M				Asai, Shuji; Otsuru, Satoru; Candela, Maria Elena; Cantley, Leslie; Uchibe, Kenta; Hofmann, Ted J.; Zhang, Kairui; Wapner, Keith L.; Soslowsky, Louis J.; Horwitz, Edwin M.; Enomoto-Iwamoto, Motomi			Tendon Progenitor Cells in Injured Tendons Have Strong Chondrogenic Potential: The CD105-Negative Subpopulation Induces Chondrogenic Degeneration	STEM CELLS			English	Article						Tendon; Progenitor; Injury; Chondrogenesis; TGF	STEM-CELLS; BONE-MARROW; HETEROTOPIC OSSIFICATION; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; REPAIR; ENDOGLIN; DIFFERENTIATION; TISSUE; EXPRESSION	To study the cellular mechanism of the tendon repair process, we used a mouse Achilles tendon injury model to focus on the cells recruited to the injured site. The cells isolated from injured tendon 1 week after the surgery and uninjured tendons contained the connective tissue progenitor populations as determined by colony-forming capacity, cell surface markers, and multipotency. When the injured tendon-derived progenitor cells (inTPCs) were transplanted into injured Achilles tendons, they were not only integrated in the regenerating area expressing tenogenic phenotype but also trans-differentiated into chondrogenic cells in the degenerative lesion that underwent ectopic endochondral ossification. Surprisingly, the micromass culture of the inTPCs rapidly underwent chondrogenic differentiation even in the absence of exogenous bone morphogenetic proteins or TGFs. The cells isolated from human ruptured tendon tissues also showed connective tissue progenitor properties and exhibited stronger chondrogenic ability than bone marrow stromal cells. The mouse inTPCs contained two subpopulations one positive and one negative for CD105, a coreceptor of the TGF superfamily. The CD105-negative cells showed superior chondrogenic potential in vitro and induced larger chondroid degenerative lesions in mice as compared to the CD105-positive cells. These findings indicate that tendon progenitor cells are recruited to the injured site of tendons and have a strong chondrogenic potential and that the CD105-negative population of these cells would be the cause for chondroid degeneration in injured tendons. The newly identified cells recruited to the injured tendon may provide novel targets to develop therapeutic strategies to facilitate tendon repair. Stem Cells2014;32:3266-3277	[Asai, Shuji; Candela, Maria Elena; Cantley, Leslie; Uchibe, Kenta; Zhang, Kairui; Enomoto-Iwamoto, Motomi] Childrens Hosp Philadelphia, Div Orthoped Surg, Translat Res Program Pediat Orthopaed, Philadelphia, PA 19104 USA; [Otsuru, Satoru; Hofmann, Ted J.; Horwitz, Edwin M.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Asai, Shuji] Nagoya Univ Grad Sch Med, Dept Orthopaed Surg, Nagoya, Aichi, Japan; [Otsuru, Satoru; Horwitz, Edwin M.] Nationwide Childrens Hosp, Ctr Childhood Canc & Blood Dis, Columbus, OH USA; [Wapner, Keith L.] Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; [Soslowsky, Louis J.] Univ Penn, McKay Orthopaed Res Lab, Perelman Sch Med, Philadelphia, PA 19104 USA; [Horwitz, Edwin M.] Nationwide Childrens Hosp, Div Hematol Oncol BMT, Columbus, OH USA	Enomoto-Iwamoto, M (reprint author), Childrens Hosp Philadelphia, Div Orthoped Surg, Dept Surg, Translat Res Program Pediat Orthopaed, 3615 Civ Ctr Blvd,ARC902, Philadelphia, PA 19104 USA.	iwamotom1@email.chop.edu			Penn Center for Musculoskeletal Disorders Pilot and Feasibility Grant [NIH/NIAMS P30AR050950]; Children's Hospital of Philadelphia;  [NIH R21AR062193]	We thank Aruni T. Gunawardena, Cheri Saunders, Dr. Mike Hast, Dr. Joseph Sarver, and Dr. Alan Flake for technical assistance; Dr. Ronen Schweitzer (Oregon Health & Science University) and Mon-li Chu (Thomas Jefferson University) for providing Scx-GFP mice. We also thank Drs. Masahiro Iwamoto (Children's Hospital of Philadelphia), Maurizio Pacifici (Children's Hospital of Philadelphia), Pramod Voleti (Hospital of the University of Pennsylvania), Robert Mauck (University of Pennsylvania), and Theresa Freeman (Thomas Jefferson University) for advice. This study was supported by the Penn Center for Musculoskeletal Disorders Pilot and Feasibility Grant (NIH/NIAMS P30AR050950), the NIH R21AR062193 Grant, and the interdepartment fund of Children's Hospital of Philadelphia. S.O. and E.M.H. are currently affiliated with the Center for Childhood Cancer and Blood Diseases, The Research Institute at Nationwide Children's Hospital, Columbus, OH.	Scherner O, 2007, J BIOL CHEM, V282, P13934, DOI 10.1074/jbc.M611062200; Matsumoto T, 2008, J CELL PHYSIOL, V215, P234, DOI 10.1002/jcp.21309; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Yin Z, 2010, BIOMATERIALS, V31, P2163, DOI 10.1016/j.biomaterials.2009.11.083; Lui PPY, 2011, STEM CELL REV REP, V7, P883, DOI 10.1007/s12015-011-9276-0; Zhang JY, 2012, J ORTHOP RES, V30, P47, DOI 10.1002/jor.21485; Ahmad Z, 2012, ARTHROSCOPY, V28, P1018, DOI 10.1016/j.arthro.2011.12.009; Finnson KW, 2010, OSTEOARTHR CARTILAGE, V18, P1518, DOI 10.1016/j.joca.2010.09.002; Schindeler A, 2009, DIFFERENTIATION, V77, P12, DOI 10.1016/j.diff.2008.09.007; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Kurth TB, 2011, ARTHRITIS RHEUM-US, V63, P1289, DOI 10.1002/art.30234; Tan Q, 2012, TISSUE ENG PT A, V18, P840, DOI [10.1089/ten.TEA.2011.0362, 10.1089/ten.tea.2011.0362]; Park S, 2013, J CELL SCI, V126, P1392, DOI 10.1242/jcs.117275; Lin L, 2010, BONE, V46, P425, DOI 10.1016/j.bone.2009.08.057; Lee NY, 2007, J BIOL CHEM, V282, P21507, DOI 10.1074/jbc.M700176200; Rees JD, 2006, RHEUMATOLOGY, V45, P508, DOI 10.1093/rheumatology/kel046; Otsuru S, 2012, BLOOD, V120, P1933, DOI 10.1182/blood-2011-12-400085; Nassiri F, 2011, ANTICANCER RES, V31, P2283; Lounev VY, 2009, J BONE JOINT SURG AM, V91A, P652, DOI 10.2106/JBJS.H.01177; Rui YF, 2010, TISSUE ENG PT A, V16, P1549, DOI 10.1089/ten.TEA.2009.0529; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Tozer Samuel, 2005, Birth Defects Research, V75, P226, DOI 10.1002/bdrc.20049; Sakabe T, 2011, BRIT MED BULL, V99, P211, DOI 10.1093/bmb/ldr025; Koelling S, 2009, CELL STEM CELL, V4, P324, DOI 10.1016/j.stem.2009.01.015; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Lee NY, 2008, J BIOL CHEM, V283, P32527, DOI 10.1074/jbc.M803059200; Aslan H, 2008, J CLIN INVEST, V118, P439, DOI [10.1172/JCI33944, 10.1172/JC133944]; Chaudhury Salma, 2012, Muscles Ligaments Tendons J, V2, P222; Daher RJ, 2011, INT J CLIN EXP MED, V4, P214; Dominici M, 2005, GENESIS, V42, P17, DOI 10.1002/gene.20121; GELBERMAN R H, 1984, Journal of Orthopaedic Research, V2, P39, DOI 10.1002/jor.1100020107; Lee SY, 2008, J ORTHOP RES, V26, P190, DOI 10.1002/jor.20412; Liu RJ, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-288; Lui Pauline Po Yee, 2012, Muscles Ligaments Tendons J, V2, P163; MANSKE PR, 1984, J BONE JOINT SURG AM, V66A, P385; Otsuru S, 2013, CYTOTHERAPY, V15, P146, DOI 10.1016/j.jcyt.2012.10.012; ROONEY P, 1992, MATRIX, V12, P274; Shimono K, 2010, J ORTHOP RES, V28, P271, DOI 10.1002/jor.20985; Valluru M, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00089; Zhang JY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-10; Zhang JY, 2010, AM J SPORT MED, V38, P2477, DOI 10.1177/0363546510376750; Zhang JY, 2010, J ORTHOP RES, V28, P1178, DOI 10.1002/jor.21123	43	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	DEC	2014	32	12					3266	3277		10.1002/stem.1847		12	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	AU4PL	WOS:000345593700021		
J	Nakatsuji, N				Nakatsuji, Norio			An Interview with Norio Nakatsuji	STEM CELLS AND DEVELOPMENT			English	Editorial Material									Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6068501, Japan	Nakatsuji, N (reprint author), Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6068501, Japan.							0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1547-3287	1557-8534		STEM CELLS DEV	Stem Cells Dev.	DEC 1	2014	23			1			2	3		10.1089/scd.2014.0400		2	Cell & Tissue Engineering; Hematology; Medicine, Research & Experimental; Transplantation	Cell Biology; Hematology; Research & Experimental Medicine; Transplantation	AU4FB	WOS:000345564200002		
J	Saito, K; Wu, XH				Saito, Kazuya; Wu, Xianghua			COMMUNICATIVE FOCUS ON FORM AND SECOND LANGUAGE SUPRASEGMENTAL LEARNING Teaching Cantonese Learners to Perceive Mandarin Tones	STUDIES IN SECOND LANGUAGE ACQUISITION			English	Article							TRAINING JAPANESE LISTENERS; R-VERTICAL-BAR; ENGLISH R/; INSTRUCTION; PERCEPTION; LANGUAGE; RECASTS; ACQUISITION; SPEECH; WORDS	The current study examined how form-focused instruction (FFI) with and without corrective feedback (CF) as output enhancement facilitated second language (L2) perception of Mandarin tones at both the phonetic and phonological levels by 41 Cantonese learners of Mandarin. Two experimental groups, FFI only and FFI-CF, received a 90-min FFI treatment designed to encourage them to notice and practice the categorical distinctions of Mandarin tones through a range of communicative input and output activities. During these activities, the instructors provided CF only to students in the FFI-CF group by recasting and pushing them to repair their mispronunciations of the target features (i.e., output enhancement). The control group received comparable meaning-oriented instruction without any FFI. The effectiveness of FFI was assessed via a forced-choice identification task with both trained and untrained items for a variety of tonal contrasts in Mandarin (high-level Tone 1 vs. mid-rising Tone 2 vs. high-falling Tone 4). According to statistical comparisons, the FFI-only group attained significant improvement in all lexical and tonal contexts, and such effectiveness was evident particularly in the acquisition of Tone 1 and Tone 4-supposedly the most difficult instances due to their identical phonological status in the learners' first language, Cantonese. The FFI-CF group, however, demonstrated marginally significant gains only under the trained lexical conditions. The results suggest that FFI promotes learners' attentional shift from vocabulary to sound learning (generalizable gains in trained and untrained items) and facilitates their access to new phonetic and phonological categories. Yet the relative advantage of adding CF to FFI as output enhancement remains unclear, especially with respect to the less experienced L2 learners in the current study.	[Saito, Kazuya] Waseda Univ, Tokyo 1698050, Japan; [Wu, Xianghua] Univ Calif Davis, Davis, CA 95616 USA	Saito, K (reprint author), Waseda Univ, Sch Commerce, Shinjuku Ku, 1-6-1 Nishi Waseda, Tokyo 1698050, Japan.	kazuya.saito@waseda.jp					Abramson A. S., 1975, STUDIES TAI LINGUIST, P1; LOGAN JS, 1991, J ACOUST SOC AM, V89, P874, DOI 10.1121/1.1894649; Spada N, 2011, LANG TEACHING, V44, P225, DOI 10.1017/S0261444810000224; Trofimovich P, 2006, MOD LANG J, V90, P519, DOI 10.1111/j.1540-4781.2006.00464.x; Norris JM, 2000, LANG LEARN, V50, P417, DOI 10.1111/0023-8333.00136; Gatbonton E, 2005, CAN MOD LANG REV, V61, P325, DOI 10.1353/cml.2005.0016; So CK, 2010, LANG SPEECH, V53, P273, DOI 10.1177/0023830909357156; Kuhl PK, 2007, DEVELOPMENTAL SCI, V10, P110, DOI 10.1111/j.1467-7687.2007.00572.x; Spada N, 2008, TESOL QUART, V42, P181; Wang Y, 2003, J ACOUST SOC AM, V113, P1033, DOI 10.1121/1.1531176; Saito K, 2012, LANG LEARN, V62, P595, DOI 10.1111/j.1467-9922.2011.00639.x; FLEGE JE, 1995, J ACOUST SOC AM, V97, P3125, DOI 10.1121/1.413041; Bradlow AR, 1999, J ACOUST SOC AM, V106, P2074, DOI 10.1121/1.427952; VanPatten B, 2002, LANG LEARN, V52, P755, DOI 10.1111/1467-9922.00203; Sheen Y, 2006, LANG TEACH RES, V10, P361, DOI 10.1191/1362168806ir2O3oa; Derwing TM, 2005, TESOL QUART, V39, P379; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9096, DOI 10.1073/pnas.1532872100; Spada N, 2010, LANG LEARN, V60, P263, DOI 10.1111/j.1467-9922.2010.00562.x; Kuhl PK, 2000, P NATL ACAD SCI USA, V97, P11850, DOI 10.1073/pnas.97.22.11850; LIVELY SE, 1994, J ACOUST SOC AM, V96, P2076, DOI 10.1121/1.410149; Field J, 2005, TESOL QUART, V39, P399; Lyster R, 2013, LANG TEACHING, V46, P1, DOI 10.1017/S0261444812000365; Imai S, 2005, J ACOUST SOC AM, V117, P896, DOI 10.1121/1.1823291; Wang Y, 1999, J ACOUST SOC AM, V106, P3649, DOI 10.1121/1.428217; Mackey A, 1998, MOD LANG J, V82, P338, DOI 10.2307/329960; Schmitt N, 2008, LANG TEACH RES, V12, P329, DOI 10.1177/1362168808089921; Ammar A, 2006, STUD SECOND LANG ACQ, V28, P543, DOI 10.1017/S0272263106060268; SHELDON A, 1982, APPL PSYCHOLINGUIST, V3, P243, DOI 10.1017/S0142716400001417; Abrahamsson N, 2012, STUD SECOND LANG ACQ, V34, P187, DOI 10.1017/S0272263112000022; Iverson P, 2005, J ACOUST SOC AM, V118, P3267, DOI 10.1121/1.2062307; McClelland JL, 2002, PHYSIOL BEHAV, V77, P657, DOI 10.1016/S0031-9384(02)00916-2; Baker W., 2006, IRAL-INT REV APPL LI, V44, P231, DOI DOI 10.1515/IRAL.2006.010; Bauer RS, 1997, MODERN CANTONESE PHO; Best Catherine T., 2007, LANGUAGE EXPERIENCE, P13, DOI DOI 10.1075/LLLT.17.07BES; Bundgaard-Nielsen RL, 2011, STUD SECOND LANG ACQ, V33, P433, DOI 10.1017/S0272263111000040; Cadierno T., 1993, STUDIES 2ND LANGUAGE, V15, P225, DOI 10.1017/S0272263100011979; Chao Y. R., 1948, MANDARIN PRIMER INTE; Conboy BT, 2011, DEVELOPMENTAL SCI, V14, P242, DOI 10.1111/j.1467-7687.2010.00973.x; Couper G., 2006, PROSPECT, V21, P46; Cutler A, 2005, FIGURE OF SPEECH: A FESTSCHRIFT FOR JOHN LAVER, P63; DeKeyser RM, 2007, CAM APPL L, P1, DOI 10.1017/CBO9780511667275; Dumay N., 2003, COGNITION, V89, P105; Ellis R., 1997, 2 LANGUAGE ACQUISITI; Ellis R, 2001, LANG LEARN, V51, P1, DOI 10.1111/j.1467-1770.2001.tb00013.x; Field J, 2008, SYSTEM, V36, P2, DOI 10.1016/j.system.2008.01.001; FLEGE JE, 1993, J ACOUST SOC AM, V93, P1589, DOI 10.1121/1.406818; Flege J. E., 1998, STUDIES 2 LANGUAGE A, V20, P155; Flege James Emil, 1995, SPEECH PERCEPTION LI, P233; Flege JE, 2003, PHONETICS PHONOLOGY, P319, DOI DOI 10.1515/9783110895094.319; Fraser H., 2011, P PHOT TEACH LEARN C, P11; GANDOUR J, 1983, J PHONETICS, V11, P149; GANDOUR J, 1981, J CHINESE LINGUIST, V9, P20; Hardison DM, 2003, APPL PSYCHOLINGUIST, V24, P495, DOI 10.1017/S0142716403000250; Hashimoto O.K.Y., 1972, PHONOLOGY CANTONESE; Lightbown P. M., 2008, UNDERSTANDING 2 LANG, P27; Lin M.C., 1988, ZHONGGUO YUWEN, V204, P437; Lyster R, 1998, LANG LEARN, V48, P183, DOI 10.1111/1467-9922.00039; Lyster R, 2007, LANG LEARN LANG TEAC, V18, P1; McDonough K., 2000, STUDIES 2 LANGUAGE A, V22, P471, DOI DOI 10.1017/S0272263100004022; Munro Murray J., 2001, STUDIES 2 LANGUAGE A, V23, P451; Nation I. S. P., 2001, LEARNING VOCABULARY; Pham M. Y., 2012, J PRAGMATICS, V44, P416; Piske T., 2007, LANGUAGE EXPERIENCE, P331; Ranta L, 2007, CAM APPL L, P141; Saito K, 2013, STUD SECOND LANG ACQ, V35, P1, DOI 10.1017/S0272263112000666; Saito K, 2015, APPL PSYCHOLINGUIST, V36, P377, DOI 10.1017/S0142716413000271; Saito K, 2012, TESOL QUART, V46, P387, DOI 10.1002/tesq.25; Saito K, 2013, LANG LEARN, V63, P499, DOI 10.1111/lang.12015; Sharwood Smith M., 1993, STUDIES 2ND LANGUAGE, V15, P165, DOI DOI 10.1017/S0272263100011943; Sheen Y., 2007, CONVERSATIONAL INTER, P301; Shintani N, 2013, LANG LEARN, V63, P296, DOI 10.1111/lang.12001; Spada N., 1997, LANG TEACHING, V29, P73, DOI DOI 10.1017/S0261444800012799; Spada N, 2005, STUD LANG ACQUIS, V25, P199; Swain M, 2005, HANDBOOK OF RESEARCH IN SECOND LANGUAGE TEACHING AND LEARNING, P471; Thomson RI, 2012, LANG LEARN, V62, P1231, DOI 10.1111/j.1467-9922.2012.00724.x; Trofimovich P, 2012, TESOL QUART, V46, P176, DOI 10.1002/tesq.9; Walley A., 2007, LANGUAGE EXPERIENCE, P315; Weenink D, 2011, PRAAT PHONETICS COMP; Williams J., 1998, FOCUS FORMS CLASSROO; Wong M. K. S, 1982, THESIS U ILLINOIS UR; Wu X., 2011, P 17 INT C PHON SCI, P2169; YU ALAN C. L., 2007, PHONOLOGY, V24, P187, DOI 10.1017/S0952675707001157; Zee E., 1999, HDB INT PHONETIC ASS, P58	83	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0272-2631	1470-1545		STUD SECOND LANG ACQ	Stud. Second Lang. Acquis.	DEC	2014	36	4					647	680		10.1017/S0272263114000114		34	Linguistics	Linguistics	AU0WU	WOS:000345343700002		
J	Saito, Y; Yurimoto, H				Saito, Yahachi; Yurimoto, Hisayoshi			Preface for the special issue of ALC13	SURFACE AND INTERFACE ANALYSIS			English	Editorial Material									[Saito, Yahachi] Nagoya Univ, Dept Quantum Engn, ALC 13, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Yurimoto, Hisayoshi] Hokkaido Univ, Nat Hist Sci & Isotope Imaging Lab, Sapporo, Hokkaido 0010021, Japan		ysaito@nagoya-u.jp; yuri@ep.sci.hokudai.ac.jp						0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1119	1120		10.1002/sia.5651		2	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200001		
J	Fujimoto, T; Ogawa, S; Yoshida, T; Uchiyama, N; Yagi, S				Fujimoto, Taishi; Ogawa, Satoshi; Yoshida, Tomoko; Uchiyama, Naoki; Yagi, Shinya			Hydrogen storage property of Ni nanoparticles fabricated by the gas evaporation method	SURFACE AND INTERFACE ANALYSIS			English	Article						hydrogen storage materials; metal hydride; Ni; nanoparticle; gas evaporation method; XPS; QCM; AFM	HYDRIDES; SURFACE	We have fabricated the Ni nanoparticles with a clean surface by the gas evaporation method and clarified the hydrogen storage property by using atomic force microscope (AFM), X-ray photoelectron spectroscopy (XPS) and quartz crystal microbalance (QCM) measurements. The diameter has been estimated as 4.0 +/- 1.5nm by AFM observation. The Ni nanoparticles possess a clean surface, because the surface chemical state has been confirmed as mainly metallic state by XPS. The hydrogen storage property has been investigated by QCM from the vacuum to the atmospheric pressure of the hydrogen at 300K. The plateau pressure of the Ni nanoparticles and a maximum hydrogen storage capacity are about 7Torr and H/Ni=0.56, respectively. And the hydrogen release from the Ni nanoparticles has not been observed by QCM. The hydrogen adsorption/desorption reaction have also been observed as the plateau like pressure by QCM. These results indicate that (i) the plateau pressure of Ni is decreased by the nanosizing of the material, (ii) the large specific surface area of the Ni nanoparticles makes it possible to observe the adsorption/desorption reaction and (iii) the Ni hydride is stable under the vacuum condition. The chemical shift of Ni 2p(3/2) has not been observed in the XPS spectrum between before and after exposure to the hydrogen. This result implies that there is no strong chemical bonding between Ni and hydrogen or the hydrogen in the lateral surface has been released. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Fujimoto, Taishi; Ogawa, Satoshi; Yoshida, Tomoko; Yagi, Shinya] Nagoya Univ, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Yoshida, Tomoko; Yagi, Shinya] Nagoya Univ, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Uchiyama, Naoki] ATSUMITEC Co Ltd, R&D Div Energy & Environm, Nishi Ku, Hamamatsu, Shizuoka 4310102, Japan	Fujimoto, T (reprint author), Nagoya Univ, Grad Sch Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	fujimoto.taishi@g.mbox.nagoya-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [24360332]; JSPS Research Fellowship for Young Scientists [236237]	The authors are grateful for the financial support of a Grant-in-Aid for Scientific Research (B) (No. 24360332) from the Japan Society for the Promotion of Science (JSPS) and JSPS Research Fellowship for Young Scientists (No. 236237).	Mazloomi K, 2012, RENEW SUST ENERG REV, V16, P3024, DOI 10.1016/j.rser.2012.02.028; MIEDEMA AR, 1976, J LESS-COMMON MET, V49, P463, DOI 10.1016/0022-5088(76)90057-6; Yamauchi M, 2008, J PHYS CHEM C, V112, P3294, DOI 10.1021/jp710447j; Schlapbach L, 2001, NATURE, V414, P353, DOI 10.1038/35104634; Biesinger MC, 2009, SURF INTERFACE ANAL, V41, P324, DOI 10.1002/sia.3026; Fukushima N., 2007, 1 ANN M JAP SOC MOL; Kulchytskyy I, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2784945; LENGELER B, 1984, SOLID STATE COMMUN, V51, P889, DOI 10.1016/0038-1098(84)91094-9; LENGELER B, 1984, PHYS REV LETT, V53, P74, DOI 10.1103/PhysRevLett.53.74; SCHEFER J, 1980, J LESS-COMMON MET, V74, P65, DOI 10.1016/0022-5088(80)90074-0; SIEGMANN HC, 1978, PHYS REV LETT, V40, P972, DOI 10.1103/PhysRevLett.40.972; Taguchi M, 2001, J JPN I MET, V65, P38; Wayman ML, 1989, B ALLOY PHASE DIAGRA, V10, P569, DOI 10.1007/BF02882416; Yagi S., 2006, SURF SCI NANOTECH, V4, P258	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1121	1124		10.1002/sia.5566		4	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200002		
J	Mizutani, T; Murai, T; Nomoto, T; Nameki, H; Yoshida, T; Yagi, S				Mizutani, Tsuyoshi; Murai, Takaaki; Nomoto, Toyokazu; Nameki, Hirofumi; Yoshida, Tomoko; Yagi, Shinya			Preparation of gold nanoparticles included in anatase-phase titania by solution plasma method	SURFACE AND INTERFACE ANALYSIS			English	Article						solution plasma method; sol-gel method; gold nanoparticles; titanium oxide; localized surface plasmon resonance; XRD; UV-Vis; XPS; XAFS	LOW-TEMPERATURE OXIDATION; SUPPORTED CATALYSTS; CARBON-MONOXIDE; CO OXIDATION; TIO2; PHOTOCATALYSIS; SURFACES	The gold nanoparticles on titania support (AuNP/TiO2) has been paid attention as a catalyst and a photocatalyst. We perform the preparation of AuNP/TiO2, which is the combination of the sol-gel method and solution plasma method. In this method, we generate the plasma in the gelatinous peroxotitanic acid solution by the discharge between the gold electrodes, and then we synthesize the peroxotitanium gel containing gold nanoparticles. After drying and calcination process, we obtain the AuNP/TiO2 samples. The X-ray diffraction results show that the AuNP/TiO2 is constituted by the nanocrystalline gold and anatase-phase TiO2, and the lattice constant decreases by the embedded gold nanoparticles in the TiO2 matrix. Ultraviolet-Visible absorption spectroscopy shows that the AuNP/TiO2 samples absorb the visible light at about 630nm based on the localized surface plasmon resonance of gold nanoparticles embedded in the TiO2 matrix. The surface chemical states of the AuNP/TiO2 samples are analyzed by the X-ray photoelectron spectroscopy. The surface of AuNP/TiO2 is composed with the majority of oxidized gold and minority of metallic gold which interacted with the TiO2 surface. The Au L-3-edge near edge X-ray absorption fine structure spectra indicate that the gold nanoparticles embedded in TiO2 have metallic chemical states. We successfully prepare the gold nanoparticles on the surface and in the matrix of anatase-phase TiO2. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Mizutani, Tsuyoshi] Nagoya Univ, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Murai, Takaaki; Nameki, Hirofumi] Aichi Ctr Ind & Sci Technol, Ctr Ind Res, Kariya, Aichi 4480013, Japan; [Nomoto, Toyokazu] Aichi Ctr Ind & Sci Technol, Toyota, Aichi 4700356, Japan; [Yoshida, Tomoko] Nagoya Univ, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Mizutani, T (reprint author), Nagoya Univ, Grad Sch Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	mizutani.tsuyoshi@g.mbox.nagoya-u.ac.jp			JSPS Research Fellowship for Young Scientists [253892]; Japan Society for the Promotion of Science (JSPS) [24360332]	The authors are grateful for the financial support of JSPS Research Fellowship for Young Scientists (No. 253892) and a Grant-in-Aid for Scientific Research (B) (No. 24360332) from the Japan Society for the Promotion of Science (JSPS). This work was performed under the approval of Aichi SR Program Advisory Committees (No. 2504037).	Kowalska E, 2010, PHYS CHEM CHEM PHYS, V12, P2344, DOI 10.1039/b917399d; Visco AM, 1999, PHYS CHEM CHEM PHYS, V1, P2869, DOI 10.1039/a900838a; Arrii S, 2004, J AM CHEM SOC, V126, P1199, DOI 10.1021/ja036352y; Comotti M, 2006, J AM CHEM SOC, V128, P917, DOI 10.1021/ja0561441; HUTCHINGS GJ, 1985, J CATAL, V96, P292, DOI 10.1016/0021-9517(85)90383-5; HARUTA M, 1989, J CATAL, V115, P301, DOI 10.1016/0021-9517(89)90034-1; Chen JJ, 2011, J PHYS CHEM C, V115, P210, DOI 10.1021/jp1074048; KRAEUTLER B, 1978, J AM CHEM SOC, V100, P4317, DOI 10.1021/ja00481a059; Moreau F, 2005, J CATAL, V231, P105, DOI 10.1016/j.jcat.2005.01.030; Ichinose H, 2001, J SOL-GEL SCI TECHN, V22, P33, DOI 10.1023/A:1011256118320; Lopez N, 2004, J CATAL, V223, P232, DOI 10.1016/j.jcat.2004.01.001; Hu XL, 2012, CRYST GROWTH DES, V12, P119, DOI 10.1021/cg2008528; LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013; HARUTA M, 1993, J CATAL, V144, P175, DOI 10.1006/jcat.1993.1322; Buso BD, 2007, ADV FUNCT MATER, V17, P347; Liz-Marzan LM, 1995, J COLLOID INTERF SCI, V176, P459, DOI 10.1006/jcis.1995.9945	16	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1125	1128		10.1002/sia.5567		4	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200003		
J	Fujii, M; Nakagawa, S; Seki, T; Aoki, T; Matsuo, J				Fujii, Makiko; Nakagawa, Shunichirou; Seki, Toshio; Aoki, Takaaki; Matsuo, Jiro			Quantitative analysis of lipids with argon gas cluster ion beam secondary ion mass spectrometry	SURFACE AND INTERFACE ANALYSIS			English	Article						SIMS; Ar-GCIB; lipid; detection limit; quantitative accuracy	SIMS	Ar gas cluster ion beam (Ar-GCIB) SIMS has been developed as one of the powerful tools used for analyzing organic materials because of the high secondary ion yield of large organic molecules due to soft' sputtering mechanism of this technique. However, for practical analysis of complex biological samples, high quantitative accuracy is strongly required besides high sensitivity. In this study, some pure and compound lipid samples were measured with our originally equipped Ar-GCIB SIMS apparatus with the aim of determining the quantitative accuracy of this technique. It was found that the detection limit of the Ar-GCIB SIMS apparatus was lower than 0.1%. In addition, there was almost no matrix effect between the organic substances of similar chemical structures. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Fujii, Makiko; Matsuo, Jiro] Kyoto Univ, Quantum Sci & Engn Ctr, Kyoto 6110011, Japan; [Nakagawa, Shunichirou; Seki, Toshio] Kyoto Univ, Dept Nucl Engn, Kyoto 6110011, Japan; [Aoki, Takaaki] Kyoto Univ, Dept Elect Sci & Engn, Nishikyo Ku, Kyoto 6158510, Japan	Fujii, M (reprint author), Kyoto Univ, Quantum Sci & Engn Ctr, Kyoto 6110011, Japan.	fujii.makiko.68x@st.kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS)	This study was partially supported by Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science (JSPS).	Fletcher JS, 2011, MASS SPECTROM REV, V30, P142, DOI 10.1002/mas.20275; Guilhaus M, 2000, MASS SPECTROM REV, V19, P65, DOI 10.1002/(SICI)1098-2787(2000)19:2<65::AID-MAS1>3.0.CO;2-E; Wucher A, 2006, APPL SURF SCI, V252, P6482, DOI 10.1016/j.apsusc.2006.02.070; Chernushevich IV, 2001, J MASS SPECTROM, V36, P849, DOI 10.1002/jms.207; Dawson J. H. J., 1989, RAPID COMMUN MASS SP, V3, P155, DOI DOI 10.1002/RCM.1290030511; Ichiki K, 2013, SURF INTERFACE ANAL, V45, P522, DOI 10.1002/sia.5092; Mahoney CM, 2010, MASS SPECTROM REV, V29, P247, DOI 10.1002/mas.20233; Matsuo J, 2010, SURF INTERFACE ANAL, V42, P1612, DOI 10.1002/sia.3585; Nakata Y, 2009, J MASS SPECTROM, V44, P128, DOI 10.1002/jms.1482; Vickerman J. C., 2001, TOF SIMS SURFACE ANA; Winograd N, 2005, ANAL CHEM, V77, p142A, DOI 10.1021/ac053355f	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1129	1132		10.1002/sia.5518		4	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200004		
J	Seki, T; Fujii, M; Kusakari, M; Nakagawa, S; Aoki, T; Matsuo, J				Seki, Toshio; Fujii, Makiko; Kusakari, Masakazu; Nakagawa, Shunichiro; Aoki, Takaaki; Matsuo, Jiro			Analysis of liquid materials in low vacuum with Wet-SIMS	SURFACE AND INTERFACE ANALYSIS			English	Article						MeV-energy ion; SIMS; liquid material	MASS-SPECTROMETRY; ION-BOMBARDMENT; LIPIDS; BEAMS	In conventional SIMS with keV-energy ion beams, elastic collisions occur between projectiles and atoms in the constituent molecules. The collisions produce fragments, making the acquisition of molecular information difficult. Volatile liquid samples (wet samples) are also difficult to measure using conventional SIMS because samples must be dried first and then introduced into the high-vacuum chamber. In contrast, ion beams with MeV-energy excite electrons near the surface and enhance the ionization of high-mass molecules; hence, a fragment-suppressed SIMS spectrum of ionized molecules can be obtained. We developed a SIMS analysis system for wet samples (Wet-SIMS) that works under low-vacuum pressures up to 1000Pa using heavy MeV-energy ion beams. The evaporation of heptanoic acid was suppressed under the low-vacuum pressure of 1000Pa, and the wet samples, which included volatile materials with different vapor pressures, could be measured using heavy MeV-energy ions. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Seki, Toshio; Kusakari, Masakazu; Nakagawa, Shunichiro] Kyoto Univ, Dept Nucl Engn, Kyoto 6110011, Japan; [Fujii, Makiko; Matsuo, Jiro] Kyoto Univ, Quantum Sci & Engn Ctr, Kyoto 6110011, Japan; [Aoki, Takaaki] Kyoto Univ, Dept Elect Sci & Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Seki, Toshio; Aoki, Takaaki; Matsuo, Jiro] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Seki, T (reprint author), Kyoto Univ, Dept Nucl Engn, Kyoto 6110011, Japan.	seki@sakura.nucleng.kyoto-u.ac.jp					Kollmer F, 2004, APPL SURF SCI, V231, P153, DOI 10.1016/j.apsusc.2004.03.101; Guilhaus M, 2000, MASS SPECTROM REV, V19, P65, DOI 10.1002/(SICI)1098-2787(2000)19:2<65::AID-MAS1>3.0.CO;2-E; Borner K, 2007, INT J MASS SPECTROM, V260, P128, DOI 10.1016/j.ijms.2006.09.014; Touboul D, 2004, ANAL CHEM, V76, P1550, DOI 10.1021/ac035243z; Brunelle A, 2005, J MASS SPECTROM, V40, P985, DOI 10.1002/jms.902; Antoine C., 1888, CR HEBD ACAD SCI, V107, P681; Bich C, 2013, INT J MASS SPECTROM, V337, P43, DOI 10.1016/j.ijms.2012.12.010; Jones BN, 2011, SURF INTERFACE ANAL, V43, P249, DOI 10.1002/sia.3520; Matsuo J, 2010, SURF INTERFACE ANAL, V42, P1612, DOI 10.1002/sia.3585; Nakata Y, 2009, J MASS SPECTROM, V44, P128, DOI 10.1002/jms.1482; SEAMAN GG, 1975, NUCL INSTRUM METHODS, V126, P473, DOI 10.1016/0029-554X(75)90715-6; STULL DR, 1947, IND ENG CHEM, V39, P517, DOI 10.1021/ie50448a022; Touboul D, 2011, CURR OPIN CHEM BIOL, V15, P725, DOI 10.1016/j.cbpa.2011.04.017; Wakamatsu Y, 2011, NUCL INSTRUM METH B, V269, P2251, DOI 10.1016/j.nimb.2011.02.069; Wakamatsu Y, 2010, AIP CONF PROC, V1321, P233; WILLIAMS ET, 1984, NUCL INSTRUM METH B, V3, P211, DOI 10.1016/0168-583X(84)90365-3; Yamada H, 2010, NUCL INSTRUM METH B, V268, P1736, DOI 10.1016/j.nimb.2010.02.038	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1133	1136		10.1002/sia.5528		4	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200005		
J	Ogawa, S; Fujimoto, T; Mizutani, T; Ogawa, M; Yogi, C; Kato, K; Ohta, T; Yoshida, T; Yagi, S				Ogawa, Satoshi; Fujimoto, Taishi; Mizutani, Tsuyoshi; Ogawa, Masahiro; Yogi, Chihiro; Kato, Kazuo; Ohta, Toshiaki; Yoshida, Tomoko; Yagi, Shinya			XAFS and XPS study of hydro-/dehydrogenation reaction of Mg-Pd nanoparticles	SURFACE AND INTERFACE ANALYSIS			English	Article						Hydrogen storage material; Mg-Pd nanoparticles; XAFS; XPS; Gas evaporation method		The nanoparticles composed of Mg and Pd atoms (Mg-Pd NPs) have been fabricated by the gas evaporation method, and the variation of the chemical state during hydro-/dehydrogenations has been investigated by X-ray photoelectron spectroscopy (XPS) and in-situ X-ray absorption fine structure (XAFS) analyses. Both XPS and XAFS spectra have indicated that the Mg-Pd NPs contain the chemical state of the metallic Pd and Mg-Pd alloy phases. The Mg-Pd alloy phase has been identified as MgPd and Mg6Pd by the Pd K-edge EXAFS analysis. The hydrogen release of the Mg-Pd NPs has not been observed after first hydrogenation due to the migration of Mg toward the surface of the Mg-Pd NPs during the hydrogen storage. This irreversible migration has led the inhibition of the hydrogen diffusion into the surface from the inside of the Mg-Pd NPs. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Ogawa, Satoshi] Nagoya Univ, Sch Engn, Dept Quantum Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Fujimoto, Taishi; Mizutani, Tsuyoshi; Yoshida, Tomoko; Yagi, Shinya] Nagoya Univ, Sch Engn, Div Quantum Sci & Energy Engn, Dept Mat Phys & Energy Engn,Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Ogawa, Masahiro; Yogi, Chihiro; Ohta, Toshiaki] Ritsumeikan Univ, SR Ctr, Kusatsu, Shiga 5258577, Japan; [Kato, Kazuo] JASRI SPring 8, Sayo, Hyogo 6795198, Japan; [Yoshida, Tomoko; Yagi, Shinya] Nagoya Univ, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Ogawa, S (reprint author), Furo Cho,Chikusa Ku, Nagoya, Aichi 4648603, Japan.	ogawa.satoshi@g.mbox.nagoya-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [24360332]; JSPS Research Fellowship for Young Scientists [236237]; Ritsumeikan University SR center Program Advisory Committee [R1316, R1345]	The authors are grateful for the financial support of a Grant-in-Aid for Scientific Research (B) (No. 24360332) from the Japan Society for the Promotion of Science (JSPS) and JSPS Research Fellowship for Young Scientists (No. 236237). This work was performed under the approval of Ritsumeikan University SR center Program Advisory Committee (Nos. R1316 and R1345) and SPring-8 (No. 2013A1589).	Krishnan G, 2010, J APPL PHYS, V107, DOI 10.1063/1.3305453; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Baldi A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.226102; Chung CJ, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.106102; Jain IP, 2010, INT J HYDROGEN ENERG, V35, P5133, DOI 10.1016/j.ijhydene.2009.08.088; Fairley N., CASAXPS VERSION 2 3; Kulchytskyy I, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2784945; Murakami S., 2011, E J SURF SCI NANOTEC, V9, P438; Nakanishi K., 2010, IEEJ T EIS, V130, P1762; Nakanishi K, 2010, AIP CONF PROC, V1234, P931, DOI 10.1063/1.3463369; Ogawa S., 2011, e-Journal of Surface Science and Nanotechnology, V9, DOI 10.1380/ejssnt.2011.315; Ogawa S., 2012, C P NANOCON 2012, V2012; Yagi S, 2006, E J SURF SCI NANOTEC, V4, P258, DOI 10.1380/ejssnt.2006.258; Yoshimura K, 2004, SURF SCI, V566, P751, DOI 10.1016/j.susc.2004.06.115	14	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1143	1146		10.1002/sia.5647		4	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200007		
J	Tang, JY; Nishimoto, K; Ogawa, S; Akitaka, Y; Ishidzuka, S; Watanabe, D; Teraoka, Y; Takakuwa, Y				Tang, Jiayi; Nishimoto, Kiwamu; Ogawa, Shuichi; Akitaka, Yoshigoe; Ishidzuka, Shinnji; Watanabe, Daiki; Teraoka, Yuden; Takakuwa, Yuji			Self-accelerating oxidation on Si(111)7 x 7 surfaces studied by real-time photoelectron spectroscopy	SURFACE AND INTERFACE ANALYSIS			English	Article						interface oxidation; real-time photoelectron spectroscopy; interface strain; Si(111)7x7	BY-LAYER OXIDATION; THERMAL-OXIDATION; INTERFACE; SILICON; GROWTH; KINETICS; O-2	Oxidation at the oxide/Si(111) interface at room temperature (RT) and 550 degrees C has been investigated by real-time X-ray photoelectron spectroscopy. Self-accelerating interface oxidation is observed in oxidation at RT, but not in oxidation at 550 degrees C. During self-acceleration at RT, the component corresponding to strained Si atoms in the second layer below the oxide/Si(111) interface, Si, increases significantly. It is suggested that the interface oxidation rate is strongly correlated with the generation of strain at the oxide/Si(111) interface. Furthermore, a self-accelerating interface oxidation model of Si(111)7x7 surfaces that includes the point defect (emitted Si atoms+vacancies) generation is proposed. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Tang, Jiayi; Nishimoto, Kiwamu; Ogawa, Shuichi; Watanabe, Daiki; Takakuwa, Yuji] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Akitaka, Yoshigoe; Teraoka, Yuden] Japan Atom Energy Agcy, Sayo, Hyogo 6795148, Japan; [Ishidzuka, Shinnji] Nagaoka Univ Technol, Nagaoka, Niigata 9402188, Japan	Tang, JY (reprint author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	ruffle@mail.tagen.tohoku.ac.jp			JSPS KAKENHI [25870064]	This work was partly supported by JSPS KAKENHI Grant-in-Aid for Young Scientists (B) 25870064. The XPS measurements using synchrotron radiation were performed at BL23SU in SPring-8 with the approval of the Nano-net and Nano-platform project of the Japan Synchrotron Research Institute (JASRI) and Japan Atomic Energy Agency (JAEA) (2012A3808 and 2013A3874).	LIU HI, 1994, APPL PHYS LETT, V64, P1383, DOI 10.1063/1.111914; Fried DM, 2003, IEEE ELECTR DEVICE L, V24, P592, DOI 10.1109/LED.2003.815946; Watanabe H, 1998, PHYS REV LETT, V80, P345, DOI 10.1103/PhysRevLett.80.345; HIMPSEL FJ, 1988, PHYS REV B, V38, P6084, DOI 10.1103/PhysRevB.38.6084; MASSOUD HZ, 1985, J ELECTROCHEM SOC, V132, P2685, DOI 10.1149/1.2113648; Ogawa S, 2006, JPN J APPL PHYS 1, V45, P7063, DOI 10.1143/JJAP.45.7063; OHISHI K, 1994, JPN J APPL PHYS 2, V33, pL675, DOI 10.1143/JJAP.33.L675; Brown GA, 2004, MATER TODAY, V7, P20; BORMAN VD, 1991, PHYS REV LETT, V67, P2387, DOI 10.1103/PhysRevLett.67.2387; DEAL BE, 1965, J APPL PHYS, V36, P3770, DOI 10.1063/1.1713945; Dreiner S, 2005, J ELECTRON SPECTROSC, V144, P405, DOI 10.1016/j.elspec.2005.01.120; ISHIZAKA A, 1979, SURF SCI, V84, P355, DOI 10.1016/0039-6028(79)90142-0; Ogawa S, 2007, JPN J APPL PHYS 1, V46, P3244, DOI 10.1143/JJAP.46.3244; Ogawa S, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.110128; Suwa T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.031302; Tang J., 2012, E J SURF SCI NANOTEC, V10, P525; Tatsumura K, 2004, JPN J APPL PHYS 1, V43, P492, DOI 10.1143/JJAP.43.492; Teraoka Y, 2001, APPL SURF SCI, V169, P738, DOI 10.1016/S0169-4332(00)00779-0; Yazyev OV, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.157601; Yoshigoe A, 2010, J PHYS CHEM C, V114, P22539, DOI 10.1021/jp104273v; Yoshigoe A, 2012, J PHYS CHEM C, V116, P4039, DOI 10.1021/jp2065453	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1147	1150		10.1002/sia.5615		4	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200008		
J	Ruammaitree, A; Nakahara, H; Saito, Y				Ruammaitree, A.; Nakahara, H.; Saito, Y.			Growth of protrusive graphene rings on Si-terminated 6H-SiC (0001)	SURFACE AND INTERFACE ANALYSIS			English	Article						epitaxial graphene; graphene ring; antenna; Si-terminated 6H-SiC; atomic force microscopy; scanning tunneling microscope	LIGHT	Optical antennas are devices that efficiently convert the energy of free propagating radiation into localized energy and vice versa. The development of optical antennas can improve the efficiency of sensing, photodetection, light emission, and spectroscopy. Graphene rings are a promising material for advanced optical antennas because their plasmons are more electromagnetically confined than metallic plasmons. In this report, we describe the growth of embedded and protrusive graphene rings by annealing Si-terminated 6H-SiC under Ar gas. We found that the growth of the graphene rings depends on both the annealing temperature and the ambient Ar pressure. A bottom-up fabrication method can preserve intact ring edges unlike electron-beam lithographic methods. Moreover, the growth of protrusive graphene rings without bonding between the ring edge and the SiC substrate is emphasized because the ring edge structures are similar to those of free-standing graphene rings, and this provides a new option for graphene applications on Si-terminated SiC. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Ruammaitree, A.; Nakahara, H.; Saito, Y.] Nagoya Univ, Dept Quantum Engn, Fac Engn, Nagoya, Aichi 4648603, Japan	Ruammaitree, A (reprint author), Nagoya Univ, Dept Quantum Engn, Fac Engn, Nagoya, Aichi 4648603, Japan.	u4605070@hotmail.com					Liu PH, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3702819; Ismach A, 2010, NANO LETT, V10, P1542, DOI 10.1021/nl9037714; Novotny L, 2011, NAT PHOTONICS, V5, P83, DOI [10.1038/nphoton.2010.237, 10.1038/NPHOTON.2010.237]; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Emtsev KV, 2009, NAT MATER, V8, P203, DOI [10.1038/nmat2382, 10.1038/NMAT2382]; Emtsev KV, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.155303; Tian JF, 2011, NANO LETT, V11, P3663, DOI 10.1021/nl201590f; Ruammaitree A, 2013, APPL SURF SCI, V282, P297, DOI 10.1016/j.apsusc.2013.05.122; Koppens FHL, 2011, NANO LETT, V11, P3370, DOI 10.1021/nl201771h; Hass J, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/32/323202; Kageshima H, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.070115; Righi MC, 2005, COMPUT PHYS COMMUN, V169, P50, DOI 10.1016/j.cpc.2005.03.013; Ruammaitree A, 2014, APPL SURF SCI, V307, P136, DOI 10.1016/j.apsusc.2014.03.181; Ruammaitree A., 2014, INT J ENG INNOVATIVE, V3, P34	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1156	1159		10.1002/sia.5612		4	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200010		
J	Horio, Y; Takakuwa, Y; Ogawa, S				Horio, Yoshimi; Takakuwa, Yuji; Ogawa, Shuichi			Auger intensity anomalies from the Si(001)2 x 1 surface excited by the wave field of RHEED	SURFACE AND INTERFACE ANALYSIS			English	Article						Auger intensity; reflection high-energy electron diffraction (RHEED); Si(001); wave field	ENERGY ELECTRON-DIFFRACTION; BEAM ROCKING METHOD; CRYSTALS	The Auger intensity of Si-LVV from the Si(001)2x1 surface has been measured at room temperature while changing the glancing angle of the incident electron beam of reflection high-energy electron diffraction (RHEED). Such a beam-rocking Auger electron spectroscopy (BRAES) profile shows intensity anomalies under surface wave resonance conditions. The surface structure of Si(001)2x1 has been analyzed by rocking curves of diffraction spots within the 0(th) Laue zone. Since RHEED intensities limited to the 0(th) Laue zone can be determined by the projected potential of Si atomic rows along the incident azimuth, the phase of asymmetric dimers with flip-flop motion can be neglected. According to the Si(001)2x1 surface structure model which was confirmed by the rocking curve analysis, it was found that the calculated wave-field intensity profile for Si atoms reveals similar intensity anomalies to those of the experimental BRAES profile. The background profile is also discussed in terms of the beam irradiation area and its transmissivity. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Horio, Yoshimi] Daido Univ, Minami Ku, Nagoya, Aichi 4578530, Japan; [Takakuwa, Yuji; Ogawa, Shuichi] IMRAM Tohoku Univ, Aoba Ku, Sendai, Miyagi 9808577, Japan	Horio, Y (reprint author), Daido Univ, Minami Ku, 10-3 Takiharu Cho, Nagoya, Aichi 4578530, Japan.	horio@daido-it.ac.jp			JSPS KAKENHI [25390085]	This work was performed under the Cooperative Research Program of "Network Joint Research Center for Materials and Devices" and was supported by JSPS KAKENHI Grant Number 25390085.	DOYLE PA, 1968, ACTA CRYSTALL A-CRYS, VA 24, P390, DOI 10.1107/S0567739468000756; HORIO Y, 1983, PHYSICA B & C, V117, P792, DOI 10.1016/0378-4363(83)90655-1; Horio Y, 1998, PHYS REV B, V57, P4736, DOI 10.1103/PhysRevB.57.4736; Horio Y, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.066501; HORIO Y, 1985, SURF SCI, V164, P589, DOI 10.1016/0039-6028(85)90767-8; Horio Y, 1998, JPN J APPL PHYS 2, V37, pL164, DOI 10.1143/JJAP.37.L164; Ichimiya A., 2004, REFLECTION HIGH ENER; ICHIMIYA A, 1983, SURF SCI, V128, P343, DOI 10.1016/S0039-6028(83)80037-5; ICHIMIYA A, 1983, JPN J APPL PHYS 1, V22, P176, DOI 10.1143/JJAP.22.176; MARTEN H, 1985, SURF SCI, V151, P570, DOI 10.1016/0039-6028(85)90394-2; RADI G, 1970, ACTA CRYSTALL A-CRYS, VA 26, P41, DOI 10.1107/S0567739470000050; RAMSTAD A, 1995, PHYS REV B, V51, P14504, DOI 10.1103/PhysRevB.51.14504; TABATA T, 1987, SURF SCI, V179, pL63	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1165	1169		10.1002/sia.5572		5	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200012		
J	Kudo, K; Suzuki, M; Kojima, K; Yasue, T; Akutsu, N; Kasai, H; Dino, WA; Bauer, E; Koshikawa, T				Kudo, Kauze; Suzuki, Masahiko; Kojima, Kazuki; Yasue, Tsuneo; Akutsu, Noriko; Kasai, Hideaki; Dino, Wilson Agerico; Bauer, Ernst; Koshikawa, Takanori			Simulations of magnetic domain patterns on the surface of Co/Ni multilayers	SURFACE AND INTERFACE ANALYSIS			English	Article						Co/Ni multilayer; magnetic anisotropy; magnetic domain pattern; Landau-Lifshitz-Gilbert equation		Magnetic domains in ultrathin films show a wide variety of patterns. Recent instrument developments, in particular in spin-polarized low-energy electron microscopy (SPLEEM), have allowed real-time observation of magnetic domain patterns in thin films. Recent SPLEEM experiments have shown that the magnetic anisotropy, and hence magnetic domain patterns, in a Co/Ni multilayer changes with the number of layers. We simulate the magnetic domain pattern formation on the surface of a Co/Ni multilayer. The numerical simulations well reproduce the magnetic domain patterns that were observed in the experiments. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Kudo, Kauze] Ochanomizu Univ, Dept Informat Sci, Tokyo 1128610, Japan; [Suzuki, Masahiko; Yasue, Tsuneo; Koshikawa, Takanori] Osaka Electrocommun Univ, Fundamental Elect Res Inst, Osaka 5728530, Japan; [Kojima, Kazuki; Kasai, Hideaki; Dino, Wilson Agerico] Osaka Univ, Dept Appl Phys, Suita, Osaka 5650871, Japan; [Akutsu, Noriko] Osaka Electrocommun Univ, Fac Engn, Osaka 5728530, Japan; [Bauer, Ernst] Arizona State Univ, Dept Phys & Astron, Tempe, AZ 85287 USA	Kudo, K (reprint author), Ochanomizu Univ, Dept Informat Sci, Tokyo 1128610, Japan.	kudo@is.ocha.ac.jp			Japan Society for the Promotion of Science [23246015, 25400413]; System Development Program for Advanced Measurement and Analysis from the Japan Science and Technology Agency	This work was partially supported by a Grant-in-Aid for Scientific Research (A) (Grant No. 23246015) and KAKENHI (Grant No. 25400413) from the Japan Society for the Promotion of Science and the System Development Program for Advanced Measurement and Analysis from the Japan Science and Technology Agency.	DUDEN T, 1995, REV SCI INSTRUM, V66, P2861, DOI 10.1063/1.1145569; Suzuki M, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.026601; Tatara G, 2008, PHYS REP, V468, P213, DOI 10.1016/j.physrep.2008.07.003; Jung SW, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2926664; Suzuki M, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/40/406001; Bauer E., 1997, HDB MICROSCOPY, P751; Bauer E., 2007, HDB MAGNETISM ADV MA, V3, P1470; Fukami S, 2008, J APPL PHYS, V103, DOI 10.1063/1.2830964; Kudo K, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/39/395005; Suzuki M., 2011, P 8 INT S AT LEV CHA, P437	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1174	1177		10.1002/sia.5562		4	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200014		
J	Kajiwara, Y; Iwai, H; Kodani, N; Migita, CT; Yano, A; Aoyagi, S				Kajiwara, Yasuko; Iwai, Hideo; Kodani, Noriko; Migita, Catharina T.; Yano, Akira; Aoyagi, Satoka			Multivariate analysis and g-ogram application to ToF-SIMS data of PEG mixed model sample	SURFACE AND INTERFACE ANALYSIS			English	Article						time-of-flight secondary ion mass spectrometry (ToF-SIMS); multivariate curve resolution (MCR); g-ogram; polyethylene glycol (PEG)	ION MASS-SPECTROMETRY; SPECTRA; IMAGES; IDENTIFICATION; SEPARATION	High-functional plastics have been attracted much attention over the various fields of industries. For evaluating their functionalities, it is essential to investigate low molecular weight components on the surface of the plastic because these components deeply affect their functionalities. In this study, multivariate analysis and g-ogram, a G-SIMS-related spectrum analysis method, were applied to the ToF-SIMS data of polyethylene glycol mixed model sample consisting of the two different average molecular weights, 600u and 2000u (PEG600 and PEG2000). As a result, the pure component spectra suggesting PEG600, PEG2000 and polydimethylsiloxane contaminant were discriminated by using multivariate curve resolution (MCR) under the condition of reducing the chemical noise such as heavily fragmented ions and contaminants. Moreover, the major peaks of the pure component spectrum suggesting PEG2000 in MCR were the characteristic fragment ions obtained by the g-ogram result for PEG2000. Therefore, it is indicated that the combination of MCR and g-ogram methods is a promising tool for evaluating the functionalities of the high-functional plastics. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Kajiwara, Yasuko] Mitsubishi Gas Chem Co Inc, MGC Anal Ctr, Tokyo 1258601, Japan; [Kajiwara, Yasuko; Aoyagi, Satoka] Seikei Univ, Grad Sch Sci & Technol, Musashino, Tokyo 1808633, Japan; [Iwai, Hideo] Natl Inst Mat Sci, Mat Anal Stn, Tsukuba, Ibaraki 3050047, Japan; [Kodani, Noriko; Yano, Akira] Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane 6908504, Japan; [Migita, Catharina T.] Yamaguchi Univ, Fac Agr, Yamaguchi 7538515, Japan	Aoyagi, S (reprint author), Seikei Univ, Grad Sch Sci & Technol, 3-3-1 Kichijoji Kitamachi, Musashino, Tokyo 1808633, Japan.	aoyagi@st.seikei.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This work was supported by NIMS microstructural characterization platform as a program of 'Nanotechnology Platform' of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Seah MP, 2010, J PHYS CHEM C, V114, P5351, DOI 10.1021/jp905037k; Wagner MS, 2004, SURF SCI, V570, P78, DOI 10.1016/j.susc.2004.06.184; Wagner MS, 2006, APPL SURF SCI, V252, P6575, DOI 10.1016/j.apsusc.2006.02.073; Keenan MR, 2004, SURF INTERFACE ANAL, V36, P203, DOI 10.1002/sia.1657; Aoyagi S, 2012, SURF INTERFACE ANAL, V44, P789, DOI 10.1002/sia.4824; Aoyagi S, 2012, RAPID COMMUN MASS SP, V26, P2815, DOI 10.1002/rcm.6409; Gilmore IS, 2000, APPL SURF SCI, V161, P465, DOI 10.1016/S0169-4332(00)00317-2; Green FM, 2008, RAPID COMMUN MASS SP, V22, P2602, DOI 10.1002/rcm.3648; Green FM, 2008, INT J MASS SPECTROM, V272, P38, DOI 10.1016/j.ijms.2007.12.016; Lee JLS, 2009, SURF INTERFACE ANAL, V41, P653, DOI 10.1002/sia.3070; Ogaki R, 2011, ANAL CHEM, V83, P3627, DOI 10.1021/ac200347a; Tyler B. J., 2006, APPL SUR SCI, V252, P6675	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1183	1186		10.1002/sia.5591		4	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200016		
J	Tsuchiya, B; Morita, K; Nagata, S; Kato, T; Iriyama, Y; Tsuchida, H; Majima, T				Tsuchiya, Bun; Morita, Kenji; Nagata, Shinji; Kato, Takehisa; Iriyama, Yasutoshi; Tsuchida, Hidetsugu; Majima, Takuya			Dynamic measurements of Li depth profiles in a Li-ion battery system under charging condition by means of ERD and RBS techniques	SURFACE AND INTERFACE ANALYSIS			English	Article						all solid-state Li-ion battery; Li depth profile; ion beam analysis	THIN-FILMS	Depth profiles of Li in a Li-ion battery system of Au/LiCoO2/LATP/Pt (LATP:Li1+X+YAlYTi2-YGeXP3-XO12) have been in situ measured at several stages of charging by means of the elastic recoil detection (ERD) and Rutherford backscattering (RBS) techniques with 9MeV O4+ ion beam. The thicknesses of LiCoO2 and Au are estimated from the RBS spectrum for the as-received specimen to be 190 and 27nm, respectively. From the ERD spectrum, it is also found that there exists impurity hydrogen of similar to 5% in LiCoO2. Moreover, it is found from the ERD data analysis after the first charging of 0.48x10(16)e/cm(2) to Au electrode that the fractional concentration of Li in LiCoO2 at the interface with Au electrode steeply decreases to 0.8, recovers with depth toward the interface with LATP and attains at 1.3 above the original value. With increasing the amount of charge supplied, the slope in the Li composition from Au electrode to LATP increases gradually. The data on the charging is concluded to include the irradiation effects due to the incident O ions, since the data on a non-irradiated part of the specimen obtained after finish of the charging shows that Li is almost completely reduced from LiCoO2. The dynamics of Li composition in LiCoO2 as a function of charging supplied is discussed in connection with hydrogen impurity and irradiation effect of the incident O ions. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Tsuchiya, Bun] Meijo Univ, Dept Gen Educ, Tenpaku Ku, Nagoya, Aichi 4688052, Japan; [Morita, Kenji] Nagoya Ind Sci Res Inst, Chikusa Ku, Nagoya, Aichi 4640819, Japan; [Nagata, Shinji] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Kato, Takehisa; Iriyama, Yasutoshi] Nagoya Univ, Grad Sch Engn, Dept Mat Engn, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Tsuchida, Hidetsugu; Majima, Takuya] Kyoto Univ, Quantum Energy Sci & Engn Ctr, Kyoto 6110011, Japan	Tsuchiya, B (reprint author), Meijo Univ, Dept Gen Educ, Tenpaku Ku, 1-501 Shiogamaguchi, Nagoya, Aichi 4688052, Japan.	rse51151@nifty.com	Nagata, Shinji/A-1796-2015		Japan Society of the Promotion of Science [25420762]	This work is partly supported for 2013-2015 by Grants-in-Aid, Scientific Research (25420762), Japan Society of the Promotion of Science. This work was also performed under the valuable co-operative program of Tan dem Accelerator both at the Quantum Energy Science and Engineering Center, Kyoto University and at the New Materials Development Co-operative Research Center, Institute for Materials Research, Tohoku University.	Kanno R, 2001, J ELECTROCHEM SOC, V148, pA742, DOI 10.1149/1.1379028; Mizuno F, 2005, ADV MATER, V17, P918, DOI 10.1002/adma.200401286; Iriyama Y, 2001, J POWER SOURCES, V94, P175, DOI 10.1016/S0378-7753(00)00580-2; ITOH M, 1994, SOLID STATE IONICS, V70, P203, DOI 10.1016/0167-2738(94)90310-7; Tsuchiya B, 2012, SURF INTERFACE ANAL, V44, P717, DOI 10.1002/sia.4818; Tsuchiya B., SOLID STATE IN PRESS; Tsuchiya B, 2013, NUCL INSTRUM METH B, V315, P341, DOI 10.1016/j.nimb.2013.04.080	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1187	1191		10.1002/sia.5620		5	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200017		
J	Abo, S; Pei, R; Yuan, YX; Wakaya, F; Takai, M				Abo, Satoshi; Pei, Ri; Yuan, Yao Xin; Wakaya, Fujio; Takai, Mikio			Analysis technique for ultra shallow junction using medium energy ion scattering time-of-flight elastic recoil detection analysis	SURFACE AND INTERFACE ANALYSIS			English	Article						time-of-flight (TOF); elastic recoil detection analysis (ERDA); medium energy ion scattering (MEIS); ultra shallow junction	SPREADING RESISTANCE MICROSCOPY; SPIKE LAMP; DOPANT PROFILES; IMPLANTATION; COMBINATION	An analysis technique for an ultra shallow junction in shrunk semiconductor devices was developed using medium energy ion scattering (MEIS) time-of-flight (TOF) elastic recoil detection analysis (ERDA). The energy of the recoiled and forward-scattered ions was analyzed using a toroidal electrostatic analyzer with an energy resolution of less than 0.4keV in MEIS-ERDA. TOF was used for a mass separation in MEIS-ERDA with high energy resolution, because an energy resolution of conventional ERDA with an absorber foil was degraded by the energy loss straggling on the foil. The probe beam of 100-keV N+ was chopped by a function generator for the TOF measurement. Three standard samples of 2-keV B+ implanted Si with doses of 0.5, 1.0, and 1.5x10(16)/cm(2) were measured using MEIS-TOF-ERDA. The measured depth profile of the B+ implanted Si sample with a dose of 0.5x10(16)/cm(2) was in good agreement with the simulated profile. The projected range and its straggling of 2-keV B+ implantation into a Si substrate measured using MEIS-TOF-ERDA were 6.3 and 6.1nm, respectively. The results indicated that an ultra shallow junction fabricated by low energy and light ion implantation can be analyzed using developed MEIS-TOF-ERDA. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Abo, Satoshi; Pei, Ri; Yuan, Yao Xin; Wakaya, Fujio; Takai, Mikio] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan	Abo, S (reprint author), Osaka Univ, Grad Sch Engn Sci, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan.	s-abo@stec.es.osaka-u.ac.jp			Japan Society for the Promotion of Science [22560295]; VLSI Design and Education Center (VDEC), the University of Tokyo; Synopsys, Inc.	This study is partially supported by the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (C) (grant no. 22560295), and VLSI Design and Education Center (VDEC), the University of Tokyo in collaboration with Synopsys, Inc. The authors are indebted to Dr. Toshiaki Iwamatsu (Mitsubishi Electric Corporation) for the B<SUP>+</SUP> implanted Si sample.	Abo S, 2008, AIP CONF PROC, V1066, P83; Abo S, 2010, AIP CONF PROC, V1321, P229; Abo S, 2012, AIP CONF PROC, V1496, P164, DOI 10.1063/1.4766515; Abo S, 2012, SURF INTERFACE ANAL, V44, P732, DOI 10.1002/sia.4878; Abo S, 2005, NUCL INSTRUM METH B, V237, P72, DOI 10.1016/j.nimb.2005.04.080; Copel M., 1993, REV SCI INSTRUM, V64, P147; Eyben P, 2007, MICROELECTRON ENG, V84, P437, DOI 10.1016/j.mee.2006.10.080; Fujita M, 2002, NUCL INSTRUM METH B, V190, P26, DOI 10.1016/S0168-583X(01)01248-4; Hashimoto H, 2012, NUCL INSTRUM METH B, V273, P241, DOI 10.1016/j.nimb.2011.07.085; Ichihara S, 2004, NUCL INSTRUM METH B, V219, P584, DOI 10.1016/j.nimb.2004.01.124; Kawasaki Y, 2005, NUCL INSTRUM METH B, V237, P25, DOI 10.1016/j.nimb.2005.04.073; Kimura K, 2004, NUCL INSTRUM METH B, V219, P351, DOI 10.1016/j.nimb.2004.01.081; Suchodolskis A, 2006, NUCL INSTRUM METH B, V253, P141, DOI 10.1016/j.nimb.2006.10.050	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1192	1195		10.1002/sia.5590		4	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200018		
J	Wang, ZP; Zhang, JW; Zhang, ZM; Ding, ZJ; Yamauchi, Y				Wang, Z. P.; Zhang, J. W.; Zhang, Z. M.; Ding, Z. J.; Yamauchi, Y.			Selective functionalization of silicon surface controlled by metastable helium atom beam for patterning chemisorbed monolayer molecular assemblies	SURFACE AND INTERFACE ANALYSIS			English	Article						metastable helium atom; functionalization; silicon; patterning	ELECTRON-BEAMS; MICROLITHOGRAPHY; NANOLITHOGRAPHY; DISSOCIATION; LITHOGRAPHY	Metastable neutral helium atoms are highly chemical sensitive to surface dangling bonds. As the basis of a new lithographic technique, a method for fabrication of self-assembled monolayers (SAMs) and mixed SAMs by the irradiation-promoted exchange reaction has been recently developed. Metastable helium atoms irradiation is shown to modify organosilane SAM films and Si-H and Si-OH covering surfaces, which render the surface amendable to further SAM modification. The exposure regions can undergo a second chemisorption reaction to produce an assembly of octadecyltrichlorosilane SAMs. Metastable helium atom beam patterned films can be used as templates for selective buildup of fluorophores, amino group, and biological cells to obtain further surface functionalization. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Wang, Z. P.; Zhang, Z. M.] Univ Sci & Technol China, Ctr Phys Expt, Hefei 230026, Anhui, Peoples R China; [Wang, Z. P.; Zhang, J. W.; Yamauchi, Y.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Zhang, J. W.; Ding, Z. J.] Univ Sci & Technol China, Dept Phys, Hefei 230026, Anhui, Peoples R China	Wang, ZP (reprint author), Univ Sci & Technol China, Ctr Phys Expt, Hefei 230026, Anhui, Peoples R China.	zpwang@ustc.edu.cn			National Natural Science Foundation of China [21002097, 11274288]; '973' projects [2011CB932801, 2012CB933702]; Ministry of Education of China [20123402110034]; Fundamental Research Funds for the Central Universities [WK2030220007]	This work was partly supported by the National Natural Science Foundation of China (Grant Nos. 21002097 and 11274288), '973' projects (Nos. 2011CB932801 and 2012CB933702), Ministry of Education of China (No. 20123402110034) and the Fundamental Research Funds for the Central Universities (Grant No. WK2030220007).	Geyer W, 1999, APPL PHYS LETT, V75, P2401, DOI 10.1063/1.125027; Ballav N, 2008, ANGEW CHEM INT EDIT, V47, P1421, DOI 10.1002/anie.200704105; BERGGREN KK, 1995, SCIENCE, V269, P1255, DOI 10.1126/science.7652572; Wang YL, 2003, LANGMUIR, V19, P1159, DOI 10.1021/la020697x; Golzhauser A, 2001, ADV MATER, V13, P806, DOI 10.1002/1521-4095(200106)13:11%3C803::AID-ADMA806%3E3.0.CO;2-W; Ju X, 2003, JPN J APPL PHYS 1, V42, P4767, DOI 10.1143/JJAP.42.4767; Olsen C, 1998, J CHEM PHYS, V108, P3750, DOI 10.1063/1.475780; Wang ZP, 2010, J NANOSCI NANOTECHNO, V10, P7443, DOI 10.1166/jnn.2010.2853; Yamauchi Y, 2003, J PHYS CHEM B, V107, P4107, DOI 10.1021/jp027013e; Yamauchi Y, 1998, MEAS SCI TECHNOL, V9, P531, DOI 10.1088/0957-0233/9/3/030; Zhang JW, 2006, JPN J APPL PHYS 1, V45, P8020, DOI 10.1143/JJAP.45.8020	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1196	1199		10.1002/sia.5598		4	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200019		
J	Karasawa, M; Fujii, M; Morita, M; Ishimura, S; Mayama, N; Uchida, H; Kawamura, Y; Itoh, KM; Owari, M				Karasawa, Masanobu; Fujii, Makiko; Morita, Masato; Ishimura, Satoshi; Mayama, Norihito; Uchida, Hiroshi; Kawamura, Yoko; Itoh, Kohei M.; Owari, Masanori			Investigation of mixing effects of silicon isotopes under shave-off condition using atom probe tomography	SURFACE AND INTERFACE ANALYSIS			English	Article						SIMS; shave-off depth profiling; mixing effects; APT	SUPERLATTICES; GROWTH	Shave-off depth profiling uses a Ga focused ion beam micro-machining process to provide highly precise depth profiles with nanometer-scale resolution. This method is a very unique process for acquiring a depth profile using the shave-off scan mode, in which the primary ion beam perpendicular to the direction of depth irradiates the sample. In our previous study, we confirmed by molecular dynamics simulation that the shave-off scan mode has a low mixing effect compared with the conventional scan mode, which uses the normal incident angle. However, the current understanding of measurement using the shave-off scan mode is insufficient. In this study, in order to estimate the sample damage in the shave-off scan mode, we investigated the degree of mixing effects after the primary ion bombardment under shave-off conditions using atom probe tomography. To evaluate the mixing effects, the intermixing of silicon isotope multilayers induced by ion beam irradiation was investigated. The depth of the damage from the sample surface caused by Ga focused ion beams was analyzed for both the shave-off scan mode and the conventional scan mode using the normal incident angle. Results showed that the shave-off scan mode has a significantly smaller mixing effect than the conventional scan mode. In addition, results showed that the attenuations of the damage and the Ga concentration exhibited almost the same tendency. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Karasawa, Masanobu; Fujii, Makiko; Morita, Masato; Owari, Masanori] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Ishimura, Satoshi; Mayama, Norihito; Uchida, Hiroshi] Toshiba Nanoanal Corp, Phys Anal Technol Ctr, Isogo Ku, Yokohama, Kanagawa 2358522, Japan; [Kawamura, Yoko; Itoh, Kohei M.] Keio Univ, Sch Fundamental Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Owari, Masanori] Univ Tokyo, Ctr Environm Sci, Bunkyo Ku, Tokyo 1130033, Japan	Karasawa, M (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.	m-kara@iis.u-tokyo.ac.jp	Itoh, Kohei/C-5738-2014				Kelly TF, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2709758; Thompson K, 2007, ULTRAMICROSCOPY, V107, P131, DOI 10.1016/j.ultramic.2006.06.008; Shimizu Y, 2009, J APPL PHYS, V106, DOI 10.1063/1.3236673; Koelling S, 2011, ULTRAMICROSCOPY, V111, P540, DOI 10.1016/j.ultramic.2011.01.004; Kojima T, 2003, APPL PHYS LETT, V83, P2318, DOI 10.1063/1.1613365; Fujii M, 2013, SURF INTERFACE ANAL, V45, P122, DOI 10.1002/sia.5044; Fujii M., 2011, JSA, V17, P232; Fujii Makiko, 2010, e-Journal of Surface Science and Nanotechnology, V8, DOI 10.1380/ejssnt.2010.237; Fujii M., 2012, E J SURF SCI NANOTEC, V10, P463; Gnaser H., 2012, J PHYS D, V45, P50503; Nakamura K, 2006, SURF INTERFACE ANAL, V38, P1734, DOI 10.1002/sia.2436; Nojima M, 2004, APPL SURF SCI, V231, P930, DOI 10.1016/j.apsusc.2004.03.176; Shimizu Y, 2011, J APPL PHYS, V109, DOI 10.1063/1.3544496; Shimizu Y, 2006, THIN SOLID FILMS, V508, P160, DOI 10.1016/j.tsf.2005.08.394; Toi M., 2005, J SURF ANAL, V12, P170; Tomita M, 2012, J VAC SCI TECHNOL B, V30, DOI 10.1116/1.3669400	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1200	1203		10.1002/sia.5645		4	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200020		
J	Yasumatsu, H; Fukui, N				Yasumatsu, Hisato; Fukui, Nobuyuki			Novel catalytic functions induced by charge accumulation at subnano interface between unisize metal cluster disk and semiconductor surface	SURFACE AND INTERFACE ANALYSIS			English	Article						platinum clusters; silicon surface; cluster deposition; CO oxidation; catalysis	PLATINUM CLUSTERS; SILICON(111)-7X7 SURFACE; OXIDATION; CO; SIZE; MGO	We have successfully accumulated electrons in a subnano-space according to the Schottky barrier junction between a subnano metal cluster and a semiconductor surface. The scanning-tunneling microscopy/spectroscopy measurements depicted spatial distributions of the accumulated charges. Taking advantages of their large charge-transfer efficiency to molecules, novel catalytic functions driven by the subnano-space charges were studied by means of ultrahigh-sensitive temperature-programmed desorption mass spectroscopy. As a representative function, we have found high-performance catalytic activity of Pt-30 monatomic-layered disks constructed on the Si(111) surface in CO oxidation. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Yasumatsu, Hisato] Genesis Res Inst Inc, Toyota Technol Inst, East Tokyo Lab, Cluster Res Lab, Ichikawa, Chiba 2720001, Japan; [Fukui, Nobuyuki] Genesis Res Inst Inc, East Tokyo Lab, Ichikawa, Chiba 2720001, Japan	Yasumatsu, H (reprint author), Genesis Res Inst Inc, Toyota Technol Inst, East Tokyo Lab, Cluster Res Lab, 717-86 Futamata, Ichikawa, Chiba 2720001, Japan.	yasumatsu@clusterlab.jp			Special Cluster Research Project of Genesis Research Institute, Inc.	This research was supported by the Special Cluster Research Project of Genesis Research Institute, Inc.	ALLERS KH, 1994, J CHEM PHYS, V100, P3985, DOI 10.1063/1.466332; Zhang C, 2007, J AM CHEM SOC, V129, P2228, DOI 10.1021/ja0684545; Jena P, 2006, P NATL ACAD SCI USA, V103, P10560, DOI 10.1073/pnas.0601782103; Sanchez A, 1999, J PHYS CHEM A, V103, P9573, DOI 10.1021/jp9935992; Lin X, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.206801; Ricci D, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.036106; Yasumatsu H, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2018639; Yasumatsu H, 2011, EUR PHYS J D, V63, P195, DOI 10.1140/epjd/e2011-10530-9; Yoon B, 2005, SCIENCE, V307, P403, DOI 10.1126/science.1104168; Yasumatsu H, 2003, REP PROG PHYS, V66, P1783, DOI 10.1088/0034-4885/66/10/R06; Heiz U, 1999, J AM CHEM SOC, V121, P3214, DOI 10.1021/ja983616l; desHeer W. A., 1993, REV MOD PHYS, V65, P611; Fukui N, 2013, EUR PHYS J D, V67, DOI 10.1140/epjd/e2013-30648-x; Bernhardt TM, 2007, NANOSCI TECHNOL, P1; Meiwes-Broer K. H., 2000, METAL CLUSTERS SURFA; Sattler K., 2010, HDB NANOPHYSICS; Yasumatsu H., 2012, PHYS STATUS SOLIDI B, V6, P1193; Yasumatsu H, 2009, Journal of Physics: Conference Series, V185, DOI 10.1088/1742-6596/185/1/012057; Yasumatsu H, 2013, J PHYS CONF SER, V438, DOI 10.1088/1742-6596/438/1/012004; Yasumatsu H, 2010, CHEM PHYS LETT, V487, P279, DOI 10.1016/j.cplett.2010.01.045; Yasumatsu H, 2014, CAN J CHEM ENG, V92, P1531, DOI 10.1002/cjce.21987; Yasumatsu H, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2126669	22	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1204	1207		10.1002/sia.5646		4	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200021		
J	Fujii, Y; Nakajima, K; Suzuki, M; Kimura, K				Fujii, Y.; Nakajima, K.; Suzuki, M.; Kimura, K.			Surface and interface roughness estimations by X-ray reflectivity and RBS measurements	SURFACE AND INTERFACE ANALYSIS			English	Article						X-ray reflectivity; Rutherford backscattering spectroscopy; surface and interface roughness	RUTHERFORD BACKSCATTERING SPECTROSCOPY; SCATTERING	X-ray reflectivity (XRR) is often used to estimate the interface roughness. In principle, XRR can measure both surface and interface roughness. However, the sensitivity to the interface roughness is rather poor compared with the surface roughness. In order to improve the accuracy in the interface roughness, a combination analysis of XRR with high-resolution Rutherford backscattering spectroscopy was performed. The surface and interface roughness were determined so that both XRR and high-resolution Rutherford backscattering spectroscopy spectra can be reproduced. We also found that the effective roughness measured by XRR may depend on the angle of incidence. This is because the roughness depends on the size of the probing area. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Fujii, Y.] Kobe Univ, Ctr Supports Res & Educ Act, Kobe, Hyogo 6578501, Japan; [Nakajima, K.; Suzuki, M.; Kimura, K.] Kyoto Univ, Dept Micro Engn, Kyoto 6158540, Japan	Fujii, Y (reprint author), Kobe Univ, Ctr Supports Res & Educ Act, Kobe, Hyogo 6578501, Japan.	fujiiyos@kobe-u.ac.jp					ANDREWS SR, 1985, J PHYS C SOLID STATE, V18, P6427, DOI 10.1088/0022-3719/18/35/008; PARRATT LG, 1954, PHYS REV, V95, P359, DOI 10.1103/PhysRev.95.359; YANG Q, 1991, NUCL INSTRUM METH B, V61, P149, DOI 10.1016/0168-583X(91)95454-L; MARRA WC, 1979, J APPL PHYS, V50, P6927, DOI 10.1063/1.325845; NEVOT L, 1980, REV PHYS APPL, V15, P761, DOI 10.1051/rphysap:01980001503076100; SINHA SK, 1988, PHYS REV B, V38, P2297, DOI 10.1103/PhysRevB.38.2297; Fujii Y, 2011, IOP CONF SER-MAT SCI, V24, DOI 10.1088/1757-899X/24/1/012009; Fujii Y, 1997, REV SCI INSTRUM, V68, P1975, DOI 10.1063/1.1148085; Kimura K, 2004, NUCL INSTRUM METH B, V219, P351, DOI 10.1016/j.nimb.2004.01.081; KIMURA K, 1994, APPL PHYS LETT, V64, P2232, DOI 10.1063/1.111653; Nakajima K, 2003, APPL PHYS LETT, V83, P296, DOI 10.1063/1.1592310; ROBINSON IK, 1986, PHYS REV B, V33, P3830, DOI 10.1103/PhysRevB.33.3830	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1208	1211		10.1002/sia.5644		4	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200022		
J	Suzuki, M; Nojima, M; Fujii, M; Seki, T; Matsuo, J				Suzuki, Masato; Nojima, Masashi; Fujii, Makiko; Seki, Toshio; Matsuo, Jiro			Mass analysis by Ar-GCIB-dynamic SIMS for organic materials	SURFACE AND INTERFACE ANALYSIS			English	Article						dynamic SIMS; Ar-GCIB; arginine; glycine; blended-polymer; principal components analysis	CLUSTER ION-BEAMS; SPECTROMETRY; POLYMERS; SURFACE; ENERGY	Generally, dynamic secondary ion mass spectrometry (SIMS) has been mainly used as one of the most powerful tools for inorganic mass analysis. On the other hand, an Ar gas cluster ion beam (GCIB) has been developed and spread as a processing tool for surface flattening and also a projectile for time-of-flight (ToF) SIMS. In this study, we newly introduced an Ar-GCIB as a primary ion source to a commercially available dynamic SIMS apparatus, and investigated mass spectra of amino acid films (such as arginine and glycine) and polymer films (polyethylene: PE and polypropylene: PP) as organic model samples. As a result, each characteristic fragment peak indicating the original molecular organic structure was observed in the acquired mass spectra. In addition, their own molecular ions of the amino acids were also clearly observed. Mass spectra of PE/PP blended-polymer films acquired using Ar-GCIB-dynamic SIMS could be identified between pure PE and PE:PP=1:3 mixture by applying principal components analysis. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Suzuki, Masato] Tokyo Univ Sci, Fac Sci & Technol, JP-2788510 Noda, Chiba, Japan; [Nojima, Masashi] Tokyo Univ Sci, RIST, JP-2788510 Noda, Chiba, Japan; [Fujii, Makiko; Matsuo, Jiro] Kyoto Univ, Quantum Sci & Engn Ctr, JP-6110011 Uji, Kyoto, Japan; [Seki, Toshio] Kyoto Univ, Dept Nucl Engn, JP-6110011 Uji, Kyoto, Japan	Suzuki, M (reprint author), Tokyo Univ Sci, Fac Sci & Technol, 2641 Yamazaki, JP-2788510 Noda, Chiba, Japan.	j7213640@ed.tus.ac.jp					Gillen G, 2006, APPL SURF SCI, V252, P6521, DOI 10.1016/j.apsusc.2006.02.234; Miyasaka T, 2008, APPL SURF SCI, V255, P1576, DOI 10.1016/j.apsusc.2008.05.137; Seki T, 2006, NUCL INSTRUM METH B, V242, P179, DOI 10.1016/j.nimb.2005.08.023; Mahoney CM, 2006, APPL SURF SCI, V252, P6502, DOI 10.1016/j.apsusc.2006.02.078; Lee JLS, 2010, ANAL CHEM, V82, P98, DOI 10.1021/ac901045q; Aoyagi S, 2004, APPL SURF SCI, V231, P470, DOI 10.1016/j.apsusc.2004.03.181; DELCORTE A, 1995, NUCL INSTRUM METH B, V100, P213, DOI 10.1016/0168-583X(94)00842-6; Matsuo J, 2012, SURF INTERFACE ANAL, V44, P729, DOI 10.1002/sia.4856; Matsuo J, 2010, SURF INTERFACE ANAL, V42, P1612, DOI 10.1002/sia.3585; Moritani K, 2011, SURF INTERFACE ANAL, V43, P241, DOI 10.1002/sia.3551; Ninomiya S, 2011, SURF INTERFACE ANAL, V43, P221, DOI 10.1002/sia.3656; Ninomiya S, 2008, APPL SURF SCI, V255, P1588, DOI 10.1016/j.apsusc.2008.05.004; vansOoij W. J., 1988, SURF INTERFACE ANAL, V11, P430	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1212	1214		10.1002/sia.5696		3	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200023		
J	Yamazaki, A; Tobe, T; Akiba, S; Owari, M				Yamazaki, Atsuko; Tobe, Teruhiko; Akiba, Shouta; Owari, Masanori			Metal-assisted SIMS for three-dimensional analysis using shave-off section processing	SURFACE AND INTERFACE ANALYSIS			English	Article						ToF-SIMS; MetA-SIMS; shave-off; FIB	ION MASS-SPECTROMETRY; ENHANCEMENT; BEAM	Three-dimensional microanalysis of the microstructure of organic materials is important in the development and progress of analytical methods on the micro-to-nanometer scales. We have developed a novel three-dimensional microanalysis method using focused ion beams for section processing (shave-off scanning) and time-of-flight secondary ion mass spectrometry for mapping. Shave-off scanning can effectively create an arbitrary section on a sample set against composites materials with a wide variety of shapes; three-dimensional sample images are then obtained by alternately operating two focused ion beams. In this study, we adapted metal-assisted secondary ion mass spectrometry for three-dimensional microanalysis. We have devised a unique method whereby gold is deposited on a section to be analyzed after every shave-off sectioning by setting a gold plate at the back of the sample. Consequently, gold was observed to be deposited on the created cross-section concurrently with shave-off sectioning, resulting in a substantially enhanced secondary ion intensity. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Yamazaki, Atsuko; Tobe, Teruhiko; Akiba, Shouta; Owari, Masanori] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Owari, Masanori] Univ Tokyo, Ctr Environm Sci, Bunkyo Ku, Tokyo 1130033, Japan	Yamazaki, A (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan.	ayama@iis.u-tokyo.ac.jp					Delcorte A, 2002, ANAL CHEM, V74, P4955, DOI 10.1021/ac020125h; Delcorte A, 2004, APPL SURF SCI, V231, P250, DOI 10.1016/j.apsusc.2004.03.029; Morita Y, 2010, SURF INTERFACE ANAL, V42, P1622, DOI 10.1002/sia.3622; Morita Y, 2008, APPL SURF SCI, V255, P1052, DOI 10.1016/j.apsusc.2008.05.078; Nittler L, 2011, SURF INTERFACE ANAL, V43, P103, DOI 10.1002/sia.3425; Owari M., 1999, J SURF ANAL, V5, P356; Prabhakaran A, 2011, SURF INTERFACE ANAL, V43, P74, DOI 10.1002/sia.3477; Sakamoto T., 2004, E J SURF SCI NANOTEC, V2, P45, DOI 10.1380/ejssnt.2004.45; SATOH H, 1988, J VAC SCI TECHNOL B, V6, P915, DOI 10.1116/1.584322; Yamazaki A., 2011, E J SURF SCI NANOTEC, V9, P426	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1215	1218		10.1002/sia.5589		4	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200024		
J	Hayasaka, T; Goto-Inoue, N; Masaki, N; Ikegami, K; Setou, M				Hayasaka, Takahiro; Goto-Inoue, Naoko; Masaki, Noritaka; Ikegami, Koji; Setou, Mitsutoshi			Application of 2,5-dihydroxyacetophenone with sublimation provides efficient ionization of lipid species by atmospheric pressure matrix-assisted laser desorption/ionization imaging mass spectrometry	SURFACE AND INTERFACE ANALYSIS			English	Article						matrix-assisted laser desorption; ionization (MALDI); imaging mass spectrometry (IMS); volatile matrix; lipid species; rat brain		Imaging mass spectrometry (IMS) is a powerful tool for detecting and visualizing biomolecules in tissue sections. Most IMS instruments are equipped with a high-vacuum chamber for matrix-assisted laser desorption/ionization (MALDI). However, the use of high-vacuum conditions restricts the usage of the matrix to less-volatile substances. We recently developed an atmospheric pressure MALDI instrument, named the mass microscope', to avoid this problem. The atmospheric pressure condition enables us to use volatile matrices. In this study, we compared the reliability of a volatile matrix, 2,5-dihydroxyacetophenone (DHAP) with that of a conventionally used matrix, 2,5-dihydroxybenzoic acid (DHB). Compared with the results obtained with DHB, the mass spectra obtained with DHAP showed a variety of signal species in a mass region corresponding to phospholipid species in both the positive and negative ion modes without any matrix-derived signals. DHAP provided highly strong signals of ganglioside (GM1) species. We also compared two matrix deposition techniques for DHAP matrix: sublimation and spraying. We found that the sublimation method for applying DHAP matrix on a tissue surface can maintain ion images of lipid species, including ganglioside species only in a tissue. In contrast, the spraying method led the diffusion of GM1 species toward the outside of the tissue sections. Consequently, the sublimation method for applications of DHAP is adequate to analyze some types of lipid species including GM1 in atmospheric pressure MALDI IMS. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Hayasaka, Takahiro; Masaki, Noritaka; Ikegami, Koji; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Goto-Inoue, Naoko] Tokyo Metropolitan Univ, Dept Hlth Promot Sci, Hachioji, Tokyo 1920397, Japan	Hayasaka, T (reprint author), Hokkaido Univ, Fac Hlth Sci, Kita Ku, Kita 12,Nishi 5, Sapporo, Hokkaido 0600812, Japan.	thaya@hs.hokudai.ac.jp			Japan Science and Technology Agency; Machineries of Bioactive Lipids in Homeostasis and Diseases; MEXT	This work was supported in part by a Grant-in-Aid for SENTAN from the Japan Science and Technology Agency (to T. H.), Machineries of Bioactive Lipids in Homeostasis and Diseases (to M. S.), a Grant-in-Aid for Scientific Research (B) (to M. S.), and the MEXT project for the Creation of Research Platforms and Sharing of Advanced Research Infrastructure (to M. S.).	Khatib-Shahidi S, 2006, ANAL CHEM, V78, P6448, DOI 10.1021/ac060788p; Cerruti C. D., 2012, ANAL CHEM, V5, P2164; Fania C., 2011, ELECTROPHORESIS, V13, P1715; Goto-Inoue N., 2010, J AM SOC MASS SPECTR, V11, P1940; Goto-Inoue N., 2008, J CHROMATOGR B, V1, P74; Harada T., 2009, ANAL CHEM, V21, P9153; Hayasaka T., 2010, J AM SOC MASS SPECTR, V8, P1446; Hayasaka T., 2009, LIPIDS, V9, P837; Hayasaka T., 2008, RAPID COMMUN MASS SP, V21, P3415; Ide Y., 2013, PLOS ONE, V4; Inutan E. D., 2010, J PROTEOME RES, V11, P6077; Sugiura Y., 2012, ANAL BIOANAL CHEM, V7, P1851; Sugiura Y., 2011, PLOS ONE, V3; Thomas A., 2012, ANAL CHEM, V4, P2048; Yao I., 2008, PROTEOMICS, V18, P3692	15	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1219	1222		10.1002/sia.5592		4	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200025		
J	Tamura, R; Takata, K				Tamura, Ryota; Takata, Keiji			Strain imaging of electrochemical reactions of a solid electrolyte Cu2S	SURFACE AND INTERFACE ANALYSIS			English	Article						solid electrolyte; ReRAM; Cu2S; electrochemical reaction; scanning probe microscopy	ATOMIC SWITCH	The electrochemical behavior of a solid electrolyte Cu2S was investigated using strain imaging. The precipitation or dissolution of Cu in Cu2S induces changes in volume. Scanning probe microscopy detects the changes in volume through surface displacements with high resolution, and so, we can observe the extension of redox-induced regions. The Cu filaments grew as the voltages were increased, and finally, a Cu bridge between the upper and lower electrodes was formed. When the Cu bridge was formed, electrochemical reactions were considerably suppressed because a large part of the current flowed through the Cu bridge. This was proven by the substantial decreases in the detected surface displacements. Further, growth of filaments was suppressed and the one-bridge connection was kept, which led to high-speed switching because the time required for disconnection was shortened. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Tamura, Ryota; Takata, Keiji] Kansai Univ, Fac Engn Sci, Suita, Osaka 5648680, Japan	Takata, K (reprint author), Kansai Univ, Fac Engn Sci, Suita, Osaka 5648680, Japan.	takatak@kansai-u.ac.jp					Sakamoto T, 2003, APPL PHYS LETT, V82, P3032, DOI 10.1063/1.1572964; Shibuta Y, 2006, SCRIPTA MATER, V55, P1095, DOI 10.1016/j.scriptamat.2006.08.043; Terabe K, 2005, NATURE, V433, P47, DOI 10.1038/nature03190; Wang Z, 2007, NANO LETT, V7, P2688, DOI 10.1021/nl0711054; Okajima Y, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.065202; Takata K, 2011, CURR APPL PHYS, V11, P1364, DOI 10.1016/j.cap.2011.04.004; Tsuchiya T, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.055002; VIGNERON JP, 1994, J VAC SCI TECHNOL B, V12, P2161, DOI 10.1116/1.587731	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1223	1225		10.1002/sia.5583		3	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200026		
J	Nishikawa, O; Taniguchi, M				Nishikawa, Osamu; Taniguchi, Masahiro			Atomic level analysis of carbon fibers by the scanning atom probe	SURFACE AND INTERFACE ANALYSIS			English	Article						carbon fiber; scanning atom probe; mass spectrometry; field evaporation	TOF-SIMS; FIELD	Carbon fibers made from polyacrilonitrile and pitch were mass analyzed utilizing the unique capability of the scanning atom probe, atom-by-atom mass analysis. The most significant mass peak is COH showing that these fibers contain large amounts of oxygen and hydrogen. Unexpected findings are the detection of C27OH and C50ONH ions from polyacrilonitrile-based fibers and C27OH and 7 mass peaks from C30OH5 to C37OH5 from pitch-based fibers. The mass difference of the seven mass peaks is 14amu possibly because of the number of bound CH2 and nitrogen atom. These mass spectra are not found by analyzing other carbon specimens such as carbon nanotubes, graphite, and graphens. Uniqueness of the mass spectra could be due to the 1different fabrication process. The relation of the mass spectra and the tensile strength and modulus of the fibers is discussed. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Nishikawa, Osamu; Taniguchi, Masahiro] Kanazawa Inst Technol, Coll Biosci & Chem, Dept Appl Chem, Nonoichi, Ishikawa 9218501, Japan	Taniguchi, M (reprint author), Kanazawa Inst Technol, Coll Biosci & Chem, Dept Appl Chem, Ohgigaoka 7-1, Nonoichi, Ishikawa 9218501, Japan.	taniguchi@neptune.kanazawa-it.ac.jp			JSPS KAKENHI [24510157]	This work was supported by JSPS KAKENHI Grant-in-Aid for Scientific Research (C) 24510157.	MULLER EW, 1968, REV SCI INSTRUM, V39, P83; Hamerton I, 1997, CHEM MATER, V9, P1972, DOI 10.1021/cm960539p; Muller E. W., 1969, FIELD ION MICROSCOPY; NISHIKAWA O, 1981, REV SCI INSTRUM, V52, P810, DOI 10.1063/1.1136701; Nishikawa O, 2003, NEW DIAM FRONT C TEC, V13, P257; Nishikawa O., 2006, CHINESE J PHYS, V43, P111; Nishikawa O, 2009, APPL SURF SCI, V256, P1210, DOI 10.1016/j.apsusc.2009.05.154; Nishikawa O, 2009, J VAC SCI TECHNOL A, V27, P1076, DOI 10.1116/1.3077280; Nishikawa O, 2000, MATER CHARACT, V44, P29, DOI 10.1016/S1044-5803(99)00046-7; Nishikawa O, 2008, J VAC SCI TECHNOL B, V26, P735, DOI 10.1116/1.2824968; NISHIKAWA O, 1994, APPL SURF SCI, V76, P424, DOI 10.1016/0169-4332(94)90376-X; Prickett AC, 2001, SURF INTERFACE ANAL, V31, P11, DOI 10.1002/sia.946	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1231	1235		10.1002/sia.5695		5	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200028		
J	Yoshida, T; Kuda, E; Muto, S				Yoshida, Tomoko; Kuda, Eriko; Muto, Shunsuke			Depth distribution of dopant effective for visible-light response in nitrogen-doped TiO2 photocatalyst	SURFACE AND INTERFACE ANALYSIS			English	Article						nitrogen doped TiO2; EELS; Methylene blue	ENERGY RESOLUTION IMPROVEMENT; SPECTRAL RESTORATION; PIXON RECONSTRUCTION; IMPLANTED NITROGEN; STATE ANALYSIS; RESOLVED EELS	Nitrogen was doped into TiO2 by an ion implantation technique to investigate the depth distribution of nitrogen most effective for fabricating a visible-light responsive photocatalyst. In the nitrogen-doped TiO2 samples, the photocatalytic activity under visible-light irradiation was enhanced, wherein two types of chemical state of nitrogen, one photocatalytically active and the other inactive, were found depending on the nitrogen concentration, using electron energy loss spectroscopy. The depth distributions of nitrogen were quantified, so that the implanted nitrogen increased with thickness from the surface up to 90nm, consistent with Monte Carlo simulations. The critical nitrogen concentration for the photocatalytically active species to form was estimated to be no higher than 1.8atom%. We also derived semi-empirical equations from the present results to estimate the critical depth of nitrogen distribution effectively reactive to be 13 +/- 5nm from the surface. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Yoshida, Tomoko; Kuda, Eriko; Muto, Shunsuke] Nagoya Univ, EcoTopia Sci Inst, Nagoya, Aichi 4648603, Japan	Yoshida, T (reprint author), Nagoya Univ, EcoTopia Sci Inst, Nagoya, Aichi 4648603, Japan.	tyoshida@nucl.nagoya-u.ac.jp			Japan Society of the Promotion of Science [24360332, 25106004]	This work was partially supported by a Grants-in-Aid for Scientific Research on Kiban-kenkyu (B) (no. 24360332) and Innovative Areas 'Nano Informatics' (no. 25106004) from the Japan Society of the Promotion of Science.	Kimoto K, 1997, J ELECTRON MICROSC, V46, P369; Asahi R, 2007, CHEM PHYS, V339, P57, DOI 10.1016/j.chemphys.2007.07.041; Yan XL, 2006, CHEM PHYS LETT, V429, P606, DOI 10.1016/j.cplett.2006.08.081; Asahi R, 2000, PHYS REV B, V61, P7459, DOI 10.1103/PhysRevB.61.7459; Vinodgopal K, 1996, ENVIRON SCI TECHNOL, V30, P1660, DOI 10.1021/es950655d; Yoshida T, 2007, MATER SCI FORUM, V561-565, P567; Yoshida T, 2010, STUD SURF SCI CATAL, V175, P267, DOI 10.1016/S0167-2991(10)75039-4; SAKAI H, 1995, J PHYS CHEM-US, V99, P11896, DOI 10.1021/j100031a017; Yoshida T, 2007, MATER TRANS, V48, P2580, DOI 10.2320/matertrans.MD2007121; Yoshida T, 2008, T MRS JAP, V33, P339; Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051; Nosaka Y, 2005, SCI TECHNOL ADV MAT, V6, P143, DOI 10.1016/j.stam.2004.11.006; Irie H, 2003, J PHYS CHEM B, V107, P5483, DOI 10.1021/jp030133h; Muto S, 2006, J ELECTRON MICROSC, V55, P225, DOI 10.1093/jmicro/dfl029; Muto S, 2006, J ELECTRON MICROSC, V55, P215, DOI 10.1093/jmicro/dfl028; Pina P. K., 1993, ASTR SOC PAC, V105, P630; Yoshida T., 2008, AMCT LETT, V2, P116	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1236	1239		10.1002/sia.5542		4	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200029		
J	Quang, NK; Miyauchi, Y; Mizutani, G; Charlton, MD; Chen, RQ; Boden, S; Rutt, H				Ngo Khoa Quang; Miyauchi, Yoshihiro; Mizutani, Goro; Charlton, Martin D.; Chen, Ruiqi; Boden, Stuart; Rutt, Harvey			Optical second harmonic generation of V-shaped chromium nanoholes-dependence on the structure parameters of the nanoholes	SURFACE AND INTERFACE ANALYSIS			English	Article						second harmonic generation (SHG); Cr metal; nanoholes; V-shaped structure; structural parameters; apex angle; arm length; bulk contribution; nonlinear susceptibility elements; modification of SHG	METAMATERIALS	We investigated optical second harmonic generation (SHG) from the arrays of V-shaped chromium nanoholes with the arm width of 50nm. We systematically investigated the dependence of the SHG intensity on the designed parameters of Cr nanoholes, i.e. the arm length and apex angle. Several combinations of structural parameters of apex angles (A) and arm lengths (L) were examined. The SHG intensity in Pin/Pout configuration was enhanced when L was enlarged. We suggest that the nonlinear optical behavior was dictated by the bulk contribution of metallic electrons. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Ngo Khoa Quang; Mizutani, Goro] Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Ishikawa 9231292, Japan; [Miyauchi, Yoshihiro] Natl Def Acad, Dept Appl Phys, Yokosuka, Kanagawa 2398686, Japan; [Charlton, Martin D.; Chen, Ruiqi; Boden, Stuart; Rutt, Harvey] Univ Southampton, Sch Elect & Comp Sci, Southampton SO17 1BJ, Hants, England	Mizutani, G (reprint author), Japan Adv Inst Sci & Technol, Sch Mat Sci, 1-1 Asahidai, Nomi, Ishikawa 9231292, Japan.	mizutani@jaist.ac.jp			Japan Society for the Promotion of Science [23540363]; Rank Prize Funds	This work was supported in part by a Grant-in-Aid for Scientific Research (c) of the Japan Society for the Promotion of Science (#23540363). H. Rutt thanks the Rank Prize Funds for support.	Gentile M, 2011, APPL PHYS B-LASERS O, V105, P149, DOI 10.1007/s00340-011-4766-y; Hubert C, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2734503; Butet J, 2013, NANO LETT, V13, P1787, DOI 10.1021/nl400393e; Lesuffleur A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.045423; Canfield BK, 2006, J OPT A-PURE APPL OP, V8, pS278, DOI 10.1088/1464-4258/8/4/S30; Wang FX, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.233402; Kujala S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.167403; Zdanowicz M, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/023025; Shalaev VM, 2007, NAT PHOTONICS, V1, P41, DOI 10.1038/nphoton.2006.49; SIPE JE, 1987, PHYS REV B, V35, P1129, DOI 10.1103/PhysRevB.35.1129; Boltasseva A., 2008, METAMATERIALS, V2, P1, DOI DOI 10.1016/J.METAMAT.2008.03.004; Brevet P. F., 1997, SURFACE 2 HARMONIC G; Guedje FK, 2012, PHYS SCRIPTA, V86, DOI 10.1088/0031-8949/86/05/055702; Husu H., 2008, METAMATERIALS, V2, P155, DOI 10.1016/j.metmat.2008.06.001; Kettle SFA, 1998, SPECTROCHIM ACTA A, V54, P1639, DOI 10.1016/S1386-1425(98)00091-2; Omote M., 2005, J PHYS CONDENS MATT, V17, P175; Quang N. K., 2014, JPN J APPL PHYS, V53; Shen YR, 1999, APPL PHYS B-LASERS O, V68, P295, DOI 10.1007/s003400050622; Valev VK, 2011, OPT MATER EXPRESS, V1, P36; Zhou RL, 2010, J OPT SOC AM B, V27, P2405	20	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1240	1244		10.1002/sia.5643		5	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200030		
J	Kitta, M; Akita, T; Maeda, Y; Tanaka, S; Kohyama, M				Kitta, Mitsunori; Akita, Tomoki; Maeda, Yasushi; Tanaka, Shingo; Kohyama, Masanori			Li-vapor induction growth of single-crystalline Li4Ti5O12 specimen for transmission electron microscopy	SURFACE AND INTERFACE ANALYSIS			English	Article						lithium-ion battery; negative electrode material; spinel lithium titanate; single-crystalline growth; transmission electron microscopy; surface and interface analysis	ENERGY-LOSS SPECTROSCOPY; SPINEL LI4TI5O12; LITHIUM DIFFUSION; PHASE-EQUILIBRIA; INSERTION; SURFACE; SYSTEM; RUTILE; LI4/3TI5/3O4; EXTRACTION	Spinel lithium titanate (LTO; Li4Ti5O12) is widely used as an electrode material in lithium-ion batteries. We have successfully prepared a well-defined LTO specimen with atomically flat thin edges suitable for transmission electron microscopy (TEM) study. A thin wafer of rutile-TiO2 was prepared by the traditional thinning procedure for TEM specimens, while it had a damaged amorphous surface layer. By heating with LiOH<bold>H</bold>2O, thin edge regions of the TiO2 specimen were transformed into an LTO single crystal. The direction of the LTO growth depends on the orientation of the TiO2 specimen, and the amorphous surface layer of the TiO2 specimen plays an important role in the single-crystalline growth. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Kitta, Mitsunori; Akita, Tomoki; Maeda, Yasushi; Tanaka, Shingo; Kohyama, Masanori] Natl Inst Adv Ind Sci & Technol, Ikeda, Osaka 5638577, Japan	Kitta, M (reprint author), Natl Inst Adv Ind Sci & Technol, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan.	m-kitta@aist.go.jp	Maeda, Yasushi/M-3417-2015		Japan Society for the Promotion of Science (JSPS) [22360279]	The Authors thank C. Fukada and M. Makino for their beneficial assistance in sample preparation. This work was supported by the Japan Society for the Promotion of Science (JSPS Grant-in-Aid for Scientific Research (B) 22360279).	Kleykamp H, 2002, FUSION ENG DES, V61-62, P361, DOI 10.1016/S0920-3796(02)00120-5; IZQUIERDO G, 1980, MATER RES BULL, V15, P1655, DOI 10.1016/0025-5408(80)90248-2; Gligor F, 2006, SOLID STATE IONICS, V177, P2741, DOI 10.1016/j.ssi.2006.03.017; Ariyoshi K, 2005, ELECTROCHIM ACTA, V51, P1125, DOI 10.1016/j.electacta.2005.05.053; Takami N, 2011, J ELECTROCHEM SOC, V158, pA725, DOI 10.1149/1.3574037; Kitta M, 2012, LANGMUIR, V28, P12384, DOI 10.1021/la301946h; Teshima K, 2011, CRYST GROWTH DES, V11, P4401, DOI 10.1021/cg200578r; FERG E, 1994, J ELECTROCHEM SOC, V141, pL147, DOI 10.1149/1.2059324; Koudriachova MV, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.235423; Kitta M, 2013, J POWER SOURCES, V237, P26, DOI 10.1016/j.jpowsour.2013.03.022; COLBOW KM, 1989, J POWER SOURCES, V26, P397, DOI 10.1016/0378-7753(89)80152-1; DESCHANV.A, 1971, MATER RES BULL, V6, P699, DOI 10.1016/0025-5408(71)90103-6; JOHNSON OW, 1964, PHYS REV A-GEN PHYS, V136, pA284, DOI 10.1103/PhysRev.136.A284; Kitta M, 2012, APPL SURF SCI, V258, P3147, DOI 10.1016/j.apsusc.2011.11.052; Kitta M, 2014, SURF SCI, V619, P5, DOI 10.1016/j.susc.2013.09.026; Kitta M, 2014, J POWER SOURCES, V257, P120, DOI 10.1016/j.jpowsour.2014.01.069; OHZUKU T, 1995, J ELECTROCHEM SOC, V142, P1431, DOI 10.1149/1.2048592; Takami N, 2009, J ELECTROCHEM SOC, V156, pA128, DOI 10.1149/1.3043441	18	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1245	1248		10.1002/sia.5560		4	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200031		
J	Akita, T; Kohyama, M				Akita, Tomoki; Kohyama, Masanori			Visualization of the distribution of anatase and rutile TiO2 crystals in Au/TiO2 powder catalysts by STEM-EELS spectrum imaging	SURFACE AND INTERFACE ANALYSIS			English	Article						EELS; STEM; TiO2; catalyst	NANOPARTICLES; SPECTROSCOPY; GOLD	Gold nanoparticles deposited on TiO2 supports exhibit high catalytic activity for various chemical reactions such as low-temperature CO oxidation. The catalytic performance is sensitive to the structure of the TiO2 supports, as reported in the epoxidation of propylene. TiO2 powder (P-25), widely used as the support for metal catalysts, contains both anatase and rutile TiO2 phases. It is important to distinguish these two crystalline phases at the nanoscale in order to understand the effect of the support structure in Au/TiO2 catalysis. In this study, the two-phase distribution is analyzed using scanning transmission microscopy-electron energy-loss spectroscopy (STEM-EELS). The distribution is revealed through multilinear least-squares fitting on the basis of the difference in the energy-loss near-edge structure. The results obtained indicate that Au particles are preferentially deposited on rutile TiO2 in the deposition/precipitation process. The STEM-EELS spectrum imaging method, with its high energy and spatial resolutions, can be employed to determine the distribution of crystal phases, components, and valence states. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Akita, Tomoki; Kohyama, Masanori] Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, Ikeda, Osaka 5638577, Japan	Akita, T (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan.	t-akita@aist.go.jp					Kosmulski M, 2009, ADV COLLOID INTERFAC, V152, P14, DOI 10.1016/j.cis.2009.08.003; BRYDSON R, 1989, J PHYS-CONDENS MAT, V1, P797, DOI 10.1088/0953-8984/1/4/012; Brunetti G, 2011, CHEM MATER, V23, P4515, DOI 10.1021/cm201783z; Tsukamoto D, 2012, J AM CHEM SOC, V134, P6309, DOI 10.1021/ja2120647; Maigne A, 2009, J ELECTRON MICROSC, V58, P99, DOI 10.1093/jmicro/dfp022; BERGER SD, 1987, PHIL MAG LETT, V56, P179, DOI 10.1080/09500838708214705; Akita T, 2001, SURF INTERFACE ANAL, V31, P73, DOI 10.1002/sia.959; Haruta M, 1997, CATAL TODAY, V36, P153, DOI 10.1016/S0920-5861(96)00208-8; Hayashi T, 1998, J CATAL, V178, P566, DOI 10.1006/jcat.1998.2157; Muto S, 2009, J ELECTROCHEM SOC, V156, pA371, DOI 10.1149/1.3076137; Saifullah M. S. M., 1997, I PHYS C SER, V153, P167; Tsubota S., 1995, PREPARATION CATALYST, P227	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1249	1252		10.1002/sia.5582		4	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200032		
J	Ohta, N; Arafune, R; Tsukahara, N; Takagi, N; Kawai, M				Ohta, Naoka; Arafune, Ryuichi; Tsukahara, Noriyuki; Takagi, Noriaki; Kawai, Maki			Adsorbed states of iron(II) phthalocyanine on Ag(111) studied by high-resolution electron energy loss spectroscopy	SURFACE AND INTERFACE ANALYSIS			English	Article						high-resolution electron energy loss spectroscopy; iron phthalocyanine; Ag(111); thin film; adsorption configuration; vibrational spectra; molecule-substrate interaction	FIELD-EFFECT TRANSISTORS; COPPER PHTHALOCYANINE; METAL PHTHALOCYANINES; SUBSTRATE; SPECTRA; FILMS; CELLS	We investigated the adsorption states of iron(II) phthalocyanine (FePc) molecules on Ag(111) by using high-resolution electron energy loss spectroscopy (HREELS). The HREELS spectra were taken as a function of the coverage of FePc. At 1 monolayer, vibrational modes assigned as A(2u) and A(1g) representations were observed mainly by the dipole scattering mechanism, which indicates that the first-layer molecules adsorb with the molecular planes parallel to the surface. The vibration associated with the motion of the central Fe2+ ion perpendicular to the molecular plane shows a considerable shift of the vibration energy. This reflects significant bonding interactions between the FePc molecule and the substrate. In the high coverage regime, multilayers were grown, and the vibration modes attributed to not only A(2u) but also E-u representation were observed. The FePc molecules in the upper layers tilt the molecular planes to the substrate. The vibrational energy is almost identical to those in the gas phase, indicating weaker interactions between the molecules. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Ohta, Naoka; Tsukahara, Noriyuki; Takagi, Noriaki; Kawai, Maki] Univ Tokyo, Dept Adv Mat Sci, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan; [Arafune, Ryuichi] Natl Inst Mat Sci, MANA, Tsukuba, Ibaraki 3050044, Japan	Ohta, N (reprint author), Univ Tokyo, Dept Adv Mat Sci, Grad Sch Frontier Sci, 5-1-5-402 Kashiwanoha, Kashiwa, Chiba 2778561, Japan.	0999273493@mail.ecc.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT) [21225001]; World Premier International Research Center Initiative; MEXT; Japan Society for the Promotion of Science [24 . 5853]	The names of sponsors of the research contained in the paper, along grant numbers, are the following: The Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT) [Grants-in-Aid for Scientific Research (No. 21225001)], World Premier International Research Center Initiative, MEXT, and Japan Society for the Promotion of Science [Grants-in-Aid for Scientific Research (No. 24 . 5853)].	Li WM, 2010, J AM CHEM SOC, V132, P17056, DOI 10.1021/ja106217u; Wang YF, 2012, AIP ADV, V2, DOI 10.1063/1.4773458; Salomon E, 2005, SURF SCI, V596, P74, DOI 10.1016/j.susc.2005.09.005; Kim HG, 2011, THIN SOLID FILMS, V519, P2011, DOI 10.1016/j.tsf.2010.09.044; Peumans P, 2003, NATURE, V425, P158, DOI 10.1038/nature01949; Imahori H, 2009, ACCOUNTS CHEM RES, V42, P1809, DOI 10.1021/ar900034t; Guillaud G, 1998, COORDIN CHEM REV, V178, P1433, DOI 10.1016/S0010-8545(98)00177-5; Gopakumar TG, 2011, J PHYS CHEM C, V115, P12173, DOI 10.1021/jp2038619; Amsalem P, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.235426; Petraki F, 2012, J PHYS CHEM C, V116, P11110, DOI 10.1021/jp302233e; Liu ZQ, 2007, SPECTROCHIM ACTA A, V67, P1232, DOI 10.1016/j.saa.2006.10.013; Auerhammer JM, 2002, SURF SCI, V506, P333, DOI 10.1016/S0039-6028(02)01517-0; Wang SD, 2004, J PHYS CHEM B, V108, P1529, DOI 10.1021/jp0361733; de la Torre G, 2007, CHEM COMMUN, P2000, DOI 10.1039/b614234f; KOBAYASH.T, 1970, SPECTROCHIM ACTA A-M, VA 26, P1305, DOI 10.1016/0584-8539(70)80036-8; lbach H., 1982, ELECT ENERGY LOSS SP; Lu J, 2009, CHEM PHYS LETT, V468, P28, DOI 10.1016/j.cplett.2008.11.076; MELENDRES CA, 1980, J PHYS CHEM-US, V84, P1936, DOI 10.1021/j100452a014; Papageorgiou N, 2004, PROG SURF SCI, V77, P139, DOI 10.1016/j.progsurf.2005.01.001; Salomon E, 2007, J PHYS CHEM C, V111, P5721, DOI 10.1021/jp0663356; Willis R. F., 1983, CHEM PHYSICS SOLID S, V2, P59; Yu M, 2006, J PHYS CHEM B, V110, P2164, DOI 10.1021/jp0552325	22	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1253	1256		10.1002/sia.5529		4	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200033		
J	Takata, K				Takata, Keiji			Domain structures of a main pole tip in a hard disk drive observed by magnetic strain imaging	SURFACE AND INTERFACE ANALYSIS			English	Article						hard disk drive; head-induced data erasure; erase-after-write; scanning probe microscopy; magnetic-field-induced strain	SCANNING TUNNELING MICROSCOPE; ELECTRON-MICROSCOPY; FORCE MICROSCOPY; FILMS; HEAD; IRON	The detection and imaging of magnetic-field-induced strains via scanning probe microscopy enable us to observe magnetic domain structures. A perpendicular-recording head in a hard disk drive has been observed using this method to investigate the causes of head-induced data erasure. Domain structures of the main pole tip in a head that induces the erase-after-write phenomenon are observed, and we confirm the presence of remanent domains. The structures are not single domain but comprise multiple domains changing with the writing currents. The remanent magnetic fields causing the erase-after-write should be generated by the large magnetization near the domain walls. Copyright (c) 2014 John Wiley & Sons, Ltd.	Kansai Univ, Dept Mech Engn, Fac Engn Sci, Suita, Osaka 5648680, Japan	Takata, K (reprint author), Kansai Univ, Dept Mech Engn, Fac Engn Sci, 3-3-35 Yamate Cho, Suita, Osaka 5648680, Japan.	takatak@kansai-u.ac.jp					RUGAR D, 1990, J APPL PHYS, V68, P1169, DOI 10.1063/1.346713; SCHEINFEIN MR, 1990, REV SCI INSTRUM, V61, P2501, DOI 10.1063/1.1141908; McCorkle P, 1923, PHYS REV, V22, P271, DOI 10.1103/PhysRev.22.271; CHANG AM, 1992, APPL PHYS LETT, V61, P1974, DOI 10.1063/1.108334; Freeman MR, 2001, SCIENCE, V294, P1484, DOI 10.1126/science.1065300; Chikazumi Soshin, PHYS MAGNETISM; FULLER HW, 1960, J APPL PHYS, V31, P238, DOI 10.1063/1.1735552; Fumagalli P, 1998, APPL PHYS LETT, V72, P2803, DOI 10.1063/1.121463; Hirata K, 2005, J MAGN MAGN MATER, V287, P352, DOI 10.1016/j.jmmm.2004.10.057; Kanai Y, 2008, IEEE T MAGN, V44, P3609, DOI 10.1109/TMAG.2008.2002409; Kim SK, 2001, APPL PHYS LETT, V78, P2742, DOI 10.1063/1.1370120; KIRTLEY JR, 1995, APPL PHYS LETT, V66, P1138, DOI 10.1063/1.113838; Koblischka MR, 2006, JPN J APPL PHYS 1, V45, P2238, DOI [10.1143/JJAP.45.2238, 10.1143/JJAP.45.22381]; Meyer G, 2003, APPL PHYS LETT, V83, P1394, DOI 10.1063/1.1603354; NESBITT EA, 1950, PHYS REV, V80, P112, DOI 10.1103/PhysRev.80.112.2; Shimizu Y, 2000, JPN J APPL PHYS 1, V39, P3957, DOI 10.1143/JJAP.39.3957; SUDO S, 1994, JPN J APPL PHYS 2, V33, pL30, DOI 10.1143/JJAP.33.L30; Takata K, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.126504; Takata K, 2009, J VAC SCI TECHNOL B, V27, P997, DOI 10.1116/1.3043457; Takata K, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.047101; Takata K, 2004, JPN J APPL PHYS 2, V43, pL608, DOI 10.1143/JJAP.43.L608; Takata K., 1994, JPN J APPL PHYS, V33, P3193; Tonomura A., 1995, ELECT HOLOGRAPHY; WIESENDANGER R, 1992, SCIENCE, V255, P583, DOI 10.1126/science.255.5044.583; WIESENDANGER R, 1990, PHYS REV LETT, V65, P247, DOI 10.1103/PhysRevLett.65.247	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1257	1261		10.1002/sia.5527		5	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200034		
J	Ogata, Y; Koshida, K; Mizutani, G				Ogata, Yoichi; Koshida, Kosuke; Mizutani, Goro			Crystalline Pd nanowires on the MgO(210) faceted template	SURFACE AND INTERFACE ANALYSIS			English	Article						MgO; Pd; nanowire; moire; facet; TEM	ELECTRON-BEAM EVAPORATION; INTERFACE; TEMPERATURE; PD/MGO(001); MORPHOLOGY; CLUSTERS; GROWTH	Shadow deposition fabricated Pd nanowires with well-oriented crystalline axes on MgO(210) faceted templates, and high-resolution transmission electron microscopy was used to examine the growth of the Pd nanowires in the [001] direction. The plane-view transmission electron microscopy images show long moire fringes in the [001] directions with some imperfections, while the diffraction patterns contain Pd spots. The [001] and [010] directions of the Pd lattices are in the same directions as those of MgO lattices, but their lattice constants differ by 7.6%. The high crystallinity of Pd nanowires likely originates from the low-density nuclei growth on the (100) facet on the MgO(210) face. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Ogata, Yoichi; Koshida, Kosuke; Mizutani, Goro] Japan Adv Inst Sci & Technol, Nomi, Ishikawa 9231292, Japan	Mizutani, G (reprint author), Japan Adv Inst Sci & Technol, 1-1 Asahidai, Nomi, Ishikawa 9231292, Japan.	mizutani@jaist.ac.jp					Akutsu N, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/48/485004; Akutsu Noriko, 2009, e-Journal of Surface Science and Nanotechnology, V7, DOI 10.1380/ejssnt.2009.39; Xu LJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146103; Graoui H, 2001, PHILOS MAG B, V81, P1649, DOI 10.1080/13642810110079908; Goniakowski J, 1999, PHYS REV B, V60, P16120, DOI 10.1103/PhysRevB.60.16120; Sutter E, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3224913; Xu LJ, 2006, SURF SCI, V600, P1351, DOI 10.1016/j.susc.2006.01.034; Haas G, 2000, PHYS REV B, V61, P11105, DOI 10.1103/PhysRevB.61.11105; LU P, 1992, ACTA METALL MATER, V40, pS259, DOI 10.1016/0956-7151(92)90284-L; Ogata Y, 2011, J APPL PHYS, V110, DOI 10.1063/1.3624593; Fornander H, 1999, THIN SOLID FILMS, V349, P4, DOI 10.1016/S0040-6090(99)00018-8; Giordano L, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.096105; Graoui H, 1998, SURF SCI, V417, P350, DOI 10.1016/S0039-6028(98)00688-8; Ogata Y, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4819916; Robach O, 1999, PHYS REV B, V60, P5858, DOI 10.1103/PhysRevB.60.5858; Renaud G, 1999, SURF SCI, V433, P142, DOI 10.1016/S0039-6028(99)00065-5; Sugawara A, 2004, SURF SCI, V558, P211, DOI 10.1016/j.susc.2004.04.002; Vervisch W, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.245411	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1278	1281		10.1002/sia.5593		4	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200038		
J	Irita, M; Homma, Y				Irita, Masaru; Homma, Yoshikazu			Field emission from diameter-defined single-walled carbon nanotubes	SURFACE AND INTERFACE ANALYSIS			English	Article						carbon nanotube; field emission; field emission image		Field electron emission (FE) from a structure-defined single-walled carbon nanotube (SWNT) was observed experimentally. A series of observations of the same SWNT by scanning electron microscopy, field emission microscopy, and transmission electron microscopy were performed for the characterization of the SWNT emitter. This characterization work was very difficult because the observations affected the sample. Additionally, different sample setups were needed in each observation. We improved measurement conditions to minimize the influence to SWNT and developed techniques of sample setup for these observations. Combining these techniques, FE from an individual diameter-defined SWNT could be observed. The diameter of SWNT was approximate to 1.73nm, and the FE current of 2.2 x 10(-7)A was obtained at a low applied voltage of 270V. We observed behaviors of the SWNT emitter including field emission microscopy image twisting during FE. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Irita, Masaru; Homma, Yoshikazu] Tokyo Univ Sci, Dept Phys, Shinjuku Ku, Tokyo 1628601, Japan	Irita, M (reprint author), Tokyo Univ Sci, Dept Phys, Shinjuku Ku, Shinjuku, Tokyo 1628601, Japan.	j1213701@ed.tus.ac.jp					Marchand M, 2009, NANO LETT, V9, P2961, DOI 10.1021/nl901380u; Dean KA, 2001, APPL PHYS LETT, V79, P1873, DOI 10.1063/1.1402157; Dean KA, 2000, APPL PHYS LETT, V76, P375, DOI 10.1063/1.125758; Dean K. A., 2010, CARBON NANOTUBE RELA, P119, DOI 10.1002/9783527630615.ch10; Dean KA, 2003, J VAC SCI TECHNOL B, V21, P868, DOI 10.1116/1.1559171; Han SW, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.241402; Hata K, 2003, ULTRAMICROSCOPY, V95, P107, DOI 10.1016/S0304-3991(02)00304-2; Heeres EC, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.036804; Irita M., 2013, E J SURF SCI NANOTEC, V11, P105; Muller EW, 1936, Z PHYS, V102, P734, DOI 10.1007/BF01338540; Oshima C, 2002, PHYS REV LETT, V88, DOI [10.1103/PhysRevLett.88.038301, 10.1103/PhysRevB.88.038301]; Saito Y, 2000, JPN J APPL PHYS 2, V39, pL271, DOI 10.1143/JJAP.39.L271	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1282	1285		10.1002/sia.5611		4	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200039		
J	Aoyama, T; Nagoshi, M; Sato, K				Aoyama, T.; Nagoshi, M.; Sato, K.			Influence of primary electron energy and takeoff angle of scanning electron microscopy on backscattered electron contrast of iron oxide	SURFACE AND INTERFACE ANALYSIS			English	Article						SEM; backscattered electron; material contrast; channeling contrast; primary electron energy; take-off angle	MONTE-CARLO SIMULATION; SCATTERING; TARGET	The contrasts in backscattered electron (BSE) images were studied from the cross section of a heat-treated steel sheet using a scanning electron microscope (SEM) equipped with a conventional annular BSE detector. BSE images were taken at various primary electron energies (E-p) and take-off angles (; measured from the specimen surface) of the detector. Low E-p and low improved surface information and channeling contrast, whereas high E-p and high enhanced bulk information and reduced channeling contrast, resulting in improved material (Z) contrast. These results regarding channeling contrast and Z contrast can be understood by the ratio of low-loss electrons (LLEs) to the inelastic BSE components detected; LLEs contribute to channeling contrast, and their ratio increases with decreasing E-p and . The systematic results obtained in this study are helpful for controlling SEM conditions in order to select Z and crystallographic information separately in BSE images for practical materials of interest. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Aoyama, T.] JFE Steel Corp, Steel Res Lab, Fukuyama, Hiroshima 7218510, Japan; [Nagoshi, M.] JFE Steel Corp, Steel Res Lab, Kawasaki Ku, Kawasaki, Kanagawa 2100855, Japan; [Sato, K.] JFE Steel Corp, Steel Res Lab, Chuo Ku, Chiba 2600835, Japan	Aoyama, T (reprint author), JFE Steel Corp, Steel Res Lab, 1 Kokan Cho, Fukuyama, Hiroshima 7218510, Japan.	to-aoyama@jfe-steel.co.jp					Aoyama T, 2011, ISIJ INT, V51, P1487, DOI 10.2355/isijinternational.51.1487; NIEDRIG H, 1982, J APPL PHYS, V53, pR15, DOI 10.1063/1.331005; TANUMA S, 1994, SURF INTERFACE ANAL, V21, P165, DOI 10.1002/sia.740210302; Berger D, 2002, SCANNING, V24, P70; ARCHARD GD, 1961, J APPL PHYS, V32, P1505, DOI 10.1063/1.1728385; Aurata R., 1989, SCANNING MICROSCOPY, V3, P736; Hoffmann K E, 1982, ELECTRON BEAM INTERA, P209; Kawano T, 2006, JFE TECH REP, V13, P5; KOTERA M, 1981, J APPL PHYS, V52, P7403, DOI 10.1063/1.328730; KOTERA M, 1981, J APPL PHYS, V52, P997, DOI 10.1063/1.328746; Nagoshi M, 2003, J SURF FINISH SOC JP, V54, P31; Niedrig H, 1982, ELECTRON BEAM INTERA, P51; Reimer L, 1998, SCANNING ELECT MICRO; Sato K., 2010, P 17 INT MICR C IMC1, pI3; Sato K., 2004, Oyo Buturi, V73	15	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	DEC	2014	46	12-13			SI		1291	1295		10.1002/sia.5564		5	Chemistry, Physical	Chemistry	AU4IN	WOS:000345574200041		
J	Watanabe, C; Salmador, MP				Watanabe, Chihiro; Paz Salmador, M.			Technology strategy and technology policy	TECHNOVATION			English	Editorial Material							INSTITUTIONS; INFRASTRUCTURE; INVESTMENT; INNOVATION; COMPLEXITY; TRADE		[Watanabe, Chihiro] Tokyo Inst Technol, Tokyo, Japan; [Paz Salmador, M.] Univ Autonoma Madrid, E-28049 Madrid, Spain	Watanabe, C (reprint author), Tokyo Inst Technol, Tokyo, Japan.						Acemoglu D, 2005, AM ECON REV, V95, P546, DOI 10.1257/0002828054201305; Lee J, 2010, TECHNOVATION, V30, P249, DOI 10.1016/j.technovation.2009.12.003; Greenwood R, 2011, ACAD MANAG ANN, V5, P317, DOI 10.1080/19416520.2011.590299; Kostova T, 2002, ACAD MANAGE J, V45, P215, DOI 10.2307/3069293; Laranja M, 2009, TECHNOVATION, V29, P23, DOI 10.1016/j.technovation.2008.07.010; Anderson P, 1999, ORGAN SCI, V10, P216, DOI 10.1287/orsc.10.3.216; Holmes RM, 2013, J MANAGE, V39, P531, DOI 10.1177/0149206310393503; Ostrom E, 2010, AM ECON REV, V100, P641, DOI 10.1257/aer.100.3.641; Bergara ME, 1998, CALIF MANAGE REV, V40, P18; Choi DG, 2012, TECHNOVATION, V32, P9, DOI 10.1016/j.technovation.2011.09.004; Cirone AE, 2013, TECHNOVATION, V33, P333, DOI 10.1016/j.technovation.2013.06.001; Clague C, 1997, I EC DEV GROWTH GOVE; GREIF A, 1993, AM ECON REV, V83, P525; Hirschman A., 1981, POLICY MAKING POLICY; McKelvey B., 1999, ORGAN SCI, V10, P249; Meyer PE, 2009, TECHNOVATION, V29, P77, DOI 10.1016/j.technovation.2008.05.004; Nakagawa M, 2009, TECHNOVATION, V29, P5, DOI 10.1016/j.technovation.2008.08.003; Nichols K.D., 1987, ROAD TRINITY PERSONA; North D.C., 1990, I I CHANGE EC PERFOR; Olson DL, 2014, TECHNOVATION, V34, P395, DOI 10.1016/j.technovation.2014.05.005; Riordan M., 1997, CRYSTAL FIRE INVENTI; Scott W.R., 1995, I ORG; Sobel RS, 2011, J LAW ECON, V54, P111, DOI 10.1086/652304; WILLIAMSON OLIVER E., 1975, MARKETS HIERARCHIES	24	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4972	1879-2383		TECHNOVATION	Technovation	DEC	2014	34	12			SI		731	733		10.1016/j.technovation.2014.10.004		3	Engineering, Industrial; Management; Operations Research & Management Science	Engineering; Business & Economics; Operations Research & Management Science	AU3XR	WOS:000345544500001		
J	Fuji, T; Wang, CJ; Fujita, S; Kawai, Y; Nakamura, M; Kimura, T; Ibusuki, K; Ushida, H; Abe, K; Tachibana, S				Fuji, Takeshi; Wang, Ching-Jen; Fujita, Satoru; Kawai, Yohko; Nakamura, Mashio; Kimura, Tetsuya; Ibusuki, Kei; Ushida, Hitoshi; Abe, Kenji; Tachibana, Shintaro			Safety and Efficacy of Edoxaban, an Oral Factor Xa Inhibitor, Versus Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty: The STARS E-3 Trial	THROMBOSIS RESEARCH			English	Article						edoxaban; enoxaparin; factor Xa; knee replacement arthroplasty; venous thromboembolism	VENOUS THROMBOEMBOLISM; DOUBLE-BLIND; TOTAL HIP; REPLACEMENT; PREVENTION; RIVAROXABAN; WARFARIN; PHARMACODYNAMICS; PHARMACOKINETICS; APIXABAN	Introduction: This phase 3 trial compared the safety and efficacy of edoxaban, an oral direct factor Xa inhibitor, with enoxaparin sodium (enoxaparin) for thromboprophylaxis after total knee arthroplasty (TKA) in patients in Japan and Taiwan. Materials and methods: In this randomized, double-blind, double-dummy study, patients received oral edoxaban 30 mg once daily beginning 6 to 24 hours postsurgery or enoxaparin 2000 IU (equivalent to 20 mg) subcutaneously twice daily beginning 24 to 36 hours postsurgery for 11 to 14 days. The primary efficacy endpoint was the composite of symptomatic pulmonary embolism and symptomatic and asymptomatic deep vein thrombosis. Safety endpoints included the incidence of major bleeding, clinically relevant non-major (CRNM) bleeding, major bleeding or CRNM bleeding, all bleeding events, adverse events, and adverse drug reactions. Results: Of 716 patients enrolled, 360 and 356 were randomized to receive edoxaban or enoxaparin, respectively. The primary efficacy outcome occurred in 22/299 (7.4%) and 41/295 (13.9%) patients in the edoxaban and enoxaparin groups, respectively (relative risk reduction = 46.8%), indicating non-inferiority (P < 0.001) and superiority (P = 0.010) of edoxaban versus enoxaparin. In the edoxaban and enoxaparin groups, major bleeding occurred in 4/354 (1.1%) versus 1/349 (0.3%) patients (P = 0.373); major or CRNM bleeding occurred in 22/354 (6.2%) versus 13/349 (3.7%) patients (P = 0.129), respectively. Conclusions: Edoxaban 30 mg once daily was more effective for thromboprophylaxis than subcutaneous enoxaparin 2000 IU twice daily following TKA and demonstrated a similar incidence of bleeding events. (C) 2014 Elsevier Ltd. All rights reserved.	[Fuji, Takeshi] Osaka Hosp, Japan Community Healthcare Org, Dept Orthoped Surg, Fukushima Ku, Osaka 5530003, Japan; [Wang, Ching-Jen] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Orthoped Surg, Kaohsiung 833, Taiwan; [Fujita, Satoru] Takarazuka Daiichi Hosp, Dept Orthoped Surg, Takarazuka, Hyogo 6650832, Japan; [Kawai, Yohko] Int Univ Hlth & Welf, Minato Ku, Tokyo 1070002, Japan; [Nakamura, Mashio] Mie Univ, Grad Sch Med, Dept Clin Cardiovasc Res, Tsu, Mie 5148507, Japan; [Kimura, Tetsuya; Ibusuki, Kei] Daiichi Sankyo Co Ltd, Clin Planning Dept, Shinagawa Ku, Tokyo 1408710, Japan; [Ushida, Hitoshi] Daiichi Sankyo Co Ltd, Asia Dev Dept, Shinagawa Ku, Tokyo 1408710, Japan; [Abe, Kenji] Daiichi Sankyo Co Ltd, Clin Data & Biostat Dept, Shinagawa Ku, Tokyo 1408710, Japan; [Tachibana, Shintaro] Mishuku Hosp, Dept Orthoped Surg, Meguro Ku, Tokyo 1530051, Japan	Fuji, T (reprint author), Osaka Hosp, Japan Community Healthcare Org, Dept Orthoped Surg, Fukushima Ku, 4-2-78 Fukushima, Osaka 5530003, Japan.	fuji-th@umin.ac.jp; w281211@adm.cgmh.org.tw; fujita@takarazuka-daiichi-hp.or.jp; yohko@iuhw.ac.jp; mashio@clin.medic.mie-u.ac.jp; kimura.tetsuya.d2@daiichisankyo.co.jp; ibusuki.kei.tx@daiichisankyo.co.jp; ushida.hitoshi.e8@rdn.daiichisankyo.co.jp; abe.kenji.v7@daiichisankyo.co.jp; s-tachi@mishuku.gr.jp			Daiichi Sankyo Co., Ltd. (Tokyo, Japan); Daiichi Sankyo	This study (ClinicalTrials.gov Identifier: NCT01181102) was sponsored by Daiichi Sankyo Co., Ltd. (Tokyo, Japan). The authors would like to acknowledge writing assistance provided by Scarlett Geunes-Boyer, PhD, of AlphaBioCom, LLC, which was funded by Daiichi Sankyo.	Agarwala S, 2003, INDIAN J SURG, V65, P159; Kakkar AK, 2008, LANCET, V372, P31, DOI 10.1016/S0140-6736(08)60880-6; Fuji T, 2008, J ORTHOP SCI, V13, P442, DOI 10.1007/s00776-008-1264-0; [Anonymous], 2012, CLEX SUBC INJ KIT 20; Raskob G, 2010, THROMB HAEMOSTASIS, V104, P642, DOI 10.1160/TH10-02-0142; Ogata K, 2010, J CLIN PHARMACOL, V50, P743, DOI 10.1177/0091270009351883; Fuji T, 2010, J THROMB HAEMOST, V8, P2458, DOI 10.1111/j.1538-7836.2010.04021.x; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Urbankova J, 2005, THROMB HAEMOSTASIS, V94, P1181, DOI 10.1160/TH05-04-0222; [Anonymous], 2009, LOV EN SOD INJ SUB I; Fuji T, 2014, THROMB RES, V133, P1016, DOI 10.1016/j.thromres.2014.03.009; Buller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638; Eriksson BI, 2008, NEW ENGL J MED, V358, P2765, DOI 10.1056/NEJMoa0800374; Eriksson BI, 2009, CLIN PHARMACOKINET, V48, P1, DOI 10.2165/0003088-200948010-00001; Falck-Ytter Yngve, 2012, Chest, V141, pe278S, DOI 10.1378/chest.11-2404; Fuji T, 2010, BLOOD, V116; Hirsh J, 2008, CHEST, V133, p141S, DOI 10.1378/chest.08-0689; Hirsh J, 2007, CIRCULATION, V116, P552, DOI 10.1161/CIRCULATIONAHA.106.685974; Ando M, 2011, CIRC J, V75, P1258, DOI 10.1253/circj.CJ-88-0010; Kakkos SK, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005258.pub2; Kearon C, 2003, CIRCULATION, V107, pI22, DOI 10.1161/01.CIR.0000078464.82671.78; Lassen MR, 2008, NEW ENGL J MED, V358, P2776, DOI 10.1056/NEJMoa076016; Lassen MR, 2009, NEW ENGL J MED, V361, P594, DOI 10.1056/NEJMoa0810773; Lassen MR, 2010, LANCET, V375, P807, DOI 10.1016/S0140-6736(09)62125-5; Matsushima N, 2013, CLIN PHARM DRUG DEV, V2, P358, DOI 10.1002/cpdd.53; Nakamura Mashio, 2003, Nihon Rinsho, V61, P1811; Nakamura M, 2004, J JPN SOC CLIN ANEST, V24, P480, DOI 10.2199/jjsca.24.480; O'Reilly RF, 2005, MED J AUSTRALIA, V182, P154; STULBERG BN, 1984, J BONE JOINT SURG AM, V66A, P194	29	8	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	DEC	2014	134	6					1198	1204		10.1016/j.thromres.2014.09.011		7	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	AU3GJ	WOS:000345500100008		
J	Ishibashi, Y; Matsui, T; Yamagishi, S				Ishibashi, Yuji; Matsui, Takanori; Yamagishi, Sho-ichi			Apixaban exerts anti-inflammatory effects in mesangial cells by blocking thrombin/protease-activated receptor-1 system	THROMBOSIS RESEARCH			English	Letter							CHRONIC KIDNEY-DISEASE; ATRIAL-FIBRILLATION; RENAL-FUNCTION; STROKE; NEPHROPATHY; EXPRESSION; PLASMA; TRIAL		[Ishibashi, Yuji; Matsui, Takanori; Yamagishi, Sho-ichi] Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Kurume, Fukuoka 830, Japan	Ishibashi, Y (reprint author), Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Kurume, Fukuoka 830, Japan.	shoichi@med.kurume-u.ac.jp					Roldan V, 2013, THROMB HAEMOSTASIS, V109, P956, DOI 10.1160/TH13-01-0054; Hohnloser SH, 2012, EUR HEART J, V33, P2821, DOI 10.1093/eurheartj/ehs274; Chiarelli F, 2002, DIABETES CARE, V25, P1829, DOI 10.2337/diacare.25.10.1829; Ahmad Y, 2013, CONTRIB NEPHROL, V179, P81, DOI 10.1159/000346726; Ye SD, 2009, EUR J CLIN INVEST, V39, P980, DOI 10.1111/j.1365-2362.2009.02203.x; Upadhyay A, 2011, NEPHROL DIAL TRANSPL, V26, P920, DOI 10.1093/ndt/gfq471; Poulsen BK, 2012, DRUGS, V72, P1739, DOI 10.2165/11635730-000000000-00000; Cairns JA, 2013, CAN J CARDIOL, V29, P1165, DOI 10.1016/j.cjca.2013.05.010; Apostolakis S, 2013, EUR HEART J, V34, P3572, DOI 10.1093/eurheartj/eht328; Hart RG, 2013, CAN J CARDIOL, V29, pS71, DOI 10.1016/j.cjca.2013.04.005; Ishibashi Y, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-60; Reinecke H, 2014, KIDNEY INT; Stinghen AEM, 2009, NEPHRON CLIN PRACT, V111, pC117, DOI 10.1159/000191205; Tsiachris D, 2014, CURR VASC PHARM	14	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	DEC	2014	134	6					1365	1367		10.1016/j.thromres.2014.09.028		3	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	AU3GJ	WOS:000345500100035		
J	Tomizawa, M; Shinozaki, F; Motoyoshi, Y; Sugiyama, T; Yamamoto, S; Sueishi, M				Tomizawa, Minoru; Shinozaki, Fuminobu; Motoyoshi, Yasufumi; Sugiyama, Takao; Yamamoto, Shigenori; Sueishi, Makoto			Dual Gene Expression in Embryoid Bodies Derived from Human Induced Pluripotent Stem Cells Using Episomal Vectors	TISSUE ENGINEERING PART A			English	Article							EPSTEIN-BARR-VIRUS; HEPATOCYTE-LIKE CELLS; EFFICIENT GENERATION; DEFINED FACTORS; DIFFERENTIATION; TRANSPLANTATION; TRANSDUCTION; FIBROBLASTS; INDUCTION	Transcription factors are essential for the differentiation of human induced pluripotent stem cells (iPS) into specialized cell types. Embryoid body (EB) formation promotes the differentiation of iPS cells. We sought to establish an efficient method of transfection and rotary culture to generate EBs that stably express two genes. The pMetLuc2-Reporter vector was transfected using FuGENE HD (FuGENE), Lipofectamine LTX (LTX), X-tremeGENE, or TransIT-2020 transfection reagents. The media was analyzed using a Metridia luciferase (MetLuc) assay. Transfections were performed on cells adherent to plates/dishes (adherent method) or suspended in the media (suspension method). The 201B7 cells transfected with episomal vectors were selected using G418 (200 mu g/mL) or hygromycin B (300 mu g/mL). Rotary culture was performed at 2.5 or 9.9 rpm. Efficiency of EB formation was compared among plates and dishes. Cell density was compared at 1.6x10(3),x10(4), andx10(5) cells/mL. The suspended method of transfection using the FuGENE HD reagent was the most efficient. The expression of pEBMulti/Met-Hyg was detected 11 days posttransfection. Double transformants were selected 6 days posttransfection with pEBNK/EGFP-Neo and pEBNK/Cherry-Hyg. Both EGFP and CherryPicker were expressed in all of the surviving cells. EBs were formed most efficiently from cells cultured at a density of 1.6x10(5) cells/mL in six-well plates or 6 cm dishes. The selected cells formed EBs. FuGENE-mediated transfection of plasmids using the suspension method was effective in transforming iPS cells. Furthermore, the episomal vectors enabled us to perform a stable double transfection of EB-forming iPS cells.	[Tomizawa, Minoru] Shimoshizu Hosp, Natl Hosp Org, Dept Gastroenterol, Yotsukaido City 2840003, Japan; [Shinozaki, Fuminobu] Shimoshizu Hosp, Natl Hosp Org, Dept Radiol, Yotsukaido City 2840003, Japan; [Motoyoshi, Yasufumi] Shimoshizu Hosp, Natl Hosp Org, Dept Neurol, Yotsukaido City 2840003, Japan; [Sugiyama, Takao; Sueishi, Makoto] Shimoshizu Hosp, Natl Hosp Org, Dept Rheumatol, Yotsukaido City 2840003, Japan; [Yamamoto, Shigenori] Shimoshizu Hosp, Natl Hosp Org, Dept Pediat, Yotsukaido City 2840003, Japan	Tomizawa, M (reprint author), Shimoshizu Hosp, Natl Hosp Org, Dept Gastroenterol, 934-5 Shikawatashi, Yotsukaido City 2840003, Japan.	nihminor-cib@umin.ac.jp			Japan Society for the Promotion of Science (JSPS) [23591002]	This work was supported by a Research Grant-in-Aid for Scientific Research (C) (23591002) from the Japan Society for the Promotion of Science (JSPS).	Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Cao F, 2010, MOL IMAGING BIOL, V12, P15, DOI 10.1007/s11307-009-0236-x; Tashiro K, 2010, CELL REPROGRAM, V12, P501, DOI 10.1089/cell.2010.0023; DeLaForest A, 2011, DEVELOPMENT, V138, P4143, DOI 10.1242/dev.062547; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029; Baharvand H, 2006, INT J DEV BIOL, V50, P645, DOI 10.1387/ijdb.052072hb; Takayama K, 2012, MOL THER, V20, P127, DOI 10.1038/mt.2011.234; Bratt-Leal AM, 2009, BIOTECHNOL PROGR, V25, P43, DOI [10.1002/btpr.139, 10.1021/bp.139]; Strom SC, 1999, SEMIN LIVER DIS, V19, P39, DOI 10.1055/s-2007-1007096; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Eiges R, 2001, CURR BIOL, V11, P514, DOI 10.1016/S0960-9822(01)00144-0; Abujarour R, 2014, STEM CELL TRANSL MED, V3, P149, DOI 10.5966/sctm.2013-0095; Romano G, 2014, J CELL PHYSIOL, V229, P148, DOI 10.1002/jcp.24437; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; Ledwith BJ, 2000, INTERVIROLOGY, V43, P258, DOI 10.1159/000053993; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Lu H, 2010, J DIGEST DIS, V11, P376, DOI 10.1111/j.1751-2980.2010.00455.x; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Lim SY, 2013, STEM CELL TRANSL MED, V2, P715, DOI 10.5966/sctm.2012-0161; FISHER RL, 1993, CRYOBIOLOGY, V30, P250, DOI 10.1006/cryo.1993.1023; Greenhough S, 2013, CELL REPROGRAM, V15, P9, DOI 10.1089/cell.2012.0049; Liskovykh M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027345; MITAKA T, 1991, HEPATOLOGY, V13, P21, DOI 10.1016/0270-9139(91)90211-D; Shibata MA, 2007, MED MOL MORPHOL, V40, P103, DOI 10.1007/s00795-007-0358-7; Takarada T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063947; Tanaka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061540; Tanaka J, 1999, BIOCHEM BIOPH RES CO, V264, P938, DOI 10.1006/bbrc.1999.1617; Tomizawa M, 2008, CELL TISSUE RES, V333, P17, DOI 10.1007/s00441-008-0618-4; Vallier L, 2004, STEM CELLS, V22, P2, DOI 10.1634/stemcells.22-1-2; Wells DJ, 2010, CELL BIOL TOXICOL, V26, P21, DOI 10.1007/s10565-009-9144-8	33	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20	23-24					3154	3162		10.1089/ten.tea.2014.0132		9	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU8EO	WOS:000345829500007		
J	Ahn, H; Ju, Y; Takahashi, H; Okano, T; Yoo, JJ; Atala, A; Lee, S				Ahn, H.; Ju, Y.; Takahashi, H.; Okano, T.; Yoo, J. J.; Atala, A.; Lee, S.			Tissue-Engineered Vascular Grafts by Combining Cell Sheet and Electrospun Scaffold	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Ahn, H.; Ju, Y.; Yoo, J. J.; Atala, A.; Lee, S.] Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC USA; [Takahashi, H.] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; [Okano, T.] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Winston Salem, NC USA								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		P-380	S94	S94				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300366		
J	Ayuningtyas, FD; Ogawa, Y; Kim, M; Barlian, A; Kino-oka, M				Ayuningtyas, F. D.; Ogawa, Y.; Kim, M.; Barlian, A.; Kino-oka, M.			Culture Surface Design to Direct Commitment of Human Mesenchymal Stem Cells to Myogenic Lineage	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Ayuningtyas, F. D.; Barlian, A.] Inst Technol Bandung, Sch Life Sci & Technol, Biotechnol Master Program, Bandung, Indonesia; [Ogawa, Y.; Kim, M.; Kino-oka, M.] Osaka Univ, Osaka, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		P-705	S127	S127				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300500		
J	Chang, D; Wang, Y; Cai, W; Okano, T; Wang, Y				Chang, D.; Wang, Y.; Cai, W.; Okano, T.; Wang, Y.			Manipulation of Induced Pluripotent Stem Cells (iPSC) with Lentivirus-Based Cardiac-Specific Promoter Enhances Restoration of Cardiac Function After Myocardial Infarction (MI)	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Chang, D.; Okano, T.] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; [Wang, Y.; Cai, W.; Wang, Y.] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH USA								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		O-90	S7	S7				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300020		
J	Fusa, S; Ngo, TX; Kino-Oka, M				Fusa, S.; Ngo, T. X.; Kino-oka, M.			Kinetic Model for Expansion Culture of iPS Cells by Considering the Deviation from Undifferentiated State on Feeder Layers	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Fusa, S.; Ngo, T. X.; Kino-oka, M.] Osaka Univ, Osaka, Japan							Kim MH, 2014, BIOTECHNOL BIOENG, V111, P1128, DOI 10.1002/bit.25188	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		P-558	S118	S118				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300462		
J	Higuchi, A; Kumar, S; Munusamy, MA; Alarfaj, AA; Higuchi, A				Higuchi, A.; Kumar, S.; Munusamy, M. A.; Alarfaj, A. A.; Higuchi, A.			Pluripotent Stem Cell Culture On Biomaterials Having Nanosegments With Optimal Elasticity	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Higuchi, A.] Natl Cent Univ, Dept Chem & Mat Engn, Jhongli, Taiwan; [Kumar, S.] Univ Putra Malaysia, Dept Med Microbiol & Parasitol, Serdang, Malaysia; [Munusamy, M. A.; Alarfaj, A. A.] King Saud Univ, Dept Bot & Microbiol, Riyadh, Saudi Arabia; [Higuchi, A.] RIKEN, Wako, Saitama, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		P-699	S126	S126				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300496		
J	Iwai, Y; Morishita, A; Nakatsuka, M; Ueno, K; Kumabe, S				Iwai, Y.; Morishita, A.; Nakatsuka, M.; Ueno, K.; Kumabe, S.			An in vitro study of Hard Tissue Formation around Implants with Culture of HMS0014 Cells in Cellmatrix Type I-A Collagen Gel 3D Scaffold	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Iwai, Y.; Morishita, A.; Nakatsuka, M.; Ueno, K.; Kumabe, S.] Osaka Dent Univ, Dept Oral Anat, Hirakata, Osaka, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		P-548	S116	S116				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300455		
J	Jinno, C; Morimoto, N; Hieu, LP; Mahara, A; Fujisato, T; Yamaoka, T; Suzuki, S				Jinno, C.; Morimoto, N.; Hieu, L. Pham; Mahara, A.; Fujisato, T.; Yamaoka, T.; Suzuki, S.			Preparation of Inactivated Dermal Substitute from Melanocytic Nevus Using High-Hydrostatic Pressure	TISSUE ENGINEERING PART A			English	Meeting Abstract	Tissue-Engineering-and-Regenerative-Medicine-International-Society - America (TERMIS-AM) Conference	DEC 13-16, 2014	Washington, DC	Tissue Engn & Regenerat Med Int Soc Amer					[Jinno, C.; Suzuki, S.] Kyoto Univ, Kyoto, Japan; [Morimoto, N.] Kansai Med Univ, Osaka, Japan; [Hieu, L. Pham] Pham Ngoc Thach Univ Med, HCMC, Ho Chi Minh City, Vietnam; [Mahara, A.; Yamaoka, T.] Natl Cerebral & Cardiovasc Ctr Res Inst, Suita, Osaka, Japan; [Fujisato, T.] Osaka Inst Technol, Osaka 535, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		P-268	S80	S80				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300312		
J	Kakinoki, S; Nakayama, M; Moritan, T; Yamaoka, T				Kakinoki, S.; Nakayama, M.; Moritan, T.; Yamaoka, T.			Electrospun Micro-Fibrous Conduits Composed of Poly(l-lactic Acid) and Elastin-Laminin Mimicking Protein for Peripheral Nerve Regeneration	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Kakinoki, S.; Nakayama, M.; Yamaoka, T.] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biomed Engn, Suita, Osaka, Japan; [Moritan, T.] Suzuka Univ Med Sci, Fac Med Engn, Dept Clin Engn, Suzuka, Mie, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		O-29	S3	S3		10.1089/ten.tea.2014.5001.abstracts		1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300002		
J	Kakinoki, S; Sakai, Y; Fujisato, T; Yamaoka, T				Kakinoki, S.; Sakai, Y.; Fujisato, T.; Yamaoka, T.			Enhancement of Subcutaneous Tissue Infiltration into Polyethylene Porous Scaffolds by Heparin/bfgf Immobilization	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Kakinoki, S.; Sakai, Y.; Yamaoka, T.] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Biomed Engn, Suita, Osaka, Japan; [Fujisato, T.] Osaka Inst Technol, Grad Sch Engn, Dept Biomed Engn, Osaka 535, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		P-157	S65	S65				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300251		
J	Kato, H; Izumi, K; Shiomi, A; Uenoyama, A; Kuo, S; Feinberg, S; Maeda, T				Kato, H.; Izumi, K.; Shiomi, A.; Uenoyama, A.; Kuo, S.; Feinberg, S.; Maeda, T.			Hypoxia Induces Undifferentiated Phenotype of Oral Keratinocytes In Vitro	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Kato, H.; Kuo, S.; Feinberg, S.] Univ Michigan, Ann Arbor, MI 48109 USA; [Izumi, K.; Shiomi, A.; Uenoyama, A.; Maeda, T.] Niigata Univ, Sch Dent, Niigata, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		O-214	S17	S17				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300058		
J	Kimura, T; Honda, S; Soma, T; Nam, K; Fujisato, T; Suzuki, I; Kishida, A				Kimura, T.; Honda, S.; Soma, T.; Nam, K.; Fujisato, T.; Suzuki, I.; Kishida, A.			Neural Cell Behavior on a Decellularized Brain Prepared by High-hydrostatic Pressure	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Kimura, T.; Honda, S.; Soma, T.; Nam, K.; Kishida, A.] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan; [Fujisato, T.] Osaka Inst Technol, Dept Bioengn, Osaka 535, Japan; [Suzuki, I.] Tohoku Inst Technol, Dept Elect & Intelligent Syst, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		P-156	S65	S65				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300250		
J	Kitajima, H; Kino-oka, M				Kitajima, H.; Kino-oka, M.			Current State of the hiPS Cell Culture Apparatus and the Culture Cost	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Kitajima, H.; Kino-oka, M.] Osaka Univ, Grad Sch Engn, Osaka, Japan							Matsuura K, 2012, BIOCHEM BIOPH RES CO, V425, P321, DOI 10.1016/j.bbrc.2012.07.089	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		P-598	S123	S123				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300482		
J	Kobayashi, H; Hattori, S; Honda, T				Kobayashi, H.; Hattori, S.; Honda, T.			Biodegradable Shortened Electrospun Nanofibers Scaffold for Big Sized Spheroid Formation	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Kobayashi, H.; Hattori, S.; Honda, T.] Natl Inst Mat Sci, WPI MANA, Tsukuba, Ibaraki, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		P-202	S71	S72				2	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300277		
J	Kobayashi, H; Hattori, S; Honda, T; Terada, D; Kameda, T; Tamada, Y				Kobayashi, H.; Hattori, S.; Honda, T.; Terada, D.; Kameda, T.; Tamada, Y.			Mid to Long Compatibility Evaluation of Fibroin Nanofiber Scaffold in Rabbit Cornea	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Kobayashi, H.; Hattori, S.; Honda, T.; Terada, D.] Natl Inst Mat Sci, WPI MANA, Tsukuba, Ibaraki, Japan; [Kameda, T.; Tamada, Y.] Natl Inst Agrobiol Sci, Silk Mat Res Unit, Tsukuba, Ibaraki, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		P-208	S73	S73				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300282		
J	Komura, M; Komura, H; Otani, Y; Tabata, Y				Komura, M.; Komura, H.; Otani, Y.; Tabata, Y.			Optimal Amount Of Basic Fibroblast Growth Factor (b-fgf) In Gelatin Sponges Incorporating beta-tricalcium Phosphate (tcp) With Chondrocytes	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Komura, M.] Saitama Med Univ, Moroyama, Saitama, Japan; [Komura, H.; Otani, Y.] Univ Tokyo, Tokyo, Japan; [Tabata, Y.] Kyoto Univ, Dept Biomat, Kyoto, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		P-709	S127	S127				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300501		
J	Kumabe, S; Nakatsuka, M; Morishita, A; Ueda, K; Iwai, Y				Kumabe, S.; Nakatsuka, M.; Morishita, A.; Ueda, K.; Iwai, Y.			The Fate and Contribution of HMS0014 Cells cultured on Cellmatrix Type I-A Scaffold	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Kumabe, S.; Nakatsuka, M.; Morishita, A.; Ueda, K.; Iwai, Y.] Osaka Dent Univ, Dept Oral Anat, Hirakata, Osaka, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		P-547	S116	S116				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300454		
J	Kunii, S; Yamamoto, E; Horiuchi, Y; Ito, H; Ida, M; Hiraoka, Y; Morimoto, K				Kunii, S.; Yamamoto, E.; Horiuchi, Y.; Ito, H.; Ida, M.; Hiraoka, Y.; Morimoto, K.			Evaluation Of Bone Regeneration With Using Novel Collagen, Which Has An Ability Of Cell Spheroid Formation	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Kunii, S.; Yamamoto, E.; Ito, H.; Morimoto, K.] Kindai Univ, Kinokawa, Japan; [Horiuchi, Y.] Kindai Univ, Life Sci Res Inst, Osaka, Japan; [Ida, M.; Hiraoka, Y.] Nitta Gelatin Inc, Yao, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		P-521	S113	S113				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300444		
J	Kuramoto, G; Takagi, S; Ishitani, K; Shimizu, T; Okano, T; Matsui, H				Kuramoto, G.; Takagi, S.; Ishitani, K.; Shimizu, T.; Okano, T.; Matsui, H.			Three-dimensional Assembly of Endometrial Tissue In Vitro	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Kuramoto, G.; Takagi, S.; Shimizu, T.; Okano, T.] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; [Kuramoto, G.; Ishitani, K.; Matsui, H.] Tokyo Womens Med Univ, Dept Obstet & Gynecol, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		P-700	S126	S126				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300497		
J	Lam, J; Lu, S; Lee, EJ; Trachtenberg, JE; Meretoja, VV; Dahlin, RL; van den Beucken, J; Tabata, Y; Wong, ME; Jansen, JA; Mikos, AG; Kasper, FK				Lam, J.; Lu, S.; Lee, E. J.; Trachtenberg, J. E.; Meretoja, V. V.; Dahlin, R. L.; van den Beucken, J.; Tabata, Y.; Wong, M. E.; Jansen, J. A.; Mikos, A. G.; Kasper, F. K.			Osteochondral Defect Repair Using Bilayered Hydrogels Encapsulating Both Chondrogenically and Osteogenically Pre-differentiated Mesenchymal Stem Cells in a Rabbit Model	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Lam, J.; Lu, S.; Lee, E. J.; Trachtenberg, J. E.; Meretoja, V. V.; Dahlin, R. L.; Mikos, A. G.; Kasper, F. K.] Rice Univ, Houston, TX USA; [van den Beucken, J.; Jansen, J. A.] Radboud Umc, Nijmegen, Netherlands; [Tabata, Y.] Kyoto Univ, Inst Frontier Med Sci, Kyoto, Japan; [Wong, M. E.] Univ Texas Sch Dent, Houston, TX USA								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		P-416	S98	S99				2	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300386		
J	Lu, S; Lam, J; Trachtenberg, JE; Lee, EJ; Seyednejad, H; van den Beucken, J; Tabata, Y; Wong, ME; Jansen, JA; Mikos, AG; Kasper, FK				Lu, S.; Lam, J.; Trachtenberg, J. E.; Lee, E. J.; Seyednejad, H.; van den Beucken, J.; Tabata, Y.; Wong, M. E.; Jansen, J. A.; Mikos, A. G.; Kasper, F. K.			Dual Growth Factor Delivery from Bilayered Hydrogel Composites for Spatially-Guided Osteochondral Tissue Repair In Vivo	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Lu, S.; Lam, J.; Trachtenberg, J. E.; Lee, E. J.; Seyednejad, H.; Mikos, A. G.; Kasper, F. K.] Rice Univ, Houston, TX USA; [van den Beucken, J.; Jansen, J. A.] Radboud Univ Nijmegen, NL-6525 ED Nijmegen, Netherlands; [Tabata, Y.] Kyoto Univ, Kyoto, Japan; [Wong, M. E.] Univ Texas Sch Dent Houston, Houston, TX USA								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		O-99	S8	S8				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300023		
J	Mahara, A; Morimoto, N; Fujisato, T; Yamaoka, T				Mahara, A.; Morimoto, N.; Fujisato, T.; Yamaoka, T.			Complete Cell Killing by Applying High Hydrostatic Pressure for Extracellular Matrix Preparation	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Mahara, A.; Yamaoka, T.] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Biomed Engn, Suita, Osaka, Japan; [Morimoto, N.] Kansai Med Univ, Dept Plast & Reconstruct Surg, Hirakata, Osaka, Japan; [Fujisato, T.] Osaka Inst Technol, Dept Biomed Engn, Osaka 535, Japan							Fujisato T, 2005, CARDIOVASCULAR REGEN; Mahara A, 2014, BIOMED RES INT	2	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		P-169	S67	S67				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300259		
J	Matsuhashi, A; Nam, K; Kimura, T; Kishida, A				Matsuhashi, A.; Nam, K.; Kimura, T.; Kishida, A.			Preparation of Fibrillized Collagen Microsphere and Evaluation of Physical and Biological Properties	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Matsuhashi, A.; Nam, K.; Kimura, T.; Kishida, A.] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		P-153	S64	S64				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300247		
J	Mihara, Y; Matsuura, K; Sakamoto, Y; Okano, T; Kokudo, N; Shimizu, T				Mihara, Y.; Matsuura, K.; Sakamoto, Y.; Okano, T.; Kokudo, N.; Shimizu, T.			Production of Glucose Stimulated Insulin Secreting Cells from Hipscs by Scalable Three Dimensional Suspension Bioreactor System	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Mihara, Y.; Sakamoto, Y.; Kokudo, N.] Univ Tokyo, Tokyo, Japan; [Matsuura, K.; Okano, T.; Shimizu, T.] Tokyo Womens Med Univ, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		P-224	S75	S75				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300291		
J	Mizutani, M; Kubo, H; Wada, M; Tanimoto, K; Shimizu, T; Kino-Oka, M				Mizutani, M.; Kubo, H.; Wada, M.; Tanimoto, K.; Shimizu, T.; Kino-Oka, M.			Development of A Novel Modular System for Preparing Regenerative Medicine Products	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Mizutani, M.] Osaka Univ, Suita, Osaka, Japan; [Kubo, H.] Nihon Koden Corp, Shinjuku Ku, Tokyo, Japan; [Wada, M.] ABLE Corp, Shinjuku Ku, Tokyo, Japan; [Tanimoto, K.] Shibuya Kogyo Co LTD, Kanazawa, Ishikawa, Japan; [Shimizu, T.] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Shinjuku Ku, Tokyo, Japan; [Kino-Oka, M.] Osaka Univ, Grad Sch Engn, Suita, Osaka, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		P-563	S118	S118				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300465		
J	Nakamura, N; Nam, K; Kimura, T; Fujisato, T; Tsuji, T; Iwata, H; Kishida, A				Nakamura, N.; Nam, K.; Kimura, T.; Fujisato, T.; Tsuji, T.; Iwata, H.; Kishida, A.			The Appropriate Microenvironment Prepared by Decellularized Cancellous Bone Induced Ectopic Hematopoiesis	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Nakamura, N.; Nam, K.; Kimura, T.; Kishida, A.] Tokyo Med & Dent Univ, Tokyo, Japan; [Fujisato, T.] Osaka Inst Technol, Osaka 535, Japan; [Tsuji, T.] RIKEN, Kobe, Hyogo, Japan; [Iwata, H.] Kyoto Univ, Kyoto, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		O-235	S18	S18				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300063		
J	Sato, Y; Wakitani, S; Takagi, M				Sato, Y.; Wakitani, S.; Takagi, M.			Increase of Type 2 Collagen Accumulation in Shrinkage-Free Scaffold-Free Cartilage-Like MSCs Sheet	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Sato, Y.; Takagi, M.] Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido, Japan; [Wakitani, S.] Hiroshima Univ, Grad Sch Biomed Sceineces, Hiroshima, Japan							Maeda S, 2011, J BIOSCI BIOENG, V111, P489, DOI 10.1016/j.jbiosc.2010.11.022	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		P-103	S57	S58				2	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300220		
J	Sawada, K; Goto, H; Saka, Y; Aoyama, T; Fujisato, T				Sawada, K.; Goto, H.; Saka, Y.; Aoyama, T.; Fujisato, T.			Scaffold for Cell Culture Made by Electrospun Keratin Nanofibers	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Sawada, K.] Osaka Seikei Coll, Osaka, Japan; [Goto, H.; Saka, Y.; Aoyama, T.; Fujisato, T.] Osaka Inst Technol, Osaka 535, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		P-155	S65	S65				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300249		
J	Takagi, S; Shimizu, T; Kuramoto, G; Ishitani, K; Matsui, H; Okano, T				Takagi, S.; Shimizu, T.; Kuramoto, G.; Ishitani, K.; Matsui, H.; Okano, T.			Ectopic Regeneration of Endometrium-Like Tissue In Vivo using Cell Sheet Technology	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Takagi, S.; Shimizu, T.; Okano, T.] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; [Kuramoto, G.; Ishitani, K.; Matsui, H.] Tokyo Womens Med Univ, Dept Obstet & Gynecol, Tokyo, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		P-237	S76	S76				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300297		
J	Tani, Y; Sato, M; Nagashima, H; Maehara, M; Yokoyama, M; Kobayashi, M; Toyoda, E; Kawake, T; Okada, E; Mochida, J				Tani, Y.; Sato, M.; Nagashima, H.; Maehara, M.; Yokoyama, M.; Kobayashi, M.; Toyoda, E.; Kawake, T.; Okada, E.; Mochida, J.			The Effect of Using Vitrified Chondrocyte Sheets on Articular Cartilage Repair	TISSUE ENGINEERING PART A			English	Meeting Abstract	TERMIS-AM Conference	DEC 13-16, 2014	Washington, DC	TERMIS AM					[Tani, Y.; Sato, M.; Yokoyama, M.; Kobayashi, M.; Toyoda, E.; Kawake, T.; Okada, E.; Mochida, J.] Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan; [Nagashima, H.; Maehara, M.] Meiji Univ, Sch Agr, Lab Dev Engn, Kawasaki, Kanagawa, Japan								0	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	DEC 1	2014	20			1		P-213	S74	S74				1	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	AU6AK	WOS:000345684300286		
J	Matsuo, S; Takahashi, M; Inoue, K; Tamura, K; Irie, K; Kodama, Y; Nishikawa, A; Yoshida, M				Matsuo, Saori; Takahashi, Miwa; Inoue, Kaoru; Tamura, Kei; Irie, Kaoru; Kodama, Yukio; Nishikawa, Akiyoshi; Yoshida, Midori			Inhibitory Potential of Postnatal Treatment with Cyclopamine, a Hedgehog Signaling Inhibitor, on Medulloblastoma Development in Ptch1 Heterozygous Mice	TOXICOLOGIC PATHOLOGY			English	Article						cyclopamine; cerebellum; medulloblastoma; patched1; preneoplastic lesion; smoothened inhibitor; sonic hedgehog inhibitor	CHILDHOOD BRAIN-TUMORS; SONIC-HEDGEHOG; MOUSE MODEL; CELL-PROLIFERATION; ANIMAL-MODELS; PATHWAY; CANCER; TUMORIGENESIS; CEREBELLUM; EXPOSURE	Medulloblastomas (MBs) are thought to be derived from granular cell precursors in the external granular layer (EGL) of the developing cerebellum. Heterozygous patched1 (Ptch1) knockout mice develop MBs that resemble those in humans when the sonic hedgehog (Shh) signaling pathway is activated. The present study was conducted to evaluate postnatal effects of a Shh signaling inhibitor, cyclopamine, on the development of MBs in Ptch1 mice. Ptch1 and wild-type mice were treated daily with subcutaneous cyclopamine at 40 mg/kg or vehicle from postnatal day (PND) 1 to PND14, and the subsequent development of MBs and preneoplastic lesions was examined up to week 12 (W12). Proliferative lesions in the cerebellum, MBs, and preneoplastic lesions were only detected in Ptch1 mice. Cyclopamine treatment resulted in a statistically significant reduction in the incidence and/or area of proliferative lesions at PND14 and 21. The trend of decreasing preneoplastic lesions persisted up to W12. At PND7, cyclopamine treatment reduced the width and proliferation of the EGL regardless of genotype. These results indicate that inhibition of Shh signaling during cerebellar development has prolonged inhibitory potential on MB development in Ptch1 mice. This inhibitory potential might be related to inhibition of EGL proliferation, including preneoplastic MB cells.	[Matsuo, Saori; Takahashi, Miwa; Inoue, Kaoru; Tamura, Kei; Irie, Kaoru; Yoshida, Midori] Natl Inst Hlth Sci, Div Pathol, Tokyo 1588501, Japan; [Matsuo, Saori; Nishikawa, Akiyoshi] Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan; [Kodama, Yukio] Natl Inst Hlth Sci, Div Toxicol, Tokyo 1588501, Japan; [Nishikawa, Akiyoshi] Natl Inst Hlth Sci, Biol Safety Res Ctr, Tokyo 1588501, Japan	Yoshida, M (reprint author), Natl Inst Hlth Sci, Div Pathol, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	midoriy@nihs.go.jp			Health and Labor Sciences Research Grants, Research on Risk of Chemical Substances, Ministry of Health, Labor and Welfare [H25-Toxicol-003]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was partly supported by Health and Labor Sciences Research Grants, Research on Risk of Chemical Substances, Ministry of Health, Labor and Welfare [H25-Toxicol-003].	Wetmore C, 2000, CANCER RES, V60, P2239; Low JA, 2010, J CLIN ONCOL, V28, P5321, DOI 10.1200/JCO.2010.27.9943; Gajjar A, 2013, CLIN CANCER RES, V19, P6305, DOI 10.1158/1078-0432.CCR-13-1425; Kimura H, 2005, ONCOGENE, V24, P4026, DOI 10.1038/sj.onc.1208567; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Ayrault O, 2009, MOL CANCER RES, V7, P33, DOI 10.1158/1541-7786.MCR-08-0369; Uziel T, 2005, GENE DEV, V19, P2656, DOI 10.1101/gad.1368605; Sanchez P, 2005, MECH DEVELOP, V122, P223, DOI 10.1016/j.mod.2004.10.002; Dhall G, 2009, J CHILD NEUROL, V24, P1418, DOI 10.1177/0883073809341668; Pazzaglia S, 2002, ONCOGENE, V21, P7580, DOI 10.1038/sj.onc.1205973; Lee MJ, 2012, P NATL ACAD SCI USA, V109, P7859, DOI 10.1073/pnas.1114718109; Birnbaum LS, 2003, ENVIRON HEALTH PERSP, V111, P389, DOI 10.1289/ehp.5686; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Heretsch P, 2010, ANGEW CHEM INT EDIT, V49, P3418, DOI 10.1002/anie.200906967; Pazzaglia S, 2006, ONCOGENE, V25, P5575, DOI 10.1038/sj.onc.1209544; Pogoriler J, 2006, DEVELOPMENT, V133, P3929, DOI 10.1242/dev.02556; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Oliver TG, 2005, DEVELOPMENT, V132, P2425, DOI 10.1242/dev.01793; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Wetmore C, 2001, CANCER RES, V61, P513; Bartlett F, 2013, CLIN ONCOL-UK, V25, P36, DOI 10.1016/j.clon.2012.09.008; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Dyer MA, 2004, J CLIN PATHOL, V57, P561, DOI 10.1136/jcp.2003.009910; Ellison DW, 2011, ACTA NEUROPATHOL, V121, P381, DOI 10.1007/s00401-011-0800-8; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; Heretsch P, 2010, BIOORGAN MED CHEM, V18, P6613, DOI 10.1016/j.bmc.2010.07.038; Kawauchi D, 2012, CANCER CELL, V21, P168, DOI 10.1016/j.ccr.2011.12.023; Roussel MF, 2011, CURR TOP DEV BIOL, V94, P235, DOI 10.1016/B978-0-12-380916-2.00008-5; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Haldipur P, 2012, STEM CELLS DEV, V21, P1059, DOI 10.1089/scd.2011.0206; Hahn H, 1999, J MOL MED-JMM, V77, P459, DOI 10.1007/s001099900018; Hatten ME, 2011, TRENDS NEUROSCI, V34, P134, DOI 10.1016/j.tins.2011.01.002; Vaillant C, 2009, CEREBELLUM, V8, P291, DOI 10.1007/s12311-009-0094-8; Behesti H, 2009, INT J BIOCHEM CELL B, V41, P435, DOI 10.1016/j.biocel.2008.06.017; Briggs KJ, 2008, GENE DEV, V22, P770, DOI 10.1101/gad.1640908; Bunin GR, 2006, AM J EPIDEMIOL, V164, P222, DOI 10.1093/aje/kwj174; Coon V, 2010, MOL CANCER THER, V9, P2627, DOI 10.1158/1535-7163.MCT-10-0486; Corcoran RB, 2001, J NEURO-ONCOL, V53, P307, DOI 10.1023/A:1012260318979; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Dietrich M, 2005, CANCER CAUSE CONTROL, V16, P619, DOI 10.1007/s10552-005-0168-y; Ecke I, 2008, MOL CARCINOGEN, V47, P361, DOI 10.1002/mc.20394; Farioli-Vecchioli S, 2007, FASEB J, V21, P2215, DOI 10.1096/fj.06-7548com; Gupta Sachin, 2010, Ther Adv Med Oncol, V2, P237, DOI 10.1177/1758834010366430; Fan Qipeng, 2011, Chin J Cancer, V30, P472, DOI 10.5732/cjc.011.10157; Lipinski RJ, 2008, TOXICOL SCI, V104, P189, DOI 10.1093/toxsci/kfn076; Matsuo S, 2013, EXP TOXICOL PATHOL, V65, P863, DOI 10.1016/j.etp.2012.12.005; McKean-Cowdin R, 2003, INT J EPIDEMIOL, V32, P211, DOI 10.1093/ije/dyg050; Norman MA, 1996, CANCER EPIDEM BIOMAR, V5, P85; Pazzaglia S, 2006, CANCER LETT, V234, P124, DOI 10.1016/j.canlet.2005.03.047; Pazzaglia S, 2009, INT J RADIAT ONCOL, V73, P1203, DOI 10.1016/j.ijrobp.2008.10.068; Raffel C, 2004, NEOPLASIA, V6, P310, DOI 10.1593/neo.03454; Stecca Barbara, 2002, J Biol, V1, P9, DOI 10.1186/1475-4924-1-9; Takahashi M, 2012, CANCER SCI, V103, P2051, DOI 10.1111/cas.12006	56	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0192-6233	1533-1601		TOXICOL PATHOL	Toxicol. Pathol.	DEC	2014	42	8					1174	1187		10.1177/0192623314530194		14	Pathology; Toxicology	Pathology; Toxicology	AU4SQ	WOS:000345602200003		
J	Inomata, A; Nakano-Ito, K; Fujikawa, Y; Sonoda, J; Hayakawa, K; Ohta, E; Taketa, Y; Van Gessel, Y; Akare, S; Hutto, D; Hosokawa, S; Tsukidate, K				Inomata, Akira; Nakano-Ito, Kyoko; Fujikawa, Yasuhiro; Sonoda, Jiro; Hayakawa, Kazuhiro; Ohta, Etsuko; Taketa, Yoshikazu; Van Gessel, Yvonne; Akare, Sandeep; Hutto, David; Hosokawa, Satoru; Tsukidate, Kazuo			Brunner's Gland Lesions in Rats Induced by a Vascular Endothelial Growth Factor Receptor Inhibitor	TOXICOLOGIC PATHOLOGY			English	Article						vascular endothelial growth factor; receptor tyrosine kinase inhibitor; lenvatinib; Brunner's gland; rats; nonclinical toxicity	SAFETY EVALUATION; SMALL-INTESTINE; STOMACH; CANCER; DIFFERENTIATION; TRACT; MOUSE; VEGF	Vascular endothelial growth factor (VEGF) receptor tyrosine kinase (RTK) inhibitors are reported to cause reversible mucosal hyperplasia (adenosis) in the duodenum of rats; however, the pathogenesis is not fully elucidated. Using lenvatinib, a VEGF RTK inhibitor, we characterized the histologic time course of this duodenal change in rats. At 4 weeks, there was degeneration and necrosis of Brunner's gland epithelium accompanied by neutrophil infiltration around the affected glands. At 13 weeks, the inflammation was more extensive, and Brunner's gland epithelium was attenuated and flattened and was accompanied by reactive hyperplasia of duodenal epithelium. At 26 weeks, the changes became more severe and chronic and characterized by marked cystic dilation, which extended to the external muscular layer. These dilated glands exhibited morphological characteristics of duodenal crypt epithelium, suggestive of replacement of disappeared Brunner's glands by regenerative duodenal crypt epithelial cells. Similar changes were not present in similar time course studies in dog and monkey studies, suggesting that this is a rodent- or species-specific change. Based on the temporal progression of Brunner's gland lesion, we identify degeneration and necrosis of the Brunner's glands as the primary change leading to inflammation, cystic dilatation, and regeneration with cells that are morphologically suggestive of duodenal crypt epithelium.	[Inomata, Akira; Nakano-Ito, Kyoko; Fujikawa, Yasuhiro; Sonoda, Jiro; Ohta, Etsuko; Taketa, Yoshikazu; Hosokawa, Satoru; Tsukidate, Kazuo] Eisai, Drug Safety Tsukuba, Tsukuba, Ibaraki 3002635, Japan; [Hayakawa, Kazuhiro] Sunplanet, Preclin Safety Res Labs, Kawashima Div, Gifu, Japan; [Van Gessel, Yvonne; Akare, Sandeep; Hutto, David] Eisai, Drug Safety Andover, Andover, MA USA	Inomata, A (reprint author), Eisai, Eisai Product Creat Syst, Global Drug Safety, Biopharmaceut Assessments Core Funct Unit, 5-1-3 Tokodai, Tsukuba, Ibaraki 3002635, Japan.	a-inomata@hhc.eisai.co.jp		Taketa, Yoshikazu/0000-0002-4792-0408			Krause WJ, 2000, PROG HISTOCHEM CYTO, V35, P255; Gerber HP, 1999, NAT MED, V5, P623; Patyna S, 2008, TOXICOL PATHOL, V36, P905, DOI 10.1177/0192623308326151; Tugues S, 2011, MOL ASPECTS MED, V32, P88, DOI 10.1016/j.mam.2011.04.004; Thomas AL, 2005, J CLIN ONCOL, V23, P4162, DOI 10.1200/JCO.2005.09.034; BAILEY DS, 1984, J CELL SCI, V72, P195; Ellis L. M., 2008, NATURE REV CANC, V2, P826; Ettlin RA, 2010, J TOXICOL PATHOL, V23, P213, DOI 10.1293/tox.23.213; Florey HW, 1939, J PATHOL BACTERIOL, V49, P105, DOI 10.1002/path.1700490112; Griffith C. A., 1956, ANN SURG, V243, P160; Hagedorn A, 2005, EXP TOXICOL PATHOL, V57, P149, DOI 10.1016/j.etp.2005.04.005; Johnson FP, 1910, AM J ANAT, V10, P521, DOI 10.1002/aja.1000100116; KRAUSE WJ, 1967, J ANAT, V101, P309; LANG IM, 1983, PFLUG ARCH EUR J PHY, V396, P115, DOI 10.1007/BF00615515; OBUOFORIBO AA, 1977, J ANAT, V124, P779; Ryan AM, 1999, TOXICOL PATHOL, V27, P78, DOI 10.1177/019262339902700115; SUGIMURA T, 1970, CANCER RES, V30, P455; TAHARA E, 1982, CANCER RES, V42, P1781; TAMANO S, 1990, JPN J CANCER RES, V81, P1222; TOOFANIAN F, 1982, AM J VET RES, V43, P2213; UWAGAWA S, 1991, JPN J CANCER RES, V82, P1397	21	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0192-6233	1533-1601		TOXICOL PATHOL	Toxicol. Pathol.	DEC	2014	42	8					1267	1274		10.1177/0192623313520350		8	Pathology; Toxicology	Pathology; Toxicology	AU4SQ	WOS:000345602200011		
J	Brozynska, M; Omar, ES; Furtado, A; Crayn, D; Simon, B; Ishikawa, R; Henry, RJ				Brozynska, Marta; Omar, Ernnie Syafika; Furtado, Agnelo; Crayn, Darren; Simon, Bryan; Ishikawa, Ryuji; Henry, Robert James			Chloroplast Genome of Novel Rice Germplasm Identified in Northern Australia	TROPICAL PLANT BIOLOGY			English	Article						Wild rice; Oryza; Chloroplast sequence; Phylogeny	EVOLUTIONARY HISTORY; CULTIVATED RICE; GENUS ORYZA; WILD-RICE; SEQUENCES; POACEAE; ORIGIN; DIVERSIFICATION; MITOCHONDRIAL; TOMATO	Rice (Oryza sativa L.) was probably domesticated from O. rufipogon in Asia in the last 10,000 years. Relatives of cultivated rice (A genome species of Oryza) are found in South America, Africa, Australia and Asia. These A genome species are the close relatives of cultivated rice and represent the effective gene pool for rice improvement. Members of this group in Northern Australia include, an annual species, O. meridionalis, and two recently distinguished perennial taxa, to one of which the name O. rufipogon has been applied and the other a perennial form of O. meridionalis. Comparison of whole chloroplast genome sequences of these taxa has now been used to determine the relationships between the wild taxa and cultivated rice. The chloroplast genomes of the perennials were both found to be distinguished from O. rufipogon from Asia by 124 or 125 variations and were distinguished from each other by 53 variations. These populations have remained isolated from the overwhelming genetic impact of the large domesticated rice populations in Asia and may be unique descendants of the gene pool from which domesticated rice arose. The conservation of this wild genetic resource may be critical for global food security.	[Brozynska, Marta; Omar, Ernnie Syafika; Furtado, Agnelo; Simon, Bryan; Henry, Robert James] Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld 4072, Australia; [Crayn, Darren] James Cook Univ, Australian Trop Herbarium, Cairns, Qld, Australia; [Ishikawa, Ryuji] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan	Henry, RJ (reprint author), Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld 4072, Australia.	robert.henry@uq.edu.au	Henry, Robert/B-5824-2008; Research ID, CTBCC /O-3564-2014; James Cook University, TESS/B-8171-2012	Henry, Robert/0000-0002-4060-0292; 	Rural Industries Research and Development Corporation (RIRDC), Australia	This work was supported by Rural Industries Research and Development Corporation (RIRDC), Australia.	Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Zhu QH, 2005, NEW PHYTOL, V167, P249, DOI 10.1111/j.1469-8137.2005.01406.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Lu F, 2009, P NATL ACAD SCI USA, V106, P2071, DOI 10.1073/pnas.0812798106; BERNATZKY R, 1986, THEOR APPL GENET, V72, P314, DOI 10.1007/BF00288567; Waters DLE, 2012, ECOL EVOL, V2, P211, DOI 10.1002/ece3.66; Vaughan DA, 2008, PLANT SCI, V174, P394, DOI 10.1016/j.plantsci.2008.01.016; Ammiraju JSS, 2010, PLANT J, V63, P430, DOI 10.1111/j.1365-313X.2010.04251.x; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Ge S, 1999, P NATL ACAD SCI USA, V96, P14400, DOI 10.1073/pnas.96.25.14400; Green BR, 2011, PLANT J, V66, P34, DOI 10.1111/j.1365-313X.2011.04541.x; Duan SH, 2007, BIOCHEM GENET, V45, P113, DOI 10.1007/s10528-006-9062-x; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Henry RJ, 2010, RICE, V3, P235, DOI 10.1007/s12284-009-9034-y; Bouchenak-Khelladi Y, 2010, BOT J LINN SOC, V162, P543, DOI 10.1111/j.1095-8339.2010.01041.x; CARROLL BJ, 1995, GENETICS, V139, P407; Clifford HT, 1981, ECOLOGICAL BIOGEOGRA; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Furtado A, 2014, CEREAL GENOMICS METH, P1; Ge S, 2001, RICE GENETICS, P89; Kellogg EA, 2009, RICE, V2, P1, DOI 10.1007/s12284-009-9022-2; Kwon SJ, 2006, GENES GENET SYST, V81, P93, DOI 10.1266/ggs.81.93; OKA HI, 1974, GENETICS, V78, P475; Prasad V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1482; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Sharma SD, 2003, MONOGRAPH GENUS ORYZ, P73; SIMON B K, 1990, Austrobaileya, V3, P239; Sotowa M, 2013, RICE, V6, DOI 10.1186/1939-8433-6-26; Stevens PF, 2014, POACEAE ANGIOSPERM P; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Vaughan DA, 1989, RES PAP SER, V138; Zou XH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r49	32	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1935-9756	1935-9764		TROP PLANT BIOL	Trop. Plant Biol.	DEC	2014	7	3-4					111	120		10.1007/s12042-014-9142-8		10	Plant Sciences	Plant Sciences	AU4PA	WOS:000345592300003		
J	Miyake, H; Behnsawy, HM; Hinata, N; Fujisawa, M				Miyake, Hideaki; Behnsawy, Hosny M.; Hinata, Nobuyuki; Fujisawa, Masato			Objective Assessment of Residual Nerve Tissues in Radical Prostatectomy Specimens by Immunohistochemical Staining of Neuronal Nitric Oxide Synthasee-positive Nerves and Its Impact on Postoperative Erectile Function	UROLOGY			English	Article							SEXUAL FUNCTION; OUTCOMES; CANCER; RARP; MEN	OBJECTIVE To compare the quality of surgical management of the neurovascular bundle (NVB) by assessment of neuronal nitric oxide synthase (nNOS)-positive nerves in surgical specimens between open retropubic radical prostatectomy (RP; ORRP) and robot-assisted RP (RARP). METHODS This study included 65 (99 sides, NVB resection; 31 sides, NVB preservation) and 83 (106 sides, NVB resection; 60 sides, NVB preservation) patients undergoing ORRP and RARP, respectively. The posterior sectors from the apex, mid, and base areas on each side were immunohistochemically stained with an nNOS antibody. RESULTS On the sides with NVB resection, there were no significant differences in the numbers of nNOS-positive nerves in any areas between the ORRP and RARP groups; however, on the sides with NVB preservation, the numbers of nNOS-positive nerves in the ORRP group were significantly higher than those in the RARP group at the apex (84.4 vs 59.2; P = .0028), mid (71.2 vs 52.4; P = .016), and base (148.0 vs 40.8; P <.001) areas. In 55 patients who were judged not to have severe erectile dysfunction before surgery and subsequently underwent nerve-sparing RP, there was a significantly inverse correlation between the total number of nNOS-positive nerves on both sides and the postoperative erectile function. CONCLUSION These findings suggest that RARP might be suitable for performing precise nerve-sparing surgery compared with ORPP, particularly in the base area of the prostate and that the quantification of nNOS-positive nerves in surgical specimens could be a useful approach for predicting the postoperative erectile function. (C) 2014 Elsevier Inc.	[Miyake, Hideaki; Behnsawy, Hosny M.; Hinata, Nobuyuki; Fujisawa, Masato] Kobe Univ, Grad Sch Med, Div Urol, Kobe, Hyogo 6500017, Japan	Miyake, H (reprint author), Kobe Univ, Grad Sch Med, Div Urol, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	hideakimiyake@hotmail.com	Hinata, Nobuyuki/M-9421-2015	Hinata, Nobuyuki/0000-0001-7014-6812			Sivarajan G, 2014, EUR UROL, V65, P58, DOI 10.1016/j.eururo.2013.08.019; Rhoden EL, 2002, INT J IMPOT RES, V14, P245, DOI 10.1038/sj.ijir.3900859; Walsh PC, 2007, J UROLOGY, V177, P1632, DOI 10.1016/j.juro.2007.01.012; Gallina A, 2008, BJU INT, V101, P1513, DOI 10.1111/j.1464-410X.2008.07519.x; Patel VR, 2007, BJU INT, V99, P1109, DOI 10.1111/j.1464-410X.2007.06762.x; McCullough AR, 2008, ASIAN J ANDROL, V10, P61, DOI 10.1111/j.1745-7262.2008.00366.x; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Tewari AK, 2011, BJU INT, V108, P984, DOI 10.1111/j.1464-410X.2011.10565.x; Bannowsky A, 2006, J UROLOGY, V175, P2214, DOI 10.1016/S0022-5347(06)00308-9; Bradford TJ, 2010, UROL ONCOL-SEMIN ORI, V28, P487, DOI 10.1016/j.urolonc.2008.09.042; BURNETT AL, 1993, J UROLOGY, V150, P73; Carter S, 2013, CURR OPIN UROL, V23, P88, DOI 10.1097/MOU.0b013e32835b6602; Hammad FT, 2008, ANN NY ACAD SCI, V1138, P267, DOI 10.1196/annals.1414.032; Ko WJ, 2013, BJU INT, V111, P451, DOI 10.1111/j.1464-410X.2012.11393.x; Koch M O, 2000, Semin Urol Oncol, V18, P33; Kurahashi T, 2007, J UROLOGY, V177, P757, DOI 10.1016/j.juro.2006.09.073; Namiki S, 2008, J UROLOGY, V179, P245, DOI 10.1016/j.juro.2007.08.164; Palisaar RR, 2005, EUR UROL, V47, P176, DOI 10.1016/j.eururo.2004.09.002; Schatloff O, 2012, EUR UROL, V61, P796, DOI 10.1016/j.eururo.2011.12.048; Schatloff O, 2013, BJU INT, V112, pE301, DOI 10.1111/bju.12038; Takenaka A, 2005, UROLOGY, V65, P136, DOI 10.1016/j.urology.2004.08.028; Tewari A, 2006, BJU INT, V98, P314, DOI 10.1111/j.1464-410X.2006.06266.x; WALSH PC, 1994, SEMIN ONCOL, V21, P662; Walz J, 2011, CURR OPIN UROL, V21, P173, DOI 10.1097/MOU.0b013e3283449d6d	24	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-4295	1527-9995		UROLOGY	Urology	DEC	2014	84	6					1395	1400		10.1016/j.urology.2014.05.081		6	Urology & Nephrology	Urology & Nephrology	AU4KT	WOS:000345580500044		
J	Funahashi, Y; Yoshino, Y; Sassa, N; Matsukawa, Y; Takai, S; Gotoh, M				Funahashi, Yasuhito; Yoshino, Yasushi; Sassa, Naoto; Matsukawa, Yoshihisa; Takai, Shun; Gotoh, Momokazu			Comparison of Warm and Cold Ischemia on Renal Function After Partial Nephrectomy	UROLOGY			English	Article							LAPAROSCOPIC PARTIAL NEPHRECTOMY; NEPHRON-SPARING SURGERY; CHRONIC KIDNEY-DISEASE; RADICAL NEPHRECTOMY; LONG-TERM; HYPOTHERMIA; IMPACT; TIME; OUTCOMES	OBJECTIVE To assess renal functional deterioration after partial nephrectomy with warm and cold ischemia using Tc-99m-mercaptoacetyltriglycine (Tc-99m-MAG3) renal scintigraphy parameters. METHODS Open partial nephrectomy was performed in 59 patients with warm ischemia and 64 patients with cold ischemia. Tc-99m-MAG3 renal scintigraphy was performed and effective renal plasma flow was calculated to evaluate split renal function. In addition, regional Tc-99m-MAG3 uptake was analyzed in the surgically unaffected parts to evaluate ischemic damage. RESULTS The mean tumor size in the warm and cold ischemia groups was 2.9 and 3.2 cm, respectively, and the mean ischemic time was 24.2 minutes (range, 8-46 minutes) and 26.7 min (range, 8-58 minutes), respectively. One week after surgery, effective renal plasma flow in the operated kidney decreased to 66.2% (from 160.2 to 105.4 mL/min/1.73 m(2)) in the warm ischemia group and to 77.4% (from 152.3 to 116.6 mL/min/1.73 m(2)) in the cold ischemia group. Regional Tc-99m-MAG3 uptake changed to 89.2% of baseline in the warm ischemia group and 101.5% of baseline in the cold ischemia group. When the ischemic time was >= 25 minutes, regional Tc-99m-MAG3 uptake in the warm ischemia group did not recover to the baseline level at 6 months. Multiple regression analyses demonstrated a significant correlation between ischemic time and the decrease in regional Tc-99m-MAG3 uptake in the warm ischemia group, but not in the cold ischemia group. CONCLUSION Warm ischemia for >= 25 minutes caused long lasting diffuse damage throughout the operated kidney, whereas cold ischemia for up to 58 minutes prevented ischemic injury to the renal remnant. (C) 2014 Elsevier Inc.	[Funahashi, Yasuhito; Yoshino, Yasushi; Sassa, Naoto; Matsukawa, Yoshihisa; Takai, Shun; Gotoh, Momokazu] Nagoya Univ, Grad Sch Med, Dept Urol, Nagoya, Aichi 4668550, Japan	Funahashi, Y (reprint author), Nagoya Univ, Grad Sch Med, Dept Urol, Showa Ku, 65 Tsuruma Cho, Nagoya, Aichi 4668550, Japan.	yfunahashi@med.nagoya-u.ac.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Thompson RH, 2010, EUR UROL, V58, P331, DOI 10.1016/j.eururo.2010.05.048; Gill IS, 2007, J UROLOGY, V178, P41, DOI 10.1016/j.juro.2007.03.038; Sun M, 2012, EUR UROL, V62, P696, DOI 10.1016/j.eururo.2012.03.051; Thompson RH, 2007, J UROLOGY, V177, P471, DOI 10.1016/j.juro.2006.09.036; Rizkala ER, 2013, UROLOGY, V82, P100, DOI 10.1016/j.urology.2013.03.042; Tan HJ, 2012, JAMA-J AM MED ASSOC, V307, P1629, DOI 10.1001/jama.2012.475; NOVICK AC, 1983, UROL CLIN N AM, V10, P637; Gill IS, 2003, J UROLOGY, V170, P52, DOI 10.1097/01.ju.0000072332.02529.10; Funahashi Y, 2012, UROLOGY, V79, P160, DOI 10.1016/j.urology.2011.08.071; Lane BR, 2011, J UROLOGY, V185, P421, DOI 10.1016/j.juro.2010.09.131; Becker F, 2009, EUR UROL, V56, P625, DOI 10.1016/j.eururo.2009.07.016; Bollens R, 2007, EUR UROL, V52, P804, DOI 10.1016/j.eururo.2007.04.011; Funahashi Y, 2009, EUR UROL, V55, P209, DOI 10.1016/j.eururo.2008.07.048; Funahashi Y, 2014, J UROLOGY, V191, P1147, DOI 10.1016/j.juro.2013.11.026; Harke N, 2014, WORLD J UROL, V32, P1259, DOI 10.1007/s00345-013-1202-4; Humke U, 1999, BJU INT, V84, P555; Iida S, 2008, UROLOGY, V72, P1083, DOI 10.1016/j.urology.2008.06.074; Iida S, 2008, UROLOGY, V72, P1088; Kates M, 2011, J UROLOGY, V186, P1247, DOI 10.1016/j.juro.2011.05.054; Kubo Atsushi, 1997, Kaku Igaku, V34, P1101; Lane BR, 2007, J UROLOGY, V177, P70, DOI 10.1016/j.juro.2006.08.093; Lane BR, 2011, J UROLOGY, V185, P1598, DOI 10.1016/j.juro.2010.12.046; Marberger M, 2007, BJU INT, V99, P3, DOI 10.1111/j.1464-410X.2007.06612,06516,06534,06605.x; MCDOUGAL WS, 1988, J UROLOGY, V140, P1325; Orvieto MA, 2007, J UROLOGY, V177, P382, DOI 10.1016/j.juro.2006.08.082; Porpiglia F, 2011, BJU INT, V108, P268, DOI 10.1111/j.1464-410X.2010.09788.x; SOUTHARD JH, 1980, CRYOBIOLOGY, V17, P148, DOI 10.1016/0011-2240(80)90019-X; Tatsugami K, 2011, J ENDOUROL, V25, P873; Tatsugami K, 2011, J ENDOUROL, V25, P869, DOI 10.1089/end.2010.0502; WARD JP, 1975, BRIT J UROL, V47, P17, DOI 10.1111/j.1464-410X.1975.tb03913.x	31	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-4295	1527-9995		UROLOGY	Urology	DEC	2014	84	6					1408	1412		10.1016/j.urology.2014.08.040		5	Urology & Nephrology	Urology & Nephrology	AU4KT	WOS:000345580500049		
J	Funahashi, Y				Funahashi, Yasuhito			Comparison of Warm and Cold Ischemia on Renal Function After Partial Nephrectomy REPLY	UROLOGY			English	Editorial Material									Nagoya Univ, Grad Sch Med, Dept Urol, Nagoya, Aichi 4648601, Japan	Funahashi, Y (reprint author), Nagoya Univ, Grad Sch Med, Dept Urol, Nagoya, Aichi 4648601, Japan.						Funahashi Y, 2012, UROLOGY, V79, P160, DOI 10.1016/j.urology.2011.08.071; Funahashi Y, 2009, EUR UROL, V55, P209, DOI 10.1016/j.eururo.2008.07.048	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-4295	1527-9995		UROLOGY	Urology	DEC	2014	84	6					1413	1413		10.1016/j.urology.2014.08.042		1	Urology & Nephrology	Urology & Nephrology	AU4KT	WOS:000345580500051		
J	Chen, SL; Liu, RF; Koyanagi, KO; Kishima, Y				Chen, Sunlu; Liu, Ruifang; Koyanagi, Kanako O.; Kishima, Yuji			Rice genomes recorded ancient pararetrovirus activities: Virus genealogy and multiple origins of endogenization during rice speciation	VIROLOGY			English	Article						Paleovirology; Endogenous pararetrovirus; Rice; Genealogy; Recombination; Rice tungro bacilliform virus; Virus lineage; Rice speciation	TUNGRO-BACILLIFORM-VIRUS; ORYZA-RUFIPOGON; NUCLEOTIDE VARIATION; MULTILOCUS ANALYSIS; ENDOGENOUS VIRUSES; VIRAL SEQUENCES; CULTIVATED RICE; GENE FLOW; WILD-RICE; DOMESTICATION	Viral fossils in rice genomes are a best entity to understand ancient pararetrovirus activities through host plant history because of our advanced knowledge of the genomes and evolutionary history with rice and its related species. Here, we explored organization, geographic origins and genealogy of rice pararetroviruses, which were turned into endogenous rice tungro bacilliform virus-like (eRTBVL) sequences. About 300 eRTBVL sequences from three representative rice genomes were clearly classified into six families. Most of the endogenization events of the eRTBVLs were initiated before differentiation of the rice progenitor (> 160,000 years ago). We successfully followed the genealogy of old relic viruses during rice speciation, and inferred the geographical origins for these viruses. Possible virus genomic sequences were explained mostly by recombinations between different virus families. Interestingly, we discovered that only a few recombination events among the numerous occasions had determined the virus genealogy. (C) 2014 Published by Elsevier Inc.	[Chen, Sunlu; Liu, Ruifang; Kishima, Yuji] Hokkaido Univ, Res Fac Agr, Lab Plant Breeding, Sapporo, Hokkaido 0608589, Japan; [Koyanagi, Kanako O.] Hokkaido Univ, Grad Sch Informat Sci & Technol, Lab Genome Sci, Sapporo, Hokkaido 0600814, Japan; [Liu, Ruifang] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China	Kishima, Y (reprint author), Hokkaido Univ, Res Fac Agr, Lab Plant Breeding, Sapporo, Hokkaido 0608589, Japan.	kishima@abs.agr.hokuda.ac.jp	Kishima, Yuji/B-4669-2010	Kishima, Yuji/0000-0002-0942-3371	National Bioresource Project, MEXT, Japan; China Scholarship Council; Clark Memorial Foundation, Hokkaido University	The authors thank Takako Takeuchi and Huizhen Zheng for technical support. The global rice core collection (69 accessions, including japonica and indica) and wild rice accessions (30 O. rufipogon accessions) used in this study were distributed from the National Institute of Agrobiological Sciences and the National Institute of Genetics supported by the National Bioresource Project, MEXT, Japan, respectively. S. C was supported by a fellowship from China Scholarship Council, and Doctoral student research grant of Clark Memorial Foundation, Hokkaido University.	Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; Yang CC, 2012, MOL BIOL EVOL, V29, P1471, DOI 10.1093/molbev/msr315; Zhu QH, 2007, MOL BIOL EVOL, V24, P875, DOI 10.1093/molbev/msm005; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; Liu RF, 2012, PLANT J, V72, P817, DOI 10.1111/tpj.12002; Kunii M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-80; Wei X, 2012, MOL ECOL, V21, P5073, DOI 10.1111/j.1365-294X.2012.05748.x; Lu TT, 2008, DNA RES, V15, P285, DOI 10.1093/dnares/dsn018; Bill CA, 2004, P NATL ACAD SCI USA, V101, P11135, DOI 10.1073/pnas.0403925101; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Gayral P, 2010, J VIROL, V84, P7346, DOI 10.1128/JVI.00401-10; Kojima Y, 2005, BREEDING SCI, V55, P431, DOI 10.1270/jsbbs.55.431; Chessa B, 2009, SCIENCE, V324, P532, DOI 10.1126/science.1170587; Roossinck MJ, 1997, ANNU REV PHYTOPATHOL, V35, P191, DOI 10.1146/annurev.phyto.35.1.191; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Zong Y, 2007, NATURE, V449, P459, DOI 10.1038/nature06135; Froissart R, 2005, PLOS BIOL, V3, P389, DOI 10.1371/journal.pbio.0030089; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Zheng XM, 2010, MOL ECOL, V19, P2439, DOI 10.1111/j.1365-294X.2010.04674.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Geering ADW, 2010, ARCH VIROL, V155, P123, DOI 10.1007/s00705-009-0488-4; Gilbert C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000495; Harper G, 2002, ANNU REV PHYTOPATHOL, V40, P119, DOI 10.1146/annurev.phyto.40.120301.105642; HAY JM, 1991, NUCLEIC ACIDS RES, V19, P2615, DOI 10.1093/nar/19.10.2615; He ZW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002100; Herzog E, 2000, J VIROL, V74, P2073, DOI 10.1128/JVI.74.5.2073-2083.2000; Hohn T., 2013, CURR OPIN VIROL, V3; Hohn Thomas, 2008, P53, DOI 10.1007/978-3-540-75763-4_4; Hu WS, 2003, FRONT BIOSCI, V8, pD143, DOI 10.2741/940; Hull R., 2002, MATTHEWS PLANT VIROL, P743, DOI 10.1016/B978-012361160-4/50068-2; Jiang L, 2006, NEW EVIDENCE ORIGINS; Liu R., 2014, PLANT VIRUS HOST INT, P229; Mette MF, 2002, EMBO J, V21, P461, DOI 10.1093/emboj/21.3.461; Oka H.-I., 1988, ORIGIN CULTIVATED RI; Project R.A., 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI DOI 10.1093/NAR/GKM978; QU RD, 1991, VIROLOGY, V185, P354, DOI 10.1016/0042-6822(91)90783-8; Rohlf F, 2000, NTSYS PC VERSION 2 1; Sharma S, 2011, ARCH VIROL, V156, P2257, DOI 10.1007/s00705-011-1092-y; Staginnus C, 2009, ARCH VIROL, V154, P1189, DOI 10.1007/s00705-009-0412-y; Staginnus C, 2006, TRENDS PLANT SCI, V11, P485, DOI 10.1016/j.tplants.2006.08.008; TEMIN HM, 1985, MOL BIOL EVOL, V2, P455; Yasaka R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085641; Zhao WM, 2004, NUCLEIC ACIDS RES, V32, pD377, DOI 10.1093/nar/gkh085	47	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0042-6822			VIROLOGY	Virology	DEC	2014	471						141	152		10.1016/j.virol.2014.09.014		12	Virology	Virology	AU3FJ	WOS:000345497600015		
J	Shimizu, N; Minami, T; Sugimoto, K; Saito, Y; Yamamoto, Y; Hayashi, T; Tsuji, H; Nozawa, M; Yoshimura, K; Ishii, T; Uemura, H; Nakamatsu, K				Shimizu, Nobutaka; Minami, Takafumi; Sugimoto, Koichi; Saito, Yoshitaka; Yamamoto, Yutaka; Hayashi, Taiji; Tsuji, Hidenori; Nozawa, Masahiro; Yoshimura, Kazuhiro; Ishii, Tokumi; Uemura, Hirotsugu; Nakamatsu, Kiyoshi			Efficacy of silodosin in patients undergoing brachytherapy: a randomized trial involving a pressure flow study	WORLD JOURNAL OF UROLOGY			English	Article						Prostatic neoplasms; Alpha-1 antagonists; Pressure flow study; Brachytherapy; Silodosin	URINARY-TRACT SYMPTOMS; PERMANENT PROSTATE BRACHYTHERAPY; QUALITY-OF-LIFE; I-125 BRACHYTHERAPY; RADIATION-THERAPY; CANCER TREATMENT; ALPHA-BLOCKERS; RETENTION; MORBIDITY; IMPLANTATION	The purpose of the study is to investigate the efficacy of an alpha-1 adrenergic receptor antagonist (silodosin) for the treatment of lower urinary tract symptoms (LUTS) associated with interstitial I-125 implantation for prostate cancer. This randomized single-center study involved 105 patients (53 with and 52 without silodosin). Silodosin was postoperatively administered, daily, for 6 months (8 mg/day). Urinary symptoms and pressure flow were evaluated preoperatively and postoperatively at 1, 3, 6, and 12 months. At 12 months, interstitial I-125 implantation had induced a significant decrease in prostate volume (28.3 +/- A 11.1-20.5 +/- A 8.1 g in the silodosin group and 26.1 +/- A 9.7-17.7 +/- A 4.9 g in the controls) and the prostate-specific antigen level (7.1 +/- A 3.6-1.4 +/- A 1.7 ng/mL in the silodosin group and 8.1 +/- A 4.3-1.3 +/- A 1.2 ng/mL in the controls). Significant improvements in the international prostate symptom voiding subscores at 6 months and quality of life at 3 months were observed in those receiving silodosin. The pressure flow studies demonstrated that silodosin had significantly enlarged the bladder capacity when the first non-voiding contraction was seen at 3 and 12 months (3M: 127.1 +/- A 74.8 vs. 118.2 +/- A 83.9 mL, p = 0.001; 12M: 123.7 +/- A 79.3 vs. 100.3 +/- A 73.4 mL, p = 0.01); however, there were no improvements in the bladder outlet obstruction index (BOOI) or urinary flow. Silodosin temporarily improved LUTS, but did not improve the BOOI after I-125 implantation in the prostate.	[Shimizu, Nobutaka; Minami, Takafumi; Sugimoto, Koichi; Saito, Yoshitaka; Yamamoto, Yutaka; Hayashi, Taiji; Tsuji, Hidenori; Nozawa, Masahiro; Yoshimura, Kazuhiro; Ishii, Tokumi; Uemura, Hirotsugu] Kinki Univ, Dept Urol, Fac Med, Osaka 5898511, Japan; [Nakamatsu, Kiyoshi] Kinki Univ, Dept Radiol, Fac Med, Osaka 5898511, Japan	Shimizu, N (reprint author), Kinki Univ, Dept Urol, Fac Med, 377-2 Ohno Higashi, Osaka 5898511, Japan.	shimizun@med.kindai.ac.jp					Aaltomaa SH, 2009, RADIOTHER ONCOL, V91, P213, DOI 10.1016/j.radonc.2008.12.009; Pardo Y, 2010, J CLIN ONCOL, V28, P4687, DOI 10.1200/JCO.2009.25.3245; Matsuda T, 2012, JPN J CLIN ONCOL, V42, P139, DOI 10.1093/jjco/hyr184; Zelefsky MJ, 1999, J CLIN ONCOL, V17, P517; Snyder KM, 2012, BJU INT, V110, P221, DOI 10.1111/j.1464-410X.2011.10800.x; Wallner K, 1996, J CLIN ONCOL, V14, P449; Ash D, 2007, RADIOTHER ONCOL, V84, P135, DOI 10.1016/j.radonc.2007.05.020; Goi Y, 2013, J UROLOGY, V190, P1116, DOI 10.1016/j.juro.2013.03.110; Choo R, 2002, INT J RADIAT ONCOL, V53, P290, DOI 10.1016/S0360-3016(02)02726-8; Nag S, 1999, INT J RADIAT ONCOL, V44, P789, DOI 10.1016/S0360-3016(99)00069-3; Okutsu H, 2010, UROLOGY, V75, P235, DOI 10.1016/j.urology.2009.05.045; Stone NN, 2002, EUR UROL, V41, P427, DOI 10.1016/S0302-2838(02)00019-2; Matsukawa Y, 2009, J UROLOGY, V182, P2831, DOI 10.1016/j.juro.2009.08.030; Terk MD, 1998, J UROLOGY, V160, P1379, DOI 10.1016/S0022-5347(01)62542-4; Grimm P, 2012, BJU INT, V109, P22, DOI 10.1111/j.1464-410X.2011.10827.x; Merrick GS, 2002, UROLOGY, V60, P650, DOI 10.1016/S0090-4295(02)01840-X; Boettcher M, 2012, BJU INT, V109, P1824, DOI 10.1111/j.1464-410X.2011.10623.x; Anscher MS, 2005, INT J RADIAT ONCOL, V62, P255, DOI 10.1016/j.ijrobp.2005.01.040; Bucci J, 2002, INT J RADIAT ONCOL, V53, P91, DOI 10.1016/S0360-3016(01)02812-7; Crawford ED, 2006, AM J CLIN ONCOL-CANC, V29, P517, DOI 10.1097/01.coc.0000225412.24750.4c; Elshaikh MA, 2003, UROLOGY, V61, P152, DOI 10.1016/S0090-4295(02)02142-8; Elshaikh MA, 2005, INT J RADIAT ONCOL, V62, P164, DOI 10.1016/j.ijrobp.2004.09.036; Inoue S, 2012, BJU INT, V110, pE118, DOI 10.1111/j.1464-410X.2011.10814.x; Locke J, 2002, INT J RADIAT ONCOL, V52, P712, DOI 10.1016/S0360-3016(01)02657-8; Merrick GS, 2005, BJU INT, V95, P597, DOI 10.1111/j.1464-410X.2005.05346.x; Merrick GS, 2000, INT J RADIAT ONCOL, V47, P121, DOI 10.1016/S0360-3016(99)00525-8; Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066; Stone NN, 2007, J UROLOGY, V177, P925, DOI 10.1016/j.juro.2006.10.018; Tsumura H, 2011, INT J RADIAT ONCOL, V81, pE385, DOI 10.1016/j.ijrobp.2011.04.026; Yoshida M, 2012, INT J UROL, V19, P306, DOI 10.1111/j.1442-2042.2011.02957.x	30	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0724-4983	1433-8726		WORLD J UROL	World J. Urol.	DEC	2014	32	6					1423	1432		10.1007/s00345-014-1239-z		10	Urology & Nephrology	Urology & Nephrology	AU0TD	WOS:000345336500008		
J	Morioka, N; Takata, K				Morioka, Norimitsu; Takata, Kazuyuki			Next Stages of Drug Discovery and Evolution for Intractable Diseases Created by Young Pharmacologists Foreword	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Editorial Material									[Morioka, Norimitsu] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pharmacol, Minami Ku, Hiroshima 7348553, Japan; [Takata, Kazuyuki] Kyoto Pharmaceut Univ, Dept Clin & Translat Physiol, Yamashina Ku, Kyoto 6078414, Japan	Morioka, N (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pharmacol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	mnori@hiroshima-u.ac.jp						0	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	DEC	2014	134	12					1237	1238				2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EL	WOS:000345495300001		
J	Nishida, M; Toyama, T; Kumagai, Y; Numaga-Tomita, T				Nishida, Motohiro; Toyama, Takashi; Kumagai, Yoshito; Numaga-Tomita, Takuro			Establishment of a Novel Therapeutic Strategy for Heart Failure Based on the Mechanism Underlying Maintenance of Redox Homeostasis by Reactive Sulfur Species	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						reactive sulfur species; heart failure; senescence; GTP binding protein; post-translational modification	HYDROGEN-SULFIDE; RAS PROTEINS; SULFHYDRATION	Cardiac redox homeostasis is precisely regulated by reactive oxygen species (ROS) or electrophilic molecules that are formed by ROS reacting with intracellular substrates, and their eliminating systems. We have focused on the role of nitric oxide (NO) generated from inducible NO synthase (iNOS) that is continuously upregulated from early stage of heart failure, and revealed that iNOS-derived NO acts as a protective factor in the early stage of heart failure, whereas it contributes to induction of cardiac early senescence in later stages. The switching mechanism of NO-mediated signaling includes formation of endogenous NO-derived electrophilic byproducts such as 8-nitroguanosine 3',5'-cyclic monophosphate (8-nitro-cGMP), which selectively targets an oncogenic small GTPase H-Ras at Cys-184, leading to cardiac cell senescence via covalent modification (S-guanylation) and activation of H-Ras. We also found that hydrogen sulfide-related reactive sulfur species (RSS) function as potent nucleophiles to eliminate electrophilic modification of H-Ras and suppress the onset of chronic heart failure after myocardial infarction. Our results strongly suggest a new concept of redox biology in which suppression of electrophilic irreversible modification of protein cysteine thiols by RSS may be a new therapeutic strategy of cardiovascular diseases.	[Nishida, Motohiro; Toyama, Takashi; Numaga-Tomita, Takuro] Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cardiocirculatory Signaling, Okazaki, Aichi 4448787, Japan; [Nishida, Motohiro; Numaga-Tomita, Takuro] Grad Univ Adv Studies Sokendai, Hayama, Kanagawa 2400193, Japan; [Nishida, Motohiro] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Nishida, Motohiro] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Translat Pharmaceut Sci, Higashi Ku, Fukuoka 8128582, Japan; [Toyama, Takashi; Kumagai, Yoshito] Univ Tsukuba, Fac Med, Environm Biol Lab, Tsukuba, Ibaraki 3058575, Japan	Nishida, M (reprint author), Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cardiocirculatory Signaling, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi 4448787, Japan.	nishida@nips.ac.jp					Akaike T, 2010, NITRIC OXIDE-BIOL CH, V23, P166, DOI 10.1016/j.niox.2010.06.006; Sawa T, 2007, NAT CHEM BIOL, V3, P727, DOI 10.1038/nchembio.2007.33; Dombkowski RA, 2004, AM J PHYSIOL-REG I, V286, pR678, DOI 10.1152/ajpregu.00419.2003; Mustafa AK, 2011, CIRC RES, V109, P1259, DOI 10.1161/CIRCRESAHA.111.240242; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Nishida M, 2012, NAT CHEM BIOL, V8, P714, DOI [10.1038/nchembio.1018, 10.1038/NCHEMBIO.1018]; Paul BD, 2012, NAT REV MOL CELL BIO, V13, P499, DOI 10.1038/nrm3391; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Misaki R, 2010, J CELL BIOL, V191, P23, DOI 10.1083/jcb.200911143; Nishida M, 2000, NATURE, V408, P492; Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111; Jones D.P, 2008, AM J PHYSIOL-CELL PH, V295, P849; Lander HM, 1996, NATURE, V381, P380, DOI 10.1038/381380a0	13	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	DEC	2014	134	12					1239	1243				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EL	WOS:000345495300002		
J	Tsubota, M; Kawabata, A				Tsubota, Maho; Kawabata, Atsufumi			Role of Hydrogen Sulfide, a Gasotransmitter, in Colonic Pain and Inflammation	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						hydrogen sulfide; Ca(v)3.2; transient receptor potential ankyrin 1; visceral pain; colonic inflammation	CALCIUM-CHANNELS; VISCERAL PAIN; NEUROPATHIC HYPERALGESIA; MUCOSAL CYTOPROTECTION; NOCICEPTIVE MESSENGER; REFERRED HYPERALGESIA; ACTIVATED RECEPTOR-2; TRPA1 CHANNELS; NG108-15 CELLS; RATS	Hydrogen sulfide (H2S), the third known gaseous transmitter following nitric oxide and carbon monoxide, is generated by multiple enzymes including cystathionine-gamma-lyase (CSE) in vivo. We previously demonstrated that H2S activates Ca(v)3.2 T-type Ca2+ channels expressed on sensory neurons, leading to hyperalgesia and facilitation of inflammation. Here, we describe the role of H2S in processing of colonic pain and inflammation. Intracolonic (i.col.) administration of NaHS, an H2S donor, to mice evoked colonic pain-like nociceptive behavior and referred hyperalgesia accompanied by phosphorylation of ERK in the superficial layers of spinal dorsal horn, a marker for excitation of nociceptive neurons. The pronociceptive effect of NaHS was abolished by inhibitors or knockdown of Ca(v)3.2 and by an inhibitor of TRPA1, another target molecule of H2S. In rats with colitis induced by 2,4,6-trinitrobenzenesulfonic acid (TNBS), on the other hand, repeated i.col. administration of NaHS prevented colonic ulcer and inflammatory symptoms, which were inhibited by ablation of capsaicin-sensitive sensory neurons or T-type Ca2+ channel inhibitor. NaHS, given i.col., caused phosphorylation of ERK in the spinal dorsal horn of rats with TNBS-induced colitis, but not of naive rats. In TNBS-treated rats, Ca(v)3.2 was upregulated in the dorsal root ganglia, while CSE was downregulated in the colon. Taken together, these findings suggest that inhibitors of the CSE/H2S/Ca(v)3.2 or TRPA1 pathways might be useful for the treatment of colonic pain diseases such as irritable bowel syndrome, while H2S donors or Ca(v)3.2 activators might be useful for the treatment of inflammatory bowel disease including Crohn's disease.	[Tsubota, Maho; Kawabata, Atsufumi] Kinki Univ, Sch Pharm, Div Pharmacol & Pathophysiol, Osaka 5778502, Japan	Tsubota, M (reprint author), Kinki Univ, Sch Pharm, Div Pharmacol & Pathophysiol, 3-4-1 Kowakae, Osaka 5778502, Japan.	maho@phar.kindai.ac.jp					Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Shibuya N, 2009, J BIOCHEM, V146, P623, DOI 10.1093/jb/mvp111; Maeda Y, 2009, PAIN, V142, P127, DOI 10.1016/j.pain.2008.12.021; Velasco-Xolalpa ME, 2013, NEUROSCIENCE, V250, P786, DOI 10.1016/j.neuroscience.2013.06.053; Nagasawa K, 2009, J NEUROCHEM, V108, P676, DOI 10.1111/j.1471-4159.2008.05808.x; Wallace JL, 2009, GASTROENTEROLOGY, V137, P569, DOI 10.1053/j.gastro.2009.04.012; Streng T, 2008, EUR UROL, V53, P391, DOI 10.1016/j.eururo.2007.10.024; Nishimura S, 2009, GUT, V58, P762, DOI 10.1136/gut.2008.151910; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Okubo K, 2011, NEUROSCIENCE, V188, P148, DOI 10.1016/j.neuroscience.2011.05.004; Matsunami M, 2011, NEUROSCIENCE, V181, P257, DOI 10.1016/j.neuroscience.2011.02.044; Nelson MT, 2007, J NEUROSCI, V27, P8250, DOI 10.1523/JNEUROSCI.1800-07.2007; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Tarui T, 2010, J NEUROCHEM, V114, P512, DOI 10.1111/j.1471-4159.2010.06774.x; Kawabata A, 2007, PAIN, V132, P74, DOI 10.1016/j.pain.2007.01.026; Distrutti E, 2006, J PHARMACOL EXP THER, V316, P325, DOI 10.1124/jpet.105.091595; Takahashi T, 2010, PAIN, V150, P183, DOI 10.1016/j.pain.2010.04.022; Okubo K, 2012, BRIT J PHARMACOL, V166, P1738, DOI 10.1111/j.1476-5381.2012.01886.x; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; PERSSON S, 1990, ORAL MICROBIOL IMMUN, V5, P195, DOI 10.1111/j.1399-302X.1990.tb00645.x; Roediger WEW, 1997, DIGEST DIS SCI, V42, P1571, DOI 10.1023/A:1018851723920; Laird JMA, 2001, PAIN, V92, P335, DOI 10.1016/S0304-3959(01)00275-5; Matsunami M, 2009, GUT, V58, P751, DOI 10.1136/gut.2007.144543; Cunha TM, 2008, EUR J PHARMACOL, V590, P127, DOI 10.1016/j.ejphar.2008.05.048; Distrutti E, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-36; Fiorucci S, 2001, P NATL ACAD SCI USA, V98, P13936, DOI 10.1073/pnas.241377298; Huycke MM, 2004, EXP BIOL MED, V229, P586; Kawabata A, 2001, J CLIN INVEST, V107, P1443, DOI 10.1172/JCI10806; Kimura H, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00101; Li L, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-89; Matsunami M, 2012, BRIT J PHARMACOL, V167, P917, DOI 10.1111/j.1476-5381.2012.02060.x; Matsunami M, 2012, J PHYSIOL PHARMACOL, V63, P61; Ogawa H, 2012, NEUROSCIENCE, V218, P335, DOI 10.1016/j.neuroscience.2012.05.044; Ohge H, 2003, FEMS MICROBIOL LETT, V228, P137, DOI 10.1016/S0378-1097(03)00748-1; Okubo K, 2012, BRIT J PHARMACOL, V166, P1058, DOI 10.1111/j.1476-5381.2012.01835.x; Shibuya N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2371; Tsubota-Matsunami M, 2012, J PHARMACOL SCI, V119, P293, DOI 10.1254/jphs.12086SC	37	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	DEC	2014	134	12					1245	1252				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EL	WOS:000345495300003		
J	Inden, M				Inden, Masatoshi			The Causative Gene of Parkinsonism and Its Medical Treatment Strategy	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						parkinsonism; Parkinson's disease; Fahr disease	BASAL GANGLIA CALCIFICATION; DISEASE-MODEL; OXIDATIVE STRESS; DJ-1 PROTECTS; MUTATIONS; ASSOCIATION; NEURODEGENERATION; PINK1; BRAIN; SLC20	Parkinsonism is a neurological syndrome characterized by tremor, hypokinesia, rigidity, and postural instability. The neurodegenerative condition of Parkinson's disease (PD) is the most common cause of parkinsonism. PD is classified as sporadic PD and familial PD. Whereas idiopathic PD is caused by a number of complex factors, familial PD is a result of mutations in PD-associated genes. Unraveling the mechanisms surrounding familial PD will offer pivotal clues in understanding etiology of not only familial PD but also sporadic PD. We have demonstrated neuroprotective effects with particular focus on DJ-1. On the other hand, idiopathic basal ganglia calcification, also known as Fahr disease (FD) is another condition characterized by parkinsonism. In 2012, solute carrier family 20A2 (SLC20A2) was identified as the causative gene for familial FD. Our analysis of patient samples revealed a novel mutation in SLC20A2. Type-III sodium-dependent phosphate transporter 2 (PiT-2), the protein encoded by SLC20A2, plays an important role in phosphate homeostasis. However, PiT-2's role in the pathology of FD remains largely unclear. We have established induced pluripotent stem (iPS) cells from FD patients and are investigating their usefulness in drug development. Here, we present some of our latest research findings.	Gifu Pharmaceut Univ, Lab Med Therapeut & Mol Therapeut, Gifu 5011196, Japan	Inden, M (reprint author), Gifu Pharmaceut Univ, Lab Med Therapeut & Mol Therapeut, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	inden@gifu-pu.ac.jp					Shimohama S, 2003, TRENDS MOL MED, V9, P360, DOI 10.1016/S1471-4914(03)00117-5; Moore DJ, 2005, HUM MOL GENET, V14, P71, DOI 10.1093/hmg/ddi007; Oliveira JRM, 2004, NEUROLOGY, V63, P2165; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Yanagisawa D, 2008, J CEREBR BLOOD F MET, V28, P563, DOI 10.1038/sj.jcbfm.9600553; Wang C, 2012, NAT GENET, V44, P254, DOI 10.1038/ng.1077; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Miyazaki S, 2008, J NEUROCHEM, V105, P2418, DOI 10.1111/j.1471-4159.2008.05327.x; Collins JF, 2004, PFLUG ARCH EUR J PHY, V447, P647, DOI 10.1007/s00424-003-1088-x; Inden M, 2013, BRAIN RES, V1531, P75, DOI 10.1016/j.brainres.2013.07.038; Nicolas G, 2013, BRAIN, V136, P3395, DOI 10.1093/brain/awt255; Forster IC, 2013, MOL ASPECTS MED, V34, P386, DOI 10.1016/j.mam.2012.07.007; Inden M, 2006, NEUROBIOL DIS, V24, P144, DOI 10.1016/j.nbd.2006.06.004; Tang BS, 2006, HUM MOL GENET, V15, P1816, DOI 10.1093/hmg/ddl104; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Keller A, 2013, NAT GENET, V45, P1077, DOI 10.1038/ng.2723; Inden M, 2011, J PHARMACOL SCI, V117, P189, DOI 10.1254/jphs.11151FP; Nicolas G, 2013, NEUROLOGY, V80, P181, DOI 10.1212/WNL.0b013e31827ccf34; SMEYERSVERBEKE J, 1975, NEUROLOGY, V25, P48; Sundal C, 2012, PARKINSONISM RELAT D, V18, P7; Yamada M, 2014, NEUROLOGY, V82, P705, DOI 10.1212/WNL.0000000000000143	21	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	DEC	2014	134	12					1253	1258				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EL	WOS:000345495300004		
J	Hinoi, E				Hinoi, Eiichi			Regulation of Osteoclastogenesis by Osteocytes through Growth Differentiation Factor-15	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						osteocyte; osteoclast; osteoblast; hypoxia; growth differentiation factor-15 (GDF15)	BONE	Osteocytes are the most abundant cells in bone. However, little attention has been paid to their role in bone remodeling. In this study, osteoclast differentiation was significantly enhanced by conditioned media derived from cultures of osteocytic MLO-Y4 cells that were cultured under hypoxic conditions. Using microarray analysis, we identified growth differentiation factor-15 (GDF15) as a pivotal factor secreted from osteocytes under hypoxia. Indeed, treatment with recombinant GDF15 markedly increased osteoclast differentiation in vitro. Further to investigate the importance of GDF15 in vivo, we used a hypoxic murine model that involved ligation of the right femoral artery. The volume of cancellons bone in the proximal tibia of the ligated limb was significantly reduced, together with a significant increase in osteoclast-related parameters. Addition of anti-GDF15 antibody prevented bone loss and osteoclastic activation in the tibiae of mice that had undergone femoral artery ligation. These results suggest that GDF15, which is secreted from osteocytes under hypoxia during bone remodeling, may be a positive regulator of osteoclastic differentiation. The in vivo usefulness of the anti-GDF15 antibody might provide insights for the development of novel therapeutics for bone disorders related to hypoxia or ischemic insults.	Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Pharmaceut Sci, Mol Pharmacol Lab, Kanazawa, Ishikawa 9201192, Japan	Hinoi, E (reprint author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Pharmaceut Sci, Mol Pharmacol Lab, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	hinoi@p.kanazawa-u.ac.jp					Hinoi E, 2007, AM J PATHOL, V170, P1277, DOI 10.2353/ajpath.2007.061039; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Bikle DD, 1999, J BONE MINER METAB, V17, P233, DOI 10.1007/s007740050090; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Hinoi E, 2012, J BONE MINER RES, V27, P938, DOI 10.1002/jbmr.1538; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; AARDEN EM, 1994, J CELL BIOCHEM, V55, P287, DOI 10.1002/jcb.240550304; PARFITT AM, 1987, J BONE MINER RES, V2, P595; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Suva Larry J, 2005, Curr Osteoporos Rep, V3, P46, DOI 10.1007/s11914-005-0003-0	14	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	DEC	2014	134	12					1259	1263				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EL	WOS:000345495300005		
J	Kinoshita, T				Kinoshita, Takeshi			A New Taxonomic System of the Genus Murraya (Rutaceae) Based on Integration of Morphology-based Taxonomy and Chemotaxonomy; and a Philological Survey on M-exotica in View of the Relationship between Okinawa and China	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						Rutaceae; Murraya; 3-prenylindole; carbazole; coumarin; chemotaxonomy	PANICULATA VAR OMPHALOCARPA; BIOACTIVE CARBAZOLE ALKALOIDS; CHEMICAL-CONSTITUENTS; CLAUSENA-EXCAVATA; GLYCOSMIS-ARBOREA; MICROMELUM-INTEGERRIMUM; ROOT BARK; STEM BARK; L JACK; COUMARINS	This review concerns the taxonomic status of the genus Murraya in tribe Clausenae, subfamily Aurantioideae, family Rutaceae, and presents a new system integrating both morphology-based taxonomy and chemotaxonomy. This genus has been morphologically divided into the sects Murraya and Bergera. This dichotomy is justified by the noticeable difference of secondary metabolites with 3-prenylindoles in Murraya and carbazoles in Bergera. As for other metabolites of genus Murraya, coumarins are found in both sects, but differ clearly in types; 8-prenylcoumarins occur throughout the sect Murraya whereas geranylated furocoumarins are known from some species of the sect Bergera. As far as chemical properties are concerned, sect Bergera is much closer to genus Clausena than sect Murraya, suggesting the dichotomy of genus Murraya to be generic rather than sectional. 8-Prenylcoumarins characterizing sect Murraya play a decisive role in the distinction of M. exotica from M. paniculata that occurs most widely in subtropical and tropical Asia and is well known for morphologic as well as chemical diversity. Though the morphological difference between the two species is slight only in leaves and leaflets, the distinction is well substantiated by the following chemical feature: 7-OMe-8-prenylcoumarins occur in M. exotica whereas 5,7-di-OMe-8-prenylcoumarins in M. paniculata. Sect Murraya has a very close relation to genus Merrillia that is chemically characterized by similar types of 8-prenylcoumarins, and is also related to a certain extent to genus Micromelum. M. exotica is philologically surveyed in view of the delicate relationships between Okinawa, the only habitat of this plant in Japan, and China in order to clarify its historical background.	Teikyo Univ, Fac Pharmaceut Sci, Lab Bioprospecting & Ethnobot & Med Plant Garden, Midori Ku, Sagamihara, Kanagawa 2525195, Japan	Kinoshita, T (reprint author), Teikyo Univ, Fac Pharmaceut Sci, Lab Bioprospecting & Ethnobot & Med Plant Garden, Midori Ku, 1091-1 Suarashi, Sagamihara, Kanagawa 2525195, Japan.	tk-1948@pharm.teikyo-u.ac.jp					Adebajo Adeleke C., 2000, Fitoterapia, V71, P334, DOI 10.1016/S0367-326X(99)00163-X; Amano T., 1979, RYUKYU RETTO SHOKUBU, P69; KONG YC, 1986, J ETHNOPHARMACOL, V15, P195; LI Q, 1988, BIOCHEM SYST ECOL, V16, P491, DOI 10.1016/0305-1978(88)90050-6; Kinoshita T, 1996, PHYTOCHEMISTRY, V42, P1207, DOI 10.1016/0031-9422(96)00058-1; IMAI F, 1989, CHEM PHARM BULL, V37, P358; Chakravarty AK, 2001, INDIAN J CHEM B, V40, P484; Kinoshita T, 1997, PHYTOCHEMISTRY, V45, P179, DOI 10.1016/S0031-9422(96)00853-9; Taufiq-Yap YH, 2007, NAT PROD RES, V21, P810, DOI 10.1080/14786410701258875; Maneerat W, 2013, PHYTOCHEMISTRY, V88, P74, DOI 10.1016/j.phytochem.2012.12.014; Ma QG, 2013, FITOTERAPIA, V87, P1, DOI 10.1016/j.fitote.2013.03.003; Songsiang U, 2011, J NAT PROD, V74, P208, DOI 10.1021/np100654m; Ito C, 2000, CHEM PHARM BULL, V48, P334; Yang XL, 2009, CHEM PHARM BULL, V57, P734; Kinoshita T, 1996, PHYTOCHEMISTRY, V43, P125, DOI 10.1016/0031-9422(96)00255-5; He HP, 2001, CHINESE CHEM LETT, V12, P603; Samuel R, 2001, PLANT BIOLOGY, V3, P77, DOI 10.1055/s-2001-11747; Shen DY, 2014, J NAT PROD, V77, P1215, DOI 10.1021/np500088u; Roy MK, 2005, BRIT J PHARMACOL, V145, P145, DOI 10.1038/sj.bjp.0706137; Pacher T, 2001, PHYTOCHEMISTRY, V58, P129, DOI 10.1016/S0031-9422(01)00186-8; Ito C, 2004, J NAT PROD, V67, P1488, DOI 10.1021/np0400611; Ito C, 2005, PHYTOCHEMISTRY, V66, P567, DOI 10.1016/j.phytochem.2004.12.030; [Anonymous], 1985, CHUYAKU DAIJITEN, V1, P472; Maneerat W, 2012, J NAT PROD, V75, P741, DOI 10.1021/np3000365; Songue JL, 2012, MOLECULES, V17, P13673, DOI 10.3390/molecules171113673; Yang GZ, 2012, HELV CHIM ACTA, V95, P1449, DOI 10.1002/hlca.201200027; BANERJI J, 1979, INDIAN J CHEM B, V17, P113; Bin Z. M., 1989, PHYTOCHEMISTRY, V28, P657; Bose P. K., 1937, J INDIAN CHEM SOC, V14, P489; BOWEN IH, 1982, PHYTOCHEMISTRY, V21, P433, DOI 10.1016/S0031-9422(00)95283-X; CHAKRABORTY A, 1995, PHYTOCHEMISTRY, V38, P787, DOI 10.1016/0031-9422(94)00666-H; CHAKRABO.DP, 1967, TETRAHEDRON LETT, P3471; Chakravarty AK, 1999, PHYTOCHEMISTRY, V50, P1263, DOI 10.1016/S0031-9422(98)00666-9; Chatterjee A., 1968, SCI CULT, V34, P366; Cheenpracha S, 2011, PHYTOCHEM LETT, V4, P187, DOI 10.1016/j.phytol.2011.03.002; Cuong NM, 2004, CHEM PHARM BULL, V52, P1175, DOI 10.1248/cpb.52.1175; DREYER DL, 1968, J ORG CHEM, V33, P3574, DOI 10.1021/jo01273a048; Hatusima S., 1971, FLORA RYUKYUS, P16; Huang C.-C., 1997, FLORA CHINA, V43, P139; Huang C.-C., 1959, ACTA PHYTOTAX SINICA, V8, P100; IMAI F, 1986, CHEM PHARM BULL, V34, P3978; IMAI F, 1989, CHEM PHARM BULL, V37, P119; ITO C, 1989, CHEM PHARM BULL, V37, P819; ITO C, 1990, J CHEM SOC PERK T 1, P2047, DOI 10.1039/p19900002047; Ito C, 2012, J NAT MED-TOKYO, V66, P357, DOI 10.1007/s11418-011-0584-0; ITO C, 1987, HETEROCYCLES, V26, P2959; JOSHI BS, 1974, INDIAN J CHEM, V12, P437; Kinoshita T, 1996, CHEM PHARM BULL, V44, P1208; Kinoshita T, 1999, HETEROCYCLES, V50, P269; KINOSHITA T, 1989, PHYTOCHEMISTRY, V28, P147, DOI 10.1016/0031-9422(89)85027-7; KINOSHITA T, 1985, CHEM PHARM BULL, V33, P1770; Kinoshita T, 1996, CHEM PHARM BULL, V44, P1261; KONG YC, 1986, BIOCHEM SYST ECOL, V14, P491, DOI 10.1016/0305-1978(86)90008-6; KONG YC, 1988, BIOCHEM SYST ECOL, V16, P47, DOI 10.1016/0305-1978(88)90116-0; KONG YC, 1988, BIOCHEM SYST ECOL, V16, P485, DOI 10.1016/0305-1978(88)90049-X; Kumar R, 2012, FITOTERAPIA, V83, P230, DOI 10.1016/j.fitote.2011.11.003; KUMAR V, 1987, PHYTOCHEMISTRY, V26, P511, DOI 10.1016/S0031-9422(00)81445-4; KUMAR V, 1989, AUST J CHEM, V42, P1375; KUMAR V, 1990, TETRAHEDRON LETT, V31, P5217, DOI 10.1016/S0040-4039(00)97846-8; Luo XM, 2012, MOLECULES, V17, P6944, DOI 10.3390/molecules17066944; Ma CY, 2005, PLANTA MED, V71, P261, DOI 10.1055/s-2005-837826; Meragelman KM, 2000, J NAT PROD, V63, P427, DOI 10.1021/np990570g; Peng WW, 2013, J ASIAN NAT PROD RES, V15, P215, DOI 10.1080/10286020.2012.758635; Perry L. M., 1980, MED PLANTS E SE ASIA, P367; Prakash D., 1978, Phytochemistry, V17, P1194; Quisumbing E. A., 1978, MED PLANTS PHILIPPIN, P463; Rahmani M, 1998, PLANTA MED, V64, P780, DOI 10.1055/s-2006-957588; RAJ K, 1976, INDIAN J CHEM B, V14, P332; RAMSTAD E, 1968, TETRAHEDRON LETT, P811; Shi XJ, 2010, HELV CHIM ACTA, V93, P985; Shimada M., 2001, THESIS TEIKYO U; Siridechakorn I, 2012, BIOCHEM SYST ECOL, V40, P69, DOI 10.1016/j.bse.2011.10.002; Swingle W. T., 1967, CITRUS IND, P196; TALAPATRA B, 1975, INDIAN J CHEM, V13, P835; Tanaka T., 1929, J SOC TROP AGR, V1, P23; Teshima N., 2004, 51 ANN M JAP SOC PHA, P73; Trinh T. T., 2004, TAP CHI HOA HOC, V42, P177; Wang JS, 2005, PHYTOCHEMISTRY, V66, P697, DOI 10.1016/j.phytochem.2005.02.003; Wang YS, 2010, BIOSCI BIOTECH BIOCH, V74, P1483, DOI 10.1271/bbb.100143; WICKRAMARATNE DBM, 1984, PHYTOCHEMISTRY, V23, P2964; WU TS, 1989, TETRAHEDRON LETT, V30, P6649, DOI 10.1016/S0040-4039(00)70641-1; WU TS, 1988, PHYTOCHEMISTRY, V27, P2357; WU TS, 1980, PHYTOCHEMISTRY, V19, P2227, DOI 10.1016/S0031-9422(00)82237-2; WU TS, 1989, PHYTOCHEMISTRY, V28, P2873, DOI 10.1016/S0031-9422(00)98115-9; WU TS, 1989, PHYTOCHEMISTRY, V28, P293, DOI 10.1016/0031-9422(89)85066-6; WU TS, 1994, PHYTOCHEMISTRY, V37, P287, DOI 10.1016/0031-9422(94)85045-3; WU TS, 1981, PHYTOCHEMISTRY, V20, P178, DOI 10.1016/0031-9422(81)85247-8; Xin ZQ, 2008, CHEM PHARM BULL, V56, P827, DOI 10.1248/cpb.56.827; Yan S., 2001, ZHONGGUO YAOWU HUAXU, V11, P345; Yang J S, 1983, Yao Xue Xue Bao, V18, P760; Yang J.-S., 1984, ZHIWU XUEBAO, V26, P184; YANG JS, 1984, ACTA CHIM SINICA, V42, P1308; Zou LX, 1999, J CHINESE MED MAT, V22, P458	93	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	DEC	2014	134	12					1265	1286				22	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EL	WOS:000345495300006		
J	Miyamoto, K				Miyamoto, Kazunori			Synthesis of Hypervalent Organo-lambda(3)-bromanes and Their Reactions by Using Leaving Group Ability of lambda(3)-Bromanyl Group	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						lambda(3)-bromane; iodine; hypervalence; leaving group ability; oxidation; C-H activation	METAL-FREE CONDITIONS; NUCLEOPHILIC VINYLIC SUBSTITUTIONS; C-H BONDS; NITRENE INSERTION; N-HETEROCYCLES; SULFONYLIMINO-LAMBDA(3)-BROMANE; SOLVOLYSIS; GENERATION; AMINATION; YLIDES	Hypervalent organo-lambda(3)-iodanes have attracted great interest in organic synthesis; however, the chemistry of hypervalent organo-lambda(3)-bromanes remains largely unexplored, mainly because of synthetic difficulties. Iodobenzene is readily oxidized by common oxidants such as peracids under mild conditions, whereas bromobenzene is inert. Since the ionization potential of bromobenzene (8.98 eV) is higher than that of iodobenzene (8.69 eV), hypervalent-lambda(3)-bromane would show much higher reactivity. We overcame this problem by using difiuoro (aryl))-lambda(3)-bromane (Frohn's reagent), which serves as a pivotal progenitor of various lambda(3)-bromanes including imino-lambda(3)-bromane, cyclopent-1-enyl-lambda(3)-bromane, (E)-beta-alkylvinyl-lambda(3)-bromane, and diacetoxy-lambda(3)-bromane. These reagents possess highly unusual reactivity based on the enormously enhanced nucleofugality of the aryl-lambda(3)-bromanyl group.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Miyamoto, K (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kmiya@mol.f.u-tokyo.ac.jp					Fructos MR, 2006, J AM CHEM SOC, V128, P11784, DOI 10.1021/ja0627850; Davies HML, 2008, NATURE, V451, P417, DOI 10.1038/nature06485; Li ZG, 2007, ANGEW CHEM INT EDIT, V46, P5184, DOI 10.1002/anie.200700760; Ochiai M, 2012, CHEM COMMUN, V48, P5280, DOI 10.1039/c2cc31523h; Okuyama T, 1999, CAN J CHEM, V77, P577, DOI 10.1139/cjc-77-5-6-577; Okuyama T, 1998, J AM CHEM SOC, V120, P2275, DOI 10.1021/ja972267c; Ochiai M, 2000, J ORGANOMET CHEM, V611, P494, DOI 10.1016/S0022-328X(00)00487-3; Godula K, 2006, SCIENCE, V312, P67, DOI 10.1126/science.1114731; Ochiai M, 2011, SCIENCE, V332, P448, DOI 10.1126/science.1201686; OCHIAI M, 1991, J AM CHEM SOC, V113, P7059, DOI 10.1021/ja00018a066; Ochiai M, 2003, J AM CHEM SOC, V125, P15304, DOI 10.1021/ja038777q; OKUYAMA T, 1995, J AM CHEM SOC, V117, P3360, DOI 10.1021/ja00117a006; Zhdankin VV, 2008, CHEM REV, V108, P5299, DOI 10.1021/cr800332c; BRESLOW DS, 1968, J AM CHEM SOC, V90, P7097, DOI 10.1021/ja01027a038; Espino CG, 2005, MODERN RHODIUM-CATALYZED ORGANIC REACTIONS, P379, DOI 10.1002/3527604693.ch17; HANACK M, 1979, J AM CHEM SOC, V101, P100, DOI 10.1021/ja00495a017; Hoque MM, 2011, ORG LETT, V13, P5428, DOI 10.1021/ol201868n; Lide D. R., 1992, CRC HDB CHEM PHYS; MASLAK P, 1989, J AM CHEM SOC, V111, P8201, DOI 10.1021/ja00203a021; Miyamoto K, 2009, ANGEW CHEM INT EDIT, V48, P8931, DOI 10.1002/anie.200903368; NESMEYANOV AN, 1978, DOKL AKAD NAUK SSSR+, V243, P1463; Ochiai M, 2010, CHEM COMMUN, V46, P511, DOI 10.1039/b922033j; Ochiai M., 1999, CHEM HYPERVALENT COM, P5; Ochiai M, 2007, J AM CHEM SOC, V129, P12938, DOI 10.1021/ja075811i; Ochiai M, 2009, ORG LETT, V11, P281, DOI 10.1021/ol802383f; Ochiai M, 2008, J AM CHEM SOC, V130, P2118, DOI 10.1021/ja074624h; Ochiai M, 2009, CHEM COMMUN, P959, DOI 10.1039/b818489e; Ochiai M, 2010, CHEM-EUR J, V16, P8713, DOI 10.1002/chem.201000759; Ochiai M, 2011, J AM CHEM SOC, V133, P3342, DOI 10.1021/ja200479p; Ochiai M, 2006, J AM CHEM SOC, V128, P9608, DOI 10.1021/ja063492+; SHINGAKI T, 1972, CHEM LETT, P155, DOI 10.1246/cl.1972.155; Slegt M, 2006, J ORG CHEM, V71, P2227, DOI 10.1021/jo0518957; Stang P. J., 1979, VINYL CATIONS; Varvoglis A., 1992, ORGANIC CHEM POLYCOO; Wirth T., 2003, TOPIC CURRENT CHEM	35	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	DEC	2014	134	12					1287	1300				14	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EL	WOS:000345495300007		
J	Watanabe, C				Watanabe, Chizuko			Mechanism of Spinal Pain Transmission and Its Regulation	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						high-dose morphine; nociceptive behavior; spinal microdialysis; substance P; glutamate; nitric oxide	HIGH-DOSE MORPHINE; NITRIC-OXIDE SYNTHASE; MEDIATED BEHAVIORAL-RESPONSES; NMDA RECEPTOR ANTAGONISTS; TACHYKININ NK1 RECEPTOR; METHYL-D-ASPARTATE; SUBSTANCE-P; INTRATHECAL MORPHINE; THERMAL HYPERALGESIA; FORMALIN TEST	Morphine has been widely used for the treatment of acute, chronic, and cancer pain and is considered the strongest analgesic in clinical care. Conversely, morphine-induced analgesia may be accompanied by several side effects. Animal studies have demonstrated that low doses of morphine administered intrathecally can produce reliable analgesia for thermal, mechanical, and chemical nociceptive stimulation. On the other hand, high doses of morphine administered intrathecally may induce spontaneous nociceptive responses such as scratching, biting, and licking in mice as well as agitation and vocalization in rats. In addition, similar nociceptive responses including hyperalgesia, allodynia, and myoclonus have been observed in humans following intrathecal or systemic administration of high-dose morphine. It has been suggested that the spontaneous nociceptive behaviors evoked by high-dose morphine may be mediated by a non-opioid mechanism that is not yet fully understood. This review describes the mechanisms of spontaneous nociceptive behaviors evoked by high-dose morphine focusing on the neurotransmitters/neuromodulators released from primary afferent fibers.	Tohoku Pharmaceut Univ, Dept Physiol & Anat, Aoba Ku, Sendai, Miyagi 9818558, Japan	Watanabe, C (reprint author), Tohoku Pharmaceut Univ, Dept Physiol & Anat, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	w-chizu@tohoku-pharm.ac.jp					ALBIN RL, 1993, BRAIN RES, V604, P354, DOI 10.1016/0006-8993(93)90391-Y; ALI NMK, 1986, ANESTHESIOLOGY, V65, P449, DOI 10.1097/00000542-198610000-00028; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Zhang Y, 2000, NAT IMMUNOL, V1, P392, DOI 10.1038/80826; Petrenko AB, 2003, ANESTH ANALG, V97, P1108, DOI 10.1213/01.ANE.0000081061.12235.55; Bellucci F, 2002, BRIT J PHARMACOL, V135, P266, DOI 10.1038/sj.bjp.0704443; Watanabe C, 2003, PAIN, V106, P269, DOI 10.1016/S0304-3959(03)00296-3; Sakurada T, 1996, NEUROCHEM INT, V29, P271, DOI 10.1016/0197-0186(96)00004-6; MELLER ST, 1992, NEUROSCIENCE, V50, P7, DOI 10.1016/0306-4522(92)90377-E; PENN RD, 1987, J NEUROSURG, V67, P182, DOI 10.3171/jns.1987.67.2.0182; MALMBERG AB, 1993, PAIN, V54, P291, DOI 10.1016/0304-3959(93)90028-N; DEBIASI S, 1988, P NATL ACAD SCI USA, V85, P7820; MELLER ST, 1993, PAIN, V52, P127, DOI 10.1016/0304-3959(93)90124-8; Chizh BA, 2001, TRENDS PHARMACOL SCI, V22, P636, DOI 10.1016/S0165-6147(00)01863-0; ARNER S, 1988, ACTA ANAESTH SCAND, V32, P253; SAKURADA T, 1995, PAIN, V60, P175, DOI 10.1016/0304-3959(94)00107-P; Quartara L, 1997, NEUROPEPTIDES, V31, P537, DOI 10.1016/S0143-4179(97)90001-9; DECONNO F, 1991, PAIN, V47, P337, DOI 10.1016/0304-3959(91)90225-M; DUN NJ, 1992, NEUROSCI LETT, V147, P217, DOI 10.1016/0304-3940(92)90599-3; FORSTERMANN U, 1995, N-S ARCH PHARMACOL, V352, P351; GARRY MG, 1992, BRAIN RES, V582, P139, DOI 10.1016/0006-8993(92)90328-7; GUARD S, 1991, NEUROCHEM INT, V18, P149, DOI 10.1016/0197-0186(91)90180-L; Hara N, 1997, BRIT J PHARMACOL, V121, P401, DOI 10.1038/sj.bjp.0701146; KRAMES ES, 1985, CANCER, V56, P696, DOI 10.1002/1097-0142(19850801)56:3<696::AID-CNCR2820560343>3.0.CO;2-8; KRISTENSEN JD, 1992, PAIN, V51, P249, DOI 10.1016/0304-3959(92)90266-E; LUTFY K, 1994, EUR J PHARMACOL, V252, P261, DOI 10.1016/0014-2999(94)90171-6; MAGGIO JE, 1988, ANNU REV NEUROSCI, V11, P13, DOI 10.1146/annurev.neuro.11.1.13; Meller S T, 1994, Drugs, V47 Suppl 5, P10, DOI 10.2165/00003495-199400475-00004; Morteau O, 2001, NAT IMMUNOL, V2, P1088, DOI 10.1038/ni1201-1088; NYBERG F, 1984, BIOCHEM BIOPH RES CO, V125, P244, DOI 10.1016/S0006-291X(84)80360-5; Nydahl KS, 2004, EUR J NEUROSCI, V19, P1789, DOI 10.1111/j.1460.9568.2004.03284.x; RADHAKRISHNAN V, 1993, NEUROREPORT, V4, P323, DOI 10.1097/00001756-199303000-00025; REGOLI D, 1987, Life Sciences, V40, P109, DOI 10.1016/0024-3205(87)90349-3; REXED B, 1952, J COMP NEUROL, V96, P415, DOI 10.1002/cne.900960303; Sakurada C, 1999, J PHARM SCI, V88, P1127, DOI 10.1021/js990149c; Sakurada C, 2001, NEUROCHEM INT, V38, P417, DOI 10.1016/S0197-0186(00)00110-8; Sakurada T, 2007, BIOCHEM PHARMACOL, V74, P758, DOI 10.1016/j.bcp.2007.05.025; Sakurada T, 2002, MOL BRAIN RES, V98, P111, DOI 10.1016/S0169-328X(01)00332-1; Sakurada T, 1996, BRAIN RES, V724, P213, DOI 10.1016/0006-8993(96)00319-8; SAKURADA T, 1988, NEUROSCI LETT, V95, P281, DOI 10.1016/0304-3940(88)90671-4; Sakurada T, 1999, EUR J PHARMACOL, V369, P261, DOI 10.1016/S0014-2999(99)00078-3; SAKURADA T, 1990, BRIT J PHARMACOL, V101, P307; Tan-No K, 2000, PAIN, V86, P55, DOI 10.1016/S0304-3959(99)00312-7; TERENGHI G, 1993, J NEUROL SCI, V118, P34, DOI 10.1016/0022-510X(93)90242-Q; Watanabe C, 2003, BRAIN RES, V990, P77, DOI 10.1016/S0006-8993(03)03440-1; WOOLF CJ, 1981, BRAIN RES, V209, P491, DOI 10.1016/0006-8993(81)90176-1; YAKSH TL, 1988, J PHARMACOL EXP THER, V244, P501	47	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	DEC	2014	134	12					1301	1307				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EL	WOS:000345495300008		
J	Ikawa, T				Ikawa, Takashi			Efficient Synthesis of Multisubstituted Aromatic Compounds from Phenol Derivatives	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						phenol; C-O bond activation; palladium-catalyzed coupling; fluoride ion; nonafluorobutanesulfonate; multisubstituted aromatic compound	CROSS-COUPLING REACTIONS; UNACTIVATED INTERNAL ALKYNES; CATALYZED DIRECT ARYLATION; OH BOND ACTIVATION; INTRAMOLECULAR ACTIVATION; OXIDATIVE ANNULATION; SECONDARY ALCOHOLS; C-H; ARYL; FLUORIDE	Phenols are abundant in nature and diverse phenols are readily available commercially at low cost. Thus, phenols can be used as the raw materials for the synthesis of valuable multisubstituted aromatic compounds by the direct activation of phenolic hydroxyl groups (C-O bond activation), followed by substitutions with other substituents. Although the derivatization of phenolic hydroxyl groups to sulfonates, such as triflates, nonaflates, tosylates and mesylates, followed by the transition-metal-catalyzed coupling reactions has been extensively investigated for this purpose, the direct C-O bond activation of phenols for subsequent functional group transformation has been a long-standing challenge in modern organic synthesis. In this review, I have summarized my recent studies on the formal direct C-O bond activation of phenols using nonafluorobutanesulfonyl fluoride (NIP) for the synthesis of multisubstituted aromatics. I have focused on the dual use of NIP, a less expensive commercially available reagent, including the tentative formation of highly reactive nonaflates from phenols and the use of the liberated fluoride ion as a nucleophile to promote the reactions of nonaflates. The following four topics are discussed: 1) palladium-catalyzed coupling reactions of phenols, 2) novel preparation of benzynes from 2-silylphenols, 3) synthesis of fluorinated aromatic compounds via the formation of benzynes, and 4) Hiyama coupling of (tert-butyldimethylsilyl) arenes activated by internal phenolic hydroxyl groups.	Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan	Ikawa, T (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan.	ikawa@phs.osaka-u.ac.jp					Nakao Y, 2010, ANGEW CHEM INT EDIT, V49, P4447, DOI 10.1002/anie.201000816; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Hogermeier J, 2009, ADV SYNTH CATAL, V351, P2747, DOI 10.1002/adsc.200900566; Sahoo AK, 2004, ADV SYNTH CATAL, V346, P1715, DOI 10.1002/adsc.200404188; Kang FA, 2008, J AM CHEM SOC, V130, P11300, DOI 10.1021/ja804804p; Ackermann L, 2012, ORG LETT, V14, P2146, DOI 10.1021/ol300671y; Bedford RB, 2003, ANGEW CHEM INT EDIT, V42, P112, DOI 10.1002/anie.200390037; Huang ZL, 2013, ANGEW CHEM INT EDIT, V52, P7151, DOI 10.1002/anie.201210023; Ikawa T, 2011, ORG LETT, V13, P1730, DOI 10.1021/ol200252c; Ackermann L, 2008, ORG LETT, V10, P5043, DOI 10.1021/ol802252m; Trost BM, 1996, J AM CHEM SOC, V118, P6305, DOI 10.1021/ja961107i; Sanz R, 2008, ORG PREP PROCED INT, V40, P215; Kuram MR, 2013, ANGEW CHEM INT EDIT, V52, P4607, DOI 10.1002/anie.201210217; Tang PP, 2011, J AM CHEM SOC, V133, P11482, DOI 10.1021/ja2048072; Yu DG, 2011, ANGEW CHEM INT EDIT, V50, P7097, DOI 10.1002/anie.201101461; Luo Y, 2009, TETRAHEDRON LETT, V50, P2103, DOI 10.1016/j.tetlet.2009.02.116; Nemoto H, 2011, ORG LETT, V13, P2714, DOI 10.1021/ol200808q; Yu DG, 2010, ANGEW CHEM INT EDIT, V49, P4566, DOI 10.1002/anie.200907359; Ciana CL, 2011, ANGEW CHEM INT EDIT, V50, P458, DOI 10.1002/anie.201004703; Luo Y, 2009, TETRAHEDRON, V65, P6810, DOI 10.1016/j.tet.2009.06.089; Zhu RY, 2013, CHEM SCI, V4, P3706, DOI 10.1039/c3sc51489g; Trost BM, 2003, ORG LETT, V5, P1895, DOI 10.1021/ol034463w; Nakao Y, 2011, CHEM SOC REV, V40, P4893, DOI 10.1039/c1cs15122c; So CM, 2011, CHEM SOC REV, V40, P4963, DOI 10.1039/c1cs15114b; Akai S, 2008, ANGEW CHEM INT EDIT, V47, P7673, DOI 10.1002/anie.200803011; Lee DH, 2012, J AM CHEM SOC, V134, P7325, DOI 10.1021/ja302710v; Watson DA, 2009, SCIENCE, V325, P1661, DOI 10.1126/science.1178239; Tadross PM, 2012, CHEM REV, V112, P3550, DOI 10.1021/cr200478h; Denmark SE, 2003, ALDRICHIM ACTA, V36, P75; Li BJ, 2011, CHEM-EUR J, V17, P1728, DOI 10.1002/chem.201002273; Sharma U, 2013, ANGEW CHEM INT EDIT, V52, P12669, DOI 10.1002/anie.201305326; Kim DW, 2008, ANGEW CHEM INT EDIT, V47, P8404, DOI 10.1002/anie.200803150; BENNUASKALMOWSKI B, 1995, TETRAHEDRON LETT, V36, P2611, DOI 10.1016/0040-4039(95)00355-G; Cernova M, 2012, SYNLETT, P1305, DOI 10.1055/s-0031-1290826; Chen GJ, 2011, CHEM-EUR J, V17, P4038, DOI 10.1002/chem.201003403; Dyke AM, 2006, SYNTHESIS-STUTTGART, P4093, DOI 10.1055/s-2006-950370; Han XJ, 1999, J AM CHEM SOC, V121, P7600, DOI 10.1021/ja991500z; Ikawa T, 2012, SYNLETT, P2241, DOI 10.1055/s-0032-1317076; Ikawa T, 2014, AUST J CHEM, V67, P475, DOI 10.1071/CH13548; Nakao Y, 2005, J AM CHEM SOC, V127, P6952, DOI 10.1021/ja051281j; Nakao Y, 2011, J SYN ORG CHEM JPN, V69, P1221; Ojima I., 2009, FLUORINE MED CHEM CH; RITTER K, 1993, SYNTHESIS-STUTTGART, P735; Shindo M, 2005, SYNLETT, P176, DOI 10.1055/s-2004-836033; Taguchi H, 2002, J ORG CHEM, V67, P8450, DOI 10.1021/jo025973r; Truong T, 2013, CHEM SCI, V4, P531, DOI 10.1039/c2sc21288a; Tyman J. H. P., 1996, SYNTHETIC NATURAL PH; Vorbruggen H, 2008, SYNTHESIS-STUTTGART, P1165, DOI 10.1055/s-2008-1067006; Zhang XS, 2014, ORG CHEM FRONT, V1, P44, DOI 10.1039/c3qo00010a	49	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	DEC	2014	134	12					1309	1317				9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EL	WOS:000345495300009		
J	Nakagawa, O				Nakagawa, Osamu			Development of Artificial Nucleic Acids Functionalized for Damaged Gene Diagnosis, Gene Inhibition and Delivery System	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						8-oxoguanine; 8-oxoG-clamp; RNA interference (RNAi); small interfering RNA (siRNA); prodrug; drug delivery system	ANTISENSE OLIGONUCLEOTIDES; CYTOSINE ANALOG; SIRNA OLIGONUCLEOTIDES; MEDIATED DELIVERY; TARGETED DELIVERY; FLUORESCENT-PROBE; RNA INTERFERENCE; CANCER-CELLS; DNA; CONJUGATION	Artificial nucleic acids have recently been widely used with their properties optimized for various technologies such as the inhibition of gene expression (antisense/antigene strategies, RNA interference) and genetic diagnosis (single nucleotide polymorphism (SNP), damaged nucleobase). For practical application of nucleic acid therapeutics, establishment of an effective delivery system for oligonucleotides is also required because of their poor permeability into cells. Various useful delivery technologies including lipoplexes formed using cationic lipids and polyplexes made with cationic polymers have been developed; however, there is no crucial tool for oligonucleotide therapeutics at present. If technologies of functional nucleic acids and adequate delivery systems are cooperatively developed, the realization of nucleic acid therapeutics might be effectively accelerated. Based on this concept, we have been cooperatively developing these technologies based on organic synthetic chemistry during the past decade. This paper summarizes our recent results: 1) development of a specific fluorescent probe for 8-oxoguanine; 2) synthesis and evaluation of a prodrug-type small interfering RNA (siRNA) molecule; and 3) targeted intracellular delivery of oligonucleotides via conjugation with receptor-targeted ligands.	Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan	Nakagawa, O (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan.	osamu_nakagawa@phs.osaka-u.ac.jp					Juliano RL, 2012, BIOCONJUGATE CHEM, V23, P147, DOI 10.1021/bc200377d; Dizdaroglu M, 2002, FREE RADICAL BIO MED, V32, P1102, DOI 10.1016/S0891-5849(02)00826-2; Bruner SD, 2000, NATURE, V403, P859; Fuchi Y, 2014, ORG LETT, V16, P1760, DOI 10.1021/ol500452r; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Guo J, 2012, ANAL BIOANAL CHEM, V402, P3115, DOI 10.1007/s00216-011-5526-x; Deleavey GF, 2012, CHEM BIOL, V19, P937, DOI 10.1016/j.chembiol.2012.07.011; GANNETT PM, 1993, CHEM RES TOXICOL, V6, P690, DOI 10.1021/tx00035a015; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Midoux P, 2009, BRIT J PHARMACOL, V157, P166, DOI 10.1111/j.1476-5381.2009.00288.x; Juliano RL, 2012, ACCOUNTS CHEM RES, V45, P1067, DOI 10.1021/ar2002123; Czauderna F, 2003, NUCLEIC ACIDS RES, V31, P2705, DOI 10.1093/nar/gkg393; Juliano RL, 2011, THERANOSTICS, V1, P211, DOI 10.7150/thno/v01p0211; Nasr T, 2009, BIOORG MED CHEM LETT, V19, P727, DOI 10.1016/j.bmcl.2008.12.036; Heinlein T, 2003, J PHYS CHEM B, V107, P7957, DOI 10.1021/jp0348068; Saito G, 2003, ADV DRUG DELIVER REV, V55, P199, DOI 10.1016/S0169-409X(02)00179-5; Wilds CJ, 2002, ANGEW CHEM INT EDIT, V41, P115, DOI 10.1002/1521-3773(20020104)41:1<115::AID-ANIE115>3.0.CO;2-R; Chiu YL, 2003, RNA, V9, P1034, DOI 10.1261/rna.5103703; Nakagawa O, 2010, J AM CHEM SOC, V132, P8848, DOI 10.1021/ja102635c; Kotula JW, 2012, NUCLEIC ACID THER, V22, P187, DOI 10.1089/nat.2012.0347; Seidel CAM, 1996, J PHYS CHEM-US, V100, P5541, DOI 10.1021/jp951507c; Hofer T, 2006, BIOL CHEM, V387, P103, DOI 10.1515/BC.2006.014; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Li SD, 2008, MOL THER, V16, P942, DOI 10.1038/mt.2008.51; Taniguchi Y, 2011, J AM CHEM SOC, V133, P7272, DOI 10.1021/ja200327u; Lin KY, 1998, J AM CHEM SOC, V120, P8531, DOI 10.1021/ja981286z; Mukherjee A, 2005, J BIOL CHEM, V280, P15619, DOI 10.1074/jbc.M409723200; Schroeder A, 2010, J INTERN MED, V267, P9, DOI 10.1111/j.1365-2796.2009.02189.x; VILNER BJ, 1995, CANCER RES, V55, P408; Hong R, 2006, J AM CHEM SOC, V128, P1078, DOI 10.1021/ja056726; Alam MR, 2013, BIOORGAN MED CHEM, V21, P6217, DOI 10.1016/j.bmc.2013.05.037; BISHOP P, 1993, TETRAHEDRON LETT, V34, P4469, DOI 10.1016/0040-4039(93)88061-M; Flanagan WM, 1999, P NATL ACAD SCI USA, V96, P3513, DOI 10.1073/pnas.96.7.3513; Johnsson R, 2011, BIOORG MED CHEM LETT, V21, P3721, DOI 10.1016/j.bmcl.2011.04.073; Juliano RL, 2013, J DRUG TARGET, V21, P27, DOI 10.3109/1061186X.2012.740674; Koga Y, 2011, TETRAHEDRON, V67, P6746, DOI 10.1016/j.tet.2011.03.111; Lavergne T, 2011, J ORG CHEM, V76, P5719, DOI 10.1021/jo200826h; Li ZC, 2010, BIOORGAN MED CHEM, V18, P3992, DOI 10.1016/j.bmc.2010.04.025; Nakae Y, 2005, HISTOCHEM CELL BIOL, V124, P335, DOI 10.1007/s00418-005-0037-5; Nakagawa O, 2007, ANGEW CHEM INT EDIT, V46, P4500, DOI 10.1002/anie.200700671; Nakagawa O, 2014, BIOCONJUGATE CHEM, V25, P165, DOI 10.1021/bc400500h; Ochi Y, 2013, CHEM COMMUN, V49, P7620, DOI 10.1039/c3cc43725f; Sazani P, 2003, J CLIN INVEST, V112, P481, DOI 10.1172/JCI200319547; Semenyuk A, 2006, J AM CHEM SOC, V128, P12356, DOI 10.1021/ja0636587; Tamura A, 2010, NANOMEDICINE-UK, V5, P1089, DOI [10.2217/nnm.10.76, 10.2217/NNM.10.76]; Taniguchi Y, 2014, BIOORGAN MED CHEM, V22, P1634, DOI 10.1016/j.bmc.2014.01.024; Taniguchi Y, 2012, BIOORG MED CHEM LETT, V22, P543, DOI 10.1016/j.bmcl.2011.10.093; TSUJITA T, 1983, EUR J BIOCHEM, V133, P215, DOI 10.1111/j.1432-1033.1983.tb07450.x	49	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	DEC	2014	134	12					1319	1329				11	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EL	WOS:000345495300010		
J	Yamada, J; Takayanagi, R; Yokoyama, H; Suzuki, Y; Sinohara, S; Yamada, Y				Yamada, Junichi; Takayanagi, Risa; Yokoyama, Haruko; Suzuki, Yasuhiro; Sinohara, Satomi; Yamada, Yasuhiko			Investigation of the Educational Effectiveness of Including Small Group Discussion as Part of a Drug Abuse Prevention Program for Junior High School Students	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						drug abuse prevention program; junior high school; small group discussion; questionnaire survey		We evaluated the effectiveness of small group discussion (SGD) in association with a drug abuse prevention program for junior high school students. The students first received a lecture about drug abuse prevention, then participated in SGD. The discussion focused on how to take action when tempted to abuse drugs. We gave a questionnaire 3 times; before and after the lecture (before SGD), and after SGD. Seventy-seven students replied to these questionnaires. After the lecture, knowledge about drug abuse was improved and all students answered that they had never abused drugs. However, in answer to a different question, a few students noted that they might use drugs in some situations. We consider it necessary to give more consideration to this problem. After the lecture, 35.5% of the students felt that they had definitely acquired skills for drug abuse prevention, whereas after the SGD this was increased to 73.7%. In addition, more than 75% of the students answered that the SGD program was useful since the opinions of other students could be heard. These results suggest that more students acquired skills to prevent drug abuse by participation in SGD. Our findings showed that SGD was useful and that the students were able to more effectively understand important concepts related to drug abuse prevention.	[Yamada, Junichi; Takayanagi, Risa; Yokoyama, Haruko; Yamada, Yasuhiko] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Clin Evaluat Drug Efficacy, Hachioji, Tokyo 1920392, Japan; [Yamada, Junichi] Yokoyama Cho Pharm, Hachioji, Tokyo 1920081, Japan; [Yamada, Junichi; Suzuki, Yasuhiro; Sinohara, Satomi] Hachioji Siroyama Jr High Sch, Hachioji, Tokyo 1930821, Japan	Yamada, Y (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Clin Evaluat Drug Efficacy, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	yamada@ps.toyaku.ac.jp					Bureau of Social Welfare and Public Health Tokyo Metropolitan Government, 2003, DRUG BUS PREV ED PRO; Council for Promoting Measures to Prevent Drug Abuse Cabinet Office Government of Japan, 2010, DRUG AB PREV STRAT A; Harada Y., 2002, JPN J SCH HLTH, V44, P96; Hashimoto K., 2003, J DRUG INTERACTION R, V27, P78; Japanese Society of School Health, 2011, INSTR REF SMOK DRINK; Japanese Society of School Health, 2013, TEXT NUMB 30164; Kamata N., 2010, KOKORO KARADA KENKO, V2, P19; Kawabata T., 2001, GAKKO HOKEN HIROBA, V22, P36; National Police Agency, SUMM JUV GUID PROT F; Sumita Y., 1996, HIKAKUHO ZASSHI, V30, P83	10	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	DEC	2014	134	12					1331	1345				15	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EL	WOS:000345495300011		
J	Satoh, M; Matsumoto, A; Hara, A; Iwamori, S; Obara, T; Kikuya, M; Metoki, H; Hosaka, M; Asayama, K; Takahashi, N; Sato, H; Mano, N; Imai, Y; Ohkubo, T				Satoh, Michihiro; Matsumoto, Akihiro; Hara, Azusa; Iwamori, Saki; Obara, Taku; Kikuya, Masahiro; Metoki, Hirohito; Hosaka, Miki; Asayama, Kei; Takahashi, Nobuyuki; Sato, Hiroshi; Mano, Nariyasu; Imai, Yutaka; Ohkubo, Takayoshi			A Survey of Self-medication Practices and Related Factors in the General Population: the Ohasama Study	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						self-medication; epidemiology; health food; over-the-counter medication	BLOOD-PRESSURE; SURVEILLANCE; FUKUYAMA; JAPAN	Encouraging self-medication is expected to reduce healthcare costs. To assess the current situation of self-medication practices in the general population, we conducted a questionnaire survey regarding the use of over-the-counter (OTC) medications or dietary supplements in 1008 participants (37% men; mean age, 64 +/- 13 years) from Ohasama, a rural Japanese community. A total of 519 (52%) participants used OTC medications or dietary supplements, with common cold medication (36%) and supplements (28%) such as shark cartilage products representing the most common choices. Stepwise logistic regression showed female gender, a higher frequency of visits from a household medicine kit distributor, dyslipidemia, and lower home systolic blood pressure levels as predictors for the use of such materials (chi-square values: 25.3, 12.6, 7.0, and 4.6, respectively; all p<0.03). Stratifying the participants according to the use of antihypertensive treatment showed a negative association between systolic blood pressure and the use of OTC medications or supplements only in participants being treated for hypertension. These results suggest that although the adoption rate of self-medication in Japan can be increased in rural areas, it may remain lower in urban areas. The present study clarifies the factors associated with the use of OTC medications or dietary supplements and indicates that appropriate self-medication practices might improve the control of hypertension, particularly in patients undergoing antihypertensive treatment.	[Satoh, Michihiro; Obara, Taku; Mano, Nariyasu] Tohoku Univ Hosp, Dept Pharm, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Matsumoto, Akihiro; Iwamori, Saki; Takahashi, Nobuyuki; Sato, Hiroshi] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacol & Therapeut, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Hara, Azusa] Univ Leuven, KU Leuven Dept Cardiovasc Sci, Res Unit Hypertens & Cardiovasc Epidemiol, Studies Coordinating Ctr, B-3000 Leuven, Belgium; [Obara, Taku; Kikuya, Masahiro] Tohoku Univ, Tohoku Med Megabank Org, Dept Prevent Med & Epidemiol, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Metoki, Hirohito] Tohoku Univ, Tohoku Med Megabank Org, Dept Community Med Supports, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Hosaka, Miki; Asayama, Kei; Imai, Yutaka] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Planning Drug Dev & Clin Evaluat, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Asayama, Kei; Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Itabashi Ku, Tokyo 1730003, Japan	Satoh, M (reprint author), Tohoku Univ Hosp, Dept Pharm, Aoba Ku, 1-1 Seiryo Cho, Sendai, Miyagi 9808574, Japan.	satoh.mchr@gmail.com					Imai Y, 2012, HYPERTENS RES, V35, P777, DOI 10.1038/hr.2012.56; [Anonymous], 2010, MON NAT I LONG SCI L; Anraku M, 2010, YAKUGAKU ZASSHI, V130, P1093; Committee to Evaluate Diagnostic Standards for Metabolic Syndrome, 2005, NIPPON NAIKA GAKKAI, V94, P794; Hara A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-540; Hara A., 2009, J DRUG INTERACTION R, V33, P7; IMAI Y, 1993, J HYPERTENS, V11, P1441, DOI 10.1097/00004872-199312000-00017; Ishihara J, 2003, INT J EPIDEMIOL, V32, P546, DOI 10.1093/ije/dyg091; Ministry of Health Labour and Welfare, EST FUT MED CAR COST; Ministry of Health Labour and Welfare, HLTH JAP 21; Ministry of Health Labour and Welfare, APPR US HLTH FOODS; Ministry of Health Labour and Welfare, PHARM MED DEV SAF IN, P3; Prime Minister of Japan and His Cabinet, JAP REV STRAT JAP BA; Sato E, 2011, YAKUGAKU ZASSHI, V131, P1117; Shimamoto Kazuaki, 2014, Hypertens Res, V37, P253, DOI 10.1038/hr.2014.20; World Health Organisation, ROL PHARM SELF CAR S; World Health Organization (WHO), 2000, GLOB WAT SUPPL SAN A, P4	17	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	DEC	2014	134	12					1347	1355				9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EL	WOS:000345495300012		
J	Koyama, J; Kodama, N				Koyama, Junko; Kodama, Noriko			Trial and Evaluation of a Remedial Education Program at Kobe Pharmaceutical University	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						remedial teaching; supplementary lesson; Office Hours Class; DVD-learning		Pharmaceutical education is suffering from the decentralization of students due to the establishment of new pharmaceutical universities, the shift to a six-year program from a four-year program in the colleges of pharmacy in 2006, and a decrease in the number of students. Combined, these have lead to academic failings, even at high-ranking universities. However, abundant knowledge and ability are necessary to pass the national examination for pharmacists. At Kobe Pharmaceutical University, a Basic Education Center for Pharmacy was instituted in 2006 for the purpose of supporting the scholastic abilities of students with various challenges, as well as for students in general. One approach at the Basic Education Center for Pharmacy, has been to offer supplementary lessons, and to provide additional opportunities for learning for the repeater. We offer supplementary lessons as an "Office Hours Class" and also use DVD-learning for remedial teaching. "Office Hours Class" is conducted in a question/answer format with a small number of students. In order to develop the DVD-learning system (pharmaceutical educational digital learning; PEDL), which promotes self-learning, our supplementary lectures and "Office Hours Class" lectures are recorded and edited on DVD media. The learning effect of using these systems, as determined by regular examination, shows that these have been helpful. As a result, we concluded that these supplementary learning programs are useful as a learning method to help students acquire necessary knowledge as potential pharmaceutical professionals, and to increase student motivation.	[Koyama, Junko; Kodama, Noriko] Kobe Pharmaceut Univ, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Koyama, J (reprint author), Kobe Pharmaceut Univ, Higashinada Ku, 4-19-1 Motoyamakitamachi, Kobe, Hyogo 6588558, Japan.	j-koyama@kobepharma-u.ac.jp					Lage MJ, 2000, J ECON EDUC, V31, P30, DOI 10.2307/1183338; Baker Wesley, 2000, 11 INT C COLL TEACH, P9; Benesse Education Research and Development Institute, 2012, 2 RES ACT SIT COLL L; Kodama N., 2011, LIBRA, V12, P43; Koyama J., 2012, LIBRA, V13, P27	5	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	DEC	2014	134	12					1357	1366				10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EL	WOS:000345495300013		
J	Nakano, T; Nakamura, Y; Togawa, A; Takata, T; Ishikura, H; Mishima, K; Futagami, K				Nakano, Takafumi; Nakamura, Yoshihiko; Togawa, Atsushi; Takata, Tohru; Ishikura, Hiroyasu; Mishima, Kenichi; Futagami, Koujiro			Necessity of Personalized Initial Loading Dose Calculation of Teicoplanin by Clinical Pharmacist -Examination of the Utility of Using Systemic Inflammatory Response Syndrome Score-	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						initial loading dose; teicoplanin; therapeutic drug monitoring; systemic inflammatory response syndrome score	SEPSIS; PHARMACOKINETICS; VANCOMYCIN	When teicoplanin (TEIC) is injected at the maintenance dose, a long period is required for achievement of the target plasma trough concentration because of its long elimination half-life. An initial loading dose is necessary for rapid achievement of an effective plasma trough concentration. Thus, we proposed that it is necessary for a pharmacist determine the initial loading dose of TEIC to reach an effective plasma trough concentration rapidly after its administration to a patient. In the present study, we evaluated the effectiveness of initial loading dose determination by pharmacists and physicians by comparing the achievement rate of target plasma trough concentrations (>15 mu g/mL) and expression of adverse effects. Among 61 patients, 34 were treated according to an initial loading dose determined by a pharmacist (pharmacist intervention) and 27 were treated according to the treating physician's discretion (non-pharmacist intervention). The achievement rate of target concentrations was 91.2% (plasma trough concentration 23.3 +/- 5.3 mu g/mL) in the pharmacist intervention group and 25.9% (plasma trough concentration 14.0 +/- 5.9 mu g/mL) in the non-pharmacist intervention group. There was no difference in the incidence of adverse effects between the two groups. Also, we found that systemic inflammatory response syndrome (SIRS) may have a correlation with plasma trough concentrations of TEIC. We suggest that the SIRS score could become a means way of determining initial loading dose. These findings suggest that it is potentially effective for a pharmacist to determine this initial dose in order to rapidly achieve the target plasma trough concentration of TEIC.	[Nakano, Takafumi; Futagami, Koujiro] Fukuoka Univ Hosp, Dept Pharm, Jonan Ku, Fukuoka 8140133, Japan; [Nakano, Takafumi; Mishima, Kenichi] Fukuoka Univ, Fac Pharmaceut Sci, Dept Neuropharmacol, Jonan Ku, Fukuoka 8140180, Japan; [Nakamura, Yoshihiko; Ishikura, Hiroyasu] Fukuoka Univ Hosp, Dept Emergency & Crit Care Med, Jonan Ku, Fukuoka 8140133, Japan; [Togawa, Atsushi; Takata, Tohru] Fukuoka Univ, Dept Oncol Hematol & Infect Dis, Sch Med, Jonan Ku, Fukuoka 8140133, Japan	Nakano, T (reprint author), Fukuoka Univ Hosp, Dept Pharm, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140133, Japan.	naka0625@fukuoka-u.ac.jp					Wilson APR, 2000, CLIN PHARMACOKINET, V39, P167, DOI 10.2165/00003088-200039030-00001; [Anonymous], 1992, CRIT CARE MED, V20, P864; Shimamoto Y, 2013, INTENS CARE MED, V39, P1247, DOI 10.1007/s00134-013-2909-9; Brink AJ, 2008, INT J ANTIMICROB AG, V32, P455, DOI 10.1016/j.ijantimicag.2008.05.012; Roberts JA, 2009, CRIT CARE MED, V37, P840, DOI 10.1097/CCM.0b013e3181961bff; ASSANDRI A, 1987, EUR J CLIN PHARMACOL, V33, P191, DOI 10.1007/BF00544566; FRYE RF, 1992, PHARMACOTHERAPY, V12, P240; Kobiki E., 2012, JPN J PHARM HLTH CAR, V38, P461; Matsuyama S., 2005, JPN J THER DRUG MONI, V22, P228; Mitsuda M, 2009, JPN J THER DRUG MONI, V26, P14; Noguchi S., 2008, JPN J PHARM HLTH CAR, V34, P662; ROWLAND M, 1990, CLIN PHARMACOKINET, V18, P184, DOI 10.2165/00003088-199018030-00002; Sugawara M., 2008, JPN J THER DRUG MONI, V25, P28; Takakura S., 2007, JPN J CHEMOTHER, V60, P501; Takesue Y., 2012, KOUKINYAKU TDM GUIDE, P38; TAKUBO S, 2013, JPN J CHEMOTHER, V61, P157; Tanaka A, 2006, JAPANESE J THERAPEUT, V23, P221; Ueda Y, 2007, JPN J CHEMOTHER, V55, P8	18	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	DEC	2014	134	12					1367	1373				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU3EL	WOS:000345495300014		
J	Engerer, P; Yoshimatsu, T; Suzuki, SC; Godinho, L				Engerer, Peter; Yoshimatsu, Takeshi; Suzuki, Sachihiro C.; Godinho, Leanne			CentrinFish Permit the Visualization of Centrosome Dynamics in a Cellular Context In Vivo	ZEBRAFISH			English	Article									[Engerer, Peter; Godinho, Leanne] Tech Univ Munich, Inst Neuronal Cell Biol, D-80802 Munich, Germany; [Yoshimatsu, Takeshi; Suzuki, Sachihiro C.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Suzuki, Sachihiro C.] Okinawa Inst Sci & Technol Grad Univ, Dev Neurobiol Unit, Kunigami, Okinawa, Japan	Godinho, L (reprint author), Tech Univ Munich, Inst Neuronal Cell Biol, D-80802 Munich, Germany.	leanne.godinho@lrz.tum.de	Suzuki, Sachihiro/G-5898-2015				Wang K, 2014, NAT METHODS, V11, P625, DOI [10.1038/nmeth.2925, 10.1038/NMETH.2925]; Chavali PL, 2014, PHILOS T R SOC LON B, V5, P369, DOI DOI 10.1098/RSTB.2013.0468; Kurokawa D, 2006, P NATL ACAD SCI USA, V103, P19350, DOI 10.1073/pnas.0604686103	3	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1545-8547	1557-8542		ZEBRAFISH	Zebrafish	DEC 1	2014	11	6					586	587		10.1089/zeb.2014.1503		2	Developmental Biology; Zoology	Developmental Biology; Zoology	AU4YH	WOS:000345613800012		
J	Makino, I; Tajima, H; Kitagawa, H; Nakagawara, H; Ohta, T				Makino, Isamu; Tajima, Hidehiro; Kitagawa, Hirohisa; Nakagawara, Hisatoshi; Ohta, Tetsuo			A rare case of hemangiomatosis of the spleen and intrapancreatic accessory spleen	ABDOMINAL IMAGING			English	Article						Splenic hemangiomatosis; Intrapancreatic accessory; spleen; CT; MRI	ISOLATED DIFFUSE HEMANGIOMATOSIS; SPLENIC HEMANGIOMATOSIS	We presented a very rare case of hemangiomatosis of the spleen and intrapancreatic accessory spleen in the tail of the pancreas. A previously healthy 45-year-old woman felt left back pain and received CT scan. Multiple splenic masses and a pancreatic mass in the tail were detected. Both the lesions presented gradual and weak enhancement and pooling of the contrast medium until very late phase on dynamic MRI. Since the lesions in the spleen and the pancreas presented the same characteristics on dynamic CT/MRI, ultrasonography, and positron emission tomography using fluorine-18-fluorodeoxyglucose, we suspected these lesions as hemangiomatosis of the spleen and intrapancreatic accessory spleen. We performed distal pancreatectomy with splenectomy, and pathological diagnosis was hemangiomatosis of the spleen and intrapancreatic accessory spleen. We should consider the possibility of splenic tumors arising from the spleen and intrapancreatic accessory spleen when we find similar lesions in the spleen and the tail of the pancreas. Gradual and weak enhancement and pooling of the contrast medium until very late phase may be important findings for diagnosing splenic hemangiomatosis.	[Makino, Isamu; Tajima, Hidehiro; Kitagawa, Hirohisa; Nakagawara, Hisatoshi; Ohta, Tetsuo] Kanazawa Univ, Kanazawa Univ Hosp, Grad Sch Med Sci, Dept Surg Gastroenterol, Kanazawa, Ishikawa 9208641, Japan	Makino, I (reprint author), Kanazawa Univ, Kanazawa Univ Hosp, Grad Sch Med Sci, Dept Surg Gastroenterol, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	i.makino@staff.kanazawa-u.ac.jp					Ambrosio MR, TUMORI, V98, pe22, DOI [10.1700/1053.11526, DOI 10.1700/1053.11526]; Gaetke-Udager K, 2014, ABDOM IMAGING, V39, P570, DOI 10.1007/s00261-014-0080-6; MOSS CN, 1986, J COMPUT ASSIST TOMO, V10, P338, DOI 10.1097/00004728-198603000-00036; Arber DA, 1997, AM J SURG PATHOL, V21, P827, DOI 10.1097/00000478-199707000-00011; Brasca LE, 2004, EUR RADIOL, V14, P1322, DOI 10.1007/s00330-003-2112-4; D'Antonio Antonio, 2002, Adv Clin Path, V6, P119; Dufau JP, 1999, HISTOPATHOLOGY, V35, P337; HALPERT B, 1964, ARCH PATHOL, V77, P652; Katuchova Jana, 2013, JOP, V14, P261, DOI 10.6092/1590-8577/1231; Loureiro AL, 2013, BMJ CASE REP, DOI [10.1136/2012-008471, DOI 10.1136/2012-008471]; Pilz JB, 2011, AM J SURG, V201, pE15, DOI 10.1016/j.amjsurg.2009.11.013; PUI MH, 1994, CAN ASSOC RADIOL J, V45, P225; ROSE SC, 1986, GASTROINTEST RADIOL, V11, P342, DOI 10.1007/BF02035105; SHIRAN A, 1990, AM J GASTROENTEROL, V85, P1515; Steininger H, 2004, PATHOL RES PRACT, V200, P479, DOI 10.1016/j.prp.2004.04.004; Suriano S, TUMORI, V97, p39e, DOI [10.1700/1018.11105, DOI 10.1700/1018.11105]; TAKAYAMA T, 1994, LANCET, V344, P957, DOI 10.1016/S0140-6736(94)92313-2	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-8925	1432-0509		ABDOM IMAGING	Abdom. Imaging	DEC	2014	39	6					1169	1174		10.1007/s00261-014-0149-2		6	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	AT5SW	WOS:000345003100004		
J	Yagyu, Y; Tsurusaki, M; Kamiyama, K; Kitagaki, H; Murakami, T				Yagyu, Yukinobu; Tsurusaki, Masakatsu; Kamiyama, Kazutoshi; Kitagaki, Hajime; Murakami, Takamichi			Feasible and technical aspects of transcatheter arterial chemoembolization for non-resectable hepatocellular carcinoma using a 3.5-French catheter system	ABDOMINAL IMAGING			English	Article						Hepatocellular carcinoma; Transcatheter arterial chemoembolization; 3.5-Fr catheter system; Feasible study	TRANSFEMORAL APPROACH; EMBOLIZATION; FUTURE	To evaluate the feasibility and technical aspects of transcatheter arterial chemoembolization (TACE) for non-resectable hepatocellular carcinoma (HCC) using a 3.5-French (Fr) catheter system. This study included 328 consecutive cases of HCC among 232 patients who underwent TACE procedures using both a 3.5-Fr catheter system and a microcatheter fitted to a 3.5-Fr system between April 2009 and November 2011. We assessed the ability to reach the catheter into the proper hepatic artery (PHA), main hepatic branch, segmental artery, and subsegmental or sub-subsegmental artery. The feasibility was rated according to the following factors: (1) the number of arteries that could be used to reach the target artery/total number of procedures using the 3.5-Fr system, (2) the rate of successful completion of the procedures without changing over to the 4-Fr system and (3) the reasons for changing over the 4-Fr system. TACE of the PHA (27 sessions), RHA/LHA (103 sessions), segmental (31 sessions), or subsegmental/sub-subsegmental arteries (162 sessions) was performed. The rate of successfully reaching the target artery using the 3.5-Fr system was 93% (306/328 sessions). We were unable to reach the target artery in 22 sessions, including 11/8/3 procedures targeting the sub-subsegmental artery, subsegmental artery, and RHA/LHA, respectively. We changed over to the 4-Fr system in six sessions; therefore, the rate of successful completion of the procedures without changing over to the 4-Fr system was 98% (322/328 sessions). TACE of the target artery can be successfully performed using the 3.5-Fr system in most patients with HCC.	[Yagyu, Yukinobu; Tsurusaki, Masakatsu; Murakami, Takamichi] Kinki Univ, Fac Med, Dept Radiol, Osaka 5898511, Japan; [Tsurusaki, Masakatsu; Kamiyama, Kazutoshi; Kitagaki, Hajime] Shimane Univ, Sch Med, Dept Radiol, Izumo, Shimane 6938501, Japan	Tsurusaki, M (reprint author), Kinki Univ, Fac Med, Dept Radiol, 377-2 Ohnohigashi, Osaka 5898511, Japan.	mtsuru@dk2.so-net.-ne.jp					UCHIDA H, 1990, CARDIOVASC INTER RAD, V13, P140, DOI 10.1007/BF02575465; Camma C, 2002, RADIOLOGY, V224, P47, DOI 10.1148/radiol.2241011262; Rahbari NN, 2011, ANN SURG, V253, P453, DOI 10.1097/SLA.0b013e31820d944f; Forner A, 2010, SEMIN LIVER DIS, V30, P61, DOI 10.1055/s-0030-1247133; MATSUI O, 1993, RADIOLOGY, V188, P79; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; KOBAYASHI A, 1991, JPN J MED, V30, P318; Matsuo N, 1993, J Vasc Interv Radiol, V4, P543, DOI 10.1016/S1051-0443(93)71918-1; Mikami Koji, 2009, Gan To Kagaku Ryoho, V36, P959; MURDACO F, 1983, CATHETER CARDIO DIAG, V9, P75, DOI 10.1002/ccd.1810090111; Ohuchi Y, 2011, HEPATO-GASTROENTEROL, V58, P916; Shiozawa Shunichi, 2007, Gan To Kagaku Ryoho, V34, P2096; Shiozawa S, 2003, J CLIN GASTROENTEROL, V37, P412, DOI 10.1097/00004836-200311000-00013; Watanabe S, 1997, DIGEST DIS SCI, V42, P47, DOI 10.1023/A:1018824819222	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-8925	1432-0509		ABDOM IMAGING	Abdom. Imaging	DEC	2014	39	6					1304	1308		10.1007/s00261-014-0148-3		5	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging	AT5SW	WOS:000345003100021		
J	Yaokawa, R; Nakano, H; Ohashi, M				Yaokawa, Ritsuko; Nakano, Hideyuki; Ohashi, Masataka			Growth of CaSi2 single-phase polycrystalline ingots using the phase relationship between CaSi2 and associated phases	ACTA MATERIALIA			English	Article						Single crystal; Transformation; Solidification microstructure; Phase diagram; Nucleation and growth	CA-SI SYSTEM; ELECTRICAL-PROPERTIES; HIGH-PRESSURE; SILICON; TRANSITIONS; EQUILIBRIA; NANOSHEETS; CALCIUM; DIAGRAM	The phase relationship between CaSi2 and associated phases was studied in order to fabricate CaSi2 single-phase polycrystalline ingots. The phase diagram of the Ca-Si binary system around CaSi2 (CaxSi2; 0.9 <= x <= 1.1) was obtained by identifying the phases in samples of varying composition and differential thermal analysis of the phase transitions. CaSi2 was treated as an incongruent-melting material that precipitates through two peritectic reactions, namely CaSi + liquid -> Ca14Si19 and Ca14Si19 + liquid -> CaSi2, according to the currently accepted phase diagram. However, at the CaSi2 stoichiometric composition, the stable peritectic reaction Ca14Si19 + liquid -> CaSi2 occurs only in the presence of impurities such as Ta, B or P. In contrast, CaSi + liquid -> CaSi2 occurs as the metastable peritectic reaction in a high-purity melt. The undercooling required for CaSi2 precipitation is less than 5 degrees C. Therefore, single-phase CaSi2 could be produced from a high-purity stoichiometric CaSi2 melt with a small amount of undercooling, and a rod-like coupled structure of CaSi2 and CaSi phases formed by peritectic coupled growth in a high-purity Ca-rich ingot. The present study also investigates the fabrication process for CaSi2 single-phase polycrystalline ingots. These can be obtained by high-cooling-rate casting (1-100 degrees C min(-1)) of high-purity, stoichiometric CaSi2 melts using new Ta crucibles. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Yaokawa, Ritsuko; Nakano, Hideyuki; Ohashi, Masataka] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan; [Nakano, Hideyuki] JST Presto, Kawaguchi, Saitama 3320012, Japan	Yaokawa, R (reprint author), Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan.	e4777@mosk.tytlabs.co.jp			PRESTO; Japan Science and Technology Agency	This work was supported in part by PRESTO, the Japan Science and Technology Agency.	Nakano H, 2006, ANGEW CHEM INT EDIT, V45, P6303, DOI 10.1002/anie.200600321; Okamoto H, 2010, J AM CHEM SOC, V132, P2710, DOI 10.1021/ja908827z; SCHAFER H, 1973, ANGEW CHEM INT EDIT, V12, P694, DOI 10.1002/anie.197306941; Sugiyama Y, 2010, J AM CHEM SOC, V132, P5946, DOI 10.1021/ja100919d; Boettinger W. J., 2006, NIST SPECIAL PUBLICA, V960-15; Bordet P, 2000, PHYS REV B, V62, P11392, DOI 10.1103/PhysRevB.62.11392; Brandt M.S., 2003, SILICON CHEM, P194, DOI 10.1002/9783527610761.ch15; Currao A, 1996, Z ANORG ALLG CHEM, V622, P501, DOI 10.1002/zaac.19966220319; Dick S, 1998, Z KRIST-NEW CRYST ST, V213, P232; Dobler S, 2004, ACTA MATER, V52, P2795, DOI 10.1016/j.actamat.2004.02.026; EVERS J, 1979, J SOLID STATE CHEM, V28, P369, DOI 10.1016/0022-4596(79)90087-2; EVERS J, 1974, MATER RES BULL, V9, P549, DOI 10.1016/0025-5408(74)90124-X; Gokhale AB, 1990, BINARY ALLOY PHASE D, V3, P2664; Grobner J, 2003, INTERMETALLICS, V11, P1065, DOI 10.1016/j.intermet.2003.07.001; HIRANO T, 1991, J LESS-COMMON MET, V167, P329, DOI 10.1016/0022-5088(91)90285-C; Manfrinetti P, 2000, INTERMETALLICS, V8, P223, DOI 10.1016/S0966-9795(99)00112-0; Nakano H., 2006, ANGEW CHEM, V118, P6451, DOI DOI 10.1002/ANGE.200600321; Sanfilippo S, 2000, PHYS REV B, V61, pR3800, DOI 10.1103/PhysRevB.61.R3800; Schlesinger ME, 1990, BINARY ALLOY PHASE D, V3, P3364; SCHURMAN.E, 1974, ARCH EISENHUTTENWES, V45, P367; Tamanaka S, 2010, DALTON T, V39, P1901; WYNNYCKY.JR, 1971, METALL TRANS, V2, P975, DOI 10.1007/BF02664227; YAMANAKA S, 1981, PHYSICA B & C, V105, P230, DOI 10.1016/0378-4363(81)90250-3; Zintl E, 1939, ANGEW CHEM-GER EDIT, V52, P1, DOI 10.1002/ange.19390520102	24	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	DEC	2014	81						41	49		10.1016/j.actamat.2014.08.009		9	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AT8JM	WOS:000345179800005		
J	Fukuda, T; Kakeshita, T; Lee, YH				Fukuda, Takashi; Kakeshita, Tomoyuki; Lee, Yong-hee			An interpretation of the kinetics of martensitic transformation in a Ni45Co5Mn36.5In13.5 alloy	ACTA MATERIALIA			English	Article						Nucleation; Specific heat; Free energy; Shape memory alloy; Thermal activation	SHAPE-MEMORY ALLOYS; TIME-DEPENDENT NATURE; NI-MN ALLOYS; HEAT	We investigated the kinetics of martensitic transformation (MT) using a Ni45Co5Mn36.5In13.5 alloy. The MT start temperature M-s of this alloy decreases gradually with increasing applied magnetic field up to 1.5 T, and M-s vanishes under 2 T. Under this magnetic field, the MT shows a clear C-curve in the time temperature transformation (TTT) diagram. To understand this behavior, we evaluated the difference in the free energy Delta g of the parent phase and the martensite phase by measuring the specific heat of the alloy. We found that M-s largely deviates from the equilibrium temperature T-0 as the magnetic field increases. We also found that Delta g at M-s increases as M-s decreases. Using Delta g thus evaluated and a thermal activation model for the nucleation of martensite, we calculated the TTT diagram for various magnetic field strengths so as to reproduce the experimentally obtained one. We estimated the size of the thermally activated cluster, which may be regarded as the nuclei of martensite, to be (5 nm)(3). (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Fukuda, Takashi; Kakeshita, Tomoyuki; Lee, Yong-hee] Osaka Univ, Grad Sch Engn, Dept Mat Sci & Engn, Suita, Osaka 5650871, Japan	Fukuda, T (reprint author), Osaka Univ, Grad Sch Engn, Dept Mat Sci & Engn, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.	fukuda@mat.eng.osaka-u.ac.jp			Japan Society for the Promotion of Science (KAKENHI) [25249086]; Global COB program (Center of Excellence for Advanced Structural and Functional Materials Design) from the Ministry of Education, Culture, Sports, Science and Technology Japan	The present study was supported by a Grant-in-Aid for Scientific Research (A) (KAKENHI, Grant Number 25249086) from the Japan Society for the Promotion of Science. This study was also supported by the Global COB program (Center of Excellence for Advanced Structural and Functional Materials Design) from the Ministry of Education, Culture, Sports, Science and Technology Japan.	Ito W, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2833699; Umetsu RY, 2009, SCRIPTA MATER, V60, P25, DOI 10.1016/j.scriptamat.2008.08.022; Uijttewaal MA, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.035702; Barandiaran JM, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4793412; Kustov S, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3130229; TONG HC, 1974, ACTA METALL MATER, V22, P887, DOI 10.1016/0001-6160(74)90055-8; Kakeshita T, 1996, MATER T JIM, V37, P299; Lee YH, 2011, SCRIPTA MATER, V64, P927, DOI 10.1016/j.scriptamat.2010.12.030; KAUFMAN L, 1958, PROG MET PHYS, V7, P165, DOI 10.1016/0502-8205(58)90005-4; PATEL JR, 1953, ACTA METALL MATER, V1, P531, DOI 10.1016/0001-6160(53)90083-2; Kustov S, 2010, SCRIPTA MATER, V63, P1240, DOI 10.1016/j.scriptamat.2010.08.047; Ito W, 2007, METALL MATER TRANS A, V38A, P759, DOI 10.1007/s11661-007-9094-9; Planes A, 2004, SCRIPTA MATER, V50, P181, DOI 10.1016/j.scriptamat.2003.09.021; Hurrich C, 2010, J ALLOY COMPD, V494, P40, DOI 10.1016/j.jallcom.2010.01.044; Kustov S, 2010, J APPL PHYS, V107, DOI 10.1063/1.3313922; KAKESHITA T, 1993, MATER T JIM, V34, P423; Kustov S, 2012, ACTA MATER, V60, P2578, DOI 10.1016/j.actamat.2012.01.025; Chernenko VA, 2008, J MAGN MAGN MATER, V320, pE156, DOI 10.1016/j.jmmm.2008.02.139; Choi MS, 2005, SCRIPTA MATER, V53, P869, DOI 10.1016/j.scriptamat.2005.05.040; Fukuda T, 2013, SCRIPTA MATER, V68, P984, DOI 10.1016/j.scriptamat.2013.02.057; Kakeshita T, 1997, MATER T JIM, V38, P668; KAKESHITA T, 1993, MATER T JIM, V34, P415; Kakeshita T, 1996, SCRIPTA MATER, V34, P147, DOI 10.1016/1359-6462(95)00483-1; Lee Y, 2012, J ALLOY COMPD, V577, pS380; Sharma V., 2007, PHYS REV B, V76, P3	25	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	DEC	2014	81						121	127		10.1016/j.actamat.2014.08.018		7	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AT8JM	WOS:000345179800012		
J	Takaki, T; Ohno, M; Shimokawabe, T; Aoki, T				Takaki, Tomohiro; Ohno, Munekazu; Shimokawabe, Takashi; Aoki, Takayuki			Two-dimensional phase-field simulations of dendrite competitive growth during the directional solidification of a binary alloy bicrystal	ACTA MATERIALIA			English	Article						Dendritic solidification; Directional solidification; Phase-field simulation	NICKEL-BASE SUPERALLOY; GRAIN-GROWTH; INTERFACE KINETICS; 3 DIMENSIONS; MODEL; MECHANISM; SELECTION	We investigated the competitive growth of dendrites at the converging grain boundaries (GBs) of bicrystals during the directional solidification of an Al-Cu alloy by means of two-dimensional phase-field simulations. In particular, the focus was on the recently observed phenomenon of unusual overgrowth during the directional solidification of a Ni-based superalloy, where the favorably oriented (FO) dendrites are overgrown by the unfavorably oriented (UO) ones. The phase-field simulations were accelerated by parallel computations on graphics processing units. The simulation results showed that unusual overgrowth occurs in Al-Cu alloys, indicating that this phenomenon is a common one in metallic materials. It was also concluded that the differences in the diffusion layers in front of the FO and UO dendrites had a dominant effect on the competitive growth of dendrites at the converging GB as well as on the unusual overgrowth. In addition, unusual overgrowth was observed in all the FO dendrites with a spacing that allowed the dendrite array to grow stably without necessitating a change in the number of dendrites. The FO dendrite at the GB is overgrown by the UO dendrite when the spacing between the FO dendrite at the GB and the next FO dendrite is approximately equal to the critical minimum spacing. However, the unusual overgrowth was not observed for UO dendrites with a large inclination angle. In this case, all the UO dendrites are blocked by the FO dendrite at the GB, and the FO dendrites migrate toward the UO dendrites. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Takaki, Tomohiro] Kyoto Inst Technol, Sakyo Ku, Kyoto 6068585, Japan; [Ohno, Munekazu] Hokkaido Univ, Div Engn & Mat Sci, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Shimokawabe, Takashi; Aoki, Takayuki] Tokyo Inst Technol, Global Sci Informat & Comp Ctr, Tokyo 1528550, Japan	Takaki, T (reprint author), Kyoto Inst Technol, Sakyo Ku, Kyoto 6068585, Japan.	takaki@kit.ac.jp	Takaki, Tomohiro/J-8405-2013; Ohno, Munekazu/A-5222-2012	Ohno, Munekazu/0000-0001-5383-412X	Japan Society for the Promotion of Science (JSPS) [25289006, 26220002]; Iron and Steel Institute of Japan (ISIJ)	This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI) (Grant Numbers 25289006 and 26220002) from the Japan Society for the Promotion of Science (JSPS) and a Research Promotion Grant from the Iron and Steel Institute of Japan (ISIJ).	WALTON D, 1959, T AM I MIN MET ENG, V215, P447; Granasy L, 2004, NAT MATER, V3, P645, DOI 10.1038/nmat1190; Diepers HJ, 2002, J CRYST GROWTH, V237, P149, DOI 10.1016/S0022-0248(01)01932-7; Meng XB, 2012, ACTA MATER, V60, P3965, DOI 10.1016/j.actamat.2012.04.002; Wang ZJ, 2011, J CRYST GROWTH, V328, P108, DOI 10.1016/j.jcrysgro.2011.06.021; RAPPAZ M, 1993, ACTA METALL MATER, V41, P345, DOI 10.1016/0956-7151(93)90065-Z; WHEELER AA, 1993, PHYS REV E, V47, P1893, DOI 10.1103/PhysRevE.47.1893; GANDIN CA, 1994, ACTA METALL MATER, V42, P2233, DOI 10.1016/0956-7151(94)90302-6; Kim SG, 1999, PHYS REV E, V60, P7186, DOI 10.1103/PhysRevE.60.7186; Granasy L, 2003, NAT MATER, V2, P92, DOI 10.1038/nmat815; Karma A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.115701; Li JJ, 2012, ACTA MATER, V60, P1478, DOI 10.1016/j.actamat.2011.11.037; Zhou YZ, 2008, ACTA MATER, V56, P2631, DOI 10.1016/j.actamat.2008.02.022; Warren JA, 2003, ACTA MATER, V51, P6035, DOI 10.1016/S1359-6454(03)00388-4; Yang CB, 2013, J ALLOY COMPD, V578, P577, DOI 10.1016/j.jallcom.2013.07.006; Steinbach I, 1999, PHYSICA D, V134, P385, DOI 10.1016/S0167-2789(99)00129-3; WHEELER AA, 1992, PHYS REV A, V45, P7424, DOI 10.1103/PhysRevA.45.7424; Asta M, 2009, ACTA MATER, V57, P941, DOI 10.1016/j.actamat.2008.10.020; Karma A, 1998, PHYS REV E, V57, P4323, DOI 10.1103/PhysRevE.57.4323; Ohno M, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031603; Esaka H, 2003, MATER TRANS, V44, P829, DOI 10.2320/matertrans.44.829; Kobayashi R, 1998, PHYSICA D, V119, P415, DOI 10.1016/S0167-2789(98)00026-8; Takaki T, 2014, ISIJ INT, V54, P437, DOI 10.2355/isijinternational.54.437; Echebarria B, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.061604; Takaki T, 2013, J CRYST GROWTH, V382, P21, DOI 10.1016/j.jcrysgro.2013.07.028; Kim SG, 2004, J CRYST GROWTH, V261, P135, DOI 10.1016/j.jcrysgro.2003.08.078; Karma A, 1996, PHYS REV E, V53, pR3017, DOI 10.1103/PhysRevE.53.R3017; Wagner A, 2004, MAT SCI ENG A-STRUCT, V374, P270, DOI 10.1016/j.msea.2004.03.017; Boettinger WJ, 2002, ANNU REV MATER RES, V32, P163, DOI 10.1146/annurev.matsci.32.101901.155803; Esaka H, 2002, MATER TRANS, V43, P1312, DOI 10.2320/matertrans.43.1312; Akamatsu S, 1997, PHYS REV E, V56, P4479, DOI 10.1103/PhysRevE.56.4479; Bottger B., 2006, ACTA MAT, V54, P2697; BOWER TF, 1967, T METALL SOC AIME, V239, P1620; Dantzig J., 2009, SOLIDIFICATION; Deschamps J., 2008, PHYS REV E, V78; D'Souza N, 2002, J MATER SCI, V37, P481, DOI 10.1023/A:1013753120867; Echebarria B., 2010, PHYS REV E, V81; KOBAYASHI R, 1993, PHYSICA D, V63, P410, DOI 10.1016/0167-2789(93)90120-P; Kurz W., 1989, FUNDAMENTALS SOLIDIF; Lan CW, 2003, J CRYST GROWTH, V250, P525, DOI 10.1016/S0022-0248(02)02393-X; Lan CW, 2005, ACTA MATER, V53, P2285, DOI 10.1016/j.actamat.2005.01.034; Liu ZY, 2013, METALL MATER TRANS A, V44A, P5113, DOI 10.1007/s11661-013-1840-6; Nestler B, 2002, COMPUT PHYS COMMUN, V147, P230, DOI 10.1016/S0010-4655(02)00252-7; Okamoto M., 2013, T JPN SOC COMPUT ENG, V2013; Shimokawabe T., 2011, P SC11, P1; TRIVEDI R, 1991, METALL TRANS A, V22, P585, DOI 10.1007/BF02656826; Yamanaka A, 2011, J CRYST GROWTH, V318, P40, DOI 10.1016/j.jcrysgro.2010.10.096; Yamanaka A., 2012, J COMPUT SCI TECHNOL, V6, P182	48	8	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	DEC	2014	81						272	283		10.1016/j.actamat.2014.08.035		12	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AT8JM	WOS:000345179800027		
J	Harada, S; Yamamoto, Y; Seki, K; Horio, A; Tagawa, M; Ujihara, T				Harada, Shunta; Yamamoto, Yuji; Seki, Kazuaki; Horio, Atsushi; Tagawa, Miho; Ujihara, Toru			Different behavior of threading edge dislocation conversion during the solution growth of 4H-SiC depending on the Burgers vector	ACTA MATERIALIA			English	Article						Silicon carbide; Dislocations; X-ray topography; Crystal growth	SCREW DISLOCATION; SINGLE-CRYSTALS; SILICON-CARBIDE; REDUCTION; MECHANISM; DENSITY; DEVICES; ENERGY; BULK; 6H	Threading edge dislocation (TED) conversion during the solution growth of SiC was investigated by synchrotron X-ray topography. TEDs were converted to basal plane dislocations by lateral growth with the advance of macrosteps on the growth surface during the solution growth. TEDs with the Burgers vector parallel to the step-flow direction were converted to basal plane dislocations with a high probability. On the other hand, the conversion ratio of TEDs whose Burgers vector is not parallel to the step-flow direction was much lower. The variation in elastic energy of the basal plane dislocations after the conversion depending on the Burgers vectors led to the different behavior of TED conversion. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Harada, Shunta; Yamamoto, Yuji; Horio, Atsushi; Tagawa, Miho; Ujihara, Toru] Nagoya Univ, Dept Mat Sci & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Seki, Kazuaki] Nagoya Univ, Dept Crystalline Mat Sci, Nagoya, Aichi 4648603, Japan	Harada, S (reprint author), Nagoya Univ, Dept Mat Sci & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan.	harada.numse@gmail.com			 [23246004];  [24686078]	The authors are grateful to Dr H. Yamaguchi and Dr K. Hirano for the X-ray topography measurements. The Xray topography was performed under the approval of the Photon Factory Program Advisory Committee (Proposal No. 2011G247). This study was partly supported by a Grant-in-Aid for Scientific Research (23246004 and 24686078).	Senzaki J, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2221525; Neudeck PG, 2000, MATER SCI FORUM, V338-3, P1161; Yamamoto Y, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.115501; Skowronski M, 2006, J APPL PHYS, V99, DOI 10.1063/1.2159578; Neudeck PG, 1999, IEEE T ELECTRON DEV, V46, P478, DOI 10.1109/16.748865; Matsunami H, 1997, MAT SCI ENG R, V20, P125, DOI 10.1016/S0927-796X(97)00005-3; Kamata I, 2009, J CRYST GROWTH, V311, P1416, DOI 10.1016/j.jcrysgro.2008.11.017; Hong MH, 2000, PHILOS MAG A, V80, P919; Shen XQ, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1849836; Klapper H, 2000, MATER CHEM PHYS, V66, P101, DOI 10.1016/S0254-0584(00)00342-4; Kamei K, 2009, J CRYST GROWTH, V311, P855, DOI 10.1016/j.jcrysgro.2008.09.142; Soueidan M, 2006, ADV FUNCT MATER, V16, P975, DOI 10.1002/adfm.200500597; Bai J, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2170407; Dost S., 2007, SINGLE CRYSTAL GROWT; Harada S, 2013, MATER SCI FORUM, V740-742, P189, DOI 10.4028/www.scientific.net/MSF.740-742.189; Harada S, 2014, MATER SCI FORUM, V778-780, P67, DOI 10.4028/www.scientific.net/MSF.778-780.67; Harada S, 2012, CRYST GROWTH DES, V12, P3209, DOI 10.1021/cg300360h; Harada S, 2013, APL MATER, V1, DOI 10.1063/1.4818357; Hirth J., 1968, THEORY DISLOCATIONS; Hull D., 1975, INTRO DISLOCATIONS; Kamitani K, 1997, J APPL PHYS, V82, P3152, DOI 10.1063/1.366100; Klapper H, 2010, SPRINGER HDB CRYSTAL; Muller St G., 2012, Journal of Crystal Growth, V352, DOI 10.1016/j.jcrysgro.2011.10.050; SAVIN MM, 1976, PHYS STATUS SOLIDI A, V35, P747, DOI 10.1002/pssa.2210350240; Steed JW, 1973, INTRO ANISOTROPIC EL; Teutonico LJ, 1970, MATER SCI ENG, V6, P2747; Ujihara T, 2011, J CRYST GROWTH, V318, P389, DOI 10.1016/j.jcrysgro.2010.10.148; Ujihara T, 2008, J CRYST GROWTH, V310, P1438, DOI 10.1016/j.jcrysgro.2007.11.210; Ujihara T, 2012, MATER SCI FORUM, V717-720, P351, DOI 10.4028/www.scientific.net/MSF.717-720.351; Yakimova R, 2000, DIAM RELAT MATER, V9, P432, DOI 10.1016/S0925-9635(99)00219-8; Yamamoto K, 2012, MATER SCI FORUM, V717-720, P477, DOI [10.4028/www.scientific.net/MSF.717-720.477, 10.4028/www.scientific.net/MST.717-720.477]; Yamamoto Y, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.065501; Yashiro N, 2010, MATER SCI FORUM, V645-648, P33, DOI 10.4028/www.scientific.net/MSF.645-648.33	33	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	DEC	2014	81						284	290		10.1016/j.actamat.2014.08.027		7	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AT8JM	WOS:000345179800028		
J	Okamoto, NL; Yasuhara, A; Inui, H				Okamoto, Norihiko L.; Yasuhara, Akira; Inui, Haruyuki			Order-disorder structure of the delta(1k) phase in the Fe-Zn system determined by scanning transmission electron microscopy	ACTA MATERIALIA			English	Article						Intemietallic compounds (IMCs); Scanning transmission electron microscopy (STEM); Electron diffraction; Single crystal; Superlattice	IRON-ZINC SYSTEM; INTERMETALLIC COMPOUND ZETA-FEZN13; THAN 1 KINDS; OD-STRUCTURES; CRYSTAL-STRUCTURE; THERMODYNAMIC EVALUATION; NEUTRON-DIFFRACTION; X-RAY; LAYERS; GAMMA	The crystal structure of the delta(1k) phase in the Fe-Zn system was investigated by scanning transmission electron microscopy. The delta(1k) phase has a superlattice structure based on the delta(1p) phase having a tripled periodicity along the a-axis direction of the delta(1p) phase, accompanied by one-dimensional stacking disorder of structural blocks (called order disorder (OD) packets) along the c-axis direction. The crystal structure can be described crystallographically in terms of the OD theory so as to belong to the category IV OD structures composed of two types of non-polar OD layers (L-2n and M2n+1). The tripled periodicity along the a-axis direction is due to chemical ordering of the constituent Fe and Zn atoms in the OD layer M2n+1. Because of the tripled periodicity of the OD layer M2n+1, three different equivalent stacking positions are generated in stacking an OD layer M2n+1 on top of the OD layer L-2n. Depending on the stacking order, the crystal structure of the delta(1k) phase can be ordered with various periodicities along the stacking direction or completely disordered. Based on the OD theory, two maximum degree of order (MDO) polytypes belonging to the space groups of P6(3)/mcm (MDO1) and R3c (MDO2) are deduced for the delta(1k) phase. The most stable MDO polytype in the OD family of the delta(1k) phase is determined experimentally to be the MDO2 polytype. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Okamoto, Norihiko L.; Inui, Haruyuki] Kyoto Univ, Dept Mat Sci & Engn, Kyoto 6068501, Japan; [Okamoto, Norihiko L.; Inui, Haruyuki] Kyoto Univ, Ctr Elements Strategy Initiat Struct Mat ESISM, Kyoto 6068501, Japan; [Yasuhara, Akira] JEOL Ltd, EM Applicat Grp, Akishima, Tokyo 1968558, Japan	Okamoto, NL (reprint author), Kyoto Univ, Dept Mat Sci & Engn, Kyoto 6068501, Japan.	okamoto.norihiko.7z@kyoto-u.ac.jp	Okamoto, Norihiko/A-7345-2010	Okamoto, Norihiko/0000-0003-0199-7271	JSPS KAKENHI [24246113, 25709066]; Elements Strategy Initiative for Structural Materials (ESISM) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Advanced Low Carbon Technology Research and Development Program (ALCA) from the Japan Science and Technology Agency (JST); ISIJ; JFE 21st Century Foundation	This work was supported by JSPS KAKENHI Grant Numbers 24246113 and 25709066, and the Elements Strategy Initiative for Structural Materials (ESISM) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and in part by Advanced Low Carbon Technology Research and Development Program (ALCA) from the Japan Science and Technology Agency (JST). This work was also supported by a Research Promotion Grant from ISIJ and Grants for Technical Research from JFE 21st Century Foundation.	Belin CHE, 2000, J SOLID STATE CHEM, V151, P85, DOI 10.1006/jssc.2000.8626; Marder AR, 2000, PROG MATER SCI, V45, P191, DOI 10.1016/S0079-6425(98)00006-1; PENNYCOOK SJ, 1988, NATURE, V336, P565, DOI 10.1038/336565a0; GRELL H, 1982, ACTA CRYSTALLOGR A, V38, P49, DOI 10.1107/S0567739482000096; BRANDON JK, 1974, ACTA CRYSTALLOGR B, VB 30, P1412, DOI 10.1107/S0567740874004997; Nakano J, 2005, CALPHAD, V29, P276, DOI 10.1016/j.calphad.2005.08.005; Reumont G, 2000, J PHASE EQUILIB, V21, P371, DOI 10.1361/105497100770339905; Yokobayashi H, 2011, ACTA MATER, V59, P7287, DOI 10.1016/j.actamat.2011.08.011; Su XP, 2001, J ALLOY COMPD, V325, P129, DOI 10.1016/S0925-8388(01)01273-7; Kishida K, 2012, INTERMETALLICS, V31, P55, DOI 10.1016/j.intermet.2012.06.010; Bablik H, 1938, Z METALLKD, V8, P249; BASTIN GF, 1974, Z METALLKD, V65, P656; Belin R, 2000, ACTA CRYSTALLOGR C, V56, P267; BROWN PJ, 1962, ACTA CRYSTALLOGR, V15, P608, DOI 10.1107/S0365110X62001528; Domberger-Schiff K., 1964, ABH DEUT AKAD WISS, V3, P1; DORNBERGERSCHIFF K, 1956, ACTA CRYSTALLOGR, V9, P593, DOI 10.1107/S0365110X56001625; DORNBERGERSCHIFF K, 1979, KRIST TECH, V14, P1027, DOI 10.1002/crat.19790140903; DORNBERGERSCHIF.K, 1959, ACTA CRYSTALLOGR, V12, P173, DOI 10.1107/S0365110X59000482; DORNBERGERSCHIFF K, 1975, CLAY CLAY MINER, V23, P219, DOI 10.1346/CCMN.1975.0230310; Dornberger-Schiff K, 1966, LEHRGANG OD STRUKTUR; DORNBERGERSCHIFF K, 1982, ACTA CRYSTALLOGR A, V38, P491, DOI 10.1107/S0567739482001053; DUROVIC S, 1974, ACTA CRYSTALLOGR B, VB 30, P76, DOI 10.1107/S0567740874002238; Durovic S., 1997, MODULAR ASPECTS MINE, V1, P3; Durovic S, 2006, Z KRISTALLOGR, V221, P63, DOI 10.1542/zkri.2005.221.1.63; Ferraris G, 2008, CRYSTALLOGRAPHY MODU; GHONIEM MA, 1972, METALL, V26, P1026; Hahn Th, 2005, INT TABLES CRYSTALLO, VA; Hong MH, 1997, SCRIPTA MATER, V36, P1423, DOI 10.1016/S1359-6462(97)00030-4; Hybler J, 2009, ACTA CRYSTALLOGR A, V65, P501, DOI 10.1107/S0108767309037702; JOHANSSO.A, 1968, ACTA CHEM SCAND, V22, P2743, DOI 10.3891/acta.chem.scand.22-2743; Kainuma R, 2005, TETSU TO HAGANE, V91, P349; Kato C., 1994, TMS ANN M PHYS MET Z, P241; Kopsky V., 2010, INT TABLES CRYSTALLO; KOSTER AS, 1981, ACTA CRYSTALLOGR B, V37, P1905, DOI 10.1107/S056774088100753X; KUBASCHEWSKI O, 1982, IRON BINARY PHASE DI; Merlino S, 1997, MODULAR ASPECTS MINE, V1, P29; MERLINO S, 1989, CAN MINERAL, V27, P625; Okamoto NL, 2014, ACTA MATER, V65, P229, DOI 10.1016/j.actamat.2013.10.065; Okamoto NL, 2014, ACTA CRYSTALLOGR B, V70, P275, DOI 10.1107/S2052520613034410; Okamoto NL, UNPUB; Okamoto NL, 2013, SCRIPTA MATER, V69, P307, DOI 10.1016/j.scriptamat.2013.05.003; Pearson P. Villars, 1997, PEARSONS HDB CRYSTAL; PERROT P, 1988, CALPHAD, V12, P33, DOI 10.1016/0364-5916(88)90027-2; PETERSEN S, 1988, THERMOCHIM ACTA, V129, P77, DOI 10.1016/0040-6031(88)87199-5; Schramm J, 1938, Z METALLKD, V30, P122; Uwakweh ONC, 2000, METALL MATER TRANS A, V31, P2739, DOI 10.1007/BF02830333	46	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	DEC	2014	81						345	357		10.1016/j.actamat.2014.08.025		13	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AT8JM	WOS:000345179800034		
J	Mitsunobu, T; Koizumi, Y; Lee, BS; Yamanaka, K; Matsumoto, H; Li, YP; Chiba, A				Mitsunobu, Takuya; Koizumi, Yuichiro; Lee, Byoung-Soo; Yamanaka, Kenta; Matsumoto, Hiroaki; Li, Yunping; Chiba, Akihiko			Role of strain-induced martensitic transformation on extrusion and intrusion formation during fatigue deformation of biomedical Co-Cr-Mo-N alloys	ACTA MATERIALIA			English	Article						Biomedical cobalt-chromium-molybdenum alloy; Martensitic phase transformation; Deformation structure; Transmission electron microscopy (TEM); Fatigue crack initiation	STACKING-FAULT ENERGY; AUSTENITIC STAINLESS-STEEL; MECHANICAL-PROPERTIES; HIGH-CARBON; CYCLIC DEFORMATION; WEAR BEHAVIOR; PHASE; AFM; MICROSTRUCTURES; BIOMATERIALS	The mechanism of extrusion and intrusion formation in Co-Cr-Mo-N alloys during fatigue deformation was investigated. In particular, we focused on the role of the strain-induced martensitic transformation (SIMT), which is the transformation of the metastable gamma face-centered cubic (fcc) phase into a stable epsilon hexagonal close-packed (hcp) phase at room temperature because of the gliding of Shockley partial dislocations in the gamma-phase matrix. We found that the SIMT also plays a crucial role in the formation of extrusions and intrusions. Further, the morphology of the extrusions and intrusions formed in the Co-Cr-Mo-N alloy specimens was very different from that seen in other fcc alloys. The extrusions and intrusions were formed by the gliding of perfect dislocations with a Burgers vector of perfect < a > dislocation on the basal plane of the epsilon-hcp phase. This suggests that the epsilon-phases introduced by the SIMT can deform readily. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Mitsunobu, Takuya; Koizumi, Yuichiro; Lee, Byoung-Soo; Yamanaka, Kenta; Matsumoto, Hiroaki; Li, Yunping; Chiba, Akihiko] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan	Koizumi, Y (reprint author), Tohoku Univ, Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	koizumi@imr.tohoku.ac.jp	Li, Yunping/A-8109-2011; Yamanaka, Kenta/G-4745-2014; Koizumi, Yuichiro/C-2697-2011	Li, Yunping/0000-0002-4657-2923; Yamanaka, Kenta/0000-0003-1675-4731; Koizumi, Yuichiro/0000-0001-7061-7135	Japan Society for the Promotion of Science (JSPS); Regional Innovation Cluster Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	This research was supported by a Grant-in-Aid for Scientific Research Development from Japan Society for the Promotion of Science (JSPS). This research was partly supported by the Regional Innovation Cluster Program 2010 of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. We thank Mr. Eiji Aoyagi and Dr. Yumiko Kodama for their assistance with the TEM operation and the preparation of the TEM samples. This work is a cooperative program (Proposal No. 13G0411) of the Cooperative Research and Development Center for Advanced Materials, Institute for Materials Research, Tohoku University.	Antunes RA, 2012, ACTA BIOMATER, V8, P937, DOI 10.1016/j.actbio.2011.09.012; Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2; Hedberg YS, 2014, DENT MATER, V30, P525, DOI 10.1016/j.dental.2014.02.008; Koyama M, 2008, MATER TRANS, V49, P812, DOI 10.2320/matertrans.MRA2007321; Tsuchida N, 2011, ISIJ INT, V51, P124, DOI 10.2355/isijinternational.51.124; HIRTH JP, 1970, METALL TRANS, V1, P2367; Koizumi Y, 2013, ACTA MATER, V61, P1648, DOI 10.1016/j.actamat.2012.11.041; Murr LE, 2011, J MECH BEHAV BIOMED, V4, P1396, DOI 10.1016/j.jmbbm.2011.05.010; CHALANT G, 1980, ACTA METALL MATER, V28, P75, DOI 10.1016/0001-6160(80)90042-5; Yan Y, 2006, TRIBOL INT, V39, P1509, DOI 10.1016/j.triboint.2006.01.016; Yamanaka K, 2012, METALL MATER TRANS A, V43A, P4875, DOI 10.1007/s11661-012-1303-5; REMY L, 1976, MATER SCI ENG, V26, P123, DOI 10.1016/0025-5416(76)90234-2; Yamanaka K, 2013, ACTA BIOMATER, V9, P6259, DOI 10.1016/j.actbio.2012.12.013; Altenberger I, 1999, MAT SCI ENG A-STRUCT, V264, P1, DOI 10.1016/S0921-5093(98)01121-6; Teoh SH, 2000, INT J FATIGUE, V22, P825, DOI 10.1016/S0142-1123(00)00052-9; Mori M, 2010, MAT SCI ENG A-STRUCT, V528, P614, DOI 10.1016/j.msea.2010.09.002; Man J, 2012, INT J FATIGUE, V39, P44, DOI 10.1016/j.ijfatigue.2011.05.002; Allain S, 2004, MAT SCI ENG A-STRUCT, V387, P158, DOI 10.1016/j.msea.2004.01.059; Huang P, 1999, MATER LETT, V39, P244, DOI 10.1016/S0167-577X(99)00021-X; Lee BS, 2011, MATER LETT, V65, P843, DOI 10.1016/j.matlet.2010.12.007; FELTNER CE, 1967, ACTA METALL MATER, V15, P1621, DOI 10.1016/0001-6160(67)90137-X; Yamanaka K, 2012, METALL MATER TRANS A, V43A, P5243, DOI 10.1007/s11661-012-1288-0; Chen Y, 2014, WEAR, V310, P51, DOI 10.1016/j.wear.2013.12.010; Arenas MA, 2013, METALL MATER TRANS A, V44A, P4382, DOI 10.1007/s11661-013-1759-y; Chiba A, 2007, ACTA MATER, V55, P1309, DOI 10.1016/j.actamat.2006.10.005; Chiba A, 2005, MATER SCI FORUM, V475-479, P2317; Tipper JL, 1999, J MATER SCI-MATER M, V10, P353, DOI 10.1023/A:1026473723777; Matsumoto H, 2010, SCRIPTA MATER, V63, P1092, DOI 10.1016/j.scriptamat.2010.08.006; LAIRD C, 1986, MATER SCI ENG, V81, P433, DOI 10.1016/0025-5416(86)90281-8; Sun SH, 2014, ACTA MATER, V64, P154, DOI 10.1016/j.actamat.2013.10.017; Gaytan SM, 2010, METALL MATER TRANS A, V41A, P3216, DOI 10.1007/s11661-010-0388-y; AWATANI J, 1979, METALL TRANS A, V10, P503, DOI 10.1007/BF02697078; Bergeon N, 2000, ACTA MATER, V48, P4053, DOI 10.1016/S1359-6454(00)00187-7; Frechard S, 2006, MAT SCI ENG A-STRUCT, V418, P312, DOI 10.1016/j.msea.2005.11.047; Khan Z, 1996, J MATER ENG PERFORM, V5, P201, DOI 10.1007/BF02650887; KUHLMANNWILSDORF D, 1977, MATER SCI ENG, V27, P137, DOI 10.1016/0025-5416(77)90166-5; Kurosu S, 2011, SCRIPTA MATER, V64, P367, DOI 10.1016/j.scriptamat.2010.07.032; Li YP, 2012, MATER CHEM PHYS, V133, P29, DOI 10.1016/j.matchemphys.2011.12.081; Matsumoto H, 2014, ACTA MATER, V64, P1, DOI 10.1016/j.actamat.2013.11.005; Nakano T., 2012, COMMUNICATION; Odahara T, 2008, MATER TRANS, V49, P1963, DOI 10.2320/matertrans.MAW200816; Polak J, 2003, INT J FATIGUE, V25, P1027, DOI 10.1016/S0142-1123(03)00114-2; Polak J, 2003, Z METALLKD, V94, P1327; Takaichi A., 2013, J MECH BEHAV BIOMED, V23, P67; THORNTON PR, 1962, PHILOS MAG, V7, P1349, DOI 10.1080/14786436208213168	45	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	DEC	2014	81						377	385		10.1016/j.actamat.2014.08.039		9	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AT8JM	WOS:000345179800036		
J	Sandstrom, H; Nordstrom, H; Johansson, J; Kjall, P; Jokura, H; Toma-Dasu, I				Sandstrom, Helena; Nordstrom, Hakan; Johansson, Jonas; Kjall, Per; Jokura, Hidefumi; Toma-Dasu, Iuliana			Variability in target delineation for cavernous sinus meningioma and anaplastic astrocytoma in stereotactic radiosurgery with Leksell Gamma Knife Perfexion	ACTA NEUROCHIRURGICA			English	Article						Leksell Gamma Knife Perfexion; Gamma Knife radiosurgery; Radiosurgery; Target delineation; Astrocytoma; Meningioma; Inter-observer variability	VOLUME DELINEATION; BRAIN-TUMORS; INTEROBSERVER VARIABILITY; CT SCANS; RADIOTHERAPY; CONFORMITY; MODALITIES; EXPERIENCE; IMPACT; CANCER	Radiosurgery clinical practice relays on empirical observations and the experience of the practitioners involved in determining and delineating the target and therefore variability in target delineation might be expected for all the radiosurgery approaches, independent of the technique and the equipment used for delivering the treatment. The main aim of this study was to quantify the variability of target delineation for two radiosurgery targets expected to be difficult to delineate. The secondary aim was to investigate the dosimetric implications with respect to the plan conformity. The primary aim of the study has therefore a very general character, not being bound to one specific radiosurgery technique. Twenty radiosurgery centers were asked to delineate one cavernous sinus meningioma and one astrocytoma and to plan the treatments for Leksell Gamma Knife Perfexion. The analysis of the delineated targets was based on the calculated 50 % agreement volume, AV(50). The AV(50) was compared to each delineated target by the concordance index and discordance index. The differences in location, size, and shape of the delineated targets were also analyzed using the encompassing volume compared to the common volume, i.e., the AV(100,) of all delineated structures. Target delineation led to major differences between the participating centers and therefore the AV(50) was small in comparison to each delineated target volume. For meningioma, the AV(50) was 5.90 cm(3), the AV(100) was 2.60 cm(3), and the encompassing volume was 13.14 cm(3). For astrocytoma, the AV(50) was 2.06 cm(3) while the AV(100) was extremely small, only 0.05 cm(3), and the encompassing volume was 43.27 cm(3). These variations translate into corresponding discrepancies in plan conformity. Significant differences in shape, size, and location between the targets included in this study were identified and therefore the clinical implications of these differences should be further investigated.	[Sandstrom, Helena; Toma-Dasu, Iuliana] Stockholm Univ, S-17176 Stockholm, Sweden; [Sandstrom, Helena; Toma-Dasu, Iuliana] Karolinska Inst, S-17176 Stockholm, Sweden; [Nordstrom, Hakan; Johansson, Jonas; Kjall, Per] Elekta Instrument AB, Stockholm, Sweden; [Jokura, Hidefumi] Furukawa Seiryo Hosp, Osaki, Japan; [Jokura, Hidefumi] Tohoku Univ, Dept Neurosurg, Sch Med, Sendi, Japan	Sandstrom, H (reprint author), Stockholm Univ, P9 Heliport, S-17176 Stockholm, Sweden.	helena.sandstrom@ki.se			Cancer Research Funds of Radiumhemmet	Financial support from the Cancer Research Funds of Radiumhemmet is gratefully acknowledged.	Regis J, 2009, NEUROSURGERY, V64, P346, DOI 10.1227/01.NEU.0000337578.00814.75; Lee JYK, 2002, J NEUROSURG, V97, P65, DOI 10.3171/jns.2002.97.1.0065; Khoo VS, 2000, INT J RADIAT ONCOL, V46, P1309, DOI 10.1016/S0360-3016(99)00541-6; Li XA, 2009, INT J RADIAT ONCOL, V73, P944, DOI 10.1016/j.ijrobp.2008.10.034; Yomo S, 2010, ACTA NEUROCHIR, V152, P47, DOI 10.1007/s00701-009-0510-3; SHAW E, 1993, INT J RADIAT ONCOL, V27, P1231; vantRiet A, 1997, INT J RADIAT ONCOL, V37, P731; Paddick I, 2000, J NEUROSURG, V93, P219; Liscak R, 1999, ACTA NEUROCHIR, V141, P473, DOI 10.1007/s007010050327; Bhatnagar Jagdish P, 2009, J Med Phys, V34, P141, DOI 10.4103/0971-6203.54848; Buis DR, 2005, INT J RADIAT ONCOL, V62, P246, DOI 10.1016/j.ijrobp.2004.12.080; Cattaneo GM, 2005, RADIOTHER ONCOL, V75, P217, DOI 10.1016/j.radonc.2005.03.012; Farace P, 2011, BRIT J RADIOL, V84, P271, DOI 10.1259/bjr/10315979; Giraud P, 2002, RADIOTHER ONCOL, V62, P27, DOI 10.1016/S0167-8140(01)00444-3; Lindquist C, 2008, NEUROSURGERY, V62, P721, DOI [10.1227/01.neu.0000316276.20586.dd, 10.1227/01.NEU.0000279989.86544.B6]; Linskey ME, 2005, J NEUROSURG, V102, P59; Ma LJ, 2008, MED PHYS, V35, P5110, DOI 10.1118/1.2987669; Monaco EA, 2012, EXPERT REV NEUROTHER, V12, P437, DOI [10.1586/ern.12.16, 10.1586/ERN.12.16]; Paddick I, 2006, J NEUROSURG, V105, P194; Perks JR, 2005, STEREOT FUNCT NEUROS, V83, P165, DOI 10.1159/000089987; Stanley J, 2013, INT J RADIAT ONCOL, V87, P924, DOI 10.1016/j.ijrobp.2013.09.013; Weltens C, 2001, RADIOTHER ONCOL, V60, P49, DOI 10.1016/S0167-8140(01)00371-1; Yamamoto M, 1999, RADIOTHER ONCOL, V50, P151, DOI 10.1016/S0167-8140(99)00015-8; Yamazaki H, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-10	24	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	DEC	2014	156	12					2303	2313		10.1007/s00701-014-2235-1		11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AT7DS	WOS:000345097700012		
J	Crary, JF; Trojanowski, JQ; Schneider, JA; Abisambra, JF; Abner, EL; Alafuzoff, I; Arnold, SE; Attems, J; Beach, TG; Bigio, EH; Cairns, NJ; Dickson, DW; Gearing, M; Grinberg, LT; Hof, PR; Hyman, BT; Jellinger, K; Jicha, GA; Kovacs, GG; Knopman, DS; Kofler, J; Kukull, WA; Mackenzie, IR; Masliah, E; McKee, A; Montine, TJ; Murray, ME; Neltner, JH; Santa-Maria, I; Seeley, WW; Serrano-Pozo, A; Shelanski, ML; Stein, T; Takao, M; Thal, DR; Toledo, JB; Troncoso, JC; Vonsattel, JP; White, CL; Wisniewski, T; Woltjer, RL; Yamada, M; Nelson, PT				Crary, John F.; Trojanowski, John Q.; Schneider, Julie A.; Abisambra, Jose F.; Abner, Erin L.; Alafuzoff, Irina; Arnold, Steven E.; Attems, Johannes; Beach, Thomas G.; Bigio, Eileen H.; Cairns, Nigel J.; Dickson, Dennis W.; Gearing, Marla; Grinberg, Lea T.; Hof, Patrick R.; Hyman, Bradley T.; Jellinger, Kurt; Jicha, Gregory A.; Kovacs, Gabor G.; Knopman, David S.; Kofler, Julia; Kukull, Walter A.; Mackenzie, Ian R.; Masliah, Eliezer; McKee, Ann; Montine, Thomas J.; Murray, Melissa E.; Neltner, Janna H.; Santa-Maria, Ismael; Seeley, William W.; Serrano-Pozo, Alberto; Shelanski, Michael L.; Stein, Thor; Takao, Masaki; Thal, Dietmar R.; Toledo, Jonathan B.; Troncoso, Juan C.; Vonsattel, Jean Paul; White, Charles L., III; Wisniewski, Thomas; Woltjer, Randall L.; Yamada, Masahito; Nelson, Peter T.			Primary age-related tauopathy (PART): a common pathology associated with human aging	ACTA NEUROPATHOLOGICA			English	Article						TPSD; TOD; Braak; Neuropathology; Consensus	MILD COGNITIVE IMPAIRMENT; NEUROFIBRILLARY TANGLE TYPE; ARGYROPHILIC GRAIN DISEASE; FRONTOTEMPORAL LOBAR DEGENERATION; PAIRED HELICAL FILAMENTS; ONSET ALZHEIMERS-DISEASE; NEUROPATHOLOGICALLY DEFINED SUBTYPES; PARKINSONISM-DEMENTIA COMPLEX; POSTERIOR CORTICAL ATROPHY; APOLIPOPROTEIN-E GENOTYPE	We recommend a new term, "primary age-related tauopathy" (PART), to describe a pathology that is commonly observed in the brains of aged individuals. Many autopsy studies have reported brains with neurofibrillary tangles (NFTs) that are indistinguishable from those of Alzheimer's disease (AD), in the absence of amyloid (A beta) plaques. For these "NFT+/A beta-aEuroe brains, for which formal criteria for AD neuropathologic changes are not met, the NFTs are mostly restricted to structures in the medial temporal lobe, basal forebrain, brainstem, and olfactory areas (bulb and cortex). Symptoms in persons with PART usually range from normal to amnestic cognitive changes, with only a minority exhibiting profound impairment. Because cognitive impairment is often mild, existing clinicopathologic designations, such as "tangle-only dementia" and "tangle-predominant senile dementia", are imprecise and not appropriate for most subjects. PART is almost universally detectable at autopsy among elderly individuals, yet this pathological process cannot be specifically identified pre-mortem at the present time. Improved biomarkers and tau imaging may enable diagnosis of PART in clinical settings in the future. Indeed, recent studies have identified a common biomarker profile consisting of temporal lobe atrophy and tauopathy without evidence of A beta accumulation. For both researchers and clinicians, a revised nomenclature will raise awareness of this extremely common pathologic change while providing a conceptual foundation for future studies. Prior reports that have elucidated features of the pathologic entity we refer to as PART are discussed, and working neuropathological diagnostic criteria are proposed.	[Crary, John F.; Santa-Maria, Ismael; Shelanski, Michael L.; Vonsattel, Jean Paul] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Crary, John F.; Santa-Maria, Ismael; Shelanski, Michael L.; Vonsattel, Jean Paul] Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Trojanowski, John Q.; Toledo, Jonathan B.] Univ Penn, Dept Pathol, Div Neuropathol, Philadelphia, PA 19104 USA; [Schneider, Julie A.] Rush Univ, Med Ctr, Dept Pathol Neuropathol, Chicago, IL 60612 USA; [Schneider, Julie A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Abisambra, Jose F.] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Abisambra, Jose F.; Abner, Erin L.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Abner, Erin L.] Univ Kentucky, Dept Publ Hlth, Lexington, KY 40536 USA; [Alafuzoff, Irina] Uppsala Univ, Dept Immunol Genet & Pathol, SE-75185 Uppsala, Sweden; [Arnold, Steven E.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Arnold, Steven E.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Attems, Johannes] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England; [Beach, Thomas G.] Banner Sun Hlth Res Inst, Civin Lab Neuropathol, Sun City, AZ 85351 USA; [Bigio, Eileen H.] Northwestern Univ, Feinberg Sch Med, Northwestern Cognit Neurol & Alzheimer Dis Ctr, Dept Pathol Neuropathol, Chicago, IL 60611 USA; [Cairns, Nigel J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Dickson, Dennis W.; Murray, Melissa E.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Gearing, Marla] Emory Univ, Sch Med, Dept Pathol & Lab Med Neuropathol, Atlanta, GA 30322 USA; [Grinberg, Lea T.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94110 USA; [Grinberg, Lea T.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94110 USA; [Grinberg, Lea T.] Univ Sao Paulo, Dept Pathol, Sao Paulo, Brazil; [Hof, Patrick R.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Hof, Patrick R.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Hyman, Bradley T.] Harvard Univ, Sch Med, Dept Neurol, Charlestown, MA 02129 USA; [Hyman, Bradley T.] Massachusetts Gen Hosp, Charlestown, MA 02129 USA; [Jellinger, Kurt] Inst Clin Neurobiol, A-1070 Vienna, Austria; [Jicha, Gregory A.] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA; [Jicha, Gregory A.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Kovacs, Gabor G.] Med Univ Vienna, Inst Neurol, A-1090 Vienna, Austria; [Knopman, David S.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Kofler, Julia] Univ Pittsburgh, Med Ctr, Dept Pathol Neuropathol, Pittsburgh, PA 15213 USA; [Kukull, Walter A.] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA; [Mackenzie, Ian R.] Univ British Columbia, Dept Pathol, Vancouver, BC V5Z 1M9, Canada; [Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [McKee, Ann] Boston Univ, Dept Pathol Neuropathol, Boston, MA 02118 USA; [Montine, Thomas J.] Univ Washington, Dept Pathol, Seattle, WA 98104 USA; [Neltner, Janna H.] Univ Kentucky, Dept Pathol, Lexington, KY 40536 USA; [Seeley, William W.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Seeley, William W.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Serrano-Pozo, Alberto] Univ Iowa Hosp & Clin, Dept Neurol, Iowa City, IA 52242 USA; [Stein, Thor] VA Med Ctr, Dept Pathol Neuropathol, Boston, MA 02118 USA; [Stein, Thor] Boston Univ, Sch Med, Boston, MA 02118 USA; [Takao, Masaki] Tokyo Metropolitan Geriatr Hosp, Dept Neuropathol, Tokyo 1730015, Japan; [Thal, Dietmar R.] Univ Ulm, Neuropathol Lab, D-89081 Ulm, Germany; [Troncoso, Juan C.] Univ Penn, Perelman Sch Med, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med,Inst Aging, Philadelphia, PA 19104 USA; [White, Charles L., III] Univ Texas Southwestern Med Sch, Dept Pathol Neuropathol, Dallas, TX 75390 USA; [Wisniewski, Thomas] NYU, Sch Med, Dept Neurol, New York, NY 10016 USA; [Wisniewski, Thomas] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Wisniewski, Thomas] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA; [Woltjer, Randall L.] Oregon Hlth & Sci Univ, Dept Pathol L113, Portland, OR 97239 USA; [Yamada, Masahito] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol, Kanazawa, Ishikawa 9208640, Japan; [Yamada, Masahito] Kanazawa Univ, Grad Sch Med Sci, Dept Neurobiol Aging, Kanazawa, Ishikawa 9208640, Japan; [Nelson, Peter T.] Univ Kentucky, Dept Pathol Neuropathol, Lexington, KY 40536 USA; [Nelson, Peter T.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA	Crary, JF (reprint author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA.	john.crary@mountsinai.org; pnels2@email.uky.edu	Attems, Johannes/B-8368-2015; Murray, Melissa/C-2763-2015; Kovacs, Gabor/A-7468-2013; 	Kukull, Walter/0000-0001-8761-9014; Kovacs, Gabor G./0000-0003-3841-5511; grinberg, lea/0000-0002-6809-0618; Murray, Melissa/0000-0001-7379-2545	Society for Supporting Research in Experimental Neurology, Vienna, Austria, National Institutes of Health [P50AG08702, R01 AG037212, P01AG07232, P30 AG028383, P50 AG005138, P50 AG016574, U01 AG006786, R01 AG041851, R01 AG011378]; Medical Research Council (MRC) [G0400074]; National Institute for Health Research (NIHR) [R:CH/ML/0712]; Dunhill Medical Trust [R173/1110]; Alzheimer's Research UK (ARUK); Alzheimer's Society [AS-PG-2013-011]; Louis V. Gerstner, Jr., Foundation; Alzheimer's Association [NIRG-11-204450, NIRGD-12-242642]; FP7 EU Project Develage [278486]; Comprehensive brain research network [26430060]; Daiwa Health Science Foundation; BrightFocus Foundation; Alzheimer Forschung Initiative (AFI) [13803]; German Ministry for Research and Education (BMBF) FTLD-Net; Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program of the Mayo Foundation; Society for Supporting Research in Experimental Neurology, Vienna, Austria, National Institutes of Health. [P01 AG003949, P30 AG012300, P50 AG005146, P50 AG005136, P50 AG025688, P01 AG002219, P50 AG005133, P50 AG005681, P01 AG003991, R01 AG038651, P30 AG019610, P30 AG013854, P30 AG036453, P30 AG010124, AG005131, AG184440, AG008051]	We are extremely grateful to the patients, clinicians, and fellow researchers that made this effort possible. We also acknowledge the following funding sources: the Society for Supporting Research in Experimental Neurology, Vienna, Austria, National Institutes of Health Grants P50AG08702, R01 AG037212, P01AG07232, P30 AG028383, P50 AG005138, P50 AG016574, U01 AG006786, R01 AG041851, R01 AG011378, P30 AG028383, P50 AG016574, P01 AG003949, P30 AG012300, P50 AG005146, P50 AG005136, P50 AG025688, P50 AG005138, P01 AG002219, P50 AG005133, P50 AG005681, P01 AG003991, R01 AG038651, P30 AG019610, P30 AG013854, P30 AG036453, P30 AG010124, AG005131, AG184440, AG008051, Medical Research Council (MRC, G0400074), National Institute for Health Research (NIHR, R:CH/ML/0712), the Dunhill Medical Trust (R173/1110), Alzheimer's Research UK (ARUK), and the Alzheimer's Society (AS-PG-2013-011), Louis V. Gerstner, Jr., Foundation, Alzheimer's Association (NIRG-11-204450), FP7 EU Project Develage (No. 278486), Comprehensive brain research network, Grant-in-Aid for Scientific Research (C; 26430060), and Daiwa Health Science Foundation, BrightFocus Foundation, Alzheimer's Association NIRGD-12-242642, Alzheimer Forschung Initiative (AFI # 13803) (DRT); German Ministry for Research and Education (BMBF) FTLD-Net, Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program of the Mayo Foundation.	Alafuzoff I, 2013, J ALZHEIMERS DIS, V33, pS173, DOI 10.3233/JAD-2012-129024; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Braak H, 2004, NEUROBIOL AGING, V25, P713, DOI 10.1016/j.neurobiolaging.2003.12.015; Thal DR, 2005, NEUROPATH APPL NEURO, V31, P270, DOI 10.1111/j.1365-2990.2004.00635.x; Davis DG, 1999, J NEUROPATH EXP NEUR, V58, P376, DOI 10.1097/00005072-199904000-00008; Ferrer I, 2008, BRAIN, V131, P1416, DOI 10.1093/brain/awm305; Petersen RC, 2006, ARCH NEUROL-CHICAGO, V63, P665, DOI 10.1001/archneur.63.5.665; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Attems J, 2006, CLIN NEUROPATHOL, V25, P265; Upadhaya AR, 2014, BRAIN, V137, P887, DOI 10.1093/brain/awt362; Dickson D, 2011, J MOL NEUROSCI, V45, P384, DOI 10.1007/s12031-011-9589-0; Jellinger KA, 2007, ACTA NEUROPATHOL, V113, P107, DOI 10.1007/s00401-006-0156-7; Geser F, 2008, ACTA NEUROPATHOL, V115, P133, DOI 10.1007/s00401-007-0257-y; Noda K, 2006, NEUROPATHOLOGY, V26, P508, DOI 10.1111/j.1440-1789.2006.00722.x; ARRIAGADA PV, 1992, NEUROLOGY, V42, P1681; Andrade-Moraes CH, 2013, BRAIN, V136, P3738, DOI 10.1093/brain/awt273; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; Murray ME, 2011, LANCET NEUROL, V10, P785, DOI 10.1016/S1474-4422(11)70156-9; BOURAS C, 1994, CEREB CORTEX, V4, P138, DOI 10.1093/cercor/4.2.138; Jicha GA, 2006, ARCH NEUROL-CHICAGO, V63, P674, DOI 10.1001/archneur.63.5.674; Prestia A, 2013, NEUROLOGY, V80, P1048, DOI 10.1212/WNL.0b013e3182872830; MIRRA SS, 1991, NEUROLOGY, V41, P479; GIANNAKOPOULOS P, 1994, ACTA NEUROPATHOL, V87, P456; Boutajangout A, 2014, GERONTOLOGY, V60, P381, DOI 10.1159/000358875; Kovacs GG, 2013, ACTA NEUROPATHOL, V126, P365, DOI 10.1007/s00401-013-1157-y; GOODMAN L, 1953, J NERV MENT DIS, V118, P97, DOI 10.1097/00005053-195308000-00001; Matsui Y, 2009, J NEUROL NEUROSUR PS, V80, P366, DOI 10.1136/jnnp.2008.155481; Yu L, 2014, NEUROBIOL AGING, V35, P819, DOI 10.1016/j.neurobiolaging.2013.10.074; BRAAK H, 1993, EUR NEUROL, V33, P403, DOI 10.1159/000116984; Petersen RC, 2013, ANN NEUROL, V74, P199, DOI 10.1002/ana.23931; Togo T, 2002, J NEUROPATH EXP NEUR, V61, P547; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Hof PR, 1997, VISION RES, V37, P3609, DOI 10.1016/S0042-6989(96)00240-4; Serrano-Pozo A, 2014, ANN NEUROL, V75, P597, DOI 10.1002/ana.24125; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Grinberg LT, 2013, ACTA NEUROPATHOL, V125, P581, DOI 10.1007/s00401-013-1080-2; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P774, DOI 10.1097/NEN.0b013e3181aacbe9; BANCHER C, 1994, ACTA NEUROPATHOL, V88, P565; Dugger BN, 2011, NEUROSCI LETT, V491, P122, DOI 10.1016/j.neulet.2011.01.020; Garcia-Sierra F, 2000, ACTA NEUROPATHOL, V100, P29; Ahmed Z, 2013, ACTA NEUROPATHOL, V126, P537, DOI 10.1007/s00401-013-1171-0; Grudzien A, 2007, NEUROBIOL AGING, V28, P327, DOI 10.1016/j.neurobiolaging.2006.02.007; Grinberg LT, 2009, NEUROPATH APPL NEURO, V35, P406, DOI [10.1111/j.1365-2990.2009.00997.x, 10.1111/j.1365-2990.2008.00997.x]; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; Dugger BN, 2013, J ALZHEIMERS DIS, V34, P529, DOI 10.3233/JAD-121864; Schneider JA, 2009, J ALZHEIMERS DIS, V18, P691, DOI 10.3233/JAD-2009-1227; Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P911; Guillozet AL, 2003, ARCH NEUROL-CHICAGO, V60, P729, DOI 10.1001/archneur.60.5.729; Knopman DS, 2003, J NEUROPATH EXP NEUR, V62, P1087; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Feany MB, 1996, ANN NEUROL, V40, P139, DOI 10.1002/ana.410400204; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23; IKEDA K, 1995, ACTA NEUROPATHOL, V90, P620; Mitchell TW, 2002, ANN NEUROL, V51, P182, DOI 10.1002/ana.10086; Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; Markesbery WR, 2006, ARCH NEUROL-CHICAGO, V63, P38, DOI 10.1001/archneur.63.1.38; Yoshida M, 2006, NEUROPATHOLOGY, V26, P457, DOI 10.1111/j.1440-1789.2006.00743.x; Dugger BN, 2014, J NEUROPATH EXP NEUR, V73, P72, DOI [10.1097/NEN.0000000000000030, 10.1097/NEN.0000000000000028]; Ikeda K, 1998, NEUROBIOL AGING, V19, pS85, DOI 10.1016/S0197-4580(98)00034-7; Braak H, 2012, CURR OPIN NEUROL, V25, P708, DOI 10.1097/WCO.0b013e32835a3432; Tsuboi Y, 2003, NEUROPATH APPL NEURO, V29, P503, DOI 10.1046/j.1365-2990.2003.00453.x; Iseki E, 2002, NEUROPATHOLOGY, V22, P34, DOI 10.1046/j.0919-6544.2001.00425.x; Sabbagh MN, 2009, ALZ DIS ASSOC DIS, V23, P229, DOI 10.1097/WAD.0b013e318199d833; Nelson PT, 2007, J NEUROPATH EXP NEUR, V66, P1136, DOI 10.1097/nen.0b013e31815c5efb; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Josephs KA, 2008, NEUROBIOL AGING, V29, P566, DOI 10.1016/j.neurobiolaging.2006.10.032; Beekly DL, 2007, ALZ DIS ASSOC DIS, V21, P249, DOI 10.1097/WAD.0b013e318142774e; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Mungas D, 2014, NEUROBIOL AGING, V35, P301, DOI 10.1016/j.neurobiolaging.2013.08.007; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Murray ME, 2014, ACTA NEUROPATHOL, V128, P411, DOI 10.1007/s00401-014-1302-2; Jack CR, 2012, ANN NEUROL, V71, P765, DOI 10.1002/ana.22628; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Vos SJB, 2013, LANCET NEUROL, V12, P957, DOI 10.1016/S1474-4422(13)70194-7; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Syed A, 2005, NEUROPATH APPL NEURO, V31, P405, DOI 10.1111/j.1365-2990.2005.00662.x; Berg L, 1998, ARCH NEUROL-CHICAGO, V55, P326, DOI 10.1001/archneur.55.3.326; Thal DR, 2013, EUR ARCH PSY CLIN N, V263, pS137, DOI 10.1007/s00406-013-0449-5; Santa-Maria I, 2012, ACTA NEUROPATHOL, V124, P693, DOI 10.1007/s00401-012-1017-1; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Mirra SS, 1997, NEUROBIOL AGING, V18, pS91, DOI 10.1016/S0197-4580(97)00058-4; Sonnen JA, 2011, ARCH NEUROL-CHICAGO, V68, P1049, DOI 10.1001/archneurol.2011.157; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Knopman DS, 2013, ANN NEUROL, V73, P472, DOI 10.1002/ana.23816; Simic G, 2009, NEUROPATH APPL NEURO, V35, P532, DOI 10.1111/j.1365-2990.2009.01038.x; Jellinger KA, 2010, J ALZHEIMERS DIS, V21, P1283, DOI 10.3233/JAD-2010-100603; Baborie A, 2012, ARCH NEUROL-CHICAGO, V69, P1052, DOI 10.1001/archneurol.2011.3323; Schultz C, 2004, NEUROBIOL AGING, V25, P397, DOI 10.1016/S0197-4580(03)00113-1; Attems J, 2012, BIOCHEM SOC T, V40, P711, DOI 10.1042/BST20120034; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; FUKUTANI Y, 1995, NEUROSCI LETT, V200, P57, DOI 10.1016/0304-3940(95)12083-G; Rohrer JD, 2011, CURR ALZHEIMER RES, V8, P266; Janocko NJ, 2012, ACTA NEUROPATHOL, V124, P681, DOI 10.1007/s00401-012-1044-y; Arai T, 2001, ACTA NEUROPATHOL, V101, P167; Attems J, 2005, J ALZHEIMERS DIS, V7, P149; BALL MJ, 1978, ACTA NEUROPATHOL, V42, P73; BALL MJ, 1981, NEUROPATH APPL NEURO, V7, P13, DOI 10.1111/j.1365-2990.1981.tb00228.x; Bancher C, 1997, ACTA NEUROPATHOL, V94, P403; Bancher C, 1997, ALZ DIS ASSOC DIS, V11, P207; BONDAREFF W, 1993, ARCH GEN PSYCHIAT, V50, P350; BONDAREFF W, 1987, ARCH GEN PSYCHIAT, V44, P412; Bondareff W, 1987, Alzheimer Dis Assoc Disord, V1, P256, DOI 10.1097/00002093-198701040-00005; BOURAS C, 1993, NEUROSCI LETT, V153, P131, DOI 10.1016/0304-3940(93)90305-5; BOWLER JV, 1995, BAILLIERE CLIN NEUR, V4, P357; Dawe RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026286; Elobeid A, 2012, ACTA NEUROPATHOL, V123, P97, DOI 10.1007/s00401-011-0906-z; HAUW JJ, 1986, REV NEUROL, V142, P107; HOF PR, 1993, ACTA NEUROPATHOL, V86, P215; HOF PR, 1991, BRAIN RES, V564, P306, DOI 10.1016/0006-8993(91)91467-F; Ikeda K, 1997, ANN NEUROL, V41, P693, DOI 10.1002/ana.410410522; Ikeda K, 1993, No To Shinkei, V45, P455; Ikeda K, 1999, DEMENT GERIATR COGN, V10, P6, DOI 10.1159/000017091; Ishizawa T, 2002, J NEUROPATH EXP NEUR, V61, P1040; Itoh Y, 1998, J NEUROL SCI, V157, P73, DOI 10.1016/S0022-510X(98)00050-1; Itoh Y, 1996, EUR NEUROL, V36, P94, DOI 10.1159/000117216; Jellinger KA, 2013, INT J NEUROPATHOL, V1; Jellinger KA, 2012, ACTA NEUROPATHOL, V123, P153, DOI 10.1007/s00401-011-0889-9; Jellinger KA, 1998, BRAIN PATHOL, V8, P367; Jicha GA, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.02.018; Knopman DS, 2012, NEURODEGENER DIS MAN, V2, P183, DOI DOI 10.2217/NMT.12.5; Kovacs GG, 2011, ACTA NEUROPATHOL, V122, P205, DOI 10.1007/s00401-011-0819-x; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Malkani RG, 2012, PARKINSONISM RELAT D, V18, P683, DOI 10.1016/j.parkreldis.2011.11.022; MIZUTANI T, 1991, ACTA PATHOL JAPON, V41, P597; MIZUTANI T, 1992, J NEUROL SCI, V108, P168, DOI 10.1016/0022-510X(92)90047-O; Mizutani T, 1993, No To Shinkei, V45, P333; Nakaya Haruaki, 2003, Nihon Yakurigaku Zasshi, V122, P243; Perl DP, 2003, J NEUROPATH EXP NEUR, V62, P381; Ranginwala NA, 2008, AM J GERIAT PSYCHIAT, V16, P384, DOI 10.1097/JGP.0b013e3181629971; Robinson JL, 2011, BRAIN, V134, P3705, DOI 10.1093/brain/awr308; Ruben GC, 2005, MICROSC RES TECHNIQ, V67, P175, DOI 10.1002/jemt.20197; Schmidt ML, 2000, NEUROREPORT, V11, P3427, DOI 10.1097/00001756-200011090-00005; Schmidt ML, 2001, J NEUROPATH EXP NEUR, V60, P1075; Schnitzler JG, 1911, Z GESAMTE NEUROL PSY, V7, P34, DOI 10.1007/BF02865132; Serrano-Pozo A, 2013, J NEUROPATH EXP NEUR, V72, P1182, DOI 10.1097/NEN.0000000000000016; Shiarli AM, 2006, NEUROPATH APPL NEURO, V32, P374, DOI 10.1111/j.1365-2990.2006.00736.x; Takahashi J, 2014, GERIATR GERONTOL INT, DOI [10.1111/ggi.12280, DOI 10.1111/GGI.12280]; Thal Dietmar R, 2006, Sci Aging Knowledge Environ, V2006, pre1, DOI 10.1126/sageke.2006.6.re1; Trachtenberg DI, 2008, ARCH NEUROL-CHICAGO, V65, P593, DOI 10.1001/archneur.65.5.593; Trojanowski JQ, 2002, EXP NEUROL, V176, P1, DOI 10.1006/exnr.2002.7940; ULRICH J, 1992, NEURODEGENERATION, V1, P257; Wirth M, 2013, JAMA NEUROL, V70, P1512, DOI 10.1001/jamaneurol.2013.4013; WISNIEWSKI HM, 1976, J NEUROL SCI, V27, P173, DOI 10.1016/0022-510X(76)90059-9; Yamada M, 1996, ANN NEUROL, V40, P243, DOI 10.1002/ana.410400217; Yamada M, 1996, NEUROPATHOLOGY, V16, P89, DOI 10.1111/j.1440-1789.1996.tb00162.x; Yamada M, 2003, NEUROPATHOLOGY, V23, P311, DOI 10.1046/j.1440-1789.2003.00522.x; Yamada M, 2001, DEMENT GERIATR COGN, V12, P117, DOI 10.1159/000051245; Yamada M, 1998, NEUROPATHOLOGY, V18, P228, DOI 10.1111/j.1440-1789.1998.tb00105.x	153	56	57	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	DEC	2014	128	6					755	766		10.1007/s00401-014-1349-0		12	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AT7TC	WOS:000345139100001		
J	Sakai, K; Boche, D; Carare, R; Johnston, D; Holmes, C; Love, S; Nicoll, JAR				Sakai, Kenji; Boche, Delphine; Carare, Roxana; Johnston, David; Holmes, Clive; Love, Seth; Nicoll, James A. R.			A beta immunotherapy for Alzheimer's disease: effects on apoE and cerebral vasculopathy	ACTA NEUROPATHOLOGICA			English	Article						Alzheimer's disease; Abeta; Immunotherapy; Apolipoprotein E; Cerebral amyloid angiopathy	APOLIPOPROTEIN-E GENOTYPE; APP-TRANSGENIC MICE; AMYLOID ANGIOPATHY; A-BETA(42) IMMUNIZATION; IMAGING ABNORMALITIES; PERIVASCULAR DRAINAGE; FOLLOW-UP; PEPTIDE; PROTEIN; BRAIN	A beta immunotherapy for Alzheimer's disease (AD) results in the removal of A beta plaques and increased cerebral amyloid angiopathy (CAA). In current clinical trials, amyloid-related imaging abnormalities (ARIAs), putatively due to exacerbation of CAA, are concerning side effects. We aimed to assess the role of the A beta transporter apolipoprotein E (apoE) in the exacerbation of CAA and development of CAA-associated vasculopathy after A beta immunotherapy. 12 A beta 42-immunized AD (iAD; AN1792, Elan Pharmaceuticals) cases were compared with 28 unimmunized AD (cAD) cases. Immunohistochemistry was quantified for A beta 42, apoE, apoE E4 and smooth muscle actin, and CAA-associated vasculopathy was analyzed. A beta immunotherapy was associated with redistribution of apoE from cortical plaques to cerebral vessel walls, mirroring the altered distribution of A beta 42. Concentric vessel wall splitting was increased threefold in leptomeningeal vessels after immunotherapy (cAD 6.3 vs iAD 20.6 %, P < 0.001), but smooth muscle cell abnormalities did not differ. The findings suggest that apoE is involved in the removal of plaques and transport of A beta to the cerebral vasculature induced by A beta immunotherapy. Immunotherapy was not associated with CAA-related vascular smooth muscle damage, but was accompanied by increased splitting of the vessel wall, perhaps reflecting enhanced deposition and subsequent removal of A beta. ARIA occurring in some current trials of A beta immunotherapy may reflect an extreme form of these vascular changes.	[Sakai, Kenji; Boche, Delphine; Carare, Roxana; Holmes, Clive; Nicoll, James A. R.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Sakai, Kenji] Kanazawa Univ Hosp, Dept Neurol, Kanazawa, Ishikawa, Japan; [Johnston, David] Univ Southampton, Fac Med, Biomed Imaging Unit, Southampton SO9 5NH, Hants, England; [Love, Seth] Univ Bristol, Dept Neuropathol, Bristol, Avon, England; [Nicoll, James A. R.] Southampton Gen Hosp, Dept Cellular Pathol, Southampton SO16 6YD, Hants, England	Nicoll, JAR (reprint author), Southampton Gen Hosp, Dept Cellular Pathol, Mailpoint 813,Level E,South Lab & Path Block, Southampton SO16 6YD, Hants, England.	J.Nicoll@soton.ac.uk	Carare, Roxana/G-9726-2011; 	Boche, Delphine/0000-0002-5884-130X	British Council Japan Association Scholarship; Alzheimer's Research UK	We thank the patients who were involved in this study and their carers. Vivienne Hopkins, David Wilkinson, Anthony Bayer, Roy Jones and Roger Bullock enrolled patients in the original trial and facilitated subsequent follow-up of the patients. Jim Neal provided 2 immunized AD cases from Cardiff and Laura Palmer at the South West Dementia Brain Bank provided the 28 non-immunized AD cases. The Department of Cellular Pathology, University Hospital Southampton NHS Foundation Trust, the Histochemistry Research Unit, and the Biomedical Imaging Unit of the Faculty of Medicine, University of Southampton facilitated tissue processing, staining and analysis. Staff at Elan Pharmaceuticals made available original clinical trial data. We are grateful to Prothena Biosciences 650 Gateway Blvd, South San Francisco, CA 94080, USA, for provision of the apoE antibodies. This study was supported partially by a British Council Japan Association Scholarship to Dr. Sakai and partly by Alzheimer's Research UK. The collection and characterization of brains in the South West Dementia Brain Bank were supported by BRACE (Bristol Research into Alzheimer's and Care of the Elderly).	Nicoll JAR, 2006, J NEUROPATH EXP NEUR, V65, P1040, DOI 10.1097/01.jnen.0000240466.10758.ce; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; WISNIEWSKI HM, 1994, ACTA NEUROPATHOL, V87, P233; Thal DR, 2007, NEUROBIOL AGING, V28, P1221, DOI 10.1016/j.neurobiolaging.2006.05.029; Eng JA, 2004, ANN NEUROL, V55, P250, DOI 10.1002/ana.10810; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Boche D, 2008, BRAIN, V131, P3299, DOI 10.1093/brain/awn261; Zlokovic BV, 2013, JAMA NEUROL, V70, P440, DOI 10.1001/jamaneurol.2013.2152; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; REBECK GW, 1993, NEURON, V11, P575; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Boche D, 2010, ACTA NEUROPATHOL, V120, P13, DOI 10.1007/s00401-010-0705-y; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P367, DOI 10.1016/j.jalz.2011.05.2351; Sperling R, 2012, LANCET NEUROL, V11, P241, DOI 10.1016/S1474-4422(12)70015-7; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Hawkes CA, 2011, ACTA NEUROPATHOL, V121, P431, DOI 10.1007/s00401-011-0801-7; Yamada M, 2012, PROG MOL BIOL TRANSL, V107, P41, DOI 10.1016/B978-0-12-385883-2.00006-0; Hawkes CA, 2013, AGING CELL, V12, P224, DOI 10.1111/acel.12045; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Orgogozo JM, 2003, NEUROLOGY, V61, P46; Yamada M, 1996, STROKE, V27, P1155; Samadi H, 2011, EXPERT OPIN BIOL TH, V11, P787, DOI 10.1517/14712598.2011.578573; Chalmers K, 2003, NEUROPATH APPL NEURO, V29, P231, DOI 10.1046/j.1365-2990.2003.00457.x; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Serrano-Pozo A, 2010, BRAIN, V133, P1312, DOI 10.1093/brain/awq056; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Pfeifer M, 2002, SCIENCE, V298, P1379, DOI 10.1126/science.1078259; Calhoun ME, 1999, P NATL ACAD SCI USA, V96, P14088, DOI 10.1073/pnas.96.24.14088; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Prada CM, 2007, J NEUROSCI, V27, P1973, DOI 10.1523/JNEUROSCI.5426-06.2007; Bayer AJ, 2005, NEUROLOGY, V64, P94; Rolyan H, 2011, J NEURAL TRANSM, V118, P699, DOI 10.1007/s00702-010-0572-7; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Vellas B, 2009, CURR ALZHEIMER RES, V6, P144; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; McCarron MO, 1999, J NEUROPATH EXP NEUR, V58, P711, DOI 10.1097/00005072-199907000-00005; Scolding NJ, 2005, BRAIN, V128, P500, DOI 10.1093/brain/awh379; Arbel-Ornath M, 2013, ACTA NEUROPATHOL, V126, P353, DOI 10.1007/s00401-013-1145-2; Weller RO, 2009, ACTA NEUROPATHOL, V117, P1, DOI 10.1007/s00401-008-0457-0; Attems J, 2011, NEUROPATH APPL NEURO, V37, P75, DOI 10.1111/j.1365-2990.2010.01137.x; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Boche D, 2010, ACTA NEUROPATHOL, V120, P369, DOI 10.1007/s00401-010-0719-5; Carare Roxana Octavia, 2013, Acta Neuropathol Commun, V1, P48, DOI 10.1186/2051-5960-1-48; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Hawkes CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041636; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Maarouf CL, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-39; Utter S, 2008, J NEUROPATH EXP NEUR, V67, P842, DOI 10.1097/NEN.0b013e3181836a71; Wilcock DM, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-24; Zago Wagner, 2013, Alzheimers Dement, V9, pS105, DOI 10.1016/j.jalz.2012.11.010; Zotova E, 2013, BRAIN, V136, P2677, DOI 10.1093/brain/awt210	55	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	DEC	2014	128	6					777	789		10.1007/s00401-014-1340-9		13	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AT7TC	WOS:000345139100004		
J	Takahashi, H; Baba, Y; Matsubara, S				Takahashi, Hironori; Baba, Yosuke; Matsubara, Shigeki			Brain damage of surviving co-twin following single fetal death in monochorionic diamniotic twin pregnancy at 8-9 weeks' gestation	ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA			English	Letter							PREDICTION; FETUS		[Takahashi, Hironori; Baba, Yosuke; Matsubara, Shigeki] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan	Matsubara, S (reprint author), Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan.	matsushi@jichi.ac.jp					Kagan KO, 2007, ULTRASOUND OBST GYN, V29, P527, DOI 10.1002/uog.4006; Simonazzi G, 2006, ULTRASOUND OBST GYN, V27, P517, DOI 10.1002/uog.2701; Jelins AC, 2008, AM J OBSTET GYNECOL, V199; Mahony R, 2011, ACTA OBSTET GYN SCAN, V90, P1274, DOI 10.1111/j.1600-0412.2011.01239.x; Malinowski W, 2005, TWIN RES HUM GENET, V8, P262, DOI 10.1375/1832427054253077; Weiss JL, 2004, AM J OBSTET GYNECOL, V190, P563, DOI 10.1016/S0002-9378(03)00824-X	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6349	1600-0412		ACTA OBSTET GYN SCAN	Acta Obstet. Gynecol. Scand.	DEC	2014	93	12					1336	1336		10.1111/aogs.12484		1	Obstetrics & Gynecology	Obstetrics & Gynecology	AT3ZS	WOS:000344876200023		
J	Koh, S; Maeda, N; Ikeda, C; Oie, Y; Soma, T; Tsujikawa, M; Watanabe, H; Nishida, K				Koh, Shizuka; Maeda, Naoyuki; Ikeda, Chikako; Oie, Yoshinori; Soma, Takeshi; Tsujikawa, Motokazu; Watanabe, Hitoshi; Nishida, Kohji			Effect of diquafosol ophthalmic solution on the optical quality of the eyes in patients with aqueous-deficient dry eye	ACTA OPHTHALMOLOGICA			English	Article						diquafosol ophthalmic solution; dry eye; higher-order aberrations; tear film	HIGHER-ORDER ABERRATIONS; SERIAL MEASUREMENTS; VISUAL FUNCTION; BREAK-UP; TEAR; RABBIT; INSTILLATION; TETRASODIUM; CONJUNCTIVA; SECRETION	PurposeTo investigate the short- and long-term effects of diquafosol ophthalmic solution on the optical quality of the eyes in patients with aqueous-deficient dry eye. MethodsSixteen eyes in 16 patients with mild or moderate aqueous-deficient dry eye were treated with 3% diquafosol ophthalmic solution. Ocular higher-order aberrations (HOAs) were measured with a wavefront sensor before and at 15min after diquafosol instillation at the baseline visit and at 4weeks after treatment initiation. Dry eye symptoms, tear break-up time (BUT), corneal/conjunctival fluorescein staining and Schirmer's test were also evaluated before and after treatment with diquafosol. ResultsTreatment with diquafosol ophthalmic solution significantly improved dry eye symptoms, corneal staining and BUT. Compared with mean total HOAs at baseline (0.1800.06m), those at 4weeks after treatment significantly decreased (0.148 +/- 0.039m; p=0.035), whereas those 15min after diquafosol instillation at the baseline visit did not change significantly (0.170 +/- 0.049m; p=0.279). ConclusionsAlthough no significant change in HOAs was observed as a short-term effect of a single-drop instillation of diquafosol, long-term use of diquafosol to treat aqueous-deficient dry eye reduced HOAs as well as improved corneal epithelial damage and tear film stability.	[Koh, Shizuka; Maeda, Naoyuki; Ikeda, Chikako; Oie, Yoshinori; Soma, Takeshi; Tsujikawa, Motokazu; Watanabe, Hitoshi; Nishida, Kohji] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Suita, Osaka 5650871, Japan; [Ikeda, Chikako] Rohto, Div Res & Dev, Kyoto, Japan	Koh, S (reprint author), Osaka Univ, Grad Sch Med, Dept Ophthalmol, Room E7,2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	skoh@ophthal.med.osaka-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [22791659]	This study was supported, in part, by a Grant-in-Aid No. 22791659 (to Dr. Koh) for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology. Ms. Ikeda is an employee of Rohto. None of the other authors or their family members has a proprietary or financial interest in any of the material or instruments mentioned in this article.	Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615; Koh S, 2013, INVEST OPHTH VIS SCI, V54, P4927, DOI 10.1167/iovs.13-12409; Koh S, 2003, AM J OPHTHALMOL, V136, P513, DOI 10.1016/S0002-9394(03)00317-9; Li YS, 2001, AM J PHYSIOL-CELL PH, V281, pC595; Kaido M, 2013, J OCUL PHARMACOL TH, V29, P595, DOI 10.1089/jop.2012.0246; Kamiya K, 2012, EYE, V26, P1363, DOI 10.1038/eye.2012.166; Jumblatt JE, 1998, EXP EYE RES, V67, P341, DOI 10.1006/exer.1998.0520; Montes-Mico R, 2010, J CATARACT REFR SURG, V36, P935, DOI 10.1016/j.jcrs.2009.12.044; Koh S, 2013, JPN J OPHTHALMOL, V57, P440, DOI 10.1007/s10384-013-0251-y; Shimazaki-Den S, 2013, CORNEA, V32, P1120, DOI 10.1097/ICO.0b013e3182930b1d; Murakami T, 2004, OPHTHAL RES, V36, P89, DOI 10.1159/000076887; Takamura E, 2012, BRIT J OPHTHALMOL, V96, P1310, DOI 10.1136/bjophthalmol-2011-301448; Montes-Mico R, 2004, J CATARACT REFR SURG, V30, P1649, DOI 10.1016/j.jcrs.2004.02.041; Martinez CE, 1998, ARCH OPHTHALMOL-CHIC, V116, P1053; Lemp MA, 2007, OCUL SURF, V5, P75; Matsumoto Y, 2012, OPHTHALMOLOGY, V119, P1954, DOI 10.1016/j.ophtha.2012.04.010; Aragona P, 2013, ACTA OPHTHALMOL, V91, pe437, DOI 10.1111/aos.12134; Kaido M, 2011, INVEST OPHTH VIS SCI, V52, P9516, DOI 10.1167/iovs.11-8412; Koh S, 2008, INVEST OPHTH VIS SCI, V49, P133, DOI 10.1167/iovs.07-0762; Koh S, 2006, INVEST OPHTH VIS SCI, V47, P3318, DOI 10.1167/iovs.06-0018; Le QH, 2014, ACTA OPHTHALMOL, V92, pE124, DOI 10.1111/aos.12204; Lemp MA, 1995, EYE CONTACT LENS, V21, P221, DOI DOI 10.1016/J.SURV0PHTHAL.2007.04.009; Lin YY, 2005, J REFRACT SURG, V21, pS525; Murakami T, 2002, OPHTHALMIC RES, V34, P371, DOI 10.1159/000067042; Ridder WH, 2009, OPTOMETRY VISION SCI, V86, P1059, DOI 10.1097/OPX.0b013e3181b599bf; Shimazaki J., 2007, J EYE, V24, P181; Takaoka-Shichijo Y, 2011, ATARASHII GANKA, V24, P181; Tung CI, 2012, CORNEA, V31, P108, DOI 10.1097/ICO.0b013e31821ea667; vansBijsterveld OP, 1969, ARCH OPHTHALMOL-CHIC, V82, P10	29	7	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-375X	1755-3768		ACTA OPHTHALMOL	Acta Ophthalmol.	DEC	2014	92	8					e671	e675		10.1111/aos.12443		5	Ophthalmology	Ophthalmology	AU0WJ	WOS:000345342600013		
J	Yamaguchi, M; Ohta, K; Shiraishi, A; Sakane, Y; Zheng, X; Kamao, T; Yamamoto, Y; Inoue, Y; Ohashi, Y				Yamaguchi, Masahiko; Ohta, Kiyohiko; Shiraishi, Atsushi; Sakane, Yuri; Zheng, Xiaodong; Kamao, Tomoyuki; Yamamoto, Yasuaki; Inoue, Yasushi; Ohashi, Yuichi			New method for viewing Krehbiel flow by polymethylmethacrylate particles suspended in fluorescein solution	ACTA OPHTHALMOLOGICA			English	Article						fluorescein; Krehbiel flow; lacrimal duct; polymethylmethacrylate; tear clearance; tear meniscus	LACRIMAL DRAINAGE FUNCTION; TEAR TURNOVER RATE; CLEARANCE	PurposeTo investigate the changes in the tear flow velocities caused by ageing. MethodsNinety-nine subjects (41 men, mean age 48.320.7years) were recruited from the Department of Ophthalmology of the Ehime University Hospital. None of the subjects had serious abnormalities of the external surface of the eye. The Krehbiel flow of tears was determined by 40-m polymethylmethacrylate (PMMA) beads suspended in a fluorescein sodium solution (PPF). The movement of the beads was video recorded through a slit-lamp during normal blinking. The flow of the beads was determined with a Motion analyzer((R))software (KEYENCE Co., Osaka, Japan). The velocity of the beads in young age, 20-40years, middle age, 41-60years and old age, 61years, groups was determined. ResultsThe equation describing the velocity (mm/second) of the PMMA particles as a function of age in the lower tear meniscus measured in the direction of the lacrimal punctum was Y=2.49-0.04X, where Y=velocity and X=age (r(2)=0.214; p<0.0001). For the upper meniscus, the equation was Y=4.83-0.05X (r(2)=0.195, p<0.0001). The average velocity was 0.70 +/- 1.66mm/second in the lower and 2.16 +/- 1.93mm/second in the upper tear meniscus (p<0.0001). The particle velocity decreased significantly with increasing age, but no significant difference between the male and female groups except for the lower tear meniscus when all subjects were analysed. ConclusionThe PPF technique is a simple method of examining Krehbiel flow of tears and may be used for evaluating functional nasolacrimal duct obstruction quantitatively.	[Yamaguchi, Masahiko; Ohta, Kiyohiko; Shiraishi, Atsushi; Sakane, Yuri; Zheng, Xiaodong; Kamao, Tomoyuki; Yamamoto, Yasuaki; Ohashi, Yuichi] Ehime Univ, Sch Med, Dept Ophthalmol, Toon, Ehime 7910295, Japan; [Inoue, Yasushi] Inoue Eye Clin, Tamano, Okayama, Japan	Yamaguchi, M (reprint author), Ehime Univ, Sch Med, Dept Ophthalmol, Toon, Ehime 7910295, Japan.	masahiko@m.ehime-u.ac.jp					WEBBER WRS, 1987, EYE, V1, P615; JORDAN A, 1980, OPHTHALMOLOGY, V87, P920; OCCHIPINTI JR, 1988, CURR EYE RES, V7, P995, DOI 10.3109/02713688809015145; XU KP, 1995, BRIT J OPHTHALMOL, V79, P1042, DOI 10.1136/bjo.79.11.1042; HAGELE JE, 1994, OPHTHALMOLOGY, V101, P612; JONES L T, 1962, Trans Am Acad Ophthalmol Otolaryngol, V66, P506; MAURICE D M, 1973, International Ophthalmology Clinics, V13, P103, DOI 10.1097/00004397-197301310-00009; Nagashima K, 1976, RINSHO GANKA, V30, P651; Sahlin S, 1996, AM J OPHTHALMOL, V122, P701; Shimizu Akiyo, 1993, Nippon Ganka Gakkai Zasshi, V97, P1047; ZAPPIA RJ, 1972, AM J OPHTHALMOL, V74, P160; Zheng XD, 2014, ACTA OPHTHALMOL, V92, pE105, DOI 10.1111/aos.12260	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-375X	1755-3768		ACTA OPHTHALMOL	Acta Ophthalmol.	DEC	2014	92	8					e676	e680		10.1111/aos.12444		5	Ophthalmology	Ophthalmology	AU0WJ	WOS:000345342600014		
J	Nomura, F; Sugimoto, T; Kitagaki, K; Ito, T; Kawachi, H; Eishi, Y; Watanabe, K; Igaue, M; Shimizu, N; Tomita, M; Kitamura, K; Kishimoto, S				Nomura, Fuminori; Sugimoto, Taro; Kitagaki, Keisuke; Ito, Takashi; Kawachi, Hiroshi; Eishi, Yoshinobu; Watanabe, Ken; Igaue, Miki; Shimizu, Norio; Tomita, Makoto; Kitamura, Ken; Kishimoto, Seiji			Clinical characteristics of Japanese oropharyngeal squamous cell carcinoma positive for human papillomavirus infection	ACTA OTO-LARYNGOLOGICA			English	Article						p16INK4A; p53; chemoradiotherapy	NECK-CANCER; CONCURRENT CHEMORADIOTHERAPY; INDUCTION CHEMOTHERAPY; HEAD; RADIATION; DOCETAXEL; TPF	Conclusion: Human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC) is considered to be a distinct entity in Japan. The combination of both HPV-DNA sequencing analysis and immunohistochemistry (IHC) for p16(INK4A) is useful to discriminate the OPSCC patients with a better prognosis from other cases, especially in the advanced stage. Surgical treatment is recommended for HPV-negative advanced cancer. Objective: The number of HPV-related OPSCCs has been increasing worldwide. However, the incidence and prognostic significance of this cancer in Japan have not yet been fully elucidated. Methods: Seventy-seven Japanese patients with OPSCC were enrolled in this study. The prevalence of HPV-DNA was assessed by PCR and sequencing. The expression of p16(INK4A) and p53 was examined by IHC. The clinicopathological parameters and disease-specific survival were analyzed for HPV-positive and -negative patients. Results: HPV-DNA was detected in 32 patients. Thirty-four patients were p16(INK4A)-positive by IHC. The patients who were positive for HPV infection were significantly younger. Furthermore, in the stage III or IV cases, the 3-year disease-specific survival of the HPV infection-positive group was significantly better than that of the HPV-negative group. Surgical treatment was demonstrated to lead to a good prognosis for the patients with HPV-negative advanced cancer.	[Nomura, Fuminori; Kishimoto, Seiji] Tokyo Med & Dent Univ, Dept Head & Neck Surg, Tokyo 1138519, Japan; [Sugimoto, Taro; Kitamura, Ken] Tokyo Med & Dent Univ, Dept Otorhinolaryngol, Tokyo 1138519, Japan; [Kitagaki, Keisuke; Ito, Takashi; Kawachi, Hiroshi; Eishi, Yoshinobu] Tokyo Med & Dent Univ, Dept Human Pathol, Tokyo 1138519, Japan; [Kawachi, Hiroshi] Tokyo Med & Dent Univ, Latin Amer Collaborat Res Ctr, Santiago, Chile; [Watanabe, Ken; Igaue, Miki; Shimizu, Norio] Tokyo Med & Dent Univ, Virus Res Unit, Frontier Sci Lab, Tokyo 1138519, Japan; [Tomita, Makoto] Tokyo Med & Dent Univ, Hosp Med, Clin Res Ctr, Tokyo 1138519, Japan	Nomura, F (reprint author), Tokyo Med & Dent Univ, Dept Head & Neck Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	wq93329@tb3.so-net.ne.jp					Reed AL, 1996, CANCER RES, V56, P3630; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Kimple RJ, 2013, CANCER RES, V73, P4791, DOI 10.1158/0008-5472.CAN-13-0587; Klussmann JP, 2003, AM J PATHOL, V162, P747, DOI 10.1016/S0002-9440(10)63871-0; Demokan S, 2012, HEAD NECK-J SCI SPEC, V34, P1470, DOI 10.1002/hed.21949; Klaes R, 2001, INT J CANCER, V92, P276, DOI 10.1002/ijc.1174; Lassen P, 2011, RADIOTHER ONCOL, V100, P49, DOI 10.1016/j.radonc.2011.02.010; Gillison ML, 2000, J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; Singhi AD, 2010, CANCER-AM CANCER SOC, V116, P2166, DOI 10.1002/cncr.25033; Karlsen F, 1996, J CLIN MICROBIOL, V34, P2095; Feller L, 2012, INT J DENT, V2012, P540; FUKUNAGA M, 1994, AM J CLIN PATHOL, V101, P177; Katori H, 2005, CLIN ONCOL-UK, V17, P148, DOI 10.1016/j.clon.2004.09.013; Marklund L, 2012, CANCER MED-US, V1, P82, DOI 10.1002/cam4.2; Matsushita K, 2011, JPN J INFECT DIS, V64, P34; Mori M, 2011, CANCER CHEMOTH PHARM, V68, P855, DOI 10.1007/s00280-010-1551-2; Schultz JD, 2010, ONCOL REP, V24, P1213, DOI 10.3892/or_00000974	18	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	DEC	2014	134	12					1265	1274		10.3109/00016489.2014.944272		10	Otorhinolaryngology	Otorhinolaryngology	AT8YE	WOS:000345214100009		
J	Watanabe, H; Kanematsu, M; Goshima, S; Kajita, K; Kawada, H; Noda, Y; Tatahashi, Y; Kawai, N; Kondo, H; Moriyama, N				Watanabe, Haruo; Kanematsu, Masayuki; Goshima, Satoshi; Kajita, Kimihiro; Kawada, Hiroshi; Noda, Yoshifumi; Tatahashi, Yukichi; Kawai, Nobuyuki; Kondo, Hiroshi; Moriyama, Noriyuki			Characterizing focal hepatic lesions by free-breathing intravoxel incoherent motion MRI at 3.0 T	ACTA RADIOLOGICA			English	Article						Hepatic nodule; Intravoxel incoherent motion; diffusion	DIFFUSION-WEIGHTED IMAGES; GRADIENT SENSITIZATION; LIVER; PERFUSION	Background Diffusion-weighted (DW) imaging is commonly used to distinguish between benign and malignant liver lesions. Purpose To prospectively evaluate the true molecular-diffusion coefficient (D), perfusion-related diffusion coefficient (D*), perfusion fraction (f), and ADC of focal hepatic lesions using a free-breathing intravoxel incoherent motion (IVIM) DW sequence, and to determine if these parameters are useful for characterizing focal hepatic lesions. Material and Methods One hundred and twenty hepatic lesions (34 metastases, 32 hepatocellular carcinoma [HCC], 33 hemangiomas, and 21 liver cysts) in 74 patients were examined. Mean D, D*, f, and ADC values of hepatic lesions were compared among pathologies. ROC curve analyses were performed to assess the performances of D, D*, f, and ADC values for the characterization of liver lesions as benign or malignant. Results The mean D and ADC values of benign lesions were greater than those of malignant lesions (P<0.001). Although the mean D and ADC values of liver cysts were greater than those of hemangiomas (P<0.001), and these values were not significantly different between metastases and HCCs (P=0.99). Area under the ROC curve for ADC values (0.98) was significantly greater (P=0.048) than that for D values (0.96) for the differentiation of benign and malignant lesions. Sensitivity and specificity for the detection of malignant lesion were 89% and 98%, respectively, when an ADC cut-off value of 1.40 was applied. ConclusionD and ADC values have more potential for characterizing focal hepatic lesions than D* or f values, and for the differentiation of malignancy and benignity.	[Watanabe, Haruo] Gifu Cent Hosp, Dept Radiol, Gifu 5011198, Japan; [Watanabe, Haruo; Kanematsu, Masayuki; Goshima, Satoshi; Kawada, Hiroshi; Noda, Yoshifumi; Tatahashi, Yukichi; Kawai, Nobuyuki; Kondo, Hiroshi] Gifu Univ Hosp, Dept Radiol, Gifu 5011198, Japan; [Kanematsu, Masayuki; Kajita, Kimihiro] Gifu Univ Hosp, Serv Radiol, Gifu 5011198, Japan; [Moriyama, Noriyuki] Natl Canc Ctr Hosp, Res Ctr Canc Prevent & Screening, Tsukiji, Japan	Watanabe, H (reprint author), Gifu Cent Hosp, Dept Radiol, 3-25 Kawabe, Gifu 5011198, Japan.	haruwow860@yahoo.co.jp			Japan Society for the Promotion of Science KAKENHI [23591758]; Grant for Scientific Research Expenses for Health, Labor, and Welfare Programs; Foundation for the Promotion of Cancer Research; Research on Cancer Prevention and Health Services	This work was supported by Japan Society for the Promotion of Science KAKENHI (23591758) and in part by the Grant for Scientific Research Expenses for Health, Labor, and Welfare Programs; Foundation for the Promotion of Cancer Research; and Research on Cancer Prevention and Health Services.	LEBIHAN D, 1988, RADIOLOGY, V168, P497; Yamada I, 1999, RADIOLOGY, V210, P617; Nasu K, 2007, MAGN RESON MATER PHY, V20, P205, DOI 10.1007/s10334-007-0084-0; PEKAR J, 1992, MAGNET RESON MED, V23, P122, DOI 10.1002/mrm.1910230113; Koh DM, 2006, EUR RADIOL, V16, P1898, DOI 10.1007/s00330-006-0201-x; TURNER R, 1990, RADIOLOGY, V177, P407; Wirestam R, 2001, ACTA RADIOL, V42, P123, DOI 10.1080/028418501127346459; Taouli B, 2009, J MAGN RESON IMAGING, V30, P561, DOI 10.1002/jmri.21876; Saito K, 2010, J MAGN RESON IMAGING, V32, P229, DOI 10.1002/jmri.22219; NEIL JJ, 1993, MAGNET RESON MED, V29, P642, DOI 10.1002/mrm.1910290510; Koh DM, 2011, AM J ROENTGENOL, V196, P1351, DOI 10.2214/AJR.10.5515; Luciani A, 2008, RADIOLOGY, V249, P891, DOI 10.1148/radiol.2493080080; Taouli B, 2010, RADIOLOGY, V254, P47, DOI 10.1148/radiol.09090021; Chow AM, 2012, J MAGN RESON IMAGING, V36, P159, DOI 10.1002/jmri.23607; Chiaradia M, 2014, J MAGN RESON IMAGING, V39, P317, DOI 10.1002/jmri.24172; Colagrande S, 2013, J MAGN RESON IMAGING, V38, P365, DOI 10.1002/jmri.23978; Gulani V, 2009, J MAGN RESON IMAGING, V30, P1203, DOI 10.1002/jmri.21945; LEBIHAN D, 1991, JMRI-J MAGN RESON IM, V1, P7, DOI 10.1002/jmri.1880010103; Yoon JH, 2014, J MAGN RESON IMAGING, V39, P276, DOI 10.1002/jmri.24158	19	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0284-1851	1600-0455		ACTA RADIOL	Acta Radiol.	DEC	2014	55	10					1166	1173		10.1177/0284185113514966		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AT9CI	WOS:000345225200003		
J	Kidoh, M; Nakaura, T; Nakamura, S; Namimoto, T; Nozaki, T; Sakaino, N; Harada, K; Yamashita, Y				Kidoh, Masafumi; Nakaura, Takeshi; Nakamura, Shinichi; Namimoto, Tomohiro; Nozaki, Toshimitsu; Sakaino, Naritsugu; Harada, Kazunori; Yamashita, Yasuyuki			Contrast material and radiation dose reduction strategy for triple-rule-out cardiac CT angiography: feasibility study of non-ECG-gated low kVp scan of the whole chest following coronary CT angiography	ACTA RADIOLOGICA			English	Article						Triple-rule-out CT angiography; low tube voltage; radiation dose; contrast dose	LOW TUBE VOLTAGE; MULTIDETECTOR ROW CT; HYPERVASCULAR LIVER-TUMORS; IMAGE QUALITY; PAIN EVALUATION; PATIENT WEIGHT; ABDOMINAL CT; SPIRAL CT; PULMONARY; 64-MDCT	Background Dedicated coronary computed tomography (CT) scan has been proven to be an accurate diagnostic modality in evaluating coronary artery disease. A second phase scan starting immediately after the coronary CT scan might enable visualization of the different vascular territories of the entire chest. Purpose To investigate the feasibility of a contrast material and radiation dose reduction triple-rule-out (TRO) CT angiography (CTA) protocol with serial non-ECG-gated low kVp scan of the whole chest, which utilizes a recirculated contrast agent. Material and Methods Thirty patients were scanned with the new TRO-CTA protocol; after the coronary scan with retrospective ECG-gating, non-ECG-gated whole-chest CTA was performed at 80kVp to evaluate aortic arch (AAr) and pulmonary trunk (PT). Another 30 patients were scanned by our conventional TRO-CTA protocol at 120kVp with retrospective ECG-gating. We compared the estimated effective dose (ED), contrast material (CM) dose, contrast-to-noise ratio (CNR) of the ascending aorta (AAo), and the rate of patients who could achieve adequate attenuation of the AAr and PT between the two protocols. Results The total ED of the new TRO-CTA protocol was 29.6% lower than that of the conventional protocol (P<0.01). The amount of CM used for the new TRO-CTA protocol was significantly lower than in the conventional protocol (60.19.6mL vs. 91.8 +/- 22.6mL, P<0.01). The CNR of the AAo was 30.2% higher with the new TRO-CTA protocol than with the conventional protocol (P<0.01). There was no significant difference in the success rate of adequate attenuation of the AAr and PT between the two protocols (P>0.05). Conclusion The new TRO-CTA protocol can reduce the total dose of radiation and the contrast dose and yield adequate vascular enhancement compared with the conventional protocol.	[Kidoh, Masafumi; Nakaura, Takeshi; Nakamura, Shinichi] Amakusa Med Ctr, Diagnost Radiol, Kumamoto, Japan; [Kidoh, Masafumi; Nakaura, Takeshi; Nakamura, Shinichi; Namimoto, Tomohiro; Yamashita, Yasuyuki] Kumamoto Univ, Grad Sch Med Sci, Dept Diagnost Radiol, Kumamoto 8608556, Japan; [Nozaki, Toshimitsu; Sakaino, Naritsugu] Amakusa Med Ctr, Dept Cardiol, Kumamoto, Japan; [Harada, Kazunori] Amakusa Med Ctr, Dept Surg, Kumamoto, Japan	Kidoh, M (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Diagnost Radiol, 1-1-1 Honjo, Kumamoto 8608556, Japan.	masafkidoh@yahoo.co.jp					Takakuwa KM, 2009, AM J ROENTGENOL, V192, P866, DOI 10.2214/AJR.08.1758; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Ertl-Wagner BB, 2004, RADIOLOGY, V231, P528, DOI 10.1148/radiol.2312030543; Johnson TRC, 2007, AM J ROENTGENOL, V188, P76, DOI 10.2214/AJR.05.1153; Nakaura T, 2008, INVEST RADIOL, V43, P512, DOI 10.1097/RLI.0b013e3181727505; Guimaraes LS, 2010, RADIOLOGY, V257, P732, DOI 10.1148/radiol.10092016; Wittram C, 2007, AM J ROENTGENOL, V188, P1255, DOI 10.2214/AJR.06.1104; Hayter RG, 2006, RADIOLOGY, V238, P841, DOI 10.1148/radiol.2383041528; Erhardt L, 2002, EUR HEART J, V23, P1153, DOI 10.1053/euhj.2002.3194; Waaijer A, 2007, RADIOLOGY, V242, P832, DOI 10.1148/radiol.2423051191; Wintermark M, 2000, AM J NEURORADIOL, V21, P1881; Sheiman RG, 1996, AM J ROENTGENOL, V167, P725; Marin D, 2009, RADIOLOGY, V251, P771, DOI 10.1148/radiol.2513081330; Bae KT, 2010, RADIOLOGY, V256, P32, DOI 10.1148/radiol.10090908; Imai E, 2007, AM J KIDNEY DIS, V50, P927, DOI 10.1053/j.ajkd.2007.09.004; Nakayama Y, 2005, RADIOLOGY, V237, P945, DOI 10.1148/radiol.2373041655; Huda W, 2000, RADIOLOGY, V217, P430; Yu LF, 2010, MED PHYS, V37, P234, DOI 10.1118/1.3264614; Schindera ST, 2008, RADIOLOGY, V246, P125, DOI 10.1148/radiol.2461070307; Cademartiri F, 2004, RADIOLOGY, V233, P817, DOI 10.1148/radiol.2333030668; Kumasaka N, 1999, JPN CIRC J, V63, P439, DOI 10.1253/jcj.63.439; Schoepf UJ, 2002, RADIOLOGY, V222, P483, DOI 10.1148/radiol.2222001802; Takakuwa KM, 2008, RADIOLOGY, V248, P438, DOI 10.1148/radiol.2482072169; Sakuma M, 2009, CIRC J, V73, P305; BLUEMKE DA, 1995, RADIOLOGY, V195, P317; Bongartz G, 2004, EUROPEAN GUIDELINES; Dodd JD, 2008, AM J ROENTGENOL, V191, P870, DOI 10.2214/AJR.07.3387; Halpern EJ, 2009, RADIOLOGY, V252, P332, DOI 10.1148/radiol.2522082335; Halpern EJ, 2009, ACAD RADIOL, V16, P1039, DOI 10.1016/j.acra.2009.03.013; Johnson TRC, 2008, EUR RADIOL, V18, P773, DOI 10.1007/s00330-007-0803-y; KARLSON BW, 1991, J INTERN MED, V230, P251; Litmanovitch D, 2008, EUR RADIOL, V18, P308, DOI 10.1007/s00330-007-0739-2; Manheimer ED, 2011, AM J CARDIOL, V107, P1093, DOI 10.1016/j.amjcard.2010.11.038; Mitsumori LM, 2010, AM J ROENTGENOL, V194, pW263, DOI 10.2214/AJR.09.2788; Nakaura T, 2011, RADIOLOGY, V261, P467, DOI 10.1148/radiol.11110021; Schussler JM, 2007, AM J EMERG MED, V25, P367, DOI 10.1016/j.ajem.2006.08.014; Sigal-Cinqualbre AB, 2004, RADIOLOGY, V231, P169, DOI 10.1148/radiol.2311030191	37	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0284-1851	1600-0455		ACTA RADIOL	Acta Radiol.	DEC	2014	55	10					1186	1196		10.1177/0284185113514886		11	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AT9CI	WOS:000345225200006		
J	Yokoyama, K; Ikeda, O; Kawanaka, K; Nakasone, Y; Inoue, S; Tamura, Y; Yamashita, Y				Yokoyama, Koichi; Ikeda, Osamu; Kawanaka, Koichi; Nakasone, Yutaka; Inoue, Seijiro; Tamura, Yoshitaka; Yamashita, Yasuyuki			Pain control in patients with hepatocellular carcinoma treated by percutaneous radiofrequency ablation: comparison of the efficacy of one-shot and continuous intravenous fentanyl delivery	ACTA RADIOLOGICA			English	Article						Pain control; hepatocellular carcinoma; percutaneous radiofrequency ablation; intravenous fentanyl delivery	COAGULATION NECROSIS; HEPATIC RESECTION; TISSUE ABLATION; LIVER; REMIFENTANIL; MODEL; COMPLICATIONS; EMBOLIZATION; MANAGEMENT; INJECTION	Background Hepatic percutaneous radiofrequency ablation (RFA) is usually performed with the patient under deep intravenous (i.v.) sedation or general anesthesia. Nonetheless, many patients report pain during and/or after the procedure. Purpose To perform a prospective study of pain control obtained by the i.v. one-shot delivery and the continuous i.v. infusion of fentanyl in patients with hepatocellular carcinoma (HCC) treated by RFA. Material and Methods Between April 2007 and March 2010, 83 patients with 106 HCCs underwent percutaneous RFA. All HCCs were addressed by computed tomography (CT)-guided percutaneous RFA performed within 5h of embolization of the tumor vessels with iodized oil and gelatin sponges. Standard anesthesia consisted of 10mL of 1% lidocaine injected locally. For conscious sedation, group one patients (n=41) were injected i.v. with 100 mu g of fentanyl before and 100 mu g of fentanyl 30min after percutaneous RFA. In group two (n=42) we delivered fentanyl by continuous i.v. infusion at 100 mu g/h during RFA. Upon request, patients in both groups also received 5mg of diazepam i.v. for pain during the RFA procedure. The severity of pain experienced by all patients was evaluated on a visual analogue scale (VAS) and complications elicited by the anesthesia regimens were recorded. We also assessed the effectiveness of the treatment on sequential follow-up CT and/or magnetic resonance imaging (MRI) at 3-month intervals. Results Percutaneous RFA was technically successful in all 83 patients. Two patients in group one (4.8%) and one patient in group two (2.4%) manifested residual enhancement 3 months post RFA. There was no significant difference in the local recurrence rate between the two groups. At 4.01.8 for group one and 3.4 +/- 1.9 for group two, the VAS score was not significantly different. Major fentanyl or diazepam toxicity was recorded in 11 patients (24.4%) in group one and two patients (4.8%) in group two; the difference was statistically significant (P<0.01). Conclusion The continuous infusion of fentanyl provided effective and safe analgesia in HCC patients undergoing percutaneous RFA.	[Yokoyama, Koichi; Ikeda, Osamu; Kawanaka, Koichi; Nakasone, Yutaka; Inoue, Seijiro; Tamura, Yoshitaka; Yamashita, Yasuyuki] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Dept Diagnost Radiol, Kumamoto 8608556, Japan	Ikeda, O (reprint author), Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Dept Diagnost Radiol, 1-1-1 Honjo, Kumamoto 8608556, Japan.	osamu-3643ik@do9.enjoy.ne.jp					Goldberg SN, 2005, RADIOLOGY, V235, P728, DOI 10.1148/radiol.2353042205; Goldberg SN, 1998, J VASC INTERV RADIOL, V9, P101, DOI 10.1016/S1051-0443(98)70491-9; Cho YK, 2010, HEPATOLOGY, V51, P1284, DOI 10.1002/hep.23466; Rhim H, 2008, AM J ROENTGENOL, V190, P91, DOI 10.2214/AJR.07.2384; Lee WS, 2008, J CLIN GASTROENTEROL, V42, P945, DOI 10.1097/MCG.0b013e318064e752; Goldberg SN, 2001, HEPATO-GASTROENTEROL, V48, P359; Arima K, 2007, INT J UROL, V14, P585, DOI 10.1111/j.1442-2042.2007.01740.x; WEWERS ME, 1990, RES NURS HEALTH, V13, P227, DOI 10.1002/nur.4770130405; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Rhim H, 2005, ABDOM IMAGING, V30, P409, DOI 10.1007/s00261-004-0255-7; Koda M, 2004, AM J ROENTGENOL, V183, P583; Gandhi S, 2006, CLIN RADIOL, V61, P888, DOI 10.1016/j.crad.2006.05.011; Mulier S, 2008, DIGEST SURG, V25, P445, DOI 10.1159/000184736; Miyamoto N, 2009, JPN J RADIOL, V27, P185, DOI 10.1007/s11604-009-0317-4; Sugimori K, 2002, HEPATOL RES, V24, P164, DOI 10.1016/S1386-6346(02)00030-X; GLASS PSA, 1993, ANESTH ANALG, V77, P1031; Patterson EJ, 1998, ANN SURG, V227, P559, DOI 10.1097/00000658-199804000-00018; Child CG, 1964, LIVER PORTAL HYPERTE, P49; Chinn SB, 2001, AM J ROENTGENOL, V176, P789; Egan TD, 2004, BRIT J ANAESTH, V92, P335, DOI 10.1093/bja/aeh075; Gillams AR, 2003, EUR J SURG ONCOL, V29, P9, DOI 10.1053/ejso.2002.1346; Groban L, 2009, ANESTH ANALG, V109, P301, DOI 10.1213/ane.0b013e3181a91944; Krucker J, 2007, J VASC INTERV RADIOL, V18, P1141, DOI 10.1016/j.jvir.2007.06.014; Kurokohchi K, 2007, WORLD J GASTROENTERO, V13, P4398; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Minami Yasunori, 2010, World J Radiol, V2, P417, DOI 10.4329/wjr.v2.i11.417; Nimmaanrat S, 2007, MINERVA ANESTESIOL, V73, P333; Rama-Maceiras P, 2005, ACTA ANAESTH SCAND, V49, P305, DOI 10.1111/j.1399.6576.2005.00650.x; Roy JD, 2006, ANESTH ANALG, V103, P990, DOI 10.1213/01.ane.0000238040.41872.7e; Rust C, 2001, Clin Liver Dis, V5, P161, DOI 10.1016/S1089-3261(05)70159-8	30	1	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0284-1851	1600-0455		ACTA RADIOL	Acta Radiol.	DEC	2014	55	10					1219	1225		10.1177/0284185113519623		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AT9CI	WOS:000345225200010		
J	Nakamura, H; Yamamura, V; Ito, H; Lin, F; Maeda, K				Nakamura, H.; Yamamura, V.; Ito, H.; Lin, F.; Maeda, K.			Development of Pre-Tensioning Device for CFRP Strips and Applicability to Repair of Cracked Steel Members	ADVANCES IN STRUCTURAL ENGINEERING			English	Article						CFRP strip; pre-tensioning device; debonding; creep; repair of fatigue crack	FATIGUE	A method of repairing cracked steel members with pre-tensioned CFRP strips was investigated experimentally. Since a compressive force is introduced into the steel members by releasing the pre-tension in the CFRP strips after bonding, this technique is an effective fatigue crack repair method. With the aim of applying the method to a real structure, a simple, compact pre-tensioning device prototype was developed, and the effectiveness of the repair method was verified experimentally. The preliminary experiments were conducted using flat steel plates and varying the pre-tension of the CFRP strips. Results of tensile and creep tests revealed that it was possible to introduce a compressive force of approximately 36 kN into the steel plate rationally. Moreover, strain in the steel plate was measured for approximately 3 yrs. after introducing the compressive force, and a pre-stress loss of approximately 20% due to creep of the adhesive joint was observed under room-temperature conditions. Fatigue test results confirm that the application of this method to fatigue crack repair is feasible.	[Nakamura, H.; Ito, H.; Maeda, K.] Tokyo Metropolitan Univ, Dept Civil & Environm Engn, Tokyo, Japan; [Yamamura, V.] Taisei Corp, Tokyo, Japan; [Lin, F.] Yunnan Univ, Sch Urban Construct & Management, Kunming, Peoples R China	Nakamura, H (reprint author), Tokyo Metropolitan Univ, Dept Civil & Environm Engn, Tokyo, Japan.	hnaka@tmu.ac.jp			JSPS KAKENHI [22560484]; JX Nippon Oil & Energy Corporation	This study is financially supported by a JSPS KAKENHI Grant Number 22560484, and is supported by JX Nippon Oil & Energy Corporation, which are greatly acknowledged.	Nakamura H, 2009, THIN WALL STRUCT, V47, P1059, DOI 10.1016/j.tws.2008.10.016; Colombi P, 2003, FATIGUE FRACT ENG M, V26, P59, DOI 10.1046/j.1460-2695.2003.00598.x; Taljsten B, 2009, CONSTR BUILD MATER, V23, P1665, DOI 10.1016/j.conbuildmat.2008.08.001; Huawen Y., 2010, J COMPOS CONSTR, V14, P609; Lin F., 2012, P 5 INT C BRIDG MAIN, P1308; Nozaka K., 2011, J STRUCTURAL ENG A, V57A, P1026; Stocklin I., 2001, P FIB REINF POL REIN, P291; Tateishi A., 2005, P 7 INT S FIB REINF, P1177	8	0	0	MULTI-SCIENCE PUBL CO LTD	BRENTWOOD	5 WATES WAY, BRENTWOOD CM15 9TB, ESSEX, ENGLAND	1369-4332	2048-4011		ADV STRUCT ENG	Adv. Struct. Eng.	DEC	2014	17	12					1705	1717				13	Construction & Building Technology; Engineering, Civil	Construction & Building Technology; Engineering	AT4MD	WOS:000344912600002		
J	Ishikawa, T; Nagao, T; Kobayashi, A; Shimizu, M; Hattori, A; Kawano, H				Ishikawa, T.; Nagao, T.; Kobayashi, A.; Shimizu, M.; Hattori, A.; Kawano, H.			Reduction of Thermal Stress Induced in a Steel Plate Strengthened by Bonded Aluminum-CFRP Composite	ADVANCES IN STRUCTURAL ENGINEERING			English	Article						CFRP; Aluminum alloy; steel plate; thermal stress		In steel members strengthened with carbon-fiber reinforced polymer (CFRP) plate, thermal stresses are introduced in the steel members, the CFRP plates and the adhesive layers when temperature changes because the linear thermal expansion coefficients of steel and CFRP are mismatched. Therefore, the thermal stress caused by temperature change has to be considered when designing the repair or strengthening of a steel member with CFRP plates. With this in mind, the authors proposed a technique to reduce thermal stress in steel members strengthened by CFRP plate on both side, which involves bonding aluminum alloy plates with CFRP plates. In this proposed method, the thermal stresses in steel member can be reduced so that there are negligible levels of stress when the cross sectional areas of CFRP and aluminum plates are designed to correspond the coefficient of thermal expansion of steel, even though the thermal stresses are introduced in the CFRP and aluminum plates. So far, a thermal bending moment was not considered in the proposed method, because the steel members strengthened by CFRP-aluminum laminated plate on top and bottom sides were assumed. However, if the proposed method is applied on one side of steel member, the thermal stress in the steel member might not be reduced completely by generated thermal bending moment. Therefore, to confirm the effectiveness of the proposed method for one-sided bonding, heat tests were conducted on a steel plate with a laminated plate bonded on one side. Additionally, to verify test results and calculate the shear and peel stresses in the adhesive layers, a numerical model that used Eigenvalue analysis was proposed and applied. The tests revealed that using the proposed method to create a two-layered laminated plate consisting of CFRP and aluminum plates could not reduce the thermal stress completely in a thin steel plate. However, it was found that the thermal stress in steel plate can be completely reduced, even in thin steel plate, when the proposed method is used to create a three-layered laminated plate consisting of one CFRP plate between two aluminum plates, which when composited has a thermal bending moment equal to zero.	[Ishikawa, T.; Shimizu, M.; Hattori, A.; Kawano, H.] Kyoto Univ, Dept Urban Management, Kyoto, Japan; [Nagao, T.] Nippon Light Met Co Ltd, Shizuoka, Japan; [Kobayashi, A.] Nippon Steel & Sumikin Mat Co Ltd, Tokyo, Japan	Ishikawa, T (reprint author), Kyoto Univ, Dept Urban Management, Kyoto, Japan.	ishikawa.toshiyuki.2e@kyoto-u.ac.jp			JSPS [24656269]	The authors gratefully acknowledge the financial support provided by JSPS Grant-in-Aid for challenging Exploratory Research (24656269).	Schnerch D, 2007, CONSTR BUILD MATER, V21, P1001, DOI 10.1016/j.conbuildmat.2006.03.003; Taljsten B, 2009, CONSTR BUILD MATER, V23, P1665, DOI 10.1016/j.conbuildmat.2008.08.001; Moy SSJ, 2007, P I CIVIL ENG-STR B, V160, P81, DOI 10.1680/stbu.2007.160.2.81; [Anonymous], 2007, 202 CNRDT; Ishikawa T., 2011, J JAPAN SOC CIVIL AI, V67, P336; Ishikawa T., 2012, AS PAC C FRP STRUCT; Miller T.C., 2001, J BRIDGE ENG, V6, P514, DOI DOI 10.1061/(ASCE)1084-0702(2001)6:6(514); Miyashita T., 2010, DOBOKU GAKKAI RONB A, V66, P378; Tamai H., 2005, J CONSTRUCTION STEEL, V13, P545	9	0	0	MULTI-SCIENCE PUBL CO LTD	BRENTWOOD	5 WATES WAY, BRENTWOOD CM15 9TB, ESSEX, ENGLAND	1369-4332	2048-4011		ADV STRUCT ENG	Adv. Struct. Eng.	DEC	2014	17	12					1771	1783				13	Construction & Building Technology; Engineering, Civil	Construction & Building Technology; Engineering	AT4MD	WOS:000344912600007		
J	Morioka, D; Ohkubo, F				Morioka, Daichi; Ohkubo, Fumio			Borderline Personality Disorder and Aesthetic Plastic Surgery	AESTHETIC PLASTIC SURGERY			English	Review						Borderline personality disorder; Body dysmorphic disorder; Aesthetic surgery; Plastic surgery; Self-mutilation; Impulsivity; Abandonment fear	BODY DYSMORPHIC DISORDER; SEEKING COSMETIC SURGERY; PSYCHOLOGICAL CONSIDERATIONS; REVISION RHINOPLASTY; SUICIDE ATTEMPTS; SELF-MUTILATION; PATIENT; COMORBIDITY; DIAGNOSIS; MANAGEMENT	Borderline personality disorder (BPD) is a common axis II disorder associated with a high risk of impulsivity and self-injury. Several authors have suggested that individuals with BPD are poor candidates for plastic surgery. Recent changes in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for BPD may be confusing to surgeons. This article reviews the literature on BPD and discusses how important it is to recognize this condition and how difficult it is to treat patients, highlighting features and signs of this condition in plastic surgery settings. Illustrative case examples from our experience are also described. Our careful search of the literature revealed that individuals with BPD may seek treatment from plastic surgeons in two different patterns: as treatment for self-injury or as insatiable requests for aesthetic procedures. Individuals with BPD tend to request corrections of multiple body parts to avoid abandonment by the surgeon or due to their impulsivity, but such preoccupation with appearance is less profound and shifts from one body part to another over time. While flexible and individualized psychological approaches are required to minimize the patient's impulsivity and abandonment fears, surgeons should be inflexible to any unrealistic requests. It is best to avoid surgery on patients with BPD. Surgeons should be aware of the nuances of this condition so as not to miss the proper timing for a psychiatric referral.	[Morioka, Daichi; Ohkubo, Fumio] Showa Univ, Div Aesthet Surg, Dept Plast & Reconstruct Surg, Shinagawa Ku, Tokyo 1428866, Japan	Morioka, D (reprint author), Showa Univ, Div Aesthet Surg, Dept Plast & Reconstruct Surg, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428866, Japan.	dmorioka@gmail.com					Ambro BT, 2008, FACIAL PLAST SURG, V24, P288, DOI 10.1055/s-0028-1083083; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; Favazza AR, 1998, J NERV MENT DIS, V186, P259, DOI 10.1097/00005053-199805000-00001; Gunderson JG, 2011, NEW ENGL J MED, V364, P2037, DOI 10.1056/NEJMcp1007358; GUNDERSON JG, 1975, AM J PSYCHIAT, V132, P1; Phillips KA, 2005, J CLIN PSYCHIAT, V66, P717; Shridharani SM, 2010, PLAST RECONSTR SURG, V126, P2243, DOI 10.1097/PRS.0b013e3181f445ae; Zanarini MC, 2010, ACTA PSYCHIAT SCAND, V122, P103, DOI 10.1111/j.1600-0447.2010.01543.x; Bjornsson AS, 2013, COMPR PSYCHIAT, V54, P893, DOI 10.1016/j.comppsych.2013.03.019; Trull TJ, 2011, CURR PSYCHIAT REP, V13, P43, DOI 10.1007/s11920-010-0170-2; Nock MK, 2006, PSYCHIAT RES, V144, P65, DOI 10.1016/j.psychres.2006.05.010; Coifman KG, 2012, J ABNORM PSYCHOL, V121, P668, DOI 10.1037/a0028502; Ruggero CJ, 2010, J PSYCHIATR RES, V44, P405, DOI 10.1016/j.jpsychires.2009.09.011; Lieb K, 2004, LANCET, V364, P453, DOI 10.1016/S0140-6736(04)16770-6; Davis RE, 2012, FACIAL PLAST SURG, V28, P374, DOI 10.1055/s-0032-1319837; Lenzenweger MF, 2007, BIOL PSYCHIAT, V62, P553, DOI 10.1016/j.biopsych.2006.09.019; Gorney M, 2010, PLAST RECONSTR SURG, V126, P2268, DOI 10.1097/PRS.0b013e3181f619da; Honigman RJ, 2004, PLAST RECONSTR SURG, V113, P1229, DOI 10.1097/01.PRS.0000110214.88868.CA; Leichsenring F, 2011, LANCET, V377, P74, DOI 10.1016/S0140-6736(10)61422-5; Sarwer DB, 1998, CLIN PSYCHOL REV, V18, P1, DOI 10.1016/S0272-7358(97)00047-0; CASTOR B, 1990, SCAND J INFECT DIS, V22, P227, DOI 10.3109/00365549009037907; Chatham DR, 2012, FACIAL PLAST SURG, V28, P253, DOI 10.1055/s-0032-1312704; CONNOLLY FH, 1978, BRIT J PSYCHIAT, V132, P568, DOI 10.1192/bjp.132.6.568; Constantian MB, 2013, PLAST RECONSTR SURG, V132, P1759, DOI 10.1097/PRS.0b013e3182a805ca; EDGERTON MT, 1991, PLAST RECONSTR SURG, V88, P594, DOI 10.1097/00006534-199110000-00006; EDGERTON M T, 1960, Br J Plast Surg, V13, P136, DOI 10.1016/S0007-1226(60)80029-X; Ericksen WL, 2012, PSYCHIAT QUART, V83, P343, DOI 10.1007/s11126-012-9204-8; Grant BF, 2008, J CLIN PSYCHIAT, V69, P533; GROENMAN NH, 1983, PSYCHOTHER PSYCHOSOM, V40, P241; Gunderson J., 2008, BORDERLINE PERSONALI; Gunderson JG, 2010, J PERS DISORD, V24, P694, DOI 10.1521/pedi.2010.24.6.694; Hayashi Kazuhiro, 2007, Aesthet Surg J, V27, P396, DOI 10.1016/j.asj.2007.05.010; Henderson A, 2013, BURNS, V39, P335, DOI 10.1016/j.burns.2012.07.014; Hodgkinson DJ, 2005, AESTHET PLAST SURG, V29, P503, DOI 10.1007/s00266-005-5033-6; In-Albon T., 2013, PSYCHIAT J, DOI [10.1155/2013/159208, DOI 10.1155/2013/159208]; Ishigooka J, 1998, PSYCHIAT CLIN NEUROS, V52, P283, DOI 10.1046/j.1440-1819.1998.00388.x; Jakubietz M, 2007, PLAST RECONSTR SURG, V119, P1924, DOI 10.1097/01.prs.0000259205.01300.8b; KIRNBERG O, 1967, J AM PSYCHOANAL ASS, V15, P641; KNORR NJ, 1967, PLAST RECONSTR SURG, V40, P285, DOI 10.1097/00006534-196740030-00016; Marcoux G S, 2000, Can J Psychiatry, V45, P395; Morioka D, 2014, AESTHET PLAST SURG, V38, P812, DOI 10.1007/s00266-014-0332-4; NABETA Y, 2011, SHINTAI SHUKEI SHOGA; NAPOLEON A, 1993, ANN PLAS SURG, V31, P193, DOI 10.1097/00000637-199309000-00001; NURNBERG HG, 1991, AM J PSYCHIAT, V148, P1371; Pavan C, 2008, AESTHET PLAST SURG, V32, P473, DOI 10.1007/s00266-008-9113-2; Picavet V, 2011, LARYNGOSCOPE, V121, P2535, DOI 10.1002/lary.21728; RASPA RF, 1990, AM FAM PHYSICIAN, V41, P1481; STEVENS L, 2006, PLASTIC SURG, P72; Sykes JM, 2009, CURR OPIN OTOLARYNGO, V17, P321, DOI 10.1097/MOO.0b013e32832da0f9; Todd Jodi, 2012, Eplasty, V12, pe23; WRIGHT MR, 1980, ARCH OTOLARYNGOL, V106, P466; Zimmerman M, 2012, J PERS DISORD, V26, P880, DOI 10.1521/pedi.2012.26.6.880; Zimmerman Mark, 2013, Dialogues Clin Neurosci, V15, P155	54	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-216X	1432-5241		AESTHET PLAST SURG	Aesthet. Plast. Surg.	DEC	2014	38	6					1169	1176		10.1007/s00266-014-0396-1		8	Surgery	Surgery	AT7RB	WOS:000345134000014		
J	Nishiura, D; Sakaguchi, H; Shimosaka, A				Nishiura, Daisuke; Sakaguchi, Hide; Shimosaka, Atsuko			Wet Dispersion Mechanism of Fine Aggregates in Multiphase Flow with Solid Beads Under Simple Shear	AICHE JOURNAL			English	Article						stirred media mill; discrete element method; direct numerical simulation; shear stress; collision	STIRRED MEDIA MILL; NANOPARTICLE DISPERSION; NUMERICAL-SIMULATION; COLLIDING PARTICLES; DEM SIMULATION; LUBRICATION; BREAKUP; MOTION	Clarifying the disintegration mechanism of aggregates in multiphase fluid flow coupled with beads and particulates is important for the optimum design of a wet dispersion process using a stirred media mill. Thus, we develop a numerical method for simulating multiphase flow with beads and particulates using a discrete element method and computational fluid dynamics, and we use the four-way coupling simulation to study the fluid-bead-particulate-coupled phenomenon that occurs in a simple shear box. The results show that the dominant force causing aggregate disintegration is the fluid force, rather than the bead contact force, because aggregates rarely collide with beads, contact force of which is too small to disintegrate aggregates. Furthermore, aggregates with strong aggregation force are effectively disintegrated by the fluid flow with a dominant high pure-shear rate induced near the bead surfaces by the expansive force, rather than the compressive force. (c) 2014 American Institute of Chemical Engineers AIChE J 60: 4076-4085, 2014	[Nishiura, Daisuke; Sakaguchi, Hide] Japan Agcy Marine Earth Sci & Technol, Dept Math Sci & Adv Technol, Kanagawa 2360001, Japan; [Shimosaka, Atsuko] Doshisha Univ, Dept Chem Engn & Mat Sci, Kyoto 6100321, Japan	Nishiura, D (reprint author), Japan Agcy Marine Earth Sci & Technol, Dept Math Sci & Adv Technol, Kanagawa 2360001, Japan.	nishiura@jamstec.go.jp			JSPS KAKENHI Grant [23740304]	This research was partially supported by JSPS KAKENHI Grant No. 23740304 (Grant-in-Aid for Young Scientists (B) to D. N.).	Blecher L, 1996, POWDER TECHNOL, V86, P59, DOI 10.1016/0032-5910(95)03038-7; Gudin D, 2006, AICHE J, V52, P3421, DOI 10.1002/aic.10956; Nishiyama T, 2013, COMPUT FLUIDS, V86, P395, DOI 10.1016/j.compfluid.2013.06.023; Tsuji Y, 2007, CHEM ENG SCI, V62, P3410, DOI 10.1016/j.ces.2006.12.090; CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47; Cleary PW, 2010, PARTICUOLOGY, V8, P106, DOI 10.1016/j.partic.2009.05.006; Yang RY, 2006, MINER ENG, V19, P984, DOI 10.1016/j.mineng.2006.05.002; WEN CY, 1966, AICHE J, V12, P610, DOI 10.1002/aic.690120343; ERGUN S, 1952, CHEM ENG PROG, V48, P89; Zhang WB, 2005, POWDER TECHNOL, V158, P92, DOI 10.1016/j.powtec.2005.04.021; TSUJI Y, 1992, POWDER TECHNOL, V71, P239, DOI 10.1016/0032-5910(92)88030-L; TSUJI Y, 1993, POWDER TECHNOL, V77, P79, DOI 10.1016/0032-5910(93)85010-7; Kajishima T, 2001, JSME INT J B-FLUID T, V44, P526, DOI 10.1299/jsmeb.44.526; AOYAMA Y., 1999, RS 6000 SP PRACTICAL; Briggs W.L., 2000, MULTIGRID TUTORIAL; Eskin D, 2005, POWDER TECHNOL, V156, P95, DOI 10.1016/j.powtec.2005.04.004; Gers R, 2010, CHEM ENG SCI, V65, P2052, DOI 10.1016/j.ces.2009.12.003; Harada S, 2006, J COLLOID INTERF SCI, V301, P123, DOI 10.1016/j.jcis.2006.04.051; Harigai K, 2006, J JPN SOC COLOR MAT, V79, P136; Hertz H., 1881, J REINE ANGEW MATH, V92, P156, DOI DOI 10.1515/CRIL.1882.92.156>; Higashitani K, 1998, J COLLOID INTERF SCI, V204, P320, DOI 10.1006/jcis.1998.5561; Higashitani K, 2001, CHEM ENG SCI, V56, P2927, DOI 10.1016/S0009-2509(00)00477-2; Inky M., 2004, J SOC POWDER TECHNOL, V41, P578; Inkyo M, 2006, J COLLOID INTERF SCI, V304, P535, DOI 10.1016/j.jcis.2006.09.021; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; Jayasundara C.T., 2011, IND ENG CHEM RES, V51, P1050; MINDLIN RD, 1949, J APPL MECH-T ASME, V16, P259; Nishiura D, 2010, J CHEM ENG JPN, V43, P841; Nishiura D, 2011, J COMPUT PHYS, V230, P1923, DOI 10.1016/j.jcp.2010.11.040; Ozcan-Task GN, 2012, P 14 EUR C MIX WARS, P353; Schilde C, 2011, CHEM ENG SCI, V66, P4943, DOI 10.1016/j.ces.2011.07.006; Shimosaka A, 2012, J CHEM ENG JPN, V45, P801; Simeonov JA, 2012, INT J MULTIPHAS FLOW, V46, P38, DOI 10.1016/j.ijmultiphaseflow.2012.05.008; Theuerkauf J, 1999, POWDER TECHNOL, V105, P406, DOI 10.1016/S0032-5910(99)00165-5	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-1541	1547-5905		AICHE J	AICHE J.	DEC	2014	60	12					4076	4085		10.1002/aic.14614		10	Engineering, Chemical	Engineering	AT9FI	WOS:000345232900008		
J	Nagasawa, H; Niimi, T; Kanezashi, M; Yoshioka, T; Tsuru, T				Nagasawa, Hiroki; Niimi, Takuya; Kanezashi, Masakoto; Yoshioka, Tomohisa; Tsuru, Toshinori			Modified Gas-Translation Model for Prediction of Gas Permeation Through Microporous Organosilica Membranes	AICHE JOURNAL			English	Article						modified gas-translation model; microporous organosilica membranes; bis(triethoxysilyl)ethane; normalized Knudsen-based permeance; gas permeation characteristics	CHEMICAL-VAPOR-DEPOSITION; SILICA MEMBRANES; SEPARATION MEMBRANES; MOLECULAR-DYNAMICS; MIXTURE SEPARATION; ZEOLITE MEMBRANE; HIGH-TEMPERATURE; STABILITY; DIFFUSION; HYDROGEN	A modified gas-translation (GT) model was applied for the theoretical analysis of gas permeation through microporous organosilica membranes derived from bis(triethoxysilyl)ethane (BTESE) via a sol-gel method using different water/alkoxide molar ratios. The pore sizes of BTESE-derived membranes were quantitatively determined by normalized Knudsen-based permeance analysis, which was based on a modified-GT model, using experimentally obtained permeances of He, H-2, N-2, C3H8, and SF6. The pore sizes of BTESE-derived membranes were successfully controlled from 0.65 to 0.46 nm by increasing the H2O/BTESE ratio from 6 to 240. Furthermore, theoretical correlations of all possible pairs of permeance ratios were calculated based on the modified-GT model. The experimental data were in good agreement with the theoretical correlation curves, indicating that the modified-GT model can clearly explain gas permeation mechanisms through microporous membranes, and, thus, can be used to predict the gas permeation properties for these membranes. (c) 2014 American Institute of Chemical Engineers AIChE J 60: 4199-4210, 2014	[Nagasawa, Hiroki; Niimi, Takuya; Kanezashi, Masakoto; Yoshioka, Tomohisa; Tsuru, Toshinori] Hiroshima Univ, Dept Chem Engn, Higashihiroshima, Hiroshima 7398527, Japan	Tsuru, T (reprint author), Hiroshima Univ, Dept Chem Engn, Higashihiroshima, Hiroshima 7398527, Japan.	tsuru@hiroshima-u.ac.jp	Nagasawa, Hiroki/D-7613-2012; Yoshioka, Tomohisa/D-7226-2011; Kanezashi, Masakoto/G-3938-2010; Tsuru, Toshinori/G-6035-2010	Nagasawa, Hiroki/0000-0001-7972-2425; 	Core Research for Evolutional Science and Technology (CREST), the Japan Science and Technology Agency	This work was supported by Core Research for Evolutional Science and Technology (CREST), the Japan Science and Technology Agency.	Duke MC, 2008, ADV FUNCT MATER, V18, P3818, DOI 10.1002/adfm.200800624; Lee HR, 2011, AICHE J, V57, P2755, DOI 10.1002/aic.12501; Tang Z, 2009, LANGMUIR, V25, P4848, DOI 10.1021/la900474y; Tomita T, 2004, MICROPOR MESOPOR MAT, V68, P71, DOI 10.1016/j.micromeso.2003.11.016; Nagasawa H, 2014, SEP PURIF TECHNOL, V121, P13, DOI 10.1016/j.seppur.2013.10.042; Hacarlioglu P, 2008, J MEMBRANE SCI, V313, P277, DOI 10.1016/j.memsci.2008.01.018; Lu GQ, 2007, J COLLOID INTERF SCI, V314, P589, DOI 10.1016/j.jcis.2007.05.067; Nagano T, 2008, J AM CERAM SOC, V91, P71, DOI 10.1111/j.1551-2916.2007.02073.x; XIAO JR, 1992, CHEM ENG SCI, V47, P1123, DOI 10.1016/0009-2509(92)80236-6; SHELEKHIN AB, 1995, AICHE J, V41, P58, DOI 10.1002/aic.690410107; Kanezashi M, 2006, J MEMBRANE SCI, V271, P86, DOI 10.1016/j.memsci.2005.07.011; Battersby S, 2009, J MEMBRANE SCI, V329, P91, DOI 10.1016/j.memsci.2008.12.051; DEVREUX F, 1990, PHYS REV A, V41, P6901, DOI 10.1103/PhysRevA.41.6901; Kanezashi M, 2010, J MEMBRANE SCI, V348, P310, DOI 10.1016/j.memsci.2009.11.014; Castricum HL, 2008, J MATER CHEM, V18, P2150, DOI 10.1039/b801972j; Yoshioka T, 2001, AICHE J, V47, P2052, DOI 10.1002/aic.690470916; Niimi T, 2014, J MEMBRANE SCI, V455, P375, DOI 10.1016/j.memsci.2014.01.003; Cui Y, 2004, J MEMBRANE SCI, V236, P17, DOI 10.1016/j.memsci.2003.12.018; Castricum HL, 2008, CHEM COMMUN, P1103, DOI 10.1039/b718082a; Asaeda M, 2001, SEP PURIF TECHNOL, V25, P151, DOI 10.1016/S1383-5866(01)00099-5; Gu YF, 2007, ADV MATER, V19, P1636, DOI 10.1002/adma.200602637; Aoki K, 1998, J MEMBRANE SCI, V141, P197, DOI 10.1016/S0376-7388(97)00300-1; desVos R, 1998, SCIENCE, V279, P1710; desVos RM, 1998, J MEMBRANE SCI, V143, P37; Gopalakrishnan S, 2008, J MEMBRANE SCI, V323, P144, DOI 10.1016/j.memsci.2008.06.016; Nagasawa H, 2013, J MEMBRANE SCI, V441, P45, DOI 10.1016/j.memsci.2013.03.056; Nomura M, 2006, DESALINATION, V193, P1, DOI 10.1016/j.desal.2005.08.019; RAMAN NK, 1995, J MEMBRANE SCI, V105, P273, DOI 10.1016/0376-7388(95)00067-M; Yoshioka T, 2013, AICHE J, V59, P2179, DOI 10.1002/aic.13966; Yoshioka T, 2004, MOL PHYS, V102, P191, DOI 10.1080/00268970310001649383	30	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-1541	1547-5905		AICHE J	AICHE J.	DEC	2014	60	12					4199	4210		10.1002/aic.14578		12	Engineering, Chemical	Engineering	AT9FI	WOS:000345232900018		
J	Pinato, DJ; Karamanakos, G; Arizumi, T; Adjogatse, D; Kim, YW; Stebbing, J; Kudo, M; Jang, JW; Sharma, R				Pinato, D. J.; Karamanakos, G.; Arizumi, T.; Adjogatse, D.; Kim, Y. W.; Stebbing, J.; Kudo, M.; Jang, J. W.; Sharma, R.			Dynamic changes of the inflammation-based index predict mortality following chemoembolisation for hepatocellular carcinoma: a prospective study	ALIMENTARY PHARMACOLOGY & THERAPEUTICS			English	Article							C-REACTIVE PROTEIN; TRANSARTERIAL CHEMOEMBOLIZATION; PROGNOSTIC SYSTEM; T-CELLS; CANCER; SURVIVAL; EMBOLIZATION; SCORE; MESOTHELIOMA; MANAGEMENT	BackgroundTransarterial chemoembolisation (TACE) is a standard treatment for unresectable, intermediate stage hepatocellular carcinoma (HCC). Survival after TACE, however, can be highly variable, with no suitable biomarker predicting therapeutic outcome. The inflammation-based index (IBI) has previously been shown to independently predict overall survival (OS) in all stages of HCC. AimTo explore the prognostic ability of IBI as a predictor of survival after TACE. MethodsBaseline staging, biochemical and clinicopathological features including IBI were studied in a derivation set of 64 patients undergoing TACE for intermediate stage HCC. Dynamic changes in IBI before and after TACE were studied as predictors of survival using both a univariate and multivariate Cox regression model and further validated in two independent patient cohorts from Korea (n=76) and Japan (n=577). ResultsPre-treatment IBI predicted for OS in the derivation set (P=0.001). Other univariate predictors of OS included radiological response to TACE (P<0.001), pre-TACE CLIP score (P<0.01), tumour diameter >5cm (P=0.05) and AFP 400 (P<0.001). Normalisation of IBI post-TACE was associated with radiological response by mRECIST criteria and improved OS (P<0.001). Normalisation of IBI remained a significant multivariate predictor of OS in both the derivation and validation sets (P<0.001). ConclusionsNormalisation of IBI after TACE is shown to be an independent predictor of survival and may be integrated into the retreatment criteria for repeat TACE in intermediate stage HCC. IBI and its dynamic changes after treatment are validated as a biomarker allowing the stratification of patients with a significant survival advantage following initial TACE.	[Pinato, D. J.; Karamanakos, G.; Sharma, R.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Div Expt Med, London W12 0HS, England; [Arizumi, T.; Kudo, M.] Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, Osaka 589, Japan; [Adjogatse, D.; Stebbing, J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Oncol, London W12 0HS, England; [Kim, Y. W.; Jang, J. W.] Catholic Univ Korea, Incheon St Marys Hosp, Dept Internal Med, Seoul, South Korea	Sharma, R (reprint author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Campus,Du Cane Rd, London W12 0HS, England.	r.sharma@imperial.ac.uk					Parkin DM, 2005, CA-CANCER J CLIN, V55, P74; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Lencioni R, 2010, ONCOLOGIST, V15, P42, DOI 10.1634/theoncologist.2010-S4-42; Canna K, 2005, BRIT J CANCER, V92, P651, DOI 10.1038/sj.bjc.6602419; Mohamed Z, 2014, BRIT J CANCER, V110, P208, DOI 10.1038/bjc.2013.683; Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x; Hsu C, 2010, CONTEMP CLIN TRIALS, V31, P55, DOI 10.1016/j.cct.2009.08.002; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Hoshida Y, 2012, SEMIN ONCOL, V39, P473, DOI 10.1053/j.seminoncol.2012.05.003; Kinoshita A, 2012, BRIT J CANCER, V107, P988, DOI 10.1038/bjc.2012.354; Ayaru L, 2007, J IMMUNOL, V178, P1914; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Pinato DJ, 2012, TRANSL RES, V160, P146, DOI 10.1016/j.trsl.2012.01.011; Korangy F, 2004, CLIN CANCER RES, V10, P4332, DOI 10.1158/1078-0432.CCR-04-0181; Kao SCH, 2010, CLIN CANCER RES, V16, P5805, DOI 10.1158/1078-0432.CCR-10-2245; Fu JL, 2007, GASTROENTEROLOGY, V132, P2328, DOI 10.1053/j.gastro.2007.03.012; Pinato DJ, 2012, BRIT J CANCER, V106, P1439, DOI 10.1038/bjc.2012.92; Camma C, 2002, RADIOLOGY, V224, P47, DOI 10.1148/radiol.2241011262; Cabibbo G, 2011, ALIMENT PHARM THER, V34, P196, DOI 10.1111/j.1365-2036.2011.04694.x; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Raoul JL, 2011, CANCER TREAT REV, V37, P212, DOI 10.1016/j.ctrv.2010.07.006; Pinato DJ, 2012, J HEPATOL, V57, P1013, DOI 10.1016/j.jhep.2012.06.022; Sieghart W, 2013, HEPATOLOGY, V57, P2261, DOI 10.1002/hep.26256; Ishizuka M, 2012, AM J SURG, V203, P101, DOI 10.1016/j.amjsurg.2010.09.030; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Pinato DJ, 2012, J THORAC ONCOL, V7, P587, DOI 10.1097/JTO.0b013e31823f45c1; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Budhu A, 2006, CANCER CELL, V10, P99, DOI 10.1016/j.ccr.2006.06.016; Proctor MJ, 2011, BRIT J CANCER, V104, P726, DOI 10.1038/sj.bjc.6606087; Kadalayil L, 2013, ANN ONCOL, V24, P2565, DOI 10.1093/annonc/mdt247; Argilés Josep M, 2009, Curr Opin Support Palliat Care, V3, P263, DOI 10.1097/SPC.0b013e3283311d09; Manghisi G, 1998, HEPATOLOGY, V28, P751; Chua W, 2012, SUPPORT CARE CANCER, V20, P1869, DOI 10.1007/s00520-011-1289-3; Dufour JF, 2013, ANN ONCOL         S2, V24, pii24, DOI DOI 10.1093/ANNONC/MDT054; Heng-jun Gao, 2014, Liver Int, V34, P612, DOI 10.1111/liv.12307; Hucke F, 2014, J HEPATOL, V60, P118, DOI 10.1016/j.jhep.2013.08.022; Kim MJ, 2013, CYTOKINE, V64, P516, DOI 10.1016/j.cyto.2013.07.021; Ko YJ, 2012, CANCER EPIDEM BIOMAR, V21, P2076, DOI 10.1158/1055-9965.EPI-12-0611; Lencioni Riccardo, 2012, Liver Cancer, V1, P41, DOI 10.1159/000339019; Morimoto M, 2012, ANTICANCER RES, V32, P619; Pinato DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083279; Sieghart W, 2013, HEPATOLOGY, V57, P2224, DOI 10.1002/hep.26057; Yoshidome H, 2011, J AM COLL SURGEONS, V212, P796, DOI 10.1016/j.jamcollsurg.2011.01.002; Zhao Y, 2013, ASIA-PAC J CLIN ONCO, V9, P357, DOI 10.1111/ajco.12081	45	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-2813	1365-2036		ALIMENT PHARM THER	Aliment. Pharmacol. Ther.	DEC	2014	40	11-12					1270	1281		10.1111/apt.12992		12	Gastroenterology & Hepatology; Pharmacology & Pharmacy	Gastroenterology & Hepatology; Pharmacology & Pharmacy	AU0OX	WOS:000345324000003		
J	Iwakiri, R; Fujimoto, K				Iwakiri, R.; Fujimoto, K.			Letter: PPI vs. teprenone in preventing recurrence of ulcers during low-dose aspirin - authors' reply	ALIMENTARY PHARMACOLOGY & THERAPEUTICS			English	Letter							ACETYLSALICYLIC-ACID; PEPTIC-ULCERS; ESOMEPRAZOLE		[Iwakiri, R.] Saga Med Sch, Dept Internal Med & Gastrointestinal Endoscopy, Saga, Japan; [Fujimoto, K.] Saga Med Sch, Dept Internal Med, Saga, Japan	Iwakiri, R (reprint author), Saga Med Sch, Dept Internal Med & Gastrointestinal Endoscopy, Saga, Japan.	iwakiri@cc.saga-u.ac.jp					Scheiman JM, 2011, HEART, V97, P797, DOI 10.1136/hrt.2010.217547; Hirakawa T, 1996, GASTROENTEROLOGY, V111, P345, DOI 10.1053/gast.1996.v111.pm8690199; Sugano K, 2011, J GASTROENTEROL, V46, P724, DOI 10.1007/s00535-011-0397-7; Sugano K, 2014, GUT, V63, P1061, DOI 10.1136/gutjnl-2013-304722; Iwakiri R, 2014, ALIMENT PHARM THER, V40, P780, DOI 10.1111/apt.12907; Howden CW, 2014, ALIMENT PHARM THER, V40, P1367, DOI 10.1111/apt.12982	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-2813	1365-2036		ALIMENT PHARM THER	Aliment. Pharmacol. Ther.	DEC	2014	40	11-12					1367	1368		10.1111/apt.12995		2	Gastroenterology & Hepatology; Pharmacology & Pharmacy	Gastroenterology & Hepatology; Pharmacology & Pharmacy	AU0OX	WOS:000345324000020		
J	Nishihara, R; Wang, ML; Qian, ZR; Baba, Y; Yamauchi, M; Mima, K; Sukawa, Y; Kim, SA; Inamura, K; Zhang, XH; Wu, KN; Giovannucci, EL; Chan, AT; Fuchs, CS; Ogino, S; Schernhammer, ES				Nishihara, Reiko; Wang, Molin; Qian, Zhi Rong; Baba, Yoshifumi; Yamauchi, Mai; Mima, Kosuke; Sukawa, Yasutaka; Kim, Sun A.; Inamura, Kentaro; Zhang, Xuehong; Wu, Kana; Giovannucci, Edward L.; Chan, Andrew T.; Fuchs, Charles S.; Ogino, Shuji; Schernhammer, Eva S.			Alcohol, one-carbon nutrient intake, and risk of colorectal cancer according to tumor methylation level of IGF2 differentially methylated region	AMERICAN JOURNAL OF CLINICAL NUTRITION			English	Article						molecular pathological epidemiology; biomarker; epigenetics; imprinting; one carbon metabolism	MOLECULAR PATHOLOGICAL EPIDEMIOLOGY; FACTOR-II GENE; DNA METHYLATION; COLON-CANCER; FOLATE; HYPOMETHYLATION; EXPRESSION; METABOLISM; METHIONINE; VITAMIN-B-6	Background: Although a higher consumption of alcohol, which is a methyl-group antagonist, was previously associated with colorectal cancer risk, mechanisms remain poorly understood. Objective: We hypothesized that excess alcohol consumption might increase risk of colorectal carcinoma with hypomethylation of insulin-like growth factor 2 (IGF2) differentially methylated region-0 (DMR0), which was previously associated with a worse prognosis. Design: With the use of a molecular pathologic epidemiology database in 2 prospective cohort studies, the Nurses' Health Study and Health Professionals Follow-up Study, we examined the association between alcohol intake and incident colorectal cancer according to the tumor methylation level of IGF2 DMR0. Duplication-method Cox proportional cause-specific hazards regression for competing risk data were used to compute HRs and 95% CIs. In addition, we investigated intakes of vitamin B-6, vitamin B-12, methionine, and folate as exposures. Results: During 3,206,985 person-years of follow-up, we identified 993 rectal and colon cancer cases with an available tumor DNA methylation status. Compared with no alcohol consumption, the consumption of >= 15 g alcohol/d was associated with elevated risk of colorectal cancer with lower levels of IGF2 DMR0 methylation [within the first and second quartiles: HRs of 1.55 (95% CI: 1.08, 2.24) and 2.11(95% CI: 1.44, 3.07), respectively]. By contrast, alcohol consumption was not associated with cancer with higher levels of IGF2 DMR0 methylation. The association between alcohol and cancer risk differed significantly by IGF2 DMR0 methylation level (P-heterogeneity = 0.006). The association of vitamin B-6, vitamin B-12, and folate intakes with cancer risk did not significantly differ according to IGF2 DMR0 methylation level (P-heterogeneity > 0.2). Conclusions: Higher alcohol consumption was associated with risk of colorectal cancer with IGF2 DMR0 hypomethylation but not risk of cancer with high-level IGF2 DMR0 methylation. The association between alcohol intake and colorectal cancer risk may differ by tumor epigenetic features.	[Nishihara, Reiko; Qian, Zhi Rong; Yamauchi, Mai; Mima, Kosuke; Sukawa, Yasutaka; Kim, Sun A.; Inamura, Kentaro; Fuchs, Charles S.; Ogino, Shuji] Harvard Univ, Sch Publ Hlth, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Nishihara, Reiko; Wang, Molin; Qian, Zhi Rong; Yamauchi, Mai; Mima, Kosuke; Sukawa, Yasutaka; Kim, Sun A.; Inamura, Kentaro; Zhang, Xuehong; Wu, Kana; Giovannucci, Edward L.; Chan, Andrew T.; Fuchs, Charles S.; Ogino, Shuji; Schernhammer, Eva S.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Nishihara, Reiko; Wu, Kana; Giovannucci, Edward L.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Wang, Molin; Giovannucci, Edward L.; Ogino, Shuji; Schernhammer, Eva S.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Wang, Molin] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Wang, Molin; Zhang, Xuehong; Wu, Kana; Giovannucci, Edward L.; Chan, Andrew T.; Fuchs, Charles S.; Schernhammer, Eva S.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Baba, Yoshifumi] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan; [Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Schernhammer, Eva S.] Appl Canc Res Inst Translat Res Vienna, Vienna, Austria	Nishihara, R (reprint author), Harvard Univ, Sch Publ Hlth, Dept Nutr, Dept Med Oncol,Dana Farber Canc Inst, 665 Huntington Ave,Bldg 2,Room 304, Boston, MA 02115 USA.	rnishiha@hsph.harvard.edu; shuji_ogino@dfci.harvard.edu			NIH [P01 CA87969, P01 CA55075, UM1 CA167552, K07CA190673, P50 CA127003, R01 CA137178, R01 CA151993]; Bennett Family Fund; Entertainment Industry Foundation through the National Colorectal Cancer Research Alliance; Asan Medical Center; Japan Society for Promotion of Sciences; Takashi Tsuruo Memorial Fund; Uehara Memorial Foundation	Supported by NIH grants (P01 CA87969 to SEH; P01 CA55075 and UM1 CA167552 to WCW; K07CA190673 to RN; P50 CA127003 to CSF; R01 CA137178 to ATC; and R01 CA151993 to SO), a grant from the Bennett Family Fund and the Entertainment Industry Foundation through the National Colorectal Cancer Research Alliance, and postdoctoral fellowships from the Asan Medical Center (to SAK), the Japan Society for Promotion of Sciences (to KI), the Takashi Tsuruo Memorial Fund (to KI), and the Uehara Memorial Foundation (to KM). ATC is a Damon Runyon Clinical Investigator.	Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107; Halsted CH, 2002, P NATL ACAD SCI USA, V99, P10072, DOI 10.1073/pnas.112336399; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Harnack L, 2002, NUTR CANCER, V43, P152, DOI 10.1207/S15327914NC432_5; Stram DO, 1996, BIOMETRICS, V52, P536, DOI 10.2307/2532893; Cravo ML, 1996, AM J CLIN NUTR, V63, P220; Bell AC, 2000, NATURE, V405, P482; Bishehsari F, 2014, WORLD J GASTROENTERO, V20, P6055, DOI 10.3748/wjg.v20.i20.6055; Schernhammer ES, 2010, GUT, V59, P794, DOI 10.1136/gut.2009.183707; Curtin K, 2011, NUTR CANCER, V63, P357, DOI 10.1080/01635581.2011.535965; Cui HM, 2002, CANCER RES, V62, P6442; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; Hark AT, 2000, NATURE, V405, P486; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Fedirko V, 2011, ANN ONCOL, V22, P1958, DOI 10.1093/annonc/mdq653; Xue XN, 2013, CANCER EPIDEM BIOMAR, V22, P275, DOI 10.1158/1055-9965.EPI-12-1050; Silva TD, 2013, ONCOL LETT, V6, P1687, DOI 10.3892/ol.2013.1606; WILLETT WC, 1988, AM J EPIDEMIOL, V127, P188; Suzuki H, 2014, BIOCHEM BIOPH RES CO, V455, P35, DOI 10.1016/j.bbrc.2014.07.007; GIOVANNUCCI E, 1993, J NATL CANCER I, V85, P875, DOI 10.1093/jnci/85.11.875; Colussi D, 2013, INT J MOL SCI, V14, P16365, DOI 10.3390/ijms140816365; Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200; Varela-Rey M, 2013, ALCOHOL RES-CURR REV, V35, P25; Byun HM, 2007, CANCER RES, V67, P10753, DOI 10.1158/0008-5472.CAN-07-0329; Nishihara R, 2013, JAMA-J AM MED ASSOC, V309, P2563, DOI 10.1001/jama.2013.6599; Barrow TM, 2014, BIOCHEM BIOPH RES CO, V455, P70, DOI 10.1016/j.bbrc.2014.08.002; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Ribarska T, 2014, EPIGENETICS-US, V9, P704, DOI 10.4161/epi.28006; Cheng YW, 2010, INT J CANCER, V127, P568, DOI 10.1002/ijc.25086; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Kim YI, 2004, ENVIRON MOL MUTAGEN, V44, P10, DOI 10.1002/em.20025; Baba Y, 2010, GASTROENTEROLOGY, V139, P1855, DOI 10.1053/j.gastro.2010.07.050; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Duthie SJ, 2011, J INHERIT METAB DIS, V34, P101, DOI 10.1007/s10545-010-9128-0; Ito Y, 2008, HUM MOL GENET, V17, P2633, DOI 10.1093/hmg/ddn163; Ogino S, 2013, MODERN PATHOL, V26, P465, DOI 10.1038/modpathol.2012.214; Zakhari S, 2013, ALCOHOL RES-CURR REV, V35, P6; Bardhan Kankana, 2013, Cancers (Basel), V5, P676, DOI 10.3390/cancers5020676; Choi SW, 1999, J NUTR, V129, P1945; Cruz-Correa M, 2004, GASTROENTEROLOGY, V126, P964, DOI 10.1053/j.gastro.2003.12.051; GIOVANNUCCI E, 1995, J NATL CANCER I, V87, P265, DOI 10.1093/jnci/87.4.265; Giovannucci E, 1998, ANN INTERN MED, V129, P517; Kohda M, 2001, MOL CARCINOGEN, V31, P184, DOI 10.1002/mc.1053; Murata A, 2014, ANN SURG ONCOL, V21, P1166, DOI 10.1245/s10434-013-3414-7; Nan HM, 2013, ANN EPIDEMIOL, V23, P558, DOI 10.1016/j.annepidem.2013.04.011; Nie ZL, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-86; Ogino S, 2013, JNCI-J NATL CANCER I, V105, P130, DOI 10.1093/jnci/djs482; Pan YQ, 2013, ONCOL REP, V30, P1814, DOI 10.3892/or.2013.2646; Schernhammer ES, 2008, GASTROENTEROLOGY, V135, P770, DOI 10.1053/j.gastro.2008.06.033; Schernhammer ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021102; Stickel F, 2000, ALCOHOL CLIN EXP RES, V24, P259, DOI 10.1097/00000374-200003000-00002; Therneau T. M., 2001, MODELING SURVIVAL DA; Tillmans LS, 2014, CANCER EPIDEM BIOMAR, V23, P350, DOI 10.1158/1055-9965.EPI-13-0780; Van Guelpen B, 2010, CANCER CAUSE CONTROL, V21, P557, DOI 10.1007/s10552-009-9484-y; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51	55	0	1	AMER SOC NUTRITION-ASN	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0002-9165	1938-3207		AM J CLIN NUTR	Am. J. Clin. Nutr.	DEC	2014	100	6					1479	1488		10.3945/ajcn.114.095539		10	Nutrition & Dietetics	Nutrition & Dietetics	AT9SZ	WOS:000345267600011		
J	Nagai, H; Maeda, H; Kuroda, R; Komori, M; Nakajima, M; Nara, A; Ito-Tsujimura, T; Shintani-Ishida, K; Yahagi, N; Yoshida, K				Nagai, Hisashi; Maeda, Hideyuki; Kuroda, Ryohei; Komori, Masatomo; Nakajima, Makoto; Nara, Akina; Ito-Tsujimura, Takako; Shintani-Ishida, Kaori; Yahagi, Naoki; Yoshida, Ken-ichi			Lethal Pulmonary Air Embolism Caused by the Removal of a Double-Lumen Hemodialysis Catheter	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						air embolism; central catheter; double-lumen catheter; hemodialysis; pulmonary artery		Pulmonary air embolisms due to the removal of a central venous catheter are rare, but catheter removal is known to be a high risk factor for air embolism. In particular, the removal of a large catheter, such as a double-lumen hemodialysis catheter, can allow a large amount of air to enter into the bloodstream, which often results in sudden death. So, during catheter removal, special care should be taken to prevent air from entering blood vessels, for example, to ensure that the patient's head is tilted downward, that they have inhaled and are holding their breath, and that a covering gauze and inert ointment have been applied to the exit site. We report a lethal case of pulmonary air embolism caused by the removal of a double-lumen catheter from the right internal jugular vein of a patient who was sitting up and had not been instructed to hold their breath.	[Nagai, Hisashi; Maeda, Hideyuki; Kuroda, Ryohei; Komori, Masatomo; Nakajima, Makoto; Nara, Akina; Ito-Tsujimura, Takako; Shintani-Ishida, Kaori; Yoshida, Ken-ichi] Univ Tokyo, Grad Sch Med, Dept Forens Med, Tokyo 1130033, Japan; [Yahagi, Naoki] Univ Tokyo, Grad Sch Med, Dept Emergency & Crit Care Med, Tokyo 1130033, Japan	Nagai, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Forens Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	nagai@legalmed.jp					ADORNATO DC, 1978, ANESTHESIOLOGY, V49, P120, DOI 10.1097/00000542-197808000-00013; Mirski MA, 2007, ANESTHESIOLOGY, V106, P164, DOI 10.1097/00000542-200701000-00026; Boer WH, 1999, NEPHROL DIAL TRANSPL, V14, P1850, DOI 10.1093/ndt/14.8.1850; FLANAGAN JP, 1969, NEW ENGL J MED, V281, P488, DOI 10.1056/NEJM196908282810907; Grifols JR, 2005, J CLIN APHERESIS, V20, P93, DOI 10.1002/jca.20055; Mendieta J M, 1988, J Ky Med Assoc, V86, P169; OREBAUGH SL, 1992, CRIT CARE MED, V20, P1169, DOI 10.1097/00003246-199208000-00017; Rademaker BMP, 2008, BRIT J ANAESTH, V101, P230, DOI 10.1093/bja/aen138; Sviri S, 2004, Crit Care Resusc, V6, P271; Toung TJK, 2001, ANESTHESIOLOGY, V94, P360, DOI 10.1097/00000542-200102000-00031; TURNAGE WS, 1991, ANESTH ANALG, V72, P559; Vesely TM, 2001, J VASC INTERV RADIOL, V12, P1291, DOI 10.1016/S1051-0443(07)61554-1	12	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0195-7910	1533-404X		AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	DEC	2014	35	4					237	238		10.1097/PAF.0b013e318288b1ee		2	Medicine, Legal; Pathology	Legal Medicine; Pathology	AU0FW	WOS:000345299900004		
J	Matui, H; Sato, Y				Matui, Hiroki; Sato, Yasuhiko			Z-STABILITY OF CROSSED PRODUCTS BY STRONGLY OUTER ACTIONS II	AMERICAN JOURNAL OF MATHEMATICS			English	Article							C-ASTERISK-ALGEBRAS; JIANG-SU ALGEBRA; ROHLIN PROPERTY; UHF ALGEBRAS; STAR-ALGEBRAS; AUTOMORPHISMS; NUCLEAR; CLASSIFICATION; HOMOTOPY	We consider a crossed product of a unital simple separable nuclear stably finite Z-stable C*-algebra A by a strongly outer cocycle action of a discrete countable amenable group P. Under the assumption that A has finitely many extremal tracial states and Gamma is elementary amenable, we show that the twisted crossed product C*-algebra is Z-stable. As an application, we also prove that all strongly outer cocycle actions of the Klein bottle group on Z are cocycle conjugate to each other. This is the first classification result for actions of non-abelian infinite groups on stably finite C*-algebras.	[Matui, Hiroki] Chiba Univ, Grad Sch Sci, Inage Ku, Chiba 2638522, Japan; [Sato, Yasuhiko] Kyoto Univ, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan	Matui, H (reprint author), Chiba Univ, Grad Sch Sci, Inage Ku, Chiba 2638522, Japan.	matui@math.s.chiba-u.ac.jp; ysato@math.kyoto-u.ac.jp					Sato Y, 2010, J FUNCT ANAL, V259, P453, DOI 10.1016/j.jfa.2010.04.006; Izumi M, 2010, ADV MATH, V224, P355, DOI 10.1016/j.aim.2009.11.014; Rordam M, 2010, J REINE ANGEW MATH, V642, P129, DOI 10.1515/CRELLE.2010.039; Toms AS, 2007, T AM MATH SOC, V359, P3999, DOI 10.1090/S0002-9947-07-04173-6; Rordam M, 2004, INT J MATH, V15, P1065, DOI 10.1142/S0129167X04002661; [Anonymous], 2002, ENC MAT SCI; CONNES A, 1975, ANN SCI ECOLE NORM S, V8, P383; Kishimoto A, 1998, J FUNCT ANAL, V160, P270, DOI 10.1006/jfan.1998.3333; Winter W, 2012, INVENT MATH, V187, P259, DOI 10.1007/s00222-011-0334-7; CHOU C, 1980, ILLINOIS J MATH, V24, P396; Matui H, 2012, COMMUN MATH PHYS, V314, P193, DOI 10.1007/s00220-011-1392-9; Matui H, 2012, ACTA MATH-DJURSHOLM, V209, P179, DOI 10.1007/s11511-012-0084-4; Winter W, 2011, J NONCOMMUT GEOM, V5, P253, DOI 10.4171/JNCG/74; Matui H, 2011, J REINE ANGEW MATH, V657, P225, DOI 10.1515/CRELLE.2011.065; Katsura T, 2008, ADV MATH, V218, P940, DOI 10.1016/j.aim.2008.01.014; Lin HX, 2009, AM J MATH, V131, P1589; Matui H, 2010, COMMUN MATH PHYS, V297, P529, DOI 10.1007/s00220-009-0969-z; KISHIMOTO A, 1995, J REINE ANGEW MATH, V465, P183; Toms AS, 2008, CAN J MATH, V60, P703, DOI 10.4153/CJM-2008-031-6; Jiang XH, 1999, AM J MATH, V121, P359; Bratteli O, 1998, J FUNCT ANAL, V160, P466, DOI 10.1006/jfan.1998.3261; Phillips NC, 2011, AM J MATH, V133, P581; Connes A., 1974, J FUNCT ANAL, V16, P415, DOI 10.1016/0022-1236(74)90059-7; Day M., 1957, ILLINOIS J MATH, V1, P509; DELAHARPE P, 1984, ANN I FOURIER, V34, P241; Futamura H, 2003, J FUNCT ANAL, V197, P560, DOI 10.1016/S0022-1236(02)00024-1; HAAGERUP U, 1983, INVENT MATH, V74, P305, DOI 10.1007/BF01394319; JOHNSON BE, 1972, AM J MATH, V94, P685, DOI 10.2307/2373751; Jones V. F. R., 1980, MEM AM MATH SOC, V28; Kishimoto A, 2001, J OPERAT THEOR, V46, P99; Kishimoto A, 1998, J OPERAT THEOR, V40, P277; Kishimoto A, 2003, CAN MATH BULL, V46, P365, DOI 10.4153/CMB-2003-038-3; Lin H., 2010, MEM AM MATH SOC, V205, p[vi, 131]; Loring T. A., 1997, FIELDS I MONOGR, V8; Masuda T., PREPRINT; Matui H, 2011, J FUNCT ANAL, V260, P797, DOI 10.1016/j.jfa.2010.11.001; Nakamura H, 1999, J MATH SOC JPN, V51, P583, DOI 10.2969/jmsj/05130583; Ocneanu A., 1985, LECT NOTES MATH, V1138; Osaka H, 2006, ERGOD THEOR DYN SYST, V26, P1623, DOI 10.1017/S0143385706000277; PACKER JA, 1989, MATH PROC CAMBRIDGE, V106, P293; Sato Y., PREPRINT; Takesaki M., 2002, ENCY MATH SCI, V124; Takesaki M., 2003, ENCY MATH SCI, V127; THOMSEN K, 1987, J FUNCT ANAL, V72, P182, DOI 10.1016/0022-1236(87)90085-1	44	2	2	JOHNS HOPKINS UNIV PRESS	BALTIMORE	JOURNALS PUBLISHING DIVISION, 2715 NORTH CHARLES ST, BALTIMORE, MD 21218-4363 USA	0002-9327	1080-6377		AM J MATH	Am. J. Math.	DEC	2014	136	6					1441	1496				56	Mathematics	Mathematics	AT4KP	WOS:000344908500001		
J	Ogura, K; Takeshita, K; Arakawa, C; Shimojima, K; Yamamoto, T				Ogura, Kaeko; Takeshita, Kenzo; Arakawa, Chikako; Shimojima, Keiko; Yamamoto, Toshiyuki			Neuropsychological Profiles of Patients With 2q37.3 Deletion Associated With Developmental Dyspraxia	AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS			English	Article						2q37; 3 deletion; intellectual disability; autism spectrum disorder; developmental dyspraxia; brachydactyly mental retardation syndrome (BDMR); Albright hereditary osteodystrophy-like syndrome (AHO-like); histone deacetylase 4 gene (HDAC4)	MENTAL-RETARDATION SYNDROME; BRACHYDACTYLY TYPE-E; CHILDHOOD AUTISM; CANDIDATE REGION; CHILDREN; HDAC4; MUTATIONS; SPECTRUM; FEATURES; FAMILY	Patients with 2q37 deletions manifest brachydactyly mental retardation syndrome (BDMR). Recent advances in human molecular research have revealed that alterations in the histone deacetylase 4 gene (HDAC4) are responsible for the clinical manifestations of BDMR. Here, we report two male patients with 2q37.3 deletions. One of the patients showed a typical BDMR phenotype, and HDAC4 was included in the deletion region. HDAC4 was preserved in the other patient, and he showed a normal intelligence level with the delayed learning of complex motor skills. Detailed neuropsychological examinations revealed similar neuropsychological profiles in these two patients (visuo-spatial dyspraxia) that suggested developmental dyspraxia. These observations suggested that some other candidate genes for neuronal development exist in the telomeric region of HDAC4. (c) 2014 Wiley Periodicals, Inc.	[Ogura, Kaeko] Res Inst Natl Rehabil Ctr Persons Disabil, Dev Disabil Study Sect, Dept Rehabil Brain Funct, Tokorozawa, Saitama, Japan; [Ogura, Kaeko] Tohoku Univ, Grad Sch Med, Dept Behav Neurol & Cognit Neurosci, Sendai, Miyagi 980, Japan; [Takeshita, Kenzo] NPO Child Guidance Ctr, Fukuoka, Japan; [Arakawa, Chikako] Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Tokyo, Japan; [Shimojima, Keiko; Yamamoto, Toshiyuki] Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo 1628666, Japan	Yamamoto, T (reprint author), Tokyo Womens Med Univ, Inst Integrated Med Sci, Shinjuku Ward, 8-1 Kawada Cho, Tokyo 1628666, Japan.	yamamoto.toshiyuki@twmu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Ministry of Health, Labor, and Welfare, Japan; Japan Society for the Promotion of Science (J.S.P.S)	Grant sponsor: Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Grant sponsor: Ministry of Health, Labor, and Welfare, Japan; Grant sponsor: Japan Society for the Promotion of Science (J.S.P.S).	Abaskharoun M, 2010, ASN NEURO, V2, DOI 10.1042/AN20100001; Chaabouni M, 2006, EUR J MED GENET, V49, P255, DOI 10.1016/j.ejng.2005.07.001; Williams SR, 2010, AM J HUM GENET, V87, P219, DOI 10.1016/j.ajhg.2010.07.011; SCHOPLER E, 1980, J AUTISM DEV DISORD, V10, P91, DOI 10.1007/BF02408436; Klebe S, 2012, EUR J HUM GENET, V20, P645, DOI 10.1038/ejhg.2011.261; Morris B, 2012, AM J MED GENET A, V158A, P2015, DOI 10.1002/ajmg.a.35463; Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001; Leroy C, 2013, EUR J HUM GENET, V21, P602, DOI 10.1038/ejhg.2012.230; Matsuki T, 2010, CELL, V143, P826, DOI 10.1016/j.cell.2010.10.029; Shimojima K, 2011, AM J MED GENET A, V155A, P732, DOI 10.1002/ajmg.a.33891; Erlich Y, 2011, GENOME RES, V21, P658, DOI 10.1101/gr.117143.110; Wilson NH, 2013, NEURON, V79, P478, DOI 10.1016/j.neuron.2013.05.025; Struys EA, 2005, AM J HUM GENET, V76, P358, DOI 10.1086/427890; Shimojima K, 2009, GENOMICS, V94, P414, DOI 10.1016/j.ygeno.2009.08.015; Taniai H, 2008, AM J MED GENET B, V147B, P844, DOI 10.1002/ajmg.b.30740; Dewey D, 1995, BRAIN COGNITION, V29, P254, DOI 10.1006/brcg.1995.1281; Fazzi E, 2004, BRAIN DEV-JPN, V26, P506, DOI 10.1016/j.braindev.2004.02.002; Felder B, 2009, AM J MED GENET A, V149A, P952, DOI 10.1002/ajmg.a.32779; Galasso C, 2008, J CHILD NEUROL, V23, P802, DOI 10.1177/0883073808314150; Ghaziuddin M, 1999, J AUTISM DEV DISORD, V29, P259, DOI 10.1023/A:1023088207468; Jen YHLD, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-33; Kanai C, 2004, PSYCHIAT CLIN NEUROS, V58, P217, DOI 10.1111/j.1440-1819.2003.01220.x; Leiserson WM, 2000, NEURON, V28, P793, DOI 10.1016/S0896-6273(00)00154-9; Lukusa T, 2004, GENET COUNSEL, V15, P293; Matsuki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031152; Mazzone L, 2012, J AUTISM DEV DISORD, V42, P2202, DOI 10.1007/s10803-011-1432-5; Shrimpton AE, 2004, CLIN GENET, V66, P537, DOI 10.1111/j.1399-0004.2004.00363.x; Syrrou M, 2002, AM J MED GENET, V108, P310, DOI 10.1002/ajmg.10266; Villavicencio-Lorini P, 2013, EUR J HUM GENET, V21, P743, DOI 10.1038/ejhg.2012.240; Wolff DJ, 2002, GENET MED, V4, P10, DOI 10.1097/00125817-200201000-00002; Yamane R, 1990, JAPAN J LOGOPEDICS P, V31, P172	31	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4841	1552-485X		AM J MED GENET B	Am. J. Med. Genet. B	DEC	2014	165	8					684	690		10.1002/ajmg.b.32274		7	Genetics & Heredity; Psychiatry	Genetics & Heredity; Psychiatry	AU0PZ	WOS:000345327200008		
J	Murakami, I; Takata, K; Matsushita, M; Nonaka, D; Iwasaki, T; Kuwamoto, S; Kato, M; Mohri, T; Nagata, K; Kitamura, Y; Yoshino, T; Hayashi, K				Murakami, Ichiro; Takata, Katsuyoshi; Matsushita, Michiko; Nonaka, Daisuke; Iwasaki, Takeshi; Kuwamoto, Satoshi; Kato, Masako; Mohri, Takashi; Nagata, Keiko; Kitamura, Yukisato; Yoshino, Tadashi; Hayashi, Kazuhiko			Immunoglobulin Expressions Are Only Associated With MCPyV-positive Merkel Cell Carcinomas But Not With MCPyV-negative Ones Comparison of Prognosis	AMERICAN JOURNAL OF SURGICAL PATHOLOGY			English	Article						Merkel cell polyomavirus; Merkel cell carcinoma; immunoglobulin gene expressions; IgH rearrangement	POTENTIAL DIAGNOSTIC PITFALL; KAPPA-LIGHT-CHAIN; EPITHELIAL CANCER-CELLS; PAX5 EXPRESSION; POLYOMAVIRUS; GENE; TDT; DIFFERENTIATION; RECOMBINATIONS; LYMPHOMA	Merkel cell carcinoma (MCC) is an aggressive neuroendocrine skin cancer, often associated with Merkel cell polyomavirus (MCPyV). Recently, immunoglobulin (Ig) expression was reported in MCC, thereby suggesting that B cells might be their cellular ancestors. We tested 30 MCCs (20 MCPyV-positive and 10 MCPyV-negative) using immunohistochemistry for the expressions of IgG, IgA, IgM, Ig kappa, Ig lambda, terminal desoxynucleotidyl transferase, paired box gene 5 (PAX5), octamer transcription factor-2 (Oct-2), and sex-determining region Y-box 11 (SOX11). We performed in situ hybridization for Ig kappa-mRNA or Ig lambda-mRNA and Ig heavy chain (IgH) gene rearrangement (IgH-R) analyses. The expressions of PAX5, TdT, Oct-2, and SOX11 were not significantly different between MCPyV-positive and MCPyV-negative MCCs. At least 1 of IgG, IgA, IgM, or Ig kappa was expressed in MCPyV-positive (14/20, 70%) and none in MCPyV-negative MCCs (P = 0.0003). There was a higher tendency for Ig kappa-mRNA expression (7/19, using in situ hybridization) and IgH-R (10/20, using polymerase chain reaction) in MCPyV-positive than in MCPyV-negative MCCs (0/10 and 2/10, respectively), thus suggesting a different Ig production pattern and pathogenesis between the 2 types of MCC. Ig expression or IgH-R in MCPyV-positive MCCs might be associated with MCPyV gene integration or expression in cancer cells but do not necessarily suggest a B-cell origin for MCCs. IgH expression or IgH-R nonsignificantly correlated with improved prognosis. However, these might be important factors that influence the survival of neoplastic cells and might allow the development of novel therapies for patients with MCPyV-positive MCCs.	[Murakami, Ichiro; Iwasaki, Takeshi; Kuwamoto, Satoshi; Kato, Masako; Mohri, Takashi; Nagata, Keiko; Hayashi, Kazuhiko] Tottori Univ, Fac Med, Div Mol Pathol, Yonago, Tottori 6838503, Japan; [Matsushita, Michiko; Kitamura, Yukisato] Tottori Univ, Fac Med, Sch Hlth Sci, Dept Pathobiol Sci & Technol, Yonago, Tottori 6838503, Japan; [Takata, Katsuyoshi; Yoshino, Tadashi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, Okayama 7008530, Japan; [Nonaka, Daisuke] Christie NHS Fdn Trust, Dept Histopathol, Manchester, Lancs, England	Murakami, I (reprint author), Tottori Univ, Fac Med, Div Mol Pathol, 86 Nishi Cho, Yonago, Tottori 6838503, Japan.	ichiro.murakami.09@gmail.com					Takata K, 2013, MODERN PATHOL, V26, P22, DOI 10.1038/modpathol.2012.127; Qiu XY, 2003, CANCER RES, V63, P6488; zur Hausen A, 2013, CANCER RES, V73, P4982, DOI 10.1158/0008-5472.CAN-13-0616; Vegliante MC, 2013, BLOOD, V121, P2175, DOI 10.1182/blood-2012-06-438937; Chen ZS, 2007, FASEB J, V21, P2931, DOI 10.1096/fj.07-8073com; Kanteti R, 2009, LAB INVEST, V89, P301, DOI 10.1038/labinvest.2008.168; Li M, 2004, INT J BIOCHEM CELL B, V36, P2250, DOI 10.1016/j.biocel.2004.03.017; Zheng J, 2009, J BIOL CHEM, V284, P13610, DOI 10.1074/jbc.M809524200; Dong HY, 2005, AM J SURG PATHOL, V29, P687, DOI 10.1097/01.pas.0000155162.33044.4f; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Rodig SJ, 2012, J CLIN INVEST, V122, P4645, DOI 10.1172/JCI64116; Kuwamoto S, 2011, HUM PATHOL, V42, P632, DOI 10.1016/j.humpath.2010.09.011; Kuwamoto S, 2011, HUM PATHOL, V42, P1063, DOI 10.1016/j.humpath.2011.01.020; Zheng H, 2007, MOL IMMUNOL, V44, P2221, DOI 10.1016/j.molimm.2006.11.010; Liao W, 1999, ACTA BIOCH BIOPH SIN, V31, P659; Kolhe R, 2013, INT J CLIN EXP PATHO, V6, P142; Buresh CJ, 2008, AM J CLIN PATHOL, V129, P894, DOI 10.1309/R494HQ9VRDJWDY30; Hu FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051423; Iwasaki T, 2013, HUM PATHOL, V44, P1912, DOI 10.1016/j.humpath.2013.01.026; Liu HD, 2007, CELL SIGNAL, V19, P419, DOI 10.1016/j.cellsig.2006.07.012; McCardle TW, 2010, CURR PROB CANCER, V34, P47, DOI 10.1016/j.currproblcancer.2010.02.002; Morgenstern DA, 2010, AM J CLIN PATHOL, V133, P407, DOI [10.1309/AJCPZPQN0LUGKMME, 10.1309/AJCPZPQNOLUGKMME]; Storey R., 2013, J ONCOL, V2013; Sur M, 2007, MODERN PATHOL, V20, P1113, DOI 10.1038/modpathol.3800936; Swann MH, 2007, SEMIN ONCOL, V34, P51, DOI 10.1053/j.seminoncol.2006.10.021; Welinder C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061749; Yang SB, 2009, SCAND J GASTROENTERO, V44, P1443, DOI 10.3109/00365520903369953	27	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0147-5185	1532-0979		AM J SURG PATHOL	Am. J. Surg. Pathol.	DEC	2014	38	12					1627	1635				9	Pathology; Surgery	Pathology; Surgery	AT7QD	WOS:000345131700006		
J	Bhinder, S; Chen, H; Sato, M; Copes, R; Evans, GJ; Chow, CW; Singer, LG				Bhinder, S.; Chen, H.; Sato, M.; Copes, R.; Evans, G. J.; Chow, C. -W.; Singer, L. G.			Air Pollution and the Development of Posttransplant Chronic Lung Allograft Dysfunction	AMERICAN JOURNAL OF TRANSPLANTATION			English	Article							BRONCHIOLITIS-OBLITERANS-SYNDROME; LONG-TERM EXPOSURE; PRIMARY GRAFT DYSFUNCTION; FINE PARTICULATE MATTER; CORONARY-HEART-DISEASE; TRANSPLANT RECIPIENTS; GASTROESOPHAGEAL-REFLUX; RESIDENTIAL PROXIMITY; RESPIRATORY VIRUSES; MORTALITY	Chronic lung allograft dysfunction (CLAD) is the leading cause of mortality following lung transplantation. We conducted a retrospective cohort study including 397 bilateral lung recipients transplanted in from 1996 to 2009 to determine the association between ambient air pollution, CLAD and mortality. Pollution exposure was assessed using satellite-based estimates of nitrogen dioxide, distance to major roadway and total length of roadways around a patient's home. Cumulative exposures to ozone and particulate matter were estimated from concentrations measured at fixed-site stations near patients' homes using inverse distance weighted interpolation. Cox proportional hazards models were used to estimate the associations of CLAD with air pollution exposure, adjusting for various individual and neighborhood characteristics. During the follow-up, 185 patients developed CLAD (47%) and 101 patients died (25%). Fifty-four deaths (53%) were due to CLAD. We observed an association between CLAD development and road density within 200m of a patient's home (HR 1.30 [95% CI 1.07-1.58]). Although based on a subgroup of 14 patients, living within 100m of a highway was associated with a high risk for developing CLAD (HR 4.91 [95% CI 2.22, 10.87]). These data suggest that exposure to traffic-related air pollution is associated with development of CLAD among lung transplant recipients. This retrospective cohort study demonstrates an association between surrogate measures of traffic-related air pollution at recipients' home addresses and the development of chronic lung allograft dysfunction.	[Bhinder, S.; Chow, C. -W.; Singer, L. G.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Chen, H.; Copes, R.] Publ Hlth Ontario, Toronto, ON, Canada; [Chen, H.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Chen, H.; Copes, R.; Chow, C. -W.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Sato, M.] Kyoto Univ, Kyoto, Japan; [Evans, G. J.; Chow, C. -W.] Univ Toronto, Dept Chem Engn & Appl Chem, Southern Ontario Ctr Atmospher Aerosol Res, Toronto, ON, Canada	Singer, LG (reprint author), Univ Toronto, Dept Med, Toronto, ON, Canada.	lianne.singer@uhn.ca			Canadian Foundation for Innovation; Ontario Ministry for Research and Innovation	The study used data from Trillium Gift of Life, Toronto General Hospital Multi-Organ Transplant Program, Public Health Ontario, Southern Ontario Centre for Atmospheric Aerosol Research and was funded by the Canadian Foundation for Innovation and the Ontario Ministry for Research and Innovation. We are grateful to Colin Lee for providing the satellite remote sensing-based exposure estimates and Steven Johnson at Public Health Ontario for providing GIS support. The NAPS fixed-site data were provided by Environment Canada and the Ontario Ministry of the Environment.	Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012; Rosenbloom JI, 2012, CIRCULATION, V125, P2197, DOI 10.1161/CIRCULATIONAHA.111.085811; Chen H, 2013, ENVIRON HEALTH PERSP, V121, P804, DOI 10.1289/ehp.1205958; Yusen RD, 2013, J HEART LUNG TRANSPL, V32, P965, DOI 10.1016/j.healun.2013.08.007; Gauderman WJ, 2007, LANCET, V369, P571, DOI 10.1016/S0140-6736(07)60037-3; Burton CM, 2009, J HEART LUNG TRANSPL, V28, P888, DOI 10.1016/j.healun.2009.04.022; Gan WQ, 2010, EPIDEMIOLOGY, V21, P642, DOI 10.1097/EDE.0b013e3181e89f19; Mehta S, 2013, AIR QUAL ATMOS HLTH, V6, P69, DOI 10.1007/s11869-011-0146-3; Penttinen P, 2001, EUR RESPIR J, V17, P428, DOI 10.1183/09031936.01.17304280; Patel MM, 2009, AM J RESP CRIT CARE, V180, P1107, DOI 10.1164/rccm.200901-0122OC; Nordenhall C, 2001, EUR RESPIR J, V17, P909, DOI 10.1183/09031936.01.17509090; Gehring U, 2010, AM J RESP CRIT CARE, V181, P596, DOI 10.1164/rccm.200906-0858OC; Gilbert NL, 2005, J AIR WASTE MANAGE, V55, P1059; Sato M, 2011, J HEART LUNG TRANSPL, V30, P735, DOI 10.1016/j.healun.2011.01.712; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Chen H, 2013, EPIDEMIOLOGY, V24, P35, DOI 10.1097/EDE.0b013e318276c005; Lee CJ, 2011, ATMOS CHEM PHYS, V11, P11761, DOI 10.5194/acp-11-11761-2011; Dales R, 2009, J OCCUP ENVIRON MED, V51, P654, DOI 10.1097/JOM.0b013e3181a0363c; Abbey DE, 1999, AM J RESP CRIT CARE, V159, P373; Chen H, 2014, CIRCULATION, V129, P562, DOI 10.1161/CIRCULATIONAHA.113.003532; Chauhan AJ, 2003, BRIT MED BULL, V68, P95, DOI 10.1093/bmb/ldg022; Kumar D, 2005, AM J TRANSPLANT, V5, P2031, DOI 10.1111/j.1600-6143.2005.00971.x; Palmer SM, 2002, TRANSPLANTATION, V74, P799, DOI 10.1097/01.TP.0000028254.63164.53; Gehring U, 2006, EPIDEMIOLOGY, V17, P545, DOI 10.1097/01.ede.0000224541.38258.87; King BJ, 2009, J HEART LUNG TRANSPL, V28, P870, DOI 10.1016/j.healun.2009.05.040; Valentine VG, 2009, J HEART LUNG TRANSPL, V28, P163, DOI 10.1016/j.healun.2008.11.907; Hadjiliadis D, 2003, CLIN TRANSPLANT, V17, P363, DOI 10.1034/j.1399-0012.2003.00060.x; Brook Robert D, 2007, J Clin Hypertens (Greenwich), V9, P629, DOI 10.1111/j.1524-6175.2007.07187.x; Brunekreef B, 2009, RES REP HLTH EFF I, V139, P5; Hoek G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-43; Huang HJ, 2008, AM J TRANSPLANT, V8, P2454, DOI 10.1111/j.1600-6143.2008.02389.x; Jerrett M, 2009, ENVIRON HEALTH PERSP, V117, P772, DOI 10.1289/ehp.11533; Johnson S., 2013, COMMUNICATION; Krewski D, 2009, RES REP HLTH EFF I, V140, P115; Krewski D., 2009, RES REP HLTH EFF I, V140, P5; Meyers BF, 2005, J THORAC CARDIOV SUR, V129, P1421, DOI 10.1016/j.jtcvs.2005.01.022; Miller RL, 2010, PEDIATR ALLERGY IMMU, V21, P260, DOI 10.1111/j.1399-3038.2009.00980.x; Nawrot TS, 2011, THORAX, V66, P748, DOI 10.1136/thx.2010.155192; Spencer-Hwang R, 2011, J CLIN EXP CARDIOLOG, VS6, P001; Spencer-Hwang R, 2011, AM J KIDNEY DIS, V58, P608, DOI 10.1053/j.ajkd.2011.05.017; The World Bank Environment, 2013, WORLD DEV IND TRAFF; Valentine VG, 1996, J HEART LUNG TRANSPL, V15, P371; Verleden SE, 2012, AM J TRANSPLANT, V12, P1831, DOI 10.1111/j.1600-6143.2012.04134.x; Vilchez RA, 2003, AM J TRANSPLANT, V3, P245, DOI 10.1034/j.1600-6143.2003.00056.x; Wallace J, 2011, CAN RESPIR J, V18, P13	46	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-6135	1600-6143		AM J TRANSPLANT	Am. J. Transplant.	DEC	2014	14	12					2749	2757		10.1111/ajt.12909		9	Surgery; Transplantation	Surgery; Transplantation	AU0DR	WOS:000345294300012		
J	Akamatsu, N; Sugawara, Y; Nagata, R; Kaneko, J; Aoki, T; Sakamoto, Y; Hasegawa, K; Kokudo, N				Akamatsu, N.; Sugawara, Y.; Nagata, R.; Kaneko, J.; Aoki, T.; Sakamoto, Y.; Hasegawa, K.; Kokudo, N.			Adult Right Living-Donor Liver Transplantation With Special Reference to Reconstruction of the Middle Hepatic Vein	AMERICAN JOURNAL OF TRANSPLANTATION			English	Article						Clinical research; practice; donor hepatectomy; liver transplantation; hepatology; liver transplantation: living donor	RIGHT-LOBE GRAFTS; SINGLE-CENTER EXPERIENCE; OUTFLOW RECONSTRUCTION; ANTERIOR SEGMENT; REGENERATION; HEPATECTOMY; CONGESTION; TOKYO; COMPLICATIONS; DRAINAGE	Two hundred fifty-three consecutive living-donor liver transplant recipients with a right liver graft (RLG) were divided into three groups: an extended right liver graft (ERLG) group (n=47) in which the middle hepatic vein (MHV) trunk was included in the graft, a modified right liver graft (MRLG) group (n=114) in which the MHV tributaries were reconstructed with cryopreserved homologous veins and a simple RLG group (n=92) in which the MHV tributaries were sacrificed. The volume of the anterior sector was significantly impaired in the RLG group compared to the other two groups, whereas the volume of the posterior sector was significantly improved in the RLG group, indicating that the impaired anterior sector regeneration by MHV deprivation was compensated by the posterior sector regeneration. The regeneration rate of the anterior sector was highest in the ERLG group (92%), moderate in the MRLG group (71%) and lowest in the RLG group (52%). The whole graft regeneration rate of the ERLG group was significantly higher than that of the other two groups. Poor regeneration, however, was not correlated with delayed functional recovery or long-term outcome. Short-term, the patency of reconstructed MHV tributaries was over 90%, but occlusion occurred frequently over the long-term, especially in V5. The authors investigate the effect of reconstruction of the middle hepatic vein on graft regeneration and function in recipients of right living donor liver grafts, and find that the congestion of the middle hepatic vein territory impairs regeneration of the anterior sector of the graft, but not the function of the graft.	[Akamatsu, N.; Sugawara, Y.; Nagata, R.; Kaneko, J.; Aoki, T.; Sakamoto, Y.; Hasegawa, K.; Kokudo, N.] Univ Tokyo, Grad Sch Med, Dept Surg, Artificial Organ & Transplantat Div,Bunkyo Ku, Tokyo, Japan	Sugawara, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg, Artificial Organ & Transplantat Div,Bunkyo Ku, Tokyo, Japan.	yasusuga-tky@umin.ac.jp					Akamatsu N, 2003, TRANSPLANTATION, V76, P832, DOI 10.1097/01.TP.0000085080.37235.81; Akamatsu N, 2006, SURGERY, V139, P765, DOI 10.1016/j.surg.2005.12.011; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Olthoff KM, 2011, LIVER TRANSPLANT, V17, P789, DOI 10.1002/lt.22288; Lee SG, 2002, TRANSPLANTATION, V74, P54; Ohshima S, 2014, J HEPATO-BIL-PAN SCI, V21, P235, DOI 10.1002/jhbp.81; Fan ST, 2003, TRANSPLANTATION, V75, pS25, DOI 10.1097/01.TP.0000046618.44722.BE; Lee S, 2001, TRANSPLANTATION, V71, P812, DOI 10.1097/00007890-200103270-00021; Satou S, 2007, TRANSPLANT P, V39, P145, DOI 10.1016/j.transproceed.2006.10.028; Kinkhabwala MM, 2003, SURGERY, V133, P243, DOI 10.1067/msy.2003.18; Hwang S, 2012, LIVER TRANSPLANT, V18, P955, DOI 10.1002/lt.23456; Sugawara Y, 2004, LIVER TRANSPLANT, V10, P715, DOI 10.1002/lt.20179; Marcos A, 2001, LIVER TRANSPLANT, V7, P845, DOI 10.1053/jlts.2001.27966; URATA K, 1995, HEPATOLOGY, V21, P1317, DOI 10.1016/0270-9139(95)90053-5; Cattral MS, 2004, AM J TRANSPLANT, V4, P751, DOI 10.1111/j.1600-6143.2004.00405.x; Sugawara Y, 2003, ANN SURG, V237, P180, DOI 10.1097/00000658-200302000-00006; Sano K, 2002, ANN SURG, V236, P241, DOI 10.1097/01.SLA.0000021845.89475.00; Kokudo N, 2005, AM J TRANSPLANT, V5, P1694, DOI 10.1111/j.1600-6143.2005.00917.x; Fan ST, 2003, ANN SURG, V238, P137, DOI 10.1097/01.sla.0000077921.38307.16; Sugawara Y, 2004, LIVER TRANSPLANT, V10, P541, DOI 10.1002/lt.20129; Bak T, 2001, LIVER TRANSPLANT, V7, P680, DOI 10.1053/jlts.2001.26509; Campsen J, 2008, TRANSPLANTATION, V85, P775, DOI 10.1097/TP.0b013e31816636ad; Chen HL, 2012, CLIN TRANSPLANT, V26, P694, DOI 10.1111/j.1399-0012.2011.01587.x; de Villa VH, 2003, ANN SURG, V238, P275, DOI 10.1097/01.SLA.0000081093.73347.28; Dulundu E, 2004, TRANSPLANTATION, V78, P574, DOI 10.1097/01.TP.0000128912.09581.46; Ghobrial RM, 2001, LIVER TRANSPLANT, V7, P551, DOI 10.1053/jlts.2001.24910; Hwang S, 2012, TRANSPL P, V44, P457, DOI 10.1016/j.transproceed.2012.01.072; Ikegami T, 2007, TRANSPLANTATION, V84, P836, DOI 10.1097/01.tp.0000282790.66889.a5; Kaneko T, 2005, SURGERY, V138, P21, DOI 10.1016/j.surg.2005.03.012; Kim BW, 2007, TRANSPL P, V39, P3228, DOI 10.1016/j.transproceed.2007.04.024; Marcos A, 2000, ANN SURG, V231, P824, DOI 10.1097/00000658-200006000-00006; Mizuno S, 2006, CLIN TRANSPLANT, V20, P509, DOI 10.1111/j.1399-0012.2006.00515.x; Motomura N, 2002, ARTIF ORGANS, V26, P449, DOI 10.1046/j.1525-1594.2002.06961.x; Pomposelli JJ, 2012, CLIN TRANSPLANT, V26, P470, DOI 10.1111/j.1399-0012.2011.01529.x; Shindoh J, 2012, HEPATO-GASTROENTEROL, V59, P1939, DOI 10.5754/hge10247; Sugawara Y, 2002, LIVER TRANSPLANT, V8, P167, DOI 10.1053/jlts.2002.30580; Toshima T, 2012, TRANSPLANTATION, V93, P929, DOI 10.1097/TP.0b013e3182488bd8; Wang CC, 2014, LIVER TRANSPLANT, V20, P173, DOI 10.1002/lt.23785; Yi NJ, 2013, WORLD J SURG, V37, P1419, DOI 10.1007/s00268-013-1976-y	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-6135	1600-6143		AM J TRANSPLANT	Am. J. Transplant.	DEC	2014	14	12					2777	2787		10.1111/ajt.12917		11	Surgery; Transplantation	Surgery; Transplantation	AU0DR	WOS:000345294300015		
J	Hattori, Y; Kusaka, S; Mukumoto, M; Ishimura, M; Ohta, Y; Takenaka, H; Uehara, K; Asano, T; Suzuki, M; Masunaga, S; Ono, K; Tanimori, S; Kirihata, M				Hattori, Yoshihide; Kusaka, Shintaro; Mukumoto, Mari; Ishimura, Miki; Ohta, Yoichiro; Takenaka, Hiroshi; Uehara, Kouki; Asano, Tomoyuki; Suzuki, Minoru; Masunaga, Shin-ichiro; Ono, Koji; Tanimori, Shinji; Kirihata, Mitsunori			Synthesis and in vitro evaluation of thiododecaborated alpha, alpha- cycloalkylamino acids for the treatment of malignant brain tumors by boron neutron capture therapy	AMINO ACIDS			English	Article						Boron neutron capture therapy; Boron cluster; Boronated amino acid; Immunocytochemistry	GLIOMA-CELLS; AMINO-ACIDS; TRANSPORTER; EXPRESSION; CANCER	Boron-neutron capture therapy (BNCT) is an attractive technique for cancer treatment. As such, alpha, alpha-cycloalkyl amino acids containing thiododecaborate ([B12H11](2-)-S-) units were designed and synthesized as novel boron delivery agents for BNCT. In the present study, new thiododecaborate alpha, alpha-cycloalkyl amino acids were synthesized, and biological evaluation of the boron compounds as boron carrier for BNCT was carried out.	[Hattori, Yoshihide; Mukumoto, Mari; Ishimura, Miki; Ohta, Yoichiro; Kirihata, Mitsunori] Osaka Prefecture Univ, Res Ctr Boron Neutron Capture Therapy, Res Org 21st Century, Naka Ku, Sakai, Osaka 591, Japan; [Kusaka, Shintaro; Tanimori, Shinji] Osaka Prefecture Univ, Dept Biosci & Informat, Grad Sch Life & Environm Sci, Naka Ku, Sakai, Osaka 591, Japan; [Takenaka, Hiroshi; Uehara, Kouki; Asano, Tomoyuki] Stella Pharma Co, Chuo Ku, Osaka, Japan; [Suzuki, Minoru; Masunaga, Shin-ichiro; Ono, Koji] Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 59004, Japan	Hattori, Y (reprint author), Osaka Prefecture Univ, Res Ctr Boron Neutron Capture Therapy, Res Org 21st Century, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 591, Japan.	y0shi_hattori@riast.osakafu-u.ac.jp			Adaptable and Seamless Technology Transfer Program through target-driven RD, JST	This work was supported by the Adaptable and Seamless Technology Transfer Program through target-driven R&D, JST. We thank Professor K. Ogawa of Osaka Prefecture University for his technical support with immunostaining. We also thank Mr. H. Nakashima and Ms. Y. Ishino for the measurement of the ESI-MS.	Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Barth RF, 2005, CLIN CANCER RES, V11, P3987, DOI 10.1158/1078-0432.CCR-05-0035; Soloway AH, 1998, CHEM REV, V98, P1515, DOI 10.1021/cr941195u; Oka S, 2012, NUCL MED BIOL, V39, P109, DOI 10.1016/j.nucmedbio.2011.06.008; Rice SL, 2011, SEMIN NUCL MED, V41, P265, DOI 10.1053/j.semnuclmed.2011.02.002; GABEL D, 1993, INORG CHEM, V32, P2276, DOI 10.1021/ic00063a014; Guo H, 2002, MOL CELL NEUROSCI, V21, P546, DOI 10.1006/mcne.2002.1198; Hattori Y, 2010, P 14 INT C NEUTR CAP, P343; Hattori Y, 2012, J MED CHEM, V55, P6980, DOI 10.1021/jm300749q; Kim DK, 2004, NEUROSCI RES, V50, P437, DOI 10.1016/j.neures.2004.08.003; Kirihata M., 2007, PCT Int. Appl, Patent No. [WO2007097065 A1 20070830, 2007097065, WO2007097065]; Kusaka S, 2011, APPL RADIAT ISOTOPES, V69, P1768, DOI 10.1016/j.apradiso.2011.03.042; Ogawa K, 2006, J CELL SCI, V119, P559, DOI 10.1242/jcs.02777; Rammeloo T, 2002, CHEM COMMUN, P250, DOI 10.1039/b110765h; Soloshonok AV, 2010, SYNTHESIS-STUTTGART, V14, P2319; Yoshimoto M, 2013, NUCL MED BIOL, V40, P625, DOI 10.1016/j.nucmedbio.2013.02.010	16	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	DEC	2014	46	12					2715	2720		10.1007/s00726-014-1829-5		6	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AT6TW	WOS:000345073100008		
J	Ushiroda, J; Inoue, S; Kirita, T; Kawaguchi, M				Ushiroda, J.; Inoue, S.; Kirita, T.; Kawaguchi, M.			A comparison of airway dimensions, measured by acoustic reflectometry and ultrasound before and after general anaesthesia	ANAESTHESIA			English	Article							DIFFICULT TRACHEAL INTUBATION; OBESE-PATIENTS; PRONE POSITION; MALLAMPATI SCORE; SOFT-TISSUE; LARYNGOSCOPY; PRESSURE; SURGERY; LABOR; QUANTIFICATION	Changes in airway dimensions can occur during general anaesthesia and surgery for a variety of reasons. This study explored factors associated with postoperative changes in airway dimensions. Patient airway volume was measured by acoustic reflectometory and neck muscle diameter by ultrasound echography in the pre- and post-anaesthetic periods in a total of 281 patients. Neck circumference was also assessed during these periods. A significant decrease in median (IQR [range]) total airway volume (from 63.8 (51.8-75.7 [14.7-103]) ml to 45.9 (33.5-57.2 [6.4-96.3])ml, p<0.0001), and a significant increase in muscle diameter (from 4.3 (3.3-5.6 [2.2-9.0]) mm to 5.8 (4.7-7.3 [2.8-1.3])mm, p<0.0001) and neck circumference (from 34.0 (32.5-37.0 [29.5-49.0]) cm to 35.0 (33.5-38.0 [30.5-50.5])cm, p<0.0001) were observed. It may be possible that changes in airway volume and neck circumference were influenced by surgical duration or peri-operative fluid management ()=-0.31 (95% CI -0.24 to -0.01), p=0.0301, -0.17 (-0.23 to -0.06), p=0.0038, 0.23 (0.12-0.34), p<0.0001, and 0.16 (0.05-0.27), p=0.0062, respectively). The intra-oral space can significantly decrease and neck thickness increase after general anaesthesia, and might increase the risk of difficult laryngoscopy and intubation if airway management is required after extubation following general anaesthesia.	[Ushiroda, J.; Kawaguchi, M.] Nara Med Univ, Dept Anesthesiol, Kashihara, Nara 634, Japan; [Inoue, S.] Nara Med Univ, Div Intens Care, Kashihara, Nara 634, Japan; [Kirita, T.] Nara Med Univ, Dept Oral & Maxillofacial Surg, Kashihara, Nara 634, Japan	Inoue, S (reprint author), Nara Med Univ, Div Intens Care, Kashihara, Nara 634, Japan.	seninoue@naramed-u.ac.jp					ALDRETE JA, 1995, J CLIN ANESTH, V7, P89, DOI 10.1016/0952-8180(94)00001-K; FAHY BG, 1995, ANESTH ANALG, V81, P744, DOI 10.1097/00000539-199510000-00015; CRUICKSHANK AM, 1990, CLIN SCI, V79, P161; Boutonnet M, 2010, BRIT J ANAESTH, V104, P67, DOI 10.1093/bja/aep356; JOUPPILA R, 1980, ACTA ANAESTH SCAND, V24, P97; Ezri T, 2003, CAN J ANAESTH, V50, P179; Ezri T, 2003, ANAESTHESIA, V58, P1111, DOI 10.1046/j.1365-2044.2003.03412.x; Toyota S, 1998, J CLIN ANESTH, V10, P32, DOI 10.1016/S0952-8180(97)00216-X; PILKINGTON S, 1995, BRIT J ANAESTH, V74, P638, DOI 10.1093/bja/74.6.638; Kodali BS, 2008, ANESTHESIOLOGY, V108, P357, DOI 10.1097/ALN.0b013e31816452d3; Su MC, 2008, RESP PHYSIOL NEUROBI, V161, P306, DOI 10.1016/j.resp.2008.03.004; Juvin P, 2003, ANESTH ANALG, V97, P595, DOI 10.1213/01.ANE.0000072547.75928.B0; Gonzalez H, 2008, ANESTH ANALG, V106, P1132, DOI 10.1213/ane.0b013e3181679659; Komatsu R, 2007, ANAESTH INTENS CARE, V35, P32; Hiremath AS, 1998, BRIT J ANAESTH, V80, P606; Brodsky JB, 2002, ANESTH ANALG, V94, P732, DOI 10.1097/00000539-200203000-00047; Rauh R, 2001, J CLIN ANESTH, V13, P361, DOI 10.1016/S0952-8180(01)00286-0; Cagini L, 2011, EUR J CARDIO-THORAC, V40, pE71, DOI 10.1016/j.ejcts.2011.03.030; Connolly CM, 2003, ANESTHESIOLOGY, V98, P670, DOI 10.1097/00000542-200303000-00015; Eckmann David M., 1996, Anesthesia and Analgesia, V83, P1084, DOI 10.1097/00000539-199611000-00033; FARCON EL, 1994, CAN J ANAESTH, V41, P50; HAUCH MA, 1995, CRIT CARE MED, V23, P510, DOI 10.1097/00003246-199503000-00016; Koh JC, 2013, SPINE, V38, pE678, DOI 10.1097/BRS.0b013e31828cb3e5; Ochroch EA, 2002, ANESTH ANALG, V95, P645, DOI 10.1213/01.ANE.0000024627.44968.7C; Pivalizza EG, 1998, J NEUROSURG ANESTH, V10, P34, DOI 10.1097/00008506-199801000-00008; Shires GT, 1961, ANN SURG, V154, P803; Tanskanen P, 1997, ACTA ANAESTH SCAND, V41, P602; Voyagis GS, 1998, EUR J ANAESTH, V15, P330; World Health Organization (WHO), BMI CLASS; Yumino Dai, 2010, Circulation, V121, P1598, DOI 10.1161/CIRCULATIONAHA.109.902452	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0003-2409	1365-2044		ANAESTHESIA	Anaesthesia	DEC	2014	69	12					1355	1363		10.1111/anae.12825		9	Anesthesiology	Anesthesiology	AT8YR	WOS:000345215400010		
J	Mihara, T; Uchimoto, K; Morita, S; Goto, T				Mihara, T.; Uchimoto, K.; Morita, S.; Goto, T.			The efficacy of lidocaine to prevent laryngospasm in children: a systematic review and meta-analysis	ANAESTHESIA			English	Review							LARYNGEAL MASK AIRWAY; INDUCED EMERGENCE PHENOMENA; 2-PERCENT LIGNOCAINE GEL; INTRAVENOUS LIDOCAINE; ENDOTRACHEAL-TUBE; TRACHEAL INTUBATION; INTRACUFF LIDOCAINE; GENERAL-ANESTHESIA; EXTUBATION LARYNGOSPASM; ALKALINIZED LIGNOCAINE	The purpose of this meta-analysis was to determine the efficacy of lidocaine in preventing laryngospasm during general anaesthesia in children. An electronic search of six databases was conducted. The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines were adhered to. We included randomised controlled trials reporting the effects of intravenous and/or topical lidocaine on the incidence of laryngospasm during general anaesthesia. Nine studies including 787 patients were analysed. The combined results demonstrated that lidocaine is effective in preventing laryngospasm (risk ratio (RR) 0.39, 95% CI 0.24-0.66; I-2=0). Subgroup analysis revealed that both intravenous lidocaine (RR 0.34, 95% CI 0.14-0.82) and topical lidocaine (RR 0.42, 95% CI 0.22-0.80) lidocaine are effective in preventing laryngospasm. The results were not affected by studies with a high risk of bias. We conclude that, both topical and intravenous lidocaine are effective for preventing laryngospasm in children.	[Mihara, T.] Kanagawa Childrens Med Ctr, Dept Anaesthesiol, Yokohama, Kanagawa, Japan; [Uchimoto, K.; Goto, T.] Yokohama City Univ, Grad Sch Med, Dept Anaesthesiol & Crit Care Med, Yokohama, Kanagawa 232, Japan; [Morita, S.] Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Kyoto, Japan	Mihara, T (reprint author), Kanagawa Childrens Med Ctr, Dept Anaesthesiol, Yokohama, Kanagawa, Japan.	miharaxxxtotoro@yahoo.co.jp					Aljonaieh KI, 2012, EFFECT INTRAVENOUS L; Allahyary E, 2012, BRIT J ANAESTH, V108, pii278; Altintas F, 2000, EUR J ANAESTH, V17, P436, DOI 10.1046/j.1365-2346.2000.00696.x; Atkins D, 2004, BRIT MED J, V328, P1490; HAMILL JF, 1981, ANESTHESIOLOGY, V55, P578, DOI 10.1097/00000542-198111000-00016; Liberati A, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000100; Minogue SC, 2004, ANESTH ANALG, V99, P1253, DOI 10.1213/01.ANE.0000132779.27085.52; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; CHAN ST, 1995, ANAESTHESIA, V50, P257, DOI 10.1111/j.1365-2044.1995.tb04571.x; OLSSON GL, 1984, ACTA ANAESTH SCAND, V28, P567; Baik HJ, 2009, EUR J ANAESTH, V26, P377, DOI 10.1097/EJA.0b013e32831dcd4d; Arslan IB, 2013, OTOLARYNG HEAD NECK, V149, P466, DOI 10.1177/0194599813495372; BARAKA A, 1978, ANESTH ANALG, V57, P506; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BIDWAI A V, 1979, Anesthesiology (Hagerstown), V51, pS50; Cavallone LF, 2013, ANESTH ANALG, V116, P368, DOI 10.1213/ANE.0b013e31827ab572; Diachun CAB, 2001, J CLIN ANESTH, V13, P447, DOI 10.1016/S0952-8180(01)00299-9; Erb TO, 2013, ANAESTHESIA, V68, P13, DOI 10.1111/j.1365-2044.2012.07295.x; Estebe JP, 2002, ANESTH ANALG, V94, P227, DOI 10.1097/00000539-200201000-00044; Estebe JP, 2005, ANESTH ANALG, V101, P1536, DOI 10.1213/01.ANE.0000180995.24211.89; Estebe JP, 2004, BRIT J ANAESTH, V92, P361, DOI 10.1093/bja/aeh078; Fagan C, 2000, ANESTH ANALG, V91, P201; Fuller P B, 1992, AANA J, V60, P374; Gefke K, 1982, Ugeskr Laeger, V144, P2096; GEFKE K, 1983, ACTA ANAESTH SCAND, V27, P111; Gulhas N, 2003, PAEDIATR ANAESTH, V13, P43, DOI 10.1046/j.1460-9592.2003.00927.x; Hamilton ND, 2012, PEDIATR ANESTH, V22, P345, DOI 10.1111/j.1460-9592.2011.03772.x; Hasanein R, 2013, EGYPTIAN J ANAESTHES, V29, P351; Higgins J.P.T., COCHRANE HDB SYSTEMA; Honarmand A, 2008, ANN SAUDI MED, V28, P11; Hooda S, 2001, TROP DOCT, V31, P120; Huang C J, 1998, Acta Anaesthesiol Sin, V36, P81; Jee D, 2003, ANESTH ANALG, V96, P293, DOI 10.1213/01.ANE.0000038695.2548.51; JOHNSON LA, 1985, ANN EMERG MED, V14, P275, DOI 10.1016/S0196-0644(85)80458-3; Kaabachi O, 2007, PEDIATR ANESTH, V17, P734, DOI 10.1111/j.1460-9592.2007.02242.x; Keller C, 1997, ANAESTHESIA, V52, P592; Koc C, 1998, OTOLARYNG HEAD NECK, V118, P880, DOI 10.1016/S0194-5998(98)70290-6; Konrad C, 1997, EUR J ANAESTH, V14, P616; LEICHT P, 1985, ANESTH ANALG, V64, P1193; Mikawa K, 1997, ANESTH ANALG, V85, P1005, DOI 10.1097/00000539-199711000-00009; Moher D, 2009, PLOS MED, V21, P6, DOI DOI 10.1371/J0URNAL.PMED.1000097; Navarro LH, 2007, SAO PAULO MED J, V125, P322, DOI 10.1590/S1516-31802007000600004; Navarro LHC, 2012, REV ASSOC MED BRAS, V58, P248, DOI 10.1590/S0104-42302012000200023; ONEILL B, 1994, ANESTH ANALG, V78, P659; Penaloza IV, 1999, ANESTESIA MEXICO, V11, P162; Rafiei MR, 2012, J RES MED SCI, V17, P338; ROY WL, 1988, CAN J ANAESTH, V35, P93; Sanikop Cs, 2010, Indian J Anaesth, V54, P132, DOI 10.4103/0019-5049.63654; Schebesta K, 2010, CAN J ANESTH, V57, P745, DOI 10.1007/s12630-010-9328-y; Shroff PP, 2009, EUR J ANAESTH, V26, P458, DOI 10.1097/EJA.0b013e32832403fa; STAFFEL JG, 1991, ARCH OTOLARYNGOL, V117, P1123; Takekawa Kimiko, 2006, J Anesth, V20, P44, DOI 10.1007/s00540-005-0363-8; Wetzel Laura E, 2008, AANA J, V76, P105; Yamasaki H, 2013, J ANESTH, V27, P822, DOI 10.1007/s00540-013-1627-3; Yorukoglu D, 2006, J NEUROSURG ANESTH, V18, P165; Yu Hai, 2012, Front Med, V6, P302, DOI 10.1007/s11684-012-0194-6; YUKIOKA H, 1985, ANESTH ANALG, V64, P1189; YUKIOK H, 1993, ANESTH ANALG, V77, P309, DOI 10.1213/00000539-199377020-00016; Zamora Lozano J, 2007, REV ESPANOLA ANESTES, V54, P596; Zeidan A, 2005, ANESTH ANALG, V101, P1563, DOI 10.1213/01.ANE.0000180236.27026.9F	60	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0003-2409	1365-2044		ANAESTHESIA	Anaesthesia	DEC	2014	69	12					1388	1396		10.1111/anae.12788		9	Anesthesiology	Anesthesiology	AT8YR	WOS:000345215400013		
J	Peckova, K; Vanecek, T; Martinek, P; Spagnolo, D; Kuroda, N; Brunelli, M; Vranic, S; Djuricic, S; Rotterova, P; Daum, O; Kokoskova, B; Vesela, P; Pivovarcikova, K; Bauleth, K; Dubova, M; Kalusova, K; Hora, M; Michal, M; Hes, O				Peckova, Kvetoslava; Vanecek, Tomas; Martinek, Petr; Spagnolo, Dominic; Kuroda, Naoto; Brunelli, Matteo; Vranic, Semir; Djuricic, Slavisa; Rotterova, Pavla; Daum, Ondrej; Kokoskova, Bohuslava; Vesela, Pavla; Pivovarcikova, Kristyna; Bauleth, Kevin; Dubova, Magdalena; Kalusova, Kristyna; Hora, Milan; Michal, Michal; Hes, Ondrej			Aggressive and nonaggressive translocation t(6;11) renal cell carcinoma: comparative study of 6 cases and review of the literature	ANNALS OF DIAGNOSTIC PATHOLOGY			English	Review						Kidney; Translocation renal cell carcinoma t(6:11); Aggressive; Nonaggressive; Immunohistochemistiy; Molecular biology	TFEB-GENE-FUSION; CLINICOPATHOLOGICAL FEATURES; KIDNEY; T(6/11)(P21,Q12); EXPRESSION; SPECTRUM; ANGIOMYOLIPOMA; MORPHOLOGY; NEOPLASIA; ADULTS	t(6;11) renal cell carcinoma (RCC) has been recognized as a rare and mostly nonaggressive tumor (NAT). The criteria for distinguishing aggressive tumors (AT) from NATs are not well established. A total of 6 cases were selected for the study. Five cases of t(6;11) RCCs behaved nonaggressively, and 1 was carcinoma with aggressive behavior. The tumors were analyzed morphologically using immunohistochemistry and by molecular-genetic methods. The specimen of aggressive t(6;11) RCC was from a 77-year-old woman who died of the disease 2.5 months after diagnosis. The specimens of nonaggressive t(6;11) RCCs were from 3 women and 2 men whose ages range between 15 and 54 years. Follow-up was available in all cases (2.5 months-8 years). The tumor size ranged from 3 to 14 cm in nonaggressive t(6:11) RCC. In the aggressive carcinoma, the tumor size was 12 cm. All tumors (6/6) were well circumscribed. Aggressive t(6;11) RCC was widely necrotic. Six (100%) of 6 all tumors displayed a solid/alveolar architecture with occasional tubules and pseudorosettes. Pseudopapillary formations lined by bizarre polymorphic cells were found focally in the aggressive t(6;11) RCC case. Mitoses, though rare, were found as well. All cases (AT and NAT) were positive for HMB-45, Melan-A, Cathepsin K, and cytokeratins. CD117 positivity was seen in 4 of 5 NATs, as well as in the primary and metastatic lesions of the AT. mTOR was positive in 2 of 5 NATs and vimentin in 4 of 5 NATs. Vimentin was negative in the primary lesion of the AT, as well as in the metastasis found in the adrenal gland. Translocation t(6;11)(Alpha-TFEB) or TFEB break was detected in 4 of 5 NATs and in the AT case. Aggressive tumor showed amplification of TFEB locus. Losses of part of chromosome 1 and chromosome 22 were found in 1 of 5 NATs and in the AT. Conclusions: (1) Aggressive t(6;11) RCCs generally occur in the older population in comparison with their indolent counterparts. (2) In regard to the histologic findings in ATs, 3 of 5 so far published cases were morphologically not typical for t(6;11) RCC. Of the 3 cases, 2 cases lacked a small cell component and 1 closely mimicked clear cell-type RCC (3) Necroses were only present in aggressive t(6;11) RCC. (4) Amplification of TFEB locus was also found only in the aggressive t(6;11) RCC. (C) 2014 Elsevier Inc. All rights reserved.	[Peckova, Kvetoslava; Vanecek, Tomas; Martinek, Petr; Rotterova, Pavla; Daum, Ondrej; Kokoskova, Bohuslava; Vesela, Pavla; Pivovarcikova, Kristyna; Bauleth, Kevin; Dubova, Magdalena; Michal, Michal; Hes, Ondrej] Charles Univ Prague, Univ Hosp Plzen, Fac Med, Dept Pathol, Plzen 30460, Czech Republic; [Spagnolo, Dominic] PathWest Lab Med WA, Dept Pathol, Nedlands, WA, Australia; [Kuroda, Naoto] Kochi Red Cross Hosp, Dept Diagnost Pathol, Kochi, Japan; [Brunelli, Matteo] Univ Verona, Dept Pathol & Diagnost, I-37100 Verona, Italy; [Vranic, Semir] Univ Sarajevo, Ctr Clin, Dept Pathol, Sarajevo 71000, Bosnia & Herceg; [Djuricic, Slavisa] Mother & Child Hlth Inst Serbia, Dept Pathol, Belgrade, Serbia; [Kalusova, Kristyna; Hora, Milan] Charles Univ Prague, Fac Med Plzen, Dept Urol, Plzen, Czech Republic; [Hes, Ondrej] Charles Univ Prague, Fac Med Plzen, Biomed Ctr, Plzen, Czech Republic	Hes, O (reprint author), Charles Univ Prague, Hosp Plzen, Fac Med, Dept Pathol, Alej Svobody 80, Plzen 30460, Czech Republic.	hes@medima.cz		Vranic, Semir/0000-0001-9743-7265	Charles University Research Fund [P36]; European Regional Development Fund [CZ.1.05/2.1.00/03.0076]	The study was supported by the Charles University Research Fund (project number P36) and by the project by the project CZ.1.05/2.1.00/03.0076 from European Regional Development Fund.	Argani P, 2006, J CLIN ONCOL, V24, P1529, DOI 10.1200/JCC.2005.04.4693; Geller JI, 2008, CANCER-AM CANCER SOC, V112, P1607, DOI 10.1002/cncr.23331; Argani P, 2007, AM J SURG PATHOL, V31, P1149, DOI 10.1097/PAS.0b013e318031ffff; Davis IJ, 2003, P NATL ACAD SCI USA, V100, P6051, DOI 10.1073/pnas.0931430100; Kuiper RP, 2003, HUM MOL GENET, V12, P1661, DOI 10.1093/hmg/ddg178; Camparo P, 2008, AM J SURG PATHOL, V32, P656, DOI 10.1097/PAS.0b013e3181609914; Nese N, 2011, AM J SURG PATHOL, V35, P161, DOI 10.1097/PAS.0b013e318206f2a9; Martignoni G, 2012, MODERN PATHOL, V25, P100, DOI 10.1038/modpathol.2011.136; Argani P, 2003, PATHOLOGY, V35, P492, DOI 10.1080/00313020310001619901; Inamura K, 2012, AM J SURG PATHOL, V36, P35, DOI 10.1097/PAS.0b013e3182293ec3; Argani P, 2006, AM J CLIN PATHOL, V126, P332, DOI 10.1309/EAEJTJGD5J4JB4F; Argani P, 2012, AM J SURG PATHOL, V36, P1516, DOI 10.1097/PAS.0b013e3182613d8f; Argani P, 2005, AM J SURG PATHOL, V29, P230, DOI 10.1097/01.pas.0000146007.54092.37; Petersson F, 2012, HUM PATHOL, V43, P726, DOI 10.1016/j.humpath.2011.07.001; Argani P, 2003, ADV ANAT PATHOL, V10, P243, DOI 10.1097/00125480-200309000-00001; Hora M, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-245; Martigioni G, 2005, MODERN PATHOL, V18, p155A; Martignoni G, 2002, ARCH PATHOL LAB MED, V126, P610; Medendorp K, 2007, CYTOGENET GENOME RES, V118, P157, DOI 10.1159/000108296; Rao Q, 2012, AM J SURG PATHOL, V36, P1327, DOI 10.1097/PAS.0b013e31825aafb5; Smith NE, 2014, AM J SURG PATHOL, V38, P604, DOI 10.1097/PAS.0000000000000203; Srigley JR, 2013, AM J SURG PATHOL, V37, P1469, DOI 10.1097/PAS.0b013e318299f2d1; Suarez-Vilela D, 2011, INT J SURG PATHOL, V19, P506, DOI 10.1177/1066896909340531; Zhong MH, 2010, AM J SURG PATHOL, V34, P757, DOI 10.1097/PAS.0b013e3181dd577e	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1092-9134	1532-8198		ANN DIAGN PATHOL	Ann. Diagn. Pathol.	DEC	2014	18	6					351	357		10.1016/j.anndiagpath.2014.10.002		7	Pathology	Pathology	AT8QA	WOS:000345196100007		
J	Markellos, M; Urakawa, H				Markellos, M.; Urakawa, H.			The bienergy of unit vector fields	ANNALS OF GLOBAL ANALYSIS AND GEOMETRY			English	Article						Unit tangent sphere bundle; Sasaki metric; Biharmonic unit vector fields; Three-dimensional Lie groups; The classical Heisenberg groups	BIHARMONIC SUBMANIFOLDS; RIEMANNIAN-MANIFOLDS; HARMONIC MAPPINGS; LIE-GROUPS; SPHERES; ENERGY; CLASSIFICATION	The bienergy of a unit vector field on a Riemannian manifold is defined to be the bienergy of the corresponding map , where the unit tangent sphere bundle is equipped with the restriction of the Sasaki metric . The constrained variational problem is studied, where variations are confined to unit vector fields, and the corresponding critical point condition characterizes biharmonic unit vector fields. Finally, we completely determine invariant biharmonic unit vector fields in three-dimensional unimodular Lie groups and the generalized Heisenberg groups .	[Markellos, M.] Pafsania, Isthmia Korinthias 20010, Corinth, Greece; [Urakawa, H.] Tohoku Univ, Inst Int Educ, Sendai, Miyagi 9808576, Japan	Markellos, M (reprint author), Pafsania, Isthmia Korinthias 20010, Corinth, Greece.	mmarkellos@hotmail.gr; urakawa@math.is.tohoku.ac.jp					WIEGMINK G, 1995, MATH ANN, V303, P325, DOI 10.1007/BF01460993; Caddeo R, 2002, ISRAEL J MATH, V130, P109, DOI 10.1007/BF02764073; Balmus A, 2013, ARK MAT, V51, P197, DOI 10.1007/s11512-012-0169-5; [Anonymous], 2008, NOTE MAT S1; EELLS J, 1964, AM J MATH, V86, P109, DOI 10.2307/2373037; Caddeo R, 2001, INT J MATH, V12, P867, DOI 10.1142/S0129167X01001027; Gil-Medrano O, 2001, DIFFER GEOM APPL, V15, P137, DOI 10.1016/S0926-2245(01)00053-5; Fetcu D, 2010, MATH Z, V266, P505, DOI 10.1007/s00209-009-0582-z; Balmus A, 2008, ISR J MATH, V168, P201, DOI 10.1007/s11856-008-1064-4; Higuchi A, 2001, J GEOM PHYS, V37, P137, DOI 10.1016/S0393-0440(00)00034-6; KAPLAN A, 1980, T AM MATH SOC, V258, P147, DOI 10.2307/1998286; Baird P., 2003, LOND MATH SOC MONOGR, V29; Balmus A, 2012, AN STI U OVID CO-MAT, V20, P89; Boeckx E, 1997, HOUSTON J MATH, V23, P427; Dragomir S, 2012, HARMONIC VECTOR FIELDS: VARIATIONAL PRINCIPLES AND DIFFERENTIAL GEOMETRY, P1; Eells J., 1983, CBMS REGIONAL C SERI, V50; Gonzalez-Davila JC, 2002, B UNIONE MAT ITAL, V5B, P377; GUDMUNDSSON S., 2002, EXPO MATH, V20, P1, DOI 10.1016/S0723-0869(02)80027-5; Han S.D., 1998, MATH Z, V227, P83; Ishihara T., 1979, J MATH TOKUSHIMA U, V13, P23; Markellos M., ARXIV14071127V2; MILNOR J, 1976, ADV MATH, V21, P293, DOI 10.1016/S0001-8708(76)80002-3; MONTALDO S., 2006, REV UNION MAT ARGENT, V47, P1; NOUHAUD O, 1977, CR ACAD SCI A MATH, V284, P815; O&rsquo;Neill B., 1983, SEMIRIEMANNIAN GEOME; Urakawa H., 1993, TRANSL MATH MONOGR, V132; Wood CM, 1997, GEOMETRIAE DEDICATA, V64, P319, DOI 10.1023/A:1017976425512	27	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0232-704X	1572-9060		ANN GLOB ANAL GEOM	Ann. Glob. Anal. Geom.	DEC	2014	46	4					431	457		10.1007/s10455-014-9432-2		27	Mathematics	Mathematics	AT7RP	WOS:000345135400006		
J	Ohnishi, H; Tortoli, E; Ramos, JP; Kazumi, Y; Yonetani, S; Matsushima, S; Ohtsuka, K; Watanabe, T				Ohnishi, Hiroaki; Tortoli, Enrico; Ramos, Jesus Pais; Kazumi, Yuko; Yonetani, Shota; Matsushima, Satsuki; Ohtsuka, Kouki; Watanabe, Takashi			Proposal of reclassification of Mycobacterium celatum type 2 as Mycobacterium kyorinense	ANNALS OF MICROBIOLOGY			English	Article						hsp65; rpoB; 16S rRNA; sodA; subspecies	MAXIMUM-LIKELIHOOD; AIDS PATIENTS; SP-NOV; INFECTION; SPECIMENS; SEQUENCES; PATHOGEN; TREES	16S rRNA, rpoB, and sodA genes of Mycobacterium celatum type 2 were re-examined to clarify its taxonomic position. Reevaluation of these sequences revealed that M. celatum type 2 strain ATCC 51130 was 100% identical to Mycobacterium kyorinense type strain, but differed substantially from M. celatum types 1 and 3 at these genes. A phylogenetic tree analysis placed M. celatum type 2 in proximity with M. kyorinense, with a clear-cut distinction from M. celatum types 1 and 3. We propose the reclassification of M. celatum type 2 as M. kyorinense, with both species maintaining their respective names and standing in the literature.	[Ohnishi, Hiroaki; Yonetani, Shota; Matsushima, Satsuki; Ohtsuka, Kouki; Watanabe, Takashi] Kyorin Univ, Sch Med, Dept Lab Med, Mitaka, Tokyo 1818611, Japan; [Tortoli, Enrico] Ist Sci San Raffaele, Emerging Bacterial Pathogens Unit, I-20132 Milan, Italy; [Ramos, Jesus Pais] Fiocruz MS, Escola Nacl Saude Publ, Ctr Referencia Prof Helio Fraga, Natl Reference Lab TB, Rio De Janeiro, RJ, Brazil; [Kazumi, Yuko] Res Inst TB, Dept Mycobacterium Reference & Res, Tokyo, Japan	Ohnishi, H (reprint author), Kyorin Univ, Sch Med, Dept Lab Med, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	onishi@ks.kyorin-u.ac.jp		Tortoli, Enrico/0000-0001-5512-704X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23590688]	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (23590688).	Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI 10.1099/ijs.0.02360-0; Springer B, 1996, J CLIN MICROBIOL, V34, P296; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; BULL TJ, 1995, INT J SYST BACTERIOL, V45, P861; BUTLER WR, 1993, INT J SYST BACTERIOL, V43, P539; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Gholizadeh Y, 1998, EUR J CLIN MICROBIOL, V17, P278, DOI 10.1007/BF01699987; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KOUKILAKAHKOLA P, 1995, INT J SYST BACTERIOL, V45, P549; Ohnishi H, 2013, EMERG INFECT DIS, V19, P508, DOI [10.3201/eid1903.120591, 10.3201/eid1903.12-0591]; Okazaki M, 2009, INT J SYST EVOL MICR, V59, P1336, DOI 10.1099/ijs.0.000760-0; Picardeau M, 1997, INT J SYST BACTERIOL, V47, P640; Piersimoni C, 1997, CLIN INFECT DIS, V24, P144; Ramos JP, 2013, INT J SYST EVOL MICR, V63, P2583, DOI 10.1099/ijs.0.046862-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Stadthagen-Gomez G, 2008, FEMS MICROBIOL LETT, V280, P102, DOI 10.1111/j.1574-6968.2007.01050.x; TORTOLI E, 1995, J CLIN MICROBIOL, V33, P137	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1590-4261	1869-2044		ANN MICROBIOL	Ann. Microbiol.	DEC	2014	64	4					1879	1882		10.1007/s13213-014-0860-9		4	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	AU0DF	WOS:000345292900044		
J	Yamamoto, T; Narushima, M; Yoshimatsu, H; Yamamoto, N; Kikuchi, K; Todokoro, T; Iida, T; Koshima, I				Yamamoto, Takumi; Narushima, Mitsunaga; Yoshimatsu, Hidehiko; Yamamoto, Nana; Kikuchi, Kazuki; Todokoro, Takeshi; Iida, Takuya; Koshima, Isao			Dynamic Indocyanine Green (ICG) Lymphography for Breast Cancer-Related Arm Lymphedema	ANNALS OF PLASTIC SURGERY			English	Article						lymphedema; indocyanine green (ICG); near-infrared fluorescence; dermal backflow; breast; cancer	LOWER-EXTREMITY-LYMPHEDEMA; DERMAL BACKFLOW PATTERNS; LYMPHATICOVENULAR ANASTOMOSIS; FLUORESCENCE LYMPHOGRAPHY; SECONDARY	Background: Lymph transportation capacity is a critical function maintaining fluid circulation. After breast cancer treatments, lymph obstruction at the axilla leads to abnormal lymph circulation, resulting in lymph pump dysfunction. As well as lymph circulation, lymph pump function is important for lymphedema evaluation. Methods: We assessed and analyzed lymph transportation capacity of 15 breast cancer-related arm lymphedema patients using dynamic indocyanine green (ICG) lymphography. Results: ICG velocity and transit time could evaluate lymph pump function; ICG velocity decreases and transit time increases as the lymphedema severity stage progresses. Measurement of ICG velocity required 3 minutes after the dye injection, whereas that of transit time took more than 1 hour in severe cases. Conclusions: ICG velocity can be easily obtained and is recommended for evaluation of lymph pump function. Dynamic ICG lymphography, which evaluates both lymph pump function and circulation, plays an important role in comprehensive assessment of lymphedema pathophysiology.	[Yamamoto, Takumi; Narushima, Mitsunaga; Yoshimatsu, Hidehiko; Yamamoto, Nana; Kikuchi, Kazuki; Todokoro, Takeshi; Iida, Takuya; Koshima, Isao] Univ Tokyo, Dept Plast & Reconstruct Surg, Grad Sch Med, Tokyo 1138655, Japan	Yamamoto, T (reprint author), Univ Tokyo, Dept Plast & Reconstruct Surg, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tyamamoto-tky@umin.ac.jp					Yamamoto T, 2011, J PLAST RECONSTR AES, V64, P1541, DOI 10.1016/j.bjps.2011.05.025; Unno N, 2010, J VASC SURG, V52, P946, DOI 10.1016/j.jvs.2010.04.067; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1987, DOI 10.1097/PRS.0b013e31820cf5c6; Ogata F, 2007, ANN PLAS SURG, V58, P652, DOI 10.1097/01.sap.0000250896.42800.a2; Yamamoto T, 2014, ANN PLAS SURG, V72, P67, DOI 10.1097/SAP.0b013e3182605580; Tan IC, 2011, ARCH PHYS MED REHAB, V92, P756, DOI 10.1016/j.apmr.2010.12.027; Unno N, 2007, J VASC SURG, V45, P1016, DOI 10.1016/j.jvs.2007.01.023; Unno N, 2008, EUR J VASC ENDOVASC, V36, P230, DOI 10.1016/j.ejvs.2008.04.013; Modi S., 2007, Lymphatic Research and Biology, V5, P183, DOI 10.1089/lrb.2007.5306; Brennan MJ, 1998, CANCER, V83, P2821, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2821::AID-CNCR33>3.0.CO;2-G; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, P941, DOI 10.1097/PRS.0b013e3182268cd9; Warren AG, 2007, ANN PLAS SURG, V59, P464, DOI 10.1097/01.sap.0000257149.42922.7e; Yamamoto T, 2011, J PLAST RECONSTR AES, V64, P812, DOI 10.1016/j.bjps.2010.10.011; Yamamoto T, 2011, ANN PLAS SURG, V67, P637, DOI 10.1097/SAP.0b013e318208fd75; Yamamoto T, 2011, PLAST RECONSTR SURG, V127, P1979, DOI 10.1097/PRS.0b013e31820cf5df; Cohen SR, 2001, CANCER, V92, P980, DOI 10.1002/1097-0142(20010815)92:4+<980::AID-CNCR1410>3.0.CO;2-E; International Society of Lymphology, 2009, LYMPHOLOGY, V42, P51; Tomczak Hanna, 2005, Nucl Med Rev Cent East Eur, V8, P37; Yamamoto T, 2013, ANN PLAS SURG, V71, P538, DOI 10.1097/SAP.0b013e318250f0a0; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, p314E, DOI 10.1097/PRS.0b013e3182268da8; Yamamoto T, 2013, ANN PLAS SURG, V71, P591, DOI 10.1097/SAP.0b013e318255168a; Yamamoto T, 2013, ANN PLAS SURG, V70, P47, DOI 10.1097/SAP.0b013e3182275d23	22	4	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-7043	1536-3708		ANN PLAS SURG	Ann. Plast. Surg.	DEC	2014	73	6					706	709		10.1097/SAP.0b013e318285875f		4	Surgery	Surgery	AT8BZ	WOS:000345160000018		
J	Watanabe, M; Miyata, H; Gotoh, M; Baba, H; Kimura, W; Tomita, N; Nakagoe, T; Shimada, M; Kitagawa, Y; Sugihara, K; Mori, M				Watanabe, Masayuki; Miyata, Hiroaki; Gotoh, Mitsukazu; Baba, Hideo; Kimura, Wataru; Tomita, Naohiro; Nakagoe, Tohru; Shimada, Mitsuo; Kitagawa, Yuko; Sugihara, Kenichi; Mori, Masaki			Total Gastrectomy Risk Model Data From 20,011 Japanese Patients in a Nationwide Internet-Based Database	ANNALS OF SURGERY			English	Article						National Clinical Database; risk factors of mortality; total gastrectomy; 30-day mortality; risk model	GASTRIC-CANCER; SUBTOTAL GASTRECTOMY; POSTOPERATIVE MORBIDITY; SURGICAL COMPLICATIONS; RANDOMIZED TRIAL; SURGERY; MORTALITY; CHEMOTHERAPY; MULTICENTER; POPULATION	Objective: To construct a risk model for total gastrectomy outcomes using a nationwide Internet-based database. Background: Total gastrectomy is a very common procedure in Japan. This procedure is among the most invasive gastrointestinal procedures and is known to carry substantial surgical risks. Methods: The National Clinical Database was used to retrieve records on more than 1,200,000 surgical cases from 3500 hospitals in 2011. After data cleanup, 20,011 records from 1623 hospitals were analyzed for procedures performed between January 1, 2011, and December 31, 2011. Results: The average patient age was 68.9 years; 73.7% were male. The overall morbidity was 26.2%, with a 30-day mortality rate of 0.9%, in-hospital mortality rate of 2.2%, and overall operative mortality rate of 2.3%. The odds ratios for 30-day mortality were as follows: ASA (American Society of Anesthesiologists) grade 4 or 5, 9.4; preoperative dialysis requirement, 3.9; and platelet count less than 50,000 per microliter, 3.1. The odds ratios for operative mortality were as follows: ASA grade 4 or 5, 5.2; disseminated cancer, 3.5; and alkaline phosphatase level of more than 600 IU/L, 3.1. The C-index of 30-day mortality and operative mortality was 0.811 (95% confidence interval [CI], 0.744-0.879) and 0.824 (95% CI, 0.781-0.866), respectively. Conclusions: We have performed the first reported risk stratification study for total gastrectomy, using a nationwide Internet-based database. The total gastrectomy outcomes in the nationwide population were satisfactory. The risk models that we have created will help improve the quality of surgical practice.	[Watanabe, Masayuki] Japanese Soc Gastroenterol Surg, Working Grp Database Comm, Tokyo, Japan; [Miyata, Hiroaki; Gotoh, Mitsukazu; Baba, Hideo; Kimura, Wataru; Tomita, Naohiro; Nakagoe, Tohru; Shimada, Mitsuo; Kitagawa, Yuko] Japanese Soc Gastroenterol Surg, Database Comm, Tokyo, Japan; [Miyata, Hiroaki; Gotoh, Mitsukazu] Natl Clin Database, Tokyo, Japan; [Sugihara, Kenichi; Mori, Masaki] Japanese Soc Gastroenterol Surg, Tokyo, Japan	Baba, H (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, 1-1-1 Chuo Ku, Honjo, Kumamoto 8608556, Japan.	hdobaba@kumamoto-u.ac.jp			Ministry of Health, Labour and Welfare	Partially supported by a research grant from Ministry of Health, Labour and Welfare (M. G.). The other authors declare no conflicts of interest.	Nashimoto A, 2013, GASTRIC CANCER, V16, P1, DOI 10.1007/s10120-012-0163-4; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Dutta S, 2011, ANN SURG ONCOL, V18, P2808, DOI 10.1245/s10434-011-1676-5; Ott K, 2011, LANGENBECK ARCH SURG, V396, P743, DOI 10.1007/s00423-010-0738-7; Davies J, 1998, WORLD J SURG, V22, P1048; Sutton R, 2002, BRIT J SURG, V89, P763, DOI 10.1046/j.1365-2168.2002.02080.x; Mahar AL, 2012, GASTRIC CANCER, V15, pS125, DOI 10.1007/s10120-011-0088-3; Shiloach M, 2010, J AM COLL SURGEONS, V210, P6, DOI 10.1016/j.jamcollsurg.2009.09.031; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Nitenberg G, 2000, CRIT REV ONCOL HEMAT, V34, P137, DOI 10.1016/S1040-8428(00)00048-2; Hartgrink HH, 2004, J CLIN ONCOL, V22, P2069, DOI 10.1200/JCO.2004.08.026; Kulig J, 2010, EJSO-EUR J SURG ONC, V36, P969, DOI 10.1016/j.ejso.2010.07.007; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; VACANTI CJ, 1970, ANESTH ANAL CURR RES, V49, P564; Haga Y, 1999, SURG TODAY, V29, P219; Kim KM, 2012, BRIT J SURG, V99, P1681, DOI 10.1002/bjs.8924; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Cuschieri A, 1996, LANCET, V347, P995, DOI 10.1016/S0140-6736(96)90144-0; Bozzetti F, 1997, ANN SURG, V226, P613, DOI 10.1097/00000658-199711000-00006; Benhamiche AM, 1997, EUR J CANCER PREV, V6, P71, DOI 10.1097/00008469-199702000-00011; Bonnenkamp JJ, 1999, NEW ENGL J MED, V340, P908; Feldman RA, 2001, HELICOBACTER PYLORI: MOLECULAR AND CELLULAR BIOLOGY, P29; Haga Y, 2012, GASTRIC CANCER, V15, P7, DOI 10.1007/s10120-011-0052-2; Hall J C, 1996, J Qual Clin Pract, V16, P103; Klotz HP, 1996, BRIT J SURG, V83, P1788, DOI 10.1002/bjs.1800831240; National Cancer Center Center for Cancer Control and Information Services, 2007, MON CANC INC JAP; ROBERTSON CS, 1994, ANN SURG, V220, P176, DOI 10.1097/00000658-199408000-00009; Roder David M, 2002, Gastric Cancer, V5 Suppl 1, P5, DOI 10.1007/s10120-002-0203-6; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Tsujinaka T, 2007, ANN SURG ONCOL, V14, P355, DOI 10.1245/s10434-006-9209-3; Viste A, 2012, GASTRIC CANCER, V15, P1, DOI 10.1007/s10120-011-0108-3	31	5	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	DEC	2014	260	6					1034	1039		10.1097/SLA.0000000000000781		6	Surgery	Surgery	AT8ZJ	WOS:000345217200017		
J	Kubo, S; Yamaoka, K; Kondo, M; Yamagata, K; Zhao, JD; Iwata, S; Tanaka, Y				Kubo, Satoshi; Yamaoka, Kunihiro; Kondo, Masahiro; Yamagata, Kaoru; Zhao, Jidong; Iwata, Shigeru; Tanaka, Yoshiya			The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells	ANNALS OF THE RHEUMATIC DISEASES			English	Article							ACTIVE RHEUMATOID-ARTHRITIS; TRYPTOPHAN CATABOLISM; CYTOKINE PRODUCTION; TRANSCRIPTION FACTORS; INADEQUATE RESPONSE; KINASE INHIBITOR; SYNOVIAL TISSUE; EXPRESSION; ACTIVATION; LIPOPOLYSACCHARIDE	Objective Tofacitinib, which is a Janus kinase (JAK) inhibitor, has shown clinical effects in the treatment of rheumatoid arthritis. JAKs are important kinases in lymphocyte differentiation; however, their function in dendritic cells (DCs) is unknown. In this study, the function of JAKs in DCs was investigated with tofacitinib. Methods The effects of tofacitinib on the maturation of human monocyte-derived DCs induced by lipopolysaccharide (LPS) stimulation were investigated. In addition, its effects on T cell stimulatory capability was investigated by coculturing with naive CD45RA-positive T cells. Results Tofacitinib decreased expression of CD80/CD86 in a concentration-dependent manner in LPS-stimulated DCs; however, it did not affect HLA-DR expression. Tofacitinib suppressed tumour necrosis factor, interleukin (IL)-6 and IL-1 beta production without affecting transforming growth factor (TGF)-beta and IL-10 production. Meanwhile, CD80/CD86 expression in DCs was enhanced by type I interferon (IFN) stimulation, and the LPS-induced CD80/CD86 expression was inhibited by an antibody to type I IFN receptor. Furthermore, tofacitinib suppressed production of type I IFN and activation of interferon regulatory factor (IRF)-7, which is a transcription factor involved in CD80/CD86 and type I IFN expression. Tofacitinib also decreased the T cell stimulatory capability of DCs and increased expression of indoleamine 2,3-dioxygenase (IDO)-1 and IDO-2. Conclusions Tofacitinib, a JAK1/JAK3 inhibitor, affected the activities of human DCs. It decreased CD80/CD86 expression and T cell stimulatory capability through suppression of type I IFN signalling. These results suggest a novel mode of action for tofacitinib and a pivotal role for JAKs in the differentiation of DCs.	[Kubo, Satoshi; Yamaoka, Kunihiro; Kondo, Masahiro; Yamagata, Kaoru; Zhao, Jidong; Iwata, Shigeru; Tanaka, Yoshiya] Univ Occupat & Environm Hlth, Dept Internal Med 1, Kitakyushu, Fukuoka 8078555, Japan	Tanaka, Y (reprint author), Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Yahata Nishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	tanaka@med.uoeh-u.ac.jp			Mitsubishi-Tanabe Pharma; Eisai; Chugai Pharma; Abbott Japan; Astellas Pharma; Daiichi-Sankyo; Abbvie; Janssen Pharma; Pfizer; Takeda Pharma; Astra-Zeneca; Eli Lilly Japan; GlaxoSmithKline; Quintiles; MSD; Asahi-Kasei Pharma; Bristol-Myers	Y Tanaka received consulting fees, lecture fees, and/or honoraria from Mitsubishi-Tanabe Pharma, Eisai, Chugai Pharma, Abbott Japan, Astellas Pharma, Daiichi-Sankyo, Abbvie, Janssen Pharma, Pfizer, Takeda Pharma, Astra-Zeneca, Eli Lilly Japan, GlaxoSmithKline, Quintiles, MSD, Asahi-Kasei Pharma, and received research grants from Bristol-Myers, Mitsubishi-Tanabe Pharma, Abbvie, MSD, Chugai Pharma, Astellas Pharma, Daiichi-Sankyo. M Kondo is an employee of the Mitsubishi Tanabe Pharma Corporation. K Yamaoka received consulting fees from Pfizer.	Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Kremer JM, 2009, ARTHRITIS RHEUM, V60, P1895, DOI 10.1002/art.24567; van Vollenhoven RF, 2012, NEW ENGL J MED, V367, P508, DOI 10.1056/NEJMoa1112072; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; MUSSO T, 1994, BLOOD, V83, P1408; Mellor AL, 1999, IMMUNOL TODAY, V20, P469, DOI 10.1016/S0167-5699(99)01520-0; Baldwin HM, 2010, ANN RHEUM DIS, V69, P1200, DOI 10.1136/ard.2009.110502; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Lodie TA, 1997, J IMMUNOL, V158, P1848; Teichmann LL, 2010, IMMUNITY, V33, P967, DOI 10.1016/j.immuni.2010.11.025; Roelofs MF, 2005, ARTHRITIS RHEUM, V52, P2313, DOI 10.1002/art.21278; Changelian PS, 2008, BLOOD, V111, P2155, DOI 10.1182/blood-2007-09-115030; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ghoreschi K, 2011, J IMMUNOL, V186, P4234, DOI 10.4049/jimmunol.1003668; Frucht DM, 2000, J IMMUNOL, V164, P4659; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Martin CA, 2003, J IMMUNOL, V171, P5736; Tanaka Y, 2011, ARTHRIT CARE RES, V63, P1150, DOI 10.1002/acr.20494; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Burmester GR, 2013, LANCET, V381, P451, DOI 10.1016/S0140-6736(12)61424-X; Coombs JH, 2010, ANN RHEUM DIS, V69, P413, DOI 10.1136/ard.2009.108159; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Li WQ, 2001, J IMMUNOL, V166, P3491; van Vollenhoven RF, 2013, CURR OPIN RHEUMATOL, V25, P391, DOI 10.1097/BOR.0b013e32835fd828; Hanke JH, 1996, J BIOL CHEM, V271, P695; Lim W, 2005, J IMMUNOL, V175, P5690; Betts BC, 2011, BLOOD, V118, P5340, DOI 10.1182/blood-2011-06-363390; Kanada S, 2011, BLOOD, V117, P2211, DOI 10.1182/blood-2010-06-291898; Kiss Róbert, 2009, Bioorg Med Chem Lett, V19, P3598, DOI 10.1016/j.bmcl.2009.04.138; Kremer JM, 2011, ARTHRITIS RHEUM, V64, P970; Kuwana M, 2002, HUM IMMUNOL, V63, P1156, DOI 10.1016/S0198-8859(02)00754-1; Maeshima K, 2012, ARTHRITIS RHEUM-US, V64, P1790, DOI 10.1002/art.34329; Maroof A, 2006, IMMUNOLOGY, V117, P271, DOI 10.1111/j.1365-2567.2005.02305.x; Muller-Ladner U, 2000, J IMMUNOL, V164, P3894; Steele AJ, 2010, BLOOD, V116, P4569, DOI 10.1182/blood-2009-09-245811; Walker JG, 2006, ANN RHEUM DIS, V65, P149, DOI 10.1136/ard.2005.037929; Walker JG, 2006, ANN RHEUM DIS, V65, P1558, DOI 10.1136/ard.2005.050385; Walker JG, 2007, ANN RHEUM DIS, V66, P992, DOI 10.1136/ard.2006.060822; Wenink MH, 2011, ARTHRITIS RHEUM-US, V63, P3313, DOI 10.1002/art.30577; Whartenby KA, 2005, P NATL ACAD SCI USA, V102, P16741, DOI 10.1073/pnas.0506088102; Yamaoka K, 2005, BLOOD, V106, P3227, DOI 10.1182/blood-2005-02-0769; Yamaoka K, 1998, J IMMUNOL, V160, P838; Zou GM, 2005, J CELL PHYSIOL, V205, P437, DOI 10.1002/jcp.20420	46	12	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-4967	1468-2060		ANN RHEUM DIS	Ann. Rheum. Dis.	DEC	2014	73	12					2192	2198		10.1136/annrheumdis-2013-203756		7	Rheumatology	Rheumatology	AT2RY	WOS:000344783900025		
J	Wang, SP; Iwata, S; Nakayamada, S; Sakata, K; Yamaoka, K; Tanaka, Y				Wang, Sheau-Pey; Iwata, Shigeru; Nakayamada, Shingo; Sakata, Kei; Yamaoka, Kunihiro; Tanaka, Yoshiya			Tofacitinib, a JAK inhibitor, inhibits human B cell activation in vitro	ANNALS OF THE RHEUMATIC DISEASES			English	Letter							DIFFERENTIATION; BACH2; IL-21		[Wang, Sheau-Pey; Iwata, Shigeru; Nakayamada, Shingo; Sakata, Kei; Yamaoka, Kunihiro; Tanaka, Yoshiya] Univ Occupat & Environm Hlth, Dept Internal Med 1, Kitakyushu, Fukuoka 8078555, Japan	Tanaka, Y (reprint author), Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	tanaka@med.uoeh-u.ac.jp					Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777; Ozaki K, 2004, J IMMUNOL, V173, P5361; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; Kubo S, 2014, ANN RHEUM DIS, V73, P2192, DOI 10.1136/annrheumdis-2013-203756; Maeshima K, 2012, ARTHRITIS RHEUM-US, V64, P1790, DOI 10.1002/art.34329	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-4967	1468-2060		ANN RHEUM DIS	Ann. Rheum. Dis.	DEC	2014	73	12					2213	U211		10.1136/annrheumdis-2014-205615		3	Rheumatology	Rheumatology	AT2RY	WOS:000344783900028		
J	Tamai, M; Kita, J; Nakashima, Y; Suzuki, T; Horai, Y; Okada, A; Koga, T; Kawashiri, S; Iwamoto, N; Ichinose, K; Arima, K; Yamasaki, S; Nakamura, H; Origuchi, T; Uetani, M; Fukushima, A; Aoyagi, K; Eguchi, K; Kawakami, A				Tamai, Mami; Kita, Junko; Nakashima, Yoshikazu; Suzuki, Takahisa; Horai, Yoshiro; Okada, Akitomo; Koga, Tomohiro; Kawashiri, Shin-ya; Iwamoto, Naoki; Ichinose, Kunihiro; Arima, Kazuhiko; Yamasaki, Satoshi; Nakamura, Hideki; Origuchi, Tomoki; Uetani, Masataka; Fukushima, Aya; Aoyagi, Kiyoshi; Eguchi, Katsumi; Kawakami, Atsushi			Combination of MRI-detected bone marrow oedema with 2010 rheumatoid arthritis classification criteria improves the diagnostic probability of early rheumatoid arthritis	ANNALS OF THE RHEUMATIC DISEASES			English	Letter							EULAR RECOMMENDATIONS; RHEUMATOLOGY/EUROPEAN LEAGUE; AMERICAN-COLLEGE; FINGER JOINTS; MANAGEMENT; WRISTS		[Tamai, Mami; Kita, Junko; Nakashima, Yoshikazu; Suzuki, Takahisa; Horai, Yoshiro; Okada, Akitomo; Koga, Tomohiro; Kawashiri, Shin-ya; Iwamoto, Naoki; Ichinose, Kunihiro; Nakamura, Hideki; Kawakami, Atsushi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Immunol & Rheumatol, Nagasaki 8528501, Japan; [Kawashiri, Shin-ya; Arima, Kazuhiko; Aoyagi, Kiyoshi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Publ Hlth, Nagasaki 8528501, Japan; [Yamasaki, Satoshi] Hiroshima Univ, Dept Clin Immunol & Rheumatol, Hiroshima, Japan; [Origuchi, Tomoki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Rehabil Sci, Nagasaki 8528501, Japan; [Uetani, Masataka; Fukushima, Aya] Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiol & Radiat Res, Nagasaki 8528501, Japan; [Eguchi, Katsumi] Sasebo City Gen Hosp, Sasebo, Japan	Tamai, M (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Immunol & Rheumatol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	tamaim@nagasaki-u.ac.jp					Combe B, 2007, ANN RHEUM DIS, V66, P34, DOI 10.1136/ard.2005.044354; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Tamai M, 2012, MOD RHEUMATOL, V22, P654, DOI 10.1007/s10165-011-0575-8; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI 10.1136/ard.2010.138461; Colebatch AN, 2013, ANN RHEUM DIS, V72, P804, DOI 10.1136/annrheumdis-2012-203158; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Kaneko Y, 2011, RHEUMATOLOGY, V50, P1268, DOI 10.1093/rheumatology/keq442; Radner H, 2014, ANN RHEUM DIS, V73, P114, DOI 10.1136/annrheumdis-2013-203284; Tamai M, 2009, ARTHRIT RHEUM-ARTHR, V61, P772, DOI 10.1002/art.24711; Tamai M, 2011, ARTHRIT CARE RES, V63, P436, DOI 10.1002/acr.20395	10	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-4967	1468-2060		ANN RHEUM DIS	Ann. Rheum. Dis.	DEC	2014	73	12					2219	2220		10.1136/annrheumdis-2013-205074		2	Rheumatology	Rheumatology	AT2RY	WOS:000344783900031		
J	Akioka, S				Akioka, Shinji			Bivalent HPV vaccine safety depending on subtypes of juvenile idiopathic arthritis	ANNALS OF THE RHEUMATIC DISEASES			English	Letter							INFECTION; DISEASES; EFFICACY; WOMEN		Kyoto Prefectural Univ Med, Dept Pediat, Kyoto 6028566, Japan	Akioka, S (reprint author), Kyoto Prefectural Univ Med, Dept Pediat, Kyoto 6028566, Japan.	sakioka@koto.kpu-m.ac.jp					Petty RE, 2004, J RHEUMATOL, V31, P390; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Pellegrino P, 2014, AUTOIMMUN REV, V13, P736, DOI 10.1016/j.autrev.2014.01.054; Heijstek MW, 2014, ANN RHEUM DIS, V73, P1500, DOI 10.1136/annrheumdis-2013-203429; Stokley S, 2014, MMWR-MORBID MORTAL W, V63, P620; Lu BB, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-13; Paavonen J, 2009, Lancet, V374, P301, DOI 10.1016/S0140-6736(09)61248-4	7	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-4967	1468-2060		ANN RHEUM DIS	Ann. Rheum. Dis.	DEC	2014	73	12					E75	E75		10.1136/annrheumdis-2014-206426		1	Rheumatology	Rheumatology	AT2RY	WOS:000344783900001		
J	Gi, M; Jeong, J; Lee, K; Lee, KM; Toyofuku, M; Yong, DE; Yoon, SS; Choi, JY				Gi, Mia; Jeong, Junhui; Lee, Keehoon; Lee, Kang-Mu; Toyofuku, Masanori; Yong, Dong Eun; Yoon, Sang Sun; Choi, Jae Young			A Drug-Repositioning Screening Identifies Pentetic Acid as a Potential Therapeutic Agent for Suppressing the Elastase-Mediated Virulence of Pseudomonas aeruginosa	ANTIMICROBIAL AGENTS AND CHEMOTHERAPY			English	Article							TO-CELL COMMUNICATION; CYSTIC-FIBROSIS; ELASTOLYTIC ACTIVITY; QUINOLONE SIGNAL; PROTEASE; LASA; PATHOGENESIS; INHIBITORS; SECRETION; BIOFILMS	Pseudomonas aeruginosa, a Gram-negative bacterium of clinical significance, produces elastase as a predominant exoprotease. Here, we screened a library of chemical compounds currently used for human medication and identified diethylene triamine penta-acetic acid (DTPA, pentetic acid) as an agent that suppresses the production of elastase. Elastase activity found in the prototype P. aeruginosa strain PAO1 was significantly decreased when grown with a concentration as low as 20 mu M DTPA. Supplementation with Zn2+ or Mn2+ ions restored the suppressive effect of DTPA, suggesting that the DTPA-mediated decrease in elastase activity is associated with ion-chelating activity. In DTPA-treated PAO1 cells, transcription of the elastase-encoding lasB gene and levels of the Pseudomonas quinolone signal (PQS), a molecule that mediates P. aeruginosa quorum sensing (QS), were significantly downregulated, reflecting the potential involvement of the PQS QS system in DTPA-mediated elastase suppression. Biofilm formation was also decreased by DTPA treatment. When A549 alveolar type II-like adenocarcinoma cells were infected with PAO1 cells in the presence of DTPA, A549 cell viability was substantially increased. Furthermore, the intranasal delivery of DTPA to PAO1-infected mice alleviated the pathogenic effects of PAO1 cells in the animals. Together, our results revealed a novel function for a known molecule that may help treat P. aeruginosa airway infection.	[Gi, Mia; Jeong, Junhui; Choi, Jae Young] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Dept Otorhinolaryngol, Seoul, South Korea; [Lee, Keehoon; Lee, Kang-Mu; Yoon, Sang Sun] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Dept Microbiol & Immunol, Seoul, South Korea; [Yoon, Sang Sun] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul, South Korea; [Yong, Dong Eun] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Toyofuku, Masanori] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	Yoon, SS (reprint author), Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Dept Microbiol & Immunol, Seoul, South Korea.	sangsun_yoon@yuhs.ac; jychoi@yuhs.ac			Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs [A110096]	This work was supported by grant A110096 from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs.	Tello A, 2012, ENVIRON HEALTH PERSP, V120, P1100, DOI 10.1289/ehp.1104650; Kocisko DA, 2003, J VIROL, V77, P10288, DOI 10.1128/JVI.77.19.10288-10294.2003; Merlo CA, 2007, CHEST, V132, P562, DOI 10.1378/chest.06-2888; Lee KM, 2012, INFECT IMMUN, V80, P1639, DOI 10.1128/IAI.06161-11; Toyofuku M, 2008, J BACTERIOL, V190, P7947, DOI 10.1128/JB.00968-08; RUST L, 1994, METHOD ENZYMOL, V235, P554; McKnight SL, 2000, J BACTERIOL, V182, P2702, DOI 10.1128/JB.182.10.2702-2708.2000; Kessler E, 1998, J BIOL CHEM, V273, P30225, DOI 10.1074/jbc.273.46.30225; HECK LW, 1986, INFECT IMMUN, V51, P115; PASSADOR L, 1993, SCIENCE, V260, P1127, DOI 10.1126/science.8493556; Parsek MR, 1999, METHOD ENZYMOL, V310, P43; Grenier D, 2000, ANTIMICROB AGENTS CH, V44, P763, DOI 10.1128/AAC.44.3.763-766.2000; TODER DS, 1991, MOL MICROBIOL, V5, P2003, DOI 10.1111/j.1365-2958.1991.tb00822.x; Moskowitz SM, 2008, PEDIATR PULM, V43, P874, DOI 10.1002/ppul.20873; Normann PT, 1995, EUR J DRUG METAB PH, V20, P307; Pendleton JN, 2013, EXPERT REV ANTI-INFE, V11, P297, DOI [10.1586/eri.13.12, 10.1586/ERI.13.12]; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2; Dubin RF, 2004, AM J PHYSIOL-LUNG C, V286, pL750, DOI 10.1152/ajplung.00326.2003; Bergan T, 2001, CHEMOTHERAPY, V47, P10, DOI 10.1159/000048495; BRUMLIK MJ, 1992, MOL MICROBIOL, V6, P337, DOI 10.1111/j.1365-2958.1992.tb01476.x; BURNS FR, 1990, ANTIMICROB AGENTS CH, V34, P2065; Cathcart GR, 2009, BIOORG MED CHEM LETT, V19, P6230, DOI 10.1016/j.bmcl.2009.08.099; DORING G, 1984, J INFECT DIS, V149, P532; DORING G, 1981, ZBL BAKT-INT J MED M, V249, P89; Fullagar JL, 2013, CHEM COMMUN, V49, P3197, DOI 10.1039/c3cc41191e; HART JR, 2000, ETHYLENEDIAMINETETRA; HECK LW, 1990, J IMMUNOL, V144, P2253; HOLDER IA, 1984, CAN J MICROBIOL, V30, P1118; KESSLER E, 1977, INVEST OPHTH VIS SCI, V16, P488; KORNIENKO VN, 1993, ZH VOPR NEIROKHIR IM, V4, P13; Lee KM, 2011, INFECT IMMUN, V79, P2792, DOI 10.1128/IAI.01361-10; MAECKE HR, 1989, J NUCL MED, V30, P1235; MARSHALL AJH, 1994, J ANTIMICROB CHEMOTH, V34, P465, DOI 10.1093/jac/34.4.465; McIver KS, 1995, MOL MICROBIOL, V18, P877, DOI 10.1111/j.1365-2958.1995.18050877.x; Mitobe K, 1976, Nihon Hinyokika Gakkai Zasshi, V67, P333; PEARSON JP, 1995, P NATL ACAD SCI USA, V92, P1490, DOI 10.1073/pnas.92.5.1490; Ryan G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001021.pub2; SAULNIER JM, 1989, BIOCHIM BIOPHYS ACTA, V995, P285, DOI 10.1016/0167-4838(89)90048-4; Schadilov AE, 2010, HEALTH PHYS, V99, P560, DOI 10.1097/HP.0b013e3181c34989; SERGEEV PV, 1997, VESTN RENTGENOL RAD, V1, P45; Wang JL, 2012, HUM VACC IMMUNOTHER, V8, P1869, DOI 10.4161/hv.21817; WATANABE S, 2003, NIHON RINSHO S4, V61, pS280; WOLZ C, 1991, MOL MICROBIOL, V5, P2125, DOI 10.1111/j.1365-2958.1991.tb02142.x; Yoon MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016105; Yoon Sang Sun, 2004, Expert Rev Anti Infect Ther, V2, P611, DOI 10.1586/14787210.2.4.611	46	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0066-4804	1098-6596		ANTIMICROB AGENTS CH	Antimicrob. Agents Chemother.	DEC	2014	58	12					7205	7214		10.1128/AAC.03063-14		10	Microbiology; Pharmacology & Pharmacy	Microbiology; Pharmacology & Pharmacy	AT9AW	WOS:000345221000021		
J	Matsumoto, Y; Izumiya, H; Sekizuka, T; Kuroda, M; Ohnishi, M				Matsumoto, Yuko; Izumiya, Hidemasa; Sekizuka, Tsuyoshi; Kuroda, Makoto; Ohnishi, Makoto			Characterization of bla(TEM-52)-Carrying Plasmids of Extended-Spectrum-beta-Lactamase-Producing Salmonella enterica Isolates from Chicken Meat with a Common Supplier in Japan	ANTIMICROBIAL AGENTS AND CHEMOTHERAPY			English	Article							KLEBSIELLA-PNEUMONIAE; POULTRY; FOOD	The acquisition of resistance to cephalosporins among Salmonella spp. is a major public health concern. This study identified clonal plasmids carrying bla(TEM-52) from 10 Salmonella enterica serovar Infantis and Manhattan isolates from retail chicken meats that originated from a common supplier in Japan. Whole-genome analyses of the representative plasmids, including pYM4, revealed that they are 38 kb in size and that pYM4 is identical to pDKX1 from beef in Denmark, suggesting a global dissemination of resistance mediated by the plasmids.	[Matsumoto, Yuko] Yokohama City Inst Hlth, Isogo Ku, Yokohama, Kanagawa 2350012, Japan; [Izumiya, Hidemasa; Ohnishi, Makoto] Natl Inst Infect Dis, Dept Bacteriol 1, Shinjuku Ku, Tokyo, Japan; [Sekizuka, Tsuyoshi; Kuroda, Makoto] Natl Inst Infect Dis, Pathogen Genom Ctr, Shinjuku Ku, Tokyo, Japan	Matsumoto, Y (reprint author), Yokohama City Inst Hlth, Isogo Ku, 1-2-17 Takigashira, Yokohama, Kanagawa 2350012, Japan.	yu02-matsumoto@city.yokohama.jp			Ministry of Health, Labor, and Welfare of Japan [H24-Shokuhin-Ippan-007, H24-Shokuhin-Ippan-008, H25-Shokuhin-Ippan-014]	Funding was provided by grants-in-aid from the Ministry of Health, Labor, and Welfare of Japan (H24-Shokuhin-Ippan-007, H24-Shokuhin-Ippan-008, and H25-Shokuhin-Ippan-014).	Paterson DL, 2003, ANTIMICROB AGENTS CH, V47, P3554, DOI 10.1128/AAC.47.11.3554-3560.2003; Matsumoto Y, 2007, JPN J INFECT DIS, V60, P236; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Poyart C, 1998, ANTIMICROB AGENTS CH, V42, P108; Hasman H, 2005, J ANTIMICROB CHEMOTH, V56, P115, DOI 10.1093/jac/dki190; Rodriguez I, 2009, J ANTIMICROB CHEMOTH, V64, P301, DOI 10.1093/jac/dkp195; Cloeckaert A, 2007, ANTIMICROB AGENTS CH, V51, P1872, DOI 10.1128/AAC.01514-06; Johnson TJ, 2012, PLASMID, V68, P43, DOI 10.1016/j.plasmid.2012.03.001; Bielak E, 2007, J ANTIMICROB CHEMOTH, V66, P2465; Clinical and Laboratory Standards Institute, 2010, M100S20 CLIN LAB STA; Politi L, 2005, J CLIN MICROBIOL, V43, P3453, DOI 10.1128/JCM.43.7.3453-3456.2005	11	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0066-4804	1098-6596		ANTIMICROB AGENTS CH	Antimicrob. Agents Chemother.	DEC	2014	58	12					7545	7547		10.1128/AAC.02731-14		3	Microbiology; Pharmacology & Pharmacy	Microbiology; Pharmacology & Pharmacy	AT9AW	WOS:000345221000062		
J	Nakano, R; Nakano, A; Hikosaka, K; Kawakami, S; Matsunaga, N; Asahara, M; Ishigaki, S; Furukawa, T; Suzuki, M; Shibayama, K; Ono, Y				Nakano, Ryuichi; Nakano, Akiyo; Hikosaka, Kenji; Kawakami, Sayoko; Matsunaga, Naohisa; Asahara, Miwa; Ishigaki, Shinobu; Furukawa, Taiji; Suzuki, Masato; Shibayama, Keigo; Ono, Yasuo			First Report of Metallo-beta-Lactamase NDM-5-Producing Escherichia coli in Japan	ANTIMICROBIAL AGENTS AND CHEMOTHERAPY			English	Letter							RIBOSOMAL-RNA METHYLASE; MULTIPLEX PCR; ENTEROBACTERIACEAE; PREVALENCE; GENES; NDM-1; CARBAPENEMASES; VARIANT		[Nakano, Ryuichi; Nakano, Akiyo; Hikosaka, Kenji; Ono, Yasuo] Teikyo Univ, Sch Med, Dept Microbiol & Immunol, Itabashi Ku, Tokyo 173, Japan; [Matsunaga, Naohisa] Teikyo Univ, Sch Med, Dept Med, Itabashi Ku, Tokyo 173, Japan; [Kawakami, Sayoko; Matsunaga, Naohisa] Teikyo Univ Hosp, Dept Infect Control & Prevent, Itabashi Ku, Tokyo, Japan; [Asahara, Miwa; Ishigaki, Shinobu; Furukawa, Taiji] Teikyo Univ Hosp, Dept Lab Med, Itabashi Ku, Tokyo, Japan; [Suzuki, Masato; Shibayama, Keigo] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan	Nakano, R (reprint author), Teikyo Univ, Sch Med, Dept Microbiol & Immunol, Itabashi Ku, Tokyo 173, Japan.	nakano@med.teikyo-u.ac.jp					Hornsey M, 2011, ANTIMICROB AGENTS CH, V55, P5952, DOI 10.1128/AAC.05108-11; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Rahman M, 2014, INT J ANTIMICROB AG, V44, P30, DOI 10.1016/j.ijantimicag.2014.03.003; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Gottig S, 2013, J ANTIMICROB CHEMOTH, V68, P1737, DOI 10.1093/jac/dkt088; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Johnson AP, 2013, J MED MICROBIOL, V62, P499, DOI 10.1099/jmm.0.052555-0; Tada T, 2013, INT J ANTIMICROB AG, V42, P372, DOI 10.1016/j.ijantimicag.2013.06.014; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Nakano R, 2004, ANTIMICROB AGENTS CH, V48, P1151, DOI 10.1128/AAC.48.4.1151-1158.2004; Nordmann P, 2011, TRENDS MICROBIOL, V19, P588, DOI 10.1016/j.tim.2011.09.005; Doi YH, 2008, ANTIMICROB AGENTS CH, V52, P1204, DOI 10.1128/AAC.01320-07; Nordmann P, 2011, J CLIN MICROBIOL, V49, P718, DOI 10.1128/JCM.01773-10; Bercot B, 2011, DIAGN MICR INFEC DIS, V71, P442, DOI 10.1016/j.diagmicrobio.2011.08.016; Clinical and Laboratory Standards Institute, 2012, M100S22 CLSI; Galani I, 2012, CLIN MICROBIOL INFEC, V18, pE52, DOI 10.1111/j.1469-0691.2011.03738.x; Hattori T, 2013, JPN J INFECT DIS, V66, P512; Wang Y, 2012, EURASIP J WIREL COMM, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0044399	18	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0066-4804	1098-6596		ANTIMICROB AGENTS CH	Antimicrob. Agents Chemother.	DEC	2014	58	12					7611	7612		10.1128/AAC.04265-14		2	Microbiology; Pharmacology & Pharmacy	Microbiology; Pharmacology & Pharmacy	AT9AW	WOS:000345221000079		
J	Nakajima, S; Katayama, T				Nakajima, Sadahiko; Katayama, Tomomi			Running-based pica in rats. Evidence for the gastrointestinal discomfort hypothesis of running-based taste aversion	APPETITE			English	Article						Conditioned taste aversion; Wheel running; Pica; Kaolin; Lithium chloride; Rats	CISPLATIN-INDUCED PICA; INDUCED KAOLIN INTAKE; CHEMOTHERAPY-INDUCED NAUSEA; MOTION SICKNESS; NEUROPHARMACOLOGICAL MECHANISMS; ACTIVITY ANOREXIA; CONSUMPTION PICA; LITHIUM-CHLORIDE; ANTIEMETIC DRUGS; ANIMAL-MODEL	Voluntary running in an activity wheel establishes aversion to paired taste in rats. A proposed mechanism underlying this taste aversion learning is gastrointestinal discomfort caused by running. We tested this hypothesis by measuring the pica behavior (kaolin clay intake) of rats, because it is known that rats engage in pica behavior after various nausea-inducing treatments including irradiation, motion sickness, and injection of emetic drugs such as lithium chloride (LiCl). Following a demonstration of the already-known phenomenon of LiCl-based pica in Experiment 1, we successfully showed running-based pica behavior in Experiment 2 where the running treatment was compared with a non-running control treatment (i.e., confinement in a locked wheel). These results suggest that not only LiCl but also running induces nausea in rats, supporting the gastrointestinal discomfort hypothesis of running-based taste aversion learning. (C) 2014 Elsevier Ltd. All rights reserved.	[Nakajima, Sadahiko; Katayama, Tomomi] Kwansei Gakuin Univ, Dept Psychol Sci, Nishinomiya, Hyogo 6628501, Japan	Nakajima, S (reprint author), Kwansei Gakuin Univ, Dept Psychol Sci, Nishinomiya, Hyogo 6628501, Japan.	nakajima@kwansei.ac.jp			JSPS KAKENHI [24530931]	We thank Takefumi Kikusui for directing our attention to nausea-based pica behavior in rats. This study was supported by JSPS KAKENHI (24530931) to the first author, who designed the experiments and prepared the manuscript. The second author administered the experiment and collected the data in partial fulfillment of requirements for the BA degree in Psychology under the close supervision of the first author. The data were analyzed by the first author. This research project and the animal facility were approved by the Animal Care and Use Committee of KGU, based on a Japanese law (the Act on Welfare and Management of Animals) and the guideline published by the Science Council of Japan (the Guidelines for Proper Conduct of Animals Experiments) in 2006, which is shown in the following web site: http://www.scj.go.jp/ja/info/kohyo/pdf/kohyo-20-k16-2e.pdf	de Jonghe BC, 2009, PHYSIOL BEHAV, V97, P87, DOI 10.1016/j.physbeh.2009.02.009; MITCHELL D, 1977, PHYSIOL BEHAV, V18, P125, DOI 10.1016/0031-9384(77)90103-2; TAKEDA N, 1993, PHARMACOL BIOCHEM BE, V45, P817, DOI 10.1016/0091-3057(93)90126-E; MITCHELL D, 1976, PHYSIOL BEHAV, V17, P691, DOI 10.1016/0031-9384(76)90171-2; Yamamoto K, 2004, PHYSIOL BEHAV, V83, P151, DOI 10.1016/j.physbeh.2004.08.006; Dominy NJ, 2004, J EXP BIOL, V207, P319, DOI 10.1242/jeb.00758; Yamamoto K, 2014, BRIT J PHARMACOL, V171, P2888, DOI 10.1111/bph.12629; Masaki T, 2006, PHYSIOL BEHAV, V88, P411, DOI 10.1016/j.physbeh.2006.04.013; Dwyer DM, 2008, BEHAV NEUROSCI, V122, P1051, DOI [10.1037/a0012703, 10.1037/0012703]; PIERCE WD, 1994, BEHAV ANALYST, V17, P7; MITCHELL D, 1977, BEHAV BIOL, V19, P206, DOI 10.1016/S0091-6773(77)91494-8; Takeda N, 1995, METHOD FIND EXP CLIN, V17, P589; Yamamoto K, 2007, EUR J PHARMACOL, V554, P34, DOI 10.1016/j.ejphar.2006.09.058; Aung HH, 2004, LIFE SCI, V74, P2685, DOI 10.1016/j.lfs.2003.08.047; Aung Han, 2005, AIDS Res Ther, V2, P12, DOI 10.1186/1742-6405-2-12; Aung HH, 2003, CANCER CHEMOTH PHARM, V52, P453, DOI 10.1007/s00280-003-0694-9; BECK IT, 1977, J MED, V8, P135; Boakes R. A., 2009, CONDITIONED TASTE AV, P159; Boakes RA, 2007, SPAN J PSYCHOL, V10, P251; Constancio J, 2011, PHYSIOL BEHAV, V104, P659, DOI 10.1016/j.physbeh.2011.07.010; De Jonghe BC, 2008, AM J PHYSIOL-REG I, V294, pR756, DOI 10.1152/ajpregu.00820.2007; Eccles S, 2005, APPETITE, V44, P325, DOI 10.1016/j.appet.2005.02.001; Epling W. F., 1996, ACTIVITY ANOREXIA TH; Forristall JR, 2007, BEHAV PROCESS, V74, P326, DOI 10.1016/j.beproc.2006.12.002; Grant VL, 2012, BEHAV PROCESS, V90, P223, DOI 10.1016/j.beproc.2012.01.011; Han Z.-X., 2014, CELL BIOCH IN PRESS; HASEGAWA S, 1992, ACTA OTO-LARYNGOL, V112, P927, DOI 10.3109/00016489209137492; Heth CD, 2001, PHYSIOL BEHAV, V74, P53, DOI 10.1016/S0031-9384(01)00553-4; Heth CD, 2007, LEARN MOTIV, V38, P35, DOI 10.1016/j.lmot.2006.07.001; Horn CC, 2009, AM J PHYSIOL-REG I, V297, pR1375, DOI 10.1152/ajpregu.00284.2009; Lett BT, 1999, LEARN MOTIV, V30, P241, DOI 10.1006/lmot.1999.1033; Lett BT, 1996, PHYSIOL BEHAV, V59, P699, DOI 10.1016/0031-9384(95)02139-6; Lett BT, 1998, APPETITE, V31, P351, DOI 10.1006/appe.1998.0171; Liu YL, 2005, PHYSIOL BEHAV, V85, P271, DOI 10.1016/j.physbeh.2005.04.009; Lubow R.E., 1989, LATENT INHIBITION CO; Malik NM, 2007, EUR J PHARMACOL, V555, P164, DOI 10.1016/j.ejphar.2006.10.043; Masaki T, 2010, LEARN MOTIV, V41, P32, DOI 10.1016/j.lmot.2009.09.001; Masaki T, 2004, BEHAV PROCESS, V67, P357, DOI 10.1016/j.beproc.2004.06.005; Masaki T, 2004, LEARN MOTIV, V35, P406, DOI 10.1016/j.lmot.2004.04.003; Masaki T, 2005, PHYSIOL BEHAV, V84, P9, DOI 10.1016/j.physbeh.2004.09.022; Masaki T, 2008, BEHAV PROCESS, V79, P43, DOI 10.1016/j.beproc.2008.04.006; MCCAFFREY RJ, 1985, PHYSIOL BEHAV, V35, P151, DOI 10.1016/0031-9384(85)90329-4; MCCUTCHEON B, 1992, PHYSIOL BEHAV, V51, P543, DOI 10.1016/0031-9384(92)90177-4; Meeusen R., 2001, EUROPEAN J SPORTS SC, V1, P1, DOI 10.1080/17461390100071103; Mehendale S, 2005, CANCER CHEMOTH PHARM, V56, P63, DOI 10.1007/s00280-004-0956-1; Mehendale SR, 2004, AM J CHINESE MED, V32, P897, DOI 10.1142/S0192415X04002508; MITCHELL D, 1977, AM J CLIN NUTR, V30, P147; MORITA M, 1988, ORL J OTO-RHINO-LARY, V50, P188; MORITA M, 1988, ORL J OTO-RHINO-LARY, V50, P330; Nakajima S, 2000, BEHAV PROCESS, V49, P35, DOI 10.1016/S0376-6357(00)00071-1; Nakajima S, 2004, PHYSIOL BEHAV, V80, P623, DOI 10.1016/j.physbeh.2003.11.006; Nakajima S, 2014, PHYSIOL BEHAV, V123, P200, DOI 10.1016/j.physbeh.2013.10.011; Nakajima S, 2004, INTEGR PHYS BEH SCI, V39, P95, DOI 10.1007/BF02734275; Nakajima S, 2011, APPETITE, V57, P605, DOI 10.1016/j.appet.2011.08.001; Nakajima S, 2012, PSYCHOL REC, V62, P83; Nakajima S, 2006, PHYSIOL BEHAV, V88, P1, DOI 10.1016/j.physbeh.2006.02.006; Parker L. A., 2009, CONDITIONED TASTE AV, P92; Parker L. A., 1995, LEARN BEHAV, V31, P143; Qian Q., 2011, J ETHNOPHARMACOL, V135, P186; Raghavendran HRB, 2011, FOOD CHEM TOXICOL, V49, P215, DOI 10.1016/j.fct.2010.10.019; Riley AL, 2004, PHARMACOL BIOCHEM BE, V77, P655, DOI 10.1016/j.pbb.2004.01.002; Rudd JA, 2002, EUR J PHARMACOL, V454, P47, DOI 10.1016/S0014-2999(02)02472-X; Saeki M, 2001, JPN J PHARMACOL, V86, P359, DOI 10.1254/jjp.86.359; Satvat E, 2006, PHYSIOL BEHAV, V89, P428, DOI 10.1016/j.physbeh.2006.07.005; Sherma S. S., 1997, ENV TOXICOLOGY PHARM, V3, P145; Sparkes S, 2003, APPETITE, V41, P161, DOI 10.1016/S0195-6663(03)00057-6; Takeda N, 1995, METHOD FIND EXP CLIN, V17, P647; Tohei A, 2011, J VET MED SCI, V73, P901, DOI 10.1292/jvms.10-0433; Wang CZ, 2005, AM J CHINESE MED, V33, P807, DOI 10.1142/S0192415X05003429; WATSON PJ, 1987, PHYSIOL BEHAV, V39, P745, DOI 10.1016/0031-9384(87)90260-5; WATSON PJ, 1988, PHYSIOL BEHAV, V43, P697, DOI 10.1016/0031-9384(88)90366-6; Yamamoto K, 2002, J RADIAT RES, V43, P135, DOI 10.1269/jrr.43.135; Yamamoto K, 2011, J PHARMACOL TOX MET, V63, P30, DOI 10.1016/j.vascn.2010.04.011; Yuan Chun-Su, 2009, AIDS Res Ther, V6, P19, DOI 10.1186/1742-6405-6-19	74	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0195-6663	1095-8304		APPETITE	Appetite	DEC 1	2014	83						178	184		10.1016/j.appet.2014.08.031		7	Behavioral Sciences; Nutrition & Dietetics	Behavioral Sciences; Nutrition & Dietetics	AT3GP	WOS:000344824200025		
J	Nakamichi, A; Matsuyama, M; Ichikawa, T				Nakamichi, Atsuko; Matsuyama, Miwa; Ichikawa, Tetsuo			Relationship between mouthful volume and number of chews in young Japanese females	APPETITE			English	Article						Mouthful volume; Chewing; Eating behavior; Health promotion	REDUCES ENERGY-INTAKE; EATING FAST LEADS; BODY-MASS INDEX; BITE SIZE; MEAL SIZE; WEIGHT-LOSS; FOOD-INTAKE; WOMEN; OBESE; MEN	Objective: Modification of eating behavior in Japan is promoted to prevent overweight and obesity, but the effects of such modifications are unclear. This study aimed to clarify the inter- and intra-individual relationship between bite size and number of chews of food. Design and methods: Subjects comprised of 50 young healthy Japanese women (mean age 19.5 years). Food materials were boiled rice and apple. First, the average bite size and the number of chews per mouthful of food were calculated across the study cohort. The number of chews was counted by the subjects themselves and then self-reported. Correlation between the individual one-bite volume and the number of chews per volume was analyzed using Spearman's rank correlation coefficient. Second, the number of chews for three different sized bites of food (half of one bite, one bite, and one-and-a-half bites) were calculated as a prospective observational study. The number of chews for each of the three volumes of food was compared using one way ANOVA with Bonferroni correction. Results: For both food types, there was a negative correlation between individual mouthful volume and number of chews for both food materials. The number of chews per volume decreased as bite sizes increased. Conclusion: This study demonstrated an inter- and intraindividual relationship between bite size and the number of chews and suggested that smaller bite sizes were associated with more chews per volume of food. (C) 2014 Elsevier Ltd. All rights reserved.	[Nakamichi, Atsuko] Univ Tokushima, Grad Sch, Sch Oral Sci, Tokushima 7708504, Japan; [Nakamichi, Atsuko] Kobe Tokiwa Jr Coll, Dept Oral Hlth, Nagata Ku, Kobe, Hyogo 6530838, Japan; [Matsuyama, Miwa] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Hlth Care & Rehabil,Subdiv Oral Hlth &, Tokushima 7708504, Japan; [Ichikawa, Tetsuo] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral & Maxillofacial Prosthodont, Tokushima 7708504, Japan	Matsuyama, M (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Hlth Care & Rehabil,Subdiv Oral Hlth &, 3-18-15 Kuramoto Cho, Tokushima 7708504, Japan.	miwa.matsuyama@tokushima-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [2450064701]	Atsuko Nakamichi conceived and carried out the experiments and analyzed the data. Miwa Matsuyama conceived the experiments. Tetsuo Ichikawa analyzed the data. All authors were involved in writing the paper and approve of the submitted and published versions. The authors would like to thank all study participants for taking part on this study, Dr. Masanori Nakano for providing advice, and Miss Asako Iwamoto for assisting with data analysis. This study was supported by the Grant-in-Aid for Scientific Research (C) (No. 2450064701) from The Ministry of Education, Culture, Sports, Science, and Technology, Japan. Conflicts of interest: None of the authors declare any conflicts of interest relevant to the content of this manuscript.	Kral JG, 2001, INT J OBESITY, V25, P258, DOI 10.1038/sj.ijo.0801469; Sasaki S, 2003, INT J OBESITY, V27, P1405, DOI 10.1038/sj.ijo.0802425; Higgs S, 2013, APPETITE, V62, P91, DOI 10.1016/j.appet.2012.11.019; Fukuda H, 2013, GERODONTOLOGY, V30, P214, DOI 10.1111/j.1741-2358.2012.00666.x; Frecka JM, 2008, EUR J CLIN NUTR, V62, P1231, DOI 10.1038/sj.ejcn.1602838; Forde CG, 2013, APPETITE, V60, P208, DOI 10.1016/j.appet.2012.09.015; Martin CK, 2007, BEHAV RES THER, V45, P2349, DOI 10.1016/j.brat.2007.03.016; Zhu Y, 2014, PHYSIOL BEHAV, V123, P62, DOI 10.1016/j.physbeh.2013.10.003; Spiegel TA, 2000, NEUROSCI BIOBEHAV R, V24, P229, DOI 10.1016/S0149-7634(99)00076-7; Leong SL, 2011, J AM DIET ASSOC, V111, P1192, DOI 10.1016/j.jada.2011.05.012; Ruijschop RMAJ, 2011, BRIT J NUTR, V105, P307, DOI 10.1017/S000711451000320X; Zhu Y, 2014, J ACAD NUTR DIET, V114, P926, DOI 10.1016/j.jand.2013.08.020; Zijlstra N, 2009, AM J CLIN NUTR, V90, P269, DOI 10.3945/ajcn.2009.27694; Burger KS, 2011, OBESITY, V19, P546, DOI 10.1038/oby.2010.233; Andrade AM, 2008, J AM DIET ASSOC, V108, P1186, DOI 10.1016/j.jada.2008.04.026; Li J, 2011, AM J CLIN NUTR, V94, P709, DOI 10.3945/ajcn.111.015164; HILL SW, 1984, APPETITE, V5, P73; SPIEGEL TA, 1993, APPETITE, V21, P131, DOI 10.1016/0195-6663(93)90005-5; Otsuka R, 2006, J EPIDEMIOL, V16, P117, DOI 10.2188/jea.16.117; Ekuni D, 2012, ARCH ORAL BIOL, V57, P981, DOI 10.1016/j.archoralbio.2012.02.001; LUCAS PW, 1984, ARCH ORAL BIOL, V29, P205, DOI 10.1016/0003-9969(84)90056-6; Maruyama K, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2002; McGee TL, 2012, OBESITY, V20, P126, DOI 10.1038/oby.2011.303; Ministry of Health Labour and Welfare, 2013, HOM PAG OB; Ministry of Health Labour and Welfare, 2013, JAP OB; Otsuka R, 2008, PREV MED, V46, P154, DOI 10.1016/j.ypmed.2007.07.031; Scisco JL, 2011, J AM DIET ASSOC, V111, P1231, DOI 10.1016/j.jada.2011.05.005; Shikany JM, 2012, OBESITY, V20, P547, DOI 10.1038/oby.2011.336; Sonoki K, 2013, ENDOCR J, V60, P311; Viskaal-van Dongen M, 2011, APPETITE, V56, P25, DOI 10.1016/j.appet.2010.11.141; Wedhera D., 2014, EAT BEHAV, V15, P132; WESTERTERPPLANTENGA MS, 1990, PHYSIOL BEHAV, V47, P569, DOI 10.1016/0031-9384(90)90128-Q; World Health Organization Features, 2013, 10 FACTS OB; Zijlstra N, 2011, BRIT J NUTR, V106, P297, DOI 10.1017/S0007114511000146	34	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0195-6663	1095-8304		APPETITE	Appetite	DEC 1	2014	83						327	332		10.1016/j.appet.2014.08.009		6	Behavioral Sciences; Nutrition & Dietetics	Behavioral Sciences; Nutrition & Dietetics	AT3GP	WOS:000344824200044		
J	Abe, T				Abe, Takayuki			Generalized RF Pulse Train with Insensitivity to B-1 Inhomogeneity	APPLIED MAGNETIC RESONANCE			English	Article							ADIABATIC PULSES; B1; SPECTROSCOPY; EXCITATION; DESIGN; BREAST; WATER; 3T	Adiabatic inversion recovery radiofrequency (RF) pulse techniques are used to address B (1) inhomogeneity; however, the specific absorption rates of these techniques are significantly higher than that of non-adiabatic RF pulse techniques. In addition, time efficiency is poorer because of the required longer inversion recovery time. Therefore, an RF pulse train with three subpulses was previously developed and reported. The purpose of this article was to generalize the RF pulse train for tissues with different T (1) relaxation times and in a different application. The RF pulse train B (1) insensitivities and frequency responses were calculated with different T (1) relaxation times and different subpulse durations using the Bloch equation. The previously reported optimal flip angle (FA) combination was used. When using the optimal FA combination, the RF pulse train B (1) insensitivity did not change even if the T (1) relaxation times and the subpulse durations did change. In other words, the optimal FA combination does not require adjustments according to the T (1) and subpulse duration. The RF pulse train frequency responses with these subpulses can be dramatically improved even if the inherent subpulse frequency response is poor. This finding will facilitate RF pulse train technique implementation on magnetic resonance imaging scanners.	Natl Inst Radiol Sci, Inage Ku, Chiba 2638555, Japan	Abe, T (reprint author), Natl Inst Radiol Sci, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	takayuki.abe.mri@gmail.com					Abe T, 2013, APPL MAGN RESON, V44, P1213, DOI 10.1007/s00723-013-0474-6; Abe T, 2012, MAGN RESON MED, V67, P464, DOI 10.1002/mrm.23015; STAEWEN RS, 1990, INVEST RADIOL, V25, P559, DOI 10.1097/00004424-199005000-00015; HAASE A, 1985, PHYS MED BIOL, V30, P341, DOI 10.1088/0031-9155/30/4/008; UGURBIL K, 1987, J MAGN RESON, V72, P177; Tannus A, 1997, NMR BIOMED, V10, P423, DOI 10.1002/(SICI)1099-1492(199712)10:8<423::AID-NBM488>3.0.CO;2-X; UGURBIL K, 1988, J MAGN RESON, V80, P448; Kuhl CK, 2007, RADIOLOGY, V244, P929, DOI 10.1148/radiol.2443070266; FRAHM J, 1985, RADIOLOGY, V156, P441; Azlan CA, 2010, J MAGN RESON IMAGING, V31, P234, DOI 10.1002/jmri.22018; BENDALL MR, 1986, J MAGN RESON, V67, P376, DOI 10.1016/0022-2364(86)90447-6; Bernstein M. A., 2004, HDB MRI PULSE SEQUEN, P117; Gu M, 2009, MAGN RESON MED, V61, P462, DOI 10.1002/mrm.21843; LEVITT MH, 1986, PROG NUCL MAG RES SP, V18, P61, DOI 10.1016/0079-6565(86)80005-X; OGG RJ, 1994, J MAGN RESON SER B, V104, P1, DOI 10.1006/jmrb.1994.1048; PAULY J, 1991, IEEE T MED IMAGING, V10, P53, DOI 10.1109/42.75611; Rosenfeld D, 1997, MAGNET RESON MED, V37, P793, DOI 10.1002/mrm.1910370524	17	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0937-9347	1613-7507		APPL MAGN RESON	Appl. Magn. Reson.	DEC	2014	45	12					1405	1416		10.1007/s00723-014-0601-z		12	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	AU0RH	WOS:000345331200009		
J	Nakajima, A; Ueda, Y; Matsuda, E; Sameshima, H; Ikenoue, T				Nakajima, Akira; Ueda, Yuto; Matsuda, Emiko; Sameshima, Hiroshi; Ikenoue, Tsuyomu			Intracerebral Antioxidant Ability of Rats Under Hypoxia Estimated Using the Microdialysis-ESR Method	APPLIED MAGNETIC RESONANCE			English	Article							ISCHEMIC BRAIN-DAMAGE; ACID-INDUCED SEIZURE; NITRIC-OXIDE; IN-VIVO; LIPID-PEROXIDATION; HYDROXYL RADICALS; ANIMAL-TISSUES; HIPPOCAMPUS; GLUTAMATE; GLUTATHIONE	The intracerebral antioxidant ability of rats in 8 and 21 % oxygen (O-2) atmospheres was estimated from the decay of the electron spin resonance (ESR) signal of 3-methoxycarbonyl-2,2,5,5-tetramethyl-pyrrolidine-1-oxyl (PCAM), blood-brain-barrier (BBB)-permeable stable cyclic nitroxide, in the perfusate from the brain of the rats using the microdialysis-ESR method. The decay rate of PCAM in 8 % O-2 was about 1.5 times that in 21 % O-2. The oxidation of the perfusate by potassium hexacyanoferrate(III) [K3Fe(CN)(6)] indicated that PCAM in the rats in 8 % O-2 was more greatly reduced to its hydroxylamine than that in 21 % O-2. These results showed that the intracerebral antioxidant ability of rats in 8 % O-2 was larger than that in 21 % O-2. The metal-catalyzed autooxidation of ascorbic acid should be one of the potent factors affecting the intracerebral antioxidant ability of rats in the atmosphere containing different oxygen concentrations.	[Nakajima, Akira; Matsuda, Emiko; Sameshima, Hiroshi; Ikenoue, Tsuyomu] Miyazaki Univ, Sect Obstet & Gynecol, Dept Reprod & Dev Med, Fac Med, Kiyotake, Miyazaki 8891692, Japan; [Ueda, Yuto] Miyazaki Univ, Sect Psychiat, Dept Clin Neurosci, Fac Med, Kiyotake, Miyazaki 8891692, Japan	Nakajima, A (reprint author), Miyazaki Univ, Sect Obstet & Gynecol, Dept Reprod & Dev Med, Fac Med, 5200 Kihara, Kiyotake, Miyazaki 8891692, Japan.	akanaka@med.miyazaki-u.ac.jp					Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Bobko AA, 2007, FREE RADICAL BIO MED, V42, P404, DOI 10.1016/j.freeradbiomed.2006.11.007; Ueda Y, 2002, EXP BRAIN RES, V147, P219, DOI 10.1007/s00221-002-1224-4; LEVINE S, 1960, AM J PATHOL, V36, P1; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Ueda Y, 2007, EXP BRAIN RES, V181, P571, DOI 10.1007/s00221-007-0954-8; Buettner G R, 1986, Free Radic Res Commun, V1, P349, DOI 10.3109/10715768609051638; Hayashi Y, 2002, BRAIN RES, V941, P107, DOI 10.1016/S0006-8993(02)02614-8; Ikeno S, 2000, J Obstet Gynaecol Res, V26, P227; Menditto A, 1997, HUM REPROD, V12, P1699, DOI 10.1093/humrep/12.8.1699; Nagatomo F, 2012, OXID MED CELL LONGEV, DOI 10.1155/2012/381763; Nagatomo K, 2007, NEUROSCI RES, V57, P477, DOI 10.1016/j.neures.2006.12.001; Nakajima A, 2013, NEUROCHEM RES, V38, P1360, DOI 10.1007/s11064-013-1031-2; Nakajima A, 2011, APPL MAGN RESON, V40, P535, DOI 10.1007/s00723-011-0230-8; Ota A, 1998, AM J OBSTET GYNECOL, V179, P1075, DOI 10.1016/S0002-9378(98)70218-2; Pellegrino J.L., 1986, STEREOTAXIC ATLAS RA; TIMOSHIN AA, 1994, EXPERIENTIA, V50, P677, DOI 10.1007/BF01952872; Timoshin AA, 2008, NITRIC OXIDE-BIOL CH, V19, P338, DOI 10.1016/j.niox.2008.07.001; Timoshin AA, 2010, DOKL BIOCHEM BIOPHYS, V432, P106, DOI 10.1134/S1607672910030038; Timoshin A, 2008, Biophysics, V53, DOI 10.1134/S0006350908040155; Ueda Y, 1998, MAGNET RESON MED, V40, P491, DOI 10.1002/mrm.1910400321; Ueda Y., 2002, MAGN RESON MED JIKIK, V13, P205; Ueda Y, 2004, NEUROCHEM RES, V29, P1695, DOI 10.1023/B:NERE.0000035804.80383.a1; Ueda Y, 2005, NEUROCHEM RES, V30, P1117, DOI 10.1007/s11064-005-7586-9; Ueda Y, 2006, EXP BRAIN RES, V169, P117, DOI 10.1007/s00221-005-0122-y; Ueda Y, 2007, NEUROSCI LETT, V417, P46, DOI 10.1016/j.neulet.2007.02.031; Vanin AF, 2011, METHODS MOL BIOL, V704, P135, DOI 10.1007/978-1-61737-964-2_11; Yang L, 2010, J OBSTET GYNAECOL RE, V36, P1102, DOI 10.1111/j.1447-0756.2010.01273.x	28	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0937-9347	1613-7507		APPL MAGN RESON	Appl. Magn. Reson.	DEC	2014	45	12					1417	1425		10.1007/s00723-014-0590-y		9	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	AU0RH	WOS:000345331200010		
J	Takasi, K; Manojlovic, JV; Milosevic, J				Takasi, Kusano; Manojlovic, Jelena V.; Milosevic, Jelena			Intermediate solutions of fourth order quasilinear differential equations in the framework of regular variation	APPLIED MATHEMATICS AND COMPUTATION			English	Article						Fourth order differential equation; Regularly varying function; Slowly varying function; Asymptotic behavior of solutions; Positive solutions	EMDEN-FOWLER TYPE; POSITIVE SOLUTIONS; ASYMPTOTIC-BEHAVIOR	Intermediate solutions of fourth-order quasilinear differential equation (p(t)vertical bar x '' (t)vertical bar(alpha-1) x '' (t))'' + q(t) vertical bar x(t)vertical bar(beta-1) x(t) - 0, alpha > beta > 0, are studied in the framework of regular variation. Under the assumptions that p(t), q(t) are regularly varying functions satisfying conditions integral(infinity)(a) t/p(t)(1/alpha) dt = infinity, integral(infinity)(a) (t/p(t))(1/alpha) dt = infinity and integral(infinity)(a) t/p(t)(1/alpha) < infinity necessary and sufficient conditions are established for the existence of regularly varying intermediate solutions and it is shown that the asymptotic behavior of all such solutions is governed by a unique explicit law. (C) 2014 Elsevier Inc. All rights reserved.	[Takasi, Kusano] Hiroshima Univ, Dept Math, Fac Sci, Higashihiroshima 7398526, Japan; [Manojlovic, Jelena V.; Milosevic, Jelena] Univ Nis, Fac Sci & Math, Dept Math, Nish 18000, Serbia	Milosevic, J (reprint author), Univ Nis, Fac Sci & Math, Dept Math, Visegradska 33, Nish 18000, Serbia.	kusanot@zj8.so-net.nejp; jelenam@pmf.ni.ac.rs; jefimija@pmf.ni.ac.rs			Ministry of Education and Science of Republic of Serbia [OI-174007]	Author is supported by the Research project OI-174007 of the Ministry of Education and Science of Republic of Serbia.	Kusano T, 2012, NONLINEAR ANAL-THEOR, V75, P2474, DOI 10.1016/j.na.2011.10.039; Jaros J, 2004, SERB AC B, P25; Jaros J, 2013, CENT EUR J MATH, V11, P2215, DOI 10.2478/s11533-013-0306-9; Kusano T, 2012, APPL MATH COMPUT, V218, P6684, DOI 10.1016/j.amc.2011.12.029; Naito M, 2004, ACTA MATH HUNG, V102, P177, DOI 10.1023/B:AMHU.0000023215.24975.ee; Kusano T, 2012, ACTA APPL MATH, V121, P81, DOI 10.1007/s10440-012-9691-5; Kusano T, 2011, COMPUT MATH APPL, V62, P551, DOI 10.1016/j.camwa.2011.05.019; Bingham N. H., 1987, ENCY MATH ITS APPL, V27; Haupt O., 1938, DIFFERENTIAL INTEGRA; HOWARD HC, 1997, SERB AC B, V114, P85; Kusano T., 2013, APPL MATH COMPUT, V219, P8178; Kusano T., 2011, B T ACAD SERBE S SMN, VCXLIII, P21; Kusano T., 2013, TAIWAN J MATH, V17, P999; Manojlovic J., 2012, MEM DIFFERENTIAL EQU, V57, P75; Maric V., 2000, LECT NOTES MATH, V1726; Maric V., 1990, PUBL I MATH-BEOGRAD, V48, P199; Matucci S., ANN MAT PURA APPL; Rehak P, 2013, NONLINEAR ANAL-THEOR, V77, P45, DOI 10.1016/j.na.2012.08.019; Seneta E., 1976, LECT NOTES MATH, V508; Wu F., 2002, FUNKC EKVACIOJ-SER I, V45, P71	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0096-3003	1873-5649		APPL MATH COMPUT	Appl. Math. Comput.	DEC 1	2014	248						246	272		10.1016/j.amc.2014.09.109		27	Mathematics, Applied	Mathematics	AT7NP	WOS:000345124800022		
J	Kouzuma, A; Kaku, N; Watanabe, K				Kouzuma, Atsushi; Kaku, Nobuo; Watanabe, Kazuya			Microbial electricity generation in rice paddy fields: recent advances and perspectives in rhizosphere microbial fuel cells	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Review						Anode respiration; Metagenomics; Methanogen; Microbiome; Rhizodeposit; Root exudate	COMMUNITY STRUCTURE; PLANTS; ELECTROGENESIS; SOIL; METHANOGENESIS; RHIZODEPOSITS; EMISSIONS; BIOENERGY; ANODES; CARBON	Microbial fuel cells (MFCs) are devices that use living microbes for the conversion of organic matter into electricity. MFC systems can be applied to the generation of electricity at water/sediment interfaces in the environment, such as bay areas, wetlands, and rice paddy fields. Using these systems, electricity generation in paddy fields as high as similar to 80 mW m(-2) (based on the projected anode area) has been demonstrated, and evidence suggests that rhizosphere microbes preferentially utilize organic exudates from rice roots for generating electricity. Phylogenetic and metagenomic analyses have been conducted to identify the microbial species and catabolic pathways that are involved in the conversion of root exudates into electricity, suggesting the importance of syntrophic interactions. In parallel, pot cultures of rice and other aquatic plants have been used for rhizosphere MFC experiments under controlled laboratory conditions. The findings from these studies have demonstrated the potential of electricity generation for mitigating methane emission from the rhizosphere. Notably, however, the presence of large amounts of organics in the rhizosphere drastically reduces the effect of electricity generation on methane production. Further studies are necessary to evaluate the potential of these systems for mitigating methane emission from rice paddy fields. We suggest that paddy-field MFCs represent a promising approach for harvesting latent energy of the natural world.	[Kouzuma, Atsushi; Watanabe, Kazuya] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo 1920392, Japan; [Kaku, Nobuo] Yamagata Univ, Fac Agr, Tsuruoka, Yamagata 9978555, Japan	Watanabe, K (reprint author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo 1920392, Japan.	kazuyaw@toyaku.ac.jp					Baudoin E, 2003, SOIL BIOL BIOCHEM, V35, P1183, DOI 10.1016/S0038-0717(03)00179-2; Reimers CE, 2006, GEOBIOLOGY, V4, P123, DOI 10.1111/j.1472-4669.2006.00071.x; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; De Schamphelaire L, 2010, APPL ENVIRON MICROB, V76, P2002, DOI 10.1128/AEM.02432-09; Strik DPBTB, 2008, INT J ENERG RES, V32, P870, DOI 10.1002/er.1397; NEUE HU, 1993, BIOSCIENCE, V43, P466, DOI 10.2307/1311906; Jung S, 2011, APPL ENVIRON MICROB, V77, P564, DOI 10.1128/AEM.01392-10; Kaku N, 2008, APPL MICROBIOL BIOT, V79, P43, DOI 10.1007/s00253-008-1410-9; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Arends JBA, 2014, APPL MICROBIOL BIOT, V98, P3205, DOI 10.1007/s00253-013-5328-5; ESWARAN H, 1993, SOIL SCI SOC AM J, V57, P192; Tender LM, 2002, NAT BIOTECHNOL, V20, P821, DOI 10.1038/nbt716; Ishii S, 2008, BIOSCI BIOTECH BIOCH, V72, P286, DOI 10.1271/bbb.70179; Takanezawa K, 2010, BIOSCI BIOTECH BIOCH, V74, P1271, DOI 10.1271/bbb.90852; Conrad R, 2007, ADV AGRON, V96, P1, DOI 10.1016/S0065-2113(07)96005-8; Chiranjeevi P, 2012, BIORESOURCE TECHNOL, V124, P364, DOI 10.1016/j.biortech.2012.08.020; de Schamphelaire L, 2008, ENVIRON SCI TECHNOL, V42, P3053, DOI 10.1021/es071938w; Pant D, 2010, BIORESOURCE TECHNOL, V101, P1533, DOI 10.1016/j.biortech.2009.10.017; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Zhao Y, 2011, PHYS CHEM CHEM PHYS, V13, P15016, DOI 10.1039/c1cp21813a; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Watanabe K, 2008, J BIOSCI BIOENG, V106, P528, DOI 10.1263/jbb.106.528; Timmers RA, 2012, APPL MICROBIOL BIOT, V94, P537, DOI 10.1007/s00253-012-3894-6; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; Cicerone R.J., 1988, GLOBAL BIOGEOCHEMICA, V2, P299, DOI DOI 10.1029/GB002I004P00299; da Rosa A. C., 2011, THESIS U MARBURG MAR; FAO (Food and Agriculture Organization of the United Nations), 2004, INT YEAR RIC 2004 RI; Helder M, 2010, BIORESOURCE TECHNOL, V101, P3541, DOI 10.1016/j.biortech.2009.12.124; Kouzuma A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077443; Rizzo A, 2013, ECOL ENG, V60, P167, DOI 10.1016/j.ecoleng.2013.07.033; Watanabe K, 2010, PATHS SUSTAINABLE EN, P563	31	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	DEC	2014	98	23					9521	9526		10.1007/s00253-014-6138-0		6	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	AT7TN	WOS:000345140200001		
